PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ciechomska, IA; Gabrusiewicz, K; Szczepankiewicz, AA; Kaminska, B				Ciechomska, I. A.; Gabrusiewicz, K.; Szczepankiewicz, A. A.; Kaminska, B.			Endoplasmic reticulum stress triggers autophagy in malignant glioma cells undergoing cyclosporine A-induced cell death	ONCOGENE			English	Article						glioma; autophagy; endoplasmic reticulum stress; mTOR kinase	AP-1 TRANSCRIPTION FACTOR; IN-VIVO; INDUCED CYTOTOXICITY; SIGNALING PATHWAYS; ER STRESS; APOPTOSIS; THERAPY; INHIBITION; MECHANISMS; CANCER	Autophagy is a conserved, self-digestion process that is activated in response to nutrient limitation but acting also as an alternative death mechanism under certain conditions. It is accompanied by the progressive formation of vesicle structures from autophagosomes to autophagolysosomes orchestrated by autophagy effectors (Atg proteins) and modulators (that is, mTOR-mammalian target of rapamycin as a negative regulator). Malignant gliomas are highly resistant to current therapies that induce apoptosis, thus induction of the alternative cell death is an attractive strategy. We demonstrate that cyclosporine A (CsA, an immunophilin/calcineurin inhibitor) induces cell death with some apoptotic features but also accompanied by the appearance of numerous cytoplasmic vacuoles, immunostained for endoplasmic reticulum (ER) and autophagy markers. The induction of ER stress in glioma cells by CsA was evidenced by detection of unfolded protein response activation (phosphorylation of PERK, accumulation of IRE1 alpha) and accumulation of ER stress-associated proteins (BIP and CHOP). Formation of the acidic vesicular organelles, increase of autophagic vacuoles, GFP-LC3 punctation (microtubule-associated protein light chain 3) and LC3-II accumulation upon CsA treatment confirmed activation of autophagy. Decrease of phosphorylation of 4E-BP1, p70S6K1 and its downstream target S6 ribosomal protein demonstrate inhibition of mTOR signaling by CsA. Salubrinal and silencing of PERK and IRE1 alpha partially blocked CsA-induced accumulation of LC3-II. It suggests that ER stress precedes CsA-induced autophagy. Surprisingly, silencing of autophagy effectors ULK1, Atg5 or Atg7 increased the level of active caspases 3, 7 and PARP degradation in CsA-treated cells. Our results demonstrate that CsA induces both apoptosis and autophagy in malignant glioma cells via induction of ER stress and inhibition of mTOR/p70S6K1 pathway, however autophagy is cytoprotective in this context. Oncogene (2013) 32, 1518-1529; doi:10.1038/onc.2012.174; published online 14 May 2012	[Ciechomska, I. A.; Gabrusiewicz, K.; Kaminska, B.] Nencki Inst Expt Biol, Dept Cell Biol, Lab Transcript Regulat, PL-02093 Warsaw, Poland; [Szczepankiewicz, A. A.] Nencki Inst Expt Biol, Dept Neurophysiol, Lab Mol & Syst Neuromorphol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Ciechomska, IA (corresponding author), Nencki Inst Expt Biol, Dept Cell Biol, Lab Transcript Regulat, 3 Pasteur Str, PL-02093 Warsaw, Poland.	jcjech@nencki.gov.pl	Kaminska, Bozena/H-4592-2011; Kaminska, Bozena/B-2915-2014; Ciechomksa, Iwona/R-4706-2016	Kaminska, Bozena/0000-0002-2642-4616; Ciechomksa, Iwona/0000-0002-8068-0020; Szczepankiewicz, Andrzej/0000-0002-1502-3147; Gabrusiewicz, Konrad/0000-0001-7857-8062	Polish Ministry of Science and Higher Education [N N301 092036]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	We are grateful to Aviva M. Tolkovsky for her critical review of the manuscript. This work was supported by a grant N N301 092036 from The Polish Ministry of Science and Higher Education (IC).	Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Ciechomska I, 2005, INT J CANCER, V117, P59, DOI 10.1002/ijc.21153; Ciechomska I, 2003, ONCOGENE, V22, P7617, DOI 10.1038/sj.onc.1207137; Ciechomska Iwona A., 2008, V445, P175, DOI 10.1007/978-1-59745-157-4_12; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dunn IF, 2003, NEUROSURGERY, V52, P1411, DOI 10.1227/01.NEU.0000064808.27512.CF; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Ge PF, 2009, MED HYPOTHESES, V73, P45, DOI 10.1016/j.mehy.2008.11.047; Gijtenbeek JMM, 1999, J NEUROL, V246, P339, DOI 10.1007/s004150050360; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Iwamaru A, 2007, ONCOGENE, V26, P1840, DOI 10.1038/sj.onc.1209992; Jia WT, 2010, INT J BIOCHEM CELL B, V42, P2019, DOI 10.1016/j.biocel.2010.09.003; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kang CH, 2008, AUTOPHAGY, V4, P82, DOI 10.4161/auto.5154; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mosieniak G, 1997, J NEUROCHEM, V68, P1142; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pallet N, 2008, AM J TRANSPLANT, V8, P2283, DOI 10.1111/j.1600-6143.2008.02396.x; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pyrzynska B, 2000, J NEUROCHEM, V74, P42, DOI 10.1046/j.1471-4159.2000.0740042.x; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yoon Hye Eun, 2009, Korean Journal of Internal Medicine, V24, P81, DOI 10.3904/kjim.2009.24.2.81; Zupanska A, 2005, NEUROCHEM INT, V47, P430, DOI 10.1016/j.neuint.2005.05.010	48	97	103	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 21	2013	32	12					1518	1529		10.1038/onc.2012.174	http://dx.doi.org/10.1038/onc.2012.174			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22580614				2022-12-25	WOS:000316456000005
J	Lang, C; Rastew, E; Hermes, B; Siegbrecht, E; Ahrends, R; Banerji, S; Flieger, A				Lang, Christina; Rastew, Elena; Hermes, Bjoern; Siegbrecht, Enrico; Ahrends, Robert; Banerji, Sangeeta; Flieger, Antje			Zinc Metalloproteinase ProA Directly Activates Legionella pneumophila PlaC Glycerophospholipid:cholesterol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROBIAL LIPASE ACYLTRANSFERASE; FURIN-INDUCED CLEAVAGE; PHOSPHOLIPASE-A; CHOLESTEROL ACYLTRANSFERASE; LEGIONNAIRES-DISEASE; LYSOPHOSPHOLIPASE-A; LIPOLYTIC ENZYMES; SECRETION SYSTEM; BACTERIAL; FAMILY	Enzymes secreted by Legionella pneumophila, such as phospholipases A (PLAs) and glycerophospholipid: cholesterol acyltransferases (GCATs), may target host cell lipids and therefore contribute to the establishment of Legionnaires disease. L. pneumophila possesses three proteins, PlaA, PlaC, and PlaD, belonging to the GDSL family of lipases/acyltransferases. We have shown previously that PlaC is the major GCAT secreted by L. pneumophila and that the zinc metalloproteinase ProA is essential for GCAT activity. Here we characterized the mode of PlaC GCAT activation and determined that ProA directly processes PlaC. We further found that not only cholesterol but also ergosterol present in protozoa was palmitoylated by PlaC. Such ester formations were not induced by either PlaA or PlaD. PlaD was shown here to possess lysophospholipase A activity, and interestingly, all three GDSL enzymes transferred short chain fatty acids to sterols. The three single putative catalytic amino acids (Ser-37, Asp-398, and His-401) proved essential for all PlaC-associated PLA, lysophospholipase A, and GCAT activities. A further four cysteine residues are important for the PLA/GCAT activities as well as their oxidized state, and we therefore conclude that PlaC likely forms at least one disulfide loop. Analysis of cleavage site and loop deletion mutants suggested that for GCAT activation deletion of several amino acids within the loop is necessary rather than cleavage at a single site. Our data therefore suggest a novel enzyme inhibition/activation mechanism where a disulfide loop inhibits PlaC GCAT activity until the protein is exported to the external space where it is ProA-activated.	[Lang, Christina; Rastew, Elena; Hermes, Bjoern; Siegbrecht, Enrico; Banerji, Sangeeta; Flieger, Antje] Robert Koch Inst, Div Bacterial Infect, D-38855 Wernigerode, Germany; [Ahrends, Robert] Humboldt Univ, Inst Analyt & Environm Chem, D-12489 Berlin Adlershof, Germany	Robert Koch Institute; Humboldt University of Berlin	Flieger, A (corresponding author), Robert Koch Inst, Div Bacterial Infect, Burgstr 37, D-38855 Wernigerode, Germany.	fliegera@rki.de		Ahrends, Robert/0000-0003-0232-3375; Banerji, Sangeeta/0000-0003-1433-5250; Flieger, Antje/0000-0003-3819-2979	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG FL 359/6-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grant DFG FL 359/6-1.	Ahrends R, 2009, ANAL CHEM, V81, P2176, DOI 10.1021/ac802310c; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Banerji S, 2005, INFECT IMMUN, V73, P2899, DOI 10.1128/IAI.73.5.2899-2909.2005; Banerji S, 2004, MICROBIOL-SGM, V150, P522, DOI 10.1099/mic.0.26957-0; Banerji S, 2008, INT J MED MICROBIOL, V298, P169, DOI 10.1016/j.ijmm.2007.11.004; Bender J, 2009, J BIOL CHEM, V284, P27185, DOI 10.1074/jbc.M109.026021; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BLACK WJ, 1990, J BACTERIOL, V172, P2608, DOI 10.1128/jb.172.5.2608-2613.1990; Brick DJ, 1995, FEBS LETT, V377, P475, DOI 10.1016/0014-5793(95)01405-5; Broich M, 2006, J BACTERIOL, V188, P1218, DOI 10.1128/JB.188.4.1218-1226.2006; Brumlik MJ, 1996, J BACTERIOL, V178, P2060, DOI 10.1128/jb.178.7.2060-2064.1996; BUCKLEY JT, 1981, CAN J BIOCHEM CELL B, V59, P430, DOI 10.1139/o81-059; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Christen M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000430; CONLAN JW, 1986, J GEN MICROBIOL, V132, P1565; Creasey EA, 2012, P NATL ACAD SCI USA, V109, P3481, DOI 10.1073/pnas.1121286109; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; DOWNING MR, 1975, J BIOL CHEM, V250, P8897; DUCKWORTH WC, 1979, P NATL ACAD SCI USA, V76, P635, DOI 10.1073/pnas.76.2.635; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; EGGSET G, 1994, J FISH DIS, V17, P17, DOI 10.1111/j.1365-2761.1994.tb00342.x; FASMAN GD, 1966, J MOL BIOL, V19, P240, DOI 10.1016/S0022-2836(66)80002-5; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Flieger A, 2000, FEMS MICROBIOL LETT, V188, P129; Flieger A, 2004, INFECT IMMUN, V72, P2648, DOI 10.1128/IAI.72.5.2648-2658.2004; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; Flieger A, 2001, J BACTERIOL, V183, P2121, DOI 10.1128/JB.183.6.2121-2124.2001; GARRED O, 1995, J BIOL CHEM, V270, P10817; Geiger O., 2010, HDB HYDROCARBON LIPI, P3195; Giannelli V, 1997, INFECT IMMUN, V65, P331, DOI 10.1128/IAI.65.1.331-334.1997; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; GOLDFINE H, 1982, CURR TOP MEMBR TRANS, V17, P1; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Hales LM, 1999, INFECT IMMUN, V67, P3662, DOI 10.1128/IAI.67.7.3662-3666.1999; Hilbi H, 2010, MOL MICROBIOL, V76, P1, DOI 10.1111/j.1365-2958.2010.07086.x; HILTON S, 1991, BIOCHEMISTRY-US, V30, P6070, DOI 10.1021/bi00238a034; HILTON S, 1990, BIOCHEMISTRY-US, V29, P9072, DOI 10.1021/bi00490a026; HILTON S, 1991, J BIOL CHEM, V266, P997; Holk A, 2002, PLANT PHYSIOL, V130, P90, DOI 10.1104/pp.006288; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; KEEN MG, 1989, INFECT IMMUN, V57, P732, DOI 10.1128/IAI.57.3.732-738.1989; KORN ED, 1973, J BIOL CHEM, V248, P439; Kurmanova A, 2007, BIOCHEM BIOPH RES CO, V357, P144, DOI 10.1016/j.bbrc.2007.03.110; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang C, 2011, EUR J CELL BIOL, V90, P903, DOI 10.1016/j.ejcb.2010.12.003; Lossi NS, 2008, MICROBIOL-SGM, V154, P2680, DOI 10.1099/mic.0.2008/019075-0; MOFFAT JF, 1994, INFECT IMMUN, V62, P751, DOI 10.1128/IAI.62.2.751-753.1994; MOFFAT JF, 1994, MOL MICROBIOL, V12, P693, DOI 10.1111/j.1365-2958.1994.tb01057.x; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; NEU HC, 1965, J BIOL CHEM, V240, P3685; OGATA M, 1992, J BIOL CHEM, V267, P25396; Okamoto T, 2004, BIOL CHEM, V385, P997, DOI 10.1515/BC.2004.130; PRESTIDGE L, 1971, J BACTERIOL, V107, P815, DOI 10.1128/JB.107.3.815-823.1971; QUINN FD, 1989, MOL MICROBIOL, V3, P797, DOI 10.1111/j.1365-2958.1989.tb00228.x; RAEDERSTORFF D, 1985, BIOCHEM J, V231, P609, DOI 10.1042/bj2310609; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; Rossier O, 2008, APPL ENVIRON MICROB, V74, P753, DOI 10.1128/AEM.01944-07; Ruggiero A, 2010, STRUCTURE, V18, P1184, DOI 10.1016/j.str.2010.06.007; SMITH FR, 1968, J LIPID RES, V9, P405; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; THORPE TC, 1981, INFECT IMMUN, V33, P632, DOI 10.1128/IAI.33.2.632-635.1981; TSUNEOKA M, 1993, J BIOL CHEM, V268, P26461; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; Winiecka-Krusnell J, 1999, SCAND J INFECT DIS, V31, P383, DOI 10.1080/00365549950163833; WINN WC, 1981, HUM PATHOL, V12, P401, DOI 10.1016/S0046-8177(81)80021-4	73	17	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23464	23478		10.1074/jbc.M112.346387	http://dx.doi.org/10.1074/jbc.M112.346387			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22582391	hybrid, Green Published			2022-12-25	WOS:000306511300019
J	Blaich, A; Pahlavan, S; Tian, QH; Oberhofer, M; Poomvanicha, M; Lenhardt, P; Domes, K; Wegener, JW; Moosmang, S; Ruppenthal, S; Scholz, A; Lipp, P; Hofmann, F				Blaich, Anne; Pahlavan, Sara; Tian, Qinghai; Oberhofer, Martin; Poomvanicha, Montatip; Lenhardt, Peter; Domes, Katrin; Wegener, Joerg W.; Moosmang, Sven; Ruppenthal, Sandra; Scholz, Anke; Lipp, Peter; Hofmann, Franz			Mutation of the Calmodulin Binding Motif IQ of the L-type Ca(v)1.2 Ca2+ Channel to EQ Induces Dilated Cardiomyopathy and Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; KINASE-II; CA2+-DEPENDENT INACTIVATION; HEART-FAILURE; FACILITATION; PHOSPHORYLATION; MECHANISMS; MYOCYTES; GENE; HYPERTROPHY	Cardiac excitation-contraction coupling (EC coupling) links the electrical excitation of the cell membrane to the mechanical contractile machinery of the heart. Calcium channels are major players of EC coupling and are regulated by voltage and Ca2+ / calmodulin (CaM). CaM binds to the IQ motif located in the C terminus of the Ca(v)1.2 channel and induces Ca2+-dependent inactivation (CDI) and facilitation (CDF). Mutation of Ile to Glu (Ile1624Glu) in the IQ motif abolished regulation of the channel by CDI and CDF. Here, we addressed the physiological consequences of such a mutation in the heart. Murine hearts expressing the Ca(v)1.2(I1624E) mutation were generated in adult heterozygous mice through inactivation of the floxed WT Ca(v)1.2(L2) allele by tamoxifen-induced cardiac-specific activation of the MerCreMer Cre recombinase. Within 10 days after the first tamoxifen injection these mice developed dilated cardiomyopathy (DCM) accompanied by apoptosis of cardiac myocytes (CM) and fibrosis. In Ca(v)1.2(I1624E) hearts, the activity of phospho-CaM kinase II and phospho-MAPK was increased. CMs expressed reduced levels of Ca(v)1.2(I1624E) channel protein and I-Ca. The Cav1.2(I1624E) channel showed "CDI" kinetics. Despite a lower sarcoplasmic reticulum Ca2+ content, cellular contractility and global Ca2+ transients remained unchanged because the EC coupling gain was up-regulated by an increased neuroendocrine activity. Treatment of mice with metoprolol and captopril reducedDCMin Cav1.2(I1624E) hearts at day 10. Weconclude that mutation of the IQ motif to IE leads to dilated cardiomyopathy and death.	[Blaich, Anne; Poomvanicha, Montatip; Lenhardt, Peter; Domes, Katrin; Wegener, Joerg W.; Moosmang, Sven; Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, Forschergrp, D-80802 Munich, Germany; [Pahlavan, Sara; Tian, Qinghai; Oberhofer, Martin; Ruppenthal, Sandra; Scholz, Anke; Lipp, Peter] Univ Saarland, Inst Mol Cell Biol, Res Ctr Mol Imaging & Screening, Fac Med, D-66424 Homburg, Germany	Technical University of Munich; Saarland University	Hofmann, F (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, Forschergrp, FOR923,Biedersteiner Str 29, D-80802 Munich, Germany.	franz.hofmann@mytum.de		Wegener, Jorg/0000-0002-8129-1537; Pahlavan, Sara/0000-0002-8854-2626	Deutsche Forschungsgemeinschaft [GraKO1326, KFO196]; Fond der Chemischen Industrie; Medical Faculty (HOMFOR) of the Saarland University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie); Medical Faculty (HOMFOR) of the Saarland University	This work was supported by grants from the Deutsche Forschungsgemeinschaft and Fond der Chemischen Industrie (to F. H.).; Supported by Deutsche Forschungsgemeinschaft Grants GraKO1326 and KFO196 and by the Medical Faculty (HOMFOR) of the Saarland University.	Acsai K, 2011, J PHYSIOL-LONDON, V589, P2569, DOI 10.1113/jphysiol.2010.202663; Altamirano J, 2007, CIRC RES, V101, P590, DOI 10.1161/CIRCRESAHA.107.152322; ANDERSON ME, 1994, CIRC RES, V75, P854, DOI 10.1161/01.RES.75.5.854; Anderson ME, 2001, J MOL CELL CARDIOL, V33, P639, DOI 10.1006/jmcc.2000.1354; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2002, J MOL CELL CARDIOL, V34, P369, DOI 10.1006/jmcc.2002.1530; Bers DM, 2006, J PHARMACOL SCI, V100, P315, DOI 10.1254/jphs.CPJ06001X; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Blaich A, 2010, P NATL ACAD SCI USA, V107, P10285, DOI 10.1073/pnas.0914287107; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Currie S, 2009, FRONT BIOSCI-LANDMRK, V14, P5134, DOI 10.2741/3591; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Hall ME, 2011, AM J PHYSIOL-HEART C, V301, pH253, DOI 10.1152/ajpheart.00786.2010; Halling D Brent, 2006, Sci STKE, V2006, per1; Hammer K, 2010, J MOL CELL CARDIOL, V49, P427, DOI 10.1016/j.yjmcc.2010.05.010; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hougen K, 2010, AM J PHYSIOL-HEART C, V299, pH1671, DOI 10.1152/ajpheart.01155.2009; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Lipp P, 2002, J PHYSIOL-LONDON, V542, P383, DOI 10.1113/jphysiol.2001.013382; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pieske B, 2002, CIRCULATION, V106, P447, DOI 10.1161/01.CIR.0000023042.50192.F4; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Poomvanicha M, 2011, J BIOL CHEM, V286, P26702, DOI 10.1074/jbc.M111.247841; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Ronkainen JJ, 2011, J PHYSIOL-LONDON, V589, P2669, DOI 10.1113/jphysiol.2010.201400; ROSS J, 1995, CIRCULATION, V92, P2327, DOI 10.1161/01.CIR.92.8.2327; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Xu L, 2010, CIRC RES, V107, P398, DOI 10.1161/CIRCRESAHA.110.222562; YUAN WL, 1994, AM J PHYSIOL, V267, pH982, DOI 10.1152/ajpheart.1994.267.3.H982; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	45	22	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22616	22625		10.1074/jbc.M112.357921	http://dx.doi.org/10.1074/jbc.M112.357921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589547	Green Published, hybrid			2022-12-25	WOS:000306495000018
J	McPherson, AJ; Snell, LM; Mak, TW; Watts, TH				McPherson, Ann J.; Snell, Laura M.; Mak, Tak W.; Watts, Tania H.			Opposing Roles for TRAF1 in the Alternative versus Classical NF-kappa B Pathway in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED FACTOR-1; ALPHA-DEPENDENT APOPTOSIS; NF-KAPPA-B2 P100; HODGKINS-LYMPHOMA; IMMUNE-RESPONSE; DOWN-REGULATION; IN-VIVO; ACTIVATION; KINASE; 4-1BB	T cells lacking TRAF1 hyperproliferate in response to T cell receptor signaling but have impaired signaling downstream of specific TNFR family members such as 4-1BB. Here we resolve this paradox by showing that while TRAF1 is required for maximal activation of the classical NF-kappa B pathway downstream of 4-1BB in primary T cells, TRAF1 also restricts the constitutive activation of NIK in anti-CD3-activated T cells. Activation of the alternative NF-kappa B pathway is restricted in unstimulated cells by a cIAP1/2:TRAF2:TRAF3:NIK complex. Using knockdown of NIK by siRNA we show that in activated CD8 T cells TRAF1 is also involved in this process and that constitutive activation of the alternative NF-kappa B pathway is responsible for costimulation independent hyperproliferation and excess cytokine production in TRAF1-deficient CD8 T cells compared with WT CD8 T cells. The T cell costimulatory molecule 4-1BB critically regulates the survival of activated and memory CD8 T cells. We demonstrate that stimulation through 4-1BB induces cIAP1-dependent TRAF3 degradation and activation of the alternative NF-kappa B pathway. We also show that while both TRAF1 and cIAP1 have non-redundant roles in suppressing the alternative NF-kappa B pathway in T cells activated in the absence of costimulation, activation of the classical NF-kappa B pathway downstream of 4-1BB requires TRAF1, whereas cIAP1 plays a redundant role with cIAP2. Collectively these results demonstrate that TRAF1 plays a critical role in regulating T cell activation both through restricting the costimulation independent activation of NIK in activated T cells and by promoting the 4-1BB-induced classical NF-kappa B pathway.	[McPherson, Ann J.; Snell, Laura M.; Mak, Tak W.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Mak, Tak W.] Univ Toronto, Princess Margaret Hosp, Campbell Family Canc Res Inst, Toronto, ON M5S 1A8, Canada; [Mak, Tak W.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Watts, TH (corresponding author), Univ Toronto, Dept Immunol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	tania.watts@utoronto.ca		Snell, Laura/0000-0001-9890-6588	Canadian Cancer Society [018119]	Canadian Cancer Society(Canadian Cancer Society (CCS))	This research was funded by Grant No. 018119 from the Canadian Cancer Society (to T. H. W.).	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Arron JR, 2002, J EXP MED, V196, P923, DOI 10.1084/jem.20020774; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Cannons JL, 2000, J IMMUNOL, V165, P6193, DOI 10.4049/jimmunol.165.11.6193; Cannons JL, 1999, J IMMUNOL, V163, P2990; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Fotin-Mleczek M, 2004, J BIOL CHEM, V279, P677, DOI 10.1074/jbc.M310969200; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Guo F, 2009, MOL IMMUNOL, V46, P2441, DOI 10.1016/j.molimm.2009.05.178; Ha H., 2009, CURRENT PROTOCOLS IM; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Hendriks J, 2005, J IMMUNOL, V175, P1665, DOI 10.4049/jimmunol.175.3.1665; Hofmann J, 2011, J EXP MED, V208, P1917, DOI 10.1084/jem.20110128; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Horie R, 2003, INT J HEMATOL, V77, P37, DOI 10.1007/BF02982601; Hurtado JC, 1997, J IMMUNOL, V158, P2600; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Jang IK, 1998, BIOCHEM BIOPH RES CO, V242, P613, DOI 10.1006/bbrc.1997.8016; Jin W, 2009, BLOOD, V113, P6603, DOI 10.1182/blood-2008-12-192914; Lavorgna A, 2009, MOL IMMUNOL, V46, P3278, DOI 10.1016/j.molimm.2009.07.029; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Matsumoto M, 2002, J IMMUNOL, V169, P1151, DOI 10.4049/jimmunol.169.3.1151; Murray SE, 2011, J CLIN INVEST, V121, P4775, DOI 10.1172/JCI44943; Nocentini G, 2009, ADV EXP MED BIOL, V647, P156, DOI 10.1007/978-0-387-89520-8_11; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Ronchetti S, 2007, J IMMUNOL, V179, P5916, DOI 10.4049/jimmunol.179.9.5916; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sabbagh L, 2008, J IMMUNOL, V180, P8093, DOI 10.4049/jimmunol.180.12.8093; Sabbagh L, 2006, P NATL ACAD SCI USA, V103, P18703, DOI 10.1073/pnas.0602919103; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sanchez-Valdepenas C, 2006, J IMMUNOL, V176, P4666, DOI 10.4049/jimmunol.176.8.4666; Sanjo H, 2010, J BIOL CHEM, V285, P17148, DOI 10.1074/jbc.M110.105874; Saoulli K, 1998, J EXP MED, V187, P1849, DOI 10.1084/jem.187.11.1849; Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Speiser DE, 1997, J EXP MED, V185, P1777, DOI 10.1084/jem.185.10.1777; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wallach D, 2008, NAT IMMUNOL, V9, P1325, DOI 10.1038/ni1208-1325; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Zapata JM, 2000, J IMMUNOL, V165, P5084, DOI 10.4049/jimmunol.165.9.5084; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	63	63	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23010	23019		10.1074/jbc.M112.350538	http://dx.doi.org/10.1074/jbc.M112.350538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570473	hybrid, Green Published			2022-12-25	WOS:000306495000057
J	Koch, B; Mitterer, V; Niederhauser, J; Stanborough, T; Murat, G; Rechberger, G; Bergler, H; Kressler, D; Pertschy, B				Koch, Barbara; Mitterer, Valentin; Niederhauser, Johannes; Stanborough, Tamsyn; Murat, Guillaume; Rechberger, Gerald; Bergler, Helmut; Kressler, Dieter; Pertschy, Brigitte			Yar1 Protects the Ribosomal Protein Rps3 from Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; ANKYRIN REPEAT; DUAL FUNCTION; YEAST; RNA; BIOGENESIS; SUBUNIT; PATHWAY; COMPLEX	2000 ribosomes have to be synthesized in yeast every minute. Therefore the fast production of ribosomal proteins, their efficient delivery to the nucleus and correct incorporation into ribosomal subunits are prerequisites for optimal growth rates. Here, we report that the ankyrin repeat protein Yar1 directly interacts with the small ribosomal subunit protein Rps3 and accompanies newly synthesized Rps3 from the cytoplasm into the nucleus where Rps3 is assembled into pre-ribosomal subunits. A yar1 deletion strain displays a similar phenotype as an rps3 mutant strain, showing an accumulation of 20S pre-rRNA and a 40S export defect. The combination of an rps3 mutation with a yar1 deletion leads to an enhancement of these phenotypes, while increased expression of RPS3 suppresses the defects of a yar1 deletion strain. We further show that Yar1 protects Rps3 from aggregation in vitro and increases its solubility in vivo. Our data suggest that Yar1 is a specific chaperone for Rps3, which serves to keep Rps3 soluble until its incorporation into the pre-ribosome.	[Koch, Barbara; Mitterer, Valentin; Niederhauser, Johannes; Stanborough, Tamsyn; Rechberger, Gerald; Bergler, Helmut; Pertschy, Brigitte] Graz Univ, Inst Mol Biowissensch, A-8010 Graz, Austria; [Murat, Guillaume; Kressler, Dieter] Univ Fribourg, Dept Biol, Biochem Unit, CH-1700 Fribourg, Switzerland	University of Graz; University of Fribourg	Pertschy, B (corresponding author), Graz Univ, Inst Mol Biowissensch, Humboldtstr 50, A-8010 Graz, Austria.	brigitte.pertschy@uni-graz.at	Mitterer, Valentin/AAV-3722-2020; Kressler, Dieter/C-2218-2012; Mitterer, Valentin/ABE-3970-2020	Mitterer, Valentin/0000-0003-1587-1194; Mitterer, Valentin/0000-0003-1587-1194; Bergler, Helmut/0000-0002-7724-309X; Rechberger, Gerald N./0000-0002-0071-317X; Pertschy, Brigitte/0000-0003-3558-0191; Kressler, Dieter/0000-0003-4855-3563; Murat, Guillaume/0000-0003-1288-984X	Austrian Science Fund (FWF) [T404-B12, P21991]; Swiss National Science Foundation [PP00P3_123341]; Austrian Science Fund (FWF) [P 21991, P 23682] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The research was funded by Grant T404-B12 from the Austrian Science Fund (FWF) (to B. P.), Grant PP00P3_123341 from the Swiss National Science Foundation (to D. K.), and Grant P21991 from the FWF (to H. B.).	Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Birner-Gruenberger R, 2008, PROTEOMICS, V8, P3645, DOI 10.1002/pmic.200800191; Demoinet E, 2007, RNA, V13, P1570, DOI 10.1261/rna.585007; Eisinger DP, 1997, MOL CELL BIOL, V17, P5146, DOI 10.1128/MCB.17.9.5146; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Grosshans H, 2000, GENE DEV, V14, P830; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Iouk TL, 2001, MOL CELL BIOL, V21, P1260, DOI 10.1128/MCB.21.4.1260-1271.2001; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Karbstein K, 2011, CURR OPIN CHEM BIOL, V15, P657, DOI 10.1016/j.cbpa.2011.07.023; Karbstein K, 2010, J CELL BIOL, V189, P11, DOI 10.1083/jcb.201002102; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Loar JW, 2004, GENETICS, V168, P1877, DOI 10.1534/genetics.104.032656; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lycan DE, 1996, GENE, V171, P33, DOI 10.1016/0378-1119(96)00023-6; Meyer AE, 2007, P NATL ACAD SCI USA, V104, P1558, DOI 10.1073/pnas.0610704104; Meyer AE, 2010, J BIOL CHEM, V285, P961, DOI 10.1074/jbc.M109.038349; Neville M, 1999, EMBO J, V18, P3746, DOI 10.1093/emboj/18.13.3746; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schaper S, 2001, CURR BIOL, V11, P1885, DOI 10.1016/S0960-9822(01)00584-X; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	36	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21806	21815		10.1074/jbc.M112.365791	http://dx.doi.org/10.1074/jbc.M112.365791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570489	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-25	WOS:000306418600022
J	Rajabi, M; Ericksen, B; Wu, XJ; de Leeuw, E; Zhao, L; Pazgier, M; Lu, WY				Rajabi, Mohsen; Ericksen, Bryan; Wu, Xueji; de Leeuw, Erik; Zhao, Le; Pazgier, Marzena; Lu, Wuyuan			Functional Determinants of Human Enteric alpha-Defensin HD5 CRUCIAL ROLE FOR HYDROPHOBICITY AT DIMER INTERFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR LIPID II; CAVITY-CREATING MUTATIONS; CONSERVED SALT BRIDGE; ANTHRAX LETHAL TOXIN; ANTIMICROBIAL PEPTIDES; MAMMALIAN DEFENSINS; MOUSE CRYPTDIN-4; INNATE IMMUNITY; PANETH CELLS; ANTIBACTERIAL ACTIVITY	Human alpha-defensins are cationic peptides that self-associate into dimers and higher-order oligomers. They bind protein toxins, such as anthrax lethal factor (LF), and kill bacteria, including Escherichia coli and Staphylococcus aureus, among other functions. There are six members of the human alpha-defensin family: four human neutrophil peptides, including HNP1, and two enteric human defensins, including HD5. We subjected HD5 to comprehensive alanine scanning mutagenesis. We then assayed LF binding by surface plasmon resonance, LF activity by enzyme kinetic inhibition, and antibacterial activity by the virtual colony count assay. Most mutations could be tolerated, resulting in activity comparable with that of wild type HD5. However, the L29A mutation decimated LF binding and bactericidal activity against Escherichia coli and Staphylococcus aureus. A series of unnatural aliphatic and aromatic substitutions at position 29, including aminobutyric acid (Abu) and norleucine (Nle) correlated hydrophobicity with HD5 function. The crystal structure of L29Abu-HD5 depicted decreased hydrophobic contacts at the dimer interface, whereas the Nle-29-HD5 crystal structure depicted a novel mode of dimerization with parallel beta strands. The effect of mutating Leu(29) is similar to that of a C-terminal hydrophobic residue of HNP1, Trp(26). In addition, in order to further clarify the role of dimerization in HD5 function, an obligate monomer was generated by N-methylation of the Glu(21) residue, decreasing LF binding and antibacterial activity against S. aureus. These results further characterize the dimer interface of the alpha-defensins, revealing a crucial role of hydrophobicity-mediated dimerization.	[Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Inst Human Virol, Sch Med, Baltimore, MD 21201 USA; [Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Pazgier, M (corresponding author), Univ Maryland, Inst Human Virol, Sch Med, 725 W Lombard St, Baltimore, MD 21201 USA.	mpazgier@ihv.umaryland.edu; wlu@ihv.umaryland.edu	Lu, Wuyuan/B-2268-2010; Lu, Wuyuan/J-8452-2017	Lu, Wuyuan/0000-0003-1318-9968; Ericksen, Bryan/0000-0002-8016-8289	Department of Energy Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NIGMS; National Institutes of Health [AI072732, AI061482]; Xian Jiaotong University School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072732, R01AI061482] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xian Jiaotong University School of Medicine(Xi'an Jiaotong University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. Changyou Zhan, Gang Wei, and Guozhang Zou and Weirong Yuan for technical assistance and useful discussions. We thank the X-ray Crystallography Core Facility of the University of Maryland at Baltimore for providing crystallographic equipment and resources. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States. Department of Energy Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (Grant P41RR001209), and NIGMS, National Institutes of Health.This work was supported, in whole or in part, by National Institutes of Health Grants AI072732 and AI061482 (to W. L.).A Guanghua Scholar supported by Xian Jiaotong University School of Medicine.	Andersson H. S., 2012, AMINO ACIDS IN PRESS; Arnett E, 2011, CELL MICROBIOL, V13, P635, DOI 10.1111/j.1462-5822.2010.01563.x; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Chapnik N, 2012, APPL BIOCHEM BIOTECH, V166, P1703, DOI 10.1007/s12010-012-9571-5; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; de Leeuw E, 2009, FEBS LETT, V583, P2507, DOI 10.1016/j.febslet.2009.06.051; Ding JA, 2011, J INNATE IMMUN, V3, P208, DOI 10.1159/000322355; Ding J, 2009, J INNATE IMMUN, V1, P413, DOI 10.1159/000226256; Durr E, 2000, BIOCHEMISTRY-US, V39, P4472, DOI 10.1021/bi992948f; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Giesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Kim C, 2006, BIOCHEM J, V399, P225, DOI 10.1042/BJ20060425; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Penberthy WT, 2011, CELL MOL LIFE SCI, V68, P2231, DOI 10.1007/s00018-011-0715-5; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Smith JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000959; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wang W, 2006, J BIOL CHEM, V281, P32755, DOI 10.1074/jbc.M603614200; Wanniarachchi YA, 2011, BIOCHEMISTRY-US, V50, P8005, DOI 10.1021/bi201043j; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WILDE CG, 1989, J BIOL CHEM, V264, P11200; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao L., 2012, J BIOL CHEM IN PRESS; Zou GZ, 2008, J MOL BIOL, V381, P1281, DOI 10.1016/j.jmb.2008.06.066; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	88	53	54	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21615	21627		10.1074/jbc.M112.367995	http://dx.doi.org/10.1074/jbc.M112.367995			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573326	Green Published, hybrid			2022-12-25	WOS:000306418600005
J	Blount, JR; Burr, AA; Denuc, A; Marfany, G; Todi, SV				Blount, Jessica R.; Burr, Aaron A.; Denuc, Amanda; Marfany, Gemma; Todi, Sokol V.			Ubiquitin-Specific Protease 25 Functions in Endoplasmic Reticulum-Associated Degradation	PLOS ONE			English	Article							POLYGLUTAMINE DISEASE PROTEIN; DEUBIQUITINATING ENZYME ATAXIN-3; QUALITY-CONTROL; USP25; ERAD; RETROTRANSLOCATION; GENERATION; MUTATIONS; TURNOVER; VCP/P97	Endoplasmic Reticulum (ER)-associated degradation (ERAD) discards abnormal proteins synthesized in the ER. Through coordinated actions of ERAD components, misfolded/anomalous proteins are recognized, ubiquitinated, extracted from the ER and ultimately delivered to the proteasome for degradation. It is not well understood how ubiquitination of ERAD substrates is regulated. Here, we present evidence that the deubiquitinating enzyme Ubiquitin-Specific Protease 25 (USP25) is involved in ERAD. Our data support a model where USP25 counteracts ubiquitination of ERAD substrates by the ubiquitin ligase HRD1, rescuing them from degradation by the proteasome.	[Blount, Jessica R.; Burr, Aaron A.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Blount, Jessica R.; Burr, Aaron A.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Burr, Aaron A.; Todi, Sokol V.] Wayne State Univ, Sch Med, Grad Program Canc Biol, Detroit, MI USA; [Denuc, Amanda; Marfany, Gemma] Univ Barcelona, Fac Med, Dept Genet, Barcelona 7, Spain	Wayne State University; Wayne State University; Wayne State University; University of Barcelona	Blount, JR (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	stodi@med.wayne.edu	Marfany, Gemma/I-5668-2015	Marfany, Gemma/0000-0001-7941-983X; TODI, SOKOL/0000-0003-4399-5549	National Institutes of Health [R00NS064097]; Albert and Goldye Nelson Fund; Ministerio de Educacion y Cienda [BFU2010-15656]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS064097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert and Goldye Nelson Fund; Ministerio de Educacion y Cienda; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant R00NS064097 to S.V.T., a research grant to S.V.T. by the Albert and Goldye Nelson Fund and by BFU2010-15656 (Ministerio de Educacion y Cienda) to G.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Bosch-Comas A, 2006, CELL MOL LIFE SCI, V63, P723, DOI 10.1007/s00018-005-5533-1; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Claessen JH, 2011, TRENDS CELL BIOL; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kim SM, 2010, J BIOL CHEM, V285, P35866, DOI 10.1074/jbc.M110.167189; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Morreale G, 2009, FEBS J, V276, P1208, DOI 10.1111/j.1742-4658.2008.06858.x; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Todi S.V., 2011, TRENDS NEUROSCI; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Valero R, 1999, GENOMICS, V62, P395, DOI 10.1006/geno.1999.6025; Valero R, 2001, GENOME BIOL, V2; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	42	47	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36542	10.1371/journal.pone.0036542	http://dx.doi.org/10.1371/journal.pone.0036542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590560	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100035
J	Dheilly, NM; Lelong, C; Huvet, A; Kellner, K; Dubos, MP; Riviere, G; Boudry, P; Favrel, P				Dheilly, Nolwenn M.; Lelong, Christophe; Huvet, Arnaud; Kellner, Kristell; Dubos, Marie-Pierre; Riviere, Guillaume; Boudry, Pierre; Favrel, Pascal			Gametogenesis in the Pacific Oyster Crassostrea gigas: A Microarrays-Based Analysis Identifies Sex and Stage Specific Genes	PLOS ONE			English	Article							RNA-BINDING PROTEIN; VASA-LIKE GENE; SUMMER MORTALITY; EXPRESSION; SPERM; GERMLINE; CYCLE; DIFFERENTIATION; TRANSCRIPTOME; SPERMATOGENESIS	Background: The Pacific oyster Crassostrea gigas (Mollusca, Lophotrochozoa) is an alternative and irregular protandrous hermaphrodite: most individuals mature first as males and then change sex several times. Little is known about genetic and phenotypic basis of sex differentiation in oysters, and little more about the molecular pathways regulating reproduction. We have recently developed and validated a microarray containing 31,918 oligomers (Dheilly et al., 2011) representing the oyster transcriptome. The application of this microarray to the study of mollusk gametogenesis should provide a better understanding of the key factors involved in sex differentiation and the regulation of oyster reproduction. Methodology/Principal Findings: Gene expression was studied in gonads of oysters cultured over a yearly reproductive cycle. Principal component analysis and hierarchical clustering showed a significant divergence in gene expression patterns of males and females coinciding with the start of gonial mitosis. ANOVA analysis of the data revealed 2,482 genes differentially expressed during the course of males and/or females gametogenesis. The expression of 434 genes could be localized in either germ cells or somatic cells of the gonad by comparing the transcriptome of female gonads to the transcriptome of stripped oocytes and somatic tissues. Analysis of the annotated genes revealed conserved molecular mechanisms between mollusks and mammals: genes involved in chromatin condensation, DNA replication and repair, mitosis and meiosis regulation, transcription, translation and apoptosis were expressed in both male and female gonads. Most interestingly, early expressed male-specific genes included bindin and a dpy-30 homolog and female-specific genes included foxL2, nanos homolog 3, a pancreatic lipase related protein, cd63 and vitellogenin. Further functional analyses are now required in order to investigate their role in sex differentiation in oysters. Conclusions/Significance: This study allowed us to identify potential markers of early sex differentiation in the oyster C. gigas, an alternative hermaphrodite mollusk. We also provided new highly valuable information on genes specifically expressed by mature spermatozoids and mature oocytes.	[Dheilly, Nolwenn M.; Lelong, Christophe; Kellner, Kristell; Dubos, Marie-Pierre; Riviere, Guillaume; Favrel, Pascal] Univ Caen Basse Normandie, IBFA, SFR ICORE, Biol Organismes Marins & Ecosyst Associes BioMEA, Caen, France; [Dheilly, Nolwenn M.; Lelong, Christophe; Kellner, Kristell; Dubos, Marie-Pierre; Riviere, Guillaume; Favrel, Pascal] CNRS INEE, BioMEA, Caen, France; [Dheilly, Nolwenn M.; Huvet, Arnaud; Boudry, Pierre] IFREMER, Lab Sci Environm Marin, Ctr Bretagne, Plouzane, France	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Dheilly, NM (corresponding author), Univ Caen Basse Normandie, IBFA, SFR ICORE, Biol Organismes Marins & Ecosyst Associes BioMEA, Caen, France.	nolwenn.dheilly@univ-perp.fr	Dheilly, Nolwenn Marie M/A-7213-2011; Boudry, Pierre/M-3213-2019; Dheilly, Nolwenn/AAU-9185-2020; Boudry, Pierre/G-2406-2010	Dheilly, Nolwenn Marie M/0000-0002-3675-5013; Dheilly, Nolwenn/0000-0002-3675-5013; Favrel, Pascal/0000-0002-2504-9957; Huvet, Arnaud/0000-0001-6912-881X; Boudry, Pierre/0000-0002-5150-2276	ANR [ANR-08-GENM-041]; GIS Europole Mer; European program FP7-KBBE-2009-3 "Reproseed'' [245119]; Ifremer and Region Basse-Normandie	ANR(French National Research Agency (ANR)); GIS Europole Mer; European program FP7-KBBE-2009-3 "Reproseed''; Ifremer and Region Basse-Normandie(Region Normandie)	This work was partly supported by the ANR project "Gametogenes'' (contract no ANR-08-GENM-041), the GIS Europole Mer project "OxyGenes'' and the European program FP7-KBBE-2009-3 "Reproseed'' (Proposal nu 245119). NMD was funded by post-doctoral grants provided by Ifremer and Region Basse-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron D, 2005, BIOL REPROD, V73, P959, DOI 10.1095/biolreprod.105.041830; BERNARDINI G, 1992, J EXP ZOOL, V263, P210, DOI 10.1002/jez.1402630211; Berthelin C, 2000, COMP BIOCHEM PHYS B, V125, P359, DOI 10.1016/S0305-0491(99)00187-X; Berthelin C, 2000, MAR BIOTECHNOL, V2, P136; Berthelin Heude C, 2001, STORAGE REPROD STRAT; Boudry P, 2009, BASICS, P87, DOI 10.1533/9781845696474.1.87; Boudry P, 2008, SUMMER MORTALITY PAC, P153; BRANDRIFF B, 1978, GAMETE RES, V1, P89, DOI 10.1002/mrd.1120010202; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; Choudhury DR, 2010, BIOL REPROD, V83, P663, DOI 10.1095/biolreprod.110.084889; Chuaqui RF, 2002, NAT GENET; Clement TM, 2007, REPRODUCTION, V134, P455, DOI 10.1530/REP-06-0341; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Degremont L, 2007, AQUACULTURE, V262, P41, DOI 10.1016/j.aquaculture.2006.10.025; Degremont L, 2010, AQUACULTURE, V299, P21, DOI 10.1016/j.aquaculture.2009.11.017; Dheilly NM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-468; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; Dridi S, 2007, AQUACULTURE, V263, P238, DOI 10.1016/j.aquaculture.2006.10.028; Eckmann CR, 2004, GENETICS, V168, P147, DOI 10.1534/genetics.104.029264; Eckmann CR, 2002, DEV CELL, V3, P697, DOI 10.1016/S1534-5807(02)00322-2; Enriquez-Diaz M, 2009, AQUACULT INT, V17, P491, DOI 10.1007/s10499-008-9219-1; Ernande B, 2003, J EVOLUTION BIOL, V16, P399, DOI 10.1046/j.1420-9101.2003.00543.x; Evans C, 2008, REPROD DOMEST ANIM, V43, P539; Fabioux C, 2005, AQUACULTURE, V250, P458, DOI 10.1016/j.aquaculture.2005.02.038; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; Fabioux C, 2009, FEBS J, V276, P2566, DOI 10.1111/j.1742-4658.2009.06982.x; Fleury E, MARINE BIOT IN PRESS; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Franco A, 2008, TISSUE CELL, V40, P251, DOI 10.1016/j.tice.2007.12.006; Franco A, 2010, CELL TISSUE RES, V340, P201, DOI 10.1007/s00441-009-0923-6; Gonzalez M, 2005, BIOCHEM BIOPH RES CO, V338, P1089, DOI 10.1016/j.bbrc.2005.10.075; Grizzi F, 2004, J HISTOCHEM CYTOCHEM, V52, P549, DOI 10.1177/002215540405200414; He X, 2011, FISH SHELLFISH IMMUN, P30; Heyer BS, 1999, DEV DYNAM, V215, P344; HSU DR, 1995, DEVELOPMENT, V121, P3323; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Huvet A, 2010, AQUACULTURE, V304, P95, DOI 10.1016/j.aquaculture.2010.03.022; Itoh N, 2011, COMP BIOCHEM PHYS B, V158, P9, DOI 10.1016/j.cbpb.2010.06.006; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; Ibanez AJ, 2008, COMP BIOCHEM PHYS A, V150, P347, DOI 10.1016/j.cbpa.2008.04.598; Jouaux A, 2010, J EXP MAR BIOL ECOL, V395, P162, DOI 10.1016/j.jembe.2010.08.030; Kim KS, 2008, COMP BIOCHEM PHYS B, V151, P52, DOI 10.1016/j.cbpb.2008.05.009; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Lango-Reynoso F, 2006, INVERTEBR REPROD DEV, V49, P41, DOI 10.1080/07924259.2006.9652192; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Matsumoto T, 2003, ZOOL SCI, V20, P37, DOI 10.2108/zsj.20.37; Moy GW, 2008, P NATL ACAD SCI USA, V105, P1993, DOI 10.1073/pnas.0711862105; Moy GW, 2008, GENE, V423, P215, DOI 10.1016/j.gene.2008.07.005; Myrand B, 1995, J SHELLFISH RES, V14, P395; Naimi A, 2009, COMP BIOCHEM PHYS A, V152, P189, DOI 10.1016/j.cbpa.2008.09.019; Naimi A, 2009, COMP BIOCHEM PHYS B, V154, P134, DOI 10.1016/j.cbpb.2009.05.011; Noble SL, 2008, J CELL BIOL, V182, P559, DOI 10.1083/jcb.200802128; Normand J, 2009, AQUAT BIOL, V7, P229, DOI 10.3354/ab00190; Normand Julien, 2008, COMP HISTOLOGICAL ST; Ortiz-Pineda PA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-262; PERDUE JA, 1984, AQUACULTURE, V37, P231, DOI 10.1016/0044-8486(84)90156-X; Rezen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-76; Rolland AD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-546; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samain JF, 2007, AQUACULTURE, V268, P227, DOI 10.1016/j.aquaculture.2007.04.044; Schlecht U, 2003, REPRODUCTION, V125, P447, DOI 10.1530/reprod/125.4.447; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; SMITH RC, 1988, GENE DEV, V2, P1284, DOI 10.1101/gad.2.10.1284; Soletchnik P, 1997, AQUAT LIVING RESOUR, V10, P177, DOI 10.1051/alr:1997019; Sutovsky P, 2001, J CELL SCI, V114, P1665; Swain A, 2006, CURR BIOL, V16, pR507, DOI 10.1016/j.cub.2006.06.009; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Togo T, 2004, MOL REPROD DEV, V67, P465, DOI 10.1002/mrd.20037; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaschenko MA, 1997, HYDROBIOLOGIA, V352, P231, DOI 10.1023/A:1003087610120; Wainman A, 2009, J CELL SCI, V122, P1747, DOI 10.1242/jcs.041798; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Watson AJ, 2007, J ANIM SCI, V85, pE1, DOI 10.2527/jas.2006-432; WORRALL CM, 1984, MAR BIOL LETT, V5, P85; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhang DC, 2009, FISH SHELLFISH IMMUN, V26, P84, DOI 10.1016/j.fsi.2008.10.009; Zheng DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-553; Zorn AM, 1997, CURR BIOL, V7, pR501, DOI 10.1016/S0960-9822(06)00248-X	84	50	53	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36353	10.1371/journal.pone.0036353	http://dx.doi.org/10.1371/journal.pone.0036353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590533	Green Published, gold			2022-12-25	WOS:000305336100026
J	Oulion, S; Bertrand, S; Belgacem, MR; Le Petillon, Y; Escriva, H				Oulion, Silvan; Bertrand, Stephanie; Belgacem, Mohamed R.; Le Petillon, Yann; Escriva, Hector			Sequencing and Analysis of the Mediterranean Amphioxus (Branchiostoma lanceolatum) Transcriptome	PLOS ONE			English	Article							FLORIDAE; GENOME; VERTEBRATE; ANNOTATION; GENES; TUNICATES; EVOLUTION; RESOURCE; BLAST2GO; RECEPTOR	Background: The basally divergent phylogenetic position of amphioxus (Cephalochordata), as well as its conserved morphology, development and genetics, make it the best proxy for the chordate ancestor. Particularly, studies using the amphioxus model help our understanding of vertebrate evolution and development. Thus, interest for the amphioxus model led to the characterization of both the transcriptome and complete genome sequence of the American species, Branchiostoma floridae. However, recent technical improvements allowing induction of spawning in the laboratory during the breeding season on a daily basis with the Mediterranean species Branchiostoma lanceolatum have encouraged European Evo-Devo researchers to adopt this species as a model even though no genomic or transcriptomic data have been available. To fill this need we used the pyrosequencing method to characterize the B. lanceolatum transcriptome and then compared our results with the published transcriptome of B. floridae. Results: Starting with total RNA from nine different developmental stages of B. lanceolatum, a normalized cDNA library was constructed and sequenced on Roche GS FLX (Titanium mode). Around 1.4 million of reads were produced and assembled into 70,530 contigs (average length of 490 bp). Overall 37% of the assembled sequences were annotated by BlastX and their Gene Ontology terms were determined. These results were then compared to genomic and transcriptomic data of B. floridae to assess similarities and specificities of each species. Conclusion: We obtained a high-quality amphioxus (B. lanceolatum) reference transcriptome using a high throughput sequencing approach. We found that 83% of the predicted genes in the B. floridae complete genome sequence are also found in the B. lanceolatum transcriptome, while only 41% were found in the B. floridae transcriptome obtained with traditional Sanger based sequencing. Therefore, given the high degree of sequence conservation between different amphioxus species, this set of ESTs may now be used as the reference transcriptome for the Branchiostoma genus.	[Oulion, Silvan; Bertrand, Stephanie; Belgacem, Mohamed R.; Le Petillon, Yann; Escriva, Hector] Univ Paris 06, CNRS, UMR7232, Observ Oceanol, Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Oulion, S (corresponding author), Univ Paris 06, CNRS, UMR7232, Observ Oceanol, Banyuls Sur Mer, France.	oulion@obs-banyuls.fr; hescriva@obs-banyuls.fr	Escriva, Hector/K-8325-2013; Bertrand, Stephanie/D-8482-2014	Escriva, Hector/0000-0001-7577-5028; Bertrand, Stephanie/0000-0002-0689-0126	Agence Nationale de la Recherche [ANR-2010-BLAN-1716 01, ANR-2010-BLAN-1234 02]	Agence Nationale de la Recherche(French National Research Agency (ANR))	The laboratory of HE is supported by the Agence Nationale de la Recherche Grants ANR-2010-BLAN-1716 01 and ANR-2010-BLAN-1234 02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; Canestro C, 2002, J MOL EVOL, V54, P81, DOI 10.1007/s00239-001-0020-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Jin P, 2010, MAR GENOM, V3, P151, DOI 10.1016/j.margen.2010.09.003; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Langlois MC, 2000, DEV GENES EVOL, V210, P471, DOI 10.1007/s004270000087; Nohara M, 2004, ZOOL SCI, V21, P203, DOI 10.2108/zsj.21.203; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Schubert M, 2008, DEV GENES EVOL, V218, P651, DOI 10.1007/s00427-008-0251-y; Somorjai I, 2008, DEV GENES EVOL, V218, P703, DOI 10.1007/s00427-008-0256-6; Takatori N, 2008, DEV GENES EVOL, V218, P579, DOI 10.1007/s00427-008-0245-9; Yu JK, 2008, DEV GENES EVOL, V218, P723, DOI 10.1007/s00427-008-0228-x; Yu JK, 2008, DEV GENES EVOL, V218, P629, DOI 10.1007/s00427-008-0229-9	26	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36554	10.1371/journal.pone.0036554	http://dx.doi.org/10.1371/journal.pone.0036554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590565	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100038
J	Mazumder, R; Morampudi, KS; Motwani, M; Vasudevan, S; Goldman, R				Mazumder, Raja; Morampudi, Krishna Sudeep; Motwani, Mona; Vasudevan, Sona; Goldman, Radoslav			Proteome-Wide Analysis of Single-Nucleotide Variations in the N-Glycosylation Sequon of Human Genes	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; LINKED GLYCOSYLATION; HYDRAZIDE CHEMISTRY; PROTEINS; DATABASE; MUTATION; ENVIRONMENT; MECHANISMS; INHIBITION; HEALTH	N-linked glycosylation is one of the most frequent post-translational modifications of proteins with a profound impact on their biological function. Besides other functions, N-linked glycosylation assists in protein folding, determines protein orientation at the cell surface, or protects proteins from proteases. The N-linked glycans attach to asparagines in the sequence context Asn-X-Ser/Thr, where X is any amino acid except proline. Any variation (e.g. non-synonymous single nucleotide polymorphism or mutation) that abolishes the N-glycosylation sequence motif will lead to the loss of a glycosylation site. On the other hand, variations causing a substitution that creates a new N-glycosylation sequence motif can result in the gain of glycosylation. Although the general importance of glycosylation is well known and acknowledged, the effect of variation on the actual glycoproteome of an organism is still mostly unknown. In this study, we focus on a comprehensive analysis of non-synonymous single nucleotide variations (nsSNV) that lead to either loss or gain of the N-glycosylation motif. We find that 1091 proteins have modified N-glycosylation sequons due to nsSNVs in the genome. Based on analysis of proteins that have a solved 3D structure at the site of variation, we find that 48% of the variations that lead to changes in glycosylation sites occur at the loop and bend regions of the proteins. Pathway and function enrichment analysis show that a significant number of proteins that gained or lost the glycosylation motif are involved in kinase activity, immune response, and blood coagulation. A structure-function analysis of a blood coagulation protein, antithrombin III and a protease, cathepsin D, showcases how a comprehensive study followed by structural analysis can help better understand the functional impact of the nsSNVs.	[Mazumder, Raja; Motwani, Mona] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Morampudi, Krishna Sudeep; Goldman, Radoslav] Georgetown Univ, Dept Oncol, Washington, DC USA; [Morampudi, Krishna Sudeep; Vasudevan, Sona; Goldman, Radoslav] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA	George Washington University; Georgetown University; Georgetown University	Mazumder, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	mazumder@gwu.edu	Motwani, Mona/AAV-8162-2020	Motwani, Mona/0000-0003-0912-5478; Mazumder, Raja/0000-0001-8823-9945	National Cancer Institute (NCI) [RO1 CA115625, CA135069]; Department of Defense PCRP [PC081609]; National Center for Research Resources (NCRR) [UL1RR031975]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [R01CA135069, R01CA115625] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031975] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense PCRP(United States Department of Defense); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by National Cancer Institute (NCI) RO1 CA115625 and CA135069 and Department of Defense PCRP grant PC081609 awarded to RG. The project has been funded in part with Federal funds (Grant # UL1RR031975) from the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA), a trademark of the Department of Health and Human Services (DHHS), part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Alavi A, 2008, RHEUMATOLOGY, V47, P760, DOI 10.1093/rheumatology/ken081; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Avanov A Ia, 1991, Mol Biol (Mosk), V25, P293; Bagriacik EU, 1996, GLYCOBIOLOGY, V6, P413, DOI 10.1093/glycob/6.4.413; Bayston TA, 1999, BLOOD, V93, P4242, DOI 10.1182/blood.V93.12.4242.412k02_4242_4247; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brumshtein B, 2006, ACTA CRYSTALLOGR D, V62, P1458, DOI 10.1107/S0907444906038303; Bunkenborg J, 2004, PROTEOMICS, V4, P454, DOI 10.1002/pmic.200300556; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; Costantino L, 2009, BREAST CANCER RES TR, V114, P449, DOI 10.1007/s10549-008-0031-4; Cui Y, 2005, CANCER EPIDEM BIOMAR, V14, P1096, DOI 10.1158/1055-9965.EPI-04-0721; Dall' olio F, 1996, CLIN MOL PATHOL, V49, P126; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dutta S, 2010, J APPL CRYSTALLOGR, V43, P1224, DOI 10.1107/S002188981002371X; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Firth SM, 2011, MOL ENDOCRINOL, V25, P307, DOI 10.1210/me.2010-0295; FORTENBERRY SC, 1995, J CELL SCI, V108, P2001; Freeze HH, 2001, BIOCHIMIE, V83, P791, DOI 10.1016/S0300-9084(01)01292-5; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Hino M, 2003, ZOOL SCI, V20, P709, DOI 10.2108/zsj.20.709; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; IMBERTY A, 1995, PROTEIN ENG, V8, P699, DOI 10.1093/protein/8.7.699; Kimber SJ, 2000, SEMIN REPROD MED, V18, P237, DOI 10.1055/s-2000-12562; Klein A, 2008, ADV CLIN CHEM, V46, P51, DOI 10.1016/S0065-2423(08)00402-2; Kobata A, 2000, GLYCOCONJUGATE J, V17, P443, DOI 10.1023/A:1011006122704; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; KRETZ KA, 1990, P NATL ACAD SCI USA, V87, P2541, DOI 10.1073/pnas.87.7.2541; Li S, 2009, PAC S BIOC, P337; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; Masson O, 2010, BIOCHIMIE, V92, P1635, DOI 10.1016/j.biochi.2010.05.009; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Ohnishi T, 2001, J IMMUNOL, V167, P3354, DOI 10.4049/jimmunol.167.6.3354; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OKAMOTO N, 1993, J INHERIT METAB DIS, V16, P435, DOI 10.1007/BF00710294; Park C, 2011, MOL BIOL EVOL, V28, P2351, DOI 10.1093/molbev/msr055; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; Raineri M, 2002, MOL CELL ENDOCRINOL, V189, P135, DOI 10.1016/S0303-7207(01)00725-0; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TYLERCROSS R, 1994, PROTEIN SCI, V3, P620; Vandenborre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016682; Varki A, 2009, GLYCOSYLATION CHANGE; Vogt G, 2005, NAT GENET, V37, P692, DOI 10.1038/ng1581; Vogt G, 2007, CURR OPIN GENET DEV, V17, P245, DOI 10.1016/j.gde.2007.04.008; Waite A, 2011, HUM MUTAT, V32, P1246, DOI 10.1002/humu.21561; Wheatley M, 1999, HUM REPROD UPDATE, V5, P356, DOI 10.1093/humupd/5.4.356; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	66	28	30	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36212	10.1371/journal.pone.0036212	http://dx.doi.org/10.1371/journal.pone.0036212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586465	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000027
J	Simonetta, F; Gestermann, N; Martinet, KZ; Boniotto, M; Tissieres, P; Seddon, B; Bourgeois, C				Simonetta, Federico; Gestermann, Nicolas; Martinet, Kim Zita; Boniotto, Michele; Tissieres, Pierre; Seddon, Benedict; Bourgeois, Christine			Interleukin-7 Influences FOXP3(+)CD4(+) Regulatory T Cells Peripheral Homeostasis	PLOS ONE			English	Article							IN-VIVO; AUTOIMMUNE-DISEASE; CD127 EXPRESSION; FOXP3 EXPRESSION; DENDRITIC CELLS; IL-7 PROMOTES; CUTTING EDGE; MEMORY CELLS; CD4(+)CD25(+); EXPANSION	Mechanisms governing peripheral CD4+ FOXP3+ regulatory T cells (Treg) survival and homeostasis are multiple suggesting tight and complex regulation of regulatory T cells homeostasis. Some specific factors, such as TGF-beta, interleukin-2 (IL-2) and B7 costimulatory molecules have been identified as essentials for maintenance of the peripheral Treg compartment. Conversely, Treg dependency upon classical T cell homeostatic factors such as IL-7 is still unclear. In this work, we formally investigated the role of IL-7 in Treg homeostasis in vivo in murine models. We demonstrated that IL-7 availability regulated the size of peripheral Treg cell pool and thus paralleled the impact of IL-7 on conventional T cell pool. Moreover, we showed that IL-7 administration increased Treg cell numbers by inducing thymic-independent Treg peripheral expansion. Importantly the impact of IL-7 on Treg expansion was detected whether conventional T cells were present or absent as IL-7 directly participates to the peripheral expansion of Treg after adoptive transfer into lymphopenic hosts. Our results definitively identify IL-7 as a central factor contributing to Treg peripheral homeostasis, thus reassembling Treg to other T cell subsets in respect of their need for IL-7 for their peripheral maintenance.	[Simonetta, Federico; Gestermann, Nicolas; Martinet, Kim Zita; Boniotto, Michele; Tissieres, Pierre; Bourgeois, Christine] INSERM, F-94275 Le Kremlin Bicetre, France; [Simonetta, Federico; Gestermann, Nicolas; Martinet, Kim Zita; Boniotto, Michele; Tissieres, Pierre; Bourgeois, Christine] Univ Paris, Le Kremlin Bicetre, France; [Seddon, Benedict] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; MRC National Institute for Medical Research	Simonetta, F (corresponding author), INSERM, F-94275 Le Kremlin Bicetre, France.	christine.bourgeois@u-psud.fr	Boniotto, Michele/AAB-4302-2020; Boniotto, Michele/F-1857-2010; Bourgeois, Christine/L-5944-2018; Bourgeois, Christine/ABA-1432-2021; Simonetta, Federico/CAH-2436-2022	Boniotto, Michele/0000-0002-9548-2254; Boniotto, Michele/0000-0002-9548-2254; Bourgeois, Christine/0000-0003-1146-6087; Bourgeois, Christine/0000-0003-1146-6087; Seddon, Benedict/0000-0003-4352-3373; Simonetta, Federico/0000-0002-0399-689X	ANRS (Agence Nationale de la recherche contre le SIDA et les hepatites virales); Fondation de France; FRM (Fondation pour la recherche medicale); MRC [MC_U117573801] Funding Source: UKRI; Medical Research Council [MC_U117573801] Funding Source: researchfish	ANRS (Agence Nationale de la recherche contre le SIDA et les hepatites virales)(ANRSFrench National Research Agency (ANR)); Fondation de France(Fondation de France); FRM (Fondation pour la recherche medicale)(Fondation pour la Recherche Medicale); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the ANRS (Agence Nationale de la recherche contre le SIDA et les hepatites virales) and Fondation de France. Federico Simonetta was also supported by the FRM (Fondation pour la recherche medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bayer AL, 2008, J IMMUNOL, V181, P225, DOI 10.4049/jimmunol.181.1.225; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Boyman O, 2008, J IMMUNOL, V180, P7265, DOI 10.4049/jimmunol.180.11.7265; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Cozzo C, 2003, J IMMUNOL, V171, P5678, DOI 10.4049/jimmunol.171.11.5678; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; de Latour RP, 2006, BLOOD, V108, P2300, DOI 10.1182/blood-2006-04-017947; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Grinberg-Bleyer Y, 2010, J CLIN INVEST, V120, P4558, DOI 10.1172/JCI42945; Harnaha J, 2006, DIABETES, V55, P158, DOI 10.2337/diabetes.55.01.06.db05-0340; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Pandiyan P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-6; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wuest TY, 2008, J LEUKOCYTE BIOL, V84, P973, DOI 10.1189/jlb.1107778; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	48	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36596	10.1371/journal.pone.0036596	http://dx.doi.org/10.1371/journal.pone.0036596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586481	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000042
J	Anand, K; Maeda, K; Gavin, AC				Anand, Kanchan; Maeda, Kenji; Gavin, Anne-Claude			Structural Analyses of the Slm1-PH Domain Demonstrate Ligand Binding in the Non-Canonical Site	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PH DOMAIN; PHOSPHOINOSITIDE BINDING; SACCHAROMYCES-CEREVISIAE; MOLECULAR REPLACEMENT; ACTIN CYTOSKELETON; PROTEINS SLM1; KINASE; SPECIFICITY; YEAST	Background: Pleckstrin homology (PH) domains are common membrane-targeting modules and their best characterized ligands are a set of important signaling lipids that include phosphatidylinositol phosphates (PtdInsPs). PH domains recognize PtdInsPs through two distinct mechanisms that use different binding pockets on opposite sides of the beta-strands 1 and 2: i) a canonical binding site delimited by the beta 1-beta 2 and beta 3-beta 4loops and ii) a non-canonical binding site bordered by the beta 1-beta 2 and beta b5-beta 6loops. The PH domain-containing protein Slm1 from budding yeast Saccharomyces cerevisiae is required for actin cytoskeleton polarization and cell growth. We recently reported that this PH domain binds PtdInsPs and phosphorylated sphingolipids in a cooperative manner. Principal Findings: To study the structural basis for the Slm1-PH domain (Slm1-PH) specificity, we co-crystallized this domain with different soluble compounds that have structures analogous to anionic lipid head groups of reported Slm1 ligands: inositol 4-phosphate, which mimics phosphatidylinositol-4-phosphate (PtdIns(4)P), and phosphoserine as a surrogate for dihydrosphingosine 1-phosphate (DHS1-P). We found electron densities for the ligands within the so-called non-canonical binding site. An additional positively charged surface that contacts a phosphate group was identified next to the canonical binding site. Conclusions: Our results suggest that Slm1-PH utilizes a non-canonical binding site to bind PtdInsPs, similar to that described for the PH domains of beta-spectrin, Tiam1 and ArhGAP9. Additionally, Slm1-PH may have retained an active canonical site. We propose that the presence of both a canonical and a non-canonical binding pocket in Slm1-PH may account for the cooperative binding to PtdInsPs and DHS-1P.	[Anand, Kanchan; Maeda, Kenji; Gavin, Anne-Claude] European Mol Biol Lab Heidelberg, Struct & Computat Biol Unit, Heidelberg, Germany; [Anand, Kanchan] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44139 Dortmund, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Anand, K (corresponding author), European Mol Biol Lab Heidelberg, Struct & Computat Biol Unit, Heidelberg, Germany.	anand@embl.de; gavin@embl.de		Gavin, Anne-Claude/0000-0003-4917-2340; Maeda, Kenji/0000-0002-9080-5691	Federal Ministry of Education and Research (BMBF) [FKZ0315162]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was partially funded by the Federal Ministry of Education and Research (BMBF; FKZ0315162) in the framework of the BioChancePLUS-4 to ACG. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Byrne RD, 2007, CELL SIGNAL, V19, P321, DOI 10.1016/j.cellsig.2006.07.004; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edlich C, 2005, STRUCTURE, V13, P277, DOI 10.1016/j.str.2004.11.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FERGUSON KM, 1995, NAT STRUCT BIOL, V2, P715, DOI 10.1038/nsb0995-715; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Hiestand Peter C., 2008, V66; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Koshiba S, 1997, J MOL BIOL, V269, P579, DOI 10.1006/jmbi.1997.1041; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Mansoor M, 2008, REV RECENT CLIN TRIA, V3, P62, DOI 10.2174/157488708783330486; Parker PJ, 1999, PHARMACOL THERAPEUT, V82, P263, DOI 10.1016/S0163-7258(98)00047-3; PARKER PJ, 1994, TRENDS BIOCHEM SCI, V19, P54, DOI 10.1016/0968-0004(94)90031-0; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; SARASTE M, 1995, CURR OPIN STRUC BIOL, V5, P403, DOI 10.1016/0959-440X(95)80104-9; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845	39	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36526	10.1371/journal.pone.0036526	http://dx.doi.org/10.1371/journal.pone.0036526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574179	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800076
J	Jiang, JF; Lu, JY; Lu, D; Liang, ZJ; Li, LC; Ouyang, SS; Kong, XQ; Jiang, HL; Shen, BR; Luo, C				Jiang, Junfeng; Lu, Junyan; Lu, Dan; Liang, Zhongjie; Li, Lianchun; Ouyang, Sisheng; Kong, Xiangqian; Jiang, Hualiang; Shen, Bairong; Luo, Cheng			Investigation of the Acetylation Mechanism by GCN5 Histone Acetyltransferase	PLOS ONE			English	Article							CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; COENZYME-A; PROTON-WIRE; TRANSCRIPTIONAL COACTIVATOR; N-ACETYLTRANSFERASES; POSITIVE REGULATION; MOLECULAR-DYNAMICS; KINETIC MECHANISM; GENE-EXPRESSION	The histone acetylation of post-translational modification can be highly dynamic and play a crucial role in regulating cellular proliferation, survival, differentiation and motility. Of the enzymes that mediate post-translation modifications, the GCN5 of the histone acetyltransferase (HAT) proteins family that add acetyl groups to target lysine residues within histones, has been most extensively studied. According to the mechanism studies of GCN5 related proteins, two key processes, deprotonation and acetylation, must be involved. However, as a fundamental issue, the structure of hGCN5/AcCoA/pH3 remains elusive. Although biological experiments have proved that GCN5 mediates the acetylation process through the sequential mechanism pathway, a dynamic view of the catalytic process and the molecular basis for hGCN5/AcCoA/pH3 are still not available and none of theoretical studies has been reported to other related enzymes in HAT family. To explore the molecular basis for the catalytic mechanism, computational approaches including molecular modeling, molecular dynamic (MD) simulation and quantum mechanics/molecular mechanics (QM/MM) simulation were carried out. The initial hGCN5/AcCoA/pH3 complex structure was modeled and a reasonable snapshot was extracted from the trajectory of a 20 ns MD simulation, with considering post-MD analysis and reported experimental results. Those residues playing crucial roles in binding affinity and acetylation reaction were comprehensively investigated. It demonstrated Glu80 acted as the general base for deprotonation of Lys171 from H3. Furthermore, the two-dimensional QM/MM potential energy surface was employed to study the sequential pathway acetylation mechanism. Energy barriers of addition-elimination reaction in acetylation obtained from QM/MM calculation indicated the point of the intermediate ternary complex. Our study may provide insights into the detailed mechanism for acetylation reaction of GCN5, and has important implications for the discovery of regulators against GCN5 enzymes and related HAT family enzymes.	[Jiang, Junfeng; Lu, Dan; Liang, Zhongjie; Li, Lianchun; Ouyang, Sisheng; Kong, Xiangqian; Shen, Bairong; Luo, Cheng] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China; [Jiang, Junfeng; Lu, Junyan; Jiang, Hualiang; Luo, Cheng] Chinese Acad Med Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai, Peoples R China	Soochow University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Jiang, JF (corresponding author), Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China.	bairong.shen@suda.edu.cn; cluo@mail.shcnc.ac.cn	Liang, Zhongjie/F-2108-2019; Shen, Bairong/E-6431-2012; Shen, Bairong/W-1254-2019; Kong, Xiangqian/J-4500-2017	Liang, Zhongjie/0000-0003-0763-5407; Shen, Bairong/0000-0003-2899-1531; Shen, Bairong/0000-0003-2899-1531; Kong, Xiangqian/0000-0002-9596-7825; Lu, Junyan/0000-0002-9211-0746	State Key Program of Basic Research of China [2009CB918502]; National Natural Science Foundation of China [20972174, 21021063, 20872107, 91029703, 91029704]; Shanghai Committee of Science and Technology [10410703900]; Chinese Academy of Sciences [XDA01040305]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors gratefully acknowledge financial support from the State Key Program of Basic Research of China grant (2009CB918502), the National Natural Science Foundation of China grants (20972174, 21021063, 20872107, 91029703 and 91029704), Shanghai Committee of Science and Technology grants (10410703900) and the Chinese Academy of Sciences (XDA01040305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2007, J PHYS CHEM B, V111, P7870, DOI 10.1021/jp071403p; Akiyama T, 2004, MOL REPROD DEV, V69, P222, DOI 10.1002/mrd.20121; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Brand M, 1999, J BIOL CHEM, V274, P18285, DOI 10.1074/jbc.274.26.18285; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Gao J, 1996, REV COMPUTATIONAL CH, P119; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; HINNEBUSCH AG, 1983, P NATL ACAD SCI-BIOL, V80, P5374, DOI 10.1073/pnas.80.17.5374; HONG L, 1993, J BIOL CHEM, V268, P305; Hu H, 2008, ANNU REV PHYS CHEM, V59, P573, DOI 10.1146/annurev.physchem.59.032607.093618; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jeppesen P, 1997, BIOESSAYS, V19, P67, DOI 10.1002/bies.950190111; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kikuchi H, 2011, J IMMUNOL, V186, P3015, DOI 10.4049/jimmunol.1000364; Kong XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025444; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; LEWENDON A, 1994, BIOCHEMISTRY-US, V33, P1944, DOI 10.1021/bi00173a043; Liang ZJ, 2010, J PHYS CHEM B, V114, P11927, DOI 10.1021/jp1054183; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Lu YX, 2009, J PHYS CHEM B, V113, P12615, DOI 10.1021/jp906352e; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; MEYER E, 1992, PROTEIN SCI, V1, P1543, DOI 10.1002/pro.5560011203; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Riccardi D, 2006, J PHYS CHEM B, V110, P6458, DOI 10.1021/jp056361o; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Schuetz A, 2007, PROTEINS, V68, P403, DOI 10.1002/prot.21407; Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019; Sternglanz R, 1999, P NATL ACAD SCI USA, V96, P8807, DOI 10.1073/pnas.96.16.8807; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 2000, BIOCHEMISTRY-US, V39, P15652, DOI 10.1021/bi005121q; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; THOMPSON S, 1989, BIOCHEMISTRY-US, V28, P5735, DOI 10.1021/bi00440a006; Timmermann S, 2001, CELL MOL LIFE SCI, V58, P728, DOI 10.1007/PL00000896; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; Vendrell O, 2008, J PHYS CHEM B, V112, P5500, DOI 10.1021/jp801169z; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Wu RB, 2010, J AM CHEM SOC, V132, P9471, DOI 10.1021/ja103932d; Zhang XD, 2007, BIOCHEMISTRY-US, V46, P5505, DOI 10.1021/bi700119p; Zhang YK, 2006, THEOR CHEM ACC, V116, P43, DOI 10.1007/s00214-005-0008-x; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	65	20	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36660	10.1371/journal.pone.0036660	http://dx.doi.org/10.1371/journal.pone.0036660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574209	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800106
J	Nicolas, V; Schaeffer, B; Missoup, AD; Kennis, J; Colyn, M; Denys, C; Tatard, C; Cruaud, C; Laredo, C				Nicolas, Violaine; Schaeffer, Brigitte; Missoup, Alain Didier; Kennis, Jan; Colyn, Marc; Denys, Christiane; Tatard, Caroline; Cruaud, Corinne; Laredo, Catherine			Assessment of Three Mitochondrial Genes (16S, Cytb, CO1) for Identifying Species in the Praomyini Tribe (Rodentia: Muridae)	PLOS ONE			English	Article							SMALL MAMMALS; LASSA FEVER; MORPHOMETRIC VARIATION; RAIN-FOREST; DNA; PHYLOGENY; PHYLOGEOGRAPHY; DIVERSITY; COMMUNITY; TAXONOMY	The Praomyini tribe is one of the most diverse and abundant groups of Old World rodents. Several species are known to be involved in crop damage and in the epidemiology of several human and cattle diseases. Due to the existence of sibling species their identification is often problematic. Thus an easy, fast and accurate species identification tool is needed for non-systematicians to correctly identify Praomyini species. In this study we compare the usefulness of three genes (16S, Cytb, CO1) for identifying species of this tribe. A total of 426 specimens representing 40 species (sampled across their geographical range) were sequenced for the three genes. Nearly all of the species included in our study are monophyletic in the neighbour joining trees. The degree of intra-specific variability tends to be lower than the divergence between species, but no barcoding gap is detected. The success rate of the statistical methods of species identification is excellent (up to 99% or 100% for statistical supervised classification methods as the k-Nearest Neighbour or Random Forest). The 16S gene is 2.5 less variable than the Cytb and CO1 genes. As a result its discriminatory power is smaller. To sum up, our results suggest that using DNA markers for identifying species in the Praomyini tribe is a largely valid approach, and that the CO1 and Cytb genes are better DNA markers than the 16S gene. Our results confirm the usefulness of statistical methods such as the Random Forest and the 1-NN methods to assign a sequence to a species, even when the number of species is relatively large. Based on our NJ trees and the distribution of all intraspecific and interspecific pairwise nucleotide distances, we highlight the presence of several potentially new species within the Praomyini tribe that should be subject to corroboration assessments.	[Nicolas, Violaine; Missoup, Alain Didier; Denys, Christiane] Museum Natl Hist Nat, CNRS, UMR 7205, Dept Systemat & Evolut, F-75231 Paris, France; [Schaeffer, Brigitte; Laredo, Catherine] INRA, Math & Informat Appl UR341, Jouy En Josas, France; [Missoup, Alain Didier] Univ Douala, Fac Sci, Dept Anim Biol Organisms, Douala, Cameroon; [Kennis, Jan] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Colyn, Marc] Univ Rennes 1, UMR CNRS Ecobio 6553, Paimpont, France; [Tatard, Caroline] IRD, Ctr Biol & Gest Populat, UMR 022, Montferrier Sur Lez, France; [Cruaud, Corinne] Ctr Natl Sequencage, Evry, France; [Laredo, Catherine] Univ Paris 07, LPMA UMR 7599, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Antwerp; Universite de Rennes; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite	Nicolas, V (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7205, Dept Systemat & Evolut, F-75231 Paris, France.	vnicolas@mnhn.fr	Denys, Christiane/K-8144-2019; Kennis, Jan/D-4064-2018; Kennis, Jan/AAD-2244-2019; Nicolas, Violaine/N-9991-2017	Denys, Christiane/0000-0002-1519-1546; Kennis, Jan/0000-0002-6431-1372; Kennis, Jan/0000-0002-6431-1372; Nicolas, Violaine/0000-0001-5384-7529; Cruaud, Corinne/0000-0002-4752-7278	Action Transversale du Museum: Taxonomie moleculaire, DNA Barcode & gestion durable des collections; 'Consortium National de Recheche en Genomique' (Evry, France); 'Service de Systematique Moleculaire' of the Museum National d'Histoire Naturelle (UMS 2700, Paris, France); Genoscope [2005/67]; Museum National d'Histoire Naturelle on the project 'Macrophylogeny of life' [2005/67]	Action Transversale du Museum: Taxonomie moleculaire, DNA Barcode & gestion durable des collections; 'Consortium National de Recheche en Genomique' (Evry, France); 'Service de Systematique Moleculaire' of the Museum National d'Histoire Naturelle (UMS 2700, Paris, France); Genoscope; Museum National d'Histoire Naturelle on the project 'Macrophylogeny of life'	This research was supported by the "Action Transversale du Museum: Taxonomie moleculaire, DNA Barcode & gestion durable des collections", the 'Consortium National de Recheche en Genomique' (Evry, France), and the 'Service de Systematique Moleculaire' of the Museum National d'Histoire Naturelle (UMS 2700, Paris, France). It is part of the agreement no. 2005/67 between the Genoscope and the Museum National d'Histoire Naturelle on the project 'Macrophylogeny of life' directed by Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Avise J.C, 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Barriere P, 2008, RAPID BIOL ASSESSMEN, P54; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brouat C, 2009, J BIOGEOGR, V36, P2237, DOI 10.1111/j.1365-2699.2009.02184.x; Bryja J, 2010, MOL ECOL, V19, P4783, DOI 10.1111/j.1365-294X.2010.04847.x; Caro TM, 2001, BIOL CONSERV, V98, P251, DOI 10.1016/S0006-3207(00)00105-1; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Clarke B, 2009, PRINICIPLES THEORY D; Colangelo P, 2007, MOL PHYLOGENET EVOL, V42, P797, DOI 10.1016/j.ympev.2006.10.001; Coulibaly-N'Golo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020893; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; de Queiroz K, 1998, ENDLESS FORMS, P57; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Dobigny G, 2008, J ZOOL, V276, P368, DOI 10.1111/j.1469-7998.2008.00500.x; Ducroz J. F., 2001, Journal of Mammalian Evolution, V8, P173, DOI 10.1023/A:1012277012303; DUPLANTIER JM, 1989, REV ECOL-TERRE VIE, V44, P329; Durnez L, 2008, APPL ENVIRON MICROB, V74, P768, DOI 10.1128/AEM.01193-07; Durnez L, 2010, APPL ENVIRON MICROB, V76, P4574, DOI 10.1128/AEM.00199-10; Fadda C, 2001, BIOCHEM SYST ECOL, V29, P585, DOI 10.1016/S0305-1978(00)00087-9; Fichet-Calvet E, 2005, BELG J ZOOL, V135, P63; Fichet-Calvet E, 2009, BELG J ZOOL, V139, P93; Fix E., 1951, DISCRIMINATORY ANAL; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Goldstein PZ, BIOESSAYS IN PRESS; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Holt J, 2006, ACTA TROP, V99, P218, DOI 10.1016/j.actatropica.2006.08.003; Janzen DH, 2004, PHILOS T R SOC B, V359, P731, DOI 10.1098/rstb.2003.1444; Kennis J, ZOOL J LINN IN PRESS; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Lecompte E, 2005, BIOCHEM SYST ECOL, V33, P681, DOI 10.1016/j.bse.2004.12.015; Lecompte E, 2002, CR BIOL, V325, P827, DOI 10.1016/S1631-0691(02)01488-9; Lecompte E, 2006, EMERG INFECT DIS, V12, P1971; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Lecompte F, 2005, MOL PHYLOGENET EVOL, V37, P899, DOI 10.1016/j.ympev.2005.06.018; Makundi RH, 2008, MAMMALIA, V72, P253, DOI 10.1515/MAMM.2008.038; Matocq MD, 2007, MOL PHYLOGENET EVOL, V42, P637, DOI 10.1016/j.ympev.2006.08.011; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monadjem A, 2005, RAPID SURVEY BATS N, P20; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Mouline K, 2008, MOL ECOL, V17, P1036, DOI 10.1111/j.1365-294X.2007.03610.x; MUSSER GG, 2005, MAMMAL SPECIES WORLD, V2, P894; Nesi N, 2011, CR BIOL, V334, P544, DOI 10.1016/j.crvi.2011.05.003; Nicolas V, 2008, MOL ECOL, V17, P5118, DOI 10.1111/j.1365-294X.2008.03974.x; Nicolas V, 2006, MOL PHYLOGENET EVOL, V38, P779, DOI 10.1016/j.ympev.2005.11.024; Nicolas V, 2005, ZOOL J LINN SOC-LOND, V145, P539, DOI 10.1111/j.1096-3642.2005.00196.x; Nicolas V, 2011, J BIOGEOGR, V38, P191, DOI 10.1111/j.1365-2699.2010.02399.x; Nicolas V, 2003, CAN J ZOOL, V81, P1034, DOI 10.1139/Z03-092; Nicolas V, 2008, J BIOGEOGR, V35, P2074, DOI 10.1111/j.1365-2699.2008.01950.x; Nicolas V, 2008, J MAMMAL, V89, P222, DOI 10.1644/06-MAMM-A-286.1; Nicolas V, 2010, ZOOTAXA, P30, DOI 10.11646/zootaxa.2579.1.2; Nicolas V, 2010, ZOOL J LINN SOC-LOND, V160, P397, DOI 10.1111/j.1096-3642.2009.00602.x; Nicolas V, 2009, BIOL J LINN SOC, V98, P29, DOI 10.1111/j.1095-8312.2009.01273.x; O'Brien C, 2006, B BIOL SOC, V12, P137; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Ogbu O., 2007, Journal of Vector Borne Diseases, V44, P1; Olayemi A, 2008, BIODIVERS CONSERV, V17, P2411, DOI 10.1007/s10531-008-9389-1; Padial JM, 2010, BIOL J LINN SOC, V101, P747, DOI 10.1111/j.1095-8312.2010.01528.x; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Palumbi S., 1991, SIMPLE FOOLS GUIDE P; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Querouil S, 2001, MOL PHYLOGENET EVOL, V20, P185, DOI 10.1006/mpev.2001.0974; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sluydts V, 2009, CROP PROT, V28, P647, DOI 10.1016/j.cropro.2009.03.018; Stenseth NC, 2001, J APPL ECOL, V38, P1020, DOI 10.1046/j.1365-2664.2001.00656.x; Swofford D, 2000, APUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobe SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014156; van der Straeten E., 1990, P73; van der Straeten E, 1999, S AFR J ZOOL, V34, P80; Van der Straeten E, 1987, STUTTGARTER BEITRAGE, V402, P1; Van der Straeten E, 2003, BONNER ZOOLOGISCHE B, V50, P329; Van der Straeten Erik, 2008, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V1, P123; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407	88	73	89	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36586	10.1371/journal.pone.0036586	http://dx.doi.org/10.1371/journal.pone.0036586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574186	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800083
J	Qin, XY; Kojima, Y; Mizuno, K; Ueoka, K; Muroya, K; Miyado, M; Zaha, H; Akanuma, H; Zeng, Q; Fukuda, T; Yoshinaga, J; Yonemoto, J; Kohri, K; Hayashi, Y; Fukami, M; Ogata, T; Sone, H				Qin, Xian-Yang; Kojima, Yoshiyuki; Mizuno, Kentaro; Ueoka, Katsuhiko; Muroya, Koji; Miyado, Mami; Zaha, Hiroko; Akanuma, Hiromi; Zeng, Qin; Fukuda, Tomokazu; Yoshinaga, Jun; Yonemoto, Junzo; Kohri, Kenjiro; Hayashi, Yutaro; Fukami, Maki; Ogata, Tsutomu; Sone, Hideko			Identification of Novel Low-Dose Bisphenol A Targets in Human Foreskin Fibroblast Cells Derived from Hypospadias Patients	PLOS ONE			English	Article							TESTICULAR DYSGENESIS SYNDROME; MATRIX-METALLOPROTEINASE STROMELYSIN-3; MESSENGER-RNA EXPRESSION; HUMAN EXPOSURE; CANCER CELLS; IN-VITRO; ABNORMALITIES; GENE; CRYPTORCHIDISM; MECHANISMS	Background/Purpose: The effect of low-dose bisphenol A (BPA) exposure on human reproductive health is still controversial. To better understand the molecular basis of the effect of BPA on human reproductive health, a genome-wide screen was performed using human foreskin fibroblast cells (hFFCs) derived from child hypospadias (HS) patients to identify novel targets of low-dose BPA exposure. Methodology/Principal Findings: Gene expression profiles of hFFCs were measured after exposure to 10 nM BPA, 0.01 nM 17 beta-estradiol (E2) or 1 nM 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for 24 h. Differentially expressed genes were identified using an unpaired Student's t test with P value cut off at 0.05 and fold change of more than 1.2. These genes were selected for network generation and pathway analysis using Ingenuity Pathways Analysis, Pathway Express and KegArray. Seventy-one genes (42 downregulated and 29 upregulated) were identified as significantly differentially expressed in response to BPA, among which 43 genes were found to be affected exclusively by BPA compared with E2 and TCDD. Of particular interest, real-time PCR analysis revealed that the expression of matrix metallopeptidase 11 (MMP11), a well-known effector of development and normal physiology, was found to be inhibited by BPA (0.47-fold and 0.37-fold at 10 nM and 100 nM, respectively). Furthermore, study of hFFCs derived from HS and cryptorchidism (CO) patients (n = 23 and 11, respectively) indicated that MMP11 expression was significantly lower in the HS group than in the CO group (0.25-fold, P = 0.0027). Conclusions/Significance: This present study suggests that an involvement of BPA in the etiology of HS might be associated with the downregulation of MMP11. Further study to elucidate the function of the novel target genes identified in this study during genital tubercle development might increase our knowledge of the effects of low-dose BPA exposure on human reproductive health.	[Qin, Xian-Yang; Zaha, Hiroko; Akanuma, Hiromi; Zeng, Qin; Yonemoto, Junzo; Sone, Hideko] Natl Inst Environm Studies, Hlth Risk Res Sect, Res Ctr Environm Risk, Tsukuba, Ibaraki, Japan; [Qin, Xian-Yang; Yoshinaga, Jun] Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Studies, Kashiwa, Chiba, Japan; [Kojima, Yoshiyuki; Mizuno, Kentaro; Kohri, Kenjiro; Hayashi, Yutaro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephro Urol, Nagoya, Aichi, Japan; [Ueoka, Katsuhiko] Natl Res Ctr Child Hlth & Dev, Dept Surg Subspecialties, Tokyo, Japan; [Muroya, Koji] Kanagawa Childrens Med Ctr, Div Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Miyado, Mami; Fukami, Maki; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo, Japan; [Fukuda, Tomokazu] Tohoku Univ, Grad Sch Agr Sci, Dept Anim Prod Sci, Sendai, Miyagi 980, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Univ Hosp, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	National Institute for Environmental Studies - Japan; University of Tokyo; Nagoya City University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Tohoku University; Hamamatsu University School of Medicine	Qin, XY (corresponding author), Natl Inst Environm Studies, Hlth Risk Res Sect, Res Ctr Environm Risk, Tsukuba, Ibaraki, Japan.	hsone@nies.go.jp	Muroya, Koji/J-1304-2016; Qin, Xian-Yang/AAB-5628-2020; Fukami, Maki/ABE-4694-2020; Mizuno, Kentaro/H-8950-2019; Fukuda, Tomokazu/O-1257-2018	Muroya, Koji/0000-0002-1810-9894; Fukami, Maki/0000-0001-9971-4035; Mizuno, Kentaro/0000-0002-9624-2009; Ogata, Tsutomu/0000-0001-7178-9991; Fukuda, Tomokazu/0000-0001-8456-0483	Ministry of the Environment, Japan; Ministry of Health, Labour and Welfare, Japan [H20-004]; Grants-in-Aid for Scientific Research [22227002] Funding Source: KAKEN	Ministry of the Environment, Japan(Ministry of the Environment, Japan); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of the Environment, Japan, and by a grant for Research on Risk on Chemical Substances (H20-004) from the Ministry of Health, Labour and Welfare, Japan (http://www.mhlw.go.jp/english/index.html). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; Baskin LS, 2001, CELL TISSUE RES, V305, P379, DOI 10.1007/s004410000345; Bronner IF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006826; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Desmedt C, 2012, CLIN CANCER RES, V18, P1004, DOI 10.1158/1078-0432.CCR-11-0383; Garavelli L, 2005, HORM RES, V63, P187, DOI 10.1159/000085894; Gibert Y, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-4; Harada Y, 2010, CANCER RES, V70, P5829, DOI 10.1158/0008-5472.CAN-10-0255; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Jorgensen N, 2010, INT J ANDROL, V33, P298, DOI 10.1111/j.1365-2605.2009.01050.x; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Kojima Y, 2010, J PEDIATR UROL, V6, P346, DOI 10.1016/j.jpurol.2009.11.007; Kojima Y, 2009, UROLOGY, V74, P571, DOI 10.1016/j.urology.2009.04.037; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Leranth C, 2008, P NATL ACAD SCI USA, V105, P14187, DOI 10.1073/pnas.0806139105; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Lupo A, 2011, INT J BIOCHEM CELL B, V43, P470, DOI 10.1016/j.biocel.2010.12.020; McCord LA, 2011, BIOL REPROD; Peruzzi D, 2009, CLIN CANCER RES, V15, P4104, DOI 10.1158/1078-0432.CCR-08-3226; Qiao LA, 2011, J UROLOGY, V185, P1888, DOI 10.1016/j.juro.2010.12.066; Qin XY, 2011, TOXICOL LETT, V206, P152, DOI 10.1016/j.toxlet.2011.07.007; Qin XY, 2012, CANC BIOL THER, P13; Rey RA, 2005, J CLIN ENDOCR METAB, V90, P6035, DOI 10.1210/jc.2005-1306; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Sharpe RM, 2010, TOXICOL SCI, V114, P1, DOI 10.1093/toxsci/kfp299; Simian M, 2001, DEVELOPMENT, V128, P3117; Singleton DW, 2006, ENVIRON RES, V100, P86, DOI 10.1016/j.envres.2005.05.004; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Toppari J, 2010, BIRTH DEFECTS RES A, V88, P910, DOI 10.1002/bdra.20707; Valdivia A, 2011, INT J CLIN EXP PATHO, V4, P674; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Virtanen HE, 2007, ACTA PAEDIATR, V96, P611, DOI 10.1111/j.1651-2227.2007.00241.x; Vottero A, 2011, J CLIN ENDOCR METAB, V96, pE1953, DOI 10.1210/jc.2011-0511; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang Z, 2007, J UROLOGY, V177, P1939, DOI 10.1016/j.juro.2007.01.014; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Wei L, 2005, HISTOL HISTOPATHOL, V20, P177, DOI 10.14670/HH-20.177; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Zhang XW, 2011, TOXICOL SCI, V121, P320, DOI 10.1093/toxsci/kfr061	44	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36711	10.1371/journal.pone.0036711	http://dx.doi.org/10.1371/journal.pone.0036711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574217	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800114
J	Regev, T; Myers, N; Zarivach, R; Fishov, I				Regev, Tomer; Myers, Nadav; Zarivach, Raz; Fishov, Itzhak			Association of the Chromosome Replication Initiator DnaA with the Escherichia coli Inner Membrane In Vivo: Quantity and Mode of Binding	PLOS ONE			English	Article							FUNCTIONAL INTERACTION; ACIDIC PHOSPHOLIPIDS; AMPHITROPIC PROTEINS; STRUCTURAL BASIS; LIPID DOMAINS; E. COLI; NUCLEOTIDE; SITE; IDENTIFICATION; MECHANISMS	DnaA initiates chromosome replication in most known bacteria and its activity is controlled so that this event occurs only once every cell division cycle. ATP in the active ATP-DnaA is hydrolyzed after initiation and the resulting ADP is replaced with ATP on the verge of the next initiation. Two putative recycling mechanisms depend on the binding of DnaA either to the membrane or to specific chromosomal sites, promoting nucleotide dissociation. While there is no doubt that DnaA interacts with artificial membranes in vitro, it is still controversial as to whether it binds the cytoplasmic membrane in vivo. In this work we looked for DnaA-membrane interaction in E. coli cells by employing cell fractionation with both native and fluorescent DnaA hybrids. We show that about 10% of cellular DnaA is reproducibly membrane-associated. This small fraction might be physiologically significant and represent the free DnaA available for initiation, rather than the vast majority bound to the datA reservoir. Using the combination of mCherry with a variety of DnaA fragments, we demonstrate that the membrane binding function is delocalized on the surface of the protein's domain III, rather than confined to a particular sequence. We propose a new binding-bending mechanism to explain the membrane-induced nucleotide release from DnaA. This mechanism would be fundamental to the initiation of replication.	[Regev, Tomer; Myers, Nadav; Zarivach, Raz; Fishov, Itzhak] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Zarivach, Raz] Ben Gurion Univ Negev, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Regev, T (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	fishov@bgu.ac.il	FISHOV, ITZHAK/F-2264-2012; ZARIVACH, RAZ/F-1671-2012	ZARIVACH, RAZ/0000-0001-6543-0296; Fishov, Itzhak/0000-0002-2125-0012				Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Aranovich A, 2006, J BIOL CHEM, V281, P12526, DOI 10.1074/jbc.M510266200; Aranovich A, 2007, FEBS LETT, V581, P4439, DOI 10.1016/j.febslet.2007.08.019; ATLUNG T, 1993, J BACTERIOL, V175, P6537, DOI 10.1128/jb.175.20.6537-6545.1993; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bipatnath M, 1998, J BACTERIOL, V180, P265, DOI 10.1128/JB.180.2.265-273.1998; Blaesing F, 2000, MOL MICROBIOL, V36, P557, DOI 10.1046/j.1365-2958.2000.01881.x; Boeneman K, 2009, MOL MICROBIOL, V72, P645, DOI 10.1111/j.1365-2958.2009.06674.x; CASTUMA CE, 1993, J BIOL CHEM, V268, P24665; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Cronan JE, 1987, ESCHERICHIA COLI SAL, P31; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; FUTAI M, 1974, J MEMBRANE BIOL, V15, P15, DOI 10.1007/BF01870079; Garner J, 1998, J BIOL CHEM, V273, P5167, DOI 10.1074/jbc.273.9.5167; Garner J, 1996, EMBO J, V15, P2313, DOI 10.1002/j.1460-2075.1996.tb00585.x; Guo S, 2008, BIOCHEMISTRY-US, V47, P4201, DOI 10.1021/bi702269u; HANSEN FG, 1991, J BACTERIOL, V173, P5194, DOI 10.1128/jb.173.16.5194-5199.1991; Hase M, 1998, J BIOL CHEM, V273, P28651, DOI 10.1074/jbc.273.44.28651; HELMSTETTER CE, 1996, ESCHERICHIA COLI SAL, P1627; Herrick J, 1996, MOL MICROBIOL, V19, P659, DOI 10.1046/j.1365-2958.1996.432956.x; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; Kitagawa R, 1996, MOL MICROBIOL, V19, P1137, DOI 10.1046/j.1365-2958.1996.453983.x; Kitchen JL, 1999, BIOCHEMISTRY-US, V38, P6213, DOI 10.1021/bi982733q; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Leonard AC, 2009, GENE DEV, V23, P1145, DOI 10.1101/gad.1809909; Li ZY, 2005, J BIOL CHEM, V280, P9796, DOI 10.1074/jbc.M413923200; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; Makise M, 2000, J BIOL CHEM, V275, P4513, DOI 10.1074/jbc.275.6.4513; Makise M, 2002, BIOCHEM J, V362, P453, DOI 10.1042/0264-6021:3620453; Makise M, 2001, J BIOL CHEM, V276, P7450, DOI 10.1074/jbc.M009643200; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Messer W, 1999, BIOCHIMIE, V81, P819, DOI 10.1016/S0300-9084(00)87165-5; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Molt KL, 2009, GENETICS, V183, P39, DOI 10.1534/genetics.109.104760; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Newman G, 2000, J BACTERIOL, V182, P2604, DOI 10.1128/JB.182.9.2604-2610.2000; Nozaki S, 2009, J BACTERIOL; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Roth A, 1998, MOL MICROBIOL, V28, P395, DOI 10.1046/j.1365-2958.1998.00813.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7136; Simmons LA, 2003, MOL MICROBIOL, V49, P849, DOI 10.1046/j.1365-2958.2003.03603.x; SKARSTAD K, 1989, MOL GEN GENET, V218, P50, DOI 10.1007/BF00330564; Skarstad K, 2000, MOL MICROBIOL, V36, P1319, DOI 10.1046/j.1365-2958.2000.01943.x; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Skovgaard O, 2005, MICROBIOL-SGM, V151, P963, DOI 10.1099/mic.0.27630-0; Soufo CD, 2008, DEV CELL, V15, P935, DOI 10.1016/j.devcel.2008.09.010; Weigel C, 1999, MOL MICROBIOL, V34, P53, DOI 10.1046/j.1365-2958.1999.01568.x; XIA WM, 1995, P NATL ACAD SCI USA, V92, P783, DOI 10.1073/pnas.92.3.783; Yamaguchi Y, 1999, BIOCHEM J, V340, P433, DOI 10.1042/0264-6021:3400433; Yamamoto K, 2008, J BIOCHEM, V143, P759, DOI 10.1093/jb/mvn025; YUNG BYM, 1988, P NATL ACAD SCI USA, V85, P7202, DOI 10.1073/pnas.85.19.7202; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x; Zawilak A, 2003, J MOL BIOL, V334, P933, DOI 10.1016/j.jmb.2003.10.018; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng WD, 2001, EMBO J, V20, P1164, DOI 10.1093/emboj/20.5.1164	68	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36441	10.1371/journal.pone.0036441	http://dx.doi.org/10.1371/journal.pone.0036441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574163	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800059
J	Ni, WY; Le Guiner, C; Moullier, P; Snyder, RO				Ni, Weiyi; Le Guiner, Caroline; Moullier, Philippe; Snyder, Richard O.			Development and Utility of an Internal Threshold Control (ITC) Real-Time PCR Assay for Exogenous DNA Detection	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; DIRECT GENE-TRANSFER; SKELETAL-MUSCLE; HOUSEKEEPING GENES; PLASMID DNA; FACTOR-IX; VECTOR; THERAPY; SAFETY; BIODISTRIBUTION	Sensitive and specific tests for detecting exogenous DNA molecules are useful for infectious disease diagnosis, gene therapy clinical trial safety, and gene doping surveillance. Taqman real-time PCR using specific sequence probes provides an effective approach to accurately and quantitatively detect exogenous DNA. However, one of the major challenges in these analyses is to eliminate false positive signals caused by either non-targeted exogenous or endogenous DNA sequences, or false negative signals caused by impurities that inhibit PCR. Although multiplex Taqman PCR assays have been applied to address these problems by adding extra primer-probe sets targeted to endogenous DNA sequences, the differences between targets can lead to different detection efficiencies. To avoid these complications, a Taqman PCR-based approach that incorporates an internal threshold control (ITC) has been developed. In this single reaction format, the target sequence and ITC template are co-amplified by the same primers, but are detected by different probes each with a unique fluorescent dye. Sample DNA, a prescribed number of ITC template molecules set near the limit of sensitivity, a single pair of primers, target probe and ITC probe are added to one reaction. Fluorescence emission signals are obtained simultaneously to determine the cycle thresholds (Ct) for amplification of the target and ITC sequences. The comparison of the target Ct with the ITC Ct indicates if a sample is a true positive for the target (i.e. Ct less than or equal to the ITC Ct) or negative (i.e. Ct greater than the ITC Ct). The utility of this approach was demonstrated in a nonhuman primate model of rAAV vector mediated gene doping in vivo and in human genomic DNA spiked with plasmid DNA.	[Ni, Weiyi; Moullier, Philippe; Snyder, Richard O.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Le Guiner, Caroline; Moullier, Philippe; Snyder, Richard O.] IRT UN, INSERM UMR1089, Lab Therapie Gen, Nantes, France; [Snyder, Richard O.] Univ Florida, Ctr Excellence Regenerat Hlth Biotechnol, Alachua, FL USA	State University System of Florida; University of Florida; Institut National de la Sante et de la Recherche Medicale (Inserm); State University System of Florida; University of Florida	Ni, WY (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	rsnyder@cerhb.ufl.edu			World Anti-Doping Agency; United States Anti-Doping Agency; Agence Francaise de Lutte contre le Dopage; The Partnership for Clean Competition; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	World Anti-Doping Agency; United States Anti-Doping Agency; Agence Francaise de Lutte contre le Dopage; The Partnership for Clean Competition; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was funded by the World Anti-Doping Agency (RS and PM), United States Anti-Doping Agency (RS), Agence Francaise de Lutte contre le Dopage (PM), and The Partnership for Clean Competition (RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Baoutina A, 2007, MOL THER, V15, P1751, DOI 10.1038/sj.mt.6300278; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Ciron C, 2009, HUM GENE THER, V20, P350, DOI 10.1089/hum.2008.155; Damen M, 2008, J CLIN MICROBIOL, V46, P3997, DOI 10.1128/JCM.00563-08; Doroudchi MM, 2011, MOL THER; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Favre D, 2001, MOL THER, V4, P559, DOI 10.1006/mthe.2001.0494; Flotte TR, 2007, HUM GENE THER, V18, P245, DOI 10.1089/hum.2006.113; Flotte TR, 2011, HUM GENE THER, V22, P1239, DOI 10.1089/hum.2011.053; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002715; Gonin P, 2004, GENE THER, V11, pS98, DOI 10.1038/sj.gt.3302378; Hagstrom JE, 2004, MOL THER, V10, P386, DOI 10.1016/j.ymthe.2004.05.004; JIAO SS, 1992, HUM GENE THER, V3, P21, DOI 10.1089/hum.1992.3.1-21; Lai LH, 2002, HUM GENE THER, V13, P2027, DOI 10.1089/10430340260395884; Lefevre J, 2003, J VIROL METHODS, V114, P135, DOI 10.1016/j.jviromet.2003.09.003; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251; Murphy RM, 2003, PHYSIOL GENOMICS, V12, P163, DOI 10.1152/physiolgenomics.00060.2002; Ni W, 2011, GENE THER, V18, P709, DOI 10.1038/gt.2011.19; Paulson DS., 2008, BIOSTATISTICS MICROB; Ponder KP, 2011, MOL THER, V19, P427, DOI 10.1038/mt.2011.13; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Provost N, 2005, MOL THER, V11, P275, DOI 10.1016/j.ymthe.2004.09.022; Ryan KJ., 2004, SHERRIS MED MICROBIO; Saulnier P, 2003, J VIROL METHODS, V114, P55, DOI 10.1016/j.jviromet.2003.08.012; Schenk-Braat EAM, 2007, J GENE MED, V9, P910, DOI 10.1002/jgm.1096; Stocher M, 2004, J CLIN VIROL, V29, P171, DOI 10.1016/S1386-6532(03)00121-5; Stocher M, 2002, J CLIN VIROL, V25, pS47; Stroes ES, 2008, ARTERIOSCL THROM VAS, V28, P2303, DOI 10.1161/ATVBAHA.108.175620; Su LT, 2005, CIRCULATION, V112, P1780, DOI 10.1161/CIRCULATIONAHA.105.534008; Templeton KE, 2003, J CLIN MICROBIOL, V41, P4016, DOI 10.1128/JCM.41.9.4016-4021.2003; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Toromanoff A, 2008, MOL THER, V16, P1291, DOI 10.1038/mt.2008.87; Ursi D, 2003, J MICROBIOL METH, V55, P149, DOI 10.1016/S0167-7012(03)00131-3; Verdier F, 1999, TOXICOL SCI, V47, P9, DOI 10.1093/toxsci/47.1.9; Verweij JJ, 2004, J CLIN MICROBIOL, V42, P1220, DOI 10.1128/JCM.42.3.1220-1223.2004; Vigen KK, 2007, HUM GENE THER, V18, P257, DOI 10.1089/hum.2006.115; Wells DJ, 2008, BRIT J PHARMACOL, V154, P623, DOI 10.1038/bjp.2008.144; WOLFF JA, 1991, BIOTECHNIQUES, V11, P474; Wooddell CI, 2011, HUM GENE THER, V22, P889, DOI 10.1089/hum.2010.160; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Zentilin L, 2007, NAT PROTOC, V2, P2092, DOI 10.1038/nprot.2007.299	47	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36461	10.1371/journal.pone.0036461	http://dx.doi.org/10.1371/journal.pone.0036461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570718	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343400034
J	Stern, ER; Fitzgerald, KD; Welsh, RC; Abelson, JL; Taylor, SF				Stern, Emily R.; Fitzgerald, Kate D.; Welsh, Robert C.; Abelson, James L.; Taylor, Stephan F.			Resting-State Functional Connectivity between Fronto-Parietal and Default Mode Networks in Obsessive-Compulsive Disorder	PLOS ONE			English	Article							BRAIN NETWORKS; TASK; ACTIVATION; CORTEX; BOLD; PSYCHOPATHOLOGY; HYPERACTIVITY; ORGANIZATION; FLUCTUATIONS; ARCHITECTURE	Background: Obsessive-compulsive disorder (OCD) is characterized by an excessive focus on upsetting or disturbing thoughts, feelings, and images that are internally-generated. Internally-focused thought processes are subserved by the "default mode network" (DMN), which has been found to be hyperactive in OCD during cognitive tasks. In healthy individuals, disengagement from internally-focused thought processes may rely on interactions between DMN and a frontoparietal network (FPN) associated with external attention and task execution. Altered connectivity between FPN and DMN may contribute to the dysfunctional behavior and brain activity found in OCD. Methods: The current study examined interactions between FPN and DMN during rest in 30 patients with OCD (17 unmedicated) and 32 control subjects (17 unmedicated). Timecourses from seven fronto-parietal seeds were correlated across the whole brain and compared between groups. Results: OCD patients exhibited altered connectivity between FPN seeds (primarily anterior insula) and several regions of DMN including posterior cingulate cortex, medial frontal cortex, posterior inferior parietal lobule, and parahippocampus. These differences were driven largely by a reduction of negative correlations among patients compared to controls. Patients also showed greater positive connectivity between FPN and regions outside DMN, including thalamus, lateral frontal cortex, and somatosensory/motor regions. Conclusions: OCD is associated with abnormal intrinsic functional connectivity between large-scale brain networks. Alteration of interactions between FPN and DMN at rest may contribute to aspects of the OCD phenotype, such as patients' inability to disengage from internally-generated scenarios and thoughts when performing everyday tasks requiring external attention.	[Stern, Emily R.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Stern, Emily R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Fitzgerald, Kate D.; Welsh, Robert C.; Abelson, James L.; Taylor, Stephan F.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Welsh, Robert C.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Stern, ER (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.	emily.stern@mssm.edu	Fitzgerald, Kate D./AAV-7278-2020; Welsh, Robert/ABH-3526-2021	Taylor, Stephan/0000-0001-8777-4292	National Institute of Mental Health (NIMH) [R01 MH071821, F32 MH082573, K23 MH082176]; Brain and Behavior Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH082176, R01MH071821, F32MH082573] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this research comes from National Institute of Mental Health (NIMH) R01 MH071821 awarded to SFT, NIMH F32 MH082573 and Brain and Behavior Foundation (formerly NARSAD) Young Investigator Award to ERS, and NIMH K23 MH082176 awarded to KDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Anderson ML, 2010, SPRINGER SER OPTIM A, V38, P31, DOI 10.1007/978-0-387-88630-5_2; Anderson ML, 2010, BEHAV BRAIN SCI, V33, P245, DOI 10.1017/S0140525X10000853; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; First M. B., 2014, SCID 5 105 STRUCTURE; Fitzgerald KD, 2011, J AM ACAD CHILD PSY, V50, P938, DOI 10.1016/j.jaac.2011.06.011; Fitzgerald KD, 2010, BIOL PSYCHIAT, V68, P1039, DOI 10.1016/j.biopsych.2010.08.018; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grigg O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013311; Gu BM, 2008, BRAIN, V131, P155, DOI 10.1093/brain/awm277; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hasson U, 2009, P NATL ACAD SCI USA, V106, P10841, DOI 10.1073/pnas.0903253106; Jang JH, 2010, NEUROSCI LETT, V474, P158, DOI 10.1016/j.neulet.2010.03.031; Jung WH, 2011, ACTA PSYCHIAT SCAND, V123, P376, DOI 10.1111/j.1600-0447.2010.01659.x; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; O'Connor K, 2003, PSYCHOL REP, V93, P227, DOI 10.2466/PR0.93.5.227-232; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Overbeek T, 2002, J CLIN PSYCHIAT, V63, P1106, DOI 10.4088/JCP.v63n1204; Page LA, 2009, PSYCHIAT RES-NEUROIM, V174, P202, DOI 10.1016/j.pscychresns.2009.05.002; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rauch S L, 2001, Adv Neurol, V85, P207; Rauch SL, 2007, BIOL PSYCHIAT, V61, P330, DOI 10.1016/j.biopsych.2005.12.012; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Rotge JY, 2008, J PSYCHIATR NEUROSCI, V33, P405; Roth RM, 2007, BIOL PSYCHIAT, V62, P901, DOI 10.1016/j.biopsych.2006.12.007; Sakai Y, 2011, EUR PSYCHIAT, V26, P463, DOI 10.1016/j.eurpsy.2010.09.005; Sanislow CA, 2010, J ABNORM PSYCHOL, V119, P631, DOI 10.1037/a0020909; Saxena S, 2000, PSYCHIAT CLIN N AM, V23, P563, DOI 10.1016/S0193-953X(05)70181-7; Schienle A, 2005, INT J PSYCHOPHYSIOL, V57, P69, DOI 10.1016/j.ijpsycho.2004.12.013; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shapira NA, 2003, BIOL PSYCHIAT, V54, P751, DOI 10.1016/S0006-3223(03)00003-9; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smallwood J, 2012, BRAIN RES, V1428, P60, DOI 10.1016/j.brainres.2011.03.072; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stawarczyk D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016997; Stern ER, 2011, BIOL PSYCHIAT, V69, P583, DOI 10.1016/j.biopsych.2010.09.048; Stern ER, 2012, HUM BRAIN MAPP; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; Ursu S, 2009, NEUROPSYCHOLOGIA, V47, P2145, DOI 10.1016/j.neuropsychologia.2009.03.018; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Yang YH, 2002, MAGN RESON MED, V48, P278, DOI 10.1002/mrm.10196; Zhang TJ, 2011, J PSYCHIATR NEUROSCI, V36, P23, DOI 10.1503/jpn.100006	74	153	159	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36356	10.1371/journal.pone.0036356	http://dx.doi.org/10.1371/journal.pone.0036356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570705	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400021
J	Li, Z; Zhang, Y; Kim, WJ; Daaka, Y				Li, Z.; Zhang, Y.; Kim, W. J.; Daaka, Y.			PGE2 promotes renal carcinoma cell invasion through activated RalA	ONCOGENE			English	Article						renal cell carcinoma; cell invasion; inflammation; PGE2; Ral	PROTEIN-COUPLED RECEPTORS; PROSTAGLANDIN-E-RECEPTORS; CANCER; GROWTH; E-2; PATHWAY; GTPASE; PHARMACOLOGY; INFLAMMATION; PROGRESSION	Incidence of kidney cancer is on the rise, and a better understanding of molecular mechanisms involved in the cancer invasion and metastasis is required for the development of curative therapeutics. In this study, we report that the proinflammatory cytokine prostaglandin E2 (PGE2) induces the malignant SN12C, but not benign HK2 kidney cell invasion. The PGE2 increases SN12C cell invasion through a signal pathway that encompasses EP2 and EP4, Akt, small GTPase RalA and Ral . GTP inactivator RGC2. The results support the idea that targeted interference of EP2/EP4 signal to RalA . GTP may provide benefit to patients diagnosed with advanced kidney cancer. Oncogene (2013) 32, 1408-1415; doi:10.1038/onc.2012.161; published online 14 May 2012	[Li, Z.; Zhang, Y.; Kim, W. J.; Daaka, Y.] Univ Florida, Coll Med, Dept Urol, Gainesville, FL 32610 USA; [Li, Z.; Zhang, Y.; Kim, W. J.; Daaka, Y.] Univ Florida, Coll Med, Prostate Dis Ctr, Gainesville, FL 32610 USA; [Daaka, Y.] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Daaka, Y (corresponding author), Univ Florida, Coll Med, Dept Urol, CGRC Rm 462,2033 Mowry Rd, Gainesville, FL 32610 USA.	ydaaka@ufl.edu			US National Institutes of Health [R01 CA129155]; NATIONAL CANCER INSTITUTE [R01CA129155] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr A Saltiel for providing anti-RGC2 and anti-phospho-RGC2 antibodies and the NCI for providing the SN12C cancer cells. We also thank Ms E Grigson and Ms K Durst for editorial assistance, and Dr Z Nie for reading and commenting on the manuscript. This work was supported, in part, by US National Institutes of Health grant R01 CA129155 (to YD).	Asano T, 2002, CLIN CANCER RES, V8, P1157; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Biswas S, 2009, NAT REV CLIN ONCOL, V6, P478, DOI 10.1038/nrclinonc.2009.91; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Bukowski RM, 2009, CANCER-AM CANCER SOC, V115, P2273, DOI 10.1002/cncr.24226; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Eruslanov E, 2011, INT IMMUNOPHARMACOL, V11, P848, DOI 10.1016/j.intimp.2011.01.033; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HALBRUGGE M, 1990, J CHROMATOGR, V521, P335, DOI 10.1016/0021-9673(90)85057-3; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Kim WJ, 2012, CANC LETT, V1820, P743; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Murai M, 2004, CURR OPIN UROL, V14, P229, DOI 10.1097/01.mou.0000135078.04721.f5; PUGH S, 1994, GUT, V35, P675, DOI 10.1136/gut.35.5.675; Salcedo R, 2003, BLOOD, V102, P1966, DOI 10.1182/blood-2002-11-3400; Schlesinger-Raab A, 2008, EUR J CANCER, V44, P2485, DOI 10.1016/j.ejca.2008.07.039; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smith SC, 2009, UROL ONCOL-SEMIN ORI, V27, P42, DOI 10.1016/j.urolonc.2008.04.012; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Sun M, 2010, NAT REV UROL, V7, P327, DOI 10.1038/nrurol.2010.57; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wu JJ, 2011, J BIOL CHEM, V286, P33954, DOI 10.1074/jbc.M110.187344; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; Young AN, 2006, UROLOGY, V67, P873, DOI 10.1016/j.urology.2005.11.042	36	29	32	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 14	2013	32	11					1408	1415		10.1038/onc.2012.161	http://dx.doi.org/10.1038/onc.2012.161			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22580611	Green Accepted			2022-12-25	WOS:000316455600007
J	Recktenwald, CV; Leisz, S; Steven, A; Mimura, K; Muller, A; Wulfanger, J; Kiessling, R; Seliger, B				Recktenwald, Christian V.; Leisz, Sandra; Steven, Andre; Mimura, Kousaku; Mueller, Anja; Wulfaenger, Jens; Kiessling, Rolf; Seliger, Barbara			HER-2/neu-mediated Down-regulation of Biglycan Associated with Altered Growth Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH PROTEOGLYCAN; MATRIX PROTEOGLYCANS; MESENCHYMAL TRANSITION; CANCER CELLS; DECORIN; EXPRESSION; PROTEIN; LUMICAN; TRANSFORMATION; INHIBITOR	The extracellular matrix protein biglycan (Bgn) is a leucine-rich proteoglycan that is involved in the matrix assembly, cellular migration and adhesion, cell growth, and apoptosis. Although a distinct expression of Bgn was found in a number of human tumors, the role of this protein in the initiation and/or maintenance of neoplastic transformation has not been studied in detail. Using an in vitro model of oncogenic transformation, a down-regulation of Bgn expression as well as an altered secretion of different Bgn isoforms was found both in murine and human HER-2/neu oncogene-transformed cells when compared with HER-2/neu(-) cells. This was associated with a reduced growth, wound closure, and migration capacity. Vice versa, silencing of Bgn in HER-2/neu(-) fibroblasts increased the growth rate and migration capacity of these cells. Bgn expression was neither modulated in HER-2/neu(-) cells by transforming growth factor-beta(1) nor by inhibition of the phosphoinositol 3-kinase and MAP kinase pathways. In contrast, inhibition of the protein kinase C (PKC) pathway led to the reconstitution of Bgn expression. In particular, the PKC target protein cAMP response element binding protein (CREB) is a major regulator of Bgn expression as the silencing of CREB by RNA interference was accompanied by similar to 5000-fold increase in Bgn-mRNA expression in HER-2/neu(+) cells. Thus, Bgn inhibits the major properties of HER-2/neu(-) transformed cells, which is inversely modulated by the PKC signaling cascade.	[Recktenwald, Christian V.; Leisz, Sandra; Steven, Andre; Mueller, Anja; Wulfaenger, Jens; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, D-06112 Halle, Germany; [Mimura, Kousaku; Kiessling, Rolf] Karolinska Inst, S-17177 Stockholm, Sweden	Martin Luther University Halle Wittenberg; Karolinska Institutet	Seliger, B (corresponding author), Univ Halle Wittenberg, Inst Med Immunol, Magdeburger Str 2, D-06112 Halle, Germany.	Barbara.Seliger@uk-halle.de		Seliger, Barbara/0000-0002-5544-4958; Leisz, Sandra/0000-0003-4581-5185; Recktenwald, Christian Viktor/0000-0003-1710-1863; Steven, Andre/0000-0003-4860-3399	Bundesministerium fur Bildung und Forschung [Colonet 0315417E]; Mildred Scheel Foundation [109247]; intramural Roux program	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Mildred Scheel Foundation(Deutsche Krebshilfe); intramural Roux program	The work was sponsored by grants of the Bundesministerium fur Bildung und Forschung (Colonet 0315417E), Mildred Scheel Foundation Grant 109247, and the intramural Roux program.	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; Benayahu D, 2002, J CELL BIOCHEM, V84, P108, DOI 10.1002/jcb.1270; Brezillon S, 2007, CLIN EXP DERMATOL, V32, P405, DOI 10.1111/j.1365-2230.2007.02437.x; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Datsis GA, 2011, FEBS J, V278, P3782, DOI 10.1111/j.1742-4658.2011.08300.x; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Gu XH, 2012, CLIN EXP MED, V12, P195, DOI 10.1007/s10238-011-0155-4; Herrmann F, 2004, CANCER RES, V64, P215, DOI 10.1158/0008-5472.CAN-2522-2; Hocking AM, 1998, MATRIX BIOL, V17, P1; HUNZELMANN N, 1995, J INVEST DERMATOL, V104, P509, DOI 10.1111/1523-1747.ep12605979; Iacob S, 2010, CONNECT TISSUE RES, V51, P347, DOI 10.3109/03008200903427695; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Makatsori E, 2003, ANTICANCER RES, V23, P3303; Markou T, 2004, J MOL CELL CARDIOL, V37, P1001, DOI 10.1016/j.yjmcc.2004.08.002; Mathias RA, 2010, J PROTEOME RES, V9, P1007, DOI 10.1021/pr900907g; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Meyer-Kirchrath J, 2009, CARDIOVASC RES, V81, P310, DOI 10.1093/cvr/cvn312; Mimura K, 2011, INT J CANCER, V128, P390, DOI 10.1002/ijc.25613; Nannuru Kalyan C, 2010, Curr Osteoporos Rep, V8, P105, DOI 10.1007/s11914-010-0011-6; Nash MA, 1999, CANCER RES, V59, P6192; Recktenwald CV, 2007, PROTEOMICS, V7, P385, DOI 10.1002/pmic.200600506; Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Rodriguez Luis G., 2004, V294, P23; Roughley PJ, 1996, BIOCHEM J, V318, P779, DOI 10.1042/bj3180779; Ruiter D, 2002, LANCET ONCOL, V3, P35, DOI 10.1016/S1470-2045(01)00620-9; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Schaefer L, 2001, FASEB J, V15, P559; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Skandalis SS, 2004, BBA-MOL BASIS DIS, V1689, P152, DOI 10.1016/j.bbadis.2004.03.006; Tchernitsa OI, 2004, ONCOGENE, V23, P4536, DOI 10.1038/sj.onc.1207585; Tiede K, 2010, BASIC RES CARDIOL, V105, P99, DOI 10.1007/s00395-009-0049-8; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Tufvesson E, 2002, EUR J BIOCHEM, V269, P3688, DOI 10.1046/j.1432-1033.2002.03058.x; Tufvesson E, 2003, J CELL SCI, V116, P4857, DOI 10.1242/jcs.00808; Ungefroren H, 2005, J BIOL CHEM, V280, P2644, DOI 10.1074/jbc.M411925200; Vuillermoz B, 2004, EXP CELL RES, V296, P294, DOI 10.1016/j.yexcr.2004.02.005; Wang B, 2011, EXP BIOL MED, V236, P1247, DOI 10.1258/ebm.2011.011124; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; Wulfaenger J, 2008, MOL MEMBR BIOL, V25, P72, DOI 10.1080/09687680701551855; Yoshioka N, 2000, J VIROL, V74, P1008, DOI 10.1128/JVI.74.2.1008-1013.2000	47	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24320	24329		10.1074/jbc.M111.334425	http://dx.doi.org/10.1074/jbc.M111.334425			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22582394	Green Published, hybrid			2022-12-25	WOS:000306651100026
J	Ryu, MJ; Liu, YG; Zhong, XF; Du, J; Peterson, N; Kong, GY; Li, HD; Wang, JY; Salamat, S; Chang, Q; Zhang, J				Ryu, Myung-Jeom; Liu, Yangang; Zhong, Xiaofen; Du, Juan; Peterson, Nicholas; Kong, Guangyao; Li, Hongda; Wang, Jinyong; Salamat, Shahriar; Chang, Qiang; Zhang, Jing			Oncogenic Kras Expression in Postmitotic Neurons Leads to S100A8-S100A9 Protein Overexpression and Gliosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC-CELLS; K-RAS; MYELOPROLIFERATIVE DISORDER; TYPE-1 NEUROFIBROMATOSIS; PILOCYTIC ASTROCYTOMA; GENE-EXPRESSION; ACTIVATION; NF1; GLIOMA; GROWTH	Previous studies suggest that up-regulation of Ras signaling in neurons promotes gliosis and astrocytoma formation in a cell nonautonomous manner. However, the underlying mechanisms remain unknown. To address this question, we generated compound mice (LSL Kras G12D/+;CamKII-Cre) that express oncogenic Kras from its endogenous locus in postmitotic neurons after birth. These mice developed progressive gliosis, which is associated with hyperactivation of Ras signaling pathways. Microarray analysis identified S100A8 and S100A9 as two secreted molecules that are significantly overexpressed in mutant cortices. In contrast to their usual predominant expression in myeloid cells, we found that overexpression of S100A8 and S100A9 in the mutant cortex is primarily in neurons. This neuronal expression pattern is associated with increased infiltration of microglia in mutant cortex. Moreover, purified S100A8-S100A9 but not S100A8 or S100A9 alone promotes growth of primary astrocytes in vitro through both TLR4 and receptor of advanced glycation end product receptors. In summary, our results identify overexpression of S100A8-S100A9 in neurons as an early step in oncogenic Kras-induced gliosis. These molecules expressed in nonhematopoietic cells may be involved in tumorigenesis at a stage much earlier than what has been reported previously.	[Ryu, Myung-Jeom; Liu, Yangang; Du, Juan; Kong, Guangyao; Wang, Jinyong; Zhang, Jing] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Zhong, Xiaofen; Li, Hongda; Chang, Qiang] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Peterson, Nicholas] Univ Wisconsin, Dept Biochem, Sch Letters & Sci, Madison, WI 53705 USA; [Salamat, Shahriar] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53792 USA; [Li, Hongda; Chang, Qiang] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Li, Hongda; Chang, Qiang] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, J (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	zhang@oncology.wisc.edu	Li, Hongda/F-3034-2017; Kong, Guangyao/L-2162-2013	Li, Hongda/0000-0001-6754-5150; 	National Institutes of Health [R01 CA152108, P30 CA014520]; Greater Milwaukee Foundation; V Foundation for Cancer Research; University of Wisconsin Carbone Comprehensive Cancer Center; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA152108, P30CA014520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greater Milwaukee Foundation; V Foundation for Cancer Research; University of Wisconsin Carbone Comprehensive Cancer Center; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA152108 and P30 CA014520-UW Comprehensive Cancer Center Support from the NCI. This work was also supported by a Howard Temin Award, a Shaw Scientist Award from the Greater Milwaukee Foundation, a V Scholar Award from the V Foundation for Cancer Research, an Investigator Initiated Grant from University of Wisconsin Carbone Comprehensive Cancer Center (to J. Z.), and a Postdoctoral Fellowship from the American Heart Association (to M. J.).	Abel TW, 2009, MOL CANCER RES, V7, P645, DOI 10.1158/1541-7786.MCR-08-0477; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bajenaru ML, 2003, CANCER RES, V63, P8573; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Dasgupta B, 2005, CANCER RES, V65, P236; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DEVERY JM, 1994, J IMMUNOL, V152, P1888; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Ghavami S, 2009, EUR J PHARMACOL, V625, P73, DOI 10.1016/j.ejphar.2009.08.044; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Gutmann DH, 2008, J CHILD NEUROL, V23, P1186, DOI 10.1177/0883073808321061; Gutmann DH, 2000, NEUROPATH APPL NEURO, V26, P361, DOI 10.1046/j.1365-2990.2000.00258.x; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hiatt KK, 2001, J BIOL CHEM, V276, P7240, DOI 10.1074/jbc.M009202200; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Janzarik WG, 2007, NEUROPEDIATRICS, V38, P61, DOI 10.1055/s-2007-984451; KRAIG RP, 1991, J NEUROSCI, V11, P2187; LACKMANN M, 1993, J IMMUNOL, V150, P2981; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; Lau N, 2000, J NEUROPATH EXP NEUR, V59, P759, DOI 10.1093/jnen/59.9.759; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Mathias RA, 2010, J PROTEOME RES, V9, P1007, DOI 10.1021/pr900907g; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; NORDLUND ML, 1995, J NEUROPATH EXP NEUR, V54, P588, DOI 10.1097/00005072-199507000-00013; Pino Paula A, 2011, J Vis Exp, DOI 10.3791/2348; Riccardi V. M., 1999, NEUROFIBROMATOSIS PH, P1; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Roth J, 2003, J IMMUNOL, V171, P5651, DOI 10.4049/jimmunol.171.11.5651; Ryu MJ, 2007, J NEUROCHEM, V102, P646, DOI 10.1111/j.1471-4159.2007.04504.x; Sharma MK, 2005, NEUROLOGY, V65, P1335, DOI 10.1212/01.wnl.0000180409.78098.d7; Sherman LS, 2000, J BIOL CHEM, V275, P30740, DOI 10.1074/jbc.M001702200; STEWARD O, 1991, P NATL ACAD SCI USA, V88, P6819, DOI 10.1073/pnas.88.15.6819; Vollrath AL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-280; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	52	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22948	22958		10.1074/jbc.M112.357772	http://dx.doi.org/10.1074/jbc.M112.357772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577135	Green Published, hybrid			2022-12-25	WOS:000306495000052
J	Wu, LF; Pan, Y; Chen, GQ; Matsunami, H; Zhuang, HY				Wu, Lifang; Pan, Yi; Chen, Guo-Qiang; Matsunami, Hiroaki; Zhuang, Hanyi			Receptor-transporting Protein 1 Short (RTP1S) Mediates Translocation and Activation of Odorant Receptors by Acting through Multiple Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; OLFACTORY RECEPTOR; TRAFFICKING; RETENTION; MEMBERS; FAMILY; RIC-8B; RAFTS	Odorant receptor (OR) proteins are retained in the endoplasmic reticulum when heterologously expressed in cultured cells of non-olfactory origins. RTP1S is an accessory protein to mammalian ORs and facilitates their trafficking to the cell-surface membrane and ligand-induced responses in heterologous cells. The mechanism by which RTP1S promotes the functional expression of ORs remains poorly understood. To obtain a better understanding of the role(s) of RTP1S, we performed a series of structure-function analyses of RTP1S in HEK293T cells. By constructing RTP1S deletion and chimera series and subsequently introducing single-site mutations into the protein, we found the N terminus of RTP1S is important for the endoplasmic reticulum exit of ORs and that a middle region of RTP1S is important for OR trafficking from the Golgi to the membrane. Using sucrose gradient centrifugation, we found that the localization of RTP1S to the lipid raft microdomain is critical to the activation of ORs. Finally, in a protein-protein interaction analysis, we determined that the C terminus of RTP1S may be interacting with ORs. These findings provide new insights into the distinct roles of RTP1S in OR translocation and activation.	[Zhuang, Hanyi] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Chen, Guo-Qiang; Zhuang, Hanyi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Wu, Lifang; Pan, Yi; Chen, Guo-Qiang; Zhuang, Hanyi] Shanghai Jiao Tong Univ, Dept Pathophysiol, Shanghai Univ E Inst Chem Biol,Key Lab Cell Diffe, Natl Minist Educ,Sch Med, Shanghai 200025, Peoples R China; [Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Mol Genet, Durham, NC 27710 USA; [Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Matsunami, Hiroaki] Duke Univ, Med Ctr, Duke Inst Brain Sci, Durham, NC 27710 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Duke University; Duke University; Duke University	Zhuang, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Bldg 1,Rm 205,225 S Chongqing Rd, Shanghai 200025, Peoples R China.	hanyizhuang@sjtu.edu.cn	Pan, Yi/AAJ-2341-2021; Wu, Lifang/R-3630-2016	chen, guo qiang/0000-0003-4936-2363; Wu, Lifang/0000-0003-3334-2923	National Institutes of Health from NIDCD [DC005782]; National Natural Science Foundation of China [30970981, 31070972]; 973 Program [2012CB910401]; Shanghai Pujiang Program [09PJ1406900]; Shanghai Municipal Education Commission [2009CG15, J50201]; Shanghai Education Development Foundation; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010857, R01DC005782] Funding Source: NIH RePORTER	National Institutes of Health from NIDCD; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by a National Institutes of Health Grant DC005782 from NIDCD (to H. M.). This work was also supported by National Natural Science Foundation of China Grants 30970981 and 31070972, 973 Program Grant 2012CB910401, Shanghai Pujiang Program Grant 09PJ1406900, the Program for Innovative Research Team of the Shanghai Municipal Education Commission, Chen Guang Project Grant 2009CG15 funded by the Shanghai Municipal Education Commission and the Shanghai Education Development Foundation, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, and Leading Academic Discipline Project Grant J50201 from the Shanghai Municipal Education Commission (to H. Z.).	Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Ilegems E, 2010, J NEUROSCI, V30, P13774, DOI 10.1523/JNEUROSCI.0091-10.2010; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Mast TG, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-61; Matsunami H, 2009, ANN NY ACAD SCI, V1170, P153, DOI 10.1111/j.1749-6632.2009.03888.x; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mombaerts P, 1999, CURR OPIN GENET DEV, V9, P315, DOI 10.1016/S0959-437X(99)80047-1; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wang TY, 2001, BIOCHEMISTRY-US, V40, P13031, DOI 10.1021/bi0112311; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	28	29	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22287	22294		10.1074/jbc.M112.345884	http://dx.doi.org/10.1074/jbc.M112.345884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570474	Green Published, hybrid			2022-12-25	WOS:000306418600066
J	Barros-Becker, F; Romero, J; Pulgar, A; Feijoo, CG				Barros-Becker, Francisco; Romero, Jaime; Pulgar, Alvaro; Feijoo, Carmen G.			Persistent Oxytetracycline Exposure Induces an Inflammatory Process That Improves Regenerative Capacity in Zebrafish Larvae	PLOS ONE			English	Article							IMMUNE-SYSTEM; RAINBOW-TROUT; OXOLINIC ACID; DANIO-RERIO; FISH; MODEL; ANTIBIOTICS; AQUACULTURE; EXPRESSION; RESIDUES	Background: The excessive use of antibiotics in aquaculture can adversely affect not only the environment, but also fish themselves. In this regard, there is evidence that some antibiotics can activate the immune system and reduce their effectiveness. None of those studies consider in detail the adverse inflammatory effect that the antibiotic remaining in the water may cause to the fish. In this work, we use the zebrafish to analyze quantitatively the effects of persistent exposure to oxytetracycline, the most common antibiotic used in fish farming. Methodology: We developed a quantitative assay in which we exposed zebrafish larvae to oxytetracycline for a period of 24 to 96 hrs. In order to determinate if the exposure causes any inflammation reaction, we evaluated neutrophils infiltration and quantified their total number analyzing the Tg(mpx:GFP)(i114) transgenic line by fluorescence stereoscope, microscope and flow cytometry respectively. On the other hand, we characterized the process at a molecular level by analyzing several immune markers (il-1 beta, il-10, lysC, mpx, cyp1a) at different time points by qPCR. Finally, we evaluated the influence of the inflammation triggered by oxytetracycline on the regeneration capacity in the lateral line. Conclusions: Our results suggest that after 48 hours of exposure, the oxytetracycline triggered a widespread inflammation process that persisted until 96 hours of exposure. Interestingly, larvae that developed an inflammation process showed an improved regeneration capacity in the mechanosensory system lateral line.	[Barros-Becker, Francisco; Pulgar, Alvaro; Feijoo, Carmen G.] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile; [Romero, Jaime] Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago 11, Chile	Universidad Andres Bello; Universidad de Chile	Barros-Becker, F (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile.	cfeijoo@unab.cl	Romero, Jaime/I-2816-2013; Feijoo, Carmen G/AAF-9003-2019	Romero, Jaime/0000-0001-9614-2393; Feijoo, Carmen G/0000-0003-1128-403X; Barros-Becker, Francisco/0000-0002-4983-110X	Fondo Nacional de Desarrolo Cientifico y Tecnologico (Fondecyt) [11090102, 1110253]; Universidad Andres Bello (UNAB) [DI39-11/R]; Comision Nacional de Investigacion Cientifica y Tecnologica (Conicyt) [79090006]	Fondo Nacional de Desarrolo Cientifico y Tecnologico (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Universidad Andres Bello (UNAB); Comision Nacional de Investigacion Cientifica y Tecnologica (Conicyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	CGF was supported by Fondo Nacional de Desarrolo Cientifico y Tecnologico (Fondecyt) 11090102, Universidad Andres Bello (UNAB) DI39-11/R, and Comision Nacional de Investigacion Cientifica y Tecnologica (Conicyt) 79090006. JR was supported by Fondecyt 1110253. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 2010, FUTURE MICROBIOL, V5, P563, DOI [10.2217/fmb.10.24, 10.2217/FMB.10.24]; Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008; Bebak-Williams J, 2002, AQUACULTURE, V205, P221, DOI 10.1016/S0044-8486(01)00690-1; BJORKLUND HV, 1991, AQUACULTURE, V97, P85, DOI 10.1016/0044-8486(91)90281-B; Cabello FC, 2004, REV MED CHILE, V132, P1001; Caipang CMA, 2009, COMP BIOCHEM PHYS C, V150, P459, DOI 10.1016/j.cbpc.2009.07.001; Carson MC, 2002, J AOAC INT, V85, P341; Chen GY, NATURE REV IMMUNOL, V10, P826; d'Alencon CA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-151; Ellett F, 2010, CURR OPIN PHARMACOL, V10, P563, DOI 10.1016/j.coph.2010.05.004; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Froehlicher M, 2009, AQUAT TOXICOL, V95, P307, DOI 10.1016/j.aquatox.2009.04.007; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; GOKSOYR A, 1992, AQUAT TOXICOL, V22, P287, DOI 10.1016/0166-445X(92)90046-P; GRONDEL JL, 1987, J FISH DIS, V10, P35, DOI 10.1111/j.1365-2761.1987.tb00716.x; Haffter P, 1996, DEVELOPMENT, V123, P1; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hernandez PP, 2006, HEARING RES, V213, P1, DOI 10.1016/j.heares.2005.10.015; Hinton DE, 2005, MAR POLLUT BULL, V51, P635, DOI 10.1016/j.marpolbul.2005.07.020; JACOBSEN P, 1988, AQUACULTURE, V70, P365, DOI 10.1016/0044-8486(88)90120-2; KAJITA Y, 1990, FISH PATHOL, V25, P93, DOI 10.3147/jsfp.25.93; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LAALE HW, 1977, CAN J ZOOL, V55, P304, DOI 10.1139/z77-041; Lalumera GM, 2004, CHEMOSPHERE, V54, P661, DOI 10.1016/j.chemosphere.2003.08.001; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Lunden T, 1998, FISH SHELLFISH IMMUN, V8, P217, DOI 10.1006/fsim.1998.0142; Lunden T, 2002, VET IMMUNOL IMMUNOP, V85, P99, DOI 10.1016/S0165-2427(01)00422-6; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Millanao A, 2011, REV MED CHILE, V139, P107, DOI /S0034-98872011000100015; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Christensen AM, 2006, ENVIRON TOXICOL CHEM, V25, P2208, DOI 10.1897/05-415R.1; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pouliquen H, 2009, ENVIRON TOXICOL CHEM, V28, P496, DOI 10.1897/08-238.1; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; RIJKERS GT, 1981, VET IMMUNOL IMMUNOP, V2, P281, DOI 10.1016/0165-2427(81)90029-5; Roex EWM, 2001, ECOTOX ENVIRON SAFE, V48, P196, DOI 10.1006/eesa.2000.2029; Rose PE, 2005, ENVIRON TOXICOL CHEM, V24, P40, DOI 10.1897/03-640.1; SAMUELSEN OB, 1992, SCI TOTAL ENVIRON, V114, P25, DOI 10.1016/0048-9697(92)90411-K; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; SIWICKI AK, 1989, VET IMMUNOL IMMUNOP, V23, P195, DOI 10.1016/0165-2427(89)90122-0; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; Tafalla C, 1999, J FISH DIS, V22, P271, DOI 10.1046/j.1365-2761.1999.00179.x; THORBURN MA, 1987, DIS AQUAT ORGAN, V2, P167; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Traver D, 2003, ADV IMMUNOL, V81, P253; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; vanderHeijden MHT, 1996, VET IMMUNOL IMMUNOP, V52, P127, DOI 10.1016/0165-2427(95)05532-0; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Williams JA, 2000, DEV BIOL, V226, P220, DOI 10.1006/dbio.2000.9860; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005	55	34	39	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36827	10.1371/journal.pone.0036827	http://dx.doi.org/10.1371/journal.pone.0036827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590621	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336400039
J	Savic, D; Bell, GI; Nobrega, MA				Savic, Daniel; Bell, Graeme I.; Nobrega, Marcelo A.			An in vivo cis-Regulatory Screen at the Type 2 Diabetes Associated TCF7L2 Locus Identifies Multiple Tissue-Specific Enhancers	PLOS ONE			English	Article							INCREASED RISK; BONE-FORMATION; GENE; CATENIN; EXPRESSION; CHROMATIN; INSIGHTS; INCREASE; GHRELIN; VARIANT	Genome-wide association studies (GWAS) have repeatedly shown an association between non-coding variants in the TCF7L2 locus and risk for type 2 diabetes (T2D), implicating a role for cis-regulatory variation within this locus in disease etiology. Supporting this hypothesis, we previously localized complex regulatory activity to the TCF7L2 T2D-associated interval using an in vivo bacterial artificial chromosome (BAC) enhancer-trapping reporter strategy. To follow-up on this broad initial survey of the TCF7L2 regulatory landscape, we performed a fine-mapping enhancer scan using in vivo mouse transgenic reporter assays. We functionally interrogated approximately 50% of the sequences within the T2D-associated interval, utilizing sequence conservation within this 92-kb interval to determine the regulatory potential of all evolutionary conserved sequences that exhibited conservation to the non-eutherian mammal opossum. Included in this study was a detailed functional interrogation of sequences spanning both protective and risk alleles of single nucleotide polymorphism (SNP) rs7903146, which has exhibited allele-specific enhancer function in pancreatic beta cells. Using these assays, we identified nine segments regulating various aspects of the TCF7L2 expression profile and that constitute nearly 70% of the sequences tested. These results highlight the regulatory complexity of this interval and support the notion that a TCF7L2 cis-regulatory disruption leads to T2D predisposition.	[Savic, Daniel; Bell, Graeme I.; Nobrega, Marcelo A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Savic, D (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	dsavic@uchicago.edu; nobrega@uchicago.edu	Savic, Daniel/N-5525-2018	Savic, Daniel/0000-0002-6693-0265	NIH [DK078871, HG004428, DK020595, T32 GM007197]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P60DK020595, R21DK078871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants DK078871 and HG004428 (M.A.N.), DK020595 (G.I.B.), T32 GM007197 (D.S.) and a gift from the Kovler Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlzen M, 2008, BIOCHEM BIOPH RES CO, V370, P49, DOI 10.1016/j.bbrc.2008.03.006; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Figeac F, 2010, AM J PHYSIOL-ENDOC M, V298, pE245, DOI 10.1152/ajpendo.00538.2009; Folsom AR, 2008, DIABETES CARE, V31, P905, DOI 10.2337/dc07-2131; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gough Stephen C L, 2005, J Psychopharmacol, V19, P47, DOI 10.1177/0269881105058380; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hansen T, 2011, BIOL PSYCHIAT, V70, P59, DOI 10.1016/j.biopsych.2011.01.031; Heppner KM, 2011, CURR OPIN ENDOCRINOL, V18, P50, DOI 10.1097/MED.0b013e328341e1d3; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Le Bacquer O, 2011, HUM MOL GENET; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lin PI, 2010, SCHIZOPHR RES, V123, P234, DOI 10.1016/j.schres.2010.08.022; Lyssenko V, 2008, CURR OPIN CLIN NUTR, V11, P385, DOI 10.1097/MCO.0b013e328304d970; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Norton L, 2011, DIABETOLOGIA, V54, P3132, DOI 10.1007/s00125-011-2289-z; Prokunina-Olsson L, 2010, DIABETOLOGIA, V53, P712, DOI 10.1007/s00125-009-1640-0; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sakabe NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-238; Savic D, 2011, GENOME RES; Savic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026897; Smith AM, 2008, GENOME RES, V18, P1422, DOI 10.1101/gr.077008.108; Sousa AGP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007697; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Zhou Y, 2011, HUM MOL GENET	42	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36501	10.1371/journal.pone.0036501	http://dx.doi.org/10.1371/journal.pone.0036501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590553	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336400020
J	Wilkerson, MD; Yin, XY; Walter, V; Zhao, N; Cabanski, CR; Hayward, MC; Miller, CR; Socinski, MA; Parsons, AM; Thorne, LB; Haithcock, BE; Veeramachaneni, NK; Funkhouser, WK; Randell, SH; Bernard, PS; Perou, CM; Hayes, DN				Wilkerson, Matthew D.; Yin, Xiaoying; Walter, Vonn; Zhao, Ni; Cabanski, Christopher R.; Hayward, Michele C.; Miller, C. Ryan; Socinski, Mark A.; Parsons, Alden M.; Thorne, Leigh B.; Haithcock, Benjamin E.; Veeramachaneni, Nirmal K.; Funkhouser, William K.; Randell, Scott H.; Bernard, Philip S.; Perou, Charles M.; Hayes, D. Neil			Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation	PLOS ONE			English	Article							CANCER CELL-LINES; GENE-EXPRESSION; CLASS DISCOVERY; BREAST-CANCER; EGFR MUTATION; THERAPY; TUMORS; CLASSIFICATION; VALIDATION; RECURRENCE	Background: Lung adenocarcinoma (LAD) has extreme genetic variation among patients, which is currently not well understood, limiting progress in therapy development and research. LAD intrinsic molecular subtypes are a validated stratification of naturally-occurring gene expression patterns and encompass different functional pathways and patient outcomes. Patients may have incurred different mutations and alterations that led to the different subtypes. We hypothesized that the LAD molecular subtypes co-occur with distinct mutations and alterations in patient tumors. Methodology/Principal Findings: The LAD molecular subtypes (Bronchioid, Magnoid, and Squamoid) were tested for association with gene mutations and DNA copy number alterations using statistical methods and published cohorts (n = 504). A novel validation (n = 116) cohort was assayed and interrogated to confirm subtype-alteration associations. Gene mutation rates (EGFR, KRAS, STK11, TP53), chromosomal instability, regional copy number, and genomewide DNA methylation were significantly different among tumors of the molecular subtypes. Secondary analyses compared subtypes by integrated alterations and patient outcomes. Tumors having integrated alterations in the same gene associated with the subtypes, e.g. mutation, deletion and underexpression of STK11 with Magnoid, and mutation, amplification, and overexpression of EGFR with Bronchioid. The subtypes also associated with tumors having concurrent mutant genes, such as KRAS-STK11 with Magnoid. Patient overall survival, cisplatin plus vinorelbine therapy response and predicted gefitinib sensitivity were significantly different among the subtypes. Conclusions/Significance: The lung adenocarcinoma intrinsic molecular subtypes co-occur with grossly distinct genomic alterations and with patient therapy response. These results advance the understanding of lung adenocarcinoma etiology and nominate patient subgroups for future evaluation of treatment response.	[Wilkerson, Matthew D.; Yin, Xiaoying; Walter, Vonn; Zhao, Ni; Cabanski, Christopher R.; Hayward, Michele C.; Miller, C. Ryan; Socinski, Mark A.; Thorne, Leigh B.; Funkhouser, William K.; Randell, Scott H.; Perou, Charles M.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Walter, Vonn; Zhao, Ni] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Cabanski, Christopher R.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC USA; [Miller, C. Ryan; Thorne, Leigh B.; Funkhouser, William K.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Socinski, Mark A.; Hayes, D. Neil] Univ N Carolina, Dept Internal Med, Div Med Oncol, Multidisciplinary Thorac Oncol Program, Chapel Hill, NC USA; [Socinski, Mark A.; Parsons, Alden M.; Haithcock, Benjamin E.; Veeramachaneni, Nirmal K.] Univ N Carolina, Dept Surg, Div Cardiothorac Surg, Chapel Hill, NC USA; [Randell, Scott H.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Bernard, Philip S.] Utah Hlth Sci Ctr, Salt Lake City, UT USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilkerson, MD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	hayes@med.unc.edu	Miller, Ryan/B-9365-2008; Walter, Vonn/AAI-3450-2021; Perou, Charles M/H-9934-2014; , Pathology Services Core/CEZ-2246-2022; Zhao, Ni/P-9086-2014	Miller, Ryan/0000-0002-0096-8762; Walter, Vonn/0000-0001-6114-6714; Perou, Charles M/0000-0001-9827-2247; Zhao, Ni/0000-0002-7762-3949; Hayes, D. Neil/0000-0001-6203-7771	National Cancer Institute (NIH) [NIH F32CA142039]; National Center for Research Resources (NIH) [K12-RR023248]; Thomas G. Labrecque Foundation through Joan's Legacy Foundation; Lineberger Comprehensive Cancer Center; National Heart, Lung, and Blood Institute (NHLBI) [1-RC1-HL100108]; NATIONAL CANCER INSTITUTE [F32CA142039, P30CA016086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023248] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100108] Funding Source: NIH RePORTER	National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Thomas G. Labrecque Foundation through Joan's Legacy Foundation; Lineberger Comprehensive Cancer Center; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MDW was supported by a Ruth L. Kirschstein National Research Service Award Individual Fellowship from the National Cancer Institute (NIH F32CA142039). Additional funding provided by National Center for Research Resources (NIH K12-RR023248), the Thomas G. Labrecque Foundation through Joan's Legacy Foundation, Lineberger Comprehensive Cancer Center Translational Small Grants Program, and the National Heart, Lung, and Blood Institute (NHLBI 1-RC1-HL100108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barletta JA, 2010, CANCER-AM CANCER SOC, V116, P659, DOI 10.1002/cncr.24831; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Bryant CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011712; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Dabney AR, 2006, BIOINFORMATICS, V22, P122, DOI 10.1093/bioinformatics/bti756; Dacic S, 2010, MODERN PATHOL, V23, P159, DOI 10.1038/modpathol.2009.154; de Wilde J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-271; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Hastak K, 2010, CANCER RES, V70, P7970, DOI 10.1158/0008-5472.CAN-09-4521; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Walter V, 2011, BIOINFORMATICS, V27, P678, DOI 10.1093/bioinformatics/btq717; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weigman VJ, 2011, BREAST CANC RES TREA; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weiss MB, 2010, ONCOGENE, V29, P4715, DOI 10.1038/onc.2010.220; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Yatabe Y, 2005, AM J SURG PATHOL, V29, P633, DOI 10.1097/01.pas.0000157935.28066.35; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	49	159	166	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36530	10.1371/journal.pone.0036530	http://dx.doi.org/10.1371/journal.pone.0036530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590557	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336400022
J	Mazzaglia, A; Studholme, DJ; Taratufolo, MC; Cai, RM; Almeida, NF; Goodman, T; Guttman, DS; Vinatzer, BA; Balestra, GM				Mazzaglia, Angelo; Studholme, David J.; Taratufolo, Maria C.; Cai, Rongman; Almeida, Nalvo F.; Goodman, Tokia; Guttman, David S.; Vinatzer, Boris A.; Balestra, Giorgio M.			Pseudomonas syringae pv. actinidiae (PSA) Isolates from Recent Bacterial Canker of Kiwifruit Outbreaks Belong to the Same Genetic Lineage	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENOME; EVOLUTION; SEQUENCE; HOST; INFECTION; SURVIVAL; SEED	Intercontinental spread of emerging plant diseases is one of the most serious threats to world agriculture. One emerging disease is bacterial canker of kiwi fruit (Actinidia deliciosa and A. chinensis) caused by Pseudomonas syringae pv. actinidiae (PSA). The disease first occurred in China and Japan in the 1980s and in Korea and Italy in the 1990s. A more severe form of the disease broke out in Italy in 2008 and in additional countries in 2010 and 2011 threatening the viability of the global kiwi fruit industry. To start investigating the source and routes of international transmission of PSA, genomes of strains from China (the country of origin of the genus Actinidia), Japan, Korea, Italy and Portugal have been sequenced. Strains from China, Italy, and Portugal have been found to belong to the same clonal lineage with only 6 single nucleotide polymorphisms (SNPs) in 3,453,192 bp and one genomic island distinguishing the Chinese strains from the European strains. Not more than two SNPs distinguish each of the Italian and Portuguese strains from each other. The Japanese and Korean strains belong to a separate genetic lineage as previously reported. Analysis of additional European isolates and of New Zealand isolates exploiting genome-derived markers showed that these strains belong to the same lineage as the Italian and Chinese strains. Interestingly, the analyzed New Zealand strains are identical to European strains at the tested SNP loci but test positive for the genomic island present in the sequenced Chinese strains and negative for the genomic island present in the European strains. Results are interpreted in regard to the possible direction of movement of the pathogen between countries and suggest a possible Chinese origin of the European and New Zealand outbreaks.	[Mazzaglia, Angelo; Taratufolo, Maria C.; Balestra, Giorgio M.] Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy; [Studholme, David J.] Univ Exeter, Dept Biosci, Exeter, Devon, England; [Cai, Rongman; Goodman, Tokia; Vinatzer, Boris A.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA; [Almeida, Nalvo F.] Univ Fed Mato Grosso do Sul, Sch Comp, Campo Grande, Brazil; [Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	Tuscia University; University of Exeter; Virginia Polytechnic Institute & State University; Universidade Federal de Mato Grosso do Sul; University of Toronto	Mazzaglia, A (corresponding author), Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy.	balestra@unitus.it; vinatzer@vt.edu	Almeida, Nalvo/B-5856-2012; Guttman, David S/A-7839-2011; Studholme, David/H-6790-2019; Cai, Rongman/C-5998-2015; Mazzaglia, Angelo/I-4336-2012	Guttman, David S/0000-0001-8479-3869; Studholme, David/0000-0002-3010-6637; Cai, Rongman/0000-0003-2404-4852; Mazzaglia, Angelo/0000-0002-1295-2565; Almeida, Nalvo/0000-0001-5615-1746; BALESTRA, Giorgio/0000-0002-0822-4506	Department of Science and Technologies for Agriculture, Forestry, Nature and Energy (DAFNE) at the University of Tuscia; Italian Minister of Agriculture and Food Polices (MIPAAF) [247]; Department of Agriculture, Regione Lazio, Italy; Fundect [23/200194/2009]; CNPq [305503/2010-3, 474814/2010-6]; National Science Foundation [IOS 0746501]; Division Of Integrative Organismal Systems [0746501] Funding Source: National Science Foundation	Department of Science and Technologies for Agriculture, Forestry, Nature and Energy (DAFNE) at the University of Tuscia; Italian Minister of Agriculture and Food Polices (MIPAAF); Department of Agriculture, Regione Lazio, Italy; Fundect(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Department of Science and Technologies for Agriculture, Forestry, Nature and Energy (DAFNE) at the University of Tuscia, the Italian Minister of Agriculture and Food Polices (MIPAAF), OIGA n. 247, and partially by the Department of Agriculture, Regione Lazio, Italy. Nalvo F. Almeida was supported through Fundect (Award 23/200194/2009) and CNPq (Awards 305503/2010-3 and 474814/2010-6). Research at the Department of Plant Pathology, Physiology, and Weed Science at Virginia Tech was supported by the National Science Foundation (Award IOS 0746501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Almeida NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208; [Anonymous], 2011, BACTERIAL CANKER KIW; Australia B, 2011, PEST RISK AN REP PSE; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balestra GM, 2009, AUSTRALAS PLANT DIS, V4, P34, DOI 10.1071/DN09014; Balestra G.M., 2010, NEW DIS REPORTS, V22; Balestra G. M., 2008, INFORM AGRARIO, V38, P75; Balestra GM, 2011, NEW DIS REPORTS, P24; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bos KI, 2011, NATURE; Bull CT, 2011, PHYTOPATHOLOGY; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapman J., 2011, 2 REPORT CHARACTERIZ; Cheng H.Y., 1995, J ANHUI AGR U, V22, P219; Deflorian S, 2009, MIGLIORAMENTO GENETI; Dye D. W., 1980, Review of Plant Pathology, V59, P153; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Everett KR, 2011, AUSTRALIASIAN PLANT; Fang Y., 1990, SICHUAN FRUIT SCI TE, V18, P28; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; HATTINGH MJ, 1989, PLANT DIS, V73, P784, DOI 10.1094/PD-73-0784; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; Li JQ, 2007, ACTA HORTICULTURAE, P753; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liang Y, 2000, J NW FORESTRY COLL, V15, P37; MALVICK DK, 1988, PLANT PATHOL, V37, P573, DOI 10.1111/j.1365-3059.1988.tb02117.x; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Mazzaglia A, 2011, CAN J PLANT PATHOL, V33, P8, DOI 10.1080/07060661.2010.538556; MCCARTER SM, 1983, PHYTOPATHOLOGY, V73, P1393, DOI 10.1094/Phyto-73-1393; Ministry of Agriculture Forestry NZ, 2011, PSA PATHW TRAC REP; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Morris CE, 2010, MBIO, V1, DOI 10.1128/mBio.00107-10; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Morton F, 1987, FRUITS WARM CLIMATES; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; SCORTICHINI M, 1994, PLANT PATHOL, V43, P1035, DOI 10.1111/j.1365-3059.1994.tb01654.x; Service ER, 2011, 1 SERV ER; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stavrinides J, 2009, APPL ENVIRON MICROB, V75, P2230, DOI 10.1128/AEM.02860-08; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; TAYLOR JD, 1979, ANN APPL BIOL, V93, P267, DOI 10.1111/j.1744-7348.1979.tb06541.x; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vanneste JL, 2011, PLANT DIS, V95, P1311, DOI 10.1094/PDIS-03-11-0195; Vanneste J. L., 2011, New Zealand Plant Protection, V64, P246	56	102	115	7	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36518	10.1371/journal.pone.0036518	http://dx.doi.org/10.1371/journal.pone.0036518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590555	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100033
J	Tomczak, A; Sontheimer, J; Drechsel, D; Hausdorf, R; Gentzel, M; Shevchenko, A; Eichler, S; Fahmy, K; Buchholz, F; Pisabarro, MT				Tomczak, Aurelie; Sontheimer, Jana; Drechsel, David; Hausdorf, Rainer; Gentzel, Marc; Shevchenko, Andrej; Eichler, Stefanie; Fahmy, Karim; Buchholz, Frank; Pisabarro, M. Teresa			3D Profile-Based Approach to Proteome-Wide Discovery of Novel Human Chemokines	PLOS ONE			English	Article							FOLD RECOGNITION; SEQUENCE ALIGNMENTS; GENE-EXPRESSION; T-CELLS; PROTEINS; PREDICTION; DATABASE; MODELS; CLASSIFICATION; IDENTIFICATION	Chemokines are small secreted proteins with important roles in immune responses. They consist of a conserved three-dimensional (3D) structure, so-called IL8-like chemokine fold, which is supported by disulfide bridges characteristic of this protein family. Sequence-and profile-based computational methods have been proficient in discovering novel chemokines by making use of their sequence-conserved cysteine patterns. However, it has been recently shown that some chemokines escaped annotation by these methods due to low sequence similarity to known chemokines and to different arrangement of cysteines in sequence and in 3D. Innovative methods overcoming the limitations of current techniques may allow the discovery of new remote homologs in the still functionally uncharacterized fraction of the human genome. We report a novel computational approach for proteome-wide identification of remote homologs of the chemokine family that uses fold recognition techniques in combination with a scaffold-based automatic mapping of disulfide bonds to define a 3D profile of the chemokine protein family. By applying our methodology to all currently uncharacterized human protein sequences, we have discovered two novel proteins that, without having significant sequence similarity to known chemokines or characteristic cysteine patterns, show strong structural resemblance to known anti-HIV chemokines. Detailed computational analysis and experimental structural investigations based on mass spectrometry and circular dichroism support our structural predictions and highlight several other chemokine-like features. The results obtained support their functional annotation as putative novel chemokines and encourage further experimental characterization. The identification of remote homologs of human chemokines may provide new insights into the molecular mechanisms causing pathologies such as cancer or AIDS, and may contribute to the development of novel treatments. Besides, the genome-wide applicability of our methodology based on 3D protein family profiles may open up new possibilities for improving and accelerating protein function annotation processes.	[Tomczak, Aurelie; Sontheimer, Jana; Hausdorf, Rainer; Pisabarro, M. Teresa] BIOTEC TU Dresden, Dresden, Germany; [Drechsel, David; Gentzel, Marc; Shevchenko, Andrej; Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Eichler, Stefanie; Fahmy, Karim] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Buchholz, Frank] Tech Univ Dresden, Univ Hosp, Dept Med Syst Biol, Dresden, Germany; [Buchholz, Frank] Med Fac Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden; Max Planck Society; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Tomczak, A (corresponding author), BIOTEC TU Dresden, Dresden, Germany.	mayte@biotec.tu-dresden.de	Buchholz, Frank/B-4700-2017; Pisabarro, M. Teresa/D-4270-2012; Fahmy, Karim/B-2708-2017	Buchholz, Frank/0000-0002-4577-3344; Fahmy, Karim/0000-0002-8752-5824; Gentzel, Marc/0000-0002-4482-6010	Klaus Tschira Stiftung (Foundation) gGmbH	Klaus Tschira Stiftung (Foundation) gGmbH	This work has been funded by the Klaus Tschira Stiftung (Foundation) gGmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Betts MJ, 2001, EMBO J, V20, P5354, DOI 10.1093/emboj/20.19.5354; Blain KY, 2007, BIOCHEMISTRY-US, V46, P10008, DOI 10.1021/bi700936w; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; Chong IW, 2000, INFLAMMATION, V24, P505, DOI 10.1023/A:1007021322323; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Colobran R, 2007, CLIN EXP IMMUNOL, V148, P208, DOI 10.1111/j.1365-2249.2007.03344.x; Cozzetto D, 2009, PROTEINS, V77, P18, DOI 10.1002/prot.22561; deJongh HHJ, 1996, ANAL BIOCHEM, V242, P95, DOI 10.1006/abio.1996.0434; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Gerber A, 2004, EUR RESPIR J, V24, P40, DOI 10.1183/09031936.04.00079203; Gille C, 2000, J MOL BIOL, V299, P1147, DOI 10.1006/jmbi.2000.3763; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kinch LN, 2003, PROTEINS, V53, P395, DOI 10.1002/prot.10557; Kumar S, 2006, CHEM BIOL, V13, P69, DOI 10.1016/j.chembiol.2005.10.012; Lata S, 2009, PROTEIN ENG DES SEL, V22, P441, DOI 10.1093/protein/gzp016; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luz JG, 2005, J MOL BIOL, V352, P1019, DOI 10.1016/j.jmb.2005.08.011; Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207; Magistrelli G, 2005, BIOCHEM BIOPH RES CO, V334, P370, DOI 10.1016/j.bbrc.2005.06.091; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Murooka TT, 2006, J BIOL CHEM, V281, P25184, DOI 10.1074/jbc.M603912200; Nibbs RJB, 2003, EXPERT OPIN BIOL TH, V3, P15, DOI 10.1517/14712598.3.1.15; Ottersbach K, 2006, BLOOD, V107, P1284, DOI 10.1182/blood-2005-08-3112; Pasquier C, 1999, PROTEIN ENG, V12, P381, DOI 10.1093/protein/12.5.381; Pease JE, 2006, BRIT J PHARMACOL, V147, pS212, DOI 10.1038/sj.bjp.0706475; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Ruggiero P, 2003, EUR CYTOKINE NETW, V14, P91; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sippl MJ, 2001, PROTEINS, P55; SIPPL MJ, 1992, PROTEINS, V13, P258, DOI 10.1002/prot.340130308; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stine JT, 2000, BLOOD, V95, P1151, DOI 10.1182/blood.V95.4.1151.004k37_1151_1157; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Tomczak A, 2011, PROTEINS, V79, P1277, DOI 10.1002/prot.22963; Ueda Y, 2007, MELANOMA RES, V17, P91, DOI 10.1097/CMR.0b013e3280a60888; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Wang G, 2005, PROTEINS, V61, P46, DOI 10.1002/prot.20721; Wang GL, 2004, PROTEIN SCI, V13, P1612, DOI 10.1110/ps.03601504; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WIDMER U, 1993, J IMMUNOL, V150, P4996; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	68	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36151	10.1371/journal.pone.0036151	http://dx.doi.org/10.1371/journal.pone.0036151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586462	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000024
J	Belatik, A; Hotchandani, S; Carpentier, R; Tajmir-Riahi, HA				Belatik, Ahmed; Hotchandani, Surat; Carpentier, Robert; Tajmir-Riahi, Heidar-Ali			Locating the Binding Sites of Pb(II) Ion with Human and Bovine Serum Albumins	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE; FLUORESCENCE SPECTROSCOPY; FTIR SPECTROSCOPY; PROTEINS; ACID	Lead is a potent environmental toxin that has accumulated above its natural level as a result of human activity. Pb cation shows major affinity towards protein complexation and it has been used as modulator of protein-membrane interactions. We located the binding sites of Pb(II) with human serum (HSA) and bovine serum albumins (BSA) at physiological conditions, using constant protein concentration and various Pb contents. FTIR, UV-visible, CD, fluorescence and X-ray photoelectron spectroscopic (XPS) methods were used to analyse Pb binding sites, the binding constant and the effect of metal ion complexation on HSA and BSA stability and conformations. Structural analysis showed that Pb binds strongly to HSA and BSA via hydrophilic contacts with overall binding constants of KPb-HSA = 8.2 (+/- 0.8) x 10(4) M-1 and KPb-BSA = 7.5 (+/- 0.7) x 10(4) M-1. The number of bound Pb cation per protein is 0.7 per HSA and BSA complexes. XPS located the binding sites of Pb cation with protein N and O atoms. Pb complexation alters protein conformation by a major reduction of alpha-helix from 57% (free HSA) to 48% (metal-complex) and 63% (free BSA) to 52% (metal-complex) inducing a partial protein destabilization.	[Belatik, Ahmed; Hotchandani, Surat; Carpentier, Robert; Tajmir-Riahi, Heidar-Ali] Univ Quebec Trois Rivieres, Dept Chim Biol, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres	Belatik, A (corresponding author), Univ Quebec Trois Rivieres, Dept Chim Biol, Trois Rivieres, PQ, Canada.	tajmirri@uqtr.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by a grant from Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED A, 1995, FEBS LETT, V363, P65, DOI 10.1016/0014-5793(95)00282-E; Ahmed MH, 2011, J PHOTOCH PHOTOBIO A, V222, P123, DOI 10.1016/j.jphotochem.2011.05.011; Ahmed-Ouameur A, 2006, CELL BIOCHEM BIOPHYS, V45, P203, DOI 10.1385/CBB:45:2:203; Barazzouk S, 2011, CELLULOSE, V18, P643, DOI 10.1007/s10570-011-9503-5; Beauchemin R, 2007, BIOMACROMOLECULES, V8, P3177, DOI 10.1021/bm700697a; Belatik A, 2012, EUR J MED CHEM, V48, P114, DOI 10.1016/j.ejmech.2011.12.002; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; DOUSSEAU F, 1989, APPL SPECTROSC, V43, P538, DOI 10.1366/0003702894202814; Dubeau S, 2010, BIOMACROMOLECULES, V11, P1507, DOI 10.1021/bm100144v; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Eslam E, 2008, J HAZARD MATER, V154, P914; Frateur I, 2007, ELECTROCHIM ACTA, V52, P7660, DOI 10.1016/j.electacta.2006.12.060; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Grdadolnik J, 2003, ACTA CHIM SLOV, V50, P777; He WY, 2005, BIOORGAN MED CHEM, V13, P1837, DOI 10.1016/j.bmc.2004.11.038; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Jiang M, 2004, J MOL STRUCT, V692, P71, DOI 10.1016/j.molstruc.2004.01.003; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kirberger M, 2008, J INORG BIOCHEM, V102, P1901, DOI 10.1016/j.jinorgbio.2008.06.014; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Liang L, 2008, BIOMACROMOLECULES, V9, P50, DOI 10.1021/bm700728k; Ling QF, 2009, BIOL TRACE ELEM RES, V129, P251, DOI 10.1007/s12011-008-8283-8; Mandeville JS, 2010, BIOMACROMOLECULES, V11, P465, DOI 10.1021/bm9011979; Mandeville JS, 2009, J PHARMACEUT BIOMED, V49, P468, DOI 10.1016/j.jpba.2008.11.035; Morales KA, 2011, J AM CHEM SOC, V133, P10599, DOI 10.1021/ja2032772; Painter L, 1998, J CHEM SOC PERK T 1, P3041, DOI 10.1039/a803429j; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Peters T., 1996, BIOCH GENETICS MED A; Qin QD, 2011, CHEM ENG J, V172, P68, DOI 10.1016/j.cej.2011.05.066; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tayeh N, 2009, J PHARMACEUT BIOMED, V50, P107, DOI 10.1016/j.jpba.2009.03.015; Tian J., 2005, ARTIC AM J IMMUNOL, V1, P21, DOI [DOI 10.3844/AJISP.2005.21.23, DOI 10.3844/ajisp.2005.21.23]; Zhang GW, 2008, J MOL STRUCT, V881, P132, DOI 10.1016/j.molstruc.2007.09.002; Zubavichus Y, 2004, J PHYS CHEM A, V108, P4557, DOI 10.1021/jp049376f	40	76	79	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36723	10.1371/journal.pone.0036723	http://dx.doi.org/10.1371/journal.pone.0036723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574219	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800116
J	Cilingir, G; Broschat, SL; Lau, AOT				Cilingir, Gokcen; Broschat, Shira L.; Lau, Audrey O. T.			ApicoAP: The First Computational Model for Identifying Apicoplast-Targeted Proteins in Multiple Species of Apicomplexa	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SIGNAL PEPTIDES; PREDICTION; SEQUENCE; ORIGIN	Background: Most of the parasites of the phylum Apicomplexa contain a relict prokaryotic-derived plastid called the apicoplast. This organelle is important not only for the survival of the parasite, but its unique properties make it an ideal drug target. The majority of apicoplast-associated proteins are nuclear encoded and targeted post-translationally to the organellar lumen via a bipartite signaling mechanism that requires an N-terminal signal and transit peptide (TP). Attempts to define a consensus motif that universally identifies apicoplast TPs have failed. Methodology/Principal Findings: In this study, we propose a generalized rule-based classification model to identify apicoplast-targeted proteins (ApicoTPs) that use a bipartite signaling mechanism. Given a training set specific to an organism, this model, called ApicoAP, incorporates a procedure based on a genetic algorithm to tailor a discriminating rule that exploits the known characteristics of ApicoTPs. Performance of ApicoAP is evaluated for four labeled datasets of Plasmodium falciparum, Plasmodium yoelii, Babesia bovis, and Toxoplasma gondii proteins. ApicoAP improves the classification accuracy of the published dataset for P. falciparum to 94%, originally 90% using PlasmoAP. Conclusions/Significance: We present a parametric model for ApicoTPs and a procedure to optimize the model parameters for a given training set. A major asset of this model is that it is customizable to different parasite genomes. The ApicoAP prediction software is available at http://code.google.com/p/apicoap/ and http://bcb.eecs.wsu.edu.	[Cilingir, Gokcen; Broschat, Shira L.] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Broschat, Shira L.; Lau, Audrey O. T.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Washington State University; Washington State University	Cilingir, G (corresponding author), Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA.	shira@eecs.wsu.edu		Lau, Audrey/0000-0001-8212-0142	Wellcome Trust [GR075800M]; United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [58-5348-7-528]	Wellcome Trust(Wellcome TrustEuropean Commission); United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors wish to acknowledge the support of GC by the Carl M. Hansen Foundation. Funding was provided by Wellcome Trust GR075800M (AOTL) and United States Department of Agriculture-Agricultural Research Service (USDA-ARS) Cooperative Agreement 58-5348-7-528 (AOTL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpaydin E., 2010, INTRO MACHINE LEARNI; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Caballero MC, 2012, MOL BIOCHEM PARASIT, V181, P125, DOI 10.1016/j.molbiopara.2011.10.009; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Fleige T, 2010, MICROBES INFECT, V12, P253, DOI 10.1016/j.micinf.2009.12.010; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Gallagher JR, 2011, TRAFFIC, V12, P1124, DOI 10.1111/j.1600-0854.2011.01232.x; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; He CY, 2001, EMBO J, V20, P330, DOI 10.1093/emboj/20.3.330; Holland J. H., 1992, ADAPTATION NATURAL A; HOLLAND JH, 1992, SCI AM, V267, P66, DOI 10.1038/scientificamerican0792-66; Johnson RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020633; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kelly Jr JD, 1991, IJCAI, V91, P645; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kumar A, 2010, MOL MICROBIOL, V75, P942, DOI 10.1111/j.1365-2958.2009.07033.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lim L, 2009, TRENDS PARASITOL, V25, P197, DOI 10.1016/j.pt.2009.02.001; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; McFadden GI, 1999, TRENDS MICROBIOL, V7, P328, DOI 10.1016/S0966-842X(99)01547-4; Mitchell M., 1993, INT C NEURAL INF PRO, V12, P51; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prevelige PE, 1989, PREDICTION PROTEIN S, P1; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7; Sabine B, 2010, MOL PARASITOLOGY; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Tonkin CJ, 2008, TRAFFIC, V9, P166, DOI 10.1111/j.1600-0854.2007.00660.x; Tonkin CJ, 2006, MOL BIOCHEM PARASIT, V150, P192, DOI 10.1016/j.molbiopara.2006.08.001; van Dooren GG, 2000, PARASITOL TODAY, V16, P421, DOI 10.1016/S0169-4758(00)01792-0; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	40	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36598	10.1371/journal.pone.0036598	http://dx.doi.org/10.1371/journal.pone.0036598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574192	Green Published, gold			2022-12-25	WOS:000305349800089
J	Huang, ZF; Zhu, GH; Sun, CC; Zhang, JG; Zhang, Y; Zhang, YT; Ye, CH; Wang, XJ; Ilghari, D; Li, XK				Huang, Zhifeng; Zhu, Guanghui; Sun, Chuanchuan; Zhang, Jingui; Zhang, Yi; Zhang, Youting; Ye, Chaohui; Wang, Xiaojie; Ilghari, Dariush; Li, Xiaokun			A Novel Solid-Phase Site-Specific PEGylation Enhances the In Vitro and In Vivo Biostabilty of Recombinant Human Keratinocyte Growth Factor 1	PLOS ONE			English	Article							POLYETHYLENE-GLYCOL; CHEMICAL-MODIFICATION; MONO-PEGYLATION; ORAL MUCOSITIS; HEPATITIS-C; STABILITY; AGGREGATION; PALIFERMIN; RATS; INTERFERON-ALPHA-2B	Keratinocyte growth factor 1 (KGF-1) has proven useful in the treatment of pathologies associated with dermal adnexae, liver, lung, and the gastrointestinal tract diseases. However, poor stability and short plasma half-life of the protein have restricted its therapeutic applications. While it is possible to improve the stability and extend the circulating half-life of recombinant human KGF-1 (rhKGF-1) using solution-phase PEGylation, such preparations have heterogeneous structures and often low specific activities due to multiple and/or uncontrolled PEGylation. In the present study, a novel solid-phase PEGylation strategy was employed to produce homogenous mono-PEGylated rhKGF-1. RhKGF-1 protein was immobilized on a Heparin-Sepharose column and then a site-selective PEGylation reaction was carried out by a reductive alkylation at the N-terminal amino acid of the protein. The mono-PEGylated rhKGF-1, which accounted for over 40% of the total rhKGF-1 used in the PEGylation reaction, was purified to homogeneity by SP Sepharose ion-exchange chromatography. Our biophysical and biochemical studies demonstrated that the solid-phase PEGylation significantly enhanced the in vitro and in vivo biostability without affecting the over all structure of the protein. Furthermore, pharmacokinetic analysis showed that modified rhKGF-1 had considerably longer plasma half-life than its intact counterpart. Our cell-based analysis showed that, similar to rhKGF-1, PEGylated rhKGF-1 induced proliferation in NIH 3T3 cells through the activation of MAPK/Erk pathway. Notably, PEGylated rhKGF-1 exhibited a greater hepatoprotection against CCl4-induced injury in rats compared to rhKGF-1.	[Huang, Zhifeng; Sun, Chuanchuan; Zhang, Jingui; Zhang, Yi; Ye, Chaohui; Wang, Xiaojie; Li, Xiaokun] Wenzhou Med Coll, Key Lab Biotechnol & Pharmaceut Engn Zhejiang Pro, Wenzhou, Peoples R China; [Zhu, Guanghui; Zhang, Youting] Wenzhou Med Coll, Affiliated Hosp 2, Med Ctr, Wenzhou, Peoples R China; [Ilghari, Dariush] NYU, Sch Med, Dept Pharmacol, New York, NY USA; [Li, Xiaokun] Jilin Univ, Normal Bethune Med Coll, Changchun 130023, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; New York University; Jilin University	Huang, ZF (corresponding author), Wenzhou Med Coll, Key Lab Biotechnol & Pharmaceut Engn Zhejiang Pro, Wenzhou, Peoples R China.	Dariush.Ilghari@nyumc.org; proflxk@163.com	Zhu, Guangshan/E-2024-2013		Natural Science Foundation [81102486]; Natural Science Foundation of Zhejiang Province of China [Y4100067]; Key Grant of Wenzhou Department of Science and Technology [Y20100004]; Zhejiang Provincial Key Research Group [2010R50042]; China Postdoctoral Science Foundation Project [20110491431]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Key Grant of Wenzhou Department of Science and Technology; Zhejiang Provincial Key Research Group; China Postdoctoral Science Foundation Project(China Postdoctoral Science Foundation)	This study was supported, in part, by grants from Natural Science Foundation, 81102486 (to ZH); Natural Science Foundation of Zhejiang Province of China, Y4100067 (to ZH); Key Grant of Wenzhou Department of Science and Technology, Y20100004 (to ZH); Zhejiang Provincial Key Research Group, 2010R50042 (to XL) and China Postdoctoral Science Foundation Project, 20110491431 (to ZH). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSPACH FB, 1995, J CHROMATOGR A, V711, P129; Balan S, 2007, BIOCONJUGATE CHEM, V18, P61, DOI 10.1021/bc0601471; Basu A, 2006, BIOCONJUGATE CHEM, V17, P618, DOI 10.1021/bc050322y; Beaven AW, 2006, EXPERT OPIN PHARMACO, V7, P2287, DOI 10.1517/14656566.7.16.2287; Berg T, 2007, HEPATOLOGY, V46, P1187, DOI 10.1002/hep.21814; Blijlevens N, 2007, ANN ONCOL, V18, P817, DOI 10.1093/annonc/mdl332; Bohm F, 2010, GASTROENTEROLOGY, V139, P1385, DOI 10.1053/j.gastro.2010.06.069; BRAUCHLE M, 1994, ONCOGENE, V9, P3199; Cai YQ, 2011, J CHROMATOGR A, V1218, P6953, DOI 10.1016/j.chroma.2011.07.107; Caliceti P, 2003, ADV DRUG DELIVER REV, V55, P1261, DOI 10.1016/S0169-409X(03)00108-X; CHEN BL, 1994, J PHARM SCI, V83, P1657, DOI 10.1002/jps.2600831204; Chen BL, 1996, J PHARM SCI, V85, P419, DOI 10.1021/js9504393; CHEN BL, 1994, PHARMACEUT RES, V11, P1581, DOI 10.1023/A:1018905720139; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; DeSantis G, 1999, CURR OPIN BIOTECH, V10, P324, DOI 10.1016/S0958-1669(99)80059-7; George S, 2008, CANCER CHEMOTH PHARM, V62, P347, DOI 10.1007/s00280-007-0594-5; Hsu E, 2006, PROTEIN ENG DES SEL, V19, P147, DOI 10.1093/protein/gzj013; Hu JL, 2010, BIOCONJUGATE CHEM, V21, P1762, DOI 10.1021/bc9005706; Huang ZF, 2007, TOXICOL LETT, V170, P146, DOI 10.1016/j.toxlet.2007.03.001; Huang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020669; Huang Z, 2009, J BIOTECHNOL, V142, P242, DOI 10.1016/j.jbiotec.2009.05.004; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kaido T, 1996, BIOCHEM BIOPH RES CO, V218, P1, DOI 10.1006/bbrc.1996.0001; Kan NG, 2009, FASEB J, V23, P3516, DOI 10.1096/fj.09-131730; KUAN CT, 1994, J BIOL CHEM, V269, P7610; Lee BK, 2007, BIOCONJUGATE CHEM, V18, P1728, DOI 10.1021/bc060245m; Lee H, 2003, PHARMACEUT RES, V20, P818, DOI 10.1023/A:1023402123119; Lin JH, 1997, PHARMACOL REV, V49, P403; Luo YD, 2004, PROTEIN EXPRES PURIF, V33, P326, DOI 10.1016/j.pep.2003.10.013; Marti Guy P., 2008, V423, P383, DOI 10.1007/978-1-59745-194-9_30; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Niall H D, 1973, Methods Enzymol, V27, P942; Nie YJ, 2006, BIOCONJUGATE CHEM, V17, P995, DOI 10.1021/bc050355d; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; PANOS RJ, 1995, J CLIN INVEST, V96, P2026, DOI 10.1172/JCI118250; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Schiffer CA, 1996, CURR OPIN BIOTECH, V7, P428, DOI 10.1016/S0958-1669(96)80119-4; Slavica A, 2007, BIOTECHNOL BIOENG, V96, P9, DOI 10.1002/bit.21181; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Steiling H, 2003, ONCOGENE, V22, P4380, DOI 10.1038/sj.onc.1206499; Tamai H, 2011, HEPATOL RES, V41, P1137, DOI 10.1111/j.1872-034X.2011.00879.x; TSUBOI R, 1993, J INVEST DERMATOL, V101, P49, DOI 10.1111/1523-1747.ep12358892; Tsutsumi Y, 2000, P NATL ACAD SCI USA, V97, P8548, DOI 10.1073/pnas.140210597; Wu XP, 2010, J CELL MOL MED, V14, P351, DOI 10.1111/j.1582-4934.2008.00506.x; Xiao JP, 2008, BIOCONJUGATE CHEM, V19, P1113, DOI 10.1021/bc800063k; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812	48	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36423	10.1371/journal.pone.0036423	http://dx.doi.org/10.1371/journal.pone.0036423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574160	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800056
J	Kumsta, C; Hansen, M				Kumsta, Caroline; Hansen, Malene			C. elegans rrf-1 Mutations Maintain RNAi Efficiency in the Soma in Addition to the Germline	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; LIFE-SPAN EXTENSION; GENETIC INTERFERENCE; GATA-FACTOR; PATHWAYS; PROTEIN; DAF-16; DIFFERENTIATION; MORPHOGENESIS; LOCALIZATION	Gene inactivation through RNA interference (RNAi) has proven to be a valuable tool for studying gene function in C. elegans. When combined with tissue-specific gene inactivation methods, RNAi has the potential to shed light on the function of a gene in distinct tissues. In this study we characterized C. elegans rrf-1 mutants to determine their ability to process RNAi in various tissues. These mutants have been widely used in RNAi studies to assess the function of genes specifically in the C. elegans germline. Upon closer analysis, we found that two rrf-1 mutants carrying different loss-of-function alleles were capable of processing RNAi targeting several somatically expressed genes. Specifically, we observed that the intestine was able to process RNAi triggers efficiently, whereas cells in the hypodermis showed partial susceptibility to RNAi in rrf-1 mutants. Other somatic tissues in rrf-1 mutants, such as the muscles and the somatic gonad, appeared resistant to RNAi. In addition to these observations, we found that the rrf-1(pk1417) mutation induced the expression of several transgenic arrays, including the FOXO transcription factor DAF-16. Unexpectedly, rrf-1(pk1417) mutants showed increased endogenous expression of the DAF-16 target gene sod-3; however, the lifespan and thermo-tolerance of rrf-1(pk1417) mutants were similar to those of wild-type animals. In sum, these data show that rrf-1 mutants display several phenotypes not previously appreciated, including broader tissue-specific RNAi-processing capabilities, and our results underscore the need for careful characterization of tissue-specific RNAi tools.	[Kumsta, Caroline; Hansen, Malene] Dell E Webb Neurosci Aging & Stem Cell Res Ctr, Sanford Burnham Med Res Inst, Program Dev & Aging, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Kumsta, C (corresponding author), Dell E Webb Neurosci Aging & Stem Cell Res Ctr, Sanford Burnham Med Res Inst, Program Dev & Aging, La Jolla, CA USA.	mhansen@sanfordburnham.org	Kumsta, Caroline/AAU-9147-2020		American Association for Cancer Research -Astellas Pharma Global Development Inc. [11-40-28-KUMS]; National Insititutes of Health/National Insititute on Aging [1 R01 AG038664-01A1, 1 R01 AG039756]; Ellison Medical Foundation New Scholar in Aging [AG-NS-0481-08]; American Association for Cancer Research; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE ON AGING [R01AG039756, R01AG038664] Funding Source: NIH RePORTER	American Association for Cancer Research -Astellas Pharma Global Development Inc.; National Insititutes of Health/National Insititute on Aging; Ellison Medical Foundation New Scholar in Aging(Lawrence Ellison Foundation); American Association for Cancer Research; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	CK is funded by an American Association for Cancer Research -Astellas Pharma Global Development Inc. Fellowship in Basic Cancer Research Grant (Grant Number: 11-40-28-KUMS - http://www.aacr.org/home/scientists/aacr-research-funding.aspx). MH is funded by National Insititutes of Health/National Insititute on Aging (Grant numbers: 1 R01 AG038664-01A1 and 1 R01 AG039756). MH is also an Ellison Medical Foundation New Scholar in Aging (Grant number: AG-NS-0481-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CK was funded by the American Association for Cancer Research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; We would like to thank all members of the Hansen Lab for fruitful discussions, and Drs. Anne Brunet, Sean Curran, Andrew Fire, and Anne O'Rourke for feedback on the manuscript. We are grateful to Joyce Chu for repeating the lifespan experiment, and to Sara Gelino, Binnan Ong and Andrew Davis, who generated some of the strains used in this study. We thank the Kenyon lab, the Tuck lab, and the Desai lab for providing strains, and the Dillin lab and Moribe lab for providing the gfp and tsp-15 RNAi clones, respectively. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center (CGC), which is funded by the NIH National Center for Research Resources (NCRR).	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BRENNER S, 1974, GENETICS, V77, P71; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Currie E, 2007, GENETICS, V177, P1569, DOI 10.1534/genetics.107.080689; Deshpande R, 2005, DEV BIOL, V278, P118, DOI 10.1016/j.ydbio.2004.10.020; Drabikowski K, 2005, DEV BIOL, V282, P27, DOI 10.1016/j.ydbio.2005.02.017; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer SEJ, 2008, NATURE, V455, P491, DOI 10.1038/nature07274; Fischer SEJ, 2010, INT J BIOCHEM CELL B, V42, P1306, DOI 10.1016/j.biocel.2010.03.006; FRANCIS R, 1995, GENETICS, V139, P579; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; GAO DL, 1995, P NATL ACAD SCI USA, V92, P9839, DOI 10.1073/pnas.92.21.9839; Govindan JA, 2009, DEVELOPMENT, V136, P2211, DOI 10.1242/dev.034595; Grishok A, 2005, FEBS LETT, V579, P5932, DOI 10.1016/j.febslet.2005.08.001; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; HAWKINS MG, 1995, J BIOL CHEM, V270, P14666, DOI 10.1074/jbc.270.24.14666; Heid PJ, 2001, DEV BIOL, V236, P165, DOI 10.1006/dbio.2001.0315; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Hurd D, 2003, DEV BIOL, V253, P54, DOI 10.1006/dbio.2002.0866; Ito S, 2010, CURR BIOL, V20, P333, DOI 10.1016/j.cub.2009.12.032; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimble Judith, 2005, WormBook, P1; Koh K, 2001, DEVELOPMENT, V128, P2867; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Maciejowski J, 2005, GENETICS, V169, P1997, DOI 10.1534/genetics.104.040121; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Maine Eleanor M., 2008, Briefings in Functional Genomics & Proteomics, V7, P184, DOI 10.1093/bfgp/eln019; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ono K, 2008, J CELL SCI, V121, P2662, DOI 10.1242/jcs.034215; Pilipiuk J, 2009, DEV BIOL, V327, P34, DOI 10.1016/j.ydbio.2008.11.025; Praitis V, 2001, GENETICS, V157, P1217; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Samuelson AV, 2007, COLD SPRING HARB SYM, V72, P489, DOI 10.1101/sqb.2007.72.068; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; THACKER C, 1995, GENE DEV, V9, P956, DOI 10.1101/gad.9.8.956; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Voutev R, 2006, DEV BIOL, V298, P45, DOI 10.1016/j.ydbio.2006.06.011; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836	61	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35428	10.1371/journal.pone.0035428	http://dx.doi.org/10.1371/journal.pone.0035428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574120	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800016
J	Umbach, JA; Adams, KL; Gundersen, CB; Novitch, BG				Umbach, Joy A.; Adams, Katrina L.; Gundersen, Cameron B.; Novitch, Bennett G.			Functional Neuromuscular Junctions Formed by Embryonic Stem Cell-Derived Motor Neurons	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; DIRECTED DIFFERENTIATION; NEUROTRANSMITTER RELEASE; SYNAPTIC VULNERABILITY; MOTONEURONS; DISEASE; TRANSPLANTATION; DIVERSITY; MOUSE	A key objective of stem cell biology is to create physiologically relevant cells suitable for modeling disease pathologies in vitro. Much progress towards this goal has been made in the area of motor neuron (MN) disease through the development of methods to direct spinal MN formation from both embryonic and induced pluripotent stem cells. Previous studies have characterized these neurons with respect to their molecular and intrinsic functional properties. However, the synaptic activity of stem cell-derived MNs remains less well defined. In this study, we report the development of low-density co-culture conditions that encourage the formation of active neuromuscular synapses between stem cell-derived MNs and muscle cells in vitro. Fluorescence microscopy reveals the expression of numerous synaptic proteins at these contacts, while dual patch clamp recording detects both spontaneous and multi-quantal evoked synaptic responses similar to those observed in vivo. Together, these findings demonstrate that stem cell-derived MNs innervate muscle cells in a functionally relevant manner. This dual recording approach further offers a sensitive and quantitative assay platform to probe disorders of synaptic dysfunction associated with MN disease.	[Umbach, Joy A.; Gundersen, Cameron B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Adams, Katrina L.; Novitch, Bennett G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Adams, Katrina L.; Novitch, Bennett G.] Univ Calif Los Angeles, Mol Biol Interdisciplinary Grad Program, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Umbach, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	bnovitch@ucla.edu	Adams, Katrina/GLV-6737-2022	Adams, Katrina/0000-0001-5290-4245; Gundersen, Cameron/0000-0002-1552-6086; Novitch, Bennett/0000-0002-2696-3708	Broad Center for Regenerative Medicine and Stem Cell Research at the University of California Los Angeles; California Institute for Regenerative Medicine [RB1-01367]; Muscular Dystrophy Association [92901]; University of California Los Angeles Cellular and Molecular Biology Training Program, Ruth L. Kirschstein National Research Service Award [GM007185]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	Broad Center for Regenerative Medicine and Stem Cell Research at the University of California Los Angeles; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Muscular Dystrophy Association(Muscular Dystrophy Association); University of California Los Angeles Cellular and Molecular Biology Training Program, Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Broad Center for Regenerative Medicine and Stem Cell Research at the University of California Los Angeles, and grants to BGN from the California Institute for Regenerative Medicine (RB1-01367) and the Muscular Dystrophy Association (92901). KLA was also supported by the University of California Los Angeles Cellular and Molecular Biology Training Program, Ruth L. Kirschstein National Research Service Award GM007185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; DENNIS MJ, 1981, DEV BIOL, V81, P266, DOI 10.1016/0012-1606(81)90290-6; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; FATT P, 1951, J PHYSIOL-LONDON, V115, P320, DOI 10.1113/jphysiol.1951.sp004675; Ferguson SM, 2004, P NATL ACAD SCI USA, V101, P8762, DOI 10.1073/pnas.0401667101; Guo XF, 2010, TISSUE ENG PART C-ME, V16, P1347, DOI [10.1089/ten.tec.2010.0040, 10.1089/ten.TEC.2010.0040]; Karumbayaram S, 2009, DIS MODEL MECH, V2, P189, DOI 10.1242/dmm.002113; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2010, NEUROPATH APPL NEURO, V36, P133, DOI [10.1111/j.1365-2990.2009.01061.x, 10.1111/j.1365-2990.2010.01061.x]; OBRIEN MK, 1990, J NEUROBIOL, V21, P341, DOI 10.1002/neu.480210208; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Patani R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1216; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Poage RE, 1999, J NEUROPHYSIOL, V82, P50, DOI 10.1152/jn.1999.82.1.50; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SINGH RN, 2005, EXP NEUROL, V196, P224, DOI DOI 10.1016/J.EXPNEUROL.2005.06.021; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Urbano FJ, 2003, P NATL ACAD SCI USA, V100, P3491, DOI 10.1073/pnas.0437991100; Vande Velde Christine, 2011, F1000 Biol Rep, V3, P18, DOI 10.3410/B3-18; Wee CD, 2010, CURR OPIN NEUROL, V23, P450, DOI 10.1097/WCO.0b013e32833e1765; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle H, 2008, CURR PROTOC STEM CEL, V1, P9; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Yohn DC, 2008, J NEUROSCI, V28, P12409, DOI 10.1523/JNEUROSCI.1761-08.2008	37	66	79	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36049	10.1371/journal.pone.0036049	http://dx.doi.org/10.1371/journal.pone.0036049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574134	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800030
J	Steg, PG; Ferrari, R; Ford, I; Greenlaw, N; Tardif, JC; Tendera, M; Abergel, H; Fox, KM				Steg, Ph Gabriel; Ferrari, Roberto; Ford, Ian; Greenlaw, Nicola; Tardif, Jean-Claude; Tendera, Michal; Abergel, Helene; Fox, Kim M.		CLARIFY Investigators	Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; VENTRICULAR SYSTOLIC DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; I-F INHIBITOR; EXTERNAL VALIDITY; SUBGROUP ANALYSIS; DOUBLE-BLIND; RISK-FACTOR; TASK-FORCE; ANGINA	Background: Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among patients with stable CAD in routine clinical practice. The goal of the present analysis was to describe HR in such patients, overall and in relation to beta-blocker use, and to describe the determinants of HR. Methods and Findings: CLARIFY is an international, prospective, observational, longitudinal registry of outpatients with stable CAD, defined as prior myocardial infarction or revascularization procedure, evidence of coronary stenosis of >50%, or chest pain associated with proven myocardial ischemia. A total of 33,438 patients from 45 countries in Europe, the Americas, Africa, Middle East, and Asia/Pacific were enrolled between November 2009 and July 2010. Most of the 33,177 patients included in this analysis were men (77.5%). Mean (SD) age was 64.2 (10.5) years, HR by pulse was 68.3 (10.6) bpm, and by electrocardiogram was 67.2 (11.4) bpm. Overall, 44.0% had HR >= 70 bpm. Beta-blockers were used in 75.1% of patients and another 14.4% had intolerance or contraindications to beta-blocker therapy. Among 24,910 patients on beta-blockers, 41.1% had HR >= 70 bpm. HR >= 70 bpm was independently associated with higher prevalence and severity of angina, more frequent evidence of myocardial ischemia, and lack of use of HR-lowering agents. Conclusions: Despite a high rate of use of beta-blockers, stable CAD patients often have resting HR >= 70 bpm, which was associated with an overall worse health status, more frequent angina and ischemia. Further HR lowering is possible in many patients with CAD. Whether it will improve symptoms and outcomes is being tested.	[Steg, Ph Gabriel; Abergel, Helene] INSERM, U698, Paris, France; [Steg, Ph Gabriel; Abergel, Helene] Univ Paris Diderot, Paris, France; [Steg, Ph Gabriel; Abergel, Helene] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Ferrari, Roberto] Univ Ferrara, Salvatore Maugeri Fdn, IRCCS, Dept Cardiol, Lumezzan, Italy; [Ferrari, Roberto] Univ Ferrara, Salvatore Maugeri Fdn, IRCCS, LTTA Ctr, Lumezzan, Italy; [Ford, Ian; Greenlaw, Nicola] Univ Glasgow, Glasgow, Lanark, Scotland; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Tendera, Michal] Med Univ Silesia, Katowice, Poland; [Fox, Kim M.] Royal Brompton Hosp, ICMS, NHLI Imperial Coll, London SW3 6LY, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Istituti Clinici Scientifici Maugeri IRCCS; University of Ferrara; Istituti Clinici Scientifici Maugeri IRCCS; University of Ferrara; University of Glasgow; Universite de Montreal; Medical University Silesia; Imperial College London; Royal Brompton Hospital	Steg, PG (corresponding author), INSERM, U698, Paris, France.	gabriel.steg@bch.ap-hop-paris.fr	Marchionni, Niccolò/ABE-3977-2020; chioncel, ovidiu/K-8425-2019; Gowdak, Luis Henrique Wolff/M-7153-2017; Dženkevičiūtė, Vilma/AAB-6975-2021; Bogdański, Paweł/ABB-2938-2020; FERRARI, ROBERTO/ABD-5169-2020; Tendera, Michal/AAA-1875-2022; Chioncel, Ovidiu/R-7556-2017; Widimsky, Petr/P-8088-2016; Makarenkova, Kseniia/AAB-5482-2019; Colquhoun, David M/F-9078-2013; Georgescu, Catalina Arsenescu/R-5709-2017; Kaab, Stefan/H-3915-2012; Hairullina, Adelya/AAF-6013-2019; Prunier, Fabrice/A-5210-2011; Lukina, Yulia/J-9925-2017; Ford, Ian/ABE-6145-2020; Gowdak, Luis Henrique Wolff/C-4844-2012; Sosner, Philippe/I-6119-2019; Díaz, José Luis JLDD Díaz/Q-2523-2015; Christodorescu, Ruxandra Maria/AAB-4653-2021; STEG, Philippe Gabriel/Z-1567-2019; Nastari, Luciano/C-8528-2012; Idoate, Miguel-Ángel/D-8502-2019; Ushakov, Alexei V/P-4465-2015; Gruchala, Marcin/S-8407-2018; Hernandez Afonso, Julio/I-2223-2017	Marchionni, Niccolò/0000-0002-8101-4695; Gowdak, Luis Henrique Wolff/0000-0002-6785-7506; Dženkevičiūtė, Vilma/0000-0003-1471-9131; Bogdański, Paweł/0000-0002-0563-1624; Chioncel, Ovidiu/0000-0002-3197-3628; Widimsky, Petr/0000-0001-5686-7752; Georgescu, Catalina Arsenescu/0000-0001-5142-7598; Hairullina, Adelya/0000-0002-7832-2267; Lukina, Yulia/0000-0001-8252-3099; Gowdak, Luis Henrique Wolff/0000-0002-6785-7506; Sosner, Philippe/0000-0002-5771-8174; Christodorescu, Ruxandra Maria/0000-0001-8267-5404; Nastari, Luciano/0000-0002-7959-3827; Idoate, Miguel-Ángel/0000-0002-1596-1192; Ushakov, Alexei V/0000-0002-7020-4442; Gomez Doblas, Juan Jose/0000-0002-9020-639X; STEG, Philippe Gabriel/0000-0001-6896-2941; Cziraki MD.PhD. Professor., Attila/0000-0002-8231-3312; Nicolino, Antonio/0000-0001-9667-703X; Aboyans, Victor/0000-0002-0322-9818; GALINIER, Michel/0000-0003-1735-3390; Aksutina, Natal'a/0000-0002-4856-2729; Walker, David/0000-0002-3541-8955; al suwaidi, MB, ChB, FACC, FESC, FSCAI, jassim/0000-0002-5299-9106; Florescu, Cristina/0000-0001-8597-3407; Freitas, Joao/0000-0001-7478-3042; Gruchala, Marcin/0000-0003-4901-2291; Phrommintikul, Arintaya/0000-0003-3986-1951; Ferrari, Roberto/0000-0003-2046-9175; Manzur, Fernando/0000-0001-6679-5609; Hernandez Afonso, Julio/0000-0002-0982-1759; Bryl, Wieslaw/0000-0003-0135-409X; Wongcharoen, Wanwarang/0000-0002-2418-329X; Shiels, Paul/0000-0002-7577-9843; gosse, philippe/0000-0002-5840-7749; Bravo Baptista, Sergio/0000-0002-4546-5261; Tendera, Michal/0000-0002-0812-6113; jourdain, patrick/0000-0002-5202-6902	Servier, France; Servier; Amgen; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo/Eli Lilly alliance; Eisai; GlaxoSmithKline; Medtronic; Merck Sharpe and Dohme; Pfizer; Roche; sanofi-aventis; Medicines Company; Menarini; TIMI Group; National Institute for Health Research [NF-SI-0611-10149] Funding Source: researchfish	Servier, France(Servier); Servier(Servier); Amgen(Amgen); Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi Sankyo/Eli Lilly alliance(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Medtronic(Medtronic); Merck Sharpe and Dohme(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); sanofi-aventis(Sanofi-Aventis); Medicines Company; Menarini(Menarini Group); TIMI Group; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by research grants from Servier, France (http://www.clarify-registry.com). The study was designed and conducted by the investigators and funded via grants from Servier, including a grant to the academic statistical center. The sponsor provided assistance for study set-up and management in each country, and funded editorial assistance in the preparation of the manuscript, tables, and figures by Sophie Rushton-Smith. The sponsor was sent the manuscript before submission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This study was supported by research grants from Servier, France. PGS: has received research grants from Servier; consultancy fees/honoraria from Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo/Eli Lilly alliance, Eisai, GlaxoSmithKline, Medtronic, Merck Sharpe and Dohme, Pfizer, Roche, sanofi-aventis, Servier, and The Medicines Company; and has equity ownership in Aterovax. RF: Speaker's bureau: Servier, Roche and Boehringer Ingelheim; Research Grant: Servier, Boehringer Ingelheim and Roche; Advisory Board: Servier, Bayer, Roche and Boehringer Ingelheim. IF: Research grants, honoraria for committee membership, and support for conference attendance from Servier. NG: none. J-CT: Research grants and honoraria from Servier. MT: Fees, honoraria, and research grants from Amgen, Bayer, Menarini, Servier and TIMI Group. HA: none. KMF: Fees, honoraria, and research grants from Servier. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Anderson GF, 2007, NEW ENGL J MED, V356, P209, DOI 10.1056/NEJMp068182; Antoni ML, 2012, EUR HEART J, V33, P96, DOI 10.1093/eurheartj/ehr293; Bagnall AJ, 2010, CIRC-CARDIOVASC QUAL, V3, P530, DOI 10.1161/CIRCOUTCOMES.109.919415; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Borer JS, 2003, CIRCULATION, V107, P817, DOI 10.1161/01.CIR.0000048143.25023.87; CLAUSEN JP, 1976, PROG CARDIOVASC DIS, V18, P459, DOI 10.1016/0033-0620(76)90012-8; Daly CA, 2010, POSTGRAD MED J, V86, P212, DOI 10.1136/pgmj.2009.084384; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Fox K, 2009, EUR HEART J, V30, P2337, DOI 10.1093/eurheartj/ehp358; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; HJALMARSON A, 1990, AM J CARDIOL, V65, P547, DOI 10.1016/0002-9149(90)91029-6; Ho JE, 2010, AM J CARDIOL, V105, P905, DOI 10.1016/j.amjcard.2009.11.035; Hsia J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b219; Kolloch R, 2008, EUR HEART J, V29, P1327, DOI 10.1093/eurheartj/ehn123; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Rambihar S, 2010, CIRCULATION, V122; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Steg PG, 2009, EUR HEART J SUPPL, V11, pD13, DOI 10.1093/eurheartj/sup017; Tardif JC, 2005, EUR HEART J, V26, P2529, DOI 10.1093/eurheartj/ehi586; Tardif JC, 2009, EUR HEART J, V30, P540, DOI 10.1093/eurheartj/ehn571; Waters DD, 2010, EUR HEART J, V31, P801	30	80	83	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36284	10.1371/journal.pone.0036284	http://dx.doi.org/10.1371/journal.pone.0036284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570699	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400015
J	Suzuki, K; Matsui, Y; Higashimoto, M; Kawaguchi, Y; Seki, S; Motomura, H; Hori, T; Yahara, Y; Kanamori, M; Kimura, T				Suzuki, Kayo; Matsui, Yoshito; Higashimoto, Mami; Kawaguchi, Yoshiharu; Seki, Shoji; Motomura, Hiraku; Hori, Takeshi; Yahara, Yasuhito; Kanamori, Masahiko; Kimura, Tomoatsu			Myxoid Liposarcoma-Associated EWSR1-DDIT3 Selectively Represses Osteoblastic and Chondrocytic Transcription in Multipotent Mesenchymal Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE; BINDING-PROTEIN; DNA METHYLATION; POSTCONFLUENCE INHIBITION; GENE-TRANSCRIPTION; FUSION PROTEIN; PPAR-GAMMA; IN-VITRO; CHOP; COLLAGEN	Background: Liposarcomas are the most common class of soft tissue sarcomas, and myxoid liposarcoma is the second most common liposarcoma. EWSR1-DDIT3 is a chimeric fusion protein generated by the myxoid liposarcoma-specific chromosomal translocation t(12;22)(q13;q12). Current studies indicate that multipotent mesenchymal cells are the origin of sarcomas. The mechanism whereby EWSR1-DDIT3 contributes to the phenotypic selection of target cells during oncogenic transformation remains to be elucidated. Methodology/Principal Findings: Reporter assays showed that the EWSR1-DDIT3 myxoid liposarcoma fusion protein, but not its wild-type counterparts EWSR1 and DDIT3, selectively repressed the transcriptional activity of cell lineage-specific marker genes in multipotent mesenchymal C3H10T1/2 cells. Specifically, the osteoblastic marker Opn promoter and chondrocytic marker Col11a2 promoter were repressed, while the adipocytic marker Ppar-gamma 2 promoter was not affected. Mutation analyses, transient ChIP assays, and treatment of cells with trichostatin A (a potent inhibitor of histone deacetylases) or 5-Aza-2'-deoxycytidine (a methylation-resistant cytosine homolog) revealed the possible molecular mechanisms underlying the above-mentioned selective transcriptional repression. The first is a genetic action of the EWSR1-DDIT3 fusion protein, which results in binding to the functional C/EBP site within Opn and Col11a2 promoters through interaction of its DNA-binding domain and subsequent interference with endogenous C/EBP beta function. Another possible mechanism is an epigenetic action of EWSR1-DDIT3, which enhances histone deacetylation, DNA methylation, and histone H3K9 trimethylation at the transcriptional repression site. We hypothesize that EWSR1-DDIT3-mediated transcriptional regulation may modulate the target cell lineage through target gene-specific genetic and epigenetic conversions. Conclusions/Significance: This study elucidates the molecular mechanisms underlying EWSR1-DDIT3 fusion protein-mediated phenotypic selection of putative target multipotent mesenchymal cells during myxoid liposarcoma development. A better understanding of this process is fundamental to the elucidation of possible direct lineage reprogramming in oncogenic sarcoma transformation mediated by fusion proteins.	[Suzuki, Kayo; Matsui, Yoshito; Higashimoto, Mami; Kawaguchi, Yoshiharu; Seki, Shoji; Motomura, Hiraku; Hori, Takeshi; Yahara, Yasuhito; Kimura, Tomoatsu] Toyama Univ, Fac Med, Dept Orthopaed Surg, Toyama 930, Japan; [Kanamori, Masahiko] Toyama Univ, Fac Med, Dept Human Sci, Toyama 930, Japan	University of Toyama; University of Toyama	Suzuki, K (corresponding author), Toyama Univ, Fac Med, Dept Orthopaed Surg, Toyama 930, Japan.	m-yoshito@umin.ac.jp	Yahara, Yasuhito/AAO-7487-2020		KAKENHI [22591683]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Grants-in-Aid for Scientific Research (C) 22591683 (KAKENHI). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmant G, 1998, J BIOL CHEM, V273, P15574, DOI 10.1074/jbc.273.25.15574; Antonescu C, 2002, PATHOLOGY GENETICS T, P40; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Carbone R, 2006, MOL CELL BIOL, V26, P1288, DOI 10.1128/MCB.26.4.1288-1296.2006; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Conyers Rachel, 2011, Sarcoma, V2011, P483154, DOI 10.1155/2011/483154; CRAIG AM, 1991, GENE, V100, P163, DOI 10.1016/0378-1119(91)90362-F; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; Gonzalez I, 2007, J MOL MED, V85, P1015, DOI 10.1007/s00109-007-0202-5; Goransson M, 2005, INT J CANCER, V115, P556, DOI 10.1002/ijc.20893; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; Illich DJ, 2011, STEM CELLS, V29, P555, DOI 10.1002/stem.611; Jalagadugula G, 2010, BLOOD, V116, P6037, DOI 10.1182/blood-2010-06-289850; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; KIMURA T, 1989, J BIOL CHEM, V264, P13910; Krishnan B, 2008, CLIN ORTHOP RELAT R, V466, P2131, DOI 10.1007/s11999-008-0342-0; Kubo T, 2006, BIOCHEM BIOPH RES CO, V340, P476, DOI 10.1016/j.bbrc.2005.12.042; Kubo T, 2010, ANTICANCER RES, V30, P661; Lammi J, 2004, MOL ENDOCRINOL, V18, P1546, DOI 10.1210/me.2003-0247; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Leung JY, 2008, ONCOGENE, V27, P4172, DOI 10.1038/onc.2008.55; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Mai A, 2006, J MED CHEM, V49, P6897, DOI 10.1021/jm060601m; Matsui Y, 2003, J BIOL CHEM, V278, P11369, DOI 10.1074/jbc.M300164200; Matsui Y, 1998, CANCER LETT, V124, P143, DOI 10.1016/S0304-3835(97)00468-0; Matsui Y, 2006, BIOCHEM BIOPH RES CO, V348, P437, DOI 10.1016/j.bbrc.2006.07.085; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; Nguyen CT, 2002, CANCER RES, V62, P6456; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Panagopoulos I, 1996, ONCOGENE, V12, P489; PARK JS, 1992, GENE, V116, P259, DOI 10.1016/0378-1119(92)90523-R; Perez-Mancera PA, 2005, SEMIN CANCER BIOL, V15, P206, DOI 10.1016/j.semcancer.2005.01.006; Perez-Mancera PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002569; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Ren YX, 2008, CANCER RES, V68, P6587, DOI 10.1158/0008-5472.CAN-08-0859; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; REZNIKOFF CA, 1973, CANCER RES, V33, P3239; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rodriguez R, 2012, CELL RES, V22, P62, DOI 10.1038/cr.2011.157; Rodriguez R, 2011, STEM CELLS, V29, P179, DOI 10.1002/stem.571; Rodriguez R, 2009, NEOPLASIA, V11, P397, DOI 10.1593/neo.81620; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rubio R, 2010, CANCER RES, V70, P4185, DOI 10.1158/0008-5472.CAN-09-4640; Secchiero P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011140; Shi XM, 2000, J CELL BIOCHEM, V76, P518, DOI 10.1002/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M; Shirakawa K, 2006, MOL CELL BIOL, V26, P6105, DOI 10.1128/MCB.02429-05; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Sugimoto M, 1998, CELL TISSUE RES, V292, P325, DOI 10.1007/s004410051063; Suzuki K, 2011, ONCOL LETT IN PRESS; Suzuki K, 2010, ANTICANCER RES, V30, P4679; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Tezuka KI, 1996, J BIOL CHEM, V271, P22713, DOI 10.1074/jbc.271.37.22713; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tsuchimochi K, 2010, J BIOL CHEM, V285, P8395, DOI 10.1074/jbc.M109.038638; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; Turriziani M, 2006, PHARMACOL RES, V53, P317, DOI 10.1016/j.phrs.2005.12.001; Valen E, 2011, TRENDS GENET, V27, P475, DOI 10.1016/j.tig.2011.08.001; Weiss SW, 2001, ENZINGER WEISSS SOFT, P641; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zohar R, 1997, J CELL PHYSIOL, V170, P88	78	10	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36682	10.1371/journal.pone.0036682	http://dx.doi.org/10.1371/journal.pone.0036682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570737	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343400053
J	Ostaszewski, M; Eifes, S; del Sol, A				Ostaszewski, Marek; Eifes, Serge; del Sol, Antonio			Evolutionary Conservation and Network Structure Characterize Genes of Phenotypic Relevance for Mitosis in Human	PLOS ONE			English	Article							PROTEIN-INTERACTION; CELL-CYCLE; REGULATORY NETWORK; POSITIVE FEEDBACK; DYNAMICS; EXPRESSION; GENOME; KINASE; MOTIFS; TOOL	The impact of gene silencing on cellular phenotypes is difficult to establish due to the complexity of interactions in the associated biological processes and pathways. A recent genome-wide RNA knock-down study both identified and phenotypically characterized a set of important genes for the cell cycle in HeLa cells. Here, we combine a molecular interaction network analysis, based on physical and functional protein interactions, in conjunction with evolutionary information, to elucidate the common biological and topological properties of these key genes. Our results show that these genes tend to be conserved with their corresponding protein interactions across several species and are key constituents of the evolutionary conserved molecular interaction network. Moreover, a group of bistable network motifs is found to be conserved within this network, which are likely to influence the network stability and therefore the robustness of cellular functioning. They form a cluster, which displays functional homogeneity and is significantly enriched in genes phenotypically relevant for mitosis. Additional results reveal a relationship between specific cellular processes and the phenotypic outcomes induced by gene silencing. This study introduces new ideas regarding the relationship between genotype and phenotype in the context of the cell cycle. We show that the analysis of molecular interaction networks can result in the identification of genes relevant to cellular processes, which is a promising avenue for future research.	[Ostaszewski, Marek; Eifes, Serge; del Sol, Antonio] Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg	University of Luxembourg	Ostaszewski, M (corresponding author), Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg.	antonio.delsol@uni.lu	del Sol, Antonio/M-7431-2017	del Sol, Antonio/0000-0002-9926-617X; Ostaszewski, Marek/0000-0003-1473-370X	Luxembourg Centre for Systems Biomedicine	Luxembourg Centre for Systems Biomedicine	The work has been funded by the Luxembourg Centre for Systems Biomedicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HS, 2007, BLOOD, V109, P4351, DOI 10.1182/blood-2006-09-047563; Albert I, 2004, BIOINFORMATICS, V20, P3346, DOI 10.1093/bioinformatics/bth402; Alvarez-Ponce D, 2011, GENOME BIOL EVOL, V3, P87, DOI 10.1093/gbe/evq084; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu MM, 2010, BIOCHEM SOC T, V38, P1155, DOI 10.1042/BST0381155; Bassermann F, 2005, CELL CYCLE, V4, P1515, DOI 10.4161/cc.4.11.2192; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Conant GC, 2003, NAT GENET, V34, P264, DOI 10.1038/ng1181; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; de Lichtenberg U, 2007, CELL CYCLE, V6, P1819, DOI 10.4161/cc.6.15.4537; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; Fasanaro P, 2010, CARDIOVASC RES, V85, P272, DOI 10.1093/cvr/cvp244; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gordo AC, 2001, MOL REPROD DEV, V59, P106, DOI 10.1002/mrd.1012; Haerty W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-399; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; He E, 2011, P NATL ACAD SCI USA, V108, P10016, DOI 10.1073/pnas.1102106108; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Jin SK, 2001, J CELL SCI, V114, P4139; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Langmead CJ, 2003, J COMPUT BIOL, V10, P521, DOI 10.1089/10665270360688165; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Lemos B, 2004, NAT GENET, V36, P1059, DOI 10.1038/ng1427; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Markowetz F, 2010, PLOS COMPUTATIONAL B, V6; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mitsushima M, 2010, J CELL BIOL, V191, P453, DOI 10.1083/jcb.201007136; Montanucci L, 2011, MOL BIOL EVOL, V28, P813, DOI 10.1093/molbev/msq259; Moseley JB, 2009, CURR OPIN CELL BIOL, V21, P82, DOI 10.1016/j.ceb.2008.12.005; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Papa R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-345; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterson LF, 2011, LEUKEMIA, V25, P761, DOI 10.1038/leu.2011.7; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Sabouri-Ghomi M, 2008, J THEOR BIOL, V250, P209, DOI 10.1016/j.jtbi.2007.09.001; Santos SDM, 2008, NATURE, V454, P288, DOI 10.1038/454288a; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schnable JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017855; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Shiraishi T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000851; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Sun QY, 1999, REPROD FERT DEVELOP, V11, P443, DOI 10.1071/RD00014; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Vinken M, 2011, BBA-REV CANCER, V1815, P13, DOI 10.1016/j.bbcan.2010.08.004; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walter T, 2010, J STRUCT BIOL, V170, P1, DOI 10.1016/j.jsb.2009.10.004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wray GA, 1999, NOVART FDN SYMP, V222, P203; Wray Gregory A., 1999, P189; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yamada T, 1998, RES COMMUN MOL PATH, V99, P283; Yang YL, 2007, CELL PROLIFERAT, V40, P397, DOI 10.1111/j.1365-2184.2007.00443.x; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	70	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36488	10.1371/journal.pone.0036488	http://dx.doi.org/10.1371/journal.pone.0036488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22577488	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341500079
J	Camara, D; Bisanz, C; Barette, C; Van Daele, J; Human, E; Barnard, B; Van Der Straeten, D; Stove, CP; Lambert, WE; Douce, R; Marechal, E; Birkholtz, LM; Cesbron-Delauw, MF; Dumas, R; Rebeille, F				Camara, Djeneb; Bisanz, Cordelia; Barette, Caroline; Van Daele, Jeroen; Human, Esmare; Barnard, Bernice; Van Der Straeten, Dominique; Stove, Christophe P.; Lambert, Willy E.; Douce, Roland; Marechal, Eric; Birkholtz, Lyn-Marie; Cesbron-Delauw, Marie-France; Dumas, Renaud; Rebeille, Fabrice			Inhibition of p-Aminobenzoate and Folate Syntheses in Plants and Apicomplexan Parasites by Natural Product Rubreserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO SYNTHESIS; ANTHRANILATE SYNTHASE; TOXOPLASMA-GONDII; 4-AMINO-4-DEOXYCHORISMATE SYNTHASE; AMINODEOXYCHORISMATE SYNTHASE; ISOCHORISMATE SYNTHASE; PLASMODIUM-FALCIPARUM; GLUCOSE ESTER; METABOLISM; BIOSYNTHESIS	Glutamine amidotransferase/aminodeoxychorismate synthase (GAT-ADCS) is a bifunctional enzyme involved in the synthesis of p-aminobenzoate, a central component part of folate cofactors. GAT-ADCS is found in eukaryotic organisms autonomous for folate biosynthesis, such as plants or parasites of the phylum Apicomplexa. Based on an automated screening to search for new inhibitors of folate biosynthesis, we found that rubreserine was able to inhibit the glutamine amidotransferase activity of the plant GAT-ADCS with an apparent IC50 of about 8 mu M. The growth rates of Arabidopsis thaliana, Toxoplasma gondii, and Plasmodium falciparum were inhibited by rubreserine with respective IC50 values of 65, 20, and 1 mu M. The correlation between folate biosynthesis and growth inhibition was studied with Arabidopsis and Toxoplasma. In both organisms, the folate content was decreased by 40-50% in the presence of rubreserine. In both organisms, the addition of p-aminobenzoate or 5-formyltetrahydrofolate in the external medium restored the growth for inhibitor concentrations up to the IC50 value, indicating that, within this range of concentrations, rubreserine was specific for folate biosynthesis. Rubreserine appeared to be more efficient than sulfonamides, antifolate drugs known to inhibit the invasion and proliferation of T. gondii in human fibroblasts. Altogether, these results validate the use of the bifunctional GAT-ADCS as an efficient drug target in eukaryotic cells and indicate that the chemical structure of rubreserine presents interesting anti-parasitic (toxoplasmosis, malaria) potential.	[Rebeille, Fabrice] Univ Grenoble 1, PCV iRTSV,Inst Rech Technol & Sci Vivant, CEA Grenoble,CNRS UMR5168,INRA USC1200, Lab Physiol Cellulaire Vegetale,Commissariat Ener, F-38054 Grenoble, France; [Bisanz, Cordelia; Cesbron-Delauw, Marie-France] Univ Grenoble 1, CNRS UMR 5163, Lab Adaptat & Pathogenie Microorganismes, Inst Jean Roget, F-38042 Grenoble, France; [Barette, Caroline] Commissariat Energie Atom Grenoble, Inst Rech Technol & Sci Vivant, Ctr Criblage Mol Bioact, F-38054 Grenoble, France; [Van Daele, Jeroen; Stove, Christophe P.; Lambert, Willy E.] Univ Ghent, Toxicol Lab, B-9000 Ghent, Belgium; [Human, Esmare; Barnard, Bernice; Birkholtz, Lyn-Marie] Univ Pretoria, Dept Biochem, Malaria Res Grp, ZA-0028 Pretoria, South Africa; [Van Der Straeten, Dominique] Univ Ghent, Lab Funct Plant Biol, Dept Physiol, B-9000 Ghent, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Ghent University; University of Pretoria; Ghent University	Rebeille, F (corresponding author), Univ Grenoble 1, PCV iRTSV,Inst Rech Technol & Sci Vivant, CEA Grenoble,CNRS UMR5168,INRA USC1200, Lab Physiol Cellulaire Vegetale,Commissariat Ener, 17 Ave Martyrs, F-38054 Grenoble, France.	frebeille@cea.fr	Stove, Christophe/B-6057-2008; Bisanz, Cordelia/M-6063-2014; Birkholtz, Lyn-Marie/AAF-8481-2019; Dumas, Renaud/E-1835-2011; Van Der Straeten, Dominique/E-7385-2016; Birkholtz, Lyn-Marie/E-2939-2010; cesbron delauw, marie france/M-6076-2014	Stove, Christophe/0000-0001-7126-348X; Birkholtz, Lyn-Marie/0000-0001-5888-2905; Van Der Straeten, Dominique/0000-0002-7755-1420; Birkholtz, Lyn-Marie/0000-0001-5888-2905; BARETTE, Caroline/0000-0003-0999-7751	Region Rhone-Alpes; Ghent University [BOF09-GOA-004]; Agence Nationale de la Recherche PlasmoExpress grant	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Ghent University(Ghent University); Agence Nationale de la Recherche PlasmoExpress grant(French National Research Agency (ANR))	This work was supported in part the Region Rhone-Alpes (Cluster 9, "Plantacter").; Supported by Ghent University Grant BOF09-GOA-004.; Supported by an Agence Nationale de la Recherche PlasmoExpress grant.	Allen RJW, 2010, MOL BIOCHEM PARASIT, V169, P63, DOI 10.1016/j.molbiopara.2009.09.005; Basset GJC, 2004, P NATL ACAD SCI USA, V101, P1496, DOI 10.1073/pnas.0308331100; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Bertino JR, 2009, BEST PRACT RES CL HA, V22, P577, DOI 10.1016/j.beha.2009.09.004; Bhat JY, 2008, BIOCHEM J, V409, P263, DOI 10.1042/BJ20070996; Bisanz C, 2006, BIOCHEM J, V394, P197, DOI 10.1042/BJ20050609; Blancquaert D, 2010, CRIT REV PLANT SCI, V29, P14, DOI 10.1080/07352680903436283; Bulloch EMM, 2004, J AM CHEM SOC, V126, P9912, DOI 10.1021/ja048312f; Camara D, 2011, ARCH BIOCHEM BIOPHYS, V505, P83, DOI 10.1016/j.abb.2010.09.010; De Brouwer V, 2007, PHYTOCHEM ANALYSIS, V18, P496, DOI 10.1002/pca.1006; De Brouwer V, 2010, J CHROMATOGR B, V878, P509, DOI 10.1016/j.jchromb.2009.12.032; de La Garza RID, 2007, P NATL ACAD SCI USA, V104, P4218, DOI 10.1073/pnas.0700409104; Dixon S, 2006, J MED CHEM, V49, P7413, DOI 10.1021/jm0609869; Ellis S, 1943, J PHARMACOL EXP THER, V79, P309; Eudes A, 2008, J BIOL CHEM, V283, P15451, DOI 10.1074/jbc.M709591200; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; Hyde JE, 2005, ACTA TROP, V94, P191, DOI 10.1016/j.actatropica.2005.04.002; Kaur K, 2009, BIOORGAN MED CHEM, V17, P3229, DOI 10.1016/j.bmc.2009.02.050; Keller S, 2007, ANGEW CHEM INT EDIT, V46, P8284, DOI 10.1002/anie.200701836; Kerbarh O, 2005, BIOCHEM SOC T, V33, P763, DOI 10.1042/BST0330763; KOZLOWSKI MC, 1995, J AM CHEM SOC, V117, P2128, DOI 10.1021/ja00113a002; Loizeau K, 2008, PLANT PHYSIOL, V148, P2083, DOI 10.1104/pp.108.130336; Massiere F, 1998, CELL MOL LIFE SCI, V54, P205, DOI 10.1007/s000180050145; Meneceur P, 2008, ANTIMICROB AGENTS CH, V52, P1269, DOI 10.1128/AAC.01203-07; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAMURA J, 1995, J BIOL CHEM, V270, P23450, DOI 10.1074/jbc.270.40.23450; Nzila A, 2005, TRENDS PARASITOL, V21, P334, DOI 10.1016/j.pt.2005.05.008; Nzila A, 2006, DRUG DISCOV TODAY, V11, P939, DOI 10.1016/j.drudis.2006.08.003; Orsomando G, 2006, PLANT J, V46, P426, DOI 10.1111/j.1365-313X.2006.02685.x; Payne RJ, 2010, ORG BIOMOL CHEM, V8, P3534, DOI 10.1039/c004062b; Payne RJ, 2009, ORG BIOMOL CHEM, V7, P2421, DOI 10.1039/b901694e; Poobrasert O, 1996, J NAT PROD, V59, P1087, DOI 10.1021/np960518+; Quinlivan EP, 2003, J BIOL CHEM, V278, P20731, DOI 10.1074/jbc.M302894200; Rattanachuen W, 2009, MOL BIOCHEM PARASIT, V168, P135, DOI 10.1016/j.molbiopara.2009.07.005; Ravanel S, 2011, ADV BOT RES, V59, P67, DOI 10.1016/B978-0-12-385853-5.00004-0; Rebeille F, 2006, PHYSIOL PLANTARUM, V126, P330, DOI 10.1111/j.1399-3054.2006.00587.x; Rebeille F, 2007, PHOTOSYNTH RES, V92, P149, DOI 10.1007/s11120-007-9167-z; Riedlinger J, 2004, J ANTIBIOT, V57, P271, DOI 10.7164/antibiotics.57.271; Roberts CW, 2002, J INFECT DIS, V185, pS25, DOI 10.1086/338004; ROBINSON B, 1965, J PHARM PHARMACOL, V17, P89, DOI 10.1111/j.2042-7158.1965.tb07619.x; ROUX B, 1992, BIOCHEMISTRY-US, V31, P6904, DOI 10.1021/bi00145a006; Sahr T, 2006, BIOCHEM J, V396, P157, DOI 10.1042/BJ20051851; Salcedo-Sora JE, 2011, J BIOL CHEM, V286, P44659, DOI 10.1074/jbc.M111.286054; Schroder M, 2005, PLANT PHYSIOL, V138, P1926, DOI 10.1104/pp.105.063693; Segel I.H., 1975, ENZYME KINETICS; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; Siehl DL, 1999, BOOK SOIL P, P171; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Storozhenko S, 2007, NAT BIOTECHNOL, V25, P1277, DOI 10.1038/nbt1351; Wang P, 2004, MOL MICROBIOL, V51, P1425, DOI 10.1111/j.1365-2958.2003.03915.x; Wang P, 2010, MOL BIOCHEM PARASIT, V172, P41, DOI 10.1016/j.molbiopara.2010.03.012; YANG ST, 1987, J PHARMACEUT BIOMED, V5, P383, DOI 10.1016/0731-7085(87)80045-6; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203; Zhang GF, 2005, RAPID COMMUN MASS SP, V19, P963, DOI 10.1002/rcm.1878; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XH, 2001, PLANT PHYSIOL, V127, P131, DOI 10.1104/pp.127.1.131; Ziebart KT, 2010, J MED CHEM, V53, P3718, DOI 10.1021/jm100158v; Ziebart KT, 2010, BIOCHEMISTRY-US, V49, P2851, DOI 10.1021/bi100021x	58	17	17	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22367	22376		10.1074/jbc.M112.365833	http://dx.doi.org/10.1074/jbc.M112.365833			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577137	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000306418600073
J	Cerna, D; Li, HY; Flaherty, S; Takebe, N; Coleman, CN; Yoo, SS				Cerna, David; Li, Hongyun; Flaherty, Siobhan; Takebe, Naoko; Coleman, C. Norman; Yoo, Stephen S.			Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) Activity by Small Molecule GMX1778 Regulates Reactive Oxygen Species (ROS)-mediated Cytotoxicity in a p53-and Nicotinic Acid Phosphoribosyltransferase1 (NAPRT1)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; OXIDATIVE STRESS; TUMOR-CELLS; P53; APOPTOSIS; ROS; ANTIOXIDANT; SURVIVAL; DAMAGE; ACTIVATION	Cancer cells undergo mitosis more frequently than normal cells and thus have increased metabolic needs, which in turn lead to higher than normal reactive oxygen species (ROS) production. Higher ROS production increases cancer cell dependence on ROS scavenging systems to balance the increased ROS. Selectively modulating intracellular ROS in cancers by exploiting cancer dependence on ROS scavenging systems provides a useful therapeutic approach. Essential to developing these therapeutic strategies is to maintain physiologically low ROS levels in normal tissues while inducing ROS in cancer cells. GMX1778 is a specific inhibitor of nicotinamide phosphoribosyltransferase, a rate-limiting enzyme required for the regeneration of NAD(+) from nicotinamide. We show that GMX1778 increases intracellular ROS in cancer cells by elevating the superoxide level while decreasing the intracellular NAD(+) level. Notably, GMX1778 treatment does not induce ROS in normal cells. GMX1778-induced ROS can be diminished by adding nicotinic acid (NA) in a NA phosphoribosyltransferase 1 (NAPRT1)-dependent manner, but NAPRT1 is lost in a high frequency of glioblastomas, neuroblastomas, and sarcomas. In NAPRT1-deficient cancer cells, ROS induced by GMX1778 was not susceptible to treatment with NA. GMX1778-mediated ROS induction is p53-dependent, suggesting that the status of both p53 and NAPRT1 might affect tumor apoptosis, as determined by annexin-V staining. However, as determined by colony formation, GMX1778 long term cytotoxicity in cancer cells was only prevented by the addition of NA to NAPRT1-expressing cells. Exposure to GMX1778 may be a novel way including ROS selectively in NAPRT1-negative tumors without inducing cytotoxic ROS in normal tissue.	[Cerna, David; Li, Hongyun; Flaherty, Siobhan; Yoo, Stephen S.] NIH, Mol Radiat Therapeut Branch Support, SAIC Frederick, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Takebe, Naoko] NCI, Mol Radiat Therapeut Branch, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA; [Coleman, C. Norman] NCI, Mol Radiat Therapeut Branch, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yoo, SS (corresponding author), NCI, Mol Radiat Therapeut Branch, Div Canc Treatment & Diag, 6130 Execut Blvd,Rm 6012, Rockville, MD USA.	yoosu@mail.nih.gov			National Institutes of Health Grant from NCI [HHSN261200800001E]	National Institutes of Health Grant from NCI	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN261200800001E from NCI.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Beauparlant P, 2009, ANTI-CANCER DRUG, V20, P346, DOI 10.1097/CAD.0b013e3283287c20; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Camhi S L, 1995, New Horiz, V3, P170; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chen Y, 2007, MOL INTERV, V7, P147, DOI 10.1124/mi.7.3.6; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fuchs D, 2010, INT J CANCER, V126, P2773, DOI 10.1002/ijc.25206; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; He X, 2011, HUM MOL GENET, V20, P80, DOI 10.1093/hmg/ddq434; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Kato H, 2010, CLIN CANCER RES, V16, P898, DOI 10.1158/1078-0432.CCR-09-1945; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Kuo PL, 2007, CANCER RES, V67, P7406, DOI 10.1158/0008-5472.CAN-07-1089; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Meng LH, 2007, ACTA PHARMACOL SIN, V28, P1460, DOI 10.1111/j.1745-7254.2007.00698.x; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sen N, 2011, MOL CELL, V44, P621, DOI 10.1016/j.molcel.2011.08.044; Shi XK, 2012, ANTIOXID REDOX SIGN, V16, P1215, DOI 10.1089/ars.2012.4529; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]	40	57	61	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22408	22417		10.1074/jbc.M112.357301	http://dx.doi.org/10.1074/jbc.M112.357301			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570471	Green Published, hybrid			2022-12-25	WOS:000306418600077
J	Dumas, G; Chavez, M; Nadel, J; Martinerie, J				Dumas, Guillaume; Chavez, Mario; Nadel, Jacqueline; Martinerie, Jacques			Anatomical Connectivity Influences both Intra- and Inter-Brain Synchronizations	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; SMALL-WORLD; CORTICAL ACTIVITY; OSCILLATIONS; MULTISTABILITY; COMMUNICATION; COMPLEXITY; SYNCHRONY; DYNAMICS; SIGNALS	Recent development in diffusion spectrum brain imaging combined to functional simulation has the potential to further our understanding of how structure and dynamics are intertwined in the human brain. At the intra-individual scale, neurocomputational models have already started to uncover how the human connectome constrains the coordination of brain activity across distributed brain regions. In parallel, at the inter-individual scale, nascent social neuroscience provides a new dynamical vista of the coupling between two embodied cognitive agents. Using EEG hyperscanning to record simultaneously the brain activities of subjects during their ongoing interaction, we have previously demonstrated that behavioral synchrony correlates with the emergence of inter-brain synchronization. However, the functional meaning of such synchronization remains to be specified. Here, we use a biophysical model to quantify to what extent inter-brain synchronizations are related to the anatomical and functional similarity of the two brains in interaction. Pairs of interacting brains were numerically simulated and compared to real data. Results show a potential dynamical property of the human connectome to facilitate inter-individual synchronizations and thus may partly account for our propensity to generate dynamical couplings with others.	[Dumas, Guillaume; Chavez, Mario; Martinerie, Jacques] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Dumas, Guillaume; Chavez, Mario; Martinerie, Jacques] INSERM, U975, Paris, France; [Dumas, Guillaume; Chavez, Mario; Martinerie, Jacques] CNRS, UMR 7225, Paris, France; [Dumas, Guillaume; Chavez, Mario; Martinerie, Jacques] ICM Inst Cerveau & Moelle Epiniere, Paris, France; [Nadel, Jacqueline] CNRS, Ctr Emot, USR 3246, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Dumas, G (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France.	guillaume.dumas@centraliens.net	Dumas, Guillaume/E-3756-2012; Chavez, Mario/D-8495-2011	Dumas, Guillaume/0000-0002-2253-1844; Chavez, Mario/0000-0003-0390-4833	French National Center for Scientific Research; Direction generale de l'armement (DGA); Computer Neuroscience Program [070005IPAM]	French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); Direction generale de l'armement (DGA); Computer Neuroscience Program	This work was supported in part by funds from the French National Center for Scientific Research (http://www.cnrs.fr/). This work was also supported by a PhD fellowship of the Direction generale de l'armement (DGA) (http://www.defense.gouv.fr/dga/) and the Computer Neuroscience Program no070005IPAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebron JA, 2005, REV MODERN PHYS; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Allen M., 2011, CONSCIOUSNESS PLASTI, P8, DOI [10.3389/fpsyg.2011.00020/abstract, DOI 10.3389/FPSYG.2011.00020/ABSTRACT]; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Bassett DS, 2011, TRENDS COGN SCI, V15, P200, DOI 10.1016/j.tics.2011.03.006; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Breakspear M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00190; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Chavez M, 2010, COMPLEX NETWORKS NEW; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028101; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Fallani FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014187; Fernandez A, 2011, NEUROIMAGE, V57, P1300, DOI 10.1016/j.neuroimage.2011.05.079; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Fuchs A, 2010, COORDINATION NEURAL; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2004, INTERSUBJECT SYNCHRO; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hinz RC, 2011, CHAOS, V21, DOI 10.1063/1.3581161; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Ikegami T, 2007, INFANT BEHAV DEV, V30, P278, DOI 10.1016/j.infbeh.2007.02.002; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Izhikevich E, 2008, LARGE SCALE MODEL MA; Jirsa V, 2010, ARCH ITALIENNES BIOL; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kelso J. A. S., 2006, COMPLEMENTARY NATURE; Kelso S., 1995, DYNAMIC PATTERNS SEL; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kuramoto, 1975, LECT NOTE PHYS, V30, P420, DOI DOI 10.1007/BFB0013365; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lachaux JP, 2000, EUR J NEUROSCI, V12, P2608, DOI 10.1046/j.1460-9568.2000.00163.x; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; LUMER ED, 1992, NEURAL COMPUT, V4, P341, DOI 10.1162/neco.1992.4.3.341; Mahalanobis P. C., 1936, P NATL I SCI; Maturana HR., 1987, TREE KNOWLEDGE BIOL; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Mori F, 2009, PHYSICA D, V238, P1180, DOI 10.1016/j.physd.2009.04.002; Nadel J., 1999, IMITATION INFANCY; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Paik SB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000342; Perez T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019900; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rodriguez E, 2010, NAT REV NEUROSCI, V11, P718; Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038; Rubinov M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-55; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Saito DN, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00127; Santo BA, 2011, P IEEE S SERIES COMP; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Schipul SE, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00010; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Tononi G, 1996, P NATL ACAD SCI USA, V93, P3422, DOI 10.1073/pnas.93.8.3422; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wallstrom GL, 2004, INT J PSYCHOPHYSIOL, V53, P105, DOI 10.1016/j.ijpsycho.2004.03.007; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yeung M, 1999, TIME DELAY KURAMOTO; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	78	67	67	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36414	10.1371/journal.pone.0036414	http://dx.doi.org/10.1371/journal.pone.0036414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590539	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336400012
J	Coulombe, F; Fiola, S; Akira, S; Cormier, Y; Gosselin, J				Coulombe, Francois; Fiola, Stephanie; Akira, Shizuo; Cormier, Yvon; Gosselin, Jean			Muramyl Dipeptide Induces NOD2-Dependent Ly6C(high) Monocyte Recruitment to the Lungs and Protects Against Influenza Virus Infection	PLOS ONE			English	Article							TREHALOSE DIMYCOLATE; ADAPTIVE IMMUNITY; DENDRITIC CELLS; HOST-DEFENSE; A VIRUS; MICE; PEPTIDOGLYCAN; MURABUTIDE; NOD2; PEPTIDES	Bacterial peptidoglycan-derived muramyl dipeptide (MDP) and derivatives have long-recognized antiviral properties but their mechanism of action remains unclear. In recent years, the pattern-recognition receptor NOD2 has been shown to mediate innate responses to MDP. Here, we show that MDP treatment of mice infected with Influenza A virus (IAV) significantly reduces mortality, viral load and pulmonary inflammation in a NOD2-dependent manner. Importantly, the induction of type I interferon (IFN) and CCL2 chemokine was markedly increased in the lungs following MDP treatment and correlated with a NOD2-dependent enhancement in circulating monocytes. Mechanistically, the protective effect of MDP could be explained by the NOD2-dependent transient increase in recruitment of Ly6C(high) "inflammatory'' monocytes and, to a lesser extent, neutrophils to the lungs. Indeed, impairment in both Ly6C(high) monocyte recruitment and survival observed in infected Nod2-/- mice treated with MDP was recapitulated in mice deficient for the chemokine receptor CCR2 required for CCL2-mediated Ly6C(high) monocyte migration from the bone marrow into the lungs. MDP-induced pulmonary monocyte recruitment occurred normally in IAV-infected and MDP-treated Ips-1-/- mice. However, IPS-1 was required for improved survival upon MDP treatment. Finally, mycobacterial N-glycolyl MDP was more potent than N-acetyl MDP expressed by most bacteria at reducing viral burden while both forms of MDP restored pulmonary function following IAV challenge. Overall, our work sheds light on the antiviral mechanism of a clinically relevant bacterial-derived compound and identifies the NOD2 pathway as a potential therapeutic target against IAV.	[Coulombe, Francois; Fiola, Stephanie; Gosselin, Jean] Univ Laval, Ctr Hosp Univ, Quebec Res Ctr, Quebec City, PQ, Canada; [Coulombe, Francois; Fiola, Stephanie; Gosselin, Jean] Univ Laval, Dept Mol Med, Fac Med, Quebec City, PQ, Canada; [Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan; [Cormier, Yvon] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Cormier, Yvon] Univ Laval, Dept Med, Fac Med, Quebec City, PQ, Canada	Laval University; Laval University; Osaka University; Osaka University; Laval University; Laval University	Coulombe, F (corresponding author), Univ Laval, Ctr Hosp Univ, Quebec Res Ctr, Quebec City, PQ, Canada.	jean.gosselin@crchul.ulaval.ca			F. Banting and C. Best Canada Graduate Scholarship; Canadian Institutes of Health Research [IBF-99052]	F. Banting and C. Best Canada Graduate Scholarship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a F. Banting and C. Best Canada Graduate Scholarship to F.C. and by a grant from the Canadian Institutes of Health Research to J.G. and Y.C. (grant #IBF-99052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Ando K, 2011, EXPERT OPIN PHARMACO, V12, P285, DOI 10.1517/14656566.2011.543129; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; AZUMA I, 1971, JPN J MICROBIOL, V15, P193, DOI 10.1111/j.1348-0421.1971.tb00569.x; AZUMA I, 1994, MED RES REV, V14, P401, DOI 10.1002/med.2610140403; BAHR GM, 1995, INT J IMMUNOPHARMACO, V17, P117, DOI 10.1016/0192-0561(94)00094-5; Bahr GM, 2003, J ANTIMICROB CHEMOTH, V51, P1377, DOI 10.1093/jac/dkg244; Bahr GM, 2003, J ANTIMICROB CHEMOTH, V51, P5, DOI 10.1093/jac/dkg063; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; CHOMEL JJ, 1988, J BIOL RESP MODIF, V7, P581; Coulombe F, 2009, J EXP MED, V206, P1709, DOI 10.1084/jem.20081779; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; De La Tribonniere Xavier, 2003, Med Sci Monit, V9, pPI43; Dienz O, 2012, MUCOSAL IMMUNOL; Dzierzbicka K, 2011, CURR MED CHEM, V18, P2438, DOI 10.2174/092986711795843173; ELLOUZ F, 1974, BIOCHEM BIOPH RES CO, V59, P1317, DOI 10.1016/0006-291X(74)90458-6; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hoeve MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029443; IKEDA S, 1985, ANTIVIR RES, V5, P207, DOI 10.1016/0166-3542(85)90025-7; Kim YG, 2011, IMMUNITY; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; MASIHI KN, 1984, J BIOL RESP MODIF, V3, P663; MASIHI KN, 1983, INT J IMMUNOPHARMACO, V5, P403; MCLAUGHLIN CA, 1980, SCIENCE, V208, P415, DOI 10.1126/science.7189295; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08; WYDE PR, 1990, J BIOL RESP MODIF, V9, P98; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200	39	50	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36734	10.1371/journal.pone.0036734	http://dx.doi.org/10.1371/journal.pone.0036734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590599	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100056
J	Laorden, ML; Ferenczi, S; Pinter-Kubler, B; Gonzalez-Martin, LL; Lasheras, MC; Kovacs, KJ; Milanes, MV; Nunez, C				Luisa Laorden, M.; Ferenczi, Szilamer; Pinter-Kuebler, Bernadett; Gonzalez-Martin, Laura L.; Carmen Lasheras, M.; Kovacs, Krisztina J.; Victoria Milanes, M.; Nunez, Cristina			Hypothalamic Orexin-A Neurons Are Involved in the Response of the Brain Stress System to Morphine Withdrawal	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PARAVENTRICULAR NUCLEUS; STRIA TERMINALIS; BED NUCLEUS; OPIATE WITHDRAWAL; RAT-BRAIN; ACTIVATION; DEPENDENCE; NEUROPEPTIDES; HYDROXYLASE	Both the hypothalamus-pituitary-adrenal (HPA) axis and the extrahypothalamic brain stress system are key elements of the neural circuitry that regulates the negative states during abstinence from chronic drug exposure. Orexins have recently been hypothesized to modulate the extended amygdala and to contribute to the negative emotional state associated with dependence. This study examined the impact of chronic morphine and withdrawal on the lateral hypothalamic (LH) orexin A (OXA) gene expression and activity as well as OXA involvement in the brain stress response to morphine abstinence. Male Wistar rats received chronic morphine followed by naloxone to precipitate withdrawal. The selective OX1R antagonist SB334867 was used to examine whether orexins' activity is related to somatic symptoms of opiate withdrawal and alterations in HPA axis and extended amygdala in rats dependent on morphine. OXA mRNA was induced in the hypothalamus during morphine withdrawal, which was accompanied by activation of OXA neurons in the LH. Importantly, SB334867 attenuated the somatic symptoms of withdrawal, and reduced morphine withdrawal-induced c-Fos expression in the nucleus accumbens (NAc) shell, bed nucleus of stria terminalis, central amygdala and hypothalamic paraventricular nucleus, but did not modify the HPA axis activity. These results highlight a critical role of OXA signalling, via OX1R, in activation of brain stress system to morphine withdrawal and suggest that all orexinergic subpopulations in the lateral hypothalamic area contribute in this response.	[Luisa Laorden, M.; Gonzalez-Martin, Laura L.; Carmen Lasheras, M.; Victoria Milanes, M.; Nunez, Cristina] Fac Med, Cellular & Mol Pharmacol Lab, Murcia, Spain; [Luisa Laorden, M.; Gonzalez-Martin, Laura L.; Carmen Lasheras, M.; Victoria Milanes, M.; Nunez, Cristina] IMIB, Murcia, Spain; [Ferenczi, Szilamer; Pinter-Kuebler, Bernadett; Kovacs, Krisztina J.] Hungarian Acad Sci, Inst Expt Med, Mol Neuroendocrinol Lab, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Laorden, ML (corresponding author), Fac Med, Cellular & Mol Pharmacol Lab, Murcia, Spain.	milanes@um.es	Núñez, Cristina/O-8288-2015; Milanés, M. Victoria/AGB-4075-2022; Milanés, M Victoria/K-6591-2017	Núñez, Cristina/0000-0002-0773-4950; Milanés, M. Victoria/0000-0002-0984-2218; Milanés, M Victoria/0000-0002-0984-2218	Ministerio de Ciencia e Innovacion, Spain [2009-07178, 2010-17907]; Red de Trastornos Adictivos, Spain [RD06/0001/1006, RD06/0001/1001]; Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia Region de Murcia, Spain [15405/PI10]; Hungarian Research Fund, OTKA (Hungarian Scientific Research Fund) [68574, 76697]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red de Trastornos Adictivos, Spain; Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia Region de Murcia, Spain; Hungarian Research Fund, OTKA (Hungarian Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the following grants: Ministerio de Ciencia e Innovacion (Grant 2009-07178 to MVM, Grant 2010-17907 to MLL), Spain, Red de Trastornos Adictivos (RD06/0001/1006 and RD06/0001/1001 to MLL), Spain, Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia Region de Murcia (15405/PI10 to MVM), Spain, and Hungarian Research Fund, OTKA (Hungarian Scientific Research Fund) grants, 68574 and 76697 (International Research Collaboration grant) to KJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 1999, ANN NY ACAD SCI, V877, P486, DOI 10.1111/j.1749-6632.1999.tb09284.x; Azizi H, 2010, NEUROSCI LETT, V482, P255, DOI 10.1016/j.neulet.2010.07.050; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Bisetti A, 2006, NEUROSCIENCE, V142, P999, DOI 10.1016/j.neuroscience.2006.07.018; Carter ME, 2009, CURR OPIN PHARMACOL, V9, P39, DOI 10.1016/j.coph.2008.12.018; Chang H, 2007, NEUROSCI RES, V57, P462, DOI 10.1016/j.neures.2006.11.009; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; Georgescu D, 2003, J NEUROSCI, V23, P3106; GOLD LH, 1994, EUR J PHARMACOL, V253, P45, DOI 10.1016/0014-2999(94)90755-2; GUITART X, 1989, J NEUROSCI, V9, P4371; Harris GC, 2007, BEHAV BRAIN RES, V176, P251, DOI 10.1016/j.bbr.2006.10.012; Harris GC, 2006, TRENDS NEUROSCI, V29, P571, DOI 10.1016/j.tins.2006.08.002; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Houshyar H, 2004, J NEUROSCI, V24, P9414, DOI 10.1523/JNEUROSCI.1641-04.2004; Kagerer SM, 2010, ACTA PHYSIOL, V198, P361, DOI 10.1111/j.1748-1716.2009.02034.x; Katayama S, 2010, NEUROSCI LETT, V484, P157, DOI 10.1016/j.neulet.2010.08.043; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; Kuru M, 2000, NEUROREPORT, V11, P1977, DOI 10.1097/00001756-200006260-00034; Laorden ML, 2000, J PHARMACOL EXP THER, V293, P578; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; Li YH, 2011, PHYSIOL BEHAV, V102, P42, DOI 10.1016/j.physbeh.2010.10.006; Lu L, 2000, EUR J NEUROSCI, V12, P4398; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; Navarro-Zaragoza J, 2011, BRIT J PHARMACOL, V162, P851, DOI 10.1111/j.1476-5381.2010.01090.x; Nunez C, 2007, J NEUROCHEM, V101, P1060, DOI 10.1111/j.1471-4159.2006.04421.x; Nunez C, 2009, ENDOCRINOLOGY, V150, P3118, DOI 10.1210/en.2008-1732; Olive MF, 2002, PHARMACOL BIOCHEM BE, V72, P213, DOI 10.1016/S0091-3057(01)00748-1; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peyron C, 1998, J NEUROSCI, V18, P9996; Sakamoto F, 2004, REGUL PEPTIDES, V118, P183, DOI 10.1016/j.regpep.2003.12.014; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Samson WK, 2002, REGUL PEPTIDES, V104, P97, DOI 10.1016/S0167-0115(01)00353-6; SAWCHENKO PE, 1982, BRAIN RES REV, V4, P275, DOI 10.1016/0165-0173(82)90010-8; Sharf R, 2008, BIOL PSYCHIAT, V64, P175, DOI 10.1016/j.biopsych.2008.03.006; STINUS L, 1990, NEUROSCIENCE, V37, P767, DOI 10.1016/0306-4522(90)90106-E; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Zhou Y, 2010, BRAIN RES, V1314, P235, DOI 10.1016/j.brainres.2009.11.015	42	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36871	10.1371/journal.pone.0036871	http://dx.doi.org/10.1371/journal.pone.0036871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590628	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336100069
J	Sheikh, AQ; Hurley, JR; Huang, W; Taghian, T; Kogan, A; Cho, HK; Wang, YG; Narmoneva, DA				Sheikh, Abdul Q.; Hurley, Jennifer R.; Huang, Wei; Taghian, Toloo; Kogan, Andrei; Cho, Hongkwan; Wang, Yigang; Narmoneva, Daria A.			Diabetes Alters Intracellular Calcium Transients in Cardiac Endothelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SARCOPLASMIC-RETICULUM; ACTIVITY CONTRIBUTES; HIGH GLUCOSE; CA2+ ATPASE; ACTIVATION; DYSFUNCTION; CARDIOMYOPATHY; MOBILIZATION; CA2+-ATPASE	Diabetic cardiomyopathy (DCM) is a diabetic complication, which results in myocardial dysfunction independent of other etiological factors. Abnormal intracellular calcium ([Ca2+](i)) homeostasis has been implicated in DCM and may precede clinical manifestation. Studies in cardiomyocytes have shown that diabetes results in impaired [Ca2+](i) homeostasis due to altered sarcoplasmic reticulum Ca2+ ATPase (SERCA) and sodium-calcium exchanger (NCX) activity. Importantly, altered calcium homeostasis may also be involved in diabetes-associated endothelial dysfunction, including impaired endothelium-dependent relaxation and a diminished capacity to generate nitric oxide (NO), elevated cell adhesion molecules, and decreased angiogenic growth factors. However, the effect of diabetes on Ca2+ regulatory mechanisms in cardiac endothelial cells (CECs) remains unknown. The objective of this study was to determine the effect of diabetes on [Ca2+](i) homeostasis in CECs in the rat model (streptozotocin-induced) of DCM. DCM-associated cardiac fibrosis was confirmed using picrosirius red staining of the myocardium. CECs isolated from the myocardium of diabetic and wild-type rats were loaded with Fura-2, and UTP-evoked [Ca2+](i) transients were compared under various combinations of SERCA, sarcoplasmic reticulum Ca2+ ATPase (PMCA) and NCX inhibitors. Diabetes resulted in significant alterations in SERCA and NCX activities in CECs during [Ca2+](i) sequestration and efflux, respectively, while no difference in PMCA activity between diabetic and wild-type cells was observed. These results improve our understanding of how diabetes affects calcium regulation in CECs, and may contribute to the development of new therapies for DCM treatment.	[Sheikh, Abdul Q.; Hurley, Jennifer R.; Cho, Hongkwan; Narmoneva, Daria A.] Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH 45221 USA; [Huang, Wei; Wang, Yigang] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Taghian, Toloo; Kogan, Andrei] Univ Cincinnati, Dept Phys, Cincinnati, OH 45221 USA	University of Cincinnati; University of Cincinnati; University of Cincinnati	Sheikh, AQ (corresponding author), Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH 45221 USA.	daira.narmoneva@uc.edu	HUANG, WEI/A-4639-2013	Huang, Wei/0000-0003-3046-4220; Kogan, Andrei/0000-0002-3859-1497	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) [1R21DK078814-01A1]; University of Cincinnati Nanomedicine Group; University of Cincinnati Research Council; University of Cincinnati Biomedical Engineering; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078814] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0804199] Funding Source: National Science Foundation	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Cincinnati Nanomedicine Group; University of Cincinnati Research Council; University of Cincinnati Biomedical Engineering; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK 1R21DK078814-01A1) (www.nih.gov); a Nanomedicine Fellowship, University of Cincinnati Nanomedicine Group (http://www.ceas.uc.edu/); an interdisciplinary faculty research grant, University of Cincinnati Research Council (http://webcentral.uc.edu/urc2/apply/programinfo.cfm); and startup funds from University of Cincinnati Biomedical Engineering (http://www.ceas.uc.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Arnalich F, 2011, CYTOKINE; Association AD, 2011, ADA FACT SHEET; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BOSSU JL, 1992, FEBS LETT, V299, P239, DOI 10.1016/0014-5793(92)80123-X; Brini M., 2011, COLD SPRING HARBOR P, V3; Chattou S, 1999, ACTA PHYSIOL SCAND, V166, P137; Choi KM, 2002, AM J PHYSIOL-HEART C, V283, pH1398, DOI 10.1152/ajpheart.00313.2002; Cook-Mills JM, 2004, BIOCHEM J, V378, P539, DOI 10.1042/BJ20030794; Cosentino F, 1998, J CARDIOVASC PHARM, V32, pS54; Dang L, 2005, CLIN EXP PHARMACOL P, V32, P771, DOI 10.1111/j.1440-1681.2005.04266.x; DELAFUENTE PG, 1995, PFLUG ARCH EUR J PHY, V429, P617, DOI 10.1007/BF00373982; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; El Amine M, 2010, Endocr Regul, V44, P17; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fleming I, 1997, AM J CARDIOL, V80, pA102, DOI 10.1016/S0002-9149(97)00464-5; Goel A, 2007, CARDIOVASC RES, V76, P351, DOI 10.1016/j.cardiores.2007.06.029; Green AK, 1997, CELL CALCIUM, V22, P99, DOI 10.1016/S0143-4160(97)90110-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; Hattori Y, 2000, J PHYSIOL-LONDON, V527, P85, DOI 10.1111/j.1469-7793.2000.00085.x; Hill BJF, 2003, ATHEROSCLEROSIS, V167, P15, DOI 10.1016/S0021-9150(02)00381-7; Huszka M, 1997, THROMB RES, V86, P173, DOI 10.1016/S0049-3848(97)00060-1; Improta-Brears T, 1999, P NATL ACAD SCI USA, V96, P4686, DOI 10.1073/pnas.96.8.4686; Inesi G, 2008, BIOCHEM BIOPH RES CO, V369, P182, DOI 10.1016/j.bbrc.2007.11.161; Lebeche D, 2008, NAT CLIN PRACT CARD, V5, P715, DOI 10.1038/ncpcardio1347; Lin S, 2000, J BIOL CHEM, V275, P17979, DOI 10.1074/jbc.275.24.17979; Ma L, 2008, CLIN EXP PHARMACOL P, V35, P568, DOI 10.1111/j.1440-1681.2007.04832.x; Moccia F, 2002, BIOCHEM J, V364, P235, DOI 10.1042/bj3640235; Moccia F, 2001, MICROVASC RES, V61, P240, DOI 10.1006/mvre.2001.2306; MORGAN JP, 1990, CIRCULATION, V81, P21; NISHIDA M, 1993, AM J PHYSIOL, V264, pH639, DOI 10.1152/ajpheart.1993.264.2.H639; Obrosova IG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1645, DOI 10.1152/ajpendo.00479.2007; PENPARGKUL S, 1980, CIRC RES, V47, P911, DOI 10.1161/01.RES.47.6.911; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Searls YM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-8; SIEGL PKS, 1984, P NATL ACAD SCI-BIOL, V81, P3238, DOI 10.1073/pnas.81.10.3238; Tchaikovski V, 2009, CIRCULATION, V120, P150, DOI 10.1161/CIRCULATIONAHA.108.817528; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Van Linthout S, 2008, BASIC RES CARDIOL, V103, P319, DOI 10.1007/s00395-008-0715-2; VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315; Westermann D, 2007, DIABETES, V56, P1834, DOI 10.2337/db06-1662; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Xavier-Vidal Ricardo, 2005, Clinics, V60, P85, DOI 10.1590/S1807-59322005000200003; YAMAMOTO N, 1995, BBA-MOL CELL RES, V1266, P157, DOI 10.1016/0167-4889(95)00011-G; Zhao XY, 2006, J PHYSIOL BIOCHEM, V62, P1, DOI 10.1007/BF03165800	47	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36840	10.1371/journal.pone.0036840	http://dx.doi.org/10.1371/journal.pone.0036840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590623	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336100065
J	Soupene, E; Rothschild, J; Kuypers, FA; Dean, D				Soupene, Eric; Rothschild, James; Kuypers, Frans A.; Dean, Deborah			Eukaryotic Protein Recruitment into the Chlamydia Inclusion: Implications for Survival and Growth	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; OBLIGATE INTRACELLULAR PATHOGEN; ENDOCYTIC MULTIVESICULAR BODIES; CYTOPLASMIC LIPID DROPLETS; TRACHOMATIS INCA; GOLGI-APPARATUS; INFECTED CELLS; III SECRETION; APOPTOSIS; TRAFFICKING	Chlamydia trachomatis (Ct) is an obligate intracellular human pathogen that multiplies within a parasitophorous vacuole called an inclusion. We report that the location of several host-cell proteins present in the cytosol, the nucleus, and membranes was altered during Ct development. The acyl-CoA synthetase enzyme ACSL3 and the soluble acyl-CoA binding protein ACBD6 were mobilized from organelle membranes and the nucleus, respectively, into the lumen of the inclusion. The nuclear protein ZNF23, a pro-apoptosis factor, was also translocated into the inclusion lumen. ZNF23, among other proteins, might be targeted by Ct to inhibit host cell apoptosis, thereby enabling bacterial survival. In contrast, the acyl-CoA: lysophosphatidylcholine acyltransferase LPCAT1, an endoplasmic reticulum membrane protein, was recruited to the inclusion membrane. The coordinated action of ACBD6, ACSL3 and LPCAT1 likely supports remodeling and scavenging of host lipids into bacterial-specific moieties essential to Ct growth. To our knowledge, these are the first identified host proteins known to be intercepted and translocated into the inclusion.	[Soupene, Eric; Kuypers, Frans A.] Childrens Hosp, Oakland Res Inst, Ctr Sickle Cell Dis & Thalassemia, Oakland, CA 94609 USA; [Rothschild, James; Dean, Deborah] Childrens Hosp, Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Dean, Deborah] Univ Calif Berkeley, Grad Program Bioengn, Berkeley, CA 94720 USA; [Dean, Deborah] Univ Calif San Francisco, Grad Program Bioengn, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Soupene, E (corresponding author), Childrens Hosp, Oakland Res Inst, Ctr Sickle Cell Dis & Thalassemia, 747 52nd St, Oakland, CA 94609 USA.	esoupene@chori.org			Public Health Service from the National Institutes of Health [R56 AI78419]; National Institutes of Health [R21HL092535]; CHORI Red Blood Cell Laboratory; CHORI Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI078419] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHORI Red Blood Cell Laboratory; CHORI Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Public Health Service grant R56 AI78419 from the National Institutes of Health (to DD), and in part by grant R21HL092535 from the National Institutes of Health as well as funds from the CHORI Red Blood Cell Laboratory and the CHORI Foundation (to FAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Bannantine JP, 1998, INFECT IMMUN, V66, P6017, DOI 10.1128/IAI.66.12.6017-6021.1998; Beatty WL, 2008, INFECT IMMUN, V76, P2872, DOI 10.1128/IAI.00129-08; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Byrne GI, 2004, NAT REV MICROBIOL, V2, P802, DOI 10.1038/nrmicro1007; Capmany A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014084; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Du K, 2011, CURR MICROBIOL, V63, P341, DOI 10.1007/s00284-011-9985-2; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Hasegawa A, 2009, INFECT IMMUN, V77, P1285, DOI 10.1128/IAI.01062-08; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Huang CX, 2008, CANCER LETT, V266, P135, DOI 10.1016/j.canlet.2008.02.059; Huang CX, 2007, EXP CELL RES, V313, P254, DOI 10.1016/j.yexcr.2006.10.009; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Lipinski AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000615; Malhotra KT, 1999, BIOCHEM J, V344, P135, DOI 10.1042/0264-6021:3440135; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pirbhai M, 2006, J BIOL CHEM, V281, P31495, DOI 10.1074/jbc.M602796200; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schwarzenbacher R, 2004, J BIOL CHEM, V279, P29320, DOI 10.1074/jbc.M401268200; Scidmore MA, 2001, MOL MICROBIOL, V39, P1638, DOI 10.1046/j.1365-2958.2001.02355.x; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Sharma M, 2009, FEMS IMMUNOL MED MIC, V55, P154, DOI 10.1111/j.1574-695X.2008.00515.x; Shi YQ, 2009, MOL CELLS, V27, P199, DOI 10.1007/s10059-009-0024-0; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Soupene E, 2008, J LIPID RES, V49, P1103, DOI 10.1194/jlr.M800007-JLR200; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Soupene E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-21; Soupene E, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-18; Stenner-Liewen F, 2002, J BIOL CHEM, V277, P9633, DOI 10.1074/jbc.C100693200; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Tse SML, 2005, J BIOL CHEM, V280, P25210, DOI 10.1074/jbc.M501980200; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Vandahl BBS, 2004, PROTEOMICS, V4, P2831, DOI 10.1002/pmic.200400940; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Wissel H, 2003, AM J RESP CELL MOL, V29, P303, DOI 10.1165/rcmb.2002-0246OC; World Health Organization, 2001, GLOB PREV INC SEL CU; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Ying SM, 2005, INFECT IMMUN, V73, P1399, DOI 10.1128/IAI.73.3.1399-1403.2005; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	66	18	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36843	10.1371/journal.pone.0036843	http://dx.doi.org/10.1371/journal.pone.0036843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590624	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336100066
J	Wei, W; Qi, XG; Guo, ST; Zhao, DP; Zhang, P; Huang, K; Li, BG				Wei, Wei; Qi, Xiao-Guang; Guo, Song-Tao; Zhao, Da-Peng; Zhang, Peng; Huang, Kang; Li, Bao-Guo			Market Powers Predict Reciprocal Grooming in Golden Snub-Nosed Monkeys (Rhinopithecus roxellana)	PLOS ONE			English	Article							QINLING MOUNTAINS; FEMALE PRIMATES; JAPANESE MACAQUES; DEMAND DETERMINE; BEHAVIOR; SIZE; INTERCHANGE; PATTERNS; SUPPORT; SEX	Social grooming is a common form of affiliative behavior in primates. Biological market theory suggests that grooming can be traded either for grooming or other social commodities and services. When no other services are exchanged, grooming is predicted to be approximately reciprocated within a dyad. In contrast, the amount of reciprocal grooming should decrease as other offered services increase. We studied grooming patterns between polygamous male and female in golden snub-nosed monkeys (Rhinopithecus roxellana) from the Qinling Mountains of central China and found that about 29.7% of grooming bouts were reciprocated. However, the durations of grooming bouts offered and returned was asymmetrical within dyads. In bisexual dyads, more grooming was initiated by females than males, which became more pronounced as the number of females per one-male unit increased. The rate of copulation per day for each female was positively correlated with the total duration of grooming time females invested in males.. Females without an infant (non-mothers) directed more grooming towards females with an infant (mothers) and were significantly more likely to be non-reciprocated. There was a significant negative relationship between non-mother and mother grooming duration and the rate of infants per female in each one-male unit. High-ranking females also received more grooming from low-ranking females than vice versa. The rate of food-related aggressive interactions was per day for low-ranking females was negatively correlated with the duration of grooming that low-ranking females gave to high-ranking females. Our results showed that grooming reciprocation in R. roxellana was discrepancy. This investment-reciprocity rate could be explained by the exchange of other social services in lieu of grooming.	[Wei, Wei; Qi, Xiao-Guang; Guo, Song-Tao; Zhao, Da-Peng; Huang, Kang; Li, Bao-Guo] Northwest Univ, Key Lab Resource Biol & Biotechnol Western China, Coll Life Sci, Xian, Peoples R China; [Zhang, Peng] Sun Yat Sen Univ, Sch Sociol & Anthropol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Bao-Guo] Shaanxi Acad Sci, Inst Zool, Xian, Peoples R China	Northwest University Xi'an; Sun Yat Sen University	Wei, W (corresponding author), Northwest Univ, Key Lab Resource Biol & Biotechnol Western China, Coll Life Sci, Xian, Peoples R China.	baoguoli@nwu.edu.cn		Guo, Songtao/0000-0002-8291-5487	National Nature Science Foundation of China [31130061, 30970444, 30970168, 30970379]; Research Fund for the Doctoral Program of Higher Education of China [20106101110005]; Special Foundation of Shaanxi Academy of Sciences, China [2010K-08]; Natural Science Foundation of Shaanxi Province, China [2009JM3002]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Special Foundation of Shaanxi Academy of Sciences, China; Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by the grants from the Key Program of National Nature Science Foundation of China (31130061); the National Nature Science Foundation of China (30970444; 30970168; 30970379); the Research Fund for the Doctoral Program of Higher Education of China (20106101110005); the Special Foundation of Shaanxi Academy of Sciences, China (2010K-08); the Natural Science Foundation of Shaanxi Province, China (2009JM3002); the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeggglen JJ, 1984, SOCIALIZATION HAMADR; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Barrett L, 1999, P ROY SOC B-BIOL SCI, V266, P665, DOI 10.1098/rspb.1999.0687; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett Louise, 2001, P119, DOI 10.1017/CBO9780511752421.009; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Chancellor RL, 2009, BEHAV ECOL, V20, P79, DOI 10.1093/beheco/arn117; CONNOR RC, 1995, ANIM BEHAV, V49, P528, DOI 10.1006/anbe.1995.0070; Cords M, 2002, BEHAVIOUR, V139, P291, DOI 10.1163/156853902760102681; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DiBitetti MS, 1997, ANIM BEHAV, V54, P199, DOI 10.1006/anbe.1996.0416; Dixson A.F., 1998, PRIMATE SEXUALITY CO; DUNBAR R, 1975, SOCIAL DYNAMICS GELA; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; Frank RE, 2009, BEHAVIOUR, V146, P889, DOI 10.1163/156853908X396656; Fruteau C, 2011, ANIM BEHAV, V81, P153, DOI 10.1016/j.anbehav.2010.09.028; Fruteau C, 2010, BEHAV PROCESS, V83, P113, DOI 10.1016/j.beproc.2009.11.004; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Gould W, 2000, STATA TECHN B REPRIN, V9, P257; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; Gumert MD, 2007, INT J PRIMATOL, V28, P1059, DOI 10.1007/s10764-007-9202-0; Guo SG, 2007, PRIMATES, V48, P268, DOI 10.1007/s10329-007-0048-z; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HART BL, 1992, ANIM BEHAV, V44, P615, DOI 10.1016/S0003-3472(05)80290-8; HEMELRIJK CK, 1994, ANIM BEHAV, V48, P479, DOI 10.1006/anbe.1994.1264; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; HEMELRIJK CK, 1991, ANIM BEHAV, V41, P923, DOI 10.1016/S0003-3472(05)80630-X; Hemelrijk CK, 1998, BEHAV ECOL SOCIOBIOL, V42, P207, DOI 10.1007/s002650050432; Henzi SP, 1997, ANIM BEHAV, V54, P1235, DOI 10.1006/anbe.1997.0520; Henzi SP, 2002, ANIM BEHAV, V63, P915, DOI 10.1006/anbe.2001.1986; Henzi SP, 1997, ANIM BEHAV, V53, P525, DOI 10.1006/anbe.1996.0302; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Hu Songmei, 2006, Acta Theriologica Sinica, V26, P417; JANSON CH, 1995, BEHAV ECOL, V6, P326, DOI 10.1093/beheco/6.3.326; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; Kutsukake N, 2010, ANIM BEHAV, V79, P271, DOI 10.1016/j.anbehav.2009.10.014; Lazaro-Perea C, 2004, ANIM BEHAV, V67, P627, DOI 10.1016/j.anbehav.2003.06.004; Leinfelder I, 2001, AM J PRIMATOL, V55, P25, DOI 10.1002/ajp.1036; Lewis RJ, 2010, AM J PRIMATOL, V72, P254, DOI 10.1002/ajp.20776; Li BG, 2007, PRIMATES, V48, P190, DOI 10.1007/s10329-006-0029-7; Li BG, 2000, FOLIA PRIMATOL, V71, P375, DOI 10.1159/000052734; Manson JH, 2004, ANIM BEHAV, V67, P493, DOI 10.1016/j.anbehav.2003.05.009; Manson JH, 1999, INT J PRIMATOL, V20, P679, DOI 10.1023/A:1020700718458; MELLER RE, 1980, PHARMACOL BIOCHEM BE, V13, P663, DOI 10.1016/0091-3057(80)90010-6; Mooring MS, 1996, BEHAV ECOL SOCIOBIOL, V39, P259, DOI 10.1007/s002650050288; MORI U, 1979, ECOLOGICAL SOCIOLOGI, P125; Newton-Fisher NE, 2011, ANIM BEHAV, V81, P439, DOI 10.1016/j.anbehav.2010.11.015; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Norscia I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004679; Payne HFP, 2003, BEHAVIOUR, V140, P453, DOI 10.1163/156853903322127931; Perez A, 2000, INT J PRIMATOL, V21, P255, DOI 10.1023/A:1005425520658; Port M, 2009, ANIM BEHAV, V77, P29, DOI 10.1016/j.anbehav.2008.08.032; Qi XG, 2008, AM J PRIMATOL, V70, P311, DOI 10.1002/ajp.20480; Qi Xiao-Guang, 2004, Acta Zoologica Sinica, V50, P697; Qi XG, 2011, AM J PRIMATOL, V73, P366, DOI 10.1002/ajp.20908; Qi XG, 2009, AM J PRIMATOL, V71, P670, DOI 10.1002/ajp.20702; Qi Xiaoguang, 2010, Acta Theriologica Sinica, V30, P322; Ren R, 2000, FIELD STUDY SOC RHIN; Schino G, 2003, BEHAV ECOL, V14, P887, DOI 10.1093/beheco/arg070; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Schino G, 2008, BIOL LETTERS, V4, P9, DOI 10.1098/rsbl.2007.0506; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; SEYFARTH RM, 1984, NATURE, V308, P541, DOI 10.1038/308541a0; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Silk JB, 1999, ANIM BEHAV, V57, P1021, DOI 10.1006/anbe.1998.1065; SILK JB, 1982, BEHAVIOUR, V79, P162, DOI 10.1163/156853982X00238; Smuts B.B., 1987, P385; Stopka P, 2001, ANIM BEHAV, V61, P19; Swedell L, 2002, INT J PRIMATOL, V23, P1205, DOI 10.1023/A:1021170703006; Tiddi B, 2010, ANIM BEHAV, V79, P1115, DOI 10.1016/j.anbehav.2010.02.008; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Ventura R, 2006, AM J PRIMATOL, V68, P1138, DOI 10.1002/ajp.20314; Zhang P, 2006, PRIMATES, V47, P374, DOI 10.1007/s10329-006-0178-8; Zhao DP, 2008, BEHAV PROCESS, V79, P165, DOI 10.1016/j.beproc.2008.07.006; Zhao DP, 2005, FOLIA PRIMATOL, V76, P172, DOI 10.1159/000084379; Zhao HT, 2011, STUDY CORRELATIONSHI; ZUMPE D, 1986, AM J PRIMATOL, V10, P291, DOI 10.1002/ajp.1350100402	80	16	21	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36802	10.1371/journal.pone.0036802	http://dx.doi.org/10.1371/journal.pone.0036802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590611	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336100061
J	Goffe, AS; Blasse, A; Mundry, R; Leendertz, FH; Calvignac-Spencer, S				Goffe, Adeelia S.; Blasse, Anja; Mundry, Roger; Leendertz, Fabian H.; Calvignac-Spencer, Sebastien			Detection of Retroviral Super-Infection from Non-Invasive Samples	PLOS ONE			English	Article							FOAMY VIRUS-INFECTION; TAI NATIONAL-PARK; PHYLOGENETIC ANALYSIS; GENE GENEALOGIES; COMPUTER-PROGRAM; DUAL INFECTION; VIRAL LOAD; CHIMPANZEES; WILD; TYPE-1	While much attention has been focused on the molecular epidemiology of retroviruses in wild primate populations, the correlated question of the frequency and nature of super-infection events, i.e., the simultaneous infection of the same individual host with several strains of the same virus, has remained largely neglected. In particular, methods possibly allowing the investigation of super-infection from samples collected non-invasively (such as faeces) have never been properly compared. Here, we fill in this gap by assessing the costs and benefits of end-point dilution PCR (EPD-PCR) and multiple bulk-PCR cloning, as applied to a case study focusing on simian foamy virus super-infection in wild chimpanzees (Pan troglodytes). We show that, although considered to be the gold standard, EPD-PCR can lead to massive consumption of biological material when only low copy numbers of the target are expected. This constitutes a serious drawback in a field in which rarity of biological material is a fundamental constraint. In addition, we demonstrate that EPD-PCR results (single/multiple infection; founder strains) can be well predicted from multiple bulk-PCR clone experiments, by applying simple statistical and network analyses to sequence alignments. We therefore recommend the implementation of the latter method when the focus is put on retroviral super-infection and only low retroviral loads are encountered.	[Goffe, Adeelia S.; Blasse, Anja; Leendertz, Fabian H.; Calvignac-Spencer, Sebastien] Robert Koch Inst, Res Grp Emerging Zoonoses, Berlin, Germany; [Goffe, Adeelia S.] Univ Oxford, Wildlife Conservat Res Unit, Oxford, England; [Mundry, Roger] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany	Robert Koch Institute; University of Oxford; Max Planck Society	Goffe, AS (corresponding author), Robert Koch Inst, Res Grp Emerging Zoonoses, Berlin, Germany.	calvignacs@rki.de	Leendertz, Fabian Hubertus/H-8902-2019; Calvignac-Spencer, Sebastien/D-2313-2010	Calvignac-Spencer, Sebastien/0000-0003-4834-0509	Robert Koch-Institut, Berlin, Germany; DFG Africa [LE1813/4-1]; FAZIT Stiftung	Robert Koch-Institut, Berlin, Germany; DFG Africa; FAZIT Stiftung	This study was funded by the Robert Koch-Institut, Berlin, Germany, the DFG Africa Grant (LE1813/4-1) and the FAZIT Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bjork A, 2011, MOL BIOL EVOL, V28, P615, DOI 10.1093/molbev/msq227; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Calattini S, 2004, J GEN VIROL, V85, P3313, DOI 10.1099/vir.0.80241-0; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Goldberg TL, 2009, J VIROL, V83, P11318, DOI 10.1128/JVI.02616-08; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kondgen S, 2010, ECOHEALTH, V7, P332, DOI 10.1007/s10393-010-0340-z; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leendertz SAJ, 2010, J VIROL, V84, P7427, DOI 10.1128/JVI.00697-10; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Ling BH, 2003, J VIROL, V77, P2214, DOI 10.1128/JVI.77.3.2214-2226.2003; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Meertens L, 2001, VIROLOGY, V287, P275, DOI 10.1006/viro.2001.1018; Morozov VA, 2009, J GEN VIROL, V90, P500, DOI 10.1099/vir.0.003939-0; Mullers E, 2011, J VIROL, V85, P1452, DOI 10.1128/JVI.01731-10; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; Pacold M, 2010, AIDS RES HUM RETROV, V26, P1291, DOI 10.1089/aid.2010.0042; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ryland EG, 2010, J VIROL, V84, P12437, DOI 10.1128/JVI.01617-10; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHWEIZER M, 1995, VIROLOGY, V207, P577, DOI 10.1006/viro.1995.1120; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; TEMPLETON AR, 1992, GENETICS, V132, P619; Van Heuverswyn Fran, 2007, Curr Infect Dis Rep, V9, P338, DOI 10.1007/s11908-007-0052-x; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36570	10.1371/journal.pone.0036570	http://dx.doi.org/10.1371/journal.pone.0036570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590569	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335500018
J	Maroun, M; Kavushansky, A; Holmes, A; Wellman, C; Motanis, H				Maroun, Mouna; Kavushansky, Alexandra; Holmes, Andrew; Wellman, Cara; Motanis, Helen			Enhanced Extinction of Aversive Memories by High-Frequency Stimulation of the Rat Infralimbic Cortex	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CONDITIONED TASTE-AVERSION; FEAR EXTINCTION; LONG-TERM; PROTEIN-SYNTHESIS; GABA(A) AGONIST; STRESS; CONSOLIDATION; RECONSOLIDATION; EXPRESSION	Electrical stimulation of the rodent medial prefrontal cortex (mPFC), including the infralimbic cortex (IL), immediately prior to or during fear extinction training facilitates extinction memory. Here we examined the effects of high-frequency stimulation (HFS) of the rat IL either prior to conditioning or following retrieval of the conditioned memory, on extinction of Pavlovian fear and conditioned taste aversion (CTA). IL-HFS applied immediately after fear memory retrieval, but not three hours after retrieval or prior to conditioning, subsequently reduced freezing during fear extinction. Similarly, IL-HFS given immediately, but not three hours after, retrieval of a CTA memory reduced aversion during extinction. These data indicate that HFS of the IL may be an effective method for reducing both learned fear and learned aversion.	[Maroun, Mouna; Kavushansky, Alexandra; Motanis, Helen] Univ Haifa, Fac Nat Sci, Dept Neurobiol, IL-31999 Haifa, Israel; [Holmes, Andrew] NIAAA, Lab Behav & Genom Neurosci, NIH, Bethesda, MD USA; [Wellman, Cara] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Wellman, Cara] Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN USA	University of Haifa; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Maroun, M (corresponding author), Univ Haifa, Fac Nat Sci, Dept Neurobiol, IL-31999 Haifa, Israel.	mouna.maroun@gmail.com		Kavushansky, Alexandra/0000-0002-8511-3068; Wellman, Cara/0000-0002-3064-4259	United States-Israel Binational Science Foundation; Ministry of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000411] Funding Source: NIH RePORTER	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ministry of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by the United States-Israel Binational Science Foundation (to AH, CLW and MM) and the Ministry of Health grant (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 2006, EUR J NEUROSCI, V23, P758, DOI 10.1111/j.1460-9568.2006.04603.x; Akirav I, 2007, NEUROPSYCHOPHARMACOL, V32, P542, DOI 10.1038/sj.npp.1301050; Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Akirav I, 2006, LEARN MEMORY, V13, P254, DOI 10.1101/lm.191706; Akirav Irit, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/30873; Akirav I, 2009, LEARN MEMORY, V16, P682, DOI 10.1101/lm.1565109; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Bahar A, 2003, EUR J NEUROSCI, V17, P1527, DOI 10.1046/j.1460-9568.2003.02551.x; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Berman DE, 2003, LEARN MEMORY, V10, P16, DOI 10.1101/lm.53703; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; BOUTON ME, 1994, J EXP PSYCHOL ANIM B, V20, P51, DOI 10.1037/0097-7403.20.1.51; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Farrell MR, 2010, NEUROBIOL LEARN MEM, V94, P240, DOI 10.1016/j.nlm.2010.06.001; Fernandez M, 2001, NEUROSCI LETT, V297, P101, DOI 10.1016/S0304-3940(00)01674-8; Herry C, 2004, EUR J NEUROSCI, V20, P781, DOI 10.1111/j.1460-9568.2004.03542.x; Herry C, 2003, BEHAV BRAIN RES, V146, P89, DOI 10.1016/j.bbr.2003.09.017; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hikind N, 2008, NEUROBIOL LEARN MEM, V90, P217, DOI 10.1016/j.nlm.2008.03.003; Holmes A, 2010, TRENDS PHARMACOL SCI, V31, P2, DOI 10.1016/j.tips.2009.10.003; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; Jay TM, 1996, J PHYSIOLOGY-PARIS, V90, P361, DOI 10.1016/S0928-4257(97)87920-X; KIM JJ, 1992, BEHAV NEUROSCI, V106, P591, DOI 10.1037/0735-7044.106.4.591; Maroun M, 2003, J NEUROSCI, V23, P4406; Maroun M, 2006, EUR J NEUROSCI, V24, P2917, DOI 10.1111/j.1460-9568.2006.05169.x; Mickley GA, 2005, BRAIN RES, V1051, P176, DOI 10.1016/j.brainres.2005.05.033; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Miracle AD, 2006, NEUROBIOL LEARN MEM, V85, P213, DOI 10.1016/j.nlm.2005.10.005; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Pare D, 2004, TRENDS NEUROSCI, V27, P440, DOI 10.1016/j.tins.2004.05.004; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rescorla RA, 1996, Q J EXP PSYCHOL-B, V49, P245; Richter-Levin G, 2010, CEREB CORTEX, V20, P2433, DOI 10.1093/cercor/bhp311; Rocher C, 2004, CEREB CORTEX, V14, P224, DOI 10.1093/cercor/bhg122; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Sara SJ, 2000, NAT REV NEUROSCI, V1, P212, DOI 10.1038/35044575; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Vouimba RM, 2011, NEUROPSYCHOPHARMACOL, V36, P2276, DOI 10.1038/npp.2011.115; Wilber AA, 2011, NEUROSCIENCE, V174, P115, DOI 10.1016/j.neuroscience.2010.10.070; Yasoshima Y, 2000, BRAIN RES, V869, P15, DOI 10.1016/S0006-8993(00)02397-0	55	58	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35853	10.1371/journal.pone.0035853	http://dx.doi.org/10.1371/journal.pone.0035853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586453	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335000015
J	Bokony, V; Kulcsar, A; Toth, Z; Liker, A				Bokony, Veronika; Kulcsar, Anna; Toth, Zoltan; Liker, Andras			Personality Traits and Behavioral Syndromes in Differently Urbanized Populations of House Sparrows (Passer domesticus)	PLOS ONE			English	Article							RESPONSES; BIRDS; NOVELTY; TEMPERAMENT; LANDSCAPE; SELECTION; SUCCESS; CITY; FEAR	Urbanization creates novel environments for wild animals where selection pressures may differ drastically from those in natural habitats. Adaptation to urban life involves changes in various traits, including behavior. Behavioral traits often vary consistently among individuals, and these so-called personality traits can be correlated with each other, forming behavioral syndromes. Despite their adaptive significance and potential to act as constraints, little is known about the role of animal personality and behavioral syndromes in animals' adaptation to urban habitats. In this study we tested whether differently urbanized habitats select for different personalities and behavioral syndromes by altering the population mean, inter-individual variability, and correlations of personality traits. We captured house sparrows (Passer domesticus) from four different populations along the gradient of urbanization and assessed their behavior in standardized test situations. We found individual consistency in neophobia, risk taking, and activity, constituting three personality axes. On the one hand, urbanization did not consistently affect the mean and variance of these traits, although there were significant differences between some of the populations in food neophobia and risk taking (both in means and variances). On the other hand, both urban and rural birds exhibited a behavioral syndrome including object neophobia, risk taking and activity, whereas food neophobia was part of the syndrome only in rural birds. These results indicate that there are population differences in certain aspects of personality in house sparrows, some of which may be related to habitat urbanization. Our findings suggest that urbanization and/or other population-level habitat differences may not only influence the expression of personality traits but also alter their inter-individual variability and the relationships among them, changing the structure of behavioral syndromes.	[Bokony, Veronika; Liker, Andras] Univ Pannonia, Dept Limnol, Veszprem, Hungary; [Kulcsar, Anna] Szent Istvan Univ, Fac Vet Sci, Dept Physiol & Biochem, Budapest, Hungary; [Toth, Zoltan] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	University of Pannonia; Hungarian University of Agriculture & Life Sciences; Jagiellonian University	Bokony, V (corresponding author), Univ Pannonia, Dept Limnol, Veszprem, Hungary.	vbokony@almos.uni-pannon.hu	Bókony, Veronika/AAH-7679-2020	Bókony, Veronika/0000-0002-2136-5346; Toth, Zoltan/0000-0002-2634-8393	Hungarian Scientific Research Fund [OTKA K84132, TAMOP -4.2.2/B-10/1-2010-0025]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The study was supported by the Hungarian Scientific Research Fund (OTKA K84132) and TAMOP -4.2.2/B-10/1-2010-0025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR., 2006, BIOL UBIQUITOUS HOUS; [Anonymous], 2001, AVIAN ECOLOGY CONSER; Arbuckle J.L., 2006, AMOS 7 0 USERS GUIDE; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bokony V, 2012, LANDSCAPE URBAN PLAN, V104, P75, DOI 10.1016/j.landurbplan.2011.10.006; Bokony V, 2010, OIKOS, V119, P437, DOI 10.1111/j.1600-0706.2009.17848.x; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Crawley MJ., 2007, R BOOK; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2010, ANIM BEHAV, V79, P439, DOI 10.1016/j.anbehav.2009.11.024; Dochtermann NA, 2010, BEHAV ECOL, V21, P437, DOI 10.1093/beheco/arq021; Echeverria AI, 2008, ETHOLOGY, V114, P616, DOI 10.1111/j.1439-0310.2008.01512.x; Edelaar P, 2012, BEHAV ECOL, V23, P619, DOI 10.1093/beheco/ars006; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Fernandez-Juricic E, 2003, CONDOR, V105, P316, DOI 10.1650/0010-5422(2003)105[0316:TTRHIA]2.0.CO;2; Fleischer AL, 2003, CONDOR, V105, P515, DOI 10.1650/7224; Greenberg Russell, 2003, P175; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Johnson WC, 2004, BIOL CONSERV, V115, P487, DOI 10.1016/S0006-3207(03)00165-4; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Lendvai AZ, 2011, J EXP BIOL, V214, P821, DOI 10.1242/jeb.047712; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Mccleery RA, 2009, LANDSCAPE ECOL, V24, P483, DOI 10.1007/s10980-009-9323-2; McDonnell MJ, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P1, DOI 10.1017/CBO9780511609763; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2010, BEHAV ECOL, V21, P913, DOI 10.1093/beheco/arq079; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Mutzel A, 2011, ANIM BEHAV, V81, P731, DOI 10.1016/j.anbehav.2011.01.001; Niemela J, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P1, DOI 10.1093/acprof:oso/9780199563562.001.0001; Prosser C, 2006, J HERPETOL, V40, P151, DOI 10.1670/38-05A.1; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Scales J, 2011, ETHOLOGY, V117, P887, DOI 10.1111/j.1439-0310.2011.01943.x; Seress G, 2011, ETHOLOGY, V117, P896, DOI 10.1111/j.1439-0310.2011.01944.x; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Snekser JL, 2009, BEHAV ECOL, V20, P124, DOI 10.1093/beheco/arn123; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019535; Sorace A, 2009, LANDSCAPE URBAN PLAN, V90, P111, DOI 10.1016/j.landurbplan.2008.10.019; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Valcarcel A, 2009, BEHAV ECOL SOCIOBIOL, V63, P673, DOI 10.1007/s00265-008-0701-6; Vangestel C, 2011, MOL ECOL, V20, P4643, DOI 10.1111/j.1365-294X.2011.05316.x; Yeh PJ, 2007, OIKOS, V116, P1473, DOI 10.1111/j.2007.0030-1299.15910.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zuur Alain F., 2009, P1	56	110	111	2	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36639	10.1371/journal.pone.0036639	http://dx.doi.org/10.1371/journal.pone.0036639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574204	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800101
J	Henson, BJ; Zhu, W; Hardaway, K; Wetzel, JL; Stefan, M; Albers, KM; Nicholls, RD				Henson, Brian J.; Zhu, Wan; Hardaway, Kelsey; Wetzel, Jaime L.; Stefan, Mihaela; Albers, Kathryn M.; Nicholls, Robert D.			Transcriptional and Post-Transcriptional Regulation of SPAST, the Gene Most Frequently Mutated in Hereditary Spastic Paraplegia	PLOS ONE			English	Article							RESPIRATORY FACTOR-I; MICROTUBULE DYNAMICS; AXON OUTGROWTH; MUTATIONS; PROTEIN; ACTIVATION; EXPRESSION; PROMOTER; SOX11; SPG4	Hereditary spastic paraplegias (HSPs) comprise a group of neurodegenerative disorders that are characterized by progressive spasticity of the lower extremities, due to axonal degeneration in the corticospinal motor tracts. HSPs are genetically heterogeneous and show autosomal dominant inheritance in similar to 70-80% of cases, with additional cases being recessive or X-linked. The most common type of HSP is SPG4 with mutations in the SPAST gene, encoding spastin, which occurs in 40% of dominantly inherited cases and in similar to 10% of sporadic cases. Both loss-of-function and dominant-negative mutation mechanisms have been described for SPG4, suggesting that precise or stoichiometric levels of spastin are necessary for biological function. Therefore, we hypothesized that regulatory mechanisms controlling expression of SPAST are important determinants of spastin biology, and if altered, could contribute to the development and progression of the disease. To examine the transcriptional and post-transcriptional regulation of SPAST, we used molecular phylogenetic methods to identify conserved sequences for putative transcription factor binding sites and miRNA targeting motifs in the SPAST promoter and 3'-UTR, respectively. By a variety of molecular methods, we demonstrate that SPAST transcription is positively regulated by NRF1 and SOX11. Furthermore, we show that miR-96 and miR-182 negatively regulate SPAST by effects on mRNA stability and protein level. These transcriptional and miRNA regulatory mechanisms provide new functional targets for mutation screening and therapeutic targeting in HSP.	[Henson, Brian J.; Hardaway, Kelsey; Wetzel, Jaime L.; Stefan, Mihaela; Nicholls, Robert D.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Med Genet,Birth Defects Labs, Pittsburgh, PA USA; [Zhu, Wan; Nicholls, Robert D.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Albers, Kathryn M.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Henson, BJ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Med Genet,Birth Defects Labs, Pittsburgh, PA USA.	robert.nicholls@chp.edu	Mandak, Kelsey/AAH-2106-2019	Albers, Kathryn/0000-0003-4597-9323	National Institutes of Health [NS049417]; Spastic Paraplegia Foundation (SPF); Research Administration Committee, Children's Hospital of Pittsburgh of UPMC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059003, R01NS049417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spastic Paraplegia Foundation (SPF); Research Administration Committee, Children's Hospital of Pittsburgh of UPMC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by research grants from the National Institutes of Health (NS049417) and the Spastic Paraplegia Foundation (SPF) to RDN. WZ was supported in part by a graduate fellowship from the Research Administration Committee, Children's Hospital of Pittsburgh of UPMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez V, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-89; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Beauloye C, 2011, CARDIOVASC RES, V90, P224, DOI 10.1093/cvr/cvr034; Beetz C, 2006, NEUROLOGY, V67, P1926, DOI 10.1212/01.wnl.0000244413.49258.f5; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burger J, 2000, EUR J HUM GENET, V8, P771, DOI 10.1038/sj.ejhg.5200528; Butler R, 2010, DIS MODEL MECH, V3, P743, DOI 10.1242/dmm.004002; Canbaz D, 2011, J NEUROCHEM, V117, P724, DOI 10.1111/j.1471-4159.2011.07243.x; Chang WT, 2005, BIOCHEM BIOPH RES CO, V334, P199, DOI 10.1016/j.bbrc.2005.06.079; CHAU CMA, 1992, J BIOL CHEM, V267, P6999; Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; David MD, 2010, J NEUROSCI RES, V88, P3011, DOI 10.1002/jnr.22464; de Bot ST, 2010, J NEUROL NEUROSUR PS, V81, P1073, DOI 10.1136/jnnp.2009.201103; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Depienne C, 2007, J MED GENET, V44, P281, DOI 10.1136/jmg.2006.046425; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Fazio IK, 2001, J BIOL CHEM, V276, P18710, DOI 10.1074/jbc.M100080200; Fink JK, 2009, GENEREVIEWS; Goodman M, 2009, P NATL ACAD SCI USA, V106, P20824, DOI 10.1073/pnas.0911239106; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Jalvy-Delvaille S, 2012, NUCLEIC ACIDS RES, V40, P1356, DOI 10.1093/nar/gkr843; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; Jensen KP, 2011, NUCLEIC ACIDS RES, V39, P701, DOI 10.1093/nar/gkq798; Jing XT, 2012, EXP NEUROL, V233, P221, DOI 10.1016/j.expneurol.2011.10.005; Juhila J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021495; Kalil K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00062; Kasher PR, 2009, J NEUROCHEM, V110, P34, DOI 10.1111/j.1471-4159.2009.06104.x; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Lee S, 2011, J NEUROIMMUNOL, V235, P56, DOI 10.1016/j.jneuroim.2011.02.007; Lehnert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004456; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lin L, 2011, DEV DYNAM, V240, P52, DOI 10.1002/dvdy.22489; Lin PF, 2008, AM J HUM GENET, V83, P752, DOI 10.1016/j.ajhg.2008.11.003; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Magariello A, 2010, J NEUROL SCI, V288, P96, DOI 10.1016/j.jns.2009.09.025; Mancuso G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-31; McCorquodale DS, 2011, CLIN GENET, V79, P523, DOI 10.1111/j.1399-0004.2010.01501.x; Pantakani DVK, 2008, J NEUROCHEM, V106, P613, DOI 10.1111/j.1471-4159.2008.05414.x; Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x; Potzner MR, 2010, DEVELOPMENT, V137, P775, DOI 10.1242/dev.042101; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Riano E, 2009, J NEUROCHEM, V108, P1277, DOI 10.1111/j.1471-4159.2009.05875.x; Rodriguez-Jato S, 2005, NUCLEIC ACIDS RES, V33, P4740, DOI 10.1093/nar/gki786; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shoukier M, 2009, EUR J HUM GENET, V17, P187, DOI 10.1038/ejhg.2008.147; Smith KT, 2004, HUM MOL GENET, V13, P1611, DOI 10.1093/hmg/ddh172; Solowska JM, 2010, HUM MOL GENET, V19, P2767, DOI 10.1093/hmg/ddq177; Stefan M, 2005, GENOMICS, V85, P630, DOI 10.1016/j.ygeno.2005.02.004; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Tarrade A, 2006, HUM MOL GENET, V15, P3544, DOI 10.1093/hmg/ddl431; Thein DC, 2010, J NEUROCHEM, V115, P131, DOI 10.1111/j.1471-4159.2010.06910.x; Valdmanis PN, 2007, AM J HUM GENET, V80, P152, DOI 10.1086/510782; Vinson C, 2011, SUBCELL BIOCHEM, V52, P205, DOI 10.1007/978-90-481-9069-0_10; Wei HG, 2010, INT J DEV NEUROSCI, V28, P545, DOI 10.1016/j.ijdevneu.2010.04.007; Wharton SB, 2003, J NEUROPATH EXP NEUR, V62, P1166, DOI 10.1093/jnen/62.11.1166; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xin N, 2011, DEVELOPMENT, V138, P4955, DOI 10.1242/dev.068890; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yang SJ, 2006, NEUROSCIENCE, V141, P1181, DOI 10.1016/j.neuroscience.2006.04.063; Yu W., 2007, J ENV BIOMED, V1, P1; Yun H, 2011, EXPERT OPIN THER PAT, V21, P983, DOI 10.1517/13543776.2011.577069	89	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36505	10.1371/journal.pone.0036505	http://dx.doi.org/10.1371/journal.pone.0036505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574173	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000305349800070
J	Liang, S; Fang, L; Zhou, RC; Tang, T; Deng, SL; Dong, SS; Huang, YL; Zhong, CR; Shi, SH				Liang, Shan; Fang, Lu; Zhou, Renchao; Tang, Tian; Deng, Shulin; Dong, Suisui; Huang, Yelin; Zhong, Cairong; Shi, Suhua			Transcriptional Homeostasis of a Mangrove Species, Ceriops tagal, in Saline Environments, as Revealed by Microarray Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; NA+/H+ ANTIPORTER; ARABIDOPSIS-THALIANA; SALT TOLERANCE; STRESS; ADAPTATION; DROUGHT; ASSIMILATION; SPECIATION; HALOPHYTE	Background: Differential responses to the environmental stresses at the level of transcription play a critical role in adaptation. Mangrove species compose a dominant community in intertidal zones and form dense forests at the sea-land interface, and although the anatomical and physiological features associated with their salt-tolerant lifestyles have been well characterized, little is known about the impact of transcriptional phenotypes on their adaptation to these saline environments. Methodology and Principal findings: We report the time-course transcript profiles in the roots of a true mangrove species, Ceriops tagal, as revealed by a series of microarray experiments. The expression of a total of 432 transcripts changed significantly in the roots of C. tagal under salt shock, of which 83 had a more than 2-fold change and were further assembled into 59 unigenes. Global transcription was stable at the early stage of salt stress and then was gradually dysregulated with the increased duration of the stress. Importantly, a pair-wise comparison of predicted homologous gene pairs revealed that the transcriptional regulations of most of the differentially expressed genes were highly divergent in C. tagal from that in salt-sensitive species, Arabidopsis thaliana. Conclusions/Significance: This work suggests that transcriptional homeostasis and specific transcriptional regulation are major events in the roots of C. tagal when subjected to salt shock, which could contribute to the establishment of adaptation to saline environments and, thus, facilitate the salt-tolerant lifestyle of this mangrove species. Furthermore, the candidate genes underlying the adaptation were identified through comparative analyses. This study provides a foundation for dissecting the genetic basis of the adaptation of mangroves to intertidal environments.	[Liang, Shan; Fang, Lu; Zhou, Renchao; Tang, Tian; Deng, Shulin; Dong, Suisui; Huang, Yelin; Shi, Suhua] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Liang, Shan; Fang, Lu; Zhou, Renchao; Tang, Tian; Deng, Shulin; Dong, Suisui; Huang, Yelin; Shi, Suhua] Sun Yat Sen Univ, Guangdong Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China; [Liang, Shan] S China Normal Univ, Guangdong Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China; [Zhong, Cairong] Hainan Dongzhai Harbor Natl Nat Reserve, Hainan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; South China Normal University	Liang, S (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	lssssh@mail.sysu.edu.cn		Huang, Yelin/0000-0002-2514-0144; Deng, Shulin/0000-0002-7231-3415	National Natural Science Foundation of China [41130208, 40976081, 31170213, 31170308, 31070290, 31171994]; Science Foundation of the State Key Laboratory of Biocontrol [SKLBC2011A06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the State Key Laboratory of Biocontrol	This study is supported by grants from the National Natural Science Foundation of China (41130208, 40976081, 31170213, 31170308, 31070290, 31171994), and Science Foundation of the State Key Laboratory of Biocontrol (SKLBC2011A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz I, 2001, AQUAT BOT, V70, P259, DOI 10.1016/S0304-3770(01)00160-7; Bohnert HJ, 2005, PLANT FUNCTIONAL GEN, P451; Bressan RA, 2001, PLANT PHYSIOL, V127, P1354, DOI 10.1104/pp.010752; CRAWFORD DL, 1992, MOL BIOL EVOL, V9, P806; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Feller I.C., 1996, MANGROVE ECOLOGY WOR; Fu XH, 2004, PLANT MOL BIOL REP, V22, p197a; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hruz T, 2008, ADV BIOINFORMATICS, V47, P5; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Lai Z, 2006, MOL ECOL, V15, P1213, DOI 10.1111/j.1365-294X.2006.02775.x; Lexer C, 2005, J EVOLUTION BIOL, V18, P893, DOI 10.1111/j.1420-9101.2005.00901.x; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; NIU XM, 1993, PLANT PHYSIOL, V103, P713, DOI 10.1104/pp.103.3.713; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Olsen KM, 2004, GENETICS, V167, P1361, DOI 10.1534/genetics.103.024950; Ouborg NJ, 2007, J ECOL, V95, P8, DOI 10.1111/j.1365-2745.2006.01197.x; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Pigliucci M, 2003, EVOLUTION, V57, P1455; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; SCHOLANDER PF, 1962, PLANT PHYSIOL, V37, P722, DOI 10.1104/pp.37.6.722; SCHOLANDER PF, 1968, PHYSIOL PLANTARUM, V21, P251, DOI 10.1111/j.1399-3054.1968.tb07248.x; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Shimada M, 2010, POPUL ECOL, V52, P5, DOI 10.1007/s10144-009-0187-8; Soensen JG, 2003, ECOL LETT, V6, P1025; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Voolstra C, 2007, GENOME RES, V17, P42, DOI 10.1101/gr.5683806; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Wong CE, 2005, PLANT MOL BIOL, V58, P561, DOI 10.1007/s11103-005-6163-6; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Zheng WJ, 1999, J EXP MAR BIOL ECOL, V233, P247, DOI 10.1016/S0022-0981(98)00131-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	53	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36499	10.1371/journal.pone.0036499	http://dx.doi.org/10.1371/journal.pone.0036499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574172	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800068
J	Nellen, A; Heinrichs, D; Berres, ML; Sahin, H; Schmitz, P; Proudfoot, AE; Trautwein, C; Wasmuth, HE				Nellen, Andreas; Heinrichs, Daniel; Berres, Marie-Luise; Sahin, Hacer; Schmitz, Petra; Proudfoot, Amanda E.; Trautwein, Christian; Wasmuth, Hermann E.			Interference with Oligomerization and Glycosaminoglycan Binding of the Chemokine CCL5 Improves Experimental Liver Injury	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HEPARIN-BINDING; STELLATE CELLS; RANTES; MECHANISMS; FIBROSIS; FIBROGENESIS; INFLAMMATION; RECEPTORS; VARIANTS	Background: The chemokine CCL5 is involved in the recruitment of immune cells and a subsequent activation of hepatic stellate cells (HSC) after liver injury. We here investigate whether inhibition of CCL5 oligomerization and glycosaminoglycan binding by a mutated CCL5 protein ((44)AANA(47)-CCL5) has the potential to ameliorate liver cell injury and fibrosis in vivo. Methodology: Liver injury was induced in C57BL/6 mice by intraperitoneal injection of carbon tetrachloride (CCl4) in an acute and a chronic liver injury model. Simultaneously, mice received either (44)AANA(47)-CCL5 or vehicle. Liver cell necrosis and fibrosis was analyzed by histology, and measurement of serum transaminases and hydroxyproline. Intrahepatic mRNA expression of fibrosis and inflammation related genes were determined by quantitative RT-PCR and infiltration of immune cells was assessed by FACS analysis and immunocytochemistry. In vitro, HSC were stimulated with conditioned media of T-cell enriched splenocytes. Principal Findings: (44)AANA(47)-CCL5 treated mice displayed a significantly reduced degree of acute liver injury (liver cell necrosis, transaminases) and fibrosis (Sirus red positive area and hydroxyproline content) compared to vehicle treated mice. Ameliorated fibrosis by (44)AANA(47)-CCL5 was associated with a decreased expression of fibrosis related genes, decreased alpha-smoth muscle antigen (alpha SMA) and a reduction of infiltrating immune cells. In the acute model, (44)AANA(47)-CCL5 treated mice displayed a reduced immune cell infiltration and mRNA levels of TNF, IL-1 and CCL3 compared to vehicle treated mice. In vitro, conditioned medium of T-cell enriched splenocytes of (44)AANA(47)-CCL5 treated mice inhibited the chemotaxis and proliferation of HSC. Conclusions: The results provide evidence that inhibition of oligomerization and glycosaminoglycan binding of the chemokine CCL5 is a new therapeutic strategy for the treatment of acute and chronic liver injuries and represents an alternative to chemokine receptor antagonism.	[Nellen, Andreas; Heinrichs, Daniel; Berres, Marie-Luise; Sahin, Hacer; Schmitz, Petra; Trautwein, Christian; Wasmuth, Hermann E.] Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Proudfoot, Amanda E.] Merck Serono, Geneva Res Ctr, Geneva, Switzerland	RWTH Aachen University; RWTH Aachen University Hospital; Merck KGaA; EMD Serono Inc.	Nellen, A (corresponding author), Univ Hosp Aachen, Dept Med 3, Aachen, Germany.	hwasmuth@ukaachen.de	Berres, Marie-Luise/AAN-5351-2021		Deutsche Forschungsgemeinschaft [SFB-TRR57, WA2557/2-1]; Else Kroner-Freseniusstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Freseniusstiftung	The study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB-TRR57, WA2557/2-1) and the Else Kroner-Freseniusstiftung to HEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; BOROJEVIC R, 1985, IN VITRO CELL DEV B, V21, P382, DOI 10.1007/BF02623469; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Hellier S, 2003, HEPATOLOGY, V38, P1468, DOI [10.1016/j.hep.2003.09.027, 10.1053/jhep.2003.09027]; Holt AP, 2008, CLIN LIVER DIS, V12, P861, DOI 10.1016/j.cld.2008.07.002; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Nischalke HD, 2004, MEDIAT INFLAMM, V13, P357, DOI 10.1080/09629350400003159; Promrat K, 2003, GASTROENTEROLOGY, V124, P352, DOI 10.1053/gast.2003.50061; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Rot A, 2010, FRONT BIOSCI-LANDMRK, V15, P645, DOI 10.2741/3638; Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062; Sahin H, 2010, NAT REV GASTRO HEPAT, V7, P682, DOI 10.1038/nrgastro.2010.168; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Wasmuth HE, 2004, HEPATOLOGY, V40, P327, DOI 10.1002/hep.20322; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x	32	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36614	10.1371/journal.pone.0036614	http://dx.doi.org/10.1371/journal.pone.0036614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574195	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800092
J	Suspene, R; Meyerhans, A				Suspene, Rodolphe; Meyerhans, Andreas			Quantification of Unintegrated HIV-1 DNA at the Single Cell Level In Vivo	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL DNA; CYTIDINE DEAMINASES; GERMINAL-CENTERS; INFECTED-CELLS; WHITE PULPS; T-CELLS; RECOMBINATION; INTEGRATION; EVOLUTION	In the nucleus of HIV-1 infected cells, unintegrated HIV-1 DNA molecules exist in the form of one and two LTR circles and linear molecules with degraded extremities. In tissue culture they are invariably more numerous than the provirus, the relative proportion of integrated to unintegrated forms varies widely from,1:1 to 1:10 and even over 1:100. In vivo, this ratio is unknown. To determine it, single nuclei from two infected patients with a known provirus copy number were microdissected, HIV DNA was amplified by nested PCR, cloned and individual clones sequenced. Given the extraordinary sequence complexity, we made the assumption that the total number of distinct sequences approximated to real number of amplifiable HIV-1 DNA templates in the nucleus. We found that the number of unintegrated DNA molecules increased linearly with the proviral copy number there being on average 86 unintegrated molecules per provirus.	[Suspene, Rodolphe; Meyerhans, Andreas] Univ Saarland, Inst Med Microbiol, Dept Virol, D-6650 Homburg, Germany	Saarland University	Suspene, R (corresponding author), Inst Pasteur, Paris, France.	rodolphe.suspene@pasteur.fr	Meyerhans, Andreas/S-2559-2019; t, lf/AAJ-4924-2020; Meyerhans, Andreas/D-3382-2014	Meyerhans, Andreas/0000-0003-0620-5317; Meyerhans, Andreas/0000-0003-0620-5317	EMBO Long Term Fellowship; Deutsche Forschungsgemeinschaft; Spanish Ministry of Science and Innovation [SAF2010-21336]	EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	RS was supported by an EMBO Long Term Fellowship. AM was supported by grants from the Deutsche Forschungsgemeinschaft and the Spanish Ministry of Science and Innovation (SAF2010-21336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bell P, 2001, J VIROL, V75, P7683, DOI 10.1128/JVI.75.16.7683-7691.2001; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2525, DOI 10.1073/pnas.86.8.2525; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; Brown RJP, 2011, J VIROL, V85, P6024, DOI 10.1128/JVI.00131-11; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; CHEYNIER R, 1994, CELL, V78, P373, DOI 10.1016/0092-8674(94)90417-0; Cheynier R, 2001, J GEN VIROL, V82, P1613, DOI 10.1099/0022-1317-82-7-1613; DELASSUS S, 1992, J VIROL, V66, P5642, DOI 10.1128/JVI.66.9.5642-5645.1992; DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994; Dumaurier MJ, 2005, J GEN VIROL, V86, P3369, DOI 10.1099/vir.0.81133-0; FARNET CM, 1991, J VIROL, V65, P6942, DOI 10.1128/JVI.65.12.6942-6952.1991; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; Graf EH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001300; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Henry M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004277; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoelscher M, 2001, AIDS, V15, P1461, DOI 10.1097/00002030-200108170-00002; Hosmalin A, 2001, BLOOD, V97, P2695, DOI 10.1182/blood.V97.9.2695; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kils-Hutten L, 2001, J GEN VIROL, V82, P1621, DOI 10.1099/0022-1317-82-7-1621; Kim EY, 2005, J VIROL, V79, P4886, DOI 10.1128/JVI.79.8.4886-4895.2005; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; McCutchan FE, 2000, AIDS, V14, pS31; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Plikat U, 1997, J VIROL, V71, P4233, DOI 10.1128/JVI.71.6.4233-4240.1997; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; Schwartz O, 1998, J VIROL, V72, P3845, DOI 10.1128/JVI.72.5.3845-3850.1998; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; TSUNETSUGUYOKOTA Y, 1995, J VIROL, V69, P4544, DOI 10.1128/JVI.69.7.4544-4547.1995; Vandegraaff N, 2001, J VIROL, V75, P11253, DOI 10.1128/JVI.75.22.11253-11260.2001; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Wain-Hobson S, 2003, J GEN VIROL, V84, P885, DOI 10.1099/vir.0.18894-0; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wooley DP, 1997, J VIROL, V71, P9650, DOI 10.1128/JVI.71.12.9650-9653.1997; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]	45	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36246	10.1371/journal.pone.0036246	http://dx.doi.org/10.1371/journal.pone.0036246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574142	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800038
J	Walsh, MC; Buzoianu, SG; Rea, MC; O'Donovan, O; Gelencser, E; Ujhelyi, G; Ross, RP; Gardiner, GE; Lawlor, PG				Walsh, Maria C.; Buzoianu, Stefan G.; Rea, Mary C.; O'Donovan, Orla; Gelencser, Eva; Ujhelyi, Gabriella; Ross, R. Paul; Gardiner, Gillian E.; Lawlor, Peadar G.			Effects of Feeding Bt MON810 Maize to Pigs for 110 Days on Peripheral Immune Response and Digestive Fate of the cry1Ab Gene and Truncated Bt Toxin	PLOS ONE			English	Article							GENETICALLY-MODIFIED MAIZE; ENDOGENOUS PLANT DNA; RECOMBINANT-DNA; FRAGMENTS; RAPESEED; PROTEIN; INGESTION; NUTRITION; TISSUES; SHEEP	Background: The objective of this study was to evaluate potential long-term (110 days) and age-specific effects of feeding genetically modified Bt maize on peripheral immune response in pigs and to determine the digestive fate of the cry1Ab gene and truncated Bt toxin. Methodology/Principal Findings: Forty day old pigs (n = 40) were fed one of the following treatments: 1) isogenic maize-based diet for 110 days (isogenic); 2) Bt maize-based diet (MON810) for 110 days (Bt); 3) Isogenic maize-based diet for 30 days followed by Bt maize-based diet for 80 days (isogenic/Bt); and 4) Bt maize-based diet (MON810) for 30 days followed by isogenic maize-based diet for 80 days (Bt/isogenic). Blood samples were collected during the study for haematological analysis, measurement of cytokine and Cry1Ab-specific antibody production, immune cell phenotyping and cry1Ab gene and truncated Bt toxin detection. Pigs were sacrificed on day 110 and digesta and organ samples were taken for detection of the cry1Ab gene and the truncated Bt toxin. On day 100, lymphocyte counts were higher (P<0.05) in pigs fed Bt/isogenic than pigs fed Bt or isogenic. Erythrocyte counts on day 100 were lower in pigs fed Bt or isogenic/Bt than pigs fed Bt/isogenic (P<0.05). Neither the truncated Bt toxin nor the cry1Ab gene were detected in the organs or blood of pigs fed Bt maize. The cry1Ab gene was detected in stomach digesta and at low frequency in the ileum but not in the distal gastrointestinal tract (GIT), while the Bt toxin fragments were detected at all sites in the GIT. Conclusions/Significance: Perturbations in peripheral immune response were thought not to be age-specific and were not indicative of Th 2 type allergenic or Th 1 type inflammatory responses. There was no evidence of cry1Ab gene or Bt toxin translocation to organs or blood following long-term feeding.	[Walsh, Maria C.; Buzoianu, Stefan G.; Lawlor, Peadar G.] Anim & Grassland Res & Innovat Ctr, Teagasc Pig Dev Dept, Fermoy, Cork, Ireland; [Buzoianu, Stefan G.; O'Donovan, Orla; Gardiner, Gillian E.] Waterford Inst Technol, Dept Chem & Life Sci, Waterford, Ireland; [Rea, Mary C.; Ross, R. Paul] Teagasc Moorepk Food Res, Fermoy, Cork, Ireland; [Rea, Mary C.; Ross, R. Paul] Univ Coll, Alimentary Pharmabiot Ctr, Cork, Ireland; [Gelencser, Eva; Ujhelyi, Gabriella] Cent Food Res Inst, Budapest, Hungary	Teagasc; South East Technological University (SETU); Teagasc; University College Cork	Walsh, MC (corresponding author), Anim & Grassland Res & Innovat Ctr, Teagasc Pig Dev Dept, Fermoy, Cork, Ireland.	peadar.lawlor@teagasc.ie	Ross, Paul/A-7584-2015; Stefan, Buzoianu/F-3030-2010; walsh, maria/H-3662-2013; Gelencser, Eva/A-2842-2013	Ross, Paul/0000-0003-4876-8839; Rea, Mary/0000-0003-3782-0232; O' Donovan, Orla/0000-0003-3980-8835	European Union's Seventh Framework Programme [211820]; Teagasc Walsh Fellowship programme	European Union's Seventh Framework Programme; Teagasc Walsh Fellowship programme	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211820 and the Teagasc Walsh Fellowship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016346; Alexander TW, 2006, BRIT J NUTR, V96, P997, DOI 10.1017/BJN20061935; Buzoianu SG, 2012, ANIMAL 1 VIEW, P1; Buzoianu SG, 2012, PLOS ONE IN PRESS; Chowdhury EH, 2004, J FOOD PROTECT, V67, P365, DOI 10.4315/0362-028X-67.2.365; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; Deaville ER, 2005, J AGR FOOD CHEM, V53, P10268, DOI 10.1021/jf051652f; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; Feldman B. F., 2000, SCHALMS VET HEMATOLO; Festi D, 2011, DIGEST DIS, V29, P518, DOI 10.1159/000332975; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Flachowsky G, 2005, ARCH ANIM NUTR, V59, P1, DOI 10.1080/17450390512331342368; Guertler P, 2008, EUR J WILDLIFE RES, V54, P36, DOI 10.1007/s10344-007-0104-4; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; Krzyzowska M, 2010, POL J VET SCI, V13, P423; Lawlor PG, 2003, ANIM SCI, V76, P401, DOI 10.1017/S1357729800058628; Mazza R, 2005, TRANSGENIC RES, V14, P775, DOI 10.1007/s11248-005-0009-5; Nemeth A, 2004, J AGR FOOD CHEM, V52, P6129, DOI 10.1021/jf049567f; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Phipps RH, 2000, J ANIM FEED SCI, V9, P543; Prescott VE, 2005, J AGR FOOD CHEM, V53, P9023, DOI 10.1021/jf050594v; Reuter T, 2003, EUR FOOD RES TECHNOL, V216, P185, DOI 10.1007/s00217-002-0642-7; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Sharma R, 2006, J AGR FOOD CHEM, V54, P1699, DOI 10.1021/jf052459o; Snell C, 2012, FOOD CHEM TOXICOL, V50, P1134, DOI 10.1016/j.fct.2011.11.048; THORN CE, 2000, SCHALMS VET HEMATOLO, P1089; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Walsh MC, 2008, FEMS MICROBIOL ECOL, V64, P317, DOI 10.1111/j.1574-6941.2008.00454.x; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177; Wiedemann S, 2009, MAMM BIOL, V74, P193, DOI 10.1016/j.mambio.2008.07.002; Yonemochi C, 2010, ANIM SCI J, V81, P94, DOI 10.1111/j.1740-0929.2009.00718.x	32	26	30	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36141	10.1371/journal.pone.0036141	http://dx.doi.org/10.1371/journal.pone.0036141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574138	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800034
J	Zhang, T; Du, J; Liu, LG; Chen, XL; Yang, F; Jin, Q				Zhang, Ting; Du, Jiang; Liu, Liguo; Chen, Xiaolan; Yang, Fang; Jin, Qi			Inhibitory Effects and Underlying Mechanism of 7-Hydroxyflavone Phosphate Ester in HeLa Cells	PLOS ONE			English	Article							IN-VITRO; CYCLE ARREST; CANCER; APOPTOSIS; PROLIFERATION; EXPRESSION; FLAVONOIDS; PROTEIN; P21(WAF1/CIP1); CHRYSIN	Chrysin and its phosphate ester have previously been shown to inhibit cell proliferation and induce apoptosis in Hela cells; however, the underlying mechanism remains to be characterized. In the present study, we therefore synthesized diethyl flavon-7-yl phosphate (FP, C19H19O6P) by a simplified Atheron-Todd reaction, and explored its anti-tumor characteristics and mechanisms. Cell proliferation, cell cycle progression and apoptosis were measured by MTS, flow cytometry and terminal deoxynucleotidyl transferase dUTP nick end labeling techniques, respectively in human cervical cancer HeLa cells treated with 7-hydroxyflavone (HF) and FP. p21, proliferating cell nuclear antigen (PCNA) and cAMP levels in Hela cells were analyzed by western blot and radioimmunoassay. Both HF and FP inhibited proliferation and induced apoptosis in HeLa cells via induction of PCNA/p21 expression, cleaved caspase-3/poly (ADP-ribose) polymerase (PARP)-1, elevation of cAMP levels, and cell cycle arrest with accumulation of cells in the G0/G1 fraction. The effects of FP were more potent than those of HF. The interactions of FP with Ca2+-calmodulin (CaM) and Ca2+-CaM-phosphodiesterase (PDE)1 were explored by electrospray ionization-mass spectrometry and fluorescence spectra. FP, but not HF, formed non-covalent complexes with Ca2+-CaM-PDE1, indicating that FP is an inhibitor of PDE1, and resulting in elevated cellular cAMP levels. It is possible that the elevated cAMP levels inhibit growth and induce apoptosis in Hela cells through induction of p21 and cleaved caspase-3/PARP-1 expression, and causing down-regulation of PCNA and cell cycle arrest with accumulation of cells in the G0/G1 and G2/M fractions. In conclusion, FP was shown to be a Ca2+-CaM-PDE inhibitor, which might account for its underlying anti-cancer mechanism in HeLa cells. These observations clearly demonstrate the special roles of phosphorylated flavonoids in biological processes, and suggest that FP might represent a potential new drug for the therapy of human cervical carcinoma.	[Zhang, Ting; Du, Jiang; Liu, Liguo; Yang, Fang; Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Zhang, Ting; Du, Jiang; Liu, Liguo; Yang, Fang; Jin, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Xiaolan] Zhengzhou Univ, Dept Chem, Key Lab Chem Biol, Zhengzhou 450052, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhengzhou University	Zhang, T (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	chenxl@zzu.edu.cn; ymf129@163.com; jinqi36@yahoo.com.cn	Zhang, Ting/S-8215-2019		National Basic Research Program from the Ministry of Science and Technology of China [2011CB504902]; National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment'' [2009ZX10004-102]; Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2009IPB112]	National Basic Research Program from the Ministry of Science and Technology of China; National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment''; Institute of Pathogen Biology, Chinese Academy of Medical Sciences	The work was supported by the National Basic Research Program (Grant No. 2011CB504902) from the Ministry of Science and Technology of China, National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment'' (2009ZX10004-102), and an intramural grant from the Institute of Pathogen Biology, Chinese Academy of Medical Sciences (2009IPB112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin A, 2007, RECENT PAT ANTI-CANC, V2, P109, DOI 10.2174/157489207780832414; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chen Xiao-lan, 2007, Yaoxue Xuebao, V42, P396; Chen XL, 2004, ANAL CHEM, V76, P211, DOI 10.1021/ac035027q; Chinery R, 1997, NAT MED, V3, P1233, DOI 10.1038/nm1197-1233; Cohausz O, 2009, CELL BIOL TOXICOL, V25, P379, DOI 10.1007/s10565-008-9092-8; Cooke BA, 1999, MOL CELL ENDOCRINOL, V151, P25, DOI 10.1016/S0303-7207(98)00255-X; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Ferreira CG, 2002, CLIN CANCER RES, V8, P2024; Fotsis T, 1997, CANCER RES, V57, P2916; Goyeneche AA, 2007, CLIN CANCER RES, V13, P3370, DOI 10.1158/1078-0432.CCR-07-0164; GUTHRIE JP, 1977, J AM CHEM SOC, V99, P3991, DOI 10.1021/ja00454a018; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; KANDASWAMI C, 1991, CANCER LETT, V56, P147, DOI 10.1016/0304-3835(91)90089-Z; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Lee YK, 2009, EXP MOL MED, V41, P201, DOI 10.3858/emm.2009.41.3.023; Lepley DM, 1997, MOL CARCINOGEN, V19, P74, DOI 10.1002/(SICI)1098-2744(199707)19:2<74::AID-MC2>3.0.CO;2-L; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Ma G, 2007, CHEM-BIOL INTERACT, V167, P153, DOI 10.1016/j.cbi.2007.02.006; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; MATSUKAWA Y, 1993, CANCER RES, V53, P1328; Middleton E, 2000, PHARMACOL REV, V52, P673; Noguera MA, 2001, N-S ARCH PHARMACOL, V363, P612, DOI 10.1007/s002100100397; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Sa F, 2008, CHEM-BIOL INTERACT, V171, P1, DOI 10.1016/j.cbi.2007.08.012; SATO F, 1994, BIOCHEM BIOPH RES CO, V204, P578, DOI 10.1006/bbrc.1994.2498; Sinicrope FA, 1998, CLIN CANCER RES, V4, P1251; Szaszak M, 2008, CELL SIGNAL, V20, P590, DOI 10.1016/j.cellsig.2007.10.020; Weng MS, 2005, BIOCHEM PHARMACOL, V69, P1815, DOI 10.1016/j.bcp.2005.03.011; WESTHEIMER FH, 1968, ACCOUNTS CHEM RES, V1, P70, DOI 10.1021/ar50003a002; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Xiang ZL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-176; YANG ZY, 1995, NAT MED, V1, P1052, DOI 10.1038/nm1095-1052; Zhang T, 2004, BIOORGAN MED CHEM, V12, P6097, DOI 10.1016/j.bmc.2004.09.013	35	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36652	10.1371/journal.pone.0036652	http://dx.doi.org/10.1371/journal.pone.0036652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574207	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800104
J	Ohrmalm, L; Wong, M; Aust, C; Ljungman, P; Norbeck, O; Broliden, K; Tolfvenstam, T				Ohrmalm, Lars; Wong, Michelle; Aust, Carl; Ljungman, Per; Norbeck, Oscar; Broliden, Kristina; Tolfvenstam, Thomas			Viral Findings in Adult Hematological Patients with Neutropenia	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; RESPIRATORY VIRUS-INFECTIONS; REAL-TIME PCR; CANCER; CYTOMEGALOVIRUS; DIAGNOSIS; CHILDREN; FEBRILE; FEVER; DNA	Background: Until recently, viral infections in patients with hematological malignancies were concerns primarily in allogeneic hematopoietic stem cell transplant (HSCT) recipients. During the last years, changed treatment regimens for non-transplanted patients with hematological malignancies have had potential to increase the incidence of viral infections in this group. In this study, we have prospectively investigated the prevalence of a broad range of respiratory viruses in nasopharyngeal aspirate (NPA) as well as viruses that commonly reactivate after allogeneic HSCT. Methodology/Principal Findings: Patients with hematological malignancies and therapy induced neutropenia (n = 159) were screened regarding a broad range of common respiratory viruses in the nasopharynx and for viruses commonly detected in severely immunosuppressed patients in peripheral blood. Quantitative PCR was used for detection of viruses. A viral pathogen was detected in 35% of the patients. The detection rate was rather similar in blood (22%) and NPA (18%) with polyoma BK virus and rhinovirus as dominating pathogens in blood and NPA, respectively. Patients with chronic lymphocytic leukemia (CLL) (p<0.01) and patients with fever (p<0.001) were overrepresented in the virus-positive group. Furthermore, viral findings in NPA were associated with upper respiratory symptoms (URTS) (p<0.0001). Conclusions/Significance: Both respiratory viral infections and low titers of viruses in blood from patients with neutropenia were common. Patients with CLL and patients with fever were independently associated to these infections, and viral findings in NPA were associated to URTS indicating active infection. These findings motivate further studies on viruses' impact on this patient category and their potential role as causative agents of fever during neutropenia.	[Ohrmalm, Lars; Wong, Michelle; Aust, Carl; Norbeck, Oscar; Broliden, Kristina; Tolfvenstam, Thomas] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Infect Dis Unit,Ctr Mol Med, Stockholm, Sweden; [Ljungman, Per] Karolinska Inst, Div Hematol, Dept Med, Stockholm, Sweden; [Ljungman, Per] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Ohrmalm, L (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med, Infect Dis Unit,Ctr Mol Med, Stockholm, Sweden.	lars.ohrmalm@ki.se	Ljungman, Per/M-4946-2019	Tolfvenstam, Thomas/0000-0003-3549-8083	Stockholm County Council/Karolinska Institutet; Swedish Society of Medicine; Clas Groschinsky foundation; Karolinska Institutet Infection Network; Swedish Childhood Cancer Foundation	Stockholm County Council/Karolinska Institutet(Stockholm County Council); Swedish Society of Medicine; Clas Groschinsky foundation; Karolinska Institutet Infection Network; Swedish Childhood Cancer Foundation(European Commission)	Grants were received from the Stockholm County Council (www.sll.se)/Karolinska Institutet (www.ki.se), the Swedish Society of Medicine (www.sls.se), the Clas Groschinsky foundation (www.groschinsky.org), Karolinska Institutet Infection Network (www.ki.se) and from The Swedish Childhood Cancer Foundation (www.barncancerfonden.se) for method development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AROLA M, 1995, PEDIATR INFECT DIS J, V14, P690, DOI 10.1097/00006454-199508000-00008; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Chakrabarti S, 2002, BLOOD, V100, P1619, DOI 10.1182/blood-2002-02-0377; Chemaly RF, 2006, MEDICINE, V85, P278, DOI 10.1097/01.md.0000232560.22098.4e; Englund JA, 1999, CURR CLIN TOPICS INF, V19, P30; Englund J, 2011, BIOL BLOOD MARROW TR, V17, pS2, DOI 10.1016/j.bbmt.2010.11.008; Engstrand M, 2003, CLIN EXP IMMUNOL, V132, P96, DOI 10.1046/j.1365-2249.2003.02098.x; Erard V, 2005, BLOOD, V106, P1130, DOI 10.1182/blood-2004-12-4988; Fairchok MP, 2010, J CLIN VIROL, V49, P16, DOI 10.1016/j.jcv.2010.06.013; Gustafson I, 2008, J CLIN VIROL, V43, P79, DOI 10.1016/j.jcv.2008.04.014; Haines HL, 2011, BIOL BLOOD MARROW TR, V17, P1512, DOI 10.1016/j.bbmt.2011.02.012; Hakim H, 2009, J PEDIAT HEMATOL ONC, V31, P623, DOI 10.1097/MPH.0b013e3181b1edc6; Hakki M, 2003, BLOOD, V102, P3060, DOI 10.1182/blood-2002-11-3472; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Koskenvuo M, 2008, PEDIATR INFECT DIS J, V27, P974, DOI 10.1097/INF.0b013e31817b0799; LAWSON RD, 1984, AM J MED SCI, V287, P16, DOI 10.1097/00000441-198401000-00004; Lindblom A, 2010, J CLIN VIROL, V47, P234, DOI 10.1016/j.jcv.2009.11.026; Ljungman P, 2005, SCAND J INFECT DIS, V37, P121, DOI 10.1080/00365540410020794; Ljungman P, 2001, BONE MARROW TRANSPL, V28, P479, DOI 10.1038/sj.bmt.1703139; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Martin ET, 2011, INFLUENZA OTHER RESP; Ng AP, 2005, HAEMATOLOGICA, V90, P1672; Nijhuis M, 2002, J CLIN MICROBIOL, V40, P3666, DOI 10.1128/JCM.40.10.3666-3670.2002; Persson L, 2003, CLIN MICROBIOL INFEC, V9, P640, DOI 10.1046/j.1469-0691.2003.00578.x; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; Terlizzi ME, 2009, J VIROL METHODS, V160, P172, DOI 10.1016/j.jviromet.2009.04.039; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Viscoli C, 2006, CLIN MICROBIOL INFEC, V12, P212, DOI 10.1111/j.1469-0691.2005.01297.x; WHIMBEY E, 1987, AM J MED, V82, P723, DOI 10.1016/0002-9343(87)90007-6	31	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36543	10.1371/journal.pone.0036543	http://dx.doi.org/10.1371/journal.pone.0036543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570724	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400040
J	Platt, NJ; Gispert, S; Auburger, G; Cragg, SJ				Platt, Nicola J.; Gispert, Suzana; Auburger, Georg; Cragg, Stephanie J.			Striatal Dopamine Transmission Is Subtly Modified in Human A53T alpha-Synuclein Overexpressing Mice	PLOS ONE			English	Article							TONICALLY ACTIVE NEURONS; ALPHA-SYNUCLEIN; MIDBRAIN DOPAMINE; RELEASE; LACKING; RECEPTORS; REWARD; INHIBITION; MUTATION; CELLS	Mutations in, or elevated dosage of, SNCA, the gene for alpha-synuclein (alpha-syn), cause familial Parkinson's disease (PD). Mouse lines overexpressing the mutant human A53T alpha-syn may represent a model of early PD. They display progressive motor deficits, abnormal cellular accumulation of alpha-syn, and deficits in dopamine-dependent corticostriatal plasticity, which, in the absence of overt nigrostriatal degeneration, suggest there are age-related deficits in striatal dopamine (DA) signalling. In addition A53T alpha-syn overexpression in cultured rodent neurons has been reported to inhibit transmitter release. Therefore here we have characterized for the first time DA release in the striatum of mice overexpressing human A53T alpha-syn, and explored whether A53T alpha-syn overexpression causes deficits in the release of DA. We used fast-scan cyclic voltammetry to detect DA release at carbon-fibre microelectrodes in acute striatal slices from two different lines of A53T alpha-syn-overexpressing mice, at up to 24 months. In A53T alpha-syn overexpressors, mean DA release evoked by a single stimulus pulse was not different from wild-types, in either dorsal striatum or nucleus accumbens. However the frequency responsiveness of DA release was slightly modified in A53T alpha-syn overexpressors, and in particular showed slight deficiency when the confounding effects of striatal ACh acting at presynaptic nicotinic receptors (nAChRs) were antagonized. The re-release of DA was unmodified after single-pulse stimuli, but after prolonged stimulation trains, A53T alpha-syn overexpressors showed enhanced recovery of DA release at old age, in keeping with elevated striatal DA content. In summary, A53T alpha-syn overexpression in mice causes subtle changes in the regulation of DA release in the striatum. While modest, these modifications may indicate or contribute to striatal dysfunction.	[Platt, Nicola J.; Cragg, Stephanie J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Gispert, Suzana; Auburger, Georg] Goethe Univ Frankfurt, Dept Neurol, Sch Med, Frankfurt, Germany	University of Oxford; Goethe University Frankfurt	Platt, NJ (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	Nicola.platt@dpag.ox.ac.uk		Cragg, Stephanie/0000-0001-9677-2256	MRC (Medical Research Council) doctoral training grant; BMBF (Bundesministerium fur Bildung und Forschung) in the NGFN2 (Das Nationale Genomforschungsnetz); NGFNplus Parkinson programs; MRC [MR/J004324/1, G0700932] Funding Source: UKRI; Medical Research Council [MR/J004324/1, G0700932] Funding Source: researchfish; Parkinson&quot;s UK [G-1103, G-0803, H-1003, G-0808] Funding Source: researchfish	MRC (Medical Research Council) doctoral training grant; BMBF (Bundesministerium fur Bildung und Forschung) in the NGFN2 (Das Nationale Genomforschungsnetz); NGFNplus Parkinson programs; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	The authors are grateful for financial support from an MRC (Medical Research Council) doctoral training grant, and from the BMBF (Bundesministerium fur Bildung und Forschung) in the NGFN2 (Das Nationale Genomforschungsnetz) and NGFNplus Parkinson programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Apicella P, 2011, J NEUROSCI, V31, P1507, DOI 10.1523/JNEUROSCI.4880-10.2011; Apicella P, 2009, EUR J NEUROSCI, V30, P515, DOI 10.1111/j.1460-9568.2009.06872.x; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; Cragg SJ, 2003, J NEUROSCI, V23, P4378; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Exley R, 2008, BRIT J PHARMACOL, V153, pS283, DOI 10.1038/sj.bjp.0707510; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; GRACE AA, 1984, J NEUROSCI, V4, P2877; Gubernator NG, 2009, SCIENCE, V324, P1441, DOI 10.1126/science.1172278; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kurz A, 2011, J NEURAL TRANSM, P1; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Threlfell S, 2010, J NEUROSCI, V30, P3398, DOI 10.1523/JNEUROSCI.5620-09.2010; Tozzi A, 2011, NEUROBIOLOGY AGING; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243; Zhang H, 2003, J NEUROSCI, V23, P10585; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	47	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36397	10.1371/journal.pone.0036397	http://dx.doi.org/10.1371/journal.pone.0036397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570709	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343400025
J	Berghard, A; Hagglund, AC; Bohm, S; Carlsson, L				Berghard, Anna; Hagglund, Anna-Carin; Bohm, Staffan; Carlsson, Leif			Lhx2-dependent specification of olfactory sensory neurons is required for successful integration of olfactory, vomeronasal, and GnRH neurons	FASEB JOURNAL			English	Article						mouse embryo development; gonadotropin-releasing hormone neurons; puberty phenotype	LIM HOMEOBOX GENE; MOLECULAR-BASIS; MOUSE; LHX2; EXPRESSION; CELLS; AXONS; IDENTITY; ORIGIN; BULB	Inactivation of the LIM-homeodomain 2 gene (Lhx2) results in a severe defect in specification of olfactory sensory neurons (OSNs). However, the ramifications of lack of Lhx2-dependent OSN specification for formation of the primary olfactory pathway have not been addressed, since mutant mice die in utero. We have analyzed prenatal and postnatal consequences of conditionally inactivating Lhx2 selectively in OSNs. A cell-autonomous effect is that OSN axons cannot innervate their target, the olfactory bulb. Moreover, the lack of Lhx2 in OSNs causes unpredicted, non-cell-autonomous phenotypes. First, the olfactory bulb shows pronounced hypoplasia in adults, and the data suggest that innervation by correctly specified OSNs is necessary for adult bulb size and organization. Second, absence of an olfactory nerve in the conditional mutant reveals that the vomeronasal nerve is dependent on olfactory nerve formation. Third, the lack of a proper vomeronasal nerve prevents migration of gonadotropin-releasing hormone (GnRH) cells the whole distance to their final positions in the hypothalamus during embryo development. As adults, the conditional mutants do not pass puberty, and these findings support the view of an exclusive nasal origin of GnRH neurons in the mouse. Thus, Lhx2 in OSNs is required for functional development of three separate systems.-Berghard, A., Hagglund, A.-C., Bohm, S., and Carlsson, L. Lhx2-dependent specification of olfactory sensory neurons is required for successful integration of olfactory, vomeronasal, and GnRH neurons. FASEB J. 26, 3464-3472 (2012). www.fasebj.org	[Berghard, Anna; Bohm, Staffan] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Hagglund, Anna-Carin; Carlsson, Leif] Umea Univ, Umea Ctr Mol Med, SE-90187 Umea, Sweden	Umea University; Umea University	Berghard, A (corresponding author), Umea Univ, Dept Mol Biol, Byggn 6L, SE-90187 Umea, Sweden.	anna.berghard@molbiol.umu.se			Swedish Research Council FORMAS [221-2006-419]; Swedish Research Council [521-2011-3130]; Swedish Cancer Society; technical-natural science and medical faculties at Umea University	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); technical-natural science and medical faculties at Umea University	The authors thank Dr. V. Vedin for input on experimental procedures, G. Tornqvist (Umea University) for the reelin probe, and the Umea Transgenic Core Facility for animal genotyping service. This study was in part supported by the Swedish Research Council FORMAS (to A.B.; no. 221-2006-419), the Swedish Research Council, (to L.C.; no. 521-2011-3130), the Swedish Cancer Society (to L.C.), and the technical-natural science and medical faculties at Umea University.	Allen Institute for Brain Science, 2009, DEV MOUS BRAIN ATL; BENTLEY D, 1983, NATURE, V304, P62, DOI 10.1038/304062a0; Berghard A, 1996, J NEUROSCI, V16, P909; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chou SJ, 2009, NAT NEUROSCI, V12, P1381, DOI 10.1038/nn.2427; CUSCHIERI A, 1975, J ANAT, V119, P277; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Forni PE, 2011, J NEUROSCI, V31, P6915, DOI 10.1523/JNEUROSCI.6087-10.2011; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; Hagglund AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023387; HINDS JW, 1976, J COMP NEUROL, V169, P15, DOI 10.1002/cne.901690103; Hirata T, 2006, DEVELOPMENT, V133, P1433, DOI 10.1242/dev.02329; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Hirota J, 2007, MOL CELL NEUROSCI, V34, P679, DOI 10.1016/j.mcn.2007.01.014; Kolterud A, 2004, DEVELOPMENT, V131, P5319, DOI 10.1242/dev.01416; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Metz H, 2010, ENDOCRINOLOGY, V151, P766, DOI 10.1210/en.2009-0875; Miller AM, 2010, J COMP NEUROL, V518, P4825, DOI 10.1002/cne.22497; Norlin EM, 2005, J NEUROCHEM, V93, P1594, DOI 10.1111/j.1471-4159.2005.03159.x; Packard A, 2011, J COMP NEUROL, V519, P3580, DOI 10.1002/cne.22726; Porter FD, 1997, DEVELOPMENT, V124, P2935; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Saha B, 2007, J NEUROSCI, V27, P2290, DOI 10.1523/JNEUROSCI.5571-06.2007; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Schwarting GA, 2004, EUR J NEUROSCI, V19, P11, DOI 10.1111/j.1460-9568.2004.03094.x; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takano-Maruyama M, 2010, DEV DYNAM, V239, P1155, DOI 10.1002/dvdy.22273; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Topaloglu AK, 2010, CURR OPIN OBSTET GYN, V22, P264, DOI 10.1097/GCO.0b013e32833bb425; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; Tucker ES, 2010, DEVELOPMENT, V137, P2471, DOI 10.1242/dev.049718; Watanabe Y, 2009, J COMP NEUROL, V515, P565, DOI 10.1002/cne.22074; Wierman ME, 2011, FRONT NEUROENDOCRIN, V32, P43, DOI 10.1016/j.yfrne.2010.07.005; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Yoshida K, 1995, J NEUROSCI, V15, P7769	36	22	22	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3464	3472		10.1096/fj.12-206193	http://dx.doi.org/10.1096/fj.12-206193			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22581782				2022-12-25	WOS:000307162800033
J	Asanuma-Date, K; Hirano, Y; Le, N; Sano, K; Kawasaki, N; Hashii, N; Hiruta, Y; Nakayama, K; Umemura, M; Ishikawa, K; Sakagami, H; Ogawa, H				Asanuma-Date, Kimie; Hirano, Yuki; Le, Na; Sano, Kotone; Kawasaki, Nana; Hashii, Noritaka; Hiruta, Yoko; Nakayama, Ken-ichi; Umemura, Mariko; Ishikawa, Kazuhiko; Sakagami, Hiromi; Ogawa, Haruko			Functional Regulation of Sugar Assimilation by N-Glycan-specific Interaction of Pancreatic alpha-Amylase with Glycoproteins of Duodenal Brush Border Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-IV; SUCRASE-ISOMALTASE; ENZYME-ACTIVITY; AMINOPEPTIDASE-N; BINDING-ACTIVITY; GLYCOSYLATION; GLUCOSE; PROTEIN; RAT; NA+	Porcine pancreatic alpha-amylase (PPA) binds to N-linked glycans of glycoproteins (Matsushita, H., Takenaka, M., and Ogawa, H. (2002) J. Biol Chem., 277, 4680-4686). Immunostaining revealed that PPA is located at the brush-border membrane (BBM) of enterocytes in the duodenum and that the binding is inhibited by mannan but not galactan, indicating that PPA binds carbohydrate-specifically to BBM. The ligands for PPA in BBM were identified as glycoprotein N-glycans that are significantly involved in the assimilation of glucose, including sucrase-isomaltase (SI) and Na+/Glc cotransporter 1 (SGLT1). Binding of SI and SGLT1 in BBM to PPA was dose-dependent and inhibited by mannan. Using BBM vesicles, we found functional changes in PPA and its ligands in BBM due to the N-glycanspecific interaction. The starch-degrading activity of PPA and maltose-degrading activity of SI were enhanced to 240 and 175%, respectively, while Glc uptake by SGLT1 was markedly inhibited by PPA at high but physiologically possible concentrations, and the binding was attenuated by the addition of mannose-specific lectins, especially from Galanthus nivalis. Additionally, recombinant human pancreatic alpha-amylases expressed in yeast and purified by single-step affinity chromatography exhibited the same carbohydrate binding specificity as PPA in binding assays with sugar-biotinyl polymer probes. The results indicate that mammalian pancreatic alpha-amylases share a common carbohydrate binding activity and specifically bind to the intestinal BBM. Interaction with N-glycans in the BBM activated PPA and SI to produce much Glc on the one hand and to inhibit Glc absorption by enterocytes via SGLT1 in order to prevent a rapid increase in blood sugar on the other.	[Asanuma-Date, Kimie; Hirano, Yuki; Le, Na; Sano, Kotone; Sakagami, Hiromi; Ogawa, Haruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Asanuma-Date, Kimie; Hirano, Yuki; Le, Na; Sano, Kotone; Sakagami, Hiromi; Ogawa, Haruko] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan; [Kawasaki, Nana; Hashii, Noritaka; Hiruta, Yoko] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan; [Nakayama, Ken-ichi; Umemura, Mariko; Ishikawa, Kazuhiko] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan	Ochanomizu University; Ochanomizu University; National Institute of Health Sciences - Japan; National Institute of Advanced Industrial Science & Technology (AIST)	Ogawa, H (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	ogawa.haruko@ocha.ac.jp	Asanuma, Kimie/AAW-2543-2020	Asanuma, Kimie/0000-0003-4311-0544	Japan Society for the Promotion of Science [22.10385]; Hayashi Memorial Foundation for Female Natural Scientists; Daiwa Health Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology [17570109, 22570111]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Daiwa Health Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science Grant 22.10385 (to K. D.) and in part by research grants of the Hayashi Memorial Foundation for Female Natural Scientists (to H. O.) and the Daiwa Health Science Foundation (to H. O.) and Grants-in-aid for Scientific Research (C) 17570109 (to H. O.) and 22570111 (to H. O.) from the Ministry of Education, Culture, Sports, Science, and Technology.	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Ait-Slimane T, 2009, MOL BIOL CELL, V20, P3792, DOI 10.1091/mbc.E09-04-0275; Brayer GD, 2000, BIOCHEMISTRY-US, V39, P4778, DOI 10.1021/bi9921182; BRUNNER J, 1979, J BIOL CHEM, V254, P1821; Cloutier M, 2006, J HISTOCHEM CYTOCHEM, V54, P781, DOI 10.1369/jhc.5A6877.2006; DAHLQVIST A, 1968, ANAL BIOCHEM, V22, P99, DOI 10.1016/0003-2697(68)90263-7; DANIELSEN EM, 1995, GASTROENTEROLOGY, V109, P1039, DOI 10.1016/0016-5085(95)90561-8; Detel D, 2008, EXP AGING RES, V34, P49, DOI 10.1080/03610730701761957; Fan H, 1997, EUR J BIOCHEM, V246, P243, DOI 10.1111/j.1432-1033.1997.00243.x; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Fukuoka S, 1992, Tanpakushitsu Kakusan Koso, V37, P795; Gallicchio MA, 2010, BBA-MOL CELL RES, V1803, P919, DOI 10.1016/j.bbamcr.2010.04.009; Georgieff MK, 1997, PLACENTA, V18, P563, DOI 10.1016/0143-4004(77)90011-X; Gordon K, 2003, BIOCHEM J, V371, P437, DOI 10.1042/BJ20021842; GORRILL ADL, 1967, J NUTR, V92, P86, DOI 10.1093/jn/92.1.86; GUPTA R, 1992, ANN NUTR METAB, V36, P288, DOI 10.1159/000177732; Harlow E., 1988, ANTIBODIES LAB MANUA; HAYES GR, 1995, GLYCOBIOLOGY, V5, P227, DOI 10.1093/glycob/5.2.227; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HEDIGER MA, 1991, BIOCHIM BIOPHYS ACTA, V1064, P360, DOI 10.1016/0005-2736(91)90323-Z; HIRAYAMA BA, 1992, BIOCHIM BIOPHYS ACTA, V1103, P37, DOI 10.1016/0005-2736(92)90054-P; HUGON J, 1966, J HISTOCHEM CYTOCHEM, V14, P629, DOI 10.1177/14.9.629; HUNZIKER W, 1986, CELL, V46, P227, DOI 10.1016/0092-8674(86)90739-7; ISHIKAWA K, 1993, BIOCHEMISTRY-US, V32, P6259, DOI 10.1021/bi00075a020; Kenan N, 2011, CLIN CHIM ACTA, V412, P129, DOI 10.1016/j.cca.2010.09.022; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Khatri IA, 2003, BIOCHEM J, V372, P263, DOI 10.1042/BJ20021333; Le Varlet B, 1991, J Dermatol Sci, V2, P287, DOI 10.1016/0923-1811(91)90053-Z; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; Matsushita H, 2002, J BIOL CHEM, V277, P4680, DOI 10.1074/jbc.M105877200; Mellitzer G, 2010, J CLIN INVEST, V120, P1708, DOI 10.1172/JCI40794; Naim HY, 1999, J BIOL CHEM, V274, P17961, DOI 10.1074/jbc.274.25.17961; Nakagawa K, 2009, GLYCOCONJUGATE J, V26, P1007, DOI 10.1007/s10719-008-9220-y; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; PUSZTAI A, 1995, GLYCOCONJUGATE J, V12, P22, DOI 10.1007/BF00731865; Radoshitzky SR, 2008, P NATL ACAD SCI USA, V105, P2664, DOI 10.1073/pnas.0709254105; ROTH J, 1993, HISTOCHEM J, V25, P687; Rueda E, 2007, BRIT POULTRY SCI, V48, P696, DOI 10.1080/00071660701713526; RUSSELL JR, 1981, J ANIM SCI, V52, P1177, DOI 10.2527/jas1981.5251177x; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; SHIOSAKI K, 1990, GENE, V89, P253, DOI 10.1016/0378-1119(90)90013-H; SJOSTROM H, 1980, J BIOL CHEM, V255, P1332; SMITS HL, 1984, ARCH BIOCHEM BIOPHYS, V228, P64, DOI 10.1016/0003-9861(84)90047-X; STEVENS BR, 1990, P NATL ACAD SCI USA, V87, P1456, DOI 10.1073/pnas.87.4.1456; Takahashi K, 2001, AM J PHYSIOL-RENAL, V281, pF1109, DOI 10.1152/ajprenal.0346.2000; Takekawa H, 2006, J BIOL CHEM, V281, P8528, DOI 10.1074/jbc.M513773200; Tokbtaeva E, 2010, BIOCHEMISTRY-US, V49, P3116, DOI 10.1021/bi100115a; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Ueda H, 2004, BIOCHEM J, V382, P821, DOI 10.1042/BJ20040584; UENO M, 1991, J BIOL CHEM, V266, P3146; VANHALBEEK H, 1983, BIOCHIM BIOPHYS ACTA, V747, P107, DOI 10.1016/0167-4838(83)90128-0; Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z; Wong TP, 2007, J PHYSIOL-LONDON, V584, P613, DOI 10.1113/jphysiol.2007.138578; WRIGHT EM, 1992, ACTA PHYSIOL SCAND, V146, P201	54	15	16	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23104	23118		10.1074/jbc.M111.314658	http://dx.doi.org/10.1074/jbc.M111.314658			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584580	hybrid, Green Published			2022-12-25	WOS:000306495000066
J	Ming, M; Wang, S; Wu, WS; Senyuk, V; Le Beau, MM; Nucifora, G; Qian, ZJ				Ming, Ming; Wang, Sheng; Wu, Wenshu; Senyuk, Vitalyi; Le Beau, Michelle M.; Nucifora, Giuseppina; Qian, Zhijian			Activation of Wnt/beta-Catenin Protein Signaling Induces Mitochondria-mediated Apoptosis in Hematopoietic Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; BETA-CATENIN; STEM-CELLS; IN-VIVO; SELF-RENEWAL; EXPRESSION; SURVIVAL; PATHWAY; APC; TRANSDUCTION	The canonical Wnt/beta-catenin signaling is activated during development, tumorigenesis, and in adult homeostasis, yet its role in maintenance of hematopoietic stem/progenitor cells is not firmly established. Here, we demonstrate that conditional expression of an active form of beta-catenin in vivo induces a marked increase in the frequency of apoptosis in hematopoietic stem/progenitor cells (HSCs/HPCs). Activation of Wnt/beta catenin signaling in HPCs in vitro elevates the activity of caspases 3 and 9 and leads to a loss of mitochondrial membrane potential (Delta Psi(m)), indicating that it induces the intrinsic mitochondrial apoptotic pathway. In vivo, expression of activated beta-catenin in HPCs is associated with down-regulation of Bcl2 and expression of Casp3. Bone marrow transplantation assays reveal that enhanced cell survival by a Bcl2 transgene re-establishes the reconstitution capacity of HSCs/HPCs that express activated beta-catenin. In addition, a Bcl2 transgene prevents exhaustion of these HSCs/HPCs in vivo. Our data suggest that activation of the Wnt/beta-catenin pathway contributes to the defective function of HPCs in part by deregulating their survival.	[Ming, Ming; Wang, Sheng; Senyuk, Vitalyi; Nucifora, Giuseppina; Qian, Zhijian] Univ Illinois, Dept Med, Chicago, IL 60621 USA; [Nucifora, Giuseppina; Qian, Zhijian] Univ Illinois, Canc Res Ctr, Chicago, IL 60621 USA; [Le Beau, Michelle M.] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; [Le Beau, Michelle M.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Wu, Wenshu] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Qian, ZJ (corresponding author), Univ Illinois, Dept Med, 909 S Wolcott Ave,COMRB Rm 5051,M-C704, Chicago, IL 60621 USA.	zjqian@uic.edu	Wu, Wen-Shu/I-1258-2014	Wu, Wen-Shu/0000-0002-0225-2522	National Institutes of Health [CA140979]; American Cancer Society Illinois Division; NATIONAL CANCER INSTITUTE [R01CA140979] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Illinois Division(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA140979 (to Z. Q.). This work was also supported in part by the American Cancer Society Illinois Division (to Z. Q.).	Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; Brault V, 2001, DEVELOPMENT, V128, P1253; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Del Principe MI, 2005, HEMATOLOGY, V10, P25, DOI 10.1080/10245330400020454; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Qian Z, 2009, LEUKEMIA, V23, P1650, DOI 10.1038/leu.2009.78; Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578; Qian ZJ, 1999, J BIOL CHEM, V274, P1621, DOI 10.1074/jbc.274.3.1621; Raab MS, 2009, BLOOD, V113, P1513, DOI 10.1182/blood-2008-05-157040; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tickenbrock L, 2005, BLOOD, V105, P3699, DOI 10.1182/blood-2004-07-2924; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	34	70	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22683	22690		10.1074/jbc.M112.342089	http://dx.doi.org/10.1074/jbc.M112.342089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589536	Green Published, hybrid			2022-12-25	WOS:000306495000025
J	Demmerle, J; Koch, AJ; Holaska, JM				Demmerle, Justin; Koch, Adam J.; Holaska, James M.			The Nuclear Envelope Protein Emerin Binds Directly to Histone Deacetylase 3 (HDAC3) and Activates HDAC3 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; TRANSCRIPTIONAL REPRESSOR; CAENORHABDITIS-ELEGANS; MUSCLE REGENERATION; MYOD PATHWAYS; LAMIN; ORGANIZATION; ARCHITECTURE; COMPLEXES; MEMBRANE	Organization of the genome is critical for maintaining cell-specific gene expression, ensuring proper cell function. It is well established that the nuclear lamina preferentially associates with repressed chromatin. However, the molecular mechanisms underlying repressive chromatin formation and maintenance at the nuclear lamina remain poorly understood. Here we show that emerin binds directly to HDAC3, the catalytic subunit of the nuclear co-repressor (NCoR) complex, and recruits HDAC3 to the nuclear periphery. Emerin binding stimulated the catalytic activity of HDAC3, and emerin-null cells exhibit increased H4K5 acetylation, which is the preferred target of the NCoR complex. Emerin-null cells exhibit an epigenetic signature similar to that seen in HDAC3-null cells. Emerin-null cells also had significantly less HDAC3 at the nuclear lamina. Collectively, these data support a model whereby emerin facilitates repressive chromatin formation at the nuclear periphery by increasing the catalytic activity of HDAC3.	[Demmerle, Justin; Holaska, James M.] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [Koch, Adam J.; Holaska, James M.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Holaska, James M.] Univ Chicago, Comm Dev Regenerat & Stem Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Holaska, JM (corresponding author), Univ Chicago, Dept Med, Cardiol Sect, 5841 S Maryland Ave,MC6088,Rm A607, Chicago, IL 60637 USA.	jholaska@uchicago.edu	Demmerle, Justin/B-1539-2016	Demmerle, Justin/0000-0002-4005-1705; Holaska, James/0000-0003-0273-9995	National Institutes of Health [T32 GM007197, T32 HL007381]; Ellison Medical Foundation; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM007197 and T32 HL007381 (to A. J. K.). This work was also supported by the Ellison Medical Foundation (to J. M. H.) and the American Heart Association (to J. M. H.).	Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Dedeic Z, 2011, J CELL SCI, V124, P1691, DOI 10.1242/jcs.080259; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Galiova G, 2008, EUR J CELL BIOL, V87, P291, DOI 10.1016/j.ejcb.2008.01.013; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Hartman HB, 2005, EMBO REP, V6, P445, DOI 10.1038/sj.embor.7400391; Holaska JM, 2008, CIRC RES, V103, P16, DOI 10.1161/CIRCRESAHA.108.172197; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Holt I, 2001, BIOCHEM BIOPH RES CO, V287, P1129, DOI 10.1006/bbrc.2001.5708; Huber MD, 2009, MOL CELL BIOL, V29, P5718, DOI 10.1128/MCB.00270-09; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Korfali N, 2010, MOL CELL PROTEOMICS, V9, P2571, DOI 10.1074/mcp.M110.002915; Lee KK, 2001, J CELL SCI, V114, P4567; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Meaburn KJ, 2007, AGING CELL, V6, P139, DOI 10.1111/j.1474-9726.2007.00270.x; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Muchir A, 2007, CURR NEUROL NEUROSCI, V7, P78, DOI 10.1007/s11910-007-0025-3; Ognibene A, 1999, MUSCLE NERVE, V22, P864, DOI 10.1002/(SICI)1097-4598(199907)22:7<864::AID-MUS8>3.3.CO;2-7; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Taimen P, 2009, P NATL ACAD SCI USA, V106, P20788, DOI 10.1073/pnas.0911895106; Vaughan OA, 2001, J CELL SCI, V114, P2577; Vlcek S, 2007, BBA-MOL CELL RES, V1773, P661, DOI 10.1016/j.bbamcr.2006.07.002; Vlcek S, 2007, CURR OPIN CELL BIOL, V19, P298, DOI 10.1016/j.ceb.2007.04.001; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Yu JJ, 2003, EMBO J, V22, P3403, DOI 10.1093/emboj/cdg326; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zullo J.M., 2012, CELL IN PRESS	41	110	114	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22080	22088		10.1074/jbc.M111.325308	http://dx.doi.org/10.1074/jbc.M111.325308			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570481	hybrid, Green Published			2022-12-25	WOS:000306418600045
J	George, NP; Ngo, KV; Chitteni-Pattu, S; Norais, CA; Battista, JR; Cox, MM; Keck, JL				George, Nicholas P.; Ngo, Khanh V.; Chitteni-Pattu, Sindhu; Norais, Cedric A.; Battista, John R.; Cox, Michael M.; Keck, James L.			Structure and Cellular Dynamics of Deinococcus radiodurans Single-stranded DNA (ssDNA)-binding Protein (SSB)-DNA Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; ESCHERICHIA-COLI; THERMUS-AQUATICUS; IONIZING-RADIATION; DDRB PROTEIN; SSB-GENE; GENOME; REPAIR; RECOMBINATION; THERMOPHILUS	The single-stranded DNA (ssDNA)-binding protein from the radiation-resistant bacterium Deinococcus radiodurans (DrSSB) functions as a homodimer in which each monomer contains two oligonucleotide-binding (OB) domains. This arrangement is exceedingly rare among bacterial SSBs, which typically form homotetramers of single-OB domain subunits. To better understand how this unusual structure influences the DNA binding and biological functions of DrSSB in D. radiodurans radiation resistance, we have examined the structure of DrSSB in complex with ssDNA and the DNA damage-dependent cellular dynamics of DrSSB. The x-ray crystal structure of the DrSSB-ssDNA complex shows that ssDNA binds to surfaces of DrSSB that are analogous to those mapped in homotetrameric SSBs, although there are distinct contacts in DrSSB that mediate species-specific ssDNA binding. Observations by electron microscopy reveal two salt-dependent ssDNA-binding modes for DrSSB that strongly resemble those of the homotetrameric Escherichia coli SSB, further supporting a shared overall DNA binding mechanism between the two classes of bacterial SSBs. In vivo, DrSSB levels are heavily induced following exposure to ionizing radiation. This accumulation is accompanied by dramatic time-dependent DrSSB cellular dynamics in which a single nucleoid-centric focus of DrSSB is observed within 1 h of irradiation but is dispersed by 3 h after irradiation. These kinetics parallel those of D. radiodurans postirradiation genome reconstitution, suggesting that DrSSB dynamics could play important organizational roles in DNA repair.	[Ngo, Khanh V.; Chitteni-Pattu, Sindhu; Norais, Cedric A.; Cox, Michael M.] Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA; [George, Nicholas P.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Battista, John R.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Norais, Cedric A.] Ecole Polytech, Dept Biol, UMR CNRS 7654, Biochim Lab, F-91128 Palaiseau, France	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Louisiana State University System; Louisiana State University; Institut Polytechnique de Paris	Cox, MM (corresponding author), Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA.	cox@biochem.wisc.edu; jlkeck@wisc.edu		Keck, James/0000-0002-5961-0220	National Institutes of Health [GM068061, GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM032335, R01GM032335, R01GM068061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068061 (to J. L. K.) and GM32335 (to M. M. C.).	Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Bauermeister A, 2011, MICROB ECOL, V61, P715, DOI 10.1007/s00248-010-9785-4; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Chan KW, 2009, J MOL BIOL, V388, P508, DOI 10.1016/j.jmb.2009.03.022; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; CURTH U, 1993, BIOCHEMISTRY-US, V32, P2585, DOI 10.1021/bi00061a016; Dabrowski S, 2002, PROTEIN EXPRES PURIF, V26, P131, DOI 10.1016/S1046-5928(02)00504-1; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorov R, 2006, NUCLEIC ACIDS RES, V34, P6708, DOI 10.1093/nar/gkl1002; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; GRIFFITH JD, 1984, COLD SPRING HARB SYM, V49, P553, DOI 10.1101/SQB.1984.049.01.062; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Jedrzejczak R, 2006, ACTA CRYSTALLOGR D, V62, P1407, DOI 10.1107/S0907444906036031; KITAYAMA S, 1982, BIOCHIM BIOPHYS ACTA, V697, P381, DOI 10.1016/0167-4781(82)90103-8; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P8266, DOI 10.1021/bi100920w; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Matsumoto T, 2000, J BIOCHEM, V127, P329, DOI 10.1093/oxfordjournals.jbchem.a022611; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSELEY BEB, 1971, J BACTERIOL, V105, P976, DOI 10.1128/JB.105.3.976-983.1971; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Nguyen HH, 2009, MOL MICROBIOL, V73, P240, DOI 10.1111/j.1365-2958.2009.06766.x; Norais CA, 2009, J BIOL CHEM, V284, P21402, DOI 10.1074/jbc.M109.010454; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Sugiman-Marangos S, 2010, NUCLEIC ACIDS RES, V38, P3432, DOI 10.1093/nar/gkq036; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Ujaoney AK, 2010, J BACTERIOL, V192, P5637, DOI 10.1128/JB.00752-10; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Witte G, 2005, NUCLEIC ACIDS RES, V33, P1662, DOI 10.1093/nar/gki310; Witte G, 2008, BIOPHYS J, V94, P2269, DOI 10.1529/biophysj.107.121533; Yadav T., 2012, NUCL ACIDS IN PRESS; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	49	43	46	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22123	22132		10.1074/jbc.M112.367573	http://dx.doi.org/10.1074/jbc.M112.367573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570477	hybrid, Green Published			2022-12-25	WOS:000306418600049
J	Manna, A; Saha, P; Sarkar, A; Mukhopadhyay, D; Bauri, AK; Kumar, D; Das, P; Chattopadhyay, S; Chatterjee, M				Manna, Alak; Saha, Piu; Sarkar, Avijit; Mukhopadhyay, Debanjan; Bauri, Ajay K.; Kumar, Deepak; Das, Padma; Chattopadhyay, Subrata; Chatterjee, Mitali			Malabaricone-A Induces A Redox Imbalance That Mediates Apoptosis in U937 Cell Line	PLOS ONE			English	Article							LEISHMANIA-DONOVANI PROMASTIGOTES; CANCER-CELLS; NITRIC-OXIDE; MITOCHONDRIAL PATHWAYS; GLUTATHIONE-PEROXIDASE; CYCLE ARREST; DEATH; STRESS; AGENTS; PROLIFERATION	Backround: The 'two-faced' character of reactive oxygen species (ROS) plays an important role in cancer biology by acting both as secondary messengers in intracellular signaling cascades and sustaining the oncogenic phenotype of cancer cells, while on the other hand, it triggers an oxidative assault that causes a redox imbalance translating into an apoptotic cell death. Principal Findings: Using a tetrazolium [{3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl}-2H-tetrazolium] based cell viability assay, we evaluated the cytotoxicity of a plant derived diarylnonanoid, malabaricone-A on leukemic cell lines U937 and MOLT-3. This cytotoxicity hinged on its ability to cause a redox imbalance via its ability to increase ROS, measured by flow cytometry using 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate and by decreasing glutathione peroxidase activity. This redox imbalance mediated apoptosis was evident by an increase in cytosolic [Ca2+], externalization of phosphatidyl serine as also depolarization of the mitochondrial membrane potential as measured by flow cytometry. There was concomitant peroxidation of cardiolipin, release of free cytochrome c to cytosol along with activation of caspases 9, 8 and 3. This led to cleavage of the DNA repair enzyme, poly (ADP-ribose) polymerase that caused DNA damage as proved by labeling with 4',6-diamidino-2-phenylindole (DAPI); furthermore, terminal deoxy ribonucleotide transferase catalysed incorporation of deoxy uridine triphosphate confirmed DNA nicking and was accompanied by arrest of cell cycle progression. Conclusions: Taken together, compounds like MAL-A having pro-oxidant activity mediate their cytotoxicity in leukemic cells via induction of oxidative stress triggering a caspase dependent apoptosis.	[Manna, Alak; Saha, Piu; Sarkar, Avijit; Mukhopadhyay, Debanjan; Chatterjee, Mitali] Inst Post Grad Med Educ & Res, Dept Pharmacol, Kolkata, W Bengal, India; [Bauri, Ajay K.; Chattopadhyay, Subrata] Bhabha Atom Res Ctr, Bioorgan Div, Bombay 400085, Maharashtra, India; [Kumar, Deepak; Das, Padma] Indian Inst Chem Biol, Dept Cell Biol & Physiol, Kolkata, W Bengal, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Bhabha Atomic Research Center (BARC); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Manna, A (corresponding author), Inst Post Grad Med Educ & Res, Dept Pharmacol, Kolkata, W Bengal, India.	ilatim@vsnl.net	Manna, Alak/AAY-1248-2021; Chatterjee, Mitali/AAV-2129-2021; Manna, Alak/AAE-7308-2021; Mukhopadhyay, Debanjan/S-3347-2019; Kumar, Deepak/J-4347-2016	Manna, Alak/0000-0003-3894-3277; Mukhopadhyay, Debanjan/0000-0002-8921-4106; 	Indian Council of Medical Research, Govt. of India	Indian Council of Medical Research, Govt. of India(Indian Council of Medical Research (ICMR))	AM, AS, DM received Senior Research fellowships from Indian Council of Medical Research, Govt. of India, and PS received a Research Associateship from Council of Scientific and Industrial Research, Govt. of India. This study had no external funding source.	ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Baneljee D, 2008, EUR J PHARMACOL, V578, P300, DOI 10.1016/j.ejphar.2007.09.041; Barbier M, 2004, CYTOM PART B-CLIN CY, V59B, P46, DOI 10.1002/cyto.b.20004; Beck R, 2011, CURR MED CHEM, V18, P2816, DOI 10.2174/092986711796011256; Bhattacharya K, 2010, BIOCHEM PHARMACOL, V79, P361, DOI 10.1016/j.bcp.2009.09.007; Brockhaus F, 1998, EXP CELL RES, V238, P33, DOI 10.1006/excr.1997.3778; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Das B, 2010, BIOORG MED CHEM LETT, V20, P6947, DOI 10.1016/j.bmcl.2010.09.126; Doering M, 2010, J MED CHEM, V53, P6954, DOI 10.1021/jm100576z; Ganguly S, 2006, J MICROBIOL METH, V66, P79, DOI 10.1016/j.mimet.2005.10.011; Guha P, 2011, J PHARMACOL EXP THER, V336, P206, DOI 10.1124/jpet.110.171983; Harada Hisashi, 2003, Rev Clin Exp Hematol, V7, P117; Jaeger T, 2006, BIOFACTORS, V27, P109, DOI 10.1002/biof.5520270110; Kim PKM, 2001, INT IMMUNOPHARMACOL, V1, P1421, DOI 10.1016/S1567-5769(01)00088-1; Laurent A, 2005, CANCER RES, V65, P948; Morita T, 2003, J AGR FOOD CHEM, V51, P1560, DOI 10.1021/jf020946n; Munoz MA, 2011, J PHOTOCH PHOTOBIO B, V103, P57, DOI 10.1016/j.jphotobiol.2011.01.012; Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paris C, 2007, APOPTOSIS, V12, P1257, DOI 10.1007/s10495-007-0052-1; Patro BS, 2010, BIOORGAN MED CHEM, V18, P7043, DOI 10.1016/j.bmc.2010.08.011; Patro BS, 2005, J AGR FOOD CHEM, V53, P6912, DOI 10.1021/jf050861x; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Saha P, 2011, INT IMMUNOPHARMACOL, V11, P1668, DOI 10.1016/j.intimp.2011.08.002; Saha P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018467; Saha P, 2009, FREE RADICAL RES, V43, P1101, DOI 10.1080/10715760903186124; Sanchez CA, 2008, CANCER INVEST, V26, P698, DOI 10.1080/07357900701874658; Sarkar A, 2011, CYTOM PART A, V79A, P35, DOI 10.1002/cyto.a.21001; Sarkar A, 2009, EXP PARASITOL, V122, P299, DOI 10.1016/j.exppara.2009.04.012; Schnelldorfer T, 2000, CANCER-AM CANCER SOC, V89, P1440, DOI 10.1002/1097-0142(20001001)89:7<1440::AID-CNCR5>3.3.CO;2-S; Sen R, 2007, J MED MICROBIOL, V56, P1213, DOI 10.1099/jmm.0.47364-0; Sen R, 2011, PHYTOMEDICINE, V18, P1056, DOI 10.1016/j.phymed.2011.03.004; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tyurina YY, 2006, MOL PHARMACOL, V70, P706, DOI 10.1124/mol.106.022731; Verma NK, 2004, ANTIMICROB AGENTS CH, V48, P3010, DOI 10.1128/AAC.48.8.3010-3015.2004; Yang ES, 2011, TOXICOL IN VITRO, V25, P1803, DOI 10.1016/j.tiv.2011.09.016; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	43	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36938	10.1371/journal.pone.0036938	http://dx.doi.org/10.1371/journal.pone.0036938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590637	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400047
J	Weiss, LC; Kruppert, S; Laforsch, C; Tollrian, R				Weiss, Linda C.; Kruppert, Sebastian; Laforsch, Christian; Tollrian, Ralph			Chaoborus and Gasterosteus Anti-Predator Responses in Daphnia pulex Are Mediated by Independent Cholinergic and Gabaergic Neuronal Signals	PLOS ONE			English	Article							LIFE-HISTORY SHIFTS; VERTICAL MIGRATION; PREDATOR; KAIROMONES; DEFENSE; COSTS	Many prey species evolved inducible defense strategies that protect effectively against predation threats. Especially the crustacean Daphnia emerged as a model system for studying the ecology and evolution of inducible defenses. Daphnia pulex e. g. shows different phenotypic adaptations against vertebrate and invertebrate predators. In response to the invertebrate phantom midge larvae Chaoborus (Diptera) D. pulex develops defensive morphological defenses (neckteeth). Cues originating from predatory fish result in life history changes in which resources are allocated from somatic growth to reproduction. While there are hints that responses against Chaoborus cues are transmitted involving cholinergic neuronal pathways, nothing is known about the neurophysiology underlying the transmission of fish related cues. We investigated the neurophysiological basis underlying the activation of inducible defenses in D. pulex using induction assays with the invertebrate predator Chaoborus and the three-spined stickleback Gasterosteus aculeatus. Predator-specific cues were combined with neuro-effective substances that stimulated or inhibited the cholinergic and gabaergic nervous system. We show that cholinergic-dependent pathways are involved in the perception and transmission of Chaoborus cues, while GABA was not involved. Thus, the cholinergic nervous system independently mediates the development of morphological defenses in response to Chaoborus cues. In contrast, only the inhibitory effect of GABA significantly influence fish-induced life history changes, while the application of cholinergic stimulants had no effect in combination with fish related cues. Our results show that cholinergic stimulation mediates signal transmission of Chaoborus cues leading to morphological defenses. Fish cues, which are responsible for predator-specific life history adaptations involve gabaergic control. Our study shows that both pathways are independent and thus potentially allow for adjustment of responses to variable predation regimes.	[Weiss, Linda C.; Kruppert, Sebastian; Tollrian, Ralph] Ruhr Univ Bochum, Bochum, Germany; [Laforsch, Christian] Univ Munich, Dept Biol 2, Munich, Germany	Ruhr University Bochum; University of Munich	Weiss, LC (corresponding author), Ruhr Univ Bochum, Univ Str 150, Bochum, Germany.	linda.weiss@rub.de	Kruppert, Sebastian/AAJ-8746-2020	Kruppert, Sebastian/0000-0001-5932-8455; Weiss, Linda C./0000-0002-7737-5017	Ruhr University Research School; Germany's Excellence Initiative [DFG] [GSC 98/1]	Ruhr University Research School; Germany's Excellence Initiative [DFG](German Research Foundation (DFG))	This work was supported by the Ruhr University Research School, which is funded by Germany's Excellence Initiative [DFG GSC 98/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT J, 1986, BRIT J PHARMACOL, V87, P771, DOI 10.1111/j.1476-5381.1986.tb14596.x; Barry MJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P179, DOI 10.1086/339389; Boeing WJ, 2005, CAN J FISH AQUAT SCI, V62, P1286, DOI 10.1139/F05-043; Dodson SI, 1997, J PLANKTON RES, V19, P969, DOI 10.1093/plankt/19.8.969; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; KRUEGER DA, 1981, LIMNOL OCEANOGR, V26, P219, DOI 10.4319/lo.1981.26.2.0219; LOOSE CJ, 1993, ARCH HYDROBIOL, V126, P329; Miyakawa H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-45; Nilsson GE, 2012, NATURE CLIMATE CHANG; Oda S, 2011, ENVIRON TOXICOL CHEM, V30, P232, DOI 10.1002/etc.378; PIJANOWSKA J, 1992, INT REV GES HYDROBIO, V77, P153, DOI 10.1002/iroh.19920770111; STIBOR H, 1994, FUNCT ECOL, V8, P97, DOI 10.2307/2390117; STIBOR H, 1992, OECOLOGIA, V92, P162, DOI 10.1007/BF00317358; TOLLRIAN R, 1995, ECOLOGY, V76, P1691, DOI 10.2307/1940703; TOLLRIAN R, 1993, J PLANKTON RES, V15, P1309, DOI 10.1093/plankt/15.11.1309; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Wojtal-Frankiewicz A, 2010, AQUAT ECOL, V44, P243, DOI 10.1007/s10452-009-9280-5	17	38	38	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36879	10.1371/journal.pone.0036879	http://dx.doi.org/10.1371/journal.pone.0036879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590631	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336100071
J	Yang, RJ; Lacson, RG; Castriota, G; Zhang, XHD; Liu, YP; Zhao, WQ; Einstein, M; Camargo, LM; Qureshi, S; Wong, KK; Zhang, BB; Ferrer, M; Berger, JP				Yang, Ruojing; Lacson, Raul G.; Castriota, Gino; Zhang, Xiaohua D.; Liu, Yaping; Zhao, Wenqing; Einstein, Monica; Camargo, Luiz Miguel; Qureshi, Sajjad; Wong, Kenny K.; Zhang, Bei B.; Ferrer, Marc; Berger, Joel P.			A Genome-Wide siRNA Screen to Identify Modulators of Insulin Sensitivity and Gluconeogenesis	PLOS ONE			English	Article							GLUCAGON RECEPTOR ANTAGONISTS; BINDING PROTEIN-1 PROMOTER; HEPATIC GLUCOSE-PRODUCTION; TRANSCRIPTION FACTOR FKHR; RESPONSE SEQUENCE; DIABETIC RATS; HYPERGLYCEMIA; PHOSPHORYLATION; METABOLISM; METFORMIN	Background: Hepatic insulin resistance impairs insulin's ability to suppress hepatic glucose production (HGP) and contributes to the development of type 2 diabetes (T2D). Although the interests to discover novel genes that modulate insulin sensitivity and HGP are high, it remains challenging to have a human cell based system to identify novel genes. Methodology/Principal Findings: To identify genes that modulate hepatic insulin signaling and HGP, we generated a human cell line stably expressing beta-lactamase under the control of the human glucose-6-phosphatase (G6PC) promoter (AH-G6PC cells). Both beta-lactamase activity and endogenous G6PC mRNA were increased in AH-G6PC cells by a combination of dexamethasone and pCPT-cAMP, and reduced by insulin. A 4-gene High-Throughput-Genomics assay was developed to concomitantly measure G6PC and pyruvate-dehydrogenase-kinase-4 (PDK4) mRNA levels. Using this assay, we screened an siRNA library containing pooled siRNA targeting 6650 druggable genes and identified 614 hits that lowered G6PC expression without increasing PDK4 mRNA levels. Pathway analysis indicated that siRNA-mediated knockdown (KD) of genes known to positively or negatively affect insulin signaling increased or decreased G6PC mRNA expression, respectively, thus validating our screening platform. A subset of 270 primary screen hits was selected and 149 hits were confirmed by target gene KD by pooled siRNA and 7 single siRNA for each gene to reduce G6PC expression in 4-gene HTG assay. Subsequently, pooled siRNA KD of 113 genes decreased PEPCK and/or PGC1alpha mRNA expression thereby demonstrating their role in regulating key gluconeogenic genes in addition to G6PC. Last, KD of 61 of the above 113 genes potentiated insulin-stimulated Akt phosphorylation, suggesting that they suppress gluconeogenic gene by enhancing insulin signaling. Conclusions/Significance: These results support the proposition that the proteins encoded by the genes identified in our cell-based druggable genome siRNA screen hold the potential to serve as novel pharmacological targets for the treatment of T2D.	[Yang, Ruojing; Castriota, Gino; Einstein, Monica; Camargo, Luiz Miguel; Qureshi, Sajjad; Zhang, Bei B.; Berger, Joel P.] Merck Res Labs, Dept Metebol Disorders Diabet, Rahway, NJ 07055 USA; [Lacson, Raul G.; Liu, Yaping; Ferrer, Marc] Merck Res Labs, Cell Based HTS, N Wales, PA USA; [Zhang, Xiaohua D.] Merck Res Labs, West Point, PA USA; [Zhao, Wenqing] Merck Res Labs, Dept Guided Solut, Rahway, NJ USA; [Wong, Kenny K.] Merck Res Labs, Dept Atherosclerosis, Rahway, NJ USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Yang, RJ (corresponding author), Merck Res Labs, Dept Metebol Disorders Diabet, Rahway, NJ 07055 USA.	ruojing_yang@merck.com; joel_berger@merck.com		Zhang, Xiaohua Douglas/0000-0002-2486-7931	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; BRAND CL, 1994, DIABETOLOGIA, V37, P985, DOI 10.1007/BF00400461; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Friedman JE, 1997, J BIOL CHEM, V272, P31475, DOI 10.1074/jbc.272.50.31475; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; JOHNSON DG, 1982, SCIENCE, V215, P1115, DOI 10.1126/science.6278587; Kim RM, 2008, BIOORG MED CHEM LETT, V18, P3701, DOI 10.1016/j.bmcl.2008.05.072; Lau J, 2007, J MED CHEM, V50, P113, DOI 10.1021/jm058026u; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Liang Y, 2005, METABOLISM, V54, P848, DOI 10.1016/j.metabol.2005.01.030; Mang Y, 2004, DIABETES, V53, P410; Martel RR, 2002, ASSAY DRUG DEV TECHN, V1, P61, DOI 10.1089/154065802761001310; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mithieux G, 2002, DIABETES, V51, P139, DOI 10.2337/diabetes.51.1.139; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qureshi SA, 2004, DIABETES, V53, P3267, DOI 10.2337/diabetes.53.12.3267; Rondinone CM, 2006, ENDOCRINOLOGY, V147, P2650, DOI 10.1210/en.2006-0147; SAAD MJA, 1995, ENDOCRINOLOGY, V136, P1579, DOI 10.1210/en.136.4.1579; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sloop KW, 2005, EXPERT OPIN THER TAR, V9, P593, DOI 10.1517/14728222.9.3.593; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Yang RJ, 2008, INT J BIOCHEM CELL B, V40, P2702, DOI 10.1016/j.biocel.2008.06.012; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P363, DOI 10.1177/1087057108317062; Zhang XD, 2007, J BIOMOL SCREEN, V12, P645, DOI 10.1177/1087057107300645; Zhang XD, 2010, PHARMACOGENOMICS, V11, P199, DOI [10.2217/pgs.09.136, 10.2217/PGS.09.136]; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	39	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36384	10.1371/journal.pone.0036384	http://dx.doi.org/10.1371/journal.pone.0036384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590537	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336100028
J	Kam, MKM; Lee, KY; Tam, PKH; Lui, VCH				Kam, Mandy Ka Man; Lee, King Yiu; Tam, Paul Kwong Hang; Lui, Vincent Chi Hang			Generation of NSE-MerCreMer Transgenic Mice with Tamoxifen Inducible Cre Activity in Neurons	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; MOUSE; EXPRESSION; ENOLASE; CELLS; PHENOTYPE; MIGRATION; GENOME; BRAIN; FORM	To establish a genetic tool for conditional deletion or expression of gene in neurons in a temporally controlled manner, we generated a transgenic mouse (NSE-MerCreMer), which expressed a tamoxifen inducible type of Cre recombinase specifically in neurons. The tamoxifen inducible Cre recombinase (MerCreMer) is a fusion protein containing Cre recombinase with two modified estrogen receptor ligand binding domains at both ends, and is driven by the neural-specific rat neural specific enolase (NSE) promoter. A total of two transgenic lines were established, and expression of MerCreMer in neurons of the central and enteric nervous systems was confirmed. Transcript of MerCreMer was detected in several non-neural tissues such as heart, liver, and kidney in these lines. In the background of the Cre reporter mouse strain Rosa26R, Cre recombinase activity was inducible in neurons of adult NSE-MerCreMer mice treated with tamoxifen by intragastric gavage, but not in those fed with corn oil only. We conclude that NSE-MerCreMer lines will be useful for studying gene functions in neurons for the conditions that Cre-mediated recombination resulting in embryonic lethality, which precludes investigation of gene functions in neurons through later stages of development and in adult.	[Kam, Mandy Ka Man; Lee, King Yiu; Tam, Paul Kwong Hang; Lui, Vincent Chi Hang] Univ Hong Kong, LKS Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Tam, Paul Kwong Hang; Lui, Vincent Chi Hang] Univ Hong Kong, LKS Fac Med, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Kam, MKM (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	vchlui@hkucc.hku.hk	/C-4405-2009; /C-4359-2009	/0000-0001-6231-3035; /0000-0002-1758-8854	Hong Kong SAR Government Research Council	Hong Kong SAR Government Research Council	Funding support came from The Hong Kong SAR Government Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; CASTILLO MB, 1995, ARCH BIOCHEM BIOPHYS, V317, P292, DOI 10.1006/abbi.1995.1165; Cinato E, 2001, GENESIS, V31, P118, DOI 10.1002/gene.10014; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Garcia EL, 2002, SEMIN CELL DEV BIOL, V13, P151, DOI 10.1016/S1084-9521(02)00019-8; GILLIES K, 1993, NEUROREPORT, V4, P911, DOI 10.1097/00001756-199307000-00018; HAMILTON DL, 1984, J MOL BIOL, V178, P481, DOI 10.1016/0022-2836(84)90154-2; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hwang DY, 2004, EXP NEUROL, V186, P20, DOI 10.1016/j.expneurol.2003.09.021; Kwon CH, 2006, GENESIS, V44, P130, DOI 10.1002/gene.20197; Levers TE, 2001, J NEUROBIOL, V48, P265, DOI 10.1002/neu.1056; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; MARANGOS PJ, 1980, BRAIN RES, V190, P185, DOI 10.1016/0006-8993(80)91168-3; Metzger D, 1999, CURR OPIN BIOTECH, V10, P470, DOI 10.1016/S0958-1669(99)00012-9; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Patzke H, 2003, J NEUROSCI, V23, P2769; Rossant J, 1999, GENE DEV, V13, P142, DOI 10.1101/gad.13.2.142; Schmechel DE, 1983, NEURON SPECIFIC ENOL; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Young HM, 2001, ANAT REC, V262, P1; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	23	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35799	10.1371/journal.pone.0035799	http://dx.doi.org/10.1371/journal.pone.0035799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586451	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335000013
J	Wich, SA; Krutzen, M; Lameira, AR; Nater, A; Arora, N; Bastian, ML; Meulman, E; Morrogh-Bernard, HC; Atmoko, SSU; Pamungkas, J; Perwitasari-Farajallah, D; Hardus, ME; van Noordwijk, M; van Schaik, CP				Wich, Serge A.; Kruetzen, Michael; Lameira, Adriano R.; Nater, Alexander; Arora, Natasha; Bastian, Meredith L.; Meulman, Ellen; Morrogh-Bernard, Helen C.; Atmoko, S. Suci Utami; Pamungkas, Joko; Perwitasari-Farajallah, Dyah; Hardus, Madeleine E.; van Noordwijk, Maria; van Schaik, Carel P.			Call Cultures in Orang-Utans?	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; WILD CHIMPANZEES; BORNEAN ORANGUTANS; EVOLUTION; SOUND; SONG; VOCALIZATIONS; TRANSMISSION; TRADITIONS; PRODUCE	Background: Several studies suggested great ape cultures, arguing that human cumulative culture presumably evolved from such a foundation. These focused on conspicuous behaviours, and showed rich geographic variation, which could not be attributed to known ecological or genetic differences. Although geographic variation within call types (accents) has previously been reported for orang-utans and other primate species, we examine geographic variation in the presence/absence of discrete call types (dialects). Because orang-utans have been shown to have geographic variation that is not completely explicable by genetic or ecological factors we hypothesized that this will be similar in the call domain and predict that discrete call type variation between populations will be found. Methodology/Principal Findings: We examined long-term behavioural data from five orang-utan populations and collected fecal samples for genetic analyses. We show that there is geographic variation in the presence of discrete types of calls. In exactly the same behavioural context (nest building and infant retrieval), individuals in different wild populations customarily emit either qualitatively different calls or calls in some but not in others. By comparing patterns in call-type and genetic similarity, we suggest that the observed variation is not likely to be explained by genetic or ecological differences. Conclusion/Significance: These results are consistent with the potential presence of 'call cultures' and suggest that wild orang-utans possess the ability to invent arbitrary calls, which spread through social learning. These findings differ substantially from those that have been reported for primates before. First, the results reported here are on dialect and not on accent. Second, this study presents cases of production learning whereas most primate studies on vocal learning were cases of contextual learning. We conclude with speculating on how these findings might assist in bridging the gap between vocal communication in non-human primates and human speech.	[Wich, Serge A.; Kruetzen, Michael; Nater, Alexander; Arora, Natasha; Meulman, Ellen; van Noordwijk, Maria; van Schaik, Carel P.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Wich, Serge A.] Sumatran Orangutan Conservat Programme PanEco YEL, Medan, Sumatra, Indonesia; [Lameira, Adriano R.] Univ Utrecht, Utrecht, Netherlands; [Bastian, Meredith L.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Morrogh-Bernard, Helen C.] Univ Cambridge, Wildlife Res Grp, Cambridge, England; [Atmoko, S. Suci Utami] Univ Nas, Fak Biol, Jakarta, Indonesia; [Pamungkas, Joko; Perwitasari-Farajallah, Dyah] Bogor Agr Univ, Primate Res Ctr, Bogor, Indonesia; [Hardus, Madeleine E.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Zurich; Utrecht University; Boston University; University of Cambridge; Universitas Nasional Pionir Perubahan; Bogor Agricultural University; University of Amsterdam	Wich, SA (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.	sergewich1@yahoo.com	Nater, Alexander/ABF-5719-2020; Arora, Natasha/L-6579-2014; Perwitasari-Farajallah, Dyah/CAE-9260-2022; Pamungkas, Joko/GPK-3471-2022; Krutzen, Michael C/D-9550-2011	Nater, Alexander/0000-0002-4805-5575; Arora, Natasha/0000-0002-6144-4743; Perwitasari-Farajallah, Dyah/0000-0001-6206-1675; Krutzen, Michael/0000-0003-1055-5299; Lameira, Adriano/0000-0003-3071-4824; Wich, Serge/0000-0003-3954-5174; utami, sri/0000-0002-5138-242X	Netherlands Organisation for Scientific Research (NWO); L.S.B. Leakey Foundation; National Geographic Society; Swiss National Science Foundation; Messerli Foundation; A.H.-Schultz Foundation; PanEco; Claraz-Schenkung; Portuguese Foundation for Science and Technology; Wenner-Gren Foundation for Anthropological Research; Dobberke Foundation; Lucie Burgers Foundation for Comparative Behaviour Research; Schure-Beijerinck-Popping Funds; Royal Anthropological Institute of Great Britain and Ireland; Primate Conservation, Inc.; Fundacao Calouste Gulbenkian	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); L.S.B. Leakey Foundation; National Geographic Society(National Geographic Society); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Messerli Foundation; A.H.-Schultz Foundation; PanEco; Claraz-Schenkung; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Wenner-Gren Foundation for Anthropological Research; Dobberke Foundation; Lucie Burgers Foundation for Comparative Behaviour Research; Schure-Beijerinck-Popping Funds; Royal Anthropological Institute of Great Britain and Ireland; Primate Conservation, Inc.; Fundacao Calouste Gulbenkian(European Commission)	This work was supported by the Netherlands Organisation for Scientific Research (NWO), L.S.B. Leakey Foundation, National Geographic Society, Swiss National Science Foundation, Messerli Foundation, A.H.-Schultz Foundation, PanEco, Claraz-Schenkung, Portuguese Foundation for Science and Technology, Wenner-Gren Foundation for Anthropological Research, Dobberke Foundation, Lucie Burgers Foundation for Comparative Behaviour Research, Schure-Beijerinck-Popping Funds, Ruggles-Gates Fund for Anthropological Scholarship of the Royal Anthropological Institute of Great Britain and Ireland, Primate Conservation, Inc., and Fundacao Calouste Gulbenkian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian ML, 2010, AM J PHYS ANTHROPOL, V143, P175, DOI 10.1002/ajpa.21304; Bertelli S, 2002, BIOL J LINN SOC, V77, P423, DOI 10.1046/j.1095-8312.2002.00112.x; Bluff LA, 2010, BIOL J LINN SOC, V101, P767, DOI 10.1111/j.1095-8312.2010.01527.x; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Crockford C, 2004, ETHOLOGY, V110, P221, DOI 10.1111/j.1439-0310.2004.00968.x; de la Torre S, 2009, AM J PRIMATOL, V71, P333, DOI 10.1002/ajp.20657; Delgado RA, 2007, ETHOLOGY, V113, P487, DOI 10.1111/j.1439-0310.2007.01345.x; Dindo M, 2011, BIOL LETTERS, V7, P181, DOI 10.1098/rsbl.2010.0637; Falconer D. S., 1996, Introduction to quantitative genetics.; Fichtel C, 2006, ETHOLOGY, V112, P839, DOI 10.1111/j.1439-0310.2006.01239.x; Fischer J, 1998, ANIM BEHAV, V56, P623, DOI 10.1006/anbe.1998.0796; Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; Hardus ME, 2009, P ROY SOC B-BIOL SCI, V276, P3689, DOI 10.1098/rspb.2009.1027; Hardus Madeleine E., 2009, P49; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Jaeggi AV, 2008, AM J PRIMATOL, V70, P533, DOI 10.1002/ajp.20525; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Krutzen M, 2012, CURRENT BIO IN PRESS; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Lameira AR., 2010, J EVOL PSYCHOL, V8, P309; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P2094, DOI 10.1098/rspb.2011.0391; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lycett SJ, 2011, P ROY SOC B-BIOL SCI, V278, P2091, DOI 10.1098/rspb.2010.2599; M Paul, 2007, NESTING SOUNDS WILD; Marshall AJ, 1999, ANIM BEHAV, V58, P825, DOI 10.1006/anbe.1999.1219; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; Miles H. Lyn, 1996, P278; Mitani JC, 1999, AM J PRIMATOL, V47, P133, DOI 10.1002/(SICI)1098-2345(1999)47:2<133::AID-AJP4>3.0.CO;2-I; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Muir CC, 2000, J MOL EVOL, V51, P471, DOI 10.1007/s002390010110; Nater A, 2011, MOL BIOL EVOL, V28, P2275, DOI 10.1093/molbev/msr042; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Owren MJ, 2010, AM J PRIMATOL, V71, P1; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rendell LE, 2003, P ROY SOC B-BIOL SCI, V270, P225, DOI 10.1098/rspb.2002.2239; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016863; Saranathan V, 2007, MOL ECOL, V16, P3689, DOI 10.1111/j.1365-294X.2007.03415.x; Schusterman R.J., 2008, EVOLUTION COMMUNICAT, P41, DOI [10.7551/mitpress/9780262151214.003.0003, DOI 10.7551/MITPRESS/9780262151214.003.0003]; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Slik JWF, 2011, P NATL ACAD SCI; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Schaik CP, 2006, BEHAVIOUR, V143, P839, DOI 10.1163/156853906778017944; Van Schaik Carel P., 2003, P297, DOI 10.1017/CBO9780511584022.012; van Schaik Carel P., 2009, P299; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Warren KS, 2001, MOL BIOL EVOL, V18, P472, DOI 10.1093/oxfordjournals.molbev.a003826; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Wich S. A., 2009, ORANGUTANS GEOGRAPHI; Wich SA, 2008, AM J PRIMATOL, V70, P566, DOI 10.1002/ajp.20527; Wich SA, 2009, PRIMATES, V50, P56, DOI 10.1007/s10329-008-0117-y; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7	60	53	54	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36180	10.1371/journal.pone.0036180	http://dx.doi.org/10.1371/journal.pone.0036180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586464	Green Accepted, gold, Green Published			2022-12-25	WOS:000305335000026
J	Austin, D; Baer, A; Lundberg, L; Shafagati, N; Schoonmaker, A; Narayanan, A; Popova, T; Panthier, JJ; Kashanchi, F; Bailey, C; Kehn-Hall, K				Austin, Dana; Baer, Alan; Lundberg, Lindsay; Shafagati, Nazly; Schoonmaker, Annalise; Narayanan, Aarthi; Popova, Taissia; Panthier, Jean Jacques; Kashanchi, Fatah; Bailey, Charles; Kehn-Hall, Kylene			p53 Activation following Rift Valley Fever Virus Infection Contributes to Cell Death and Viral Production	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; NSS PROTEIN; DOWN-REGULATION; PHOSPHORYLATION; TRANSCRIPTION; APOPTOSIS; REPLICATION; INHIBITION; PROMOTES; PATHOGENESIS	Rift Valley fever virus (RVFV) is an emerging viral zoonosis that is responsible for devastating outbreaks among livestock and is capable of causing potentially fatal disease in humans. Studies have shown that upon infection, certain viruses have the capability of utilizing particular cellular signaling pathways to propagate viral infection. Activation of p53 is important for the DNA damage signaling cascade, initiation of apoptosis, cell cycle arrest and transcriptional regulation of multiple genes. The current study focuses on the role of p53 signaling in RVFV infection and viral replication. These results show an up-regulation of p53 phosphorylation at several serine sites after RVFV MP-12 infection that is highly dependent on the viral protein NSs. qRT-PCR data showed a transcriptional up-regulation of several p53 targeted genes involved in cell cycle and apoptosis regulation following RVFV infection. Cell viability assays demonstrate that loss of p53 results in less RVFV induced cell death. Furthermore, decreased viral titers in p53 null cells indicate that RVFV utilizes p53 to enhance viral production. Collectively, these experiments indicate that the p53 signaling pathway is utilized during RVFV infection to induce cell death and increase viral production.	[Austin, Dana; Baer, Alan; Lundberg, Lindsay; Shafagati, Nazly; Schoonmaker, Annalise; Narayanan, Aarthi; Popova, Taissia; Kashanchi, Fatah; Bailey, Charles; Kehn-Hall, Kylene] George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA; [Panthier, Jean Jacques] Inst Pasteur, Paris, France	George Mason University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Austin, D (corresponding author), George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA.	kkehnhal@gmu.edu	Kehn-Hall, Kylene/I-5752-2013; PANTHIER, Jean-Jacques/I-4366-2014	PANTHIER, Jean-Jacques/0000-0002-7966-0663; Kehn-Hall, Kylene/0000-0001-8036-7213	USA Department of Energy grant [DE-FC52-04NA25455]	USA Department of Energy grant	This work was supported by the USA Department of Energy grant DE-FC52-04NA25455 (to CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer A, 2012, J BIOL CHEM, V287, P7399, DOI 10.1074/jbc.M111.296608; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy Michele, 2010, Open Virol J, V4, P8, DOI 10.2174/1874357901004020008; CHEN XB, 1993, GENE DEV, V7, P1837, DOI 10.1101/gad.7.10.1837; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Devireddy LR, 1999, J VIROL, V73, P3778, DOI 10.1128/JVI.73.5.3778-3788.1999; Di Lello P, 2008, P NATL ACAD SCI USA, V105, P106, DOI 10.1073/pnas.0707892105; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Gerrard SR, 2007, VIROLOGY, V359, P459, DOI 10.1016/j.virol.2006.09.035; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Kurihara A, 2007, GENES CELLS, V12, P853, DOI 10.1111/j.1365-2443.2007.01097.x; Lazo PA, 2011, REV MED VIROL; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Mansuroglu Z, 2010, J VIROL, V84, P928, DOI 10.1128/JVI.01165-09; MEEK DW, 1994, SEMIN CANCER BIOL, V5, P203; Milczarek GJ, 1996, LIFE SCI, V60, P1, DOI 10.1016/S0024-3205(96)00479-1; Moll UM, 2003, MOL CANCER RES, V1, P1001; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Myskiw C, 2011, J VIROL; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Pepin M, 2010, VET RES, V41, P40; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Pise-Masison CA, 2005, FRONT BIOSCI-LANDMRK, V10, P919, DOI 10.2741/1586; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Steegenga WT, 1996, J MOL BIOL, V263, P103, DOI 10.1006/jmbi.1996.0560; Tabakin-Fix Y, 2006, CARCINOGENESIS, V27, P673, DOI 10.1093/carcin/bgi274; Thakur VS, 2010, CANCER LETT, V296, P225, DOI 10.1016/j.canlet.2010.04.012; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Verbruggen P, 2011, J BIOL CHEM, V286, P3681, DOI 10.1074/jbc.M110.154799; Vialat P, 1997, VIRUS RES, V52, P43, DOI 10.1016/S0168-1702(97)00097-X; Vialat P, 2000, J VIROL, V74, P1538, DOI 10.1128/JVI.74.3.1538-1543.2000; WANG P, 1994, MOL CELL BIOL, V14, P5182, DOI 10.1128/MCB.14.8.5182; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06; Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x; Zamoto-Niikura A, 2009, J VIROL, V83, P12779, DOI 10.1128/JVI.01310-09; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	55	41	41	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36327	10.1371/journal.pone.0036327	http://dx.doi.org/10.1371/journal.pone.0036327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574148	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349800044
J	Li, N; Hong, WF; Huang, H; Lu, HP; Lin, GY; Hong, M				Li, Nan; Hong, Weifang; Huang, Hong; Lu, Hanping; Lin, Guangyun; Hong, Mei			Identification of Amino Acids Essential for Estrone-3-Sulfate Transport within Transmembrane Domain 2 of Organic Anion Transporting Polypeptide 1B1	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; FUNCTIONAL-CHARACTERIZATION; OATP TRANSPORTERS; HUMAN LIVER; HOAT1; POLYMORPHISMS; SUPERFAMILY; STABILITY; FAMILY	As an important structure in membrane proteins, transmembrane domains have been found to be crucial for properly targeting the protein to cell membrane as well as carrying out transport functions in transporters. Computer analysis of OATP sequences revealed transmembrane domain 2 (TM2) is among those transmembrane domains that have high amino acid identities within different family members. In the present study, we identify four amino acids (Asp70, Phe73, Glu74, and Gly76) that are essential for the transport function of OATP1B1, an OATP member that is specifically expressed in the human liver. A substitution of these four amino acids with alanine resulted in significantly reduced transport activity. Further mutagenesis showed the charged property of Asp70 and Glu74 is critical for proper function of the transporter protein. Comparison of the kinetic parameters indicated that Asp70 is likely to interact with the substrate while Glu74 may be involved in stabilizing the binding site through formation of a salt-bridge. The aromatic ring structure of Phe73 seems to play an important role because substitution of Phe73 with tyrosine, another amino acid with a similar structure, led to partially restored transport function. On the other hand, replacement of Gly76 with either alanine or valine could not recover the function of the transporter. Considering the nature of a transmembrane helix, we proposed that Gly76 may be important for maintaining the proper structure of the protein. Interestingly, when subjected to transport function analysis of higher concentration of esteone-3-sulfate (50 mu M) that corresponds to the low affinity binding site of OATP1B1, mutants of Phe73, Glu74, and Gly76 all showed a transport function that is comparable to that of the wild-type, suggesting these amino acids may have less impact on the low affinity component of esteone-3-sulfate within OATP1B1, while Asp 70 seems to be involved in the interaction of both sites.	[Li, Nan; Hong, Weifang; Hong, Mei] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Huang, Hong] Univ S Florida, Sch Informat, Tampa, FL USA; [Lu, Hanping; Lin, Guangyun] Zhongshan Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; State University System of Florida; University of South Florida; Sun Yat Sen University	Li, N (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	mh2788@scau.edu.cn	Huang, Hong/G-5957-2016	Huang, Hong/0000-0002-8957-4881; Hong, Mei/0000-0001-9219-2844	Guangdong Province Talent Introduction Project Grant	Guangdong Province Talent Introduction Project Grant	This work was supported by Guangdong Province Talent Introduction Project Grant (2009) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossuyt X, 1996, J HEPATOL, V25, P733, DOI 10.1016/S0168-8278(96)80246-7; Cai SY, 2002, AM J PHYSIOL-GASTR L, V282, pG702, DOI 10.1152/ajpgi.00458.2001; Glaeser H, 2010, BRIT J PHARMACOL, V159, P698, DOI 10.1111/j.1476-5381.2009.00568.x; Gui CS, 2009, PROTEIN SCI, V18, P2298, DOI 10.1002/pro.240; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hong M, 2007, J PHARMACOL EXP THER, V320, P1209, DOI 10.1124/jpet.106.117663; Hong M, 2010, J PHARMACOL EXP THER, V332, P650, DOI 10.1124/jpet.109.160515; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Konig J, 2011, HANDB EXP PHARMACOL, V201, P1, DOI 10.1007/978-3-642-14541-4_1; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; Meier-Abt F, 2005, J MEMBRANE BIOL, V208, P213, DOI 10.1007/s00232-005-7004-x; Mikkaichi Tsuyoshi, 2004, Drug Metab Pharmacokinet, V19, P171, DOI 10.2133/dmpk.19.171; Miyagawa M, 2009, J PHARMACOL EXP THER, V329, P551, DOI 10.1124/jpet.108.148411; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; Noe J, 2007, DRUG METAB DISPOS, V35, P1308, DOI 10.1124/dmd.106.012930; Poirier A, 2007, CURR OPIN DRUG DISC, V10, P74; Rizwan AN, 2007, J BIOL CHEM, V282, P13402, DOI 10.1074/jbc.M609849200; Shitara Y, 2005, ANNU REV PHARMACOL, V45, P689, DOI 10.1146/annurev.pharmtox.44.101802.121444; Tamai I, 2001, PHARMACEUT RES, V18, P1262, DOI 10.1023/A:1013077609227; Tirona RG, 2001, J BIOL CHEM, V276, P35669, DOI 10.1074/jbc.M103792200; van Montfoort JE, 2003, CURR DRUG METAB, V4, P185, DOI 10.2174/1389200033489460; Weaver YM, 2010, J MEMBRANE BIOL, V236, P279, DOI 10.1007/s00232-010-9300-3	24	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36647	10.1371/journal.pone.0036647	http://dx.doi.org/10.1371/journal.pone.0036647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574206	Green Published, gold			2022-12-25	WOS:000305349800103
J	Fan, S; Niu, Y; Tan, N; Wu, Z; Wang, Y; You, H; Ke, R; Song, J; Shen, Q; Wang, W; Yao, G; Shu, H; Lin, H; Yao, M; Zhang, Z; Gu, J; Qin, W				Fan, S.; Niu, Y.; Tan, N.; Wu, Z.; Wang, Y.; You, H.; Ke, R.; Song, J.; Shen, Q.; Wang, W.; Yao, G.; Shu, H.; Lin, H.; Yao, M.; Zhang, Z.; Gu, J.; Qin, W.			LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump	ONCOGENE			English	Article						breast cancer; LASS2; V-ATPase; acidic tumor microenvironment; multidrug resistance	RESISTANT CELL-LINES; DRUG-RESISTANCE; ANTICANCER AGENTS; P-GLYCOPROTEIN; H+-ATPASES; KAPPA-B; EXPRESSION; LYSOSOMES; APOPTOSIS; THERAPY	A main obstacle to overcome during the treatment of tumors is drug resistance to chemotherapy; emerging studies indicate that a key factor contributing to this problem is the acidic tumor microenvironment. Here, we found that LASS2 expression was significantly lower in drug-resistant Michigan Cancer Foundation-7/adriamycin (MCF-7/ADR) human breast cancer cells than the drug-sensitive MCF-7 cells, and low expression of LASS2 was associated with poor prognosis in patients with breast cancer. Our results showed that the overexpression of LASS2 in MCF-7/ADR cells increased the chemosensitivity to multiple chemotherapeutic agents, including doxorubicin (Dox), whereas LASS2 knockdown in MCF-7 cells decreased the chemosensitivity. Cell-cycle analysis revealed a corresponding increase in apoptosis in the LASS2-overexpressing cells following Dox exposure, showing that the overexpression of LASS2 increased the susceptibility to Dox cytotoxicity. This effect was mediated by a significant increase in pH(e) (extracellular pH) and lysosomal pH, and more Dox entered the cells and stayed in the nuclei of cells. In nude mice, the combination of LASS2 overexpression and Dox significantly inhibited the growth of xenografts. Our findings suggest that LASS2 is involved in chemotherapeutic outcomes and low LASS2 expression may predict chemoresistance. Oncogene ( 2013) 32, 1682-1690; doi:10.1038/onc.2012.183; published online 14 May 2012	[Fan, S.; Niu, Y.; Wu, Z.; You, H.; Ke, R.; Song, J.; Shen, Q.; Wang, W.; Yao, G.; Shu, H.; Lin, H.; Zhang, Z.; Gu, J.; Qin, W.] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200032, Peoples R China; [Fan, S.] Jiangsu Normal Univ, Sch Life Sci, Dept Biotechnol, Xuzhou, Peoples R China; [Tan, N.] Guangdong Med Coll, Key Lab Med Mol Diag, Zhanjiang, Guangdong, Peoples R China; [Wang, Y.] Xuzhou Med Coll, Affiliated City Hosp, Dept Oncol, Xuzhou, Peoples R China; [Yao, M.] Shanghai Jiao Tong Univ, Sch Med, Dept Expt Pathol, Shanghai Canc Inst,Renji Hosp, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Jiangsu Normal University; Guangdong Medical University; Xuzhou Medical University; Shanghai Jiao Tong University	Qin, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, 25-2200 Xietu Rd, Shanghai 200032, Peoples R China.	wxqin@sjtu.edu.cn	Ke, Rough/AAM-9687-2021; niu, yd/C-5030-2009	Fan, Shaohua/0000-0003-1878-5902; Zhang, Zhi-gang/0000-0001-8965-223X; Niu, Yongdong/0000-0002-5392-3736	National Key Basic Research Program of China [2009CB521803]; National Key Sci-Tech Special Project of China [2012ZX10002011-004]; National Natural Science Foundation of China [30973492, 81030038]	National Key Basic Research Program of China(National Basic Research Program of China); National Key Sci-Tech Special Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We are grateful to Shenglin Huang, Jun Li and Jie Chen for the kind suggestions and technical assistance. This work was supported by grants from the National Key Basic Research Program of China ( 2009CB521803), National Key Sci-Tech Special Project of China (2012ZX10002011-004) and National Natural Science Foundation of China (30973492 and 81030038).	Andreetta C, 2009, ANN ONCOL, V20, P265, DOI 10.1093/annonc/mdn592; Ben-Batalla I, 2010, J CLIN INVEST, V120, P4289, DOI 10.1172/JCI42015; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; COLEY HM, 1993, BRIT J CANCER, V67, P1316, DOI 10.1038/bjc.1993.244; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Dai Y, 2009, AM J TRANSL RES, V1, P1; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Erez-Roman R, 2010, BIOCHEM BIOPH RES CO, V391, P219, DOI 10.1016/j.bbrc.2009.11.035; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Furu M, 2011, ONCOGENE, V30, P4015, DOI 10.1038/onc.2011.108; Generali D, 2006, ENDOCR-RELAT CANCER, V13, P921, DOI 10.1677/erc.1.01216; GERVASONI JE, 1991, CANCER RES, V51, P4955; Gerweck LE, 1996, CANCER RES, V56, P1194; Gong YP, 2003, J BIOL CHEM, V278, P50234, DOI 10.1074/jbc.M306606200; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hurwitz SJ, 1997, BLOOD, V89, P3745, DOI 10.1182/blood.V89.10.3745.3745_3745_3754; Jiffar T, 2011, ONCOGENE, V30, P3163, DOI 10.1038/onc.2011.39; Kawasaki K, 2009, CANCER GENE THER, V16, P65, DOI 10.1038/cgt.2008.58; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Lou PJ, 2006, INT J CANCER, V119, P2692, DOI 10.1002/ijc.22098; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; MA LD, 1992, BIOCHEM BIOPH RES CO, V182, P675, DOI 10.1016/0006-291X(92)91785-O; Mahoney BP, 2003, BIOCHEM PHARMACOL, V66, P1207, DOI 10.1016/S0006-2952(03)00467-2; National Comprehensive Cancer Network, 2011, NCCN CLIN PRACT GUID; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Ouar Z, 2003, BIOCHEM J, V370, P185, DOI 10.1042/BJ20021411; Pan H, 2001, GENOMICS, V77, P58, DOI 10.1006/geno.2001.6614; Petrangolini G, 2006, J PHARMACOL EXP THER, V318, P939, DOI 10.1124/jpet.106.103481; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P1047, DOI 10.1016/S0006-2952(99)00021-0; Rojas JD, 2006, AM J PHYSIOL-HEART C, V291, pH1147, DOI 10.1152/ajpheart.00166.2006; Schiffmann S, 2009, CARCINOGENESIS, V30, P745, DOI 10.1093/carcin/bgp061; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Thomsen P, 1999, BBA-MOL CELL RES, V1452, P285, DOI 10.1016/S0167-4889(99)00132-9; Thussbas C, 2006, J CLIN ONCOL, V24, P3747, DOI 10.1200/JCO.2005.04.8587; Torigoe T, 2002, J BIOL CHEM, V277, P36534, DOI 10.1074/jbc.M202605200; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Wojtkowiak JW, 2011, MOL PHARMACEUT, V8, P2032, DOI 10.1021/mp200292c; Wulfing P, 2004, BRIT J CANCER, V91, P434, DOI 10.1038/sj.bjc.6601889; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023; Zhao YJ, 2011, HEPATOLOGY, V53, P493, DOI 10.1002/hep.24079	45	77	80	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2013	32	13					1682	1690		10.1038/onc.2012.183	http://dx.doi.org/10.1038/onc.2012.183			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22580606				2022-12-25	WOS:000316855800008
J	Ye, Y; Tian, H; Lange, AR; Yearsley, K; Robertson, FM; Barsky, SH				Ye, Y.; Tian, H.; Lange, A. R.; Yearsley, K.; Robertson, F. M.; Barsky, S. H.			The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin	ONCOGENE			English	Article						calpain-mediated proteolysis; E-cadherin fragments; spheroidgenesis; lymphovascular emboli	INFLAMMATORY BREAST-CANCER; P120 CATENIN; BETA-CATENIN; DOWN-REGULATION; CELL-ADHESION; CLEAVAGE; PROTEINS; GTPASE; GROWTH; DOMAIN	The genesis and unique properties of the lymphovascular tumor embolus are poorly understood largely because of the absence of an experimental model that specifically reflects this important step of tumor progression. The lymphovascular tumor embolus is a blastocyst-like structure resistant to chemotherapy, efficient at metastasis and overexpressing E-cadherin (E-cad). Conventional dogma has regarded E-cad as a metastasis-suppressor gene involved in epithelial-mesenchymal transition. However, within the lymphovascular embolus, E-cad and its proteolytic processing by calpain and other proteases have a dominant oncogenic rather than suppressive role in metastasis formation and tumor cell survival. Studies using a human xenograft model of inflammatory breast cancer, MARY-X, demonstrated the equivalence of xenograft-generated spheroids with lymphovascular emboli in vivo with both structures demonstrating E-cad overexpression and specific proteolytic processing. Western blot revealed full-length (FL) E-cad (120 kDa) and four fragments: E-cad/NTF1 (100 kDa), E-cad/NTF2 (95 kDa), E-cad/NTF3 (85 kDa) and E-cad/NTF4 (80 kDa). Compared with MARY-X, only E-cad/NTF1 was present in the spheroids. E-cad/NTF1 was produced by calpain, E-cad/NTF2 by gamma-secretase and E-cad/NTF3 by a matrix metalloproteinase (MMP). Spheroidgenesis and lymphovascular emboli formation are the direct result of calpain-mediated cleavage of E-cad and the generation of E-cad/NTF1 from membrane-associated E-cad rather than the de novo presence of either E-cad/NTF1 or E-cad/CTF1. E-cad/NTF1 retained the p120ctn-binding site but lost both the beta-catenin and alpha-binding sites, facilitating its disassembly from traditional cadherin-based adherens junctions and its 360 degrees distribution around the embolus. This calpain-mediated proteolysis of E-cad generates the formation of the lymphovascular embolus and is responsible for its unique properties of increased homotypic adhesion, apoptosis resistance and budding. Oncogene (2013) 32, 1702-1713; doi:10.1038/onc.2012.180; published online 14 May 2012	[Ye, Y.; Tian, H.; Lange, A. R.; Barsky, S. H.] Univ Nevada, Sch Med, Dept Pathol, Reno, NV 89557 USA; [Yearsley, K.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Robertson, F. M.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Robertson, F. M.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Barsky, S. H.] Whittemore Peterson Inst, Reno, NV USA; [Barsky, S. H.] Nevada Canc Inst, Las Vegas, NV USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego	Barsky, SH (corresponding author), Univ Nevada, Sch Med, Dept Pathol, Whittemore Peterson Inst, 1 Manville Med Bldg,Reno 0350, Reno, NV 89557 USA.	sbarsky@medicine.nevada.edu			Department of Defense Breast Cancer Research Program [BC990959, BC024258, BC053405]; American Airlines-Susan G Komen for the Cure Promise [KG081287-02]; University of Nevada Vasco A Salvadorini Endowment	Department of Defense Breast Cancer Research Program(United States Department of Defense); American Airlines-Susan G Komen for the Cure Promise(Susan G. Komen Breast Cancer Foundation); University of Nevada Vasco A Salvadorini Endowment	We thank Dr John J Hasenau, Dr Walter F Mandeville, Patricia L Atkins and Jared H Smith of Laboratory Animal Medicine for their veterinarian and technical assistance with the maintenance of the MARY-X xenografts. This work was supported by the Department of Defense Breast Cancer Research Program Grants BC990959, BC024258 and BC053405, the American Airlines-Susan G Komen for the Cure Promise Grant KG081287-02 and the University of Nevada Vasco A Salvadorini Endowment.	Alattia JR, 1997, FEBS LETT, V417, P405, DOI 10.1016/S0014-5793(97)01333-1; Albini A, 2010, CURR OPIN CELL BIOL, V22, P677, DOI 10.1016/j.ceb.2010.08.017; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Beronja S, 2005, J CELL BIOL, V169, P635, DOI 10.1083/jcb.200410081; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOPALAKRISHNA R, 1985, ANAL BIOCHEM, V148, P413, DOI 10.1016/0003-2697(85)90247-7; GOPALAKRISHNA R, 1986, J BIOL CHEM, V261, P13936; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hajra KM, 2002, CANCER RES, V62, P1613; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ito K, 1999, ONCOGENE, V18, P7080, DOI 10.1038/sj.onc.1203191; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; NGUYEN M, 1993, NATURE, V365, P267, DOI 10.1038/365267a0; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Quigley JP, 1998, CELL, V94, P281, DOI 10.1016/S0092-8674(00)81470-1; Rios-Doria J, 2003, J BIOL CHEM, V278, P1372, DOI 10.1074/jbc.M208772200; Robertson FM, 2010, J BIOMOL SCREEN, V15, P820, DOI 10.1177/1087057110376541; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; Silvera D, 2009, CELL CYCLE, V8, P3091, DOI 10.4161/cc.8.19.9637; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Tomlinson JS, 2001, CANCER RES, V61, P5231; Toyoshima M, 2007, CANCER RES, V67, P5162, DOI 10.1158/0008-5472.CAN-06-2756; Vallorosi CJ, 2000, J BIOL CHEM, V275, P3328, DOI 10.1074/jbc.275.5.3328; van IJzendoorn SCD, 2006, J CELL SCI, V119, P1679, DOI 10.1242/jcs.02948; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xiao Y, 2011, ONCOGENE, V30, P287, DOI 10.1038/onc.2010.405; Xiao Y, 2008, AM J PATHOL, V173, P561, DOI 10.2353/ajpath.2008.071214; Ye Y, 2010, ANTICANCER RES, V30, P3903; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	51	32	36	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2013	32	13					1702	1713		10.1038/onc.2012.180	http://dx.doi.org/10.1038/onc.2012.180			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22580607				2022-12-25	WOS:000316855800010
J	Cheng, W; Wang, L; Zhang, R; Du, P; Yang, BY; Zhuang, HQ; Tang, B; Yao, C; Yu, M; Wang, YX; Zhang, J; Yin, W; Li, JH; Zheng, WJ; Lu, M; Hua, ZC				Cheng, Wei; Wang, Lu; Zhang, Rong; Du, Pan; Yang, Bingya; Zhuang, Hongqin; Tang, Bo; Yao, Chun; Yu, Mei; Wang, Yuxuan; Zhang, Jing; Yin, Wu; Li, Jiahuang; Zheng, Weijuan; Lu, Min; Hua, Zichun			Regulation of Protein Kinase C Inactivation by Fas-associated Protein with Death Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TURN MOTIF PHOSPHORYLATION; CELL-CYCLE; PHOSPHATASE 2A; MEDIATED APOPTOSIS; FADD RECRUITMENT; CANCER CELLS; ALPHA; PROLIFERATION; DEPHOSPHORYLATION; ACTIVATION	Protein kinase C (PKC) plays important roles in diverse cellular processes. PKC has been implicated in regulating Fas-associated protein with death domain (FADD), an important adaptor protein involved in regulating death receptor-mediated apoptosis. FADD also plays an important role in non-apoptosis processes. The functional interaction of PKC and FADD in non-apoptotic processes has not been examined. In this study, we show that FADD is involved in maintaining the phosphorylation of the turn motif and hydrophobic motif in the activated conventional PKC (cPKC). A phosphoryl-mimicking mutation (S191D) in FADD (FADD-D) abolished the function of FADD in the facilitation of the turn motif and hydrophobic motif dephosphorylation of cPKC, suggesting that phosphorylation of Ser-191 negatively regulates FADD. We show that FADD interacts with PP2A, which is a major phosphatase involved in dephosphorylation of activated cPKC and FADD deficiency abolished PP2A mediated dephosphorylation of cPKC. We show that FADD deficiency leads to increased stability and activity of cPKC, which, in turn, promotes cytoskeleton reorganization, cell motility, and chemotaxis. Collectively, these results reveal a novel function of FADD in a non-apoptotic process by modulating cPKC dephosphorylation, stability, and signaling termination.	[Cheng, Wei; Wang, Lu; Zhang, Rong; Du, Pan; Yang, Bingya; Zhuang, Hongqin; Yao, Chun; Yu, Mei; Wang, Yuxuan; Zhang, Jing; Yin, Wu; Li, Jiahuang; Zheng, Weijuan; Lu, Min; Hua, Zichun] Nanjing Univ, Dept Biochem, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Tang, Bo; Hua, Zichun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou 213164, Peoples R China; [Tang, Bo; Hua, Zichun] Jiangsu Target Pharma Labs Inc, Changzhou 213164, Peoples R China	Nanjing University; Nanjing University	Hua, ZC (corresponding author), Nanjing Univ, Dept Biochem, State Key Lab Pharmaceut Biotechnol, Hankou Rd 22, Nanjing 210093, Jiangsu, Peoples R China.	zchua@nju.edu.cn	Yu, Mei/K-2206-2017		Chinese Ministry of Science and Technology [2012CB967000, 2011CB933502]; Chinese National Nature Sciences Foundation [30821006, 50973046, 31071196, 81072712, 30270291, 30330530, 30425009]; Chinese Ministry of Education [200802840023, 20030284040]; Jiangsu Provincial Nature Science Foundation [BK2010046, B22010074]; Scientific Research Foundation of the Graduate School of Nanjing University	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Nature Sciences Foundation; Chinese Ministry of Education(Ministry of Education, China); Jiangsu Provincial Nature Science Foundation; Scientific Research Foundation of the Graduate School of Nanjing University(Nanjing University)	This study was supported in part by National Key Basic Research Project from the Chinese Ministry of Science and Technology Grants 2012CB967000 and 2011CB933502); Chinese National Nature Sciences Foundation Grants 30821006, 50973046, 31071196, 81072712, 30270291, 30330530, and 30425009; Specialized Research Fund for the Doctoral Program of Higher Education from the Chinese Ministry of Education Grants 200802840023 and 20030284040; Jiangsu Provincial Nature Science Foundation Grant BK2010046 and B22010074; and by the Scientific Research Foundation of the Graduate School of Nanjing University.	Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Bhojani MS, 2005, CELL CYCLE, V4, P1478; Boudreau RTM, 2002, J BIOL CHEM, V277, P5322, DOI 10.1074/jbc.M108623200; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; de Thonel A, 2001, BLOOD, V98, P3770, DOI 10.1182/blood.V98.13.3770; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gibcus JH, 2007, CLIN CANCER RES, V13, P6257, DOI 10.1158/1078-0432.CCR-07-1247; Gomez-Angelats M, 2001, J BIOL CHEM, V276, P44944, DOI 10.1074/jbc.M104919200; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Gysin S, 1997, EUR J BIOCHEM, V249, P156, DOI 10.1111/j.1432-1033.1997.t01-2-00156.x; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Ikehara T, 2006, PROTEIN EXPRES PURIF, V45, P150, DOI 10.1016/j.pep.2005.06.002; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kabra NH, 2001, P NATL ACAD SCI USA, V98, P6307, DOI 10.1073/pnas.111158698; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kotone-Miyahara Y, 2004, J LEUKOCYTE BIOL, V76, P1047, DOI 10.1189/jlb.0104048; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Matsuyoshi S, 2006, BRIT J CANCER, V94, P532, DOI 10.1038/sj.bjc.6602955; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; MEREDITH SD, 1995, ARCH OTOLARYNGOL, V121, P790; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Osborn SL, 2007, J BIOL CHEM, V282, P22786, DOI 10.1074/jbc.M703163200; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Shen HM, 2004, MOL CELL BIOL, V24, P5914, DOI 10.1128/MCB.24.13.5914-5922.2004; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Sun XG, 1999, CELL GROWTH DIFFER, V10, P343; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoo NJ, 2007, PATHOL RES PRACT, V203, P73, DOI 10.1016/j.prp.2006.11.002; Zeidman R, 1999, INT J CANCER, V81, P494, DOI 10.1002/(SICI)1097-0215(19990505)81:3<494::AID-IJC26>3.0.CO;2-L; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang J, 2001, J BIOL CHEM, V276, P29815, DOI 10.1074/jbc.M103838200; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	52	18	18	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26126	26135		10.1074/jbc.M112.342170	http://dx.doi.org/10.1074/jbc.M112.342170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22582393	Green Published, hybrid			2022-12-25	WOS:000306916300040
J	Arbel, N; Ben-Hail, D; Shoshan-Barmatz, V				Arbel, Nir; Ben-Hail, Danya; Shoshan-Barmatz, Varda			Mediation of the Antiapoptotic Activity of Bcl-xL Protein upon Interaction with VDAC1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; MITOCHONDRIAL OUTER-MEMBRANE; CYTOCHROME-C RELEASE; APOPTOTIC CELL-DEATH; DNA-BINDING DOMAIN; FAMILY PROTEINS; MICROSCALE THERMOPHORESIS; CANCER-THERAPY; BAX; BCL-X(L)	The mitochondrial protein, the voltage-dependent anion channel (VDAC), is implicated in the control of apoptosis, including via its interaction with the pro-and antiapoptotic proteins. We previously demonstrated the direct interaction of Bcl2 with VDAC, leading to reduced channel conductance. VDAC1-based peptides interacted with Bcl2 to prevent its antiapoptotic activity. Here, using a variety of approaches, we show the interaction of the antiapoptotic protein, Bcl-xL, with VDAC1 and reveal that this interaction mediates Bcl-xL protection against apoptosis. C-terminally truncated Bcl-xL(Delta 21) interacts with purified VDAC1, as revealed by microscale thermophoresis and as reflected in the reduced channel conductivity of bilayer-reconstituted VDAC1. Overexpression of Bcl-xL prevented staurosporine-induced apoptosis in cells expressing native VDAC1 but not certain VDAC1 mutants. Having identified mutations in VDAC1 that interfere with the Bcl-xL interaction, certain peptides representing VDAC1 sequences, including the N-terminal domain, were designed and generated as recombinant and synthetic peptides. The VDAC1 N-terminal region and two internal sequences were found to bind specifically, and in a concentration-and time-dependent manner, to immobilized Bcl-xL(Delta 21), as revealed by surface plasmon resonance. Moreover, expression of the recombinant peptides in cells overexpressing Bcl-xL prevented protection offered by the protein against staurosporine-induced apoptosis. These results point to Bcl-xL acting as antiapoptotic protein, promoting tumor cell survival via binding to VDAC1. These findings suggest that interfering with Bcl-xL binding to the mitochondria by VDAC1-based peptides may serve to induce apoptosis in cancer cells and to potentiate the efficacy of conventional chemotherapeutic agents.	[Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il		Ben-Hail, Danya/0000-0002-8210-3446	Israel Science Foundation [649/09]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Grant 649/09 from the Israel Science Foundation.	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dias N, 2002, MOL CANCER THER, V1, P347; Gincel D, 2000, J BIOENERG BIOMEMBR, V32, P571, DOI 10.1023/A:1005670527340; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Johnson BW, 2000, J BIOL CHEM, V275, P31546, DOI 10.1074/jbc.M001363200; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Khaw SL, 2011, PATHOLOGY, V43, P525, DOI 10.1097/PAT.0b013e32834b1b34; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Oancea M, 2004, INT J HEMATOL, V80, P224, DOI 10.1532/IJH97.04107; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Reed JC, 1999, J NATL CANCER I, V91, P1099, DOI 10.1093/jnci/91.13.1099; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shimizu S, 2000, ONCOGENE, V19, P4309, DOI 10.1038/sj.onc.1203788; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; TANAKA S, 1993, J BIOL CHEM, V268, P10920; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yi XL, 2003, J BIOL CHEM, V278, P16992, DOI 10.1074/jbc.M300039200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; ZEHAVA CL, 1990, J BIOL CHEM, V265, P4929; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x; Zillner K, 2012, METHODS MOL BIOL, V815, P241, DOI 10.1007/978-1-61779-424-7_18	60	122	126	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23152	23161		10.1074/jbc.M112.345918	http://dx.doi.org/10.1074/jbc.M112.345918			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589539	hybrid, Green Published			2022-12-25	WOS:000306495000070
J	Kemp, MG; Reardon, JT; Lindsey-Boltz, LA; Sancar, A				Kemp, Michael G.; Reardon, Joyce T.; Lindsey-Boltz, Laura A.; Sancar, Aziz			Mechanism of Release and Fate of Excised Oligonucleotides during Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DNA-REPAIR; ESCHERICHIA-COLI; THYMINE DIMERS; HUMAN-CELLS; PYRIMIDINE DIMERS; HUMAN-FIBROBLASTS; NUCLEASE; DAMAGE	A wide range of environmental and carcinogenic agents form bulky lesions on DNA that are removed from the human genome in the form of short, similar to 30-nucleotide oligonucleotides by the process of nucleotide excision repair. Although significant insights have been made regarding the mechanisms of damage recognition, dual incisions, and repair resynthesis during nucleotide excision repair, the fate of the dual incision/excision product is unknown. Using excision assays with both mammalian cell-free extract and purified proteins, we unexpectedly discovered that lesion-containing oligonucleotides are released from duplex DNA in complex with the general transcription and repair factor, Transcription Factor IIH (TFIIH). Release of excision products from TFIIH requires ATP but not ATP hydrolysis, and release occurs slowly, with a t(1/2) of 3.3 h. Excised oligonucleotides released from TFIIH then become bound by the single-stranded binding protein Replication Protein A or are targeted by cellular nucleases. These results provide a mechanism for release and an understanding of the initial fate of excised oligonucleotides during nucleotide excision repair.	[Kemp, Michael G.; Reardon, Joyce T.; Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010; Kemp, Michael G./AAT-1545-2021	Lindsey-Boltz, Laura/0000-0001-6493-8194; Kemp, Michael G./0000-0001-8203-0745	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32833 (to A. S.).	Bessho T, 1997, MOL CELL BIOL, V17, P6822, DOI 10.1128/MCB.17.12.6822; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; BOYCE RP, 1964, P NATL ACAD SCI USA, V51, P293, DOI 10.1073/pnas.51.2.293; CLEAVER JE, 1991, PHOTOCHEM PHOTOBIOL, V54, P393, DOI 10.1111/j.1751-1097.1991.tb02033.x; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HUANG JC, 1994, J BIOL CHEM, V269, P19034; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; KAYE J, 1980, CANCER RES, V40, P696; LABELLE M, 1982, PHOTOCHEM PHOTOBIOL, V36, P319, DOI 10.1111/j.1751-1097.1982.tb04381.x; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Mu D, 1997, J BIOL CHEM, V272, P28971, DOI 10.1074/jbc.272.46.28971; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; ORREN DK, 1992, J BIOL CHEM, V267, P780; Pathania S, 2011, MOL CELL, V44, P235, DOI 10.1016/j.molcel.2011.09.002; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reardon JT, 1996, J BIOL CHEM, V271, P19451, DOI 10.1074/jbc.271.32.19451; Reardon JT, 1997, NUCLEIC ACIDS RES, V25, P1015, DOI 10.1093/nar/25.5.1015; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Reardon JT, 2002, MOL CELL BIOL, V22, P5938, DOI 10.1128/MCB.22.16.5938-5945.2002; REGAN JD, 1968, BIOPHYS J, V8, P319, DOI 10.1016/S0006-3495(68)86490-2; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SETLOW RB, 1969, P NATL ACAD SCI USA, V64, P1035, DOI 10.1073/pnas.64.3.1035; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; WEINFELD M, 1986, BIOCHEMISTRY-US, V25, P2656, DOI 10.1021/bi00357a055; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	43	64	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22889	22899		10.1074/jbc.M112.374447	http://dx.doi.org/10.1074/jbc.M112.374447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573372	Green Published, hybrid			2022-12-25	WOS:000306495000046
J	Liew, CW; Nilsson, M; Chen, MW; Sun, HH; Cornvik, T; Liang, ZX; Lescar, J				Liew, Chong Wai; Nilsson, Martina; Chen, Ming Wei; Sun, Huihua; Cornvik, Tobias; Liang, Zhao-Xun; Lescar, Julien			Crystal Structure of the Acyltransferase Domain of the Iterative Polyketide Synthase in Enediyne Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; ANTITUMOR ANTIBIOTIC C-1027; COA-ACP TRANSACYLASE; MALONYL-COA; GENE-CLUSTER; 6-DEOXYERYTHRONOLIDE-B SYNTHASE; STREPTOMYCES-COELICOLOR; HELICOBACTER-PYLORI; ESCHERICHIA-COLI; DOCKING SITE	Biosynthesis of the enediyne natural product dynemicin in Micromonospora chersina is initiated by DynE8, a highly reducing iterative type I polyketide synthase that assembles polyketide intermediates from the acetate units derived solely from malonyl-CoA. To understand the substrate specificity and the evolutionary relationship between the acyltransferase (AT) domains of DynE8, fatty acid synthase, and modular polyketide synthases, we overexpressed a 44-kDa fragment of DynE8 (hereafter named AT(DYN10)) encompassing its entire AT domain and the adjacent linker domain. The crystal structure at 1.4 angstrom resolution unveils a alpha/beta hydrolase and a ferredoxin-like subdomain with the Ser-His catalytic dyad located in the cleft between the two subdomains. The linker domain also adopts a alpha/beta fold abutting the AT catalytic domain. Co-crystallization with malonyl-CoA yielded a malonyl-enzyme covalent complex that most likely represents the acyl-enzyme intermediate. The structure explains the preference for malonyl-CoA with a conserved arginine orienting the carboxylate group of malonate and several nonpolar residues that preclude alpha-alkyl malonyl-CoA binding. Co-crystallization with acetyl-CoA revealed two noncovalently bound acetates generated by the enzymatic hydrolysis of acetylCoA that acts as an inhibitor for DynE8. This suggests that the AT domain can upload the acyl groups from either malonyl-CoA or acetyl-CoA onto the catalytic Ser(651) residue. However, although the malonyl group can be transferred to the acyl carrier protein domain, transfer of the acetyl group to the acyl carrier protein domain is suppressed. Local structural differences may account for the different stability of the acyl-enzyme intermediates.	[Liew, Chong Wai; Nilsson, Martina; Chen, Ming Wei; Sun, Huihua; Cornvik, Tobias; Liang, Zhao-Xun; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Lescar, Julien] CNRS, UMR 6098, Marseille, France	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Liang, ZX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	zxliang@ntu.edu.sg; Julien@ntu.edu.sg	Liang, Zhao-Xun/A-2191-2011	Chen, Ming Wei/0000-0003-0718-866X; Liang, Zhao-Xun/0000-0002-3128-1330; Sun, Huihua/0000-0002-0538-7553	Ministry of Education of Singapore through Academic Research Council; Biomedical Research Council [08/1/22/19/589]; CNRS	Ministry of Education of Singapore through Academic Research Council(Ministry of Education, Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work is supported by the Ministry of Education of Singapore through Academic Research Council grants (to Z.-X. L.), Biomedical Research Council grant 08/1/22/19/589, and an Action Thematique et Incitative sur Programme from the CNRS (to J. L.).	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Chen AY, 2007, CHEM BIOL, V14, P784, DOI 10.1016/j.chembiol.2007.05.015; Chen AY, 2006, J AM CHEM SOC, V128, P3067, DOI 10.1021/ja058093d; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dreier J, 2001, BIOCHEMISTRY-US, V40, P12407, DOI 10.1021/bi011108+; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao Q, 2008, FEMS MICROBIOL LETT, V282, P105, DOI 10.1111/j.1574-6968.2008.01112.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hong SK, 2010, FEBS LETT, V584, P1240, DOI 10.1016/j.febslet.2010.02.038; JOSHI VC, 1971, ARCH BIOCHEM BIOPHYS, V143, P493, DOI 10.1016/0003-9861(71)90234-7; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kim CY, 2004, BIOCHEMISTRY-US, V43, P13892, DOI 10.1021/bi048418n; Kong R, 2008, J AM CHEM SOC, V130, P8142, DOI 10.1021/ja8019643; Kotaka M, 2009, J BIOL CHEM, V284, P15739, DOI 10.1074/jbc.M809669200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang ZX, 2010, NAT PROD REP, V27, P499, DOI 10.1039/b908165h; Liew CW, 2010, J MOL BIOL, V404, P291, DOI 10.1016/j.jmb.2010.09.041; Lim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020549; Liu W, 2005, CHEM BIOL, V12, P293, DOI 10.1016/j.chembiol.2004.12.013; Liu W, 2000, ANTIMICROB AGENTS CH, V44, P382, DOI 10.1128/AAC.44.2.382-392.2000; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; Liu WZ, 2006, FEBS LETT, V580, P697, DOI 10.1016/j.febslet.2005.12.085; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Murugan E, 2008, FEBS LETT, V582, P1097, DOI 10.1016/j.febslet.2008.02.061; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SERRE L, 1994, J MOL BIOL, V242, P99, DOI 10.1006/jmbi.1994.1559; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen B., 2005, FRONTIER MED CHEM, V2, P357; Smith AL, 1996, J MED CHEM, V39, P2103, DOI 10.1021/jm9600398; Sun HH, 2009, CHEM COMMUN, P7399, DOI 10.1039/b916751j; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Van Lanen SG, 2007, J AM CHEM SOC, V129, P13082, DOI 10.1021/ja073275o; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wong FT, 2011, BIOCHEMISTRY-US, V50, P6539, DOI 10.1021/bi200632j; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784; Zhang L, 2007, PROTEIN SCI, V16, P1184, DOI 10.1110/ps.072757307; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200	48	28	28	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23203	23215		10.1074/jbc.M112.362210	http://dx.doi.org/10.1074/jbc.M112.362210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589546	Green Published, hybrid			2022-12-25	WOS:000306495000075
J	Sricholpech, M; Perdivara, I; Yokoyama, M; Nagaoka, H; Terajima, M; Tomer, KB; Yamauchi, M				Sricholpech, Marnisa; Perdivara, Irina; Yokoyama, Megumi; Nagaoka, Hideaki; Terajima, Masahiko; Tomer, Kenneth B.; Yamauchi, Mitsuo			Lysyl Hydroxylase 3-mediated Glucosylation in Type I Collagen MOLECULAR LOCI AND BIOLOGICAL SIGNIFICANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING; BONE-COLLAGEN; OSTEOGENESIS IMPERFECTA; TRABECULAR BONE; POSTTRANSLATIONAL MODIFICATIONS; MATRIX MINERALIZATION; ARTICULAR-CARTILAGE; GLYCOSYLATED COLLAGEN; AMINO-ACIDS; RAT	Recently, by employing the short hairpin RNA technology, we have generated MC3T3-E1 (MC)-derived clones stably suppressing lysyl hydroxylase 3 (LH3) (short hairpin (Sh) clones) and demonstrated the LH3 function as glucosyltransferase in type I collagen (Sricholpech, M., Perdivara, I., Nagaoka, H., Yokoyama, M., Tomer, K. B., and Yamauchi, M. (2011) Lysyl hydroxylase 3 glucosylates galactosylhydroxylysine residues in type I collagen in osteoblast culture. J. Biol. Chem. 286, 8846-8856). To further elucidate the biological significance of this modification, we characterized and compared type I collagen phenotypes produced by Sh clones and two control groups, MC and those transfected with empty vector. Mass spectrometric analysis identified five glycosylation sites in type I collagen (i.e. alpha 1,2-87, alpha 1,2-174, and alpha 2-219. Of these, the predominant glycosylation site was alpha 1-87, one of the major helical cross-linking sites. In Sh collagen, the abundance of glucosylgalactosylhydroxylysine was significantly decreased at all of the five sites with a concomitant increase in galactosylhydroxylysine at four of these sites. The collagen cross-links were significantly diminished in Sh clones, and, for the major cross-link, dihydroxylysinonorleucine (DHLNL), glucosylgalactosyl-DHLNL was diminished with a concomitant increase in galactosyl-DHLNL. When subjected to in vitro incubation, in Sh clones, the rate of decrease in DHLNL was lower, whereas the rate of increase in its maturational cross-link, pyridinoline, was comparable with controls. Furthermore, in Sh clones, the mean diameters of collagen fibrils were significantly larger, and the onset of mineralized nodule formation was delayed when compared with those of controls. These results indicate that the LH3-mediated glucosylation occurs at the specific molecular loci in the type I collagen molecule and plays critical roles in controlling collagen cross-linking, fibrillogenesis, and mineralization.	[Yamauchi, Mitsuo] Univ N Carolina, NC Oral Hlth Inst, Sch Dent, Chapel Hill, NC 27599 USA; [Perdivara, Irina; Tomer, Kenneth B.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Yamauchi, M (corresponding author), Univ N Carolina, NC Oral Hlth Inst, Sch Dent, CB 7454, Chapel Hill, NC 27599 USA.	mitsuo_yamauchi@dentistry.unc.edu	Tomer, Kenneth B/E-8018-2013	Sricholpech, Marnisa/0000-0003-2139-0688	National Institutes of Health [R21 DE019569, DE020909, AR060978]; National Institutes of Health, NIEHS [ES050171]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE020909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050171, Z01ES050171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DE019569, DE020909, and AR060978 and the Intramural Research Program of National Institutes of Health, NIEHS, Project ES050171.	AGUILAR JH, 1973, J BIOL CHEM, V248, P5106; AMUDESWARI S, 1987, COLLAGEN REL RES, V7, P215; Atsawasuwan P, 2005, BIOCHEM BIOPH RES CO, V327, P1042, DOI 10.1016/j.bbrc.2004.12.119; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; BAILEY AJ, 1973, BIOCHIM BIOPHYS ACTA, V328, P383, DOI 10.1016/0005-2795(73)90272-9; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; Batge B, 1997, J BIOCHEM, V122, P109; BRENNER RE, 1990, EUR J CLIN INVEST, V20, P8, DOI 10.1111/j.1365-2362.1990.tb01785.x; Brinckmann J, 1999, J INVEST DERMATOL, V113, P617, DOI 10.1046/j.1523-1747.1999.00735.x; BUTLER WT, 1966, J BIOL CHEM, V241, P3882; CETTA G, 1983, CONNECT TISSUE RES, V11, P103, DOI 10.3109/03008208309004847; CRONLUND AL, 1985, CONNECT TISSUE RES, V14, P109, DOI 10.3109/03008208509015017; CUNNINGH.LW, 1968, J BIOL CHEM, V243, P2390; Dominguez LJ, 2005, BIOCHEM BIOPH RES CO, V330, P1, DOI 10.1016/j.bbrc.2005.02.050; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2010, J BIOL CHEM, V285, P16675, DOI 10.1074/jbc.M110.111534; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; EYRE DR, 1973, BIOCHEM BIOPH RES CO, V52, P663, DOI 10.1016/0006-291X(73)90764-X; EYRE DR, 1980, BIOCHEM BIOPH RES CO, V92, P403, DOI 10.1016/0006-291X(80)90347-2; Fietzek P P, 1976, Int Rev Connect Tissue Res, V7, P1; Gineyts E, 2001, RHEUMATOLOGY, V40, P315, DOI 10.1093/rheumatology/40.3.315; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; HENKEL W, 1976, EUR J BIOCHEM, V69, P223, DOI 10.1111/j.1432-1033.1976.tb10877.x; Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kivirikko K I, 1979, Int Rev Connect Tissue Res, V8, P23; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; LEHMANN HW, 1995, J CANCER RES CLIN, V121, P413, DOI 10.1007/BF01212948; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MICHALSKY M, 1993, BIOCHEM BIOPH RES CO, V192, P1281, DOI 10.1006/bbrc.1993.1555; Miller EJ, 1984, EXTRACELLULAR MATRIX, P41; Mochida Y, 2003, BIOCHEM BIOPH RES CO, V305, P6, DOI 10.1016/S0006-291X(03)00693-4; Mochida Y, 2009, MATRIX BIOL, V28, P44, DOI 10.1016/j.matbio.2008.11.003; MORGAN PH, 1970, J BIOL CHEM, V245, P5042; Moro L, 1997, EUR J CLIN CHEM CLIN, V35, P29; Moro L, 1997, EUR J CLIN CHEM CLIN, V35, P269; Moro L, 2000, CALCIFIED TISSUE INT, V66, P151, DOI 10.1007/s002230010030; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; OTSUBO K, 1992, BIOCHEMISTRY-US, V31, P396, DOI 10.1021/bi00117a013; Palmieri D, 2010, EXP CELL RES, V316, P789, DOI 10.1016/j.yexcr.2009.12.006; Parisuthiman D, 2005, J BONE MINER RES, V20, P1878, DOI 10.1359/JBMR.050612; PETRUSKA JA, 1964, P NATL ACAD SCI USA, V51, P871, DOI 10.1073/pnas.51.5.871; PINNELL SR, 1971, BIOCHIM BIOPHYS ACTA, V229, P119, DOI 10.1016/0005-2795(71)90325-4; Pornprasertsuk S, 2005, J BONE MINER RES, V20, P81, DOI 10.1359/JBMR.041026; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; ROBINS SP, 1983, BIOCHEM J, V215, P175, DOI 10.1042/bj2150175; ROBINS SP, 1975, BIOCHEM J, V149, P381, DOI 10.1042/bj1490381; ROBINS SP, 1983, BIOCHEM J, V215, P167, DOI 10.1042/bj2150167; ROBINS SP, 1977, BIOCHIM BIOPHYS ACTA, V492, P408, DOI 10.1016/0005-2795(77)90092-7; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; SAVOLAINEN ER, 1981, NEW ENGL J MED, V304, P197, DOI 10.1056/NEJM198101223040403; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; SCHOFIELD JD, 1971, BIOCHEM J, V124, P467, DOI 10.1042/bj1240467; SEGREST JP, 1970, J CLIN INVEST, V49, P1497, DOI 10.1172/JCI106367; SHINKAI H, 1979, BIOCHEM J, V177, P847, DOI 10.1042/bj1770847; Siegel R C, 1976, Adv Exp Med Biol, V74, P438; Silver FH, 2011, CONNECT TISSUE RES, V52, P242, DOI 10.3109/03008207.2010.551567; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Suarez KN, 1996, CALCIFIED TISSUE INT, V58, P65, DOI 10.1007/s002239900012; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; TENNI R, 1993, AM J MED GENET, V45, P252, DOI 10.1002/ajmg.1320450219; TOOLE BP, 1972, BIOCHEM J, V127, P715, DOI 10.1042/bj1270715; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; YAMAUCHI M, 1982, P NATL ACAD SCI-BIOL, V79, P7684, DOI 10.1073/pnas.79.24.7684; Yamauchi M, 1989, Connect Tissue Res, V21, P159, DOI 10.3109/03008208909050006; YAMAUCHI M, 1993, CONNECT TISSUE RES, V29, P81, DOI 10.3109/03008209309014236; YAMAUCHI M, 1986, BIOCHEMISTRY-US, V25, P4907, DOI 10.1021/bi00365a027; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI DOI 10.1042/BSE0520113; Yamauchi M, 1988, COLLAGEN, P157; Yamauchi M., 1989, CONNECT TISSUE RES, V21, P168; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; YANG CLL, 1993, EUR J BIOCHEM, V213, P1297, DOI 10.1111/j.1432-1033.1993.tb17881.x	81	65	67	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22998	23009		10.1074/jbc.M112.343954	http://dx.doi.org/10.1074/jbc.M112.343954			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573318	Green Published, hybrid			2022-12-25	WOS:000306495000056
J	Manske, SL; Good, CA; Zernicke, RF; Boyd, SK				Manske, Sarah L.; Good, Craig A.; Zernicke, Ronald F.; Boyd, Steven K.			High-Frequency, Low-Magnitude Vibration Does Not Prevent Bone Loss Resulting from Muscle Disuse in Mice following Botulinum Toxin Injection	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; MECHANICAL SIGNALS; LOW-LEVEL; MEDIAL GASTROCNEMIUS; POSTMENOPAUSAL WOMEN; INBRED STRAINS; STRENGTH; DENSITY; MASS; ENHANCE	High-frequency, low-magnitude vibration enhances bone formation ostensibly by mimicking normal postural muscle activity. We tested this hypothesis by examining whether daily exposure to low-magnitude vibration (VIB) would maintain bone in a muscle disuse model with botulinum toxin type A (BTX). Female 16-18 wk old BALB/c mice (N = 36) were assigned to BTX-VIB, BTX-SHAM, VIB, or SHAM. BTX mice were injected with BTX (20 mu L; 1 U/100 g body mass) into the left hindlimb posterior musculature. All mice were anaesthetized for 20 min/d, 5 d/wk, for 3 wk, and the left leg mounted to a holder. Through the holder, VIB mice received 45 Hz, =0.6 g sinusoidal acceleration without weight bearing. SHAM mice received no vibration. At baseline and 3 wk, muscle cross-sectional area (MCSA) and tibial bone properties (epiphysis, metaphysis and diaphysis) were assessed by in vivo micro-CT. Bone volume fraction in the metaphysis decreased 12 +/- 9% and 7 +/- 6% in BTX-VIB and BTX-SHAM, but increased in the VIB and SHAM. There were no differences in dynamic histomorphometry outcomes between BTX-VIB and BTX nor between VIB and SHAM. Thus, vibration did not prevent bone loss induced by a rapid decline in muscle activity nor produce an anabolic effect in normal mice. The daily loading duration was shorter than would be expected from postural muscle activity, and may have been insufficient to prevent bone loss. Based on the approach used in this study, vibration does not prevent bone loss in the absence of muscle activity induced by BTX.	[Manske, Sarah L.; Zernicke, Ronald F.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Manske, Sarah L.; Good, Craig A.; Boyd, Steven K.] Univ Calgary, Schulich Sch Engn, Calgary, AB, Canada; [Zernicke, Ronald F.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Zernicke, Ronald F.] Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Zernicke, Ronald F.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Zernicke, Ronald F.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	University of Calgary; University of Calgary; University of Calgary; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Manske, SL (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.	zernicke@umich.edu	Boyd, Steven K/E-9595-2010; Manske, Sarah/B-5920-2011; Manske, Sarah/AAF-6917-2020	Boyd, Steven K/0000-0002-2930-5997; Manske, Sarah/0000-0003-0888-9556; Manske, Sarah/0000-0003-0888-9556	Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Innovates - Health Solutions; Killam Trust	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates - Health Solutions; Killam Trust	Sarah L. Manske was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca/), Alberta Innovates - Health Solutions, and the Killam Trust. Steven K. Boyd is a Senior Scholar supported by Alberta Innovates - Health Solutions (http://www.aihealthsolutions.ca/). Neither funder is a profit-making organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD EK, 1987, EXP NEUROL, V96, P635, DOI 10.1016/0014-4886(87)90225-1; Bacabac RG, 2006, FASEB J, V20, P858, DOI 10.1096/fj.05-4966.com; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; Belavy DL, 2009, J MUSCULOSKEL NEURON, V9, P225; Bemben DA, 2010, BONE, V47, P650, DOI 10.1016/j.bone.2010.06.019; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brouwers JEM, 2010, J ORTHOP RES, V28, P62, DOI 10.1002/jor.20951; Buie HR, 2007, BONE, V41, P505, DOI 10.1016/j.bone.2007.07.007; Buie HR, 2008, J BONE MINER RES, V23, P2048, DOI 10.1359/JBMR.080808; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; Christiansen BA, 2006, ANN BIOMED ENG, V34, P1149, DOI 10.1007/s10439-006-9133-5; Christiansen BA, 2009, BONE, V45, P750, DOI 10.1016/j.bone.2009.06.025; Eleopra R, 1997, MOVEMENT DISORD, V12, P89, DOI 10.1002/mds.870120115; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; Garman R, 2007, J ORTHOP RES; Garman R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000653; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang RP, 1999, J GERONTOL A-BIOL, V54, pB352, DOI 10.1093/gerona/54.8.B352; JANKOVICH JP, 1972, J BIOMECH, V5, P241, DOI 10.1016/0021-9290(72)90038-3; Judex S, 2004, J BONE MINER RES, V19, P607, DOI 10.1359/JBMR.040110; Judex S, 2002, FASEB J, V16, P1280, DOI 10.1096/fj.01-0913fje; Judex S, 2005, J CELL BIOCHEM, V94, P982, DOI 10.1002/jcb.20363; Judex S, 2010, J MUSCULOSKEL NEURON, V10, P3; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; Kang BS, 2007, AM J PHYS MED REHAB, V86, P901, DOI 10.1097/PHM.0b013e3181520449; Kim HS, 2003, DEV MED CHILD NEUROL, V45, P200, DOI 10.1017/S0012162203000380; Lau E, 2010, BONE, V46, P1508, DOI 10.1016/j.bone.2010.02.031; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Manske SL, 2011, J BIOMECH, V44, P637, DOI 10.1016/j.jbiomech.2010.11.011; Manske SL, 2010, CALCIFIED TISSUE INT, V87, P541, DOI 10.1007/s00223-010-9428-2; Manske SL, 2010, BONE, V46, P24, DOI 10.1016/j.bone.2009.10.016; Manske SL, J BIOMECH UNPUB; Misiaszek JE, 2002, J NEUROPHYSIOL, V87, P229, DOI 10.1152/jn.00410.2001; MONSTER AW, 1977, J NEUROPHYSIOL, V40, P1432, DOI 10.1152/jn.1977.40.6.1432; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; ORIZIO C, 1990, J APPL PHYSIOL, V68, P508, DOI 10.1152/jappl.1990.68.2.508; Oxlund BS, 2003, BONE, V32, P69, DOI 10.1016/S8756-3282(02)00916-X; Ozcivici E, 2007, J BIOMECH, V40, P3404, DOI 10.1016/j.jbiomech.2007.05.015; Ozcivici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011178; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Poliachik SL, 2010, BONE, V46, P18, DOI 10.1016/j.bone.2009.10.025; Qin YX, 1998, J ORTHOPAED RES, V16, P482, DOI 10.1002/jor.1100160414; Robling AG, 2009, MED SCI SPORT EXER, V41, P2044, DOI 10.1249/MSS.0b013e3181a8c702; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; RUBIN CT, 1994, CLIN ORTHOP RELAT R, P165; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; Russo CR, 2003, ARCH PHYS MED REHAB, V84, P1854, DOI 10.1016/S0003-9993(03)00357-5; Slatkovska L, 2010, J BONE MINER RES; Slatkovska L, 2011, ANN INTERN MED, V155, P668, DOI 10.7326/0003-4819-155-10-201111150-00005; Tabachnick B.G., 2007, EXPT DESIGNS USING A; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; von Stengel S, 2011, OSTEOPOROSIS INT, V22, P317, DOI 10.1007/s00198-010-1215-4; Wakeling JM, 2001, J APPL PHYSIOL, V90, P412, DOI 10.1152/jappl.2001.90.2.412; WALMSLEY B, 1978, J NEUROPHYSIOL, V41, P1203, DOI 10.1152/jn.1978.41.5.1203; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Warner SE, 2006, RANKL INHIBITION PRE; Xie LQ, 2008, J APPL PHYSIOL, V104, P1056, DOI 10.1152/japplphysiol.00764.2007; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012	65	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36486	10.1371/journal.pone.0036486	http://dx.doi.org/10.1371/journal.pone.0036486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590551	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336400018
J	Murata, Y; Oda, S; Mitani, H				Murata, Yasuhiko; Oda, Shoji; Mitani, Hiroshi			Allelic Expression Changes in Medaka (Oryzias latipes) Hybrids between Inbred Strains Derived from Genetically Distant Populations	PLOS ONE			English	Article							GENE-EXPRESSION; DNMT3L; DIVERGENCE; EVOLUTION; FAMILY; SCALE; JAPAN; DNA	Variations in allele expressions between genetically distant populations are one of the most important factors which affects their morphological and physiological variations. These variations are caused by natural mutations accumulated in their habitats. It has been reported that allelic expression differences in the hybrids of genetically distant populations are different from parental strains. In that case, there is a possibility that allelic expression changes lead to novel phenotypes in hybrids. Based on genomic information of the genetically distant populations, quantification and comparison of allelic expression changes make importance of regulatory sequences (cis-acting factors) or upstream regulatory factors (transacting modulators) for these changes clearer. In this study, we focused on two Medaka inbred strains, Hd-rR and HNI, derived from genetically distant populations and their hybrids. They are highly polymorphic and we can utilize whole-genome information. To analyze allelic expression changes, we established a method to quantify and compare allele-specific expressions of 11 genes between the parental strains and their reciprocal hybrids. In intestines of reciprocal hybrids, allelic expression was either similar or different in comparison with the parental strains. Total expressions in Hd-rR and HNI were tissue-dependent in the case of HPRT1, with high up-regulation of Hd-rR allele expression in liver. The proportion of genes with differential allelic expression in Medaka hybrids seems to be the same as that in other animals, despite the high SNP rate in the genomes of the two inbred strains. It is suggested that each tissue of the strain difference in trans-acting modulators is more important than polymorphisms in cis-regulatory sequences in producing the allelic expression changes in reciprocal hybrids.	[Murata, Yasuhiko; Oda, Shoji; Mitani, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	University of Tokyo	Murata, Y (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 755, Japan.	mitani@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, and Technology of Japan [21221003]	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grand-in-Aid for Scientific Research (21221003) from the Ministry of Education, Culture, Sports, and Technology of Japan to H.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; EGAMI N., 1954, ANNOT ZOOL JAPONENSES, V27, P7; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Hata K, 2002, DEVELOPMENT, V129, P1983; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kimura T, 2004, MECH DEVELOP, V121, P915, DOI 10.1016/j.mod.2004.03.033; Kondo M, 2004, CURR BIOL, V14, P1664, DOI 10.1016/j.cub.2004.09.026; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; KWOK S, 1994, PCR METH APPL, V3, pS39; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Matsumoto Yoshifumi, 2009, BMC Res Notes, V2, P88, DOI 10.1186/1756-0500-2-88; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Oota H, 2011, MEDAKA: A MODEL FOR ORGANOGENESIS, HUMAN DISEASE, AND EVOLUTION, P339, DOI 10.1007/978-4-431-92691-7_22; SAKAIZUMI M, 1986, GENETICA, V69, P119, DOI 10.1007/BF00115131; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Setiamarga DHE, 2009, BIOL LETTERS, V5, P812, DOI 10.1098/rsbl.2009.0419; Shima A, 2004, MECH DEVELOP, V121, P599, DOI 10.1016/j.mod.2004.03.011; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; YAMAMOTO TO, 1968, J EXP ZOOL, V168, P215, DOI 10.1002/jez.1401680209; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36875	10.1371/journal.pone.0036875	http://dx.doi.org/10.1371/journal.pone.0036875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590630	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336400042
J	Armstrong, NJ; Fagotto, F; Prothmann, C; Rupp, RAW				Armstrong, Neil J.; Fagotto, Francois; Prothmann, Christian; Rupp, Ralph A. W.			Maternal Wnt/beta-Catenin Signaling Coactivates Transcription through NF-kappa B Binding Sites during Xenopus Axis Formation	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; BETA-CATENIN; SPEMANN ORGANIZER; NEURAL INDUCTION; GENE-EXPRESSION; LAEVIS EMBRYOS; ACTIVE REPRESSION; DROSOPHILA EMBRYO; ACTIVATION; PROTEIN	Maternal Wnt/beta-Catenin signaling establishes a program of dorsal-specific gene expression required for axial patterning in Xenopus. We previously reported that a subset of dorsally expressed genes depends not only on Wnt/beta-Catenin stimulation, but also on a MyD88-dependent Toll-like receptor/IL1-receptor (TLR/IL1-R) signaling pathway. Here we show that these two signal transduction cascades converge in the nucleus to coactivate gene transcription in blastulae through a direct interaction between beta-Catenin and NF-kappa B proteins. A transdominant inhibitor of NF-kappa B, Delta NI kappa B alpha, phenocopies loss of MyD88 protein function, implicating Rel/NF-kappa B proteins as selective activators of dorsal-specific gene expression. Sensitive axis formation assays in the embryo demonstrate that dorsalization by Wnt/beta-Catenin requires NF-kappa B protein activity, and vice versa. Xenopus nodal-related 3 (Xnr3) is one of the genes with dual beta-Catenin/NF-kappa B input, and a proximal NF-kappa B consensus site contributes to the regional activity of its promoter. We demonstrate in vitro binding of Xenopus beta-Catenin to several XRel proteins. This interaction is observed in vivo upon Wnt-stimulation. Finally, we show that a synthetic luciferase reporter gene responds to both endogenous and exogenous beta-Catenin levels in an NF-kappa B motif dependent manner. These results suggest that beta-Catenin acts as a transcriptional co-activator of NF-kappa B-dependent transcription in frog primary embryonic cells.	[Armstrong, Neil J.; Prothmann, Christian; Rupp, Ralph A. W.] Univ Munich, Dept Mol Biol, Adolf Butenandt Inst, Munich, Germany; [Fagotto, Francois] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Munich; McGill University	Armstrong, NJ (corresponding author), DNALogic Ltd, Dept Evolutionary Algorithms, Stockton Brook, Staffs, England.	ralph.rupp@med.uni-muenchen.de	Fagotto, Francois/AAA-9983-2021	Fagotto, Francois/0000-0002-1495-2112; rupp, ralph/0000-0002-8068-9957	Deutsche Forschungsgemeinschaft [SPP1027, Ru448/3-3]; Canadian Cancer Research Society; CCSRI [017162]; Cancer Research Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Cancer Research Society; CCSRI; Cancer Research Society	RR received support from the Deutsche Forschungsgemeinschaft (SPP1027/project Ru448/3-3). FF was supported by the Canadian Cancer Research Society and by CCSRI grant #017162. FF was partly supported by a Cancer Research Society Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Armstrong NJ, 1998, MECH DEVELOP, V71, P99, DOI 10.1016/S0925-4773(98)00003-3; BEARER EL, 1994, EUR J CELL BIOL, V63, P255; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Combriato G, 2002, J IMMUNOL, V168, P1259, DOI 10.4049/jimmunol.168.3.1259; Correa RG, 2004, MOL CELL BIOL, V24, P5257, DOI 10.1128/MCB.24.12.5257-5268.2004; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; DEMARAIS AA, 1992, DEV BIOL, V153, P337, DOI 10.1016/0012-1606(92)90118-Z; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Dissing M, 2001, EMBO J, V20, P2387, DOI 10.1093/emboj/20.10.2387; DOMINGUEZ I, 1993, MOL CELL BIOL, V13, P1290, DOI 10.1128/MCB.13.2.1290; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hansen CS, 1997, DEVELOPMENT, V124, P483; Haramoto Y, 2004, DEV BIOL, V265, P155, DOI 10.1016/j.ydbio.2003.09.015; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden Matthew S, 2006, Cell, V127, P1286; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Houston DW, 2002, DEVELOPMENT, V129, P4015; Ishii A, 2007, IMMUNOGENETICS, V59, P281, DOI 10.1007/s00251-007-0193-y; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; KAO KR, 1991, P NATL ACAD SCI USA, V88, P2697, DOI 10.1073/pnas.88.7.2697; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kurth T, 1999, DEV DYNAM, V215, P155, DOI 10.1002/(SICI)1097-0177(199906)215:2<155::AID-DVDY8>3.0.CO;2-S; Laurent MN, 1997, DEVELOPMENT, V124, P4905; LeMosy EK, 2001, P NATL ACAD SCI USA, V98, P5055, DOI 10.1073/pnas.081026598; Li QT, 2000, GENE DEV, V14, P1729; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; NIEHRS C, 1994, SCIENCE, V263, P817, DOI 10.1126/science.7905664; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; Prothmann C, 2000, MECH DEVELOP, V97, P85, DOI 10.1016/S0925-4773(00)00447-0; RICHARDSON JC, 1994, MECH DEVELOP, V45, P173, DOI 10.1016/0925-4773(94)90031-0; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schohl A, 2002, DEVELOPMENT, V129, P37; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH WC, 1995, CELL, V82, P37, DOI 10.1016/0092-8674(95)90050-0; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Standley HJ, 2006, DEV BIOL, V289, P318, DOI 10.1016/j.ydbio.2005.10.012; Steinbach OC, 1999, METH MOL B, V127, P41, DOI 10.1385/1-59259-678-9:41; Stoetzel C, 1998, INT J DEV BIOL, V42, P747; Sun J, 2005, AM J PHYSIOL-GASTR L, V289, pG129, DOI 10.1152/ajpgi.00515.2004; Suzuki K, 1998, GENE, V206, P1, DOI 10.1016/S0378-1119(97)00561-1; SUZUKI K, 1995, NUCLEIC ACIDS RES, V23, P4664, DOI 10.1093/nar/23.22.4664; TANNAHILL D, 1995, INT J DEV BIOL, V39, P549; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; VODICKA MA, 1995, DEVELOPMENT, V121, P3505; Wardle FC, 2006, SEMIN CELL DEV BIOL, V17, P99, DOI 10.1016/j.semcdb.2005.11.008; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yang J, 2002, DEVELOPMENT, V129, P5743, DOI 10.1242/dev.00150; Yang SS, 1998, J BIOL CHEM, V273, P13746, DOI 10.1074/jbc.273.22.13746; Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1	70	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36136	10.1371/journal.pone.0036136	http://dx.doi.org/10.1371/journal.pone.0036136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590521	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336100019
J	Ormerod, KG; Rogasevskaia, TP; Coorssen, JR; Mercier, AJ				Ormerod, Kiel G.; Rogasevskaia, Tatiana P.; Coorssen, Jens R.; Mercier, A. Joffre			Cholesterol-Independent Effects of Methyl-beta-Cyclodextrin on Chemical Synapses	PLOS ONE			English	Article							CA2+-TRIGGERED MEMBRANE-FUSION; CRAYFISH NEUROMUSCULAR-JUNCTION; ACTION-POTENTIAL PROPAGATION; LIPID RAFTS; TRANSMITTER RELEASE; GLUTAMATE; MUSCLE; MICRODOMAINS; ASSOCIATION; EXTRACTION	The cholesterol chelating agent, methyl-beta-cyclodextrin (M beta CD), alters synaptic function in many systems. At crayfish neuromuscular junctions, M beta CD is reported to reduce excitatory junctional potentials (EJPs) by impairing impulse propagation to synaptic terminals, and to have no postsynaptic effects. We examined the degree to which physiological effects of M beta CD correlate with its ability to reduce cholesterol, and used thermal acclimatization as an alternative method to modify cholesterol levels. M beta CD impaired impulse propagation and decreased EJP amplitude by 40% (P < 0.05) in preparations from crayfish acclimatized to 14 degrees C but not from those acclimatized to 21 degrees C. The reduction in EJP amplitude in the cold-acclimatized group was associated with a 49% reduction in quantal content (P < 0.05). M beta CD had no effect on input resistance in muscle fibers but decreased sensitivity to the neurotransmitter L-glutamate in both warm- and cold-acclimatized groups. This effect was less pronounced and reversible in the warm-acclimatized group (90% reduction in cold, P < 0.05; 50% reduction in warm, P < 0.05). M beta CD reduced cholesterol in isolated nerve and muscle from cold- and warm-acclimatized groups by comparable amounts (nerve: 29% cold, 25% warm; muscle: 20% cold, 18% warm; P < 0.05). This effect was reversed by cholesterol loading, but only in the warm-acclimatized group. Thus, effects of M beta CD on glutamate-sensitivity correlated with its ability to reduce cholesterol, but effects on impulse propagation and resulting EJP amplitude did not. Our results indicate that M beta CD can affect both presynaptic and postsynaptic properties, and that some effects of M beta CD are unrelated to cholesterol chelation.	[Ormerod, Kiel G.; Mercier, A. Joffre] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Rogasevskaia, Tatiana P.] Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB, Canada; [Coorssen, Jens R.] Univ Western Sydney, Sch Med, Dept Mol Physiol, Penrith, NSW, Australia; [Coorssen, Jens R.] Univ Western Sydney, Mol Med Res Grp, Penrith, NSW, Australia	Brock University; University of Calgary; Western Sydney University; Western Sydney University	Ormerod, KG (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.	j.coorssen@uws.edu.au; jmercier@brocku.ca		Ormerod, Kiel/0000-0002-9739-8777	Natural 509 Sciences and Engineering Research Council [46292, 261972]	Natural 509 Sciences and Engineering Research Council	This work was supported by Natural 509 Sciences and Engineering Research Council grants to AJM (46292) and JRC (261972). www.nserc-crsng.gc.ca. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2005, J NEUROCHEM, V92, P1477, DOI 10.1111/j.1471-4159.2005.03001.x; Atwood H.L., 1982, P105; Becher A, 2001, J NEUROCHEM, V79, P787, DOI 10.1046/j.1471-4159.2001.00614.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borisova T, 2010, NEUROCHEM INT, V56, P466, DOI 10.1016/j.neuint.2009.12.006; BRUNER J, 1970, J PHYSIOL-PARIS, V62, P137; Cheng HH, 2009, J NEUROSCI RES, V87, P460, DOI 10.1002/jnr.21852; Churchward MA, 2005, J CELL SCI, V118, P4833, DOI 10.1242/jcs.02601; Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984; Churchward Matthew A, 2008, J Chem Biol, V1, P79, DOI 10.1007/s12154-008-0007-1; Churchward MA, 2009, BIOCHEM J, V423, P1, DOI 10.1042/BJ20090969; Clark J, 2008, PEPTIDES, V29, P1140, DOI 10.1016/j.peptides.2008.02.013; Del Castillo, 1954, J PHYSL, V124, P560; Delint-Ramirez I, 2010, J NEUROSCI, V30, P8162, DOI 10.1523/JNEUROSCI.1792-10.2010; DUDEL J, 1981, PFLUG ARCH EUR J PHY, V391, P35, DOI 10.1007/BF00580691; DUDEL J, 1965, PFLUG ARCH GES PHYS, V282, P323, DOI 10.1007/BF00412507; EDWARDS FR, 1976, J PHYSIOL-LONDON, V259, P689, DOI 10.1113/jphysiol.1976.sp011489; Gasque G, 2005, FEBS LETT, V579, P5129, DOI 10.1016/j.febslet.2005.08.022; Gil C, 2006, BIOCHEM BIOPH RES CO, V348, P1334, DOI 10.1016/j.bbrc.2006.07.201; Giocondi MC, 2004, BIOPHYS J, V86, P861, DOI 10.1016/S0006-3495(04)74161-2; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; JOHNSON EW, 1971, J PHYSIOL-LONDON, V218, P757, DOI 10.1113/jphysiol.1971.sp009642; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; Lopez CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002020; LUSCHER HR, 1990, BIOPHYS J, V58, P1377, DOI 10.1016/S0006-3495(90)82484-X; Ma MT, 2010, NEUROSCI LETT, V476, P36, DOI 10.1016/j.neulet.2010.03.078; Maccarrone M, 2009, J NEUROCHEM, V109, P371, DOI 10.1111/j.1471-4159.2009.05948.x; MATHERS DA, 1978, COMP BIOCHEM PHYS C, V59, P151, DOI 10.1016/0306-4492(78)90046-1; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MERCIER AJ, 1989, J EXP BIOL, V145, P9; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Oldfield S, 2009, MOL PHARMACOL, V76, P1279, DOI 10.1124/mol.109.058008; PARNAS I, 1966, COMP BIOCHEM PHYSIOL, V18, P701, DOI 10.1016/0010-406X(66)90206-4; PEREZDELAMORA M, 1989, ANAL BIOCHEM, V180, P248, DOI 10.1016/0003-2697(89)90425-9; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; PRUITT NL, 1988, AM J PHYSIOL, V254, pR870, DOI 10.1152/ajpregu.1988.254.6.R870; ROCHE H, 1984, COMP BIOCHEM PHYS B, V78, P755, DOI 10.1016/0305-0491(84)90130-5; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rogasevskaia T, 2006, J CELL SCI, V119, P2688, DOI 10.1242/jcs.03007; Rogasevskaia Tatiana P, 2011, J Chem Biol, V4, P117, DOI 10.1007/s12154-011-0056-8; Rufini S, 2009, BRAIN RES, V1298, P178, DOI 10.1016/j.brainres.2009.08.037; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Smith AJ, 2010, J NEUROSCI, V30, P6116, DOI 10.1523/JNEUROSCI.0170-10.2010; SMITH DO, 1980, J PHYSIOL-LONDON, V301, P243, DOI 10.1113/jphysiol.1980.sp013202; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TAKEUCHI A, 1964, J PHYSIOL-LONDON, V170, P296, DOI 10.1113/jphysiol.1964.sp007332; Tarasenko AS, 2010, J MOL NEUROSCI, V41, P358, DOI 10.1007/s12031-010-9351-z; Taverna E, 2004, J BIOL CHEM, V279, P5127, DOI 10.1074/jbc.M308798200; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Wang DS, 2010, NEUROSCI LETT, V479, P327, DOI 10.1016/j.neulet.2010.05.090; Wang N, 2010, J NEUROSCI, V30, P3904, DOI 10.1523/JNEUROSCI.4000-09.2010; Wasser CR, 2007, J PHYSIOL-LONDON, V579, P413, DOI 10.1113/jphysiol.2006.123133; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Zacco A, 2003, J NEUROSCI, V23, P11104; Zamir O, 2006, J PHYSIOL-LONDON, V571, P83, DOI 10.1113/jphysiol.2005.098319; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	58	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36395	10.1371/journal.pone.0036395	http://dx.doi.org/10.1371/journal.pone.0036395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590538	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335500011
J	Zhang, XB; Volpe, EA; Gandhi, NB; Schaumburg, CS; Siemasko, KF; Pangelinan, SB; Kelly, SD; Hayday, AC; Li, DQ; Stern, ME; Niederkorn, JY; Pflugfelder, SC; De Paiva, CS				Zhang, Xiaobo; Volpe, Eugene A.; Gandhi, Niral B.; Schaumburg, Chris S.; Siemasko, Karyn F.; Pangelinan, Solherny B.; Kelly, Scott D.; Hayday, Adrian C.; Li, De-Quan; Stern, Michael E.; Niederkorn, Jerry Y.; Pflugfelder, Stephen C.; De Paiva, Cintia S.			NK Cells Promote Th-17 Mediated Corneal Barrier Disruption in Dry Eye	PLOS ONE			English	Article							MUCOSA-SPECIFIC LYMPHOCYTES; NATURAL-KILLER-CELLS; DELTA-T-CELLS; EPITHELIAL-CELLS; DESICCATING STRESS; OCULAR SURFACE; LACRIMAL KERATOCONJUNCTIVITIS; SJOGRENS-SYNDROME; INTERFERON-GAMMA; DENDRITIC CELLS	Background: The conjunctiva contains a specialized population of lymphocytes that reside in the epithelium, named intraepithelial lymphocytes (IEL). Methodology/Principal Findings: Here we characterized the IEL population prior to and after experimental desiccating stress (DS) for 5 or 10 days (DS5, DS10) and evaluated the effect of NK depletion on DS. The frequency of IELs in normal murine conjunctiva was CD3(+)CD103(+) (similar to 22%), CD3(+)gamma delta(+) (similar to 9.6%), CD3(+)NK(+) (2%), CD3(+)NK(+) (similar to 4.4%), CD3(+)CD8 alpha (similar to 0.9%), and CD4 (similar to 0.6%). Systemic depletion of NK cells prior and during DS led to a decrease in the frequency of total and activated DCs, a decrease in T helper-17(+) cells in the cervical lymph nodes and generation of less pathogenic CD4(+)T cells. B6.nude recipient mice of adoptively transferred CD4(+)T cells isolated from NK-depleted DS5 donor mice showed significantly less corneal barrier disruption, lower levels of IL-17A, CCL20 and MMP-3 in the cornea epithelia compared to recipients of control CD4(+)T cells. Conclusions/Significance: Taken together, these results show that the NK IELs are involved in the acute immune response to desiccation-induced dry eye by activating DC, which in turn coordinate generation of the pathogenic Th-17 response.	[Zhang, Xiaobo; Volpe, Eugene A.; Gandhi, Niral B.; Pangelinan, Solherny B.; Kelly, Scott D.; Li, De-Quan; Stern, Michael E.; Pflugfelder, Stephen C.; De Paiva, Cintia S.] Baylor Coll Med, Ocular Surface Ctr, Dept Ophthalmol, Houston, TX 77030 USA; [Zhang, Xiaobo] Wenzhou Med Coll, Dept Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Schaumburg, Chris S.; Siemasko, Karyn F.; Stern, Michael E.] Allergan Pharmaceut Inc, Dept Biol Sci, Irvine, CA USA; [Hayday, Adrian C.] Guys Hosp, Kings Coll London, Dept Immunobiol, London SE1 9RT, England; [Niederkorn, Jerry Y.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	Baylor College of Medicine; Wenzhou Medical University; AbbVie; Allergan; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, XB (corresponding author), Baylor Coll Med, Ocular Surface Ctr, Dept Ophthalmol, Houston, TX 77030 USA.	cintiadp@bcm.tmc.edu	De Paiva, Cintia/AAH-8354-2021; Volpe, Eugene A./D-2000-2012	De Paiva, Cintia/0000-0002-9057-5494; Volpe, Eugene A./0000-0002-9128-754X; HAYDAY, ADRIAN/0000-0002-9495-5793	National Institute of Health [EY018888, EY018090, EY11915, P30-EY002520]; Oshman Foundation; William Stamps Farish Fund; Hamill Foundation; NATIONAL EYE INSTITUTE [R21EY018888, R01EY011915, P30EY002520, R01EY018090] Funding Source: NIH RePORTER; Medical Research Council [G0600698B] Funding Source: researchfish	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oshman Foundation; William Stamps Farish Fund; Hamill Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institute of Health Grants EY018888 (CSDP), EY018090 (SCP, MES, JYN) EY11915 (SCP), NIH Grant RPB, NIH Core Grant P30-EY002520, Oshman Foundation, William Stamps Farish Fund, Hamill Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CEPEK KL, 1993, J IMMUNOL, V150, P3459; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chen YH, 2011, J LEUKOCYTE BIOL, V89, P965, DOI 10.1189/jlb.1110611; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Corthay A, 2006, SCAND J IMMUNOL, V64, P93, DOI 10.1111/j.1365-3083.2006.01782.x; De Paiva CS, 2011, MUCOSAL IMMUNOL, V4, P397, DOI 10.1038/mi.2010.82; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; De Paiva CS, 2007, INVEST OPHTH VIS SCI, V48, P2553, DOI 10.1167/iovs.07-0069; DUA HS, 1995, EYE, V9, P261, DOI 10.1038/eye.1995.51; DUA HS, 1994, CURR EYE RES, V13, P87, DOI 10.3109/02713689409042401; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hazlett LD, 2007, J IMMUNOL, V179, P1138, DOI 10.4049/jimmunol.179.2.1138; Hingorani M, 1997, EXP EYE RES, V64, P905, DOI 10.1006/exer.1996.0280; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Hornung M, 2006, EUR J IMMUNOL, V36, P1210, DOI 10.1002/eji.200535332; Huber S, 2002, J VIROL, V76, P6487, DOI 10.1128/JVI.76.13.6487-6494.2002; Jameson JM, 2004, FRONT BIOSCI-LANDMRK, V9, P2640, DOI 10.2741/1423; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Jung S, 2009, BIOCHEM BIOPH RES CO, V390, P399, DOI 10.1016/j.bbrc.2009.09.008; KOO GC, 1986, J IMMUNOL, V137, P3742; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; LIDER O, 1989, J IMMUNOL, V142, P748; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Matangkasombut P, 2009, MUCOSAL IMMUNOL, V2, P383, DOI 10.1038/mi.2009.96; Middendorp S, 2009, MUCOSAL IMMUNOL, V2, P393, DOI 10.1038/mi.2009.99; MILLER A, 1991, J EXP MED, V174, P791, DOI 10.1084/jem.174.4.791; Muhlen KA, 2004, J IMMUNOL, V172, P3034, DOI 10.4049/jimmunol.172.5.3034; NAKATA M, 1992, INT IMMUNOL, V4, P1049, DOI 10.1093/intimm/4.9.1049; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Oh K, 2011, EUR J IMMUNOL, V41, P392, DOI 10.1002/eji.201040569; RAPHAEL M, 1988, HISTOPATHOLOGY, V13, P191, DOI 10.1111/j.1365-2559.1988.tb02024.x; Rojas B, 2005, EXP EYE RES, V81, P313, DOI 10.1016/j.exer.2005.02.004; SACKS EH, 1986, OPHTHALMOLOGY, V93, P1276; Schaumburg CS, 2011, J IMMUNOL, V187, P3653, DOI 10.4049/jimmunol.1101442; SENTMAN CL, 1989, J IMMUNOL, V142, P1847; Siddiqui KRR, 2008, MUCOSAL IMMUNOL, V1, pS34, DOI 10.1038/mi.2008.43; Sugita S, 2004, J IMMUNOL, V172, P4184, DOI 10.4049/jimmunol.172.7.4184; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Yagi Y, 2007, J GASTROENTEROL, V42, P746, DOI 10.1007/s00535-007-2091-3; Zheng XF, 2010, INVEST OPHTH VIS SCI, V51, P3083, DOI 10.1167/iovs.09-3838	44	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36822	10.1371/journal.pone.0036822	http://dx.doi.org/10.1371/journal.pone.0036822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590618	Green Submitted, gold, Green Published			2022-12-25	WOS:000305335500032
J	Gershon, AS; Guan, J; Wang, CN; Victor, JC; To, T				Gershon, Andrea S.; Guan, Jun; Wang, Chengning; Victor, J. Charles; To, Teresa			Describing and Quantifying Asthma Comorbidty: A Population Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH ADMINISTRATIVE DATABASES; DIAGNOSED COPD; PRIMARY-CARE; METAANALYSIS; INDIVIDUALS; PREVALENCE; WEIGHT; BURDEN; ADULTS	Background: Asthma comorbidity has been correlated with poor asthma control, increased health services use, and decreased quality of life. Managing it improves these outcomes. Little is known about the amount of different types of comorbidity associated with asthma and how they vary by age. Methodology/Principal Findings: The authors conducted a population study using health administrative data on all individuals living in Ontario, Canada (population 12 million). Types of asthma comorbidity were quantified by comparing physician health care claims between individuals with and without asthma in each of 14 major disease categories; results were adjusted for demographic factors and other comorbidity and stratified by age. Compared to those without asthma, individuals with asthma had higher rates of comorbidity in most major disease categories. Most notably, they had about fifty percent or more physician health care claims for respiratory disease (other than asthma) in all age groups; psychiatric disorders in individuals age four and under and age 18 to 44; perinatal disorders in individuals 17 years and under, and metabolic and immunity, and hematologic disorders in children four years and under. Conclusion/Significance: Asthma appears to be associated with significant rates of various types of comorbidity that vary according to age. These results can be used to develop strategies to recognize and address asthma comorbidity to improve the overall health of individuals with asthma.	[Gershon, Andrea S.; Guan, Jun; Victor, J. Charles; To, Teresa] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Gershon, Andrea S.; Wang, Chengning; To, Teresa] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Gershon, Andrea S.; Victor, J. Charles; To, Teresa] Univ Toronto, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Gershon, AS (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	andrea.gershon@ices.on.ca	Victor, J Charles/F-8765-2011	Victor, J Charles/0000-0003-1720-9356	University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care	University of Toronto, Toronto, Ontario, Canada(University of Toronto); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	Dr. Gershon was supported by an Ontario Ministry of Health Career Scientist Award when she worked on this study. Dr. To is supported by The Dales Award in Medical Research from the University of Toronto, Toronto, Ontario, Canada. Funding for this project was made available through the Government of Ontario who had no role in study design, collection, analysis, interpretation of data, writing of the report, or in the decision to submit the report for publication. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Adams RJ, 2006, CHEST, V129, P285, DOI 10.1378/chest.129.2.285; [Anonymous], POPULATION SELECTED; Ben Noun L, 2001, PUBLIC HLTH REV, V29, P49; Boulet LP, 2009, EUR RESPIR J, V33, P897, DOI 10.1183/09031936.00121308; Chapman KR, 2008, EUR RESPIR J, V31, P320, DOI 10.1183/09031936.00039707; Chida Y, 2008, PSYCHOSOM MED, V70, P102, DOI 10.1097/PSY.0b013e31815c1b71; Chun TH, 2008, CHEST, V134, P1176, DOI 10.1378/chest.08-1528; Deshmukh VM, 2008, RESPIROLOGY, V13, P695, DOI 10.1111/j.1440-1843.2008.01310.x; Eneli IU, 2008, THORAX, V63, P671, DOI 10.1136/thx.2007.086470; Ernst Pierre, 2008, Curr Infect Dis Rep, V10, P223, DOI 10.1007/s11908-008-0037-4; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Gershon AS, 2010, THORAX, V65, P612, DOI 10.1136/thx.2009.131078; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Global Strategy for Asthma Management and Prevention, 2009, GLOB STRAT ASTHM MAN; Lehrer PM, 2008, J ANXIETY DISORD, V22, P671, DOI 10.1016/j.janxdis.2007.07.001; Onufrak SJ, 2008, AM J CARDIOL, V101, P1247, DOI 10.1016/j.amjcard.2007.12.024; Plessis V, 2002, DEFINITIONS RURAL; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Starfleld B, 2005, ANN FAM MED, V3, P215, DOI 10.1370/afm.307; Statistics Canada, 2004, PCCF VERS 4D US GUID; To T, 2010, AM J RESP CRIT CARE, V181, P337, DOI 10.1164/rccm.200907-1035OC; WATSON WTA, 1993, J ALLERGY CLIN IMMUN, V91, P97, DOI 10.1016/0091-6749(93)90301-U; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; Wijnhoven HAH, 2003, RESP MED, V97, P468, DOI 10.1053/rmed.2002.1463; Yuksel H, 2008, J ASTHMA, V45, P545, DOI 10.1080/02770900801990016; Zhang TT, 2009, J ASTHMA, V46, P1021, DOI 10.3109/02770900903350473	31	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e34967	10.1371/journal.pone.0034967	http://dx.doi.org/10.1371/journal.pone.0034967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586445	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335000007
J	Linsuwanon, P; Puenpa, J; Suwannakarn, K; Auksornkitti, V; Vichiwattana, P; Korkong, S; Theamboonlers, A; Poovorawan, Y				Linsuwanon, Piyada; Puenpa, Jiratchaya; Suwannakarn, Kamol; Auksornkitti, Vittawat; Vichiwattana, Preeyaporn; Korkong, Sumeth; Theamboonlers, Apiradee; Poovorawan, Yong			Molecular Epidemiology and Evolution of Human Enterovirus Serotype 68 in Thailand, 2006-2011	PLOS ONE			English	Article							RESPIRATORY ILLNESS; SPECIES C; RECOMBINATION; INFECTIONS; CHILDREN; DYNAMICS; SEQUENCE; STRAINS; PCR; RHINOVIRUS	Background: Publications worldwide have reported on the re-occurrence of human enterovirus 68 (EV68), a rarely detected pathogen usually causing respiratory illness. However, epidemiological data regarding this virus in particular on the Asian continent has so far been limited. Methodology/Findings: We investigated the epidemiology and genetic variability of EV68 infection among Thai children with respiratory illnesses from 2006-2011 (n = 1810). Semi-nested PCR using primer sets for amplification of the 5'-untranslated region through VP2 was performed for rhino-enterovirus detection. Altogether, 25 cases were confirmed as EV68 infection indicating a prevalence of 1.4% in the entire study population. Interestingly, the majority of samples were children aged >5 years (64%). Also, co-infection with other viruses was found in 28%, while pandemic H1N1 influenza/2009 virus was the most common co-infection. Of EV68-positive patients, 36% required hospitalizations with the common clinical presentations of fever, cough, dyspnea, and wheezing. The present study has shown that EV68 was extremely rare until 2009 (0.9%). An increasing annual prevalence was found in 2010 (1.6%) with the highest detection frequency in 2011 (4.3%). Based on analysis of the VP1 gene, the evolutionary rate of EV68 was estimated at 4.93x10(-3) substitutions/site/year. Major bifurcation of the currently circulating EV68 strains occurred 66 years ago (1945.31 with (1925.95-1960.46)95% HPD). Among the current lineages, 3 clusters of EV68 were categorized based on the different molecular signatures in the BC and DE loops of VP1 combined with high posterior probability values. Each cluster has branched off from their common ancestor at least 36 years ago (1975.78 with (1946.13-1984.97) 95% HPD). Conclusion: Differences in epidemiological characteristic and seasonal profile of EV68 have been found in this study. Results from Bayesian phylogenetic investigations also revealed that EV68 should be recognized as a genetically diverse virus with a substitution rate identical to that of enterovirus 71 genotype B (4.2x10(-3) s/s/y).	[Linsuwanon, Piyada; Puenpa, Jiratchaya; Suwannakarn, Kamol; Auksornkitti, Vittawat; Vichiwattana, Preeyaporn; Korkong, Sumeth; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Bangkok, Thailand	Chulalongkorn University	Linsuwanon, P (corresponding author), Chulalongkorn Univ, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Linsuwanon, Piyada/AAS-7642-2020	Poovorawan, Yong/0000-0002-2337-6807	Higher Commission of Education, Ministry of Education; Center of Excellence Research Fund (Royal Golden Jubilee Ph. D. Program); Chulalongkorn University; King Chulalongkorn Memorial Hospital; Outstanding Professor Research Fund; Thailand Research Fund	Higher Commission of Education, Ministry of Education; Center of Excellence Research Fund (Royal Golden Jubilee Ph. D. Program)(Thailand Research Fund (TRF)); Chulalongkorn University(Chulalongkorn University); King Chulalongkorn Memorial Hospital(Chulalongkorn University); Outstanding Professor Research Fund; Thailand Research Fund(Thailand Research Fund (TRF))	This study was supported by the Higher Commission of Education, Ministry of Education; The Center of Excellence Research Fund (Royal Golden Jubilee Ph. D. Program); CU Centenary Academic Development Project, Chulalongkorn University, King Chulalongkorn Memorial Hospital; CU Cluster Emerging HR1155A under National Research University Fund; and the Outstanding Professor Research Fund, Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2002, VIRUS RES, V85, P71, DOI 10.1016/S0168-1702(02)00019-9; [Anonymous], MMWR MORB MORTAL WKL, V60, P1301; Baranowski E, 2001, SCIENCE, V292, P1102, DOI 10.1126/science.1058613; Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Calvert J, 2010, J GEN VIROL, V91, P1229, DOI 10.1099/vir.0.018747-0; Chevaliez S, 2004, VIROLOGY, V325, P56, DOI 10.1016/j.virol.2004.04.026; Combelas N, 2011, VIRUSES-BASEL, V3, P1460, DOI 10.3390/v3081460; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Faria NR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-164; Gavrilin GV, 2000, J VIROL, V74, P7381, DOI 10.1128/JVI.74.16.7381-7390.2000; Hasegawa S, 2011, ALLERGY, V66, P1618, DOI 10.1111/j.1398-9995.2011.02725.x; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Hicks AL, 2011, J VIROL, V85, P7942, DOI 10.1128/JVI.02535-10; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Ishiko H, 2002, J INFECT DIS, V185, P744, DOI 10.1086/339298; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Lewis-Rogers N, 2009, MOL BIOL EVOL, V26, P969, DOI 10.1093/molbev/msp009; Linsuwanon P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-5; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Moratorio G, 2007, J GEN VIROL, V88, P3039, DOI 10.1099/vir.0.83038-0; Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P839, DOI 10.3109/00365548.2010.498020; Nasri D, 2007, J CLIN MICROBIOL, V45, P2370, DOI 10.1128/JCM.00093-07; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Petitjean-Lecherbonnier J, 2011, PATHOL BIOL, V59, P113, DOI 10.1016/j.patbio.2010.07.010; Piralla A, 2011, J CLIN MICROBIOL, V49, P373, DOI 10.1128/JCM.01814-10; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rahamat-Langendoen J, 2011, J CLIN VIROL, V52, P103, DOI 10.1016/j.jcv.2011.06.019; Savolainen-Kopra C, 2010, REV MED VIROL, V20, P358, DOI 10.1002/rmv.663; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10	47	77	82	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35190	10.1371/journal.pone.0035190	http://dx.doi.org/10.1371/journal.pone.0035190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586446	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000008
J	Prideaux, M; Loveridge, N; Pitsillides, AA; Farquharson, C				Prideaux, Matthew; Loveridge, Nigel; Pitsillides, Andrew A.; Farquharson, Colin			Extracellular Matrix Mineralization Promotes E11/gp38 Glycoprotein Expression and Drives Osteocytic Differentiation	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BONE-FORMATION; OXYGEN-TENSION; OSTEOBLASTS; PODOPLANIN; SCLEROSTIN; CULTURE; CD44; MECHANOTRANSDUCTION; MATURATION	Osteocytes are terminally differentiated osteoblasts which reside in a mineralized extracellular matrix (ECM). The factors that regulate this differentiation process are unknown. We have investigated whether ECM mineralization could promote osteocyte formation. To do this we have utilised MLO-A5 pre-osteocyte-like cells and western blotting and comparative RTPCR to examine whether the expression of osteocyte-selective markers is elevated concurrently with the onset of ECM mineralization. Secondly, if mineralization of the ECM is indeed a driver of osteocyte formation, we reasoned that impairment of ECM mineralization would result in a reversible inhibition of osteocyte formation. Supplementation of MLO-A5 cell cultures with ascorbic acid and phosphate promoted progressive ECM mineralization as well as temporally associated increases in expression of the osteocyte-selective markers, E11/gp38 glycoprotein and sclerostin. Consistent with a primary role for ECM mineralization in osteocyte formation, we also found that inhibition of ECM mineralization, by omitting phosphate or adding sodium pyrophosphate, a recognized inhibitor of hydroxyapatite formation, resulted in a 15-fold decrease in mineral deposition that was closely accompanied by lower expression of E11 and other osteocyte markers such as Dmp1, Cd44 and Sost whilst expression of osteoblast markers Ocn and Col1a increased. To rule out the possibility that such restriction of ECM mineralization may produce an irreversible modification in osteoblast behaviour to limit E11 expression and osteocytogenesis, we also measured the capacity of MLO-A5 cells to re-enter the osteocyte differentiation programme. We found that the mineralisation process was re-initiated and closely allied to increased expression of E11 protein after re-administration of phosphate or omission of sodium pyrophosphate, indicating an ECM mineralization-induced restoration in osteocyte formation. These results emphasise the importance of cell-ECM interactions in regulating osteoblast behaviour and, more importantly, suggest that ECM mineralization exerts pivotal control during terminal osteoblast differentiation and acquisition of the osteocyte phenotype.	[Prideaux, Matthew; Farquharson, Colin] Univ Edinburgh, Roslin Inst, Div Dev Biol, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Prideaux, Matthew; Pitsillides, Andrew A.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England; [Loveridge, Nigel] Univ Cambridge, Bone Res Grp, Cambridge, England; [Loveridge, Nigel] Univ Cambridge, Orthopaed Res Grp, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; University of London Royal Veterinary College; University of Cambridge; University of Cambridge	Prideaux, M (corresponding author), Univ Missouri, Sch Dent, Kansas City, MO 64108 USA.	prideauxm@umkc.edu	farquharson, colin/C-2956-2011	farquharson, colin/0000-0002-4970-4039; Loveridge, Nigel/0000-0002-5550-7584	Biotechnology and Biological Sciences Research Council (BBSRC) UK; BBSRC; EU [Health-F2-2008-201099]; Arthritis Research UK; Versus Arthritis [18768] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) UK through a studentship award (MP) and Institute Strategic Programme Grant Funding from the BBSRC (CF). NL acknowledges the support of the EU FP7 (TALOS: Health-F2-2008-201099). AP acknowledges continued funding to his group from Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GJ, 2009, OSTEOPOROSIS INT, V20, P653, DOI 10.1007/s00198-008-0728-6; Atkins GJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1358, DOI 10.1152/ajpcell.00216.2009; Barragan-Adjemian C, 2006, CALCIFIED TISSUE INT, V79, P340, DOI 10.1007/s00223-006-0107-2; Bonewald L. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P321; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Candeliere GA, 2001, BONE, V28, P351, DOI 10.1016/S8756-3282(01)00410-0; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferretti A, 2002, ANAT EMBRYOL, V206, P21, DOI 10.1007/s00429-002-0265-6; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; HUGHES DE, 1994, J BONE MINER RES, V9, P39; Irie K, 2008, J HISTOCHEM CYTOCHEM, V56, P561, DOI 10.1369/jhc.2008.950527; Kato Y, 2001, J BONE MINER RES, V16, P1622, DOI 10.1359/jbmr.2001.16.9.1622; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Meury T, 2010, MOL CELL BIOL, V30, P43, DOI 10.1128/MCB.00378-09; MIKUNITAKAGAKI Y, 1995, J BONE MINER RES, V10, P231, DOI 10.1002/jbmr.5650100209; Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214; Nefussi J R, 1991, J Biol Buccale, V19, P75; Ohizumi I, 2000, BBA-MOL CELL RES, V1497, P197, DOI 10.1016/S0167-4889(00)00063-X; Palumbo C, 2004, ANAT REC PART A, V278A, P474, DOI 10.1002/ar.a.20032; PALUMBO C, 1986, CELL TISSUE RES, V246, P125; PALUMBO C, 1990, ACTA ANAT, V137, P350; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; SKERRY TM, 1989, J BONE MINER RES, V4, P783, DOI 10.1002/jbmr.5650040519; Tate MLK, 2004, INT J BIOCHEM CELL B, V36, P1, DOI 10.1016/S1357-2725(03)00241-3; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Temiyasathit S, 2010, ANN NY ACAD SCI, V1192, P422, DOI 10.1111/j.1749-6632.2009.05243.x; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Xiao ZS, 2010, ANN NY ACAD SCI, V1192, P410, DOI 10.1111/j.1749-6632.2009.05239.x; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Yang W., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P386; Zahm AM, 2008, BONE, V43, P25, DOI 10.1016/j.bone.2008.03.010; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294; Zhu DX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019595	45	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36786	10.1371/journal.pone.0036786	http://dx.doi.org/10.1371/journal.pone.0036786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586496	gold, Green Submitted, Green Published			2022-12-25	WOS:000305335000058
J	Bharath, SR; Bisht, S; Harijan, RK; Savithri, HS; Murthy, MRN				Bharath, Sakshibeedu R.; Bisht, Shveta; Harijan, Rajesh K.; Savithri, Handanahal S.; Murthy, Mathur R. N.			Structural and Mutational Studies on Substrate Specificity and Catalysis of Salmonella typhimurium D-Cysteine Desulfhydrase	PLOS ONE			English	Article							D-SERINE DEHYDRATASE; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE; 3-DIMENSIONAL STRUCTURE; SECONDARY-STRUCTURE; CRYSTAL-STRUCTURES; IDENTIFICATION; CEPHAMYCIN; MECHANISM; INSIGHT; COMPLEX	Salmonella typhimurium DCyD (StDCyD) is a fold type II pyridoxal 5' phosphate (PLP)-dependent enzyme that catalyzes the degradation of D-Cys to H2S and pyruvate. It also efficiently degrades beta-chloro-D-alanine (beta CDA). D-Ser is a poor substrate while the enzyme is inactive with respect to L-Ser and 1-amino-1-carboxy cyclopropane (ACC). Here, we report the X-ray crystal structures of StDCyD and of crystals obtained in the presence of D-Cys, beta CDA, ACC, D-Ser, L-Ser, D-cycloserine (DCS) and L-cycloserine (LCS) at resolutions ranging from 1.7 to 2.6 angstrom. The polypeptide fold of StDCyD consisting of a small domain (residues 48-161) and a large domain (residues 1-47 and 162-328) resembles other fold type II PLP dependent enzymes. The structures obtained in the presence of D-Cys and beta CDA show the product, pyruvate, bound at a site 4.0-6.0 angstrom away from the active site. ACC forms an external aldimine complex while D- and L-Ser bind non-covalently suggesting that the reaction with these ligands is arrested at C alpha proton abstraction and transimination steps, respectively. In the active site of StDCyD cocrystallized with DCS or LCS, electron density for a pyridoxamine phosphate (PMP) was observed. Crystals soaked in cocktail containing these ligands show density for PLP-cycloserine. Spectroscopic observations also suggest formation of PMP by the hydrolysis of cycloserines. Mutational studies suggest that Ser78 and Gln77 are key determinants of enzyme specificity and the phenolate of Tyr287 is responsible for C alpha proton abstraction from D-Cys. Based on these studies, a probable mechanism for the degradation of D-Cys by StDCyD is proposed.	[Bharath, Sakshibeedu R.; Bisht, Shveta; Harijan, Rajesh K.; Murthy, Mathur R. N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Savithri, Handanahal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Bharath, SR (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	mm@mbu.iisc.ernet.in	Harijan, Rajesh K./AAY-3277-2021	Bisht, Shveta/0000-0002-5566-3472; Harijan, Rajesh/0000-0003-1503-5057	Department of Science and Technology, Government of India; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India; Department of Science and Technology (DST); ESRF Grenoble	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST)(Department of Science & Technology (India)); ESRF Grenoble	This work supported by: (1) Department of Science and Technology, Government of India and (2) Department of Biotechnology, Government of India and (3) Council of Scientific and Industrial Research, Government of India. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The diffraction data were collected using the X-ray facility at Molecular Biophysics Unit, Indian Institute of Science, supported by the Department of Science and Technology (DST) and the Department of Biotechnology (DBT), Government of India and at ESRF Grenoble. We thank the staff at the X-ray laboratory in MBU and beam line scientists at BM14, ESRF for their cooperation during data collection.	ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bharath SR, 2011, FEBS J, V278, P2879, DOI 10.1111/j.1742-4658.2011.08210.x; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Davis L, ENZYMES, P33; DeLano W.L., PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEDERIUK CS, 1983, J BIOL CHEM, V258, P5372; Fujino A, 2004, J MOL BIOL, V341, P999, DOI 10.1016/j.jmb.2004.06.062; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Goto M, 2009, J BIOL CHEM, V284, P25944, DOI 10.1074/jbc.M109.010470; GRABOWSKI R, 1993, TRENDS BIOCHEM SCI, V18, P297, DOI 10.1016/0968-0004(93)90040-T; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; INOUYE S, 1984, ANTIMICROB AGENTS CH, V26, P722, DOI 10.1128/AAC.26.5.722; INOUYE S, 1984, J ANTIBIOT, V37, P1403, DOI 10.7164/antibiotics.37.1403; Ito T, 2008, BIOCHEM J, V409, P399, DOI 10.1042/BJ20070642; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karthikeyan S, 2004, BIOCHEMISTRY-US, V43, P13328, DOI 10.1021/bi048878g; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; NAGASAWA T, 1985, EUR J BIOCHEM, V153, P541, DOI 10.1111/j.1432-1033.1985.tb09335.x; Ose T, 2003, J BIOL CHEM, V278, P41069, DOI 10.1074/jbc.M305865200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavelka A, 2009, NUCLEIC ACIDS RES, V37, pW376, DOI 10.1093/nar/gkp410; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P3557, DOI 10.1021/bi00583a019; Sharif S, 2007, J AM CHEM SOC, V129, P6313, DOI 10.1021/ja070296+; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Simanshu DK, 2006, J BIOL CHEM, V281, P39630, DOI 10.1074/jbc.M605721200; Smith MA, 2010, J BIOL CHEM, V285, P12873, DOI 10.1074/jbc.M109.050062; Todorovic B, 2008, PLANTA, V229, P193, DOI 10.1007/s00425-008-0820-3; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p; Yao M, 2000, J BIOL CHEM, V275, P34557, DOI 10.1074/jbc.M004681200	39	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36267	10.1371/journal.pone.0036267	http://dx.doi.org/10.1371/journal.pone.0036267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574144	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000305349800040
J	Hugo, S; Van Rensburg, BJ; Van Wyk, AE; Steenkamp, Y				Hugo, Sanet; Van Rensburg, Berndt J.; Van Wyk, Abraham E.; Steenkamp, Yolande			Alien Phytogeographic Regions of Southern Africa: Numerical Classification, Possible Drivers, and Regional Threats	PLOS ONE			English	Article							SPECIES RICHNESS; PLANT INVASIONS; DISTRIBUTIONS; CONSERVATION; MANAGEMENT; MODEL; CONSEQUENCES; DIVERSITY; PATTERNS; GRASSES	The distributions of naturalised alien plant species that have invaded natural or semi-natural habitat are often geographically restricted by the environmental conditions in their new range, implying that alien species with similar environmental requirements and tolerances may form assemblages and characterise particular areas. The aim of this study was to use objective numerical techniques to reveal any possible alien phytogeographic regions (i.e. geographic areas with characteristic alien plant assemblages) in southern Africa. Quarter degree resolution presence records of naturalised alien plant species of South Africa, Lesotho, Swaziland, Namibia and Botswana were analysed through a divisive hierarchical classification technique, and the output was plotted on maps for further interpretation. The analyses revealed two main alien phytogeographic regions that could be subdivided into eight lower level phytogeographic regions. Along with knowledge of the environmental requirements of the characteristic species and supported by further statistical analyses, we hypothesised on the main drivers of alien phytogeographic regions, and suggest that environmental features such as climate and associated biomes were most important, followed by human activities that modify climatic and vegetation features, such as irrigation and agriculture. Most of the characteristic species are not currently well-known as invasive plant species, but many may have potential to become troublesome in the future. Considering the possibility of biotic homogenization, these findings have implications for predicting the characteristics of the plant assemblages of the future. However, the relatively low quality of the dataset necessitates further more in-depth studies with improved data before the findings could be directly beneficial for management.	[Hugo, Sanet; Van Rensburg, Berndt J.] Univ Pretoria, Dept Zool & Entomol, DST NRF Ctr Excellence Invas Biol, ZA-0002 Pretoria, South Africa; [Van Rensburg, Berndt J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Van Wyk, Abraham E.] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa; [Steenkamp, Yolande] S African Natl Biodivers Inst, Biosystemat Res & Biodivers Collect Div, Pretoria, South Africa	National Research Foundation - South Africa; University of Pretoria; University of Queensland; University of Pretoria; South African National Biodiversity Institute	Hugo, S (corresponding author), Univ Pretoria, Dept Zool & Entomol, DST NRF Ctr Excellence Invas Biol, ZA-0002 Pretoria, South Africa.	shugo@zoology.up.ac.za	van Wyk, Abraham Erasmus/A-2181-2008; van Rensburg, Berndt/A-4154-2009	van Wyk, Abraham Erasmus/0000-0002-0437-3272; Hugo, Sanet/0000-0001-8636-3985; van Rensburg, Berndt/0000-0002-5274-5536	University of Pretoria; DST-NRF Centre of Excellence for Invasion Biology	University of Pretoria; DST-NRF Centre of Excellence for Invasion Biology(Department of Science & Technology (India))	This study was funded by the University of Pretoria (www.up.ac.za) and the DST-NRF Centre of Excellence for Invasion Biology (http://academic.sun.ac.za/cib/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn T.M., 2003, MACROECOLOGY CONCEPT; Chown SL, 2003, ECOL APPL, V13, P1233, DOI 10.1890/02-5105; COBLENTZ BE, 1990, CONSERV BIOL, V4, P261, DOI 10.1111/j.1523-1739.1990.tb00287.x; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Ebach Malte, 2003, Biologist (London), V50, P48; Evans KL, 2006, P ROY SOC B-BIOL SCI, V273, P1779, DOI 10.1098/rspb.2006.3487; Feenstra KR, 2008, PAC SCI, V62, P161, DOI 10.2984/1534-6188(2008)62[161:BAIOPI]2.0.CO;2; Gaston Kevin J., 2003, P345; GATES CT, 1972, AUST J BOT, V20, P261, DOI 10.1071/BT9720261; GAUCH HG, 1981, J ECOL, V69, P537, DOI 10.2307/2259682; Gotelli NJ, 1996, NULL MODELS ECOLOGY; Hawkins BA, 2001, TRENDS ECOL EVOL, V16, P470, DOI 10.1016/S0169-5347(01)02197-8; Henderson L, 2007, BOTHALIA, V37, P215, DOI 10.4102/abc.v37i2.322; Higgins SI, 1999, CONSERV BIOL, V13, P303, DOI 10.1046/j.1523-1739.1999.013002303.x; Higgins SI, 2000, ECOL APPL, V10, P1833, DOI 10.1890/1051-0761(2000)010[1833:UADLMF]2.0.CO;2; Hill M.O., 1979, TWINSPAN FORTRAN PRO; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Irish J, 1994, RES NAT MUS BLOEMFON, V10, P550; Kent M, 2006, PROG PHYS GEOG, V30, P399, DOI 10.1191/0309133306pp489pr; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lawesson JE, 2002, PLANT ECOL, V158, P113, DOI 10.1023/A:1014757324453; Le Maitre DC, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P295; Le Maitre DC, 2000, WATER SA, V26, P397; Linder HP, 2004, BIOL SKIFTER COPENHA, V55, P229; Marais C., 2001, ENVIRON DEV SUSTAIN, V3, P145, DOI [DOI 10.1023/A:1011668417953, 10.1023/A:1011668417953]; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Milton S. J., 1998, Diversity and Distributions, V4, P175, DOI 10.1046/j.1472-4642.1998.00024.x; Milton SJ, 2004, S AFR J SCI, V100, P69; Mucina I., 2006, STRELITZIA, V19; Mucina L, 2006, STRELETZIA; Mucina Ladislav, 2006, V19, P2; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nel JL, 2004, S AFR J SCI, V100, P53; NELSON G, 1978, Journal of the History of Biology, V11, P269, DOI 10.1007/BF00389302; Neter J., 1996, APPL LINEAR STAT MOD; Ojeda F, 1998, J BIOGEOGR, V25, P165, DOI 10.1046/j.1365-2699.1998.251141.x; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Parker-Allie F, 2009, CLIMATIC CHANGE, V94, P87, DOI 10.1007/s10584-009-9549-7; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Richardson DM, 2005, ECOSCIENCE, V12, P391, DOI 10.2980/i1195-6860-12-3-391.1; Richardson DM, 2004, S AFR J SCI, V100, P45; Richardson DM, 2004, P 10 MEDECOS C APR 2; Ringrose S, 2002, ENVIRON MANAGE, V30, P98, DOI 10.1007/s00267-002-2486-0; Robertson MP, 2003, S AFR J SCI, V99, P37; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Rutherford MC, 2006, STRELETZIA; Saiz JCM, 1998, J BIOGEOGR, V25, P179, DOI 10.1046/j.1365-2699.1998.251118.x; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Schulze R.E., 1997, TT8296 WRC; Steenkamp Y., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P253; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Stohlgren TJ, 2003, FRONT ECOL ENVIRON, V1, P11; Stromberg J.C., 1993, Journal of the Arizona-Nevada Academy of Science, V27, P111; Thompson M, 1996, S AFR J SCI, V92, P34; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; Van Rooy J, 2010, J BRYOL, V32, P80, DOI 10.1179/037366810X12578498136039; van Wilgen BW, 2008, J ENVIRON MANAGE, V89, P336, DOI 10.1016/j.jenvman.2007.06.015; van Wyk AE., 2001, REGIONS FLORISTIC EN; White F., 1993, Bulletin du Jardin Botanique National de Belgique, V62, P225, DOI 10.2307/3668279; Wolmarans R, 2010, J BIOGEOGR, V37, P1797, DOI 10.1111/j.1365-2699.2010.02325.x	61	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36269	10.1371/journal.pone.0036269	http://dx.doi.org/10.1371/journal.pone.0036269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574145	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800041
J	Undurraga, EA; Zebrowitz, L; Eisenberg, DTA; Reyes-Garcia, V; Godoy, RA				Undurraga, Eduardo A.; Zebrowitz, Leslie; Eisenberg, Dan T. A.; Reyes-Garcia, Victoria; Godoy, Ricardo A.		TAPS Bolivia Study Team	The Perceived Benefits of Height: Strength, Dominance, Social Concern, and Knowledge among Bolivian Native Amazonians	PLOS ONE			English	Article							FACTORS INFLUENCING PREFERENCES; LABOR-MARKET OUTCOMES; REPRODUCTIVE SUCCESS; SEXUAL-DIMORPHISM; VARIABLE PREFERENCES; NUTRITIONAL-STATUS; PHYSICAL STATURE; CHILDRENS HEIGHT; HEALTH; WOMEN	Research in industrial countries suggests that, with no other knowledge about a person, positive traits are attributed to taller people and correspondingly, that taller people have slightly better socioeconomic status (SES). However, research in some non-industrialized contexts has shown no correlation or even negative correlations between height and socioeconomic outcomes. It remains unclear whether positive traits remain attributed to taller people in such contexts. To address this question, here we report the results of a study in a foraging-farming society of native Amazonians in Bolivia (Tsimane')-a group in which we have previously shown little association between height and socioeconomic outcomes. We showed 24 photographs of pairs of Tsimane' women, men, boys, and girls to 40 women and 40 men >16 years of age. We presented four behavioral scenarios to each participant and asked them to point to the person in the photograph with greater strength, dominance, social concern, or knowledge. The pairs in the photographs were of the same sex and age, but one person was shorter. Tsimane' women and men attributed greater strength, dominance, and knowledge to taller girls and boys, but they did not attribute most positive traits to taller adults, except for strength, and more social concern only when women assessed other women in the photographs. These results raise a puzzle: why would Tsimane' attribute positive traits to tall children, but not tall adults? We propose three potential explanations: adults' expectations about the more market integrated society in which their children will grow up, height as a signal of good child health, and children's greater variation in the traits assessed corresponding to maturational stages.	[Undurraga, Eduardo A.; Reyes-Garcia, Victoria; Godoy, Ricardo A.] Brandeis Univ, Heller Sch Social Policy, Waltham, MA 02254 USA; [Zebrowitz, Leslie] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA; [Eisenberg, Dan T. A.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Eisenberg, Dan T. A.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Reyes-Garcia, Victoria] Univ Autonoma Barcelona, ICREA, E-08193 Barcelona, Spain; [Reyes-Garcia, Victoria] Univ Autonoma Barcelona, Inst Ciencia Tecnol & Ambientals, E-08193 Barcelona, Spain; [TAPS Bolivia Study Team] TAPS, San Borja, Beni, Bolivia	Brandeis University; Brandeis University; Northwestern University; University of Washington; University of Washington Seattle; Autonomous University of Barcelona; ICREA; Autonomous University of Barcelona	Undurraga, EA (corresponding author), Brandeis Univ, Heller Sch Social Policy, Waltham, MA 02254 USA.	eundurra@brandeis.edu	Eisenberg, Dan T.A./D-7691-2011; Undurraga, Eduardo/I-3739-2014; Reyes-Garcia, Victoria/C-4552-2008	Eisenberg, Dan T.A./0000-0003-0812-1862; Undurraga, Eduardo/0000-0002-4425-1253; Reyes-Garcia, Victoria/0000-0002-2914-8055	NSF; NSG GRF grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	NSF(National Science Foundation (NSF)); NSG GRF grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ICREA(ICREA)	The Cultural Anthropology Programs of NSF provided funding. DTAE is funded by an NSG GRF grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akachi Y, 2007, ANN HUM BIOL, V34, P397, DOI 10.1080/03014460701452868; BOOTH ND, 1990, J SOC PSYCHOL, V130, P609, DOI 10.1080/00224545.1990.9922952; BRACKBILL Y, 1981, MERRILL PALMER QUART, V27, P429; Brown JL, 1996, SCI AM, V274, P38, DOI 10.1038/scientificamerican0296-38; Byron E., 2003, MARKET INTEGRATION H; Case A, 2008, J POLIT ECON, V116, P499, DOI 10.1086/589524; Case A, 2008, AM ECON REV, V98, P463, DOI 10.1257/aer.98.2.463; Chu S, 2005, PERS INDIV DIFFER, V38, P1927, DOI 10.1016/j.paid.2004.10.004; Cinnirella F, 2011, EC HUMAN BI IN PRESS; Cronk L., 2004, MUKOGODO MAASAI ETHN; Deady DK, 2006, PERS INDIV DIFFER, V40, P17, DOI 10.1016/j.paid.2005.06.014; Deaton A, 2007, P NATL ACAD SCI USA, V104, P13232, DOI 10.1073/pnas.0611500104; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; Dinda S, 2006, ECON HUM BIOL, V4, P342, DOI 10.1016/j.ehb.2005.10.003; EISENBERG N, 1984, SEX ROLES, V11, P719, DOI 10.1007/BF00288123; EKWO F, 1991, AM J HUM BIOL, V3, P181, DOI 10.1002/ajhb.1310030212; Ellis R, 1996, THESIS ST ANDREWS U; Fink B, 2007, PERS INDIV DIFFER, V43, P2249, DOI 10.1016/j.paid.2007.07.014; Godoy RA, 2004, HUM ECOL, V32, P339, DOI 10.1023/B:HUEC.0000028085.47707.08; Godoy R, 2008, EVOL HUM BEHAV, V29, P201, DOI 10.1016/j.evolhumbehav.2007.12.003; Godoy R, 2008, FIELD METHOD, V20, P26, DOI 10.1177/1525822X07309356; Godoy R, 2010, AM J HUM BIOL, V22, P336, DOI 10.1002/ajhb.20996; Godoy R, 2010, ECON HUM BIOL, V8, P88, DOI 10.1016/j.ehb.2009.08.002; Godoy RA, 2006, ECON HUM BIOL, V4, P184, DOI 10.1016/j.ehb.2005.11.001; HADDAD LJ, 1991, OXFORD B ECON STAT, V53, P45, DOI 10.1111/j.1468-0084.1991.mp53001004.x; HENSLEY WE, 1993, PSYCHOLOGY, V30, P40; Hersch J, 2008, J LABOR ECON, V26, P345, DOI 10.1086/587428; Huanca Tomas, 2008, TSIMANE ORAL TRADITI; Hunt L, 2000, HORM RES, V53, P129, DOI 10.1159/000023561; Irons W, 1979, EVOLUTIONARY BIOL HU, P284; JACKSON LA, 1992, J SOC PSYCHOL, V132, P433, DOI 10.1080/00224545.1992.9924723; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Leatherman T, 1998, SOC SCI MED, V47, P1031, DOI 10.1016/S0277-9536(98)00160-9; LEE PDK, 1987, PEDIATR CLIN N AM, V34, P851; Lee RB, 1979, KUNGSAN MEN WOMEN WO; Leonard WR, 2008, ECON HUM BIOL, V6, P299, DOI 10.1016/j.ehb.2008.04.001; Long J.S., 2006, REGRESSION MODELS CA; Martel LF., 1987, STATURE STIGMA BIOPS; Martorell R, 1986, HUMAN GROWTH COMPREH, V3, P241; MONTEPARE JM, 1995, J NONVERBAL BEHAV, V19, P31, DOI 10.1007/BF02173411; Nettle D, 2002, HUM NATURE-INT BIOS, V13, P473, DOI 10.1007/s12110-002-1004-7; Nettle D, 2002, P ROY SOC B-BIOL SCI, V269, P1919, DOI 10.1098/rspb.2002.2111; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Persico N, 2004, J POLIT ECON, V112, P1019, DOI 10.1086/422566; Reyes-Garcia V, 2008, J DEV STUD, V44, P217, DOI 10.1080/00220380701789901; Reyes-Garcia Victoria, 2001, INDIGENOUS PEOPLE ET; Ringhofer L, 2010, FISHING, FORAGING AND FARMING IN THE BOLIVIAN AMAZON, P1, DOI 10.1007/978-90-481-3487-8; ROTH K, 1983, J GENET PSYCHOL, V143, P45, DOI 10.1080/00221325.1983.10533532; Salska I, 2008, PERS INDIV DIFFER, V44, P203, DOI 10.1016/j.paid.2007.08.008; Sear R, 2010, HOMONOVUS HUMAN ILUS; Sear R, 2009, BIOL LETTERS, V5, P606, DOI 10.1098/rsbl.2009.0342; Seckler D., 1982, NEWER CONCEPTS NUTR, P127; SHEPPERD JA, 1989, PERS SOC PSYCHOL B, V15, P617, DOI 10.1177/0146167289154014; Sorokowski P, 2012, J CROSS CULT PSYCHOL, V43, P32, DOI 10.1177/0022022110395140; Spears D, 2011, EC HUMAN BI IN PRESS; Steckel RH, 2009, EXPLOR ECON HIST, V46, P1, DOI 10.1016/j.eeh.2008.12.001; Strauss J, 1998, J ECON LIT, V36, P766; Swami V, 2008, PERS INDIV DIFFER, V45, P395, DOI 10.1016/j.paid.2008.05.012; Tanner S, 2009, AM J HUM BIOL, V21, P651, DOI 10.1002/ajhb.20944; Tanner S, 2005, THESIS U MICHIGAN; Tanner S, 2011, SOC SCI MED, V72, P701, DOI 10.1016/j.socscimed.2010.12.012; Thomas D, 1997, J ECONOMETRICS, V77, P159, DOI 10.1016/S0304-4076(96)01811-8; UNDERWOOD LE, 1991, ACTA PAEDIATR SCAND, P3; Undurraga EA, 2010, MED ANTHROPOL Q, V24, P522, DOI 10.1111/j.1548-1387.2010.01121.x; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074	66	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35391	10.1371/journal.pone.0035391	http://dx.doi.org/10.1371/journal.pone.0035391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WV	22574118	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800014
J	Van Klinken, JB; van den Berg, SAA; Havekes, LM; Van Dijk, KW				Van Klinken, Jan Bert; van den Berg, Sjoerd A. A.; Havekes, Louis M.; Van Dijk, Ko Willems			Estimation of Activity Related Energy Expenditure and Resting Metabolic Rate in Freely Moving Mice from Indirect Calorimetry Data	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIVITY THERMOGENESIS; ADAPTIVE-CHANGES; OBESITY; IDENTIFICATION; DETERMINANTS; RESISTANCE; MODELS; GAIN	Physical activity (PA) is a main determinant of total energy expenditure (TEE) and has been suggested to play a key role in body weight regulation. However, thus far it has been challenging to determine what part of the expended energy is due to activity in freely moving subjects. We developed a computational method to estimate activity related energy expenditure (AEE) and resting metabolic rate (RMR) in mice from activity and indirect calorimetry data. The method is based on penalised spline regression and takes the time dependency of the RMR into account. In addition, estimates of AEE and RMR are corrected for the regression dilution bias that results from inaccurate PA measurements. We evaluated the performance of our method based on 500 simulated metabolic chamber datasets and compared it to that of conventional methods. It was found that for a sample time of 10 minutes the penalised spline model estimated the time-dependent RMR with 1.7 times higher accuracy than the Kalman filter and with 2.7 times higher accuracy than linear regression. We assessed the applicability of our method on experimental data in a case study involving high fat diet fed male and female C57Bl/6J mice. We found that TEE in male mice was higher due to a difference in RMR while AEE levels were similar in both groups, even though female mice were more active. Interestingly, the higher activity did not result in a difference in AEE because female mice had a lower caloric cost of activity, which was likely due to their lower body weight. In conclusion, TEE decomposition by means of penalised spline regression provides robust estimates of the time-dependent AEE and RMR and can be applied to data generated with generic metabolic chamber and indirect calorimetry set-ups.	[Van Klinken, Jan Bert; van den Berg, Sjoerd A. A.; Van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Havekes, Louis M.; Van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Gen Internal Med, Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Havekes, Louis M.] Netherlands Org Appl Sci Res Qual Life, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Van Klinken, JB (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	J.B.van_Klinken@lumc.nl	van den Berg, Sjoerd A/R-9541-2018; van den Berg, Sjoerd AA/B-1994-2009; van Dijk, Ko Willems/AAT-4681-2021; van Dijk, Ko Willems/A-1798-2008	van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; van den Berg, Sjoerd/0000-0001-8967-376X; van den Berg, Sjoerd/0000-0001-5937-7505	Netherlands Consortium for Systems Biology (NCSB); Center of Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO); TSE systems (Bad Homburg, Germany)	Netherlands Consortium for Systems Biology (NCSB); Center of Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); TSE systems (Bad Homburg, Germany)	This work was supported by grants from the Netherlands Consortium for Systems Biology (NCSB) and the Center of Medical Systems Biology (CMSB) established by The Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO). Funding has also been received from TSE systems (Bad Homburg, Germany) in the form of indirect calorimetry equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Blaxter K, 1989, ENERGY METABOLISM AN; Bursztein S., 1989, ENERGY METABOLISM IN; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cooper CE, 2010, PHYSIOL BIOCHEM ZOOL, V83, P385, DOI 10.1086/605612; CRAVEN P, 1979, NUMER MATH, V31, P377, DOI 10.1007/BF01437407; DAUNCEY MJ, 1990, CAN J PHYSIOL PHARM, V68, P17, DOI 10.1139/y90-002; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; DULLOO AG, 1990, AM J CLIN NUTR, V52, P415, DOI 10.1093/ajcn/52.3.415; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; EVEN PC, 1991, PHYSIOL BEHAV, V49, P177, DOI 10.1016/0031-9384(91)90252-J; EVEN PC, 1993, BRIT J NUTR, V70, P421, DOI 10.1079/BJN19930136; Fuller W.A., 2009, MEASUREMENT ERROR MO; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; GREEN PJ, 1987, INT STAT REV, V55, P245, DOI 10.2307/1403404; Institute for Laboratory Animal Research, 2011, GUID CAR US LAB AN; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lighton JRB, 2011, COMP BIOCHEM PHYS A, V158, P265, DOI 10.1016/j.cbpa.2010.11.026; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lusk G, 1928, ELEMENTS SCI NUTR; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; NAKAMURA T, 1990, BIOMETRIKA, V77, P127; Nonogaki K, 2003, DIABETES, V52, P315, DOI 10.2337/diabetes.52.2.315; Novak CM, 2006, AM J PHYSIOL-ENDOC M, V290, pE396, DOI 10.1152/ajpendo.00293.2005; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Proakis J.G., 1996, DIGIT SIGNAL PROCESS; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Ruppert D, 2002, J COMPUT GRAPH STAT, V11, P735, DOI 10.1198/106186002853; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Stepien M, 2010, J NUTR, V140, P939, DOI 10.3945/jn.109.120139; Tataranni PA, 2003, INT J OBESITY, V27, P1578, DOI 10.1038/sj.ijo.0802469; Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; VanMilgen J, 1997, BRIT J NUTR, V78, P397, DOI 10.1079/BJN19970159; Weinsier RL, 2002, AM J CLIN NUTR, V75, P499, DOI 10.1093/ajcn/75.3.499; Zhong XP, 2002, ANN I STAT MATH, V54, P595, DOI 10.1023/A:1022467212133	46	41	41	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36162	10.1371/journal.pone.0036162	http://dx.doi.org/10.1371/journal.pone.0036162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574139	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349800035
J	Gronroos, NN; Chamberlain, AM; Folsom, AR; Soliman, EZ; Agarwal, SK; Nettleton, JA; Alonso, A				Gronroos, Noelle N.; Chamberlain, Alanna M.; Folsom, Aaron R.; Soliman, Elsayed Z.; Agarwal, Sunil K.; Nettleton, Jennifer A.; Alonso, Alvaro			Fish, Fish-Derived n-3 Fatty Acids, and Risk of Incident Atrial Fibrillation in the Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ARTERY-BYPASS SURGERY; PREVENTION; OMEGA-3-FATTY-ACIDS; CONSUMPTION; DIET; ASSOCIATION; ARRHYTHMIAS; WHITES	Background: Results of observational and experimental studies investigating the association between intake of long-chain n-3 polyunsaturated fatty acids (PUFAs) and risk of atrial fibrillation (AF) have been inconsistent. Methods: We studied the association of fish and the fish-derived n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with the risk of incident AF in individuals aged 45-64 from the Atherosclerosis Risk in Communities (ARIC) cohort (n = 14,222, 27% African Americans). Intake of fish and of DHA and EPA were measured via food frequency questionnaire. Plasma levels of DHA and EPA were measured in phospholipids in a subset of participants (n = 3,757). Incident AF was identified through the end of 2008 using ECGs, hospital discharge codes and death certificates. Cox proportional hazards regression was used to estimate hazard ratios of AF by quartiles of n-3 PUFAs or by fish intake. Results: During the average follow-up of 17.6 years, 1,604 AF events were identified. In multivariable analyses, total fish intake and dietary DHA and EPA were not associated with AF risk. Higher intake of oily fish and canned tuna was associated with a nonsignificant lower risk of AF (p for trend = 0.09). Phospholipid levels of DHA+EPA were not related to incident AF. However, DHA and EPA showed differential associations with AF risk when analyzed separately, with lower risk of AF in those with higher levels of DHA but no association between EPA levels and AF risk. Conclusions: In this racially diverse sample, dietary intake of fish and fish-derived n-3 fatty acids, as well as plasma biomarkers of fish intake, were not associated with AF risk.	[Gronroos, Noelle N.; Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Chamberlain, Alanna M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Soliman, Elsayed Z.] Wake Forest Univ, Sch Med, EPICARE, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC 27109 USA; [Agarwal, Sunil K.] Univ N Carolina, Chapel Hill, NC USA; [Nettleton, Jennifer A.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Gronroos, NN (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	alonso@umn.edu	Soliman, Elsayed Z/AAD-7135-2020; Alonso, Alvaro/A-4917-2010	Soliman, Elsayed Z/0000-0001-5632-8150; Alonso, Alvaro/0000-0002-2225-8323; Chamberlain, Alanna/0000-0003-1888-9584	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI [RC1HL099452]; American Heart Association [09SDG2280087]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099452] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). This work was additionally funded by grant RC1HL099452 from NHLBI and 09SDG2280087 from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Anselmi CV, 2010, J INTERV CARD ELECTR, V27, P95, DOI 10.1007/s10840-009-9466-8; Berry JD, 2010, AM J CARDIOL, V105, P844, DOI 10.1016/j.amjcard.2009.11.039; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Breslow JL, 2006, AM J CLIN NUTR, V83, p1477S, DOI 10.1093/ajcn/83.6.1477S; Brouwer IA, 2006, AM HEART J, V151, P857, DOI 10.1016/j.ahj.2005.07.029; Calo L, 2005, J AM COLL CARDIOL, V45, P1723, DOI 10.1016/j.jacc.2005.02.079; CASALE PN, 1987, CIRCULATION, V75, P565, DOI 10.1161/01.CIR.75.3.565; Chamberlain AM, 2010, AM HEART J, V159, P850, DOI 10.1016/j.ahj.2010.02.005; Freedman LS, 2010, AM J EPIDEMIOL, V172, P836, DOI 10.1093/aje/kwq194; Frost L, 2005, AM J CLIN NUTR, V81, P50; Gronroos NN, 2010, CIRC J, V74, P2029, DOI 10.1253/circj.CJ-10-0820; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; Heidarsdottir R, 2010, EUROPACE, V12, P356, DOI 10.1093/europace/eup429; Huxley RR, 2011, CIRCULATION, V123, P1501, DOI [10.1161/circulationaha.110.009035, 10.1161/CIRCULATIONAHA.110.009035]; Kang JX, 1996, EUR J PHARMACOL, V297, P97, DOI 10.1016/0014-2999(95)00701-6; Kowey PR, 2010, JAMA-J AM MED ASSOC, V304, P2363, DOI 10.1001/jama.2010.1735; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; MA J, 1995, AM J CLIN NUTR, V62, P564, DOI 10.1093/ajcn/62.3.564; Mariscalco G, 2010, ANGIOLOGY, V61, P643, DOI 10.1177/0003319710370962; Mayyas F, 2011, CARDIOVASC RES, V89, P852, DOI 10.1093/cvr/cvq380; Mozaffarian D, 2006, AM J CARDIOL, V97, P216, DOI 10.1016/j.amjcard.2005.08.025; Mozaffarian D, 2004, CIRCULATION, V110, P368, DOI 10.1161/01.CIR.0000138154.00779.A5; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Mozaffarian D, 2008, AM J CLIN NUTR, V87, p1991S, DOI 10.1093/ajcn/87.6.1991S; Mozaffarian D, 2008, CIRCULATION, V117, P1130, DOI 10.1161/CIRCULATIONAHA.107.732826; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Nodari S, 2011, CIRCULATION, V124, P1100, DOI 10.1161/CIRCULATIONAHA.111.022194; Patel Dimpi, 2009, Indian Pacing Electrophysiol J, V9, P292; RIBOLI E, 1987, CANCER SURV, V6, P685; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saravanan P, 2010, CIRC-ARRHYTHMIA ELEC, V3, P46, DOI 10.1161/CIRCEP.109.899633; Shen JA, 2011, AM J CLIN NUTR, V93, P261, DOI 10.3945/ajcn.110.001305; Virtanen JK, 2009, CIRCULATION, V120, P2315, DOI 10.1161/CIRCULATIONAHA.109.852657; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Willett WC, 2008, MODERN EPIDEMIOLOGY, P1188; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu JHY, 2012, CIRCULATION, V125, P1084, DOI 10.1161/CIRCULATIONAHA.111.062653; Xiao YF, 1997, P NATL ACAD SCI USA, V94, P4182, DOI 10.1073/pnas.94.8.4182	40	28	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36686	10.1371/journal.pone.0036686	http://dx.doi.org/10.1371/journal.pone.0036686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570739	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400055
J	Rios, FJO; Koga, MM; Ferracini, M; Jancar, S				Rios, Francisco J. O.; Koga, Mariana M.; Ferracini, Matheus; Jancar, Sonia			Co-Stimulation of PAFR and CD36 Is Required for oxLDL-Induced Human Macrophages Activation	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; MONOCYTE-DERIVED MACROPHAGES; FOAM CELL-FORMATION; OXIDIZED LDL; GENE-EXPRESSION; PPAR-GAMMA; CARDIOVASCULAR-DISEASE; FACTOR RECEPTOR; INTERLEUKIN-8; ATHEROSCLEROSIS	The oxidative process of LDL particles generates molecules which are structurally similar to platelet-activating factor (PAF), and some effects of oxidized LDL (oxLDL) have been shown to be dependent on PAF receptor (PAFR) activation. In a previous study, we showed that PAFR is required for upregulation of CD36 and oxLDL uptake. In the present study we analyzed the molecular mechanisms activated by oxLDL in human macrophages and the contribution of PAFR to this response. Human adherent monocytes/macrophages were stimulated with oxLDL. Uptake of oxLDL and CD36 expression were determined by flow cytometry; MAP kinases and Akt phosphorylation by Western blot; IL-8 and MCP-1 concentration by ELISA and mRNA expression by real-time PCR. To investigate the participation of the PI3K/Akt pathway, G alpha i-coupled protein or PAFR, macrophages were treated with LY294002, pertussis toxin or with the PAFR antagonists WEB2170 and CV3988, respectively before addition of oxLDL. It was found that the addition of oxLDL to human monocytes/macrophages activates the PI3K/Akt pathway which in turn activates the MAPK (p38 and JNK). Phosphorylation of Akt requires the engagement of PAFR and a G alpha i-coupled protein. The upregulation of CD36 protein and the uptake of oxLDL as well as the IL-8 production are dependent on PI3K/Akt pathway activation. The increased CD36 protein expression is dependent on PAFR and G alpha i-coupled protein. Transfection studies using HEK 293t cells showed that oxLDL uptake occurs with either PAFR or CD36, but IL-8 production requires the co-transfection of both PAFR and CD36. These findings show that PAFR has a pivotal role in macrophages response to oxLDL and suggest that pharmacological intervention at the level of PAFR activation might be beneficial in atherosclerosis.	[Rios, Francisco J. O.; Koga, Mariana M.; Ferracini, Matheus; Jancar, Sonia] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo	Rios, FJO (corresponding author), Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil.	fjorios@usp.br	Jancar, Sonia/C-5153-2012; Ferracini, Matheus/E-3820-2010; Rios, Francisco J./C-6059-2012	Jancar, Sonia/0000-0001-7983-3459; Ferracini, Matheus/0000-0003-1523-6457; Rios, Francisco/0000-0002-8194-0787; Koga, Marianna/0000-0003-3244-9059	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/03982-5, 2009/05290-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP: 2006/03982-5; 2009/05290-1), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Brocheriou I, 2000, CIRCULATION, V102, P2569; D'Archivio M, 2008, FEBS LETT, V582, P2291, DOI 10.1016/j.febslet.2008.05.029; Dentan C, 1996, EUR J BIOCHEM, V236, P48, DOI 10.1111/j.1432-1033.1996.00048.x; Dobreva I, 2006, J BIOL CHEM, V281, P199, DOI 10.1074/jbc.M508857200; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Fremont L, 1999, LIFE SCI, V64, P2511, DOI 10.1016/S0024-3205(99)00209-X; Fritz JM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-76; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Inoue T, 2008, INT J CARDIOL, V124, P319, DOI 10.1016/j.ijcard.2007.02.012; Ketelhuth DFJ, 2011, CIRCULATION, V124, P2433, DOI 10.1161/CIRCULATIONAHA.111.051599; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marathe GK, 2001, TRENDS CARDIOVAS MED, V11, P139, DOI 10.1016/S1050-1738(01)00100-1; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Prieto P, 2010, CELL DEATH DIFFER, V17, P1179, DOI 10.1038/cdd.2009.220; Riazy M, 2011, BIOCHEM CELL BIOL, V89, P387, DOI 10.1139/O11-035; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Rios FJO, 2011, CELL PHYSIOL BIOCHEM, V27, P363, DOI 10.1159/000327962; Rios FJO, 2008, CELL PHYSIOL BIOCHEM, V22, P549, DOI 10.1159/000185539; SAKAI H, 1982, AM J CLIN PATHOL, V78, P58, DOI 10.1093/ajcp/78.1.58; Senokuchi T, 2004, ATHEROSCLEROSIS, V176, P233, DOI 10.1016/j.atherosclerosis.2004.05.019; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Subbanagounder G, 1999, CIRC RES, V85, P311, DOI 10.1161/01.RES.85.4.311; Svensjo E, 2003, INFLAMM RES, V52, P215, DOI 10.1007/s000110300074; Taketa K, 2008, J BIOL CHEM, V283, P9852, DOI 10.1074/jbc.M703318200; Carvalho MDT, 2010, J ATHEROSCLER THROMB, V17, P844, DOI 10.5551/jat.3905; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Zhao M, 2002, APMIS, V110, P458, DOI 10.1034/j.1600-0463.2002.100604.x	32	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36632	10.1371/journal.pone.0036632	http://dx.doi.org/10.1371/journal.pone.0036632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570732	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400048
J	Singh, B; Tai, KR; Madan, S; Raythatha, MR; Cady, AM; Braunlin, M; Irving, LR; Bajaj, A; Lucci, A				Singh, Balraj; Tai, Karen; Madan, Simran; Raythatha, Milan R.; Cady, Amanda M.; Braunlin, Megan; Irving, LaTashia R.; Bajaj, Ankur; Lucci, Anthony			Selection of Metastatic Breast Cancer Cells Based on Adaptability of Their Metabolic State	PLOS ONE			English	Article							DISSEMINATED TUMOR-CELLS; MOUSE MAMMARY-TUMOR; GENOMIC INSTABILITY; STEM-CELLS; GROWTH; SUPPRESSION; EXPRESSION; GENES; MODEL; COX-2	A small subpopulation of highly adaptable breast cancer cells within a vastly heterogeneous population drives cancer metastasis. Here we describe a function-based strategy for selecting rare cancer cells that are highly adaptable and drive malignancy. Although cancer cells are dependent on certain nutrients, e.g., glucose and glutamine, we hypothesized that the adaptable cancer cells that drive malignancy must possess an adaptable metabolic state and that such cells could be identified using a robust selection strategy. As expected, more than 99.99% of cells died upon glutamine withdrawal from the aggressive breast cancer cell line SUM149. The rare cells that survived and proliferated without glutamine were highly adaptable, as judged by additional robust adaptability assays involving prolonged cell culture without glucose or serum. We were successful in isolating rare metabolically plastic glutamine-independent (Gln-ind) variants from several aggressive breast cancer cell lines that we tested. The Gln-ind cells overexpressed cyclooxygenase-2, an indicator of tumor aggressiveness, and they were able to adjust their glutaminase level to suit glutamine availability. The Gln-ind cells were anchorage-independent, resistant to chemotherapeutic drugs doxorubicin and paclitaxel, and resistant to a high concentration of a COX-2 inhibitor celecoxib. The number of cells being able to adapt to non-availability of glutamine increased upon prior selection of cells for resistance to chemotherapy drugs or resistance to celecoxib, further supporting a linkage between cellular adaptability and therapeutic resistance. Gln-ind cells showed indications of oxidative stress, and they produced cadherin11 and vimentin, indicators of mesenchymal phenotype. Gln-ind cells were more tumorigenic and more metastatic in nude mice than the parental cell line as judged by incidence and time of occurrence. As we decreased the number of cancer cells in xenografts, lung metastasis and then primary tumor growth was impaired in mice injected with parental cell line, but not in mice injected with Gln-ind cells.	[Singh, Balraj; Tai, Karen; Madan, Simran; Raythatha, Milan R.; Cady, Amanda M.; Braunlin, Megan; Irving, LaTashia R.; Bajaj, Ankur; Lucci, Anthony] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Singh, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	alucci@mdanderson.org	Singh, Balraj/AHD-5938-2022	Lucci, Anthony/0000-0003-4039-174X	United States Army Medical Research and Material Command [DAMD17-03-1-0669 W81XWH-09-1-0590]; National Institutes of Health, HostGator [CA16672]; Breast Cancer Micrometastasis Research Program at MD Anderson Cancer Center; Morgan Welch Inflammatory Breast Cancer Multi-Disciplinary Research Program at MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Health, HostGator; Breast Cancer Micrometastasis Research Program at MD Anderson Cancer Center; Morgan Welch Inflammatory Breast Cancer Multi-Disciplinary Research Program at MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants DAMD17-03-1-0669 W81XWH-09-1-0590 from the United States Army Medical Research and Material Command (AL), CA16672 (Core) from the National Institutes of Health, HostGator (AL), Breast Cancer Micrometastasis Research Program at MD Anderson Cancer Center (AL), and Morgan Welch Inflammatory Breast Cancer Multi-Disciplinary Research Program at MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barry M, 2009, IRISH J MED SCI, V178, P201, DOI 10.1007/s11845-009-0335-3; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Guo LX, 2011, AM J PATHOL, V178, P2357, DOI 10.1016/j.ajpath.2011.01.047; Hall C, 2012, CANCER-AM CANCER SOC, V118, P342, DOI 10.1002/cncr.26202; Janni W, 2011, CLIN CANCER RES, V17, P2967, DOI 10.1158/1078-0432.CCR-10-2515; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Lev DC, 2003, CLIN EXP METASTAS, V20, P515; LI LM, 1989, JNCI-J NATL CANCER I, V81, P1406, DOI 10.1093/jnci/81.18.1406; Li YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017421; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Lucci A, 2009, BREAST CANCER RES TR, V117, P61, DOI 10.1007/s10549-008-0135-x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Mustafa A, 2008, CLIN CANCER RES, V14, P4935, DOI 10.1158/1078-0432.CCR-08-0958; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; NICOLSON GL, 1982, SCIENCE, V215, P176, DOI 10.1126/science.7053568; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Pan QT, 2003, MOL CANCER RES, V1, P701; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Pishvaian MJ, 1999, CANCER RES, V59, P947; POSTE G, 1980, CANCER RES, V40, P1636; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Singh B, 2005, INT J ONCOL, V26, P1393; Singh B, 2006, J SURG RES, V134, P44, DOI 10.1016/j.jss.2006.03.018; Singh B, 2008, J SURG RES, V147, P240, DOI 10.1016/j.jss.2008.02.026; Singh B, 2007, J SURG RES, V140, P220, DOI 10.1016/j.jss.2007.01.039; Singh B, 2011, J SURG RES, V168, pE39, DOI 10.1016/j.jss.2010.03.003; Singh B, 2010, J SURG RES, V163, P235, DOI 10.1016/j.jss.2010.04.061; Singh B, 2010, CLIN EXP METASTAS, V27, P233, DOI 10.1007/s10585-010-9321-4; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; TALMADGE JE, 1982, SCIENCE, V217, P361, DOI 10.1126/science.6953592; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Zhang DW, 2009, CLIN CANCER RES, V15, P6639, DOI 10.1158/1078-0432.CCR-09-0951	51	15	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36510	10.1371/journal.pone.0036510	http://dx.doi.org/10.1371/journal.pone.0036510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570721	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343400037
J	Wallington-Beddoe, CT; Don, AS; Hewson, J; Qiao, Q; Papa, RA; Lock, RB; Bradstock, KF; Bendall, LJ				Wallington-Beddoe, Craig T.; Don, Anthony S.; Hewson, John; Qiao, Qiao; Papa, Rachael A.; Lock, Richard B.; Bradstock, Kenneth F.; Bendall, Linda J.			Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							RELAPSING MULTIPLE-SCLEROSIS; LYMPHOCYTIC-LEUKEMIA; PRECLINICAL ACTIVITY; ORAL FINGOLIMOD; STROMAL CELLS; PROLIFERATION; RECEPTOR-1; INHIBITORS; APOPTOSIS; SURVIVAL	Most patients with acute lymphoblastic leukemia (ALL) respond well to standard chemotherapy-based treatments. However a significant proportion of patients, particularly adult patients, relapse with the majority dying of leukemia. FTY720 is an immunosuppressive drug that was recently approved for the treatment of multiple sclerosis and is currently under preclinical investigation as a therapy for a number of hematological malignancies. Using human ALL xenografts in NOD/SCID gamma c(-/-) mice, we show for the first time that three Ph+ human ALL xenografts responded to FTY720 with an 80 +/- 12% (p = 0.048) reduction in overall disease when treatment was commenced early. In contrast, treatment of mice with FTY720 did not result in reduced leukemia compared to controls using four separate human Ph- ALL xenografts. Although FTY720 reactivated PP2A in vitro, this reactivation was not required for death of Ph- ALL cells. The plasma levels of FTY720 achieved in the mice were in the high nanomolar range. However, the response seen in the Ph+ ALL xenografts when treatment was initiated early implies that in vivo efficacy may be obtained with substantially lower drug concentrations than those required in vitro. Our data suggest that while FTY720 may have potential as a treatment for Ph+ ALL it will not be a useful agent for the treatment of Ph- B-ALL.	[Wallington-Beddoe, Craig T.; Hewson, John; Bendall, Linda J.] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2006, Australia; [Don, Anthony S.; Qiao, Qiao] Univ New S Wales, Fac Med, Lowy Canc Res Ctr, Prince Wales Clin Sch, Sydney, NSW, Australia; [Papa, Rachael A.; Lock, Richard B.] Univ New S Wales, Childrens Canc Inst Australia Med Res, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Bradstock, Kenneth F.] Westmead Hosp, Dept Hematol, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of New South Wales Sydney; Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; University of Sydney	Wallington-Beddoe, CT (corresponding author), Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2006, Australia.	linda.bendall@sydney.edu.au	Lock, Richard/G-4253-2013; Don, Anthony Simon/AAE-9687-2021	Don, Anthony Simon/0000-0003-1655-1184; Wallington-Gates, Craig Thomas/0000-0002-7457-5937; Lock, Richard/0000-0002-3436-9071	Leukemia Foundation of Australia PhD Scholarship (Clinical); Cancer Institute NSW Research Scholar Award [10/RSA/1-34]; Cancer Institute NSW Early Career Fellowship [08/ECF/1-03]; Royal College of Pathologists of Australasia Research Award; NHMRC [511965, 568703]	Leukemia Foundation of Australia PhD Scholarship (Clinical); Cancer Institute NSW Research Scholar Award; Cancer Institute NSW Early Career Fellowship; Royal College of Pathologists of Australasia Research Award; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the following grants: Leukemia Foundation of Australia PhD Scholarship (Clinical) (www.leukaemia.org.au), Cancer Institute NSW Research Scholar Award No. 10/RSA/1-34, Cancer Institute NSW Early Career Fellowship 08/ECF/1-03 (www.cancerinstitute.org.au), Royal College of Pathologists of Australasia Research Award (www.rcpa.edu.au), NHMRC CDA2 No. 511965 and NHMRC Senior Research Fellowship No. 568703 (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Crazzolara R, 2009, BLOOD, V113, P3297, DOI 10.1182/blood-2008-02-137752; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Gaundar SS, 2009, CELL CYCLE, V8, P2975; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Gokbuget N, 2009, SEMIN HEMATOL, V46, P64, DOI 10.1053/j.seminhematol.2008.09.003; Hung JH, 2008, CANCER RES, V68, P1204, DOI 10.1158/0008-5472.CAN-07-2621; Jary E, 2010, MOL PHARMACOL, V78, P685, DOI 10.1124/mol.110.064873; Juarez J, 2003, LEUKEMIA, V17, P1294, DOI 10.1038/sj.leu.2402998; Juarez J, 2007, HAEMATOLOGICA, V92, P450, DOI 10.3324/haematol.10621; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Liao AJ, 2011, BLOOD, V118, P2793, DOI 10.1182/blood-2011-01-331447; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Liu Q, 2010, CLIN CANCER RES, V16, P3182, DOI 10.1158/1078-0432.CCR-09-2484; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Meno-Tetang GML, 2005, BASIC CLIN PHARMACOL, V96, P182, DOI 10.1111/j.1742-7843.2005.pto960307.x; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Nikolova Z, 2001, TRANSPL IMMUNOL, V8, P267, DOI 10.1016/S0966-3274(01)00031-4; Roberts KG, 2010, CANCER RES, V70, P5438, DOI 10.1158/0008-5472.CAN-09-2544; Sensken SC, 2009, J PHARMACOL EXP THER, V328, P963, DOI 10.1124/jpet.108.148163; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Wallington-Beddoe CT, 2011, AUTOPHAGY, V7, P707, DOI 10.4161/auto.7.7.15154; Yasui H, 2005, CANCER RES, V65, P7478, DOI 10.1158/0008-5472.CAN-05-0850	32	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36429	10.1371/journal.pone.0036429	http://dx.doi.org/10.1371/journal.pone.0036429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570713	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000305343400029
J	Campbell, SJ; Edwards, RA; Leung, CCY; Neculai, D; Hodge, CD; Dhe-Paganon, S; Glover, JNM				Campbell, Stephen J.; Edwards, Ross A.; Leung, Charles C. Y.; Neculai, Dante; Hodge, Curtis D.; Dhe-Paganon, Sirano; Glover, J. N. Mark			Molecular Insights into the Function of RING Finger (RNF)-containing Proteins hRNF8 and hRNF168 in Ubc13/Mms2-dependent Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; UBIQUITIN RECOGNITION; POLYUBIQUITIN CHAINS; COMPLEX; REPLACEMENT; REVEALS; LIGASE; MODEL	The repair of DNA double strand breaks by homologous recombination relies on the unique topology of the chains formed by Lys-63 ubiquitylation of chromatin to recruit repair factors such as breast cancer 1 (BRCA1) to sites of DNA damage. The human RING finger (RNF) E3 ubiquitin ligases, RNF8 and RNF168, with the E2 ubiquitin-conjugating complex Ubc13/Mms2, perform the majority of Lys-63 ubiquitylation in homologous recombination. Here, we show that RNF8 dimerizes and binds to Ubc13/Mms2, thereby stimulating formation of Lys-63 ubiquitin chains, whereas the related RNF168 RING domain is a monomer and does not catalyze Lys-63 polyubiquitylation. The crystal structure of the RNF8/Ubc13/Mms2 ternary complex reveals the structural basis for the interaction between Ubc13 and the RNF8 RING and that an extended RNF8 coiled-coil is responsible for its dimerization. Mutations that disrupt the RNF8/Ubc13 binding surfaces, or that truncate the RNF8 coiled-coil, reduce RNF8-catalyzed ubiquitylation. These findings support the hypothesis that RNF8 is responsible for the initiation of Lys-63-linked ubiquitylation in the DNA damage response, which is subsequently amplified by RNF168.	[Glover, J. N. Mark] Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada; [Neculai, Dante; Dhe-Paganon, Sirano] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada	University of Alberta; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Glover, JNM (corresponding author), Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada.	mark.glover@ualberta.ca	Neculai, Dante/M-2884-2013; Neculai, Dante/A-9923-2011	Neculai, Dante/0000-0001-8887-9168; Hodge, Curtis/0000-0002-7528-4058	Canadian Cancer Society	Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by a research grant from the Canadian Cancer Society.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Lok GTM, 2012, NUCLEIC ACIDS RES, V40, P196, DOI 10.1093/nar/gkr655; LOVERING R, 1993, P NATL ACAD SCI USA, V90, P2112, DOI 10.1073/pnas.90.6.2112; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Serniwka SA, 2009, BIOCHEMISTRY-US, V48, P12169, DOI 10.1021/bi901686j; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	49	56	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23900	23910		10.1074/jbc.M112.359653	http://dx.doi.org/10.1074/jbc.M112.359653			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589545	Green Published, hybrid			2022-12-25	WOS:000306511300060
J	Wu, YL; Sommers, JA; Loiland, JA; Kitao, H; Kuper, J; Kisker, C; Brosh, RM				Wu, Yuliang; Sommers, Joshua A.; Loiland, Jason A.; Kitao, Hiroyuki; Kuper, Jochen; Kisker, Caroline; Brosh, Robert M., Jr.			The Q Motif of Fanconi Anemia Group J Protein (FANCJ) DNA Helicase Regulates Its Dimerization, DNA Binding, and DNA Repair Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOMS-SYNDROME; BREAST-CANCER; ATP BINDING; HOMOLOGOUS RECOMBINATION; INACTIVATING MUTATIONS; STRUCTURAL BASIS; RECQ HELICASES; GENE-PRODUCT; MECHANISMS; BACH1	The Q motif, conserved in a number of RNA and DNA helicases, is proposed to be important for ATP binding based on structural data, but its precise biochemical functions are less certain. FANCJ encodes a Q motif DEAH box DNA helicase implicated in Fanconi anemia and breast cancer. A Q25A mutation of the invariant glutamine in the Q motif abolished its ability to complement cisplatin or telomestatin sensitivity of a fancj null cell line and exerted a dominant negative effect. Biochemical characterization of the purified recombinant FANCJ-Q25A protein showed that the mutation disabled FANCJ helicase activity and the ability to disrupt protein-DNA interactions. FANCJ-Q25A showed impaired DNA binding and ATPase activity but displayed ATP binding and temperature-induced unfolding transition similar to FANCJ-WT. Size exclusion chromatography and sedimentation velocity analyses revealed that FANCJ-WT existed as molecular weight species corresponding to a monomer and a dimer, and the dimeric form displayed a higher specific activity for ATPase and helicase, as well as greater DNA binding. In contrast, FANCJ-Q25A existed only as a monomer, devoid of helicase activity. Thus, the Q motif is essential for FANCJ enzymatic activity in vitro and DNA repair function in vivo.	[Wu, Yuliang; Sommers, Joshua A.; Loiland, Jason A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Kitao, Hiroyuki] Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Kuper, Jochen; Kisker, Caroline] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Inst Biol Struct, D-97080 Wurzburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Kyushu University; University of Wurzburg	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020; Kisker, Caroline/T-1724-2019	Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health Intramural Research Program, NIA; Fanconi Anemia Research Fund; Deutsche Forschungsgemeinschaft [Forschungszentrum FZ82]; NATIONAL INSTITUTE ON AGING [ZIAAG000752, ZIAAG000753, ZIAAG000741] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NIA. This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.) and Deutsche Forschungsgemeinschaft Grant Forschungszentrum FZ82 (to C. K.).	Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2003, NUCLEIC ACIDS RES, V31, P2778, DOI 10.1093/nar/gkg376; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Gallivan JP, 2003, FEBS LETT, V554, P485, DOI 10.1016/S0014-5793(03)01229-8; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Guo RB, 2007, NUCLEIC ACIDS RES, V35, P6297, DOI 10.1093/nar/gkm536; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Hiom K, 2010, DNA REPAIR, V9, P250, DOI 10.1016/j.dnarep.2010.01.005; Hsieh J, 1999, J MOL BIOL, V288, P255, DOI 10.1006/jmbi.1999.2666; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Killoran MP, 2006, NUCLEIC ACIDS RES, V34, P4098, DOI 10.1093/nar/gkl538; Kitao H, 2011, GENES CELLS, V16, P714, DOI 10.1111/j.1365-2443.2011.01523.x; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; Neff NF, 1999, MOL BIOL CELL, V10, P665, DOI 10.1091/mbc.10.3.665; Nongkhlaw M, 2012, BIOCHEMISTRY-US, V51, P3711, DOI 10.1021/bi2014757; Oksenych V, 2010, CELL CYCLE, V9, P90, DOI 10.4161/cc.9.1.10267; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Strohmeier J, 2011, BIOL CHEM, V392, P357, DOI 10.1515/BC.2011.034; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Tsay JM, 2009, P NATL ACAD SCI USA, V106, P14355, DOI 10.1073/pnas.0904364106; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2010, BLOOD, V116, P3780, DOI 10.1182/blood-2009-11-256016; Wu YL, 2010, CELL CYCLE, V9, P4080, DOI 10.4161/cc.9.20.13667; Wu YL, 2009, CURR MOL MED, V9, P470, DOI 10.2174/156652409788167159; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	59	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21699	21716		10.1074/jbc.M112.351338	http://dx.doi.org/10.1074/jbc.M112.351338			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22582397	Green Published, hybrid			2022-12-25	WOS:000306418600012
J	Benhamron, S; Reiner, I; Zcharia, E; Atallah, M; Grau, A; Vlodavsky, I; Mevorach, D				Benhamron, Sandrine; Reiner, Inna; Zcharia, Eyal; Atallah, Mizhir; Grau, Amir; Vlodavsky, Israel; Mevorach, Dror			Dissociation between Mature Phenotype and Impaired Transmigration in Dendritic Cells from Heparanase-Deficient Mice	PLOS ONE			English	Article							SUBENDOTHELIAL EXTRACELLULAR-MATRIX; 1-MATRIX METALLOPROTEINASE; REGULATES DEGRADATION; MAMMALIAN HEPARANASE; CHEMOKINE RECEPTOR; CANCER METASTASIS; LYMPH-NODES; MIGRATION; EXPRESSION; ANGIOGENESIS	To reach the lymphatics, migrating dendritic cells (DCs) need to interact with the extracellular matrix (ECM). Heparanase, a mammalian endo-beta-D-glucuronidase, specifically degrades heparan sulfate proteoglycans ubiquitously associated with the cell surface and ECM. The role of heparanase in the physiology of bone marrow-derived DCs was studied in mutant heparanase knock-out (Hpse-KO) mice. Immature DCs from Hpse-KO mice exhibited a more mature phenotype; however their transmigration was significantly delayed, but not completely abolished, most probably due to the observed upregulation of MMP-14 and CCR7. Despite their mature phenotype, uptake of beads was comparable and uptake of apoptotic cells was more efficient in DCs from Hpse-KO mice. Heparanase is an important enzyme for DC transmigration. Together with CCR7 and its ligands, and probably MMP-14, heparanase controls DC trafficking.	[Benhamron, Sandrine; Reiner, Inna; Atallah, Mizhir; Grau, Amir; Mevorach, Dror] Hadassah Hebrew Univ, Med Ctr, Rheumatol Res Ctr, Lab Cellular & Mol Immunol,Dept Med, Jerusalem, Israel; [Zcharia, Eyal; Vlodavsky, Israel] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel; [Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Benhamron, S (corresponding author), Hadassah Hebrew Univ, Med Ctr, Rheumatol Res Ctr, Lab Cellular & Mol Immunol,Dept Med, Jerusalem, Israel.	mevorachd@hadassah.org.il			Hadassah Medical Organization	Hadassah Medical Organization	This study was supported by a grant from Hadassah Medical Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablin J, 2005, APOPTOSIS, V10, P1009, DOI 10.1007/s10495-005-1189-4; Baumjohann D, 2006, EUR J IMMUNOL, V36, P2544, DOI 10.1002/eji.200535742; Benhamron S, 2006, J IMMUNOL, V176, P6417, DOI 10.4049/jimmunol.176.11.6417; Cera MR, 2004, J CLIN INVEST, V114, P729, DOI 10.1172/JCI200421231; D'Amico G, 1998, BLOOD, V92, P207, DOI 10.1182/blood.V92.1.207.413a02_207_214; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Duriancik DA, 2009, CYTOM PART A, V75A, P951, DOI 10.1002/cyto.a.20794; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Freeman C, 1998, BIOCHEM J, V330, P1341, DOI 10.1042/bj3301341; FRIDMAN R, 1987, J CELL PHYSIOL, V130, P85, DOI 10.1002/jcp.1041300113; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matias-Roman S, 2005, BLOOD, V105, P3956, DOI 10.1182/blood-2004-06-2382; Mevorach D, 2003, CLIN REV ALLERG IMMU, V25, P49, DOI 10.1385/CRIAI:25:1:49; Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8; Osman M, 2002, IMMUNOLOGY, V105, P73, DOI 10.1046/j.0019-2805.2001.01349.x; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Sasaki N, 2004, J IMMUNOL, V172, P3830, DOI 10.4049/jimmunol.172.6.3830; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; VLODAVSKY I, 1994, INVAS METAST, V14, P290; VLODAVSKY I, 1983, CANCER RES, V43, P2704; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 1999, CURR PROTOCOLS CE S1, P10; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Yang MX, 2006, IMMUNOL CELL BIOL, V84, P557, DOI 10.1111/j.1440-1711.2006.01465.x; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181	41	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e35602	10.1371/journal.pone.0035602	http://dx.doi.org/10.1371/journal.pone.0035602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590508	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336400004
J	Ring, H; Mendu, SK; Shirazi-Fard, S; Birnir, B; Hallbook, F				Ring, Henrik; Mendu, Suresh Kumar; Shirazi-Fard, Shahrzad; Birnir, Bryndis; Hallbook, Finn			GABA Maintains the Proliferation of Progenitors in the Developing Chick Ciliary Marginal Zone and Non-Pigmented Ciliary Epithelium	PLOS ONE			English	Article							RETINAL STEM-CELLS; GLUCAGON-EXPRESSING NEURONS; MULLER GLIA; TRANSCRIPTION FACTORS; INTERNATIONAL-UNION; NEURAL PROGENITORS; CALCIUM-CHANNELS; RECEPTORS; EYE; PHARMACOLOGY	GABA is more than the main inhibitory neurotransmitter found in the adult CNS. Several studies have shown that GABA regulates the proliferation of progenitor and stem cells. This work examined the effects of the GABA(A) receptor system on the proliferation of retinal progenitors and non-pigmented ciliary epithelial (NPE) cells. qRT-PCR and whole-cell patch-clamp electrophysiology were used to characterize the GABA(A) receptor system. To quantify the effects on proliferation by GABA(A) receptor agonists and antagonists, incorporation of thymidine analogues was used. The results showed that the NPE cells express functional extrasynaptic GABA(A) receptors with tonic properties and that low concentration of GABA is required for a baseline level of proliferation. Antagonists of the GABA(A) receptors decreased the proliferation of dissociated E12 NPE cells. Bicuculline also had effects on progenitor cell proliferation in intact E8 and E12 developing retina. The NPE cells had low levels of the Cl-transporter KCC2 compared to the mature retina, suggesting a depolarising role for the GABA(A) receptors. Treatment with KCl, which is known to depolarise membranes, prevented some of the decreased proliferation caused by inhibition of the GABA(A) receptors. This supported the depolarising role for the GABA(A) receptors. Inhibition of L-type voltage-gated Ca2+ channels (VGCCs) reduced the proliferation in the same way as inhibition of the GABA(A) receptors. Inhibition of the channels increased the expression of the cyclin-dependent kinase inhibitor p27(KIP1), along with the reduced proliferation. These results are consistent with that when the membrane potential indirectly regulates cell proliferation with hyperpolarisation of the membrane potential resulting in decreased cell division. The increased expression of p27(KIP1) after inhibition of either the GABA(A) receptors or the L-type VGCCs suggests a link between the GABA(A) receptors, membrane potential, and intracellular Ca2+ in regulating the cell cycle.	[Ring, Henrik; Mendu, Suresh Kumar; Shirazi-Fard, Shahrzad; Birnir, Bryndis; Hallbook, Finn] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Ring, H (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Finn.hallbook@neuro.uu.se		Mendu, Suresh Kumar/0000-0002-6785-0806; Birnir, Bryndis/0000-0002-1763-0266; Hallbook, Finn/0000-0001-7552-187X	Swedish Research Council [20859-01-3, 12187-15-3]; FORMAS, Barncancerfonden [PROJ09/038]; Ogonfonden; Kronprinsessan Margaretas arbetsnamnd for synskadade; Swedish foundation for strategic research	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS, Barncancerfonden; Ogonfonden; Kronprinsessan Margaretas arbetsnamnd for synskadade; Swedish foundation for strategic research(Swedish Foundation for Strategic Research)	The work was supported by the Swedish Research Council (http://www.vr.se; 20859-01-3, 12187-15-3), FORMAS, Barncancerfonden (www.barncancerfonden.se; PROJ09/038), Ogonfonden (www.ogonfonden.se) and Kronprinsessan Margaretas arbetsnamnd for synskadade (www.stiftelsenkma.com), and a grant from the Swedish foundation for strategic research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-51; Amato MA, 2004, INT J DEV BIOL, V48, P993, DOI 10.1387/ijdb.041879ma; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bhatia B, 2011, EXP EYE RES, V93, P852, DOI 10.1016/j.exer.2011.09.015; Birnir B, 2007, CURR PHARM DESIGN, V13, P3169, DOI 10.2174/138161207782341330; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Catsicas M, 2001, J NEUROSCI, V21, P897, DOI 10.1523/JNEUROSCI.21-03-00897.2001; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Diederen RMH, 2006, EXP EYE RES, V83, P45, DOI 10.1016/j.exer.2005.10.031; Donovan SL, 2005, SEMIN CELL DEV BIOL, V16, P407, DOI 10.1016/j.semcdb.2005.02.012; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Edqvist PHD, 2006, EUR J HISTOCHEM, V50, P147; EHRLICH D, 1987, J COMP NEUROL, V266, P220, DOI 10.1002/cne.902660208; Eilers J, 2001, J PHYSIOL-LONDON, V536, P429, DOI 10.1111/j.1469-7793.2001.0429c.xd; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Fischer AJ, 2006, J COMP NEUROL, V496, P479, DOI 10.1002/cne.20937; Fischer AJ, 2000, DEV BIOL, V220, P197, DOI 10.1006/dbio.2000.9640; Fischer AJ, 2005, J NEUROSCI, V25, P10157, DOI 10.1523/JNEUROSCI.3247-05.2005; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Fischer AJ, 2003, DEV BIOL, V259, P225, DOI 10.1016/S0012-1606(03)00178-7; Fischer AJ, 2010, MOL NEUROBIOL, V42, P199, DOI 10.1007/s12035-010-8152-2; Fiszman ML, 1999, DEV BRAIN RES, V115, P1, DOI 10.1016/S0165-3806(99)00035-8; Fiumelli H, 2007, CURR OPIN NEUROBIOL, V17, P81, DOI 10.1016/j.conb.2007.01.002; Ghai K, 2008, BRAIN RES, V1192, P76, DOI 10.1016/j.brainres.2007.01.105; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HARPER JW, 1993, CELL, V75, P805; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; HEAULME M, 1986, BRAIN RES, V384, P224, DOI 10.1016/0006-8993(86)91158-3; HEINAMAKI AA, 1986, NEUROCHEM RES, V11, P535, DOI 10.1007/BF00965323; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; HOKOC JN, 1990, BRAIN RES, V532, P197, DOI 10.1016/0006-8993(90)91760-E; Jackson JR, 2000, CANCER RES, V60, P566; JOHNSTON GA, 1968, BIOCHEM PHARMACOL, V17, P2488, DOI 10.1016/0006-2952(68)90141-X; Khattar E, 2010, J BIOL CHEM, V285, P4554, DOI 10.1074/jbc.M109.029280; Kokkinopoulos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018921; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; Mendu SK, 2011, MOL IMMUNOL, V48, P399, DOI 10.1016/j.molimm.2010.08.005; Mitterdorfer J, 1998, J BIOENERG BIOMEMBR, V30, P319, DOI 10.1023/A:1021933504909; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; Morokuma J, 2008, P NATL ACAD SCI USA, V105, P16608, DOI 10.1073/pnas.0808328105; Moshiri A, 2005, DEV DYNAM, V233, P66, DOI 10.1002/dvdy.20299; Nguyen L, 2003, J NEUROSCI, V23, P3278; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Olsen RW, 2006, P NATL ACAD SCI USA, V103, P6081, DOI 10.1073/pnas.0601121103; OLSEN RW, 1976, BRAIN RES, V102, P283, DOI 10.1016/0006-8993(76)90883-0; Pai VP, 2012, DEVELOPMENT, V139, P313, DOI 10.1242/dev.073759; Purves D., 2012, NEUROSCIENCE; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; REH TA, 1987, NATURE, V330, P68, DOI 10.1038/330068a0; Reh TA, 2006, METHOD ENZYMOL, V419, P52, DOI 10.1016/S0076-6879(06)19003-5; Ring H, 2010, VISUAL NEUROSCI, V27, P149, DOI 10.1017/S0952523810000180; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; STONE LS, 1950, ANAT REC, V106, P89, DOI 10.1002/ar.1091060108; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; TAKUWA N, 1995, CELL SIGNAL, V7, P93, DOI 10.1016/0898-6568(94)00074-L; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Xue XY, 2011, DEV NEUROBIOL; YAMASHITA M, 1993, J NEUROBIOL, V24, P1600, DOI 10.1002/neu.480241205; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; Zhao YL, 2011, ANESTH ANALG, V113, P1152, DOI 10.1213/ANE.0b013e318230b3fd	75	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36874	10.1371/journal.pone.0036874	http://dx.doi.org/10.1371/journal.pone.0036874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590629	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336100070
J	Liu, YX; Sun, Y; Broaddus, R; Liu, JS; Sood, AK; Shmulevich, I; Zhang, W				Liu, Yuexin; Sun, Yan; Broaddus, Russell; Liu, Jinsong; Sood, Anil K.; Shmulevich, Ilya; Zhang, Wei			Integrated Analysis of Gene Expression and Tumor Nuclear Image Profiles Associated with Chemotherapy Response in Serous Ovarian Carcinoma	PLOS ONE			English	Article							CANCER; PREDICTION; CHEMORESISTANT; PATHWAY; DNA	Background: Small sample sizes used in previous studies result in a lack of overlap between the reported gene signatures for prediction of chemotherapy response. Although morphologic features, especially tumor nuclear morphology, are important for cancer grading, little research has been reported on quantitatively correlating cellular morphology with chemotherapy response, especially in a large data set. In this study, we have used a large population of patients to identify molecular and morphologic signatures associated with chemotherapy response in serous ovarian carcinoma. Methodology/Principal Findings: A gene expression model that predicts response to chemotherapy is developed and validated using a large-scale data set consisting of 493 samples from The Cancer Genome Atlas (TCGA) and 244 samples from an Australian report. An identified 227-gene signature achieves an overall predictive accuracy of greater than 85% with a sensitivity of approximately 95% and specificity of approximately 70%. The gene signature significantly distinguishes between patients with unfavorable versus favorable prognosis, when applied to either an independent data set (P = 0.04) or an external validation set (P < 0.0001). In parallel, we present the production of a tumor nuclear image profile generated from 253 sample slides by characterizing patients with nuclear features (such as size, elongation, and roundness) in incremental bins, and we identify a morphologic signature that demonstrates a strong association with chemotherapy response in serous ovarian carcinoma. Conclusions: A gene signature discovered on a large data set provides robustness in accurately predicting chemotherapy response in serous ovarian carcinoma. The combination of the molecular and morphologic signatures yields a new understanding of potential mechanisms involved in drug resistance.	[Liu, Yuexin; Sun, Yan; Broaddus, Russell; Liu, Jinsong; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Reprod Med & Canc Biol, Houston, TX 77030 USA; [Sun, Yan] Tianjin Med Univ, Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China; [Shmulevich, Ilya] Inst Syst Biol, Seattle, WA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical University; Institute for Systems Biology (ISB)	Liu, YX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	wzhang@mdanderson.org			National Institutes of Health [U24 CA143835]; NATIONAL CANCER INSTITUTE [U24CA143835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding for the Genome Data Analysis Centers from the National Institutes of Health (U24 CA143835 to I.S. and W.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bachvarov D, 2006, INT J ONCOL, V29, P919; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardini M, 2005, NEOPLASIA, V7, P603, DOI 10.1593/neo.04760; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Capo-chichi Callinice D, 2011, Chin J Cancer, V30, P415; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Dalakas E, 2005, FASEB J, V19, P1225, DOI 10.1096/fj.04-2604rev; Diest PJ, 1991, HUM PATHOL, V22, P326; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Fischer MJM, 2010, MICROVASC RES, V80, P258, DOI 10.1016/j.mvr.2010.04.004; Gandhi KS, 2010, PLOS ONE, V5; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Hsu CY, 2005, HUM PATHOL, V36, P1049, DOI 10.1016/j.humpath.2005.07.014; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kashiwagi Y, 2010, MOL VIS, V16, P970; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Lysetska M, 2002, NUCLEIC ACIDS RES, V30, P2686, DOI 10.1093/nar/gkf378; Nafe R, 2005, CLIN CANCER RES, V11, P2141, DOI 10.1158/1078-0432.CCR-04-1198; National Cancer Institute, COMPR CANC INF; National Institutes of Health, IMAGEJ US GUID IJ 1; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Park MJ, 2007, J BIOL CHEM, V282, P30485, DOI 10.1074/jbc.M701081200; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ritter N, 2009, J MATH IMAGING VIS, V35, P117, DOI 10.1007/s10851-009-0158-x; Selvanayagam ZE, 2004, CANCER GENET CYTOGEN, V154, P63, DOI 10.1016/j.cancergencyto.2004.01.024; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; WILS J, 1988, CANCER, V61, P1920, DOI 10.1002/1097-0142(19880501)61:9<1920::AID-CNCR2820610933>3.0.CO;2-2	41	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36383	10.1371/journal.pone.0036383	http://dx.doi.org/10.1371/journal.pone.0036383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590536	gold, Green Submitted, Green Published			2022-12-25	WOS:000305335500010
J	Matta, H; Gopalakrishnan, R; Graham, C; Tolani, B; Khanna, A; Yi, H; Suo, YL; Chaudhary, PM				Matta, Hittu; Gopalakrishnan, Ramakrishnan; Graham, Ciaren; Tolani, Bhairavi; Khanna, Akshat; Yi, Han; Suo, Yulan; Chaudhary, Preet M.			Kaposi's Sarcoma Associated Herpesvirus Encoded Viral FLICE Inhibitory Protein K13 Activates NF-kappa B Pathway Independent of TRAF6, TAK1 and LUBAC	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CHAIN ASSEMBLY COMPLEX; TNF-R1 SIGNALING COMPLEX; KINASE COMPLEX; IKK-BETA; POLYUBIQUITIN CHAINS; INDUCED APOPTOSIS; UBIQUITIN CHAINS; GENE INDUCTION; KSHV VFLIP	Background: Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein (vFLIP) K13 activates the NF-kappa B pathway by binding to the NEMO/IKK gamma subunit of the I kappa B kinase (IKK) complex. However, it has remained enigmatic how K13-NEMO interaction results in the activation of the IKK complex. Recent studies have implicated TRAF6, TAK1 and linear ubiquitin chains assembled by a linear ubiquitin chain assembly complex (LUBAC) consisting of HOIL-1, HOIP and SHARPIN in IKK activation by proinflammatory cytokines. Methodology/Principal Findings: Here we demonstrate that K13-induced NF-kappa B DNA binding and transcriptional activities are not impaired in cells derived from mice with targeted disruption of TRAF6, TAK1 and HOIL-1 genes and in cells derived from mice with chronic proliferative dermatitis (cpdm), which have mutation in the Sharpin gene (Sharpin(cpdm/ cpdm)). Furthermore, reconstitution of NEMO-deficient murine embryonic fibroblast cells with NEMO mutants that are incapable of binding to linear ubiquitin chains supported K13-induced NF-kappa B activity. K13-induced NF-kappa B activity was not blocked by CYLD, a deubiquitylating enzyme that can cleave linear and Lys63-linked ubiquitin chains. On the other hand, NEMO was required for interaction of K13 with IKK1/IKK alpha and IKK2/IKK beta, which resulted in their activation by "T Loop'' phosphorylation. Conclusions/Significance: Our results demonstrate that K13 activates the NF-kappa B pathway by binding to NEMO which results in the recruitment of IKK1/IKK alpha and IKK2/IKK beta and their subsequent activation by phosphorylation. Thus, K13 activates NF-kappa B via a mechanism distinct from that utilized by inflammatory cytokines. These results have important implications for the development of therapeutic agents targeting K13-induced NF-kappa B for the treatment of KSHV-associated malignancies.	[Matta, Hittu] Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Ctr Study Blood Dis, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Matta, H (corresponding author), Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA.	preet.chaudhary@med.usc.edu	Chaudhary, Preet/E-1970-2018; Gopalakrishnan, Ramakrishnan/N-3454-2015; Khanna, Akshat/M-6621-2018	Gopalakrishnan, Ramakrishnan/0000-0002-5068-6886; Graham, Ciaren/0000-0003-1851-7369; Khanna, Akshat/0000-0001-7651-3265; Tolani, Bhairavi/0000-0001-9076-866X	National Institutes of Health [DE019811, CA139119]; Leukemia & Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA139119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (DE019811 and CA139119) and the Leukemia & Lymphoma Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CANC TREAT, V126, P103, DOI 10.1007/0-387-24361-5_5; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bottero V, 2011, J VIROL, V85, P1980, DOI 10.1128/JVI.01911-10; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Emmerich CH, 2011, ADV EXP MED BIOL, V691, P115, DOI 10.1007/978-1-4419-6612-4_12; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Matta H, 2008, ONCOGENE, V27, P5243, DOI 10.1038/onc.2008.150; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Matta H, 2011, J BIOL CHEM, V286, P21555, DOI 10.1074/jbc.M111.224048; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777; Morris K, 2003, LANCET ONCOL, V4, P5, DOI 10.1016/S1470-2045(03)00969-0; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ren H, 2002, J IMMUNOL, V168, P3721, DOI 10.4049/jimmunol.168.8.3721; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shimizu A, 2011, J VIROL, V85, P7444, DOI 10.1128/JVI.02337-10; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Sturzl M, 1999, J NATL CANCER I, V91, P1725, DOI 10.1093/jnci/91.20.1725; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Suzuki S, 2007, J BIOL CHEM, V282, P25177, DOI 10.1074/jbc.C700065200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; WABINGA HR, 1993, INT J CANCER, V54, P26, DOI 10.1002/ijc.2910540106; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Zhao JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001067	71	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36601	10.1371/journal.pone.0036601	http://dx.doi.org/10.1371/journal.pone.0036601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590573	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335500020
J	Chatterjee, PK; Yeboah, MM; Dowling, O; Xue, XY; Powell, SR; Al-Abed, Y; Metz, CN				Chatterjee, Prodyot K.; Yeboah, Michael M.; Dowling, Oonagh; Xue, Xiangying; Powell, Saul R.; Al-Abed, Yousef; Metz, Christine N.			Nicotinic Acetylcholine Receptor Agonists Attenuate Septic Acute Kidney Injury in Mice by Suppressing Inflammation and Proteasome Activity	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; TUMOR-NECROSIS-FACTOR; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; ISCHEMIA-REPERFUSION INJURY; ENDOTHELIAL-CELL ACTIVATION; NITRIC-OXIDE SYNTHASE; KAPPA-B PATHWAY; PROTEIN-DEGRADATION; VAGUS NERVE; RAT-KIDNEY	Sepsis is one of the leading causes of acute kidney injury (AKI). Septic patients who develop acute kidney injury (AKI) are at increased risk of death. To date there is no effective treatment for AKI or septic AKI. Based on their anti-inflammatory properties, we examined the effects of nicotinic acetylcholine receptor agonists on renal damage using a mouse model of lipopolysaccharide (LPS)-induced AKI where localized LPS promotes inflammation-mediated kidney damage. Administration of nicotine (1 mg/kg) or GTS-21 (4 mg/kg) significantly abrogated renal leukocyte infiltration (by 40%) and attenuated kidney injury. These renoprotective effects were accompanied by reduced systemic and localized kidney inflammation during LPS-induced AKI. Consistent with these observations, nicotinic agonist treatment significantly decreased renal I kappa beta alpha degradation and NF kappa B activation during LPS-induced AKI. Treatment of human kidney cells with nicotinic agonists, an NF kappa beta inhibitor (Bay11), or a proteasome inhibitor (MG132) effectively inhibited their inflammatory responses following stimulation with LPS or TNF alpha. Renal proteasome activity, a major regulator of NF kappa beta-mediated inflammation, was enhanced by approximately 50% during LPS-induced AKI and elevated proteasome activity was significantly blunted by nicotinic agonist administration in vivo. Taken together, our results identify enhanced renal proteasome activity during LPS-induced AKI and the suppression of both proteasome activity and inflammation by nicotinic agonists to attenuate LPS-induced kidney injury.	[Chatterjee, Prodyot K.; Dowling, Oonagh; Xue, Xiangying; Metz, Christine N.] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA; [Yeboah, Michael M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA; [Powell, Saul R.] Feinstein Inst Med Res, Ctr Heart & Lung Res, Manhasset, NY USA; [Al-Abed, Yousef] Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY USA	Northwell Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Northwell Health; Northwell Health	Chatterjee, PK (corresponding author), Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA.	cmetz@nshs.edu		Christine, Metz/0000-0002-1013-1691	National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) [R01 GM070727]; NIH/National Heart, Lung, and Blood Institute [HL68936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070727] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS)-R01 GM070727 (CNM) and NIH/National Heart, Lung, and Blood Institute-HL68936 (SRP). The funders had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript.	Ahmed AS, 2010, ARTHRITIS RHEUM-US, V62, P2160, DOI 10.1002/art.27492; Andersson U, 2011, ANN REV IMMUNOL 0324; BERTANI T, 1989, AM J PATHOL, V134, P419; Briggs CA, 1998, NEUROPHARMACOLOGY, V37, P1095, DOI 10.1016/S0028-3908(98)00110-5; Chade AR, 2005, J AM SOC NEPHROL, V16, P1005, DOI 10.1681/ASN.2004080674; Chatterjee PK, 2009, AM J PHYSIOL-CELL PH, V297, pC1294, DOI 10.1152/ajpcell.00160.2009; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; D'hoedt D, 2009, EXPERT OPIN THER TAR, V13, P395, DOI [10.1517/14728220902841045 , 10.1517/14728220902841045]; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Vriese AS, 2003, J AM SOC NEPHROL, V14, P792, DOI 10.1097/01.ASN.0000055652.37763.F7; Drews O, 2010, CIRC RES, V107, P1094, DOI 10.1161/CIRCRESAHA.110.222364; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675, DOI 10.1152/ajplung.2000.279.4.L675; FOUQUERAY B, 1993, J AM SOC NEPHROL, V3, P1783; Gupta A, 2007, AM J PHYSIOL-RENAL, V293, pF245, DOI 10.1152/ajprenal.00477.2006; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; Hoste EAJ, 2003, J AM SOC NEPHROL, V14, P1022, DOI 10.1097/01.ASN.0000059863.48590.E9; Huston JM, 2009, J IMMUNOL, V183, P552, DOI 10.4049/jimmunol.0802684; JEVNIKAR AM, 1991, KIDNEY INT, V40, P203, DOI 10.1038/ki.1991.201; Kamthong PJ, 2001, BIOCHEM J, V356, P525, DOI 10.1042/0264-6021:3560525; KANG YH, 1995, SHOCK, V4, P441; KITA T, 1993, INT J EXP PATHOL, V74, P471; Klaude M, 2007, CLIN SCI, V112, P499, DOI 10.1042/CS20060265; Knotek M, 2001, KIDNEY INT, V59, P2243, DOI 10.1046/j.1523-1755.2001.00740.x; Lecker SH, 2011, J AM SOC NEPHROL, V22, P821, DOI 10.1681/ASN.2010090958; Leelahavanichkul A, 2008, AM J PHYSIOL-RENAL, V295, pF1825, DOI 10.1152/ajprenal.90442.2008; Letoha T, 2007, WORLD J GASTROENTERO, V13, P4452; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Liu MC, 2009, MICROVASC RES, V77, P340, DOI 10.1016/j.mvr.2009.01.011; Lutz J, 2008, J MOL MED, V86, P1329, DOI 10.1007/s00109-008-0405-4; Meyer-Schwesinger C, 2009, AM J PHYSIOL-RENAL, V296, pF1088, DOI 10.1152/ajprenal.90746.2008; Monteiro RMM, 2009, TRANSPL IMMUNOL, V21, P50, DOI 10.1016/j.trim.2009.02.003; Mustafa SB, 1998, J BIOL CHEM, V273, P5073, DOI 10.1074/jbc.273.9.5073; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pocock J, 2003, J IMMUNOL, V170, P6280, DOI 10.4049/jimmunol.170.12.6280; Powell SR, 2007, J MOL CELL CARDIOL, V42, P265, DOI 10.1016/j.yjmcc.2006.10.010; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; Qureshi N, 2003, J IMMUNOL, V171, P1515, DOI 10.4049/jimmunol.171.3.1515; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85; Rezvani K, 2007, J NEUROSCI, V27, P10508, DOI 10.1523/JNEUROSCI.3353-07.2007; Ricci Z, 2009, CURR DRUG TARGETS, V10, P1179, DOI 10.2174/138945009789753192; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Schor N, 2002, KIDNEY INT, V61, P764, DOI 10.1046/j.1523-1755.2002.00178.x; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Sheehan M, 2002, MOL PHARMACOL, V61, P953, DOI 10.1124/mol.61.5.953; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Szewczyk NJ, 2000, J CELL SCI, V113, P2003; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Viedt C, 2002, NEPHROL DIAL TRANSPL, V17, P2043, DOI 10.1093/ndt/17.12.2043; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94; Yeboah MM, 2008, AM J PHYSIOL-RENAL, V295, pF654, DOI 10.1152/ajprenal.90255.2008; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484; ZOLTEWICZ JA, 1993, HETEROCYCLES, V35, P171	66	65	69	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35361	10.1371/journal.pone.0035361	http://dx.doi.org/10.1371/journal.pone.0035361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586448	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000010
J	Han, X; Byrne, P; Kahana, MJ; Becker, S				Han, Xue; Byrne, Patrick; Kahana, Michael J.; Becker, Suzanna			When Do Objects Become Landmarks? A VR Study of the Effect of Task Relevance on Spatial Memory	PLOS ONE			English	Article							REAL-WORLD; MENTAL REPRESENTATIONS; NEURAL REPRESENTATION; INTRINSIC FRAMES; LAYOUT GEOMETRY; HIPPOCAMPUS; NAVIGATION; ROUTE; STRATEGIES; LOCATION	We investigated how objects come to serve as landmarks in spatial memory, and more specifically how they form part of an allocentric cognitive map. Participants performing a virtual driving task incidentally learned the layout of a virtual town and locations of objects in that town. They were subsequently tested on their spatial and recognition memory for the objects. To assess whether the objects were encoded allocentrically we examined pointing consistency across tested viewpoints. In three experiments, we found that spatial memory for objects at navigationally relevant locations was more consistent across tested viewpoints, particularly when participants had more limited experience of the environment. When participants' attention was focused on the appearance of objects, the navigational relevance effect was eliminated, whereas when their attention was focused on objects' locations, this effect was enhanced, supporting the hypothesis that when objects are processed in the service of navigation, rather than merely being viewed as objects, they engage qualitatively distinct attentional systems and are incorporated into an allocentric spatial representation. The results are consistent with evidence from the neuroimaging literature that when objects are relevant to navigation, they not only engage the ventral "object processing stream'', but also the dorsal stream and medial temporal lobe memory system classically associated with allocentric spatial memory.	[Han, Xue; Becker, Suzanna] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Byrne, Patrick] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Kahana, Michael J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	McMaster University; York University - Canada; University of Pennsylvania	Han, X (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	becker@mcmaster.ca	Becker, Suzanna/H-8197-2013	Byrne, Patrick/0000-0002-5276-5393; Becker, Suzanna/0000-0002-2645-070X	Natural Sciences and Engineering Council; National Institutes of Health [MH61975]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061975] Funding Source: NIH RePORTER	Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by a grant from the Natural Sciences and Engineering Council to Suzanna Becker, by scholarships CGS M and PGS D3 from the Natural Sciences and Engineering Council to XH, and by grant MH61975 from the National Institutes of Health to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohbot VD, 2007, J NEUROSCI, V27, P10078, DOI 10.1523/JNEUROSCI.1763-07.2007; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; EVANS GW, 1980, J EXP PSYCHOL-HUM L, V6, P13, DOI 10.1037/0278-7393.6.1.13; Galati G, 2000, EXP BRAIN RES, V133, P156, DOI 10.1007/s002210000375; Goodale MA, 1998, NEUROSCI BIOBEHAV R, V22, P161, DOI 10.1016/S0149-7634(97)00007-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gramann K, 2006, BRAIN RES, V1118, P116, DOI 10.1016/j.brainres.2006.08.005; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; HOLSCHER C, 1994, BEHAV BRAIN RES, V63, P187, DOI 10.1016/0166-4328(94)90090-6; Iaria G, 2003, J NEUROSCI, V23, P5945; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Janzen G, 2007, BRAIN RES, V1165, P116, DOI 10.1016/j.brainres.2007.05.074; Jordan K, 2004, NEUROREPORT, V15, P135, DOI 10.1097/00001756-200401190-00026; Kelly JW, 2008, PSYCHON B REV, V15, P322, DOI 10.3758/PBR.15.2.322; King JA, 2004, NEUROPSYCHOLOGY, V18, P405, DOI 10.1037/0894-4105.18.3.405; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lavenex PB, 2010, BEHAV BRAIN RES, V207, P125, DOI 10.1016/j.bbr.2009.09.046; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Miller J, 2010, PSYCHONOMIC B R 1117; Morgan LK, 2011, J NEUROSCI, V31, P1238, DOI 10.1523/JNEUROSCI.4667-10.2011; Mou WM, 2008, COGNITION, V108, P136, DOI 10.1016/j.cognition.2008.02.004; Mou WM, 2007, J EXP PSYCHOL LEARN, V33, P145, DOI 10.1037/0278-7393.33.1.145; Mou WM, 2006, J EXP PSYCHOL LEARN, V32, P1274, DOI 10.1037/0278-7393.32.6.1274; Mou WM, 2009, J EXP PSYCHOL HUMAN, V35, P83, DOI 10.1037/0096-1523.35.1.83; Mou WM, 2002, J EXP PSYCHOL LEARN, V28, P162, DOI 10.1037//0278-7393.28.1.162; Mou WM, 2004, J EXP PSYCHOL LEARN, V30, P142, DOI 10.1037/0278-7393.30.1.142; MULLER RU, 1994, J NEUROSCI, V14, P7235; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Redish AD, 2000, NEUROCOMPUTING, V32, P235, DOI 10.1016/S0925-2312(00)00169-7; Roskos-Ewoldsen B, 1998, J EXP PSYCHOL LEARN, V24, P215, DOI 10.1037/0278-7393.24.1.215; Schenk T, 2006, NAT NEUROSCI, V9, P1369, DOI 10.1038/nn1784; Schinazi VR, 2010, NEUROIMAGE, V53, P725, DOI 10.1016/j.neuroimage.2010.06.065; Shelton AL, 2004, J EXP PSYCHOL LEARN, V30, P158, DOI 10.1037/0278-7393.30.1.158; Shelton AL, 1997, PSYCHON B REV, V4, P102, DOI 10.3758/BF03210780; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Valiquette C, 2007, PSYCHON B REV, V14, P676, DOI 10.3758/BF03196820; Valiquette CM, 2007, PSYCHOL RES-PSYCH FO, V71, P288, DOI 10.1007/s00426-006-0084-0; Valiquette CM, 2003, MEM COGNITION, V31, P479, DOI 10.3758/BF03194405; Wang RXF, 2000, COGNITION, V77, P215, DOI 10.1016/S0010-0277(00)00105-0; Werner S., 1999, SPAT COGN COMPUT, V1, P447, DOI DOI 10.1023/A:1010095831166	54	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35940	10.1371/journal.pone.0035940	http://dx.doi.org/10.1371/journal.pone.0035940			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TC	22586455	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000017
J	Hartleben, B; Widmeier, E; Wanner, N; Schmidts, M; Kim, ST; Schneider, L; Mayer, B; Kerjaschki, D; Miner, JH; Walz, G; Huber, TB				Hartleben, Bjoern; Widmeier, Eugen; Wanner, Nicola; Schmidts, Miriam; Kim, Sung Tae; Schneider, Lisa; Mayer, Britta; Kerjaschki, Dontscho; Miner, Jeffrey H.; Walz, Gerd; Huber, Tobias B.			Role of the Polarity Protein Scribble for Podocyte Differentiation and Maintenance	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; TIGHT JUNCTION PROTEIN; LOOP-TAIL; CELL POLARITY; EPITHELIAL-CELLS; SLIT DIAPHRAGMS; E-CADHERIN; MOUSE; EXPRESSION; MUTANT	The kidney filter represents a unique assembly of podocyte epithelial cells that tightly enwrap the glomerular capillaries with their complex foot process network. While deficiency of the polarity proteins Crumbs and aPKC result in impaired podocyte foot process architecture, the function of basolateral polarity proteins for podocyte differentiation and maintenance remained unclear. Here we report, that Scribble is expressed in developing podocytes, where it translocates from the lateral aspects of immature podocytes to the basal cell membrane and foot processes of mature podocytes. Immunogold electron microscopy reveals membrane associated localisation of Scribble predominantly at the basolateral site of foot processes. To further study the role of Scribble for podocyte differentiation Scribble(flox/flox) mice were generated by introducing loxP-sites into the Scribble introns 1 and 8 and these mice were crossed to NPHS2.Cre mice and Cre deleter mice. Podocyte-specific Scribble knockout mice develop normally and display no histological, ultrastructural or clinical abnormalities up to 12 months of age. In addition, no increased susceptibility to glomerular stress could be detected in these mice. In contrast, constitutive Scribble knockout animals die during embryonic development indicating the fundamental importance of Scribble for embryogenesis. Like in podocyte-specific Scribble knockout mice, the development of podocyte foot processes and the slit diaphragm was unaffected in kidney cultures from constitutive Scribble knockout animals. In summary these results indicate that basolateral polarity signaling via Scribble is dispensable for podocyte function, highlighting the unique feature of podocyte development with its significant apical membrane expansions being dominated by apical polarity complexes rather than by basolateral polarity signaling.	[Hartleben, Bjoern; Widmeier, Eugen; Wanner, Nicola; Schmidts, Miriam; Schneider, Lisa; Mayer, Britta; Walz, Gerd; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Wanner, Nicola; Huber, Tobias B.] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79106 Freiburg, Germany; [Kim, Sung Tae] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA; [Kerjaschki, Dontscho] Med Univ, Clin Inst Pathol, Vienna, Austria; [Walz, Gerd; Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; Washington University (WUSTL); University of Freiburg	Hartleben, B (corresponding author), Univ Hosp Freiburg, Div Renal, Freiburg, Germany.	tobias.huber@uniklinik-freiburg.de	Schmidts, Miriam/A-3777-2012; Widmeier, Eugen/AAQ-9854-2020	Schmidts, Miriam/0000-0002-1714-6749; Widmeier, Eugen/0000-0002-7773-5190; Huber, Tobias B./0000-0001-7175-5062	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft [SFB 592]; Excellence Initiative of the German Federal; State Governments [EXC 294]; Deutsche Nierenstiftung; Peter-Stiftung fur die Nierenwissenschaft; National Institutes of Health [R01DK081156, P30DK079333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333, R01DK081156] Funding Source: NIH RePORTER	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal; State Governments; Deutsche Nierenstiftung; Peter-Stiftung fur die Nierenwissenschaft; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Else Kroner-Fresenius-Stiftung (T.B.H.), Deutsche Forschungsgemeinschaft SFB 592 (T.B.H.), the Excellence Initiative of the German Federal and State Governments EXC 294 (T.B.H.), Deutsche Nierenstiftung (B.H.), Peter-Stiftung fur die Nierenwissenschaft (M.S.), and National Institutes of Health R01DK081156 and P30DK079333 (J.H.M. and S.T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVNER ED, 1983, J UROLOGY, V129, P660, DOI 10.1016/S0022-5347(17)52273-9; Bilder D, 2000, NAT CELL BIOL, V2, pE114, DOI 10.1038/35017119; COPP AJ, 1994, DEV BIOL, V165, P20, DOI 10.1006/dbio.1994.1230; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Ebarasi L, 2009, DEV BIOL, V334, P1, DOI 10.1016/j.ydbio.2009.04.017; Economou CG, 2004, J CELL SCI, V117, P3281, DOI 10.1242/jcs.01163; Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Hirose T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004194; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Huber TB, 2009, J AM SOC NEPHROL, V20, P798, DOI 10.1681/ASN.2008080871; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Morita H, 2005, J AM SOC NEPHROL, V16, P1703, DOI 10.1681/ASN.2004050387; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nakagawa S, 2004, BRIT J CANCER, V90, P194, DOI 10.1038/sj.bjc.6601465; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pearson HB, 2011, J CLIN INVEST, V121, P4257, DOI 10.1172/JCI58509; Pieczynski J, 2011, AM J PHYSIOL-RENAL, V300, pF589, DOI 10.1152/ajprenal.00615.2010; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; WEENING JJ, 1987, AM J PATHOL, V129, P64; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	37	40	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36705	10.1371/journal.pone.0036705	http://dx.doi.org/10.1371/journal.pone.0036705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586490	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335000051
J	Parrott, BB; Hudson, A; Brady, R; Schulz, C				Parrott, Benjamin B.; Hudson, Alicia; Brady, Regina; Schulz, Cordula			Control of Germline Stem Cell Division Frequency - A Novel, Developmentally Regulated Role for Epidermal Growth Factor Signaling	PLOS ONE			English	Article							SOMATIC SUPPORT CELLS; SELF-RENEWAL; DROSOPHILA SPERMATOGENESIS; GENE-EXPRESSION; TESTIS; PROLIFERATION; DIFFERENTIATION; MELANOGASTER; ACTIVATION; OOGENESIS	Exploring adult stem cell dynamics in normal and disease states is crucial to both better understanding their in vivo role and better realizing their therapeutic potential. Here we address the division frequency of Germline Stem Cells (GSCs) in testes of Drosophila melanogaster. We show that GSC division frequency is under genetic control of the highly conserved Epidermal Growth Factor (EGF) signaling pathway. When EGF signaling was attenuated, we detected a two-fold increase in the percentage of GSCs in mitotic division compared to GSCs in control animals. Ex vivo and in vivo experiments using a marker for cells in S-phase of the cell cycle showed that the GSCs in EGF mutant testes divide faster than GSCs in control testes. The increased mitotic activity of GSCs in EGF mutants was rescued by restoring EGF signaling in the GSCs, and reproduced in testes from animals with soma-depleted EGF-Receptor (EGFR). Interestingly, EGF attenuation specifically increased the GSC division frequency in adult testes, but not in larval testes. Furthermore, GSCs in testes with tumors resulting from the perturbation of other conserved signaling pathways divided at normal frequencies. We conclude that EGF signaling from the GSCs to the CySCs normally regulates GSC division frequency. The EGF signaling pathway is bifurcated and acts differently in adult compared to larval testes. In addition, regulation of GSC division frequency is a specific role for EGF signaling as it is not affected in all tumor models. These data advance our understanding concerning stem cell dynamics in normal tissues and in a tumor model.	[Parrott, Benjamin B.] Med Univ S Carolina, Hollings Marine Lab, Charleston, SC 29425 USA; [Hudson, Alicia; Schulz, Cordula] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Brady, Regina] Mercer Med Sch, Macon, GA USA	Medical University of South Carolina; University System of Georgia; University of Georgia	Parrott, BB (corresponding author), Med Univ S Carolina, Hollings Marine Lab, Charleston, SC 29425 USA.	cschulz@uga.edu			American Foundation for Aging; National Science Foundation (NSF) [0841419]; University of Georgia (UGA); Direct For Biological Sciences [0841419] Funding Source: National Science Foundation	American Foundation for Aging; National Science Foundation (NSF)(National Science Foundation (NSF)); University of Georgia (UGA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by an American Foundation for Aging Research fellowship to BBP, and a National Science Foundation (NSF) grant (#0841419) and University of Georgia (UGA) start-up funds awarded to CS. The funder had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	[Anonymous], NUCL ACIDS RES, V31, P172; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bunt SM, 2004, GENESIS, V39, P84, DOI 10.1002/gene.20030; Cheng J, 2011, DEVELOPMENT, V138, P831, DOI 10.1242/dev.057901; Cheng T, 2006, ESSENTIALS STEM CELL, P63; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Fuller Margaret T., 1993, P71; Guichard A, 2000, DEV BIOL, V226, P255, DOI 10.1006/dbio.2000.9851; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Matunis E, 1997, DEVELOPMENT, V124, P4383; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Schulz C, 2002, DEVELOPMENT, V129, P4523; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tsruya R, 2002, GENE DEV, V16, P222, DOI 10.1101/gad.214202; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Van Doren M, 1998, CURR BIOL, V8, P243; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2010, CURR OPIN CELL BIOL, V22, P605, DOI 10.1016/j.ceb.2010.07.009	38	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36460	10.1371/journal.pone.0036460	http://dx.doi.org/10.1371/journal.pone.0036460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586473	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335000035
J	Willer, Y; Muller, B; Bumann, D				Willer, Yvonne; Mueller, Beatrice; Bumann, Dirk			Intestinal Inflammation Responds to Microbial Tissue Load Independent of Pathogen/Non-Pathogen Discrimination	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ESCHERICHIA-COLI NISSLE-1917; ORAL SALMONELLA INFECTION; INNATE IMMUNE-SYSTEM; DENDRITIC CELLS; ULCERATIVE-COLITIS; LYMPHOID-TISSUE; MUCOSAL DEFENSE; PEYERS-PATCHES; COMMENSAL	The intestinal immune system mounts inflammatory responses to pathogens but tolerates harmless commensal microbiota. Various mechanisms for pathogen/non-pathogen discrimination have been proposed but their general relevance for inflammation control is unclear. Here, we compared intestinal responses to pathogenic Salmonella and non-pathogenic E. coli. Both microbes entered intestinal Peyer's patches and, surprisingly, induced qualitatively and quantitatively similar initial inflammatory responses revealing a striking discrimination failure. Diverging inflammatory responses only occurred when Salmonella subsequently proliferated and induced escalating neutrophil infiltration, while harmless E. coli was rapidly cleared from the tissue and inflammation resolved. Transient intestinal inflammation induced by harmless E. coli tolerized against subsequent exposure thereby preventing chronic inflammation during repeated exposure. These data revealed a striking failure of the intestinal immune system to discriminate pathogens from harmless microbes based on distinct molecular signatures. Instead, appropriate intestinal responses to gut microbiota might be ensured by immediate inflammatory responses to any rise in microbial tissue loads, and desensitization after bacterial clearance.	[Willer, Yvonne; Bumann, Dirk] Hannover Med Sch, Jr Grp Mucosal Infect, D-3000 Hannover, Germany; [Bumann, Dirk] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Mueller, Beatrice; Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland	Hannover Medical School; Max Planck Society; University of Basel	Willer, Y (corresponding author), Hannover Med Sch, Jr Grp Mucosal Infect, D-3000 Hannover, Germany.	Dirk.Bumann@unibas.ch			Deutsche Forschungsgemeinschaft [SFB 621 A9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was in part supported by Deutsche Forschungsgemeinschaft (SFB 621 A9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Cheminay U, 2004, INFECT IMMUN, V72, P468, DOI 10.1128/IAI.72.1.468-477.2004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fukushima K, 1999, J GASTROENTEROL, V34, P54, DOI 10.1007/s005350050216; Grabig A, 2006, INFECT IMMUN, V74, P4075, DOI 10.1128/IAI.01449-05; Halle S, 2007, INFECT IMMUN, V75, P1577, DOI 10.1128/IAI.01392-06; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Ogawa H, 2000, AM J PHYSIOL-GASTR L, V279, pG492, DOI 10.1152/ajpgi.2000.279.3.G492; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Rakoff-Nahoum S, 2006, CURR TOP MICROBIOL, V308, P1; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789; Rydstrom A, 2009, EUR J IMMUNOL, V39, P3019, DOI 10.1002/eji.200939483; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463	31	5	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35992	10.1371/journal.pone.0035992	http://dx.doi.org/10.1371/journal.pone.0035992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586458	Green Published, gold, Green Accepted			2022-12-25	WOS:000305335000020
J	Ma, FF; Li, YL; Jia, LX; Han, YL; Cheng, JZ; Li, HH; Qi, YF; Du, J				Ma, Feifei; Li, Yulin; Jia, Lixin; Han, Yalei; Cheng, Jizhong; Li, Huihua; Qi, Yongfen; Du, Jie			Macrophage-Stimulated Cardiac Fibroblast Production of IL-6 Is Essential for TGF beta/Smad Activation and Cardiac Fibrosis Induced by Angiotensin II	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA(1); RECEPTOR; INTERLEUKIN-6; HYPERTROPHY; DYSFUNCTION; INFLAMMATION; MECHANISMS; PRECURSORS; EXPRESSION; INDUCTION	Interleukin-6 (IL-6) is an important cytokine participating in multiple biologic activities in immune regulation and inflammation. IL-6 has been associated with cardiovascular remodeling. However, the mechanism of IL-6 in hypertensive cardiac fibrosis is still unclear. Angiotensin II (Ang II) infusion in mice increased IL-6 expression in the heart. IL-6 knockout (IL-6-/-) reduced Ang II-induced cardiac fibrosis: 1) Masson trichrome staining showed that Ang II infusion significantly increased fibrotic areas of the wild-type mouse heart, which was greatly suppressed in IL-6-/- mice and 2) immunohistochemistry staining showed decreased expression of alpha-smooth muscle actin (alpha-SMA), transforming growth factor beta 1 (TGF-beta 1) and collagen I in IL-6-/- mouse heart. The baseline mRNA expression of IL-6 in cardiac fibroblasts was low and was absent in cardiomyocytes or macrophages; however, co-culture of cardiac fibroblasts with macrophages significantly increased IL-6 production and expression of alpha-SMA and collagen I in fibroblasts. Moreover, TGF-beta 1 expression and phosphorylation of TGF-beta downstream signal Smad3 was stimulated by co-culture of macrophages with cardiac fibroblasts, while IL-6 neutralizing antibody decreased TGF-beta 1 expression and Smad3 phosphorylation in co-culture of macrophage and fibroblast. Taken together, our results indicate that macrophages stimulate cardiac fibroblasts to produce IL-6, which leads to TGF-beta 1 production and Smad3 phosphorylation in cardiac fibroblasts and thus stimulates cardiac fibrosis.	[Ma, Feifei; Li, Yulin; Jia, Lixin; Han, Yalei; Cheng, Jizhong; Qi, Yongfen; Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Du, Jie] Minist Educ, Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China; [Li, Huihua] Capital Med Univ, Dept Pathol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Ma, FF (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China.	yongfenqi@163.com; jdu@bcm.edu	Li, yulin/AGZ-5611-2022		Chinese Ministry of Science and Technology [2012CB517802, 2012CB945104]; National Science Foundation of China [30888004, 31090363]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the Chinese Ministry of Science and Technology (2012CB517802 and 2012CB945104) and from the National Science Foundation of China (30888004 and 31090363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aoki H, 2006, J CELL BIOCHEM, V99, P221, DOI 10.1002/jcb.20906; Brewster UC, 2003, AM J MED SCI, V326, P15, DOI 10.1097/00000441-200307000-00003; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Euler-Taimor G, 2006, CARDIOVASC RES, V69, P15, DOI 10.1016/j.cardiores.2005.07.007; Hafizi S, 1998, CIRCULATION, V98, P2553, DOI 10.1161/01.CIR.98.23.2553; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Haugen Espen, 2008, Exp Clin Cardiol, V13, P19; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Lijnen PJ, 2001, J RENIN-ANGIO-ALDO S, V2, P117, DOI 10.3317/jraas.2001.012; Marvar PJ, 2010, CIRC RES, V107, P263, DOI 10.1161/CIRCRESAHA.110.217299; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mollmann H, 2010, CARDIOVASC RES, V87, P395, DOI 10.1093/cvr/cvq186; Moustakas Aristidis, 2002, Journal of Cell Science, V115, P3355; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Qi GM, 2011, CARDIOVASC TOXICOL, V11, P157, DOI 10.1007/s12012-011-9109-z; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ruiz-Ortega M, 2003, CURR HYPERTENS REP, V5, P73, DOI 10.1007/s11906-003-0014-0; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Schrader LI, 2007, ARTERIOSCL THROM VAS, V27, P2576, DOI 10.1161/ATVBAHA.107.153080; Seong GJ, 2009, MOL VIS, V15, P2123; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Staufenberger S, 2001, J CELL PHYSIOL, V187, P326, DOI 10.1002/jcp.1079; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Widder JD, 2007, ARTERIOSCL THROM VAS, V27, P762, DOI 10.1161/01.ATV.0000259298.11129.a2; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628; Zhang XL, 2005, J BIOL CHEM, V280, P12239, DOI 10.1074/jbc.M413284200	38	193	206	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35144	10.1371/journal.pone.0035144	http://dx.doi.org/10.1371/journal.pone.0035144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574112	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800008
J	Nygaard, TK; Pallister, KB; DuMont, AL; DeWald, M; Watkins, RL; Pallister, EQ; Malone, C; Griffith, S; Horswill, AR; Torres, VJ; Voyich, JM				Nygaard, Tyler K.; Pallister, Kyler B.; DuMont, Ashley L.; DeWald, Mark; Watkins, Robert L.; Pallister, Erik Q.; Malone, Cheryl; Griffith, Shannon; Horswill, Alexander R.; Torres, Victor J.; Voyich, Jovanka M.			Alpha-Toxin Induces Programmed Cell Death of Human T cells, B cells, and Monocytes during USA300 Infection	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; VIRULENCE GENE-EXPRESSION; SHOCK SYNDROME; EMERGENCY-DEPARTMENT; SEPTICEMIA STRAINS; HEMOLYSIN; PNEUMONIA; SKIN; SAE	This investigation examines the influence of alpha-toxin (Hla) during USA300 infection of human leukocytes. Survival of an USA300 isogenic deletion mutant of hla (USA300 Delta hla) in human blood was comparable to the parental wild-type strain and polymorphonuclear leukocyte (PMN) plasma membrane permeability caused by USA300 did not require Hla. Flow cytometry analysis of peripheral blood mononuclear cells (PBMCs) following infection by USA300, USA300 Delta hla, and USA300 Delta hla transformed with a plasmid over-expressing Hla (USA300 Delta hla Comp) demonstrated this toxin plays a significant role inducing plasma membrane permeability of CD14(+), CD3(+), and CD19(+) PBMCs. Rapid plasma membrane permeability independent of Hla was observed for PMNs, CD14(+) and CD19(+) PBMCs following intoxication with USA300 supernatant while the majority of CD3(+) PBMC plasma membrane permeability induced by USA300 required Hla. Addition of recombinant Hla to USA300 Delta hla supernatant rescued CD3(+) and CD19(+) PBMC plasma membrane permeability generated by USA300 supernatant. An observed delay in plasma membrane permeability caused by Hla in conjunction with Annexin V binding and ApoBrdU Tunel assays examining PBMCs intoxicated with recombinant Hla or infected with USA300, USA300 Delta hla, USA300 Delta hla Comp, and USA300 Delta saeR/S suggest Hla induces programmed cell death of monocytes, B cells, and T cells that results in plasma membrane permeability. Together these findings underscore the importance of Hla during S. aureus infection of human tissue and specifically demonstrate Hla activity during USA300 infection triggers programmed cell death of human monocytes, T cells and B cells that leads to plasma membrane permeability.	[Nygaard, Tyler K.; Pallister, Kyler B.; DeWald, Mark; Watkins, Robert L.; Pallister, Erik Q.; Griffith, Shannon; Voyich, Jovanka M.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [DuMont, Ashley L.; Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Malone, Cheryl; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	Montana State University System; Montana State University Bozeman; New York University; University of Iowa	Nygaard, TK (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	jovanka@montana.edu		Torres, Victor/0000-0002-7126-0489; Nygaard, Tyler/0000-0002-4736-0156	National Institute of Health (NIH) [NIH-PAR98-072, NIH-RR020185, NIH-R01, A1090046-01]; Molecular Biosciences Fellowship; Montana State University Agricultural Experiment Station; New York University School of Medicine Development Funds; American Heart Association Scientist Development Grant [09SDG2060036]; NIH Training Grant [5T32 AI007180-27]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078921, R01AI090046, T32AI007180] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biosciences Fellowship; Montana State University Agricultural Experiment Station; New York University School of Medicine Development Funds; American Heart Association Scientist Development Grant(American Heart Association); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health (NIH) grants NIH-PAR98-072 and NIH-RR020185, and NIH-R01 award A1090046-01 and a Molecular Biosciences Fellowship (to RLW) as well as Montana State University Agricultural Experiment Station (TKN, KBP, RLW, EQP, SG, MD and JMV), and New York University School of Medicine Development Funds (VJT), American Heart Association Scientist Development Grant (09SDG2060036) (VJT), and NIH Training Grant 5T32 AI007180-27 (ALD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; CHRISTENSSON B, 1986, SCAND J INFECT DIS, V18, P297, DOI 10.3109/00365548609032340; CLYNE M, 1988, J CLIN MICROBIOL, V26, P535, DOI 10.1128/JCM.26.3.535-539.1988; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Garcia-Lara J, 2009, CURR OPIN PHARMACOL, V9, P552, DOI 10.1016/j.coph.2009.07.008; Goerke C, 2005, INFECT IMMUN, V73, P3415, DOI 10.1128/IAI.73.6.3415-3421.2005; Graves SF, 2010, MICROBES INFECT, V12, P446, DOI 10.1016/j.micinf.2010.02.005; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134; Li DM, 2008, INFECT IMMUN, V76, P1068, DOI 10.1128/IAI.01069-07; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; Miller LS, 2011, NAT REV IMMUNOL; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nygaard TK, 2008, CURR OPIN INFECT DIS, V21, P147, DOI 10.1097/QCO.0b013e3282f64819; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; OREILLY M, 1990, MOL MICROBIOL, V4, P1947, DOI 10.1111/j.1365-2958.1990.tb02044.x; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Otto M, 2010, EXPERT OPIN BIOL TH, V10, P1049, DOI 10.1517/14712598.2010.495115; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; SCHLIEVERT PM, 1982, ANN INTERN MED, V96, P937, DOI 10.7326/0003-4819-96-6-937; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Valeva A, 1997, P NATL ACAD SCI USA, V94, P11607, DOI 10.1073/pnas.94.21.11607; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210	46	76	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36532	10.1371/journal.pone.0036532	http://dx.doi.org/10.1371/journal.pone.0036532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574180	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800077
J	Suzuki, S; Ishida, T; Kurokawa, K; Akiyama, Y				Suzuki, Shuji; Ishida, Takashi; Kurokawa, Ken; Akiyama, Yutaka			GHOSTM: A GPU-Accelerated Homology Search Tool for Metagenomics	PLOS ONE			English	Article							READ ALIGNMENT; PROTEIN; DATABASE; BLAST; SEQUENCES; KEGG	Background: A large number of sensitive homology searches are required for mapping DNA sequence fragments to known protein sequences in public and private databases during metagenomic analysis. BLAST is currently used for this purpose, but its calculation speed is insufficient, especially for analyzing the large quantities of sequence data obtained from a next-generation sequencer. However, faster search tools, such as BLAT, do not have sufficient search sensitivity for metagenomic analysis. Thus, a sensitive and efficient homology search tool is in high demand for this type of analysis. Methodology/Principal Findings: We developed a new, highly efficient homology search algorithm suitable for graphics processing unit (GPU) calculations that was implemented as a GPU system that we called GHOSTM. The system first searches for candidate alignment positions for a sequence from the database using pre-calculated indexes and then calculates local alignments around the candidate positions before calculating alignment scores. We implemented both of these processes on GPUs. The system achieved calculation speeds that were 130 and 407 times faster than BLAST with 1 GPU and 4 GPUs, respectively. The system also showed higher search sensitivity and had a calculation speed that was 4 and 15 times faster than BLAT with 1 GPU and 4 GPUs. Conclusions: We developed a GPU-optimized algorithm to perform sensitive sequence homology searches and implemented the system as GHOSTM. Currently, sequencing technology continues to improve, and sequencers are increasingly producing larger and larger quantities of data. This explosion of sequence data makes computational analysis with contemporary tools more difficult. We developed GHOSTM, which is a cost-efficient tool, and offer this tool as a potential solution to this problem.	[Suzuki, Shuji; Ishida, Takashi; Akiyama, Yutaka] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan; [Kurokawa, Ken] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Suzuki, S (corresponding author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan.	akiyama@cs.titech.ac.jp	Akiyama, Yutaka/D-2048-2015	Akiyama, Yutaka/0000-0003-2863-8703	HPCI Strategic Program Computational Life Science and Application in Drug Discovery and Medical Development by MEXT of Japan; National Cancer Center, Japan; CUDA COE Program by NVIDIA; Grants-in-Aid for Scientific Research [22380176] Funding Source: KAKEN	HPCI Strategic Program Computational Life Science and Application in Drug Discovery and Medical Development by MEXT of Japan; National Cancer Center, Japan(National Cancer Center - Japan); CUDA COE Program by NVIDIA; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by HPCI Strategic Program Computational Life Science and Application in Drug Discovery and Medical Development by MEXT of Japan, Cancer Research Development funding by National Cancer Center, Japan, and the CUDA COE Program by NVIDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WG, 2011, IEEE ACM T COMPUT BI, V8, P1678, DOI 10.1109/TCBB.2011.33; Liu Yongchao, 2010, BMC Res Notes, V3, P93, DOI 10.1186/1756-0500-3-93; Liu Yongchao, 2009, BMC Res Notes, V2, P73, DOI 10.1186/1756-0500-2-73; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vouzis PD, 2011, BIOINFORMATICS, V27, P182, DOI 10.1093/bioinformatics/btq644; Walters JP, 2009, INT PARALL DISTRIB P, P1010; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X	25	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36060	10.1371/journal.pone.0036060	http://dx.doi.org/10.1371/journal.pone.0036060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574135	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800031
J	Cardaci, A; Papasergi, S; Midiri, A; Mancuso, G; Domina, M; Cariccio, VL; Mandanici, F; Galbo, R; Lo Passo, C; Pernice, I; Donato, P; Ricci, S; Biondo, C; Teti, G; Felici, F; Beninati, C				Cardaci, Angela; Papasergi, Salvatore; Midiri, Angelina; Mancuso, Giuseppe; Domina, Maria; Cariccio, Veronica Lanza; Mandanici, Francesca; Galbo, Roberta; Lo Passo, Carla; Pernice, Ida; Donato, Paolo; Ricci, Susanna; Biondo, Carmelo; Teti, Giuseppe; Felici, Franco; Beninati, Concetta			Protective Activity of Streptococcus pneumoniae Spr1875 Protein Fragments Identified Using a Phage Displayed Genomic Library	PLOS ONE			English	Article							HYPERVARIABLE REGION; PNEUMOCOCCAL DISEASE; EPITHELIAL-CELLS; VIRULENCE FACTOR; BINDING PROTEIN; LAMBDA-DISPLAY; VACCINATION; DISSECTION; INFECTION; ADHERENCE	There is considerable interest in pneumococcal protein antigens capable of inducing serotype-independent immunoprotection and of improving, thereby, existing vaccines. We report here on the immunogenic properties of a novel surface antigen encoded by ORF spr1875 in the R6 strain genome. An antigenic fragment encoded by spr1875, designated R4, was identified using a Streptococcus pneumoniae phage displayed genomic library after selection with a human convalescent serum. Immunofluorescence analysis with anti-R4 antisera showed that Spr1875 was expressed on the surface of strains belonging to different serotypes. Moreover, the gene was present with little sequence variability in 27 different pneumococcal strains isolated worldwide. A mutant lacking Spr1875 was considerably less virulent than the wild type D39 strain in an intravenous mouse model of infection. Moreover, immunization with the R4 recombinant fragment, but not with the whole Spr1875 protein, induced significant protection against sepsis in mice. Lack of protection after immunization with the whole protein was related to the presence of immunodominant, non-protective epitopes located outside of the R4 fragment. In conclusion, our data indicate that Spr1875 has a role in pneumococcal virulence and is immunogenic. As the R4 fragment conferred immunoprotection from experimental sepsis, selected antigenic fragments of Spr1875 may be useful for the development of a pneumococcal protein-based vaccine.	[Cardaci, Angela; Papasergi, Salvatore; Midiri, Angelina; Mancuso, Giuseppe; Domina, Maria; Cariccio, Veronica Lanza; Mandanici, Francesca; Biondo, Carmelo; Teti, Giuseppe; Beninati, Concetta] Univ Messina, Elie Metchnikoff Dept, Messina, Italy; [Galbo, Roberta; Lo Passo, Carla; Pernice, Ida] Univ Messina, Dipartimento Sci Vita M Malpighi, Messina, Italy; [Donato, Paolo] Novartis Vaccines & Diagnost, Messina, Italy; [Ricci, Susanna] Univ Siena, Dipartimento Biotecnol, I-53100 Siena, Italy; [Felici, Franco] Univ Molise, Dipartimento STAT, Pesche, IS, Italy	University of Messina; University of Messina; University of Siena; University of Molise	Cardaci, A (corresponding author), Univ Messina, Elie Metchnikoff Dept, Messina, Italy.	cbeninati@unime.it	ricci, susanna/R-4184-2018; Felici, Franco/H-5693-2012; papasergi, salvatore/AAE-8818-2021; Biondo, Carmelo/AAA-3391-2019; GALBO, Roberta/AAR-8424-2021; Domina, Maria/K-7883-2016	ricci, susanna/0000-0002-2279-6391; Felici, Franco/0000-0003-2205-5195; GALBO, Roberta/0000-0002-2880-3871; Pernice, Ida/0000-0001-8328-2776; Mancuso, Giuseppe/0000-0001-5454-3228; Lo Passo, Carla/0000-0001-5531-6748; BENINATI, Concetta/0000-0001-8305-1337; Domina, Maria/0000-0002-0445-8356; Midiri, Angelina/0000-0002-4128-9678	Progetti di Ricerca di Rilevante Interesse Nazionale from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy [287/2005, 1407/2008]	Progetti di Ricerca di Rilevante Interesse Nazionale from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy	This study was supported by grants Progetti di Ricerca di Rilevante Interesse Nazionale 2005 (DM n. 287/2005) and 2008 (DM n. 1407/2008) from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beghetto E, 2003, INT J PARASITOL, V33, P163, DOI 10.1016/S0020-7519(02)00256-4; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Bogaert D, 2004, VACCINE, V22, P2209, DOI 10.1016/j.vaccine.2003.11.038; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Downer R, 2002, J BIOL CHEM, V277, P243, DOI 10.1074/jbc.M107621200; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Garibaldi M, 2010, VACCINE, V28, P3609, DOI 10.1016/j.vaccine.2010.01.009; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Lannergard J, 2011, CELL HOST MICROBE, V10, P147, DOI 10.1016/j.chom.2011.06.011; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Martin D, 2002, INFECT IMMUN, V70, P4897, DOI 10.1128/IAI.70.9.4897-4901.2002; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Ng WL, 2005, J BACTERIOL, V187, P7444, DOI 10.1128/JB.187.21.7444-7459.2005; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Pearce BJ, 2002, RES MICROBIOL, V153, P243, DOI 10.1016/S0923-2508(02)01312-8; Rehm SJ, 2009, POSTGRAD MED, V121, P101, DOI 10.3810/pgm.2009.11.2069; Stalhammar-Carlemalm M, 2007, CELL HOST MICROBE, V2, P427, DOI 10.1016/j.chom.2007.10.003; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Waldemarsson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007279	25	23	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36588	10.1371/journal.pone.0036588	http://dx.doi.org/10.1371/journal.pone.0036588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570729	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400045
J	Cuddapah, S; Roh, TY; Cui, KR; Jose, CC; Fuller, MT; Zhao, KJ; Chen, X				Cuddapah, Suresh; Roh, Tae-Young; Cui, Kairong; Jose, Cynthia C.; Fuller, Margaret T.; Zhao, Keji; Chen, Xin			A Novel Human Polycomb Binding Site Acts As a Functional Polycomb Response Element in Drosophila	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; GROUP PROTEINS; DEVELOPMENTAL REGULATORS; SILENCING MECHANISMS; CHROMATIN DOMAINS; CELLULAR MEMORY; TARGET GENES; DNA-BINDING; COMPLEX; METHYLATION	Polycomb group (PcG) proteins are key chromatin regulators implicated in multiple processes including embryonic development, tissue homeostasis, genomic imprinting, X-chromosome inactivation, and germ cell differentiation. The PcG proteins recognize target genomic loci through cis DNA sequences known as Polycomb Response Elements (PREs), which are well characterized in Drosophila. However, mammalian PREs have been elusive until two groups reported putative mammalian PREs recently. Consistent with the existence of mammalian PREs, here we report the identification and characterization of a potential PRE from human T cells. The putative human PRE has enriched binding of PcG proteins, and such binding is dependent on a key PcG component SUZ12. We demonstrate that the putative human PRE carries both genetic and molecular features of Drosophila PRE in transgenic flies, implying that not only the trans PcG proteins but also certain features of the cis PREs are conserved between mammals and Drosophila.	[Cuddapah, Suresh; Jose, Cynthia C.] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Roh, Tae-Young; Cui, Kairong; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Fuller, Margaret T.] Stanford Univ, Dept Dev Biol & Genet, Sch Med, Stanford, CA 94305 USA	New York University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Stanford University	Cuddapah, S (corresponding author), NYU, Dept Environm Med, Sch Med, 550 1St Ave, New York, NY 10016 USA.	Suresh.Cuddapah@nyumc.org; xchen32@jhu.edu	Cuddapah, Suresh/AAU-4288-2021	Roh, Tae-Young/0000-0001-5833-0844; Cuddapah, Suresh/0000-0002-4556-2029; Fuller, Margaret T/0000-0002-3804-4987	Leukemia and Lymphoma Society [LLS-3598-06]; National Institutes of Health (NIH) [K99/R00 HD055052, 1R01HD065816, 1R01GM61986]; National Heart, Lung and Blood Institute (NHLBI), NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065816] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD055052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061986] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute (NHLBI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Leukemia and Lymphoma Society Special Fellowship (grant LLS-3598-06), National Institutes of Health (NIH) grants K99/R00 HD055052 Pathway to Independence Award and 1R01HD065816 to XC, NIH grant 1R01GM61986 to MTF, and National Heart, Lung and Blood Institute (NHLBI), NIH intramural grants to KZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Hur MW, 2002, DEVELOPMENT, V129, P1339; Jacobs JJL, 1999, SEMIN CELL DEV BIOL, V10, P227, DOI 10.1006/scdb.1999.0304; Kassis JA, 2002, ADV GENET, V46, P421; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Moschetti R, 2004, MOL GENET GENOMICS, V271, P394, DOI 10.1007/s00438-004-1007-7; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Mulholland NM, 2003, GENE DEV, V17, P2741, DOI 10.1101/gad.1143303; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Przybyla-Zawislak BD, 2005, ANN NY ACAD SCI, V1053, P162, DOI 10.1196/annals.1344.014; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schwartz YB, 2004, COLD SPRING HARB SYM, V69, P301, DOI 10.1101/sqb.2004.69.301; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; SIMON J, 1993, DEV BIOL, V158, P131, DOI 10.1006/dbio.1993.1174; Simon JA, 2003, CURR BIOL, V13, pR79, DOI 10.1016/S0960-9822(03)00028-9; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Su YL, 2011, EPIGENETICS-US, V6, P9, DOI 10.4161/epi.6.1.13298; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707	65	22	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36365	10.1371/journal.pone.0036365	http://dx.doi.org/10.1371/journal.pone.0036365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570707	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343400023
J	Hoose, SA; Duran, C; Malik, I; Eslamfam, S; Shasserre, SC; Downing, SS; Hoover, EM; Dowd, KE; Smith, R; Polymenis, M				Hoose, Scott A.; Duran, Camille; Malik, Indranil; Eslamfam, Shabnam; Shasserre, Samantha C.; Downing, S. Sabina; Hoover, Evelyn M.; Dowd, Katherine E.; Smith, Roger, III; Polymenis, Michael			Systematic Analysis of Cell Cycle Effects of Common Drugs Leads to the Discovery of a Suppressive Interaction between Gemfibrozil and Fluoxetine	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; G1; LOVASTATIN; INITIATION; DIVISION; RECEPTOR	Screening chemical libraries to identify compounds that affect overall cell proliferation is common. However, in most cases, it is not known whether the compounds tested alter the timing of particular cell cycle transitions. Here, we evaluated an FDA-approved drug library to identify pharmaceuticals that alter cell cycle progression in yeast, using DNA content measurements by flow cytometry. This approach revealed strong cell cycle effects of several commonly used pharmaceuticals. We show that the antilipemic gemfibrozil delays initiation of DNA replication, while cells treated with the antidepressant fluoxetine severely delay progression through mitosis. Based on their effects on cell cycle progression, we also examined cell proliferation in the presence of both compounds. We discovered a strong suppressive interaction between gemfibrozil and fluoxetine. Combinations of interest among diverse pharmaceuticals are difficult to identify, due to the daunting number of possible combinations that must be evaluated. The novel interaction between gemfibrozil and fluoxetine suggests that identifying and combining drugs that show cell cycle effects might streamline identification of drug combinations with a pronounced impact on cell proliferation.	[Hoose, Scott A.; Duran, Camille; Malik, Indranil; Eslamfam, Shabnam; Shasserre, Samantha C.; Downing, S. Sabina; Hoover, Evelyn M.; Dowd, Katherine E.; Polymenis, Michael] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Smith, Roger, III] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Hoose, SA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	polymenis@tamu.edu	Smith III, Roger/C-8685-2013; Polymenis, Michael/AAJ-3389-2021	Duran, Camille/0000-0002-7614-3265; Smith, Roger/0000-0001-5645-8422	National Science Foundation [MCB-0818248]; Direct For Biological Sciences [0818248] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (MCB-0818248) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Blank HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008018; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Escriva H, 2000, BIOESSAYS, V22, P717; Formenti LR, 2011, J MOL MICROB BIOTECH, V20, P191, DOI 10.1159/000329068; Haase SB, 1997, METHOD ENZYMOL, V283, P322; Hoose SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002590; Huggins DJ, 2011, ACS CHEM BIOL, V6, P208, DOI 10.1021/cb100420r; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; KELLER HU, 1995, J LEUKOCYTE BIOL, V58, P519, DOI 10.1002/jlb.58.5.519; KEYOMARSI K, 1991, CANCER RES, V51, P3602; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PARKS LW, 1995, ANNU REV MICROBIOL, V49, P95, DOI 10.1146/annurev.mi.49.100195.000523; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Pirrone V, 2011, ANTIMICROB AGENTS CH, V55, P1831, DOI 10.1128/AAC.00976-10; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; Roy A, 2009, IMMUNOPHARM IMMUNOT, V31, P339, DOI 10.1080/08923970902785253; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Wiens M, 2003, J EXP BIOL, V206, P3261, DOI 10.1242/jeb.00541; WONG DT, 1974, LIFE SCI, V15, P471, DOI 10.1016/0024-3205(74)90345-2	22	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36503	10.1371/journal.pone.0036503	http://dx.doi.org/10.1371/journal.pone.0036503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567160	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500080
J	Kiebish, MA; Yang, K; Sims, HF; Jenkins, CM; Liu, XP; Mancuso, DJ; Zhao, ZD; Guan, SP; Abendschein, DR; Han, XL; Gross, RW				Kiebish, Michael A.; Yang, Kui; Sims, Harold F.; Jenkins, Christopher M.; Liu, Xinping; Mancuso, David J.; Zhao, Zhongdan; Guan, Shaoping; Abendschein, Dana R.; Han, Xianlin; Gross, Richard W.			Myocardial Regulation of Lipidomic Flux by Cardiolipin Synthase SETTING THE BEAT FOR BIOENERGETIC EFFICIENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; ADP/ATP CARRIER PROTEIN; SHOTGUN LIPIDOMICS; BARTH-SYNDROME; HEART-FAILURE; MITOCHONDRIAL DYSFUNCTION; RESPIRATORY-CHAIN; TETRALINOLEOYL-CARDIOLIPIN; F0F1-ATPASE ACTIVITY; LIVER-MITOCHONDRIA	Lipidomic regulation of mitochondrial cardiolipin content and molecular species composition is a prominent regulator of bioenergetic efficiency. However, the mechanisms controlling cardiolipin metabolism during health or disease progression have remained elusive. Herein, we demonstrate that cardiac myocyte-specific transgenic expression of cardiolipin synthase results in accelerated cardiolipin lipidomic flux that impacts multiple aspects of mitochondrial bioenergetics and signaling. During the postnatal period, cardiolipin synthase transgene expression results in marked changes in the temporal maturation of cardiolipin molecular species during development. In adult myocardium, cardiolipin synthase transgene expression leads to a marked increase in symmetric tetra-18:2 molecular species without a change in total cardiolipin content. Mechanistic analysis demonstrated that these alterations result from increased cardiolipin remodeling by sequential phospholipase and transacylase/acyltransferase activities in conjunction with a decrease in phosphatidylglycerol content. Moreover, cardiolipin synthase transgene expression results in alterations in signaling metabolites, including a marked increase in the cardioprotective eicosanoid 14,15-epoxyeicosatrienoic acid. Examination of mitochondrial bioenergetic function by high resolution respirometry demonstrated that cardiolipin synthase transgene expression resulted in improved mitochondrial bioenergetic efficiency as evidenced by enhanced electron transport chain coupling using multiple substrates as well as by salutary changes in Complex III and IV activities. Furthermore, transgenic expression of cardiolipin synthase attenuated maladaptive cardiolipin remodeling and bioenergetic inefficiency in myocardium rendered diabetic by streptozotocin treatment. Collectively, these results demonstrate the unanticipated role of cardiolipin synthase in maintaining physiologic membrane structure and function even under metabolic stress, thereby identifying cardiolipin synthase as a novel therapeutic target to attenuate mitochondrial dysfunction in diabetic myocardium.	[Zhao, Zhongdan; Guan, Shaoping; Han, Xianlin; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Abendschein, Dana R.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [5PO1HL57278]; Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5PO1HL57278. This work was also supported by the Barth Syndrome Foundation. X. H. has a financial relationship with LipoSpectrum. R. W. G. has financial relationships with LipoSpectrum and Platomics.	Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Barth PG, 1996, J INHERIT METAB DIS, V19, P157, DOI 10.1007/BF01799418; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Bosetti F, 2000, MOL CELL BIOCHEM, V215, P31, DOI 10.1023/A:1026558922596; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brown JCL, 2007, AM J PHYSIOL-REG I, V293, pR1833, DOI 10.1152/ajpregu.00310.2007; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; DZAU VJ, 1984, NEW ENGL J MED, V310, P347, DOI 10.1056/NEJM198402093100603; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Esposti MD, 2001, METHOD CELL BIOL, V65, P75; Frohman MA, 2010, J MOL MED, V88, P967, DOI 10.1007/s00109-010-0662-x; GELLERICH FN, 1990, FEBS LETT, V274, P167, DOI 10.1016/0014-5793(90)81355-R; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Guillet V, 2010, NEUROGENETICS, V11, P127, DOI 10.1007/s10048-009-0207-z; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2000, BIOCHEM J, V352, P79, DOI 10.1042/0264-6021:3520079; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Hatch GM, 1998, INT J MOL MED, V1, P33; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Jullig M, 2008, PROTEOMICS, V8, P2556, DOI 10.1002/pmic.200700977; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; King T.E., 1967, METHOD ENZYMOL, V10, P322, DOI DOI 10.1016/0076-6879(67)10061-X; Kipp JL, 2001, ENDOCRINE, V15, P165, DOI 10.1385/ENDO:15:2:165; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003; Li Ning, 2011, Congest Heart Fail, V17, P42, DOI 10.1111/j.1751-7133.2010.00209.x; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; Mitchell RW, 2009, BBA-BIOMEMBRANES, V1788, P2015, DOI 10.1016/j.bbamem.2009.06.002; NOEL H, 1986, EUR J BIOCHEM, V155, P99, DOI 10.1111/j.1432-1033.1986.tb09463.x; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Oliveira PJ, 2006, TOXICOLOGY, V220, P160, DOI 10.1016/j.tox.2005.12.009; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pope S, 2008, BBA-BIOENERGETICS, V1777, P794, DOI 10.1016/j.bbabio.2008.03.011; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Roussel D, 2000, FEBS LETT, V477, P141, DOI 10.1016/S0014-5793(00)01790-7; Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; SCHLAME M, 1991, J BIOL CHEM, V266, P22398; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; Sudhahar V, 2010, CURR MED CHEM, V17, P1181, DOI 10.2174/092986710790827843; Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322; Tyurin VA, 2007, CELL DEATH DIFFER, V14, P872, DOI 10.1038/sj.cdd.4402068; van Gestel RA, 2010, J PROTEOMICS, V73, P806, DOI 10.1016/j.jprot.2009.11.009; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wang DR, 2009, P NATL ACAD SCI USA, V106, P7548, DOI 10.1073/pnas.0805806106; Wang R, 2009, PROSTAG LEUKOTR ESS, V81, P53, DOI 10.1016/j.plefa.2009.04.008; Xu FY, 2010, BBA-BIOMEMBRANES, V1798, P1577, DOI 10.1016/j.bbamem.2010.04.007; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Yonetani T, 1967, METHODS ENZYMOL, V10, P332; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhao M, 1998, J BIOL CHEM, V273, P2402, DOI 10.1074/jbc.273.4.2402; Zheng JB, 1999, EUR J PHARMACOL, V368, P95, DOI 10.1016/S0014-2999(99)00012-6	75	34	35	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25086	25097		10.1074/jbc.M112.340521	http://dx.doi.org/10.1074/jbc.M112.340521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22584571	hybrid, Green Published			2022-12-25	WOS:000306651700021
J	Chujo, M; Tarumoto, Y; Miyatake, K; Nishida, E; Ishikawa, F				Chujo, Moeko; Tarumoto, Yusuke; Miyatake, Koichi; Nishida, Eisuke; Ishikawa, Fuyuki			HIRA, a Conserved Histone Chaperone, Plays an Essential Role in Low-dose Stress Response via Transcriptional Stimulation in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; DNA-SYNTHESIS; CELL-CYCLE; GENE-TRANSCRIPTION; DIGEORGE-SYNDROME; OXIDATIVE STRESS; CHROMATIN; PATHWAY	Cells that have been pre-exposed to mild stress (priming stress) acquire transient resistance to subsequent severe stress even under different combinations of stresses. This phenomenon is called cross-tolerance. Although it has been reported that cross-tolerance occurs in many organisms, the molecular basis is not clear yet. Here, we identified slm9(+) as a responsible gene for the cross-tolerance in the fission yeast Schizosaccharomyces pombe. Slm9 is a homolog of mammalian HIRA histone chaperone. HIRA forms a conserved complex and gene disruption of other HIRA complex components, Hip1, Hip3, and Hip4, also yielded a cross-tolerance-defective phenotype, indicating that the fission yeast HIRA is involved in the cross-tolerance as a complex. We also revealed that Slm9 was recruited to the stress-responsive gene loci upon stress treatment in an Atf1-dependent manner. The expression of stress-responsive genes under stress conditions was compromised in HIRA disruptants. Consistent with this, Pol II recruitment and nucleosome eviction at these gene loci were impaired in slm9 Delta cells. Furthermore, we found that the priming stress enhanced the expression of stress-responsive genes in wild-type cells that were exposed to the severe stress. These observations suggest that HIRA functions in stress response through transcriptional regulation.	[Chujo, Moeko; Tarumoto, Yusuke; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Kyoto 6068501, Japan; [Miyatake, Koichi; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fishikaw@lif.kyoto-u.ac.jp	Tarumoto, Yusuke/H-6698-2014; Ishikawa, Fuyuki/AAU-4056-2021; Tarumoto, Yusuke/AAV-5246-2020	Ishikawa, Fuyuki/0000-0002-5580-2305; Tarumoto, Yusuke/0000-0001-6652-9618	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to F. I.).; Recipient of a fellowship from the Japan Society for the Promotion of Science.	Ahmad A, 2005, J BIOL CHEM, V280, P32090, DOI 10.1074/jbc.M501426200; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Alfa C, 1993, EXPT FISSION YEAST L; Anderson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013488; Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Balaji S, 2009, MOL BIOSYST, V5, P269, DOI 10.1039/b816424j; Banumathy G, 2009, MOL CELL BIOL, V29, P758, DOI 10.1128/MCB.01047-08; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Blackwell C, 2004, MOL CELL BIOL, V24, P4309, DOI 10.1128/MCB.24.10.4309-4320.2004; Calabrese EJ, 1999, TOXICOL PATHOL, V27, P195, DOI 10.1177/019262339902700207; Calabrese EJ, 2001, CRIT REV TOXICOL, V31, P353, DOI 10.1080/20014091111730; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; DAVIES JMS, 1995, ARCH BIOCHEM BIOPHYS, V317, P1, DOI 10.1006/abbi.1995.1128; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Dohke K, 2008, GENES CELLS, V13, P1027, DOI 10.1111/j.1365-2443.2008.01225.x; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Formosa T, 2002, GENETICS, V162, P1557; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Greenall A, 2006, J BIOL CHEM, V281, P8732, DOI 10.1074/jbc.M512170200; HAHN GM, 1989, INT J RADIAT BIOL, V56, P817, DOI 10.1080/09553008914552101; HENGGEARONIS R, 1993, J BACTERIOL, V175, P259, DOI 10.1128/JB.175.1.259-265.1993; KANOH J, 1995, MOL BIOL CELL, V6, P1185, DOI 10.1091/mbc.6.9.1185; Kanoh J, 2000, GENETICS, V155, P623; Keszenman DJ, 2005, ENVIRON MOL MUTAGEN, V45, P36, DOI 10.1002/em.20083; Kirov N, 1998, GENE, V212, P323, DOI 10.1016/S0378-1119(98)00143-7; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Lantermann A, 2009, METHODS, V48, P218, DOI 10.1016/j.ymeth.2009.02.004; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Larkindale J, 2004, J PLANT PHYSIOL, V161, P405, DOI 10.1078/0176-1617-01239; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mizuki F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019442; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Moskalev A, 2009, BIOGERONTOLOGY, V10, P3, DOI 10.1007/s10522-008-9147-5; Nakagawa CW, 2000, J BIOCHEM-TOKYO, V127, P233, DOI 10.1093/oxfordjournals.jbchem.a022599; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Prochasson P, 2005, GENE DEV, V19, P2534, DOI 10.1101/gad.1341105; Rai TS, 2011, MOL CELL BIOL, V31, P4107, DOI 10.1128/MCB.05546-11; Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Roberts C, 1997, HUM MOL GENET, V6, P237, DOI 10.1093/hmg/6.2.237; Sanso M, 2011, NUCLEIC ACIDS RES, V39, P6369, DOI 10.1093/nar/gkr255; Santos BC, 1998, AM J PHYSIOL-RENAL, V274, pF1054, DOI 10.1152/ajprenal.1998.274.6.F1054; Scamps C, 1996, BBA-GENE STRUCT EXPR, V1306, P5, DOI 10.1016/0167-4781(96)00010-3; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; SHERWOOD PW, 1993, MOL CELL BIOL, V13, P28, DOI 10.1128/MCB.13.1.28; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Spector MS, 1997, MOL CELL BIOL, V17, P545, DOI 10.1128/MCB.17.2.545; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Williams SK, 2007, CURR OPIN GENET DEV, V17, P88, DOI 10.1016/j.gde.2007.02.001; Yamane K, 2011, MOL CELL, V41, P56, DOI 10.1016/j.molcel.2010.12.009; Yonezawa M, 1996, MUTAT RES-FUND MOL M, V358, P237, DOI 10.1016/S0027-5107(96)00126-1; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhou GA, 2010, PLANT MOL BIOL, V72, P357, DOI 10.1007/s11103-009-9575-x	63	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23440	23450		10.1074/jbc.M112.349944	http://dx.doi.org/10.1074/jbc.M112.349944			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589550	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000306511300017
J	Zhou, MY; Lu, G; Gao, C; Wang, YB; Sun, HP				Zhou, Meiyi; Lu, Gang; Gao, Chen; Wang, Yibin; Sun, Haipeng			Tissue-specific and Nutrient Regulation of the Branched-chain alpha-Keto Acid Dehydrogenase Phosphatase, Protein Phosphatase 2Cm (PP2Cm)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY-DISEASE; SKELETAL-MUSCLE; KINASE; EXPRESSION; METABOLISM; CATABOLISM; MICE; IDENTIFICATION; TRANSPORT; COMPLEX	Branched-chain amino acid (BCAA) homeostasis is maintained through highly regulated catabolic activities where the rate-limiting step is catalyzed by branched-chain alpha-keto dehydrogenase (BCKD). Our previous study has identified a mitochondria-targeted protein phosphatase, PP2Cm, as the BCKD phosphatase and thus serves as a key regulator for BCAA catabolism. In this report, we performed comprehensive molecular and biochemical studies of PP2Cm regulation using both in vivo and in vitro systems. We show that PP2Cm expression is highly enriched in brain, heart, liver, kidney, and diaphragm, but low in skeletal muscle. The PP2Cm expression is regulated at the transcriptional level in response to nutrient status. Furthermore, we have established that PP2Cm interacts with the BCKD E2 subunit and competes with the BCKD kinase in a substrate-dependent and mutually exclusive manner. These data suggest that BCAA homeostasis is at least in part contributed by nutrient-dependent PP2Cm expression and interaction with the BCKD complex. Finally, a number of human PP2Cm single nucleotide polymorphic changes as identified in the public data base can produce either inactive or constitutive active mutant phosphatases, suggesting that putative PP2Cm mutations may contribute to BCAA catabolic defects in human.	[Sun, Haipeng] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol Med & Physiol,Mol Biol Inst, Div Mol Med,Cardiovasc Res Labs,CHS, Los Angeles, CA 90095 USA; [Zhou, Meiyi; Wang, Yibin; Sun, Haipeng] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol,Chinese Minist Educ, Shanghai 200025, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Shanghai Jiao Tong University	Sun, HP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol Med & Physiol,Mol Biol Inst, Div Mol Med,Cardiovasc Res Labs,CHS, Rm BH 569,650 Charles E Young Dr, Los Angeles, CA 90095 USA.	hp.sun@ucla.edu		Wang, Yibin/0000-0003-0852-0767; Sun, Haipeng/0000-0003-2128-3209	National Institutes of Health [HL108186, HL103205, HL098954]; National Natural Science Foundation of China [NSFC30971094]; Ministry of Science and Technology of China [2012BAI02B05]; Science and Technology Commission of Shanghai Municipality [11410709000]; Shanghai Jiaotong University K. C. Wong Medical Fellowship Fund; American Heart Association postdoctoral fellowship (Great Western Affiliate); American Heart Association Scientist Development Grant (National Research Center); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103205, R01HL098954, R01HL108186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Jiaotong University K. C. Wong Medical Fellowship Fund; American Heart Association postdoctoral fellowship (Great Western Affiliate)(American Heart Association); American Heart Association Scientist Development Grant (National Research Center)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL108186, HL103205, and HL098954. This work was also supported by National Natural Science Foundation of China Grant NSFC30971094, Ministry of Science and Technology of China Grant 2012BAI02B05, Science and Technology Commission of Shanghai Municipality Grant 11410709000, and the Shanghai Jiaotong University K. C. Wong Medical Fellowship Fund.; Supported by an American Heart Association postdoctoral fellowship (Great Western Affiliate) and American Heart Association Scientist Development Grant (National Research Center). To whom correspondence should be addressed: Rm. BH 569, CHS, 650 Charles E. Young Dr., David Geffen School of Medicine, UCLA, Los Angeles, CA 90095. Fax: 310-206-5907; E-mail: hp.sun@ucla.edu.	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Chuang DT, 2006, J NUTR, V136, p243S, DOI 10.1093/jn/136.1.243S; Chuang JL, 2002, J BIOL CHEM, V277, P36905, DOI 10.1074/jbc.C200430200; Doering CB, 2000, AM J PHYSIOL-CELL PH, V279, pC1587, DOI 10.1152/ajpcell.2000.279.5.C1587; HARRIS RA, 1990, ADV ENZYME REGUL, V30, P245; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; Harris RA, 2001, J NUTR, V131, p841S, DOI 10.1093/jn/131.3.841S; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; Iwanaka N, 2010, J APPL PHYSIOL, V108, P274, DOI 10.1152/japplphysiol.00420.2009; Joshi M, 2007, BIOCHEM BIOPH RES CO, V356, P38, DOI 10.1016/j.bbrc.2007.02.108; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Lu G, 2008, CLIN EXP PHARMACOL P, V35, P107, DOI 10.1111/j.1440-1681.2007.04843.x; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Mukakami T, 2005, J NUTR SCI VITAMINOL, V51, P48, DOI 10.3177/jnsv.51.48; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishimura J, 2010, J NUTR, V140, P496, DOI 10.3945/jn.109.108977; PAXTON R, 1984, ARCH BIOCHEM BIOPHYS, V231, P48, DOI 10.1016/0003-9861(84)90361-8; POPOV KM, 1992, J BIOL CHEM, V267, P13127; POPOV KM, 1995, ARCH BIOCHEM BIOPHYS, V316, P148, DOI 10.1006/abbi.1995.1022; Sakai R, 2004, J NEUROCHEM, V88, P612, DOI 10.1111/j.1471-4159.2004.02179.x; Serdikoff C, 2001, J NUTR, V131, P1682, DOI 10.1093/jn/131.6.1682; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; Yoshizawa F, 2004, BIOCHEM BIOPH RES CO, V313, P417, DOI 10.1016/j.bbrc.2003.07.013	31	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23397	23406		10.1074/jbc.M112.351031	http://dx.doi.org/10.1074/jbc.M112.351031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589535	hybrid, Green Published			2022-12-25	WOS:000306511300012
J	Craig, TJ; Jaafari, N; Petrovic, MM; Rubin, PP; Mellor, JR; Henley, JM				Craig, Tim J.; Jaafari, Nadia; Petrovic, Milos M.; Rubin, Philip P.; Mellor, Jack R.; Henley, Jeremy M.			Homeostatic Synaptic Scaling Is Regulated by Protein SUMOylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA; MECHANISMS; EXPRESSION; ARC	Homeostatic scaling allows neurons to alter synaptic transmission to compensate for changes in network activity. Here, we show that suppression of network activity with tetrodotoxin, which increases surface expression of AMPA receptors (AMPARs), dramatically reduces levels of the deSUMOylating (where SUMO is small ubiquitin-like modifier) enzyme SENP1, leading to a consequent increase in protein SUMOylation. Overexpression of the catalytic domain of SENP1 prevents this scaling effect, and we identify Arc as a SUMO substrate involved in the tetrodotoxin-induced increase in AMPAR surface expression. Thus, protein SUMOylation plays an important and previously unsuspected role in synaptic trafficking of AMPARs that underlies homeostatic scaling.	[Craig, Tim J.; Jaafari, Nadia; Rubin, Philip P.; Henley, Jeremy M.] Univ Bristol, Sch Biochem, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; [Petrovic, Milos M.; Mellor, Jack R.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Petrovic, Milos M.] Univ Belgrade, Inst Med Physiol, Sch Med, Belgrade 11000, Serbia	University of Bristol; University of Bristol; University of Belgrade	Henley, JM (corresponding author), Univ Bristol, Sch Biochem, MRC, Ctr Synapt Plast, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	j.m.henley@bristol.ac.uk	MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Henley, Jeremy/0000-0003-3589-8335	Medical Research Council; European Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Trust; Marie Curie fellowship; European Molecular Biology Organization short-term fellowship; Medical Research Council [G0601810] Funding Source: researchfish; MRC [G0601810] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Marie Curie fellowship(European Commission); European Molecular Biology Organization short-term fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council and the European Research Council (to J. M. H.), the Biotechnology and Biological Sciences Research Council and the Wellcome Trust (to J. M. H. and J. R. M.), and a Marie Curie fellowship and a European Molecular Biology Organization short-term fellowship (to M. M. P.).	Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cimarosti H, 2012, J CEREBR BLOOD F MET, V32, P17, DOI 10.1038/jcbfm.2011.146; Feligioni M, 2006, J NEUROCHEM, V99, P549, DOI 10.1111/j.1471-4159.2006.04087.x; Feligioni M, 2009, EUR J NEUROSCI, V29, P1348, DOI 10.1111/j.1460-9568.2009.06692.x; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Kantamneni S, 2007, J NEUROCHEM, V100, P1003, DOI 10.1111/j.1471-4159.2006.04271.x; Kantamneni S, 2011, BIOCHEM BIOPH RES CO, V409, P657, DOI 10.1016/j.bbrc.2011.05.060; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Plant LD, 2011, J GEN PHYSIOL, V137, P441, DOI 10.1085/jgp.201110604; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi A, 2007, J NEUROSCI, V27, P10037, DOI 10.1523/JNEUROSCI.0361-07.2007; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wilkinson KA, 2008, NEUROSCI LETT, V436, P239, DOI 10.1016/j.neulet.2008.03.029; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158	28	60	60	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22781	22788		10.1074/jbc.M112.356337	http://dx.doi.org/10.1074/jbc.M112.356337			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22582390	hybrid, Green Published			2022-12-25	WOS:000306495000035
J	Sambrooks, CL; Carpio, MA; Hallak, ME				Lopez Sambrooks, Cecilia; Carpio, Marcos A.; Hallak, Marta E.			Arginylated Calreticulin at Plasma Membrane Increases Susceptibility of Cells to Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM LUMINAL ENVIRONMENT; RECEPTOR-RELATED PROTEIN; CLASS-I MOLECULES; STRESS GRANULES; ENDOPLASMIC-RETICULUM; SURFACE CALRETICULIN; CHAPERONE CALRETICULIN; BINDING PROTEIN; EXPOSURE; CALCIUM	Post-translational modifications of proteins are important for the regulation of cell fate and functions; one of these post-translational modifications is arginylation. We have previously established that calreticulin (CRT), an endoplasmic reticulum resident, is also one of the arginylated substrates found in the cytoplasm. In the present study, we describe that arginylated CRT (R-CRT) binds to the cell membrane and identified its role as a preapoptotic signal. We also show that cells lacking arginyl-tRNA protein transferase are less susceptible to apoptosis than wild type cells. Under these conditions R-CRT is present on the cell membrane but at early stages is differently localized in stress granules. Moreover, cells induced to undergo apoptosis by arsenite show increased R-CRT on their cell surface. Exogenously applied R-CRT binds to the cell membrane and is able to both increase the number of cells undergoing apoptosis in wild type cells and overcome apoptosis resistance in cells lacking arginyl-tRNA protein transferase that express R-CRT on the cell surface. Thus, these results demonstrate the importance of surface R-CRT in the apoptotic response of cells, implying that post-translational arginylation of CRT can regulate its intracellular localization, cell function, and survival.	[Lopez Sambrooks, Cecilia; Carpio, Marcos A.; Hallak, Marta E.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC CONICET, Dept Quim Biol, Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Hallak, ME (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC CONICET, Dept Quim Biol, Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	mhallak@fcq.unc.edu.ar			Agencia Nacional de Promocion Cientifica y Technologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba; CONICET;  [BID 1728/OC-AR PICT 1661]	Agencia Nacional de Promocion Cientifica y Technologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); 	This work was supported by Grant BID 1728/OC-AR PICT 1661 and grants from the Agencia Nacional de Promocion Cientifica y Technologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba.; Recipient of a fellowship from CONICET.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Carpio MA, 2010, BIOCHEM J, V429, P63, DOI 10.1042/BJ20091953; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chen DQ, 2005, J BIOL CHEM, V280, P22425, DOI 10.1074/jbc.M413380200; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Decca MB, 2007, J BIOL CHEM, V282, P8237, DOI 10.1074/jbc.M608559200; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Donnelly S, 2006, ARTHRITIS RHEUM-US, V54, P1543, DOI 10.1002/art.21783; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Gold LI, 2006, J INVEST DERM SYMP P, V11, P57, DOI 10.1038/sj.jidsymp.5650011; GRAY AJ, 1995, J BIOL CHEM, V270, P26602, DOI 10.1074/jbc.270.44.26602; Hamilton MH, 2003, P NATL ACAD SCI USA, V100, P5081, DOI 10.1073/pnas.0831228100; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kepp O, 2009, CELL CYCLE, V8, P3971, DOI 10.4161/cc.8.23.10191; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lim S, 2008, MOL CELLS, V25, P390; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, IMMUNOL REV, V220, P22, DOI 10.1111/j.1600-065X.2007.00567.x; Obeid M, 2007, CANCER RES, V67, P7941, DOI 10.1158/0008-5472.CAN-07-1622; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Olkku A, 2009, BONE, V44, P555, DOI 10.1016/j.bone.2008.11.013; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Orr AW, 2002, J BIOL CHEM, V277, P20453, DOI 10.1074/jbc.M112091200; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; SINGH NK, 1994, P NATL ACAD SCI USA, V91, P12770, DOI 10.1073/pnas.91.26.12770; Tarr JM, 2010, J MOL BIOL, V401, P799, DOI 10.1016/j.jmb.2010.06.064; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; Xiao GQ, 1999, J NEUROSCI RES, V58, P652, DOI 10.1002/(SICI)1097-4547(19991201)58:5<652::AID-JNR6>3.0.CO;2-H; Xie W, 2011, MOL BIOL INT, V2011, P1; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhu Q, 1997, BIOCHEM BIOPH RES CO, V232, P354, DOI 10.1006/bbrc.1997.6195	55	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22043	22054		10.1074/jbc.M111.338335	http://dx.doi.org/10.1074/jbc.M111.338335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577148	Green Published, hybrid			2022-12-25	WOS:000306418600042
J	Elgbratt, K; Jansson, A; Hultgren-Hornquist, E				Elgbratt, Kristina; Jansson, Andreas; Hultgren-Hornquist, Elisabeth			A Quantitative Study of the Mechanisms behind Thymic Atrophy in G alpha i2-Deficient Mice during Colitis Development	PLOS ONE			English	Article							T-CELL HOMEOSTASIS; RHEUMATOID-ARTHRITIS; POPULATION-DYNAMICS; ULCERATIVE-COLITIS; OUTPUT; MOUSE; THYMOCYTES; EMIGRANTS; MIGRATION; POOL	Mice deficient for the G protein subunit G alpha i2 spontaneously develop colitis, a chronic inflammatory disease associated with dysregulated T cell responses. We and others have previously demonstrated a thymic involution in these mice and an aberrant thymocyte dynamics. The G alpha i2(-/-) mice have a dramatically reduced fraction of double positive thymocytes and an increased fraction of single positive (SP) thymocytes. In this study, we quantify a number of critical parameters in order to narrow down the underlying mechanisms that cause the dynamical changes of the thymocyte development in the G alpha i2(-/-) mice. Our data suggest that the increased fraction of SP thymocytes results only from a decreased number of DP thymocytes, since the number of SP thymocytes in the Gai2(-/-) mice is comparable to the control littermates. By measuring the frequency of T cell receptor excision circles (TRECs) in the thymocytes, we demonstrate that the number of cell divisions the G alpha i2(-/-) SP thymocytes undergo is comparable to SP thymocytes from control littermates. In addition, our data show that the mature SP CD4(+) and CD8(+) thymocytes divide to the same extent before they egress from the thymus. By estimating the number of peripheral TREC+ T lymphocytes and their death rate, we could calculate the daily egression of thymocytes. G alpha i2(-/-) mice with no/mild and moderate colitis were found to have a slower export rate in comparison to the control littermates. The quantitative measurements in this study suggest a number of dynamical changes in the thymocyte development during the progression of colitis.	[Elgbratt, Kristina; Hultgren-Hornquist, Elisabeth] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden; [Jansson, Andreas] Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden	Orebro University; University of Skovde	Elgbratt, K (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden.	elisabeth.hultgren-hornquist@oru.se			Swedish Research Council [2008-4075]; Swedish Cancer Society [CAN 2008/591]; Foundation of Professor Nanna Svartz; Orebro University; Swedish Society of Medicine; Knowledge Foundation [2010/0171]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Foundation of Professor Nanna Svartz; Orebro University; Swedish Society of Medicine; Knowledge Foundation	The Swedish Research Council [Grant no. 2008-4075] to [EHH]; The Swedish Cancer Society [Grant no. CAN 2008/591] to [EHH]; The Foundation of Professor Nanna Svartz [KE]; Orebro University to [EHH] and The Swedish Society of Medicine to [EHH]: The Knowledge Foundation [2010/0171]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2001, INT IMMUNOPHARMACOL, V1, P1261, DOI 10.1016/S1567-5769(01)00057-1; Arron ST, 2005, EUR J IMMUNOL, V35, P46, DOI 10.1002/eji.200424996; Berzins SP, 2002, TRENDS MOL MED, V8, P469, DOI 10.1016/S1471-4914(02)02415-2; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Capparelli R, 1997, CYTOMETRY, V29, P261, DOI 10.1002/(SICI)1097-0320(19971101)29:3<261::AID-CYTO9>3.0.CO;2-E; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; CLARKE AG, 1994, IMMUNOL TODAY, V15, P545, DOI 10.1016/0167-5699(94)90212-7; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; Dulude G, 2008, J IMMUNOL, V181, P7818, DOI 10.4049/jimmunol.181.11.7818; Elgbratt K, 2010, CLIN EXP IMMUNOL, V162, P325, DOI 10.1111/j.1365-2249.2010.04230.x; Elgbratt K, 2007, IMMUNOLOGY, V122, P199, DOI 10.1111/j.1365-2567.2007.02629.x; Fredin MF, 2007, SCAND J IMMUNOL, V65, P421, DOI 10.1111/j.1365-3083.2007.01923.x; Graziano M, 1998, EXP CELL RES, V240, P75, DOI 10.1006/excr.1997.3900; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hoff J, 2000, LAB ANIMAL, V29, P47; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Hug A, 2003, J IMMUNOL, V171, P432, DOI 10.4049/jimmunol.171.1.432; Jin YZ, 2008, MOL IMMUNOL, V45, P3401, DOI 10.1016/j.molimm.2008.04.007; Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203; Krenger W, 2004, J IMMUNOL, V172, P7359, DOI 10.4049/jimmunol.172.12.7359; Ludviksson BR, 1997, J IMMUNOL, V158, P104; Mitchell WA, 2006, BIOGERONTOLOGY, V7, P461, DOI 10.1007/s10522-006-9061-7; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Ponchel F, 2002, BLOOD, V100, P4550, DOI 10.1182/blood-2002-03-0671; Ribeiro RM, 2007, IMMUNOL REV, V216, P21; ROCHA B, 1983, J IMMUNOL, V131, P2158; RUDOLPH U, 1995, J CLIN IMMUNOL, V15, pS101, DOI 10.1007/BF01540899; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Shimizu T, 2000, SCAND J IMMUNOL, V51, P285; Singh S, 2007, J AM SOC NEPHROL, V18, P461, DOI 10.1681/ASN.2006040405; Thomas-Vaslin V, 2008, J IMMUNOL, V180, P2240, DOI 10.4049/jimmunol.180.4.2240; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Verschuren MCM, 1997, J IMMUNOL, V158, P1208; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105; WESTERMANN J, 1990, IMMUNOL TODAY, V11, P406, DOI 10.1016/0167-5699(90)90160-B; Zhang YJ, 2005, INT IMMUNOL, V17, P233, DOI 10.1093/intimm/dxh204	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36726	10.1371/journal.pone.0036726	http://dx.doi.org/10.1371/journal.pone.0036726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590596	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336400031
J	Graham, RT; Witt, MJ; Castellanos, DW; Remolina, F; Maxwell, S; Godley, BJ; Hawkes, LA				Graham, Rachel T.; Witt, Matthew J.; Castellanos, Dan W.; Remolina, Francisco; Maxwell, Sara; Godley, Brendan J.; Hawkes, Lucy A.			Satellite Tracking of Manta Rays Highlights Challenges to Their Conservation	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; MARINE PROTECTED AREAS; LEATHERBACK TURTLES; DIVING BEHAVIOR; WHALE SHARKS; MOVEMENTS; ALFREDI	We describe the real-time movements of the last of the marine mega-vertebrate taxa to be satellite tracked - the giant manta ray (or devil fish, Manta birostris), the world's largest ray at over 6 m disc width. Almost nothing is known about manta ray movements and their environmental preferences, making them one of the least understood of the marine mega-vertebrates. Red listed by the International Union for the Conservation of Nature as 'Vulnerable' to extinction, manta rays are known to be subject to direct and incidental capture and some populations are declining. Satellite-tracked manta rays associated with seasonal upwelling events and thermal fronts off the Yucatan peninsula, Mexico, and made short-range shuttling movements, foraging along and between them. The majority of locations were received from waters shallower than 50 m deep, representing thermally dynamic and productive waters. Manta rays remained in the Mexican Exclusive Economic Zone for the duration of tracking but only 12% of tracking locations were received from within Marine Protected Areas (MPAs). Our results on the spatio-temporal distribution of these enigmatic rays highlight opportunities and challenges to management efforts.	[Graham, Rachel T.] Wildlife Conservat Soc, Gulf & Caribbean Sharks & Rays Program, Punta Gorda, Belize; [Graham, Rachel T.; Godley, Brendan J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Witt, Matthew J.; Hawkes, Lucy A.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Remolina, Francisco] Natl Commiss Protected Areas, Domino Project, Cancun, Quintana Roo, Mexico; [Maxwell, Sara] Marine Conservat Inst, Glen Ellen, CA USA; [Maxwell, Sara] Univ Calif Santa Cruz, Long Marine Lab, Santa Cruz, CA 95064 USA; [Hawkes, Lucy A.] Bangor Univ, Brambell Labs, Bangor, Gwynedd, Wales	University of Exeter; University of Exeter; University of California System; University of California Santa Cruz; Bangor University	Graham, RT (corresponding author), Wildlife Conservat Soc, Gulf & Caribbean Sharks & Rays Program, Punta Gorda, Belize.	rgraham@wcs.org	godley, brendan/O-1959-2019; Witt, Matthew/V-3318-2018; godley, brendan j/A-6139-2009; Hawkes, Lucy/L-7407-2014	godley, brendan/0000-0003-3845-0034; Witt, Matthew/0000-0002-9498-5378; godley, brendan j/0000-0003-3845-0034; Hawkes, Lucy/0000-0002-6696-1862; Maxwell, Sara/0000-0002-4425-9378	Summit Foundation	Summit Foundation	This study was funded by the The Summit Foundation (http://www.summitfdn.org/ and by two other foundations who wish to remain anonymous. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Canadas A, 2005, AQUAT CONSERV, V15, P495, DOI 10.1002/aqc.689; Canese Simonepietro, 2011, Endangered Species Research, V14, P171, DOI 10.3354/esr00349; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Deakos MH, 2011, MAR ECOL PROG SER, V429, P245, DOI 10.3354/meps09085; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Gore MA, 2008, BIOL LETTERS, V4, P395, DOI 10.1098/rsbl.2008.0147; Graham Rachel T., 2007, Gulf and Caribbean Research, V19, P149; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hart KM, 2012, BIOL CONSERV, V145, P185, DOI 10.1016/j.biocon.2011.10.030; Hart Kristen M., 2010, Endangered Species Research, V10, P9, DOI 10.3354/esr00238; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Hooker SK, 2007, DEEP-SEA RES PT II, V54, P177, DOI 10.1016/j.dsr2.2007.01.001; Hoolihan JP, 2011, ICES J MAR SCI, V68, P880, DOI 10.1093/icesjms/fsr024; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kooyman G, 2007, MAR TECHNOL SOC J, V41, P6, DOI 10.4031/002533207787441935; Marshall A, 2011, IUCN 2011 IUCN RED L; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall AD, 2009, ZOOTAXA, P1; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; Maxwell SM, 2012, MARINE MAMMAL SCI; OHMAN MD, 1983, SCIENCE, V220, P1404, DOI 10.1126/science.220.4604.1404; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Sims DW, 2010, CRC MAR BIOL SER, P351; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; White WT, 2006, FISH RES, V82, P65, DOI 10.1016/j.fishres.2006.08.008; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; Witt MJ, 2010, J EXP BIOL, V213, P901, DOI 10.1242/jeb.038133; Witt MJ, 2011, P ROY SOC B-BIOL SCI, V278, P2338, DOI 10.1098/rspb.2010.2467; Witt MJ, 2010, AQUAT BIOL, V8, P169, DOI 10.3354/ab00221	46	83	86	2	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36834	10.1371/journal.pone.0036834	http://dx.doi.org/10.1371/journal.pone.0036834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590622	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400040
J	Honsa, P; Pivonkova, H; Dzamba, D; Filipova, M; Anderova, M				Honsa, Pavel; Pivonkova, Helena; Dzamba, David; Filipova, Marcela; Anderova, Miroslava			Polydendrocytes Display Large Lineage Plasticity following Focal Cerebral Ischemia	PLOS ONE			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; SPINAL-CORD-INJURY; K+ CHANNEL EXPRESSION; NEURAL STEM-CELLS; GLIAL-CELLS; NG2 CELLS; PROGENITOR CELLS; NG2-EXPRESSING CELLS; SUBVENTRICULAR ZONE; RAT HIPPOCAMPUS	Polydendrocytes (also known as NG2 glial cells) constitute a fourth major glial cell type in the adult mammalian central nervous system (CNS) that is distinct from other cell types. Although much evidence suggests that these cells are multipotent in vitro, their differentiation potential in vivo under physiological or pathophysiological conditions is still controversial. To follow the fate of polydendrocytes after CNS pathology, permanent middle cerebral artery occlusion (MCAo), a commonly used model of focal cerebral ischemia, was carried out on adult NG2creBAC:ZEG double transgenic mice, in which enhanced green fluorescent protein (EGFP) is expressed in polydendrocytes and their progeny. The phenotype of the EGFP(+) cells was analyzed using immunohistochemistry and the patch-clamp technique 3, 7 and 14 days after MCAo. In sham-operated mice (control), EGFP(+) cells in the cortex expressed protein markers and displayed electrophysiological properties of polydendrocytes and oligodendrocytes. We did not detect any co-labeling of EGFP with neuronal, microglial or astroglial markers in this region, thus proving polydendrocyte unipotent differentiation potential under physiological conditions. Three days after MCAo the number of EGFP(+) cells in the gliotic tissue dramatically increased when compared to control animals, and these cells displayed properties of proliferating cells. However, in later phases after MCAo a large subpopulation of EGFP(+) cells expressed protein markers and electrophysiological properties of astrocytes that contribute to the formation of glial scar. Importantly, some EGFP(+) cells displayed membrane properties typical for neural precursor cells, and moreover these cells expressed doublecortin (DCX) - a marker of newly-derived neuronal cells. Taken together, our data indicate that polydendrocytes in the dorsal cortex display multipotent differentiation potential after focal ischemia.	[Honsa, Pavel; Pivonkova, Helena; Dzamba, David; Filipova, Marcela; Anderova, Miroslava] Acad Sci Czech Republ, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic; [Honsa, Pavel; Pivonkova, Helena; Dzamba, David] Charles Univ Prague, Fac Med 2, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague	Honsa, P (corresponding author), Acad Sci Czech Republ, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic.	anderova@biomed.cas.cz	Filipova, Marcela/P-2793-2016; Anderova, Miroslava/H-2249-2014; Pivonkova, Helena/ABE-4845-2021	Filipova, Marcela/0000-0003-3503-7973; Anderova, Miroslava/0000-0002-9030-4571; Pivonkova, Helena/0000-0003-2790-9778	Grant Agency of the Czech Republic [CZ: GA CR: GA309/09/0717, GA P303/12/0855, GA 309/08/H079]; Grant Agency of Charles University [CZ: GA UK:383711]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of Charles University	This work was supported by the Grant Agency of the Czech Republic - CZ: GA C.R: GA309/09/0717, GA P303/12/0855 and GA 309/08/H079, and by the Grant Agency of Charles University - CZ: GA UK:383711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Anderova M, 2004, GLIA, V48, P311, DOI 10.1002/glia.20076; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Chen PH, 2008, BRAIN RES, V1243, P27, DOI 10.1016/j.brainres.2008.09.029; Chvatal A, 2004, J NEUROSCI RES, V78, P668, DOI 10.1002/jnr.20284; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Gao Q, 2010, NEUROSCIENCE, V165, P386, DOI 10.1016/j.neuroscience.2009.10.022; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Komitova M, 2011, GLIA, V59, P800, DOI 10.1002/glia.21152; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Lacar, 2010, FRONT NEUROSCI; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Montiel-Eulefi E, 2012, CYTOM PART A, V81A, P65, DOI 10.1002/cyto.a.21152; Muskhelishvili L, 2003, J HISTOCHEM CYTOCHEM, V51, P1681, DOI 10.1177/002215540305101212; Nishiyama A, 1997, J NEUROSCI RES, V48, P299, DOI 10.1002/(SICI)1097-4547(19970515)48:4<299::AID-JNR2>3.0.CO;2-6; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Pettigrew LC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-47; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Schools GP, 2003, J NEUROSCI RES, V73, P765, DOI 10.1002/jnr.10680; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Tatsumi K, 2008, J NEUROSCI RES, V86, P3494, DOI 10.1002/jnr.21862; Tian DS, 2007, BRAIN RES, V1154, P206, DOI 10.1016/j.brainres.2007.04.005; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Wohl SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022408; Xie M, 2007, NEUROSCIENCE, V150, P853, DOI 10.1016/j.neuroscience.2007.09.057; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yang Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-108; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhu L, 2010, NEUROSCIENCE, V166, P842, DOI 10.1016/j.neuroscience.2009.12.057; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	56	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36816	10.1371/journal.pone.0036816	http://dx.doi.org/10.1371/journal.pone.0036816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590616	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400038
J	Bashar, MK; Komatsu, K; Fujimori, T; Kobayashi, TJ				Bashar, Md Khayrul; Komatsu, Koji; Fujimori, Toshihiko; Kobayashi, Tetsuya J.			Automatic Extraction of Nuclei Centroids of Mouse Embryonic Cells from Fluorescence Microscopy Images	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LINEAGE; SPECIFICATION	Accurate identification of cell nuclei and their tracking using three dimensional (3D) microscopic images is a demanding task in many biological studies. Manual identification of nuclei centroids from images is an error-prone task, sometimes impossible to accomplish due to low contrast and the presence of noise. Nonetheless, only a few methods are available for 3D bioimaging applications, which sharply contrast with 2D analysis, where many methods already exist. In addition, most methods essentially adopt segmentation for which a reliable solution is still unknown, especially for 3D bio-images having juxtaposed cells. In this work, we propose a new method that can directly extract nuclei centroids from fluorescence microscopy images. This method involves three steps: (i) Pre-processing, (ii) Local enhancement, and (iii) Centroid extraction. The first step includes two variations: first variation (Variant-1) uses the whole 3D pre-processed image, whereas the second one (Variant-2) modifies the preprocessed image to the candidate regions or the candidate hybrid image for further processing. At the second step, a multiscale cube filtering is employed in order to locally enhance the pre-processed image. Centroid extraction in the third step consists of three stages. In Stage-1, we compute a local characteristic ratio at every voxel and extract local maxima regions as candidate centroids using a ratio threshold. Stage-2 processing removes spurious centroids from Stage-1 results by analyzing shapes of intensity profiles from the enhanced image. An iterative procedure based on the nearest neighborhood principle is then proposed to combine if there are fragmented nuclei. Both qualitative and quantitative analyses on a set of 100 images of 3D mouse embryo are performed. Investigations reveal a promising achievement of the technique presented in terms of average sensitivity and precision (i. e., 88.04% and 91.30% for Variant-1; 86.19% and 95.00% for Variant-2), when compared with an existing method (86.06% and 90.11%), originally developed for analyzing C. elegans images.	[Bashar, Md Khayrul; Kobayashi, Tetsuya J.] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Komatsu, Koji; Fujimori, Toshihiko] Natl Inst Basic Biol, Div Embryol, Okazaki, Aichi 444, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Bashar, MK (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	kbashar@sat.t.u-tokyo.ac.jp	Bashar, Md Khayrul/AHB-9800-2022; Fujimori, Toshihiko/L-7711-2016	Bashar, Md Khayrul/0000-0002-5580-0422; Fujimori, Toshihiko/0000-0001-5200-4634	KAKENHI [2116006]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [21116005] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (KAKENHI), Grant No. 2116006; Japan Society for the Promotion of Science; and the Ministry of Education, Culture, Sports, Science and Technology. http://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bukhari SS, 2009, J UNIVERS COMPUT SCI, V15, P3343; Dzyubachyk O, 2010, IEEE T MED IMAGING, V29, P852, DOI 10.1109/TMI.2009.2038693; Foucher S, 2001, IEEE T IMAGE PROCESS, V10, P49, DOI 10.1109/83.892442; Fujimori T, 2010, DEV GROWTH DIFFER, V52, P253, DOI 10.1111/j.1440-169X.2010.01172.x; Hamahashi S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-125; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lakshmanan V, 2004, IEEE GEOSCI REMOTE S, V1, P192, DOI 10.1109/LGRS.2004.828178; Li G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-40; Makhoul John, 1999, P DARPA BROADCAST NE, P249; Olson DL, 2008, ADV DATA MINING TECH, DOI DOI 10.1007/978-3-540-76917-0; Ostu Nobuyuki, 1979, IEEE T SYST MAN CYB, VSMC-9, P62, DOI DOI 10.1109/TSMC.1979.4310076; Parfitt DE, 2010, MOL BIOL CELL, V21, P2649, DOI 10.1091/mbc.E10-01-0053; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; PLUTO, PLUTO COMP AID DIAGN; Russ JC, 2007, IMAGE PROCESSING HDB; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Wang QL, 2010, CYTOM PART A, V77A, P101, DOI 10.1002/cyto.a.20812; Williams D. B, 1999, DETECTION DETERMININ	20	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e35550	10.1371/journal.pone.0035550	http://dx.doi.org/10.1371/journal.pone.0035550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590505	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335500004
J	Kershenbaum, A; Stone, L; Ostfeld, RS; Blaustein, L				Kershenbaum, Arik; Stone, Lewi; Ostfeld, Richard S.; Blaustein, Leon			Modelling Transmission of Vector-Borne Pathogens Shows Complex Dynamics When Vector Feeding Sites Are Limited	PLOS ONE			English	Article							AEDES-TRISERIATUS DIPTERA; WEST-NILE-VIRUS; LYME-DISEASE; BIODIVERSITY; IMPACT; PERSISTENCE; COMPETITION; DIVERSITY; SCIURIDAE; COMMUNITY	The relationship between species richness and the prevalence of vector-borne disease has been widely studied with a range of outcomes. Increasing the number of host species for a pathogen may decrease infection prevalence (dilution effect), increase it (amplification), or have no effect. We derive a general model, and a specific implementation, which show that when the number of vector feeding sites on each host is limiting, the effects on pathogen dynamics of host population size are more complex than previously thought. The model examines vector-borne disease in the presence of different host species that are either competent or incompetent (i.e. that cannot transmit the pathogen to vectors) as reservoirs for the pathogen. With a single host species present, the basic reproduction ratio R-0 is a non-monotonic function of the population size of host individuals (H), i.e. a value (H) over cap exists that maximises R-0. Surprisingly, if H > (H) over cap, a reduction in host population size may actually increase R-0. Extending this model to a two-host species system, incompetent individuals from the second host species can alter the value of (H) over cap, which may reverse the effect on pathogen prevalence of host population reduction. We argue that when vector-feeding sites on hosts are limiting, the net effect of increasing host diversity might not be correctly predicted using simple frequency-dependent epidemiological models.	[Kershenbaum, Arik; Blaustein, Leon] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Kershenbaum, Arik; Blaustein, Leon] Univ Haifa, Fac Nat Sci, Inst Evolut, IL-31999 Haifa, Israel; [Stone, Lewi] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY USA	University of Haifa; University of Haifa; Tel Aviv University; Cary Institute of Ecosystem Studies	Kershenbaum, A (corresponding author), Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	arik.kershenbaum@gmail.com	Kershenbaum, Arik/C-3552-2012	Kershenbaum, Arik/0000-0003-0464-0243; Stone, Lewi/0000-0002-6465-579X; Ostfeld, Richard/0000-0002-3707-9301	University of Haifa	University of Haifa	The lead author (AK) received a personal PhD scholarship ($ 1000 pcm) from the University of Haifa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; Brinkerhoff RJ, 2009, FRONTIERS ECOLOGY EN, V9, P103, DOI [DOI 10.1890/090062, DOI 10.1890/090062)]; BULL CM, 1993, OECOLOGIA, V96, P415, DOI 10.1007/BF00317513; Daley D. J., 2001, CAMBRIDGE STUDIES MA; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Gilbert L, 2001, J ANIM ECOL, V70, P1053, DOI 10.1046/j.0021-8790.2001.00558.x; GRIMM V, 1994, ECOL MODEL, V75, P641, DOI 10.1016/0304-3800(94)90056-6; Hart B, 1997, HOSTPARASITE EVOLUTI; Hawlena H, 2007, INT J PARASITOL, V37, P919, DOI 10.1016/j.ijpara.2007.01.015; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly DW, 1996, J ANIM ECOL, V65, P517, DOI 10.2307/5786; Levin ML, 1998, J PARASITOL, V84, P36, DOI 10.2307/3284526; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Ostfeld RS, 2010, INFECT DIS ECOLOGY E; Pacejka AJ, 1998, ECOLOGY, V79, P1797, DOI 10.1890/0012-9658(1998)079[1797:DPVMAH]2.0.CO;2; Peixoto ID, 2006, ECOLOGY, V87, P873, DOI 10.1890/0012-9658(2006)87[873:TEOBOT]2.0.CO;2; Rosa R, 2007, MATH BIOSCI, V208, P216, DOI 10.1016/j.mbs.2006.10.002; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Svobodova M, 2006, EMERG INFECT DIS, V12, P1860; Swei A, 2011, P ROY SOC B-BIOL SCI, V278, P2970, DOI 10.1098/rspb.2010.2402; TATCHELL RJ, 1987, INT J PARASITOL, V17, P597, DOI 10.1016/0020-7519(87)90136-6; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Tyre AJ, 2003, AUSTRAL ECOL, V28, P196, DOI 10.1046/j.1442-9993.2003.01270.x; VANBUSKIRK J, 1995, ECOL APPL, V5, P1133, DOI 10.2307/2269360; WAAGE JK, 1986, J ANIM ECOL, V55, P171, DOI 10.2307/4700; WALKER ED, 1986, J MED ENTOMOL, V23, P1, DOI 10.1093/jmedent/23.1.1; WALKER ED, 1985, J MED ENTOMOL, V22, P287, DOI 10.1093/jmedent/22.3.287	40	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36730	10.1371/journal.pone.0036730	http://dx.doi.org/10.1371/journal.pone.0036730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590597	gold, Green Published			2022-12-25	WOS:000305335500025
J	Lau, SKM; Shields, DJ; Murphy, EA; Desgrosellier, JS; Anand, S; Huang, M; Kato, S; Lim, ST; Weis, SM; Stupack, DG; Schlaepfer, DD; Cheresh, DA				Lau, Steven K. M.; Shields, David J.; Murphy, Eric A.; Desgrosellier, Jay S.; Anand, Sudarshan; Huang, Miller; Kato, Shumei; Lim, Ssang-Taek; Weis, Sara M.; Stupack, Dwayne G.; Schlaepfer, David D.; Cheresh, David A.			EGFR-Mediated Carcinoma Cell Metastasis Mediated by Integrin alpha v beta 5 Depends on Activation of c-Src and Cleavage of MUC1	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; BREAST-CANCER PATIENTS; CYTOPLASMIC TAIL; PROSTATE-CANCER; ONCOPROTEIN; PHOSPHORYLATION; TRANSCRIPTION; SURVIVAL; MOTILITY; INTRAVASATION	Receptor tyrosine kinases and integrins play an essential role in tumor cell invasion and metastasis. We previously showed that EGF and other growth factors induce human carcinoma cell invasion and metastasis mediated by integrin alpha v beta 5 that is prevented by Src blockade [1]. MUC1, a transmembrane glycoprotein, is expressed in most epithelial tumors as a heterodimer consisting of an extracellular and a transmembrane subunit. The MUC1 cytoplasmic domain of the transmembrane subunit (MUC1.CD) translocates to the nucleus where it promotes the transcription of a metastatic gene signature associated with epithelial to mesenchymal transition. Here, we demonstrate a requirement for MUC1 in carcinoma cell metastasis dependent on EGFR and Src without affecting primary tumor growth. EGF stimulates Src-dependent MUC1 cleavage and nuclear localization leading to the expression of genes linked to metastasis. Moreover, expression of MUC1.CD results in its nuclear localization and is sufficient for transcription of the metastatic gene signature and tumor cell metastasis. These results demonstrate that EGFR and Src activity contribute to carcinoma cell invasion and metastasis mediated by integrin alpha v beta 5 in part by promoting proteolytic cleavage of MUC1 and highlight the ability of MUC1.CD to promote metastasis in a context-dependent manner. Our findings may have implications for the use and future design of targeted therapies in cancers known to express EGFR, Src, or MUC1.	[Lau, Steven K. M.; Shields, David J.; Murphy, Eric A.; Desgrosellier, Jay S.; Anand, Sudarshan; Huang, Miller; Weis, Sara M.; Cheresh, David A.] Moores Univ Calif San Diego, Ctr Canc, Dept Pathol, La Jolla, CA 92093 USA; [Kato, Shumei] Moores Univ Calif San Diego, Ctr Canc, Dept Med, La Jolla, CA USA; [Lim, Ssang-Taek; Stupack, Dwayne G.; Schlaepfer, David D.] Moores Univ Calif San Diego, Ctr Canc, Dept Reprod Med, La Jolla, CA USA		Lau, SKM (corresponding author), Moores Univ Calif San Diego, Ctr Canc, Dept Pathol, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu	ANAND, SUDARSHAN/I-5316-2019; Desgrosellier, Jay S/A-8756-2008	ANAND, SUDARSHAN/0000-0002-4969-6884; Huang, Miller/0000-0002-3371-0100; Lim, Steve/0000-0003-0323-8607; Lau, Steven/0000-0002-6433-8735	National Institutes of Health [CA045726, CA102310]; UCSD [PHSGM07198]; NATIONAL CANCER INSTITUTE [R01CA045726, R01CA102310, T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants CA045726 (D.A.C.), CA102310 (D.D.S.) (http://grants.nih.gov/grants/oer.htm) and PHSGM07198 (UCSD Medical Scientist Training Program) (http://mstp.ucsd.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Apostolopoulos V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1505; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; Bitler BG, 2009, CLIN CANCER RES, V15, P100, DOI 10.1158/1078-0432.CCR-08-1745; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brooks PC, 1997, J CLIN INVEST, V99, P1390, DOI 10.1172/JCI119298; Butts C, 2010, CLIN LUNG CANCER, V11, P391, DOI 10.3816/CLC.2010.n.101; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Golas JM, 2003, CANCER RES, V63, P375; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Huang M, 2012, ONCOGENE, V31, P2783, DOI 10.1038/onc.2011.450; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Joshi MD, 2009, MOL CANCER THER, V8, P3056, DOI 10.1158/1535-7163.MCT-09-0646; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kohlgraf KG, 2003, CANCER RES, V63, P5011; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 2003, MOL CANCER RES, V1, P765; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Oudard S, 2011, CANCER IMMUNOL IMMUN, V60, P261, DOI 10.1007/s00262-010-0935-9; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Shields DJ, 2011, ONCOGENE, V30, P2123, DOI 10.1038/onc.2010.589; Singh PK, 2008, J BIOL CHEM, V283, P26985, DOI 10.1074/jbc.M805036200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Thompson EJ, 2006, MOL CANCER RES, V4, P489, DOI 10.1158/1541-7786.MCR-06-0038; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; von Mensdorff-Pouilly S, 2000, J CLIN ONCOL, V18, P574, DOI 10.1200/JCO.2000.18.3.574; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wu YM, 2009, P NATL ACAD SCI USA, V106, P5807, DOI 10.1073/pnas.0810094106; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou YC, 2011, MOL PHARMACOL, V79, P886, DOI 10.1124/mol.110.070797; Zijlstra A, 2002, CANCER RES, V62, P7083	60	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36753	10.1371/journal.pone.0036753	http://dx.doi.org/10.1371/journal.pone.0036753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586492	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335000053
J	Arguello, RJ; Albareda, MC; Alvarez, MG; Bertocchi, G; Armenti, AH; Vigliano, C; Meckert, PC; Tarleton, RL; Laucella, SA				Argueello, Rafael J.; Albareda, Maria C.; Alvarez, Mari G.; Bertocchi, Graciela; Armenti, Alejandro H.; Vigliano, Carlos; Meckert, Patricia C.; Tarleton, Rick L.; Laucella, Susana A.			Inhibitory Receptors Are Expressed by Trypanosoma cruzi-Specific Effector T Cells and in Hearts of Subjects with Chronic Chagas Disease	PLOS ONE			English	Article							INTERFERON-GAMMA; VIRAL-INFECTION; CTLA-4; LYMPHOCYTES; EXHAUSTION; MOLECULES; DIFFERENTIATION; PHENOTYPE; SUBSETS; PROGRESSION	We had formerly demonstrated that subjects chronically infected with Trypanosoma cruzi show impaired T cell responses closely linked with a process of T cell exhaustion. Recently, the expression of several inhibitory receptors has been associated with T cell dysfunction and exhaustion. In this study, we have examined the expression of the cytotoxic T lymphocyte antigen 4 (CTLA-4) and the leukocyte immunoglobulin like receptor 1 (LIR-1) by peripheral T. cruzi antigen-responsive IFN-gamma (IFN-gamma)-producing and total T cells from chronically T. cruzi-infected subjects with different clinical forms of the disease. CTAL-4 expression was also evaluated in heart tissue sections from subjects with severe myocarditis. The majority of IFN-gamma-producing CD4(+) T cells responsive to a parasite lysate preparation were found to express CTLA-4 but considerably lower frequencies express LIR-1, irrespective of the clinical status of the donor. Conversely, few IFN-gamma-producing T cells responsive to tetanus and diphtheria toxoids expressed CTLA-4 and LIR-1. Polyclonal stimulation with anti-CD3 antibodies induced higher frequencies of CD4(+)CTAL-4(+) T cells in patients with severe heart disease than in asymptomatic subjects. Ligation of CTLA-4 and LIR-1 with their agonistic antibodies, in vitro, reduces IFN-gamma production. Conversely, CTLA-4 blockade did not improved IFN-gamma production in response to T. cruzi antigens. Subjects with chronic T. cruzi infection had increased numbers of CD4(+)LIR-1(+) among total peripheral blood mononuclear cells, relative to uninfected individuals and these numbers decreased after treatment with benznidazole. CTLA-4 was also expressed by CD3(+) T lymphocytes infiltrating heart tissues from chronically infected subjects with severe myocarditis. These findings support the conclusion that persistent infection with T. cruzi leads to the upregulation of inhibitory receptors which could alter parasite specific T cell responses in the chronic phase of Chagas disease.	[Argueello, Rafael J.; Albareda, Maria C.; Laucella, Susana A.] Inst Nacl Parasitol Dr Mario Fatala Chaben, Buenos Aires, DF, Argentina; [Vigliano, Carlos; Meckert, Patricia C.] Hosp Univ Fdn Favaloro, Dept Patol, Buenos Aires, DF, Argentina; [Tarleton, Rick L.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University of Buenos Aires; University System of Georgia; University of Georgia	Arguello, RJ (corresponding author), Inst Nacl Parasitol Dr Mario Fatala Chaben, Buenos Aires, DF, Argentina.	slaucella@yahoo.com	Tarleton, Rick/AES-8572-2022	Tarleton, Rick/0000-0002-9589-5243; Arguello, Rafael J/0000-0001-9785-3883	National Council for Scientific and Technical Research, Argentina (CONICET PIP) [5686]; National Institutes of Health, United States of America [P01AI044979]; Ministerio de Salud de la Nacion, Argentina; Ministerio de Salud de la Provincia de Buenos Aires, Argentina; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044979] Funding Source: NIH RePORTER	National Council for Scientific and Technical Research, Argentina (CONICET PIP); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Salud de la Nacion, Argentina; Ministerio de Salud de la Provincia de Buenos Aires, Argentina; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Council for Scientific and Technical Research, Argentina (CONICET PIP No5686) to SAL; The National Institutes of Health, United States of America (P01AI044979) to RLT; Ministerio de Salud de la Nacion, Argentina, and Ministerio de Salud de la Provincia de Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Albareda MC, 2006, INT IMMUNOL, V18, P465, DOI 10.1093/intimm/dxh387; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; [Anonymous], 2002, WHO TECHN REP SER; Antrobus RD, 2005, J INFECT DIS, V191, P1842, DOI 10.1086/429927; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Bank/WHO UW UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 1995, 12 PROGR REP UNDP WO, P125; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2007, J VIROL, V81, P945, DOI 10.1128/JVI.01354-06; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; Albareda MC, 2009, J IMMUNOL, V183, P4103, DOI 10.4049/jimmunol.0900852; Cella M, 2000, CURR TOP MICROBIOL, V251, P161; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chen YQ, 2006, ALLERGY, V61, P15, DOI 10.1111/j.1398-9995.2006.01008.x; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; EDWARDS WD, 1981, MAYO CLIN PROC, V56, P479; Graefe SEB, 2004, PARASITE IMMUNOL, V26, P19, DOI 10.1111/j.0141-9838.2004.00679.x; Greenwald RJ, 2002, EUR J IMMUNOL, V32, P366, DOI 10.1002/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5; Gutierrez FRS, 2011, INFECT IMMUN, V79, P1873, DOI 10.1128/IAI.01047-10; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hermann E, 2010, IMMUNOLOGY, V129, P418, DOI 10.1111/j.1365-2567.2009.03194.x; Higuchi MD, 1997, AM J TROP MED HYG, V56, P485; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Ince MN, 2004, IMMUNOLOGY, V112, P531, DOI 10.1046/j.1365-2567.2004.01907.x; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Jimenez-Martinez MC, 2004, IMMUNOLOGY, V111, P100, DOI 10.1111/j.1365-2567.2004.01785.x; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kassu A, 2010, J IMMUNOL, V185, P3007, DOI 10.4049/jimmunol.1000156; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kumar S, 2001, J IMMUNOL, V166, P4596, DOI 10.4049/jimmunol.166.7.4596; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Laguens RP, 1999, MEDICINA-BUENOS AIRE, V59, P63; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Laucella SA, 2009, CLIN INFECT DIS, V49, P1675, DOI 10.1086/648072; Marinova E, 2007, J IMMUNOL, V178, P5010, DOI 10.4049/jimmunol.178.8.5010; Martins GA, 2004, J IMMUNOL, V172, P4893, DOI 10.4049/jimmunol.172.8.4893; Merlo A, 2001, INFECT IMMUN, V69, P6022, DOI 10.1128/IAI.69.10.6022-6029.2001; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Northfield J, 2005, IMMUNOL CELL BIOL, V83, P182, DOI 10.1111/j.1440-1711.2005.01321.x; Olivera GC, 2010, MICROBES INFECT, V12, P359, DOI 10.1016/j.micinf.2010.01.011; Radziewicz H, 2007, WORLD J GASTROENTERO, V13, P4848, DOI 10.3748/wjg.v13.i36.4848; Raziorrouh B, 2011, GASTROENTEROLOGY, V141, P1422, DOI 10.1053/j.gastro.2011.07.004; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Saverino D, 2004, J IMMUNOL, V172, P5629, DOI 10.4049/jimmunol.172.9.5629; Schijman AG, 2004, AM J TROP MED HYG, V70, P210, DOI 10.4269/ajtmh.2004.70.210; Schlotmann T, 2000, J INFECT DIS, V182, P367, DOI 10.1086/315690; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Souza PEA, 2007, INFECT IMMUN, V75, P1886, DOI 10.1128/IAI.01931-06; TARLETON RL, 1994, INFECT IMMUN, V62, P1820, DOI 10.1128/IAI.62.5.1820-1829.1994; TARLETON RL, 1992, NATURE, V356, P338, DOI 10.1038/356338a0; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Vandenborre K, 1998, AM J PATHOL, V152, P963; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Wagner CS, 2007, J IMMUNOL, V178, P3536, DOI 10.4049/jimmunol.178.6.3536; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wizel B, 1998, J CLIN INVEST, V102, P1062, DOI 10.1172/JCI3835; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zammit DJ, 2006, MICROBES INFECT, V8, P1108, DOI 10.1016/j.micinf.2005.12.002; Zaunders JJ, 2006, J VIROL, V80, P10162, DOI 10.1128/JVI.00249-06	69	41	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35966	10.1371/journal.pone.0035966	http://dx.doi.org/10.1371/journal.pone.0035966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574131	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349800027
J	Krause, ET; Caspers, BA				Krause, E. Tobias; Caspers, Barbara A.			Are Olfactory Cues Involved in Nest Recognition in Two Social Species of Estrildid Finches?	PLOS ONE			English	Article							RECEPTOR GENE REPERTOIRES; ODOR RECOGNITION; INDIVIDUAL RECOGNITION; PARENTAL EFFORT; BEGGING CALLS; ZEBRA; SIZE; PROCELLARIIFORM; SITE; SONG	Reliably recognizing their own nest provides parents with a necessary skill to invest time and resources efficiently in raising their offspring and thereby maximising their own reproductive success. Studies investigating nest recognition in adult birds have focused mainly on visual cues of the nest or the nest site and acoustic cues of the nestlings. To determine whether adult songbirds also use olfaction for nest recognition, we investigated the use of olfactory nest cues for two estrildid finch species, zebra finches (Taeniopygia guttata) and Bengalese finches (Lonchura striata var. domestica) during the nestling and fledgling phase of their offspring. We found similar behavioural responses to nest odours in both songbird species. Females preferred the odour of their own nest over a control and avoided the foreign conspecific nest scent over a control during the nestling phase of their offspring, but when given the own odour and the foreign conspecific odour simultaneously we did not find a preference for the own nest odour. Males of both species did not show any preferences at all. The behavioural reaction to any nest odour decreased after fledging of the offspring. Our results show that only females show a behavioural response to olfactory nest cues, indicating that the use of olfactory cues for nest recognition seems to be sex-specific and dependent on the developmental stage of the offspring. Although estrildid finches are known to use visual and acoustic cues for nest recognition, the similar behavioural pattern of both species indicates that at least females gain additional information by olfactory nest cues during the nestling phase of their offspring. Thus olfactory cues might be important in general, even in situations in which visual and acoustic cues are known to be sufficient.	[Krause, E. Tobias; Caspers, Barbara A.] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany	University of Bielefeld	Krause, ET (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	tobias.krause@uni-bielefeld.de	Caspers, Barbara/C-5573-2011; Krause, E. Tobias/A-9900-2009	Caspers, Barbara/0000-0002-4380-0476; Krause, E. Tobias/0000-0002-8327-3711				Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Amo L, 2011, ARDEA, V99, P177, DOI 10.5253/078.099.0207; Arnaiz-Villena Antonio, 2009, Open Ornithology Journal, V2, P29; Aubin T, 1998, P ROY SOC B-BIOL SCI, V265, P1665, DOI 10.1098/rspb.1998.0486; BANG BG, 1968, AUK, V85, P55; BARG JJ, 1994, AUK, V111, P459, DOI 10.2307/4088610; BAUER JH, 1983, PHYSIOL BEHAV, V30, P229, DOI 10.1016/0031-9384(83)90010-0; BIRKE LIA, 1974, BEHAVIOUR, V48, P111, DOI 10.1163/156853974X00282; BOAG PT, 1987, AUK, V104, P155, DOI 10.1093/auk/104.2.155; Bonadonna F, 2003, J EXP BIOL, V206, P3719, DOI 10.1242/jeb.00610; Bonadonna F, 2003, BEHAV ECOL SOCIOBIOL, V54, P174, DOI 10.1007/s00265-003-0610-7; Bonadonna F, 2002, J EXP BIOL, V205, P2519; Bouwman KM, 2005, BEHAV ECOL, V16, P499, DOI 10.1093/beheco/ari021; Caspers BA, 2011, BIOL LETTERS, V7, P184, DOI 10.1098/rsbl.2010.0775; Celerier A, 2011, BIOL LETTERS, V7, P807, DOI 10.1098/rsbl.2011.0340; Coffin HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025002; Cunningham GB, 2011, J AVIAN BIOL, V42, P85, DOI 10.1111/j.1600-048X.2010.05184.x; DAVIES NB, 1992, ANIM BEHAV, V43, P729, DOI 10.1016/S0003-3472(05)80197-6; De Leon A, 2003, BEHAVIOUR, V140, P925, DOI 10.1163/156853903770238382; Eckmeier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003956; Eisner E., 1961, Ardea, V49, P51; EISNER ERICA, 1960, AUK, V77, P271; FLEMING AS, 1989, PHYSIOL BEHAV, V46, P449, DOI 10.1016/0031-9384(89)90019-X; Goodwin, 1982, ESTRILDID FINCHES WO; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Holland RA, 2009, J EXP BIOL, V212, P4065, DOI 10.1242/jeb.034504; HUGHES BO, 1995, APPL ANIM BEHAV SCI, V42, P271, DOI 10.1016/0168-1591(94)00541-L; Immelmann K., 1965, AUSTR FINCHES BUSH A; Immelmann K., 1969, ZEBRAFINK TAENIOPYGI; Jacot A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1515, DOI 10.1007/s00265-010-0965-5; Kempenaers B, 1996, ANIM BEHAV, V51, P1165, DOI 10.1006/anbe.1996.0118; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Krause ET, 2011, BEHAVIOUR, V148, P1239, DOI 10.1163/000579511X600619; Krause ET, 2011, ANIM BEHAV, V81, P1295, DOI 10.1016/j.anbehav.2011.03.021; Krause ET, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005015; LEMON WC, 1993, PHYSIOL ZOOL, V66, P946, DOI 10.1086/physzool.66.6.30163748; Leonard ML, 2012, BIOL LETTERS, V8, P530, DOI 10.1098/rsbl.2012.0032; Levrero F, 2009, CR BIOL, V332, P579, DOI 10.1016/j.crvi.2009.02.006; Mennerat A, 2008, BEHAV PROCESS, V79, P189, DOI 10.1016/j.beproc.2008.07.003; Mennerat A, 2005, BEHAV PROCESS, V70, P264, DOI 10.1016/j.beproc.2005.07.005; Nice MM, 1964, STUDIES LIVE HIST SO; O'Dwyer TW, 2008, J EXP BIOL, V211, P337, DOI 10.1242/jeb.010512; PEEK FW, 1972, WILSON BULL, V84, P243; Reers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018466; Rehling A, 2012, ANIM BEHAV, V83, P35, DOI 10.1016/j.anbehav.2011.10.003; Robiller F, 1978, PRACHTFINKEN VOGEL D; Soma M, 2006, ETHOLOGY, V112, P1071, DOI 10.1111/j.1439-0310.2006.01263.x; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; Steiger SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-446; Tinbergen JM, 2002, AVIAN INCUBATION BEH; TRILLMICH F, 1976, Z TIERPSYCHOL, V42, P1; Whittaker DJ, 2011, BEHAV ECOL, V22, P1256, DOI 10.1093/beheco/arr122; Whittaker DJ, 2010, BEHAV ECOL, V21, P608, DOI 10.1093/beheco/arq033; Whittaker DJ, 2009, J AVIAN BIOL, V40, P579, DOI 10.1111/j.1600-048X.2009.04813.x; Witte K, 2006, BEHAVIOUR, V143, P969, DOI 10.1163/156853906778623626; Zann RA., 1996, ZEBRA FINCH SYNTHESI	58	29	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36615	10.1371/journal.pone.0036615	http://dx.doi.org/10.1371/journal.pone.0036615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574196	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800093
J	Kumar, S; Chagne, D; Bink, MCAM; Volz, RK; Whitworth, C; Carlisle, C				Kumar, Satish; Chagne, David; Bink, Marco C. A. M.; Volz, Richard K.; Whitworth, Claire; Carlisle, Charmaine			Genomic Selection for Fruit Quality Traits in Apple (Malus x domestica Borkh.)	PLOS ONE			English	Article							GENETIC-RELATIONSHIP INFORMATION; ESTIMATED BREEDING VALUE; MOLECULAR MARKERS; STATUS NUMBER; RED FLESH; ACCURACY; PREDICTION; VALUES; PROGRESS; MODELS	The genome sequence of apple (Malusxdomestica Borkh.) was published more than a year ago, which helped develop an 8K SNP chip to assist in implementing genomic selection (GS). In apple breeding programmes, GS can be used to obtain genomic breeding values (GEBV) for choosing next-generation parents or selections for further testing as potential commercial cultivars at a very early stage. Thus GS has the potential to accelerate breeding efficiency significantly because of decreased generation interval or increased selection intensity. We evaluated the accuracy of GS in a population of 1120 seedlings generated from a factorial mating design of four females and two male parents. All seedlings were genotyped using an Illumina Infinium chip comprising 8,000 single nucleotide polymorphisms (SNPs), and were phenotyped for various fruit quality traits. Random-regression best liner unbiased prediction (RR-BLUP) and the Bayesian LASSO method were used to obtain GEBV, and compared using a cross-validation approach for their accuracy to predict unobserved BLUP-BV. Accuracies were very similar for both methods, varying from 0.70 to 0.90 for various fruit quality traits. The selection response per unit time using GS compared with the traditional BLUP-based selection were very high (>100%) especially for low-heritability traits. Genome-wide average estimated linkage disequilibrium (LD) between adjacent SNPs was 0.32, with a relatively slow decay of LD in the long range (r(2) = 0.33 and 0.19 at 100 kb and 1,000 kb respectively), contributing to the higher accuracy of GS. Distribution of estimated SNP effects revealed involvement of large effect genes with likely pleiotropic effects. These results demonstrated that genomic selection is a credible alternative to conventional selection for fruit quality traits.	[Kumar, Satish; Volz, Richard K.; Whitworth, Claire] New Zealand Inst Plant & Food Res Ltd, Havelock North, New Zealand; [Chagne, David; Carlisle, Charmaine] New Zealand Inst Plant & Food Res Ltd, Palmerston North, New Zealand; [Bink, Marco C. A. M.] Univ Wageningen & Res Ctr, Wageningen, Netherlands	New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; Wageningen University & Research	Kumar, S (corresponding author), New Zealand Inst Plant & Food Res Ltd, Havelock North, New Zealand.	Satish.Kumar@plantandfood.co.nz			PrevarTM [26015]; New Zealand Foundation for Research Science and Technology [C06X0812]; Commission of the European Communities [FP7-KBBE-2010-265582]; USDA's National Institute of Food and Agriculture - Speciality Crop Research Initiative RosBREED [2009-51181-05808]; PrevarTM Limited	PrevarTM; New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Commission of the European Communities(European Commission); USDA's National Institute of Food and Agriculture - Speciality Crop Research Initiative RosBREED; PrevarTM Limited	This research was partly funded by PrevarTM (Contract no. 26015) and the New Zealand Foundation for Research Science and Technology (Contract no. C06X0812). The contribution of M. Bink was carried out as part of the COST Action TD0801 "StatSeq" and the EU-FruitBreedomics project funded by the Commission of the European Communities (Contract FP7-KBBE-2010-265582) and supported by USDA's National Institute of Food and Agriculture - Speciality Crop Research Initiative RosBREED (2009-51181-05808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PrevarTM Limited (which is one of the funding sources of this study) is an incorporated joint venture between pipfruit industry organisations (Pipfruit New Zealand (PNZ); Apple & Pear Australia Limited (APAL)) and the New Zealand government-owned Crown Research Institute (The New Zealand Institute for Plant and Food Research Limited). All authors (except M. Bink - who is affiliated with Biometris department at the Wageningen University, The Netherlands) of this study are full-time employees of the New Zealand government-owned Crown Research Institute (The New Zealand Institute for Plant and Food Research Limited). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bus Vincent G. M., 2009, V6, P563, DOI 10.1007/978-0-387-77491-6_27; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Chagne D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-212; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Chagne D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-12; Chia JM, 2011, NAT BIOTECHNOL, V29, P138, DOI 10.1038/nbt.1756; Costa F, 2010, J EXP BOT, V61, P3029, DOI 10.1093/jxb/erq130; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Farnir F, 2000, GENOME RES, V10, P220, DOI 10.1101/gr.10.2.220; Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; GILMOUR AR, 2006, ASREML UPDATE WHATS; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Gredler B, 2010, P 9 WORLD C GEN APPL; Guo G, 2010, J ANIM BREED GENET, V127, P423, DOI 10.1111/j.1439-0388.2010.00878.x; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Kenis K, 2008, TREE GENET GENOMES, V4, P647, DOI 10.1007/s11295-008-0140-6; Kouassi AB, 2009, TREE GENET GENOMES, V5, P659, DOI 10.1007/s11295-009-0217-x; Kumar S, 2012, TREE GENET GENOMES, V8, P1, DOI 10.1007/s11295-011-0425-z; Kumar S, 2010, EUPHYTICA, V173, P207, DOI 10.1007/s10681-009-0090-6; Liebhard R, 2003, PLANT MOL BIOL, V52, P511, DOI 10.1023/A:1024886500979; Lindgren D, 1998, CAN J FOREST RES, V28, P276, DOI 10.1139/cjfr-28-2-276; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Moser G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-56; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; Noiton DAM, 1996, J AM SOC HORTIC SCI, V121, P773, DOI 10.21273/JASHS.121.5.773; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; R Development Core Team, 2009, R FDN STAT COMP; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Toosi A, 2010, J ANIM SCI, V88, P32, DOI 10.2527/jas.2009-1975; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Volz RK, 2009, ACTA HORTIC, V814, P337, DOI 10.17660/ActaHortic.2009.814.54; Yao YX, 2007, PLANT PHYSIOL BIOCH, V45, P139, DOI 10.1016/j.plaphy.2007.01.010; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	47	147	151	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36674	10.1371/journal.pone.0036674	http://dx.doi.org/10.1371/journal.pone.0036674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574211	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800108
J	Nishiyama, T; Miyawaki, K; Ohshima, M; Thompson, K; Nagashima, A; Hasebe, M; Kurata, T				Nishiyama, Tomoaki; Miyawaki, Kaori; Ohshima, Masumi; Thompson, Kari; Nagashima, Akitomo; Hasebe, Mitsuyasu; Kurata, Tetsuya			Digital Gene Expression Profiling by 5 '-End Sequencing of cDNAs during Reprogramming in the Moss Physcomitrella patens	PLOS ONE			English	Article							SHOOT DEVELOPMENT; ARABIDOPSIS-THALIANA; AUXIN BIOSYNTHESIS; HISTONE H4R3; GENOME; TRANSCRIPTOME; PROTEINS; KINASE; LAND; ROOT	Stem cells self-renew and repeatedly produce differentiated cells during development and growth. The differentiated cells can be converted into stem cells in some metazoans and land plants with appropriate treatments. After leaves of the moss Physcomitrella patens are excised, leaf cells reenter the cell cycle and commence tip growth, which is characteristic of stem cells called chloronema apical cells. To understand the underlying molecular mechanisms, a digital gene expression profiling method using mRNA 5'-end tags (5'-DGE) was established. The 5'-DGE method produced reproducible data with a dynamic range of four orders that correlated well with qRT-PCR measurements. After the excision of leaves, the expression levels of 11% of the transcripts changed significantly within 6 h. Genes involved in stress responses and proteolysis were induced and those involved in metabolism, including photosynthesis, were reduced. The later processes of reprogramming involved photosynthesis recovery and higher macromolecule biosynthesis, including of RNA and proteins. Auxin and cytokinin signaling pathways, which are activated during stem cell formation via callus in flowering plants, are also activated during reprogramming in P. patens, although no exogenous phytohormone is applied in the moss system, suggesting that an intrinsic phytohormone regulatory system may be used in the moss.	[Nishiyama, Tomoaki; Miyawaki, Kaori; Ohshima, Masumi; Thompson, Kari; Nagashima, Akitomo; Hasebe, Mitsuyasu; Kurata, Tetsuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Okazaki, Aichi, Japan; [Nishiyama, Tomoaki] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Hasebe, Mitsuyasu] Natl Inst Basic Biol, Div Evolutionary Biol, Okazaki, Aichi 444, Japan; [Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan	Japan Science & Technology Agency (JST); Kanazawa University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Nishiyama, T (corresponding author), Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Okazaki, Aichi, Japan.	tomoakin@staff.kanazawa-u.ac.jp; mhasebe@nibb.ac.jp; tekurata@bs.naist.jp		Hasebe, Mitsuyasu/0000-0001-7425-8758; Nishiyama, Tomoaki/0000-0003-1279-7806	Japan Science and Technology Agency under Exploratory Research for Advanced Technology program; Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 22128008, 21370107, 22128002]	Japan Science and Technology Agency under Exploratory Research for Advanced Technology program; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japan Science and Technology Agency under the Exploratory Research for Advanced Technology program, and the Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 22128008 to TN, 21370107 and 22128002 to MH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bao YH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-132; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; Che P, 2007, PLANTA, V226, P1183, DOI 10.1007/s00425-007-0565-4; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Chopra RN, 1988, BIOL BRYOPHYTES; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Demura T, 2002, P NATL ACAD SCI USA, V99, P15794, DOI 10.1073/pnas.232590499; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Eklund DM, 2010, DEVELOPMENT, V137, P1275, DOI 10.1242/dev.039594; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Hashimoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004108; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kulpa D, 1997, EMBO J, V16, P856, DOI 10.1093/emboj/16.4.856; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Ludwig-Muller J, 2009, NEW PHYTOL, V181, P323, DOI 10.1111/j.1469-8137.2008.02677.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Moon J, 2007, PLANT PHYSIOL, V143, P684, DOI 10.1104/pp.106.091439; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/nmeth.1470, 10.1038/NMETH.1470]; Prigge MJ, 2010, DEVELOPMENT, V137, P3535, DOI 10.1242/dev.049023; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; Sakakibara K, 2003, DEVELOPMENT, V130, P4835, DOI 10.1242/dev.00644; Sakakibara K, 2008, EVOL DEV, V10, P555, DOI 10.1111/j.1525-142X.2008.00271.x; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Su N, 2007, PLANT MOL BIOL, V63, P337, DOI 10.1007/s11103-006-9092-0; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Sugiura C, 2003, NUCLEIC ACIDS RES, V31, P5324, DOI 10.1093/nar/gkg726; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Toronen P, 1999, FEBS LETT, V451, P142, DOI 10.1016/S0014-5793(99)00524-4; Tsuchihara K, 2009, NUCLEIC ACIDS RES, V37, P2249, DOI 10.1093/nar/gkp066; Turner BM, 2002, CHROMATIN GENE REGUL; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; WILLIAMS EG, 1986, ANN BOT-LONDON, V57, P443, DOI 10.1093/oxfordjournals.aob.a087127; Witte CP, 2010, J BIOL CHEM, V285, P9740, DOI 10.1074/jbc.M109.052126; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhang ZL, 2011, PLANT CELL, V23, P396, DOI 10.1105/tpc.110.081356; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	65	18	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36471	10.1371/journal.pone.0036471	http://dx.doi.org/10.1371/journal.pone.0036471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574165	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800061
J	Rowell, JT; Servedio, MR				Rowell, Jonathan T.; Servedio, Maria R.			Vocal Communications and the Maintenance of Population Specific Songs in a Contact Zone	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; GEOGRAPHIC-VARIATION; BIRD SONG; ZEBRA FINCHES; HYBRID ZONE; DIALECTS; EVOLUTION; DISPERSAL; DIVERGENCE; BARRIERS	Bird song has been hypothesized to play a role in several important aspects of the biology of songbirds, including the generation of taxonomic diversity by speciation; however, the role that song plays in speciation within this group may be dependent upon the ability of populations to maintain population specific songs or calls in the face of gene flow and external cultural influences. Here, in an exploratory study, we construct a spatially explicit model of population movement to examine the consequences of secondary contact of populations singing distinct songs. We concentrate on two broad questions: 1) will population specific songs be maintained in a contact zone or will they be replaced by shared song, and 2) what spatial patterns in the distribution of songs may result from contact? We examine the effects of multiple factors including song-based mating preferences and movement probabilities, oblique versus paternal learning of song, and both cultural and genetic mutations. We find a variety of conditions under which population specific songs can be maintained, particularly when females have preferences for their population specific songs, and we document many distinct patterns of song distribution within the contact zone, including clines, banding, and mosaics.	[Rowell, Jonathan T.; Servedio, Maria R.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Rowell, JT (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	jtrowell@email.unc.edu	Servedio, Maria R/A-9743-2008	Servedio, Maria R/0000-0002-3965-4445	National Science Foundation [DEB 0614166]	National Science Foundation(National Science Foundation (NSF))	Funding for both authors was provided by National Science Foundation grant DEB 0614166 to MRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2005, AM NAT, V165, P449, DOI 10.1086/428595; Baker M.C., 1985, Evolution, V39, P1177, DOI 10.1111/j.1558-5646.1985.tb00461.x; BAKER MC, 1981, SCIENCE, V214, P819, DOI 10.1126/science.214.4522.819; BAKER MC, 1975, EVOLUTION, V29, P226, DOI 10.1111/j.1558-5646.1975.tb00203.x; BAKER MC, 1981, EVOLUTION, V35, P189, DOI 10.1111/j.1558-5646.1981.tb04872.x; BAKER MC, 1987, ANIM BEHAV, V35, P395, DOI 10.1016/S0003-3472(87)80263-4; BAKER MC, 1978, EVOLUTION, V32, P712, DOI 10.1111/j.1558-5646.1978.tb04624.x; BAKER MC, 1983, BEHAV ECOL SOCIOBIOL, V12, P309, DOI 10.1007/BF00302898; BAKER MC, 1982, AM ZOOL, V22, P561; Baker MC, 2008, AUK, V125, P651, DOI 10.1525/auk.2008.07111; Baker MC, 2010, J AVIAN BIOL, V41, P50, DOI 10.1111/j.1600-048X.2009.04801.x; BAPTISTA LF, 1982, AUK, V99, P537; Baptista LF, 1975, U CALIFORNIA PUBL ZO, V105, P1; Bee MA, 2000, BEHAV ECOL, V11, P169, DOI 10.1093/beheco/11.2.169; Beecher MD, 2000, ANIM BEHAV, V59, P29, DOI 10.1006/anbe.1999.1304; Bell DA, 1998, ANIM BEHAV, V55, P939, DOI 10.1006/anbe.1997.0644; Bradbury Jack W., 1998, pi; Catchpole C., 1995, BIRD SONG BIOL THEME; CLAYTON NS, 1990, PHILOS T R SOC B, V330, P351, DOI 10.1098/rstb.1990.0205; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1368, DOI 10.1073/pnas.89.4.1368; Doutrelant C, 2000, BEHAV ECOL SOCIOBIOL, V48, P119, DOI 10.1007/s002650000220; Ellers J, 2003, ANIM BEHAV, V65, P671, DOI 10.1006/anbe.2003.2081; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GOODFELLOW DJ, 1986, ANIM BEHAV, V34, P1579, DOI 10.1016/S0003-3472(86)80233-0; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; Grant PR, 1997, BIOL J LINN SOC, V60, P317; Grant PR, 1997, AM NAT, V149, P1, DOI 10.1086/285976; Haavie J, 2004, J EVOLUTION BIOL, V17, P227, DOI 10.1111/j.1420-9101.2003.00682.x; HAFNER DJ, 1985, EVOLUTION, V39, P687, DOI 10.1111/j.1558-5646.1985.tb00405.x; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; Irwin DE, 2000, EVOLUTION, V54, P998; JENKINS PF, 1978, ANIM BEHAV, V26, P50, DOI 10.1016/0003-3472(78)90007-6; Koetz AH, 2007, ANIM BEHAV, V74, P1019, DOI 10.1016/j.anbehav.2006.11.035; Lachlan RF, 1999, P ROY SOC B-BIOL SCI, V266, P701, DOI 10.1098/rspb.1999.0692; Lachlan RF, 2003, J EVOLUTION BIOL, V16, P1084, DOI 10.1046/j.1420-9101.2003.00624.x; Lachlan RF, 2004, EVOLUTION, V58, P2049; Liu IA, 2008, CONDOR, V110, P102, DOI 10.1525/cond.2008.110.1.102; LOUGHEED SC, 1993, CONDOR, V95, P889, DOI 10.2307/1369426; LOUGHEED SC, 1992, EVOLUTION, V46, P1443, DOI 10.1111/j.1558-5646.1992.tb01135.x; LYNCH A, 1989, AM NAT, V133, P634, DOI 10.1086/284942; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; MARLER P., 1962, CONDOR, V64, P368, DOI 10.2307/1365545; Martens Jochen, 1996, P221; MILLER DB, 1979, NATURE, V280, P389, DOI 10.1038/280389a0; MUNDINGER P, 1975, CONDOR, V77, P407, DOI 10.2307/1366088; Mundinger PC., 1982, ACOUSTIC COMMUNICATI, Vvol. 2, P147; MUNN CA, 1986, NATURE, V319, P143, DOI 10.1038/319143a0; Nelson DA, 2004, ANIM BEHAV, V68, P395, DOI 10.1016/j.anbehav.2003.08.027; Nelson DA, 2000, ANIM BEHAV, V60, P887, DOI 10.1006/anbe.2000.1560; NOTTEBOHM F, 1969, CONDOR, V71, P299, DOI 10.2307/1366306; Olofsson H, 2011, EVOL IN PRESS; Olofsson H, 2008, BEHAV ECOL, V19, P594, DOI 10.1093/beheco/arn002; Patten MA, 2004, EVOLUTION, V58, P2144; PETRINOVICH L, 1981, Z TIERPSYCHOL, V57, P1; PETRINOVICH L, 1981, EVOLUTION, V35, P180, DOI 10.1111/j.1558-5646.1981.tb04871.x; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Ribot RFH, 2009, ANIM BEHAV, V77, P581, DOI 10.1016/j.anbehav.2008.10.029; Riebel K, 2000, P ROY SOC B-BIOL SCI, V267, P2553, DOI 10.1098/rspb.2000.1320; Rowell JT, 2010, AM NAT, V176, P638, DOI 10.1086/656494; Rowell JT, 2009, THEOR POPUL BIOL, V75, P216, DOI 10.1016/j.tpb.2009.03.001; Sattler GD, 2007, AUK, V124, P926, DOI 10.1642/0004-8038(2007)124[926:AAOSAA]2.0.CO;2; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEARCY WA, 1992, NATO ADV SCI I A-LIF, V228, P175; Searcy WA, 2002, AM NAT, V159, P221, DOI 10.1086/338509; Searcy WA, 1997, CONDOR, V99, P651, DOI 10.2307/1370477; Secondi J, 2003, BIOL J LINN SOC, V80, P507, DOI 10.1046/j.1095-8312.2003.00248.x; Sewall KB, 2011, BEHAV ECOL SOCIOBIOL, V65, P157, DOI 10.1007/s00265-010-1022-0; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Soha JA, 2004, BEHAV ECOL, V15, P636, DOI 10.1093/beheco/arh055; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; THIELCKE G, 1970, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V8, P309; WEISMAN R, 1994, BEHAVIOUR, V128, P15, DOI 10.1163/156853994X00028; WILLIAMS JM, 1990, J THEOR BIOL, V145, P487, DOI 10.1016/S0022-5193(05)80483-7; Wilson PL, 2000, CONDOR, V102, P355, DOI 10.1650/0010-5422(2000)102[0355:SASTSI]2.0.CO;2; Witte K, 2003, ANIM BEHAV, V65, P195, DOI 10.1006/anbe.2002.2009; Wright TF, 2005, MOL ECOL, V14, P1197, DOI 10.1111/j.1365-294X.2005.02466.x; Wright TF, 2001, ETHOLOGY, V107, P111, DOI 10.1046/j.1439-0310.2001.00632.x; Wright TF, 2001, P ROY SOC B-BIOL SCI, V268, P609, DOI 10.1098/rspb.2000.1403; Wright TF, 2008, ANIM BEHAV, V76, P1017, DOI 10.1016/j.anbehav.2008.03.025	79	12	12	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35257	10.1371/journal.pone.0035257	http://dx.doi.org/10.1371/journal.pone.0035257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574116	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800012
J	Valdivia, N; Gollety, C; Migne, A; Davoult, D; Molis, M				Valdivia, Nelson; Gollety, Claire; Migne, Aline; Davoult, Dominique; Molis, Markus			Stressed but Stable: Canopy Loss Decreased Species Synchrony and Metabolic Variability in an Intertidal Hard-Bottom Community	PLOS ONE			English	Article							COMPENSATORY DYNAMICS; BIODIVERSITY; DISTURBANCE; HABITAT; BIOMASS; COMPETITION; ALGAE; COEXISTENCE; STABILITY; KELP	The temporal stability of aggregate community properties depends on the dynamics of the component species. Since species growth can compensate for the decline of other species, synchronous species dynamics can maintain stability (i.e. invariability) in aggregate properties such as community abundance and metabolism. In field experiments we tested the separate and interactive effects of two stressors associated with storminess-loss of a canopy-forming species and mechanical disturbances-on species synchrony and community respiration of intertidal hard-bottom communities on Helgoland Island, NE Atlantic. Treatments consisted of regular removal of the canopy-forming seaweed Fucus serratus and a mechanical disturbance applied once at the onset of the experiment in March 2006. The level of synchrony in species abundances was assessed from estimates of species percentage cover every three months until September 2007. Experiments at two sites consistently showed that canopy loss significantly reduced species synchrony. Mechanical disturbance had neither separate nor interactive effects on species synchrony. Accordingly, in situ measurements of CO2-fluxes showed that canopy loss, but not mechanical disturbances, significantly reduced net primary productivity and temporal variation in community respiration during emersion periods. Our results support the idea that compensatory dynamics may stabilise aggregate properties. They further suggest that the ecological consequences of the loss of a single structurally important species may be stronger than those derived from smaller-scale mechanical disturbances in natural ecosystems.	[Valdivia, Nelson] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Valdivia, Nelson] Univ Catolica Norte, Fac Ciencias Mar, CEAZA, Coquimbo, Chile; [Gollety, Claire; Migne, Aline; Davoult, Dominique] Univ Paris 06, Stn Biol Roscoff, Roscoff, France; [Gollety, Claire; Migne, Aline; Davoult, Dominique] CNRS, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Gollety, Claire] Univ St Andrews, Scottish Oceans Inst, Sediment Ecol Res Grp, St Andrews, Fife, Scotland; [Molis, Markus] Biol Anstalt Helgoland, Alfred Wegener Inst Polar & Marine Res, Sect Funct Ecol, Helgoland, Germany	Universidad Austral de Chile; Universidad Catolica del Norte; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; University of St Andrews; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Valdivia, N (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	nelson.valdivia@uach.cl	Gollety, Claire/D-6743-2011; Davoult, dominique/D-5932-2012; Valdivia, Nelson A/C-3613-2009	Davoult, dominique/0000-0001-8678-3998; Valdivia, Nelson A/0000-0002-5394-2072	European Community [GOCE-CT-2003-505446]; Alfred Wegener Institute for Polar and Marine Research; Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [3100014]	European Community(European Commission); Alfred Wegener Institute for Polar and Marine Research; Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Research was supported by the Sustainable Development, Global Change and Ecosystems Programme of the European Community's Sixth Framework Programme (contract # GOCE-CT-2003-505446), and by funds from the Alfred Wegener Institute for Polar and Marine Research and the Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT, grant # 3100014) to NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali A, 2007, CLIMATE CHANGE 2007; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bartsch I, 2004, HELGOLAND MAR RES, V58, P289, DOI 10.1007/s10152-004-0194-2; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Benedetti-Cecchi L, 2000, OECOLOGIA, V123, P265, DOI 10.1007/s004420051013; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.1890/0012-9658(1999)080[2711:TTRCOP]2.0.CO;2; Bertocci I, 2010, MAR ECOL PROG SER, V414, P107, DOI 10.3354/meps08729; Box GE., 1978, STAT EXPT; Bulleri F, 2012, OIKOS, V121, P1801, DOI 10.1111/j.1600-0706.2011.19967.x; Burnaford JL, 2004, ECOLOGY, V85, P2837, DOI 10.1890/03-0113; Cardinale BJ, 2002, ECOLOGY, V83, P1915; Cavanaugh KC, 2011, MAR ECOL PROG SER, V429, P1, DOI 10.3354/meps09141; Cavanaugh KC, 2010, MAR ECOL PROG SER, V403, P13, DOI 10.3354/meps08467; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Connell J.H., 1985, P125; Connell SD, 2003, MAR BIOL, V142, P1065, DOI 10.1007/s00227-003-1021-z; Connell SD, 2003, OECOLOGIA, V137, P97, DOI 10.1007/s00442-003-1312-6; Connell Sean D., 2007, P556; Connolly SR, 2003, ECOLOGY, V84, P2979, DOI 10.1890/02-0347; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Downing AL, 2008, ECOLOGY, V89, P3204, DOI 10.1890/07-1652.1; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Dunstan PK, 2006, ECOLOGY, V87, P2842, DOI 10.1890/0012-9658(2006)87[2842:LRCVAI]2.0.CO;2; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Ernest SKM, 2009, ECOL LETT, V12, P507, DOI 10.1111/j.1461-0248.2009.01305.x; Ernest SKM, 2001, ECOLOGY, V82, P2118, DOI 10.2307/2680220; Eschweiler N, 2009, HELGOLAND MAR RES, V63, P119, DOI 10.1007/s10152-008-0131-x; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Gollety C, 2008, J PHYCOL, V44, P1146, DOI 10.1111/j.1529-8817.2008.00569.x; Gomez I, 2011, MAR ECOL PROG SER, V422, P77, DOI 10.3354/meps08937; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Irving AD, 2006, OECOLOGIA, V148, P491, DOI 10.1007/s00442-006-0389-0; JANKE K, 1990, HELGOLANDER MEERESUN, V44, P219, DOI 10.1007/BF02365466; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Kiirikki M, 1996, EUR J PHYCOL, V31, P61, DOI 10.1080/09670269600651201; Klug JL, 2000, ECOLOGY, V81, P387; Kohlmeier D, 2009, PHYSL REAKTIONEN UNT; Kornmann P, 1993, MEERESALGEN HELGOLAN; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; LITTLER MM, 1980, AM NAT, V116, P25, DOI 10.1086/283610; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Micheli F, 1999, OIKOS, V85, P161, DOI 10.2307/3546802; Migne A, 2002, MAR BIOL, V140, P865, DOI 10.1007/s00227-001-0741-1; Molis M, 2011, J ECOL, V99, P807, DOI 10.1111/j.1365-2745.2011.01800.x; Moore P, 2007, MAR ECOL PROG SER, V334, P11, DOI 10.3354/meps334011; Morrow K, 2008, MAR ECOL PROG SER, V361, P119, DOI 10.3354/meps07371; MUNDA IM, 1982, HELGOLANDER MEERESUN, V35, P131, DOI 10.1007/BF01997550; Nielsen KJ, 2007, ENCY TIDEPOOLS ROCKY, P10; Polley HW, 2007, OIKOS, V116, P2044, DOI 10.1111/j.2007.0030-1299.16080.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; Rowe RJ, 2011, ECOLOGY, V92, P1366, DOI 10.1890/10-1634.1; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Schiel DR, 2011, J EXP MAR BIOL ECOL, V407, P108, DOI 10.1016/j.jembe.2011.07.004; SCHLUTER D, 1984, ECOLOGY, V65, P998, DOI 10.2307/1938071; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Steiner CF, 2005, OIKOS, V110, P556, DOI 10.1111/j.0030-1299.2005.13665.x; Svensson JR, 2007, ECOLOGY, V88, P830, DOI 10.1890/06-0976; Tait LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026986; Taper ML, 1996, AM NAT, V147, P1072, DOI 10.1086/285893; Thibaut L, 2011, ECOLOGY; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Underwood AJ, 2006, J EXP MAR BIOL ECOL, V330, P221, DOI 10.1016/j.jembe.2005.12.029; Valdivia N, 2009, AQUAT BIOL, V4, P263, DOI 10.3354/ab00114; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; White EP, 2004, AM NAT, V164, P670, DOI 10.1086/424766; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	82	19	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36541	10.1371/journal.pone.0036541	http://dx.doi.org/10.1371/journal.pone.0036541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574181	Green Published, gold			2022-12-25	WOS:000305349800078
J	Xu, J; Wang, SX; Viollet, B; Zou, MH				Xu, Jian; Wang, Shuangxi; Viollet, Benoit; Zou, Ming-Hui			Regulation of the Proteasome by AMPK in Endothelial Cells: The Role of O-GlcNAc Transferase (OGT)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LINKED N-ACETYLGLUCOSAMINE; IN-VIVO; DEPENDENT DEGRADATION; UBIQUITIN SYSTEM; CYCLOHYDROLASE-I; CELLULAR-ENERGY; 26S PROTEASOME; DYSFUNCTION; PATHWAY	26S proteasome is a macromolecular multi-subunit complex responsible for recognizing, unfolding, and ultimately destroying proteins. It remains poorly understood how 26S proteasome activity is regulated. The present study was to investigate if AMP-activated protein kinase (AMPK) functions as a physiological suppressor of the 26S proteasome in endothelial cells. 26S proteasome assembly, activity, and O-GlcNAcylation of P700 were assayed in cultured human umbilical vein endothelial cells (HUVEC) and mouse aortas isolated from C57BL6 wild type and AMPK alpha 2 knockout mice with or without being exposed to selective AMPK activators or inhibitors. Pharmacological and genetic activation of AMPK effectively suppresses 26S proteasomes in endothelial cells. Conversely, inactivation of AMPK either pharmacologically or genetically increases 26S proteasome activity; furthermore, the inactivation decreases the O-GlcNAcylation of PA700/S10B (the regulatory complex in 26S proteasomes) and increases the assembly of 26S proteasomes. In contrast, AMPK activation increases levels of O-GlcNAcylated PA700/S10B, likely through enhanced association of PA700 with O-GlcNAc transferase (OGT), the enzyme that catalyzes protein O-GlcNAcylation. Finally, aortas from AMPK-KO vs wild type mice exhibit elevated 26S proteasome activity in parallel with decreased PA700/S10B O-GlcNAcylation and PA700/S10B-OGT association. Taken together, we conclude that AMPK functions as a physiological suppressor of 26S proteasomes.	[Xu, Jian] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol, Oklahoma City, OK USA; [Viollet, Benoit] Inst Cochin, INSERM, U1016, Paris, France; [Viollet, Benoit] CNRS, UMR 8104, Paris, France; [Viollet, Benoit] Univ Paris 05, Paris, France	University of Oklahoma System; University of Oklahoma Health Sciences Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Xu, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol, Oklahoma City, OK USA.	ming-hui-zou@ouhsc.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	National Institutes of Health [HL079584, HL074399, HL080499, HL105157, HL110488]; American Diabetes Association (ADA); Warren Chair in Diabetes Research of the University of Oklahoma Health Sciences Center; National Established Investigator Award of American Heart Association; Scientist Development Grant (AHA) [10SDG2600164]; Center of Biomedical Research Excellence (COBRE) grant (NIH/NCRR) [5P20RR024215-5]; Junior Faculty Award (ADA) [1-12-JF-58]; Oklahoma Center for Advancement of Science and Technology [HR11-200]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL080499, R01HL110488, R01HL079584, R01HL105157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association (ADA)(American Diabetes Association); Warren Chair in Diabetes Research of the University of Oklahoma Health Sciences Center; National Established Investigator Award of American Heart Association; Scientist Development Grant (AHA); Center of Biomedical Research Excellence (COBRE) grant (NIH/NCRR); Junior Faculty Award (ADA); Oklahoma Center for Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants (HL079584, HL074399, HL080499, HL105157, and HL110488), a research award from the American Diabetes Association (ADA), and funds from the Warren Chair in Diabetes Research of the University of Oklahoma Health Sciences Center (all to MHZ). MHZ is a recipient of the National Established Investigator Award of American Heart Association (AHA). JX is supported by a Scientist Development Grant (AHA, 10SDG2600164), a Center of Biomedical Research Excellence (COBRE) grant (NIH/NCRR: 5P20RR024215-5), a Junior Faculty Award (ADA, 1-12-JF-58), and a research award from the Oklahoma Center for Advancement of Science and Technology (HR11-200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Desterro JMP, 2000, CELL MOL LIFE SCI, V57, P1207, DOI 10.1007/PL00000760; Edwards CM, 2009, AM J HEMATOL, V84, P268, DOI 10.1002/ajh.21374; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Fekete MR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-114; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012; Hardie DG, 2007, SCIENCE, V315, P1671, DOI 10.1126/science.1140737; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Li C, 2008, CURR OPIN LIPIDOL, V19, P541, DOI 10.1097/MOL.0b013e32830f4a44; Li Y, 2007, BIOCHEMISTRY-US, V46, P13163, DOI 10.1021/bi700694c; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; Madura K, 2009, NATURE, V459, P787, DOI 10.1038/459787a; Magill L, 2004, HAEMATOLOGICA, V89, P1428; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; Marshall Stephen, 2006, Sci STKE, V2006, pre7; McCarty MF, 2005, MED HYPOTHESES, V64, P1211, DOI 10.1016/j.mehy.2004.01.042; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Poredos P, 2002, PATHOPHYSIOL HAEMO T, V32, P274, DOI 10.1159/000073580; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sherman D L, 1997, Cardiologia, V42, P177; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Whitsett J, 2007, ARTERIOSCL THROM VAS, V27, P2340, DOI 10.1161/ATVBAHA.107.153742; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029649; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zou MH, 2008, CLIN EXP PHARMACOL P, V35, P535, DOI 10.1111/j.1440-1681.2007.04851.x	59	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36717	10.1371/journal.pone.0036717	http://dx.doi.org/10.1371/journal.pone.0036717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574218	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800115
J	Tung, EKK; Wong, BYC; Yau, TO; Ng, IOL				Tung, Edmund Kwok-Kwan; Wong, Betty Yin-Chi; Yau, Tai-On; Ng, Irene Oi-Lin			Upregulation of the Wnt Co-Receptor LRP6 Promotes Hepatocarcinogenesis and Enhances Cell Invasion	PLOS ONE			English	Article							BETA-CATENIN MUTATIONS; HEPATOCELLULAR-CARCINOMA; MOLECULAR PATHOGENESIS; SIGNALING PATHWAY; EXPRESSION; OVEREXPRESSION; TARGET; VIRUS; GENES; ACTIVATION	Background: Activation of the Wnt/beta-catenin signaling pathway plays a crucial role in hepatocellular carcinoma (HCC). Low-density lipoprotein (LDL) receptor-related protein-6 (LRP6) is one of the co-receptors of the Wnt/beta-catenin pathway and forms a signaling complex with Wnt ligand and Frizzled receptor to activate downstream signaling. However, the role of LRP6 in hepatocarcinogenesis is unclear. In this study, we examined its expression and roles in human HCC. Methodology/Principal Findings: Using real-time quantitative RT-PCR, we found that LRP6 was frequently (45%) overexpressed in human HCCs (P = 0.003). In vitro studies showed that ectopic expression of LRP6 increased the protein level of beta-catenin. Moreover, overexpression of the full-length and constitutively active LRP6, respectively, activated the WNT/beta-catenin signaling pathway, as shown by the TCF/beta-catenin reporter assay. With regard to the effects of LRP6 overexpression in HCC cells, stable overexpression of the constitutively active LRP6 in BEL-7402 HCC cells enhanced cell proliferation, cell migration, and invasion in vitro as well as tumorigenicity in nude mice. Conclusions/Significance: Our findings indicate that overexpression of LRP6 contributes to the hyperactivation of the Wnt/beta-catenin signaling pathway in human HCCs and suggest it may play a role in hepatocarcinogenesis.	[Tung, Edmund Kwok-Kwan; Ng, Irene Oi-Lin] Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China; [Tung, Edmund Kwok-Kwan; Wong, Betty Yin-Chi; Yau, Tai-On; Ng, Irene Oi-Lin] Univ Hong Kong, Dept Pathol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Tung, EKK (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China.	iolng@hku.hk		Ng, Irene Oi-lin/0000-0001-7532-2029	Research Grants Council (RGC) General Research Fund [HKU 7615/06M]; National Natural Science Foundation of China (NSFC)/RGC Joint Research Scheme grant [N_HKU 716/06]; RGC Collaborative Research Fund [HKU 1/06C, HKU 7/CRG/09]	Research Grants Council (RGC) General Research Fund; National Natural Science Foundation of China (NSFC)/RGC Joint Research Scheme grant(National Natural Science Foundation of China (NSFC)); RGC Collaborative Research Fund(Hong Kong Research Grants Council)	The study was supported by the Research Grants Council (RGC) General Research Fund (HKU 7615/06M), a National Natural Science Foundation of China (NSFC)/RGC Joint Research Scheme grant (N_HKU 716/06), and the RGC Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09). I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beagle B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011821; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Bjorklund P, 2007, PLOS MED, V4, P1829, DOI 10.1371/journal.pmed.0040328; Brennan K, 2004, ONCOGENE, V23, P4873, DOI 10.1038/sj.onc.1207642; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Devereux TR, 2001, MOL CARCINOGEN, V31, P68, DOI 10.1002/mc.1041; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guo Y, 2008, CLIN ORTHOP RELAT R, V466, P2039, DOI 10.1007/s11999-008-0344-y; Hoang BH, 2004, INT J CANCER, V109, P106, DOI 10.1002/ijc.11677; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Hu L, 2004, CANCER GENET CYTOGEN, V148, P80, DOI 10.1016/S0165-4608(03)00206-1; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; Ishizaki Y, 2004, INT J ONCOL, V24, P1077; Janssens N, 2004, TUMOR BIOL, V25, P161, DOI 10.1159/000081098; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Kim YD, 2008, J GASTROEN HEPATOL, V23, P110, DOI 10.1111/j.1440-1746.2007.05250.x; Kirikoshi H, 2001, INT J ONCOL, V19, P767; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Li Yonghe, 2005, Future Oncol, V1, P673, DOI 10.2217/14796694.1.5.673; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Merle P, 2005, J HEPATOL, V43, P854, DOI 10.1016/j.jhep.2005.05.018; Merle P, 2004, GASTROENTEROLOGY, V127, P1110, DOI 10.1053/j.gastro.2004.07.009; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Park JY, 2005, LIVER INT, V25, P70, DOI 10.1111/j.1478-3231.2004.0995.x; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Takigawa Y, 2008, CURR DRUG TARGETS, V9, P1013, DOI 10.2174/138945008786786127; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Tommasi S, 2007, CURR PHARM DESIGN, V13, P3279, DOI 10.2174/138161207782360663; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wong CM, 2008, LIVER INT, V28, P160, DOI 10.1111/j.1478-3231.2007.01637.x; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Zender L, 2008, ONKOLOGIE, V31, P550, DOI 10.1159/000151586; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhang Z, 2006, NEUROPATH APPL NEURO, V32, P615, DOI 10.1111/j.1365-2990.2006.00770.x	41	47	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36565	10.1371/journal.pone.0036565	http://dx.doi.org/10.1371/journal.pone.0036565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570728	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343400044
J	Kishikawa, J; Yokoyama, K				Kishikawa, Jun-ichi; Yokoyama, Ken			Reconstitution of Vacuolar-type Rotary H+-ATPase/Synthase from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; CENTRAL STALK; PERIPHERAL STALK; SUBUNIT; ROTATION; HYDROLYSIS; MOTOR; V-1	Vacuolar-type rotary H+-ATPase/synthase (VoV1) from Thermus thermophilus, composed of nine subunits, A, B, D, F, C, E, G, I, and L, has been reconstituted from individually isolated V-1 (A(3)B(3)D(1)F(1)) and V-o (C(1)E(2)G(2)I(1)L(12)) subcomplexes in vitro. A(3)B(3)D and A(3)B(3) also reconstituted with V-o, resulting in a holoenzyme-like complexes. However, A(3)B(3)D-V-o and A(3)B(3)-V-o did not show ATP synthesis and dicyclohexylcarbodiimide-sensitive ATPase activity. The reconstitution process was monitored in real time by fluorescence resonance energy transfer (FRET) between an acceptor dye attached to subunit F or D in V-1 or A(3)B(3)D and a donor dye attached to subunit C in V-o. The estimated dissociation constants K-d for VoV1 and A(3)B(3)D-V-o were similar to 0.3 and similar to 1 nM at 25 degrees C, respectively. These results suggest that the A(3)B(3) domain tightly associated with the two EG peripheral stalks of V-o, even in the absence of the central shaft subunits. In addition, F subunit is essential for coupling of ATP hydrolysis and proton translocation and has a key role in the stability of whole complex. However, the contribution of the F subunit to the association of A(3)B(3) with V-o is much lower than that of the EG peripheral stalks.	[Kishikawa, Jun-ichi; Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan	Kyoto Sangyo University	Yokoyama, K (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan.	yokoken@cc.kyoto-su.ac.jp		Kishikawa, Jun-ichi/0000-0003-3913-7330; Yokoyama, Ken/0000-0002-6813-1096	Ministry of Education, Science, Sports and Culture of Japan [21370042, 24370059]; TPRP [B-37]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); TPRP	This work was partly supported by Grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (No. 21370042 and 24370059, to K. Y.) and TPRP (B-37, to K. Y.).	Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Imamura H, 2006, J BIOL CHEM, V281, P38582, DOI 10.1074/jbc.M608253200; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Kakinuma Y, 1999, J BIOENERG BIOMEMBR, V31, P7, DOI 10.1023/A:1005499126939; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Parra KJ, 1996, J BIOL CHEM, V271, P19592, DOI 10.1074/jbc.271.32.19592; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PUOPOLO K, 1990, J BIOL CHEM, V265, P14836; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Tamakoshi M, 1997, J BACTERIOL, V179, P4811, DOI 10.1128/jb.179.15.4811-4814.1997; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; TSUTSUMI S, 1991, BIOCHIM BIOPHYS ACTA, V1098, P13, DOI 10.1016/0005-2728(91)90003-7; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 1998, NATURE, V393, P29, DOI 10.1038/29908; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; YOKOYAMA K, 1990, J BIOL CHEM, V265, P21946; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Yokoyama K, 2000, J BIOL CHEM, V275, P13955, DOI 10.1074/jbc.275.18.13955	30	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24597	24603		10.1074/jbc.M112.367813	http://dx.doi.org/10.1074/jbc.M112.367813			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22582389	Green Published, hybrid			2022-12-25	WOS:000306651100054
J	Cheng, XW; Liu, Y; Chu, H; Kao, HY				Cheng, Xiwen; Liu, Yu; Chu, Hao; Kao, Hung-Ying			Promyelocytic Leukemia Protein (PML) Regulates Endothelial Cell Network Formation and Migration in Response to Tumor Necrosis Factor alpha (TNF alpha) and Interferon alpha (IFN alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; INFLAMMATORY ANGIOGENESIS; SIGNAL TRANSDUCER; INDUCED APOPTOSIS; KINASE PATHWAY; RAR-ALPHA; STAT1; ACTIVATION; RECEPTOR; INDUCTION	Promyelocytic leukemia protein (PML) is a tumor suppressor that is highly expressed in vascular endothelium and inflamed tissues, yet its role in inflammation-associated cytokine-regulated angiogenesis and underlying mechanism remains largely unclear. We show that tumor necrosis factor alpha (TNF alpha) and interferon alpha (IFN alpha) stimulate PML expression while suppressing EC network formation and migration, two key events during angiogenesis. By a knockdown approach, we demonstrate that PML is indispensable for TNF alpha- and IFN alpha-mediated inhibition of EC network formation. We further demonstrate that signal transducer and activator of transcription 1 (STAT1) binds PML promoter and that is an important regulator of PML expression. Knockdown of STAT1 reduces endogenous PML and blocks TNF alpha- and IFN alpha-induced PML accumulation and relieves TNF alpha- and IFN alpha-mediated inhibition of EC network formation. Our data also indicate that PML regulates EC migration, in part, by modulating expression of downstream genes, such as negatively regulating integrin beta 1 (ITGB1). In addition, knockdown of STAT1 or PML alleviates TNF alpha- and IFN alpha-mediated inhibition of ITGB1 expression. Antibody blockade demonstrates that ITGB1 is functionally important for PML- and STAT1-regulated EC migration. Taken together, our data provide novel mechanistic insights that PML functions as a negative regulator in EC network formation and migration.	[Cheng, Xiwen; Liu, Yu; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Cheng, Xiwen; Liu, Yu; Kao, Hung-Ying] CWRU, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Cheng, Xiwen; Liu, Yu; Kao, Hung-Ying] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Chu, Hao] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Cheng, Xiwen/B-8385-2014; Pinheiro, Maísa/E-7424-2012	Cheng, Xiwen/0000-0001-7398-1522; 	National Institutes of Health [R01 DK078965, HL093269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, R01 DK078965 and HL093269 (to H. Y. K.).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Albini A, 2005, CANCER RES, V65, P10637, DOI 10.1158/0008-5472.CAN-05-3473; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Breau MA, 2009, DEVELOPMENT, V136, P2791, DOI 10.1242/dev.031419; Caporali A, 2008, CIRC RES, V103, pE15, DOI 10.1161/CIRCRESAHA.108.177386; Caraglia M, 1999, CELL DEATH DIFFER, V6, P773, DOI 10.1038/sj.cdd.4400550; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Crowder C, 2005, BLOOD, V105, P1280, DOI 10.1182/blood-2004-04-1614; de Totero D, 2008, BLOOD, V111, P517, DOI 10.1182/blood-2007-04-087882; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dougan M, 2011, J CLIN INVEST, V121, P2436, DOI 10.1172/JCI44796; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Feng Gang, 2010, BMC Res Notes, V3, P10, DOI 10.1186/1756-0500-3-10; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gambaryan S, 2010, J BIOL CHEM, V285, P18352, DOI 10.1074/jbc.M109.077602; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lehembre F, 2001, ONCOGENE, V20, P1, DOI 10.1038/sj.onc.1204063; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mahboubi K, 2002, J BIOL CHEM, V277, P8012, DOI 10.1074/jbc.M107542200; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; Mbow ML, 2004, TRENDS BIOTECHNOL, V22, P395, DOI 10.1016/j.tibtech.2004.06.002; Medina J, 2004, HEPATOLOGY, V39, P1185, DOI 10.1002/hep.20193; MIELE ME, 1994, EXP CELL RES, V214, P231, DOI 10.1006/excr.1994.1253; Mottet D, 2007, CIRC RES, V101, P1237, DOI 10.1161/CIRCRESAHA.107.149377; Nakao S, 2003, J IMMUNOL, V170, P5704, DOI 10.4049/jimmunol.170.11.5704; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Pradhan M, 2010, J BIOL CHEM, V285, P31100, DOI 10.1074/jbc.M110.155309; Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521; Reineke Erin L, 2009, Cancer Ther, V7, P219; Reineke EL, 2010, J BIOL CHEM, V285, P9485, DOI 10.1074/jbc.M109.063362; Reineke EL, 2009, INT J BIOL SCI, V5, P366; ROSENBAUM JT, 1988, AM J PATHOL, V133, P47; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stadler M, 1995, ONCOGENE, V11, P2565; SUNDERKOTTER C, 1990, AM J PATHOL, V137, P511; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Team RDC, 2009, R LANG ENV STAT COMP; TERRIS B, 1995, CANCER RES, V55, P1590; Uddin S, 2000, J BIOL CHEM, V275, P27634; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wong LH, 2002, J BIOL CHEM, V277, P19408, DOI 10.1074/jbc.M111302200; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Xie B, 2001, J BIOL CHEM, V276, P19512, DOI 10.1074/jbc.M009063200	58	29	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23356	23367		10.1074/jbc.M112.340505	http://dx.doi.org/10.1074/jbc.M112.340505			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589541	hybrid, Green Published			2022-12-25	WOS:000306511300009
J	McFarlan, JT; Yoshida, Y; Jain, SS; Han, XX; Snook, LA; Lally, J; Smith, BK; Glatz, JFC; Luiken, JJFP; Sayer, RA; Tupling, AR; Chabowski, A; Holloway, GP; Bonen, A				McFarlan, Jay T.; Yoshida, Yuko; Jain, Swati S.; Han, Xioa-Xia; Snook, Laelie A.; Lally, James; Smith, Brennan K.; Glatz, Jan F. C.; Luiken, Joost J. F. P.; Sayer, Ryan A.; Tupling, A. Russell; Chabowski, Adrian; Holloway, Graham P.; Bonen, Arend			In Vivo, Fatty Acid Translocase (CD36) Critically Regulates Skeletal Muscle Fuel Selection, Exercise Performance, and Training-induced Adaptation of Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; INSULIN-RESISTANCE; PALMITATE OXIDATION; GLUCOSE-TRANSPORT; LIPID-METABOLISM; BIOCHEMICAL ADAPTATIONS; MITOCHONDRIAL FAT/CD36; RESPIRATORY CAPACITY; GLYCOGEN UTILIZATION; SUBMAXIMAL EXERCISE	For similar to 40 years it has been widely accepted that (i) the exercise-induced increase in muscle fatty acid oxidation( FAO) is dependent on the increased delivery of circulating fatty acids, and (ii) exercise training-induced FAO up-regulation is largely attributable to muscle mitochondrial biogenesis. These long standing concepts were developed prior to the recent recognition that fatty acid entry into muscle occurs via a regulatable sarcolemmal CD36-mediated mechanism. We examined the role of CD36 in muscle fuel selection under basal conditions, during a metabolic challenge (exercise), and after exercise training. We also investigated whether CD36 overexpression, independent of mitochondrial changes, mimicked exercise training-induced FAO up-regulation. Under basal conditions CD36-KO versus WT mice displayed reduced fatty acid transport (-21%) and oxidation (-25%), intramuscular lipids (less than or equal to -31%), and hepatic glycogen (-20%); but muscle glycogen, VO2max, and mitochondrial content and enzymes did not differ. In acutely exercised (78% VO2max) CD36-KO mice, fatty acid transport (-41%), oxidation (-37%), and exercise duration (-44%) were reduced, whereas muscle and hepatic glycogen depletions were accelerated by 27-55%, revealing 2-fold greater carbohydrate use. Exercise training increased mtDNA and beta-hydroxyacyl-CoA dehydrogenase similarly in WT and CD36-KO muscles, but FAO was increased only in WT muscle (+90%). Comparable CD36 increases, induced by exercise training (+44%) or by CD36 overexpression (+41%), increased FAO similarly (84-90%), either when mitochondrial biogenesis and FAO enzymes were up-regulated (exercise training) or when these were unaltered(CD36 overexpression). Thus, sarcolemmal CD36 has a key role in muscle fuel selection, exercise performance, and training-induced muscle FAO adaptation, challenging long held views of mechanisms involved in acute and adaptive regulation of muscle FAO.	[McFarlan, Jay T.; Yoshida, Yuko; Jain, Swati S.; Han, Xioa-Xia; Snook, Laelie A.; Lally, James; Smith, Brennan K.; Holloway, Graham P.; Bonen, Arend] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Sayer, Ryan A.; Tupling, A. Russell] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Chabowski, Adrian] Med Univ Bialystok, Dept Physiol, PL-15222 Bialystok, Poland	University of Guelph; Maastricht University; University of Waterloo; Medical University of Bialystok	Bonen, A (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	arend.bonen@gmail.com	; Chabowski, Adrian/T-2225-2018	Tupling, A. Russell/0000-0002-3895-6767; Chabowski, Adrian/0000-0002-7407-8156	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; Canada Research Chair program; Medical University of Bialystok [3-18950]; Vitamin Scholarship; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research Master's Award; Frederick Banting and Charles Best Canada Graduate Scholarship	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canada Research Chair program(Canada Research Chairs); Medical University of Bialystok; Vitamin Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research Master's Award(Canadian Institutes of Health Research (CIHR)); Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Natural Sciences and Engineering Research Council, the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, and the Canada Research Chair program and Medical University of Bialystok Grant 3-18950.; Supported by a Vitamin Scholarship.; Supported by a graduate scholarship from the Natural Sciences and Engineering Research Council of Canada.; Supported by a Canadian Institutes of Health Research Master's Award and a Frederick Banting and Charles Best Canada Graduate Scholarship.	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Alkhateeb H, 2007, AM J PHYSIOL-ENDOC M, V293, pE783, DOI 10.1152/ajpendo.00685.2006; Alkhateeb H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1056, DOI 10.1152/ajpendo.90908.2008; BALDWIN KM, 1972, AM J PHYSIOL, V222, P373, DOI 10.1152/ajplegacy.1972.222.2.373; Benton CR, 2010, DIABETOLOGIA, V53, P2008, DOI 10.1007/s00125-010-1773-1; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Benton CR, 2008, PHYSIOL GENOMICS, V35, P45, DOI 10.1152/physiolgenomics.90217.2008; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Bonen A, 2000, AM J PHYSIOL-ENDOC M, V278, pE1067, DOI 10.1152/ajpendo.2000.278.6.E1067; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; Bruce CR, 2006, AM J PHYSIOL-ENDOC M, V291, pE99, DOI 10.1152/ajpendo.00587.2005; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Clarke DC, 2004, PHYSIOL GENOMICS, V17, P31, DOI 10.1152/physiolgenomics.00190.2003; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Dyck DJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE778, DOI 10.1152/ajpendo.2000.278.5.E778; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE179, DOI 10.1152/ajpendo.00282.2007; FITTS RH, 1975, AM J PHYSIOL, V228, P1029, DOI 10.1152/ajplegacy.1975.228.4.1029; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Habets DDJ, 2007, BIOCHEM BIOPH RES CO, V355, P204, DOI 10.1016/j.bbrc.2007.01.141; HAGENFELDT L, 1979, DIABETES, V28, P66, DOI 10.2337/diab.28.1.S66; Han XX, 2007, AM J PHYSIOL-ENDOC M, V293, pE566, DOI 10.1152/ajpendo.00106.2007; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; HICKSON RC, 1977, J APPL PHYSIOL, V43, P829, DOI 10.1152/jappl.1977.43.5.829; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Holloszy JO, 1996, ANNU REV NUTR, V16, P121, DOI 10.1146/annurev.nu.16.070196.001005; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Holloway GP, 2009, AM J PHYSIOL-REG I, V297, pR960, DOI 10.1152/ajpregu.91021.2008; Holloway GP, 2009, AM J PHYSIOL-ENDOC M, V296, pE738, DOI 10.1152/ajpendo.90896.2008; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Jain SS, 2009, FEBS LETT, V583, P2294, DOI 10.1016/j.febslet.2009.06.020; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V293, pE286, DOI 10.1152/ajpendo.00693.2006; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Koonen DPY, 2004, AM J PHYSIOL-ENDOC M, V286, pE1042, DOI 10.1152/ajpendo.00531.2003; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kuang M, 2004, CIRCULATION, V109, P1550, DOI 10.1161/01.CIR.0000121730.41801.12; Kuznetsov AV, 1996, EUR J BIOCHEM, V241, P909, DOI 10.1111/j.1432-1033.1996.00909.x; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Love-Gregory L, 2011, CURR OPIN CLIN NUTR, V14, P527, DOI 10.1097/MCO.0b013e32834bbac9; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; MOLE PA, 1971, J CLIN INVEST, V50, P2323, DOI 10.1172/JCI106730; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Perry CGR, 2008, APPL PHYSIOL NUTR ME, V33, P1112, DOI 10.1139/H08-097; Raney MA, 2005, AM J PHYSIOL-ENDOC M, V288, pE592, DOI 10.1152/ajpendo.00301.2004; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Roepstorff C, 2006, J PHYSIOL-LONDON, V574, P125, DOI 10.1113/jphysiol.2006.108720; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Shearer J, 2005, J APPL PHYSIOL, V99, P957, DOI 10.1152/japplphysiol.00275.2005; Shearer J, 2005, AM J PHYSIOL-ENDOC M, V289, pE508, DOI 10.1152/ajpendo.00100.2005; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watt MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE120, DOI 10.1152/ajpendo.00542.2003; Wright DC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1062, DOI 10.1152/ajpendo.00561.2004; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YOUN JH, 1991, AM J PHYSIOL, V260, pC555, DOI 10.1152/ajpcell.1991.260.3.C555	74	73	77	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23502	23516		10.1074/jbc.M111.315358	http://dx.doi.org/10.1074/jbc.M111.315358			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22584574	Green Published, hybrid			2022-12-25	WOS:000306511300022
J	Agarwal, P; Zwolanek, D; Keene, DR; Schulz, JN; Blumbach, K; Heinegard, D; Zaucke, F; Paulsson, M; Krieg, T; Koch, M; Eckes, B				Agarwal, Pallavi; Zwolanek, Daniela; Keene, Douglas R.; Schulz, Jan-Niklas; Blumbach, Katrin; Heinegard, Dick; Zaucke, Frank; Paulsson, Mats; Krieg, Thomas; Koch, Manuel; Eckes, Beate			Collagen XII and XIV, New Partners of Cartilage Oligomeric Matrix Protein in the Skin Extracellular Matrix Suprastructure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; SYSTEMIC-SCLEROSIS; CAUSE PSEUDOACHONDROPLASIA; DIFFERENTIAL EXPRESSION; ENDOPLASMIC-RETICULUM; ANCHORING FIBRILS; VII COLLAGEN; IX COLLAGEN; TENASCIN-X; COMP	The tensile and scaffolding properties of skin rely on the complex extracellular matrix (ECM) that surrounds cells, vasculature, nerves, and adnexus structures and supports the epidermis. In the skin, collagen I fibrils are the major structural component of the dermal ECM, decorated by proteoglycans and by fibril-associated collagens with interrupted triple helices such as collagens XII and XIV. Here we show that the cartilage oligomeric matrix protein (COMP), an abundant component of cartilage ECM, is expressed in healthy human skin. COMP expression is detected in the dermal compartment of skin and in cultured fibroblasts, whereas epidermis and HaCaT cells are negative. In addition to binding collagen I, COMP binds to collagens XII and XIV via their C-terminal collagenous domains. All three proteins codistribute in a characteristic narrow zone in the superficial papillary dermis of healthy human skin. Ultrastructural analysis by immunogold labeling confirmed colocalization and further revealed the presence of COMP along with collagens XII and XIV in anchoring plaques. On the basis of these observations, we postulate that COMP functions as an adapter protein in human skin, similar to its function in cartilage ECM, by organizing collagen I fibrils into a suprastructure, mainly in the vicinity of anchoring plaques that stabilize the cohesion between the upper dermis and the basement membrane zone.	[Agarwal, Pallavi; Schulz, Jan-Niklas; Blumbach, Katrin; Krieg, Thomas; Eckes, Beate] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Zwolanek, Daniela; Zaucke, Frank; Paulsson, Mats] Univ Cologne, Ctr Biochem, D-50937 Cologne, Germany; [Paulsson, Mats; Krieg, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Paulsson, Mats; Krieg, Thomas; Koch, Manuel] Univ Cologne, Ctr Mol Med CMMC, D-50937 Cologne, Germany; [Koch, Manuel] Univ Cologne, Inst Dent Res & Musculoskeletal Biol, D-50937 Cologne, Germany; [Keene, Douglas R.] Shriners Hosp Children Res Unit, Microimaging Ctr, Portland, OR 97239 USA; [Heinegard, Dick] Lund Univ, S-22184 Lund, Sweden	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Lund University	Eckes, B (corresponding author), Univ Cologne, Dept Dermatol, Kerpener Str 62, D-50937 Cologne, Germany.	beate.eckes@uni-koeln.de	Zaucke, Frank/AAT-2688-2021; Zaucke, Frank/E-2077-2012; Zwolanek, Daniela/AAN-8767-2020; Agarwal, Pallavi/AAR-6007-2020; Koch, Manuel/AAG-9914-2021	Agarwal, Pallavi/0000-0003-3139-5589; Koch, Manuel/0000-0002-2962-7814; Schulz, Jan-Niklas/0000-0001-9286-206X	Deutsche Forschungsgemeinschaft [KR558/14-1, ZA561/2-1, SFB 829]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft through Grants KR558/14-1 (to T. K. and B. E.), ZA561/2-1 (to F. Z.), and SFB 829 (to M. P. and M. K.).	Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; Birk DE, 1997, EUR J CELL BIOL, V72, P352; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; Dinser R, 2002, J CLIN INVEST, V110, P505, DOI 10.1172/JCI200214386; EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Farina G, 2009, ANN RHEUM DIS, V68, P435, DOI 10.1136/ard.2007.086850; Farina G, 2006, MATRIX BIOL, V25, P213, DOI 10.1016/j.matbio.2006.01.007; FONT B, 1993, J BIOL CHEM, V268, P25015; Font B, 1996, MATRIX BIOL, V15, P341, DOI 10.1016/S0945-053X(96)90137-7; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Giry-Lozinguez C, 1998, MATRIX BIOL, V17, P145, DOI 10.1016/S0945-053X(98)90027-0; Gordon MK, 1990, CURR OPIN CELL BIOL, V2, P833, DOI 10.1016/0955-0674(90)90080-X; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hansen U, 2011, ARTHRITIS RHEUM-US, V63, P159, DOI 10.1002/art.30073; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; Haudenschild DR, 2011, J BIOL CHEM, V286, P43250, DOI 10.1074/jbc.M111.234716; Hecht JT, 2005, MATRIX BIOL, V23, P525, DOI 10.1016/j.matbio.2004.09.006; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Hesselstrand R, 2008, ANN RHEUM DIS, V67, P1242, DOI 10.1136/ard.2007.082099; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Koch M, 2004, J BIOL CHEM, V279, P22514, DOI 10.1074/jbc.M400536200; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; KRIEG T, 1985, ANN NY ACAD SCI, V460, P375, DOI 10.1111/j.1749-6632.1985.tb51184.x; Lethias C, 2006, FEBS LETT, V580, P6281, DOI 10.1016/j.febslet.2006.10.037; Maddox BK, 1997, J BIOL CHEM, V272, P30993, DOI 10.1074/jbc.272.49.30993; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; PERLISH JS, 1988, J INVEST DERMATOL, V90, P48, DOI 10.1111/1523-1747.ep12462561; Pirog KA, 2010, HUM MOL GENET, V19, P52, DOI 10.1093/hmg/ddp466; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Saalbach A, 1997, CELL TISSUE RES, V290, P593, DOI 10.1007/s004410050964; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Schmitz M, 2006, J BIOL CHEM, V281, P32587, DOI 10.1074/jbc.M601976200; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; Sodersten F, 2005, MATRIX BIOL, V24, P376, DOI 10.1016/j.matbio.2005.06.003; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Spitznagel L, 2004, BIOCHEM J, V377, P479, DOI 10.1042/BJ20031179; Suleman F, 2012, HUM MUTAT, V33, P218, DOI 10.1002/humu.21631; Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; Veit G, 2006, J BIOL CHEM, V281, P27461, DOI 10.1074/jbc.M603147200; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; WALCHLI C, 1994, J CELL SCI, V107, P669; WALZER C, 1989, J INVEST DERMATOL, V92, P78, DOI 10.1111/1523-1747.ep13071253; WOTTON SF, 1988, FEBS LETT, V234, P79, DOI 10.1016/0014-5793(88)81307-3; Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5	68	92	95	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22549	22559		10.1074/jbc.M111.335935	http://dx.doi.org/10.1074/jbc.M111.335935			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573329	Green Published, hybrid			2022-12-25	WOS:000306495000012
J	Pitts, A; Dailey, K; Newington, JT; Chien, A; Arseneault, R; Cann, T; Thompson, LM; Cumming, RC				Pitts, Andrea; Dailey, Kyle; Newington, Jordan T.; Chien, Andrew; Arseneault, Robert; Cann, Tyler; Thompson, Leslie M.; Cumming, Robert C.			Dithiol-based Compounds Maintain Expression of Antioxidant Protein Peroxiredoxin 1 That Counteracts Toxicity of Mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CELL-DEATH; DISEASE; INDUCTION; CYSTEINE; HYPEROXIDATION; INACTIVATION; SULFIREDOXIN; PATHOGENESIS; REDUCTION	Mitochondrial dysfunction and elevated reactive oxygen species are strongly implicated in both aging and various neurodegenerative disorders, including Huntington disease (HD). Because reactive oxygen species can promote the selective oxidation of protein cysteine sulfhydryl groups to disulfide bonds we examined the spectrum of disulfide-bonded proteins that were specifically altered in a HD context. Protein extracts from PC12 cells overexpressing the amino-terminal fragment of the Huntingtin (Htt) protein with either a nonpathogenic or pathogenic polyglutamine repeat (Htt-103Q) were resolved by redox two-dimensional PAGE followed by mass spectrometry analysis. Several antioxidant proteins were identified that exhibited changes in disulfide bonding unique to Htt-103Q expressing cells. In particular, the antioxidant protein peroxiredoxin 1 (Prx1) exhibited both decreased expression and hyperoxidation in response to mutant Htt expressed in either PC12 cells or immortalized striatal cells exposed to 3-nitropropionic acid. Ectopic expression of Prx1 in PC12 cells attenuated mutant Htt-induced toxicity. In contrast, short hairpin RNA-mediated knockdown of Prx1 potentiated mHtt toxicity. Furthermore, treatment with the dithiol-based compounds dimercaptopropanol and dimercaptosuccinic acid suppressed toxicity in both HD cell models, whereas monothiol compounds were relatively ineffective. Dimercaptopropanol treatment also prevented mutant Htt-induced loss of Prx1 expression in both cell models. Our studies reveal for the first time that pathogenic Htt can affect the expression and redox state of antioxidant proteins; an event countered by specific dithiol-based compounds. These findings should provide a catalyst to explore the use of dithiol-based drugs for the treatment of neurodegenerative diseases.	[Pitts, Andrea; Dailey, Kyle; Newington, Jordan T.; Chien, Andrew; Arseneault, Robert; Cann, Tyler; Cumming, Robert C.] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Thompson, Leslie M.] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	Western University (University of Western Ontario); University of California System; University of California Irvine	Cumming, RC (corresponding author), 1151 Richmond St N, London, ON N6A 5B7, Canada.	rcummin5@uwo.ca	Cumming, Robert/G-2185-2010		Natural Sciences and Engineering Research Council (NSERC) of Canada [355806-2008]; Canada Foundation of Innovation Leaders Opportunity Fund (CFI-LOF)	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation of Innovation Leaders Opportunity Fund (CFI-LOF)(Canada Foundation for Innovation)	This work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Grant 355806-2008 and the Canada Foundation of Innovation Leaders Opportunity Fund (CFI-LOF).	AASETH J, 1995, ANALYST, V120, P853, DOI 10.1039/an9952000853; Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Bae SH, 2009, ANTIOXID REDOX SIGN, V11, P937, DOI [10.1089/ars.2008.2325, 10.1089/ARS.2008.2325]; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; CORYSLECHTA DA, 1988, J PHARMACOL EXP THER, V246, P84; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; Cumming Robert C., 2008, V476, P165, DOI 10.1007/978-1-59745-129-1_12; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Esposti MD, 2002, METHODS, V26, P335, DOI 10.1016/S1046-2023(02)00039-7; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Firdaus WJJ, 2006, FEBS J, V273, P3076, DOI 10.1111/j.1742-4658.2006.05318.x; HASLAM MT, 1967, J NEUROL NEUROSUR PS, V30, P185, DOI 10.1136/jnnp.30.2.185; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Kieburtz K, 2001, NEUROLOGY, V57, P397; Kim BJ, 2006, PROTEOMICS, V6, P1250, DOI 10.1002/pmic.200500447; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; NIELSEN J M, 1955, Bull Los Angel Neuro Soc, V20, P38; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Russell RL, 1999, ARCH BIOCHEM BIOPHYS, V370, P236, DOI 10.1006/abbi.1999.1404; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Sitia Roberto, 2004, Sci STKE, V2004, ppe27, DOI 10.1126/stke.2392004pe27; Soriano FX, 2008, J NEUROCHEM, V107, P533, DOI 10.1111/j.1471-4159.2008.05648.x; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Verbessem P, 2003, NEUROLOGY, V61, P925, DOI 10.1212/01.WNL.0000090629.40891.4B; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	47	27	28	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22717	22729		10.1074/jbc.M111.334565	http://dx.doi.org/10.1074/jbc.M111.334565			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577145	Green Published, hybrid			2022-12-25	WOS:000306495000029
J	Sekiya, M; Nakamoto, RK; Nakanishi-Matsui, M; Futai, M				Sekiya, Mizuki; Nakamoto, Robert K.; Nakanishi-Matsui, Mayumi; Futai, Masamitsu			Binding of Phytopolyphenol Piceatannol Disrupts beta/gamma Subunit Interactions and Rate-limiting Step of Steady-state Rotational Catalysis in Escherichia coli F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE F-1 SECTOR; ATP SYNTHASE; GAMMA-SUBUNIT; ROTARY MOTOR; MECHANISM; INHIBITION; REVEALS; ENERGY; RESOLUTION; MUTATIONS	In observations of single molecule behavior under V-max conditions with minimal load, the F-1 sector of the ATP synthase (F-ATPase) rotates through continuous cycles of catalytic dwells (similar to 0.2 ms) and 120 degrees rotation steps (similar to 0.6 ms). We previously established that the rate-limiting transition step occurs during the catalytic dwell at the initiation of the 120 degrees rotation. Here, we use the phytopolyphenol, piceatannol, which binds to a pocket formed by contributions from alpha and beta stator subunits and the carboxyl-terminal region of the rotor gamma subunit. Piceatannol did not interfere with the movement through the 120 degrees rotation step, but caused increased duration of the catalytic dwell. The duration time of the intrinsic inhibited state of F-1 also became significantly longer with piceatannol. All of the beads rotated at a lower rate in the presence of saturating piceatannol, indicating that the inhibitor stays bound throughout the rotational catalytic cycle. The Arrhenius plot of the temperature dependence of the reciprocal of the duration of the catalytic dwell (catalytic rate) indicated significantly increased activation energy of the rate-limiting step to trigger the 120 degrees rotation. The activation energy was further increased by combination of piceatannol and substitution of gamma subunit Met(23) with Lys, indicating that the inhibitor and the beta/gamma interface mutation affect the same transition step, even though they perturb physically separated rotor-stator interactions.	[Sekiya, Mizuki; Nakanishi-Matsui, Mayumi; Futai, Masamitsu] Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Yahaba, Iwate 0283694, Japan; [Sekiya, Mizuki; Nakanishi-Matsui, Mayumi; Futai, Masamitsu] Iwate Med Univ, Futai Special Lab, Yahaba, Iwate 0283694, Japan; [Nakamoto, Robert K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	Iwate Medical University; Iwate Medical University; University of Virginia	Futai, M (corresponding author), Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Yahaba, Iwate 0283694, Japan.	futaim@iwate-med.ac.jp			Japan Science and Technology Agency, Research Seeds Quest Program	Japan Science and Technology Agency, Research Seeds Quest Program	This work was supported by a grant from Japan Science and Technology Agency, Research Seeds Quest Program.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12954, DOI 10.1021/bi971477z; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Dadi PK, 2009, INT J BIOL MACROMOL, V45, P72, DOI 10.1016/j.ijbiomac.2009.04.004; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Futai M., 2004, HDB ATPASES BIOCH CE, P237; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; IWAMOTO A, 1990, J BIOL CHEM, V265, P5043; JEANTEURDEBEUKELAER C, 1995, J BIOL CHEM, V270, P22850; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; NAKAMOTO RK, 1993, J BIOL CHEM, V268, P867; NAKAMOTO RK, 1995, J BIOL CHEM, V270, P14042, DOI 10.1074/jbc.270.23.14042; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Sekiya M, 2009, J BIOL CHEM, V284, P22401, DOI 10.1074/jbc.M109.009019; SHIN K, 1992, J BIOL CHEM, V267, P20835; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397	33	18	18	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22771	22780		10.1074/jbc.M112.374868	http://dx.doi.org/10.1074/jbc.M112.374868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22582396	Green Published, hybrid			2022-12-25	WOS:000306495000034
J	Li, XF; Zhang, R; Draheim, KM; Liu, WZ; Calderwood, DA; Boggon, TJ				Li, Xiaofeng; Zhang, Rong; Draheim, Kyle M.; Liu, Weizhi; Calderwood, David A.; Boggon, Titus J.			Structural Basis for Small G Protein Effector Interaction of Ras-related Protein 1 (Rap1) and Adaptor Protein Krev Interaction Trapped 1 (KRIT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATION; DOMAIN-ASSOCIATED PROTEIN-1; CELL-CELL JUNCTIONS; FERM DOMAIN; MOLECULAR-GRAPHICS; CCM PATHOGENESIS; 2-HIT MECHANISM; ERM PROTEINS; TALIN HEAD; COMPLEX	Cerebral cavernous malformations (CCMs) affect 0.1-0.5% of the population resulting in leaky vasculature and severe neurological defects. KRIT1 (Krev interaction trapped-1) mutations associate with similar to 40% of familial CCMs. KRIT1 is an effector of Ras-related protein 1 (Rap1) GTPase. Rap1 relocalizes KRIT1 from microtubules to cell membranes to impact integrin activation, potentially important for CCM pathology. We report the 1.95 angstrom co-crystal structure of KRIT1 FERM domain in complex with Rap1. Rap1-KRIT1 interaction encompasses an extended surface, including Rap1 Switch I and II and KRIT1FERMF1 and F2 lobes. Rap1 binds KRIT1-F1 lobe using a GTPase-ubiquitin-like fold interaction but binds KRIT1-F2 lobe by a novel interaction. Point mutagenesis confirms the interaction. High similarity between KRIT1-F2/F3 and talin is revealed. Additionally, the mechanism for FERM domains acting as GTPase effectors is suggested. Finally, structure-based alignment of each lobe suggests classification of FERM domains as ERM-like and TMFK-like (talin-myosin-FAK-KRIT-like) and that FERM lobes resemble domain "modules."	[Li, Xiaofeng; Zhang, Rong; Draheim, Kyle M.; Liu, Weizhi; Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu	Calderwood, David A/AAC-6954-2019; Li, Xiaofeng/F-3735-2011	Calderwood, David A/0000-0002-0791-4142; 	American Heart Association; American Cancer Society; National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085078] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Recipient of an American Heart Association Founders Affiliate Spring 2011 postdoctoral fellowship.r Recipient of an American Cancer Society postdoctoral fellowship.r Supported by the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beraud-Dufour S, 2007, FEBS J, V274, P5518, DOI 10.1111/j.1742-4658.2007.06068.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Fournier HN, 2005, MOL BIOL CELL, V16, P1859, DOI 10.1091/mbc.E04-08-0744; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Retief J D, 2000, Methods Mol Biol, V132, P243; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Victor M., 2001, ADAMS VICTOR PRINCIP; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2008, NEUROSURGERY, V63, P571, DOI 10.1227/01.NEU.0000325255.30268.B0	64	42	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22317	22327		10.1074/jbc.M112.361295	http://dx.doi.org/10.1074/jbc.M112.361295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577140	hybrid, Green Published			2022-12-25	WOS:000306418600069
J	Mohanty, AR; Kan, QM; Srivastava, S; Uranbileg, B; Arakawa-Takeuchi, S; Fujita, N; Okayama, H				Mohanty, Atish R.; Kan, Qiuming; Srivastava, Saumya; Uranbileg, Baasanjav; Arakawa-Takeuchi, Shiho; Fujita, Naoya; Okayama, Hiroto			Successive Phosphorylation of p27(KIP1) Protein at Serine-10 and C Terminus Crucially Controls Its Potency to Inactivate Cdk2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT-KINASE; CELL-CYCLE; MAMMALIAN TARGET; CDC6; P27; ACTIVATION; ANCHORAGE; PATHWAY; COMPLEX; STABILIZATION	During the G(1)-S transition, the activity of Cdk2 is regulated by its association with p27(KIP1), which in rodent fibroblasts undergoes phosphorylation mainly at serine 10, threonine 187, and C-terminal threonine 197 by KIS, Cdk2, and Pim or ROCK, respectively. Recently Cdc6 the AAA+ ATPase, identified initially to assemble pre-replicative complexes on origins of replication and later to activate p21(CIP1)-inactivated Cdk2, was found also to activate p27-bound Cdk2 but only after the bound p27 is C-terminally phosphorylated. On the other hand, the biological significance of the serine 10 phosphorylation remains elusive aside from its involvement in the stability of p27 itself. We report here that serine 10 phosphorylation is required for efficient C-terminal phosphorylation of its own by PIM and ROCK kinases and critically controls the potency of p27 as a Cdk2 inhibitor. In vitro, PIM1 and active ROCK1 efficiently phosphorylated free as well as Cdk2-bound p27 but only when the p27 was phosphorylated at Ser-10 in advance. Consistently, a Ser-10 nonphosphorylatable mutant p27 protein was not phosphorylated at the C terminus in vivo. Furthermore, when double-phosphorylated, free p27 was no longer a potent inhibitor of Cdk2, and Cdk2-bound p27 could be removed by Cdc6 to reactivate the Cdk2. Thus, phosphorylation at these two sites crucially controls the potency of this CDK inhibitor in two distinct modes.	[Mohanty, Atish R.; Kan, Qiuming; Srivastava, Saumya; Uranbileg, Baasanjav; Arakawa-Takeuchi, Shiho; Okayama, Hiroto] Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Tokyo 1130033, Japan; [Mohanty, Atish R.; Kan, Qiuming; Srivastava, Saumya; Uranbileg, Baasanjav; Arakawa-Takeuchi, Shiho; Okayama, Hiroto] Univ Tokyo, Fac Med, Grad Sch, Tokyo 1130033, Japan; [Fujita, Naoya] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan	University of Tokyo; University of Tokyo; Japanese Foundation for Cancer Research	Okayama, H (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Tokyo 1130033, Japan.	okayama@m.u-tokyo.ac.jp	Fujita, Naoya/A-7349-2010	Fujita, Naoya/0000-0002-9631-9264	Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research (S) and Global Center of Excellence from the Ministry of Education, Science, and Culture of Japan.	Abbas T, 2007, CELL CYCLE, V6, P843, DOI 10.4161/cc.6.7.4000; Arakawa-Takeuchi S, 2010, FEBS LETT, V584, P2779, DOI 10.1016/j.febslet.2010.05.005; Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Jinno S, 2002, ONCOGENE, V21, P1777, DOI 10.1038/sj.onc.1205249; Kan QM, 2008, J BIOL CHEM, V283, P17864, DOI 10.1074/jbc.M802055200; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Lunn CL, 2010, CELL CYCLE, V9, P4533, DOI 10.4161/cc.9.22.13789; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Nevis KR, 2009, CELL CYCLE, V8, P1952, DOI 10.4161/cc.8.12.8811; Park J, 2011, J BIOL CHEM, V286, P23132, DOI 10.1074/jbc.M110.209114; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sotillo E, 2009, J BIOL CHEM, V284, P14126, DOI 10.1074/jbc.M900687200; Uranbileg B, 2012, J BIOL CHEM, V287, P6275, DOI 10.1074/jbc.M111.318295; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750	27	7	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21757	21764		10.1074/jbc.M112.346254	http://dx.doi.org/10.1074/jbc.M112.346254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22584582	hybrid, Green Published			2022-12-25	WOS:000306418600017
J	Veldhuis, NA; Lew, MJ; Abogadie, FC; Poole, DP; Jennings, EA; Ivanusic, JJ; Eilers, H; Bunnett, NW; McIntyre, P				Veldhuis, Nicholas A.; Lew, Michael J.; Abogadie, Fe C.; Poole, Daniel P.; Jennings, Ernest A.; Ivanusic, Jason J.; Eilers, Helge; Bunnett, Nigel W.; McIntyre, Peter			N-Glycosylation Determines Ionic Permeability and Desensitization of the TRPV1 Capsaicin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; VANILLOID RECEPTOR-1; RAT TRPV1; PROTEIN-KINASE; PORE DILATION; CELL-LINE; CHANNEL; CALCIUM; PHOSPHORYLATION; SELECTIVITY	The balance of glycosylation and deglycosylation of ion channels can markedly influence their function and regulation. However, the functional importance of glycosylation of the TRPV1 receptor, a key sensor of pain-sensing nerves, is not well understood, and whether TRPV1 is glycosylated in neurons is unclear. We report that TRPV1 is N-glycosylated and that N-glycosylation is a major determinant of capsaicin-evoked desensitization and ionic permeability. Both N-glycosylated and unglycosylated TRPV1 was detected in extracts of peripheral sensory nerves by Western blotting. TRPV1 expressed in HEK-293 cells exhibited various degrees of glycosylation. A mutant of asparagine 604 (N604T) was not glycosylated but did not alter plasma membrane expression of TRPV1. Capsaicin-evoked increases in intracellular calcium ([ Ca2+](i)) were sustained in wild-type TRPV1 HEK-293 cells but were rapidly desensitized in N604T TRPV1 cells. There was marked cell-to-cell variability in capsaicin responses and desensitization between individual cells expressing wild-type TRPV1 but highly uniform responses in cells expressing N604T TRPV1, consistent with variable levels of glycosylation of the wild-type channel. These differences were also apparent when wild-type or N604T TRPV1-GFP fusion proteins were expressed in neurons from trpv1(-/-) mice. Capsaicin evoked a marked, concentration-dependent increase in uptake of the large cationic dye YO-PRO-1 in cells expressing wild-type TRPV1, indicative of loss of ion selectivity, that was completely absent in cells expressing N604T TRPV1. Thus, TRPV1 is variably N-glycosylated and glycosylation is a key determinant of capsaicin regulation of TRPV1 desensitization and permeability. Our findings suggest that physiological or pathological alterations in TRPV1 glycosylation would affect TRPV1 function and pain transmission.	[McIntyre, Peter] Univ Melbourne, Dept Pharmacol, Fac Med Dent & Hlth Sci, Parkville, Vic 3010, Australia; [Lew, Michael J.; Poole, Daniel P.; Ivanusic, Jason J.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Jennings, Ernest A.] James Cook Univ, Sch Med & Dent, Cairns, Qld 4870, Australia; [Eilers, Helge] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; James Cook University; University of California System; University of California San Francisco	McIntyre, P (corresponding author), Univ Melbourne, Dept Pharmacol, Fac Med Dent & Hlth Sci, Grattan St, Parkville, Vic 3010, Australia.	pmci@unimelb.edu.au	Mcintyre, Peter/N-4109-2013; Jennings, Ernest A/A-5439-2008; Poole, Daniel/AET-6645-2022; Ivanusic, Jason John/AAN-9056-2021	Poole, Daniel/0000-0002-6168-8422; Ivanusic, Jason John/0000-0002-7413-5704; Bunnett, Nigel W./0000-0003-3367-0644; Veldhuis, Nicholas/0000-0002-8902-9365; Lew, Michael/0000-0002-2523-7990; McIntyre, Peter/0000-0001-9506-5998; Jennings, Ernest/0000-0002-8912-6894	NHMRC [566834, 633033]; National Institutes of Health [DK57840, DK43207, DK39957]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039957, R01DK043207, R01DK057840, R37DK039957, R56DK043207] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole or in part, by NHMRC Grant 566834 (to P. M. and N. W. B.), 633033 (to N. W. B.) and National Institutes of Health Grants DK57840, DK43207, DK39957 (to N. W. B.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2009, ANESTHESIOLOGY, V111, P127, DOI 10.1097/ALN.0b013e3181a915e7; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; CHOLEWINSKI A, 1993, NEUROSCIENCE, V55, P1015, DOI 10.1016/0306-4522(93)90315-7; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Grant ER, 2002, J PHARMACOL EXP THER, V300, P9, DOI 10.1124/jpet.300.1.9; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; JANCSO N, 1967, BRIT J PHARM CHEMOTH, V31, P138, DOI 10.1111/j.1476-5381.1967.tb01984.x; JANCSOGABOR A, 1967, J PHARM PHARMACOL, V19, P486, DOI 10.1111/j.2042-7158.1967.tb08119.x; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Karai LJ, 2004, J BIOL CHEM, V279, P16377, DOI 10.1074/jbc.M310891200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Koplas PA, 1997, J NEUROSCI, V17, P3525; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Lam PMW, 2005, BRIT J ANAESTH, V94, P649, DOI 10.1093/bja/aei098; Lu P, 2008, NEPHROL DIAL TRANSPL, V23, P3397, DOI 10.1093/ndt/gfn291; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; McIntyre P, 2001, BRIT J PHARMACOL, V132, P1084, DOI 10.1038/sj.bjp.0703918; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Sandor Z, 2005, CELL MOL BIOL LETT, V10, P499; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Toth A, 2005, LIFE SCI, V76, P2921, DOI 10.1016/j.lfs.2004.10.056; Tyrrell L, 2001, J NEUROSCI, V21, P9629, DOI 10.1523/JNEUROSCI.21-24-09629.2001; Ursu D, 2010, EUR J PHARMACOL, V641, P114, DOI 10.1016/j.ejphar.2010.05.029; Vyklicky L, 2008, PHYSIOL RES, V57, pS59, DOI 10.33549/physiolres.931478; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Wirkner K, 2005, NEUROREPORT, V16, P997, DOI 10.1097/00001756-200506210-00023; Xu HS, 2006, AM J PHYSIOL-RENAL, V290, pF1103, DOI 10.1152/ajprenal.00245.2005	38	42	45	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21765	21772		10.1074/jbc.M112.342022	http://dx.doi.org/10.1074/jbc.M112.342022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570472	Green Published, hybrid			2022-12-25	WOS:000306418600018
J	Thomas, MG; Luchelli, L; Pascual, M; Gottifredi, V; Boccaccio, GL				Gabriela Thomas, Maria; Luchelli, Luciana; Pascual, Malena; Gottifredi, Vanesa; Lidia Boccaccio, Graciela			A Monoclonal Antibody against p53 Cross-Reacts with Processing Bodies	PLOS ONE			English	Article							MESSENGER-RNA DECAY; STRESS GRANULES; CYTOPLASMIC SEQUESTRATION; DNA-DAMAGE; TUMOR-SUPPRESSOR; PROTEIN; ACTIVATION; PATHWAY; NEUROBLASTOMA; EXPRESSION	The p53 tumor suppressor protein is an important regulator of cell proliferation and apoptosis. p53 can be found in the nucleus and in the cytosol, and the subcellular location is key to control p53 function. In this work, we found that a widely used monoclonal antibody against p53, termed Pab 1801 (Pan antibody 1801) yields a remarkable punctate signal in the cytoplasm of several cell lines of human origin. Surprisingly, these puncta were also observed in two independent p53-null cell lines. Moreover, the foci stained with the Pab 1801 were present in rat cells, although Pab 1801 recognizes an epitope that is not conserved in rodent p53. In contrast, the Pab 1801 nuclear staining corresponded to genuine p53, as it was upregulated by p53-stimulating drugs and absent in p53-null cells. We identified the Pab 1801 cytoplasmic puncta as P Bodies (PBs), which are involved in mRNA regulation. We found that, in several cell lines, including U2OS, WI38, SK-N-SH and HCT116, the Pab 1801 puncta strictly colocalize with PBs identified with specific antibodies against the PB components Hedls, Dcp1a, Xrn1 or Rck/p54. PBs are highly dynamic and accordingly, the Pab 1801 puncta vanished when PBs dissolved upon treatment with cycloheximide, a drug that causes polysome stabilization and PB disruption. In addition, the knockdown of specific PB components that affect PB integrity simultaneously caused PB dissolution and the disappearance of the Pab 1801 puncta. Our results reveal a strong cross-reactivity of the Pab 1801 with unknown PB component(s). This was observed upon distinct immunostaining protocols, thus meaning a major limitation on the use of this antibody for p53 imaging in the cytoplasm of most cell types of human or rodent origin.	[Gabriela Thomas, Maria; Luchelli, Luciana; Pascual, Malena; Gottifredi, Vanesa; Lidia Boccaccio, Graciela] Inst Leloir, Buenos Aires, DF, Argentina; [Gabriela Thomas, Maria; Luchelli, Luciana; Pascual, Malena; Gottifredi, Vanesa; Lidia Boccaccio, Graciela] IIBBA CONICET, Buenos Aires, DF, Argentina; [Luchelli, Luciana; Pascual, Malena; Gottifredi, Vanesa; Lidia Boccaccio, Graciela] Univ Buenos Aires, Fac Ciencias Exactas & Nat, RA-1053 Buenos Aires, DF, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Thomas, MG (corresponding author), Inst Leloir, Av Patricias Argentinas, Buenos Aires, DF, Argentina.	mthomas@leloir.org.ar	Gottifredi, Vanesa/AAI-1788-2019	Gottifredi, Vanesa/0000-0001-9656-5951	University of Buenos Aires (UBA), Argentina [UBACyT X311]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) [PIP 205-2011-2013]; Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina [PICT 2010-2339, PICT 2008-0133, PICT 2011-1850]; Universidad de Buenos Aires; Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnologicas	University of Buenos Aires (UBA), Argentina(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas	UBACyT X311 to GLB from University of Buenos Aires (UBA), Argentina; PIP 205-2011-2013 from the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) to MGT; PICT 2010-2339, PICT 2008-0133 and PICT 2011-1850 from the Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina, to MGT, VG and GLB, respectively.Universidad de Buenos Aires http://www.uba.ar/homepage.php Agencia Nacional de Promocion Cientifica y Tecnologica: http://www.agencia.gov.ar/index.php Consejo Nacional de Investigaciones Cientificas y Tecnologicas: http://www.conicet.gov.ar/web/conicet/inicio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Baez MV, 2005, J BIOL CHEM, V280, P43131, DOI 10.1074/jbc.M508374200; BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; Becker K, 2007, CELL DEATH DIFFER, V14, P1350, DOI 10.1038/sj.cdd.4402126; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Dekanty A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000994; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Thomas MG, 2009, J CELL SCI, V122, P563, DOI 10.1242/jcs.038208; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kruse JP, 2009, J BIOL CHEM, V284, P3250, DOI 10.1074/jbc.M805658200; LEGROS Y, 1994, ONCOGENE, V9, P2071; Lin DL, 1996, J BIOL CHEM, V271, P14649, DOI 10.1074/jbc.271.25.14649; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Moll UM, 1996, MOL CELL BIOL, V16, P1126; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Rzeczkowski K, 2011, J CELL BIOL, V194, P581, DOI 10.1083/jcb.201006089; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; STEPHEN CW, 1992, J MOL BIOL, V225, P577, DOI 10.1016/0022-2836(92)90386-X; Takahashi S, 2011, NUCLEIC ACIDS RES, V39, P3446, DOI 10.1093/nar/gkq1302; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Baez MV, 2011, J CELL BIOL, V195, P1141, DOI 10.1083/jcb.201108159; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; WADEEVANS A, 1985, EMBO J, V4, P699, DOI 10.1002/j.1460-2075.1985.tb03686.x; Wang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013459; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36447	10.1371/journal.pone.0036447	http://dx.doi.org/10.1371/journal.pone.0036447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590546	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336400016
J	Chen, HC; Zhu, YT; Chen, SY; Tseng, SCG				Chen, Hung-Chi; Zhu, Ying-Ting; Chen, Szu-Yu; Tseng, Scheffer C. G.			Selective Activation of p120(ctn)-Kaiso Signaling to Unlock Contact Inhibition of ARPE-19 Cells without Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; BETA-CATENIN; P120 CATENIN; PROLIFERATIVE VITREORETINOPATHY; TGF-BETA; NUCLEAR-LOCALIZATION; CADHERIN EXPRESSION; ENDOTHELIAL-CELLS; RISK-FACTORS; RHO-GTPASES	Contact-inhibition ubiquitously exists in non-transformed cells and explains the poor regenerative capacity of in vivo human retinal pigment epithelial cells (RPE) during aging, injury and diseases. RPE injury or degeneration may unlock mitotic block mediated by contact inhibition but may also promote epithelial-mesenchymal transition (EMT) contributing to retinal blindness. Herein, we confirmed that EMT ensued in post-confluent ARPE-19 cells when contact inhibition was disrupted with EGTA followed by addition of EGF and FGF-2 because of activation of canonical Wnt and Smad/ZEB signaling. In contrast, knockdown of p120-catenin (p120) unlocked such mitotic block by activating p120/Kaiso, but not activating canonical Wnt and Smad/ZEB signaling, thus avoiding EMT. Nuclear BrdU labeling was correlated with nuclear release of Kaiso through p120 nuclear translocation, which was associated with activation of RhoA-ROCK signaling, destabilization of microtubules. Prolonged p120 siRNA knockdown followed by withdrawal further expanded RPE into more compact monolayers with a normal phenotype and a higher density. This new strategy based on selective activation of p120/Kaiso but not Wnt/beta-catenin signaling obviates the need of using single cells and the risk of EMT, and may be deployed to engineer surgical grafts containing RPE and other tissues.	[Chen, Hung-Chi; Zhu, Ying-Ting; Chen, Szu-Yu; Tseng, Scheffer C. G.] Tissue Tech Inc, Ocular Surface Ctr, Miami, FL USA; [Chen, Hung-Chi; Zhu, Ying-Ting; Chen, Szu-Yu; Tseng, Scheffer C. G.] Ocular Surface Res & Educ Fdn, Miami, FL USA; [Chen, Hung-Chi] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chen, Hung-Chi] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chen, HC (corresponding author), Tissue Tech Inc, Ocular Surface Ctr, Miami, FL USA.	stseng@ocularsurface.com		Zhu, Yingting/0000-0002-3332-9713	National Eye Institute, National Institutes of Health, Bethesda, MD, USA [R43 EY022502]; TissueTech, Inc., Miami, FL; Chang Gung Memorial Hospital [CMRPG-340191]; National Science Council in Taiwan [NSC100-2918-I-182A-001]; Tissue Tech Inc; NATIONAL EYE INSTITUTE [R01EY006819, R43EY022502] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); TissueTech, Inc., Miami, FL; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Tissue Tech Inc; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by R43 EY022502 from the National Eye Institute, National Institutes of Health, Bethesda, MD, USA (Zhu YT and Tseng SCG), a research grant from TissueTech, Inc., Miami, FL, and a grant from Chang Gung Memorial Hospital (CMRPG-340191) and National Science Council (NSC100-2918-I-182A-001) in Taiwan (Chen HC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: All authors are employed by Tissue Tech Inc, who provided a research grant for this study. Tseng SCG has filed a patent (12/446,740" and published as "2010-0003299'' on 1/7/10) on the method of isolation, preservation and expansion of human corneal endothelial cells and other cells by transient knockdown of cell junction proteins via p120 siRNA. There are no other patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Ban Y, 1997, Mol Vis, V3, P18; Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002; Bovolenta P, 2009, NAT NEUROSCI, V12, P5, DOI 10.1038/nn0109-5; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Ferreri DM, 2008, CELL COMMUN ADHES, V15, P333, DOI 10.1080/15419060802440377; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200; Georgiadis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015730; Hinterhuber G, 2004, J INVEST DERMATOL, V122, P406, DOI 10.1046/j.0022-202X.2004.22216.x; Hiyama A, 2011, J CELL PHYSIOL, V226, P1139, DOI 10.1002/jcp.22438; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7; Ichii T, 2007, GENES CELLS, V12, P827, DOI 10.1111/j.1365-2443.2007.01095.x; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Itoh Y, 2007, EXP EYE RES, V84, P464, DOI 10.1016/j.exer.2006.10.017; Iyer S, 2004, AM J PHYSIOL-LUNG C, V286, pL1143, DOI 10.1152/ajplung.00305.2003; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Kaida M, 2000, INVEST OPHTH VIS SCI, V41, P3215; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lee J, 2010, J BIOL CHEM, V285, P26618, DOI 10.1074/jbc.M109.073155; Lee SC, 2001, OPHTHALMIC RES, V33, P80, DOI 10.1159/000055648; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; McKay BS, 1997, EXP EYE RES, V65, P661, DOI 10.1006/exer.1997.0374; Nagasaki H, 1998, PROG RETIN EYE RES, V17, P77, DOI 10.1016/S1350-9462(97)00007-4; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ogden SR, 2008, MOL BIOL CELL, V19, P4110, DOI 10.1091/mbc.E08-03-0283; OKAMI T, 1990, J HISTOCHEM CYTOCHEM, V38, P1267, DOI 10.1177/38.9.2167328; Parapuram SK, 2009, INVEST OPHTH VIS SCI, V50, P5965, DOI 10.1167/iovs.09-3621; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Schneider M, 2008, J MOL MED, V86, P507, DOI 10.1007/s00109-007-0301-3; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Walia S, 2009, OPHTHALMIC GENET, V30, P63, DOI 10.1080/13816810802695550; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang JH, 2010, MICROVASC RES, V80, P233, DOI 10.1016/j.mvr.2010.04.001; Zhu YT, 2012, J CELL SCI IN PRESS	62	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36864	10.1371/journal.pone.0036864	http://dx.doi.org/10.1371/journal.pone.0036864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590627	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336100068
J	Samocha-Bonet, D; Campbell, LV; Mori, TA; Croft, KD; Greenfield, JR; Turner, N; Heilbronn, LK				Samocha-Bonet, Dorit; Campbell, Lesley V.; Mori, Trevor A.; Croft, Kevin D.; Greenfield, Jerry R.; Turner, Nigel; Heilbronn, Leonie K.			Overfeeding Reduces Insulin Sensitivity and Increases Oxidative Stress, without Altering Markers of Mitochondrial Content and Function in Humans	PLOS ONE			English	Article							HIGH-FAT DIET; SKELETAL-MUSCLE; RESISTANCE; CAPACITY; ASSOCIATION; METABOLISM; EXPRESSION; PROTEIN; GENES; RATS	Background: Mitochondrial dysfunction and increased oxidative stress are associated with obesity and type 2 diabetes. High fat feeding induces insulin resistance and increases skeletal muscle oxidative stress in rodents, but there is controversy as to whether skeletal muscle mitochondrial biogenesis and function is altered. Methodology and Principal Findings: Forty (37 +/- 2 y) non-obese (25.6 +/- 0.6 kg/m(2)) sedentary men (n = 20) and women (n = 20) were overfed (+1040 +/- 100 kcal/day, 46 +/- 1% of energy from fat) for 28 days. Hyperinsulinemic-euglycemic clamps were performed at baseline and day 28 of overfeeding and skeletal muscle biopsies taken at baseline, day 3 and day 28 of overfeeding in a sub cohort of 26 individuals (13 men and 13 women) that consented to having all 3 biopsies performed. Weight increased on average in the whole cohort by 0.6 +/- 0.1 and 2.7 +/- 0.3 kg at days 3 and 28, respectively (P<0.0001, without a significant difference in the response between men and women (P=0.4). Glucose infusion rate during the hyperinsulinemic-euglycemic clamp decreased from 54.8 +/- 2.8 at baseline to 50.3 +/- 2.5 mu mol/min/kg FFM at day 28 of overfeeding (P=0.03) without a significant difference between men and women (P=0.4). Skeletal muscle protein carbonyls and urinary F2-isoprostanes increased with overfeeding (P<0.05). Protein levels of muscle peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC1 alpha) and subunits from complex I, II and V of the electron transport chain were increased at day 3 (all P<0.05) and returned to basal levels at day 28. No changes were detected in muscle citrate synthase activity or ex vivo CO2 production at either time point. Conclusions: Peripheral insulin resistance was induced by overfeeding, without reducing any of the markers of mitochondrial content that were examined. Oxidative stress was however increased, and may have contributed to the reduction in insulin sensitivity observed.	[Samocha-Bonet, Dorit; Campbell, Lesley V.; Greenfield, Jerry R.; Turner, Nigel; Heilbronn, Leonie K.] St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia; [Samocha-Bonet, Dorit; Campbell, Lesley V.; Greenfield, Jerry R.; Turner, Nigel] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Mori, Trevor A.; Croft, Kevin D.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Heilbronn, Leonie K.] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Western Australia; University of Adelaide	Samocha-Bonet, D (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia.	leonie.heilbronn@adelaide.edu.au	Turner, Nigel/H-7176-2013; Croft, Kevin D/C-4675-2013; Heilbronn, Leonie K/H-1874-2013; Mori, Trevor/H-5485-2014	Turner, Nigel/0000-0002-0119-9328; Heilbronn, Leonie K/0000-0003-2106-7303; Mori, Trevor/0000-0002-5264-9229; Croft, Kevin/0000-0003-1596-4913; Samocha-Bonet, Dorit/0000-0001-9422-7852	National Health and Medical Research Council Australia (NHMRC); Australian Diabetes Society (ADS)	National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Diabetes Society (ADS)	The study was funded by the National Health and Medical Research Council Australia (NHMRC), LKH and NT were supported by NHMRC Career Development Award, JRG by NHMRC Neil Hamilton Fairley Fellowship and DS-B by the Australian Diabetes Society (ADS) Skip Martin Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bachmann OP, 2001, DIABETES, V50, P2579, DOI 10.2337/diabetes.50.11.2579; Boyle KE, 2011, J CLIN ENDOCR METAB, V96, P775, DOI 10.1210/jc.2010-2253; Brehm A, 2010, AM J PHYSIOL-ENDOC M, V299, pE33, DOI 10.1152/ajpendo.00756.2009; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; De Feyter HM, 2008, EUR J ENDOCRINOL, V158, P643, DOI 10.1530/EJE-07-0756; Gregersen S, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/238056; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hoeks J, 2006, DIABETOLOGIA, V49, P2419, DOI 10.1007/s00125-006-0369-2; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Iossa S, 2002, PFLUG ARCH EUR J PHY, V445, P431, DOI 10.1007/s00424-002-0964-0; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Meigs JB, 2007, DIABETES CARE, V30, P2529, DOI 10.2337/dc07-0817; MILLER WC, 1984, J APPL PHYSIOL, V56, P78, DOI 10.1152/jappl.1984.56.1.78; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Mori TA, 1999, ANAL BIOCHEM, V268, P117, DOI 10.1006/abio.1998.3037; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Samocha-Bonet D, 2010, DIABETOLOGIA, V53, P1700, DOI 10.1007/s00125-010-1768-y; Samocha-Bonet D, 2010, TRENDS ENDOCRIN MET, V21, P83, DOI 10.1016/j.tem.2009.09.008; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Tam CS, 2010, DIABETES, V59, P2164, DOI 10.2337/db10-0162; Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wijers SLJ, 2010, J PROTEOME RES, V9, P2226, DOI 10.1021/pr9010074	34	62	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36320	10.1371/journal.pone.0036320	http://dx.doi.org/10.1371/journal.pone.0036320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586466	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335000028
J	Sander, G; Borner, T; Kriegeskorte, A; von Eiff, C; Becker, K; Mahabir, E				Sander, Gunnar; Boerner, Tina; Kriegeskorte, Andre; von Eiff, Christof; Becker, Karsten; Mahabir, Esther			Catheter Colonization and Abscess Formation Due to Staphylococcus epidermidis with Normal and Small-Colony-Variant Phenotype Is Mouse Strain Dependent	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; INFECTION MODEL; HEMB MUTANT; BIOFILM FORMATION; SLIME PRODUCTION; MEDICAL DEVICES; IN-VIVO; AUREUS; MICE; VIRULENCE	Coagulase-negative staphylococci (CoNS) form a thick, multilayered biofilm on foreign bodies and are a major cause of nosocomial implant-associated infections. Although foreign body infection models are well-established, limited in vivo data are available for CoNS with small-colony-variant (SCV) phenotype described as causative agents in implant-associated infections. Therefore, we investigated the impact of the Staphylococcus epidermidis phenotype on colonization of implanted PVC catheters and abscess formation in three different mouse strains. Following introduction of a catheter subcutaneously in each flank of 8- to 12-week-old inbred C57BL/6JCrl (B6J), outbred Crl:CD1(ICR) (CD-1), and inbred BALB/cAnNCrl (BALB/c) male mice, doses of S. epidermidis O-47 wild type, its hemB mutant with stable SCV phenotype, or its complemented mutant at concentrations of 10(6) to 10(9) colony forming units (CFUs) were gently spread onto each catheter. On day 7, mice were sacrificed and the size of the abscesses as well as bacterial colonization was determined. A total of 11,500 CFUs of the complemented mutant adhered to the catheter in BALB/c followed by 9,960 CFUs and 9,900 CFUs from S. epidermidis wild type in BALB/c and CD-1, respectively. SCV colonization was highest in CD-1 with 9,500 CFUs, whereas SCVs were not detected in B6J. The minimum dose that led to colonization or abscess formation in all mouse strains was 10(7) or 10(8) CFUs of the normal phenotype, respectively. A minimum dose of 10(8) or 10(9) CFU of the hemB mutant with stable SCV phenotype led to colonization only or abscess formation, respectively. The largest abscesses were detected in BALB/c inoculated with wild type bacteria or SCV (64 mm(2) vs. 28 mm(2)). Our results indicate that colonization and abscess formation by different phenotypes of S. epidermidis in a foreign body infection model is most effective in inbred BALB/c followed by outbred CD-1 and inbred B6J mice.	[Sander, Gunnar; Boerner, Tina; Mahabir, Esther] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Kriegeskorte, Andre; von Eiff, Christof; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany	University of Cologne; University of Munster	Sander, G (corresponding author), Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany.	gunnar.sander@uk-koeln.de	Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341	Center for Molecular Medicine, University of Cologne (CMMC); Bundesministerium fur Bildung und Forschung (BMBF), Germany [01KI1009A]	Center for Molecular Medicine, University of Cologne (CMMC); Bundesministerium fur Bildung und Forschung (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This study was supported by intramural funding from the Center for Molecular Medicine, University of Cologne (CMMC) to EM and GS and in part by a grant to KB from the Bundesministerium fur Bildung und Forschung (BMBF), Germany (01KI1009A "Skin Staph" [Susceptibility and Resistance towards Infections]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Al Laham N, 2007, J BACTERIOL, V189, P4494, DOI 10.1128/JB.00160-07; BADDOUR LM, 1987, REV INFECT DIS, V9, P1168; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870, DOI 10.1128/IAI.55.12.2870-2877.1987; Deighton MA, 1996, EPIDEMIOL INFECT, V117, P267, DOI 10.1017/S0950268800001448; Hart E, 2010, J ANTIMICROB CHEMOTH, V65, P974, DOI 10.1093/jac/dkq057; Heilmann C, 1996, INFECT IMMUN, V64, P277, DOI 10.1128/IAI.64.1.277-282.1996; Hume EBH, 2005, IMMUNOL CELL BIOL, V83, P294, DOI 10.1111/j.1440-1711.2005.01326.x; Jonsson IM, 2003, MICROB PATHOGENESIS, V34, P73, DOI 10.1016/S0882-4010(02)00208-5; Lannergard J, 2008, ANTIMICROB AGENTS CH, V52, P4017, DOI 10.1128/AAC.00668-08; Lannergard J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028366; Nippe N, 2011, J INVEST DERMATOL, V131, P125, DOI 10.1038/jid.2010.282; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Otto M, 2011, SEMIN IMMUNOPATHOL; PATRICK CC, 1992, INFECT IMMUN, V60, P1363, DOI 10.1128/IAI.60.4.1363-1367.1992; PFALLER M, 1988, EUR J CLIN MICROBIOL, V7, P30, DOI 10.1007/BF01962167; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Rupp ME, 1999, INFECT IMMUN, V67, P2627, DOI 10.1128/IAI.67.5.2627-2632.1999; Seggewiss J, 2006, J BACTERIOL, V188, P7765, DOI 10.1128/JB.00774-06; Seifert H, 2005, EMERG INFECT DIS, V11, P1283, DOI 10.3201/eid1108.041177; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047; von Eiff C, 1999, CLIN INFECT DIS, V29, P932, DOI 10.1086/520462; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; Vuong C, 2008, J INFECT DIS, V198, P258, DOI 10.1086/589307; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520	31	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36602	10.1371/journal.pone.0036602	http://dx.doi.org/10.1371/journal.pone.0036602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586482	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335000043
J	Saunders, MI; Thompson, PA; Jeffs, AG; Sawstrom, C; Sachlikidis, N; Beckley, LE; Waite, AM				Saunders, Megan I.; Thompson, Peter A.; Jeffs, Andrew G.; Saewstroem, Christin; Sachlikidis, Nikolas; Beckley, Lynnath E.; Waite, Anya M.			Fussy Feeders: Phyllosoma Larvae of the Western Rocklobster (Panulirus cygnus) Demonstrate Prey Preference	PLOS ONE			English	Article							LOBSTER JASUS-EDWARDSII; SOUTHERN ROCK LOBSTER; EARLY-STAGE PHYLLOSOMA; FATTY-ACID-COMPOSITION; SPINY LOBSTER; BIOCHEMICAL-COMPOSITION; CONTINENTAL-SHELF; LIPID-COMPOSITION; FOOD-WEB; GROWTH	The Western Rocklobster (Panulirus cygnus) is the most valuable single species fishery in Australia and the largest single country spiny lobster fishery in the world. In recent years a well-known relationship between oceanographic conditions and lobster recruitment has become uncoupled, with significantly lower recruitment than expected, generating interest in the factors influencing survival and development of the planktonic larval stages. The nutritional requirements and wild prey of the planktotrophic larval stage (phyllosoma) of P. cygnus were previously unknown, hampering both management and aquaculture efforts for this species. Ship-board feeding trials of wild-caught mid-late stage P. cygnus phyllosoma in the eastern Indian Ocean, off the coast of Western Australia, were conducted in July 2010 and August-September 2011. In a series of experiments, phyllosoma were fed single and mixed species diets of relatively abundant potential prey items (chaetognaths, salps, and krill). Chaetognaths were consumed in 2-8 times higher numbers than the other prey, and the rate of consumption of chaetognaths increased with increasing concentration of prey. The highly variable lipid content of the phyllosoma, and the fatty acid profiles of the phyllosoma and chaetognaths, indicated they were from an oligotrophic oceanic food chain where food resources for macrozooplankton were likely to be constrained. Phyllosoma fed chaetognaths over 6 days showed significant changes in some fatty acids and tended to accumulate lipid, indicating an improvement in overall nutritional condition. The discovery of a preferred prey for P. cygnus will provide a basis for future oceanographic, management and aquaculture research for this economically and ecologically valuable species.	[Saunders, Megan I.; Saewstroem, Christin; Waite, Anya M.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Saunders, Megan I.; Saewstroem, Christin; Waite, Anya M.] Univ Western Australia, Sch Environm Syst Engn, Crawley, WA, Australia; [Saunders, Megan I.] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Thompson, Peter A.] Australian Commonwealth Sci Ind & Res Org, Hobart, Tas, Australia; [Jeffs, Andrew G.] Univ Auckland, Leigh Marine Lab, Warkworth, Northland, New Zealand; [Sachlikidis, Nikolas] Queensland Govt, Dept Primary Ind & Fisheries, Cairns, Qld, Australia; [Beckley, Lynnath E.] Murdoch Univ, Sch Environm Sci, Murdoch, WA 6150, Australia	University of Western Australia; University of Western Australia; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Auckland; Murdoch University	Saunders, MI (corresponding author), Univ Western Australia, Oceans Inst, Crawley, WA, Australia.	anya.waite@uwa.edu.au	Saunders, Megan/I-7731-2012; Thompson, Peter A/A-2361-2012; Jeffs, Andrew G/D-9474-2012; Säwström, Christin/F-5462-2018; Waite, Anya M/A-5492-2015	Saunders, Megan/0000-0002-8549-5609; Thompson, Peter A/0000-0002-9504-5433; Säwström, Christin/0000-0001-9297-3093; Waite, Anya M/0000-0003-2965-0296; Jeffs, Andrew/0000-0002-8504-1949	Fisheries Research Development Corporation, (FRDC) [2010/047]; CSIRO Australian National Marine Facility; Australian National Government; Australian Research Council (Super Science scheme); Glenn Family Foundation	Fisheries Research Development Corporation, (FRDC)(Fisheries R&D Corp); CSIRO Australian National Marine Facility; Australian National Government; Australian Research Council (Super Science scheme)(Australian Research Council); Glenn Family Foundation	This research was funded by a grant from the Fisheries Research Development Corporation, (FRDC) project number: 2010/047 "The Biological Oceanography of Western Rock Lobster Larvae" awarded to AMW et al. Ship time on the R.V. Southern Surveyor was funded by the CSIRO Australian National Marine Facility. MIS was supported in part by Postdoctoral Research Fellowships from the Australian National Government (Endeavour Awards), and Australian Research Council (Super Science scheme). AJ was supported by the Glenn Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudes M, 2008, COMP BIOCHEM PHYS A, V150, P40, DOI 10.1016/j.cbpa.2008.02.023; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braine S, 1979, CSIRO AUSTR DIVISION, V13; Brown R, 2011, GOVERNANCE W ROCK LO; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Caputi N, 2008, FISH OCEANOGR, V17, P147, DOI 10.1111/j.1365-2419.2008.00471.x; Caputi Nicolavito, 1993, Fisheries Oceanography, V2, P1, DOI 10.1111/j.1365-2419.1993.tb00007.x; Chittleborough RG, 1969, MARINE FRESHWATER RE, V20, P199, DOI DOI 10.1071/MF9690199; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; COBB JS, 1980, BIOL MANAGEMENT LOBS; Cox SL, 2003, REV FISH SCI, V11, P89, DOI 10.1080/713610924; de Lestang S., 2006, STATE FISHERIES REPO; de Lestang S, 2009, STATE FISHERIES REPO; DEXTER DM, 1972, CALIF FISH GAME, V58, P107; Feng M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001763; Gaughan D, 1997, ESTUARINE COASTAL SH, V45, P88; Gaughan DJ, 2009, ESTUAR COAST SHELF S, V83, P443, DOI 10.1016/j.ecss.2009.04.015; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Jeffs AG, 2004, COMP BIOCHEM PHYS B, V137, P487, DOI 10.1016/j.cbpc.2004.02.003; Jeffs AG, 2002, COMP BIOCHEM PHYS A, V131, P305, DOI 10.1016/S1095-6433(01)00455-X; Jeffs AG, 1999, COMP BIOCHEM PHYS A, V123, P351, DOI 10.1016/S1095-6433(99)00073-2; Jeffs Andrew, 2007, Bulletin of Fisheries Research Agency, P9; Johnston DJ, 2001, MAR FRESHWATER RES, V52, P1375, DOI 10.1071/MF01105; KITTAKA J, 1994, CRUSTACEANA, V66, P258, DOI 10.1163/156854094X00026; Kittaka J, 2001, MAR FRESHWATER RES, V52, P1439, DOI 10.1071/MF01188; Kruse S, 2010, MAR ECOL PROG SER, V416, P105, DOI 10.3354/meps08773; LEGENDRE L, 1995, OPHELIA, V41, P153, DOI 10.1080/00785236.1995.10422042; LEMMENS JWTJ, 1994, J MORPHOL, V220, P271, DOI 10.1002/jmor.1052200306; Liddy GC, 2004, AQUACULTURE, V242, P207, DOI 10.1016/j.aquaculture.2004.05.034; Liddy GC, 2004, J SHELLFISH RES, V23, P265; Liddy GC, 2003, AQUACULT INT, V11, P53, DOI 10.1023/A:1024100110378; Limbourn AJ, 2009, COMP BIOCHEM PHYS B, V152, P292, DOI 10.1016/j.cbpb.2008.12.009; Macmillan DL, 1997, MAR FRESHWATER RES, V48, P19, DOI 10.1071/MF96040; MAYZAUD P, 1989, MAR ECOL PROG SER, V56, P189, DOI 10.3354/meps056189; Mitchell JR, 1971, FOOD PREFERENCES FEE; Najdek M, 1996, MAR ECOL PROG SER, V139, P219, DOI 10.3354/meps139219; Nelson MM, 2004, AQUACULT NUTR, V10, P237, DOI 10.1111/j.1365-2095.2004.00295.x; Nelson MM, 2003, J SHELLFISH RES, V22, P225; Nelson MM, 2002, J WORLD AQUACULT SOC, V33, P146, DOI 10.1111/j.1749-7345.2002.tb00489.x; NICHOLS PD, 1991, PHYTOCHEMISTRY, V30, P3209, DOI 10.1016/0031-9422(91)83177-M; OLSON RR, 1989, ANNU REV ECOL SYST, V20, P225; PEARCE AF, 1994, BIOPHYSICS MARINE LA, P279; Phillips BF, 2006, COMP BIOCHEM PHYS B, V143, P219, DOI 10.1016/j.cbpb.2005.11.009; PHILLIPS BF, 1979, AUST J MAR FRESH RES, V30, P773; PHILLIPS BF, 1986, CAN J FISH AQUAT SCI, V43, P2126, DOI 10.1139/f86-261; Phleger CF, 2001, MAR FRESHWATER RES, V52, P1475, DOI 10.1071/MF01071; Reuss N, 2002, MAR BIOL, V141, P423, DOI 10.1007/s00227-002-0841-6; RIMMER DW, 1979, MAR BIOL, V54, P109, DOI 10.1007/BF00386590; Ritar AJ, 2003, COMP BIOCHEM PHYS A, V136, P353, DOI 10.1016/S1095-6433(03)00167-3; Saisho T, 1966, INFORMATION B PLANKT, V13, P67; SKERRATT JH, 1995, MAR CHEM, V51, P93, DOI 10.1016/0304-4203(95)00047-U; Suzuki N, 2008, MAR BIOTECHNOL, V10, P49, DOI 10.1007/s10126-007-9038-9; Suzuki N, 2006, FISHERIES SCI, V72, P342, DOI 10.1111/j.1444-2906.2006.01155.x; THOMAS LR, 1963, NATURE, V198, P208, DOI 10.1038/198208a0; Thompson PA, 2009, MAR ECOL PROG SER, V394, P1, DOI 10.3354/meps08297; Tong LJ, 1997, MAR FRESHWATER RES, V48, P935, DOI 10.1071/MF97073; Waite AM, 2007, DEEP-SEA RES PT II, V54, P1055, DOI 10.1016/j.dsr2.2006.12.010; Wilkin JL., 2011, LIMNOLOGY OCEANOGRAP, V1, P163, DOI [10.1215/21573698-1504363, DOI 10.1215/21573698-1504363]	58	38	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36580	10.1371/journal.pone.0036580	http://dx.doi.org/10.1371/journal.pone.0036580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586479	gold, Green Published			2022-12-25	WOS:000305335000040
J	Shah, M; DiPietro, D; Greenbaum, A; Ketemepi, S; Martins-Evora, M; Marsiglia, V; Dorman, SE				Shah, Maunank; DiPietro, Danielle; Greenbaum, Adena; Ketemepi, Sherry; Martins-Evora, Maria; Marsiglia, Vincent; Dorman, Susan E.			Programmatic Impact of QuantiFERON-TB Gold In-Tube Implementation on Latent Tuberculosis Diagnosis and Treatment in a Public Health Clinic	PLOS ONE			English	Article							INFECTION; ASSAYS	Background: QuantiFERON-TB Gold In-Tube (QFT-GIT) is considered an alternative to the tuberculin skin test (TST) for the diagnosis of tuberculosis (TB) infection, but the programmatic impact of QFT-GIT implementation is largely unknown. In March, 2010, the Baltimore City Health Department (BCHD) introduced routine QFT-GIT testing for individuals referred to the TB program for suspected latent TB infection (LTBI). Design: Retrospective study comparing LTBI diagnosis and treatment during the 13 months before and after QFT-GIT implementation at the BCHD TB clinic. Results: 607 and 750 individuals were referred by community-providers for suspected LTBI in the pre- and post-QFT-GIT periods, respectively. Most individuals in the pre- and post-QFT-GIT periods were referred on the basis of a positive TST (597/607 [98%] vs. 690/750 [92%], respectively) and were foreign-born (363/607[59%] vs. 507/750[68%], respectively). BCHD performed QFT-GIT testing for 375/543 (69%) eligible individuals in the post-QFT-GIT period, of which 185 (49%) were positive, 178 (47%) were negative, 1 (0.25%) was indeterminate, and 11 (3%) did not yield results. Concordance of QFT-GIT with TST was low (183/352[52%]). Foreign-born individuals had higher proportions of QFT-GIT positivity (57%) than US-born individuals (36%; AOR 3.3 [95% CI 1.7-6.2]). Significantly fewer individuals received a final diagnosis of LTBI in the post-QFT-GIT period (397/567 [70%]) compared to the pre- QFT-GIT period (445/452 [98%], p, 0.001). In the post-QFT-GIT period, only 230/399 (58%) of those receiving QFT-GIT testing had a final diagnosis of LTBI, while 167/168 (99%) of those without QFT-GIT testing were diagnosed with LTBI (p, 0.001). There was no difference in treatment initiation between those with and without QFT-GIT testing (175/230 [76%]) vs. 133/167 [80%], respectively) in the post-QFT-GIT period. Conclusion: QFT-GIT implementation for LTBI evaluation in a public health clinic significantly reduced the proportion of referred individuals in whom LTBI was diagnosed. QFT-GIT testing had no impact on treatment initiation or completion among those diagnosed with LTBI.	[Shah, Maunank; Greenbaum, Adena; Dorman, Susan E.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Ketemepi, Sherry; Martins-Evora, Maria; Marsiglia, Vincent] Baltimore City Dept Hlth, Baltimore, MD USA; [DiPietro, Danielle] Tulane Univ, New Orleans, LA 70118 USA	Johns Hopkins University; Tulane University	Shah, M (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	mshah28@jhmi.edu			National Institutes Health [AI089259]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089259] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MS is supported through a National Institutes Health K23 grant(AI089259) to study novel TB diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Cellestis, 2006, QUANT TB GOLD IN TUB; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Dewan PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-47; DHMH-Maryland, 2011, MAR TB STAT; Grinsdale JA, 2011, INT J TUBERC LUNG D, V15, P1614, DOI 10.5588/ijtld.11.0102; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Kunimoto D, 2009, INT J TUBERC LUNG D, V13, P726; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Ozuah PO, 1999, CHEST, V116, P104, DOI 10.1378/chest.116.1.104; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413	14	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36551	10.1371/journal.pone.0036551	http://dx.doi.org/10.1371/journal.pone.0036551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586476	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335000037
J	Kopera, E; Belczyk-Ciesielska, A; Bal, W				Kopera, Edyta; Belczyk-Ciesielska, Agnieszka; Bal, Wojciech			Application of Ni(II)-Assisted Peptide Bond Hydrolysis to Non-Enzymatic Affinity Tag Removal	PLOS ONE			English	Article							CATALYZED PROTEIN CLEAVAGE; C-TERMINAL TAIL; HISTONE H2A; RECOMBINANT PROTEINS; FUSION; PURIFICATION; COPPER(II); COMPLEX; SITE; NICKEL(II)	In this study, we demonstrate a non-enzymatic method for hydrolytic peptide bond cleavage, applied to the removal of an affinity tag from a recombinant fusion protein, SPI2-SRHWAP-His(6). This method is based on a highly specific Ni(II) reaction with (S/T) XHZ peptide sequences. It can be applied for the protein attached to an affinity column or to the unbound protein in solution. We studied the effect of pH, temperature and Ni(II) concentration on the efficacy of cleavage and developed an analytical protocol, which provides active protein with a 90% yield and similar to 100% purity. The method works well in the presence of non-ionic detergents, DTT and GuHCl, therefore providing a viable alternative for currently used techniques.	[Kopera, Edyta; Belczyk-Ciesielska, Agnieszka; Bal, Wojciech] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Kopera, E (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	wbal@ibb.waw.pl		Bal, Wojciech/0000-0003-3780-083X	Polish National Center for Research and Development [KB/138/13749/IT1-B/U/08]	Polish National Center for Research and Development	This study was financed by Polish National Center for Research and Development, grant no. KB/138/13749/IT1-B/U/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 1996, INT J PEPT PROT RES, V48, P265; Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Baker RT, 1996, CURR OPIN BIOTECH, V7, P541, DOI 10.1016/S0958-1669(96)80059-0; Bal W, 1998, CHEM RES TOXICOL, V11, P1014, DOI 10.1021/tx980051y; Bal W, 2000, CHEM RES TOXICOL, V13, P616, DOI 10.1021/tx000044l; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Dou F, 2000, PREP BIOCHEM BIOTECH, V30, P69, DOI 10.1080/10826060008544946; Humphreys DP, 1999, PROTEIN ENG, V12, P179, DOI 10.1093/protein/12.2.179; Humphreys DP, 2000, PROTEIN ENG, V13, P201, DOI 10.1093/protein/13.3.201; JENCKS WP, 1960, J BIOL CHEM, V235, P3608; Jeon JW, 2003, BIOORGAN MED CHEM, V11, P2901, DOI 10.1016/S0968-0896(03)00216-5; Karaczyn AA, 2003, CHEM RES TOXICOL, V16, P1555, DOI 10.1021/tx0300277; Kludkiewicz B, 2005, PROTEIN EXPRES PURIF, V43, P94, DOI 10.1016/j.pep.2005.06.011; Kopera E, 2010, INORG CHEM, V49, P6636, DOI 10.1021/ic1005709; Krezel A, 2006, ACTA BIOCHIM POL, V53, P721, DOI 10.18388/abp.2006_3299; Krezel A, 2010, J AM CHEM SOC, V132, P3355, DOI 10.1021/ja907567r; Kurowska E, 2011, METALLOMICS, V3, P1227, DOI 10.1039/c1mt00081k; Mao HY, 2004, PROTEIN EXPRES PURIF, V37, P253, DOI 10.1016/j.pep.2004.06.013; Milovic NM, 2003, CHEM-EUR J, V9, P5097, DOI 10.1002/chem.200304772; Mylonas M, 2002, J CHEM SOC DALTON, P4296, DOI 10.1039/b206585a; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 1998, NAT STRUCT BIOL, V5, P249, DOI 10.1038/nsb0498-249; Sadilkova L, 2008, PROTEIN SCI, V17, P1834, DOI 10.1110/ps.035733.108; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Surovtsev VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P531, DOI 10.1023/A:1010211019260; YASHIRO M, 1997, J INORG BIOCHEM, V67, P225	27	25	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36350	10.1371/journal.pone.0036350	http://dx.doi.org/10.1371/journal.pone.0036350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574150	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800046
J	Ogmundsdottir, MH; Heublein, S; Kazi, S; Reynolds, B; Visvalingam, SM; Shaw, MK; Goberdhan, DCI				Oegmundsdottir, Margret H.; Heublein, Sabine; Kazi, Shubana; Reynolds, Bruno; Visvalingam, Shivanthy M.; Shaw, Michael K.; Goberdhan, Deborah C. I.			Proton-Assisted Amino Acid Transporter PAT1 Complexes with Rag GTPases and Activates TORC1 on Late Endosomal and Lysosomal Membranes	PLOS ONE			English	Article							PROMOTES CELL-GROWTH; TUMOR-SUPPRESSOR; SLC36 FAMILY; MTOR; DROSOPHILA; CANCER; IDENTIFICATION; METABOLISM; INHIBITORS; AUTOPHAGY	Mammalian Target of Rapamycin Complex 1 (mTORC1) is activated by growth factor-regulated phosphoinositide 3-kinase (PI3K)/Akt/Rheb signalling and extracellular amino acids (AAs) to promote growth and proliferation. These AAs induce translocation of mTOR to late endosomes and lysosomes (LELs), subsequent activation via mechanisms involving the presence of intralumenal AAs, and interaction between mTORC1 and a multiprotein assembly containing Rag GTPases and the heterotrimeric Ragulator complex. However, the mechanisms by which AAs control these different aspects of mTORC1 activation are not well understood. We have recently shown that intracellular Proton-assisted Amino acid Transporter 1 (PAT1)/SLC36A1 is an essential mediator of AA-dependent mTORC1 activation. Here we demonstrate in Human Embryonic Kidney (HEK-293) cells that PAT1 is primarily located on LELs, physically interacts with the Rag GTPases and is required for normal AA-dependent mTOR relocalisation. We also use the powerful in vivo genetic methodologies available in Drosophila to investigate the regulation of the PAT1/Rag/Ragulator complex. We show that GFP-tagged PATs reside at both the cell surface and LELs in vivo, mirroring PAT1 distribution in several normal mammalian cell types. Elevated PI3K/Akt/Rheb signalling increases intracellular levels of PATs and synergistically enhances PAT-induced growth via a mechanism requiring endocytosis. In light of the recent identification of the vacuolar H+-ATPase as another Rag-interacting component, we propose a model in which PATs function as part of an AA-sensing engine that drives mTORC1 activation from LEL compartments.	[Oegmundsdottir, Margret H.; Heublein, Sabine; Kazi, Shubana; Reynolds, Bruno; Visvalingam, Shivanthy M.; Goberdhan, Deborah C. I.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Shaw, Michael K.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Ogmundsdottir, MH (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, S Parks Rd, Oxford, England.	deborah.goberdhan@dpag.ox.ac.uk			Cancer Research UK (CR-UK) through the Oxford Cancer Research Centre Development Fund [C19591/A6181, C19591/A9093, C7713/A6174, C38302/A12278]; Newton Abraham Studentship (Oxford); Overseas Research Student Award (Oxford); Studiensiftung des deutschen Volkes; Max Weber Programm Bayern (Germany); Biotechnology and Biological Sciences Research Council (BBSRC)	Cancer Research UK (CR-UK) through the Oxford Cancer Research Centre Development Fund; Newton Abraham Studentship (Oxford); Overseas Research Student Award (Oxford); Studiensiftung des deutschen Volkes; Max Weber Programm Bayern (Germany); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding to DCIG from Cancer Research UK (CR-UK) grant numbers C19591/A6181, C19591/A9093, C7713/A6174 and also C38302/A12278, through the Oxford Cancer Research Centre Development Fund. In addition, these studies were supported by a Newton Abraham Studentship (Oxford) and an Overseas Research Student Award (Oxford) to MHO, funding from the Studiensiftung des deutschen Volkes and the Max Weber Programm Bayern (Germany) to SH, and a Biotechnology and Biological Sciences Research Council (BBSRC) Studentship to SMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Azim H, 2010, TARGET ONCOL, V5, P269, DOI 10.1007/s11523-010-0141-x; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broer S, 2008, PHYSIOLOGY, V23, P95, DOI 10.1152/physiol.00045.2007; Bryk B, 2010, DEV BIOL, V344, P150, DOI 10.1016/j.ydbio.2010.04.027; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chen Z, 2003, J PHYSIOL-LONDON, V546, P349, DOI 10.1113/jphysiol.2002.026500; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cohen A, 2009, CELL, V136, P399, DOI 10.1016/j.cell.2009.01.021; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Dorn M, 2009, J BIOL CHEM, V284, P22123, DOI 10.1074/jbc.M109.023713; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Garcia-Echeverria C, 2010, BIOORG MED CHEM LETT, V20, P4308, DOI 10.1016/j.bmcl.2010.05.099; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Goberdhan DCI, 2003, HUM MOL GENET, V12, pR239, DOI 10.1093/hmg/ddg288; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Goberdhan DCI, 2002, DEV GENES EVOL, V212, P196, DOI 10.1007/s00427-002-0226-3; Goberdhan DCI, 2010, CURR OPIN INVEST DR, V11, P1360; Goberdhan DCI, 2009, BIOCHEM SOC T, V37, P248, DOI 10.1042/BST0370248; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hafen E, 2004, SWISS MED WKLY, V134, P711; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Heublein S, 2010, ONCOGENE, V29, P4068, DOI 10.1038/onc.2010.177; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Moline MM, 1999, DEVELOPMENT, V126, P4375; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Pillai SM, 2011, J BIOL CHEM, V286, P2455, DOI 10.1074/jbc.M110.172403; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Resnik-Docampo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014528; Reynolds B, 2007, BIOCHEM SOC T, V35, P1215, DOI 10.1042/BST0351215; Rubio-Aliaga I, 2004, J BIOL CHEM, V279, P2754, DOI 10.1074/jbc.M305556200; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08; Thwaites DT, 2011, BRIT J PHARMACOL, V164, P1802, DOI 10.1111/j.1476-5381.2011.01438.x; Toba G, 1999, GENETICS, V151, P725; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Vanhaesebroeck B, 2011, CURR TOP MICROBIOL, V347, P1, DOI 10.1007/82_2010_65; Vereshchagina N, 2008, J CELL SCI, V121, P3383, DOI 10.1242/jcs.035220; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Woods SC, 2008, ANNU REV NUTR, V28, P295, DOI 10.1146/annurev.nutr.28.061807.155505; Wreden CC, 2003, J NEUROSCI, V23, P1265, DOI 10.1523/JNEUROSCI.23-04-01265.2003; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	73	91	94	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36616	10.1371/journal.pone.0036616	http://dx.doi.org/10.1371/journal.pone.0036616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574197	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349800094
J	Shao, M; Lin, YS; Liu, ZZ; Zhang, Y; Wang, LF; Liu, CB; Zhang, HW				Shao, Ming; Lin, Yushuang; Liu, Zhongzhen; Zhang, Ying; Wang, Lifeng; Liu, Changbin; Zhang, Hongwei			GSK-3 Activity Is Critical for the Orientation of the Cortical Microtubules and the Dorsoventral Axis Determination in Zebrafish Embryos	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; XENOPUS-LAEVIS EMBRYOS; DORSAL DETERMINATION; ORGANIZER FORMATION; SPEMANNS ORGANIZER; YOLK CELL; LITHIUM; MECHANISM; MESODERM; NEUROECTODERM	The formation of dorsal-ventral (D-V) axis is the earliest event that breaks the radial symmetry and determines the bilateral body plan of a vertebrate embryo, however, the maternal control of this process is not fully understood. Here, we discovered a new dorsalizing window of acute lithium treatment, which covers only less than 10 minutes after fertilization. Lithium treatment in this window was not able to reverse the ventralized phenotype in tokkeabi (tkk) mutant embryos, and its dorsalizing activity on wild-type embryos was inhibited by nocodazole co-treatment. These evidences indicate that the underlying mechanism is independent of a direct activation of Wnt/beta-catenin signaling, but depends on the upstream level of the microtubule mediated dorsal determinant transport. In order to identify the target of lithium in this newly discovered sensitive window, GSK-3 inhibitor IX as well as the IMPase inhibitor L690, 330 treatments were performed. We found that only GSK-3 inhibitor IX treatment mimicked the lithium treatment in the dorsalizing activity. Further study showed that the parallel pattern of cortical microtubules in the vegetal pole region and the directed migration of the Wnt8a mRNA were randomized by either lithium or GSK-3 inhibitor IX treatment. These results thus revealed an early and critical role of GSK-3 activity that regulates the orientation of the cortical microtubules and the directed transport of the dorsal determinants in zebrafish embryos.	[Shao, Ming; Lin, Yushuang; Liu, Zhongzhen; Zhang, Ying; Wang, Lifeng; Liu, Changbin; Zhang, Hongwei] Shandong Univ, Life Sci Coll, Key Lab Anim Cells & Dev Biol Shandong Prov, Key Lab Expt Teratol,Minist Educ, Jinan 250100, Peoples R China	Shandong University	Shao, M (corresponding author), Shandong Univ, Life Sci Coll, Key Lab Anim Cells & Dev Biol Shandong Prov, Key Lab Expt Teratol,Minist Educ, Jinan 250100, Peoples R China.	zhw@sdu.edu.cn	Shao, Ming/AAZ-8099-2021		Independent Innovation Foundation of Shandong University, IIFSDU [11200070614069]; China Postdoctoral Science Foundation [10000070311136]; National Natural Science Foundation of China [30570967, 30671072]; 973 Major Science Programs from the Ministry of Science and Technology of China [2007CB947100, 2007CB815800]	Independent Innovation Foundation of Shandong University, IIFSDU; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Major Science Programs from the Ministry of Science and Technology of China	This work was supported by the Independent Innovation Foundation of Shandong University, IIFSDU (11200070614069) and China Postdoctoral Science Foundation (10000070311136), the National Natural Science Foundation of China (30570967, 30671072), and the 973 Major Science Programs (2007CB947100, 2007CB815800) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanstad P, 1999, MECH DEVELOP, V88, P33, DOI 10.1016/S0925-4773(99)00171-9; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; DRIEVER W, 1995, CURR OPIN GENET DEV, V5, P610, DOI 10.1016/0959-437X(95)80030-1; Fekany K, 1999, DEVELOPMENT, V126, P1427; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Gurvich N, 2002, PHARMACOL THERAPEUT, V96, P45, DOI 10.1016/S0163-7258(02)00299-1; HAINSKI AM, 1992, DEVELOPMENT, V116, P347; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hibi M, 2002, RES PRO CEL, V40, P48; Inoue D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019713; Jesuthasan S, 1997, CURR BIOL, V7, P31, DOI 10.1016/S0960-9822(06)00025-X; Johnson G V, 1999, J Alzheimers Dis, V1, P329; Joore J, 1996, MECH DEVELOP, V55, P3, DOI 10.1016/0925-4773(95)00481-5; KAO KR, 1989, DEV BIOL, V132, P81, DOI 10.1016/0012-1606(89)90207-8; KAO KR, 1986, NATURE, V322, P371, DOI 10.1038/322371a0; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kelly C, 2000, DEVELOPMENT, V127, P3899; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Langdon YG, 2010, MATERNAL ZYGOTIC CON; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Mizuno T, 1999, MECH DEVELOP, V81, P51, DOI 10.1016/S0925-4773(98)00202-0; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Nojima H, 2010, DEVELOPMENT, V137, P923, DOI 10.1242/dev.046425; Ober EA, 1999, DEV BIOL, V215, P167, DOI 10.1006/dbio.1999.9455; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; SCHARF SR, 1989, DEV BIOL, V134, P175, DOI 10.1016/0012-1606(89)90087-0; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Sconzo G, 1998, CELL BIOL INT, V22, P91, DOI 10.1006/cbir.1998.0229; Shaldubina A, 2001, PROG NEURO-PSYCHOPH, V25, P855, DOI 10.1016/S0278-5846(01)00154-3; Sirotkin HI, 2000, DEVELOPMENT, V127, P2583; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; STRAHLE U, 1993, DEVELOPMENT, V119, P909; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Weaver C, 2003, DEVELOPMENT, V130, P5425, DOI 10.1242/dev.00737; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Westfall TA, 2003, DEV BIOL, V259, P380, DOI 10.1016/S0012-1606(03)00209-4; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012	48	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36655	10.1371/journal.pone.0036655	http://dx.doi.org/10.1371/journal.pone.0036655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574208	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800105
J	Wong, KL; Chen, WQ; Balakrishnan, T; Toh, YX; Fink, K; Wong, SC				Wong, Kok Loon; Chen, Weiqiang; Balakrishnan, Thavamalar; Toh, Ying Xiu; Fink, Katja; Wong, Siew-Cheng			Susceptibility and Response of Human Blood Monocyte Subsets to Primary Dengue Virus Infection	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CHEMOKINE RECEPTOR EXPRESSION; CELL-DEATH APOPTOSIS; DIFFERENTIAL REGULATION; TNF-ALPHA; T-CELLS; PERMEABILITY; SUBPOPULATIONS; MACROPHAGES; ENHANCEMENT	Human blood monocytes play a central role in dengue infections and form the majority of virus infected cells in the blood. Human blood monocytes are heterogeneous and divided into CD16(-) and CD16(+) subsets. Monocyte subsets play distinct roles during disease, but it is not currently known if monocyte subsets differentially contribute to dengue protection and pathogenesis. Here, we compared the susceptibility and response of the human CD16(-) and CD16(+) blood monocyte subsets to primary dengue virus in vitro. We found that both monocyte subsets were equally susceptible to dengue virus (DENV2 NGC), and capable of supporting the initial production of new infective virus particles. Both monocyte subsets produced anti-viral factors, including IFN-alpha, CXCL10 and TRAIL. However, CD16(+) monocytes were the major producers of inflammatory cytokines and chemokines in response to dengue virus, including IL-1 beta, TNF-alpha, IL-6, CCL2, 3 and 4. The susceptibility of both monocyte subsets to infection was increased after IL-4 treatment, but this increase was more profound for the CD16(+) monocyte subset, particularly at early time points after virus exposure. These findings reveal the differential role that monocyte subsets might play during dengue disease.	[Wong, Kok Loon; Chen, Weiqiang; Balakrishnan, Thavamalar; Toh, Ying Xiu; Fink, Katja; Wong, Siew-Cheng] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Wong, KL (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.	wong_kok_loon@immunol.a-star.edu.sg	Fink, Katja/AAI-1881-2021	Fink, Katja/0000-0002-3571-0390; Chen, Weiqiang/0000-0002-8840-1823	Biomedical Research Council, ASTAR, Singapore	Biomedical Research Council, ASTAR, Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by the Biomedical Research Council, ASTAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Carr JM, 2003, J MED VIROL, V69, P521, DOI 10.1002/jmv.10340; Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Chen YC, 2002, J VIROL, V76, P9877, DOI 10.1128/JVI.76.19.9877-9887.2002; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Devignot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011671; Dewi BE, 2004, J VIROL METHODS, V121, P171, DOI 10.1016/j.jviromet.2004.06.013; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Fahy RJ, 1999, J IMMUNOL, V163, P1755; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Fink K, 2009, EUR J IMMUNOL, V39, P2809, DOI 10.1002/eji.200939389; Frankenberger M, 1996, BLOOD, V87, P373; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; HALSTEAD SB, 1977, J EXP MED, V146, P218, DOI 10.1084/jem.146.1.218; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Ip PP, 2010, J IMMUNOL, V184, P5705, DOI 10.4049/jimmunol.0903484; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Kumar-Sinha C, 2002, J BIOL CHEM, V277, P575, DOI 10.1074/jbc.M107795200; KURANE I, 1988, J GEN VIROL, V69, P445, DOI 10.1099/0022-1317-69-2-445; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MANGAN DF, 1991, J IMMUNOL, V147, P3408; MANGAN DF, 1991, J IMMUNOL, V146, P1541; McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Spain-Santana TA, 2001, J MED VIROL, V65, P324, DOI 10.1002/jmv.2037; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566; Wang L, 2007, AM J TROP MED HYG, V77, P297, DOI 10.4269/ajtmh.2007.77.297; Warke RV, 2008, J VIROL, V82, P555, DOI 10.1128/JVI.01694-06; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08; Zawada AM, 2011, BLOOD; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZieglerHeitbrock HWL, 1996, IMMUNOL TODAY, V17, P424, DOI 10.1016/0167-5699(96)10029-3	62	52	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36435	10.1371/journal.pone.0036435	http://dx.doi.org/10.1371/journal.pone.0036435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574162	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800058
J	Naidoo, R; Du Preez, P; Stuart-Hill, G; Jago, M; Wegmann, M				Naidoo, Robin; Du Preez, Pierre; Stuart-Hill, Greg; Jago, Mark; Wegmann, Martin			Home on the Range: Factors Explaining Partial Migration of African Buffalo in a Tropical Environment	PLOS ONE			English	Article							PREDATION RISK; BEHAVIOR; MIGRANT; ECOLOGY; FORAGE; NDVI; SIZE	Partial migration (when only some individuals in a population undertake seasonal migrations) is common in many species and geographical contexts. Despite the development of modern statistical methods for analyzing partial migration, there have been no studies on what influences partial migration in tropical environments. We present research on factors affecting partial migration in African buffalo (Syncerus caffer) in northeastern Namibia. Our dataset is derived from 32 satellite tracking collars, spans 4 years and contains over 35,000 locations. We used remotely sensed data to quantify various factors that buffalo experience in the dry season when making decisions on whether and how far to migrate, including potential man-made and natural barriers, as well as spatial and temporal heterogeneity in environmental conditions. Using an information-theoretic, non-linear regression approach, our analyses showed that buffalo in this area can be divided into 4 migratory classes: migrants, non-migrants, dispersers, and a new class that we call "expanders". Multimodel inference from least-squares regressions of wet season movements showed that environmental conditions (rainfall, fires, woodland cover, vegetation biomass), distance to the nearest barrier (river, fence, cultivated area) and social factors (age, size of herd at capture) were all important in explaining variation in migratory behaviour. The relative contributions of these variables to partial migration have not previously been assessed for ungulates in the tropics. Understanding the factors driving migratory decisions of wildlife will lead to better-informed conservation and land-use decisions in this area.	[Naidoo, Robin] WWF US, Conservat Sci Program, Washington, DC USA; [Du Preez, Pierre; Jago, Mark] Minist Environm & Tourism, Directorate Sci Serv, Windhoek, Namibia; [Stuart-Hill, Greg] World Wildlife Fund WWF Namibia, Windhoek, Namibia; [Wegmann, Martin] Univ Wurzburg, Dept Remote Sensing, Wurzburg, Bavaria, Germany	World Wildlife Fund; University of Wurzburg	Naidoo, R (corresponding author), WWF US, Conservat Sci Program, Washington, DC USA.	robin.naidoo@wwfus.org		Wegmann, Martin/0000-0003-0335-9601	WWF-US; WWF-Germany; Game Products Trust Fund; Ministry of Environment and Tourism, Namibia [1537/2010, 1339/2008, 1184/2007]	WWF-US; WWF-Germany; Game Products Trust Fund; Ministry of Environment and Tourism, Namibia	The work was funded by WWF-US and by WWF-Germany, as well as by the Game Products Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Erica Rieder, Carol Murphy, Julie Taylor, Ortwin Aschenborn, Vincent Guillemin, Simon Mayes, Beavan Munali, Hans Swartbooi, Bollen Zingolo, Shadrich Siloka, Jannie du Preez, Carl-Heinz Moelle, Piet Beytell, Lise Hansen, Euan Anderson, Andrea Capobianco, Scott Loarie, Ally Thompson, Sylvia Thompson, Russell Taylor, Chris Weaver, Dave Ward, Raymond Peters, Jo Tagg, and Bucker assisted with field work and/or data interpretation and analysis. Comments from Mark Boyce and two anonymous reviewers greatly improved an earlier manuscript draft. The research was conducted under permits 1537/2010, 1339/2008, and 1184/2007 from the Ministry of Environment and Tourism, Namibia, whom we thank for their support.	Ball JP, 2001, WILDLIFE BIOL, V7, P39, DOI 10.2981/wlb.2001.007; BERTHOLD P, 1981, SCIENCE, V212, P77, DOI 10.1126/science.212.4490.77; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Bolger DT, 2008, ECOL LETT, V11, P63; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Bucini G, 2007, GLOBAL ECOL BIOGEOGR, V16, P593, DOI 10.1111/j.1466-8238.2007.00325.x; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chase MJ, 2009, AFR J ECOL, V47, P223, DOI 10.1111/j.1365-2028.2008.01017.x; Cornelis D, 2011, J MAMMAL, V92, P1287, DOI 10.1644/10-MAMM-A-397.1; de Beer Y, 2008, J ARID ENVIRON, V72, P2017, DOI 10.1016/j.jaridenv.2008.07.002; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Geremia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016848; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Grayson KL, 2011, ECOLOGY, V92, P1236, DOI 10.1890/11-0133.1; Halley DJ, 2004, S AFR J WILDL RES, V34, P105; Halley DJ, 2002, AFR J ECOL, V40, P97, DOI 10.1046/j.0141-6707.2001.00336.x; Hansen BB, 2010, CAN J ZOOL, V88, P1202, DOI 10.1139/Z10-086; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Holdo RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016370; Holdo RM, 2009, AM NAT, V173, P431, DOI 10.1086/597229; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Jahn AE, 2010, J ANIM ECOL, V79, P983, DOI 10.1111/j.1365-2656.2010.01713.x; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Martin RB, 2002, TRANSBOUNDARY SPECIE; McLoughlin PD, 2000, ECOSCIENCE, V7, P123, DOI 10.1080/11956860.2000.11682580; Mendelsohn J., 1997, ENV PROFILE ATLAS CA; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; R Core Team, 2022, R LANG ENV STAT COMP; Redfern JV, 2005, J ARID ENVIRON, V63, P406, DOI 10.1016/j.jaridenv.2005.03.016; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Rivrud IM, 2010, J ANIM ECOL, V79, P1280, DOI 10.1111/j.1365-2656.2010.01731.x; Robillard MM, 2011, BIOL CONSERV, V144, P1931, DOI 10.1016/j.biocon.2011.03.022; Robinson BG, 2010, OECOLOGIA, V164, P265, DOI 10.1007/s00442-010-1620-6; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Sekercioglu CH, 2010, J ANIM ECOL, V79, P933, DOI 10.1111/j.1365-2656.2010.01739.x; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; Taylor JJ, 2008, GEOFORUM, V39, P1766, DOI 10.1016/j.geoforum.2008.04.001; Traill LW, 2007, AFR J ECOL, V45, P347, DOI 10.1111/j.1365-2028.2006.00717.x; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; White PJ, 2007, BIOL CONSERV, V135, P502, DOI 10.1016/j.biocon.2006.10.041; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; Yackulic CB, 2011, J ANIM ECOL, V80, P1088, DOI 10.1111/j.1365-2656.2011.01851.x	55	50	52	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36527	10.1371/journal.pone.0036527	http://dx.doi.org/10.1371/journal.pone.0036527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570722	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305343400038
J	Andersen, JT; Foss, S; Kenanova, VE; Olafsen, T; Leikfoss, IS; Roopenian, DC; Wu, AM; Sandlie, I				Andersen, Jan Terje; Foss, Stian; Kenanova, Vania E.; Olafsen, Tove; Leikfoss, Ingvild S.; Roopenian, Derry C.; Wu, Anna M.; Sandlie, Inger			Anti-carcinoembryonic Antigen Single-chain Variable Fragment Antibody Variants Bind Mouse and Human Neonatal Fc Receptor with Different Affinities That Reveal Distinct Cross-species Differences in Serum Half-life	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-RELATED RECEPTOR; ENGINEERED ANTIBODY; IMMUNOGLOBULIN-G; IGG HOMEOSTASIS; THERAPEUTIC ANTIBODIES; COLORECTAL-CANCER; RAT HEPATOCYTES; DENDRITIC CELLS; FUSION PROTEIN; EXPRESSION	Serum half-life of IgG is controlled by the neonatal Fc receptor (FcRn) that interacts with the IgG Fc region and may be increased or decreased as a function of altered FcRn binding. Preclinical evaluations of modified IgGs are frequently carried out in mice, but such IgGs may bind differently to mouse and human FcRn (mFcRn and hFcRn). Here, we report a detailed characterization of a matched set of mouse-human chimeric T84.66 scFv-Fc variants with specificity for the tumor carcinoembryonic antigen and mutations in the FcRn-binding site. Binding to soluble mFcRn and hFcRn was measured using in vitro assays, and the results were compared with blood clearance in vivo in normal (mFcRn bearing) and hFcRn transgenic mice. All variants bound better to mFcRn than to hFcRn. The loss of affinity varied among the mutants, however, and also the hierarchy of binding differed depending on the receptor. The mutations had no major impact on binding to the classical Fc gamma receptors. Importantly, the trend of blood clearance in both strains of mice correlated with the hierarchy of binding obtained using soluble FcRn. Consequently, in vitro interaction analysis of engineered IgGs regarding their cross-species FcRn binding ability provides information for prediction of in vivo pharmacokinetics.	[Andersen, Jan Terje; Foss, Stian; Leikfoss, Ingvild S.; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, N-0316 Oslo, Norway; [Andersen, Jan Terje; Foss, Stian; Leikfoss, Ingvild S.; Sandlie, Inger] Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; [Andersen, Jan Terje; Foss, Stian; Leikfoss, Ingvild S.; Sandlie, Inger] Univ Hosp, Ctr Immune Regulat, Rikshosp, N-0424 Oslo, Norway; [Andersen, Jan Terje; Foss, Stian; Leikfoss, Ingvild S.; Sandlie, Inger] Univ Hosp, Dept Immunol, Rikshosp, N-0424 Oslo, Norway; [Kenanova, Vania E.; Olafsen, Tove; Wu, Anna M.] Univ Calif Los Angeles, David Geffen Sch Med, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Leikfoss, Ingvild S.] Univ Oslo, Inst Basic Med Sci, N-0317 Oslo, Norway; [Roopenian, Derry C.] Jackson Lab, Bar Harbor, ME 04609 USA	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oslo; Jackson Laboratory	Sandlie, I (corresponding author), Natl Hosp Norway, CIR, Oslo Univ Hosp, POB 4956, N-0424 Oslo, Norway.	inger.sandlie@imbv.uio.no	Andersen, Jan Terje/AAB-6209-2020	Wu, Anna/0000-0001-8487-823X; Foss, Stian/0000-0001-6527-051X; Andersen, Jan Terje/0000-0003-1710-1628	National Institutes of Health [CA043902, CA086306, CA016042]; Norwegian Research Council [179573/V40]; South-Eastern Norway Regional Health Authority [9375]; NATIONAL CANCER INSTITUTE [R01CA043902, P30CA016042, P50CA086306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA043902, CA086306, and CA016042 (to V. E. K., T. O., and A. M. W.).; Supported by Norwegian Research Council Grant 179573/V40 and South-Eastern Norway Regional Health Authority Grant 9375. To whom correspondence may be addressed: Centre for Immune Regulation and Dept. of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P. O. Box 4956, Oslo N-0424, Norway. E-mail: j.t.andersen@imbv.uio.no.	Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; BLUMBERG D, 1995, METABOLISM, V44, P145, DOI 10.1016/0026-0495(95)90255-4; Blumberg RS, 2005, NAT BIOTECHNOL, V23, P1232, DOI 10.1038/nbt1005-1232; BLUMBERG RS, 1995, J CLIN INVEST, V95, P2397, DOI 10.1172/JCI117934; BOUCHER D, 1989, CANCER RES, V49, P847; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; ESTEBAN JM, 1993, HUM PATHOL, V24, P322, DOI 10.1016/0046-8177(93)90044-H; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; Girgis MD, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-24; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hu SZ, 1996, CANCER RES, V56, P3055; Kamei DT, 2005, BIOTECHNOL BIOENG, V92, P748, DOI 10.1002/bit.20624; Kenanova V, 2005, CANCER RES, V65, P622; Kenanova V, 2007, CANCER RES, V67, P718, DOI 10.1158/0008-5472.CAN-06-0454; Kenanova Vania, 2006, Expert Opin Drug Deliv, V3, P53, DOI 10.1517/17425247.3.1.53; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Medesan C, 1997, J IMMUNOL, V158, P2211; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Olafsen T, 2005, CANCER RES, V65, P5907, DOI 10.1158/0008-5472.CAN-04-4472; Olafsen T, 2010, PROTEIN ENG DES SEL, V23, P243, DOI 10.1093/protein/gzp081; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Popov S, 1996, MOL IMMUNOL, V33, P521, DOI 10.1016/0161-5890(96)00004-1; Prabhat P, 2007, P NATL ACAD SCI USA, V104, P5889, DOI 10.1073/pnas.0700337104; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; RAGHAVAN M, 1994, IMMUNITY, V1, P303, DOI 10.1016/1074-7613(94)90082-5; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; SPIEGELBERG HL, 1968, J CLIN INVEST, V47, P2323, DOI 10.1172/JCI105917; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; Stein C, 2012, MAMM GENOME, V23, P259, DOI 10.1007/s00335-011-9379-6; Sundaresan G, 2003, J NUCL MED, V44, P1962; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Vaccaro C, 2006, P NATL ACAD SCI USA, V103, P18709, DOI 10.1073/pnas.0606304103; Ward ES, 2003, INT IMMUNOL, V15, P187, DOI 10.1093/intimm/dxg018; Wong JYC, 2004, CLIN CANCER RES, V10, P5014, DOI 10.1158/1078-0432.CCR-03-0576; Wu AM, 2000, P NATL ACAD SCI USA, V97, P8495, DOI 10.1073/pnas.150228297; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zhou JC, 2005, J MOL BIOL, V345, P1071, DOI 10.1016/j.jmb.2004.11.014; Zhu XP, 2001, J IMMUNOL, V166, P3266, DOI 10.4049/jimmunol.166.5.3266	57	25	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22927	22937		10.1074/jbc.M112.355131	http://dx.doi.org/10.1074/jbc.M112.355131			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570488	Green Published, hybrid			2022-12-25	WOS:000306495000050
J	Bentley, AA; Merkulov, SM; Peng, Y; Rozmarynowycz, R; Qi, XP; Pusztai-Carey, M; Merrick, WC; Yee, VC; McCrae, KR; Komar, AA				Bentley, Amber A.; Merkulov, Sergei M.; Peng, Yi; Rozmarynowycz, Rita; Qi, Xiaoping; Pusztai-Carey, Marianne; Merrick, William C.; Yee, Vivien C.; McCrae, Keith R.; Komar, Anton A.			Chimeric Glutathione S-Transferases Containing Inserts of Kininogen Peptides POTENTIAL NOVEL PROTEIN THERAPEUTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; INHIBITS ANGIOGENESIS; RATIONAL DESIGN; STABILITY; DOMAIN-5; LOOP; CONFORMATION; JAPONICUM; EVOLUTION; GRAPHICS	The study of synthetic peptides corresponding to discrete regions of proteins has facilitated the understanding of protein structure-activity relationships. Short peptides can also be used as powerful therapeutic agents. However, in many instances, small peptides are prone to rapid degradation or aggregation and may lack the conformation required to mimic the functional motifs of the protein. For peptides to function as pharmacologically active agents, efficient production or expression, high solubility, and retention of biological activity through purification and storage steps are required. We report here the design, expression, and functional analysis of eight engineered GST proteins (denoted GSHKTs) in which peptides ranging in size from 8 to 16 amino acids and derived from human high molecular weight kininogen (HK) domain 5 were inserted into GST (between Gly-49 and Leu-50). Peptides derived from HK are known to inhibit cell proliferation, angiogenesis, and tumor metastasis, and the biological activity of the HK peptides was dramatically (>50-fold) enhanced following insertion into GST. GSHKTs are soluble and easily purified from Escherichia coli by affinity chromatography. Functionally, these hybrid proteins cause inhibition of endothelial cell proliferation. Crystallographic analysis of GSHKT10 and GSHKT13 (harboring 10- and 13-residue HK peptides, respectively) showed that the overall GST structure was not perturbed. These results suggest that the therapeutic efficacy of short peptides can be enhanced by insertion into larger proteins that are easily expressed and purified and that GST may potentially be used as such a carrier.	[McCrae, Keith R.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [McCrae, Keith R.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Komar, Anton A.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Merkulov, Sergei M.; Qi, Xiaoping] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Peng, Yi; Pusztai-Carey, Marianne; Merrick, William C.; Yee, Vivien C.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland State University; Case Western Reserve University; Case Western Reserve University	McCrae, KR (corresponding author), Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA.	mccraek@ccf.org; a.komar@csuohio.edu		Komar, Anton/0000-0003-4188-0633	National Institutes of Health [HL089796, GM68079]; National American Heart Association [0730120N];  [DK075897];  [GM61388]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388, R01GM068079, U01GM061388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National American Heart Association(American Heart Association); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089796 (to K. R. M.), GM68079 (to W. C. M.), and DK075897 and GM61388 (to V. C. Y. and Y. P.). This work was supported by National American Heart Association Grant 0730120N (to A. A. K.).	Brockwell D, 2001, PROTEIN SCI, V10, P572, DOI 10.1110/ps.46001; Cardoso RMF, 2003, PROTEINS, V51, P137, DOI 10.1002/prot.10345; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Church WB, 2001, J BIOL CHEM, V276, P33156, DOI 10.1074/jbc.M101272200; Collinet B, 2001, EUR J BIOCHEM, V268, P5107, DOI 10.1046/j.0014-2956.2001.02439.x; Colman RW, 2000, BLOOD, V95, P543, DOI 10.1182/blood.V95.2.543; Daly ME, 2003, JNCI-J NATL CANCER I, V95, P1660, DOI 10.1093/jnci/djg101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fowler SB, 2005, P NATL ACAD SCI USA, V102, P10105, DOI 10.1073/pnas.0501215102; Greenberg M, 2004, REV MED VIROL, V14, P321, DOI 10.1002/rmv.440; Kamiyama F, 2001, BIOCHEM BIOPH RES CO, V288, P975, DOI 10.1006/bbrc.2001.5864; Kawasaki M, 2003, J BIOL CHEM, V278, P49301, DOI 10.1074/jbc.M308790200; KELLEY LA, 1999, RECOMB 99 P 3 ANN C, P218; Kiyota S, 2003, J MED CHEM, V46, P2325, DOI 10.1021/jm020543e; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuhlman B, 2002, J MOL BIOL, V315, P471, DOI 10.1006/jmbi.2001.5229; Ladurner AG, 1997, J MOL BIOL, V273, P330, DOI 10.1006/jmbi.1997.1304; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazar GA, 2003, CURR OPIN STRUC BIOL, V13, P513, DOI 10.1016/S0959-440X(03)00104-0; Marshall SA, 2003, DRUG DISCOV TODAY, V8, P212, DOI 10.1016/S1359-6446(03)02610-2; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Mehta N. M., 2003, Current Pharmaceutical Design, V9, P2659, DOI 10.2174/1381612033453622; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miyamoto Fusako, 2012, Antiviral Chemistry & Chemotherapy, V22, P151, DOI 10.3851/IMP1930; Moult J, 2000, CURR OPIN STRUC BIOL, V10, P384, DOI 10.1016/S0959-440X(00)00101-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagi AD, 1997, FOLD DES, V2, P67, DOI 10.1016/S1359-0278(97)00007-2; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pokala N, 2001, J STRUCT BIOL, V134, P269, DOI 10.1006/jsbi.2001.4349; Regan L, 1999, CURR OPIN STRUC BIOL, V9, P494, DOI 10.1016/S0959-440X(99)80070-0; Sambrook J., 2002, MOL CLONING LAB MANU; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sheffield W. P., 2001, Current Drug Targets - Cardiovascular and Haematological Disorders, V1, P1, DOI 10.2174/1568006013338150; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; SIBANDA BL, 1993, J MOL BIOL, V229, P428, DOI 10.1006/jmbi.1993.1044; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Sundaram R, 2002, BIOPOLYMERS, V66, P200, DOI 10.1002/bip.10258; Thanki N, 1997, PROTEIN ENG, V10, P159, DOI 10.1093/protein/10.2.159; Tibbetts SA, 2000, PEPTIDES, V21, P1161, DOI 10.1016/S0196-9781(00)00255-2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com; Zhang JC, 2002, P NATL ACAD SCI USA, V99, P12224, DOI 10.1073/pnas.192668299; Zhang JC, 2002, CAN J PHYSIOL PHARM, V80, P85, DOI 10.1139/Y02-011	44	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22142	22150		10.1074/jbc.M112.372854	http://dx.doi.org/10.1074/jbc.M112.372854			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577144	Green Published, hybrid			2022-12-25	WOS:000306418600051
J	Oh, HJ; Abraham, LS; van Hengel, J; Stove, C; Proszynski, TJ; Gevaert, K; DiMario, JX; Sanes, JR; van Roy, F; Kim, H				Oh, Hyun J.; Abraham, Linu S.; van Hengel, Jolanda; Stove, Christophe; Proszynski, Tomasz J.; Gevaert, Kris; DiMario, Joseph X.; Sanes, Joshua R.; van Roy, Frans; Kim, Hongkyun			Interaction of alpha-Catulin with Dystrobrevin Contributes to Integrity of Dystrophin Complex in Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; MUSCULAR-DYSTROPHIES; SKELETAL-MUSCLE; PROTEIN COMPLEX; BK CHANNEL; MDX MICE; GLYCOPROTEIN COMPLEX; C. ELEGANS; LOCALIZATION; PATHOGENESIS	The dystrophin complex is a multimolecular membrane-associated protein complex whose defects underlie many forms of muscular dystrophy. The dystrophin complex is postulated to function as a structural element that stabilizes the cell membrane by linking the contractile apparatus to the extracellular matrix. Abetter understanding of how this complex is organized and localized will improve our knowledge of the pathogenic mechanisms of diseases that involve the dystrophin complex. In a Caenorhabditis elegans genetic study, we demonstrate that CTN-1/alpha-catulin, a cytoskeletal protein, physically interacts with DYB-1/alpha-dystrobrevin (a component of the dystrophin complex) and that this interaction is critical for the localization of the dystrophin complex near dense bodies, structures analogous to mammalian costameres. We further show that in mouse alpha-catulin is localized at the sarcolemma and neuromuscular junctions and interacts with alpha-dystrobrevin and that the level of alpha-catulin is reduced in alpha-dystrobrevin- deficient mouse muscle. Intriguingly, in the skeletal muscle of mdx mice lacking dystrophin, we discover that the expression of alpha-catulin is increased, suggesting a compensatory role of alpha-catulin in dystrophic muscle. Together, our study demonstrates that the interaction between alpha-catulin and alpha-dystrobrevin is evolutionarily conserved in C. elegans and mammalian muscles and strongly suggests that this interaction contributes to the integrity of the dystrophin complex.	[Oh, Hyun J.; Abraham, Linu S.; DiMario, Joseph X.; Kim, Hongkyun] Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, Chicago Med Sch, N Chicago, IL 60064 USA; [van Hengel, Jolanda; Stove, Christophe; van Roy, Frans] VIB, Dept Mol Biomed Res, Ghent, Belgium; [van Hengel, Jolanda; Stove, Christophe; van Roy, Frans] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium; [Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Proszynski, Tomasz J.] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02140 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Harvard University	Kim, H (corresponding author), Rosalind Franklin Univ, Dept Cell Biol & Anat, Chicago Med Sch, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	hongkyun.kim@rosalindfranklin.edu	Gevaert, Kris/D-6489-2017; Gevaert, Kris/AAE-4212-2019; Stove, Christophe/B-6057-2008; Proszynski, Tomasz/S-2221-2016; Gevaert, Kris/H-3637-2013; van Roy, Frans M/C-6123-2009	Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Stove, Christophe/0000-0001-7126-348X; Proszynski, Tomasz/0000-0002-1115-0069; Gevaert, Kris/0000-0002-4237-0283; van Roy, Frans M/0000-0003-4358-1039; Oh, Kelly/0000-0001-8203-5247; Kim, Hongkyun/0000-0002-4879-7122	National Institute of Health [R01NS058814, R01NS059853, R01AR058043]; Concerted Research Actions (GOA) of Ghent University; Research Foundation-Flanders (FWO-Vlaanderen); National Center for Research Resources; NICHD, National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR058043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059853, R01NS058814] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Concerted Research Actions (GOA) of Ghent University; Research Foundation-Flanders (FWO-Vlaanderen)(FWO); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institute of Health Grants R01NS058814 (to H. K.), R01NS059853 (to J. R. S.), and R01AR058043 (to J. X. D.). This work was also supported by the Concerted Research Actions (GOA) of Ghent University and the Research Foundation-Flanders (FWO-Vlaanderen) (to F. v. R.).; Some strains used in this study were provided by the Caenorhabditis Genetics Center, which is funded by the National Center for Research Resources. Anti-dystrophin antibody and anti-alpha-tubulin antibody were obtained from Developmental Hybridoma Bank developed under auspices of the NICHD, National Institutes of Health.	Abraham LS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001077; Albrecht DE, 2004, J BIOL CHEM, V279, P7014, DOI 10.1074/jbc.M312205200; Baltgalvis KA, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-32; Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192; Bohm SV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-85; BRENNER S, 1974, GENETICS, V77, P71; Brown SC, 2005, MUSCLE NERVE, V32, P715, DOI 10.1002/mus.20431; Carre-Pierrat M, 2006, J MOL BIOL, V358, P387, DOI 10.1016/j.jmb.2006.02.037; Ceccarini M, 2005, J MOL BIOL, V354, P872, DOI 10.1016/j.jmb.2005.09.069; Chen BJ, 2010, EMBO J, V29, P3184, DOI 10.1038/emboj.2010.194; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Ghesquiere B, 2006, RAPID COMMUN MASS SP, V20, P2885, DOI 10.1002/rcm.2676; Gieseler K, 1999, NEUROGENETICS, V2, P87, DOI 10.1007/s100480050057; Gieseler K, 2001, J MOL BIOL, V307, P107, DOI 10.1006/jmbi.2000.4480; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grisoni K, 2002, GENE, V294, P77, DOI 10.1016/S0378-1119(02)00762-X; Grisoni K, 2003, J MOL BIOL, V332, P1037, DOI 10.1016/j.jmb.2003.08.021; Hanft LM, 2006, P NATL ACAD SCI USA, V103, P5385, DOI 10.1073/pnas.0600980103; Janssens B, 1999, BBA-GENE STRUCT EXPR, V1447, P341, DOI 10.1016/S0167-4781(99)00170-0; Kim H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000780; Lyssand JS, 2010, P NATL ACAD SCI USA, V107, P21854, DOI 10.1073/pnas.1010819107; Moerman D. G., 2006, WORMBOOK, DOI [/10.1895/wormbook.1.7.1, DOI 10.1895/WORMBOOK.1.7.1]; Nawrotzki R, 1998, J CELL SCI, V111, P2595; Newey SE, 2001, MOL CELL NEUROSCI, V17, P127, DOI 10.1006/mcne.2000.0918; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PARDO JV, 1983, J CELL BIOL, V97, P1081, DOI 10.1083/jcb.97.4.1081; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Poon E, 2002, J BIOL CHEM, V277, P3433, DOI 10.1074/jbc.M105273200; PORTER GA, 1992, J CELL BIOL, V117, P997, DOI 10.1083/jcb.117.5.997; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sancar F, 2011, J BIOL CHEM, V286, P33501, DOI 10.1074/jbc.M111.227678; Straub V, 1998, AM J PATHOL, V153, P1623, DOI 10.1016/S0002-9440(10)65751-3; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; Williams MW, 1999, J CELL BIOL, V144, P1259, DOI 10.1083/jcb.144.6.1259; YOSHIDA M, 1995, FEBS LETT, V367, P311, DOI 10.1016/0014-5793(95)00574-S	43	17	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21717	21728		10.1074/jbc.M112.369496	http://dx.doi.org/10.1074/jbc.M112.369496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577143	Green Published, hybrid			2022-12-25	WOS:000306418600013
J	Abdelkrim, J; Hunt, GR; Gray, RD; Gemmell, NJ				Abdelkrim, Jawad; Hunt, Gavin R.; Gray, Russell D.; Gemmell, Neil J.			Population Genetic Structure and Colonisation History of the Tool-Using New Caledonian Crow	PLOS ONE			English	Article							MANUFACTURE; WILD; INFERENCE; NUMBER; G(ST); LOCI	New Caledonian crows exhibit considerable variation in tool making between populations. Here, we present the first study of the species' genetic structure over its geographical distribution. We collected feathers from crows on mainland Grande Terre, the inshore island of Toupeti, and the nearby island of Mare where it is believed birds were introduced after European colonisation. We used nine microsatellite markers to establish the genotypes of 136 crows from these islands and classical population genetic tools as well as Approximate Bayesian Computations to explore the distribution of genetic diversity. We found that New Caledonian crows most likely separate into three main distinct clusters: Grande Terre, Toupeti and Mare. Furthermore, Toupeti and Mare crows represent a subset of the genetic diversity observed on Grande Terre, confirming their mainland origin. The genetic data are compatible with a colonisation of Mare taking place after European colonisation around 1900. Importantly, we observed (1) moderate, but significant, genetic differentiation across Grande Terre, and (2) that the degree of differentiation between populations on the mainland increases with geographic distance. These data indicate that despite individual crows' potential ability to disperse over large distances, most gene flow occurs over short distances. The temporal and spatial patterns described provide a basis for further hypothesis testing and investigation of the geographical variation observed in the tool skills of these crows.	[Abdelkrim, Jawad; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Mol Ecol Lab, Christchurch 1, New Zealand; [Abdelkrim, Jawad; Gemmell, Neil J.] Univ Otago, Dept Anat, Ctr Reprod & Genom, Dunedin, New Zealand; [Abdelkrim, Jawad] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR Conservat Especes Restaurat & Suivi Populat 7, F-75231 Paris, France; [Hunt, Gavin R.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Canterbury; University of Otago; Museum National d'Histoire Naturelle (MNHN); University of Auckland	Abdelkrim, J (corresponding author), Univ Canterbury, Sch Biol Sci, Mol Ecol Lab, Christchurch 1, New Zealand.	jawad@mnhn.fr; g.hunt@auckland.ac.nz	Gemmell, Neil J/C-6774-2009; Gray, Russell/H-2078-2015	Gemmell, Neil J/0000-0003-0671-3637; Gray, Russell/0000-0002-9858-0191	New Zealand Marsden Fund; University of Auckland; University of Canterbury; University of Otago	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Auckland; University of Canterbury; University of Otago	This research was funded by grants from the New Zealand Marsden Fund (RDG and GRH), the University of Auckland (RDG and GRH), the University of Canterbury and the University of Otago (JA and NJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Delacourt J, 1966, GUIDE OISEAUX NOUVEL; Earl DA, 2011, CONSERVATION GENETIC; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fidler AE, 2007, P ROY SOC B-BIOL SCI, V274, P1685, DOI 10.1098/rspb.2007.0337; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Holzhaider JC, 2011, ANIM BEHAV, V81, P83, DOI 10.1016/j.anbehav.2010.09.015; Holzhaider JC, 2010, BEHAVIOUR, V147, P553, DOI 10.1163/000579510X12629536366284; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hunt GR, 2007, NEW ZEAL J ZOOL, V34, P1; Hunt GR, 2007, AUST J ZOOL, V55, P291, DOI 10.1071/ZO07048; Hunt GR, 2012, ETHOLOGY, V118, P423, DOI 10.1111/j.1439-0310.2012.02027.x; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 2004, ANIM COGN, V7, P114, DOI 10.1007/s10071-003-0200-0; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Hunt GR, 2002, EMU, V102, P349, DOI 10.1071/MU01056; Hunt GR, 2003, P ROY SOC B-BIOL SCI, V270, P867, DOI 10.1098/rspb.2002.2302; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kenward B, 2005, NATURE, V433, P121, DOI 10.1038/433121a; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P2094, DOI 10.1098/rspb.2011.0391; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Lycett SJ, 2011, P ROY SOC B-BIOL SCI, V278, P2091, DOI 10.1098/rspb.2010.2599; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rutz C, 2012, NATURWISSENSCHAFTEN, V99, P313, DOI 10.1007/s00114-012-0904-6; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Schoenle LA, 2007, MOL ECOL NOTES, V7, P46, DOI 10.1111/j.1471-8286.2006.01520.x; Tarr CL, 1998, MOL ECOL, V7, P253; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Weir JT, 2009, P NATL ACAD SCI USA, V106, P21737, DOI 10.1073/pnas.0903811106	36	11	11	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36608	10.1371/journal.pone.0036608	http://dx.doi.org/10.1371/journal.pone.0036608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590576	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100047
J	Noell, S; Ritz, R; Wolburg-Buchholz, K; Wolburg, H; Fallier-Becker, P				Noell, Susan; Ritz, Rainer; Wolburg-Buchholz, Karen; Wolburg, Hartwig; Fallier-Becker, Petra			An Allograft Glioma Model Reveals the Dependence of Aquaporin-4 Expression on the Brain Microenvironment	PLOS ONE			English	Article							CHANNEL PROTEIN AQUAPORIN-4; ORTHOGONAL ARRAYS; GLIOBLASTOMA-MULTIFORME; CULTURED ASTROCYTES; WATER CHANNELS; CELL-ADHESION; M23 ISOFORMS; AGRIN; TUMORS; EDEMA	Aquaporin-4 (AQP4), the main water channel of the brain, is highly expressed in animal glioma and human glioblastoma in situ. In contrast, most cultivated glioma cell lines don't express AQP4, and primary cell cultures of human glioblastoma lose it during the first passages. Accordingly, in C6 cells and RG2 cells, two glioma cell lines of the rat, and in SMA mouse glioma cell lines, we found no AQP4 expression. We confirmed an AQP4 loss in primary human glioblastoma cell cultures after a few passages. RG-2 glioma cells if grafted into the brain developed AQP4 expression. This led us consider the possibility of AQP4 expression depends on brain microenvironment. In previous studies, we observed that the typical morphological conformation of AQP4 as orthogonal arrays of particles (OAP) depended on the extracellular matrix component agrin. In this study, we showed for the first time implanted AQP4 negative glioma cells in animal brain or flank to express AQP4 specifically in the intracerebral gliomas but neither in the extracranial nor in the flank gliomas. AQP4 expression in intracerebral gliomas went along with an OAP loss, compared to normal brain tissue. AQP4 staining in vivo normally is polarized in the astrocytic endfoot membranes at the glia limitans superficialis and perivascularis, but in C6 and RG2 tumors the AQP4 staining is redistributed over the whole glioma cell as in human glioblastoma. In contrast, primary rat or mouse astrocytes in culture did not lose their ability to express AQP4, and they were able to form few OAPs.	[Noell, Susan; Ritz, Rainer] Univ Tubingen, Dept Neurosurg, Tubingen, Germany; [Wolburg-Buchholz, Karen; Wolburg, Hartwig; Fallier-Becker, Petra] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Noell, S (corresponding author), Univ Tubingen, Dept Neurosurg, Tubingen, Germany.	petra.fallier-becker@med.uni-tuebingen.de			Deutsche Krebshilfe (Mildred Scheel Foundation) [107686, 109219]	Deutsche Krebshilfe (Mildred Scheel Foundation)(Deutsche Krebshilfe)	This work was supported by grants of the Deutsche Krebshilfe (Mildred Scheel Foundation; grant numbers 107686 and 109219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAS AT, 1995, J NEURO-ONCOL, V23, P175, DOI 10.1007/BF01059948; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Barber AJ, 1997, DEV DYNAM, V208, P62, DOI 10.1002/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO;2-#; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DERMIETZEL R, 1973, NATURWISSENSCHAFTEN, V60, P208, DOI 10.1007/BF00599446; Engel A, 2008, CURR OPIN STRUC BIOL, V18, P229, DOI 10.1016/j.sbi.2007.11.003; Engelhorn T, 2009, CANCER SCI, V100, P1856, DOI 10.1111/j.1349-7006.2009.01259.x; Fallier-Becker P, 2011, BRAIN RES, V1367, P2, DOI 10.1016/j.brainres.2010.09.092; Frericks M, 2008, BBA-GENE REGUL MECH, V1779, P830, DOI 10.1016/j.bbagrm.2008.08.007; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Ivanova T, 2002, J NEUROENDOCRINOL, V14, P73, DOI 10.1046/j.0007-1331.2001.00742.x; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Lee J, 2009, BRAIN RES, V1288, P125, DOI 10.1016/j.brainres.2009.06.095; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mccoy ES, 2010, NEUROSCIENCE, V168, P971, DOI 10.1016/j.neuroscience.2009.09.020; Mccoy E, 2007, GLIA, V55, P1034, DOI 10.1002/glia.20524; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Noell S, 2007, EUR J NEUROSCI, V26, P2109, DOI 10.1111/j.1460-9568.2007.05850.x; Noell S, 2009, CELL TISSUE RES, V337, P185, DOI 10.1007/s00441-009-0812-z; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Rascher G, 2002, ACTA NEUROPATHOL, V104, P85, DOI 10.1007/s00401-002-0524-x; ROHLMANN A, 1992, GLIA, V5, P259, DOI 10.1002/glia.440050404; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; SERANO RD, 1980, ACTA NEUROPATHOL, V51, P53, DOI 10.1007/BF00688850; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Sontheimer H, 2004, MOL NEUROBIOL, V29, P61, DOI 10.1385/MN:29:1:61; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Verkman AS, 2000, CURR OPIN NEPHROL HY, V9, P517, DOI 10.1097/00041552-200009000-00010; Warth A, 2005, ACTA NEUROPATHOL, V109, P418, DOI 10.1007/s00401-005-0984-x; Warth A, 2004, ACTA NEUROPATHOL, V107, P311, DOI 10.1007/s00401-003-0812-0; Wolburg H, 2012, MOL ASPECTS IN PRESS; Wolburg H, 2011, INT REV CEL MOL BIO, V287, P1, DOI 10.1016/B978-0-12-386043-9.00001-3; ZELENINA M N, 1985, Biokhimiya, V50, P439; ZELENINA M N, 1986, Biokhimiya, V51, P77; Zhang H, 2008, J MOL BIOL, V382, P1136, DOI 10.1016/j.jmb.2008.07.089	43	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36555	10.1371/journal.pone.0036555	http://dx.doi.org/10.1371/journal.pone.0036555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590566	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336100039
J	Wilson, C; Maxwell, PJ; Longley, DB; Wilson, RH; Johnston, PG; Waugh, DJJ				Wilson, Catherine; Maxwell, Pamela J.; Longley, Daniel B.; Wilson, Richard H.; Johnston, Patrick G.; Waugh, David J. J.			Constitutive and Treatment-Induced CXCL8-Signalling Selectively Modulates the Efficacy of Anti-Metabolite Therapeutics in Metastatic Prostate Cancer	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE; PHASE-II; INTERLEUKIN-8; EXPRESSION; 5-FLUOROURACIL; PROLIFERATION; CHEMOTHERAPY; CELLS; GENE; OXALIPLATIN	Background: The current study was undertaken to characterize the effect of anti-metabolites on inducing CXCL8 signaling and determining whether the constitutive and/or drug-induced CXCL8 signaling in metastatic prostate cancer (CaP) cells modulates their sensitivity to this class of agent. Methods: The response of metastatic CaP cells to 5-Fluorouracil (5-FU), Pemetrexed or Tomudex was determined using cell count assays, flow cytometry and PARP cleavage analysis. Quantitative-PCR, ELISA and immunoblots were employed to determine effects of drugs or CXCL8 administration on target gene/protein expression. Results: Administration of 5-FU but not pemetrexed potentiated CXCL8 secretion and increased CXCR1 and CXCR2 gene expression in metastatic PC3 cells. Consistent with this, the inhibition of CXCL8 signaling using a CXCR2 antagonist, AZ10397767, increased the cytotoxicity of 5-FU by 4-fold ( P<0.001), and increased 5-FU-induced apoptosis in PC3 cells (P<0.01). In contrast, while administration of AZ10397767 had no effect on the sensitivity of pemetrexed, the CXCR2 antagonist exerted the greatest effect in increasing the sensitivity of PC3 cells to Tomudex, a directed thymidylate synthase (TS) inhibitor. Subsequent experiments confirmed that administration of recombinant human CXCL8 increased TS expression, a response mediated in part by the CXCR2 receptor. Moreover, siRNA-mediated knockdown of the CXCL8-target gene Bcl-2 increased the sensitivity of PC3 cells to 5-FU. Conclusions: CXCL8 signaling provides a selective resistance of metastatic prostate cancer cells to specific anti-metabolites by promoting a target-associated resistance, in addition to underpinning an evasion of treatment-induced apoptosis.	[Wilson, Catherine; Maxwell, Pamela J.; Longley, Daniel B.; Wilson, Richard H.; Johnston, Patrick G.; Waugh, David J. J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast	Wilson, C (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	d.waugh@qub.ac.uk		WAUGH, DAVID/0000-0002-4022-3765	Ulster Cancer Foundation; Department of Employment and Learning, Northern Ireland	Ulster Cancer Foundation; Department of Employment and Learning, Northern Ireland	Research was supported by an unrestricted research grant from the Ulster Cancer Foundation (DJJW and PGJ) and a PhD Stipend award ( CW) from the Department of Employment and Learning, Northern Ireland. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2004, CLIN CANCER RES, V10, p4276S, DOI 10.1158/1078-0432.CCR-040010; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Attard G, 2010, J CLIN ONCOL, V28, pE560, DOI 10.1200/JCO.2010.29.5170; Bendre MS, 2002, CANCER RES, V62, P5571; Caffo O, 2011, UROL ONCOL; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Droz JP, 2003, ANN ONCOL, V14, P1291, DOI 10.1093/annonc/mdg342; Blesa JMG, 2011, AM J CLIN ONCOL-CANC, V34, P155, DOI 10.1097/COC.0b013e3181d6b453; Hahn NM, 2009, ANN ONCOL, V20, P1971, DOI 10.1093/annonc/mdp244; JOHNSTON PG, 1995, CANCER RES, V55, P1407; KAIGHN ME, 1979, INVEST UROL, V17, P16; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; MacManus CF, 2007, MOL CANCER RES, V5, P737, DOI 10.1158/1541-7786.MCR-07-0032; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Salonga D, 2000, CLIN CANCER RES, V6, P1322; Seaton A, 2009, BRIT J CANCER, V101, P1620, DOI 10.1038/sj.bjc.6605356; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Uehara H, 2005, PROSTATE, V64, P40, DOI 10.1002/pros.20223; Vaishampayan UN, 2009, J UROLOGY, V182, P317, DOI 10.1016/j.juro.2009.02.105; Veltri RW, 2001, CANCER-AM CANCER SOC, V91, P2322, DOI 10.1002/1097-0142(20010615)91:12<2322::AID-CNCR1264>3.0.CO;2-H; Wilson C, 2008, J PHARMACOL EXP THER, V327, P746, DOI 10.1124/jpet.108.143826; Wilson C, 2008, MOL CANCER THER, V7, P2649, DOI 10.1158/1535-7163.MCT-08-0148	25	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36545	10.1371/journal.pone.0036545	http://dx.doi.org/10.1371/journal.pone.0036545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590561	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336100036
J	Yoder, AR; Robinson, JW; Dickey, DM; Andersland, J; Rose, BA; Stone, MD; Griffin, TJ; Potter, LR				Yoder, Andrea R.; Robinson, Jerid W.; Dickey, Deborah M.; Andersland, Joshua; Rose, Beth A.; Stone, Matthew D.; Griffin, Timothy J.; Potter, Lincoln R.			A Functional Screen Provides Evidence for a Conserved, Regulatory, Juxtamembrane Phosphorylation Site in Guanylyl Cyclase A and B	PLOS ONE			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; PROTEIN-KINASE-C; DEPENDENT DESENSITIZATION; DEPHOSPHORYLATION; ACTIVATION; IDENTIFICATION; MECHANISM; INHIBITION	Kinase homology domain (KHD) phosphorylation is required for activation of guanylyl cyclase (GC)-A and -B. Phosphopeptide mapping identified multiple phosphorylation sites in GC-A and GC-B, but these approaches have difficulty identifying sites in poorly detected peptides. Here, a functional screen was conducted to identify novel sites. Conserved serines or threonines in the KHDs of phosphorylated receptor GCs were mutated to alanine and tested for reduced hormone to detergent activity ratios. Mutation of Ser-489 in GC-B to alanine but not glutamate reduced the activity ratio to 60% of wild type (WT) levels. Similar results were observed with Ser-473, the homologous site in GC-A. Receptors containing glutamates for previously identified phosphorylation sites (GC-A-6E and GC-B-6E) were activated to similar to 20% of WT levels but the additional glutamate substitution for S473 or S489 increased activity to near WT levels. Substrate-velocity assays indicated that GC-B-WT-S489E and GC-B-6E-S489E had lower Km values and that WT-GC-B-S489A, GC-B-6E and GC-B-6E-S489A had higher Km values than WT-GC-B. Homologous desensitization was enhanced when GC-A contained the S473E substitution, and GC-B-6E-S489E was resistant to inhibition by a calcium elevating treatment or protein kinase C activation - processes that dephosphorylate GC-B. Mass spectrometric detection of a synthetic phospho-Ser-473 containing peptide was 200-1300-fold less sensitive than other phosphorylated peptides and neither mass spectrometric nor (PO4)-P-32 co-migration studies detected phospho-Ser-473 or phospho-Ser-489 in cells. We conclude that Ser-473 and Ser-489 are Km-regulating phosphorylation sites that are difficult to detect using current methods.	[Yoder, Andrea R.; Robinson, Jerid W.; Potter, Lincoln R.] Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA; [Dickey, Deborah M.; Andersland, Joshua; Rose, Beth A.; Stone, Matthew D.; Griffin, Timothy J.; Potter, Lincoln R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Potter, LR (corresponding author), Univ Minnesota, Dept Pharmacol, Sch Med, 3-249 Millard Hall, Minneapolis, MN 55455 USA.	potter@umn.edu		Griffin, Timothy/0000-0001-6801-2559	NHLBI NIH HHS [R21 HL093402] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093402] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbey-Hosch SE, 2005, BIOCHEM PHARMACOL, V70, P686, DOI 10.1016/j.bcp.2005.04.034; Antos LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1756, DOI 10.1152/ajpendo.00321.2007; Antos LK, 2005, J BIOL CHEM, V280, P26928, DOI 10.1074/jbc.M505648200; BENTLEY JK, 1986, J BIOL CHEM, V261, P4859; Duda T, 2011, BIOCHEMISTRY-US, V50, P1213, DOI 10.1021/bi1018978; Fan DH, 2005, MOL PHARMACOL, V67, P174, DOI 10.1124/mol.104.002436; Joubert S, 2001, BIOCHEMISTRY-US, V40, P11096, DOI 10.1021/bi010580s; KOLLER KJ, 1993, J BIOL CHEM, V268, P5997; Misono KS, 2011, FEBS J, V278, P1818, DOI 10.1111/j.1742-4658.2011.08083.x; Muller D, 2006, ENDOCRINOLOGY, V147, P2974, DOI 10.1210/en.2006-0092; Potter LR, 2011, CELL SIGNAL, V23, P1921, DOI 10.1016/j.cellsig.2011.09.001; Potter LR, 2011, PHARMACOL THERAPEUT, V130, P71, DOI 10.1016/j.pharmthera.2010.12.005; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Potter LR, 2000, J BIOL CHEM, V275, P31099, DOI 10.1074/jbc.M005506200; Potter LR, 1998, J BIOL CHEM, V273, P15533, DOI 10.1074/jbc.273.25.15533; POTTER LR, 1992, J BIOL CHEM, V267, P14531; Potter LR, 1998, BIOCHEMISTRY-US, V37, P2422, DOI 10.1021/bi972303k; POTTER LR, 1994, J BIOL CHEM, V269, P14636; Potter LR, 1999, MOL BIOL CELL, V10, P1811, DOI 10.1091/mbc.10.6.1811; Potter LR, 1999, METHODS, V19, P506, DOI 10.1006/meth.1999.0893; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Potthast R, 2004, J BIOL CHEM, V279, P48513, DOI 10.1074/jbc.M408247200; RAMARAO CS, 1988, J BIOL CHEM, V263, P1524; Robinson JW, 2011, J BIOL CHEM, V286, P33841, DOI 10.1074/jbc.M111.273565; Schroter J, 2010, FEBS J, V277, P2440, DOI 10.1111/j.1742-4658.2010.07658.x; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VACQUIER VD, 1986, BIOCHEM BIOPH RES CO, V137, P1148, DOI 10.1016/0006-291X(86)90345-1; Yoder AR, 2010, BIOCHEMISTRY-US, V49, P10137, DOI 10.1021/bi101700e	29	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36747	10.1371/journal.pone.0036747	http://dx.doi.org/10.1371/journal.pone.0036747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590601	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336100058
J	Chatonnet, F; Guyot, R; Picou, F; Bondesson, M; Flamant, F				Chatonnet, Fabrice; Guyot, Romain; Picou, Frederic; Bondesson, Maria; Flamant, Frederic			Genome-Wide Search Reveals the Existence of a Limited Number of Thyroid Hormone Receptor Alpha Target Genes in Cerebellar Neurons	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CELL; IDENTIFICATION; EXPRESSION; MUTATION; ABSENCE; MICE; THYROID-HORMONE-RECEPTOR-ALPHA-1; DISRUPTION; IMPAIRMENT	Thyroid hormone (T3) has a major influence on cerebellum post-natal development. The major phenotypic landmark of exposure to low levels of T3 during development (hypothyroidism) in the cerebellum is the retarded inward migration of the most numerous cell type, granular neurons. In order to identify the direct genetic regulation exerted by T3 on cerebellar neurons and their precursors, we used microarray RNA hybridization to perform a time course analysis of T3 induced gene expression in primary cultures of cerebellar neuronal cell. These experiments suggest that we identified a small set of genes which are directly regulated, both in vivo and in vitro, during cerebellum post-natal development. These modest changes suggest that T3 does not acts directly on granular neurons and mainly indirectly influences the cellular interactions taking place during development.	[Chatonnet, Fabrice; Guyot, Romain; Picou, Frederic; Flamant, Frederic] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, INRA,Ecole Normale Super Lyon, F-69365 Lyon, France; [Bondesson, Maria] Karolinska Inst, Novum, Stockholm, Sweden	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Karolinska Institutet	Chatonnet, F (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, INRA,Ecole Normale Super Lyon, F-69365 Lyon, France.	Frederic.Flamant@ens-lyon.fr	Bondesson, Maria/H-3027-2012; Chatonnet, Fabrice/AHI-8250-2022; PICOU, FREDERIC/AAC-4695-2022	Bondesson, Maria/0000-0001-6358-5788; Chatonnet, Fabrice/0000-0003-3639-6775; PICOU, FREDERIC/0000-0002-2066-2146	CRESCENDO [LSHM-CT-2005-018652]; CASCADE network of excellence [FOOD-CT-2004-506319]; Agence Nationale pour la Recherche	CRESCENDO(European Commission); CASCADE network of excellence; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the CRESCENDO European integrated project (LSHM-CT-2005-018652), CASCADE network of excellence (FOOD-CT-2004-506319), and Agence Nationale pour la Recherche (Switch program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CDC, 2005, PROG EXP TUMOR RES, V38, P139; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Chatonnet F, 2011, J THROID RES, V2011, DOI 10.4061/2011/145762; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Chesney J, 2005, BIOCHEM BIOPH RES CO, V331, P139, DOI 10.1016/j.bbrc.2005.02.193; Denver RJ, 1999, J BIOL CHEM, V274, P23128, DOI 10.1074/jbc.274.33.23128; Denver RJ, 2009, ENDOCRINOLOGY, V150, P3935, DOI 10.1210/en.2009-0050; Diez D, 2008, ENDOCRINOLOGY; Dong HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004610; Dong HY, 2005, BIOCHEM BIOPH RES CO, V330, P1182, DOI 10.1016/j.bbrc.2005.03.099; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Durand B, 2000, BIOESSAYS, V22, P64; Fauquier T, 2011, DEV BIOL, V356, P350, DOI 10.1016/j.ydbio.2011.05.657; Fossat N, 2006, EMBO REP, V7, P824, DOI 10.1038/sj.embor.7400751; Furlow JD, 2002, ENDOCRINOLOGY, V143, P3295, DOI 10.1210/en.2002-220126; Harper ME, 2008, THYROID, V18, P145, DOI 10.1089/thy.2007.0250; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Heuer H, 2003, J NEUROSCI, V23, P10604; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P9913, DOI 10.1073/pnas.171319498; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Kobayashi K, 2009, BRAIN RES, V1264, P24, DOI 10.1016/j.brainres.2008.12.029; Koibuchi N, 2009, CEREBELLUM, V8, P89, DOI 10.1007/s12311-008-0089-x; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Manzano J, 2007, ENDOCRINOLOGY, V148, P5746, DOI 10.1210/en.2007-0567; Manzano J, 2007, INT J DEV NEUROSCI, V25, P171, DOI 10.1016/j.ijdevneu.2007.01.003; Martel J, 2002, NEUROREPORT, V13, P1849, DOI 10.1097/00001756-200210280-00003; Mi RF, 2005, EXP NEUROL, V194, P301, DOI 10.1016/j.expneurol.2004.07.011; Michalski JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019772; Molnar ZN, 2002, J NEUROSCI, V22, P10313; Morita M, 2003, MOL CELL BIOL, V23, P2489, DOI 10.1128/MCB.23.7.2489-2500.2003; Morte B, 2002, P NATL ACAD SCI USA, V99, P3985, DOI 10.1073/pnas.062413299; Morte B, 2010, ENDOCRINOLOGY, V151, P810, DOI 10.1210/en.2009-0958; NICHOLSO.JL, 1972, BRAIN RES, V44, P13, DOI 10.1016/0006-8993(72)90362-9; Nielsen JV, 2010, CEREB CORTEX, V20, P1904, DOI 10.1093/cercor/bhp261; Pascual M, 2007, P NATL ACAD SCI USA, V104, P5193, DOI 10.1073/pnas.0605699104; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Poguet AL, 2003, DEV BIOL, V254, P188, DOI 10.1016/S0012-1606(02)00039-8; Potter GB, 2001, J NEUROSCI, V21, P4373, DOI 10.1523/JNEUROSCI.21-12-04373.2001; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; Quignodon L, 2007, J MOL ENDOCRINOL, V39, P17, DOI 10.1677/JME-06-0054; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sutherland APR, 2009, MOL CELL BIOL, V29, P2804, DOI 10.1128/MCB.01667-08; Takahashi M, 2008, J NEUROCHEM, V104, P640, DOI 10.1111/j.1471-4159.2007.05049.x; Thompson CC, 2000, CEREB CORTEX, V10, P939, DOI 10.1093/cercor/10.10.939; Trentin AG, 1998, IN VITRO CELL DEV-AN, V34, P280; Venero C, 2005, GENE DEV, V19, P2152, DOI 10.1101/gad.346105; Wallis K, 2010, MOL ENDOCRINOL, V24, P1904, DOI 10.1210/me.2010-0175; Xie ZF, 2010, P NATL ACAD SCI USA, V107, P6510, DOI 10.1073/pnas.0912315107; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303; Zhang HM, 2008, MOL CELL BIOCHEM, V307, P169, DOI 10.1007/s11010-007-9596-1	65	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e30703	10.1371/journal.pone.0030703	http://dx.doi.org/10.1371/journal.pone.0030703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586439	Green Submitted, gold, Green Published			2022-12-25	WOS:000305335000001
J	Lee, S; Rocha, LEC; Liljeros, F; Holme, P				Lee, Sungmin; Rocha, Luis E. C.; Liljeros, Fredrik; Holme, Petter			Exploiting Temporal Network Structures of Human Interaction to Effectively Immunize Populations	PLOS ONE			English	Article							TRANSMISSION; VACCINATION; SPREAD	Decreasing the number of people who must be vaccinated to immunize a community against an infectious disease could both save resources and decrease outbreak sizes. A key to reaching such a lower threshold of immunization is to find and vaccinate people who, through their behavior, are more likely than average to become infected and to spread the disease further. Fortunately, the very behavior that makes these people important to vaccinate can help us to localize them. Earlier studies have shown that one can use previous contacts to find people that are central in static contact networks. However, real contact patterns are not static. In this paper, we investigate if there is additional information in the temporal contact structure for vaccination protocols to exploit. We answer this affirmative by proposing two immunization methods that exploit temporal correlations and showing that these methods outperform a benchmark static-network protocol in four empirical contact datasets under various epidemic scenarios. Both methods rely only on obtainable, local information, and can be implemented in practice. For the datasets directly related to contact patterns of potential disease spreading ( of sexually-transmitted and nosocomial infections respectively), the most efficient protocol is to sample people at random and vaccinate their latest contacts. The network datasets are temporal, which enables us to make more realistic evaluations than earlier studies-we use only information about the past for the purpose of vaccination, and about the future to simulate disease outbreaks. Using analytically tractable models, we identify two temporal structures that explain how the protocols earn their efficiency in the empirical data. This paper is a first step towards real vaccination protocols that exploit temporal-network structure-future work is needed both to characterize the structure of real contact sequences and to devise immunization methods that exploit these.	[Lee, Sungmin; Rocha, Luis E. C.; Holme, Petter] Umea Univ, Dept Phys, IceLab, Umea, Sweden; [Liljeros, Fredrik; Holme, Petter] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea	Umea University; Stockholm University; Sungkyunkwan University (SKKU)	Lee, S (corresponding author), Umea Univ, Dept Phys, IceLab, Umea, Sweden.	petter.holme@physics.umu.se	Rocha, Luis/D-5333-2011; Rocha, Luis/AAB-4049-2019; Liljeros, Fredrik G I/I-2667-2018; Lee, Sungmin/F-2317-2010; Holme, Petter/A-7646-2008	Rocha, Luis/0000-0001-9046-8739; Liljeros, Fredrik G I/0000-0001-8642-6624; Lee, Sungmin/0000-0001-7902-3229; Holme, Petter/0000-0003-2156-1096	Wenner-Gren Foundations; Swedish Research Council; National Research Foundation Korea; Ministry of Education, Science and Technology [R31-2008-000-10029-0]; Riksbankens Jubileumsfond	Wenner-Gren Foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Research Foundation Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Riksbankens Jubileumsfond	This research was supported by the Wenner-Gren Foundations (SL), the Swedish Research Council (PH) and the World Class University program through National Research Foundation Korea funded by Ministry of Education, Science and Technology R31-2008-000-10029-0 (PH) and Riksbankens Jubileumsfond (FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2004, INFECT DIS HUMANS; Balthrop J, 2004, SCIENCE, V304, P527, DOI 10.1126/science.1095845; Bansal Shweta, 2010, Journal of Biological Dynamics, V4, P478, DOI 10.1080/17513758.2010.503376; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Chen YP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058701; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Holme P, 2004, EUROPHYS LETT, V68, P908, DOI 10.1209/epl/i2004-10286-2; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; House T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000721; KATZ BP, 1992, STAT MED, V11, P565, DOI 10.1002/sim.4780110502; Khan A, 2005, SEX TRANSM DIS, V32, P260, DOI 10.1097/01.olq.0000161089.53411.cb; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Liljeros F, 2007, MATH POPUL STUD, V14, P269, DOI 10.1080/08898480701612899; Litvak-Hinenzon A, 2009, J R SOC INTERFACE, V6, P749, DOI 10.1098/rsif.2008.0343; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Nordvik MK, 2006, SEX TRANSM DIS, V33, P342, DOI 10.1097/01.olq.0000194601.25488.b8; Riolo CS, 2001, J URBAN HEALTH, V78, P446, DOI 10.1093/jurban/78.3.446; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Shaw LB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046120; Thomas HC, 1998, ENCY IMMUNOLOGY, P1075; Wang B, 2009, PHYS LETT A, V373, P3877, DOI 10.1016/j.physleta.2009.08.023; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201	30	66	71	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36439	10.1371/journal.pone.0036439	http://dx.doi.org/10.1371/journal.pone.0036439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586472	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000305335000034
J	Buzoianu, SG; Walsh, MC; Rea, MC; O'Sullivan, O; Crispie, F; Cotter, PD; Ross, RP; Gardiner, GE; Lawlor, PG				Buzoianu, Stefan G.; Walsh, Maria C.; Rea, Mary C.; O'Sullivan, Orla; Crispie, Fiona; Cotter, Paul D.; Ross, R. Paul; Gardiner, Gillian E.; Lawlor, Peadar G.			The Effect of Feeding Bt MON810 Maize to Pigs for 110 Days on Intestinal Microbiota	PLOS ONE			English	Article							GUT MICROBIOTA; GASTROINTESTINAL-TRACT; ANTIMICROBIAL ACTIVITY; BACTERIAL COMMUNITY; DIVERSITY; HEALTH; DIET; LACTOBACILLI; PERFORMANCE; REVEALS	Objective: To assess the effects of feeding Bt MON810 maize to pigs for 110 days on the intestinal microbiota. Methodology/Principal Findings: Forty male pigs (similar to 40 days old) were blocked by weight and litter ancestry and assigned to one of four treatments; 1) Isogenic maize-based diet for 110 days (Isogenic); 2) Bt maize-based diet (MON810) for 110 days (Bt); 3) Isogenic maize-based diet for 30 days followed by a Bt maize-based diet for 80 days (Isogenic/Bt); 4) Bt maize-based diet for 30 days followed by an isogenic maize-based diet for 80 days (Bt/Isogenic). Enterobacteriaceae, Lactobacillus and total anaerobes were enumerated in the feces using culture-based methods on days 0, 30, 60 and 100 of the study and in ileal and cecal digesta on day 110. No differences were found between treatments for any of these counts at any time point. The relative abundance of cecal bacteria was also determined using high-throughput 16 S rRNA gene sequencing. No differences were observed in any bacterial taxa between treatments, with the exception of the genus Holdemania which was more abundant in the cecum of pigs fed the isogenic/Bt treatment compared to pigs fed the Bt treatment (0.012 vs 0.003%; P <= 0.05). Conclusions/Significance: Feeding pigs a Bt maize-based diet for 110 days did not affect counts of any of the culturable bacteria enumerated in the feces, ileum or cecum. Neither did it influence the composition of the cecal microbiota, with the exception of a minor increase in the genus Holdemania. As the role of Holdemania in the intestine is still under investigation and no health abnormalities were observed, this change is not likely to be of clinical significance. These results indicate that feeding Bt maize to pigs in the context of its influence on the porcine intestinal microbiota is safe.	[Buzoianu, Stefan G.; Walsh, Maria C.; Lawlor, Peadar G.] Teagasc, Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland; [Buzoianu, Stefan G.; Gardiner, Gillian E.] Waterford Inst Technol, Dept Chem & Life Sci, Waterford, Ireland; [Rea, Mary C.; O'Sullivan, Orla; Crispie, Fiona; Cotter, Paul D.; Ross, R. Paul] Teagasc, Food Res Ctr, Fermoy, Cork, Ireland; [Rea, Mary C.; Crispie, Fiona; Cotter, Paul D.; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	Teagasc; South East Technological University (SETU); Teagasc; University College Cork	Buzoianu, SG (corresponding author), Teagasc, Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland.	ggardiner@wit.ie	Ross, Paul/A-7584-2015; walsh, maria/H-3662-2013; Cotter, Paul/B-7781-2008; Stefan, Buzoianu/F-3030-2010; Cotter, Paul/AAX-5449-2021; O'Sullivan, Orla/ABE-5980-2020; STANTON, CATHERINE/A-9549-2015	Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; Cotter, Paul/0000-0002-5465-9068; O'Sullivan, Orla/0000-0002-4332-1109; STANTON, CATHERINE/0000-0002-6724-7011; Rea, Mary/0000-0003-3782-0232	European Union [211820]; Teagasc Walsh Fellowship programme	European Union(European Commission); Teagasc Walsh Fellowship programme	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211820 and the Teagasc Walsh Fellowship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	22 SAS/STATH&REG;9, 2010, 22 SAS STAT 9 US GUI; Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Buddington RK, 2011, J ANIM SCI, V89, P1506, DOI 10.2527/jas.2010-3705; Buzoianu SG, 2012, ANIMAL, V6, P1609, DOI 10.1017/S1751731112000249; Buzoianu SG, 2012, APPL ENV MI IN PRESS; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Canibe N, 2005, J ANIM SCI, V83, P1287; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castillo M, 2007, LIVEST SCI, V109, P149, DOI 10.1016/j.livsci.2007.01.129; Chassard C, 2008, FEMS MICROBIOL ECOL, V66, P496, DOI 10.1111/j.1574-6941.2008.00595.x; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Domingo JL, 2011, ENVIRON INT, V37, P734, DOI 10.1016/j.envint.2011.01.003; Dona A, 2009, CRIT REV FOOD SCI, V49, P164, DOI 10.1080/10408390701855993; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; EFSA (European Food Safety Authority). S, 2009, EFSA J, V1149, P1, DOI DOI 10.2903/J.EFSA.2009.1149; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Franklin MA, 2002, J ANIM SCI, V80, P2904; Gardiner GE, 2004, APPL ENVIRON MICROB, V70, P1895, DOI 10.1128/AEM.70.4.1895-1906.2004; GASKELL GSS, 2005, EUROPEANS BIOTECHNOL; Hartnell G. F., 2007, BEST PRACTICES CONDU; ILSI International Life Sciences Institute Crop Composition Database, ILSI INT LIF SCI I C; JENSEN BB, 1994, APPL ENVIRON MICROB, V60, P1897, DOI 10.1128/AEM.60.6.1897-1904.1994; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Koskella J, 2002, CAN J MICROBIOL, V48, P262, DOI [10.1139/w02-005, 10.1139/W02-005]; KRAUSE DO, 1995, J ANIM SCI, V73, P2347; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Martinez-Poveda A, 2009, FOOD POLICY, V34, P519, DOI 10.1016/j.foodpol.2009.08.001; Moughan P J, 1992, World Rev Nutr Diet, V67, P40; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; NAITO S, 1995, J APPL BACTERIOL, V79, P230, DOI 10.1111/j.1365-2672.1995.tb00940.x; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Poletto R, 2009, J ANIM SCI, V87, P304, DOI 10.2527/jas.2008-1188; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Rantakokko-Jalava K, 2002, J CLIN MICROBIOL, V40, P4211, DOI 10.1128/JCM.40.11.4211-4217.2002; Rea MC, 2007, J MED MICROBIOL, V56, P940, DOI 10.1099/jmm.0.47085-0; Rollin F, 2011, TRENDS FOOD SCI TECH, V22, P99, DOI 10.1016/j.tifs.2010.09.001; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Saarela M, 2002, INT J FOOD MICROBIOL, V78, P99, DOI 10.1016/S0168-1605(02)00235-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Trabalza-Marinucci M, 2008, LIVEST SCI, V113, P178, DOI 10.1016/j.livsci.2007.03.009; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Vrieze A, 2010, DIABETOLOGIA, V53, P606, DOI 10.1007/s00125-010-1662-7; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wiedemann S, 2007, APPL ENVIRON MICROB, V73, P8012, DOI 10.1128/AEM.01060-06; Yudina TG, 2007, ANAEROBE, V13, P6, DOI 10.1016/j.anaerobe.2006.09.006; [No title captured]	56	33	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e33668	10.1371/journal.pone.0033668	http://dx.doi.org/10.1371/journal.pone.0033668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574106	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800002
J	McKenzie, JH; McDevitt, JJ; Fabian, MP; Hwang, GM; Milton, DK				McKenzie, Jennifer H.; McDevitt, James J.; Fabian, M. Patricia; Hwang, Grace M.; Milton, Donald K.			Collection of Aerosolized Human Cytokines Using Teflon (R) Filters	PLOS ONE			English	Article							EXHALED BREATH CONDENSATE; ELECTROSTATIC PRECIPITATOR; ASSAYS; VALIDATION; BIOMARKERS; ASTHMA	Background: Collection of exhaled breath samples for the analysis of inflammatory biomarkers is an important area of research aimed at improving our ability to diagnose, treat and understand the mechanisms of chronic pulmonary disease. Current collection methods based on condensation of water vapor from exhaled breath yield biomarker levels at or near the detection limits of immunoassays contributing to problems with reproducibility and validity of biomarker measurements. In this study, we compare the collection efficiency of two aerosol-to-liquid sampling devices to a filter-based collection method for recovery of dilute laboratory generated aerosols of human cytokines so as to identify potential alternatives to exhaled breath condensate collection. Methodology/Principal Findings: Two aerosol-to-liquid sampling devices, the SKC (R) Biosampler and Omni 3000 (TM), as well as Teflon (R) filters were used to collect aerosols of human cytokines generated using a HEART nebulizer and single-pass aerosol chamber setup in order to compare the collection efficiencies of these sampling methods. Additionally, methods for the use of Teflon (R) filters to collect and measure cytokines recovered from aerosols were developed and evaluated through use of a high-sensitivity multiplex immunoassay. Our results show successful collection of cytokines from pg/m(3) aerosol concentrations using Teflon (R) filters and measurement of cytokine levels in the sub-picogram/mL concentration range using a multiplex immunoassay with sampling times less than 30 minutes. Significant degradation of cytokines was observed due to storage of cytokines in concentrated filter extract solutions as compared to storage of dry filters. Conclusions: Use of filter collection methods resulted in significantly higher efficiency of collection than the two aerosol-to-liquid samplers evaluated in our study. The results of this study provide the foundation for a potential new technique to evaluate biomarkers of inflammation in exhaled breath samples.	[McKenzie, Jennifer H.] Univ Massachusetts, Biomed Engn & Biotechnol Program, Lowell, MA USA; [McDevitt, James J.; Fabian, M. Patricia] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Hwang, Grace M.] MITRE Corp, Mclean, VA USA; [Milton, Donald K.] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA	University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Harvard T.H. Chan School of Public Health; MITRE Corporation; University System of Maryland; University of Maryland College Park	McKenzie, JH (corresponding author), Univ Massachusetts, Biomed Engn & Biotechnol Program, Lowell, MA USA.	dmilton@umd.edu	Hwang, Grace/L-6096-2019; Milton, Donald K/G-3286-2010	Hwang, Grace/0000-0002-3335-8688; Milton, Donald K/0000-0002-0550-7834; Fabian, M. Patricia/0000-0002-1658-3349	National Institute Environmental Health Sciences [NIEHS 2P30ES00002]; MITRE Corporation, Bedford, Massachusetts, United States of America; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	National Institute Environmental Health Sciences; MITRE Corporation, Bedford, Massachusetts, United States of America; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work has received financial support from the National Institute Environmental Health Sciences (grant NIEHS 2P30ES00002) and The MITRE Corporation, Bedford, Massachusetts, United States of America. MITRE acknowledges the Air Transportation Center of Excellence in Airliner Cabin Environment Research (ACER, also known as the National Center for Research in Intermodal Transport Environments - RITES). The contribution of MITRE employee (GMH) was reviewed and approved for public release by the MITRE Corporation (file number 11-0311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2008, ANALYST, V133, P702, DOI 10.1039/b718587c; Almstrand AC, 2012, EUR RESPIR J, V39, P59, DOI 10.1183/09031936.00195610; Almstrand AC, 2009, ANAL CHEM, V81, P662, DOI 10.1021/ac802055k; Aziz N, 1999, CLIN DIAGN LAB IMMUN, V6, P89, DOI 10.1128/CDLI.6.1.89-95.1999; Bayley DL, 2008, EUR RESPIR J, V31, P943, DOI 10.1183/09031936.00081707; Doherty DE, 2008, COPD, V5, P310, DOI 10.1080/15412550802363386; Effros RM, 2002, AM J RESP CRIT CARE, V165, P663, DOI 10.1164/ajrccm.165.5.2101018; Effros RM, 2005, J APPL PHYSIOL, V99, P1286, DOI 10.1152/japplphysiol.00362.2005; Fabian MP, 2007, QUANTIFICATION RESP; Fabian P, 2011, J AEROSOL MED PULM D, V24, P137, DOI 10.1089/jamp.2010.0815; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Han T, 2010, AEROSOL SCI TECH, V44, P339, DOI 10.1080/02786821003649352; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Holmgren H, 2010, J AEROSOL SCI, V41, P439, DOI 10.1016/j.jaerosci.2010.02.011; Horvath I, 2009, EUR RESPIR J, V34, P261, DOI 10.1183/09031936.00142508; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Kazani S, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/4/047001; Khaltaev N, 2007, GLOBAL SURVEILLANCE, Vvii, P146; KIETZMANN D, 1993, INTENS CARE MED, V19, P78, DOI 10.1007/BF01708366; Larsson P, 2012, RESP MED, V106, P197, DOI 10.1016/j.rmed.2011.10.008; Loukides S, 2011, CURR MED CHEM, V18, P1432, DOI 10.2174/092986711795328418; Mainelis G, 2002, AEROSOL SCI TECH, V36, P1073, DOI 10.1080/02786820290092212; Mannino David M, 2007, Proc Am Thorac Soc, V4, P502, DOI 10.1513/pats.200701-001FM; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Panicker G, 2007, CYTOKINE, V37, P176, DOI 10.1016/j.cyto.2007.03.006; Papineni RS, 1996, J AEROSOL MED, V10, P105, DOI 10.1089/jam.1997.10.105; Sack U, 2006, CYTOM PART A, V69A, P169, DOI 10.1002/cyto.a.20231; Sapey E, 2008, EUR RESPIR J, V32, P1408, DOI 10.1183/09031936.00088608; THAVASU PW, 1992, J IMMUNOL METHODS, V153, P115, DOI 10.1016/0022-1759(92)90313-I; Urbano FL, 2008, J MANAGE CARE PHARM, V14, P41, DOI 10.18553/jmcp.2008.14.1.41; Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08; Weist S, 2010, PROTEOMICS, V10, P1515, DOI 10.1002/pmic.200900471	32	5	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35814	10.1371/journal.pone.0035814	http://dx.doi.org/10.1371/journal.pone.0035814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574123	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800019
J	Nonaka, D; Jimba, M; Mizoue, T; Kobayashi, J; Yasuoka, J; Ayi, I; Jayatilleke, AC; Shrestha, S; Kikuchi, K; Haque, SE; Yi, SY				Nonaka, Daisuke; Jimba, Masamine; Mizoue, Tetsuya; Kobayashi, Jun; Yasuoka, Junko; Ayi, Irene; Jayatilleke, Achini C.; Shrestha, Sabina; Kikuchi, Kimiyo; Haque, Syed E.; Yi, Siyan			Content Analysis of Primary and Secondary School Textbooks Regarding Malaria Control: A Multi-Country Study	PLOS ONE			English	Article							HEALTH-EDUCATION; NET USE; COMMUNITY; KNOWLEDGE; SCHOOLCHILDREN; CONSEQUENCES; CHILDREN	Background: In tropical settings, malaria education at school is potentially useful, but textbook content related to malaria education has so far received little attention. This study aimed to examine whether school textbooks contain sufficient knowledge and skills to help children in primary and lower secondary schools and their family members to cope with malaria. Methodology/Principal Findings: This was a descriptive, cross-country study. We collected textbooks that were used by children in grades one to nine from nine countries endemic for malaria: Laos, Cambodia, Nepal, Bangladesh, Sri Lanka, Zambia, Niger, Benin, and Ghana. Two reviewers per country identified descriptions about malaria by seeking the term "malaria" or a local word that corresponds to malaria in languages other than English. The authors categorized the identified descriptions according to the content of the descriptions. Additionally, the authors examined whether the identified contents addressed life skill messages. Of a total of 474 textbooks collected, 35 contained descriptions about malaria. The most commonly included content was transmission mode/vector (77.1%), followed by preventive measures (60.0%), epidemiology (57.1%), cause/agent (54.3%), signs/symptoms (37.1%) and treatment (22.9%). Treatment-related content was not included in any textbooks from four countries and textbooks failed to recommend the use of insecticide-treated bed nets in five countries. Very few textbooks included content that facilitated prompt treatment, protection of risk groups, and use of recommended therapy. Conclusion/Significance: Textbooks rarely included knowledge and skills that are crucial to protect schoolchildren and their families from malaria. This study identified the need for improvement to textbook contents regarding malaria.	[Nonaka, Daisuke] Univ Ryukyus, Grad Sch Med, Dept Parasitol & Int Hlth, Okinawa, Japan; [Jimba, Masamine; Yasuoka, Junko; Jayatilleke, Achini C.; Shrestha, Sabina; Kikuchi, Kimiyo; Haque, Syed E.] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Dept Epidemiol & Prevent, Tokyo, Japan; [Kobayashi, Jun] Nagasaki Univ, Grad Sch Int Hlth Dev, Nagasaki 852, Japan; [Kobayashi, Jun] Natl Ctr Global Hlth & Med, Dept Int Med Cooperat, Tokyo, Japan; [Ayi, Irene] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Yi, Siyan] Stanford Univ, Walter H Shorenstein Asia Pacific Res Ctr, Freeman Spogli Inst Int Studies, Palo Alto, CA 94304 USA	University of the Ryukyus; University of Tokyo; National Center for Global Health & Medicine - Japan; Nagasaki University; National Center for Global Health & Medicine - Japan; University of Ghana; Stanford University	Nonaka, D (corresponding author), Univ Ryukyus, Grad Sch Med, Dept Parasitol & Int Hlth, Okinawa, Japan.	laodaisuke@hotmail.co.jp	Nonaka, Daisuke/AAP-7918-2021; Yasuoka, Junko/GVT-8950-2022; Ayi, Irene/AAD-3588-2020; Ayi, Irene/AFR-9042-2022; Daisuke, Nonaka/AAB-8509-2020; Jimba, Masamine/AAF-5630-2020	Ayi, Irene/0000-0003-3054-9494; Daisuke, Nonaka/0000-0001-6793-2062; Emdadul Haque, Syed/0000-0002-9739-1225	Ministry of Health, Labour, and Welfare of Japan [H21-chikyukibo-wakate-011]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was funded by the Ministry of Health, Labour, and Welfare of Japan (research grant number: H21-chikyukibo-wakate-011; http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo16/02-01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adongo PB, 2005, TROP MED INT HEALTH, V10, P366, DOI 10.1111/j.1365-3156.2005.01361.x; Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; Akello Grace, 2007, Afr Health Sci, V7, P73; Alper Z, 2005, EDUC HEALTH, V18, P209, DOI 10.1080/13576280500148163; [Anonymous], ROLL BACK MAL STRAT; [Anonymous], 2004, COCHRANE DB SYST REV; Arogundade ED, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-170; Asante KP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-409; Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; Biswas AK, 2010, T ROY SOC TROP MED H, V104, P423, DOI 10.1016/j.trstmh.2010.01.001; Brooker S, 2008, T ROY SOC TROP MED H, V102, P304, DOI 10.1016/j.trstmh.2008.01.010; Bundy DAP, 2000, PARASITOL TODAY, V16, P181, DOI 10.1016/S0169-4758(00)01658-6; CNN, 2012, IPAD SOL ED TOOL STU; d'Almeida TCDA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-108; de Irala J, 2008, PUBLIC HEALTH, V122, P1093, DOI 10.1016/j.puhe.2008.01.005; Edson F, 2007, Tanzan Health Res Bull, V9, P207; FRESH tool kit, 2001, LEARN MAL PRIM SCH; Garcia-Basteiro AL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-179; Geissler PW, 2001, HEALTH POLICY PLANN, V16, P362, DOI 10.1093/heapol/16.4.362; Hwang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011692; Ibidapo Comfort A, 2005, Aust J Rural Health, V13, P214, DOI 10.1111/j.1440-1584.2005.00704.x; Imbahale SS, 2010, ACTA TROP, V115, P248, DOI 10.1016/j.actatropica.2010.04.005; Khun S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000143; Kinung'hi SM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-395; Lalloo DG, 2006, LANCET INFECT DIS, V6, P780, DOI 10.1016/S1473-3099(06)70655-7; Matranga A, 2007, THE J, V34, P40; Midzi N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-169; Ministry of Education Youth Sport, 2006, SCH HLTH POL; Nomoto M, 2011, BIOSCI TRENDS, V5, P61, DOI 10.5582/bst.2011.v5.2.61; Nonaka D, 2008, PARASITOL INT, V57, P76, DOI 10.1016/j.parint.2007.09.005; Paulander Johan, 2009, Glob Health Action, V2, DOI 10.3402/gha.v2i0.1839; Phinney R, 1993, Dev Commun Rep, P7; Pleasant A, 2008, HEALTH PROMOT INT, V23, P152, DOI 10.1093/heapro/dan001; UNESCO, 2011, OV IN WHY GOV MATT; United Nations Children's Fund (UNICEF), 2010, FACTS LIF, VFourth; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organisation, 2008, WORLD MAL REP 2008; World Health Organization, 2007, WHO INF SER SCH HLTH; Yasuoka J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-4; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	41	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36629	10.1371/journal.pone.0036629	http://dx.doi.org/10.1371/journal.pone.0036629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WV	22574203	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800100
J	Sanchez, MB; Martinez, JL				Sanchez, Maria B.; Martinez, Jose L.			Differential Epigenetic Compatibility of qnr Antibiotic Resistance Determinants with the Chromosome of Escherichia coli	PLOS ONE			English	Article							QUINOLONE RESISTANCE; PLASMID; GENES; MUTATIONS; EVOLUTION; COST; DISSEMINATION; ADAPTATION; SELECTION; DNA	Environmental bacteria harbor a plethora of genes that, upon their horizontal transfer to new hosts, may confer resistance to antibiotics, although the number of such determinants actually acquired by pathogenic bacteria is very low. The founder effect, fitness costs and ecological connectivity all influence the chances of resistance transfer being successful. We examined the importance of these bottlenecks using the family of quinolone resistance determinants Qnr. The results indicate the epigenetic compatibility of a determinant with the host genome to be of great importance in the acquisition and spread of resistance. A plasmid carrying the widely distributed QnrA determinant was stable in Escherichia coli, whereas the SmQnr determinant was unstable despite both proteins having very similar tertiary structures. This indicates that the fitness costs associated with the acquisition of antibiotic resistance may not derive from a non-specific metabolic burden, but from the acquired gene causing specific changes in bacterial metabolic and regulatory networks. The observed stabilization of the plasmid encoding SmQnr by chromosomal mutations, including a mutant lacking the global regulator HNS, reinforces this idea. Since quinolones are synthetic antibiotics, and since the origin of QnrA is the environmental bacterium Shewanella algae, the role of QnrA in this organism is unlikely to be that of conferring resistance. Its evolution toward this may have occurred through mutations or because of an environmental change (exaptation). The present results indicate that the chromosomally encoded Qnr determinants of S. algae can confer quinolone resistance upon their transfer to E. coli without the need of any further mutation. These results suggest that exaptation is important in the evolution of antibiotic resistance.	[Sanchez, Maria B.; Martinez, Jose L.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Sanchez, MB (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain.	jlmtnez@cnb.csic.es	Martinez, Jose L/A-4725-2013; Sanchez, Maria Blanca/AAD-8294-2020	Martinez, Jose L/0000-0001-8813-7607; Sanchez, Maria Blanca/0000-0002-5209-4518	Spanish Ministry of Science and Innovation [BIO2008-00090, BIO2011-25255]; European the Union [KBBE-227258 (BIOHYPO), HEALTH-F3-2010-241476 (PAR), HEALTH-F3-2011-282004 (EVOTAR)]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European the Union	Work in our laboratory is funded by grants BIO2008-00090 and BIO2011-25255 from the Spanish Ministry of Science and Innovation, KBBE-227258 (BIOHYPO), HEALTH-F3-2010-241476 (PAR), and HEALTH-F3-2011-282004 (EVOTAR) from European the Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Atlas R, 1993, HDB MICROBIOLOGICAL; Baquero F, 2009, ENV MICROBIOL REP, V1, P469, DOI 10.1111/j.1758-2229.2009.00053.x; BAQUERO F, 1985, J ANTIMICROB CHEMOTH, V15, P151; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Blaby IK, 2009, MICROBIOL-SGM, V155, P2676, DOI 10.1099/mic.0.029777-0; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cattoir V, 2006, J ANTIMICROB CHEMOTH, V58, P1054, DOI 10.1093/jac/dkl361; Cohen O, 2011, MOL BIOL EVOL, V28, P1481, DOI 10.1093/molbev/msq333; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Davies JE, 1997, CIBA F SYMP, V207, P15; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Field CM, 2011, PLASMID IN PRESS; Foucault ML, 2010, P NATL ACAD SCI USA, V107, P16964, DOI 10.1073/pnas.1006855107; GomezGomez JM, 1996, MOL MICROBIOL, V19, P909, DOI 10.1046/j.1365-2958.1996.443955.x; GomezGomez JM, 1997, FEMS MICROBIOL LETT, V154, P271, DOI 10.1111/j.1574-6968.1997.tb12655.x; Gould SJ, 1999, P NATL ACAD SCI USA, V96, P11904, DOI 10.1073/pnas.96.21.11904; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hernandez A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00022; Hodgman TC, 1998, MOL MICROBIOL, V29, P545, DOI 10.1046/j.1365-2958.1998.00948.x; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kim HB, 2011, ANTIMICROB AGENTS CH, V55, P414, DOI 10.1128/AAC.00991-10; Laskaris P, 2010, ENVIRON MICROBIOL, V12, P783, DOI 10.1111/j.1462-2920.2009.02125.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Marshall CG, 1998, ANTIMICROB AGENTS CH, V42, P2215, DOI 10.1128/AAC.42.9.2215; Martinez JL, 2011, CURR OPIN PHARM; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Mojica FJM, 1997, J BACTERIOL, V179, P3528, DOI 10.1128/jb.179.11.3528-3533.1997; Poirel Laurent, 2005, Antimicrob Agents Chemother, V49, P3523, DOI 10.1128/AAC.49.8.3523-3525.2005; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Sambrook J, 2001, MOL CLONING HARBOR A; Sanchez MB, 2010, ANTIMICROB AGENTS CH, V54, P580, DOI 10.1128/AAC.00496-09; Sanchez MB, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-148; Shimizu K, 2008, ANTIMICROB AGENTS CH, V52, P3823, DOI 10.1128/AAC.00026-08; Skippington E, 2011, FEMS MICROBIOL REV, V35, P707, DOI 10.1111/j.1574-6976.2010.00261.x; Sorensen AH, 2003, ANTIMICROB AGENTS CH, V47, P798, DOI 10.1128/AAC.47.2.798-799.2003; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; SUMMERS DK, 1991, TRENDS BIOTECHNOL, V9, P273, DOI 10.1016/0167-7799(91)90089-Z; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P118, DOI 10.1128/AAC.49.1.118-125.2005; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P3050, DOI 10.1128/AAC.49.7.3050-3052.2005; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Vetting MW, 2011, J BIOL CHEM, V286, P25265, DOI 10.1074/jbc.M111.226936; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07	61	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35149	10.1371/journal.pone.0035149	http://dx.doi.org/10.1371/journal.pone.0035149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574114	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800010
J	Frost, NA; Lu, HE; Blanpied, TA				Frost, Nicholas A.; Lu, Hsiangmin E.; Blanpied, Thomas A.			Optimization of Cell Morphology Measurement via Single-Molecule Tracking PALM	PLOS ONE			English	Article							PHOTOACTIVATION LOCALIZATION MICROSCOPY; SERIAL ELECTRON-MICROSCOPY; DENDRITIC SPINES; BIOPHYSICAL CHARACTERISTICS; FLUORESCENT PROTEIN; RAT HIPPOCAMPUS; LIVING CELLS; HIGH-DENSITY; LIVE CELLS; DYNAMICS	In neurons, the shape of dendritic spines relates to synapse function, which is rapidly altered during experience-dependent neural plasticity. The small size of spines makes detailed measurement of their morphology in living cells best suited to super-resolution imaging techniques. The distribution of molecular positions mapped via live-cell Photoactivated Localization Microscopy (PALM) is a powerful approach, but molecular motion complicates this analysis and can degrade overall resolution of the morphological reconstruction. Nevertheless, the motion is of additional interest because tracking single molecules provides diffusion coefficients, bound fraction, and other key functional parameters. We used Monte Carlo simulations to examine features of single-molecule tracking of practical utility for the simultaneous determination of cell morphology. We find that the accuracy of determining both distance and angle of motion depend heavily on the precision with which molecules are localized. Strikingly, diffusion within a bounded region resulted in an inward bias of localizations away from the edges, inaccurately reflecting the region structure. This inward bias additionally resulted in a counterintuitive reduction of measured diffusion coefficient for fast-moving molecules; this effect was accentuated by the long camera exposures typically used in single-molecule tracking. Thus, accurate determination of cell morphology from rapidly moving molecules requires the use of short integration times within each image to minimize artifacts caused by motion during image acquisition. Sequential imaging of neuronal processes using excitation pulses of either 2 ms or 10 ms within imaging frames confirmed this: processes appeared erroneously thinner when imaged using the longer excitation pulse. Using this pulsed excitation approach, we show that PALM can be used to image spine and spine neck morphology in living neurons. These results clarify a number of issues involved in interpretation of single-molecule data in living cells and provide a method to minimize artifacts in single-molecule experiments.	[Frost, Nicholas A.; Lu, Hsiangmin E.; Blanpied, Thomas A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Frost, Nicholas A.; Blanpied, Thomas A.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Lu, Hsiangmin E.; Blanpied, Thomas A.] Univ Maryland, Sch Med, Program Mol Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Frost, NA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	tblanpied@som.umaryland.edu		Frost, Nicholas/0000-0002-2270-643X; Blanpied, Thomas/0000-0003-4957-557X	National Institutes of Health (NIH)/National Institute of Mental Health (NIMH) [NRSA F32-MH086185, NIMH R01-MH080046, R01-MH096376]; Dana Foundation; Katherine D. and Theodore J. Carski Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080046, R01MH096376] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Dana Foundation; Katherine D. and Theodore J. Carski Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was from the National Institutes of Health (NIH)/National Institute of Mental Health (NIMH) (http://www.nimh.nih.gov) NRSA F32-MH086185 to NAF, NIMH R01-MH080046, and R01-MH096376 to TAB; and from the Dana Foundation (www.dana.org) and the Katherine D. and Theodore J. Carski Foundation to TAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E, 1874, PROC BRISTOL NAT SOC, VI, P200; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Frost NA, 2010, CURR OPIN NEUROBIOL, V20, P578, DOI 10.1016/j.conb.2010.06.009; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; Gould TJ, 2009, NAT PROTOC, V4, P291, DOI 10.1038/nprot.2008.246; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Helmholtz H., 1876, MONTHLY MICROSC J, V16, P15, DOI DOI 10.1111/J.1365-2818.1876.TB05606.X; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Lippincott-Schwartz J, 2009, NAT METHODS, V6, P21, DOI [10.1038/NMETH.F.233, 10.1038/nmeth.f.233]; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Newpher TM, 2009, TRENDS CELL BIOL; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Ober RJ, 2004, BIOPHYS J, V86, P1185, DOI 10.1016/S0006-3495(04)74193-4; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Ram S, 2006, P NATL ACAD SCI USA, V103, P4457, DOI 10.1073/pnas.0508047103; Ram S, 2008, BIOPHYS J, V95, P6025, DOI 10.1529/biophysj.108.140392; Renner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025731; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; SAXTON MJ, 1995, BIOPHYS J, V69, P389, DOI 10.1016/S0006-3495(95)79911-8; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	43	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36751	10.1371/journal.pone.0036751	http://dx.doi.org/10.1371/journal.pone.0036751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570741	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400057
J	Morales, L; Del Olmo, N; Valladolid-Acebes, I; Fole, A; Cano, V; Merino, B; Stucchi, P; Ruggieri, D; Lopez, L; Alguacil, LF; Ruiz-Gayo, M				Morales, Lidia; Del Olmo, Nuria; Valladolid-Acebes, Ismael; Fole, Alberto; Cano, Victoria; Merino, Beatriz; Stucchi, Paula; Ruggieri, Daniela; Lopez, Laura; Fernando Alguacil, Luis; Ruiz-Gayo, Mariano			Shift of Circadian Feeding Pattern by High-Fat Diets Is Coincident with Reward Deficits in Obese Mice	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; MILD TRAUMATIC LESION; RIGHT PARIETAL CORTEX; NUCLEUS-ACCUMBENS; FOOD PREFERENCES; DOPAMINE; LEPTIN; RATS; MORPHINE; RHYTHMS	Recent studies provide evidence that high-fat diets (HF) trigger both i) a deficit of reward responses linked to a decrease of mesolimbic dopaminergic activity, and ii) a disorganization of circadian feeding behavior that switch from a structured meal-based schedule to a continuous snacking, even during periods normally devoted to rest. This feeding pattern has been shown to be a cause of HF-induced overweight and obesity. Our hypothesis deals with the eventual link between the rewarding properties of food and the circadian distribution of meals. We have investigated the effect of circadian feeding pattern on reward circuits by means of the conditioned-place preference (CPP) paradigm and we have characterized the rewarding properties of natural (food) and artificial (cocaine) reinforcers both in free-feeding ad libitum HF mice and in HF animals submitted to a re-organized feeding schedule based on the standard feeding behavior displayed by mice feeding normal chow ("forced synchronization"). We demonstrate that i) ad libitum HF diet attenuates cocaine and food reward in the CPP protocol, and ii) forced synchronization of feeding prevents this reward deficit. Our study provides further evidence that the rewarding impact of food with low palatability is diminished in mice exposed to a high-fat diet and strongly suggest that the decreased sensitivity to chow as a positive reinforcer triggers a disorganized feeding pattern which might account for metabolic disorders leading to obesity.	[Morales, Lidia; Del Olmo, Nuria; Valladolid-Acebes, Ismael; Fole, Alberto; Cano, Victoria; Merino, Beatriz; Ruggieri, Daniela; Lopez, Laura; Fernando Alguacil, Luis; Ruiz-Gayo, Mariano] Univ CEU San Pablo, Fac Farm, Dept Ciencias Farmaceut & Alimentac, Madrid, Spain; [Stucchi, Paula] Univ Complutense, Inst Pluridisciplinar, E-28040 Madrid, Spain; [Fernando Alguacil, Luis] Hosp Gen Ciudad Real, Unidad Traslac, Ciudad Real, Spain	San Pablo CEU University; Complutense University of Madrid	Morales, L (corresponding author), Univ CEU San Pablo, Fac Farm, Dept Ciencias Farmaceut & Alimentac, Madrid, Spain.	ruigayo@ceu.es	Ruiz-Gayo, Mariano/H-3720-2015; PALACIOS, BEATRIZ MERINO/F-5517-2017; del Olmo, Nuria/K-8789-2014; Alguacil, Luis Fernando/J-6466-2016; Del Olmo, Nuria/ABG-2171-2020; Cano, Victoria/GRO-4093-2022	Ruiz-Gayo, Mariano/0000-0002-2805-5076; del Olmo, Nuria/0000-0001-5611-4152; Alguacil, Luis Fernando/0000-0002-2542-5983; Del Olmo, Nuria/0000-0001-5611-4152; Valladolid-Acebes, Ismael/0000-0002-7699-9207	Ministerio de Ciencia e Innovacion [SAF 2009-09714, SAF2008-02902]; Fondo de Investigaciones Sanitarias [ISCIII CP08/00188]; Fundacion Universitaria San Pablo-CEU	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Universitaria San Pablo-CEU	This work was supported by Ministerio de Ciencia e Innovacion (SAF 2009-09714; SAF2008-02902), Fondo de Investigaciones Sanitarias (ISCIII CP08/00188), and Fundacion Universitaria San Pablo-CEU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; BARDO MT, 1995, NEUROSCI BIOBEHAV R, V19, P39, DOI 10.1016/0149-7634(94)00021-R; Berthoud HR, 2004, APPETITE, V43, P315, DOI 10.1016/j.appet.2004.04.009; Bray MS, 2010, INT J OBESITY, V34, P1589, DOI 10.1038/ijo.2010.63; Cadoni C, 1999, NEUROSCIENCE, V90, P447, DOI 10.1016/S0306-4522(98)00466-7; Cota D, 2006, NEURON, V51, P678, DOI 10.1016/j.neuron.2006.09.009; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; DREWNOWSKI A, 1992, APPETITE, V18, P207, DOI 10.1016/0195-6663(92)90198-F; DREWNOWSKI A, 1992, INT J OBESITY, V16, P639; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Figlewicz DP, 2001, PHYSIOL BEHAV, V73, P229, DOI 10.1016/S0031-9384(01)00486-3; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gambarana C, 2003, NEUROSCIENCE, V121, P179, DOI 10.1016/S0306-4522(03)00383-X; Guzman-Ruiz R, 2009, OBESITY FACTS, V2, P149; Hogg S, 1998, BEHAV BRAIN RES, V93, P143, DOI 10.1016/S0166-4328(97)00146-0; Hogg S, 1998, BEHAV BRAIN RES, V93, P157, DOI 10.1016/S0166-4328(97)00145-9; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kosobud Ann E K, 2007, ScientificWorldJournal, V7, P203; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; McClung Colleen A, 2007, ScientificWorldJournal, V7, P194; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 1998, APPETITE, V30, P255, DOI 10.1006/appe.1997.0134; Morales L, 2007, ADDICT BIOL, V12, P482, DOI 10.1111/j.1369-1600.2007.00071.x; Morgan D, 2011, CURR PHARM DESIGN, V17, P1168, DOI 10.2174/138161211795656747; Perreau-Lenz S, 2007, 8 EMBO, V8, pS20; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Stucchi P, 2012, ENDOCRINOLOGY, V153, P690, DOI 10.1210/en.2011-1023; Stucchi P, 2011, BIOCHIMIE, V93, P1779, DOI 10.1016/j.biochi.2011.06.020; Warren M, 2005, J ADDICT DIS, V24, P95, DOI 10.1300/J069v24n03_08; Zheng H, 2007, J NEUROSCI, V27, P11075, DOI 10.1523/JNEUROSCI.3542-07.2007	39	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36139	10.1371/journal.pone.0036139	http://dx.doi.org/10.1371/journal.pone.0036139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570696	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343400012
J	Ng, AKL; Chan, WH; Choi, ST; Lam, MKH; Lau, KF; Chan, PKS; Au, SWN; Fodor, E; Shaw, PC				Ng, Andy Ka-Leung; Chan, Wai-Hon; Choi, Sze-Ting; Lam, Mandy Ka-Han; Lau, Kwok-Fai; Chan, Paul Kay-Sheung; Au, Shannon Wing-Ngor; Fodor, Ervin; Shaw, Pang-Chui			Influenza Polymerase Activity Correlates with the Strength of Interaction between Nucleoprotein and PB2 through the Host-Specific Residue K/E627	PLOS ONE			English	Article							SINGLE AMINO-ACID; VIRUS POLYMERASE; A-VIRUS; RNA-BINDING; CAPPED RNAS; HUMAN-CELLS; PA SUBUNIT; REPLICATION; RIBONUCLEOPROTEIN; PROTEINS	The ribonucleoprotein (RNP) complex is the essential transcription-replication machinery of the influenza virus. It is composed of the trimeric polymerase (PA, PB1 and PB2), nucleoprotein (NP) and RNA. Elucidating the molecular mechanisms of RNP assembly is central to our understanding of the control of viral transcription and replication and the dependence of these processes on the host cell. In this report, we show, by RNP reconstitution assays and co-immunoprecipitation, that the interaction between NP and polymerase is crucial for the function of the RNP. The functional association of NP and polymerase involves the C-terminal '627' domain of PB2 and it requires NP arginine-150 and either lysine-627 or arginine-630 of PB2. Using surface plasmon resonance, we demonstrate that the interaction between NP and PB2 takes place without the involvement of RNA. At 33, 37 and 41 degrees C in mammalian cells, more positive charges at aa. 627 and 630 of PB2 lead to stronger NP-polymerase interaction, which directly correlates with the higher RNP activity. In conclusion, our study provides new information on the NP-PB2 interaction and shows that the strength of NP-polymerase interaction and the resulting RNP activity are promoted by the positive charges at aa. 627 and 630 of PB2.	[Ng, Andy Ka-Leung; Chan, Wai-Hon; Choi, Sze-Ting; Lam, Mandy Ka-Han; Lau, Kwok-Fai; Au, Shannon Wing-Ngor; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Chan, Paul Kay-Sheung] Chinese Univ Hong Kong, Dept Microbiol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; University of Oxford	Ng, AKL (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	pcshaw@cuhk.edu.hk	Chan, Paul KS/J-9360-2013	Chan, Paul KS/0000-0002-6360-4608; Lau, Kwok-Fai/0000-0002-0193-1152; Fodor, Ervin/0000-0003-3249-196X	Research Grants Council General Research Fund grant [CUHK473111]; University Grants Council One-Off Special Equipment Grant from Hong Kong SAR [SEG CUHK08]; MRC [G0700848] Funding Source: UKRI; Medical Research Council [G0700848] Funding Source: researchfish	Research Grants Council General Research Fund grant; University Grants Council One-Off Special Equipment Grant from Hong Kong SAR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Research Grants Council General Research Fund grant (CUHK473111) and a University Grants Council One-Off Special Equipment Grant (SEG CUHK08) from Hong Kong SAR. Some equipment used in this study was obtained through a Special Equipment Grant (SEG CUHK08) of the University Grants Council of Hong Kong SAR. EF was supported by a grant from the MRC (G0700848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Chan WH, J VIROL, V84, P7337; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HUANG TS, 1990, J VIROL, V64, P5669, DOI 10.1128/JVI.64.11.5669-5673.1990; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Li OTW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005658; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; Mase M, 2006, J GEN VIROL, V87, P3655, DOI 10.1099/vir.0.81843-0; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Medcalf L, 1999, J VIROL, V73, P7349, DOI 10.1128/JVI.73.9.7349-7356.1999; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Moncorge O, 2010, J VIROL, V84, P9978, DOI 10.1128/JVI.01134-10; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; MURPHY BR, 1982, INFECT IMMUN, V37, P1119, DOI 10.1128/IAI.37.3.1119-1126.1982; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; PONS MW, 1969, VIROLOGY, V39, P250, DOI 10.1016/0042-6822(69)90045-2; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; WHO, 2012, CUM NUMB CONF HUM CA; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	44	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36415	10.1371/journal.pone.0036415	http://dx.doi.org/10.1371/journal.pone.0036415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570712	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343400028
J	Clausen, TM; Christoffersen, S; Dahlback, M; Langkilde, AE; Jensen, KE; Resende, M; Agerbaek, MO; Andersen, D; Berisha, B; Ditlev, SB; Pinto, VV; Nielsen, MA; Theander, TG; Larsen, S; Salanti, A				Clausen, Thomas M.; Christoffersen, Stig; Dahlback, Madeleine; Langkilde, Annette Eva; Jensen, Kamilla E.; Resende, Mafalda; Agerbaek, Mette O.; Andersen, Daniel; Berisha, Besim; Ditlev, Sisse B.; Pinto, Vera V.; Nielsen, Morten A.; Theander, Thor G.; Larsen, Sine; Salanti, Ali			Structural and Functional Insight into How the Plasmodium falciparum VAR2CSA Protein Mediates Binding to Chondroitin Sulfate A in Placental Malaria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTED ERYTHROCYTES; VACCINE CANDIDATE; PREGNANCY; DOMAINS; ADHERENCE; ADHESION; IDENTIFICATION; PROTEOGLYCANS; EXPRESSION; PFEMP1	Malaria is a major global health problem. Pregnant women are susceptible to infection regardless of previously acquired immunity. Placental malaria is caused by parasites capable of sequestering in the placenta. This is mediated by VAR2CSA, a parasite antigen that interacts with chondroitin sulfateA(CSA). One vaccine strategy is to block this interaction with VAR2CSA-specific antibodies. It is a priority to define a small VAR2CSA fragment that can be used in an adhesion blocking vaccine. In this, the obvious approach is to define regions of VAR2CSA involved in receptor binding. It has been shown that full-length recombinant VAR2CSA binds specifically to CSA with nanomolar affinity, and that the CSA-binding site lies in the N-terminal part of the protein. In this study we define the minimal binding region by truncating VAR2CSA and analyzing CSA binding using biosensor technology. We show that the core CSA-binding site lies within the DBL2X domain and parts of the flanking interdomain regions. This is in contrast to the idea that single domains do not possess the structural requirements for specific CSA binding. Small-angle x-ray scattering measurements enabled modeling of VAR2CSA and showed that the CSA-binding DBL2X domain is situated in the center of the structure. Mutating classic sulfate-binding sites in VAR2CSA, along with testing dependence of ionic interactions, suggest that the CSA binding is not solely dependent on the sulfated CSA structure. Based on these novel PfEMP1 structure-function studies, we have constructed a small VAR2CSA antigen that has the capacity to induce highly adhesion-blocking antibodies.	[Clausen, Thomas M.; Dahlback, Madeleine; Jensen, Kamilla E.; Resende, Mafalda; Agerbaek, Mette O.; Andersen, Daniel; Berisha, Besim; Ditlev, Sisse B.; Pinto, Vera V.; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali] Rigshosp, Copenhagen Univ Hosp, Ctr Med Parasitol, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Clausen, Thomas M.; Dahlback, Madeleine; Jensen, Kamilla E.; Resende, Mafalda; Agerbaek, Mette O.; Andersen, Daniel; Berisha, Besim; Ditlev, Sisse B.; Pinto, Vera V.; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali] Rigshosp, Copenhagen Univ Hosp, Dept Int Hlth Immunol & Microbiol, DK-2100 Copenhagen, Denmark; [Christoffersen, Stig; Larsen, Sine] Univ Copenhagen, Dept Chem, DK-1014 Copenhagen, Denmark; [Langkilde, Annette Eva] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-1014 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Clausen, TM (corresponding author), Univ Copenhagen, CSS, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Oster Farigmagsgade 5A, DK-1014 Copenhagen K, Denmark.	tmc@sund.ku.dk; Stig@chem.ku.dk; Salanti@sund.ku.dk	Larsen, Sine/A-4487-2017; Theander, Thor/F-6714-2015	Larsen, Sine/0000-0003-3848-1789; Theander, Thor/0000-0002-3509-7514; Salanti, Ali/0000-0003-2207-5575; Ditlev, Sisse Bolm/0000-0003-4417-9711; Nielsen, Morten Agertoug/0000-0003-2668-4992; Langkilde, Annette Eva/0000-0003-2467-4205; Agerbaek, Mette Orskov/0000-0001-5865-2034	Lundbeck Foundation; Danish Council for Independent Research Medical Sciences, Sapere Aude; University of Copenhagen-Programme of Excellence; Novo Nordisk Foundation; Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research Medical Sciences, Sapere Aude; University of Copenhagen-Programme of Excellence; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU	This work was supported grants from the Lundbeck Foundation and the Danish Council for Independent Research Medical Sciences, Sapere Aude (to A. E. L.), the University of Copenhagen-Programme of Excellence (to S. C.), the Novo Nordisk Foundation, Danish National Advanced Technology Foundation, and Proof of Concept Foundation DTU (to T. M. C., A. S., and M. N.).	Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016622; Avril M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-143; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Bordbar B, 2012, VACCINE, V30, P1343, DOI 10.1016/j.vaccine.2011.12.065; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; FALLER B, 1992, BIOCHEMISTRY-US, V31, P8285, DOI 10.1021/bi00150a023; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gruber A, 2011, INFECT IMMUN, V79, P2880, DOI 10.1128/IAI.01326-10; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Klein MM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000147; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; McGregor I A, 1987, Parassitologia, V29, P153; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Srivastava A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020270; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	43	123	132	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23332	23345		10.1074/jbc.M112.348839	http://dx.doi.org/10.1074/jbc.M112.348839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22570492	Green Published, hybrid			2022-12-25	WOS:000306511300007
J	Leida, C; Conejero, A; Arbona, V; Gomez-Cadenas, A; Llacer, G; Badenes, ML; Rios, G				Leida, Carmen; Conejero, Ana; Arbona, Vicent; Gomez-Cadenas, Aurelio; Llacer, Gerardo; Luisa Badenes, Maria; Rios, Gabino			Chilling-Dependent Release of Seed and Bud Dormancy in Peach Associates to Common Changes in Gene Expression	PLOS ONE			English	Article							PRUNUS-PERSICA L.; MADS-BOX GENES; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; SPURGE EUPHORBIA-ESULA; FLOWERING-LOCUS-T; ARABIDOPSIS-THALIANA; LEAFY SPURGE; JAPANESE APRICOT; GROWTH CESSATION; VEGETATIVE BUDS	Reproductive meristems and embryos display dormancy mechanisms in specialized structures named respectively buds and seeds that arrest the growth of perennial plants until environmental conditions are optimal for survival. Dormancy shows common physiological features in buds and seeds. A genotype-specific period of chilling is usually required to release dormancy by molecular mechanisms that are still poorly understood. In order to find common transcriptional pathways associated to dormancy release, we analyzed the chilling-dependent expression in embryos of certain genes that were previously found related to dormancy in flower buds of peach. We propose the presence of short and long-term dormancy events affecting respectively the germination rate and seedling development by independent mechanisms. Short periods of chilling seem to improve germination in an abscisic acid-dependent manner, whereas the positive effect of longer cold treatments on physiological dwarfing coincides with the accumulation of phenylpropanoids in the seed.	[Leida, Carmen; Conejero, Ana; Arbona, Vicent; Llacer, Gerardo; Luisa Badenes, Maria; Rios, Gabino] IVIA, Valencia, Spain; [Gomez-Cadenas, Aurelio] Univ Jaume 1, Dept Ciencias Agr & Medio Nat, Castellon De La Plana, Spain	Universitat Jaume I	Leida, C (corresponding author), IVIA, Valencia, Spain.	rios_gab@gva.es	Gomez-Cadenas, Aurelio/K-6084-2012; Rios, Gabino/F-4046-2011; Arbona, Vicent/K-1748-2015; Badenes, Maria Luisa/C-6606-2014	Gomez-Cadenas, Aurelio/0000-0002-4598-2664; Rios, Gabino/0000-0002-1398-282X; Arbona, Vicent/0000-0003-2232-106X; Badenes, Maria Luisa/0000-0001-9722-6783; Leida, Carmen Alice/0000-0001-9513-8448	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)-FEDER [RTA2007-00060]; Ministry of Science and Innovation of Spain [AGL2010-20595]; IVIA (Instituto Valenciano de Investigaciones Agrarias)	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)-FEDER(Instituto de Investigacion Agropecuaria (INIA)European Commission); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); IVIA (Instituto Valenciano de Investigaciones Agrarias)	This work was supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)-FEDER (grant no. RTA2007-00060), and the Ministry of Science and Innovation of Spain (grant no. AGL2010-20595). CL was funded by a fellowship from IVIA (Instituto Valenciano de Investigaciones Agrarias). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JV, 2001, WEED SCI, V49, P581, DOI 10.1614/0043-1745(2001)049[0581:RCROTR]2.0.CO;2; Arend M, 2009, PLANT PHYSIOL, V151, P2110, DOI 10.1104/pp.109.144956; Arora R, 2003, HORTSCIENCE, V38, P911, DOI 10.21273/HORTSCI.38.5.911; Bentsink L., 2007, Seed development, dormancy and germination, P113; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bielenberg DG, 2008, TREE GENET GENOMES, V4, P495, DOI 10.1007/s11295-007-0126-9; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Carles C, 2002, PLANT J, V30, P373, DOI 10.1046/j.1365-313X.2002.01295.x; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; DAVIES FT, 1983, HORTSCIENCE, V18, P959; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; DHARMAWARDHANA DP, 1992, CAN J BOT, V70, P2238, DOI 10.1139/b92-277; Durgbanshi A, 2005, J AGR FOOD CHEM, V53, P8437, DOI 10.1021/jf050884b; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; FRISBY JW, 1993, J AM SOC HORTIC SCI, V118, P248, DOI 10.21273/JASHS.118.2.248; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gomez-Porras JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-260; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Horvath DP, 2010, PLANT MOL BIOL, V73, P169, DOI 10.1007/s11103-009-9596-5; Horvath DP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-536; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jia Y, 2006, PLANT MOL BIOL, V61, P329, DOI 10.1007/s11103-006-0015-x; Jimenez S, 2010, PLANT MOL BIOL, V73, P157, DOI 10.1007/s11103-010-9608-5; Jimenez S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-25; KESTER D.E., 2011, HARTMANN KESTERS PLA, V8th; KESTER DE, 1969, J AM SOC HORTIC SCI, V94, P318; KESTER DE, 1977, J AM SOC HORTIC SCI, V102, P145; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; LANG GA, 1987, HORTSCIENCE, V22, P817; Leida C, 2012, NEW PHYTOL, V193, P67, DOI 10.1111/j.1469-8137.2011.03863.x; Leida C, 2010, TREE PHYSIOL, V30, P655, DOI 10.1093/treephys/tpq008; Liu YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022241; Lloyd GB, 1980, COMB P INT PLANT PRO, V30, P421; Martinez-Gomez P, 2001, SCI HORTIC-AMSTERDAM, V91, P51, DOI 10.1016/S0304-4238(01)00235-7; Mathiason K, 2009, FUNCT INTEGR GENOMIC, V9, P81, DOI 10.1007/s10142-008-0090-y; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MEHLENBACHER SA, 1991, J AM SOC HORTIC SCI, V116, P565, DOI 10.21273/JASHS.116.3.565; Nakamura S, 2001, PLANT J, V26, P627, DOI 10.1046/j.1365-313x.2001.01069.x; North H, 2010, PLANT J, V61, P971, DOI 10.1111/j.1365-313X.2009.04095.x; PASTERNAK G, 1980, HORTSCIENCE, V15, P408; PerezGonzalez S, 1997, HORTSCIENCE, V32, P1064, DOI 10.21273/HORTSCI.32.6.1064; POLLOCK BM, 1962, PLANT PHYSIOL, V37, P190, DOI 10.1104/pp.37.2.190; POWELL LE, 1987, HORTSCIENCE, V22, P845; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Ren J, 2010, J PLANT PHYSIOL, V167, P1486, DOI 10.1016/j.jplph.2010.05.027; Rinne PLH, 2011, PLANT CELL, V23, P130, DOI 10.1105/tpc.110.081307; Rohde A, 2002, PLANT CELL, V14, P1885, DOI 10.1105/tpc.003186; Rohde A, 2007, J EXP BOT, V58, P4047, DOI 10.1093/jxb/erm261; Rohde A, 2007, TRENDS PLANT SCI, V12, P217, DOI 10.1016/j.tplants.2007.03.012; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Sasaki R, 2011, PLANT PHYSIOL, V157, P485, DOI 10.1104/pp.111.181982; Thevenin J, 2011, MOL PLANT, V4, P70, DOI 10.1093/mp/ssq045; VEGIS A, 1964, ANN REV PLANT PHYSIO, V15, P185, DOI 10.1146/annurev.pp.15.060164.001153; Xue GP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf076; Yamane H, 2008, J AM SOC HORTIC SCI, V133, P708, DOI 10.21273/JASHS.133.5.708; Yamane H, 2011, J JPN SOC HORTIC SCI, V80, P276, DOI 10.2503/jjshs1.80.276; Yamane H, 2011, J EXP BOT, V62, P3481, DOI 10.1093/jxb/err028	65	52	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e35777	10.1371/journal.pone.0035777	http://dx.doi.org/10.1371/journal.pone.0035777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590512	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400007
J	Huang, GJ; Huang, SS; Deng, JS				Huang, Guan-Jhong; Huang, Shyh-Shyun; Deng, Jeng-Shyan			Anti-Inflammatory Activities of Inotilone from Phellinus linteus through the Inhibition of MMP-9, NF-kappa B, and MAPK Activation In Vitro and In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SIGNAL-REGULATED KINASE; RAW264.7 CELLS; ANTI-INFLAMMATION; PROTEIN-KINASES; LIPOPOLYSACCHARIDE; EXPRESSION; PATHWAYS; P38; CYCLOOXYGENASE-2	Inotilone was isolated from Phellinus linteus. The anti-inflammatory effects of inotilone were studied by using lipopolysaccharide (LPS)-stimulated mouse macrophage RAW264.7 cells and lambda-carrageenan (Carr)-induced hind mouse paw edema model. Inotilone was tested for its ability to reduce nitric oxide (NO) production, and the inducible nitric oxide synthase (iNOS) expression. Inotilone was tested in the inhibitor of mitogen-activated protein kinase (MAPK) [extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal kinase (JNK), p38], and nuclear factor-kappa B (NF-kappa B), matrix-metalloproteinase (MMP)-9 protein expressions in LPS-stimulated RAW264.7 cells. When RAW264.7 macrophages were treated with inotilone together with LPS, a significant concentration-dependent inhibition of NO production was detected. Western blotting revealed that inotilone blocked the protein expression of iNOS, NF-kappa B, and MMP-9 in LPS-stimulated RAW264.7 macrophages, significantly. Inotilone also inhibited LPS-induced ERK, JNK, and p38 phosphorylation. In in vivo tests, inotilone decreased the paw edema at the 4th and the 5th h after Carr administration, and it increased the activities of catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx). We also demonstrated that inotilone significantly attenuated the malondialdehyde (MDA) level in the edema paw at the 5th h after Carr injection. Inotilone decreased the NO and tumor necrosis factor (TNF-alpha) levels on serum at the 5th h after Carr injection. Western blotting revealed that inotilone decreased Carr-induced iNOS, cyclooxygenase-2 (COX-2), NF-kappa B, and MMP-9 expressions at the 5th h in the edema paw. An intraperitoneal (i.p.) injection treatment with inotilone diminished neutrophil infiltration into sites of inflammation, as did indomethacin (Indo). The anti-inflammatory activities of inotilone might be related to decrease the levels of MDA, iNOS, COX-2, NF-kappa B, and MMP-9 and increase the activities of CAT, SOD, and GPx in the paw edema through the suppression of TNF-alpha and NO. This study presents the potential utilization of inotilone, as a lead for the development of anti-inflammatory drugs.	[Huang, Guan-Jhong] China Med Univ, Coll Pharm, Sch Chinese Pharmaceut Sci & Chinese Med Resource, Taichung, Taiwan; [Huang, Shyh-Shyun] China Med Univ, Coll Pharm, Dept Pharm, Taichung, Taiwan; [Deng, Jeng-Shyan] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Huang, GJ (corresponding author), China Med Univ, Coll Pharm, Sch Chinese Pharmaceut Sci & Chinese Med Resource, Taichung, Taiwan.	gjhuang@mail.cmu.edu.tw; dengjs@asia.edu.tw			National Science Council [NSC100-2313-B-039-004-, NSC 100-2320-B-039-033-]; China Medical University (CMU) [CMU99-S-29, CCM-P99-RD-042, CMU99-COL-10]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University (CMU)(China Medical University); Taiwan Department of Health Clinical Trial and Research Center of Excellence	The authors want to thank for financial support the National Science Council (NSC100-2313-B-039-004- and NSC 100-2320-B-039-033-), China Medical University (CMU) (CMU99-S-29, CCM-P99-RD-042, and CMU99-COL-10), and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achoui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015105; Aebi H, 1984, Methods Enzymol, V105, P121; Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bhat NR, 1998, J NEUROSCI, V18, P1633; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Chang CT, 2011, FOOD CHEM, V127, P1131, DOI 10.1016/j.foodchem.2011.01.114; Chang Heng-Yuan, 2011, Evid Based Complement Alternat Med, V2011, P478246, DOI 10.1093/ecam/nep027; Chang TN, 2011, J AGR FOOD CHEM, V59, P9112, DOI 10.1021/jf201375u; Chapelsky S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001421; Chaturvedi P, 2008, EVID-BASED COMPL ALT, V5, P55, DOI 10.1093/ecam/nel077; Committee for Research and Ethical Issues of the IASP, 1983, PAIN, V16, P161; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Haddad JJ, 2002, BRIT J PHARMACOL, V135, P520, DOI 10.1038/sj.bjp.0704467; Handy RLC, 1998, BRIT J PHARMACOL, V123, P1119, DOI 10.1038/sj.bjp.0701735; Hsing CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017598; Huang GJ, 2011, J AGR FOOD CHEM, V59, P11211, DOI 10.1021/jf200576f; Huang GJ, 2011, J AGR FOOD CHEM, V59, P7104, DOI 10.1021/jf201289e; Huang GJ, 2011, J AGR FOOD CHEM, V59, P5702, DOI 10.1021/jf2003943; Huang GJ, 2010, J AGR FOOD CHEM, V58, P9468, DOI 10.1021/jf101508r; Huang GJ, 2010, J AGR FOOD CHEM, V58, P7445, DOI 10.1021/jf1013764; Huang MH, 2011, J ETHNOPHARMACOL, V135, P545, DOI 10.1016/j.jep.2011.03.057; Huang MH, 2011, J ETHNOPHARMACOL, V133, P743, DOI 10.1016/j.jep.2010.11.005; Huang SS, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/895857; Jeong JB, 2010, FOOD CHEM TOXICOL, V48, P2148, DOI 10.1016/j.fct.2010.05.020; Jung JY, 2008, J APPL MICROBIOL, V104, P1824, DOI 10.1111/j.1365-2672.2008.03737.x; Ku KT, 2008, J AGR FOOD CHEM, V56, P8911, DOI 10.1021/jf8019369; Kuo YC, 2009, MOL NUTR FOOD RES, V53, P1386, DOI 10.1002/mnfr.200800583; Lai CS, 2009, J AGR FOOD CHEM, V57, P10990, DOI 10.1021/jf9025713; Lee IK, 2011, J ANTIBIOT, V64, P349, DOI 10.1038/ja.2011.2; Liao YC, 2009, J AGR FOOD CHEM, V57, P8933, DOI 10.1021/jf902630w; Lu Y, 2010, BIOL PHARM BULL, V33, P1944, DOI 10.1248/bpb.33.1944; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pan MH, 2009, CARCINOGENESIS, V30, P1234, DOI 10.1093/carcin/bgp121; Park EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027739; Rajapakse N, 2008, IMMUNOLOGY, V123, P348, DOI 10.1111/j.1365-2567.2007.02683.x; Wen CL, 2011, J ETHNOPHARMACOL, V137, P575, DOI 10.1016/j.jep.2011.06.009; Woo CH, 2004, J IMMUNOL, V173, P6973, DOI 10.4049/jimmunol.173.11.6973; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948	39	75	80	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e35922	10.1371/journal.pone.0035922	http://dx.doi.org/10.1371/journal.pone.0035922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590514	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335500005
J	Tveteras, S; Asche, F; Bellemare, MF; Smith, MD; Guttormsen, AG; Lem, A; Lien, K; Vannuccini, S				Tveteras, Sigbjorn; Asche, Frank; Bellemare, Marc F.; Smith, Martin D.; Guttormsen, Atle G.; Lem, Audun; Lien, Kristin; Vannuccini, Stefania			Fish Is Food - The FAO's Fish Price Index	PLOS ONE			English	Article							EXCHANGE-RATES; SALMON	World food prices hit an all-time high in February 2011 and are still almost two and a half times those of 2000. Although three billion people worldwide use seafood as a key source of animal protein, the Food and Agriculture Organization (FAO) of the United Nations-which compiles prices for other major food categories-has not tracked seafood prices. We fill this gap by developing an index of global seafood prices that can help to understand food crises and may assist in averting them. The fish price index (FPI) relies on trade statistics because seafood is heavily traded internationally, exposing non-traded seafood to price competition from imports and exports. Easily updated trade data can thus proxy for domestic seafood prices that are difficult to observe in many regions and costly to update with global coverage. Calculations of the extent of price competition in different countries support the plausibility of reliance on trade data. Overall, the FPI shows less volatility and fewer price spikes than other food price indices including oils, cereals, and dairy. The FPI generally reflects seafood scarcity, but it can also be separated into indices by production technology, fish species, or region. Splitting FPI into capture fisheries and aquaculture suggests increased scarcity of capture fishery resources in recent years, but also growth in aquaculture that is keeping pace with demand. Regionally, seafood price volatility varies, and some prices are negatively correlated. These patterns hint that regional supply shocks are consequential for seafood prices in spite of the high degree of seafood tradability.	[Tveteras, Sigbjorn] Pontificia Univ Catolica Peru, CTR Catolica Grad Sch Business, Lima, Peru; [Asche, Frank] Univ Stavanger, Dept Ind Econ, Stavanger, Norway; [Bellemare, Marc F.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Bellemare, Marc F.; Smith, Martin D.] Duke Univ, Dept Econ, Durham, NC 27706 USA; [Smith, Martin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Guttormsen, Atle G.] Norwegian Univ Life Sci, Dept Econ & Resource Management, As, Norway; [Lem, Audun; Vannuccini, Stefania] Food & Agr Org United Nations, Fisheries & Aquaculture Policy & Econ Div, Rome, Italy; [Lien, Kristin] Norwegian Seafood Council, Tromso, Norway	Pontificia Universidad Catolica del Peru; Universitetet i Stavanger; Duke University; Duke University; Duke University; Norwegian University of Life Sciences; Food & Agriculture Organization of the United Nations (FAO)	Tveteras, S (corresponding author), Pontificia Univ Catolica Peru, CTR Catolica Grad Sch Business, Lima, Peru.	stveteras@pucp.pe	Smith, Martin D/D-9168-2016; Guttormsen, Atle/GZG-2356-2022; Asche, Frank/AAG-9920-2020; Tveteraas, SIgbjorn/Y-2283-2019; Bellemare, Marc F./HCH-3192-2022	Smith, Martin D/0000-0002-4714-463X; Asche, Frank/0000-0002-1540-9728; 	Food and Agricultural Organization of the United Nations; CENTRUM Catolica; Department of Industrial Economics; Sanford School of Public Policy; Nicholas School of the Environment, Duke University, Durham; Department of Economics; Department of Economics and Resource Management; Norwegian Seafood Export Council; Pontificia Universidad Catolica del Peru; University of Stavanger; Duke University, Durham; Norwegian University of Life Sciences	Food and Agricultural Organization of the United Nations; CENTRUM Catolica; Department of Industrial Economics; Sanford School of Public Policy; Nicholas School of the Environment, Duke University, Durham; Department of Economics; Department of Economics and Resource Management; Norwegian Seafood Export Council; Pontificia Universidad Catolica del Peru; University of Stavanger; Duke University, Durham; Norwegian University of Life Sciences	The funder of this study is the Food and Agricultural Organization of the United Nations, and the respective institutions of the coauthors (CENTRUM Catolica, Pontificia Universidad Catolica del Peru; Department of Industrial Economics, University of Stavanger; Sanford School of Public Policy, Duke University; Nicholas School of the Environment, Duke University, Durham; Department of Economics, Duke University, Durham; Department of Economics and Resource Management, Norwegian University of Life Sciences; Norwegian Seafood Export Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.L., 2003, INT SEAFOOD TRADE; Anderson J.L., 2010, HDB MARINE FISHERIES; [Anonymous], 2011, LET THEM EAT BREAD F; Asche F, 2007, APPL ECON, V39, P2535, DOI 10.1080/00036840500486524; Asche Frank, 2009, Aquaculture Economics and Management, V13, P76, DOI 10.1080/13657300902881641; Asche F, 2008, MAR RESOUR ECON, V23, P527, DOI 10.1086/mre.23.4.42629678; Barrett CB, 1996, AM J AGR ECON, V78, P656, DOI 10.2307/1243283; Barrett CB, 1996, J DEV ECON, V51, P193, DOI 10.1016/S0304-3878(96)00412-9; Bellemare MF, 2012, YOU SOW SO SHALL YOU; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Deaton A, 2010, AM ECON REV, V100, P5, DOI 10.1257/aer.100.1.5; Diewert W.E., 2008, NEW PALGRAVE DICT EC, P1, DOI [10.1057/978-1-349-95121-5_940-2, DOI 10.1057/978-1-349-95121-5_940-2]; Diewert WE, 1998, J ECON PERSPECT, V12, P47, DOI 10.1257/jep.12.1.47; Duarte CM, 2009, BIOSCIENCE, V59, P967, DOI 10.1525/bio.2009.59.11.8; FAO (Food and Agriculture Organization of the United Nations), 2010, STAT WORLD FISH AQ 2; Food and Agricultural Organization of the United Nations, 2011, FAO FOOD OUTL GLOB M; Food and Agricultural Organization of the United Nations, 2011, FISHST J; Food and Agriculture Organization of the United Nations, 2012, FAO FOOD PRIC IND; Funke H., 1978, THEORY APPL EC INDIC; Goldberg PK, 1997, J ECON LIT, V35, P1243; Hu YW, 2009, P NATL ACAD SCI USA, V106, P10971, DOI 10.1073/pnas.0904826106; McMichael P, 2009, AGR HUM VALUES, V26, P281, DOI 10.1007/s10460-009-9218-5; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; OECD, 2008, OECD BENCHM DEF FOR, V4th; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Reardon T, 2003, AM J AGR ECON, V85, P1140, DOI 10.1111/j.0092-5853.2003.00520.x; Smith MD, 2010, SCIENCE, V330, P1052, DOI 10.1126/science.1197769; Smith MD, 2010, SCIENCE, V327, P784, DOI 10.1126/science.1185345; Timmer CP, 2010, J NUTR, V140, p224S, DOI 10.3945/jn.109.110379; Tveteras S, 2008, APPL ECON, V40, P1745, DOI 10.1080/00036840600905134; Valderrama D, 2010, J ENVIRON ECON MANAG, V59, P115, DOI 10.1016/j.jeem.2009.12.001; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	33	182	185	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36731	10.1371/journal.pone.0036731	http://dx.doi.org/10.1371/journal.pone.0036731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TF	22590598	Green Submitted, gold, Green Published			2022-12-25	WOS:000305335500026
J	Sun, QQ; Jiang, S; Li, X; Huang, XH; Xie, KN; Cheng, DR; Chen, JS; Ji, SM; Wen, JQ; Zhang, MC; Zeng, CH; Liu, ZH				Sun, Qiquan; Jiang, Song; Li, Xue; Huang, Xianghua; Xie, Kenan; Cheng, Dongrui; Chen, Jinsong; Ji, Shuming; Wen, Jiqiu; Zhang, Mingchao; Zeng, Caihong; Liu, Zhihong			The Prevalence of Immunologic Injury in Renal Allograft Recipients with De Novo Proteinuria	PLOS ONE			English	Article							ANTIBODY-MEDIATED REJECTION; RECURRENT IGA NEPHROPATHY; BETA-D-GLUCOSAMINIDASE; KIDNEY-TRANSPLANTATION; GRAFT; SURVIVAL; BIOPSIES; CLASSIFICATION; GLOMERULOPATHY; MANAGEMENT	Post-transplant proteinuria is a common complication after renal transplantation; it is associated with reduced graft and recipient survival. However, the prevalence of histological causes has been reported with considerable variation. A clinicopathological re-evaluation of post-transplant proteinuria is necessary, especially after dismissal of the term "chronic allograft nephropathy," which had been considered to be an important cause of proteinuria. Moreover, urinary protein can promote interstitial inflammation in native kidney, whether this occurs in renal allograft remains unknown. Factors that affect the graft outcome in patients with proteinuria also remain unclear. Here we collected 98 cases of renal allograft recipients who developed proteinuria after transplant, histological features were characterized using Banff scoring system. Cox proportional hazard regression models were used for graft survival predictors. We found that transplant glomerulopathy was the leading (40.8%) cause of post-transplant proteinuria. Immunological causes, including transplant glomerulopathy, acute rejection, and chronic rejection accounted for the majority of all pathological causes of proteinuria. Nevertheless, almost all patients that developed proteinuria had immunological lesions in the graft, especially for interstitial inflammation. Intraglomerular C3 deposition was unexpectedly correlated with the severity of proteinuria. Moreover, the severity of interstitial inflammation was an independent risk factor for graft loss, while high level of hemoglobin was a protective factor for graft survival. This study revealed a predominance of immunological parameters in renal allografts with post-transplant proteinuria. These parameters not only correlate with the severity of proteinuria, but also with the outcome of the graft.	[Sun, Qiquan; Jiang, Song; Li, Xue; Huang, Xianghua; Xie, Kenan; Cheng, Dongrui; Chen, Jinsong; Ji, Shuming; Wen, Jiqiu; Zhang, Mingchao; Zeng, Caihong; Liu, Zhihong] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Nephrol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Sun, QQ (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Nephrol, Nanjing 210008, Jiangsu, Peoples R China.	sunqiquan@hotmail.com	Liu, Zhihong/ABB-6918-2021	Liu, Zhihong/0000-0001-6093-0726; Li, Xue/0000-0001-7073-7532; Sun, Qiquan/0000-0002-7296-316X	National Natural Science Foundation of China [81070593, 30600572]; 333 Talent Training Program of Jiangsu Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 333 Talent Training Program of Jiangsu Province, China	This study was supported by a grant from the General Program of National Natural Science Foundation of China (No. 81070593, No. 30600572), and a grant from 333 Talent Training Program of Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer H, 2007, AM J TRANSPLANT, V7, P2748, DOI 10.1111/j.1600-6143.2007.02006.x; Amer H, 2009, J AM SOC NEPHROL, V20, P2490, DOI 10.1681/ASN.2008091005; BERNARD AM, 1987, CLIN CHEM, V33, P775; Borchhardt K, 1997, KIDNEY INT, V52, P1622, DOI 10.1038/ki.1997.494; Chandrakantan A, 2005, NEPHROL DIAL TRANSPL, V20, P1214, DOI 10.1093/ndt/gfh773; Cherukuri A, 2010, TRANSPLANTATION, V89, P200, DOI 10.1097/TP.0b013e3181c352c5; Choukroun G, 2012, J AM SOC NEPHROL, V23, P360, DOI 10.1681/ASN.2011060546; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; Fernandez-Fresnedo G, 2004, NEPHROL DIAL TRANSPL, V19, P47, DOI 10.1093/ndt/gfh1015; FIRST MR, 1984, TRANSPLANTATION, V38, P607, DOI 10.1097/00007890-198412000-00012; GREKAS D, 1995, CLIN NEPHROL, V44, P299; Halimi JM, 2005, AM J TRANSPLANT, V5, P2281, DOI 10.1111/j.1600-6143.2005.01020.x; Hohage H, 1997, NEPHRON, V75, P160, DOI 10.1159/000189525; ISONIEMI HM, 1992, KIDNEY INT, V41, P155, DOI 10.1038/ki.1992.21; Issa N, 2008, TRANSPLANTATION, V86, P681, DOI 10.1097/TP.0b013e3181837626; Kotanko P, 2000, NEPHRON, V84, P228, DOI 10.1159/000045582; LEVY M, 1988, AM J KIDNEY DIS, V12, P340, DOI 10.1016/S0272-6386(88)80021-0; Morath C, 2007, NAT CLIN PRACT NEPHR, V3, P18, DOI 10.1038/ncpneph0376; Myslak M, 2006, AM J TRANSPLANT, V6, P1660, DOI 10.1111/j.1600-6143.2006.01361.x; Navarro JF, 1998, AM J NEPHROL, V18, P261, DOI 10.1159/000013332; Pei R, 1998, HUM IMMUNOL, V59, P313, DOI 10.1016/S0198-8859(98)00020-2; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Reichel H, 2004, NEPHROL DIAL TRANSPL, V19, P301, DOI 10.1093/ndt/gfh002; RELL K, 1993, TRANSPLANT INT, V6, P213, DOI 10.1007/BF00337102; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Roodnat JL, 2001, TRANSPLANTATION, V72, P438, DOI 10.1097/00007890-200108150-00014; SETHI K, 1977, NEPHRON, V18, P49, DOI 10.1159/000180766; Sis B, 2007, AM J TRANSPLANT, V7, P1743, DOI 10.1111/j.1600-6143.2007.01836.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Sund S, 2003, TRANSPLANTATION, V75, P1204, DOI 10.1097/01.TP.0000062835.30165.2C; Sund S, 1998, APMIS, V106, P1017, DOI 10.1111/j.1699-0463.1998.tb00254.x; Wang AYM, 2001, AM J KIDNEY DIS, V38, P588, DOI 10.1053/ajkd.2001.26885; Wiland P, 1997, BRIT J RHEUMATOL, V36, P59; Yakupoglu U, 2004, KIDNEY INT, V65, P2360, DOI 10.1111/j.1523-1755.2004.00655.x	37	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36654	10.1371/journal.pone.0036654	http://dx.doi.org/10.1371/journal.pone.0036654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586485	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335000046
J	Gonzalo-Gomez, A; Turiegano, E; Leon, Y; Molina, I; Torroja, L; Canal, I				Gonzalo-Gomez, Alicia; Turiegano, Enrique; Leon, Yolanda; Molina, Isabel; Torroja, Laura; Canal, Inmaculada			Ih Current Is Necessary to Maintain Normal Dopamine Fluctuations and Sleep Consolidation in Drosophila	PLOS ONE			English	Article							CIRCADIAN MODULATION; LOCOMOTOR-ACTIVITY; HCN CHANNELS; CLOCK GENES; NEURONS; RHYTHMS; RAT; EXPRESSION; AROUSAL; ETHANOL	HCN channels are becoming pharmacological targets mainly in cardiac diseases. But apart from their well-known role in heart pacemaking, these channels are widely expressed in the nervous system where they contribute to the neuron firing pattern. Consequently, abolishing Ih current might have detrimental consequences in a big repertoire of behavioral traits. Several studies in mammals have identified the Ih current as an important determinant of the firing activity of dopaminergic neurons, and recent evidences link alterations in this current to various dopamine-related disorders. We used the model organism Drosophila melanogaster to investigate how lack of Ih current affects dopamine levels and the behavioral consequences in the sleep: activity pattern. Unlike mammals, in Drosophila there is only one gene encoding HCN channels. We generated a deficiency of the DmIh core gene region and measured, by HPLC, levels of dopamine. Our data demonstrate daily variations of dopamine in wild-type fly heads. Lack of Ih current dramatically alters dopamine pattern, but different mechanisms seem to operate during light and dark conditions. Behaviorally, DmIh mutant flies display alterations in the rest: activity pattern, and altered circadian rhythms. Our data strongly suggest that Ih current is necessary to prevent dopamine overproduction at dark, while light input allows cycling of dopamine in an Ih current dependent manner. Moreover, lack of Ih current results in behavioral defects that are consistent with altered dopamine levels.	[Gonzalo-Gomez, Alicia; Turiegano, Enrique; Leon, Yolanda; Molina, Isabel; Torroja, Laura; Canal, Inmaculada] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid	Gonzalo-Gomez, A (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	inmaculada.canal@uam.es	Torroja, Laura/L-2449-2013; Torroja, Laura/AAU-7896-2021; Leon, Yolanda/ABG-6797-2020; Molina, Isabel/L-2432-2013; Turiegano, Enrique/M-8679-2013	Torroja, Laura/0000-0001-6939-6259; Torroja, Laura/0000-0001-6939-6259; Molina, Isabel/0000-0003-1687-2447; Turiegano, Enrique/0000-0003-4620-7894; Leon Alvarez, Yolanda/0000-0002-4536-8373	Ministerio de Ciencia e Innovacion [BFU2008-04683]; Comunidad Autonoma de Madrid grant [P-SEM-0255-2006, BFU2010-10981-E]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid grant	This work was supported by Ministerio de Ciencia e Innovacion grant BFU2008-04683 to LT, Comunidad Autonoma de Madrid grant P-SEM-0255-2006 to IC, and BFU2010-10981-E to ET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Andretic R, 2000, P NATL ACAD SCI USA, V97, P1873, DOI 10.1073/pnas.97.4.1873; Andretic R, 2008, P NATL ACAD SCI USA, V105, P20392, DOI 10.1073/pnas.0806776105; Arencibia-Albite F, 2007, NEUROSCIENCE, V149, P303, DOI 10.1016/j.neuroscience.2007.08.009; Arnsten AFT, 2007, CEREB CORTEX, V17, pI6, DOI 10.1093/cercor/bhm033; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Baruscotti M, 2010, PFLUG ARCH EUR J PHY, V460, P405, DOI 10.1007/s00424-010-0810-8; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; Brodie MS, 1998, ALCOHOL CLIN EXP RES, V22, P236, DOI 10.1111/j.1530-0277.1998.tb03644.x; Bushey D, 2009, J NEUROSCI, V29, P1948, DOI 10.1523/JNEUROSCI.4830-08.2009; CAHILL GM, 1991, J NEUROSCI, V11, P2959; Cangiano L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001327; Castaneda TR, 2004, J PINEAL RES, V36, P177, DOI 10.1046/j.1600-079X.2003.00114.x; Cathala L, 1999, EUR J NEUROSCI, V11, P398, DOI 10.1046/j.1460-9568.1999.00452.x; Cathala L, 1997, J PHYSIOL-LONDON, V503, P87, DOI 10.1111/j.1469-7793.1997.087bi.x; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cervetto L, 2007, BRIT J PHARMACOL, V150, P383, DOI 10.1038/sj.bjp.0706998; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan CS, 2011, NAT NEUROSCI, V14, P85, DOI 10.1038/nn.2692; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Chu HY, 2010, ACTA PHARMACOL SIN, V31, P1036, DOI 10.1038/aps.2010.105; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; Demontis GC, 2002, NEWS PHYSIOL SCI, V17, P110, DOI 10.1152/nips.01364.2001; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Draper I, 2007, DEV NEUROBIOL, V67, P378, DOI 10.1002/dneu.20355; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Gisselmann GN, 2005, INSECT BIOCHEM MOLEC, V35, P505, DOI 10.1016/j.ibmb.2005.02.001; Gravotta L, 2011, J MOL NEUROSCI, V45, P162, DOI 10.1007/s12031-011-9520-8; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Herrmann S, 2007, PFLUG ARCH EUR J PHY, V454, P517, DOI 10.1007/s00424-007-0224-4; Hirsh J, 2010, CURR BIOL, V20, P209, DOI 10.1016/j.cub.2009.11.037; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lee KH, 1996, NEURON, V17, P309, DOI 10.1016/S0896-6273(00)80162-2; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu ZP, 2003, J NEUROPHYSIOL, V90, P3201, DOI 10.1152/jn.00281.2003; Lu B, 2008, GENES BRAIN BEHAV, V7, P730, DOI 10.1111/j.1601-183X.2008.00411.x; Lyons LC, 2009, LEARN MEMORY, V16, P19, DOI 10.1101/lm.1146009; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Marx Thomas, 1999, Invertebrate Neuroscience, V4, P55, DOI 10.1007/s101580050007; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Okamoto T, 2006, J NEUROPHYSIOL, V95, P619, DOI 10.1152/jn.00682.2005; Parashar V, 2008, RADIAT RES, V169, P707, DOI 10.1667/RR1225.1; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Seutin V, 2001, NEUROREPORT, V12, P255, DOI 10.1097/00001756-200102120-00015; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shi WM, 1999, CIRC RES, V85, pE1; Sicaeros Beatriz, 2007, J Vis Exp, P200, DOI 10.3791/200; Sleipness EP, 2008, SYNAPSE, V62, P877, DOI 10.1002/syn.20552; Sorribes A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002075; Stieber J, 2006, MOL PHARMACOL, V69, P1328, DOI 10.1124/mol.105.020701; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Thollon C, 2010, ADV PHARMACOL, V59, P53, DOI 10.1016/S1054-3589(10)59003-3; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Vandecasteele M, 2008, P NATL ACAD SCI USA, V105, P4904, DOI 10.1073/pnas.0703121105; Vermeulen CJ, 2006, MECH AGEING DEV, V127, P610, DOI 10.1016/j.mad.2006.02.004; Zhang YQ, 2005, MOL CELL PROTEOMICS, V4, P278, DOI 10.1074/mcp.M400174-MCP200; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zhou XJ, 2005, J BIOL RHYTHM, V20, P237, DOI 10.1177/0748730405274451; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	73	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36477	10.1371/journal.pone.0036477	http://dx.doi.org/10.1371/journal.pone.0036477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574167	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800063
J	Li, SG; Wang, JY; Luo, F				Li, Sheng-Guang; Wang, Jin-Yan; Luo, Fei			Adult-Age Inflammatory Pain Experience Enhances Long-Term Pain Vigilance in Rats	PLOS ONE			English	Article							REPETITIVE NOCICEPTIVE STIMULATION; CHRONIC BACK-PAIN; PSYCHOLOGICAL VARIABLES; SUBJECTIVE EXPERIENCE; PREEMPTIVE ANALGESIA; LASTING HYPERALGESIA; NEURONAL RESPONSES; CINGULUM BUNDLE; ANIMAL-MODELS; FORMALIN TEST	Background: Previous animal studies have illustrated a modulatory effect of neonatal pain experience on subsequent pain-related behaviors. However, the relationship between chronic pain status in adulthood and future pain perception remains unclear. Methodology/Principal Findings: In the current study, we investigated the effects of inflammatory pain experience on subsequent formalin-evoked pain behaviors and fear conditioning induced by noxious stimulation in adult rats. Our results demonstrated an increase of the second but not the first phase of formalin-induced pain behaviors in animals with a history of inflammatory pain that have recovered. Similarly, rats with persistent pain experience displayed facilitated acquisition and prolonged retention of pain-related conditioning. These effects of prior pain experience on subsequent behavior were prevented by repeated morphine administration at an early stage of inflammatory pain. Conclusions/Significance: These results suggest that chronic pain diseases, if not properly and promptly treated, may have a long-lasting impact on processing and perception of environmental threats. This may increase the susceptibility of patients to subsequent pain-related disorders, even when chronic pain develops in adulthood. These data highlight the importance of treatment of chronic pain at an early stage.	[Li, Sheng-Guang; Wang, Jin-Yan; Luo, Fei] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Li, Sheng-Guang] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, SG (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangjy@psych.ac.cn; luof@psych.ac.cn			NNSF [30700223, 30770688, 30970959, 61033011, 31171067]; Knowledge Innovation Project from the Chinese Academy of Sciences [KSCX2-EW-Q-18]; Knowledge Innovation Project of the Chinese Academy of Sciences [YZ200944, KSCX2-YW-R-254, KSCX2-EW-J-8]; National Institutes of Health Fogarty International Center [R03 TW008038]; FOGARTY INTERNATIONAL CENTER [R03TW008038] Funding Source: NIH RePORTER	NNSF(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project from the Chinese Academy of Sciences; Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by an NNSF grant (30700223) and the Knowledge Innovation Project (KSCX2-EW-Q-18) from the Chinese Academy of Sciences to JYW; NNSF grants (30770688, 30970959, 61033011, and 31171067), the Knowledge Innovation Project (YZ200944, KSCX2-YW-R-254, and KSCX2-EW-J-8) of the Chinese Academy of Sciences, and a grant from National Institutes of Health Fogarty International Center (R03 TW008038) to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi AM, 2003, ANN NY ACAD SCI, V1007, P232, DOI 10.1196/annals.1286.022; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Arnow BA, 2006, PSYCHOSOM MED, V68, P262, DOI 10.1097/01.psy.0000204851.15499.fc; BACHIOCCO V, 1993, CLIN J PAIN, V9, P266, DOI 10.1097/00002508-199312000-00008; Bayer TL, 1998, PAIN, V74, P327, DOI 10.1016/S0304-3959(97)00196-6; Bhutta AT, 2001, PHYSIOL BEHAV, V73, P51, DOI 10.1016/S0031-9384(01)00432-2; Boersma K, 2005, BEHAV RES THER, V43, P1495, DOI 10.1016/j.brat.2004.11.006; Boersma K, 2006, CLIN J PAIN, V22, P160, DOI 10.1097/01.ajp.0000159582.37750.39; BORSZCZ GS, 1995, BEHAV NEUROSCI, V109, P648, DOI 10.1037/0735-7044.109.4.648; Brown CA, 2008, PAIN, V135, P240, DOI 10.1016/j.pain.2007.05.022; Ceccarelli I, 2003, PAIN, V104, P35, DOI 10.1016/S0304-3959(02)00460-8; Ceccarelli I, 2006, BRAIN RES, V1106, P142, DOI 10.1016/j.brainres.2006.05.089; Celerier E, 2000, ANESTHESIOLOGY, V92, P465, DOI 10.1097/00000542-200002000-00029; Cipher DJ, 1997, BEHAV RES THER, V35, P437, DOI 10.1016/S0005-7967(96)00121-0; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; FAN RJ, 1995, PHYSIOL BEHAV, V57, P1131, DOI 10.1016/0031-9384(94)00372-C; Fan RJ, 2009, PHYSIOL BEHAV, V98, P108, DOI 10.1016/j.physbeh.2009.04.022; Flor H, 2007, Handb Exp Pharmacol, P415; Flor H, 2003, J REHABIL MED, V35, P66, DOI 10.1080/16501960310010179; GAMSA A, 1991, PAIN, V44, P271, DOI 10.1016/0304-3959(91)90096-G; Gatchel RJ, 2003, J OCCUP REHABIL, V13, P1, DOI 10.1023/A:1021823505774; GRAF P, 1987, J EXP PSYCHOL LEARN, V13, P45, DOI 10.1037/0278-7393.13.1.45; Hasenbring M, 2001, SCHMERZ, V15, P442, DOI 10.1007/s004820100030; Hermann C, 2006, PAIN, V125, P278, DOI 10.1016/j.pain.2006.08.026; Holzl R, 2005, PAIN, V115, P12, DOI 10.1016/j.pain.2005.01.026; Huang J, 2006, EXP NEUROL, V200, P124, DOI 10.1016/j.expneurol.2006.01.036; Hummel M, 2008, PAIN, V140, P436, DOI 10.1016/j.pain.2008.09.020; JACOBY LL, 1983, J EXP PSYCHOL LEARN, V9, P21, DOI 10.1037/0278-7393.9.1.21; KATZ J, 1992, ANESTHESIOLOGY, V77, P439, DOI 10.1097/00000542-199209000-00006; Kissin I, 2000, ANESTHESIOLOGY, V93, P1138, DOI 10.1097/00000542-200010000-00040; Ko S, 2004, DRUG DISCOV TODAY, V1, P101; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Laprairie JL, 2008, PEDIATR RES, V64, P625, DOI 10.1203/PDR.0b013e31818702d4; Lehner M, 2010, ACTA NEUROBIOL EXP, V70, P56; Leo Raphael J, 2005, Curr Treat Options Neurol, V7, P403, DOI 10.1007/s11940-005-0032-0; Lidow MS, 2002, PAIN, V99, P377, DOI 10.1016/S0304-3959(02)00258-0; Loyd DR, 2008, EUR J NEUROSCI, V27, P1517, DOI 10.1111/j.1460-9568.2008.06100.x; MELZACK R, 1957, J COMP PHYSIOL PSYCH, V50, P155, DOI 10.1037/h0047770; Moiniche S, 2002, ANESTHESIOLOGY, V96, P725, DOI 10.1097/00000542-200203000-00032; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Pedersen LH, 2007, PAIN, V127, P17, DOI 10.1016/j.pain.2006.06.036; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; Rivat C, 2002, ANESTHESIOLOGY, V96, P381, DOI 10.1097/00000542-200202000-00025; Robinson ME, 2004, J PAIN, V5, P264, DOI 10.1016/j.jpain.2004.04.003; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SCHINDLER CW, 1983, J PHARMACOL EXP THER, V227, P639; SCHINDLER CW, 1984, PSYCHOPHARMACOLOGY, V83, P114, DOI 10.1007/BF00427434; Schmelzle-Lublecki BM, 2007, EUR J PAIN, V11, P799, DOI 10.1016/j.ejpain.2006.12.009; Schmulson M, 1999, AM J GASTROENTEROL, V94, P2929, DOI 10.1111/j.1572-0241.1999.01440.x; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4; Shyu BC, 2003, BRAIN RES PROTOC, V12, P1, DOI 10.1016/S1385-299X(03)00041-2; Slipp S, 2000, J Am Acad Psychoanal, V28, P191; SLOMAN SA, 1988, J EXP PSYCHOL LEARN, V14, P223, DOI 10.1037/0278-7393.14.2.223; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sternberg WF, 2005, PAIN, V113, P347, DOI 10.1016/j.pain.2004.11.013; TASKER RAR, 1987, PAIN, V31, P237, DOI 10.1016/0304-3959(87)90039-X; Turk DC, 2002, J CONSULT CLIN PSYCH, V70, P678, DOI 10.1037//0022-006X.70.3.678; Vaccarino AL, 1997, NEUROSCI LETT, V236, P117, DOI 10.1016/S0304-3940(97)00770-2; VACCARINO AL, 1989, PAIN, V39, P213, DOI 10.1016/0304-3959(89)90008-0; VACCARINO AL, 1992, PAIN, V49, P257, DOI 10.1016/0304-3959(92)90150-A; Wang N, 2009, PAIN, V142, P108, DOI 10.1016/j.pain.2008.12.016; Whitehead WE, 1998, GASTROENTEROLOGY, V115, P1263, DOI 10.1016/S0016-5085(98)70099-X; Yu YC, 2002, J NEUROSCI METH, V115, P107, DOI 10.1016/S0165-0270(02)00011-0; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003; Zhuo M, 2006, J NEUROSCI RES, V84, P927, DOI 10.1002/jnr.21003	71	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36767	10.1371/journal.pone.0036767	http://dx.doi.org/10.1371/journal.pone.0036767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574223	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800120
J	Martinez-Martinez, E; Galvan-Hernandez, CI; Toscano-Marquez, B; Gutierrez-Ospina, G				Martinez-Martinez, Eduardo; Galvan-Hernandez, Claudio I.; Toscano-Marquez, Brenda; Gutierrez-Ospina, Gabriel			Modulatory Role of Sensory Innervation on Hair Follicle Stem Cell Progeny during Wound Healing of the Rat Skin	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; NEUROPEPTIDE SUBSTANCE-P; KERATINOCYTE PROLIFERATION; CAPSAICIN TREATMENT; BULGE AREA; CALCITONIN; EXPRESSION; RECEPTOR; NEURONS; GROWTH	Background: The bulge region of the hair follicle contains resident epithelial stem cells (SCs) that are activated and mobilized during hair growth and after epidermal wounding. However, little is known about the signals that modulate these processes. Clinical and experimental observations show that a reduced supply of sensory innervation is associated with delayed wound healing. Since axon terminals of sensory neurons are among the components of the bulge SC niche, we investigated whether these neurons are involved in the activation and mobilization of the hair stem cells during wound healing. Methodology/Principal Findings: We used neonatal capsaicin treatment to reduce sensory terminals in the rat skin and performed morphometric analyses using design-based stereological methods. Epithelial proliferation was analyzed by quantifying the number of bromodeoxyuridine-labeled (BrdU(+)) nuclei in the epidermis and hair follicles. After wounding, the epidermis of capsaicin-treated rats presented fewer BrdU(+) nuclei than in control rats. To assess SC progeny migration, we employed a double labeling protocol with iododeoxyuridine and chlorodeoxyuridine (IdU(+)/CldU(+)). The proportion of double-labeled cells was similar in the hair follicles of both groups at 32 h postwounding. IdU(+)/CldU(+) cell proportion increased in the epidermis of control rats and decreased in treated rats at 61 h postwounding. The epidermal volume immunostained for keratin 6 was greater in treated rats at 61 h. Confocal microscopy analysis revealed that substance P (SP) and calcitonin gene-related peptide (CGRP) receptor immunoreactivity were both present in CD34(+) and BrdU-retaining cells of the hair follicles. Conclusions/Significance: Our results suggest that capsaicin denervation impairs SC progeny egress from the hair follicles, a circumstance associated with a greater epidermal activation. Altogether, these phenomena would explain the longer times for healing in denervated skin. Thus, sensory innervation may play a functional role in the modulation of hair SC physiology during wound healing.	[Martinez-Martinez, Eduardo; Galvan-Hernandez, Claudio I.; Toscano-Marquez, Brenda; Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Coyoacan, DF, Mexico; [Martinez-Martinez, Eduardo; Galvan-Hernandez, Claudio I.; Toscano-Marquez, Brenda; Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Grp Multidisciplinario Invest Celulas Troncales I, Coyoacan, DF, Mexico; [Gutierrez-Ospina, Gabriel] Colonia Copilco Univ, Fac Psicol, Coyoacan, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Martinez-Martinez, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Coyoacan, DF, Mexico.	emartin@biomedicas.unam.mx; gabo@biomedicas.unam.mx	Martínez, Eduardo Martínez/A-2558-2009	Martínez, Eduardo Martínez/0000-0002-9020-559X; Gutierrez Ospina, Gabriel/0000-0002-6286-8281	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [38615N, 45872M, 53194]; Direccion General de Asuntos del Personal Academico [IN215208]; UNAM (DGAPA); grant IMPULSA-02 from Coordinacion de la Investigacion Cientifica, UNAM (CIC-UNAM); Direccion General de Estudios de Posgrado-UNAM; IMPULSA-02	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico; UNAM (DGAPA)(Universidad Nacional Autonoma de Mexico); grant IMPULSA-02 from Coordinacion de la Investigacion Cientifica, UNAM (CIC-UNAM); Direccion General de Estudios de Posgrado-UNAM(Universidad Nacional Autonoma de Mexico); IMPULSA-02	This work was supported by grants 38615N, 45872M, and 53194 from Consejo Nacional de Ciencia y Tecnologia (CONACYT), grant IN215208 from Direccion General de Asuntos del Personal Academico, UNAM (DGAPA), and grant IMPULSA-02 from Coordinacion de la Investigacion Cientifica, UNAM (CIC-UNAM) to GGO. EMM and BTM were fellows of CONACYT. EMM also received support from Direccion General de Estudios de Posgrado-UNAM and IMPULSA-02. CIGH was a fellow of the Fundacion Lorena Alejandra Gallardo I. A. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki R, 2010, J CELL BIOCHEM, V110, P80, DOI 10.1002/jcb.22512; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Barker AR, 2006, ANN PLAS SURG, V57, P339, DOI 10.1097/01.sap.0000221465.69826.b7; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Boerzsei R, 2008, NEUROSCIENCE, V152, P82, DOI 10.1016/j.neuroscience.2007.12.005; Bowers MC, 2005, HYPERTENSION, V46, P51, DOI 10.1161/01.HYP.0000168926.44648.ed; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; BUCK SH, 1983, J NEUROSCI, V3, P2064; Bulut K, 2008, INT J COLORECTAL DIS, V23, P535, DOI 10.1007/s00384-008-0447-7; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; CARR RW, 1993, NEUROREPORT, V4, P467, DOI 10.1097/00001756-199305000-00001; Carrillo P, 1998, NEUROTOXICOL TERATOL, V20, P75, DOI 10.1016/S0892-0362(97)00077-9; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Delgado AV, 2005, EXP BIOL MED, V230, P271; Dong J, 2010, PEPTIDES, V31, P1860, DOI 10.1016/j.peptides.2010.07.007; Engin C, 1998, PLAST RECONSTR SURG, V101, P1887, DOI 10.1097/00006534-199806000-00017; Erin N, 2006, BREAST CANCER RES TR, V99, P351, DOI 10.1007/s10549-006-9219-7; Felderbauer P, 2007, INT J COLORECTAL DIS, V22, P1475, DOI 10.1007/s00384-007-0321-z; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; FUJITA S, 1984, EXP EYE RES, V38, P165, DOI 10.1016/0014-4835(84)90100-3; Fukai T, 2005, WOUND REPAIR REGEN, V13, P175, DOI 10.1111/j.1067-1927.2005.130208.x; Hagner S, 2002, PEPTIDES, V23, P109, DOI 10.1016/S0196-9781(01)00586-1; Harsum S, 2001, DEV BIOL, V238, P27, DOI 10.1006/dbio.2001.0395; Heath J, 2009, J INVEST DERMATOL, V129, P2358, DOI 10.1038/jid.2009.102; Hou QZ, 2011, PAIN, V152, P2036, DOI 10.1016/j.pain.2011.04.033; Huebner AK, 2008, ARCH BIOCHEM BIOPHYS, V473, P210, DOI 10.1016/j.abb.2008.02.013; Ikawa A, 2002, HISTOL HISTOPATHOL, V17, P419, DOI 10.14670/HH-17.419; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Jing C, 2010, WOUND REPAIR REGEN, V18, P319, DOI 10.1111/j.1524-475X.2010.00589.x; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kruger L, 1996, PROG BRAIN RES, V113, P255, DOI 10.1016/S0079-6123(08)61093-6; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; MAGGI CA, 1987, N-S ARCH PHARMACOL, V336, P538; Martinez-Martinez E, 2011, ANAT REC, V294, P173, DOI 10.1002/ar.21237; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mowa CN, 2004, J HISTOCHEM CYTOCHEM, V52, P1249, DOI 10.1369/jhc.4R6383.2004; Muller FB, 2003, BRIT J DERMATOL, V148, P30, DOI 10.1046/j.1365-2133.2003.05016.x; Offley SC, 2005, J BONE MINER RES, V20, P257, DOI 10.1359/JBMR.041108; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Pecze L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003419; Peters EMJ, 2001, J INVEST DERMATOL, V116, P236, DOI 10.1046/j.1523-1747.2001.01232.x; Rook JM, 2009, BIOCHEM PHARMACOL, V77, P1747, DOI 10.1016/j.bcp.2009.03.003; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Seike M, 2002, J DERMATOL SCI, V28, P135, DOI 10.1016/S0923-1811(01)00155-4; Smith PG, 2002, CELL TISSUE RES, V307, P281, DOI 10.1007/s00441-001-0477-8; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Toda M, 2008, BIOMED PHARMACOTHER, V62, P352, DOI 10.1016/j.biopha.2008.02.003; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Westerman R A, 1993, Clin Exp Neurol, V30, P39; Yong EXZ, 2008, J PEDIATR SURG, V43, P1533, DOI 10.1016/j.jpedsurg.2007.11.037; Yu XJ, 2009, CELL BIOL INT, V33, P1144, DOI 10.1016/j.cellbi.2009.07.003	58	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36421	10.1371/journal.pone.0036421	http://dx.doi.org/10.1371/journal.pone.0036421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574159	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349800055
J	Sztal, T; Chung, H; Berger, S; Currie, PD; Batterham, P; Daborn, PJ				Sztal, Tamar; Chung, Henry; Berger, Silke; Currie, Peter D.; Batterham, Philip; Daborn, Phillip J.			A Cytochrome P450 Conserved in Insects Is Involved in Cuticle Formation	PLOS ONE			English	Article							HUMAN-BODY LOUSE; DROSOPHILA-MELANOGASTER; HALLOWEEN GENES; MOLTING HORMONE; P450 ENZYMES; DEVELOPMENTAL EXPRESSION; DETOXIFICATION GENES; ECDYSONE; BIOSYNTHESIS; MORPHOGENESIS	The sequencing of numerous insect genomes has revealed dynamic changes in the number and identity of cytochrome P450 genes in different insects. In the evolutionary sense, the rapid birth and death of many P450 genes is observed, with only a small number of P450 genes showing orthology between insects with sequenced genomes. It is likely that these conserved P450s function in conserved pathways. In this study, we demonstrate the P450 gene, Cyp301a1, present in all insect genomes sequenced to date, affects the formation of the adult cuticle in Drosophila melanogaster. A Cyp301a1 piggyBac insertion mutant and RNAi of Cyp301a1 both show a similar cuticle malformation phenotype, which can be reduced by 20-hydroxyecdysone, suggesting that Cyp301a1 is an important gene involved in the formation of the adult cuticle and may be involved in ecdysone regulation in this tissue.	[Sztal, Tamar; Chung, Henry; Batterham, Philip; Daborn, Phillip J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Genet, Melbourne, Vic, Australia; [Sztal, Tamar] Monash Univ, Dept Biol Sci, Melbourne, Vic 3004, Australia; [Sztal, Tamar; Berger, Silke; Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3004, Australia	University of Melbourne; Monash University; Australian Regenerative Medicine Institute; Monash University	Sztal, T (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Genet, Melbourne, Vic, Australia.	tamar.sztal@monash.edu	Chung, Henry/C-9374-2014; Batterham, Philip/G-5914-2012	Chung, Henry/0000-0001-5056-2755; Batterham, Philip/0000-0001-9840-9119; Sztal, Tamar/0000-0001-9745-3580; Currie, Peter/0000-0001-8874-8862	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council through an Australian Research Fellowship to PJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff M, 2009, DEVELOPMENT, V136, P2403, DOI 10.1242/dev.035410; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R., 2005, P1; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Guittard E, 2011, DEV BIOL, V349, P35, DOI 10.1016/j.ydbio.2010.09.023; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Horn C, 2003, GENETICS, V163, P647; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Lafont R., 2005, P125; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lewis DFV, 2004, PHARMACOGENOMICS, V5, P305, DOI 10.1517/phgs.5.3.305.29827; Li LO, 2008, P NATL ACAD SCI USA, V105, P13883, DOI 10.1073/pnas.0804099105; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; MADHAVAN MM, 1980, J EMBRYOL EXP MORPH, V60, P1; Maibeche-Coisne M, 2000, BIOCHEM BIOPH RES CO, V273, P1132, DOI 10.1006/bbrc.2000.3058; MILNER MJ, 1977, J EMBRYOL EXP MORPH, V37, P105; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; Ninov N, 2007, DEVELOPMENT, V134, P367, DOI 10.1242/dev.02728; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Rewitz KF, 2006, BIOCHEM SOC T, V34, P1256, DOI 10.1042/BST0341256; Rewitz KF, 2006, MOL CELL ENDOCRINOL, V247, P166, DOI 10.1016/j.mce.2005.12.053; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Riddiford L. M., 1994, ADV INSECT PHYSL; ROSELAND CR, 1979, ROUX ARCH DEV BIOL, V186, P235, DOI 10.1007/BF00848591; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sekyrova P, 2010, DEVELOPMENT, V137, P141, DOI 10.1242/dev.037861; Stoilov I, 2001, TRENDS GENET, V17, P629, DOI 10.1016/S0168-9525(01)02444-1; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Sztal T, 2007, INSECT BIOCHEM MOLEC, V37, P1044, DOI 10.1016/j.ibmb.2007.05.017; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Yao QO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014058; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	51	44	46	9	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36544	10.1371/journal.pone.0036544	http://dx.doi.org/10.1371/journal.pone.0036544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574182	Green Published, gold			2022-12-25	WOS:000305349800079
J	Westerman, BA; Blom, M; Tanger, E; van der Valk, M; Song, JY; van Santen, M; Gadiot, J; Cornelissen-Steijger, P; Zevenhoven, J; Prosser, HM; Uren, A; Aronica, E; van Lohuizen, M				Westerman, Bart A.; Blom, Marleen; Tanger, Ellen; van der Valk, Martin; Song, Ji-Ying; van Santen, Marije; Gadiot, Jules; Cornelissen-Steijger, Paulien; Zevenhoven, John; Prosser, Haydn M.; Uren, Anthony; Aronica, Eleonora; van Lohuizen, Maarten			GFAP-Cre-Mediated Transgenic Activation of Bmi1 Results in Pituitary Tumors	PLOS ONE			English	Article							CELL SELF-RENEWAL; NEURAL STEM-CELLS; CEREBELLAR DEVELOPMENT; RETINOBLASTOMA GENE; SUBVENTRICULAR ZONE; H2A UBIQUITINATION; TARGET GENE; EXPRESSION; PROLIFERATION; PATHWAY	Bmi1 is a member of the polycomb repressive complex 1 and plays different roles during embryonic development, depending on the developmental context. Bmi1 over expression is observed in many types of cancer, including tumors of astroglial and neural origin. Although genetic depletion of Bmi1 has been described to result in tumor inhibitory effects partly through INK4A/Arf mediated senescence and apoptosis and also through INK4A/Arf independent effects, it has not been proven that Bmi1 can be causally involved in the formation of these tumors. To see whether this is the case, we developed two conditional Bmi1 transgenic models that were crossed with GFAP-Cre mice to activate transgenic expression in neural and glial lineages. We show here that these mice generate intermediate and anterior lobe pituitary tumors that are positive for ACTH and beta-endorphin. Combined transgenic expression of Bmi1 together with conditional loss of Rb resulted in pituitary tumors but was insufficient to induce medulloblastoma therefore indicating that the oncogenic function of Bmi1 depends on regulation of p16(INK4A)/Rb rather than on regulation of p19(ARF)/p53. Human pituitary adenomas show Bmi1 overexpression in over 50% of the cases, which indicates that Bmi1 could be causally involved in formation of these tumors similarly as in our mouse model.	[Westerman, Bart A.; Blom, Marleen; Tanger, Ellen; Gadiot, Jules; Cornelissen-Steijger, Paulien; Zevenhoven, John; Uren, Anthony; van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Westerman, Bart A.] Acad Med Ctr, Dept Oncogen, Amsterdam, Netherlands; [van der Valk, Martin; Song, Ji-Ying] Netherlands Canc Inst, Dept Animal Pathol, NL-1066 CX Amsterdam, Netherlands; [van Santen, Marije] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Prosser, Haydn M.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Uren, Anthony] MRC Clin Sci Ctr, Canc Genom Grp, London, England; [Aronica, Eleonora] Acad Med Ctr, Dept Neuro Pathol, Amsterdam, Netherlands; [van Lohuizen, Maarten] Acad Med Ctr, Ctr Biomed Genet, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Wellcome Trust Sanger Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Westerman, BA (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.v.lohuizen@nki.nl	Westerman, Bart/ACM-8337-2022; Uren, Anthony G/A-5784-2009	Westerman, Bart/0000-0002-9898-9616; Uren, Anthony G/0000-0002-6019-7111; Aronica, Eleonora/0000-0002-3542-3770	Dutch Cancer Society; Medical Research Council [MC_UP_A652_1001, 1116184] Funding Source: researchfish; MRC [MC_UP_A652_1001] Funding Source: UKRI	Dutch Cancer Society(KWF Kankerbestrijding); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the Dutch Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft JD, 2008, THEORY PRACTICE HIST, P131; Bea S, 2001, CANCER RES, V61, P2409; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dutton A, 2007, BLOOD, V109, P2597, DOI 10.1182/blood-2006-05-020545; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Farrell WE, 2000, FRONT NEUROENDOCRIN, V21, P174, DOI 10.1006/frne.1999.0195; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Foijer F, 2007, CANCER RES, V67, P9244, DOI 10.1158/0008-5472.CAN-07-1650; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; GRAY F, 2004, MANUAL BASIC NEUROPA; Guidi CJ, 2006, CANCER RES, V66, P8076, DOI 10.1158/0008-5472.CAN-06-1451; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hayry V, 2008, NEUROPATH APPL NEURO, V34, P555, DOI 10.1111/j.1365-2990.2008.00949.x; Hayry V, 2008, ACTA NEUROPATHOL, V116, P97, DOI 10.1007/s00401-008-0376-0; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Hinton DR, 1998, CANCER LETT, V126, P209, DOI 10.1016/S0304-3835(98)00013-5; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johnson MD, 2007, J HISTOCHEM CYTOCHEM, V55, P1265, DOI 10.1369/jhc.7A7311.2007; Kovacs K, 2001, J NEURO-ONCOL, V54, P121, DOI 10.1023/A:1012945129981; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Liu JH, 2008, J SURG ONCOL, V97, P267, DOI 10.1002/jso.20934; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; Marino S, 2000, GENE DEV, V14, P994; Michael LE, 2008, NEOPLASIA, V10, P1343, DOI 10.1593/neo.81078; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Ogino A, 2005, J NEUROPATH EXP NEUR, V64, P398, DOI 10.1093/jnen/64.5.398; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Sanchez-Beato M, 2006, MODERN PATHOL, V19, P684, DOI 10.1038/modpathol.3800577; Shakhova O, 2006, CANCER RES, V66, P5190, DOI 10.1158/0008-5472.CAN-05-3545; Simpson DJ, 2000, CANCER RES, V60, P1211; Stec DE, 1999, J BIOL CHEM, V274, P21285, DOI 10.1074/jbc.274.30.21285; Subkhankulova T, 2010, MOL CELL NEUROSCI, V45, P151, DOI 10.1016/j.mcn.2010.06.006; Tirabosco R, 2008, PATHOL RES PRACT, V204, P625, DOI 10.1016/j.prp.2008.02.007; Tunici P, 2009, METHODS MOL BIOL, V568, P195, DOI 10.1007/978-1-59745-280-9_12; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Yadirgi G, 2011, STEM CELLS; Yang GF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-133; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yoshino A, 2007, J NEURO-ONCOL, V83, P153, DOI 10.1007/s11060-006-9316-9	60	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35943	10.1371/journal.pone.0035943	http://dx.doi.org/10.1371/journal.pone.0035943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574128	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800024
J	Barker, M; Solinski, HJ; Hashimoto, H; Tagoe, T; Pilati, N; Hamann, M				Barker, Matthew; Solinski, Hans Juergen; Hashimoto, Haruka; Tagoe, Thomas; Pilati, Nadia; Hamann, Martine			Acoustic Overexposure Increases the Expression of VGLUT-2 Mediated Projections from the Lateral Vestibular Nucleus to the Dorsal Cochlear Nucleus	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; SUPERIOR OLIVARY COMPLEX; INTENSE SOUND EXPOSURE; AUDITORY-NERVE FIBERS; INDUCED HEARING-LOSS; BRAIN-STEM; GUINEA-PIG; INFERIOR COLLICULUS; DISCHARGE PATTERNS; SYNAPTIC ENDINGS	The dorsal cochlear nucleus (DCN) is a first relay of the central auditory system as well as a site for integration of multimodal information. Vesicular glutamate transporters VGLUT-1 and VGLUT-2 selectively package glutamate into synaptic vesicles and are found to have different patterns of organization in the DCN. Whereas auditory nerve fibers predominantly co-label with VGLUT-1, somatosensory inputs predominantly co-label with VGLUT-2. Here, we used retrograde and anterograde transport of fluorescent conjugated dextran amine (DA) to demonstrate that the lateral vestibular nucleus (LVN) exhibits ipsilateral projections to both fusiform and deep layers of the rat DCN. Stimulating the LVN induced glutamatergic synaptic currents in fusiform cells and granule cell interneurones. We combined the dextran amine neuronal tracing method with immunohistochemistry and showed that labeled projections from the LVN are co-labeled with VGLUT-2 by contrast to VGLUT-1. Wistar rats were exposed to a loud single tone (15 kHz, 110 dB SPL) for 6 hours. Five days after acoustic overexposure, the level of expression of VGLUT-1 in the DCN was decreased whereas the level of expression of VGLUT-2 in the DCN was increased including terminals originating from the LVN. VGLUT-2 mediated projections from the LVN to the DCN are likely to play a role in the head position in response to sound. Amplification of VGLUT-2 expression after acoustic overexposure could be a compensatory mechanism from vestibular inputs in response to hearing loss and to a decrease of VGLUT-1 expression from auditory nerve fibers.	[Barker, Matthew; Solinski, Hans Juergen; Hashimoto, Haruka; Tagoe, Thomas; Pilati, Nadia; Hamann, Martine] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Barker, M (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	mh86@le.ac.uk	Hamann, Martine/P-8054-2014	Hamann, Martine/0000-0002-9142-6773; Tagoe, Thomas/0000-0002-3352-2142	Wellcome Trust [072033]; Royal Society [RG061307]; Medisearch (University of Leicester) [RM 36G0010]	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Medisearch (University of Leicester)	This work has been supported by: Wellcome Trust (Ref 072033) to MH, http://www.wellcome.ac.uk; Royal Society (Ref RG061307) to MH, http://royalsociety.org; and Medisearch (University of Leicester) RM 36G0010 to MH, http://www2.le.ac.uk/colleges/medbiopsych. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1983, NEUROSCI LETT, V37, P205, DOI 10.1016/0304-3940(83)90431-7; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Babalian AL, 2005, EXP BRAIN RES, V167, P451, DOI 10.1007/s00221-005-0178-8; Babalian AL, 2003, EXP BRAIN RES, V153, P452, DOI 10.1007/s00221-003-1619-x; Baguley DM, 2006, SKULL BASE-INTERD AP, V16, P49, DOI 10.1055/s-2005-926216; Balakrishnan V, 2008, J NEUROPHYSIOL, V99, P208, DOI 10.1152/jn.00971.2007; Barker M, 2009, J NEUROSCI METH, V177, P273, DOI 10.1016/j.jneumeth.2008.10.021; BATZRIIZRAELI R, 1990, BRAIN BEHAV EVOLUT, V36, P237, DOI 10.1159/000115310; Billups B, 2005, NEUROSCI LETT, V382, P66, DOI 10.1016/j.neulet.2005.02.071; Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; BROWN MC, 1990, HEARING RES, V49, P105, DOI 10.1016/0378-5955(90)90098-A; BROWNER RH, 1975, BRAIN BEHAV EVOLUT, V11, P322, DOI 10.1159/000123643; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Bukowska D, 2003, ARCH ITAL BIOL, V141, P39; Bukowska D, 2002, CELLS TISSUES ORGANS, V170, P61, DOI 10.1159/000047921; BURIAN M, 1988, NEUROSCI LETT, V84, P13, DOI 10.1016/0304-3940(88)90329-1; CHAN YS, 1979, EXP BRAIN RES, V35, P591; D'Sa C, 2007, EUR J NEUROSCI, V26, P666, DOI 10.1111/j.1460-9568.2007.05695.x; Daniels RW, 2011, NEUROBIOL DIS, V41, P415, DOI 10.1016/j.nbd.2010.10.009; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Davis KA, 1996, J NEUROPHYSIOL, V76, P3012, DOI 10.1152/jn.1996.76.5.3012; Ding J, 1999, J NEUROPHYSIOL, V82, P3434, DOI 10.1152/jn.1999.82.6.3434; Doucet JR, 1997, J COMP NEUROL, V385, P245; FEKETE DM, 1984, J COMP NEUROL, V229, P432, DOI 10.1002/cne.902290311; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Freeman Sharon, 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P173; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fyk-Kolodziej B, 2011, NEUROSCIENCE, V178, P218, DOI 10.1016/j.neuroscience.2010.12.059; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; HACKNEY CM, 1990, ANAT EMBRYOL, V182, P123; Herraiz C, 2007, PROG BRAIN RES, V166, P389, DOI 10.1016/S0079-6123(07)66037-3; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hurley PA, 2007, EUR J NEUROSCI, V26, P1813, DOI 10.1111/j.1460-9568.2007.05811.x; Ito T, 2011, J COMP NEUROL, V519, P316, DOI 10.1002/cne.22521; ITOH K, 1987, BRAIN RES, V400, P145, DOI 10.1016/0006-8993(87)90662-7; Izraeli R, 2002, EUR J NEUROSCI, V15, P693, DOI 10.1046/j.1460-9568.2002.01902.x; Jacomme AV, 2003, EXP BRAIN RES, V153, P467, DOI 10.1007/s00221-003-1606-2; Kaltenbach JA, 2004, NEUROSCI LETT, V355, P121, DOI 10.1016/j.neulet.2003.10.038; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kaltenbach JA, 2007, HEARING RES, V226, P232, DOI 10.1016/j.heares.2006.07.001; Kameda K, 2010, J NEUROSURG, V112, P152, DOI 10.3171/2009.3.JNS081053; Kaneko T, 2002, NEUROSCI RES, V42, P243, DOI 10.1016/S0168-0102(02)00009-3; Kanold PO, 2001, J NEUROSCI, V21, P7848, DOI 10.1523/JNEUROSCI.21-19-07848.2001; Kanold PO, 1999, J NEUROSCI, V19, P2195; Kim JJ, 2004, J NEUROSCI RES, V77, P829, DOI 10.1002/jnr.20211; Kim JN, 1997, HEARING RES, V103, P169, DOI 10.1016/S0378-5955(96)00173-6; Koehler SD, 2011, EUR J NEUROSCI, V33, P409, DOI 10.1111/j.1460-9568.2010.07547.x; Kong WJ, 2010, BRAIN RES, V1331, P28, DOI 10.1016/j.brainres.2010.02.058; Lai SK, 2006, EUR J NEUROSCI, V23, P2431, DOI 10.1111/j.1460-9568.2006.04762.x; Lawner BE, 1997, INT J DEV NEUROSCI, V15, P601, DOI 10.1016/S0736-5748(96)00115-3; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; MARLINSKY VV, 1992, EXP BRAIN RES, V90, P583; May BJ, 2000, HEARING RES, V148, P74, DOI 10.1016/S0378-5955(00)00142-8; Morest DK, 1998, MICROSC RES TECHNIQ, V41, P205; MOREST DK, 1983, HEARING RES, V9, P145, DOI 10.1016/0378-5955(83)90024-2; MUGNAINI E, 1980, J COMP NEUROL, V191, P581, DOI 10.1002/cne.901910406; Muly SM, 2002, EXP NEUROL, V177, P202, DOI 10.1006/exnr.2002.7963; Murashita H, 2006, HEARING RES, V214, P1, DOI 10.1016/j.heares.2005.12.008; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Oh SH, 2007, ACTA OTO-LARYNGOL, V127, P341, DOI 10.1080/00016480701275246; ORLOVSKY GN, 1972, BRAIN RES, V46, P85, DOI 10.1016/0006-8993(72)90007-8; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Piche M, 2007, NEUROSCIENCE, V145, P1144, DOI 10.1016/j.neuroscience.2006.12.050; PIERSON M, 1992, EPILEPSY RES, V13, P35, DOI 10.1016/0920-1211(92)90005-E; Pilati N, 2008, J HISTOCHEM CYTOCHEM, V56, P539, DOI 10.1369/jhc.2008.950246; Pinchoff RJ, 1998, AM J OTOL, V19, P785; Rybalko N, 2011, PHYSIOL BEHAV, V102, P453, DOI 10.1016/j.physbeh.2010.12.010; Ryugo DK, 2003, EXP BRAIN RES, V153, P477, DOI 10.1007/s00221-003-1605-3; Sanes DH, 2011, HEAR RES; Santos MS, 2009, NEUROSCIENCE, V158, P189, DOI 10.1016/j.neuroscience.2008.03.029; Schofield BR, 2005, HEARING RES, V206, P3, DOI 10.1016/j.heares.2005.03.005; Shore SE, 2008, EUR J NEUROSCI, V27, P155, DOI 10.1111/j.1460-9568.2007.05983.x; Shore SE, 2005, EUR J NEUROSCI, V21, P3334, DOI 10.1111/j.1460-9568.2005.04142.x; Shore SE, 2000, J COMP NEUROL, V419, P271, DOI 10.1002/(SICI)1096-9861(20000410)419:3<271::AID-CNE1>3.0.CO;2-M; Shore SE, 2006, HEARING RES, V216, P90, DOI 10.1016/j.heares.2006.01.006; SNYDER RL, 1988, J COMP NEUROL, V278, P209, DOI 10.1002/cne.902780205; Street SE, 2007, J NEUROPHYSIOL, V97, P4162, DOI 10.1152/jn.00469.2006; Sumner CJ, 2005, J NEUROPHYSIOL, V94, P4234, DOI 10.1152/jn.00401.2005; Sutherland DP, 1998, BEHAV BRAIN RES, V97, P1, DOI 10.1016/S0166-4328(98)00008-4; Tascioglu AB, 2005, NEUROANATOMY, V4, P24; THOMPSON AM, 1995, J COMP NEUROL, V351, P104, DOI 10.1002/cne.903510110; WEBSTER DB, 1982, AM J ANAT, V163, P103, DOI 10.1002/aja.1001630202; WEINBERG RJ, 1989, J COMP NEUROL, V282, P142, DOI 10.1002/cne.902820111; WEINBERG RJ, 1987, NEUROSCIENCE, V20, P209, DOI 10.1016/0306-4522(87)90013-3; Wright DD, 1996, J COMP NEUROL, V365, P159, DOI 10.1002/(SICI)1096-9861(19960129)365:1<159::AID-CNE12>3.0.CO;2-L; YOUNG ED, 1995, J NEUROPHYSIOL, V73, P743, DOI 10.1152/jn.1995.73.2.743; Zeng C, 2011, NEUROSCIENCE, V176, P142, DOI 10.1016/j.neuroscience.2010.12.010; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009; Zhang FX, 2011, NEUROSCIENCE, V173, P179, DOI 10.1016/j.neuroscience.2010.11.013; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208; Zhou JX, 2004, J NEUROSCI RES, V78, P901, DOI 10.1002/jnr.20343	95	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35955	10.1371/journal.pone.0035955	http://dx.doi.org/10.1371/journal.pone.0035955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570693	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400009
J	Waldhaus, J; Cimerman, J; Gohlke, H; Ehrich, M; Muller, M; Lowenheim, H				Waldhaus, Joerg; Cimerman, Jelka; Gohlke, Henning; Ehrich, Mathias; Mueller, Marcus; Loewenheim, Hubert			Stemness of the Organ of Corti Relates to the Epigenetic Status of Sox2 Enhancers	PLOS ONE			English	Article							MAMMALIAN INNER-EAR; COCHLEAR SUPPORTING CELLS; HAIR-CELLS; SELF-RENEWAL; GENE-EXPRESSION; DIFFERENTIATION; GENERATION; NOTCH; SPECIFICATION; PLURIPOTENCY	In the adult mammalian auditory epithelium, the organ of Corti, loss of sensory hair cells results in permanent hearing loss. The underlying cause for the lack of regenerative response is the depletion of otic progenitors in the cell pool of the sensory epithelium. Here, we show that an increase in the sequence-specific methylation of the otic Sox2 enhancers NOP1 and NOP2 is correlated with a reduced self-renewal potential in vivo and in vitro; additionally, the degree of methylation of NOP1 and NOP2 is correlated with the dedifferentiation potential of postmitotic supporting cells into otic stem cells. Thus, the stemness the organ of Corti is related to the epigenetic status of the otic Sox2 enhancers. These observations validate the continued exploration of treatment strategies for dedifferentiating or reprogramming of differentiated supporting cells into progenitors to regenerate the damaged organ of Corti.	[Waldhaus, Joerg; Cimerman, Jelka; Mueller, Marcus; Loewenheim, Hubert] Univ Tubingen, Med Ctr, Hearing Res Ctr Tubingen, Dept Otorhinolaryngol Head & Neck Surg, Tubingen, Germany; [Gohlke, Henning] SEQUENOM GmbH, Hamburg, Germany; [Ehrich, Mathias] SEQUENOM Inc, San Diego, CA USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Sequenom	Waldhaus, J (corresponding author), Stanford Univ, Dept Otolaryngol, Sch Med, Stanford, CA 94305 USA.	hubert.loewenheim@uni-tuebingen.de	Löwenheim, Hubert/GPS-7207-2022	Löwenheim, Hubert/0000-0001-8200-8804; Ehrich, Mathias/0000-0001-8415-0310	Federal Ministry of Education and Research (BMBF) [BioProfile 0313612A]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported in part by a grant from the Federal Ministry of Education and Research (BMBF) - project BioProfile 0313612A. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Batts SA, 2009, HEARING RES, V249, P15, DOI 10.1016/j.heares.2008.12.008; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chai RJ, 2011, JARO-J ASSOC RES OTO, V12, P455, DOI 10.1007/s10162-011-0267-2; Chaudhary J, 1999, MOL ENDOCRINOL, V13, P774, DOI 10.1210/me.13.5.774; Chen P, 2002, DEVELOPMENT, V129, P2495; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Diensthuber M, 2009, JARO-J ASSOC RES OTO, V10, P173, DOI 10.1007/s10162-009-0161-3; Do JT, 2009, TRENDS PHARMACOL SCI, V30, P296, DOI 10.1016/j.tips.2009.03.003; Doetzlhofer A, 2004, DEV BIOL, V272, P432, DOI 10.1016/j.ydbio.2004.05.013; Iwafuchi-Doi M, 2011, DEV BIOL, V352, P354, DOI 10.1016/j.ydbio.2010.12.027; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lee YS, 2006, DEVELOPMENT, V133, P2817, DOI 10.1242/dev.02453; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Malgrange B, 2002, MECH DEVELOP, V112, P79, DOI 10.1016/S0925-4773(01)00642-6; Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Oshima Kazuo, 2009, V493, P141, DOI 10.1007/978-1-59745-523-7_9; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sahly I, 1997, ANAT EMBRYOL, V196, P159, DOI 10.1007/s004290050088; Savary E, 2007, STEM CELLS, V25, P332, DOI 10.1634/stemcells.2006-0303; Schilham MW, 1998, SEMIN IMMUNOL, V10, P127, DOI 10.1006/smim.1998.0114; Senn P, 2007, JARO-J ASSOC RES OTO, V8, P194, DOI 10.1007/s10162-007-0079-6; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Sinkkonen ST, 2011, SCI REP-UK, V1, DOI 10.1038/srep00026; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	52	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36066	10.1371/journal.pone.0036066	http://dx.doi.org/10.1371/journal.pone.0036066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570694	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400010
J	Zhai, H; Song, B; Xu, X; Zhu, W; Ju, J				Zhai, H.; Song, B.; Xu, X.; Zhu, W.; Ju, J.			Inhibition of autophagy and tumor growth in colon cancer by miR-502	ONCOGENE			English	Article						miR-502; autophagy; p53; colon cancer	CELL-CYCLE; GENE-EXPRESSION; SMALL RNAS; TRANSCRIPTIONAL ACTIVATION; P53; MICRORNAS; MIR-34A; PROLIFERATION; CHEMORESISTANCE; 5-FLUOROURACIL	Autophagy is a catabolic process that allows cellular macromolecules to be broken down and recycled as metabolic precursors. The influence of non-coding microRNAs in autophagy has not been explored in colon cancer. In this study, we discover a novel mechanism of autophagy regulated by hsa-miR-502-5p (miR-502) by suppression of Rab1B, a critical mediator of autophagy. A number of other miR-502 suppressed mRNA targets (for example, dihydroorotate dehydrogenase) are also identified by microarray analysis. Ectopic expression of miR-502 inhibited autophagy, colon cancer cell growth and cell-cycle progression of colon cancer cells in vitro. miR-502 also inhibited in-vivo colon cancer growth in a mouse tumor xenografts model. In addition, the expression of miR-502 was regulated by p53 via a negative feedback regulatory mechanism. The expression of miR-502 was downregulated in colon cancer patient specimens compared with the paired normal control samples. These results suggest that miR-502 may function as a potential tumor suppressor and therefore be a novel candidate for developing miR-502-based therapeutic strategies. Oncogene (2013) 32, 1570-1579; doi:10.1038/onc.2012.167; published online 14 May 2012	[Zhai, H.; Ju, J.] SUNY Stony Brook, Dept Pathol, Translat Res Lab, Stony Brook, NY 11794 USA; [Song, B.] Dalian Med Univ, Dept Pathol, Dalian, Peoples R China; [Xu, X.; Zhu, W.] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Dalian Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ju, J (corresponding author), SUNY Stony Brook, Dept Pathol, Translat Res Lab, BST L9,Room 185, Stony Brook, NY 11794 USA.	jingfang.ju@stonybrookmedicine.edu	zhai, haiyan/K-4659-2014	Ju, Jingfang/0000-0002-4821-7458	Stony Brook University Translational Research Laboratory [R01CA155019, R33CA147966]; NATIONAL CANCER INSTITUTE [R01CA155019, R33CA147966] Funding Source: NIH RePORTER	Stony Brook University Translational Research Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciate the critical review by Ms Sonya R Lorrain. We thank Dr Stella E Tsirka for technical support in animal experiments. This study was supported in part by Stony Brook University Translational Research Laboratory Start-up Fund (J Ju), R01CA155019 (J Ju) and R33CA147966 (J Ju).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Akao Y, 2009, LEUKEMIA RES, V33, P1530, DOI 10.1016/j.leukres.2009.04.019; Alwan A, 2007, DISASTER MED PUBLIC, V1, P7, DOI 10.1097/DMP.0b013e3180676d32; Baumann P, 2009, MOL CANCER THER, V8, P366, DOI 10.1158/1535-7163.MCT-08-0664; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Crawford L V, 1984, Mol Biol Med, V2, P261; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DRESSLER LG, 1988, CANCER, V61, P420, DOI 10.1002/1097-0142(19880201)61:3<420::AID-CNCR2820610303>3.0.CO;2-0; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Fu LN, 1996, EMBO J, V15, P4392, DOI 10.1002/j.1460-2075.1996.tb00812.x; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; Gunaratne PH, 2010, METHODS MOL BIOL, V667, P297, DOI 10.1007/978-1-60761-811-9_20; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hegde Sanjay R, 2008, Expert Rev Gastroenterol Hepatol, V2, P135, DOI 10.1586/17474124.2.1.135; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Karaayvaz M, 2011, CLIN COLORECTAL CANC, V10, P340, DOI 10.1016/j.clcc.2011.06.002; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miller SJ, 2000, MOL CELL BIOL, V20, P8420, DOI 10.1128/MCB.20.22.8420-8431.2000; Navarro F, 2010, J IMMUNOL, V184, P5939, DOI 10.4049/jimmunol.0902567; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; SCOTT N, 1991, BRIT J CANCER, V63, P317, DOI 10.1038/bjc.1991.74; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shin S, 2009, INT J ONCOL, V35, P1343, DOI 10.3892/ijo_00000452; Shin S, 2009, INT J ONCOL, V34, P1645, DOI 10.3892/ijo_00000295; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Song B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-96; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tang FC, 2010, DIFFERENTIATION, V79, P141, DOI 10.1016/j.diff.2009.11.002; Tang XH, 2004, ONCOGENE, V23, P5759, DOI 10.1038/sj.onc.1207706; Tasdemir E, 2008, CELL CYCLE, V7, P3006, DOI 10.4161/cc.7.19.6702; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang XD, 2010, FEBS LETT, V584, P3392, DOI 10.1016/j.febslet.2010.06.033; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhao RB, 2000, GENE DEV, V14, P981; Zhou JF, 2010, ONCOL REP, V23, P121, DOI 10.3892/or_00000613	72	103	113	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2013	32	12					1570	1579		10.1038/onc.2012.167	http://dx.doi.org/10.1038/onc.2012.167			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22580605	Green Accepted			2022-12-25	WOS:000316456000010
J	Yin, D; Ogawa, S; Kawamata, N; Leiter, A; Ham, M; Li, D; Doans, NB; Said, JW; Black, KL; Koeffler, HP				Yin, D.; Ogawa, S.; Kawamata, N.; Leiter, A.; Ham, M.; Li, D.; Doans, N. B.; Said, J. W.; Black, K. L.; Koeffler, H. Phillip			miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme	ONCOGENE			English	Article						glioblastoma multiforme; genomic profiling; miR-34a; EGFR; YY-1	GROWTH-FACTOR RECEPTOR; PROSTATE-CANCER; DOWN-REGULATION; EXPRESSION PROFILES; GENE-EXPRESSION; C-MET; APOPTOSIS; IDENTIFICATION; NEUROBLASTOMA; PATHWAY	Chromosome 1p36.23 is frequently deleted in glioblastoma multiforme (GBM). miR-34a localizes in this region. Our experiments found that miR-34a was often deleted and epidermal growth factor receptor (EGFR) was frequently amplified in genomic DNA of 55 GBMs using single-nucleotide polymorphism DNA microarray. Notably, we found that the mean survival time was significantly shortened for patients whose GBMs had both EGFR amplification and miR-34a deletion. Expression of miR-34a was significantly lower in GBM samples compared with normal brain tissue. Forced expression of miR-34a in GBM cells decreased their ability to migrate and profoundly decreased their levels of cyclin-A1, -B1, -D1, and -D3, as well as cyclin-dependent kinase and increased expression of cyclin kinase inhibitor proteins (p21, p27). Also, human GBM cells (U251) stable overexpressing mir-34a formed smaller tumors when growing as xenografts in immunodeficient mice compared with wild-type U251 GBM cells. Furthermore, the protein expression of EGFR decreased in the cells with forced overexpression of miR-34a. Additional studies showed that mir-34a targeted Yin Yang-1 (YY1) and YY1 is a transcription factor that can stimulate the expression of EGFR. Thus, our data suggest that miR-34a acts as a tumor suppressor by inhibiting growth of GBM cells in vitro and in vivo associated with moderating the expression of cell-cycle proteins and EGFR. Moreover, we discovered for the first time that both deletion of miR-34a and amplification of EGFR were associated with significantly decreased overall survival of GBM patients. Oncogene (2013) 32, 1155-1163; doi:10.1038/onc.2012.132; published online 14 May 2012	[Yin, D.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Key Lab Malignant Tumor Gene Regulat, Guangzhou 510275, Guangdong, Peoples R China; [Yin, D.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Target Therapy Guangdong Higher Educ Inst, Guangzhou 510275, Guangdong, Peoples R China; [Yin, D.; Kawamata, N.; Leiter, A.; Ham, M.; Koeffler, H. Phillip] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Cedars Sinai Med Ctr, Los Angeles, CA 90024 USA; [Ogawa, S.] Univ Tokyo, Sch Med, Tokyo 113, Japan; [Li, D.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Said, J. W.] Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA; [Black, K. L.] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Los Angeles, CA USA; [Koeffler, H. Phillip] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Hematol Oncol, Singapore, Singapore; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore	Sun Yat Sen University; Sun Yat Sen University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tokyo; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; National University of Singapore	Yin, D (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou 510275, Guangdong, Peoples R China.	Dong.Yin@cshs.org	Ogawa, Seishi/AAE-7088-2019	Black, Keith/0000-0002-0546-4934	National Institutes of Health [1U54CA143930-02, 5R01CA026038-32]; Tom Collier Foundation; A *STAR award of Singapore; Maxine Dunitz Neurosurgical Institute; Cedars-Sinai Medical Center; NSFC [81071788]; '985 project' of Sun Yat-sen University; NATIONAL CANCER INSTITUTE [U54CA143930, P50CA092131, R01CA026038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tom Collier Foundation; A *STAR award of Singapore; Maxine Dunitz Neurosurgical Institute; Cedars-Sinai Medical Center; NSFC(National Natural Science Foundation of China (NSFC)); '985 project' of Sun Yat-sen University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health grant 1U54CA143930-02 and 5R01CA026038-32, Tom Collier Foundation, A *STAR award of Singapore (HPK); a grant from the Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center (KLB); NSFC grant 81071788, '985 project' of Sun Yat-sen University. HPK is a member of the Molecular Biology Institute and Jonsson Comprehensive Cancer Center at UCLA, and holds the endowed Mark Goodson Chair of Oncology Research at Cedars-Sinai Medical Center/UCLA School of Medicine. This study is in loving memory of matt schreck.	Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Bheda A, 2008, ONCOGENE, V27, P4315, DOI 10.1038/onc.2008.65; Chakravarti A, 2001, CLIN CANCER RES, V7, P2387; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen H, 2009, INT J NEUROPSYCHOPH, V12, P1; Chen QR, 2011, J PROTEOME RES, V10, P479, DOI 10.1021/pr1006697; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Dong Z, 2004, BRIT J CANCER, V91, P1105, DOI 10.1038/sj.bjc.6602093; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; Feinberg-Gorenshtein G, 2009, GENE CHROMOSOME CANC, V48, P539, DOI 10.1002/gcc.20662; Ghimenti C, 2003, J NEURO-ONCOL, V61, P95, DOI 10.1023/A:1022127302008; Guessous F, CELL CYCLE, V9, P1031; Hagman Z, 2010, INT J CANCER, V127, P2768, DOI 10.1002/ijc.25269; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Ichimura K, 2008, ONCOGENE, V27, P2097, DOI 10.1038/sj.onc.1210848; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Lee CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007314; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Ljubimova JY, 2001, INT J ONCOL, V18, P287; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Ragnarsson G, 1999, BRIT J CANCER, V79, P1468, DOI 10.1038/sj.bjc.6690234; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rokhlin OW, 2008, CANCER BIOL THER, V7, P1288, DOI 10.4161/cbt.7.8.6284; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Solomon DA, 2008, CANCER RES, V68, P2564, DOI 10.1158/0008-5472.CAN-07-6388; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Ueki K, 1996, CANCER RES, V56, P150; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681; Yin D, 2010, INT J CANCER, V127, P2257, DOI 10.1002/ijc.25257; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003	45	87	93	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2013	32	9					1155	1163		10.1038/onc.2012.132	http://dx.doi.org/10.1038/onc.2012.132			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110FU	22580610	Green Accepted			2022-12-25	WOS:000316428800009
J	Nagasawa, K; Giannetto, A; Fernandes, JMO				Nagasawa, Kazue; Giannetto, Alessia; Fernandes, Jorge M. O.			Photoperiod Influences Growth and mll (Mixed-Lineage Leukaemia) Expression in Atlantic Cod	PLOS ONE			English	Article							GADUS-MORHUA; GENE-EXPRESSION; H3K4 METHYLATION; METHYLTRANSFERASE COMPLEX; HISTONE MODIFICATIONS; DROSOPHILA-TRITHORAX; MYELOID-LEUKEMIA; MUTANT MICE; IDENTIFICATION; HOMOLOG	Photoperiod is associated to phenotypic plasticity of somatic growth in several teleost species. However, the molecular mechanisms underlying this phenomenon are currently unknown but it is likely that epigenetic regulation by methyltransferases is involved. The MLL (mixed-lineage leukaemia) family comprises histone methyltransferases that play a critical role in regulating gene expression during early development in mammals. So far, these genes have received scant attention in teleost fish. In the present study, the mean weight of Atlantic cod juveniles reared under continuous illumination was found to be 13% greater than those kept under natural photoperiod conditions for 120 days. We newly determined cDNA sequences of five mll (mll1, mll2, mll3a, mll4b and mll5) and two setd1 (setd1a and setd1ba) paralogues from Atlantic cod. Phylogenetic analysis revealed that the cod genes clustered within the appropriate mll clade and comparative mapping of mll paralogues showed that these genes lie within a region of conserved synteny among teleosts. All mll and setd1 genes were highly expressed in gonads and fast muscle of adult cod, albeit at different levels, and they were differentially regulated with photoperiod in muscle of juvenile fish. Following only one day of exposure to constant light, mll1, mll4b and setd1a were up to 57% lower in these fish compared to the natural photoperiod group. In addition, mRNA expression of myogenic regulatory factors (myog and myf-5) and pax7 in fast muscle was also affected by different photoperiod conditions. Notably, myog was significantly elevated in the continuous illumination group throughout the time course of the experiment. The absence of a day/night cycle is associated with a generalised decrease in mll expression concomitant with an increase in myog transcript levels in fast muscle of Atlantic cod, which may be involved in the observed epigenetic regulation of growth by photoperiod in this species.	[Nagasawa, Kazue; Giannetto, Alessia; Fernandes, Jorge M. O.] Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway	Nord University	Nagasawa, K (corresponding author), Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway.	Jorge.fernandes@uin.no	Nagasawa, Kazue/ABH-6117-2020; Fernandes, Jorge/AAC-4632-2022; Giannetto, Alessia/AAA-6735-2019; Fernandes, Jorge MO/A-3526-2013	Nagasawa, Kazue/0000-0003-2819-3302; Fernandes, Jorge/0000-0002-2550-1640; Giannetto, Alessia/0000-0002-5853-2881; Fernandes, Jorge MO/0000-0002-2550-1640	Research Council of Norway [190350/S40]	Research Council of Norway(Research Council of Norway)	This work was supported by a grant to Jorge Fernandes from the Research Council of Norway (ref. 190350/S40, http://www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amali AA, 2004, DEV DYNAM, V229, P847, DOI 10.1002/dvdy.10454; Ansari KI, 2008, BBA-GENE REGUL MECH, V1779, P66, DOI 10.1016/j.bbagrm.2007.11.006; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Begtashi I, 2004, AQUACULTURE, V241, P539, DOI 10.1016/j.aquaculture.2004.07.011; Caldas C, 1998, ONCOGENE, V16, P3233, DOI 10.1038/sj.onc.1201873; Campos C, 2010, J EXP BIOL, V213, P200, DOI 10.1242/jeb.033126; Davie A, 2007, CAN J FISH AQUAT SCI, V64, P98, DOI 10.1139/F06-170; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Endal HP, 2000, AQUACULTURE, V191, P337, DOI 10.1016/S0044-8486(00)00444-0; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Fernandes JMO, 2006, COMP BIOCHEM PHYS D, V1, P35, DOI 10.1016/j.cbd.2005.09.003; FitzGerald KT, 1999, GENOMICS, V59, P187, DOI 10.1006/geno.1999.5860; Fulberth M, 2009, AQUACULTURE, V292, P225, DOI 10.1016/j.aquaculture.2009.04.028; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Grant SM, 1998, CAN J FISH AQUAT SCI, V55, P1307, DOI 10.1139/cjfas-55-6-1307; Guasconi V, 2009, TRENDS CELL BIOL, V19, P286, DOI 10.1016/j.tcb.2009.03.002; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hansen T, 2001, AQUACULTURE, V203, P51, DOI 10.1016/S0044-8486(01)00610-X; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Imsland AK, 2007, J FISH BIOL, V71, P1371, DOI 10.1111/j.1095-8649.2007.01600.x; Imsland AK, 2005, AQUACULTURE, V250, P525, DOI 10.1016/j.aquaculture.2005.03.001; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lappin Terence R J, 2006, Ulster Med J, V75, P23; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; Nagasawa K, 2011, AQUACULTURE, P1; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schraets D, 2003, ONCOGENE, V22, P3655, DOI 10.1038/sj.onc.1206438; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	43	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36908	10.1371/journal.pone.0036908	http://dx.doi.org/10.1371/journal.pone.0036908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590633	gold, Green Published			2022-12-25	WOS:000305336100072
J	Gulyas-Kovacs, A				Gulyas-Kovacs, Attila			Integrated Analysis of Residue Coevolution and Protein Structure in ABC Transporters	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BINDING CASSETTE TRANSPORTERS; MULTIPLE SEQUENCE ALIGNMENTS; CYSTIC-FIBROSIS; MUTUAL INFORMATION; ATP-BINDING; COEVOLVING POSITIONS; CORRELATED MUTATIONS; PHYLOGENETIC TREES; CONTACT PREDICTION	Intraprotein side chain contacts can couple the evolutionary process of amino acid substitution at one position to that at another. This coupling, known as residue coevolution, may vary in strength. Conserved contacts thus not only define 3-dimensional protein structure, but also indicate which residue-residue interactions are crucial to a protein's function. Therefore, prediction of strongly coevolving residue-pairs helps clarify molecular mechanisms underlying function. Previously, various coevolution detectors have been employed separately to predict these pairs purely from multiple sequence alignments, while disregarding available structural information. This study introduces an integrative framework that improves the accuracy of such predictions, relative to previous approaches, by combining multiple coevolution detectors and incorporating structural contact information. This framework is applied to the ABC-B and ABC-C transporter families, which include the drug exporter P-glycoprotein involved in multidrug resistance of cancer cells, as well as the CFTR chloride channel linked to cystic fibrosis disease. The predicted coevolving pairs are further analyzed based on conformational changes inferred from outward- and inward-facing transporter structures. The analysis suggests that some pairs coevolved to directly regulate conformational changes of the alternating-access transport mechanism, while others to stabilize rigid-body-like components of the protein structure. Moreover, some identified pairs correspond to residues previously implicated in cystic fibrosis.	Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10021 USA	Rockefeller University	Gulyas-Kovacs, A (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, 1230 York Ave, New York, NY 10021 USA.	agulyaskov@rockefeller.edu	Jones, Attila/AAP-9804-2021	Jones, Attila/0000-0003-0257-8781	National Institutes of Health (NIH) [NIH DK51767]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051767] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported from National Institutes of Health (NIH) research grant NIH DK51767 (to D. C. Gadsby). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022; ACKERS GK, 1985, ANNU REV BIOCHEM, V54, P597, DOI 10.1146/annurev.bi.54.070185.003121; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Caporaso JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-327; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dimmic MW, 2005, BIOINFORMATICS, V21, pI126, DOI 10.1093/bioinformatics/bti1032; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Dutheil J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-242; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fawcett T, 2004, MACHINE LEARNING, V31; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fuchs A, 2007, BIOINFORMATICS, V23, P3312, DOI 10.1093/bioinformatics/btm515; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galtier N., 2007, V3, P1, DOI 10.1159/000107599; Gloor GB, 2010, MOL BIOL EVOL, V27, P1181, DOI 10.1093/molbev/msq004; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gouveia-Oliveira R, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-12; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Haq O, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S10; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Jeon J, 2011, MOL BIOL EVOL, V28, P2675, DOI 10.1093/molbev/msr094; Jeon J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000522; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kosiol C, 2011, J MOL BIOL, V411, P910, DOI 10.1016/j.jmb.2011.06.005; Lee BC, 2009, BIOINFORMATICS, V25, P2506, DOI 10.1093/bioinformatics/btp455; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Pagant S, 2010, J BIOL CHEM, V285, P36304, DOI 10.1074/jbc.M110.142760; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Poon AFY, 2010, MOL BIOL EVOL, V27, P819, DOI 10.1093/molbev/msp289; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Shackelford G, 2007, PROTEINS, V69, P159, DOI 10.1002/prot.21791; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	74	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36546	10.1371/journal.pone.0036546	http://dx.doi.org/10.1371/journal.pone.0036546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590562	Green Published, gold			2022-12-25	WOS:000305335500016
J	Patschull, AOM; Gooptu, B; Ashford, P; Daviter, T; Nobeli, I				Patschull, Anathe O. M.; Gooptu, Bibek; Ashford, Paul; Daviter, Tina; Nobeli, Irene			In Silico Assessment of Potential Druggable Pockets on the Surface of alpha(1)-Antitrypsin Conformers	PLOS ONE			English	Article							PROTEIN SURFACES; HIGH-THROUGHPUT; NATIVE STRAIN; BINDING; MECHANISM; SERPINS; IDENTIFICATION; VISUALIZATION; INHIBITION; LIGANDS	The search for druggable pockets on the surface of a protein is often performed on a single conformer, treated as a rigid body. Transient druggable pockets may be missed in this approach. Here, we describe a methodology for systematic in silico analysis of surface clefts across multiple conformers of the metastable protein alpha 1-antitrypsin (A1AT). Pathological mutations disturb the conformational landscape of A1AT, triggering polymerisation that leads to emphysema and hepatic cirrhosis. Computational screens for small molecule inhibitors of polymerisation have generally focused on one major druggable site visible in all crystal structures of native A1AT. In an alternative approach, we scan all surface clefts observed in crystal structures of A1AT and in 100 computationally produced conformers, mimicking the native solution ensemble. We assess the persistence, variability and druggability of these pockets. Finally, we employ molecular docking using publicly available libraries of small molecules to explore scaffold preferences for each site. Our approach identifies a number of novel target sites for drug design. In particular one transient site shows favourable characteristics for druggability due to high enclosure and hydrophobicity. Hits against this and other druggable sites achieve docking scores corresponding to a K-d in the mu M-nM range, comparing favourably with a recently identified promising lead. Preliminary ThermoFluor studies support the docking predictions. In conclusion, our strategy shows considerable promise compared with the conventional single pocket/single conformer approach to in silico screening. Our best-scoring ligands warrant further experimental investigation.	[Patschull, Anathe O. M.; Gooptu, Bibek; Ashford, Paul; Daviter, Tina; Nobeli, Irene] Univ London, Inst Struct & Mol Biol, Dept Biol Sci, London, England; [Daviter, Tina] Univ London, Sch Sci, ISMB Biophys Ctr, London, England	University of London; Birkbeck University London; University of London	Patschull, AOM (corresponding author), Univ London, Inst Struct & Mol Biol, Dept Biol Sci, London, England.	i.nobeli@mail.cryst.bbk.ac.uk		Ashford, Paul/0000-0003-4079-0257; Gooptu, Bibek/0000-0002-5223-1121; Nobeli, Irene/0000-0001-8616-170X	Wellcome Trust; Biotechnology and Biological Sciences Research Council (BBSRC); Pfizer; University of Cambridge	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); University of Cambridge(University of Cambridge)	AOMP was supported by a Wellcome Trust PhD studentship. PA was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Collaborative Awards in Science and Engineering (CASE) studentship, which was part-funded by Pfizer. BG was supported by a Wellcome Trust Intermediate Clinical Fellowship and a Clinical Lectureship from the University of Cambridge. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Ashford P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-39; Berjanskii M, 2010, NUCLEIC ACIDS RES, V38, pW633, DOI 10.1093/nar/gkq375; Bottegoni G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018845; Chang YP, 2011, METHOD ENZYMOL, V501, P139, DOI 10.1016/B978-0-12-385950-1.00008-0; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Eyrisch S, 2009, J COMPUT AID MOL DES, V23, P73, DOI 10.1007/s10822-008-9239-y; Gooptu B, 2008, J EXP MED, V205, P1529, DOI 10.1084/jem.20072080; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Gooptu B, 2009, J MOL BIOL, V387, P857, DOI 10.1016/j.jmb.2009.01.069; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Huang C, 2010, BIOTECHNIQUES, V49, P881, DOI 10.2144/000113550; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; IHLENFELDT WD, 1994, J CHEM INF COMP SCI, V34, P109, DOI 10.1021/ci00017a013; Im H, 1999, J BIOL CHEM, V274, P11072, DOI 10.1074/jbc.274.16.11072; Im H, 2002, J BIOL CHEM, V277, P46347, DOI 10.1074/jbc.M207682200; Ivetac A, 2012, METHODS MOL BIOL, V819, P3, DOI 10.1007/978-1-61779-465-0_1; Kim SJ, 2001, J MOL BIOL, V306, P109, DOI 10.1006/jmbi.2000.4357; Kumar S, 2000, PROTEIN SCI, V9, P10; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Mallyat M, 2007, J MED CHEM, V50, P5357, DOI 10.1021/jm070687z; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Nichols SE, 2012, METHODS MOL BIOL, V819, P93, DOI 10.1007/978-1-61779-465-0_7; Parfrey H, 2003, J BIOL CHEM, V278, P33060, DOI 10.1074/jbc.M302646200; Pearce MC, 2008, PROTEIN SCI, V17, P2127, DOI 10.1110/ps.037234.108; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ryu SE, 1996, STRUCTURE, V4, P1181, DOI 10.1016/S0969-2126(96)00126-8; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Seo EJ, 2000, J BIOL CHEM, V275, P16904, DOI 10.1074/jbc.M001006200; Seo EJ, 2002, J BIOL CHEM, V277, P14216, DOI 10.1074/jbc.M110272200; Sheridan RP, 2010, J CHEM INF MODEL, V50, P2029, DOI 10.1021/ci100312t; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Singh P, 2012, J MOL MODEL, V18, P1143, DOI 10.1007/s00894-011-1110-8; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; WEBER AE, 1991, J MED CHEM, V34, P2692, DOI 10.1021/jm00113a005; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	51	28	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36612	10.1371/journal.pone.0036612	http://dx.doi.org/10.1371/journal.pone.0036612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590577	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305335500021
J	Huang, AJ; Yu, KD; Li, J; Fan, L; Shao, ZM				Huang, A-Ji; Yu, Ke-Da; Li, Jing; Fan, Lei; Shao, Zhi-Ming			Polymorphism rs4919510:C > G in Mature Sequence of Human MicroRNA-608 Contributes to the Risk of HER2-Positive Breast Cancer but Not Other Subtypes	PLOS ONE			English	Article							GENETIC-VARIATION; SUSCEPTIBILITY; ASSOCIATION	Background: A few polymorphisms are located in the mature microRNA sequences. Such polymorphisms could directly affect the binding of microRNA to hundreds of target mRNAs. It remains unknown whether rs4919510:C>G located in the mature miR-608 alters breast cancer susceptibility. Methods: The association of rs4919510:C>G with risk and pathologic features of breast cancer were investigated in two independent case-control studies, the first set including 1,138 sporadic breast cancer patients (including 927 invasive ductal carcinoma patients, 777 of them with known subtypes: 496 luminal-like, 133 HER2-positive, and 148 triple-negative) and 1,434 community-based controls, and the second set including 294 familial/early-onset breast cancer patients and 500 hospital-based cancer-free controls. Odds ratios (ORs) were estimated by logistic regression. Predicted targets of miR-608 and complementary sequences containing rs4919510:C>G were surveyed to reveal potential pathological mechanism. Results: In the first set, although rs4919510:C>G was unrelated to breast cancer in general patients, variant genotypes (CG/GG) were specifically associated with increased risk of HER2-positive subtype (Adjusted OR = 1.97, 95% CI, 1.34-2.90 in the recessive model). Variant G-allele was the risk allele with OR of 1.62 (95% CI, 1.23-2.15). Patients carrying GG-genotype also had larger HER2-positive tumors (P for Kruskal-Wallis test = 0.006). The relationship between rs4919510:C>G and risk of HER2-positive subgroup was validated in the second set (Bonferroni corrected P = 0.06). The adjusted combined OR (total 164 HER2-positive cases) in the recessive model was 1.97 (95% CI, 1.43-2.72) for GG genotype (corrected P = 1.1x10(-4)). Bioinformatic analysis indicated that, HSF1, which is required for HER2-induced tumorigenesis, might be a target of miR-608. The minimum free-energy of ancestral-miR-608 (C-allele) binding to HSF1 is -35.9 kcal/mol, while that of variant-form (G-allele) is -31.5 kcal/mol, indicating a lower affinity of variant-miR-608 to HSF1 mRNA. Conclusion: rs4919510:C>G in mature miR-608 may influence HER2-positive breast cancer risk and tumor proliferation.	[Huang, A-Ji] Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Huang, AJ (corresponding author), Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			National Natural Science Foundation of China [30971143, 30972936, 81001169]; Municipal Hospitals [SHDC12010116]; Ministry of Health; Fudan University; Shanghai Public Health Bureau; Shanghai Committee of Science and Technology [11QA1401400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Hospitals; Ministry of Health; Fudan University; Shanghai Public Health Bureau; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This research is supported by grants from the National Natural Science Foundation of China (30971143, 30972936, 81001169), the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), the Key Clinical Program of the Ministry of Health (2010-2012), the Zhuo-Xue Project of Fudan University, the 2009 Youth Fund of Shanghai Public Health Bureau, and the Shanghai Committee of Science and Technology Fund for 2011 Qimingxing Project (11QA1401400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broeks A, 2011, HUM MOL GENET, V20, P3289, DOI 10.1093/hmg/ddr228; Canzian F, 2010, HUM MOL GENET, V19, P3873, DOI 10.1093/hmg/ddq291; Chen AX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002259; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Hu Z, 2010, BREAST CANCER RES TR, V120, P705, DOI 10.1007/s10549-009-0488-9; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Knowlden JM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3018; Landi D, 2008, DNA CELL BIOL, V27, P35, DOI 10.1089/dna.2007.0650; Latif A, 2010, J MED GENET, V47, P126, DOI 10.1136/jmg.2009.067256; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Li WF, 2008, BREAST CANCER RES TR, V110, P99, DOI 10.1007/s10549-007-9708-3; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Peterlongo P, 2011, J MED GENET, V48, P703, DOI 10.1136/jmedgenet-2011-100103; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Yin WJ, 2009, BREAST CANCER RES TR, V115, P325, DOI 10.1007/s10549-008-0096-0; Yu KD, 2009, HUM MOL GENET, V18, P2502, DOI 10.1093/hmg/ddp171; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	18	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35252	10.1371/journal.pone.0035252	http://dx.doi.org/10.1371/journal.pone.0035252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586447	Green Submitted, gold, Green Published			2022-12-25	WOS:000305335000009
J	Link, J; Kockum, I; Lorentzen, AR; Lie, BA; Celius, EG; Westerlind, H; Schaffer, M; Alfredsson, L; Olsson, T; Brynedal, B; Harbo, HF; Hillert, J				Link, Jenny; Kockum, Ingrid; Lorentzen, Aslaug R.; Lie, Benedicte A.; Celius, Elisabeth G.; Westerlind, Helga; Schaffer, Marie; Alfredsson, Lars; Olsson, Tomas; Brynedal, Boel; Harbo, Hanne F.; Hillert, Jan			Importance of Human Leukocyte Antigen (HLA) Class I and II Alleles on the Risk of Multiple Sclerosis	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; CLINICAL-COURSE; MHC HAPLOTYPES; SUSCEPTIBILITY; GENES; COMPLEX; REGION; ASSOCIATION; HLA-DRB1; HETEROGENEITY	Multiple sclerosis (MS) is a complex disease of the central nervous system of unknown etiology. The human leukocyte antigen (HLA) locus on chromosome 6 confers a considerable part of the susceptibility to MS, and the most important factor is the class II allele HLA-DRB1*15:01. In addition, we and others have previously established a protective effect of HLA-A*02. Here, we genotyped 1,784 patients and 1,660 healthy controls from Scandinavia for the HLA-A, HLA-B, HLA-C and HLA-DRB1 genes and investigated their effects on MS risk by logistic regression. Several allele groups were found to exert effects independently of DRB1*15 and A*02, in particular DRB1*01 (OR = 0.82, p = 0.034) and B*12 (including B*44/45, OR = 0.76, p = 0.0028), confirming previous reports. Furthermore, we observed interaction between allele groups: DRB1*15 and DRB1*01 (multiplicative: OR = 0.54, p = 0.0041; additive: AP = 0.47, p = 4x10(-06)), DRB1*15 and C*12 (multiplicative: OR = 0.37, p = 0.00035; additive: AP = 0.58, p = 2.6x10(-05)), indicating that the effect size of these allele groups varies when taking DRB1*15 into account. Analysis of inferred haplotypes showed that almost all DRB1*15 bearing haplotypes were risk haplotypes, and that all A*02 bearing haplotypes were protective as long as they did not carry DRB1*15. In contrast, we found one class I haplotype, carrying A*02-C*05-B*12, which abolished the risk of DRB1*15. In conclusion, these results confirms a complex role of HLA class I and II genes that goes beyond DRB1*15 and A*02, in particular by including all three classical HLA class I genes as well as functional interactions between DRB1*15 and several alleles of DRB1 and class I genes.	[Link, Jenny; Kockum, Ingrid; Westerlind, Helga; Olsson, Tomas; Brynedal, Boel; Hillert, Jan] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lorentzen, Aslaug R.; Lie, Benedicte A.] Oslo Univ Hosp, Inst Immunol, Rikshosp, Oslo, Norway; [Lorentzen, Aslaug R.; Celius, Elisabeth G.; Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Schaffer, Marie] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway	Karolinska Institutet; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska Institutet; University of Oslo	Link, J (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	jenny.link@ki.se	Kockum, Ingrid/O-8781-2018; Celius, Elisabeth Gulowsen/S-1387-2019; Link, Jenny/J-1629-2012; Alfredsson, Lars/AAC-9007-2019; Westerlind, Helga/T-6191-2018	Kockum, Ingrid/0000-0002-0867-4726; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Alfredsson, Lars/0000-0003-1688-6697; Westerlind, Helga/0000-0003-3380-5342; Olsson, Tomas/0000-0002-2938-1877; Link, Jenny/0000-0002-6134-9404; Brynedal, Boel/0000-0002-7872-2981	Bibbi & Nils Jensen Foundation; Swedish Research Council; Swedish Council for Working Life and Social Research; Karolinska Institutet; European Union, NeuroproMiSe [LSHM-CT-2005-018637]; University of Oslo; Research Council of Norway [166005/V5]; South and Eastern Regional Health Authority; Ulleval University Hospital Scientific Advisory Council (UUHSAC); Odd Fellow MS Society	Bibbi & Nils Jensen Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet(Karolinska Institutet); European Union, NeuroproMiSe(European Commission); University of Oslo; Research Council of Norway(Research Council of Norway); South and Eastern Regional Health Authority; Ulleval University Hospital Scientific Advisory Council (UUHSAC); Odd Fellow MS Society	This study was funded by the Bibbi & Nils Jensen Foundation, the Swedish Research Council, the Swedish Council for Working Life and Social Research, Karolinska Institutet, and the 6th Framework Program of the European Union, NeuroproMiSe (LSHM-CT-2005-018637). The Norwegian work was supported by the University of Oslo, the Research Council of Norway (166005/V5), South and Eastern Regional Health Authority, Ulleval University Hospital Scientific Advisory Council (UUHSAC) and Odd Fellow MS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi L, 2010, GENES IMMUN, V11, P173, DOI 10.1038/gene.2009.101; Bergamaschi L, 2011, J MED GENET; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Burfoot RK, 2008, TISSUE ANTIGENS, V71, P42, DOI 10.1111/j.1399-0039.2007.00962.x; Chao MJ, 2007, HUM MOL GENET, V16, P1951, DOI 10.1093/hmg/ddm142; Cree BAC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011296; D'Alfonso S, 2008, GENES IMMUN, V9, P7, DOI 10.1038/sj.gene.6364437; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Friese MA, 2006, CURR OPIN IMMUNOL, V18, P704, DOI 10.1016/j.coi.2006.09.003; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Healy BC, 2010, NEUROLOGY, V75, P634, DOI 10.1212/WNL.0b013e3181ed9c9c; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; HILLERT J, 1992, J NEUROL NEUROSUR PS, V55, P887, DOI 10.1136/jnnp.55.10.887; Hoppenbrouwers IA, 2011, BBA-MOL BASIS DIS, V1812, P194, DOI 10.1016/j.bbadis.2010.09.017; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; JERSILD C, 1973, LANCET, V2, P1221; JERSILD C, 1972, ACTA NEUROL SCAND, V48, P377; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Link J, 2010, J NEUROIMMUNOL, V226, P172, DOI 10.1016/j.jneuroim.2010.07.006; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McMahon RM, 2011, ACTA CRYSTALLOGR D, V67, P447, DOI 10.1107/S0907444911007888; MUSTAFA M, 1994, J IMMUNOL, V153, P3337; NAITO S, 1972, TISSUE ANTIGENS, V2, P1; NEPOM BS, 1987, DIABETES, V36, P114, DOI 10.2337/diabetes.36.1.114; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; R Core Team, 2022, R LANG ENV STAT COMP; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayer DC, 2004, TISSUE ANTIGENS, V63, P412, DOI 10.1111/j.0001-2815.2004.00214.x; Wu JS, 2010, MULT SCLER J, V16, P526, DOI 10.1177/1352458510362997; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063	37	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36779	10.1371/journal.pone.0036779	http://dx.doi.org/10.1371/journal.pone.0036779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586495	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335000056
J	Judah, D; Rudkouskaya, A; Wilson, R; Carter, DE; Dagnino, L				Judah, David; Rudkouskaya, Alena; Wilson, Ryan; Carter, David E.; Dagnino, Lina			Multiple Roles of Integrin-Linked Kinase in Epidermal Development, Maturation and Pigmentation Revealed by Molecular Profiling	PLOS ONE			English	Article							FOLLICLE STEM-CELLS; HAIR FOLLICLE; SKIN; GROWTH; EXPRESSION; BETA; MORPHOGENESIS; PROLIFERATION; KERATINOCYTES; ADHESION	Integrin-linked kinase (ILK) is an important scaffold protein that mediates a variety of cellular responses to integrin stimulation by extracellular matrix proteins. Mice with epidermis-restricted inactivation of the Ilk gene exhibit pleiotropic phenotypic defects, including impaired hair follicle morphogenesis, reduced epidermal adhesion to the basement membrane, compromised epidermal integrity, as well as wasting and failure to thrive leading to perinatal death. To better understand the underlying molecular mechanisms that cause such a broad range of alterations, we investigated the impact of Ilk gene inactivation on the epidermis transcriptome. Microarray analysis showed over 700 differentially regulated mRNAs encoding proteins involved in multiple aspects of epidermal function, including keratinocyte differentiation and barrier formation, inflammation, regeneration after injury, and fundamental epidermal developmental pathways. These studies also revealed potential effects on genes not previously implicated in ILK functions, including those important for melanocyte and melanoblast development and function, regulation of cytoskeletal dynamics, and homeobox genes. This study shows that ILK is a critical regulator of multiple aspects of epidermal function and homeostasis, and reveals the previously unreported involvement of ILK not only in epidermal differentiation and barrier formation, but also in melanocyte genesis and function.	[Judah, David; Rudkouskaya, Alena; Wilson, Ryan; Dagnino, Lina] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Judah, David; Rudkouskaya, Alena; Wilson, Ryan; Dagnino, Lina] Childrens Hlth Res Inst, London, ON, Canada; [Judah, David; Rudkouskaya, Alena; Wilson, Ryan; Dagnino, Lina] Lawson Hlth Res Inst, London, ON, Canada; [Carter, David E.] Univ Western Ontario, London Reg Genom Ctr, London, ON, Canada; [Dagnino, Lina] Univ Western Ontario, Dept Paediat, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Judah, D (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	ldagnino@uwo.ca		Dagnino, Lina/0000-0003-1483-5159; Rudkouskaya, Alena/0000-0002-3632-9743	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funding from an operating grant of the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) to Lina Dagnino. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; BEERMANN F, 1992, P NATL ACAD SCI USA, V89, P2809, DOI 10.1073/pnas.89.7.2809; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; Dassule HR, 2000, DEVELOPMENT, V127, P4775; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Harris PJ, 2010, CANCER PREV RES, V3, P1217, DOI 10.1158/1940-6207.CAPR-10-0210; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P462, DOI 10.1111/j.1755-148X.2011.00845.x; Hitomi K, 2005, EUR J DERMATOL, V15, P313; Ho E, 2009, MOL BIOL CELL, V20, P3033, DOI 10.1091/mbc.E09-01-0050; Hou L, 2006, P NATL ACAD SCI USA, V103, P9081, DOI 10.1073/pnas.0603114103; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Inoue S, 2004, J INVEST DERMATOL, V122, P565, DOI 10.1046/j.0022-202X.2004.12628.x; Ivanova IA, 2007, ONCOGENE, V26, P1147, DOI 10.1038/sj.onc.1209894; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kizawa K, 2011, BIOCHIMIE; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee J, 2007, DEVELOPMENT, V134, P2795, DOI 10.1242/dev.02868; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Morgan MR, 2011, ONCOGENE, V30, P1422, DOI 10.1038/onc.2010.535; Nakrieko KA, 2008, MOL BIOL CELL, V19, P1462, DOI 10.1091/mbc.E07-06-0526; Nakrieko KA, 2008, CELL CYCLE, V7, P2157, DOI 10.4161/cc.7.14.6241; Nakrieko KA, 2011, MOL BIOL CELL, V22, P2532, DOI 10.1091/mbc.E11-01-0035; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Oklu R, 2000, BIOCHEM J, V352, P601, DOI 10.1042/0264-6021:3520601; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rallis C, 2010, DEVELOPMENT, V137, P3591, DOI 10.1242/dev.050070; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Vespa A, 2005, MOL BIOL CELL, V16, P4084, DOI 10.1091/mbc.e05-02-0087; Wang X, 2011, STEM CELLS DEV; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Yamane A, 2010, FEBS J, V277, P3564, DOI 10.1111/j.1742-4658.2010.07765.x; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36704	10.1371/journal.pone.0036704	http://dx.doi.org/10.1371/journal.pone.0036704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574216	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800113
J	Patel, DA; Patel, AC; Nolan, WC; Zhang, Y; Holtzman, MJ				Patel, Dhara A.; Patel, Anand C.; Nolan, William C.; Zhang, Yong; Holtzman, Michael J.			High Throughput Screening for Small Molecule Enhancers of the Interferon Signaling Pathway to Drive Next-Generation Antiviral Drug Discovery	PLOS ONE			English	Article							RESPIRATORY VIRAL-INFECTION; VASCULAR DISRUPTING AGENT; INNATE IMMUNE-RESPONSE; HOUSEKEEPING GENES; STAT1 DEFICIENCY; TOPOISOMERASE-II; DOUBLE-BLIND; PCR DATA; VIRUS; VALIDATION	Most of current strategies for antiviral therapeutics target the virus specifically and directly, but an alternative approach to drug discovery might be to enhance the immune response to a broad range of viruses. Based on clinical observation in humans and successful genetic strategies in experimental models, we reasoned that an improved interferon (IFN) signaling system might better protect against viral infection. Here we aimed to identify small molecular weight compounds that might mimic this beneficial effect and improve antiviral defense. Accordingly, we developed a cell-based high-throughput screening (HTS) assay to identify small molecules that enhance the IFN signaling pathway components. The assay is based on a phenotypic screen for increased IFN-stimulated response element (ISRE) activity in a fully automated and robust format (Z'>0.7). Application of this assay system to a library of 2240 compounds (including 2160 already approved or approvable drugs) led to the identification of 64 compounds with significant ISRE activity. From these, we chose the anthracycline antibiotic, idarubicin, for further validation and mechanism based on activity in the sub-mu M range. We found that idarubicin action to increase ISRE activity was manifest by other members of this drug class and was independent of cytotoxic or topoisomerase inhibitory effects as well as endogenous IFN signaling or production. We also observed that this compound conferred a consequent increase in IFN-stimulated gene (ISG) expression and a significant antiviral effect using a similar dose-range in a cell-culture system inoculated with encephalomyocarditis virus (EMCV). The antiviral effect was also found at compound concentrations below the ones observed for cytotoxicity. Taken together, our results provide proof of concept for using activators of components of the IFN signaling pathway to improve IFN efficacy and antiviral immune defense as well as a validated HTS approach to identify small molecules that might achieve this therapeutic benefit.	[Patel, Dhara A.; Patel, Anand C.; Nolan, William C.; Zhang, Yong; Holtzman, Michael J.] Washington Univ, Sch Med, Dept Med, Drug Discovery Program, St Louis, MO 63110 USA; [Patel, Anand C.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Holtzman, Michael J.] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Patel, DA (corresponding author), Washington Univ, Sch Med, Dept Med, Drug Discovery Program, St Louis, MO 63110 USA.	holtzmanm@wustl.edu	; Patel, Anand/B-1441-2009	Patel, Dhara/0000-0002-2736-124X; Patel, Anand/0000-0002-6570-8582	National Institutes of Health (National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases); Martin Schaeffer Fund; Roche Postdoctoral Fellowship; Hoffmann-La Roche; Forest Labs	National Institutes of Health (National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Heart Lung & Blood Institute (NHLBI)); Martin Schaeffer Fund; Roche Postdoctoral Fellowship; Hoffmann-La Roche(Hoffmann-La Roche); Forest Labs	This work was supported by grants from the National Institutes of Health (National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases) and the Martin Schaeffer Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DAP is the recipient of a Roche Postdoctoral Fellowship, and MJH is the principal investigator for research grants to Washington University from Hoffmann-La Roche and Forest Labs. These awards do not alter the authors' adherence to all of the PLoS ONE policies on sharing data and materials.	Adams O, 2010, CLIN INFECT DIS, V51, P185, DOI 10.1086/653534; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ASHESHOV IN, 1961, BIOCHEM J, V81, P101, DOI 10.1042/bj0810101; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calvaruso V, 2011, EXPERT OPIN DRUG SAF, V10, P429, DOI 10.1517/14740338.2011.559161; Cencic R, 2011, J VIROL, V85, P6381, DOI 10.1128/JVI.00078-11; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Chen B, 2008, MOL MED, V14, P374, DOI 10.2119/2008-00028.Chen; Cheng GJ, 2011, AM J RESP CELL MOL, V45, P480, DOI 10.1165/rcmb.2010-0288OC; Cheng GJ, 2010, J BIOL CHEM, V285, P10553, DOI 10.1074/jbc.M109.065631; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; COHEN A, 1969, NATURE, V222, P36, DOI 10.1038/222036a0; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Eastwood B, 2011, NATL CTR TRANSLATION; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groothuis JR, 2011, ADV THER, V28, P91, DOI 10.1007/s12325-010-0100-z; Gu BH, 2006, ANTIVIR RES, V70, P39, DOI 10.1016/j.antiviral.2006.01.005; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Holtzman MJ, 2011, CURR OPIN IMMUNOL, V23, P487, DOI 10.1016/j.coi.2011.05.010; HUME V, 1965, J GEN MICROBIOL, V38, P143, DOI 10.1099/00221287-38-1-143; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Ketley NJ, 1997, BLOOD, V90, P4578, DOI 10.1182/blood.V90.11.4578.4578_4578_4587; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kogan NM, 2007, MOL CANCER THER, V6, P173, DOI 10.1158/1535-7163.MCT-06-0039; Kumar B, 2011, SEX TRANSM INFECT, V87, P432, DOI 10.1136/sextrans-2011-050025; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lee YK, 2009, ARCH PHARM RES, V32, P1409, DOI 10.1007/s12272-009-2010-7; Leonov H, 2011, J AM CHEM SOC, V133, P9903, DOI 10.1021/ja202288m; Lynch RA, 2007, CANCER RES, V67, P1254, DOI 10.1158/0008-5472.CAN-06-2439; Mata MA, 2011, NAT CHEM BIOL, V7, P712, DOI [10.1038/NCHEMBIO.645, 10.1038/nchembio.645]; McHutchison JG, 2007, HEPATOLOGY, V46, P1341, DOI 10.1002/hep.21773; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Monto AS, 2008, PEDIATR INFECT DIS J, V27, pS110, DOI 10.1097/INF.0b013e318168b739; Nguyen DN, 2009, BIOTECHNOL BIOENG, V103, P664, DOI 10.1002/bit.22312; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Patel U, 2011, BRIT J DERMATOL, V164, P670, DOI 10.1111/j.1365-2133.2010.10124.x; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Pelz O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-185; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Phillips T, 2011, J VIROL METHODS, V173, P182, DOI 10.1016/j.jviromet.2011.02.002; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Shornick LP, 2008, J IMMUNOL, V180, P3319, DOI 10.4049/jimmunol.180.5.3319; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; TANABE K, 1991, CANCER RES, V51, P4903; Tang JW, 2010, INFECT DIS CLIN N AM, V24, P603, DOI 10.1016/j.idc.2010.04.001; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wallace A, 2007, CANCER RES, V67, P7011, DOI 10.1158/0008-5472.CAN-06-3757; Walter MJ, 2002, J CLIN INVEST, V110, P165, DOI 10.1172/JCI200214345; Webster D, 2011, CAN MED ASSOC J, V183, pE420, DOI 10.1503/cmaj.100313; Wiles AM, 2008, J BIOMOL SCREEN, V13, P777, DOI 10.1177/1087057108323125; Xiao WH, 1997, P NATL ACAD SCI USA, V94, P7227, DOI 10.1073/pnas.94.14.7227; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2005, J BIOL CHEM, V280, P34306, DOI 10.1074/jbc.M503263200; Zhang Y, 2010, AM J RESP CELL MOL, V43, P507, DOI 10.1165/rcmb.2009-0213ED; Zhao LL, 2007, INVEST NEW DRUG, V25, P271, DOI 10.1007/s10637-006-9029-0; Zhu Q, 2011, J INFECT DIS, V203, P674, DOI 10.1093/infdis/jiq100	68	34	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36594	10.1371/journal.pone.0036594	http://dx.doi.org/10.1371/journal.pone.0036594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574190	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800087
J	Qin, Y; Schneider, TM; Brenner, MP				Qin, Yu; Schneider, Tobias M.; Brenner, Michael P.			Sequencing by Hybridization of Long Targets	PLOS ONE			English	Article							ACID SEQUENCE; DNA; SEARCH	Sequencing by Hybridization (SBH) reconstructs an n-long target DNA sequence from its biochemically determined l-long subsequences. In the standard approach, the length of a uniformly random sequence that can be unambiguously reconstructed is limited to n=O(2(l)) due to repetitive subsequences causing reconstruction degeneracies. We present a modified sequencing method that overcomes this limitation without the need for different types of biochemical assays and is robust to error.	[Qin, Yu] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Qin, Y (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	brenner@seas.harvard.edu	Schneider, Tobias/C-5797-2015	Schneider, Tobias/0000-0002-8617-8998	National Science Foundation, through the Harvard Materials Research and Engineering Center [DMR-0820484]; Division of Mathematical Sciences [DMS-0907985]	National Science Foundation, through the Harvard Materials Research and Engineering Center(National Science Foundation (NSF)); Division of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is supported by the National Science Foundation, through the Harvard Materials Research and Engineering Center DMR-0820484) and the Division of Mathematical Sciences (DMS-0907985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate AR, 2010, P NATL ACAD SCI USA, V107, P19163, DOI 10.1073/pnas.1006888107; Abate AR, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3431281; Arratia R, 1996, J COMPUT BIOL, V3, P425, DOI 10.1089/cmb.1996.3.425; BAINS W, 1988, J THEOR BIOL, V135, P303, DOI 10.1016/S0022-5193(88)80246-7; Blazewicz J, 2005, ANN OPER RES, V138, P67, DOI 10.1007/s10479-005-2445-2; Blazewicz J, 2003, THEOR COMPUT SCI, V290, P1459, DOI 10.1016/S0304-3975(02)00063-4; Blazewicz J, 2000, EUR J OPER RES, V125, P257, DOI 10.1016/S0377-2217(99)00456-7; Blum C, 2008, COMPUT OPER RES, V35, P3620, DOI 10.1016/j.cor.2007.03.007; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; DRMANAC R, 1993, SCIENCE, V260, P1649, DOI 10.1126/science.8503011; DRMANAC R, 1989, GENOMICS, V4, P114; Dyer M, 1994, J Comput Biol, V1, P105, DOI 10.1089/cmb.1994.1.105; Endo TA, 2004, BIOINFORMATICS, V20, P2181, DOI 10.1093/bioinformatics/bth202; Frieze AM, 1999, J COMPUT BIOL, V6, P361, DOI 10.1089/106652799318328; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PEVZNER PA, 1989, J BIOMOL STRUCT DYN, V7, P63, DOI 10.1080/07391102.1989.10507752	16	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35819	10.1371/journal.pone.0035819	http://dx.doi.org/10.1371/journal.pone.0035819			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574124	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349800020
J	Ramakrishnan, C; Rademacher, A; Soichot, J; Costa, G; Waters, AP; Janse, CJ; Ramesar, J; Franke-Fayard, BM; Levashina, EA				Ramakrishnan, Chandra; Rademacher, Annika; Soichot, Julien; Costa, Giulia; Waters, Andrew P.; Janse, Chris J.; Ramesar, Jai; Franke-Fayard, Blandine M.; Levashina, Elena A.			Salivary Gland-Specific P. berghei Reporter Lines Enable Rapid Evaluation of Tissue-Specific Sporozoite Loads in Mosquitoes	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; PLASMODIUM-BERGHEI; ANOPHELES-GAMBIAE; MALARIA PARASITES; BLOOD STAGES; LIFE-CYCLE; EXPRESSING GFP; INVASION; STAGE; PHAGOCYTOSIS	Malaria is a life-threatening human infectious disease transmitted by mosquitoes. Levels of the salivary gland sporozoites (sgs), the only mosquito stage infectious to a mammalian host, represent an important cumulative index of Plasmodium development within a mosquito. However, current techniques of sgs quantification are laborious and imprecise. Here, transgenic P. berghei reporter lines that produce the green fluorescent protein fused to luciferase (GFP-LUC) specifically in sgs were generated, verified and characterised. Fluorescence microscopy confirmed the sgs stage specificity of expression of the reporter gene. The luciferase activity of the reporter lines was then exploited to establish a simple and fast biochemical assay to evaluate sgs loads in whole mosquitoes. Using this assay we successfully identified differences in sgs loads in mosquitoes silenced for genes that display opposing effects on P. berghei ookinete/oocyst development. It offers a new powerful tool to study infectivity of P. berghei to the mosquito, including analysis of vector-parasite interactions and evaluation of transmission-blocking vaccines.	[Ramakrishnan, Chandra; Rademacher, Annika; Soichot, Julien; Costa, Giulia; Levashina, Elena A.] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS UPR9022, INSERM U963, Strasbourg, France; [Waters, Andrew P.] Univ Glasgow, Glasgow Biomed Res Ctr, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Waters, Andrew P.] Univ Glasgow, Div Infect & Immun, Fac Biomed Life Sci, Glasgow, Lanark, Scotland; [Janse, Chris J.; Ramesar, Jai; Franke-Fayard, Blandine M.] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Parasitol,Leiden Malaria Res Grp, Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Glasgow; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ramakrishnan, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Cell & Mol Biol, London, England.	e.levashina@ibmc-cnrs.unistra.fr	Waters, Andy P/C-9377-2009	Waters, Andy P/0000-0001-8900-2982; Levashina, Elena/0000-0003-4605-906X; , Blandine/0000-0001-6041-4182; Janse, Chris J/0000-0002-6410-6205	EC FP6th BioMalPar Network of Excellence; EC FP7th EviMalar Network of Excellence; Centre National de la Recherche Scientifique [UPR9022]; Inserm [U963]	EC FP6th BioMalPar Network of Excellence; EC FP7th EviMalar Network of Excellence; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by EC FP6th BioMalPar (http://www.biomalpar.org/) and EC FP7th EviMalar (http://www.evimalar.org/) Networks of Excellence, and by funding from the Centre National de la Recherche Scientifique (UPR9022) and Inserm (U963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILLINGSLEY PF, 1991, T ROY SOC TROP MED H, V85, P450, DOI 10.1016/0035-9203(91)90215-K; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2004, CURR OPIN IMMUNOL, V16, P16, DOI 10.1016/j.coi.2003.11.010; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Franke-Fayard B, 2006, NAT PROTOC, V1, P476, DOI 10.1038/nprot.2006.69; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Hernandez-Martinez S, 2002, J MED ENTOMOL, V39, P61, DOI 10.1603/0022-2585-39.1.61; Hillyer JF, 2003, J PARASITOL, V89, P62, DOI 10.1645/0022-3395(2003)089[0062:RPAMOB]2.0.CO;2; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Jacobs-Lorena VY, 2010, MOL BIOCHEM PARASIT, V171, P40, DOI 10.1016/j.molbiopara.2009.12.009; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kooij TWA, 2005, MOL BIOCHEM PARASIT, V144, P16, DOI 10.1016/j.molbiopara.2005.07.003; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Ono T, 2007, EXP PARASITOL, V115, P310, DOI 10.1016/j.exppara.2006.09.008; Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Sambrook J., 2002, MOL CLONING LAB MANU; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Thompson J, 2001, MOL BIOCHEM PARASIT, V118, P147, DOI 10.1016/S0166-6851(01)00377-2; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; Vernick KD, 1996, AM J TROP MED HYG, V54, P430, DOI 10.4269/ajtmh.1996.54.430; Vernick KD, 1995, EXP PARASITOL, V81, P436, DOI 10.1006/expr.1995.1136; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044	32	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36376	10.1371/journal.pone.0036376	http://dx.doi.org/10.1371/journal.pone.0036376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574152	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000305349800048
J	Zhang, CY; de Silva, S; Wang, JH; Wu, L				Zhang, Chiyu; de Silva, Suresh; Wang, Jian-Hua; Wu, Li			Co-Evolution of Primate SAMHD1 and Lentivirus Vpx Leads to the Loss of the vpx Gene in HIV-1 Ancestor	PLOS ONE			English	Article							RESTRICTION FACTOR SAMHD1; POSITIVE SELECTION; ORIGIN; EVOLUTIONARY; ADAPTATION; LIKELIHOOD; DIVERSITY; PARSIMONY; INFECTION; INFERENCE	Cross-species transmission and adaptation of simian immunodeficiency viruses (SIVs) to humans have given rise to human immunodeficiency viruses (HIVs). HIV type 1 (HIV-1) and type 2 (HIV-2) were derived from SIVs that infected chimpanzee (SIVcpz) and sooty mangabey (SIVsm), respectively. The HIV-1 restriction factor SAMHD1 inhibits HIV-1 infection in human myeloid cells and can be counteracted by the Vpx protein of HIV-2 and the SIVsm lineage. However, HIV-1 and its ancestor SIVcpz do not encode a Vpx protein and HIV-1 has not evolved a mechanism to overcome SAMHD1-mediated restriction. Here we show that the co-evolution of primate SAMHD1 and lentivirus Vpx leads to the loss of the vpx gene in SIVcpz and HIV-1. We found evidence for positive selection of SAMHD1 in orangutan, gibbon, rhesus macaque, and marmoset, but not in human, chimpanzee and gorilla that are natural hosts of Vpx-negative HIV-1, SIVcpz and SIVgor, respectively, indicating that vpx drives the evolution of primate SAMHD1. Ancestral host state reconstruction and temporal dynamic analyses suggest that the most recent common ancestor of SIVrcm, SIVmnd, SIVcpz, SIVgor and HIV-1 was a SIV that had a vpx gene; however, the vpx gene of SIVcpz was lost approximately 3643 to 2969 years ago during the infection of chimpanzees. Thus, HIV-1 could not inherit the lost vpx gene from its ancestor SIVcpz. The lack of Vpx in HIV-1 results in restricted infection in myeloid cells that are important for antiviral immunity, which could contribute to the AIDS pandemic by escaping the immune responses.	[Zhang, Chiyu] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [de Silva, Suresh; Wu, Li] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Zhang, Chiyu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai, Peoples R China; [Wang, Jian-Hua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Wu, Li] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	Jiangsu University; University System of Ohio; Ohio State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University System of Ohio; Ohio State University	Zhang, CY (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	zhangcy1999@ips.ac.cn; wu.840@osu.edu	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Zhang, Chiyu/0000-0001-8735-9857	"Top-notch personnel" Project of Jiangsu University; National Natural Science Foundation of China from the National Institutes of Health (NIH) [81071391, AI078762, AI098524]; Public Health Preparedness for Infectious Diseases Program of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078762, R21AI098524, R21AI102822] Funding Source: NIH RePORTER	"Top-notch personnel" Project of Jiangsu University; National Natural Science Foundation of China from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Preparedness for Infectious Diseases Program of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the "Top-notch personnel" Project of Jiangsu University and the National Natural Science Foundation of China (No. 81071391) to Dr. Zhang, by grants (AI078762 and AI098524) to Dr. Wu from the National Institutes of Health (NIH), and by the Public Health Preparedness for Infectious Diseases Program of The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bashirova AA, 2003, J VIROL, V77, P217, DOI 10.1128/JVI.77.1.217-227.2003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Freed EO, 2007, FIELDS VIROLOGY; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Kanthaswamy S, 2009, J MED PRIMATOL, V38, P17, DOI 10.1111/j.1600-0684.2009.00371.x; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2012, TRENDS IMMUNOL, V33, P26, DOI 10.1016/j.it.2011.11.002; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sharp Paul M, 2010, Philos Trans R Soc Lond B Biol Sci, V365, P2487, DOI 10.1098/rstb.2010.0031; Shin EC, 2008, J VIROL, V82, P9782, DOI 10.1128/JVI.00475-08; Snoeck J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-87; Soares AER, 2008, J MOL EVOL, V66, P598, DOI 10.1007/s00239-008-9112-6; St Gelais C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-55; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266; Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Worobey M, 2010, SCIENCE, V329, P1487, DOI 10.1126/science.1193550; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	44	33	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e37477	10.1371/journal.pone.0037477	http://dx.doi.org/10.1371/journal.pone.0037477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574228	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800125
J	Cui, YH; Ge, ZQ; Rizak, JD; Zhai, C; Zhou, Z; Gong, SJ; Che, Y				Cui, Yonghua; Ge, Zhiqiang; Rizak, Joshua Dominic; Zhai, Chao; Zhou, Zhu; Gong, Songjie; Che, Yi			Deficits in Water Maze Performance and Oxidative Stress in the Hippocampus and Striatum Induced by Extremely Low Frequency Magnetic Field Exposure	PLOS ONE			English	Article							50 HZ; ELECTROMAGNETIC-FIELDS; 1 MT; MEMORY; RATS; MORTALITY; BRAIN; TASK	The exposures to extremely low frequency magnetic field (ELF-MF) in our environment have dramatically increased. Epidemiological studies suggest that there is a possible association between ELF-MF exposure and increased risks of cardiovascular disease, cancers and neurodegenerative disorders. Animal studies show that ELF-MF exposure may interfere with the activity of brain cells, generate behavioral and cognitive disturbances, and produce deficits in attention, perception and spatial learning. Although, many research efforts have been focused on the interaction between ELF-MF exposure and the central nervous system, the mechanism of interaction is still unknown. In this study, we examined the effects of ELF-MF exposure on learning in mice using two water maze tasks and on some parameters indicative of oxidative stress in the hippocampus and striatum. We found that ELF-MF exposure (1 mT, 50 Hz) induced serious oxidative stress in the hippocampus and striatum and impaired hippocampal-dependent spatial learning and striatum-dependent habit learning. This study provides evidence for the association between the impairment of learning and the oxidative stress in hippocampus and striatum induced by ELF-MF exposure.	[Cui, Yonghua; Ge, Zhiqiang; Zhai, Chao; Zhou, Zhu; Gong, Songjie; Che, Yi] Soochow Univ, Coll Med, Suzhou, Peoples R China; [Rizak, Joshua Dominic] Chinese Acad Sci, Lab Primate Neurosci Res, Key Lab Anim Models, Kunming Inst Zool, Kunming, Peoples R China	Soochow University - China; Chinese Academy of Sciences; Kunming Institute of Zoology	Cui, YH (corresponding author), Soochow Univ, Coll Med, Suzhou, Peoples R China.	cheyiwenshan@sina.com			National Basic Research Program of China, Chinese National Science Foundation [31172089]	National Basic Research Program of China, Chinese National Science Foundation	This work was supported by National Basic Research Program of China, Chinese National Science Foundation (31172089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2008, BRAIN RES, V1221, P30, DOI 10.1016/j.brainres.2008.05.007; Amara S, 2009, GEN PHYSIOL BIOPHYS, V28, P260, DOI 10.4149/gpb_2009_03_260; Buttiglione M, 2007, J CELL PHYSIOL, V213, P759, DOI 10.1002/jcp.21146; Che Y, 2007, BRAIN RES BULL, V74, P178, DOI 10.1016/j.brainresbull.2007.06.009; Davanipour Z, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-13; Davanipour Zoreh, 2009, Pathophysiology, V16, P149, DOI 10.1016/j.pathophys.2009.01.005; Hakansson N, 2003, AM J EPIDEMIOL, V158, P534, DOI 10.1093/aje/kwg197; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Helbert A. L., 1998, FASEB J, V12, P395; Jelenkovic A, 2006, BRAIN RES BULL, V68, P355, DOI 10.1016/j.brainresbull.2005.09.011; Keck ME, 2001, NEUROPSYCHOPHARMACOL, V24, P337, DOI 10.1016/S0893-133X(00)00191-3; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lai H, 2004, ENVIRON HEALTH PERSP, V112, P687, DOI 10.1289/ehp.6355; Lee H. J., 2011, BIOELECTROMAGNETICS; LISSI E, 1992, FREE RADICAL RES COM, V17, P299, DOI 10.3109/10715769209079523; Ljubuncic P, 2000, GUT, V47, P710, DOI 10.1136/gut.47.5.710; LOOMIS DP, 1990, BRIT J IND MED, V47, P633; Lopuch S, 2009, BEHAV PROCESS, V81, P133, DOI 10.1016/j.beproc.2008.12.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maaroufi K, 2009, NEUROBIOL LEARN MEM, V92, P345, DOI 10.1016/j.nlm.2009.04.002; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Miyoshi E, 2002, BRAIN RES BULL, V58, P41, DOI 10.1016/S0361-9230(02)00754-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mostafa RM, 2002, PHYSIOL BEHAV, V765, P89; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; Prasad K, 2009, EXP NEUROL, V215, P358, DOI 10.1016/j.expneurol.2008.11.003; Prato FS, 1996, BIOELECTROMAGNETICS, V17, P123, DOI 10.1002/(SICI)1521-186X(1996)17:2<123::AID-BEM6>3.0.CO;2-5; Ravera S, 2011, ELECTROMAGN BIOL MED, V30, P67, DOI 10.3109/15368378.2011.566770; Reyes-Guerrero G, 2006, BRAIN RES, V1095, P131, DOI 10.1016/j.brainres.2006.04.020; ROY S, 1995, FEBS LETT, V376, P164, DOI 10.1016/0014-5793(95)01266-X; Sienkiewicz ZJ, 2001, BIOELECTROMAGNETICS, V22, P19, DOI 10.1002/1521-186X(200101)22:1<19::AID-BEM3>3.0.CO;2-0; Sun H, 2010, BIOELECTROMAGNETICS, V311, P50; Trimmel M, 1998, TOXICOL LETT, V96-7, P377, DOI 10.1016/S0378-4274(98)00096-4	33	36	40	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e32196	10.1371/journal.pone.0032196	http://dx.doi.org/10.1371/journal.pone.0032196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570685	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343400001
J	Hegemann, A; Matson, KD; Versteegh, MA; Tieleman, BI				Hegemann, Arne; Matson, Kevin D.; Versteegh, Maaike A.; Tieleman, B. Irene			Wild Skylarks Seasonally Modulate Energy Budgets but Maintain Energetically Costly Inflammatory Immune Responses throughout the Annual Cycle	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; BASAL METABOLIC-RATE; TRADE-OFFS; LIFE-HISTORY; ECOLOGICAL IMMUNOLOGY; PARENTAL EFFORT; WIND-TUNNEL; STRESS; ADJUSTMENTS; BIRDS	A central hypothesis of ecological immunology is that immune defences are traded off against competing physiological and behavioural processes. During energetically demanding periods, birds are predicted to switch from expensive inflammatory responses to less costly immune responses. Acute phase responses (APRs) are a particularly costly form of immune defence, and, hence, seasonal modulations in APRs are expected. Yet, hypotheses about APR modulation remain untested in free-living organisms throughout a complete annual cycle. We studied seasonal modulations in the APRs and in the energy budgets of skylarks Alauda arvensis, a partial migrant bird from temperate zones that experiences substantial ecological changes during its annual cycle. We characterized throughout the annual cycle changes in their energy budgets by measuring basal metabolic rate (BMR) and body mass. We quantified APRs by measuring the effects of a lipopolysaccharide injection on metabolic rate, body mass, body temperature, and concentrations of glucose and ketone. Body mass and BMR were lowest during breeding, highest during winter and intermediate during spring migration, moult and autumn migration. Despite this variation in energy budgets, the magnitude of the APR, as measured by all variables, was similar in all annual cycle stages. Thus, while we find evidence that some annual cycle stages are relatively more energetically constrained, we find no support for the hypothesis that during these annual cycle stages birds compromise an immune defence that is itself energetically costly. We suggest that the ability to mount an APR may be so essential to survival in every annual cycle stage that skylarks do not trade off this costly form of defence with other annual cycle demands.	[Hegemann, Arne; Matson, Kevin D.; Versteegh, Maaike A.; Tieleman, B. Irene] Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	University of Groningen	Hegemann, A (corresponding author), Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	a.hegemann@rug.nl	Matson, Kevin/G-3855-2010; Hegemann, Arne/I-3092-2019; Matson, Kevin D./R-1986-2019	Matson, Kevin/0000-0002-4373-5926; Hegemann, Arne/0000-0002-3309-9866	BirdLife Netherlands; Schure-Beijerinck-Popping Fonds; Rosalind Franklin Fellowship; Netherlands Organization for Scientific Research [Veni 863.04.023, Veni 863.08.026]; NWO [036.001.690]	BirdLife Netherlands; Schure-Beijerinck-Popping Fonds; Rosalind Franklin Fellowship; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from BirdLife Netherlands (BIT), Schure-Beijerinck-Popping Fonds (AH), a Rosalind Franklin Fellowship (BIT) and the Netherlands Organization for Scientific Research (Veni 863.04.023 to BIT, Veni 863.08.026 to KDM). Open access publishing costs were paid by the NWO (036.001.690). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardia DR, 2005, ECOLOGY, V86, P2040, DOI 10.1890/04-1619; BARACOS VE, 1987, CAN J PHYSIOL PHARM, V65, P1248, DOI 10.1139/y87-199; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Burness G, 2010, J EXP BIOL, V213, P1386, DOI 10.1242/jeb.027011; CHEREL Y, 1988, AM J PHYSIOL, V254, pR170, DOI 10.1152/ajpregu.1988.254.2.R170; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; Davis AK, 2005, J FIELD ORNITHOL, V76, P334, DOI 10.1648/0273-8570-76.4.334; Deerenberg C, 1998, J COMP PHYSIOL B, V168, P507, DOI 10.1007/s003600050171; Deerenberg C., 2003, AVIAN SCI, V2, P217; Donald P., 2004, SKYLARK; DRENT RH, 1980, ARDEA, V68, P225; Gessaman J.A., 1987, National Wildlife Federation Scientific and Technical Series, P289; Glutz von Blotzheim, 1985, HDB VOGEL MITTELEURO; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Hasselquist D, 2007, J ORNITHOL, V148, pS571, DOI 10.1007/s10336-007-0201-x; Hasselquist D, 2007, J EXP BIOL, V210, P1123, DOI 10.1242/jeb.02712; Hegemann A, 2012, RING MIGRAT IN PRESS, V27; Hegemann A, 2012, OECOLOGIA IN PRESS; Hegemann A, 2010, ARDEA, V98, P135, DOI 10.5253/078.098.0202; HILL RW, 1972, J APPL PHYSIOL, V33, P261, DOI 10.1152/jappl.1972.33.2.261; Ilmonen P, 2000, P ROY SOC B-BIOL SCI, V267, P665, DOI 10.1098/rspb.2000.1053; Jenni-Eiermann S, 2002, J EXP BIOL, V205, P2453; King JR., 1974, AVIAN ENERGETICS, P4; KLASING K. C., 1998, COMP AVIAN NUTR; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Koutsos EA, 2001, COMP BIOCHEM PHYS C, V128, P255, DOI 10.1016/S1532-0456(00)00199-X; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Martin LB, 2005, CAN J ZOOL, V83, P780, DOI 10.1139/Z05-062; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; MCNAB BK, 1988, OECOLOGIA, V77, P343, DOI 10.1007/BF00378040; Mendes L, 2006, J ORNITHOL, V147, P274, DOI 10.1007/s10336-006-0070-8; Merino S, 2006, J ANIM ECOL, V75, P1147, DOI 10.1111/j.1365-2656.2006.01135.x; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; Nelson RJ, 1996, Q REV BIOL, V71, P511, DOI 10.1086/419555; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; Nilsson JA, 2007, J AVIAN BIOL, V38, P488, DOI 10.1111/j.2007.0908-8857.03919.x; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Nudds RL, 2001, FUNCT ECOL, V15, P458, DOI 10.1046/j.0269-8463.2001.00546.x; Ots I, 2001, P ROY SOC B-BIOL SCI, V268, P1175, DOI 10.1098/rspb.2001.1636; Owen JC, 2008, J ETHOL, V26, P383, DOI 10.1007/s10164-008-0092-1; Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Owen-Ashley NT, 2006, J EXP BIOL, V209, P3062, DOI 10.1242/jeb.02371; Owen-Ashley NT, 2006, HORM BEHAV, V49, P15, DOI 10.1016/j.yhbeh.2005.04.009; Pap PL, 2010, ARDEA, V98, P105, DOI 10.5253/078.098.0113; Pap PL, 2010, NATURWISSENSCHAFTEN, V97, P891, DOI 10.1007/s00114-010-0706-7; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Piersma T, 1996, PHYSIOL ZOOL, V69, P191, DOI 10.1086/physzool.69.1.30164207; R Development Core Team, 2009, R FDN STAT COMP; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Tieleman BI, 2008, BEHAV ECOL, V19, P949, DOI 10.1093/beheco/arn051; Tieleman BI, 2004, ECOLOGY, V85, P1399, DOI 10.1890/03-0170; Tieleman BI, 2003, ECOLOGY, V84, P1800, DOI 10.1890/0012-9658(2003)084[1800:PVOLAA]2.0.CO;2; Tieleman BI, 2002, PHYSIOL BIOCHEM ZOOL, V75, P305, DOI 10.1086/341998; VAN DOBBEN W. H., 1939, Ardea, V28, P61; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Warnes G.R., Various R Programming Tools for Plotting Data 2020	66	54	61	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36358	10.1371/journal.pone.0036358	http://dx.doi.org/10.1371/journal.pone.0036358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570706	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400022
J	Ono, M; Qiang, WN; Serna, VA; Yin, P; Coon, JS; Navarro, A; Monsivais, D; Kakinuma, T; Dyson, M; Druschitz, S; Unno, K; Kurita, T; Bulun, SE				Ono, Masanori; Qiang, Wenan; Serna, Vanida Ann; Yin, Ping; Coon, John S.; Navarro, Antonia; Monsivais, Diana; Kakinuma, Toshiyuki; Dyson, Matthew; Druschitz, Stacy; Unno, Kenji; Kurita, Takeshi; Bulun, Serdar E.			Role of Stem Cells in Human Uterine Leiomyoma Growth	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; STEM/PROGENITOR CELLS; AROMATASE EXPRESSION; SIDE POPULATION; PROGESTERONE; FIBROIDS; MOUSE; GENE; IDENTIFICATION; ACTIVATION	Background: Uterine leiomyoma is the most common benign tumor in reproductive-age women. Each leiomyoma is thought to be a benign monoclonal tumor arising from a single transformed myometrial smooth muscle cell; however, it is not known what leiomyoma cell type is responsible for tumor growth. Thus, we tested the hypothesis that a distinct stem/reservoir cell-enriched population, designated as the leiomyoma-derived side population (LMSP), is responsible for cell proliferation and tumor growth. Principal Findings: LMSP comprised approximately 1% of all leiomyoma and 2% of all myometrium-derived cells. All LMSP and leiomyoma-derived main population (LMMP) but none of the side or main population cells isolated from adjacent myometrium carried a mediator complex subunit 12 mutation, a genetic marker of neoplastic transformation. Messenger RNA levels for estrogen receptor-alpha, progesterone receptor and smooth muscle cell markers were barely detectable and significantly lower in the LMSP compared with the LMMP. LMSP alone did not attach or survive in monolayer culture in the presence or absence of estradiol and progestin, whereas LMMP readily grew under these conditions. LMSP did attach and survive when directly mixed with unsorted myometrial cells in monolayer culture. After resorting and reculturing, LMSP gained full potential of proliferation. Intriguingly, xenografts comprised of LMSP and unsorted myometrial smooth muscle cells grew into relatively large tumors (3.67 +/- 1.07 mm(3)), whereas xenografts comprised of LMMP and unsorted myometrial smooth muscle cells produced smaller tumors (0.54 +/- 0.20 mm(3), p<0.05, n = 10 paired patient samples). LMSP xenografts displayed significantly higher proliferative activity compared with LMMP xenografts (p<0.05). Conclusions: Our data suggest that LMSP, which have stem/reservoir cell characteristics, are necessary for in vivo growth of leiomyoma xenograft tumors. Lower estrogen and progesterone receptor levels in LMSP suggests an indirect paracrine effect of steroid hormones on stem cells via the mature neighboring cells.	[Ono, Masanori; Qiang, Wenan; Serna, Vanida Ann; Yin, Ping; Coon, John S.; Navarro, Antonia; Monsivais, Diana; Kakinuma, Toshiyuki; Dyson, Matthew; Druschitz, Stacy; Unno, Kenji; Kurita, Takeshi; Bulun, Serdar E.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Biol Res, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Ono, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Biol Res, Chicago, IL 60611 USA.	s-bulun@northwestern.edu	Qiang, Wenan/AAA-7633-2021; Kurita, Takeshi/A-2236-2013; Ono, Masanori/F-7443-2019	Kurita, Takeshi/0000-0003-4281-5884; Qiang, Wenan/0000-0001-5068-7128; Dyson, Matthew/0000-0003-3596-5753; Ono, Masanori/0000-0001-9249-6813; Kakinuma, Toshiyuki/0000-0001-7853-4860	Northwestern University Flow Cytometry Facility; Cancer Center Support Grant [NCI CA060553]; National Institutes of Health [NIH/NICHD 5P01HD057877, 1R01HD064402, NIH/NCI 1R01CA154358]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064402, P01HD057877] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA154358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER	Northwestern University Flow Cytometry Facility; Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant (NCI CA060553). This study was supported by National Institutes of Health Grant NIH/NICHD 5P01HD057877, 1R01HD064402, NIH/NCI 1R01CA154358. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Canevari RA, 2005, AM J OBSTET GYNECOL, V193, P1395, DOI 10.1016/j.ajog.2005.02.097; Cervello I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021221; Chang HL, 2010, REPROD SCI, V17, P158, DOI 10.1177/1933719109348924; Fernandez-Valdivia R, 2011, MOL CELL ENDOCRINOL; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Greathouse KL, 2008, REPROD SCI, V15, P765, DOI 10.1177/1933719108322440; HASHIMOTO K, 1995, GYNECOL OBSTET INVES, V40, P204, DOI 10.1159/000292336; Hodge JC, 2009, GENE CHROMOSOME CANC, V48, P865, DOI 10.1002/gcc.20692; Ishikawa H, 2008, J CLIN ENDOCR METAB, V93, P981, DOI 10.1210/jc.2007-2507; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Ishikawa H, 2009, J CLIN ENDOCR METAB, V94, P1752, DOI 10.1210/jc.2008-2327; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Khazaei M, 2009, FERTIL STERIL, V91, P2172, DOI 10.1016/j.fertnstert.2008.02.090; Kurita T, 2005, DIFFERENTIATION, V73, P313, DOI 10.1111/j.1432-0436.2005.00033.x; Kurita T, 2010, DIFFERENTIATION, V80, P99, DOI 10.1016/j.diff.2010.06.007; Lydon JP, 2010, NATURE, V465, P695, DOI 10.1038/465695a; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; McDonnel AC, 2005, CANCER LETT, V221, P49, DOI 10.1016/j.canlet.2004.09.011; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Ono M, 2010, HUM REPROD, V25, P2059, DOI 10.1093/humrep/deq163; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Othman EER, 2008, BEST PRACT RES CL OB, V22, P589, DOI 10.1016/j.bpobgyn.2008.01.014; Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Quesenberry PJ, 2002, BLOOD, V100, P4266, DOI 10.1182/blood-2002-04-1246; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schwab KE, 2008, HUM REPROD, V23, P934, DOI 10.1093/humrep/den051; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Szotek PP, 2007, STEM CELLS, V25, P1317, DOI 10.1634/stemcells.2006-0204; Usadi RS, 2008, J CLIN ENDOCR METAB, V93, P4058, DOI 10.1210/jc.2008-0460; Velagaleti GVN, 2010, CANCER GENET CYTOGEN, V202, P11, DOI 10.1016/j.cancergencyto.2010.06.002; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Wallach EE, 2004, OBSTET GYNECOL, V104, P393, DOI 10.1097/01.AOG.0000136079.62513.39; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Yin P, 2007, J CLIN ENDOCR METAB, V92, P4459, DOI 10.1210/jc.2007-0725; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021; Young HE, 2004, CURR TOP MICROBIOL, V280, P71; Zhang P, 2006, HUM PATHOL, V37, P1350, DOI 10.1016/j.humpath.2006.05.005	43	101	104	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36935	10.1371/journal.pone.0036935	http://dx.doi.org/10.1371/journal.pone.0036935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570742	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400058
J	Nakayama, S; Harcourt, JL; Johnstone, RA; Manica, A				Nakayama, Shinnosuke; Harcourt, Jennifer L.; Johnstone, Rufus A.; Manica, Andrea			Initiative, Personality and Leadership in Pairs of Foraging Fish	PLOS ONE			English	Article							STICKLEBACKS GASTEROSTEUS-ACULEATUS; ROACH RUTILUS-RUTILUS; DECISION-MAKING; COLLECTIVE BEHAVIOR; SOCIAL-CONTEXT; BOLDNESS; SHOALS; MOVEMENTS; EVOLUTION; DYNAMICS	Studies of coordinated movement have found that, in many animal species, bolder individuals are more likely to initiate movement and shyer individuals to follow. Here, we show that in pairs of foraging stickleback fish, leadership is not merely a passive consequence of temperamental differences. Instead, the act of initiating a joint foraging trip out of cover itself brings about a change in the role that an individual plays throughout the subsequent trip, and success in recruiting a partner affects an individual's tendency to initiate the next trip. On each joint trip, whichever fish took the initiative in leading out of cover gains greater influence over its partner's behaviour, which persists even after several changes in position (i.e. termination attempts and re-joining). During any given trip, the initiator is less responsive to its partner's movements than during trips initiated by the partner. An individual's personality had an important effect on its response to failure to recruit a partner: while bold fish were unaffected by failures to initiate a joint trip, shy individuals were less likely to attempt another initiation after a failure. This difference provides a positive feedback mechanism that can partially stabilise social roles within the pair, but it is not strong enough to prevent occasional swaps, with individuals dynamically adjusting their responses to one another as they exchange roles.	[Nakayama, Shinnosuke; Harcourt, Jennifer L.; Johnstone, Rufus A.; Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Nakayama, S (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	sn407@cam.ac.uk; raj1003@cam.ac.uk; am315@cam.ac.uk	Manica, Andrea/B-5497-2008; Manica, Andrea/N-9013-2019	Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X	Association for the Study of Animal Behaviour; NERC; Japan Society of the Promotion of Science	Association for the Study of Animal Behaviour; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by a grant from the Association for the Study of Animal Behaviour to AM, a NERC studentship to JLH, and a fellowship from Japan Society of the Promotion of Science to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Borg B, 2004, BEHAVIOUR, V141, P1521, DOI 10.1163/1568539042948213; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Faria JJ, 2010, ANIM BEHAV, V79, P895, DOI 10.1016/j.anbehav.2009.12.039; Flack A, 2012, ANIM BEHAV, V83, P703, DOI 10.1016/j.anbehav.2011.12.018; FOSSEY D, 1972, ANIM BEHAV, V20, P36, DOI 10.1016/S0003-3472(72)80171-4; Harcourt JL, 2010, CURR BIOL, V20, P156, DOI 10.1016/j.cub.2009.11.045; Harcourt JL, 2009, ANIM BEHAV, V77, P1501, DOI 10.1016/j.anbehav.2009.03.004; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Jacobs A, 2008, BEHAV PROCESS, V79, P111, DOI 10.1016/j.beproc.2008.05.004; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; King AJ, 2011, ANIM BEHAV, V82, P1337, DOI 10.1016/j.anbehav.2011.09.017; King AJ, 2010, BEHAV PROCESS, V84, P671, DOI 10.1016/j.beproc.2010.03.006; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; KRAUSE J, 1993, OECOLOGIA, V93, P356, DOI 10.1007/BF00317878; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Lewis JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1061, DOI 10.1007/s00265-010-1113-y; Magnhagen C, 2005, BEHAV ECOL SOCIOBIOL, V57, P295, DOI 10.1007/s00265-004-0834-1; Magnhagen C, 2009, P ROY SOC B-BIOL SCI, V276, P3369, DOI 10.1098/rspb.2009.0851; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nakayama S, 2011, J ANIM ECOL, V80, P1299, DOI 10.1111/j.1365-2656.2011.01859.x; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pike TW, 2008, P ROY SOC B-BIOL SCI, V275, P2515, DOI 10.1098/rspb.2008.0744; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2010, BEHAV PROCESS, V84, P668, DOI 10.1016/j.beproc.2010.03.001; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; van Oers K, 2005, BEHAV ECOL, V16, P716, DOI 10.1093/beheco/ari045; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Webster MM, 2007, BEHAVIOUR, V144, P351, DOI 10.1163/156853907780425721; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x	43	50	53	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36606	10.1371/journal.pone.0036606	http://dx.doi.org/10.1371/journal.pone.0036606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567168	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500088
J	Huang, WM; DaGloria, J; Fox, H; Ruan, QR; Tillou, J; Shi, K; Aihara, H; Aron, J; Casjens, S				Huang, Wai Mun; DaGloria, Jeanne; Fox, Heather; Ruan, Qiurong; Tillou, John; Shi, Ke; Aihara, Hideki; Aron, John; Casjens, Sherwood			Linear Chromosome-generating System of Agrobacterium tumefaciens C58 PROTELOMERASE GENERATES AND PROTECTS HAIRPIN ENDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYME-DISEASE SPIROCHETE; COVALENTLY CLOSED ENDS; PLASMID-LIKE PROPHAGE; VIBRIO-PARAHAEMOLYTICUS; BORRELIA-BURGDORFERI; NUCLEOTIDE-SEQUENCE; TELOMERIC PROTEINS; GENOMIC SEQUENCE; DNA; EVOLUTION	Agrobacterium tumefaciens C58, the pathogenic bacteria that causes crown gall disease in plants, harbors one circular and one linear chromosome and two circular plasmids. The telomeres of its unusual linear chromosome are covalently closed hairpins. The circular and linear chromosomes co-segregate and are stably maintained in the organism. We have determined the sequence of the two ends of the linear chromosome thus completing the previously published genome sequence of A. tumefaciens C58. We found that the telomeres carry nearly identical 25-bp sequences at the hairpin ends that are related by dyad symmetry. We further showed that its Atu2523 gene encodes a protelomerase (resolvase) and that the purified enzyme can generate the linear chromosomal closed hairpin ends in a sequence-specific manner. Agrobacterium protelomerase, whose presence is apparently limited to biovar 1 strains, acts via a cleavage-and-religation mechanism by making a pair of transient staggered nicks invariably at 6-bp spacing as the reaction intermediate. The enzyme can be significantly shortened at both the N and C termini and still maintain its enzymatic activity. Although the full-length enzyme can uniquely bind to its product telomeres, the N-terminal truncations cannot. The target site can also be shortened from the native 50-bp inverted repeat to 26 bp; thus, the Agrobacterium hairpin-generating system represents the most compact activity of all hairpin linear chromosome- and plasmid-generating systems to date. The biochemical analyses of the protelomerase reactions further revealed that the tip of the hairpin telomere may be unusually polymorphically capable of accommodating any nucleotide.	[Huang, Wai Mun; Aron, John; Casjens, Sherwood] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84112 USA; [Shi, Ke; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Utah System of Higher Education; University of Utah; University of Minnesota System; University of Minnesota Twin Cities	Huang, WM (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84112 USA.	waimun.huang@path.utah.edu		, Ke/0000-0003-4175-3714	National Institutes of Health [GM095558, AI49003]; National Science Foundation Grant [MCB-0213124]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM095558 (to H. A.) and AI49003 (to S. R. C.). This work was also supported by National Science Foundation Grant MCB-0213124 (to W. M. H.).	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; ALLARDETSERVENT A, 1993, J BACTERIOL, V175, P7869, DOI 10.1128/JB.175.24.7869-7874.1993; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; Casjens S, 1997, MOL MICROBIOL, V26, P581, DOI 10.1046/j.1365-2958.1997.6051963.x; Casjens S, 1999, CURR OPIN MICROBIOL, V2, P529, DOI 10.1016/S1369-5274(99)00012-0; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2004, J BACTERIOL, V186, P1818, DOI 10.1128/JB.186.6.1818-1832.2004; Chaconas G, 2010, ANNU REV MICROBIOL, V64, P185, DOI 10.1146/annurev.micro.112408.134037; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Delaroque N, 2003, J MOL EVOL, V57, P613, DOI 10.1007/s00239-003-2501-y; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Deneke J, 2004, J BIOL CHEM, V279, P53699, DOI 10.1074/jbc.M409001200; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Hertwig S, 2003, MOL MICROBIOL, V48, P989, DOI 10.1046/j.1365-2958.2003.03458.x; Huang WM, 2004, J MOL BIOL, V337, P77, DOI 10.1016/j.jmb.2004.01.012; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Lan SF, 2009, APPL ENVIRON MICROB, V75, P2659, DOI 10.1128/AEM.02483-08; Mobberley JM, 2008, J VIROL, V82, P6618, DOI 10.1128/JVI.00140-08; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; Oakey HJ, 2002, J APPL MICROBIOL, V93, P1089, DOI 10.1046/j.1365-2672.2002.01776.x; Ravin V, 2000, J MOL BIOL, V299, P53, DOI 10.1006/jmbi.2000.3731; Rybchin VN, 1999, MOL MICROBIOL, V33, P895, DOI 10.1046/j.1365-2958.1999.01533.x; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tourand Y, 2009, J BIOL CHEM, V284, P7264, DOI 10.1074/jbc.M808918200; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Wibberg D, 2011, J BIOTECHNOL, V155, P50, DOI 10.1016/j.jbiotec.2011.01.010; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Young JM, 2001, INT J SYST EVOL MICR, V51, P89, DOI 10.1099/00207713-51-1-89; Zabala B, 2009, J VIROL, V83, P9313, DOI 10.1128/JVI.00672-09	34	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25551	25563		10.1074/jbc.M112.369488	http://dx.doi.org/10.1074/jbc.M112.369488			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22582388	Green Published, hybrid			2022-12-25	WOS:000306651700063
J	Cherian, MT; Wilson, EM; Shapiro, DJ				Cherian, Milu T.; Wilson, Elizabeth M.; Shapiro, David J.			A Competitive Inhibitor That Reduces Recruitment of Androgen Receptor to Androgen-responsive Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; LIGAND-BINDING DOMAIN; REFRACTORY PROSTATE-CANCER; TRANSCRIPTION COMPLEX; INCREASED EXPRESSION; CELL-GROWTH; LNCAP CELLS; ESTROGEN; ACTIVATION; ANTIANDROGEN	The androgen receptor (AR) has a critical role in the growth and progression of androgen-dependent and castration-resistant prostate cancers. To identify novel inhibitors of AR trans-activation that block growth of prostate cancer cells, a luciferase-based high-throughput screen of similar to 160,000 small molecules was performed in cells stably expressing AR and a prostate-specific antigen (PSA)-luciferase reporter. CPIC (1-(3-(2-chlorophenoxy) propyl)-1H-indole-3-carbonitrile) was identified as a small molecule that blocks AR transactivation to a greater extent than other steroid receptors. CPIC inhibited AR-mediated proliferation of androgen-sensitive prostate cancer cell lines, with minimal toxicity in AR-negative cell lines. CPIC treatment also reduced the anchorage-independent growth of LAPC-4 prostate cancer cells. CPIC functioned as a pure antagonist by inhibiting the expression of AR-regulated genes in LAPC-4 cells that express wild-type AR and exhibited weak agonist activity in LNCaP cells that express the mutant AR-T877A. CPIC treatment did not reduce AR levels or alter its nuclear localization. We used chromatin immunoprecipitation to identify the site of action of CPIC. CPIC inhibited recruitment of androgen-bound AR to the PSA promoter and enhancer sites to a greater extent than bicalutamide. CPIC is a new therapeutic inhibitor that targets AR-mediated gene activation with potential to arrest the growth of prostate cancer.	[Shapiro, David J.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cherian, Milu T.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Wilson, Elizabeth M.] Univ N Carolina, Reprod Biol Lab, Dept Pediat, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Reprod Biol Lab, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Shapiro, DJ (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	djshapir@life.illinois.edu			National Institutes of Health [DK-071909, HD16910]; National Institutes of Health (NCI) [P01-CA77739]; Department of Defense Prostate Cancer Research Program Grant [W81XWH-09-1-0309]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016910, R37HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Research Program Grant(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-071909 (to D. J. S.), HD16910 (to E. M. W.), and P01-CA77739 (NCI; to E. M. W.). This work was also supported by Department of Defense Prostate Cancer Research Program Grant W81XWH-09-1-0309 (to D. J. S.).	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P4315; He B, 2006, J BIOL CHEM, V281, P6648, DOI 10.1074/jbc.M511738200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Hodgson MC, 2007, CANCER RES, V67, P8388, DOI 10.1158/0008-5472.CAN-07-0617; Jia L, 2004, CANCER RES, V64, P2619, DOI 10.1158/0008-5472.CAN-03-3486; Jiang X, 2007, ONCOGENE, V26, P4106, DOI 10.1038/sj.onc.1210197; Joseph JD, 2009, P NATL ACAD SCI USA, V106, P12178, DOI 10.1073/pnas.0900185106; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kretzer NM, 2010, J BIOL CHEM, V285, P41863, DOI 10.1074/jbc.M110.183723; Lagarde WH, 2012, J BIOL CHEM, V287, P10905, DOI 10.1074/jbc.M111.336081; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Linja MJ, 2001, CANCER RES, V61, P3550; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Putt KS, 2004, ANAL BIOCHEM, V333, P256, DOI 10.1016/j.ab.2004.04.032; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shapiro DJ, 2011, J BIOL CHEM, V286, P4043, DOI 10.1074/jbc.R110.203026; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; WILDING G, 1989, PROSTATE, V14, P103, DOI 10.1002/pros.2990140204; Wilson EM, 2011, METHODS MOL BIOL, V776, P113, DOI 10.1007/978-1-61779-243-4_8; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; Wilson Elizabeth M., 2009, V505, P21, DOI 10.1007/978-1-60327-575-0_2; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180	51	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23368	23380		10.1074/jbc.M112.344671	http://dx.doi.org/10.1074/jbc.M112.344671			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589544	Green Published, hybrid			2022-12-25	WOS:000306511300010
J	Nemec, AA; Donigan, KA; Murphy, DL; Jaeger, J; Sweasy, JB				Nemec, Antonia A.; Donigan, Katherine A.; Murphy, Drew L.; Jaeger, Joachim; Sweasy, Joann B.			Colon Cancer-associated DNA Polymerase beta Variant Induces Genomic Instability and Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; CONSEQUENCES; SEQUENCE; LYASE	Rapidly advancing technology has resulted in the generation of the genomic sequences of several human tumors. We have identified several mutations of the DNA polymerase beta (pol beta) gene in human colorectal cancer. We have demonstrated that the expression of the pol beta G231D variant increased chromosomal aberrations and induced cellular transformation. The transformed phenotype persisted in the cells even once the expression of G231D was extinguished, suggesting that it resulted as a consequence of genomic instability. Biochemical analysis revealed that its catalytic rate was 140-fold slower than WTpol beta, and this was a result of the decreased binding affinity of nucleotides by G231D. Residue 231 of pol beta lies in close proximity to the template strand of the DNA. Molecular modeling demonstrated that the change from a small and nonpolar glycine to a negatively charged aspartate resulted in a repulsion between the template and residue 231 leading to the distortion of the dNTP binding pocket. In addition, expression of G231D was insufficient to rescue pol beta-deficient cells treated with chemotherapeutic agents suggesting that these agents may be effectively used to treat tumors harboring this mutation. More importantly, this suggests that the G231D variant has impaired base excision repair. Together, these data indicate that the G231D variant plays a role in driving cancer.	[Nemec, Antonia A.; Donigan, Katherine A.; Murphy, Drew L.; Sweasy, Joann B.] Yale Univ, Dept Therapeut Radiol, Sch Med, New Haven, CT 06520 USA; [Nemec, Antonia A.; Donigan, Katherine A.; Murphy, Drew L.; Sweasy, Joann B.] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA; [Jaeger, Joachim] New York State Dept Hlth, Wadsworth Ctr, Ctr Med Sci, Albany, NY 12208 USA	Yale University; Yale University; State University of New York (SUNY) System; Wadsworth Center	Sweasy, JB (corresponding author), Yale Univ, Dept Therapeut Radiol, Sch Med, POB 208040, New Haven, CT 06520 USA.	joann.sweasy@yale.edu			National Institutes of Health [F32 CA156843, T32 CA009259, 1 PO1 CA129186]; NATIONAL CANCER INSTITUTE [T32CA009259, F32CA156843, P01CA129186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 CA156843 and T32 CA009259 (to A.A.N.) and 1 PO1 CA129186 (to J.B.S.).	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Dalal S, 2005, BIOCHEMISTRY-US, V44, P15664, DOI 10.1021/bi051179z; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Donigan KA, 2012, DNA REPAIR, V11, P381, DOI 10.1016/j.dnarep.2012.01.004; Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230; Gandhi VV, 2011, NUCLEOS NUCLEOT NUCL, V30, P317, DOI 10.1080/15257770.2011.586955; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kirby TW, 2012, NUCLEIC ACIDS RES, V40, P2974, DOI 10.1093/nar/gkr1218; Lai CC, 2005, J VIROL, V79, P1924, DOI 10.1128/JVI.79.3.1924-1929.2005; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; Lang TM, 2004, P NATL ACAD SCI USA, V101, P6074, DOI 10.1073/pnas.0308571101; LOWY DR, 1978, J VIROL, V26, P291, DOI 10.1128/JVI.26.2.291-298.1978; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Murphy DL, 2011, J AM CHEM SOC, V133, P6279, DOI 10.1021/ja111099b; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Shih IM, 2001, CANCER RES, V61, P818; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Yamtich J, 2010, BIOCHEMISTRY-US, V49, P2326, DOI 10.1021/bi901735a	24	36	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23840	23849		10.1074/jbc.M112.362111	http://dx.doi.org/10.1074/jbc.M112.362111			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22573322	Green Published, hybrid			2022-12-25	WOS:000306511300053
J	Ochiai, H; Okada, S; Saito, A; Hoshi, K; Yamashita, H; Takato, T; Azuma, T				Ochiai, Hiromi; Okada, Shoko; Saito, Akiko; Hoshi, Kazuto; Yamashita, Haruto; Takato, Tsuyoshi; Azuma, Toshifumi			Inhibition of Insulin-like Growth Factor-1 (IGF-1) Expression by Prolonged Transforming Growth Factor-beta 1 (TGF-beta 1) Administration Suppresses Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; BONE MORPHOGENETIC PROTEIN-7; PERIODONTAL-LIGAMENT CELLS; FACTOR-BETA; TGF-BETA; GENE-EXPRESSION; MINERALIZATION; CANCER; JNK; INDUCTION	TGF-beta 1 can regulate osteoblast differentiation not only positively but also negatively. However, the mechanisms of negative regulation are not well understood. We previously established the reproducible model for studying the suppression of osteoblast differentiation by repeated or high dose treatment with TGF-beta 1, although single low dose TGF-beta 1 strongly induced osteoblast differentiation. The mRNA expression and protein level of insulin-like growth factor-1 (IGF-1) were remarkably decreased by repeated TGF-beta 1 administration in human periodontal ligament cells, human mesenchymal stem cells, and murine preosteoblast MC3T3-E1 cells. Repeated TGF-beta 1 administration subsequently decreased alkaline phosphatase (ALP) activity and mRNA expression of osteoblast differentiation marker genes, such as RUNX2, ALP, and bone sialoprotein (BSP). Additionally, repeated administration significantly reduced the downstream signaling pathway of IGF-1, such as Akt phosphorylation in these cells. Surprisingly, exogenous and overexpressed IGF-1 recovered ALP activity and mRNA expression of osteoblast differentiation marker genes even with repeated TGF-beta 1 administration. These facts indicate that the key mechanism of inhibition of osteoblast differentiation induced by repeated TGF-beta 1 treatment is simply due to the down-regulation of IGF-1 expression. Inhibition of IGF-1 signaling using small interfering RNA (siRNA) against insulin receptor substrate-1 (IRS-1) suppressed mRNA expression of RUNX2, ALP, BSP, and IGF-1 even with single TGF-beta 1 administration. This study showed that persistence of TGF-beta 1 inhibited osteoblast differentiation via suppression of IGF-1 expression and subsequent down-regulation of the PI3K/Akt pathway. We think this fact could open the way to use IGF-1 as a treatment tool for bone regeneration in prolonged inflammatory disease.	[Ochiai, Hiromi; Azuma, Toshifumi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiba 2618502, Japan; [Ochiai, Hiromi; Okada, Shoko; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Chiba 2618502, Japan; [Hoshi, Kazuto] Univ Tokyo, Grad Sch Med, Dept Cartilage & Bone Regenerat Fujisoft, Tokyo 1138655, Japan; [Yamashita, Haruto] Tokyo Dent Coll, Dept Pediat Dent, Chiba 2618502, Japan; [Takato, Tsuyoshi] Univ Tokyo, Grad Sch Med, Dept Oral & Maxillofacial Surg, Div Tissue Engn,Fac Med, Tokyo 1138655, Japan	Tokyo Dental College; Tokyo Dental College; University of Tokyo; Tokyo Dental College; University of Tokyo	Azuma, T (corresponding author), 1-2-2 Masago,Mihama Ku, Chiba 2618502, Japan.	tazuma@tdc.ac.jp			Oral Health Science Center from Tokyo Dental College; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24593050] Funding Source: KAKEN	Oral Health Science Center from Tokyo Dental College; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Oral Health Science Center Grant hrc8 from activity in murine bone marrow stromal Tokyo Dental College and by a Project for Private Universities, matching fund subsidy from Ministry of Education, Culture, Sports, Science and Technology of Japan, 2010-2012.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bernstein A, 2010, J BIOMED MATER RES B, V92B, P215, DOI 10.1002/jbm.b.31508; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Centrella M, 1996, J BIOL CHEM, V271, P18616, DOI 10.1074/jbc.271.31.18616; Chernausek SD, 2007, J CLIN ENDOCR METAB, V92, P902, DOI 10.1210/jc.2006-1610; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Davies LC, 2008, TISSUE ENG PT A, V14, P1251, DOI [10.1089/ten.tea.2007.0211, 10.1089/tea.2007.0211]; Ge Q, 2010, J CELL PHYSIOL, V225, P846, DOI 10.1002/jcp.22295; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; He WX, 2004, ARCH ORAL BIOL, V49, P911, DOI 10.1016/j.archoralbio.2004.05.005; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kadowaki Takashi, 1996, Endocrine Journal, V43, pS33, DOI 10.1507/endocrj.43.Suppl_S33; Kaji H, 2006, HORM METAB RES, V38, P740, DOI 10.1055/s-2006-955085; Kwok S, 2009, J CELL BIOCHEM, V106, P161, DOI 10.1002/jcb.21991; Lee JY, 2006, J BIOMED MATER RES A, V76A, P530, DOI 10.1002/jbm.a.30434; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Miyazono A, 2007, FEBS LETT, V581, P5321, DOI 10.1016/j.febslet.2007.10.021; Nakagawa T, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-76; Nakayama Y, 2006, J CELL PHYSIOL, V208, P326, DOI 10.1002/jcp.20664; Ochiai H, 2010, J HARD TISSUE BIOL, V19, P187, DOI 10.2485/jhtb.19.187; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Power RA, 2002, BONE, V31, P143, DOI 10.1016/S8756-3282(02)00799-8; Ripamonti U, 1997, J BONE MINER RES, V12, P1584, DOI 10.1359/jbmr.1997.12.10.1584; Ripamonti U, 2009, J CRANIOFAC SURG, V20, P1544, DOI 10.1097/SCS.0b013e3181b09ca6; Sowa H, 2002, J BONE MINER RES, V17, P1190, DOI 10.1359/jbmr.2002.17.7.1190; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Walsh S, 2003, BONE, V33, P80, DOI 10.1016/S8756-3282(03)00165-0; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yakar S, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.234; Yang L, 2010, J PERIODONTAL RES, V45, P532, DOI 10.1111/j.1600-0765.2009.01268.x; Zhang H, 2003, BIOMATERIALS, V24, P2013, DOI 10.1016/S0142-9612(02)00616-6; Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]; Zimmermann G, 2005, BONE, V36, P779, DOI 10.1016/j.bone.2005.02.011	40	64	69	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22654	22661		10.1074/jbc.M111.279091	http://dx.doi.org/10.1074/jbc.M111.279091			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573330	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000306495000022
J	Sela, D; Chen, L; Martin-Brown, S; Washburn, MP; Florens, L; Conaway, JW; Conaway, RC				Sela, Dotan; Chen, Lu; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Conaway, Joan Weliky; Conaway, Ronald C.			Endoplasmic Reticulum Stress-responsive Transcription Factor ATF6 alpha Directs Recruitment of the Mediator of RNA Polymerase II Transcription and Multiple Histone Acetyltransferase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; SPECTRAL ABUNDANCE FACTORS; ER STRESS; IN-VIVO; SHOTGUN PROTEOMICS; ACTIVATION DOMAIN; GENE-EXPRESSION; LUMINAL DOMAIN; FACTOR ATF6; SAGA	The basic leucine zipper transcription factor ATF6 alpha functions as a master regulator of endoplasmic reticulum (ER) stress response genes. Previous studies have established that, in response to ER stress, ATF6 alpha translocates to the nucleus and activates transcription of ER stress response genes upon binding sequence specifically to ER stress response enhancer elements in their promoters. In this study, we investigate the biochemical mechanism by which ATF6 alpha activates transcription. By exploiting a combination of biochemical and multidimensional protein identification technology-based mass spectrometry approaches, we have obtained evidence that ATF6 alpha functions at least in part by recruiting to the ER stress response enhancer elements of ER stress response genes a collection of RNA polymerase II coregulatory complexes, including the Mediator and multiple histone acetyltransferase complexes, among which are the Spt-Ada-Gcn5 acetyltransferase (SAGA) and Ada-Two-A-containing (ATAC) complexes. Our findings shed new light on the mechanism of action of ATF6 alpha, and they outline a straightforward strategy for applying multidimensional protein identification technology mass spectrometry to determine which RNA polymerase II transcription factors and coregulators are recruited to promoters and other regulatory elements to control transcription.	[Sela, Dotan; Chen, Lu; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Conaway, Joan Weliky; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Chen, Lu; Conaway, Joan Weliky; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org; rcc@stowers.org	Chen, Lu/AAN-4886-2021	Chen, Lu/0000-0002-4571-7975; Florens, Laurence/0000-0002-9310-6650; Conaway, Joan/0000-0002-2786-0663; Washburn, Michael/0000-0001-7568-2585	National Institutes of Health [GM41628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041628, R37GM041628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41628 (to J. W. C. and R. C. C.). This work was also supported by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation.	Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bontems F, 2011, J STRUCT BIOL, V174, P245, DOI 10.1016/j.jsb.2010.10.011; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; CAREY MF, 2009, TRANSCRIPTIONAL REGU, P439; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Eletsky Alexander, 2011, Journal of Structural and Functional Genomics, V12, P159, DOI 10.1007/s10969-011-9115-1; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Ikeda K, 2002, GENES CELLS, V7, P49, DOI 10.1046/j.1356-9597.2001.00492.x; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Luo R, 2008, J CELL BIOCHEM, V104, P1708, DOI 10.1002/jcb.21736; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Nagy Z, 2009, MOL CELL BIOL, V29, P1649, DOI 10.1128/MCB.01076-08; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pijnappel WWMP, 2008, MOL CELL, V29, P152, DOI 10.1016/j.molcel.2008.01.007; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shen JS, 2004, J BIOL CHEM, V279, P43046, DOI 10.1074/jbc.M408466200; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thuerauf DJ, 2002, J BIOL CHEM, V277, P20734, DOI 10.1074/jbc.M201749200; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	50	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23035	23045		10.1074/jbc.M112.369504	http://dx.doi.org/10.1074/jbc.M112.369504			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577136	Green Published, hybrid			2022-12-25	WOS:000306495000060
J	Devaux, S; Poulain, FE; Devignot, V; Lachkar, S; Irinopoulou, T; Sobel, A				Devaux, Sara; Poulain, Fabienne E.; Devignot, Veronique; Lachkar, Sylvie; Irinopoulou, Theano; Sobel, Andre			Specific Serine-Proline Phosphorylation and Glycogen Synthase Kinase 3 beta-directed Subcellular Targeting of Stathmin 3/Sclip in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT-RAT BRAIN; GROWTH-CONE; FAMILY PROTEINS; MICROTUBULE DYNAMICS; IN-VITRO; PHYLOGENETIC CONSERVATION; MULTISITE PHOSPHORYLATION; CYTOSKELETAL DYNAMICS; PHOSPHOPROTEIN FAMILY; HIPPOCAMPAL-NEURONS	During nervous system development, neuronal growth, migration, and functional morphogenesis rely on the appropriate control of the subcellular cytoskeleton including microtubule dynamics. Stathmin family proteins play major roles during the various stages of neuronal differentiation, including axonal growth and branching, or dendritic development. We have shown previously that stathmins 2 (SCG10) and 3 (SCLIP) fulfill distinct, independent and complementary regulatory roles in axonal morphogenesis. Although the two proteins have been proposed to display the four conserved phosphorylation sites originally identified in stathmin 1, we show here that they possess distinct phosphorylation sites within their specific prolinerich domains (PRDs) that are differentially regulated by phosphorylation by proline-directed kinases involved in the control of neuronal differentiation. ERK2 or CDK5 phosphorylate the two proteins but with different site specificities. We also show for the first time that, unlike stathmin 2, stathmin 3 is a substrate for glycogen synthase kinase (GSK) 3 beta both in vitro and in vivo. Interestingly, stathmin 3 phosphorylated at its GSK-3 beta target site displays a specific subcellular localization at neuritic tips and within the actin-rich peripheral zone of the growth cone of differentiating hippocampal neurons in culture. Finally, pharmacological inhibition of GSK-3 beta induces a redistribution of stathmin 3, but not stathmin 2, from the periphery toward the Golgi region of neurons. Stathmin proteins can thus be either regulated locally or locally targeted by specific phosphorylation, each phosphoprotein of the stathmin family fulfilling distinct and specific roles in the control of neuronal differentiation.	INSERM U839, F-75005 Paris, France; Univ Paris 06, UMR S839, F-75005 Paris, France; [Sobel, Andre] Inst Fer Moulin, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Sobel, A (corresponding author), UMR S 839 INSERM UPMC, F-75005 Paris, France.	andre.sobel@inserm.fr		POULAIN, Fabienne/0000-0002-7867-748X	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Pierre et Marie Curie (UPMC); Agence Nationale pour la Recherche (ANR)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie (UPMC); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Pierre et Marie Curie (UPMC), and the Agence Nationale pour la Recherche (ANR).	Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; Atilla-Gokcumen GE, 2006, CHEMBIOCHEM, V7, P1443, DOI 10.1002/cbic.200600117; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Charbaut E, 2005, J CELL SCI, V118, P2313, DOI 10.1242/jcs.02349; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Chauvin S, 2008, BIOL CELL, V100, P577, DOI 10.1042/BC20070119; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Di Paolo G, 1997, J NEUROSCI RES, V50, P1000, DOI 10.1002/(SICI)1097-4547(19971215)50:6<1000::AID-JNR10>3.0.CO;2-8; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Gavet O, 1998, J CELL SCI, V111, P3333; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Goold RG, 2004, BIOCHEM SOC T, V32, P809, DOI 10.1042/BST0320809; Goslin K., 1998, CULTURING NERVE CELL, P339; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Gupta A, 2003, NEUROSIGNALS, V12, P173, DOI 10.1159/000074618; Hanger Diane P, 2011, Int J Alzheimers Dis, V2011, P352805, DOI 10.4061/2011/352805; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; HIMI T, 1994, NEUROSCIENCE, V60, P907, DOI 10.1016/0306-4522(94)90271-2; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Lachkar S, 2010, J BIOL CHEM, V285, P11667, DOI 10.1074/jbc.M109.096727; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; le Gouvello S, 1998, J IMMUNOL, V161, P1113; LEIGHTON IA, 1993, MOL CELL BIOCHEM, V128, P151, DOI 10.1007/BF01076766; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Manceau V, 1999, ELECTROPHORESIS, V20, P409, DOI 10.1002/(SICI)1522-2683(19990201)20:2<409::AID-ELPS409>3.3.CO;2-E; MARKLUND U, 1994, EUR J BIOCHEM, V225, P53, DOI 10.1111/j.1432-1033.1994.00053.x; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; Ohkawa N, 2007, J CELL SCI, V120, P1447, DOI 10.1242/jcs.001461; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1999, J NEUROSCI RES, V56, P553, DOI 10.1002/(SICI)1097-4547(19990601)56:5<553::AID-JNR11>3.0.CO;2-J; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Poulain FE, 2008, J NEUROSCI, V28, P7387, DOI 10.1523/JNEUROSCI.1942-08.2008; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Redeker V, 2000, J BIOL CHEM, V275, P6841, DOI 10.1074/jbc.275.10.6841; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; Rothenberg ME, 2003, NEURON, V39, P779, DOI 10.1016/S0896-6273(03)00508-7; SANCHEZ I, 1994, CELL MOTIL CYTOSKEL, V29, P57, DOI 10.1002/cm.970290106; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; SOBEL A, 1989, J BIOL CHEM, V264, P3765; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Steinmetz MO, 2001, EMBO REP, V2, P505, DOI 10.1093/embo-reports/kve105; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Szebenyi G, 1998, J NEUROSCI, V18, P7930; Takahashi K, 2010, CELL SIGNAL, V22, P510, DOI 10.1016/j.cellsig.2009.11.005; Takahashi K, 2009, CELL SIGNAL, V21, P695, DOI 10.1016/j.cellsig.2009.01.007; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	72	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22341	22353		10.1074/jbc.M112.344044	http://dx.doi.org/10.1074/jbc.M112.344044			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577147	Green Published, hybrid			2022-12-25	WOS:000306418600071
J	Pinton, G; Manente, AG; Angeli, G; Mutti, L; Moro, L				Pinton, Giulia; Manente, Arcangela Gabriella; Angeli, Giovanni; Mutti, Luciano; Moro, Laura			Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma	PLOS ONE			English	Article							CANCER CELLS; PHASE-II; KINASE-B; RECEPTOR; GROWTH; ACTIVATION; MET; ASBESTOS; CARCINOGENESIS; PATHWAY	Background: PI3K/AKT signalling pathway is aberrantly active and plays a critical role for cell cycle progression of human malignant pleural mesothelioma (MMe) cells. AKT is one of the important cellular targets of perifosine, a novel bio-available alkylphospholipid that has displayed significant anti-proliferative activity in vitro and in vivo in several human tumour model systems and is currently being tested in clinical trials. Methods: We tested Perifosine activity on human mesothelial cells and different mesothelioma cell lines, in order to provide evidence of its efficacy as single agent and combined therapy. Results: We demonstrate here that perifosine, currently being evaluated as an anti-cancer agent in phase 1 and 2 clinical trials, caused a dose-dependent reduction of AKT activation, at concentrations causing MMe cell growth arrest. In this study we firstly describe that MMe cells express aside from AKT1 also AKT3 and that either the myristoylated, constitutively active, forms of the two proteins, abrogated perifosine-mediated cell growth inhibition. Moreover, we describe here a novel mechanism of perifosine that interferes, upstream of AKT, affecting EGFR and MET phosphorylation. Finally, we demonstrate a significant increase in cell toxicity when MMe cells were treated with perifosine in combination with cisplatin. Conclusions: This study provides a novel mechanism of action of perifosine, directly inhibiting EGFR/MET-AKT1/3 axis, providing a rationale for a novel translational approach to the treatment of MMe.	[Pinton, Giulia; Manente, Arcangela Gabriella; Moro, Laura] Univ Piemonte Orientale, Dept Pharmaceut Sci, Novara, Italy; [Pinton, Giulia; Manente, Arcangela Gabriella; Moro, Laura] Univ Piemonte Orientale, Drug & Food Biotechnol Ctr, Novara, Italy; [Angeli, Giovanni] Vercelli Hosp, Serv Pathol, Vercelli, Italy; [Mutti, Luciano] Vercelli Hosp, Dept Med, Vercelli, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Pinton, G (corresponding author), Univ Piemonte Orientale, Dept Pharmaceut Sci, Novara, Italy.	moro@pharm.unipmn.it	Moro, Laura/ABF-2175-2020; Mutti, Luciano/A-3545-2011; Pinton, Giulia/ABF-2199-2020	Pinton, Giulia/0000-0003-0496-0378; Moro, Laura/0000-0003-3421-2522; Mutti, Luciano/0000-0002-1578-2637	Mesothelioma Applied Research Foundation (MARF); Fondazione Buzzi Unicem; GIMe (Italian Mesothelioma interest Group)	Mesothelioma Applied Research Foundation (MARF); Fondazione Buzzi Unicem; GIMe (Italian Mesothelioma interest Group)	Work was supported by Mesothelioma Applied Research Foundation (MARF grant 2009), Fondazione Buzzi Unicem and GIMe (Italian Mesothelioma interest Group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, ONCOGENE, V24, P6080, DOI 10.1038/sj.onc.1208744; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bendell JC, 2011, J CLIN ONCOL, V29, P4394, DOI 10.1200/JCO.2011.36.1980; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brognard J, 2001, CANCER RES, V61, P3986; Cacciotti P, 2005, CANCER RES, V65, P5256, DOI 10.1158/0008-5472.CAN-05-0127; Cacciotti P, 2001, P NATL ACAD SCI USA, V98, P12032, DOI 10.1073/pnas.211026798; Campbell NP, 2011, SEMIN RESP CRIT CARE, V32, P102, DOI 10.1055/s-0031-1272874; Carbone M, 2012, CLIN CANCER RES, V18, P598, DOI 10.1158/1078-0432.CCR-11-2259; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Festuccia C, 2008, PROSTATE, V68, P965, DOI 10.1002/pros.20757; Garland LL, 2007, J CLIN ONCOL, V25, P2406, DOI 10.1200/JCO.2006.09.7634; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hideshima T, 2006, BLOOD, V107, P4053, DOI 10.1182/blood-2005-08-3434; Jagadeeswaran R, 2006, CANCER RES, V66, P352, DOI 10.1158/0008-5472.CAN-04-4567; Kawaguchi K, 2009, CARCINOGENESIS, V30, P1097, DOI 10.1093/carcin/bgp097; Kazan-Allen L, 2005, LUNG CANCER, V49, pS3, DOI 10.1016/j.lungcan.2005.03.002; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Li X, 2006, ONCOGENE, V25, P525, DOI 10.1038/sj.onc.1209075; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mukohara T, 2005, CLIN CANCER RES, V11, P8122, DOI 10.1158/1078-0432.CCR-05-1191; Pinton G, 2009, CANCER RES, V69, P4598, DOI 10.1158/0008-5472.CAN-08-4523; Ray M, 2009, CHEST, V136, P888, DOI 10.1378/chest.08-2665; Richardson PG, 2011, J CLIN ONCOL, V29, P4243, DOI 10.1200/JCO.2010.33.9788; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tolnay E, 1998, J CANCER RES CLIN, V124, P291, DOI 10.1007/s004320050171; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241	34	33	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36856	10.1371/journal.pone.0036856	http://dx.doi.org/10.1371/journal.pone.0036856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590625	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400041
J	Pare, A; Kim, M; Juarez, MT; Brody, S; McGinnis, W				Pare, Adam; Kim, Myungjin; Juarez, Michelle T.; Brody, Stuart; McGinnis, William			The Functions of Grainy Head-Like Proteins in Animals and Fungi and the Evolution of Apical Extracellular Barriers	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTOR FAMILY; DROSOPHILA-MELANOGASTER; NEUROSPORA-CRASSA; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-FUMIGATUS; SIGNALING PATHWAYS; EPIDERMAL BARRIER; IMMUNE-RESPONSES; STRESS-RESPONSE	The Grainy head (GRH) family of transcription factors are crucial for the development and repair of epidermal barriers in all animals in which they have been studied. This is a high-level functional conservation, as the known structural and enzymatic genes regulated by GRH proteins differ between species depending on the type of epidermal barrier being formed. Interestingly, members of the CP2 superfamily of transcription factors, which encompasses the GRH and LSF families in animals, are also found in fungi - organisms that lack epidermal tissues. To shed light on CP2 protein function in fungi, we characterized a Neurospora crassa mutant lacking the CP2 member we refer to as grainy head-like (grhl). We show that Neurospora GRHL has a DNA-binding specificity similar to that of animal GRH proteins and dissimilar to that of animal LSF proteins. Neurospora grhl mutants are defective in conidial-spore dispersal due to an inability to remodel the cell wall, and we show that grhl mutants and the long-known conidial separation-2 (csp-2) mutants are allelic. We then characterized the transcriptomes of both Neurospora grhl mutants and Drosophila grh mutant embryos to look for similarities in the affected genes. Neurospora grhl appears to play a role in the development and remodeling of the cell wall, as well as in the activation of genes involved in defense and virulence. Drosophila GRH is required to activate the expression of many genes involved in cuticular/epidermal-barrier formation. We also present evidence that GRH plays a role in adult antimicrobial defense. These results, along with previous studies of animal GRH proteins, suggest the fascinating possibility that the apical extracellular barriers of some animals and fungi might share an evolutionary connection, and that the formation of physical barriers in the last common ancestor was under the control of a transcriptional code that included GRH-like proteins.	[Pare, Adam; Kim, Myungjin; Juarez, Michelle T.; McGinnis, William] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Brody, Stuart] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Pare, A (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	adamcpare@gmail.com; wmcginnis@ucsd.edu		Juarez, Michelle/0000-0002-6910-0881	National Institutes of Health [GM077197, HD28315, T32GM007240]; family of Herbert Stern; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028315] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240, R01GM077197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); family of Herbert Stern; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health Grants (http://grants.nih.gov/) GM077197 and HD28315 (to WM), NIH Training Grant T32GM007240 (to AP) and also received support from the family of Herbert Stern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Auden A, 2006, GENE EXPR PATTERNS, V6, P964, DOI 10.1016/j.modgep.2006.03.011; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Brody S, 2010, FUNGAL GENET BIOL, V47, P159, DOI 10.1016/j.fgb.2009.09.006; Bruneau JM, 2001, ELECTROPHORESIS, V22, P2812, DOI 10.1002/1522-2683(200108)22:13&lt;2812::AID-ELPS2812&gt;3.0.CO;2-Q; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Carroll SB., 2005, DNA DIVERSITY; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Chalmers AD, 2006, MECH DEVELOP, V123, P702, DOI 10.1016/j.mod.2006.04.006; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Davis R.H., 2000, NEUROSPORA CONTRIBUT; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Delserone LM, 1999, PHYSIOL MOL PLANT P, V55, P317, DOI 10.1006/pmpp.1999.0237; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Guo JR, 2005, BIOTECHNOL LETT, V27, P3, DOI 10.1007/s10529-004-6294-x; Gustavsson P, 2008, BIRTH DEFECTS RES A, V82, P728, DOI 10.1002/bdra.20494; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Huang JD, 1995, GENE DEV, V9, P3177, DOI 10.1101/gad.9.24.3177; Hung CY, 2005, INFECT IMMUN, V73, P6689, DOI 10.1128/IAI.73.10.6689-6703.2005; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jeong JS, 2007, FEMS MICROBIOL LETT, V273, P157, DOI 10.1111/j.1574-6968.2007.00796.x; Kasuga T, 2005, NUCLEIC ACIDS RES, V33, P6469, DOI 10.1093/nar/gki953; Kasuga T, 2008, EUKARYOT CELL, V7, P1549, DOI 10.1128/EC.00195-08; Kim M, 2011, P NATL ACAD SCI USA, V108, P650, DOI 10.1073/pnas.1016386108; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kirk DL, 2005, BIOESSAYS, V27, P299, DOI 10.1002/bies.20197; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Koharudin LMI, 2008, STRUCTURE, V16, P570, DOI 10.1016/j.str.2008.01.015; Kokoszynska K, 2008, CELL CYCLE, V7, P2907, DOI 10.4161/cc.7.18.6680; Kraaijeveld Alex R., 2009, P187; Kudryavtseva EI, 2003, DEV DYNAM, V226, P604, DOI 10.1002/dvdy.10255; Lambreghts R, 2009, GENETICS, V181, P767, DOI 10.1534/genetics.108.089292; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li DX, 2002, J BIOL CHEM, V277, P7905, DOI 10.1074/jbc.M108799200; Liaw GJ, 1995, GENE DEV, V9, P3163, DOI 10.1101/gad.9.24.3163; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Maddi A, 2009, FUNGAL GENET BIOL, V46, P768, DOI 10.1016/j.fgb.2009.06.005; Matova N, 2010, J CELL SCI, V123, P627, DOI 10.1242/jcs.060731; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Meek IB, 2003, APPL ENVIRON MICROB, V69, P1607, DOI 10.1128/AEM.69.3.1607-1613.2003; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Ostrowski S, 2002, GENETICS, V161, P171; Pearson JC, 2009, P NATL ACAD SCI USA, V106, P2224, DOI 10.1073/pnas.0810219106; Percudani R, 2005, PROTEINS, V60, P670, DOI 10.1002/prot.20543; PERKINS DD, 2000, FUNGAL GENET NEWSL, V47, P40; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Romeo Yves, 2008, V415, P379, DOI 10.1007/978-1-59745-570-1_22; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Schauber J, 2009, J ALLERGY CLIN IMMUN, V124, pR13, DOI 10.1016/j.jaci.2009.07.014; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Sebe-Pedros A, 2011, MOL BIOL EVOL, V28, P1241, DOI 10.1093/molbev/msq309; SELITRENNIKOFF CP, 1974, GENETICS, V78, P679; Shirra MK, 1998, J BIOL CHEM, V273, P19260, DOI 10.1074/jbc.273.30.19260; SPRINGER ML, 1989, GENE DEV, V3, P559, DOI 10.1101/gad.3.4.559; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Tang HP, 2009, FLY, V3, P105, DOI 10.4161/fly.3.1.7747; Tao JN, 2005, DEVELOPMENT, V132, P1021, DOI 10.1242/dev.01641; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting SB, 2003, NAT MED, V9, P1513, DOI 10.1038/nm961; Ting Stephen B, 2005, Organogenesis, V2, P33; Traylor-Knowles N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-101; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tzou P, 2002, METHOD MICROBIOL, V31, P507, DOI 10.1016/S0580-9517(02)31028-6; UV AE, 1994, MOL CELL BIOL, V14, P4020, DOI 10.1128/MCB.14.6.4020; Veljkovic J, 2004, GENE, V343, P23, DOI 10.1016/j.gene.2004.08.010; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; Wang SQ, 2009, NAT CELL BIOL, V11, P890, DOI 10.1038/ncb1898; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; Wilanowski T, 2008, EMBO J, V27, P886, DOI 10.1038/emboj.2008.24; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Yin QY, 2008, TRENDS MICROBIOL, V16, P20, DOI 10.1016/j.tim.2007.10.011; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200; Yu ZQ, 2008, DEV BIOL, V319, P56, DOI 10.1016/j.ydbio.2008.04.001; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zhao XJ, 1996, J BIOL CHEM, V271, P25131, DOI 10.1074/jbc.271.41.25131	94	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36254	10.1371/journal.pone.0036254	http://dx.doi.org/10.1371/journal.pone.0036254			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590528	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100024
J	Ahmed, SE; Ewers, RM				Ahmed, Sadia E.; Ewers, Robert M.			Spatial Pattern of Standing Timber Value across the Brazilian Amazon	PLOS ONE			English	Article							ABOVEGROUND LIVE BIOMASS; NATURAL-RESOURCE; CLIMATE-CHANGE; WOOD DENSITY; LAND-USE; DEFORESTATION; FORESTS; FRAGMENTATION; ECOSYSTEM; TURNOVER	The Amazon is a globally important system, providing a host of ecosystem services from climate regulation to food sources. It is also home to a quarter of all global diversity. Large swathes of forest are removed each year, and many models have attempted to predict the spatial patterns of this forest loss. The spatial patterns of deforestation are determined largely by the patterns of roads that open access to frontier areas and expansion of the road network in the Amazon is largely determined by profit seeking logging activities. Here we present predictions for the spatial distribution of standing value of timber across the Amazon. We show that the patterns of timber value reflect large-scale ecological gradients, determining the spatial distribution of functional traits of trees which are, in turn, correlated with timber values. We expect that understanding the spatial patterns of timber value across the Amazon will aid predictions of logging movements and thus predictions of potential future road developments. These predictions in turn will be of great use in estimating the spatial patterns of deforestation in this globally important biome.	[Ahmed, Sadia E.; Ewers, Robert M.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England	Imperial College London	Ahmed, SE (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England.	sadia.ahmed05@imperial.ac.uk			Grantham Institute for Climate Change and Microsoft Research	Grantham Institute for Climate Change and Microsoft Research(Microsoft)	The work was funded by The Grantham Institute for Climate Change (http://www3.imperial.ac.uk/climatechange) and Microsoft Research (http://research.microsoft.com/en-us/labs/cambridge/) through Ph.D. funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima EY, 2008, PHOTOGRAMM ENG REM S, V74, P699, DOI 10.14358/PERS.74.6.699; Arima EY, 2005, ANN ASSOC AM GEOGR, V95, P525, DOI 10.1111/j.1467-8306.2005.00473.x; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; Asner GP, 2004, P NATL ACAD SCI USA, V101, P6039, DOI 10.1073/pnas.0400168101; Baker TR, 2009, BIOGEOSCIENCES, V6, P297, DOI 10.5194/bg-6-297-2009; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Betts RA, 2008, PHILOS T R SOC B, V363, P1729, DOI 10.1098/rstb.2008.0011; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bradshaw CJA, 2007, GLOBAL CHANGE BIOL, V13, P2379, DOI 10.1111/j.1365-2486.2007.01446.x; Caldas MM, 2010, J LAT AM GEOGR, V9, P125, DOI 10.1353/lag.0.0066; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Evans TP, 2001, ECOL MODEL, V143, P95, DOI 10.1016/S0304-3800(01)00357-X; FEARNSIDE P M, 1987, Conservation Biology, V1, P214, DOI 10.1111/j.1523-1739.1987.tb00035.x; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; GENTRY AH, 1992, ANN MO BOT GARD, V79, P53, DOI 10.2307/2399809; Gerwing JJ, 1996, REDUCING WASTE LOGGI, V187; Giraudoux P., 2011, PGIRMESS DATA ANAL E; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Melillo JM, 1996, ANNU REV ENERG ENV, V21, P293, DOI 10.1146/annurev.energy.21.1.293; Merry F, 2009, ENVIRON MANAGE, V44, P395, DOI 10.1007/s00267-009-9337-1; Mertens B, 2002, AGR ECON, V27, P269, DOI 10.1016/S0169-5150(02)00076-2; MONTAGNINI F, 2005, TROP FOR, P1; MORAN EF, 1993, HUM ECOL, V21, P1, DOI 10.1007/BF00890069; Nepstad D, 2007, REDD UN FRAM CONV CL; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Perz SG, 2007, DEV CHANGE, V38, P529, DOI 10.1111/j.1467-7660.2007.00422.x; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Prates-Clark CD, 2008, ECOL MODEL, V211, P309, DOI 10.1016/j.ecolmodel.2007.09.024; Quesada C.A., 2009, BIOGEOSCI DISCUSS, V6, P3993, DOI DOI 10.5194/BGD-6-3993-2009; R Development Core Team, 2009, R FDN STAT COMP; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Southworth J, 2011, REMOTE SENS-BASEL, V3, P1047, DOI 10.3390/rs3051047; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; Stone SW, 1998, ECOL ECON, V27, P43, DOI 10.1016/S0921-8009(97)00130-4; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Uhl C, 1997, BIOSCIENCE, V47, P160, DOI 10.2307/1313035; VERISSIMO A, 1995, FOREST ECOL MANAG, V72, P39, DOI 10.1016/0378-1127(94)03432-V; Verissimo A, 2002, CONSERV ECOL, V6	50	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36099	10.1371/journal.pone.0036099	http://dx.doi.org/10.1371/journal.pone.0036099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590520	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335500006
J	Lee, JW; Yeo, SG; Kang, BH; Lee, HK; Kim, JW; Lee, SH; Kim, KS; Cheon, DS				Lee, June-Woo; Yeo, Sang-Gu; Kang, Byung-Hak; Lee, Hoe-Kyu; Kim, Jin-Won; Lee, Sun-Hwa; Kim, Ki-Sang; Cheon, Doo-Sung			Echovirus 30 Induced Neuronal Cell Death through TRIO-RhoA Signaling Activation	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; STRESS FIBER FORMATION; ASEPTIC-MENINGITIS; CYTOSKELETON REORGANIZATION; GEF INHIBITOR; IDENTIFICATION; EXPRESSION; FAMILY; KOREA; ENTEROVIRUS-71	Background: Echovirus 30 (Echo30) is one of the most frequently identified human enteroviruses (EVs) causing aseptic meningitis and encephalitis. However the mechanism underlying the pathogenesis of Echo30 infection with significant clinical outcomes is not completely understood. The aim of this investigation is to illustrate molecular pathologic alteration in neuronal cells induced by Echo30 infection using clinical isolate from young patient with neurologic involvement. Methodology/Principal Findings: To characterize the neuronal cellular response to Echo30 infection, we performed a proteomic analysis based on two-dimensional gel electrophoresis (2-DE) and MALDI-TOF/TOF Mass Spectrophotometric (MS) analysis. We identified significant alteration of several protein expression levels in Echo30-infected SK-N-SH cells. Among these proteins, we focused on an outstanding up-regulation of Triple functional domain (TRIO) in Echo30-infected SK-N-SH cells. Generally, TRIO acts as a key component in the regulation of axon guidance and cell migration. In this study, we determined that TRIO plays a role in the novel pathways in Echo30 induced neuronal cell death. Conclusions/Significance: Our finding shows that TRIO plays a critical role in neuronal cell death by Echo30 infection. Echo30 infection activates TRIO-guanine nucleotide exchange factor (GEF) domains (GEFD2) and RhoA signaling in turn. These results suggest that Echo30 infection induced neuronal cell death by activation of the TRIO-RhoA signaling. We expect the regulation of TRIO-RhoA signaling may represent a new therapeutic approach in treating aseptic meningitis and encephalitis induced by Echo30.	[Lee, June-Woo; Yeo, Sang-Gu; Kang, Byung-Hak; Lee, Hoe-Kyu; Kim, Jin-Won; Lee, Sun-Hwa; Kim, Ki-Sang; Cheon, Doo-Sung] Natl Inst Hlth, Ctr Infect Dis, Div Enter & Hepatitis Viruses, Osong, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease	Lee, JW (corresponding author), Natl Inst Hlth, Ctr Infect Dis, Div Enter & Hepatitis Viruses, Osong, South Korea.	cheonds@hanmail.net			Korean National Institutes of Health [2011-N42002-00]	Korean National Institutes of Health	This work was supported by research grants from the Korean National Institutes of Health (2011-N42002-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Allen C, 2010, STROKE, V41, P2056, DOI 10.1161/STROKEAHA.109.574939; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Baek K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-297; Bateman J, 2001, J CELL SCI, V114, P1973; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Brunel D, 2008, J CLIN VIROL, V42, P225, DOI 10.1016/j.jcv.2008.02.008; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Choi YJ, 2010, J MICROBIOL BIOTECHN, V20, P643, DOI 10.4014/jmb.0909.09002; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Dalwai A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-236; Dyer Jamie O, 2010, Small GTPases, V1, P44; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Ferraro F, 2007, MOL BIOL CELL, V18, P4813, DOI 10.1091/mbc.E07-05-0503; Frantzidou F, 2008, EUR J NEUROL, V15, P995, DOI 10.1111/j.1468-1331.2008.02233.x; Henson PM, 2005, CURR BIOL, V15, pR29, DOI 10.1016/j.cub.2004.12.017; Kadi A, 2007, CLIN HEMORHEOL MICRO, V37, P131; Kim HJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-38; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Lee JS, 2005, AM J PATHOL, V166, P1861, DOI 10.1016/S0002-9440(10)62495-9; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; Leong SK, 2002, ANN NY ACAD SCI, V962, P161, DOI 10.1111/j.1749-6632.2002.tb04066.x; Leong WF, 2006, CELL MICROBIOL, V8, P565, DOI 10.1111/j.1462-5822.2005.00644.x; Ma XM, 2005, J COMP NEUROL, V482, P333, DOI 10.1002/cne.20404; Medley QG, 2000, J BIOL CHEM, V275, P36116, DOI 10.1074/jbc.M003775200; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Palacios G, 2002, J VIROL, V76, P4940, DOI 10.1128/JVI.76.10.4940-4949.2002; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; Portales-Casamar E, 2006, BIOL CELL, V98, P183, DOI 10.1042/BC20050009; Schmidt S, 2002, FEBS LETT, V523, P35, DOI 10.1016/S0014-5793(02)02928-9; Seipel K, 1999, J CELL SCI, V112, P1825; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Xu D, 2012, CELL SIGNAL, V24, P282, DOI 10.1016/j.cellsig.2011.09.013; Ruiz-Loredo AY, 2011, J CELL PHYSIOL, V226, P414, DOI 10.1002/jcp.22347	40	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36656	10.1371/journal.pone.0036656	http://dx.doi.org/10.1371/journal.pone.0036656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586486	Green Submitted, gold, Green Published			2022-12-25	WOS:000305335000047
J	Luo, C; Guo, ZW; Lai, YX; Liao, W; Liu, Q; Kendrick, KM; Yao, DZ; Li, H				Luo, Cheng; Guo, Zhi-wei; Lai, Yong-xiu; Liao, Wei; Liu, Qiang; Kendrick, Keith M.; Yao, De-zhong; Li, Hong			Musical Training Induces Functional Plasticity in Perceptual and Motor Networks: Insights from Resting-State fMRI	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; HUMAN BRAIN; CAUSAL CONNECTIVITY; GRANGER CAUSALITY; SMALL-WORLD; AUDITORY-CORTEX; MUSICIANS BRAIN; NEURAL-NETWORKS; GLOBAL SIGNAL; LOW-FREQUENCY	A number of previous studies have examined music-related plasticity in terms of multi-sensory and motor integration but little is known about the functional and effective connectivity patterns of spontaneous intrinsic activity in these systems during the resting state in musicians. Using functional connectivity and Granger causal analysis, functional and effective connectivity among the motor and multi-sensory (visual, auditory and somatosensory) cortices were evaluated using resting-state functional magnetic resonance imaging (fMRI) in musicians and non-musicians. The results revealed that functional connectivity was significantly increased in the motor and multi-sensory cortices of musicians. Moreover, the Granger causality results demonstrated a significant increase outflow-inflow degree in the auditory cortex with the strongest causal outflow pattern of effective connectivity being found in musicians. These resting state fMRI findings indicate enhanced functional integration among the lower-level perceptual and motor networks in musicians, and may reflect functional consolidation (plasticity) resulting from long-term musical training, involving both multi-sensory and motor functional integration.	[Luo, Cheng; Guo, Zhi-wei; Lai, Yong-xiu; Liao, Wei; Kendrick, Keith M.; Yao, De-zhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Liu, Qiang; Li, Hong] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China	University of Electronic Science & Technology of China; Southwest University - China	Luo, C (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	dyao@uestc.edu.cn; lihong1@swnu.edu.cn	Liu, Qiang/AAA-2260-2020; Luo, Cheng/A-4647-2015	Luo, Cheng/0000-0003-0524-5886; Kendrick, Keith/0000-0002-0371-5904; Yao, Dezhong/0000-0002-8042-879X	National Nature Science Foundation of China [60736029, 2011CB707803]; PCSIRT	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This project was funded by grants from the National Nature Science Foundation of China (60736029), the 973 project 2011CB707803 and the PCSIRT project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Altenmuller EO, 2001, ANN NY ACAD SCI, V930, P273, DOI 10.1111/j.1749-6632.2001.tb05738.x; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BEVER TG, 1974, SCIENCE, V185, P537, DOI 10.1126/science.185.4150.537; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Efron B., 1994, INTRO BOOTSTRAP; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Gaser C, 2003, J NEUROSCI, V23, P9240; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Habib M, 2009, MUSIC PERCEPT, V26, P279, DOI 10.1525/MP.2009.26.3.279; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Herdener M, 2010, J NEUROSCI, V30, P1377, DOI 10.1523/JNEUROSCI.4513-09.2010; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krause V, 2010, NEUROIMAGE, V52, P245, DOI 10.1016/j.neuroimage.2010.03.081; Lee DJ, 2003, NEUROREPORT, V14, P205, DOI 10.1097/00001756-200302100-00009; Levitin DJ, 2009, ANN NY ACAD SCI, V1156, P211, DOI 10.1111/j.1749-6632.2009.04417.x; Li R, 2011, NEUROIMAGE, V56, P1035, DOI 10.1016/j.neuroimage.2011.03.010; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Liao W, 2009, IEEE T MED IMAGING, V28, P1825, DOI 10.1109/TMI.2009.2025126; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Luo C, 2012, HUM BRAIN MAPP, V33, P1279, DOI 10.1002/hbm.21286; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Oechslin MS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.076.2009; Pantev C, 2009, ANN NY ACAD SCI, V1169, P143, DOI 10.1111/j.1749-6632.2009.04588.x; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stilla R, 2007, J NEUROSCI, V27, P11091, DOI 10.1523/JNEUROSCI.1808-07.2007; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tian LX, 2007, NEUROIMAGE, V36, P684, DOI 10.1016/j.neuroimage.2007.03.044; Tian L, 2007, HUM BRAIN MAPP, V28, P681, DOI 10.1002/hbm.20300; Tramo MJ, 2001, SCIENCE, V291, P54, DOI 10.1126/SCIENCE.1056899; Upadhyay J, 2008, J NEUROSCI, V28, P3341, DOI 10.1523/JNEUROSCI.4434-07.2008; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Yan CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023460; Yasui T, 2009, HUM BRAIN MAPP, V30, P588, DOI 10.1002/hbm.20529; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982	66	64	66	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36568	10.1371/journal.pone.0036568	http://dx.doi.org/10.1371/journal.pone.0036568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586478	gold, Green Submitted, Green Published			2022-12-25	WOS:000305335000039
J	Zhang, X; Cheng, W; Listgarten, J; Kadie, C; Huang, SP; Wang, W; Heckerman, D				Zhang, Xiang; Cheng, Wei; Listgarten, Jennifer; Kadie, Carl; Huang, Shunping; Wang, Wei; Heckerman, David			Learning Transcriptional Regulatory Relationships Using Sparse Graphical Models	PLOS ONE			English	Article							NETWORK COMPONENT ANALYSIS; GENE; RECONSTRUCTION; MICROARRAY	Understanding the organization and function of transcriptional regulatory networks by analyzing high-throughput gene expression profiles is a key problem in computational biology. The challenges in this work are 1) the lack of complete knowledge of the regulatory relationship between the regulators and the associated genes, 2) the potential for spurious associations due to confounding factors, and 3) the number of parameters to learn is usually larger than the number of available microarray experiments. We present a sparse (L1 regularized) graphical model to address these challenges. Our model incorporates known transcription factors and introduces hidden variables to represent possible unknown transcription and confounding factors. The expression level of a gene is modeled as a linear combination of the expression levels of known transcription factors and hidden factors. Using gene expression data covering 39,296 oligonucleotide probes from 1109 human liver samples, we demonstrate that our model better predicts out-of-sample data than a model with no hidden variables. We also show that some of the gene sets associated with hidden variables are strongly correlated with Gene Ontology categories. The software including source code is available at http://grnl1.codeplex.com.	[Zhang, Xiang; Listgarten, Jennifer; Kadie, Carl; Heckerman, David] Microsoft Res, Los Angeles, CA 90024 USA; [Zhang, Xiang] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Zhang, Xiang; Cheng, Wei; Huang, Shunping; Wang, Wei] Univ N Carolina, Chapel Hill, NC USA	Microsoft; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill	Zhang, X (corresponding author), Microsoft Res, Los Angeles, CA 90024 USA.	heckerma@microsoft.com		Wang, Wei/0000-0002-8180-2886				Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Andrew G., 2007, INT C MACH LEARN; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop C.M., 2006, PATTERN RECOGNITION; Boorsma A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003112; Chang CQ, 2008, BIOINFORMATICS, V24, P1349, DOI 10.1093/bioinformatics/btn131; Edgar R., 2002, NUCLEIC ACIDS RES, V30; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Guan Y, 2009, INT C AR INT STAT; Hache H, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/617281; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Ng A., 2004, INT C MACH LEARN; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Parts L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001276; Sabatti C, 2006, BIOINFORMATICS, V22, P739, DOI 10.1093/bioinformatics/btk017; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Stegle O, 2008, LECT N BIOINFORMAT, V4955, P411; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tipping ME, 1999, J R STAT SOC B, V61, P611, DOI 10.1111/1467-9868.00196; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Zou H, 2006, J COMPUTATIONAL GRAP, V15	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35762	10.1371/journal.pone.0035762	http://dx.doi.org/10.1371/journal.pone.0035762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586449	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335000011
J	Ali, SS; Hsiao, M; Zhao, HWW; Dugan, LL; Haddad, GG; Zhou, D				Ali, Sameh S.; Hsiao, Mary; Zhao, Huiwen W.; Dugan, Laura L.; Haddad, Gabriel G.; Zhou, Dan			Hypoxia-Adaptation Involves Mitochondrial Metabolic Depression and Decreased ROS Leakage	PLOS ONE			English	Article							REACTIVE OXYGEN; COMPLEX-III; DROSOPHILA-MELANOGASTER; EXPERIMENTAL SELECTION; ELECTRON-TRANSPORT; RESPIRATORY-CHAIN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; NEURONAL DEATH; FREE-RADICALS	Through long-term laboratory selection, we have generated a Drosophila melanogaster population that tolerates severe, normally lethal, level of hypoxia. This strain lives perpetually under severe hypoxic conditions (4% O-2). In order to shed light on the mechanisms involved in this adaptation, we studied the respiratory function of isolated mitochondria from the thorax of hypoxia-adapted flies (AF) using polarographic oxygen consumption while monitoring superoxide generation by electron paramagnetic resonance (EPR) techniques. AF mitochondria exhibited a significant 30% decrease in respiratory rate during state 3, while enhancing the resting respiratory rate during State 4-oligo by 220%. The activity of individual electron transport complexes I, II and III were 107%, 65%, and 120% in AF mitochondria as compared to those isolated from control flies. The sharp decrease in complex II activity and modest increase in complexes I and III resulted in >60% reduction in superoxide leakage from AF mitochondria during both NAD(+)-linked state 3 and State 4-oligo respirations. These results provide evidence that flies with mitochondria exhibiting decreased succinate dehydrogenase activity and reduced superoxide leakage give flies an advantage for survival in long-term hypoxia.	[Ali, Sameh S.; Dugan, Laura L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Ali, Sameh S.] Zewail City Sci & Technol, Ctr Aging & Associated Dis, Helmy Inst Med Sci, Giza, Egypt; [Hsiao, Mary; Zhao, Huiwen W.; Haddad, Gabriel G.; Zhou, Dan] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Dugan, Laura L.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Haddad, Gabriel G.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Ali, SS (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	ssali@ucsd.edu; d2zhou@ucsd.edu	Zhou, Dan/T-7203-2017	Ali, Sameh Saad/0000-0002-0339-6106; Zhou, Dan/0000-0001-6401-9040	National Institutes of Health [PO1HD32573, O1NS037756]; American Heart Association [0835188N]; National Institute on Aging [1K25AG026379]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG026379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants PO1HD32573 and O1NS037756 to GGH, American Heart Association grant 0835188N to DZ, and by the National Institute on Aging grant 1K25AG026379 to SSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biniecka M, 2011, ARTHRITIS RHEUM-US, V63, P2172, DOI 10.1002/art.30395; Bosc LVG, 2010, J CELL MOL MED, V14, P3, DOI 10.1111/j.1582-4934.2009.00929.x; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Campian JL, 2007, J BIOL CHEM, V282, P12430, DOI 10.1074/jbc.M604547200; Chalier F, 2002, J CHEM SOC P2, V12, P2110; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Douglas RM, 2010, AM J PHYSIOL-CELL PH, V298, pC1594, DOI 10.1152/ajpcell.00298.2009; Esteva S, 2010, WILD ENVIRON MED, V21, P325, DOI 10.1016/j.wem.2010.09.004; Feala JD, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-91; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Grishko V, 2001, FASEB J, V15, P1267, DOI 10.1096/fj.00-0755fje; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kovacic P, 2005, CURR MED CHEM, V12, P2601, DOI 10.2174/092986705774370646; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Martin R, 2002, EXP GERONTOL, V37, P1481, DOI 10.1016/S0531-5565(02)00168-7; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; SLATER EC, 1973, BIOCHIM BIOPHYS ACTA, V301, P129, DOI 10.1016/0304-4173(73)90002-5; Stolze K, 2000, FREE RADICAL BIO MED, V29, P1005, DOI 10.1016/S0891-5849(00)00401-9; SUGIOKA K, 1988, BIOCHIM BIOPHYS ACTA, V936, P377, DOI 10.1016/0005-2728(88)90014-X; Tormos KV, 2010, J CELL MOL MED; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wigfield SM, 2008, BRIT J CANCER, V98, P1975, DOI 10.1038/sj.bjc.6604356; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	43	59	61	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36801	10.1371/journal.pone.0036801	http://dx.doi.org/10.1371/journal.pone.0036801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574227	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800124
J	Hirose, S; Watanabe, T; Jimura, K; Katsura, M; Kunimatsu, A; Abe, O; Ohtomo, K; Miyashita, Y; Konishi, S				Hirose, Satoshi; Watanabe, Takamitsu; Jimura, Koji; Katsura, Masaki; Kunimatsu, Akira; Abe, Osamu; Ohtomo, Kuni; Miyashita, Yasushi; Konishi, Seiki			Local Signal Time-Series during Rest Used for Areal Boundary Mapping in Individual Human Brains	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; ORIENTATION COLUMNS; CINGULATE CORTEX; VISUAL-CORTEX; NETWORKS; FLUCTUATIONS; ARCHITECTURE; PARCELLATION; FREQUENCY; LOBE	It is widely thought that resting state functional connectivity likely reflects functional interaction among brain areas and that different functional areas interact with different sets of brain areas. A method for mapping areal boundaries has been formulated based on the large-scale spatial characteristics of regional interaction revealed by resting state functional connectivity. In the present study, we present a novel analysis for areal boundary mapping that requires only the signal timecourses within a region of interest, without reference to the information from outside the region. The areal boundaries were generated by the novel analysis and were compared with those generated by the previously-established standard analysis. The boundaries were robust and reproducible across the two analyses, in two regions of interest tested. These results suggest that the information for areal boundaries is readily available inside the region of interest.	[Hirose, Satoshi; Watanabe, Takamitsu; Jimura, Koji; Miyashita, Yasushi; Konishi, Seiki] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan; [Katsura, Masaki; Kunimatsu, Akira; Abe, Osamu; Ohtomo, Kuni] Univ Tokyo, Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Hirose, S (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan.	sahirose@m.u-tokyo.ac.jp; konishi@m.u-tokyo.ac.jp	Kunimatsu, Akira/AAC-8617-2019; Watanabe, Takamitsu/H-7234-2018; Miyashita, Yasushi/B-7171-2019	Kunimatsu, Akira/0000-0002-7141-2585; Watanabe, Takamitsu/0000-0002-8104-6873; Miyashita, Yasushi/0000-0003-3496-8637; Abe, Osamu/0000-0002-1180-2629	JSPS Fellowship [20-6285]; Global COE Program "Integrative Life Science Based on the study of Biosignaling Mechanisms" from Ministry of Education, Culture, Sports, Science and Technology, Japan [12601-A03]; Takeda Science Foundation;  [19002010];  [22300134]	JSPS Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program "Integrative Life Science Based on the study of Biosignaling Mechanisms" from Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; 	SH is supported by JSPS Fellowship (20-6285) for Young Scientists. This work was supported by a Grant-in-Aid for Specially Promoted Research (19002010) to YM, a Grant-in-Aid for Scientific Research B (22300134) to SK, the Global COE Program "Integrative Life Science Based on the study of Biosignaling Mechanisms" (12601-A03) to YM from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behrens TEJ, 2006, NEUROIMAGE, V30, P220, DOI 10.1016/j.neuroimage.2005.09.036; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Carr VA, 2010, NEURON, V65, P298, DOI 10.1016/j.neuron.2009.12.022; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hirose S, 2009, NEUROIMAGE, V47, P442, DOI 10.1016/j.neuroimage.2009.04.094; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jimura K, 2004, NEUROIMAGE, V22, P1578, DOI 10.1016/j.neuroimage.2004.04.012; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Kimura HM, 2010, NEUROIMAGE, V49, P3474, DOI 10.1016/j.neuroimage.2009.11.003; Klein JC, 2007, NEUROIMAGE, V34, P204, DOI 10.1016/j.neuroimage.2006.08.022; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Moon CH, 2007, J NEUROSCI, V27, P6892, DOI 10.1523/JNEUROSCI.0445-07.2007; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Talairach J., 1988, COPLANAR STEREOTAXIC; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zeineh MM, 2001, ANAT RECORD, V265, P111, DOI 10.1002/ar.1061; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	51	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36496	10.1371/journal.pone.0036496	http://dx.doi.org/10.1371/journal.pone.0036496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574171	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800067
J	Velho, TAF; Lu, K; Ribeiro, S; Pinaud, R; Vicario, D; Mello, CV				Velho, Tarciso A. F.; Lu, Kai; Ribeiro, Sidarta; Pinaud, Raphael; Vicario, David; Mello, Claudio V.			Noradrenergic Control of Gene Expression and Long-Term Neuronal Adaptation Evoked by Learned Vocalizations in Songbirds	PLOS ONE			English	Article							LOCUS-COERULEUS NEURONS; IMMEDIATE-EARLY GENE; ZEBRA FINCH BRAIN; AUDITORY RESPONSES; PROTEIN-SYNTHESIS; LASTING MEMORIES; PERFORANT PATH; DENTATE GYRUS; AWAKE RATS; LATE-PHASE	Norepinephrine (NE) is thought to play important roles in the consolidation and retrieval of long-term memories, but its role in the processing and memorization of complex acoustic signals used for vocal communication has yet to be determined. We have used a combination of gene expression analysis, electrophysiological recordings and pharmacological manipulations in zebra finches to examine the role of noradrenergic transmission in the brain's response to birdsong, a learned vocal behavior that shares important features with human speech. We show that noradrenergic transmission is required for both the expression of activity-dependent genes and the long-term maintenance of stimulus-specific electrophysiological adaptation that are induced in central auditory neurons by stimulation with birdsong. Specifically, we show that the caudomedial nidopallium (NCM), an area directly involved in the auditory processing and memorization of birdsong, receives strong noradrenergic innervation. Song-responsive neurons in this area express alpha-adrenergic receptors and are in close proximity to noradrenergic terminals. We further show that local alpha-adrenergic antagonism interferes with song-induced gene expression, without affecting spontaneous or evoked electrophysiological activity, thus dissociating the molecular and electrophysiological responses to song. Moreover, alpha-adrenergic antagonism disrupts the maintenance but not the acquisition of the adapted physiological state. We suggest that the noradrenergic system regulates long-term changes in song-responsive neurons by modulating the gene expression response that is associated with the electrophysiological activation triggered by song. We also suggest that this mechanism may be an important contributor to long-term auditory memories of learned vocalizations.	[Velho, Tarciso A. F.; Pinaud, Raphael; Mello, Claudio V.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Velho, Tarciso A. F.; Pinaud, Raphael; Mello, Claudio V.] Oregon Hlth & Sci Univ, Inst Neurol Sci, Portland, OR 97201 USA; [Lu, Kai; Vicario, David] Rutgers State Univ, Dept Psychol, Piscataway, NJ USA; [Ribeiro, Sidarta] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Oregon Health & Science University; Oregon Health & Science University; Rutgers State University New Brunswick; Universidade Federal do Rio Grande do Norte	Velho, TAF (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	melloc@ohsu.edu	Ribeiro, Sidarta/C-5794-2016	Ribeiro, Sidarta/0000-0001-9325-9545; Mello, Claudio/0000-0002-9826-8421	NINDS (National Institute of Neurological Disorders and Stroke) [DC03823, DC008854]; NIGMS (National Institute of General Medical Sciences) [GM092842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM092842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008854] Funding Source: NIH RePORTER	NINDS (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from NINDS (National Institute of Neurological Disorders and Stroke; DC03823) and NIGMS (National Institute of General Medical Sciences; GM092842) to CVM, and a grant from NINDS (DC008854) to DV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; Bramham CR, 1997, NEUROREPORT, V8, P719, DOI 10.1097/00001756-199702100-00028; Brenowitz EA, 1997, J NEUROBIOL, V33, P495, DOI 10.1002/(SICI)1097-4695(19971105)33:5<495::AID-NEU1>3.3.CO;2-D; Cardin JA, 2004, J NEUROSCI, V24, P7745, DOI 10.1523/JNEUROSCI.1951-04.2004; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Cheng HY, 2004, J NEUROSCI, V24, P7503, DOI 10.1523/JNEUROSCI.1405-04.2004; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Cirelli C, 2000, J NEUROSCI, V20, P9187; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; Denisenko-Nehrbass NI, 2000, NEURON, V27, P359, DOI 10.1016/S0896-6273(00)00043-X; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; GEORGE JM, 1992, MOL BRAIN RES, V12, P323, DOI 10.1016/0169-328X(92)90134-W; Gibbs ME, 2002, PROG NEUROBIOL, V67, P345, DOI 10.1016/S0301-0082(02)00023-0; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; JARVIS ED, 1995, LEARN MEMORY, V2, P62, DOI 10.1101/lm.2.2.62; Jeong JK, 2005, J COMP NEUROL, V489, P23, DOI 10.1002/cne.20605; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Lindquist JM, 2000, J BIOL CHEM, V275, P22670, DOI 10.1074/jbc.M909093199; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; Mandairon N, 2008, EUR J NEUROSCI, V27, P1210, DOI 10.1111/j.1460-9568.2008.06101.x; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2000, TRENDS PHARMACOL SCI, V21, P208, DOI 10.1016/S0165-6147(00)01473-5; Mello C V, 1997, Methods Mol Biol, V85, P205; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; Mello CV, 1998, J COMP NEUROL, V400, P207; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Pawlisch BA, 2011, NEUROSCI LETT, V496, P20, DOI 10.1016/j.neulet.2011.03.078; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pinaud R, 2008, J NEUROPHYSIOL; Poirier C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020131; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Scheiderer CL, 2004, J NEUROPHYSIOL, V91, P1071, DOI 10.1152/jn.00420.2003; Sizemore M, 2008, J NEUROPHYSIOL, V100, P8, DOI 10.1152/jn.01212.2007; Solis MM, 2006, J NEUROPHYSIOL, V95, P2265, DOI 10.1152/jn.00836.2005; STANTON PK, 1985, J NEUROSCI, V5, P2169; STROSBERG AD, 1993, PROTEIN SCI, V2, P1198, DOI 10.1002/pro.5560020802; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Velho TAF, 2008, J NEUROSCI, V28, P11871, DOI 10.1523/JNEUROSCI.2307-08.2008; Velho TAF, 2008, TRANSCRIPTIONAL REGULATION BY NEURONAL ACTIVITY, P3, DOI 10.1007/978-0-387-73609-9_1; Walling SG, 2004, J NEUROSCI, V24, P598, DOI 10.1523/JNEUROSCI.4426-03.2004; Wang YA, 2010, P NATL ACAD SCI USA, V107, P12676, DOI 10.1073/pnas.1006645107	55	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36276	10.1371/journal.pone.0036276	http://dx.doi.org/10.1371/journal.pone.0036276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574146	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800042
J	Nilsson, E; Larsen, G; Manikkam, M; Guerrero-Bosagna, C; Savenkova, MI; Skinner, MK				Nilsson, Eric; Larsen, Ginger; Manikkam, Mohan; Guerrero-Bosagna, Carlos; Savenkova, Marina I.; Skinner, Michael K.			Environmentally Induced Epigenetic Transgenerational Inheritance of Ovarian Disease	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; FOLLICLE DEVELOPMENT; BISPHENOL-A; PRENATAL TESTOSTERONE; DEVELOPMENTAL ORIGINS; PRIMORDIAL FOLLICLES; NEONATAL EXPOSURE; GENE-EXPRESSION; JET FUELS; PREVALENCE	The actions of environmental toxicants and relevant mixtures in promoting the epigenetic transgenerational inheritance of ovarian disease was investigated with the use of a fungicide, a pesticide mixture, a plastic mixture, dioxin and a hydrocarbon mixture. After transient exposure of an F0 gestating female rat during embryonic gonadal sex determination, the F1 and F3 generation progeny adult onset ovarian disease was assessed. Transgenerational disease phenotypes observed included an increase in cysts resembling human polycystic ovarian disease (PCO) and a decrease in the ovarian primordial follicle pool size resembling primary ovarian insufficiency (POI). The F3 generation granulosa cells were isolated and found to have a transgenerational effect on the transcriptome and epigenome (differential DNA methylation). Epigenetic biomarkers for environmental exposure and associated gene networks were identified. Epigenetic transgenerational inheritance of ovarian disease states was induced by all the different classes of environmental compounds, suggesting a role of environmental epigenetics in ovarian disease etiology.	[Nilsson, Eric; Larsen, Ginger; Manikkam, Mohan; Guerrero-Bosagna, Carlos; Savenkova, Marina I.; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Nilsson, E (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020; Guerrero-Bosagna, Carlos/W-7319-2019; Savenkova, Marina/AAN-9927-2021	Guerrero-Bosagna, Carlos/0000-0003-1935-5875; 	Department of Defense; National Institutes of Health; National Institute of Environmental Health Sciences	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research was supported by Department of Defense and National Institutes of Health. National Institute of Environmental Health Sciences support to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2009, AM J PRIMATOL, V71, P776, DOI 10.1002/ajp.20679; Acosta JI, 2010, ENDOCRINOLOGY, V151, P3795, DOI 10.1210/en.2010-0055; Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2008, REPROD BIOMED ONLINE, V16, P23, DOI 10.1016/S1472-6483(10)60553-6; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Anzalone CR, 2001, BIOL REPROD, V64, P1056, DOI 10.1095/biolreprod64.4.1056; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Binelli M, 2010, REPROD FERT DEVELOP, V22, P1, DOI 10.1071/RD09218; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Brouwers MM, 2006, HUM REPROD, V21, P666, DOI 10.1093/humrep/dei398; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Buratini J, 2011, REPROD FERT DEVELOP, V23, P32, DOI 10.1071/RD10224; Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201; Chen Zi-Jiang, 2010, Front Med China, V4, P280, DOI 10.1007/s11684-010-0098-2; Choong MK, 2011, CLIN GASTROENTE 0429; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Cordts EB, 2011, ARCH GYNECOL OBSTET, V283, P635, DOI 10.1007/s00404-010-1815-4; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; Dasgupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012401; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Dixit H, 2010, REPROD BIOMED ONLINE, V20, P724, DOI 10.1016/j.rbmo.2010.02.018; Dole G, 2008, REPRODUCTION, V135, P671, DOI 10.1530/REP-07-0405; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fernandez M, 2010, ENVIRON HEALTH PERSP, V118, P1217, DOI 10.1289/ehp.0901257; Franks S, 2006, INT J ANDROL, V29, P278, DOI 10.1111/j.1365-2605.2005.00623.x; Glintborg D, 2010, GYNECOL ENDOCRINOL, V26, P281, DOI 10.3109/09513590903247873; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hakre S, 2011, CURR OPIN HIV AIDS, V6, P19, DOI 10.1097/COH.0b013e3283412384; Hart R, 2004, BEST PRACT RES CL OB, V18, P671, DOI 10.1016/j.bpobgyn.2004.05.001; Hickey TE, 2006, J CLIN ENDOCR METAB, V91, P2789, DOI 10.1210/jc.2006-0069; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Hylkema Machteld N, 2009, Proc Am Thorac Soc, V6, P660, DOI 10.1513/pats.200907-065DP; Jablonska O, 2010, INT J ANDROL, V33, P405, DOI 10.1111/j.1365-2605.2009.01031.x; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones GL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-149; Jordan CD, 2010, J HISTOCHEM CYTOCHEM, V58, P903, DOI 10.1369/jhc.2010.956615; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaminsky Z, 2011, MOL PSYCHIATR; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; Kenigsberg S, 2009, MOL HUM REPROD, V15, P89, DOI 10.1093/molehr/gan082; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Kitchen LW, 2009, J VECTOR ECOL, V34, P50, DOI [10.1111/j.1948-7134.2009.00007.x, 10.3376/038.034.0107]; Knauff EAH, 2009, HUM REPROD, V24, P2372, DOI 10.1093/humrep/dep197; Kuriakose JS, 2010, CLIN EXP ALLERGY, V40, P1602, DOI 10.1111/j.1365-2222.2010.03599.x; Li ZX, 2008, MED HYPOTHESES, V70, P638, DOI 10.1016/j.mehy.2006.09.076; Lohff JC, 2006, MENOPAUSE, V13, P482, DOI 10.1097/01.gme.0000191883.59799.2e; Macklon NS, 1999, HORM RES, V52, P161, DOI 10.1159/000023456; Maclaran K, 2011, J FAM PLAN REPROD H, V37, P35, DOI 10.1136/jfprhc.2010.0015; Manikkam M, 2006, ENDOCRINOLOGY, V147, P1997, DOI 10.1210/en.2005-1338; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Martino D, 2011, CHEST, V139, P640, DOI 10.1378/chest.10-1800; Mattie DR, 2011, TOXICOL APPL PHARM, V254, P127, DOI 10.1016/j.taap.2010.04.022; McGuire MM, 2011, FERTIL STERIL, V95, P1595, DOI 10.1016/j.fertnstert.2010.12.052; Menke MN, 2007, CURR OPIN OBSTET GYN, V19, P355, DOI 10.1097/GCO.0b013e328220e877; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Moran C, 2010, GYNECOL OBSTET INVES, V69, P274, DOI 10.1159/000277640; Mukherjee S, 2010, INDIAN J MED RES, V131, P743; Nan HM, 2005, WORLD J GASTROENTERO, V11, P3834; Nestler JE, 1998, J CLIN ENDOCR METAB, V83, P2001, DOI 10.1210/jc.83.6.2001; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; Nuyt AM, 2008, CLIN SCI, V114, P1, DOI 10.1042/CS20070113; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Perry AS, 2010, NAT REV UROL, V7, P668, DOI 10.1038/nrurol.2010.185; Persani L, 2011, J ENDOCRINOL INVEST, V34, P244, DOI [10.1007/BF03347073, 10.3275/7502]; Persani L, 2010, J MOL ENDOCRINOL, V45, P257, DOI 10.1677/JME-10-0070; Peters CA, 1999, J BIOL CHEM, V274, P37499, DOI 10.1074/jbc.274.52.37499; PETERS H, 1975, J REPROD FERTIL, V45, P559, DOI 10.1530/jrf.0.0450559; Pogribny IP, 2006, MUTAT RES-FUND MOL M, V593, P80, DOI 10.1016/j.mrfmmm.2005.06.028; Pyun JA, 2011, FERTIL STERIL, V95, P397, DOI 10.1016/j.fertnstert.2010.08.038; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Ritchie GD, 2003, J TOXICOL ENV HEAL B, V6, P357, DOI 10.1080/10937400306473; Rodriguez HA, 2010, REPROD TOXICOL, V30, P550, DOI 10.1016/j.reprotox.2010.07.008; Roghair RD, 2005, AM J PHYSIOL-REG I, V288, pR46, DOI 10.1152/ajpregu.00165.2004; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Salian S, 2009, LIFE SCI, V85, P742, DOI 10.1016/j.lfs.2009.10.004; Schindler R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012979; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Skinner MK, 2011, BIRTH DEFECTS RES C, V93, P51, DOI 10.1002/bdrc.20199; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Smith P, 2009, BIOL REPROD, V80, P726, DOI 10.1095/biolreprod.108.072801; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Susiarjo M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030005; Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Thornburg KL, 2010, ADV GENET, V71, P57, DOI [10.1016/B978-0-12-380864-6.00003-1, 10.1016/S0065-2660(10)71003-8]; van Houten EL, 2012, ENDOCRINOLOGY; Wan LB, 2008, ADV GENET, V61, P207, DOI 10.1016/S0065-2660(07)00007-7; Wang BB, 2011, HUM REPROD, V26, P950, DOI 10.1093/humrep/der001; Wickenheisser JK, 2006, TRENDS ENDOCRIN MET, V17, P63, DOI 10.1016/j.tem.2006.01.003; Wong SS, 2008, TOXICOLOGY, V254, P106, DOI 10.1016/j.tox.2008.09.018; Woods KS, 2002, FERTIL STERIL, V77, P1125, DOI 10.1016/S0015-0282(02)03119-9; Yanes LL, 2011, GENDER MED, V8, P103, DOI 10.1016/j.genm.2010.11.013; Zhao ZY, 2011, ACTA OBSTET GYN SCAN, V90, P678, DOI 10.1111/j.1600-0412.2011.01118.x	106	163	165	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36129	10.1371/journal.pone.0036129	http://dx.doi.org/10.1371/journal.pone.0036129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570695	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400011
J	Yokoyama, U; Ishiwata, R; Jin, MH; Kato, Y; Suzuki, O; Jin, HL; Ichikawa, Y; Kumagaya, S; Katayama, Y; Fujita, T; Okumura, S; Sato, M; Sugimoto, Y; Aoki, H; Suzuki, S; Masuda, M; Minamisawa, S; Ishikawa, Y				Yokoyama, Utako; Ishiwata, Ryo; Jin, Mei-Hua; Kato, Yuko; Suzuki, Orie; Jin, Huiling; Ichikawa, Yasuhiro; Kumagaya, Syun; Katayama, Yuzo; Fujita, Takayuki; Okumura, Satoshi; Sato, Motohiko; Sugimoto, Yukihiko; Aoki, Hiroki; Suzuki, Shinichi; Masuda, Munetaka; Minamisawa, Susumu; Ishikawa, Yoshihiro			Inhibition of EP4 Signaling Attenuates Aortic Aneurysm Formation	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHESIS; DUCTUS-ARTERIOSUS; RECEPTOR; MICE; EXPRESSION; ACTIVATION; CYCLOOXYGENASE; INFLAMMATION; MACROPHAGES; RISK	Background: Aortic aneurysm is a common but life-threatening disease among the elderly, for which no effective medical therapy is currently available. Activation of prostaglandin E-2 (PGE(2)) is known to increase the expression of matrix metalloproteinase (MMP) and the release of inflammatory cytokines, and may thus exacerbate abdominal aortic aneurism (AAA) formation. We hypothesized that selective blocking of PGE(2), in particular, EP4 prostanoid receptor signaling, would attenuate the development of AAA. Methods and Findings: Immunohistochemical analysis of human AAA tissues demonstrated that EP4 expression was greater in AAA areas than that in non-diseased areas. Interestingly, EP4 expression was proportional to the degree of elastic fiber degradation. In cultured human aortic smooth muscle cells (ASMCs), PGE(2) stimulation increased EP4 protein expression (1.4 +/- 0.08-fold), and EP4 stimulation with ONO-AE1-329 increased MMP-2 activity and interleukin-6 (IL-6) production (1.4 +/- 0.03- and 1.7 +/- 0.14-fold, respectively, P<0.05). Accordingly, we examined the effect of EP4 inhibition in an ApoE(-/-) mouse model of AAA infused with angiotensin II. Oral administration of ONO-AE3-208 (0.01-0.5 mg/kg/day), an EP4 antagonist, for 4 weeks significantly decreased the formation of AAA (45-87% reduction, P<0.05). Similarly, EP4(+/-)/ApoE(-/-) mice exhibited significantly less AAA formation than EP4(+/+)/ApoE(-/-) mice (76% reduction, P<0.01). AAA formation induced by periaortic CaCl2 application was also reduced in EP4(+/-) mice compared with wild-type mice (73% reduction, P<0.001). Furthermore, in human AAA tissue organ cultures containing SMCs and macrophages, doses of the EP4 antagonist at 10-100 nM decreased MMP-2 activation and IL-6 production (0.6 +/- 0.06- and 0.7 +/- 0.06-fold, respectively, P<0.05) without increasing MMP-9 activity or MCP-1 secretion. Thus, either pharmacological or genetic EP4 inhibition attenuated AAA formation in multiple mouse and human models by lowering MMP activity and cytokine release. Conclusion: An EP4 antagonist that prevents the activation of MMP and thereby inhibits the degradation of aortic elastic fiber may serve as a new strategy for medical treatment of AAA.	[Yokoyama, Utako; Ishiwata, Ryo; Jin, Mei-Hua; Kato, Yuko; Suzuki, Orie; Jin, Huiling; Ichikawa, Yasuhiro; Kumagaya, Syun; Fujita, Takayuki; Okumura, Satoshi; Sato, Motohiko; Ishikawa, Yoshihiro] Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan; [Katayama, Yuzo; Suzuki, Shinichi; Masuda, Munetaka] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan; [Sugimoto, Yukihiko] Kumamoto Univ, Dept Pharmaceut Biochem, Kumamoto, Japan; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 830, Japan; [Ishiwata, Ryo; Kumagaya, Syun; Minamisawa, Susumu] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan	Yokohama City University; Yokohama City University; Kumamoto University; Kurume University; Waseda University	Yokoyama, U (corresponding author), Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan.	utako@yokohama-cu.ac.jp; yishikaw@med.yokohama-cu.ac.jp	Yokoyama, Utako/AAD-1404-2022; Sugimoto, Yukihiko/AAV-6470-2021	Yokoyama, Utako/0000-0003-1803-0155; Sugimoto, Yukihiko/0000-0001-6973-932X; Ishiwata, Ryo/0000-0001-8006-5485; Minamisawa, Susumu/0000-0003-4728-2116	Ministry of Education, Culture, Sports, Science and Technology of Japan; Adaptable and Seamless Technology transfer Program through target-driven R D [AS231Z00231G]; Yokohama Foundation for Advanced Medical Science; Takeda Science Foundation; Japan Heart Foundation Research Grant; Sumitomo Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Kitsuen Research Foundation;  [1123116514];  [22136009]; Grants-in-Aid for Scientific Research [23136516, 24659100, 21590936, 23791233] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology transfer Program through target-driven R D; Yokohama Foundation for Advanced Medical Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Heart Foundation Research Grant; Sumitomo Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Kitsuen Research Foundation; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (UY, SS, MM, SM, YI), Adaptable and Seamless Technology transfer Program through target-driven R & D (UY, AS231Z00231G), Grant-in-Aid for Scientific Research on Innovative Areas (UY, 1123116514; YI, 22136009), the Yokohama Foundation for Advanced Medical Science (UY, SM), the Takeda Science Foundation (UY, SM, YI), the Japan Heart Foundation Research Grant (UY), the Sumitomo Foundation (UY), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (UY), the Kanae Foundation for the Promotion of Medical Science (UY) and Kitsuen Research Foundation (YI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annambhotla S, 2008, WORLD J SURG, V32, P976, DOI 10.1007/s00268-007-9456-x; Bayston T, 2003, J VASC SURG, V38, P354, DOI 10.1016/S0741-5214(03)00339-2; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1925, DOI 10.1161/01.ATV.0000177814.41505.41; COLLIN J, 1988, LANCET, V2, P613; CORCORAN ML, 1992, J BIOL CHEM, V267, P515; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Gitlin JM, 2007, CARDIOVASC RES, V73, P227, DOI 10.1016/j.cardiores.2006.10.015; Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013; Hishikari K, 2009, CARDIOVASC RES, V81, P123, DOI 10.1093/cvr/cvn254; Holmes DR, 1997, J VASC SURG, V25, P810, DOI 10.1016/S0741-5214(97)70210-6; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Khan KMF, 2004, J BIOL CHEM, V279, P22039, DOI 10.1074/jbc.M312735200; King VL, 2006, ARTERIOSCL THROM VAS, V26, P1137, DOI 10.1161/01.ATV.0000216119.79008.ac; Kossakowska AE, 1999, BLOOD, V94, P2080, DOI 10.1182/blood.V94.6.2080.418k30_2080_2089; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Pavlovic S, 2006, J BIOL CHEM, V281, P3321, DOI 10.1074/jbc.M506846200; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; SCOTT RAP, 1991, BRIT J SURG, V78, P1122, DOI 10.1002/bjs.1800780929; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Steenport M, 2009, J IMMUNOL, V183, P8119, DOI 10.4049/jimmunol.0901925; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tang EHC, 2011, ARTERIOSCL THROM VAS, V31, P261, DOI 10.1161/ATVBAHA.110.216580; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Treska V, 2002, CYTOKINES CELL MOL T, V7, P91, DOI 10.1080/13684730310001652; Walton LJ, 1999, CIRCULATION, V100, P48, DOI 10.1161/01.CIR.100.1.48; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	33	58	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36724	10.1371/journal.pone.0036724	http://dx.doi.org/10.1371/journal.pone.0036724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570740	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400056
J	Smith, MA; Bertrand, C; Crosby, K; Eveleigh, ES; Fernandez-Triana, J; Fisher, BL; Gibbs, J; Hajibabaei, M; Hallwachs, W; Hind, K; Hrcek, J; Huang, DW; Janda, M; Janzen, DH; Li, YW; Miller, SE; Packer, L; Quicke, D; Ratnasingham, S; Rodriguez, J; Rougerie, R; Shaw, MR; Sheffield, C; Stahlhut, JK; Steinke, D; Whitfield, J; Wood, M; Zhou, X				Smith, M. Alex; Bertrand, Claudia; Crosby, Kate; Eveleigh, Eldon S.; Fernandez-Triana, Jose; Fisher, Brian L.; Gibbs, Jason; Hajibabaei, Mehrdad; Hallwachs, Winnie; Hind, Katharine; Hrcek, Jan; Huang, Da-Wei; Janda, Milan; Janzen, Daniel H.; Li, Yanwei; Miller, Scott E.; Packer, Laurence; Quicke, Donald; Ratnasingham, Sujeevan; Rodriguez, Josephine; Rougerie, Rodolphe; Shaw, Mark R.; Sheffield, Cory; Stahlhut, Julie K.; Steinke, Dirk; Whitfield, James; Wood, Monty; Zhou, Xin			Wolbachia and DNA Barcoding Insects: Patterns, Potential, and Problems	PLOS ONE			English	Article							PARASITOID FLIES DIPTERA; MITOCHONDRIAL-DNA; HYBRID INTROGRESSION; BACTERIAL SYMBIONTS; SELECTIVE SWEEPS; DIVERSITY; GENUS; IDENTIFICATIONS; COMMUNITIES; DISCORDANCE	Wolbachia is a genus of bacterial endosymbionts that impacts the breeding systems of their hosts. Wolbachia can confuse the patterns of mitochondrial variation, including DNA barcodes, because it influences the pathways through which mitochondria are inherited. We examined the extent to which these endosymbionts are detected in routine DNA barcoding, assessed their impact upon the insect sequence divergence and identification accuracy, and considered the variation present in Wolbachia COI. Using both standard PCR assays (Wolbachia surface coding protein - wsp), and bacterial COI fragments we found evidence of Wolbachia in insect total genomic extracts created for DNA barcoding library construction. When >2 million insect COI trace files were examined on the Barcode of Life Datasystem (BOLD) Wolbachia COI was present in 0.16% of the cases. It is possible to generate Wolbachia COI using standard insect primers; however, that amplicon was never confused with the COI of the host. Wolbachia alleles recovered were predominantly Supergroup A and were broadly distributed geographically and phylogenetically. We conclude that the presence of the Wolbachia DNA in total genomic extracts made from insects is unlikely to compromise the accuracy of the DNA barcode library; in fact, the ability to query this DNA library (the database and the extracts) for endosymbionts is one of the ancillary benefits of such a large scale endeavor - for which we provide several examples. It is our conclusion that regular assays for Wolbachia presence and type can, and should, be adopted by large scale insect barcoding initiatives. While COI is one of the five multi-locus sequence typing (MLST) genes used for categorizing Wolbachia, there is limited overlap with the eukaryotic DNA barcode region.	[Smith, M. Alex; Bertrand, Claudia; Fernandez-Triana, Jose; Hajibabaei, Mehrdad; Ratnasingham, Sujeevan; Stahlhut, Julie K.; Steinke, Dirk] Univ Guelph, Dept Integrat Biol & Biodivers, Inst Ontario, Guelph, ON N1G 2W1, Canada; [Crosby, Kate] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Eveleigh, Eldon S.] Atlantic Forestry Ctr, Nat Resources Canada, Canadian Forest Serv, Fredericton, NB, Canada; [Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Gibbs, Jason] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Hallwachs, Winnie; Janzen, Daniel H.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Hind, Katharine] Univ New Brunswick, Fredericton, NB, Canada; [Hrcek, Jan] Univ S Bohemia, Ctr Biol, Czech Acad Sci, Ceske Budejovice, Czech Republic; [Hrcek, Jan] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Huang, Da-Wei; Li, Yanwei] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Janda, Milan; Miller, Scott E.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Packer, Laurence; Sheffield, Cory] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Quicke, Donald] Imperial Coll London, Div Biol, Ascot, Berks, England; [Quicke, Donald] Nat Hist Museum, Dept Entomol, London SW7 5BD, England; [Rodriguez, Josephine] Univ Calif Santa Barbara, NCEAS, Santa Barbara, CA 93106 USA; [Rougerie, Rodolphe] Univ Rouen, Lab ECODIV, Mont St Aignan, France; [Shaw, Mark R.] Natl Museums Scotland, Edinburgh, Midlothian, Scotland; [Whitfield, James] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Wood, Monty] Agr & Agri Food Canada, Diptera Unit, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Zhou, Xin] Beijing Genom Inst BGI BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	University of Guelph; Dalhousie University; Natural Resources Canada; Canadian Forest Service; California Academy of Sciences; Cornell University; University of Pennsylvania; University of New Brunswick; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; Chinese Academy of Sciences; Institute of Zoology, CAS; Harvard University; York University - Canada; Imperial College London; Natural History Museum London; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Universite de Rouen Normandie; University of Illinois System; University of Illinois Urbana-Champaign; Agriculture & Agri Food Canada; Beijing Genomics Institute (BGI)	Smith, MA (corresponding author), Univ Guelph, Dept Integrat Biol & Biodivers, Inst Ontario, Guelph, ON N1G 2W1, Canada.	salex@uoguelph.ca	Hrček, Jan/D-7335-2015; Sheffield, Cory/I-4812-2019; Zhou, Xin/AAI-9326-2021; Steinke, Dirk/D-4700-2009; Rougerie, Rodolphe/D-2930-2009; Smith, M Alex/B-4468-2013; Ratnasingham, Sujeevan/G-9103-2014; Zhou, Xin/D-4025-2009; Janda, Milan/H-7216-2014; Quicke, Donald LJ/I-5948-2012; Gibbs, Jason/H-6963-2012; li, yan/GTI-4638-2022; Fisher, Brian L./S-9374-2019	Hrček, Jan/0000-0003-0711-6447; Sheffield, Cory/0000-0003-0603-7333; Zhou, Xin/0000-0002-1407-7952; Rougerie, Rodolphe/0000-0003-0937-2815; Smith, M Alex/0000-0002-8650-2575; Zhou, Xin/0000-0002-1407-7952; Janda, Milan/0000-0003-3038-0107; Gibbs, Jason/0000-0002-4945-5423; Crosby, Kate/0000-0003-1860-8367; Stahlhut, Julie/0000-0001-6813-5727; packer, laurence/0000-0002-1711-8203; Fernandez-Triana, Jose/0000-0003-0425-0309; Fisher, Brian/0000-0002-4653-3270; Steinke, Dirk/0000-0002-8992-575X; Quicke, Donald/0000-0003-4471-6775; Miller, Scott/0000-0002-4138-1378	Natural Sciences and Engineering Research Council of Canada (NSERC); Centre national de la recherche scientifique (CNRS) (French Guiana); Natural Resources Canada; Canadian Forest Service; Alfred P. Sloan Foundation; National Science Foundation [DEB-0072713, DEB-0344731, DEB-0842395, DEB 1020510]; USDA [AG sub UGA RC293-359]; NSF [DEB-0841885, DEB 0515699]; Czech Science Foundation [P505/10/0673]; Marie Currie Fellowship [PIOFGA2009-25448]; National Natural Science Foundation of China (NSFC) [31090253]; National Center for Ecological Analysis and Synthesis, US NSF [EF-0553768]; Wege Foundation of Grand Rapids, Michigan; International Conservation Fund of Canada (Nova Scotia); Genome Canada; Government of Canada through Genome Canada; Ontario Genomics Institute [2008-0GI-ICI-03]; Division Of Environmental Biology [0842395] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre national de la recherche scientifique (CNRS) (French Guiana); Natural Resources Canada(Natural Resources CanadaCanadian Forest Service); Canadian Forest Service(Natural Resources CanadaCanadian Forest Service); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Czech Science Foundation(Grant Agency of the Czech Republic); Marie Currie Fellowship; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Center for Ecological Analysis and Synthesis, US NSF(National Science Foundation (NSF)); Wege Foundation of Grand Rapids, Michigan; International Conservation Fund of Canada (Nova Scotia); Genome Canada(Genome Canada); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	MAS was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant and the Nouragues research grant by the Centre national de la recherche scientifique (CNRS) (French Guiana). ESE was supported by Natural Resources Canada, Canadian Forest Service. MH was supported by an NSERC Discovery Grant. DS was supported by the Alfred P. Sloan Foundation. BLF was supported by National Science Foundation Grants DEB-0072713, DEB-0344731, and DEB-0842395. JBW was supported by NSF grant DEB 1020510 and USDA Grant AG sub UGA RC293-359. SEM, JH and MJ were supported by NSF grant DEB-0841885 and Czech Science Foundation grant P505/10/0673. MJ was supported by a Marie Currie Fellowship (PIOFGA2009-25448). HDW was supported by the National Natural Science Foundation of China (NSFC grant no. 31090253). JR was supported by the National Center for Ecological Analysis and Synthesis, US NSF Grant #EF-0553768. DHJ was supported by NSF DEB 0515699, the Wege Foundation of Grand Rapids, Michigan, the International Conservation Fund of Canada (Nova Scotia), and private donors to the Guanacaste Dry Forest Conservation Fund. JG was supported through funding to the Canadian Barcode of Life Network from Genome Canada, NSERC, and other sponsors listed at www.BOLNET.ca. Laboratory analyses on sequences generated since 2009 were funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (2008-0GI-ICI-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2007, CURR MICROBIOL, V55, P81, DOI 10.1007/s00284-007-0055-8; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Ballard JWO, 2000, MOL BIOL EVOL, V17, P1126, DOI 10.1093/oxfordjournals.molbev.a026394; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Chen LL, 2010, INSECT SCI, V17, P101, DOI 10.1111/j.1744-7917.2009.01291.x; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Engelstadter J, 2010, ANNU REV ECOL SYST, V40, P127; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez Triana J, 2011, PLOS ONE, V6; Fernandez Triana J, PLOS ONE IN PRESS; Ferrari J, 2011, PHILOS T R SOC B, V366, P1389, DOI 10.1098/rstb.2010.0226; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Gompert Z, 2008, MOL ECOL, V17, P5231, DOI 10.1111/j.1365-294X.2008.03988.x; Grasso DA, 2000, ETHOL ECOL EVOL, V12, P309; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Jiggins FM, 2003, GENETICS, V164, P5; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Li YW, 2010, MOL ECOL RESOUR, V10, P31, DOI 10.1111/j.1755-0998.2009.02671.x; Linares MC, 2009, MOL PHYLOGENET EVOL, V50, P485, DOI 10.1016/j.ympev.2008.11.008; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Nice CC, 2009, BIOL CONSERV, V142, P3137, DOI 10.1016/j.biocon.2009.08.020; Rasmussen RS, 2009, J AGR FOOD CHEM, V57, P8379, DOI 10.1021/jf901618z; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raychoudhury R, 2010, HEREDITY, V104, P318, DOI 10.1038/hdy.2009.160; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Schmidt BC, 2009, ZOOL J LINN SOC-LOND, V156, P507, DOI 10.1111/j.1096-3642.2008.00496.x; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014424; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Sun XJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-86; Swartz ER, 2008, S AFR J SCI, V104, P293; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447, DOI 10.1098/rspb.1998.0456; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062	47	102	107	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36514	10.1371/journal.pone.0036514	http://dx.doi.org/10.1371/journal.pone.0036514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567162	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500082
J	Zhao, XH; Park, YN; Todor, H; Moomau, C; Masison, D; Eisenberg, E; Greene, LE				Zhao, Xiaohong; Park, Yang-Nim; Todor, Horia; Moomau, Christine; Masison, Daniel; Eisenberg, Evan; Greene, Lois E.			Sequestration of Sup35 by Aggregates of huntingtin Fragments Causes Toxicity of [PSI+] Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY FORMATION; POLYGLUTAMINE AGGREGATION; SACCHAROMYCES-CEREVISIAE; MOLECULAR PATHOGENESIS; CHAPERONE PROTEINS; PRION PROPAGATION; MUTANT HUNTINGTIN; NEURONAL DEATH; DISEASE; OLIGOMERS	Expression of huntingtin fragments with 103 glutamines (HttQ103) is toxic in yeast containing either the [PIN+] prion, which is the amyloid form of Rnq1, or [PSI+] prion, which is the amyloid form of Sup35. We find that HttQP103, which has a polyproline region at the C-terminal end of the polyQ repeat region, is significantly more toxic in [PSI+] yeast than in [PIN+], even though HttQP103 formed multiple aggregates in both [PSI+] and [PIN+] yeast. This toxicity was only observed in the strong [PSI+] variant, not the weak [PSI+] variant, which has more soluble Sup35 present than the strong variant. Furthermore, expression of the MC domains of Sup35, which retains the C-terminal domain of Sup35, but lacks the N-terminal prion domain, almost completely rescued HttQP103 toxicity, but was less effective in rescuing HttQ103 toxicity. Therefore, the toxicity of HttQP103 in yeast containing the [PSI+] prion is primarily due to sequestration of the essential protein, Sup35.	[Zhao, Xiaohong; Park, Yang-Nim; Todor, Horia; Moomau, Christine; Eisenberg, Evan; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Masison, Daniel] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Greene, LE (corresponding author), NHLBI, Cell Biol Lab, NIH, 50 South Dr,Rm 2537 MSC 8017, Bethesda, MD 20892 USA.	greenel@helix.nih.gov			National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was authored, in whole or in part, by National Institutes of Health staff.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Cox B, 2003, GENETICS, V165, P23; Crow ET, 2011, SEMIN CELL DEV BIOL, V22, P452, DOI 10.1016/j.semcdb.2011.03.003; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jung G, 2000, GENETICS, V156, P559; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kirkland PA, 2011, GENETICS, V188, P565, DOI 10.1534/genetics.111.129460; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Truant R, 2008, FEBS J, V275, P4252, DOI 10.1111/j.1742-4658.2008.06561.x; Vishveshwara N, 2009, MOL MICROBIOL, V73, P1101, DOI 10.1111/j.1365-2958.2009.06836.x; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114	30	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23346	23355		10.1074/jbc.M111.287748	http://dx.doi.org/10.1074/jbc.M111.287748			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22573320	hybrid, Green Published			2022-12-25	WOS:000306511300008
J	Fan, MM; Zhang, WK; Buraei, Z; Yang, J				Fan, Mingming; Zhang, Wei K.; Buraei, Zafir; Yang, Jian			Molecular Determinants of Gem Protein Inhibition of P/Q-type Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; BETA-SUBUNIT; RGK-FAMILY; NUCLEAR TRANSPORT; CA(V)1.2 CHANNELS; CALCIUM-CHANNELS; REM GTPASE; CELL-SHAPE; CALMODULIN; RAD	The RGK family of monomeric GTP-binding proteins potently inhibits high voltage-activated Ca2+ channels. The molecular mechanisms of this inhibition are largely unclear. In Xenopus oocytes, Gem suppresses the activity of P/Q-type Ca2+ channels on the plasma membrane. This is presumed to occur through direct interactions of one or more Gem inhibitory sites and the pore-forming Ca(v)2.1 subunit in a manner dependent on the Ca2+ channel subunit beta (Ca-v beta). In this study we investigated the molecular determinants in Gem that are critical for this inhibition. Like other RGK proteins, Gem contains a conserved Ras-like core and extended N and C termini. A 12-amino acid fragment in the C terminus was found to be crucial for and sufficient to produce Ca-v beta-dependent inhibition, suggesting that this region forms an inhibitory site. A three-amino acid motif in the core was also found to be critical, possibly forming another inhibitory site. Mutating either site individually did not hamper Gem inhibition, but mutating both sites together completely abolished Gem inhibition without affecting Gem protein expression level or disrupting Gem interaction with Ca(v)2.1 or Ca-v beta. Mutating Gem residues that are crucial for interactions with previously demonstrated RGK modulators such as calmodulin, 14-3-3, and phosphatidylinositol lipids did not significantly affect Gem inhibition. These results suggest that Gem contains two candidate inhibitory sites, each capable of producing full inhibition of P/Q-type Ca2+ channels.	[Yang, Jian] Columbia Univ, Dept Biol Sci, Fairchild Ctr 917, New York, NY 10027 USA	Columbia University	Yang, J (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild Ctr 917, MC2462, New York, NY 10027 USA.	jy160@columbia.edu	Zhang, Wei/M-4241-2019	Zhang, Wei/0000-0003-4960-6137; , Zafir/0000-0001-6485-8987	National Institutes of Health [NS053494, NS045383]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045383, R01NS053494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS053494 and NS045383 (to J. Y.).	Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beguin P, 2007, J BIOL CHEM, V282, P11509, DOI 10.1074/jbc.M606423200; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Correll RN, 2007, J BIOL CHEM, V282, P28431, DOI 10.1074/jbc.M706176200; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; Felix R, 2005, J RECEPT SIG TRANSD, V25, P57, DOI 10.1081/RRS-200068102; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 1999, ARCH BIOCHEM BIOPHYS, V368, P401, DOI 10.1006/abbi.1999.1316; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Flynn R, 2008, BIOCHEM BIOPH RES CO, V368, P827, DOI 10.1016/j.bbrc.2008.02.020; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Kelly K, 2005, TRENDS CELL BIOL, V15, P640, DOI 10.1016/j.tcb.2005.10.002; Leyris JP, 2009, FASEB J, V23, P2627, DOI 10.1096/fj.08-122135; Mahalakshmi RN, 2007, TRAFFIC, V8, P1164, DOI 10.1111/j.1600-0854.2007.00599.x; Mahalakshmi RN, 2007, TRAFFIC, V8, P1150, DOI 10.1111/j.1600-0854.2007.00598.x; Moyers JS, 1997, J BIOL CHEM, V272, P11832, DOI 10.1074/jbc.272.18.11832; Pang CY, 2010, CHANNELS, V4, P192, DOI 10.4161/chan.4.3.11867; Sasaki T, 2005, J BIOL CHEM, V280, P9308, DOI 10.1074/jbc.M413773200; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; Splingard A, 2007, J BIOL CHEM, V282, P1905, DOI 10.1074/jbc.M604363200; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; Xu XH, 2010, CIRC RES, V107, P620, DOI 10.1161/CIRCRESAHA.110.224717; Yada H, 2007, CIRC RES, V101, P69, DOI 10.1161/CIRCRESAHA.106.146399; Yang T, 2007, NAT CHEM BIOL, V3, P795, DOI 10.1038/nchembio.2007.42; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203; Yanuar A, 2006, GENES CELLS, V11, P961, DOI 10.1111/j.1365-2443.2006.00994.x	35	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22749	22758		10.1074/jbc.M111.291872	http://dx.doi.org/10.1074/jbc.M111.291872			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589533	Green Published, hybrid			2022-12-25	WOS:000306495000032
J	Patsalo, V; Yondola, MA; Luan, BW; Shoshani, I; Kisker, C; Green, DF; Raleigh, DP; Hearing, P				Patsalo, Vadim; Yondola, Mark A.; Luan, Bowu; Shoshani, Ilana; Kisker, Caroline; Green, David F.; Raleigh, Daniel P.; Hearing, Patrick			Biophysical and Functional Analyses Suggest That Adenovirus E4-ORF3 Protein Requires Higher-order Multimerization to Function against Promyelocytic Leukemia Protein Nuclear Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E4 ORF3 PROTEIN; MESSENGER-RNA EXPORT; 5 E1B 55K; DNA-REPLICATION; ANTIVIRAL DEFENSE; MRE11-RAD50-NBS1 COMPLEX; 55-KILODALTON PROTEIN; E4ORF3 PROTEIN; VIRAL-DNA; INFECTION	The early region 4 open reading frame 3 protein (E4-ORF3; UniProt ID P04489) is the most highly conserved of all adenovirus- encoded gene products at the amino acid level. A conserved attribute of the E4-ORF3 proteins of different human adenoviruses is the ability to disrupt PML nuclear bodies from their normally punctate appearance into heterogeneous filamentous structures. This E4-ORF3 activity correlates with the inhibition of PML-mediated antiviral activity. The mechanism of E4-ORF3-mediated reorganization of PML nuclear bodies is unknown. Biophysical analysis of the purified WT E4-ORF3 protein revealed an ordered secondary/tertiary structure and the ability to form heterogeneous higher-order multimers in solution. Importantly, a nonfunctional E4-ORF3 mutant protein, L103A, forms a stable dimer with WT secondary structure content. Because the L103A mutant is incapable of PML reorganization, this result suggests that higher-order multimerization of E4-ORF3 may be required for the activity of the protein. In support of this hypothesis, we demonstrate that the E4-ORF3 L103A mutant protein acts as a dominant-negative effector when coexpressed with theWTE4-ORF3 in mammalian cells. It preventsWTE4-ORF3-mediated PML track formation presumably by binding to the WT protein and inhibiting the formation of higher-order multimers. In vitro protein binding studies support this conclusion as demonstrated by copurification of coexpressed WT and L103A proteins in Escherichia coli and coimmunoprecipitation of WT.L103A E4-ORF3 complexes in mammalian cells. These results provide new insight into the properties of the Ad E4-ORF3 protein and suggest that higher-order protein multimerization is essential for E4-ORF3 activity.	[Yondola, Mark A.; Shoshani, Ilana; Hearing, Patrick] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Patsalo, Vadim; Green, David F.] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Luan, Bowu; Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Kisker, Caroline] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hearing, P (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	phearing@ms.cc.sunysb.edu	Kisker, Caroline/T-1724-2019	Patsalo, Vadim/0000-0001-6047-5858; raleigh, daniel/0000-0003-3248-7493; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health [CA122677, GM078114, GM086199, CA009176, GM007518]; NATIONAL CANCER INSTITUTE [R01CA122677, T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078114, T32GM007518, R01GM086199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122677 (to P. H.), GM078114 (to D. P. R.), and GM086199 (to D. F. G.) and by Training Grants CA009176 and GM007518 (to M. A. Y.).	Araujo FD, 2005, J VIROL, V79, P11382, DOI 10.1128/JVI.79.17.11382-11391.2005; Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Blanchette P, 2008, J VIROL, V82, P2642, DOI 10.1128/JVI.02309-07; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; Evans JD, 2005, J VIROL, V79, P6207, DOI 10.1128/JVI.79.10.6207-6215.2005; Evans JD, 2003, J VIROL, V77, P5295, DOI 10.1128/JVI.77.9.5295-5304.2003; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Forrester NA, 2012, J VIROL, V86, P3167, DOI 10.1128/JVI.06583-11; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Gonzalez R, 2006, J VIROL, V80, P964, DOI 10.1128/JVI.80.2.964-974.2006; Goodrum FD, 1999, J VIROL, V73, P7474, DOI 10.1128/JVI.73.9.7474-7488.1999; Gualfetti PJ, 1999, BIOCHEMISTRY-US, V38, P13367, DOI 10.1021/bi991296s; Guinier A, 1955, SMALL ANGLE XRAY SCA; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Karen KA, 2009, J VIROL, V83, P4565, DOI 10.1128/JVI.00042-09; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Koide S, 1999, BIOCHEMISTRY-US, V38, P4757, DOI 10.1021/bi982443+; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lakdawala SS, 2008, J VIROL, V82, P8362, DOI 10.1128/JVI.00900-08; Leppard KN, 1999, J GEN VIROL, V80, P997, DOI 10.1099/0022-1317-80-4-997; Lethbridge KJ, 2003, J GEN VIROL, V84, P259, DOI 10.1099/vir.0.18820-0; Liao DQ, 1999, VIROLOGY, V254, P11, DOI 10.1006/viro.1998.9512; Liu Y, 2005, J VIROL, V79, P14004, DOI 10.1128/JVI.79.22.14004-14016.2005; Mathew SS, 2007, VIROLOGY, V365, P346, DOI 10.1016/j.virol.2007.03.049; Mathew SS, 2008, VIROLOGY, V374, P11, DOI 10.1016/j.virol.2007.12.034; Nevels M, 1999, J VIROL, V73, P1591, DOI 10.1128/JVI.73.2.1591-1600.1999; NORDQVIST K, 1994, MOL CELL BIOL, V14, P437, DOI 10.1128/MCB.14.1.437; OHMAN K, 1993, VIROLOGY, V194, P50, DOI 10.1006/viro.1993.1234; Orazio NI, 2011, J VIROL, V85, P1887, DOI 10.1128/JVI.02134-10; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; SANDLER AB, 1989, J VIROL, V63, P624, DOI 10.1128/JVI.63.2.624-630.1989; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Shepard RN, 2004, J VIROL, V78, P9924, DOI 10.1128/JVI.78.18.9924-9935.2004; Shepard RN, 2003, J VIROL, V77, P8593, DOI 10.1128/JVI.77.15.8593-8595.2003; Skolnick J, 1997, J MOL BIOL, V265, P217, DOI 10.1006/jmbi.1996.0720; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Ullman AJ, 2008, J VIROL, V82, P7325, DOI 10.1128/JVI.00723-08; Ullman AJ, 2007, J VIROL, V81, P4744, DOI 10.1128/JVI.02385-06; Vink EI, 2012, VIROLOGY, V422, P317, DOI 10.1016/j.virol.2011.10.033; WEIDEN MD, 1994, P NATL ACAD SCI USA, V91, P153, DOI 10.1073/pnas.91.1.153; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Weitzman MD, 2005, ONCOGENE, V24, P7686, DOI 10.1038/sj.onc.1209063; Woo JL, 2007, J VIROL, V81, P575, DOI 10.1128/JVI.01725-06; Yondola MA, 2007, J VIROL, V81, P4264, DOI 10.1128/JVI.02629-06	47	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22573	22583		10.1074/jbc.M112.344234	http://dx.doi.org/10.1074/jbc.M112.344234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573317	Green Published, hybrid			2022-12-25	WOS:000306495000014
J	van Domselaar, R; Quadir, R; van der Made, AM; Broekhuizen, R; Bovenschen, N				van Domselaar, Robert; Quadir, Razi; van der Made, Astrid M.; Broekhuizen, Roel; Bovenschen, Niels			All Human Granzymes Target hnRNP K That Is Essential for Tumor Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RIBONUCLEOPROTEIN-K; ASSEMBLY PROTEIN SET; STRANDED-DNA NICKS; MITOCHONDRIAL DAMAGE; POOR-PROGNOSIS; DEATH; CARCINOMA; APOPTOSIS; CANCER; CYTOTOXICITY	Granule exocytosis by cytotoxic lymphocytes is the key mechanism to eliminate virus-infected cells and tumor cells. These lytic granules contain the pore-forming protein perforin and a set of five serine proteases called granzymes. All human granzymes display distinct substrate specificities and induce cell death by cleaving critical intracellular death substrates. In the present study, we show that all human granzymes directly cleaved the DNA/RNA-binding protein heterogeneous nuclear ribonucleoprotein K (hnRNP K), designating hnRNP K as the first known pan-granzyme substrate. Cleavage of hnRNP K was more efficient in the presence of RNA and occurred in two apparent proteolysis-sensitive amino acid regions, thereby dissecting the functional DNA/RNA-binding hnRNP K domains. HnRNP K was cleaved under physiological conditions when purified granzymes were delivered into living tumor cells and during lymphokine-activated killer cell-mediated attack. HnRNP K is essential for tumor cell viability, since knockdown of hnRNP K resulted in spontaneous tumor cell apoptosis with caspase activation and reactive oxygen species production. This apoptosis was more pronounced at low tumor cell density where hnRNP K knockdown also triggered a caspase-independent apoptotic pathway. This suggests that hnRNP K promotes tumor cell survival in the absence of cell-cell contact. Silencing of hnRNP K protein expression rendered tumor cells more susceptible to cellular cytotoxicity. We conclude that hnRNP K is indispensable for tumor cell viability and our data suggest that targeting of hnRNP K by granzymes contributes to or reinforces the cell death mechanisms by which cytotoxic lymphocytes eliminate tumor cells.	[van Domselaar, Robert; Quadir, Razi; van der Made, Astrid M.; Broekhuizen, Roel; Bovenschen, Niels] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Bovenschen, N (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	n.bovenschen@umcutrecht.nl			Netherlands Organization for Scientific Research (NWO) [916.66.044]; Dutch Cancer Society [UU-2009-4302]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	This study was supported by The Netherlands Organization for Scientific Research (NWO) (Grant 916.66.044) and the Dutch Cancer Society (UU-2009-4302) (to N. B.).	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Barboro P, 2009, BRIT J CANCER, V100, P1608, DOI 10.1038/sj.bjc.6605057; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bovenschen N, 2008, J IMMUNOL, V180, P8184, DOI 10.4049/jimmunol.180.12.8184; Bovenschen N, 2010, IMMUNOL REV, V235, P117, DOI 10.1111/j.0105-2896.2010.00889.x; Bovenschen N, 2009, J BIOL CHEM, V284, P3504, DOI 10.1074/jbc.M806716200; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; Chen L. C., 2010, ANTIAPOPTOTIC PROTEI; Chen LC, 2008, CLIN CANCER RES, V14, P3807, DOI 10.1158/1078-0432.CCR-08-0155; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cullen SP, 2009, J BIOL CHEM, V284, P5137, DOI 10.1074/jbc.M807913200; de Poot SAH, 2011, BIOCHEM J, V437, P431, DOI 10.1042/BJ20110210; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Fellows E, 2007, BLOOD, V110, P544, DOI 10.1182/blood-2006-10-051649; Gao FH, 2009, EXP CELL RES, V315, P3250, DOI 10.1016/j.yexcr.2009.09.005; Guo YM, 2008, MOL IMMUNOL, V45, P2225, DOI 10.1016/j.molimm.2007.11.020; Guo YM, 2010, J IMMUNOL, V185, P5348, DOI 10.4049/jimmunol.0903792; Hou Q, 2008, MOL IMMUNOL, V45, P1044, DOI 10.1016/j.molimm.2007.07.032; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Hua GQ, 2009, J IMMUNOL, V182, P2152, DOI 10.4049/jimmunol.0802307; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Ng LFP, 2005, PLOS MED, V2, P673, DOI 10.1371/journal.pmed.0020163; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; Plasman K., 2011, MOL CELL PR IN PRESS; Revil T, 2009, J BIOL CHEM, V284, P21458, DOI 10.1074/jbc.M109.019711; Roychoudhury P, 2007, BRIT J CANCER, V97, P574, DOI 10.1038/sj.bjc.6603911; Schmidt T, 2010, FEBS LETT, V584, P4361, DOI 10.1016/j.febslet.2010.09.038; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Van Damme P, 2010, BIOL CHEM, V391, P983, DOI 10.1515/BC.2010.096; Van Damme P, 2010, NAT METHODS, V7, P512, DOI [10.1038/NMETH.1469, 10.1038/nmeth.1469]; van Domselaar R, 2010, EXPERT REV PROTEOMIC, V7, P347, DOI 10.1586/EPR.10.24; Wang S, 2012, CELL DEATH DIFFER, V19, P605, DOI 10.1038/cdd.2011.130; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Zhao T, 2007, CELL DEATH DIFFER, V14, P489, DOI 10.1038/sj.cdd.4402040; Zhao TB, 2007, J BIOL CHEM, V282, P12104, DOI 10.1074/jbc.M611006200; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744; Zhu PC, 2006, EMBO REP, V7, P431, DOI 10.1038/sj.embor.7400622	45	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22854	22864		10.1074/jbc.M112.365692	http://dx.doi.org/10.1074/jbc.M112.365692			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22582387	Green Published, hybrid			2022-12-25	WOS:000306495000042
J	Boldogh, I; Hajas, G; Aguilera-Aguirre, L; Hegde, ML; Radak, Z; Bacsi, A; Sur, S; Hazra, TK; Mitra, S				Boldogh, Istvan; Hajas, Gyorgy; Aguilera-Aguirre, Leopoldo; Hegde, Muralidhar L.; Radak, Zsolt; Bacsi, Attila; Sur, Sanjiv; Hazra, Tapas K.; Mitra, Sankar			Activation of Ras Signaling Pathway by 8-Oxoguanine DNA Glycosylase Bound to Its Excision Product, 8-Oxoguanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL INTERACTION; REPAIR; 8-HYDROXYGUANINE; ACCUMULATION; DAMAGE	8-Oxo-7,8-dihydroguanine (8-oxoG), arguably the most abundant base lesion induced in mammalian genomes by reactive oxygen species, is repaired via the base excision repair pathway that is initiated with the excision of 8-oxoG by OGG1. Here we show that OGG1 binds the 8-oxoG base with high affinity and that the complex then interacts with canonical Ras family GTPases to catalyze replacement of GDP with GTP, thus serving as a guanine nuclear exchange factor. OGG1-mediated activation of Ras leads to phosphorylation of the mitogen-activated kinases MEK1,2/ERK1,2 and increasing downstream gene expression. These studies document for the first time that in addition to its role in repairing oxidized purines, OGG1 has an independent guanine nuclear exchange factor activity when bound to 8-oxoG.	[Boldogh, Istvan; Hajas, Gyorgy; Aguilera-Aguirre, Leopoldo; Radak, Zsolt; Bacsi, Attila] Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sur, Sanjiv; Hazra, Tapas K.; Mitra, Sankar] Univ Texas Med Branch Galveston, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Hegde, Muralidhar L.; Mitra, Sankar] Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sur, Sanjiv; Hazra, Tapas K.] Univ Texas Med Branch Galveston, Dept Internal Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Boldogh, I (corresponding author), Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, 301 Univ Blvd, Galveston, TX 77555 USA.	sboldogh@utmb.edu	Classen, Scott/AAY-8176-2020; Aguilera-Aguirre, Leopoldo/B-9864-2012	Hegde, Muralidhar/0000-0001-7333-8123; Radak, Zsolt/0000-0003-1297-6804; Bacsi, Attila/0000-0002-2311-2975; Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402	National Institutes of Health from the NIEHS [RO1 ES018948]; NIA/AG [021830]; NIAID [NIAID/AI062885-01]; NHLBI Proteomic Center [N01HV00245, R01CA81063]; NIEHS [T32 ES007254]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA081063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, T32ES007254, R01ES018948] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS; NIA/AG; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI Proteomic Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES018948 (to I. B.) from the NIEHS, 021830 (to I. B.) from the NIA/AG, and NIAID/AI062885-01 (to I. B.) from the NIAID and the Grants N01HV00245 (to Dr. A. Kurosky) and R01CA81063 (to S. M.) from the NHLBI Proteomic Center.; An Environmental Toxicology Research Training Fellow (Grant T32 ES007254 from the NIEHS).	Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CHATAWAY TK, 1995, MOL CELL BIOCHEM, V144, P167, DOI 10.1007/BF00944396; CHENG KC, 1992, J BIOL CHEM, V267, P166; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; FIELD J, 1987, MOL CELL BIOL, V7, P2128, DOI 10.1128/MCB.7.6.2128; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Mitra S, 1997, MOL CELLS, V7, P305; MOSTELLER RD, 1994, MOL CELL BIOL, V14, P1104, DOI 10.1128/MCB.14.2.1104; Nakabeppu Y, 2010, MUTAT RES-GEN TOX EN, V703, P51, DOI 10.1016/j.mrgentox.2010.06.006; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Touati E, 2006, HELICOBACTER, V11, P494, DOI 10.1111/j.1523-5378.2006.00442.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wittinghofer F, 1998, NATURE, V394, P317, DOI 10.1038/28492	28	101	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20769	20773		10.1074/jbc.C112.364620	http://dx.doi.org/10.1074/jbc.C112.364620			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22568941	Green Published, hybrid			2022-12-25	WOS:000306416800001
J	Hayes, S; Horbay, MA; Hayes, C				Hayes, Sidney; Horbay, Monique A.; Hayes, Connie			A CI-Independent Form of Replicative Inhibition: Turn Off of Early Replication of Bacteriophage Lambda	PLOS ONE			English	Article							SPECIALIZED NUCLEOPROTEIN STRUCTURES; ESCHERICHIA-COLI O157-H7; PHAGE-LAMBDA; NUCLEOTIDE-SEQUENCE; DNA-REPLICATION; GENETIC-STRUCTURE; COLIPHAGE-LAMBDA; OOP-RNA; ESTABLISHMENT TRANSCRIPTION; DELETION ANALYSIS	Several earlier studies have described an unusual exclusion phenotype exhibited by cells with plasmids carrying a portion of the replication region of phage lambda. Cells exhibiting this inhibition phenotype (IP) prevent the plating of homo-immune and hybrid hetero-immune lambdoid phages. We have attempted to define aspects of IP, and show that it is directed to rep lambda phages. IP was observed in cells with plasmids containing a l DNA fragment including oop, encoding a short OOP micro RNA, and part of the lambda origin of replication, ori lambda, defined by iteron sequences ITN1-4 and an adjacent high AT-rich sequence. Transcription of the intact oop sequence from its promoter, p(O) is required for IP, as are iterons ITN3-4, but not the high AT-rich portion of oril. The results suggest that IP silencing is directed to theta mode replication initiation from an infecting repl genome, or an induced repl prophage. Phage mutations suppressing IP, i.e., Sip, map within, or adjacent to cro or in O, or both. Our results for plasmid based IP suggest the hypothesis that there is a natural mechanism for silencing early theta-mode replication initiation, i.e. the buildup of l genomes with oop(+) ori lambda(+) sequence.	[Hayes, Sidney; Horbay, Monique A.; Hayes, Connie] Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Hayes, S (corresponding author), Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 0W0, Canada.	sjh092@mail.usask.ca		Hayes, Sidney/0000-0002-4218-3939	NSERC Canada [138296]	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by NSERC Canada Discovery grant 138296 to SH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1968, P NATL ACAD SCI USA, V61, P956, DOI 10.1073/pnas.61.3.956; ANDERL A, 1982, NUCLEIC ACIDS RES, V10, P1733, DOI 10.1093/nar/10.5.1733; Bachmann B.J., 1987, E COLI S TYPHIMURIUM, V2, P1192; BIEK DP, 1986, J BACTERIOL, V167, P594, DOI 10.1128/jb.167.2.594-603.1986; Bull H. J, 1995, BACTERIOPHAGE LAMBDA; Bull HJ, 1996, MOL GEN GENET, V252, P755, DOI 10.1007/BF02173984; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; COHEN A, 1986, J BACTERIOL, V167, P327, DOI 10.1128/jb.167.1.327-335.1986; Creuzburg K, 2005, MICROBIOL-SGM, V151, P941, DOI 10.1099/mic.0.27632-0; DANIELS DL, 1983, LAMBDA, V2, P519; DENNISTONTHOMPSON K, 1977, SCIENCE, V198, P1051, DOI 10.1126/science.929187; DODSON M, 1985, P NATL ACAD SCI USA, V82, P4678, DOI 10.1073/pnas.82.14.4678; DODSON M, 1986, P NATL ACAD SCI USA, V83, P7638, DOI 10.1073/pnas.83.20.7638; DODSON M, 1989, J BIOL CHEM, V264, P10719; DOVE WF, 1971, BACTERIOPHAGE LAMBDA, P747; EISEN H, 1975, VIROLOGY, V68, P266, DOI 10.1016/0042-6822(75)90168-3; EISEN H, 1970, P NATL ACAD SCI USA, V66, P855, DOI 10.1073/pnas.66.3.855; ENQUIST LW, 1973, J MOL BIOL, V75, P185, DOI 10.1016/0022-2836(73)90016-8; FEISS M, 1983, LAMBDA 2, P305; FOLKMANIS A, 1977, VIROLOGY, V81, P352, DOI 10.1016/0042-6822(77)90151-9; FREIFELDER D, 1974, J MOL BIOL, V83, P503, DOI 10.1016/0022-2836(74)90510-5; FURTH ME, 1977, SCIENCE, V198, P1046, DOI 10.1126/science.929186; Gamage LNA, 2009, VACCINE, V27, P6595, DOI 10.1016/j.vaccine.2009.08.019; GROSSCHEDL R, 1979, NUCLEIC ACIDS RES, V6, P867, DOI 10.1093/nar/6.3.867; GROSSCHEDL R, 1979, NATURE, V277, P621, DOI 10.1038/277621a0; Gussin G.N., 1983, LAMBDA 2, P93; HAYES S, 1990, MOL GEN GENET, V222, P17, DOI 10.1007/BF00283017; HAYES S, 1991, MOL GEN GENET, V231, P139, DOI 10.1007/BF00293831; Hayes S, 2005, GENETICS, V170, P1485, DOI 10.1534/genetics.105.042341; HAYES S, 1979, VIROLOGY, V97, P415, DOI 10.1016/0042-6822(79)90352-0; Hayes S, 2005, CAN J MICROBIOL, V51, P37, DOI 10.1139/W04-115; Hayes S, 1998, GENE, V223, P115, DOI 10.1016/S0378-1119(98)00363-1; HAYES S, 1978, MOL GEN GENET, V164, P63, DOI 10.1007/BF00267600; Hayes S, 1997, GENE, V189, P35, DOI 10.1016/S0378-1119(96)00824-4; HAYES S, 1973, MOL GEN GENET, V126, P275, DOI 10.1007/BF00269438; HAYES S, 1979, MOL GEN GENET, V170, P75, DOI 10.1007/BF00268582; HAYES S, 1986, J VIROL, V58, P835, DOI 10.1128/JVI.58.3.835-842.1986; Hayes S, 1999, ACTA BIOCHIM POL, V46, P879, DOI 10.18388/abp.1999_4109; Hayes S., 1988, DNA REPLICATION MUTA, P367; Hayes S, 2010, VACCINE, V28, P6789, DOI 10.1016/j.vaccine.2010.07.047; Horbay M. A., 2006, MODERN BACTERIOPHAGE, P37; Horbay M.A., 2005, INHIBITION PHENOTYPE; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Kobiler O, 2002, P NATL ACAD SCI USA, V99, P14964, DOI 10.1073/pnas.222172499; KRINKE L, 1990, GENE DEV, V4, P2223, DOI 10.1101/gad.4.12a.2223; KUMAR S, 1970, VIROLOGY, V41, P665, DOI 10.1016/0042-6822(70)90431-9; KUSANO K, 1989, J MOL BIOL, V209, P623, DOI 10.1016/0022-2836(89)90000-4; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LUSKY M, 1979, GENE, V6, P137, DOI 10.1016/0378-1119(79)90068-4; MATSUBARA K, 1976, J MOL BIOL, V102, P427, DOI 10.1016/0022-2836(76)90325-9; Matsubara K, 1968, LAMBDADV AUTONOMOUSL, P769; MCMILIN KD, 1972, J MOL BIOL, V68, P49, DOI 10.1016/0022-2836(72)90261-6; Miyamoto H, 1999, DNA Res, V6, P235, DOI 10.1093/dnares/6.4.235; Mmolawa PT, 2003, J BACTERIOL, V185, P3473, DOI 10.1128/JB.185.11.3473-3475.2003; MOORE DD, 1979, COLD SPRING HARB SYM, V43, P155, DOI 10.1101/SQB.1979.043.01.022; Motamedi MR, 1999, GENE DEV, V13, P2889, DOI 10.1101/gad.13.21.2889; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; OBERTO J, 1994, NUCLEIC ACIDS RES, V22, P354, DOI 10.1093/nar/22.3.354; OGAWA T, 1988, J MOL BIOL, V202, P537, DOI 10.1016/0022-2836(88)90284-7; Oppenheim AB, 2004, VIROLOGY, V319, P185, DOI 10.1016/j.virol.2003.11.007; PACKMAN S, 1968, VIROLOGY, V34, P778, DOI 10.1016/0042-6822(68)90099-8; PARKINSO.JS, 1968, GENETICS, V59, P311; Pedulla ML, 2003, J BACTERIOL, V185, P1475, DOI 10.1128/JB.185.4.1475-1477.2003; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; RAO RN, 1978, GENE, V3, P247; ROSENBERG M, 1978, NATURE, V272, P414, DOI 10.1038/272414a0; SALZMAN LA, 1967, J MOL BIOL, V28, P53, DOI 10.1016/S0022-2836(67)80077-9; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; Sato T, 2003, GENE, V309, P35, DOI 10.1016/S0378-1119(03)00487-6; Sato T, 2003, J BACTERIOL, V185, P3966, DOI 10.1128/JB.185.13.3966-3971.2003; SCHERER G, 1977, NATURE, V265, P117, DOI 10.1038/265117a0; SCHERER G, 1978, NUCLEIC ACIDS RES, V5, P3141, DOI 10.1093/nar/5.9.3141; Schicklmaier P, 1997, GENE, V195, P93, DOI 10.1016/S0378-1119(97)00182-0; SCHWARZ E, 1978, NATURE, V272, P410, DOI 10.1038/272410a0; SCLAFANI RA, 1981, VIROLOGY, V113, P314, DOI 10.1016/0042-6822(81)90158-6; SILBERSTEIN Z, 1987, J BACTERIOL, V169, P3131, DOI 10.1128/jb.169.7.3131-3137.1987; Skalka A, 1975, DNA SYNTHESIS ITS RE, P460; SKALKA AM, 1977, CURR TOP MICROBIOL, P201; SMITH GR, 1975, VIROLOGY, V64, P544, DOI 10.1016/0042-6822(75)90131-2; STAHL FW, 1972, J MOL BIOL, V68, P57, DOI 10.1016/0022-2836(72)90262-8; Stephens KM, 1997, J BIOL CHEM, V272, P28800, DOI 10.1074/jbc.272.45.28800; Struble EB, 2007, ACTA CRYSTALLOGR F, V63, P542, DOI 10.1107/S1744309107022762; TAKAYAMA KM, 1987, MOL GEN GENET, V210, P184, DOI 10.1007/BF00337778; Tanaka K, 2004, J CLIN MICROBIOL, V42, P1807, DOI 10.1128/JCM.42.4.1807-1812.2004; TAYLOR KD, 1981, J BACTERIOL, V145, P1113, DOI 10.1128/JB.145.2.1113-1115.1981; THOMAS R, 1964, VIROLOGY, V24, P241, DOI 10.1016/0042-6822(64)90163-1; TSURIMOTO T, 1981, NUCLEIC ACIDS RES, V9, P1789, DOI 10.1093/nar/9.8.1789; TSURIMOTO T, 1982, P NATL ACAD SCI-BIOL, V79, P7639, DOI 10.1073/pnas.79.24.7639; Vander Byl C, 2000, J BACTERIOL, V182, P6472, DOI 10.1128/JB.182.22.6472-6481.2000; WEIGLE J, 1966, P NATL ACAD SCI USA, V55, P1462, DOI 10.1073/pnas.55.6.1462; WICKNER S, 1987, J BIOL CHEM, V262, P13163; Wulff D.L., 1983, LAMBDA 2, P519	95	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36498	10.1371/journal.pone.0036498	http://dx.doi.org/10.1371/journal.pone.0036498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590552	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336400019
J	Kawashima, J; Alquier, T; Tsuji, Y; Peroni, OD; Kahn, BB				Kawashima, Junji; Alquier, Thierry; Tsuji, Youki; Peroni, Odile D.; Kahn, Barbara B.			Ca2+/Calmodulin-Dependent Protein Kinase Kinase Is Not Involved in Hypothalamic AMP-Activated Protein Kinase Activation by Neuroglucopenia	PLOS ONE			English	Article							ALPHA-LIPOIC ACID; UPSTREAM KINASE; GLUCOSE-UPTAKE; CELLS; BETA; HYPOGLYCEMIA; RESPONSES	Hypoglycemia and neuroglucopenia stimulate AMP-activated protein kinase (AMPK) activity in the hypothalamus and this plays an important role in the counterregulatory responses, i.e. increased food intake and secretion of glucagon, corticosterone and catecholamines. Several upstream kinases that activate AMPK have been identified including Ca2+/Calmodulin-dependent protein kinase kinase (CaMKK), which is highly expressed in neurons. However, the involvement of CaMKK in neuroglucopenia-induced activation of AMPK in the hypothalamus has not been tested. To determine whether neuroglucopenia-induced AMPK activation is mediated by CaMKK, we tested whether STO-609 (STO), a CaMKK inhibitor, would block the effects of 2-deoxy-D-glucose (2DG)-induced neuroglucopenia both ex vivo on brain sections and in vivo. Preincubation of rat brain sections with STO blocked KCl-induced alpha 1 and alpha 2-AMPK activation but did not affect AMPK activation by 2DG in the medio-basal hypothalamus. To confirm these findings in vivo, STO was pre-administrated intracerebroventricularly (ICV) in rats 30 min before 2DG ICV injection (40 mu mol) to induce neuroglucopenia. 2DG-induced neuroglucopenia lead to a significant increase in glycemia and food intake compared to saline-injected control rats. ICV pre-administration of STO (5, 20 or 50 nmol) did not affect 2DG-induced hyperglycemia and food intake. Importantly, activation of hypothalamic alpha 1 and alpha 2-AMPK by 2DG was not affected by ICV pre-administration of STO. In conclusion, activation of hypothalamic AMPK by 2DG-induced neuroglucopenia is not mediated by CaMKK.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kawashima, J (corresponding author), Kumamoto Univ, Dept Metab Med, Fac Life Sci, Kumamoto, Japan.	bkahn@bidmc.harvard.edu	Alquier, Thierry/Z-1917-2019	Alquier, Thierry/0000-0001-8171-802X	National Institutes of Health [P01 DK56116, P30 DK57521]; ADA; Picower Foundation; ADA-EASD; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056116, P30DK057521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA(American Diabetes Association); Picower Foundation; ADA-EASD; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P01 DK56116 and P30 DK57521, an ADA Mentor-Based Fellowship, a grant from the Picower Foundation (BBK), and an ADA-EASD fellowship grant (TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alquier T, 2007, ENDOCRINOLOGY, V148, P1367, DOI 10.1210/en.2006-1039; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Claret M, 2011, DIABETES, V60, P735, DOI 10.2337/db10-1055; Han SM, 2005, DIABETOLOGIA, V48, P2170, DOI 10.1007/s00125-005-1913-1; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Lee K, 2005, ENDOCRINOLOGY, V146, P3, DOI 10.1210/en.2004-0968; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; Merlin J, 2010, CELL SIGNAL, V22, P1104, DOI 10.1016/j.cellsig.2010.03.004; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Mount PF, 2008, ATHEROSCLEROSIS, V200, P28, DOI 10.1016/j.atherosclerosis.2007.12.003; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Sakagami H, 2000, EUR J NEUROSCI, V12, P89, DOI 10.1046/j.1460-9568.2000.00883.x; Shen QWW, 2007, AM J PHYSIOL-CELL PH, V293, pC1395, DOI 10.1152/ajpcell.00115.2007; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Tekkok S, 1999, J NEUROPHYSIOL, V81, P174, DOI 10.1152/jn.1999.81.1.174; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	23	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36335	10.1371/journal.pone.0036335	http://dx.doi.org/10.1371/journal.pone.0036335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590531	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336400010
J	Lupold, SE; Johnson, T; Chowdhury, WH; Rodriguez, R				Lupold, Shawn E.; Johnson, Tamara; Chowdhury, Wasim H.; Rodriguez, Ronald			A Real Time Metridia Luciferase Based Non-Invasive Reporter Assay of Mammalian Cell Viability and Cytotoxicity via the beta-actin Promoter and Enhancer	PLOS ONE			English	Article							IN-VIVO; SECRETED LUCIFERASE; GENE; EXPRESSION; ENZYME; CDNA; UPSTREAM; CULTURE; CLONING; GROWTH	Secreted reporter molecules offer a means to evaluate biological processes in real time without the need to sacrifice samples at pre-determined endpoints. Here we have adapted the secreted bioluminescent reporter gene, Metridia luciferase, for use in a real-time viability assay for mammalian cells. The coding region of the marine copepod gene has been codon optimized for expression in human cells (hMLuc) and placed under the control of the human beta-actin promoter and enhancer. Metridia luciferase activity of stably transfected cell models corresponded linearly with cell number over a 4-log dynamic range, detecting as few as 40 cells. When compared to standard endpoint viability assays, which measure the mitochondrial dehydrogenase reduction of tetrazolium salts, the hMLuc viability assay had a broader linear range of detection, was applicable to large tissue culture vessels, and allowed the same sample to be repeatedly measured over several days. Additional studies confirmed that MLuc activity was inhibited by serum, but demonstrated that assay activity remained linear and was measurable in the serum of mice bearing subcutaneous hMLuc-expressing tumors. In summary, these comparative studies demonstrate the value of humanized Metridia luciferase as an inexpensive and non-invasive method for analyzing viable cell number, growth, tumor volume, and therapeutic response in real time.	[Lupold, Shawn E.; Johnson, Tamara; Chowdhury, Wasim H.; Rodriguez, Ronald] Johns Hopkins Univ, James Buchanan Brady Urol Inst, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Lupold, SE (corresponding author), Johns Hopkins Univ, James Buchanan Brady Urol Inst, Sch Med, Baltimore, MD 21218 USA.	slupold@jhmi.edu; rrodrig@jhmi.edu	Chowdhury, Wasim/ABD-5379-2020	Chowdhury, Wasim/0000-0002-6731-646X	National Institutes of Health, National Cancer Institute [5R01CA121153-05]; Department of Defense Prostate Cancer [W81XWH-11-1-0475]; NATIONAL CANCER INSTITUTE [R01CA121153] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from the National Institutes of Health, National Cancer Institute: 5R01CA121153-05 and The Department of Defense Prostate Cancer Research Program: W81XWH-11-1-0475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr CE, 2011, ASSAY DRUG DEV TECHN, V9, P281, DOI 10.1089/adt.2010.0324; Berger F, 2008, EUR J NUCL MED MOL I, V35, P2275, DOI 10.1007/s00259-008-0870-6; Coombe DR, 1998, J IMMUNOL METHODS, V215, P145, DOI 10.1016/S0022-1759(98)00081-7; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Hiramatsu N, 2005, ANAL BIOCHEM, V339, P249, DOI 10.1016/j.ab.2005.01.023; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Langer SJ, 2002, NUCLEIC ACIDS RES, V30, P3067, DOI 10.1093/nar/gkf421; Lupold SE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm914; Markova SV, 2004, J BIOL CHEM, V279, P3212, DOI 10.1074/jbc.M309639200; Markova SV, 2012, BIOCHEM BIOPH RES CO, V417, P98, DOI 10.1016/j.bbrc.2011.11.063; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Mosmann T., 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565; NG SY, 1989, NUCLEIC ACIDS RES, V17, P601, DOI 10.1093/nar/17.2.601; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; SHRIVASTAVA R, 1992, CELL BIOL TOXICOL, V8, P157; SUGIYAMA H, 1988, GENE, V65, P135; Takenaka Y, 2008, GENE, V425, P28, DOI 10.1016/j.gene.2008.07.041; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Zhang YM, 2007, CANCER RES, V67, P9389, DOI 10.1158/0008-5472.CAN-07-0944	23	22	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36535	10.1371/journal.pone.0036535	http://dx.doi.org/10.1371/journal.pone.0036535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590558	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336100034
J	Purushotham, P; Arun, PVPS; Prakash, JSS; Podile, AR				Purushotham, Pallinti; Arun, P. V. Parvati Sai; Prakash, Jogadhenu S. S.; Podile, Appa Rao			Chitin Binding Proteins Act Synergistically with Chitinases in Serratia proteamaculans 568	PLOS ONE			English	Article							ALPHA-CHITIN; BETA-CHITIN; MARCESCENS; DEGRADATION; CBP21; RESOLUTION; RESIDUES; CHITOSAN; SYSTEM; ENZYME	Genome sequence of Serratia proteamaculans 568 revealed the presence of three family 33 chitin binding proteins (CBPs). The three Sp CBPs (Sp CBP21, Sp CBP28 and Sp CBP50) were heterologously expressed and purified. Sp CBP21 and Sp CBP50 showed binding preference to beta-chitin, while Sp CBP28 did not bind to chitin and cellulose substrates. Both Sp CBP21 and Sp CBP50 were synergistic with four chitinases from S. proteamaculans 568 (Sp ChiA, Sp ChiB, Sp ChiC and Sp ChiD) in degradation of alpha- and beta-chitin, especially in the presence of external electron donor (reduced glutathione). Sp ChiD benefited most from Sp CBP21 or Sp CBP50 on alpha-chitin, while Sp ChiB and Sp ChiD had major advantage with these Sp CBPs on beta-chitin. Dose responsive studies indicated that both the Sp CBPs exhibit synergism >= 0.2 mu M. The addition of both Sp CBP21 and Sp CBP50 in different ratios to a synergistic mixture did not significantly increase the activity. Highly conserved polar residues, important in binding and activity of CBP21 from S. marcescens (Sm CBP21), were present in Sp CBP21 and Sp CBP50, while Sp CBP28 had only one such polar residue. The inability of Sp CBP28 to bind to the test substrates could be attributed to the absence of important polar residues.	[Purushotham, Pallinti; Arun, P. V. Parvati Sai; Prakash, Jogadhenu S. S.; Podile, Appa Rao] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Purushotham, P (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	arpsl@uohyd.ernet.in	Arun, PV Parvati Sai/ABI-6028-2020; Podile, Appa Rao/W-5077-2018	Arun, PV Parvati Sai/0000-0002-9175-7900; Pallinti, Purushotham Naidu/0000-0002-5565-1762; Podile, Appa Rao/0000-0003-3208-765X	Department of Biotechnology, Government of India; DST-FIST; UGC-SAP; DBT-CREBB; University of Hyderabad	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); DST-FIST(Department of Science & Technology (India)); UGC-SAP(University Grants Commission, India); DBT-CREBB(Department of Biotechnology (DBT) India); University of Hyderabad(University of Hyderabad)	The work was supported by Department of Biotechnology, Government of India in the form of a research project to ARP; http://dbtindia.nic.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank DST-FIST, UGC-SAP and DBT-CREBB for the support to the Department of Plant Sciences, University of Hyderabad. PP thanks the University of Hyderabad for research fellowship, Dr. Daniel van der Lelie, Brookhaven National Laboratory, USA for providing the S. proteamaculans 568, and Dr. Dominique Gillete, Mahatani Chitosan, Veraval, Gujarat, for chitinous substrates.	Berger LR, 1988, METHODS ENZYMOLOGY, V161, P140; Chu HH, 2001, MICROBIOL-SGM, V147, P1793, DOI 10.1099/00221287-147-7-1793; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Folders J, 2000, J BACTERIOL, V182, P1257, DOI 10.1128/JB.182.5.1257-1263.2000; Hardt M, 2004, ARCH BIOCHEM BIOPHYS, V426, P286, DOI 10.1016/j.abb.2004.03.017; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Kolbe S, 1998, MICROBIOL-SGM, V144, P1291, DOI 10.1099/00221287-144-5-1291; Mehmood MA, 2011, ANTON LEEUW INT J G, V53, P125; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; Neeraja C, 2010, CRIT REV BIOTECHNOL, V30, P231, DOI 10.3109/07388551.2010.487258; Neeraja C, 2010, MOL BIOSYST, V6, P1492, DOI 10.1039/b923048c; Neeraja C, 2010, BIORESOURCE TECHNOL, V101, P3635, DOI 10.1016/j.biortech.2009.12.118; Orikoshi H, 2005, APPL ENVIRON MICROB, V71, P1811, DOI 10.1128/AEM.71.4.1811-1815.2005; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Purushotham P, 2012, BIORESOURCE TECHNOL, V112, P261, DOI 10.1016/j.biortech.2012.02.062; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; Saito A, 2001, APPL ENVIRON MICROB, V67, P1268, DOI 10.1128/AEM.67.3.1268-1273.2001; SCHNELLMANN J, 1994, MOL MICROBIOL, V13, P807, DOI 10.1111/j.1365-2958.1994.tb00473.x; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Zamil SS, 2010, BIORESOURCE TECHNOL, V101, P7177, DOI 10.1016/j.biortech.2010.03.141; Zeltins A, 1997, EUR J BIOCHEM, V246, P557, DOI 10.1111/j.1432-1033.1997.t01-1-00557.x	29	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36714	10.1371/journal.pone.0036714	http://dx.doi.org/10.1371/journal.pone.0036714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590591	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336100054
J	Heine, M; Freund, B; Nielsen, P; Jung, C; Reimer, R; Hohenberg, H; Zangemeister-Wittke, U; Wester, HJ; Luers, GH; Schumacher, U				Heine, Markus; Freund, Barbara; Nielsen, Peter; Jung, Caroline; Reimer, Rudolph; Hohenberg, Heinrich; Zangemeister-Wittke, Uwe; Wester, Hans-Juergen; Lueers, Georg H.; Schumacher, Udo			High Interstitial Fluid Pressure Is Associated with Low Tumour Penetration of Diagnostic Monoclonal Antibodies Applied for Molecular Imaging Purposes	PLOS ONE			English	Article							EP-CAM EXPRESSION; BREAST-CANCER; MELANOMA CELLS; CARCINOMA; THERAPY; SURVIVAL; TARGET; EPCAM; BIODISTRIBUTION; OVEREXPRESSION	The human epithelial cell adhesion molecule (EpCAM) is highly expressed in a variety of clinical tumour entities. Although an antibody against EpCAM has successfully been used as an adjuvant therapy in colon cancer, this therapy has never gained wide-spread use. We have therefore investigated the possibilities and limitations for EpCAM as possible molecular imaging target using a panel of preclinical cancer models. Twelve human cancer cell lines representing six tumour entities were tested for their EpCAM expression by qPCR, flow cytometry analysis and immunocytochemistry. In addition, EpCAM expression was analyzed in vivo in xenograft models for tumours derived from these cells. Except for melanoma, all cell lines expressed EpCAM mRNA and protein when grown in vitro. Although they exhibited different mRNA levels, all cell lines showed similar EpCAM protein levels upon detection with monoclonal antibodies. When grown in vivo, the EpCAM expression was unaffected compared to in vitro except for the pancreatic carcinoma cell line 5072 which lost its EpCAM expression in vivo. Intravenously applied radio-labelled anti EpCAM MOC31 antibody was enriched in HT29 primary tumour xenografts indicating that EpCAM binding sites are accessible in vivo. However, bound antibody could only be immunohistochemically detected in the vicinity of perfused blood vessels. Investigation of the fine structure of the HT29 tumour blood vessels showed that they were immature and prone for higher fluid flux into the interstitial space. Consistent with this hypothesis, a higher interstitial fluid pressure of about 12 mbar was measured in the HT29 primary tumour via "wick-in-needle'' technique which could explain the limited diffusion of the antibody into the tumour observed by immunohistochemistry.	[Heine, Markus; Lueers, Georg H.; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany; [Freund, Barbara; Nielsen, Peter] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Jung, Caroline] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany; [Reimer, Rudolph; Hohenberg, Heinrich] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany; [Zangemeister-Wittke, Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Wester, Hans-Juergen] Tech Univ Munich, D-8046 Garching, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University of Bern; Technical University of Munich	Heine, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany.	ma.heine@uke.uni-hamburg.de			Bundesministerium fur Bildung und Forschung (TOMCAT) [01EZ0824]; Landesexzellenzinitiative Hamburg (State Excellence Initiative, Nanotechnology in Medicine - NAME)	Bundesministerium fur Bildung und Forschung (TOMCAT); Landesexzellenzinitiative Hamburg (State Excellence Initiative, Nanotechnology in Medicine - NAME)	This work was supported by the Bundesministerium fur Bildung und Forschung (TOMCAT, grant number 01EZ0824; http://www.bmbf.de/) and Landesexzellenzinitiative Hamburg (State Excellence Initiative, Nanotechnology in Medicine - NAME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita H, 2011, ONCOGENE, V30, P3468, DOI 10.1038/onc.2011.59; Andratschke M, 2007, ANTICANCER RES, V27, P431; Boucher Y, 1997, BRIT J CANCER, V75, P829, DOI 10.1038/bjc.1997.148; BOUCHER Y, 1991, CANCER RES, V51, P6691; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chauhan VP, 2011, ANNU REV CHEM BIOMOL, V2, P281, DOI 10.1146/annurev-chembioeng-061010-114300; DEJONGE MWA, 1993, EUR J CANCER, V29A, P1885, DOI 10.1016/0959-8049(93)90543-O; FADNES HO, 1977, MICROVASC RES, V14, P27, DOI 10.1016/0026-2862(77)90138-8; FERNSTEN PD, 1990, CANCER RES, V50, P4656; FODSTAD O, 1988, CANCER RES, V48, P4382; Fong D, 2008, J CLIN PATHOL, V61, P31, DOI 10.1136/jcp.2006.037333; Gastl G, 2000, LANCET, V356, P1981, DOI 10.1016/S0140-6736(00)03312-2; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Hall MA, 2011, PROSTATE; Heine M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028030; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Klosowska-Wardega A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008149; Kosterink JGW, 2007, J IMMUNOL, V179, P1362, DOI 10.4049/jimmunol.179.2.1362; Lange A, 2011, LUNG CANCER, V74, P178, DOI 10.1016/j.lungcan.2011.03.017; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; MOMBURG F, 1987, CANCER RES, V47, P2883; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; RIETHMULLER G, 1994, LANCET, V343, P1177, DOI 10.1016/S0140-6736(94)92398-1; SEARS HF, 1982, LANCET, V1, P762; Seligson DB, 2004, CLIN CANCER RES, V10, P2659, DOI 10.1158/1078-0432.CCR-1132-03; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Stoecklein NH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-165; Thurber GM, 2010, J SURG ONCOL, V102, P758, DOI 10.1002/jso.21735; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Varga M, 2004, CLIN CANCER RES, V10, P3131, DOI 10.1158/1078-0432.CCR-03-0528; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5	34	42	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36258	10.1371/journal.pone.0036258	http://dx.doi.org/10.1371/journal.pone.0036258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590529	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335500009
J	Furukawa, H; Oka, S; Shimada, K; Sugii, S; Ohashi, J; Matsui, T; Ikenaka, T; Nakayama, H; Hashimoto, A; Takaoka, H; Arinuma, Y; Okazaki, Y; Futami, H; Komiya, A; Fukui, N; Nakamura, T; Migita, K; Suda, A; Nagaoka, S; Tsuchiya, N; Tohma, S				Furukawa, Hiroshi; Oka, Shomi; Shimada, Kota; Sugii, Shoji; Ohashi, Jun; Matsui, Toshihiro; Ikenaka, Tatsuoh; Nakayama, Hisanori; Hashimoto, Atsushi; Takaoka, Hirokazu; Arinuma, Yoshiyuki; Okazaki, Yuko; Futami, Hidekazu; Komiya, Akiko; Fukui, Naoshi; Nakamura, Tadashi; Migita, Kiyoshi; Suda, Akiko; Nagaoka, Shouhei; Tsuchiya, Naoyuki; Tohma, Shigeto			Association of Human Leukocyte Antigen with Interstitial Lung Disease in Rheumatoid Arthritis: A Protective Role for Shared Epitope	PLOS ONE			English	Article							EXTRAARTICULAR MANIFESTATIONS; HAPLOTYPE RECONSTRUCTION; PULMONARY-FIBROSIS; JAPANESE PATIENTS; HLA-DRB1-ASTERISK-15; COMPLEX; IMPACT; GENES	Introduction: Interstitial Lung Disease (ILD) is frequently associated with Rheumatoid Arthritis (RA) as one of extra-articularmanifestations. Many studies for Human Leukocyte Antigen (HLA) allelic association with RA have been reported, but few have been validated in an RA subpopulation with ILD. In this study, we investigated the association of HLA class II alleles with ILD in RA. Methods: An association study was conducted on HLA-DRB1, DQB1, and DPB1 in 450 Japanese RA patients that were or were not diagnosed with ILD, based on the findings of computed tomography images of the chest. Results: Unexpectedly, HLA-DRB1*04 (corrected P [Pc] = 0.0054, odds ratio [OR] 0.57), shared epitope (SE) (P = 0.0055, OR 0.66) and DQB1*04 (Pc = 0.0036, OR 0.57) were associated with significantly decreased risk of ILD. In contrast, DRB1*16 (Pc = 0.0372, OR 15.21), DR2 serological group (DRB1*15 and *16 alleles) (P = 0.0020, OR 1.75) and DQB1*06 (Pc = 0.0333, OR 1.57, respectively) were significantly associated with risk of ILD. Conclusion: HLA-DRB1 SE was associated with reduced, while DR2 serological group (DRB1*15 and *16) with increased, risk for ILD in Japanese patients with RA.	[Furukawa, Hiroshi; Oka, Shomi; Komiya, Akiko; Fukui, Naoshi; Tohma, Shigeto] Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Sugii, Shoji; Matsui, Toshihiro; Ikenaka, Tatsuoh; Nakayama, Hisanori; Hashimoto, Atsushi; Takaoka, Hirokazu; Arinuma, Yoshiyuki; Okazaki, Yuko; Futami, Hidekazu] Natl Hosp Org, Sagamihara Hosp, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Sugii, Shoji] Tokyo Metropolitan Tama Med Ctr, Fuchu, Tokyo, Japan; [Ohashi, Jun; Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan; [Nakamura, Tadashi] Kumamoto Ctr Arthrit & Rheumatol, Kumamoto, Japan; [Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, Omura, Japan; [Suda, Akiko; Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Kanazawa Ku, Yokohama, Kanagawa, Japan	University of Tsukuba	Furukawa, H (corresponding author), Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan.	h-furukawa@sagamihara-hosp.gr.jp	Tsuchiya, Naoyuki/CAA-4545-2022; OHASHI, JUN/G-5907-2015; Arinuma, Yoshiyuki/CAH-4707-2022; Matsui, Toshihiro/AFU-8893-2022	Tsuchiya, Naoyuki/0000-0002-6776-5580; Matsui, Toshihiro/0000-0002-7686-3211	Japan Society for the Promotion of Science, Health and Labour Science Research; Clinical Research from National Hospital Organization; Japan Research Foundation for Clinical Pharmacology; Takeda Science Foundation; Daiwa Securities Health Foundation,; Nakatomi Foundation; Manabe Foundation; Takeda Pharmaceutical Company; Hisamitsu Pharmaceutical Co., Inc.; Daiwa Securities Health Foundation	Japan Society for the Promotion of Science, Health and Labour Science Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Clinical Research from National Hospital Organization; Japan Research Foundation for Clinical Pharmacology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Daiwa Securities Health Foundation,; Nakatomi Foundation; Manabe Foundation; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Hisamitsu Pharmaceutical Co., Inc.; Daiwa Securities Health Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Health and Labour Science Research Grants from the Ministry of Health, Labour, and Welfare of Japan, Grants-in-Aid for Clinical Research from National Hospital Organization, Research Grants from Japan Research Foundation for Clinical Pharmacology, Research Grants from Takeda Science Foundation, Research Grants from Daiwa Securities Health Foundation, Research Grants from The Nakatomi Foundation, and Research Grants from The Manabe Foundation. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The following funders are supported in whole or in part by the subsequent pharmaceutical companies. The Japan Research Foundation for Clinical Pharmacology is run by Daiichi Sankyo, the Takeda Science Foundation is supported by an endowment from Takeda Pharmaceutical Company and the Nakatomi Foundation was established by Hisamitsu Pharmaceutical Co., Inc. The Daiwa Securities Health Foundation was established by Daiwa Securities Group Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Falfan-Valencia R, 2005, HUM GENET, V118, P235, DOI 10.1007/s00439-005-0035-7; Kim HY, 1997, BRIT J RHEUMATOL, V36, P440; Koduri G, 2010, RHEUMATOLOGY, V49, P1483, DOI 10.1093/rheumatology/keq035; LANCHBURY JSS, 1991, HUM IMMUNOL, V32, P56, DOI 10.1016/0198-8859(91)90117-R; Lewis SN, 2011, PLOS ONE, V6; Mattey DL, 2000, J RHEUMATOL, V27, P2611; Migita K, 2010, J RHEUMATOL, V37, P205, DOI 10.3899/jrheum.090303; Ohashi J, 2001, ANN HUM GENET, V65, P197, DOI 10.1017/S000348000100851X; Perricone C, 2011, AUTOIMMUN REV, V10, P599, DOI 10.1016/j.autrev.2011.04.021; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; Scott IC, 2011, BEST PRACT RES CL RH, V25, P447, DOI 10.1016/j.berh.2011.10.010; Shibue T, 2000, ARTHRITIS RHEUM, V43, P753, DOI 10.1002/1529-0131(200004)43:4<753::AID-ANR5>3.0.CO;2-O; Simeon CP, 2009, J RHEUMATOL, V36, P2733, DOI 10.3899/jrheum.090377; Sirikong M, 2002, TISSUE ANTIGENS, V59, P113, DOI 10.1034/j.1399-0039.2002.590206.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tokunaga NK, 1999, NEPHRON, V81, P165, DOI 10.1159/000045273; Turesson C, 2005, ARTHRITIS RES THER, V7, pR1386, DOI 10.1186/ar1837; Turesson C, 2004, ARTHRIT RHEUM-ARTHR, V51, P853, DOI 10.1002/art.20693; Turesson C, 2004, SCAND J RHEUMATOL, V33, P65, DOI 10.1080/03009740310004621; Webb WR, 2006, RADIOLOGY, V239, P322, DOI 10.1148/radiol.2392041968; WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Xue JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014715	26	58	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e33133	10.1371/journal.pone.0033133	http://dx.doi.org/10.1371/journal.pone.0033133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586441	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000003
J	Franca-Costa, J; Wanderley, JLM; Deolindo, P; Zarattini, JB; Costa, J; Soong, L; Barcinski, MA; Barral, A; Borges, VM				Franca-Costa, Jaqueline; Mendes Wanderley, Joao Luiz; Deolindo, Poliana; Zarattini, Jessica B.; Costa, Jackson; Soong, Lynn; Barcinski, Marcello Andre; Barral, Aldina; Borges, Valeria M.			Exposure of Phosphatidylserine on Leishmania amazonensis Isolates Is Associated with Diffuse Cutaneous Leishmaniasis and Parasite Infectivity	PLOS ONE			English	Article							CELLS IN-VITRO; APOPTOTIC CELLS; MEXICANA-AMAZONENSIS; HOST-CELLS; AMASTIGOTES; DISEASE; MACROPHAGES; MIMICRY; EVASION; MICE	Diffuse cutaneous leishmaniasis (DCL) is a rare clinical manifestation of leishmaniasis, characterized by an inefficient parasite-specific cellular response and heavily parasitized macrophages. In Brazil, Leishmania (Leishmania) amazonensis is the main species involved in DCL cases. In the experimental model, recognition of phosphatidylserine (PS) molecules exposed on the surface of amastigotes forms of L. amazonensis inhibits the inflammatory response of infected macrophages as a strategy to evade the host immune surveillance. In this study, we examined whether PS exposure on L. amazonensis isolates from DCL patients operated as a parasite pathogenic factor and as a putative suppression mechanism of immune response during the infection. Peritoneal macrophages from F1 mice (BALB/cxC57BL/6) were infected with different L. amazonensis isolates from patients with localized cutaneous leishmaniasis (LCL) or DCL. DCL isolates showed higher PS exposure than their counterparts from LCL patients. In addition, PS exposure was positively correlated with clinical parameters of the human infection (number of lesions and time of disease) and with characteristics of the experimental infection (macrophage infection and anti-inflammatory cytokine induction). Furthermore, parasites isolated from DCL patients displayed an increased area in parasitophorous vacuoles (PV) when compared to those isolated from LCL patients. Thus, this study shows for the first time that a parasite factor (exposed PS) might be associated with parasite survival/persistence in macrophages and lesion exacerbation during the course of DCL, providing new insights regarding pathogenic mechanism in this rare chronic disease.	[Franca-Costa, Jaqueline; Costa, Jackson; Barral, Aldina; Borges, Valeria M.] Ctr Pesquisas Goncalo Moniz FIOCRUZ BA, Salvador, BA, Brazil; [Franca-Costa, Jaqueline; Barral, Aldina; Borges, Valeria M.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Mendes Wanderley, Joao Luiz] Univ Fed Rio de Janeiro, Polo Univ Macae, Rio de Janeiro, Brazil; [Mendes Wanderley, Joao Luiz; Deolindo, Poliana; Zarattini, Jessica B.; Barcinski, Marcello Andre] Inst Nacl Canc, Div Expt Med, Rio De Janeiro, Brazil; [Deolindo, Poliana; Barcinski, Marcello Andre] Inst Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil; [Zarattini, Jessica B.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Soong, Lynn] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Soong, Lynn] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Franca-Costa, J (corresponding author), Ctr Pesquisas Goncalo Moniz FIOCRUZ BA, Salvador, BA, Brazil.	vborges@bahia.fiocruz.br	Barral, Aldina/B-4191-2009; Borges, Valeria/G-2009-2014; Wanderley, Joao Luiz/J-6711-2014; Borges, Val/N-6647-2019	Barral, Aldina/0000-0002-7177-464X; Borges, Val/0000-0002-2775-5409	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) e PAPES V-FIOCRUZ; National Institutes of Health [AI043003]; CAPES; CNPq; Programa de Cooperacao INCA/FIOCRUZ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043003, R56AI043003] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) e PAPES V-FIOCRUZ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Cooperacao INCA/FIOCRUZ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) e PAPES V-FIOCRUZ (V. Borges), Programa de Cooperacao INCA/FIOCRUZ (M. Barcinski and A. Barral) and by National Institutes of Health grant AI043003 (L. Soong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Manoel Barral-Netto, Dr. Ana Cristina Rodrigues Saldanha, Dr. Roque Almeida and Dr. Camila Indiani de Oliveira for helpful discussions. We thank Fernanda Lourenco for helpful technical assistance, Mr. Theo Araujo dos Santos for assistance with the image processing, and Ms. Mardelle Susman for proofreading. JFC is recipient of a CAPES fellowship and JLMW is recipient of a CNPq fellowship. VMB, AB, JC and MAB are senior investigators from CNPq.	AKUFFO JH, 1987, SCAND J IMMUNOL, V26, P717, DOI 10.1111/j.1365-3083.1987.tb02308.x; Almeida RP, 1996, AM J TROP MED HYG, V54, P178, DOI 10.4269/ajtmh.1996.54.178; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Balestieri FMP, 2002, MICROBES INFECT, V4, P23, DOI 10.1016/S1286-4579(01)01505-2; BARCINSKI MA, 1992, INFECT IMMUN, V60, P3523, DOI 10.1128/IAI.60.9.3523-3527.1992; BENCHIMOL M, 1981, Z PARASITENKD, V66, P25, DOI 10.1007/BF00941942; Bomfim G, 1996, EXP PARASITOL, V84, P188, DOI 10.1006/expr.1996.0104; CARVALHO EM, 1994, ACTA TROP, V56, P315, DOI 10.1016/0001-706X(94)90103-1; CONVIT J, 1972, T ROY SOC TROP MED H, V66, P603, DOI 10.1016/0035-9203(72)90306-9; CONVIT J, 1993, T ROY SOC TROP MED H, V87, P444, DOI 10.1016/0035-9203(93)90030-T; Courret N, 2002, J CELL SCI, V115, P2303; CUPOLILLO E, 1994, AM J TROP MED HYG, V50, P296, DOI 10.4269/ajtmh.1994.50.296; DaMatta RA, 2007, FEMS MICROBIOL LETT, V266, P29, DOI 10.1111/j.1574-6968.2006.00495.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Giudice A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-7; Kawakami K, 1997, INFECT IMMUN, V65, P1307, DOI 10.1128/IAI.65.4.1307-1312.1997; LEAO SD, 1995, J CELL SCI, V108, P3219; McMahon-Pratt D, 2004, IMMUNOL REV, V201, P206, DOI 10.1111/j.0105-2896.2004.00190.x; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Sanabria MXH, 2008, INFECT IMMUN, V76, P5100, DOI 10.1128/IAI.00438-08; Saraiva EM, 2005, EXP PARASITOL, V110, P39, DOI 10.1016/j.exppara.2005.01.004; SARAIVA EMB, 1983, J PARASITOL, V69, P627, DOI 10.2307/3281388; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Seabra SH, 2004, BIOCHEM BIOPH RES CO, V324, P744, DOI 10.1016/j.bbrc.2004.09.114; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Wilson J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000179; Xin LJ, 2008, MOL IMMUNOL, V45, P3371, DOI 10.1016/j.molimm.2008.04.018; Xin LJ, 2007, INFECT IMMUN, V75, P5018, DOI 10.1128/IAI.00499-07	36	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36595	10.1371/journal.pone.0036595	http://dx.doi.org/10.1371/journal.pone.0036595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574191	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800088
J	Grant, AV; Araujo, MI; Ponte, EV; Oliveira, RR; Gao, P; Cruz, AA; Barnes, KC; Beaty, TH				Grant, Audrey V.; Araujo, Maria Ilma; Ponte, Eduardo Vieira; Oliveira, Ricardo Riccio; Gao, Peisong; Cruz, Alvaro A.; Barnes, Kathleen C.; Beaty, Terri H.			Functional Polymorphisms in IL13 Are Protective against High Schistosoma mansoni Infection Intensity in a Brazilian Population	PLOS ONE			English	Article							IMMUNOGLOBULIN-E; PROMOTER POLYMORPHISM; CHROMOSOME 5Q31-Q33; ASSOCIATION; ASTHMA; LOCUS; IL-13; HAPLOTYPE; ATOPY; IGE	Background: IL-13 is a signature cytokine of the helper T cell type 2 (TH2) pathway which underlies host defense to helminthic infection and activates production of IgE in both parasitized populations and in urban settings after allergen exposure. Methodology/Principal Findings: Two functional polymorphisms in IL13, rs1800925 (or c.1-1111C>T) and rs20541 (or R130Q) were previously found to be associated with Schistosoma hematobium infection intensity. They have not been thoroughly explored in S. mansoni-endemic populations, however, and were selected along with 5 tagging SNPs for genotyping in 812 individuals in 318 nuclear families from a schistosomiasis-endemic area of Conde, Bahia, in Brazil. Regression models using GEE to account for family membership and family-based quantitative transmission disequilibrium tests (QTDT) were used to evaluate associations with total serum IgE (tIgE) levels and S. mansoni fecal egg counts adjusted for non-genetic covariates. We identified a protective effect for the T allele at rs20541 (P = 0.005) against high S. mansoni egg counts, corroborated by QTDT (P = 0.014). Our findings also suggested evidence for protective effects for the T allele at rs1800925 and A allele at rs2066960 after GEE analysis only (P = 0.050, 0.0002). Conclusions/Significance: The two functional variants in IL13 are protective against high S. mansoni egg counts. These markers showed no evidence of association with tIgE levels, unlike tIgE levels previously studied in non-parasitized or atopic study populations.	[Grant, Audrey V.; Barnes, Kathleen C.; Beaty, Terri H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Grant, Audrey V.; Gao, Peisong; Barnes, Kathleen C.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Araujo, Maria Ilma; Oliveira, Ricardo Riccio; Cruz, Alvaro A.] Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil; [Ponte, Eduardo Vieira; Cruz, Alvaro A.] Univ Fed Bahia, Sch Med, Programa Controle Asma & Rinite Alerg Bahia, Salvador, BA, Brazil	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Universidade Federal da Bahia	Grant, AV (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	audrey.grant@inserm.fr	Oliveira, Ricardo/E-7707-2017; Cruz, Alvaro A/I-1676-2012	Oliveira, Ricardo/0000-0001-9586-2313; Cruz, Alvaro A/0000-0002-7403-3871	Glaxo-Smith-Kline [WE445]; National Institutes of Health [AI050024]; Mary Beryl Patch Turnbull Scholar Program; Glaxo-Smith-Kline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112088] Funding Source: NIH RePORTER	Glaxo-Smith-Kline(GlaxoSmithKline); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Beryl Patch Turnbull Scholar Program; Glaxo-Smith-Kline(GlaxoSmithKline); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by Glaxo-Smith-Kline under the project WE445 entitled "Immunogenetics of Schistosomiasis and Asthma," and National Institutes of Health grant #AI050024. KCB was supported in part by the Mary Beryl Patch Turnbull Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study benefited from financial support from Glaxo-Smith-Kline. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Arima K, 2002, J ALLERGY CLIN IMMUN, V109, P980, DOI 10.1067/mai.2002.124656; AZEVEDO ES, 1980, ANN HUM GENET, V44, P55, DOI 10.1111/j.1469-1809.1980.tb00945.x; Bethony JM, 2008, ACTA TROP, V108, P166, DOI 10.1016/j.actatropica.2007.11.008; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gatlin MR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000375; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; GERRARD JW, 1978, AM J HUM GENET, V30, P46; Grant AV, 2011, GENES IMMUN, V12, P46, DOI 10.1038/gene.2010.50; Grant AV, 2008, J INFECT DIS, V198, P1227, DOI 10.1086/591946; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Hoffjan S, 2002, CURR OPIN IMMUNOL, V14, P709, DOI 10.1016/S0952-7915(02)00393-X; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Hummelshoj T, 2003, EUR J IMMUNOGENET, V30, P355, DOI 10.1046/j.1365-2370.2003.00416.x; Isnard A, 2011, GENES IMMUN, V12, P31, DOI 10.1038/gene.2010.43; KATZ N, 1970, J PARASITOL, V56, P1032, DOI 10.2307/3277532; Katz N., 1978, Revista do Instituto de Medicina Tropical de Sao Paulo, V20, P273; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Kouriba B, 2005, J IMMUNOL, V174, P6274, DOI 10.4049/jimmunol.174.10.6274; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Maier LM, 2006, J ALLERGY CLIN IMMUN, V117, P1306, DOI 10.1016/j.jaci.2005.12.1354; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Masters M, 1985, EPIDEMIOLOGY REV, V7, P49; MEYERS DA, 1991, GENET EPIDEMIOL, V8, P351, DOI 10.1002/gepi.1370080507; MullerMyhsok B, 1997, AM J HUM GENET, V61, P452, DOI 10.1016/S0002-9297(07)64073-7; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Quinnell RJ, 2003, INT J PARASITOL, V33, P1219, DOI 10.1016/S0020-7519(03)00175-9; Tarazona-Santos E, 2005, GENES IMMUN, V6, P53, DOI 10.1038/sj.gene.6364149; Vercelli D, 2002, CURR OPIN ALLERGY CL, V2, P389, DOI 10.1097/00130832-200210000-00004; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35863	10.1371/journal.pone.0035863	http://dx.doi.org/10.1371/journal.pone.0035863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574126	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800022
J	Hicks, CC; McClanahan, TR				Hicks, Christina C.; McClanahan, Timothy R.			Assessing Gear Modifications Needed to Optimize Yields in a Heavily Exploited, Multi-Species, Seagrass and Coral Reef Fishery	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; SOUTHERN ARABIAN GULF; LIFE-HISTORY; POPULATION BIOLOGY; ARTISANAL FISHERY; MARINE RESERVES; FISHING GEAR; LENGTH; BEDS; SUSTAINABILITY	Effective management is necessary if small-scale fisheries, such as those found in mixed habitats including seagrass and coral reefs, are to continue providing food for many of the poorest communities of the world. Gear-based management, although under represented and under studied, has the potential to be adaptive, address multiple objectives, and be crafted to the socio-economic setting. Management effectiveness in seagrass and coral reef fisheries has generally been evaluated at the scale of the fish community. However, community level indicators can mask species-specific declines that provide significant portions of the fisheries yields and income. Using a unique dataset, containing ten years of species level length frequency catch data from a multi-gear, multi-species seagrass and coral reef fishery in Kenya, we evaluate species specific fishery statuses, compare gear use to gear regulations and estimate the potential needs for further gear restrictions. Despite the high diversity of the fishery, fifteen species represented over 90% of the catch, and only three species represented 60% of the catch. The three most abundant species in the catch, Lethrinus lentjan (Lacepede), Siganus sutor (Valenciennes) and Leptoscarus vaigiensis (Quoy & Gaimard) all showed evidence of growth overfishing. Lethrinus lentjan, with an exploitation rate of 0.82, also shows evidence of recruitment overfishing. Current legal but weakly enforced gear restrictions are capable of protecting a significant portion of the catch up to maturity but optimization of yield will require that the current mesh size be increased from 6.3 to 8.8 and 9.2 cm to increase yields of L. lentjan and S. sutor, respectively. Given the difficulties of enforcing mesh size, we recommend that the economic benefits of these larger mesh sizes be communicated and enforced through co-management. This abstract is also available in Kiswahili (Abstract S1).	[Hicks, Christina C.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia; [Hicks, Christina C.] Coral Reef Conservat Project, Mombasa, Kenya; [McClanahan, Timothy R.] Wildlife Conservat Soc, Marine Programs, New York, NY USA	James Cook University; Wildlife Conservation Society	Hicks, CC (corresponding author), James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia.	Christina.c.hicks@gmail.com	Hicks, christina/B-1421-2013; McClanahan, Tim/K-4998-2019; Hicks, Christina/M-6182-2015	Hicks, Christina/0000-0002-7399-4603; McClanahan, Timothy/0000-0001-5821-3584	Eppley Foundation; McBean Foundation; Tiffany Foundation; Pew Fellows Program in Marine Conservation	Eppley Foundation; McBean Foundation; Tiffany Foundation; Pew Fellows Program in Marine Conservation	This study was funded through grants from the Eppley, McBean, Tiffany Foundations and the Pew Fellows Program in Marine Conservation. Research clearance was provided by Kenya's Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; [Anonymous], 2001, QUANTITATIVE FISHERI; Armsworth PR, 2002, ECOLOGY, V83, P1092, DOI 10.1890/0012-9658(2002)083[1092:RLPRAL]2.0.CO;2; Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Beverton R.J.H., 1956, J CONS INT EXPLOR ME, V14, P67; Cinner JE, 2009, MAR POLICY, V33, P489, DOI 10.1016/j.marpol.2008.11.001; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Currey LM, 2009, COMP BIOL KEY INTERR; Davies TE, 2009, FISHERIES MANAG ECOL, V16, P279, DOI 10.1111/j.1365-2400.2009.00665.x; Donner SD, 2007, BIOSCIENCE, V57, P214, DOI 10.1641/B570302; Dorenbosch M, 2006, HYDROBIOLOGIA, V563, P45, DOI 10.1007/s10750-005-1428-2; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; EHRHARDT NM, 1992, T AM FISH SOC, V121, P115, DOI 10.1577/1548-8659(1992)121<0115:AOTLMM>2.3.CO;2; Froese R, 2000, J FISH BIOL, V56, P758, DOI 10.1111/j.1095-8649.2000.tb00870.x; Froese R., 2012, FISHBASE; Gell FR, 2002, MAR FRESHWATER RES, V53, P115, DOI 10.1071/MF01125; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Grandcourt E, 2007, J APPL ICHTHYOL, V23, P53, DOI 10.1111/j.1439-0426.2006.00796.x; Grandcourt EM, 2004, FISH RES, V69, P331, DOI 10.1016/j.fishres.2004.06.008; Grandcourt EM, 2002, MAR FRESHWATER RES, V53, P123, DOI 10.1071/MF01123; Grol MGG, 2011, OECOLOGIA, V165, P79, DOI 10.1007/s00442-010-1833-8; Gulland JA., 1971, FISH RESOURCES OCEAN; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hilborn R, 2004, B MAR SCI, V74, P493; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 2004, MAR ECOL PROG SER, V274, P279; Jennings S., 2001, MARINE FISHERIES ECO; Jennings S, 2007, ICES J MAR SCI, V64, P1525, DOI 10.1093/icesjms/fsm104; Johnson JE, 2010, REV FISH SCI, V18, P106, DOI 10.1080/10641260903434557; Kaunda-Arara Boaz, 2003, Western Indian Ocean Journal of Marine Science, V2, P105; Kimirei IA, 2011, ESTUAR COAST SHELF S, V92, P47, DOI 10.1016/j.ecss.2010.12.016; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lieske E, 1994, COLLINGS POCKET GUID; MACLENNAN DN, 1992, FISH RES, V13, P201, DOI 10.1016/0165-7836(92)90076-6; Mahon R, 1997, CAN J FISH AQUAT SCI, V54, P2207, DOI 10.1139/cjfas-54-9-2207; Mangi SC, 2006, MAR POLLUT BULL, V52, P1646, DOI 10.1016/j.marpolbul.2006.06.006; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McClanahan TR, 2011, J EXP MAR BIOL ECOL, V408, P3, DOI 10.1016/j.jembe.2011.07.021; McClanahan TR, 2011, FISHERIES MANAG ECOL, V18, P50, DOI 10.1111/j.1365-2400.2010.00768.x; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; McClanahan TR, 2004, FISHERIES MANAG ECOL, V11, P51, DOI 10.1111/j.1365-2400.2004.00358.x; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Munro JL, 2003, PROCEEDINGS OF THE FIFTY-FOURTH ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P28; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D., 1983, FAO FISH TECH PAP, P1; Peterman RM, 2004, ICES J MAR SCI, V61, P1331, DOI 10.1016/j.icesjms.2004.08.017; Quinn GP, 2003, EXPT DESIGN DATA ANA; ROBERTS CM, 1993, AMBIO, V22, P363; Rochet MJ, 2000, OIKOS, V91, P255, DOI 10.1034/j.1600-0706.2000.910206.x; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Smith M.M., 1986, SMITHS SEA FISHES; Sparre P., 1998, INTRO TROPICAL FIS 1; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x	63	83	91	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36022	10.1371/journal.pone.0036022	http://dx.doi.org/10.1371/journal.pone.0036022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574133	Green Published, Green Accepted, gold			2022-12-25	WOS:000305349800029
J	Li, L; Lu, JR; Tao, Z; Huang, Q; Chai, YC; Li, XH; Huang, ZW; Li, Y; Xiang, ML; Yang, J; Yao, GY; Wang, Y; Yang, T; Wu, H				Li, Lei; Lu, Jingrong; Tao, Zheng; Huang, Qi; Chai, Yongchuan; Li, Xiaohua; Huang, Zhiwu; Li, Yun; Xiang, Mingliang; Yang, Jun; Yao, Guoyin; Wang, Yu; Yang, Tao; Wu, Hao			The p.V37I Exclusive Genotype Of GJB2: A Genetic Risk-Indicator of Postnatal Permanent Childhood Hearing Impairment	PLOS ONE			English	Article							CONNEXIN-26 MUTATIONS; HIGH PREVALENCE; CHILDREN; DEAFNESS; INTERVENTION; IDENTIFY; LANGUAGE	Postnatal permanent childhood hearing impairment (PCHI) is frequent (0.25%-0.99%) and difficult to detect in the early stage, which may impede the speech, language and cognitive development of affected children. Genetic tests of common variants associated with postnatal PCHI in newborns may provide an efficient way to identify those at risk. In this study, we detected a strong association of the p.V37I exclusive genotype of GJB2 with postnatal PCHI in Chinese Hans (P = 1.4x10(-10); OR 62.92, 95% CI 21.27-186.12). This common genotype in Eastern Asians was present in a substantial percentage (20%) of postnatal PCHI subjects, and its prevalence was significantly increased in normal-hearing newborns who failed at least one newborn hearing screen. Our results indicated that the p.V37I exclusive genotype of GJB2 may cause subclinical hearing impairment at birth and increases risk for postnatal PCHI. Genetic testing of GJB2 in East Asian newborns will facilitate prompt detection and intervention of postnatal PCHI.	[Li, Lei; Lu, Jingrong; Huang, Qi; Li, Xiaohua; Huang, Zhiwu; Li, Yun; Xiang, Mingliang; Yang, Jun; Yang, Tao; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Li, Lei; Lu, Jingrong; Tao, Zheng; Huang, Qi; Chai, Yongchuan; Li, Xiaohua; Huang, Zhiwu; Li, Yun; Xiang, Mingliang; Yang, Jun; Yang, Tao; Wu, Hao] Shanghai Jiao Tong Univ, Ear Inst, Shanghai 200030, Peoples R China; [Tao, Zheng] Shanghai Childrens Med Ctr, Shanghai, Peoples R China; [Yao, Guoyin; Wang, Yu] Shanghai Child Hlth Care Inst, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China.	yangtfxl@sina.com; wuhao@shsmu.edu.cn		Yang, Tao/0000-0001-6011-987X	National Basic Research Program of China [2011CB504501]; Shanghai Municipal Science and Technology Commission [08DZ1980100, 09DJ1400604, 11PJ1407000]; National Science Foundation of China [30971596]; "Shu Guang" project [09SG19]; Oriental Scholar project from Shanghai Municipal Education Commission and Shanghai Education Development Foundation; Shanghai Jiaotong University School of Medicine [BXJ201121]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Shu Guang" project(Chinese Academy of Sciences); Oriental Scholar project from Shanghai Municipal Education Commission and Shanghai Education Development Foundation; Shanghai Jiaotong University School of Medicine	This research was supported by a grant from National Basic Research Program of China 2011CB504501 (HW); grants from Shanghai Municipal Science and Technology Commission 08DZ1980100 (HW), 09DJ1400604 and 11PJ1407000 (TY); a grant from National Science Foundation of China 30971596 (TY); "Shu Guang" project 09SG19 and Oriental Scholar project from Shanghai Municipal Education Commission and Shanghai Education Development Foundation (TY); and a grant from Shanghai Jiaotong University School of Medicine BXJ201121 (LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Chan DK, 2010, GENET MED, V12, P174, DOI 10.1097/GIM.0b013e3181d0d42b; Cohn ES, 1999, PEDIATRICS, V103, P546, DOI 10.1542/peds.103.3.546; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Downs MP, 1999, PEDIATR CLIN N AM, V46, P79, DOI 10.1016/S0031-3955(05)70082-1; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Finitzo T, 2000, PEDIATRICS, V106, P798, DOI 10.1044/1059-0889(2000/005); Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536; Green GE, 2000, JAMA-J AM MED ASSOC, V284, P1245, DOI 10.1001/jama.284.10.1245; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Lu JR, 2011, INT J PEDIATR OTORHI, V75, P1045, DOI 10.1016/j.ijporl.2011.05.022; Moeller MP, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e43; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Norris VW, 2006, EAR HEARING, V27, P732, DOI 10.1097/01.aud.0000240492.78561.d3; Oguchi T, 2005, J HUM GENET, V50, P76, DOI 10.1007/s10038-004-0223-7; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; Sun Xiaoming, 2009, World Health Popul, V11, P14; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x; Weichbold V, 2006, PEDIATRICS, V117, pE631, DOI 10.1542/peds.2005-1455; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	21	29	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36621	10.1371/journal.pone.0036621	http://dx.doi.org/10.1371/journal.pone.0036621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574200	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800097
J	Nawaz, HM; Kylsten, P; Hamada, N; Yamamoto, D; Smith, CIE; Lindvall, JM				Nawaz, Hossain M.; Kylsten, Per; Hamada, Noriko; Yamamoto, Daisuke; Smith, C. I. Edvard; Lindvall, Jessica M.			Differential Evolutionary Wiring of the Tyrosine Kinase Btk	PLOS ONE			English	Article							X-LINKED AGAMMAGLOBULINEMIA; TEC-FAMILY; B-CELLS; BONE-MARROW; XID MICE; DROSOPHILA; SRC64; ACTIN; EXPRESSION; LOCALIZATION	Background: A central question within biology is how intracellular signaling pathways are maintained throughout evolution. Btk29A is considered to be the fly-homolog of the mammalian Bruton's tyrosine kinase (Btk), which is a non-receptor tyrosine-kinase of the Tec-family. In mammalian cells, there is a single transcript splice-form and the corresponding Btk-protein plays an important role for B-lymphocyte development with alterations within the human BTK gene causing the immunodeficiency disease X-linked agammaglobulinemia in man and a related disorder in mice. In contrast, the Drosophila Btk29A locus encodes two splice-variants, where the type 2-form is the more related to the mammalian Btk gene product displaying more than 80% homology. In Drosophila, Btk29A displays a dynamic pattern of expression through the embryonic to adult stages. Complete loss-of-function of both splice-forms is lethal, whereas selective absence of the type 2-form reduces the adult lifespan of the fly and causes developmental abnormalities in male genitalia. Methodology/Principal Findings: Out of 7004-7979 transcripts expressed in the four sample groups, 5587 (70-79%) were found in all four tissues and strains. Here, we investigated the role of Btk29A type 2 on a transcriptomic level in larval CNS and adult heads. We used samples either selectively defective in Btk29A type 2 (Btk29A(ficP)) or revertant flies with restored Btk29A type 2-function (Btk29A((fic Exc1-16))). The whole transcriptomic profile for the different sample groups revealed Gene Ontology patterns reflecting lifespan abnormalities in adult head neuronal tissue, but not in larvae. Conclusions: In the Btk29A type 2-deficient strains there was no significant overlap between transcriptomic alterations in adult heads and larvae neuronal tissue, respectively. Moreover, there was no significant overlap of the transcriptomic changes between flies and mammals, suggesting that the evolutionary conservation is confined to components of the proximal signaling, whereas the corresponding, downstream transcriptional regulation has been differentially wired.	[Nawaz, Hossain M.; Smith, C. I. Edvard] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med,Clin Res Ctr, Stockholm, Sweden; [Kylsten, Per] Europaskolan, Strangnas, Sweden; [Hamada, Noriko; Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Sendai, Miyagi 980, Japan; [Lindvall, Jessica M.] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Lindvall, Jessica M.] BioinformaticServ, Saltsjobaden, Sweden	Karolinska Institutet; Karolinska University Hospital; Tohoku University; Karolinska Institutet; Karolinska University Hospital	Lindvall, JM (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med,Clin Res Ctr, Stockholm, Sweden.	jessica.lindvall@ki.se	Lindvall, Jessica M/A-1762-2013	SMITH, C. I. Edvard/0000-0003-1907-3392; Lindvall, Jessica/0000-0002-5042-8481; , Daisuke/0000-0002-4623-0106	Swedish Cancer Society; Torsten and Ragnar Soderberg Foundation	Swedish Cancer Society(Swedish Cancer Society); Torsten and Ragnar Soderberg Foundation	This work was supported by the Swedish Cancer Society and the Torsten and Ragnar Soderberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DR, 2005, DEV BIOL, V286, P57, DOI 10.1016/j.ydbio.2005.07.006; Baba K, 1999, MOL CELL BIOL, V19, P4405; Bina S, 2010, EMBO REP, V11, P201, DOI 10.1038/embor.2010.1; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; CAMPANA D, 1990, J IMMUNOL, V145, P1675; Chandrasekaran V, 2005, DEVELOPMENT, V132, P3515, DOI 10.1242/dev.01926; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CHOU TB, 1992, GENETICS, V131, P643; Djagaeva I, 2005, DEV BIOL, V284, P143, DOI 10.1016/j.ydbio.2005.05.012; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Guarnieri DJ, 1998, MOL CELL, V1, P831, DOI 10.1016/S1097-2765(00)80082-9; Hamada N, 2005, FEBS LETT, V579, P4131, DOI 10.1016/j.febslet.2005.06.042; Hicks JK, 2007, EUKARYOT CELL, V6, P413, DOI 10.1128/EC.00213-06; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Islam TC, 2000, J GENE MED, V2, P204; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lindvall JM, 2006, BIOCHEM BIOPH RES CO, V346, P461, DOI 10.1016/j.bbrc.2006.05.146; Lindvall JM, 2004, EUR J IMMUNOL, V34, P1981, DOI 10.1002/eji.200324051; Liu CH, 2011, J IMMUNOL, V187, P230, DOI 10.4049/jimmunol.1100157; Lu N, 2004, EMBO J, V23, P1089, DOI 10.1038/sj.emboj.7600127; Monroe JG, 2007, ADV IMMUNOL, V95, P1, DOI 10.1016/S0065-2776(07)95001-4; Mukhopadhyay S, 2001, J CELL BIOCHEM, V81, P659, DOI 10.1002/jcb.1088; Noordzij JG, 2002, PEDIATR RES, V51, P159, DOI 10.1203/00006450-200202000-00007; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Ortutay C, 2008, ADV GENET, V64, P51, DOI 10.1016/S0065-2660(08)00803-1; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Read RD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000374; Roulier EM, 1998, MOL CELL, V1, P819, DOI 10.1016/S1097-2765(00)80081-7; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Tateno M, 2000, SCIENCE, V287, P324, DOI 10.1126/science.287.5451.324; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Thomas JH, 2004, DEVELOPMENT, V131, P863, DOI 10.1242/dev.00989; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Uckun FM, 1998, BIOCHEM PHARMACOL, V56, P683, DOI 10.1016/S0006-2952(98)00122-1; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851	41	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35640	10.1371/journal.pone.0035640	http://dx.doi.org/10.1371/journal.pone.0035640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574122	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800018
J	Ventoso, I; Kochetov, A; Montaner, D; Dopazo, J; Santoyo, J				Ventoso, Ivan; Kochetov, Alex; Montaner, David; Dopazo, Joaquin; Santoyo, Javier			Extensive Translatome Remodeling during ER Stress Response in Mammalian Cells	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; UNFOLDED PROTEIN RESPONSE; INDUCED GENE-EXPRESSION; RIBOSOME ENTRY SITES; GENOME-WIDE ANALYSIS; SECONDARY STRUCTURE; 5'-UNTRANSLATED REGION; EUKARYOTIC RIBOSOMES; INTERNAL INITIATION; IN-VIVO	In this work we have described the translatome of two mammalian cell lines, NIH3T3 and Jurkat, by scoring the relative polysome association of similar to 10,000 mRNA under normal and ER stress conditions. We have found that translation efficiencies of mRNA correlated poorly with transcript abundance, although a general tendency was observed so that the highest translation efficiencies were found in abundant mRNA. Despite the differences found between mouse (NIH3T3) and human (Jurkat) cells, both cell types share a common translatome composed by similar to 800-900 mRNA that encode proteins involved in basic cellular functions. Upon stress, an extensive remodeling in translatomes was observed so that translation of similar to 50% of mRNA was inhibited in both cell types, this effect being more dramatic for those mRNA that accounted for most of the cell translation. Interestingly, we found two subsets comprising 1000-1500 mRNA whose translation resisted or was induced by stress. Translation arrest resistant class includes many mRNA encoding aminoacyl tRNA synthetases, ATPases and enzymes involved in DNA replication and stress response such as BiP. This class of mRNA is characterized by high translation rates in both control and stress conditions. Translation inducible class includes mRNA whose translation was relieved after stress, showing a high enrichment in early response transcription factors of bZIP and zinc finger C2H2 classes. Unlike yeast, a general coordination between changes in translation and transcription upon stress (potentiation) was not observed in mammalian cells. Among the different features of mRNA analyzed, we found a relevant association of translation efficiency with the presence of upstream ATG in the 5'UTR and with the length of coding sequence of mRNA, and a looser association with other parameters such as the length and the G+C content of 5'UTR. A model for translatome remodeling during the acute phase of stress response in mammalian cells is proposed.	[Ventoso, Ivan] Univ Autonoma Madrid, Dept Biol Mol, Madrid, Spain; [Ventoso, Ivan] Ctr Biol Mol Severo Ochoa UAM CSIC, Madrid, Spain; [Montaner, David; Dopazo, Joaquin; Santoyo, Javier] CIPF, Dept Bioinformat & Genom, Valencia, Spain; [Dopazo, Joaquin; Santoyo, Javier] ISCIII, CIBERER, Valencia, Spain; [Dopazo, Joaquin] CIPF, Funct Genom Node INB, Valencia, Spain; [Kochetov, Alex] Inst Cytol & Genet, Novosibirsk, Russia	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Prince Felipe Research Center; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Ventoso, I (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Madrid, Spain.	iventoso@cbm.uam.es	Ventoso, Iván/N-4018-2014; Kochetov, Alex/R-9689-2016; Santoyo-Lopez, Javier/C-9714-2012; Dopazo, Joaquin/A-9270-2014; Montaner, David/A-9362-2014	Ventoso, Iván/0000-0001-7887-3520; Kochetov, Alex/0000-0003-3151-5181; Santoyo-Lopez, Javier/0000-0003-1988-5059; Dopazo, Joaquin/0000-0003-3318-120X; Montaner, David/0000-0002-2484-3278	Fundacion Mutua Madrilena [BFU2010-17411]; Ministerio de Ciencia e Innovacion [BIO2008-04212]; Generalitat Valenciana-Fondo Europeo Desarrollo Regional (GVA-FEDER) [PROMETEO/2010/001]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion [RD06/0020/1019]; Russian Academy of Sciences; Russian Ministry of Science Education; SD RAS Complex Integration Program; RFBR [12-04-00686]; Russian Ministry of Science Education [02.740.11.0705]; RAS (Molecular and Cellular Biology); SD RAS Partner Integration Program;  [BFBR811-04-00471]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana-Fondo Europeo Desarrollo Regional (GVA-FEDER); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion; Russian Academy of Sciences(Russian Academy of Sciences); Russian Ministry of Science Education(Ministry of Education and Science, Russian Federation); SD RAS Complex Integration Program; RFBR(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Science Education(Ministry of Education and Science, Russian Federation); RAS (Molecular and Cellular Biology); SD RAS Partner Integration Program; 	This work was supported by grants of the Fundacion Mutua Madrilena (FMM2008), BFU2010-17411 and BIO2008-04212 from the Ministerio de Ciencia e Innovacion and PROMETEO/2010/001 from the Generalitat Valenciana-Fondo Europeo Desarrollo Regional (GVA-FEDER). The Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Raras is an initiative of the Instituto de Salud carlos III (ISCIII). This work was also partly supported by a grant (RD06/0020/1019) from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion. AK was supported by BFBR811-04-00471, the Programme of Russian Academy of Sciences, Russian Ministry of Science & Education and SD RAS Complex Integration Program. AK is grateful to RFBR (12-04-00686), Russian Ministry of Science & Education (02.740.11.0705), Program of RAS (Molecular and Cellular Biology) and SD RAS Partner Integration Program for support. Institutional support from the Fundacion Ramon Areces is also acknowledged. Completion of this project took about 1 year and the estimated cost was 5,000 (sic) excluding salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2008, NUCLEIC ACIDS RES, V36, pW341, DOI 10.1093/nar/gkn318; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Baranick BT, 2008, P NATL ACAD SCI USA, V105, P4733, DOI 10.1073/pnas.0710650105; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Do AND, 2009, PHYSIOL GENOMICS, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fountoulakis M, 2004, J CHROMATOGR A, V1038, P247, DOI 10.1016/j.chroma.2004.03.032; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gulow K, 2002, J CELL SCI, V115, P2443; Gundacker N, 2006, ELECTROPHORESIS, V27, P2712, DOI 10.1002/elps.200500964; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Halbeisen RE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000105; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kimball SR, 2010, J BIOL CHEM, V285, P29027, DOI 10.1074/jbc.R110.137208; Kochetov AV, 2008, FEBS LETT, V582, P1293, DOI 10.1016/j.febslet.2008.03.014; Kochetov AV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-318; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lasko P, 2003, DEV CELL, V5, P671, DOI 10.1016/S1534-5807(03)00333-2; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Palam LR, 2011, J BIOL CHEM; Parsyan A, 2009, P NATL ACAD SCI USA, V106, P22217, DOI 10.1073/pnas.0909773106; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Robbins-Pianka A, 2010, BIOINFORMATICS, V26, P2651, DOI 10.1093/bioinformatics/btq509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sehgal A, 2000, ONCOGENE, V19, P2836, DOI 10.1038/sj.onc.1203601; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spence J, 2006, MOL CANCER RES, V4, P47, DOI 10.1158/1541-7786.MCR-04-0187; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; Traxler E, 2004, PROTEOMICS, V4, P1314, DOI 10.1002/pmic.200300774; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071; Wu L, 2007, MOL CELL PROTEOMICS, V6, P1343, DOI 10.1074/mcp.M700017-MCP200; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	83	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35915	10.1371/journal.pone.0035915	http://dx.doi.org/10.1371/journal.pone.0035915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574127	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800023
J	Franck, E; Bonneau, C; Jean, L; Henry, JP; Lacoume, Y; Salvetti, A; Boyer, O; Adriouch, S				Franck, Emilie; Bonneau, Carole; Jean, Laetitia; Henry, Jean-Paul; Lacoume, Yann; Salvetti, Anna; Boyer, Olivier; Adriouch, Sahil			Immunological Tolerance to Muscle Autoantigens Involves Peripheral Deletion of Autoreactive CD8(+) T Cells	PLOS ONE			English	Article							IDIOPATHIC INFLAMMATORY MYOPATHIES; CLASS-I; DENDRITIC CELLS; SELF-ANTIGENS; CROSS-PRESENTATION; EXPRESSION; INDUCTION; CTLA-4; PD-1; AUTOIMMUNITY	Muscle potentially represents the most abundant source of autoantigens of the body and can be targeted by a variety of severe autoimmune diseases. Yet, the mechanisms of immunological tolerance toward muscle autoantigens remain mostly unknown. We investigated this issue in transgenic SM-Ova mice that express an ovalbumin (Ova) neo-autoantigen specifically in skeletal muscle. We previously reported that antigen specific CD4(+) T cell are immunologically ignorant to endogenous Ova in this model but can be stimulated upon immunization. In contrast, Ova-specific CD8(+) T cells were suspected to be either unresponsive to Ova challenge or functionally defective. We now extend our investigations on the mechanisms governing CD8(+) tolerance in SM-Ova mice. We show herein that Ova-specific CD8(+) T cells are not detected upon challenge with strongly immunogenic Ova vaccines even after depletion of regulatory T cells. Ova-specific CD8(+) T cells from OT-I mice adoptively transferred to SM-Ova mice started to proliferate in vivo, acquired CD69 and PD-1 but subsequently down-regulated Bcl-2 and disappeared from the periphery, suggesting a mechanism of peripheral deletion. Peripheral deletion of endogenous Ova-specific cells was formally demonstrated in chimeric SM-Ova mice engrafted with bone marrow cells containing T cell precursors from OT-I TCR-transgenic mice. Thus, the present findings demonstrate that immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8(+) T cells.	[Franck, Emilie; Bonneau, Carole; Jean, Laetitia; Boyer, Olivier; Adriouch, Sahil] INSERM, U905, Rouen, France; [Franck, Emilie; Bonneau, Carole; Jean, Laetitia; Henry, Jean-Paul; Lacoume, Yann; Boyer, Olivier; Adriouch, Sahil] Univ Rouen, IRIB, Normandy, France; [Henry, Jean-Paul] INSERM, U1096, Rouen, France; [Salvetti, Anna] Ecole Normale Super Lyon ENS, INSERM, U758, Lyon, France; [Boyer, Olivier] Rouen Univ Hosp, Dept Immunol, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen	Franck, E (corresponding author), INSERM, U905, Rouen, France.	olivier.boyer@chu-rouen.fr; sahil.adriouch@univ-rouen.fr	Boyer, Olivier/N-6552-2013; Salvetti, Anna/I-6204-2016; ADRIOUCH, Sahil/G-8999-2012; Salvetti, Anna/F-9560-2013	Boyer, Olivier/0000-0002-7591-307X; ADRIOUCH, Sahil/0000-0002-0265-7773; Salvetti, Anna/0000-0003-2007-8350	"Association Francaise contre les Myopathies" (AFM); "Institut National de la Sante Et de la Recherche Medicale" (INSERM); Region Haute-Normandie	"Association Francaise contre les Myopathies" (AFM)(Association Francaise contre les Myopathies); "Institut National de la Sante Et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Haute-Normandie(Region Normandie)	This study was funded by the "Association Francaise contre les Myopathies" (AFM). E. F. was the recipient of a joint Ph.D. fellowship from "Institut National de la Sante Et de la Recherche Medicale" (INSERM) and "Region Haute-Normandie". No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriouch S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00199; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; BENDER A, 1995, J EXP MED, V181, P1863, DOI 10.1084/jem.181.5.1863; Benveniste O, 2001, J IMMUNOL, V167, P3521, DOI 10.4049/jimmunol.167.6.3521; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Calbo S, 2008, J IMMUNOL, V181, P408, DOI 10.4049/jimmunol.181.1.408; Cox S, 2010, INT J RHEUM DIS, V13, P117, DOI 10.1111/j.1756-185X.2010.01472.x; Dalakas MC, 2010, CURR OPIN PHARMACOL, V10, P346, DOI 10.1016/j.coph.2010.03.001; Dalakas MC, 2010, NAT REV RHEUMATOL, V6, P129, DOI 10.1038/nrrheum.2010.2; EMSLIESMITH AM, 1989, HUM PATHOL, V20, P224, DOI 10.1016/0046-8177(89)90128-7; Englund P, 2001, AM J PATHOL, V159, P1263, DOI 10.1016/S0002-9440(10)62513-8; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freitas AA, 1996, EUR J IMMUNOL, V26, P2640, DOI 10.1002/eji.1830261115; GOEBELS N, 1992, J IMMUNOL, V149, P661; Haverkamp JM, 2011, PROSTATE, V71, P1139, DOI 10.1002/pros.21327; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Leitao C, 2009, J IMMUNOL, V182, P5232, DOI 10.4049/jimmunol.0804071; Lutz MB, 2009, EUR J IMMUNOL, V39, P2325, DOI 10.1002/eji.200939548; Marino M, 2011, GENE THER, V18, P109, DOI 10.1038/gt.2010.124; MCDOUALL RM, 1989, J NEUROL SCI, V89, P213, DOI 10.1016/0022-510X(89)90023-3; Miller JFAP, 1998, IMMUNOL REV, V165, P267, DOI 10.1111/j.1600-065X.1998.tb01244.x; Murata K, 1999, AM J PATHOL, V155, P453, DOI 10.1016/S0002-9440(10)65141-3; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Rowe HM, 2006, MOL THER, V13, P310, DOI 10.1016/j.ymthe.2005.08.025; Shibaki A, 2004, J INVEST DERMATOL, V123, P109, DOI 10.1111/j.0022-202X.2004.22701.x; van der Pas J, 2004, J NEUROL NEUROSUR PS, V75, P136; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2; Wang LX, 2005, BLOOD, V105, P4226, DOI 10.1182/blood-2004-03-0848; Wiendl H, 2003, FASEB J, V17, P1892, DOI 10.1096/fj.03-0039fje; Williams MB, 1997, J IMMUNOL, V159, P1746	37	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36444	10.1371/journal.pone.0036444	http://dx.doi.org/10.1371/journal.pone.0036444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570714	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343400030
J	Gong, JL; Hoyos, B; Acin-Perez, R; Vinogradov, V; Shabrova, E; Zhao, F; Leitges, M; Fischman, D; Manfredi, G; Hammerling, U				Gong, Jianli; Hoyos, Beatrice; Acin-Perez, Rebeca; Vinogradov, Valerie; Shabrova, Elena; Zhao, Feng; Leitges, Michael; Fischman, Donald; Manfredi, Giovanni; Hammerling, Ulrich			Two protein kinase C isoforms, delta and epsilon, regulate energy homeostasis in mitochondria by transmitting opposing signals to the pyruvate dehydrogenase complex	FASEB JOURNAL			English	Article						mitochondrial energy metabolism; retinoids; vitamin A physiology; redox biology; respiration; signal transduction	RETINOL-BINDING-PROTEIN; OXIDASE SUBUNIT-IV; CYTOCHROME-C; PKC-DELTA; OXIDATIVE-PHOSPHORYLATION; INSULIN SENSITIVITY; RETRO-RETINOIDS; GENE-EXPRESSION; VITAMIN-A; ACTIVATION	Energy production in mitochondria is a multistep process that requires coordination of several subsystems. While reversible phosphorylation is emerging as the principal tool, it is still unclear how this signal network senses the workloads of processes as different as fuel procurement, catabolism in the Krebs cycle, and stepwise oxidation of reducing equivalents in the electron transfer chain. We previously proposed that mitochondria use oxidized cytochrome c in concert with retinol to activate protein kinase C delta, thereby linking a prominent kinase network to the redox balance of the ETC. Here, we show that activation of PKC epsilon in mitochondria also requires retinol as a cofactor, implying a redox-mechanism. Whereas activated PKC delta transmits a stimulatory signal to the pyruvate dehdyrogenase complex (PDHC), PKC epsilon opposes this signal and inhibits the PDHC. Our results suggest that the balance between PKC delta and epsilon is of paramount importance not only for flux of fuel entering the Krebs cycle but for overall energy homeostasis. We observed that the synthetic retinoid fenretinide substituted for the retinol cofactor function but, on chronic use, distorted this signal balance, leading to predominance of PKC epsilon over PKC delta. The suppression of the PDHC might explain the proapoptotic effect of fenretinide on tumor cells, as well as the diminished adiposity observed in experimental animals and humans. Furthermore, a disturbed balance between PKC delta and PKC epsilon might underlie the injury inflicted on the ischemic myocardium during reperfusion.-Gong, J., Hoyos, B., Acin-Perez, R., Vinogradov, V., Shabrova, E., Zhao, F., Leitges, M., Fischman, D., Manfredi, G., Hammerling, U. Two protein kinase C isoforms, delta and epsilon, regulate energy homeostasis in mitochondria by transmitting opposing signals to the pyruvate dehydrogenase complex. FASEB J. 26, 3537-3549 (2012). www.fasebj.org	[Gong, Jianli; Hoyos, Beatrice; Vinogradov, Valerie; Shabrova, Elena; Zhao, Feng; Hammerling, Ulrich] Sloan Kettering Inst Canc Res, Program Immunol, New York, NY 10065 USA; [Acin-Perez, Rebeca; Manfredi, Giovanni] Weill Cornell Med Sch, Dept Neurol & Neurosci, New York, NY USA; [Fischman, Donald] Weill Cornell Med Sch, Dept Cell Biol & Dev Biol, New York, NY USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Oslo	Hammerling, U (corresponding author), Sloan Kettering Inst Canc Res, Program Immunol, New York, NY 10065 USA.	u-hammerling@ski.mskcc.org	Leitges, Michael/AAN-1953-2021; Acin-Perez, Rebeca/H-6160-2015; Acin-Perez, Rebeca/AAU-4913-2020	Acin-Perez, Rebeca/0000-0001-9553-8337; Acin-Perez, Rebeca/0000-0001-9553-8337; Leitges, Michael/0000-0003-4203-6995	U.S. National Institutes of Health [K-089348, GM-088999]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088999] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the generous gifts by Dr. P. Parker (Cancer Research UK London Institute, London, UK) of the PKC epsilon<SUP>-/-</SUP> and the PKC epsilon-overexpressing cell lines, and by Dr. U. Kikkawa (Biosignal Research Centre, Kobe University, Kobe, Japan) of the PKC delta Y332F mutant cell line. The authors also thank Dr. Gavril Pasternak and Dr. Richard Kolesnick for their advice on binding affinity measurements. This work was supported by grants from the U.S. National Institutes of Health, DK-089348 (to U. H.) and GM-088999 (to G. M.), and from the Muscular Dystrophy Association. Author contributions: G. M. and U. H. designed research; J.G., B. H., R. A-P., F.Z., E. S., and V. V. performed research; M. L. provided research materials; D. F., G. M., and UH wrote the article. The authors declare no conflicts of interest.	Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Barnett M, 2008, EXP EYE RES, V86, P226, DOI 10.1016/j.exer.2007.10.012; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Bright R, 2005, STROKE, V36, P2781, DOI 10.1161/01.STR.0000189996.71237.f7; BUCK J, 1993, J EXP MED, V178, P675, DOI 10.1084/jem.178.2.675; Budas GR, 2007, PHARMACOL RES, V55, P523, DOI 10.1016/j.phrs.2007.04.005; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen YQ, 1999, CANCER RES, V59, P3985; Chiu HJ, 2008, FASEB J, V22, P3878, DOI 10.1096/fj.08-112375; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Frangioudakis G, 2009, DIABETOLOGIA, V52, P2616, DOI 10.1007/s00125-009-1543-0; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Guo DH, 2007, AM J PHYSIOL-HEART C, V293, pH2219, DOI 10.1152/ajpheart.01306.2006; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Halim ND, 2010, GLIA, V58, P1168, DOI 10.1002/glia.20996; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hayden MR, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-4; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hoyos B, 2005, J BIOL CHEM, V280, P6872, DOI 10.1074/jbc.M412695200; Hoyos B, 2000, J EXP MED, V192, P835, DOI 10.1084/jem.192.6.835; Hoyos B., 2011, BIOCHIM BIOPHYS ACTA, V1821, P241; Hu YY, 2007, CELL SIGNAL, V19, P410, DOI 10.1016/j.cellsig.2006.07.017; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Imam A, 2001, FASEB J, V15, P28; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Johansson H, 2008, CANCER RES, V68, P9512, DOI 10.1158/0008-5472.CAN-08-0553; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Korichneva I, 2003, J PHARMACOL EXP THER, V305, P426, DOI 10.1124/jpet.103.048900; Korichneva I, 1999, J CELL SCI, V112, P2521; Kurie JM, 2000, CLIN CANCER RES, V6, P2973; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leitges M, 2001, J CLIN INVEST, V108, P1505; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Mayr M, 2009, J MOL CELL CARDIOL, V46, P268, DOI 10.1016/j.yjmcc.2008.10.008; Morita M, 2008, J BIOCHEM, V143, P31, DOI 10.1093/jb/mvm190; NORRIS AW, 1994, BBA-PROTEIN STRUCT M, V1209, P10, DOI 10.1016/0167-4838(94)90130-9; Nowak G, 2011, AM J PHYSIOL-RENAL, V301, pF197, DOI 10.1152/ajprenal.00364.2010; NOY N, 1991, BIOCHEMISTRY-US, V30, P6380, DOI 10.1021/bi00240a005; NOY N, 1990, BIOCHEMISTRY-US, V29, P3888, DOI 10.1021/bi00468a014; OConnell MJ, 1996, J EXP MED, V184, P549, DOI 10.1084/jem.184.2.549; Ogbi M, 2006, BIOCHEM J, V393, P191, DOI 10.1042/BJ20050757; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Palaniyandi SS, 2009, CARDIOVASC RES, V82, P229, DOI 10.1093/cvr/cvp001; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Ping PP, 2001, CIRC RES, V88, P59, DOI 10.1161/01.RES.88.1.59; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Sapin V, 2000, MECH DEVELOP, V92, P295, DOI 10.1016/S0925-4773(00)00241-0; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; WALSH DA, 1976, BIOCHEM J, V157, P41, DOI 10.1042/bj1570041; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yin XL, 2009, CELL PHYSIOL BIOCHEM, V24, P219, DOI 10.1159/000233248; Zhao F, 2011, ANTIOXID REDOX SIGN, V14, P757, DOI 10.1089/ars.2010.3773	71	15	15	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3537	3549		10.1096/fj.11-197376	http://dx.doi.org/10.1096/fj.11-197376			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22573912	Green Published			2022-12-25	WOS:000307162800040
J	Donigan, KA; Sun, KW; Nemec, AA; Murphy, DL; Cong, XY; Northrup, V; Zelterman, D; Sweasy, JB				Donigan, Katherine A.; Sun, Ka-Wai; Nemec, Antonia A.; Murphy, Drew L.; Cong, Xiangyu; Northrup, Veronika; Zelterman, Daniel; Sweasy, Joann B.			Human POLB Gene Is Mutated in High Percentage of Colorectal Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; BASE-EXCISION-REPAIR; MISMATCH REPAIR; COLON-CANCER; PROMOTER HYPERMETHYLATION; CELLULAR-TRANSFORMATION; CATALYTIC MECHANISM; GASTRIC-CANCER; MUTATIONS; VARIANT	Previous small scale sequencing studies have indicated that DNA polymerase beta (pol beta) variants are present on average in 30% of human tumors of varying tissue origin. Many of these variants have been shown to have aberrant enzyme function in vitro and to induce cellular transformation and/or genomic instability in vivo, suggesting that their presence is associated with tumorigenesis or its progression. In this study, the human POLB gene was sequenced in a collection of 134 human colorectal tumors and was found to contain coding region mutations in 40% of the samples. The variants map to many different sites of the pol beta protein and are not clustered. Many variants are non-synonymous amino acid substitutions predicted to affect enzyme function. A subset of these variants was found to have reduced enzyme activity in vitro and failed to fully rescue pol beta-deficient cells from methylmethane sulfonate-induced cytotoxicity. Tumors harboring variants with reduced enzyme activity may have compromised base excision repair function, as evidenced by our methylmethane sulfonate sensitivity studies. Such compromised base excision repair may drive tumorigenesis by leading to an increase in mutagenesis or genomic instability.	[Donigan, Katherine A.; Sun, Ka-Wai; Nemec, Antonia A.; Murphy, Drew L.; Sweasy, Joann B.] Yale Univ, Dept Therapeut Radiol & Genet, Sch Med, New Haven, CT 06520 USA; [Cong, Xiangyu; Northrup, Veronika; Zelterman, Daniel] Yale Univ, Dept Epidemiol & Publ Hlth, Sch Med, New Haven, CT 06520 USA	Yale University; Yale University	Sweasy, JB (corresponding author), Yale Univ, Dept Therapeut Radiol, Hunter Radiat Therapy Ctr, POB 208040, New Haven, CT 06520 USA.	joann.sweasy@yale.edu		Zelterman, Daniel/0000-0003-0711-8688	National Institutes of Health [CA120098, 5-U19-CA105010]; National Institutes of Health Predoctoral Genetics Training Grant [T32 GM007499]; NATIONAL CANCER INSTITUTE [R21CA120098, U19CA105010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Predoctoral Genetics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA120098 and 5-U19-CA105010 (to J.B.S.).; Supported by National Institutes of Health Predoctoral Genetics Training Grant T32 GM007499.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Bhattacharyya N, 1997, P NATL ACAD SCI USA, V94, P10324, DOI 10.1073/pnas.94.19.10324; Bhattacharyya N, 2001, LIFE SCI, V69, P271, DOI 10.1016/S0024-3205(01)01120-1; Bhattacharyya N, 2001, BIOCHEMISTRY-US, V40, P9005, DOI 10.1021/bi0028789; BORRESEN AL, 1995, HUM MOL GENET, V4, P2065, DOI 10.1093/hmg/4.11.2065; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Esteller M, 2001, CANCER RES, V61, P4689; Esteller M, 2000, CANCER RES, V60, P2368; Fink D, 1998, CLIN CANCER RES, V4, P1; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Ginty F, 2008, CLIN CANCER RES, V14, P3814, DOI 10.1158/1078-0432.CCR-08-0180; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Iwanaga A, 1999, MUTAT RES-DNA REPAIR, V435, P121, DOI 10.1016/S0921-8777(99)00036-1; Jiricny J, 2003, CURR OPIN GENET DEV, V13, P61, DOI 10.1016/S0959-437X(03)00004-2; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Kosa J. L., 1999, THESIS YALE U; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; Lang TM, 2004, P NATL ACAD SCI USA, V101, P6074, DOI 10.1073/pnas.0308571101; Lefevre JH, 2010, FAM CANCER, V9, P589, DOI 10.1007/s10689-010-9367-0; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lynch HT, 1999, J MED GENET, V36, P801; Maitra M, 2002, J BIOL CHEM, V277, P35550, DOI 10.1074/jbc.M204953200; Meyers M, 2004, ENVIRON MOL MUTAGEN, V44, P249, DOI 10.1002/em.20056; Muniappan BP, 2002, CANCER RES, V62, P3271; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Murphy DL, 2011, J AM CHEM SOC, V133, P6279, DOI 10.1021/ja111099b; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nemec AA, 2012, J BIOL CHEM, V287, P23840, DOI 10.1074/jbc.M112.362111; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sarnowska E, 2007, NUCLEIC ACIDS RES, V35, P5499, DOI 10.1093/nar/gkm502; Shima K, 2011, CANCER CAUSE CONTROL, V22, P301, DOI 10.1007/s10552-010-9698-z; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1999, CARCINOGENESIS, V20, P1049, DOI 10.1093/carcin/20.6.1049; Starcevic D, 2004, CELL CYCLE, V3, P998; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; WANG LM, 1992, CANCER RES, V52, P4824; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; WIDEN SG, 1988, J BIOL CHEM, V263, P16992; Yamtich J, 2009, DNA REPAIR, V8, P579, DOI 10.1016/j.dnarep.2008.12.005	53	67	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23830	23839		10.1074/jbc.M111.324947	http://dx.doi.org/10.1074/jbc.M111.324947			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22577134	Green Published, hybrid			2022-12-25	WOS:000306511300052
J	Linn, DE; Yang, X; Xie, YQ; Alfano, A; Deshmukh, D; Wang, X; Shimelis, H; Chen, HG; Li, W; Xu, KX; Chen, MY; Qiu, Y				Linn, Douglas E.; Yang, Xi; Xie, Yingqiu; Alfano, Alan; Deshmukh, Dhanraj; Wang, Xin; Shimelis, Hermela; Chen, Hegang; Li, Wei; Xu, Kexin; Chen, Mingyuan; Qiu, Yun			Differential Regulation of Androgen Receptor by PIM-1 Kinases via Phosphorylation-dependent Recruitment of Distinct Ubiquitin E3 Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; LIGAND-INDEPENDENT ACTIVATION; TYROSINE PHOSPHORYLATION; C-MYC; TRANSCRIPTIONAL ACTIVATION; SIGNALING PATHWAY; RESISTANT GROWTH; SPLICE VARIANT; PROTEIN; PROMOTES	Androgen receptor (AR) plays a pivotal role in prostate cancer. Regulation of AR transcriptional activity by post-translational modifications, such as phosphorylation by multiple kinases, is well documented. Here, we report that two PIM-1 kinase isoforms which are up-regulated during prostate cancer progression, namely PIM-1S and PIM-1L, modulate AR stability and transcriptional activity through differentially phosphorylating AR at serine 213 (Ser-213) and threonine 850 (Thr-850). Although both kinases are capable of interacting with and phosphorylating AR at Ser-213, only PIM-1L could phosphorylate Thr-850. We also showed that PIM-1S induced Ser-213 phosphorylation destabilizes AR by recruiting the ubiquitin E3 ligase Mdm2 and promotes AR degradation in a cell cycle-dependent manner, while PIM-1L-induced Thr-850 phosphorylation stabilizes AR by recruiting the ubiquitin E3 ligase RNF6 and promotes AR-mediated transcription under low-androgen conditions. Furthermore, both PIM-1 isoforms could promote prostate cancer cell growth under low-androgen conditions. Our data suggest that these kinases regulate AR stability and transcriptional activity through recruitment of different functional partners in a phosphorylation-dependent manner. As AR turnover has been previously shown to be critical for cell cycle progression in prostate cancer cells, PIM-1 kinase isoforms may promote prostate cancer cell growth, at least in part, through modulating AR activity via distinct mechanisms.	[Linn, Douglas E.; Yang, Xi; Xie, Yingqiu; Alfano, Alan; Deshmukh, Dhanraj; Wang, Xin; Shimelis, Hermela; Li, Wei; Xu, Kexin; Chen, Mingyuan; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Qiu, Y (corresponding author), Univ Maryland, Dept Pharmacol, Sch Med, 655 W Baltimore St,BRB Rm 4-002, Baltimore, MD 21202 USA.	yqiu@som.umaryland.edu	Deshmukh, Dhanraj/Y-5195-2019; Chen, Ming/GVU-8412-2022; Xie, Yingqiu/C-5346-2011	Shimelis, Hermela/0000-0003-1284-8909	National Institutes of Health [CA106504, W81XWH-08-1-0068, W81XWH-10-1-0492]; NATIONAL CANCER INSTITUTE [R01CA106504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (CA106504) (to Y. Q.) and pre-doctoral fellowships (W81XWH-08-1-0068) (to D. L.) and (W81XWH-10-1-0492) (to H. S.).	Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Bachmann M, 2006, INT J BIOCHEM CELL B, V38, P430, DOI 10.1016/j.biocel.2005.10.010; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Cibull TL, 2006, J CLIN PATHOL, V59, P285, DOI 10.1136/jcp.2005.027672; Cinar B, 2005, CANCER RES, V65, P2547, DOI 10.1158/0008-5472.CAN-04-3411; Culig Z, 2002, ENDOCR-RELAT CANCER, V9, P155, DOI 10.1677/erc.0.0090155; Culig Z, 2000, UROL RES, V28, P211, DOI 10.1007/s002400000111; CUYPERS HT, 1984, CELL, V37, P141; Dai BJ, 2010, CANCER RES, V70, P5587, DOI 10.1158/0008-5472.CAN-09-4610; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; FRIEDMANN M, 1992, ARCH BIOCHEM BIOPHYS, V298, P594, DOI 10.1016/0003-9861(92)90454-5; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Gregory CW, 2001, CANCER RES, V61, P2892; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hogan C, 2008, J BIOL CHEM, V283, P18012, DOI 10.1074/jbc.M709695200; Hong H, 2004, CANCER-AM CANCER SOC, V101, P83, DOI 10.1002/cncr.20327; Jiang TY, 2004, J BIOL CHEM, V279, P50181, DOI 10.1074/jbc.M409108200; Kim O, 2004, ONCOGENE, V23, P1838, DOI 10.1038/sj.onc.1207304; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Kraus S, 2006, CANCER RES, V66, P11047, DOI 10.1158/0008-5472.CAN-06-0596; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Liang H, 1996, ARCH BIOCHEM BIOPHYS, V330, P259, DOI 10.1006/abbi.1996.0251; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Marcelli M, 1999, J CLIN ENDOCR METAB, V84, P3463, DOI 10.1210/jc.84.10.3463; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McPhaul MJ, 2003, J INVEST DERM SYMP P, V8, P1, DOI 10.1046/j.1523-1747.2003.12163.x; Milne D, 2004, FEBS LETT, V577, P270, DOI 10.1016/j.febslet.2004.09.081; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Taneja SS, 2005, J BIOL CHEM, V280, P40916, DOI 10.1074/jbc.M508442200; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; Vander Griend DJ, 2007, CELL CYCLE, V6, P647; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Wang ZP, 2001, ARCH BIOCHEM BIOPHYS, V390, P9, DOI 10.1006/abbi.2001.2370; Wood NT, 2009, FEBS LETT, V583, P615, DOI 10.1016/j.febslet.2009.01.003; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Yang X, 2011, J BIOL CHEM, V286, P36152, DOI 10.1074/jbc.M111.265124; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	75	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22959	22968		10.1074/jbc.M111.338350	http://dx.doi.org/10.1074/jbc.M111.338350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584579	Green Published, hybrid			2022-12-25	WOS:000306495000053
J	Louzao, M; Delord, K; Garcia, D; Boue, A; Weimerskirch, H				Louzao, Maite; Delord, Karine; Garcia, David; Boue, Amelie; Weimerskirch, Henri			Protecting Persistent Dynamic Oceanographic Features: Transboundary Conservation Efforts Are Needed for the Critically Endangered Balearic Shearwater	PLOS ONE			English	Article							ANCHOVY ENGRAULIS-ENCRASICOLUS; SPECIES DISTRIBUTION; MEDITERRANEAN-SEA; DISTRIBUTION MODELS; SEABIRD; FISHERIES; HABITAT; PHYTOPLANKTON; POPULATIONS; PERFORMANCE	The protection of key areas for biodiversity at sea is not as widespread as on land and research investment is necessary to identify biodiversity hotspots in the open ocean. Spatially explicit conservation measures such as the creation of representative networks of marine protected areas (MPAs) is a critical step towards the conservation and management of marine ecosystems, as well as to improve public awareness. Conservation efforts in ecologically rich and threatened ecosystems are specially needed. This is particularly urgent for the Mediterranean marine biodiversity, which includes highly mobile marine vertebrates. Here, we studied the at sea distribution of one of the most endangered Mediterranean seabird, the critically endangered Balearic shearwater Puffinus mauretanicus. Present knowledge, from vessel-based surveys, suggests that this species has a coastal distribution over the productive Iberian shelf in relation to the distribution of their main prey, small pelagic fish. We used miniaturised satellite transmitters to determine the key marine areas of the southern population of Balearic shearwaters breeding on Eivissa and spot the spatial connections between breeding and key marine areas. Our tracking study indicates that Balearic shearwaters do not only forage along the Iberian continental shelf but also in more distant marine areas along the North African coast, in particular W of Algeria, but also NE coast of Morocco. Birds recurrently visit these shelf areas at the end of the breeding season. Species distribution modelling identified chlorophyll a as the most important environmental variable in defining those oceanographic features characterizing their key habitats in the western Mediterranean. We identified persistent oceanographic features across time series available in the study area and discuss our results within the current conservation scenario in relation to the ecology of the species.	[Louzao, Maite; Delord, Karine; Weimerskirch, Henri] Ctr Natl Rech Sci UPR 1934, Ctr Etud Biol Chize, Villiers En Bois, France; [Louzao, Maite] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Louzao, Maite] Inst Espanol Oceanog, Ctr Oceanog Xixon, Xixon, Spain; [Garcia, David] SEO BirdLife, Barcelona, Spain; [Boue, Amelie] LPO Birdlife France Serv Etud Patrimoine Nat, Rochefort, France	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Spanish Institute of Oceanography	Louzao, M (corresponding author), Ctr Natl Rech Sci UPR 1934, Ctr Etud Biol Chize, Villiers En Bois, France.	maite.louzao@gmail.com	Weimerskirch, Henri/F-5562-2013; Louzao, Maite/N-5379-2014; Weimerskirch, Henri/K-7306-2019	Weimerskirch, Henri/0000-0002-0457-586X; Louzao, Maite/0000-0002-9997-5144	LPO; SEO/BirdLife; Marie Curie Individual Fellowship [PIEF-GA-2008-220063]; Juan de la Cierva postdoctoral programme [JCI-2010-07639]	LPO; SEO/BirdLife; Marie Curie Individual Fellowship(European Commission); Juan de la Cierva postdoctoral programme	Funding support was provided by LPO and SEO/BirdLife through the Future Atlantic Marine Environment Interreg FAME project. ML was supported by the Marie Curie Individual Fellowship (PIEF-GA-2008-220063) and Juan de la Cierva postdoctoral programme (JCI-2010-07639, Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Abello P, 2003, SCI MAR, V67, P69, DOI 10.3989/scimar.2003.67s269; Agreement on the Conservation of Albatrosses and Petrels, 2010, SPEC ASS BAL SHEARW; Arcos J.M., 2009, AREAS IMPORTANTES CO; Arcos J. M, 2011, INT SPECIES ACTION P; Arcos JM, 2002, MAR ECOL PROG SER, V239, P209, DOI 10.3354/meps239209; Arcos JM, 2008, AM FISH S S, V49, P1471; Bacha M, 2010, CYBIUM, V34, P47; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 052161256X; BROOKE M, 1990, MANX SHEARWATER; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FAO, 2011, FISHSTATJ UN SOFTW F; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Genovart M, 2003, WATERBIRDS, V26, P72, DOI 10.1675/1524-4695(2003)026[0072:ADFFPS]2.0.CO;2; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; Guilford T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033753; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hafferssas A, 2010, ZOOL STUD, V49, P353; Hunt G.L. Jr, 1987, P7; ICES, 2008, REP WORK GROUP SEAB; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Kahru M, 1999, INT J REMOTE SENS, V20, P3423, DOI 10.1080/014311699211453; Laneri K, 2010, MAR ECOL PROG SER, V420, P241, DOI 10.3354/meps08847; Lloret J, 2004, FISH OCEANOGR, V13, P102, DOI 10.1046/j.1365-2419.2003.00279.x; Louzao M, 2011, MAR ECOL PROG SER, V429, P291, DOI 10.3354/meps09126; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Louzao M, 2012, ACT 6 C GIAM TALL IN; Louzao M, 2006, ECOL APPL, V16, P1683, DOI 10.1890/1051-0761(2006)016[1683:OHOAEM]2.0.CO;2; Louzao M, 2006, MAR ECOL PROG SER, V318, P247, DOI 10.3354/meps318247; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; McAlpine CA, 2008, J APPL ECOL, V45, P558, DOI 10.1111/j.1365-2664.2007.01431.x; Moran XAG, 2001, DEEP-SEA RES PT I, V48, P405, DOI 10.1016/S0967-0637(00)00042-X; Navarro J, 2009, MAR BIOL, V156, P2571, DOI 10.1007/s00227-009-1281-3; Orians G.H., 1979, P155; Oro D, 2004, BIOL CONSERV, V116, P93, DOI 10.1016/S0006-3207(03)00180-0; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; RAIMBAULT P, 1993, DEEP-SEA RES PT I, V40, P791, DOI 10.1016/0967-0637(93)90072-B; Riandey V, 2005, DEEP-SEA RES PT I, V52, P2029, DOI 10.1016/j.dsr.2005.06.004; Ruiz A, 2004, PARDELA BALEAR; Seridji R, 2000, CRUSTACEANA, V73, P1, DOI 10.1163/156854000504084; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; VLIZ, 2011, MAR BOUND GEOD VERS; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wurtz M., 2010, MEDITERRANEAN PELAGI	57	43	45	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e35728	10.1371/journal.pone.0035728	http://dx.doi.org/10.1371/journal.pone.0035728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590510	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400006
J	Fonseca, MM; Rocha, S; Posada, D				Fonseca, Miguel M.; Rocha, Sara; Posada, David			Base-Pairing Versatility Determines Wobble Sites in tRNA Anticodons of Vertebrate Mitogenomes	PLOS ONE			English	Article							FUNGAL MITOCHONDRIAL GENOMES; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; NUCLEOTIDE COMPOSITION; CODON USAGE; SELECTION; MUTATION; GENES	Background: Vertebrate mitochondrial genomes typically have one transfer RNA (tRNA) for each synonymous codon family. This limited anticodon repertoire implies that each tRNA anticodon needs to wobble (establish a non-Watson-Crick base pairing between two nucleotides in RNA molecules) to recognize one or more synonymous codons. Different hypotheses have been proposed to explain the factors that determine the nucleotide composition of wobble sites in vertebrate mitochondrial tRNA anticodons. Until now, the two major postulates - the "codon-anticodon adaptation hypothesis'' and the "wobble versatility hypothesis'' - have not been formally tested in vertebrate mitochondria because both make the same predictions regarding the composition of anticodon wobble sites. The same is true for the more recent "wobble cost hypothesis''. Principal Findings: In this study we have analyzed the occurrence of synonymous codons and tRNA anticodon wobble sites in 1553 complete vertebrate mitochondrial genomes, focusing on three fish species with mtDNA codon usage bias reversal (L-strand is GT-rich). These mitogenomes constitute an excellent opportunity to study the evolution of the wobble nucleotide composition of tRNA anticodons because due to the reversal the predictions for the anticodon wobble sites differ between the existing hypotheses. We observed that none of the wobble sites of tRNA anticodons in these unusual mitochondrial genomes coevolved to match the new overall codon usage bias, suggesting that nucleotides at the wobble sites of tRNA anticodons in vertebrate mitochondrial genomes are determined by wobble versatility. Conclusions/Significance: Our results suggest that, at wobble sites of tRNA anticodons in vertebrate mitogenomes, selection favors the most versatile nucleotide in terms of wobble base-pairing stability and that wobble site composition is not influenced by codon usage. These results are in agreement with the "wobble versatility hypothesis''.	[Fonseca, Miguel M.; Rocha, Sara; Posada, David] Univ Porto, Res Ctr Biodivers & Genet Resources, CIBIO, P-4100 Oporto, Portugal; [Fonseca, Miguel M.; Rocha, Sara; Posada, David] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain	Universidade do Porto; Universidade de Vigo	Fonseca, MM (corresponding author), Univ Porto, Res Ctr Biodivers & Genet Resources, CIBIO, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	mig.m.fonseca@gmail.com	Posada, David/C-4502-2008; Rocha, Sara/L-9557-2013; Fonseca, Miguel M/L-7944-2013	Posada, David/0000-0003-1407-3406; Rocha, Sara/0000-0002-9705-1511; Fonseca, Miguel M/0000-0003-4598-670X	European Social Fund; Operational Human of Potential Program - POPH; FCT (Portuguese Foundation for Science and Technology) [SFRH/BPD/73115/2010, SFRH/BD/31158/2006, SFRH/BPD/70654/2010]	European Social Fund(European Social Fund (ESF)); Operational Human of Potential Program - POPH; FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology)	The European Social Fund and the Operational Human of Potential Program - POPH, supported this study. FCT (Portuguese Foundation for Science and Technology) research grants SFRH/BPD/73115/2010 (SR), SFRH/BD/31158/2006 (MMF) and SFRH/BPD/70654/2010 ( MMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; ASAKAWA S, 1991, J MOL EVOL, V32, P511, DOI 10.1007/BF02102653; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; Carullo M, 2008, J MOL EVOL, V66, P484, DOI 10.1007/s00239-008-9102-8; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; FOLLEY LS, 1991, GENETICS, V129, P659; Fonseca MM, 2008, MOL BIOL EVOL, V25, P805, DOI 10.1093/molbev/msn050; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; MULERO JJ, 1994, MOL GEN GENET, V242, P383, DOI 10.1007/BF00281787; Nett JH, 2001, EUR J BIOCHEM, V268, P5209, DOI 10.1046/j.0014-2956.2001.02454.x; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perseke M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-134; ROMERO A, 1991, FEMS MICROBIOL LETT, V84, P325, DOI 10.1016/0378-1097(91)90377-M; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Tong KL, 2004, GENE, V333, P169, DOI 10.1016/j.gene.2004.02.028; Xia XH, 2005, GENE, V345, P13, DOI 10.1016/j.gene.2004.11.019; Xia XH, 1998, GENETICS, V149, P37; Xia XH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-211; Xia XH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000227; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016147	22	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36605	10.1371/journal.pone.0036605	http://dx.doi.org/10.1371/journal.pone.0036605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590575	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336100046
J	Shanahan, M; Wildie, M				Shanahan, Murray; Wildie, Mark			Knotty-Centrality: Finding the Connective Core of a Complex Network	PLOS ONE			English	Article							ORGANIZATION	A network measure called knotty-centrality is defined that quantifies the extent to which a given subset of a graph's nodes constitutes a densely intra-connected topologically central connective core. Using this measure, the knotty centre of a network is defined as a sub-graph with maximal knotty-centrality. A heuristic algorithm for finding subsets of a network with high knotty-centrality is presented, and this is applied to previously published brain structural connectivity data for the cat and the human, as well as to a number of other networks. The cognitive implications of possessing a connective core with high knotty-centrality are briefly discussed.	[Shanahan, Murray; Wildie, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	Imperial College London	Shanahan, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England.	m.shanahan@imperial.ac.uk			EPSRC [EP/F033516/1]; Engineering and Physical Sciences Research Council [EP/F033516/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grant no. EP/F033516/1 from EPSRC (www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Hamelin J.I., 2006, ADV NEURAL INFORM PR, P41; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Kintali S., 2008, 08091906 ARXIV; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman M.E.J., 2010, NETWORKS INTRO; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sackur J, 2009, COGNITION, V111, P187, DOI 10.1016/j.cognition.2009.01.010; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Shanahan MP, 2010, EMBODIMENT INER LIFE; Shanahan M, 2012, PHILOS T R SOC B, V367, P2704, DOI 10.1098/rstb.2012.0128; Shanahan M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041924; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zamora-Lopez G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00083; Zamora-Lopez Gorka, 2010, Front Neuroinform, V4, P1, DOI 10.3389/neuro.11.001.2010; Zhang HQ, 2009, LECT NOTES COMPUT SC, V5652, P131, DOI 10.1007/978-3-642-02924-0_11; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426; Zylberberg A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000765	24	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36579	10.1371/journal.pone.0036579	http://dx.doi.org/10.1371/journal.pone.0036579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590571	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100042
J	Braun, TE; Poole, E; Sinclair, J				Braun, Tamara Evans; Poole, Emma; Sinclair, John			Depletion of Cellular Pre-Replication Complex Factors Results in Increased Human Cytomegalovirus DNA Replication	PLOS ONE			English	Article							ORIGIN RECOGNITION COMPLEX; IE86 PROTEIN; S-PHASE; FUNCTIONAL INTERACTION; CYCLE PROGRESSION; TERMINAL REPEATS; MCM PROTEINS; ORC; EXPRESSION; INHIBITION	Although HCMV encodes many genes required for the replication of its DNA genome, no HCMV-encoded orthologue of the origin binding protein, which has been identified in other herpesviruses, has been identified. This has led to speculation that HCMV may use other viral proteins or possibly cellular factors for the initiation of DNA synthesis. It is also unclear whether cellular replication factors are required for efficient replication of viral DNA during or after viral replication origin recognition. Consequently, we have asked whether cellular pre-replication (pre-RC) factors that are either initially associated with cellular origin of replication (e. g. ORC2), those which recruit other replication factors (e. g. Cdt1 or Cdc6) or those which are subsequently recruited (e. g. MCMs) play any role in the HCMV DNA replication. We show that whilst RNAi-mediated knock-down of these factors in the cell affects cellular DNA replication, as predicted, it results in concomitant increases in viral DNA replication. These data show that cellular factors which initiate cellular DNA synthesis are not required for the initiation of replication of viral DNA and suggest that inhibition of cellular DNA synthesis, in itself, fosters conditions which are conducive to viral DNA replication.	[Braun, Tamara Evans; Poole, Emma; Sinclair, John] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Braun, TE (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.	js@mole.bio.cam.ac.uk		Poole, Emma/0000-0003-3904-6121	British Medical Research Council; MRC [G9202171, G0701279] Funding Source: UKRI; Medical Research Council [G9202171, G0701279] Funding Source: researchfish	British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the British Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton BA, 2006, J BIOL CHEM, V281, P5224, DOI 10.1074/jbc.M506900200; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; Bennett NJ, 2010, J IMMUNOL, V185, P1093, DOI 10.4049/jimmunol.1000789; Biswas N, 2003, J VIROL, V77, P2369, DOI 10.1128/JVI.77.4.2369-2376.2003; Bresnahan WA, 1998, J BIOL CHEM, V273, P22075, DOI 10.1074/jbc.273.34.22075; Castillo JP, 2000, J VIROL, V74, P8028, DOI 10.1128/JVI.74.17.8028-8037.2000; Chaudhuri B, 2001, P NATL ACAD SCI USA, V98, P10085, DOI 10.1073/pnas.181347998; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Colletti KS, 2007, J VIROL, V81, P7077, DOI 10.1128/JVI.00058-07; Crevel G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000833; Da-Silva LF, 2007, CELL CYCLE, V6, P128, DOI 10.4161/cc.6.2.3743; DePamphilis ML, 2003, GENE, V310, P1, DOI 10.1016/S0378-1119(03)00546-8; DEPTO AS, 1992, J VIROL, V66, P3241, DOI 10.1128/JVI.66.5.3241-3246.1992; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; ERTL PF, 1991, J GEN VIROL, V72, P1729, DOI 10.1099/0022-1317-72-7-1729; ERTL PF, 1992, J VIROL, V66, P4126, DOI 10.1128/JVI.66.7.4126-4133.1992; Fortunato EA, 2002, J VIROL, V76, P5369, DOI 10.1128/JVI.76.11.5369-5379.2002; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Gao Y, 2008, J VIROL, V82, P96, DOI 10.1128/JVI.01559-07; Gao Y, 2009, J VIROL, V83, P2393, DOI 10.1128/JVI.02339-08; Griffin C, 2005, J GEN VIROL, V86, P2999, DOI 10.1099/vir.0.81126-0; HAGEMEIER C, 1994, EMBO J, V13, P2897, DOI 10.1002/j.1460-2075.1994.tb06584.x; Ishimi Y, 2003, EUR J BIOCHEM, V270, P1089, DOI 10.1046/j.1432-1033.2003.03440.x; Iskenderian AC, 1996, J VIROL, V70, P383, DOI 10.1128/JVI.70.1.383-392.1996; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; Kagele D, 2009, VIROLOGY, V392, P16, DOI 10.1016/j.virol.2009.06.035; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Lim C, 2002, J VIROL, V76, P10320, DOI 10.1128/JVI.76.20.10320-10331.2002; Machida YJ, 2005, J BIOL CHEM, V280, P27624, DOI 10.1074/jbc.M502615200; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Murphy EA, 2000, J VIROL, V74, P7108, DOI 10.1128/JVI.74.15.7108-7118.2000; Nevis KR, 2009, CELL CYCLE, V8, P1952, DOI 10.4161/cc.8.12.8811; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Noris E, 2002, J VIROL, V76, P12135, DOI 10.1128/JVI.76.23.12135-12148.2002; Pari GS, 2008, CURR TOP MICROBIOL, V325, P153; Park MY, 2006, J VIROL, V80, P2718, DOI 10.1128/JVI.80.6.2718-2727.2006; Petrik DT, 2006, J VIROL, V80, P3872, DOI 10.1128/JVI.80.8.3872-3883.2006; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Qian Z, 2008, PLOS PATHOG, V6; Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Rialland M, 2002, J CELL SCI, V115, P1435; RIPALTI A, 1995, J VIROL, V69, P2047, DOI 10.1128/JVI.69.4.2047-2057.1995; Salvant BS, 1998, J VIROL, V72, P3729, DOI 10.1128/JVI.72.5.3729-3741.1998; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Sinclair J, 2000, J GEN VIROL, V81, P1553, DOI 10.1099/0022-1317-81-6-1553; Song YJ, 2002, P NATL ACAD SCI USA, V99, P2836, DOI 10.1073/pnas.052010099; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Spector DJ, 2010, VIROLOGY, V407, P171, DOI 10.1016/j.virol.2010.08.029; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Sun JY, 2010, ACTA BIOCH BIOPH SIN, V42, P433, DOI 10.1093/abbs/gmq048; Verma SC, 2006, J VIROL, V80, P11178, DOI 10.1128/JVI.01334-06; White EA, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P264; Wiebusch L, 2003, EMBO REP, V4, P42, DOI 10.1038/sj.embor.embor707; Wiebusch L, 2001, EMBO J, V20, P1086, DOI 10.1093/emboj/20.5.1086; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Woon HG, 2008, VIRUS GENES, V37, P193, DOI 10.1007/s11262-008-0255-8; Ying CY, 2005, EMBO J, V24, P4334, DOI 10.1038/sj.emboj.7600892; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200	62	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36057	10.1371/journal.pone.0036057	http://dx.doi.org/10.1371/journal.pone.0036057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586460	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335000022
J	Powell, AA; Talasaz, AH; Zhang, HY; Coram, MA; Reddy, A; Deng, G; Telli, ML; Advani, RH; Carlson, RW; Mollick, JA; Sheth, S; Kurian, AW; Ford, JM; Stockdale, FE; Quake, SR; Pease, RF; Mindrinos, MN; Bhanot, G; Dairkee, SH; Davis, RW; Jeffrey, SS				Powell, Ashley A.; Talasaz, AmirAli H.; Zhang, Haiyu; Coram, Marc A.; Reddy, Anupama; Deng, Glenn; Telli, Melinda L.; Advani, Ranjana H.; Carlson, Robert W.; Mollick, Joseph A.; Sheth, Shruti; Kurian, Allison W.; Ford, James M.; Stockdale, Frank E.; Quake, Stephen R.; Pease, R. Fabian; Mindrinos, Michael N.; Bhanot, Gyan; Dairkee, Shanaz H.; Davis, Ronald W.; Jeffrey, Stefanie S.			Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; NF-KAPPA-B; TGF-BETA; PROGNOSTIC-SIGNIFICANCE; CLINICAL-IMPLICATIONS; PROSTATE-CANCER; HER2 STATUS; STEM-CELL; RT-QPCR	Background: To improve cancer therapy, it is critical to target metastasizing cells. Circulating tumor cells (CTCs) are rare cells found in the blood of patients with solid tumors and may play a key role in cancer dissemination. Uncovering CTC phenotypes offers a potential avenue to inform treatment. However, CTC transcriptional profiling is limited by leukocyte contamination; an approach to surmount this problem is single cell analysis. Here we demonstrate feasibility of performing high dimensional single CTC profiling, providing early insight into CTC heterogeneity and allowing comparisons to breast cancer cell lines widely used for drug discovery. Methodology/Principal Findings: We purified CTCs using the MagSweeper, an immunomagnetic enrichment device that isolates live tumor cells from unfractionated blood. CTCs that met stringent criteria for further analysis were obtained from 70% (14/20) of primary and 70% (21/30) of metastatic breast cancer patients; none were captured from patients with non-epithelial cancer (n = 20) or healthy subjects (n = 25). Microfluidic-based single cell transcriptional profiling of 87 cancer-associated and reference genes showed heterogeneity among individual CTCs, separating them into two major subgroups, based on 31 highly expressed genes. In contrast, single cells from seven breast cancer cell lines were tightly clustered together by sample ID and ER status. CTC profiles were distinct from those of cancer cell lines, questioning the suitability of such lines for drug discovery efforts for late stage cancer therapy. Conclusions/Significance: For the first time, we directly measured high dimensional gene expression in individual CTCs without the common practice of pooling such cells. Elevated transcript levels of genes associated with metastasis NPTN, S100A4, S100A9, and with epithelial mesenchymal transition: VIM, TGF beta 1, ZEB2, FOXC1, CXCR4, were striking compared to cell lines. Our findings demonstrate that profiling CTCs on a cell-by-cell basis is possible and may facilitate the application of 'liquid biopsies' to better model drug discovery.	[Powell, Ashley A.; Zhang, Haiyu; Deng, Glenn; Dairkee, Shanaz H.; Jeffrey, Stefanie S.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Talasaz, AmirAli H.; Mindrinos, Michael N.; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Talasaz, AmirAli H.; Pease, R. Fabian] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Coram, Marc A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Biostat, Stanford, CA 94305 USA; [Reddy, Anupama; Bhanot, Gyan] Rutgers State Univ, Dept Phys, BioMaPS Inst Quantitat Biol, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Telli, Melinda L.; Advani, Ranjana H.; Carlson, Robert W.; Mollick, Joseph A.; Sheth, Shruti; Kurian, Allison W.; Ford, James M.; Stockdale, Frank E.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA; [Bhanot, Gyan] Canc Inst New Jersey, New Brunswick, NJ USA; [Bhanot, Gyan] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Dairkee, Shanaz H.] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Rutgers State University New Brunswick; Stanford University; Howard Hughes Medical Institute; Stanford University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Institute for Advanced Study - USA; California Pacific Medical Center; California Pacific Medical Center Research Institute	Powell, AA (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	dairkes@cpmcri.org; dbowe@stanford.edu; ssj@stanford.edu	Carlson, Robert/AAQ-8098-2020; Kurian, Allison/A-4560-2019	Jeffrey, Stefanie/0000-0003-4478-2764; Coram, Marc/0000-0002-8877-2501; Kurian, Allison/0000-0002-6175-9470; Dairkee, Shanaz/0000-0002-2073-9684; Ford, James/0000-0002-2513-7025; Advani, Ranjana/0000-0002-3219-2292	National Institutes of Health [R01GM085601, P01HG00020, U54GM621195, DP1OD000251, R01CA109325]; California Breast Cancer Research; Office of the University of California [11IB-0175]; Marva Warnock Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA109325] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085601, U54GM062119] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research; Office of the University of California; Marva Warnock Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by National Institutes of Health grants R01GM085601 (SSJ), P01HG000205 (RWD), U54GM62119 (RWD), DP1OD000251 (SRQ), R01CA109325 (SHD); the California Breast Cancer Research Grants Program Office of the University of California, Grant Number 11IB-0175 (SSJ); the John and Marva Warnock Cancer Research Fund; and generous contributions from Andrew and Debra Rachleff and Vladimir and Natalie Ermakoff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas B, 2011, GYNECOL ONCOL, V122, P356, DOI 10.1016/j.ygyno.2011.04.039; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Ameri K, 2010, BRIT J CANCER, V102, P561, DOI 10.1038/sj.bjc.6605491; Arai K, 2008, CURR CANCER DRUG TAR, V8, P243, DOI 10.2174/156800908784533445; Barcellos-Hoff MH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2224; Bertran E, 2009, CELL SIGNAL, V21, P1595, DOI 10.1016/j.cellsig.2009.06.006; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; Chow JYC, 2007, CARCINOGENESIS, V28, P2321, DOI 10.1093/carcin/bgm159; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Cohen SJ, 2009, ANN ONCOL, V20, P1223, DOI 10.1093/annonc/mdn786; Comen E, 2011, NAT REV CLIN ONCOL, V8, P369, DOI 10.1038/nrclinonc.2011.64; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dairkee SH, 2007, ONCOGENE, V26, P6269, DOI 10.1038/sj.onc.1210452; Dairkee SH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-47; DAIRKEE SH, 1987, LANCET, V1, P514; Dairkee SH, 2009, CANCER RES, V69, P7826, DOI 10.1158/0008-5472.CAN-09-1564; Fehm T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1783; Fehm T, 2010, BREAST CANCER RES TR, V124, P403, DOI 10.1007/s10549-010-1163-x; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Giordano A, 2012, ANN ONCOL, V23, P1144, DOI 10.1093/annonc/mdr434; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; Habib AA, 2001, J BIOL CHEM, V276, P8865, DOI 10.1074/jbc.M008458200; He H, 2010, PROSTATE, V70, P518, DOI 10.1002/pros.21086; Igntiadis M, 2008, EUR J CANCER, V44, P2726, DOI 10.1016/j.ejca.2008.09.033; Jeffrey Stefanie S, 2005, J Natl Compr Canc Netw, V3, P291; Jensen JD, 2011, CLIN CANCER RES, V17, P667, DOI 10.1158/1078-0432.CCR-10-1133; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Korsching E, 2008, J CLIN PATHOL, V61, P553, DOI 10.1136/jcp.2008.055475; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Liu J, 2003, ANAL CHEM, V75, P4718, DOI 10.1021/ac0346407; Luciani MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020016; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Moreno JG, 2005, UROLOGY, V65, P713, DOI 10.1016/j.urology.2004.11.006; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Patel AS, 2011, ONCOTARGET, V2, P752, DOI 10.18632/oncotarget.336; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Rodriguez-Pinto D, 2009, CANCER IMMUNOL IMMUN, V58, P221, DOI 10.1007/s00262-008-0543-0; Sieuwerts AM, 2009, BREAST CANCER RES TR, V118, P455, DOI 10.1007/s10549-008-0290-0; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Strati A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-422; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van de Stolpe A, 2011, CANCER RES, V71, P5955, DOI 10.1158/0008-5472.CAN-11-1254; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Watson MA, 2007, CLIN CANCER RES, V13, P5001, DOI 10.1158/1078-0432.CCR-07-0024; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Wulfing P, 2006, CLIN CANCER RES, V12, P1715, DOI 10.1158/1078-0432.CCR-05-2087	62	415	437	6	231	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e33788	10.1371/journal.pone.0033788	http://dx.doi.org/10.1371/journal.pone.0033788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586443	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335000005
J	Cherutich, P; Kaiser, R; Galbraith, J; Williamson, J; Shiraishi, RW; Ngare, C; Mermin, J; Marum, E; Bunnell, R				Cherutich, Peter; Kaiser, Reinhard; Galbraith, Jennifer; Williamson, John; Shiraishi, Ray W.; Ngare, Carol; Mermin, Jonathan; Marum, Elizabeth; Bunnell, Rebecca		KAIS Study Grp	Lack of Knowledge of HIV Status a Major Barrier to HIV Prevention, Care and Treatment Efforts in Kenya: Results from a Nationally Representative Study	PLOS ONE			English	Article							RISK-REDUCTION; TRANSMISSION; AFRICA	Background: We analyzed HIV testing rates, prevalence of undiagnosed HIV, and predictors of testing in the Kenya AIDS Indicator Survey (KAIS) 2007. Methods: KAIS was a nationally representative sero-survey that included demographic and behavioral indicators and testing for HIV, HSV-2, syphilis, and CD4 cell counts in the population aged 15-64 years. We used gender-specific multivariable regression models to identify factors independently associated with HIV testing in sexually active persons. Results: Of 19,840 eligible persons, 80% consented to interviews and blood specimen collection. National HIV prevalence was 7.1% (95% CI 6.5-7.7). Among ever sexually active persons, 27.4% (95% CI 25.6-29.2) of men and 44.2% (95% CI 42.5-46.0) of women reported previous HIV testing. Among HIV-infected persons, 83.6% (95% CI 76.2-91.0) were unaware of their HIV infection. Among sexually active women aged 15-49 years, 48.7% (95% CI 46.8-50.6) had their last HIV test during antenatal care (ANC). In multivariable analyses, the adjusted odds ratio (AOR) for ever HIV testing in women >= 35 versus 15-19 years was 0.2 (95% CI: 0.1-0.3; p<0.0001). Other independent associations with ever HIV testing included urban residence (AOR 1.6, 95% CI: 1.2-2.0; p = 0.0005, women only), highest wealth index versus the four lower quintiles combined (AOR 1.8, 95% CI: 1.3-2.5; p = 0.0006, men only), and an increasing testing trend with higher levels of education. Missed opportunities for testing were identified during general or pregnancy-specific contacts with health facilities; 89% of adults said they would participate in home-based HIV testing. Conclusions: The vast majority of HIV-infected persons in Kenya are unaware of their HIV status, posing a major barrier to HIV prevention, care and treatment efforts. New approaches to HIV testing provision and education, including home-based testing, may increase coverage. Targeted interventions should involve sexually active men, sexually active women without access to ANC, and rural and disadvantaged populations.	[Cherutich, Peter; Ngare, Carol] Natl AIDS STI Control Programme NASCOP, Nairobi, Kenya; [Kaiser, Reinhard; Galbraith, Jennifer; Williamson, John; Mermin, Jonathan; Bunnell, Rebecca] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Nairobi, Kenya; [Shiraishi, Ray W.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Mermin, Jonathan] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Marum, Elizabeth] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Lusaka, Zambia; [Bunnell, Rebecca] Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Cherutich, P (corresponding author), Natl AIDS STI Control Programme NASCOP, Nairobi, Kenya.	r_kaiser@gmx.de	Mermin, Jonathan/J-9847-2012	Kim, Evelyn/0000-0002-9650-2093; Shiraishi, Ray/0000-0001-7640-0666	United States President's Emergency Plan for AIDS Relief; Department of Health and Human Services; Centers for Disease Control and Prevention (CDC)	United States President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Health and Human Services; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded through the United States President's Emergency Plan for AIDS Relief and the Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also funded through the Centers for Disease Control and Prevention (CDC). Several authors are employees of CDC and contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; CBS Kenya ORC Macro, 2004, KEN DEM HLTH SURV 20; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; [Joint United Nations Program on HIV/AIDS (UNAIDS) World Health Organization (WHO)], 2007, AIDS EP UPD 2007; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kellerman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000285; Kenya National AIDS/STI Control Programme (NASCOP), 2009, 2007 KEN AIDS IND SU; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KEN DEM HLTH SURV 20; Kim AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017535; KNBS, 2006, REV POP PROJ KEN 200; Marum E, 2006, JAMA-J AM MED ASSOC, V296, P859, DOI 10.1001/jama.296.7.859; Matovu JKB, 2010, CURR HIV RES, V8, P430, DOI 10.2174/157016210793499303; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; NASCOP, 2001, NAT GUID HIV TEST CO; National AIDS and STI Control Programme (NASCOP) Ministry of Health Kenya, 2008, NAT GUID HIV TEST CO; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Rutstein SO, 2004, DHS COMP REPORTS, V6; Wanyenze R, 2006, AIDS BEHAV, V10, P361, DOI 10.1007/s10461-005-9035-9; Were W, 2003, LANCET, V361, P1569, DOI 10.1016/S0140-6736(03)13212-6; WHO, 2009, UN ACC SCAL PRIOR HI; [World Health Organization (WHO) UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI	30	61	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36797	10.1371/journal.pone.0036797	http://dx.doi.org/10.1371/journal.pone.0036797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574226	Green Published, gold			2022-12-25	WOS:000305349800123
J	Eros, T; Gustafsson, P; Greenberg, LA; Bergman, E				Eros, Tibor; Gustafsson, Par; Greenberg, Larry A.; Bergman, Eva			Forest-Stream Linkages: Effects of Terrestrial Invertebrate Input and Light on Diet and Growth of Brown Trout (Salmo trutta) in a Boreal Forest Stream	PLOS ONE			English	Article							DWELLING ATLANTIC SALMON; RIPARIAN BUFFER WIDTH; FOOD WEBS; HABITAT USE; EXPERIMENTAL MANIPULATION; ARTHROPOD INPUTS; HEADWATER STREAM; RAINBOW-TROUT; BROOK TROUT; PREY	Subsidies of energy and material from the riparian zone have large impacts on recipient stream habitats. Human-induced changes, such as deforestation, may profoundly affect these pathways. However, the strength of individual factors on stream ecosystems is poorly understood since the factors involved often interact in complex ways. We isolated two of these factors, manipulating the flux of terrestrial input and the intensity of light in a 262 factorial design, where we followed the growth and diet of two size-classes of brown trout (Salmo trutta) and the development of periphyton, grazer macroinvertebrates, terrestrial invertebrate inputs, and drift in twelve 20 m long enclosed stream reaches in a five-month-long experiment in a boreal coniferous forest stream. We found that light intensity, which was artificially increased 2.5 times above ambient levels, had an effect on grazer density, but no detectable effect on chlorophyll a biomass. We also found a seasonal effect on the amount of drift and that the reduction of terrestrial prey input, accomplished by covering enclosures with transparent plastic, had a negative impact on the amount of terrestrial invertebrates in the drift. Further, trout growth was strongly seasonal and followed the same pattern as drift biomass, and the reduction of terrestrial prey input had a negative effect on trout growth. Diet analysis was consistent with growth differences, showing that trout in open enclosures consumed relatively more terrestrial prey in summer than trout living in covered enclosures. We also predicted ontogenetic differences in the diet and growth of old and young trout, where we expected old fish to be more affected by the terrestrial prey reduction, but we found little evidence of ontogenetic differences. Overall, our results showed that reduced terrestrial prey inputs, as would be expected from forest harvesting, shaped differences in the growth and diet of the top predator, brown trout.	[Eros, Tibor; Gustafsson, Par; Greenberg, Larry A.; Bergman, Eva] Karlstad Univ, Dept Biol, Karlstad, Sweden; [Eros, Tibor] Hungarian Acad Sci, Balaton Limnol Inst, Ctr Ecol Res, Tihany, Hungary; [Gustafsson, Par] Cty Board Varmland, Karlstad, Sweden	Karlstad University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute	Eros, T (corresponding author), Karlstad Univ, Dept Biol, Karlstad, Sweden.	eva.bergman.1868@kau.se	Bergman, Eva/R-8464-2016; Bergman, Eva/AAR-8368-2021; Eros, Tibor/I-1671-2019	Bergman, Eva/0000-0003-2220-1615; Bergman, Eva/0000-0003-2220-1615; 	Trygger's Foundation; Karlstad University	Trygger's Foundation; Karlstad University	This work was funded by the Trygger's Foundation and Karlstad University. TE is a Bolyai Janos Research Fellow at the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan J.D., 2009, STREAM ECOLOGY STRUC, V2nd; Allan JD, 2003, CAN J FISH AQUAT SCI, V60, P309, DOI 10.1139/F03-019; ALLEN KR, 1951, NZ MARINE DEP FISHER, V10, P1; Anderson M.J., 2004, CAP FORTRAN COMPUTER; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Andersson J., 2009, GIS BASED LANDSCAPE; BACHMAN RA, 1984, T AM FISH SOC, V113, P1, DOI 10.1577/1548-8659(1984)113&lt;1:FBOFWA&gt;2.0.CO;2; Baxter CV, 2007, OECOLOGIA, V153, P461, DOI 10.1007/s00442-007-0743-x; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Bergkvist A, 2002, SMALL FOREST STREAMS; Bremset G, 1999, ANIM BEHAV, V58, P1047, DOI 10.1006/anbe.1999.1218; Bridcut EE, 2000, HYDROBIOLOGIA, V427, P83, DOI 10.1023/A:1003927331472; Bridcut EE, 1995, CAN J FISH AQUAT SCI, V52, P2543, DOI 10.1139/f95-845; BRIDCUT EE, 1993, J FISH BIOL, V43, P889, DOI 10.1006/jfbi.1993.1192; Carlson SM, 2007, J FISH BIOL, V71, P1430, DOI 10.1111/j.1095-8649.2007.01615.x; Cloe WW, 1996, FRESHWATER BIOL, V36, P105; COOPER EL, 1953, COPEIA, P107; COOPER SD, 1990, ECOLOGY, V71, P1503, DOI 10.2307/1938287; Crisp DT, EUROPE SPECIAL REFER; Cummins K.W., 1971, INT ASS THEORETICAL, V18, P1, DOI [DOI 10.1080/05384680.1971.11903918, 10. 1080/05384680. 1971. 11903918]; Dineen G, 2007, BIOL ENVIRON, V107B, P167, DOI 10.3318/BIOE.2007.107.3.167; Dineen G, 2007, J FISH BIOL, V71, P17, DOI 10.1111/j.1095-8649.2007.01441.x; DUNBRACK RL, 1983, ENVIRON BIOL FISH, V8, P203, DOI 10.1007/BF00001086; Elliott JM, 1994, QUANTITATIVE ECOLOGY, Vviii; Fausch KD, 2002, TRENDS ECOL EVOL, V17, P429, DOI 10.1016/S0169-5347(02)02572-7; FEMINELLA JW, 1989, FRESHWATER BIOL, V22, P445, DOI 10.1111/j.1365-2427.1989.tb01117.x; Gille E, 2002, RIPARIAN ZONE SMALL; Greenberg L, 2005, ARCH HYDROBIOL, V164, P39, DOI 10.1127/0003-9136/2005/0164-0039; GREENBERG LA, 1994, FRESHWATER BIOL, V32, P1, DOI 10.1111/j.1365-2427.1994.tb00860.x; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Heggenes J, 2002, J FISH BIOL, V60, P72, DOI 10.1006/jfbi.2001.1811; Heggenes J, 1999, ECOL FRESHW FISH, V8, P1, DOI 10.1111/j.1600-0633.1999.tb00048.x; Heggenes J., 1989, NORDIC J FRESHWATER, V64, P74; HILL WR, 1995, ECOLOGY, V76, P1297, DOI 10.2307/1940936; Hill WR, 2002, FRESHWATER BIOL, V47, P1245, DOI 10.1046/j.1365-2427.2002.00837.x; Hill WR, 2001, ECOLOGY, V82, P2306, DOI 10.1890/0012-9658(2001)082[2306:SERTFL]2.0.CO;2; Hynes H. B. N., 1970, ECOLOGY RUNNING WATE; Kawaguchi Y, 2001, FRESHWATER BIOL, V46, P303, DOI 10.1046/j.1365-2427.2001.00667.x; Kiffney PM, 2004, J N AM BENTHOL SOC, V23, P542, DOI 10.1899/0887-3593(2004)023&lt;0542:ELAACM&gt;2.0.CO;2; Kiffney PM, 2003, J APPL ECOL, V40, P1060, DOI 10.1111/j.1365-2664.2003.00855.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Letcher BH, 2003, J FISH BIOL, V62, P97, DOI 10.1046/j.1095-8649.2003.00009.x; MakiPetays A, 1997, CAN J FISH AQUAT SCI, V54, P520, DOI 10.1139/cjfas-54-3-520; Mallory MA, 2005, J ANIM ECOL, V74, P1020, DOI 10.1111/j.1365-2656.2005.01000.x; Marczak LB, 2008, OECOLOGIA, V156, P249, DOI 10.1007/s00442-008-0989-y; MASON CF, 1982, FRESHWATER BIOL, V12, P305, DOI 10.1111/j.1365-2427.1982.tb00624.x; Meissner K, 2006, J ANIM ECOL, V75, P421, DOI 10.1111/j.1365-2656.2006.01063.x; Montori A, 2006, INT REV HYDROBIOL, V91, P438, DOI 10.1002/iroh.200510899; Murdock JN, 2007, J PHYCOL, V43, P449, DOI 10.1111/j.1529-8817.2007.00357.x; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Nakano S, 1999, ECOL RES, V14, P351, DOI 10.1046/j.1440-1703.1999.00315.x; Nakano S, 1999, ECOLOGY, V80, P2435; Nakano S., 1994, Ecology of Freshwater Fish, V3, P153, DOI 10.1111/j.1600-0633.1994.tb00017.x; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Nilsson A., 1996, AQUATIC INSECTS NO E; Northcote TG, FISHES FORESTRY; Persson A, 2002, OIKOS, V97, P271, DOI 10.1034/j.1600-0706.2002.970213.x; Ricker WE, 1979, GROWTH RATES MODELS; ROSEMOND AD, 1993, OECOLOGIA, V94, P585, DOI 10.1007/BF00566976; Rosemond AD, 2000, CAN J FISH AQUAT SCI, V57, P66, DOI 10.1139/cjfas-57-1-66; Sabo JL, 2002, ECOLOGY, V83, P1860, DOI 10.2307/3071770; Sempeski P, 1996, CAN J ZOOL, V74, P1597, DOI 10.1139/z96-176; Steingrimsson SO, 2002, ENVIRON BIOL FISH, V63, P417, DOI 10.1023/A:1014976612970; Teixeira A, 2006, B FR PECHE PISCIC, P1, DOI 10.1051/kmae:2006004; TWOMEY H, 1990, Aquaculture and Fisheries Management, V21, P137, DOI 10.1111/j.1365-2109.1990.tb00390.x; Webster JJ, 2005, J FRESHWATER ECOL, V20, P101, DOI 10.1080/02705060.2005.9664942; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wipfli MS, 1997, CAN J FISH AQUAT SCI, V54, P1259, DOI 10.1139/cjfas-54-6-1259; Zadorina V. M., 1988, VOP IKHTIOL, V2, P259; Zimmerman JKH, 2006, J N AM BENTHOL SOC, V25, P453, DOI 10.1899/0887-3593(2006)25[453:EOSEOD]2.0.CO;2	71	29	30	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36462	10.1371/journal.pone.0036462	http://dx.doi.org/10.1371/journal.pone.0036462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574164	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800060
J	Ku, YX; Hong, B; Zhou, WJ; Bodner, M; Zhou, YD				Ku, Yixuan; Hong, Bo; Zhou, Wenjing; Bodner, Mark; Zhou, Yong-Di			Sequential Neural Processes in Abacus Mental Addition: An EEG and fMRI Case Study	PLOS ONE			English	Article							WORKING-MEMORY RESOURCES; DIGIT MEMORY; TEMPORAL GYRUS; BRAIN; EXPERTS; ACTIVATION; AREAS; COMPONENTS; CHILDREN; MIDDLE	Abacus experts are able to mentally calculate multi-digit numbers rapidly. Some behavioral and neuroimaging studies have suggested a visuospatial and visuomotor strategy during abacus mental calculation. However, no study up to now has attempted to dissociate temporally the visuospatial neural process from the visuomotor neural process during abacus mental calculation. In the present study, an abacus expert performed the mental addition tasks (8-digit and 4-digit addends presented in visual or auditory modes) swiftly and accurately. The 100% correct rates in this expert's task performance were significantly higher than those of ordinary subjects performing 1-digit and 2-digit addition tasks. ERPs, EEG source localizations, and fMRI results taken together suggested visuospatial and visuomotor processes were sequentially arranged during the abacus mental addition with visual addends and could be dissociated from each other temporally. The visuospatial transformation of the numbers, in which the superior parietal lobule was most likely involved, might occur first (around 380 ms) after the onset of the stimuli. The visuomotor processing, in which the superior/middle frontal gyri were most likely involved, might occur later (around 440 ms). Meanwhile, fMRI results suggested that neural networks involved in the abacus mental addition with auditory stimuli were similar to those in the visual abacus mental addition. The most prominently activated brain areas in both conditions included the bilateral superior parietal lobules (BA 7) and bilateral middle frontal gyri (BA 6). These results suggest a supra-modal brain network in abacus mental addition, which may develop from normal mental calculation networks.	[Ku, Yixuan] E China Normal Univ, Sch Psychol & Cognit Sci, Inst Cognit Neurosci, Key Lab Brain Funct Genom MOE, Shanghai 200062, Peoples R China; [Ku, Yixuan; Hong, Bo; Zhou, Wenjing] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China; [Bodner, Mark] MIND Res Inst, Santa Ana, CA USA; [Zhou, Yong-Di] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA	East China Normal University; Tsinghua University; Johns Hopkins University	Ku, YX (corresponding author), E China Normal Univ, Sch Psychol & Cognit Sci, Inst Cognit Neurosci, Key Lab Brain Funct Genom MOE, Shanghai 200062, Peoples R China.	yixuanku@gmail.com; yzhou12@jhmi.edu	Zhou, Yongdi/GOH-3291-2022; Ku, Yixuan/D-4063-2018	Ku, Yixuan/0000-0003-2804-5123	National Natural Science Foundation of China [31100742]; China Postdoctoral Science Foundation [20100480615, 201104246]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31100742) and China Postdoctoral Science Foundation (20100480615 and 201104246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera JA, 2011, J COGNITIVE NEUROSCI, V23, P11, DOI 10.1162/jocn.2010.21451; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Chen FY, 2006, NEUROSCI LETT, V403, P46, DOI 10.1016/j.neulet.2006.04.041; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; De Rammelaere S, 1999, PSYCHOL RES-PSYCH FO, V62, P72, DOI 10.1007/s004260050041; De Rammelaere S, 2001, MEM COGNITION, V29, P267, DOI 10.3758/BF03194920; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 2005, MONKEY BRAIN HUMAN B, P133; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Frank MC, 2012, J EXP PSYCHOL GEN, V141, P134, DOI 10.1037/a0024427; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Furst AJ, 2000, MEM COGNITION, V28, P774, DOI 10.3758/BF03198412; Godinho F, 2006, J NEUROSCI, V26, P11454, DOI 10.1523/JNEUROSCI.2260-06.2006; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Hanakawa T, 2003, NEUROIMAGE, V19, P296, DOI 10.1016/S1053-8119(03)00050-8; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; HATANO G, 1983, COGNITION, V15, P95, DOI 10.1016/0010-0277(83)90035-5; HATANO G, 1977, COGNITION, V5, P47, DOI 10.1016/0010-0277(77)90016-6; HATTA T, 1989, APPL COGNITIVE PSYCH, V3, P23, DOI 10.1002/acp.2350030104; Hu YZ, 2011, HUM BRAIN MAPP, V32, P10, DOI 10.1002/hbm.20996; Iguchi Y, 2000, CLIN NEUROPHYSIOL, V111, P204, DOI 10.1016/S1388-2457(99)00244-8; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Ku YX, 2010, NEUROSCI LETT, V472, P5, DOI 10.1016/j.neulet.2010.01.040; Langan J, 2011, BEHAV BRAIN RES, V225, P160, DOI 10.1016/j.bbr.2011.07.014; Lemaire P, 1996, EUR J COGN PSYCHOL, V8, P73, DOI 10.1080/095414496383211; LOGIE RH, 1994, MEM COGNITION, V22, P395, DOI 10.3758/BF03200866; Menninger K., 1992, NUMBER WORDS NUMBER; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Onitsuka T, 2004, AM J PSYCHIAT, V161, P1603, DOI 10.1176/appi.ajp.161.9.1603; Oshio R, 2010, NEUROIMAGE, V49, P1108, DOI 10.1016/j.neuroimage.2009.07.034; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PAULI P, 1994, COGNITIVE BRAIN RES, V2, P21, DOI 10.1016/0926-6410(94)90017-5; Pinel P, 2010, J COGNITIVE NEUROSCI, V22, P48, DOI 10.1162/jocn.2009.21184; Potts GF, 2004, BRAIN COGNITION, V56, P5, DOI 10.1016/j.bandc.2004.03.006; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Rueckert L, 1996, NEUROIMAGE, V3, P97, DOI 10.1006/nimg.1996.0011; Sakai K, 1998, J NEUROSCI, V18, P1827; Seitz K, 2000, EUR J COGN PSYCHOL, V12, P552, DOI 10.1080/095414400750050231; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; STIGLER JW, 1984, COGNITIVE PSYCHOL, V16, P145, DOI 10.1016/0010-0285(84)90006-9; Tanaka S, 2002, NEUROREPORT, V13, P2187, DOI 10.1097/00001756-200212030-00005; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697	49	22	22	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36410	10.1371/journal.pone.0036410	http://dx.doi.org/10.1371/journal.pone.0036410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574155	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800051
J	Mallet, S; Weiss, S; Jacques, N; Leh-Louis, V; Sacerdot, C; Casaregola, S				Mallet, Sandrine; Weiss, Stephanie; Jacques, Noemie; Leh-Louis, Veronique; Sacerdot, Christine; Casaregola, Serge			Insights into the Life Cycle of Yeasts from the CTG Clade Revealed by the Analysis of the Millerozyma (Pichia) farinosa Species Complex	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NATURAL HYBRIDS; SACCHAROMYCES-KUDRIAVZEVII; GEN. NOV; DEBARYOMYCES; RECOMBINATION; DNA; SORBITOPHILA; POLYMORPHISM; INHERITANCE	Among ascomycetous yeasts, the CTG clade is so-called because its constituent species translate CTG as serine instead of leucine. Though the biology of certain pathogenic species such as Candida albicans has been much studied, little is known about the life cycles of non-pathogen species of the CTG clade. Taking advantage of the recently obtained sequence of the biotechnological Millerozyma (Pichiasorbitophila) farinosa strain CBS 7064, we used MLST to better define phylogenic relationships between most of the Millerozyma farinosa strains available in public collections. This led to the constitution of four phylogenetic clades diverging from 8% to 15% at the DNA level and possibly constituting a species complex (M. farinosa) and to the proposal of two new species: Millerozyma miso sp. nov. CBS 2004(T) (=CLIB 1230(T)) and Candida pseudofarinosa sp. nov.NCYC 386(T) (=CLIB 1231(T)). Further analysis showed that M. farinosa isolates exist as haploid and inter-clade hybrids. Despite the sequence divergence between the clades, secondary contacts after reproductive isolation were evidenced, as revealed by both introgression and mitochondria transfer between clades. We also showed that the inter-clade hybrids do sporulate to generate mainly viable vegetative diploid spores that are not the result of meiosis, and very rarely aneuploid spores possibly through the loss of heterozygosity during sporulation. Taken together, these results show that in this part of the CTG clade, non-Mendelian genetic exchanges occur at high rates through hybridization between divergent strainsfrom distinct clades and subsequent massive loss of heterozygosity. This combination of mechanisms could constitute an alternative sexuality leading to an unsuspected biodiversity.	[Mallet, Sandrine; Weiss, Stephanie; Jacques, Noemie; Casaregola, Serge] CIRM Levures, INRA, Micalis Inst, UMR1319, Thiverval Grignon, France; [Mallet, Sandrine; Weiss, Stephanie; Jacques, Noemie; Casaregola, Serge] AgroParisTech, Micalis Inst, UMR1319, Thiverval Grignon, France; [Leh-Louis, Veronique] Univ Strasbourg, CNRS, UMR7156, Strasbourg, France; [Sacerdot, Christine] Univ Paris 06, UFR 927, UMR 3525, CNRS,Unite Genet Mol Levures,Inst Pasteur, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Mallet, S (corresponding author), CIRM Levures, INRA, Micalis Inst, UMR1319, Thiverval Grignon, France.	serge.casaregola@grignon.inra.fr		Sacerdot, Christine/0000-0002-7402-3411	AIP Bioresources INRA grant; European Community [FP7-228310]	AIP Bioresources INRA grant; European Community(European Commission)	This work was supported by an AIP Bioresources INRA grant. This work has received funding from the European Community's Seventh Framework Programme (FP7, 2007-2013), Research Infrastructures action, under grant agreement No. FP7-228310 (EMbaRC project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2007, J CLIN MICROBIOL, V45, P3456, DOI 10.1128/JCM.00788-07; ANAISSIE E, 1989, REV INFECT DIS, V11, P369; Bennett RJ, 2005, ANNU REV MICROBIOL, V59, P233, DOI 10.1146/annurev.micro.59.030804.121310; Berger KH, 2000, TRENDS MICROBIOL, V8, P508, DOI 10.1016/S0966-842X(00)01862-X; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Corredor M, 2003, ANTON LEEUW INT J G, V83, P215, DOI 10.1023/A:1023322301634; Daniel HM, 2001, INT J SYST EVOL MICR, V51, P1593, DOI 10.1099/00207713-51-4-1593; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forche A, 2005, EUKARYOT CELL, V4, P156, DOI 10.1128/EC.4.1.156-165.2005; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Fritsch ES, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-99; Fundyga RE, 2004, INFECT GENET EVOL, V4, P37, DOI 10.1016/j.meegid.2003.11.002; Gangl H, 2009, NEW BIOTECHNOL, V25, P244, DOI 10.1016/j.nbt.2008.10.001; GarciaMartos P, 1996, MYCOPATHOLOGIA, V136, P67, DOI 10.1007/BF00437497; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Groth G, 1999, INT J SYST BACTERIOL, V49, P1933; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heitman Joseph, 2011, Fungal Biology Reviews, V25, P48, DOI 10.1016/j.fbr.2011.01.003; HERSKOWITZ I, 1988, MICROBIOL REV, V52, P536, DOI 10.1128/MMBR.52.4.536-553.1988; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Jacques N, 2010, EUKARYOT CELL, V9, P449, DOI 10.1128/EC.00263-09; Jacques N, 2009, INT J SYST EVOL MICR, V59, P1242, DOI 10.1099/ijs.0.004325-0; James SA, 2005, FEMS YEAST RES, V5, P747, DOI 10.1016/j.femsyr.2005.02.004; Jung PP, 2010, CURR GENET, V56, P507, DOI 10.1007/s00294-010-0318-y; Jung PP, 2009, FEMS YEAST RES, V9, P903, DOI 10.1111/j.1567-1364.2009.00540.x; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kuehne HA, 2007, CURR BIOL, V17, P407, DOI 10.1016/j.cub.2006.12.047; Kurtzman C. P., 1998, P273, DOI 10.1016/B978-044481312-1/50046-0; Kurtzman CP, 2008, FEMS YEAST RES, V8, P939, DOI 10.1111/j.1567-1364.2008.00419.x; Kurtzman CP, 2007, FEMS YEAST RES, V7, P141, DOI 10.1111/j.1567-1364.2006.00157.x; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; KURTZMAN CP, 1975, MYCOPATHOLOGIA, V55, P29, DOI 10.1007/BF00467088; LAGES F, 1995, YEAST, V11, P111, DOI 10.1002/yea.320110203; Lee F-L, 1992, B JPN FED CULTURE CO, V8, P71; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Louis VL, 2012, G3-GENES GENOM GENET, V2, P299, DOI 10.1534/g3.111.000745; Maresova L, 2003, FOLIA MICROBIOL, V48, P211, DOI 10.1007/BF02930958; Marinoni G, 2004, FEMS YEAST RES, V4, P587, DOI 10.1016/j.femsyr.2003.12.005; MARTINI AV, 1985, INT J SYST BACTERIOL, V35, P508; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; PAULA CR, 1990, MYCOPATHOLOGIA, V112, P119, DOI 10.1007/BF00436507; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Porman AM, 2011, P NATL ACAD SCI USA, V108, P21158, DOI 10.1073/pnas.1112076109; Prillinger H, 1999, ANTON LEEUW INT J G, V75, P267, DOI 10.1023/A:1001889917533; Rainieri S, 2008, FEMS YEAST RES, V8, P586, DOI 10.1111/j.1567-1364.2008.00363.x; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; Rodrigues F, 2003, APPL ENVIRON MICROB, V69, P649, DOI 10.1128/AEM.69.1.649-653.2003; RODRIGUESDEMIRANDA L, 1980, A VAN LEEUW J MICROB, V46, P157, DOI 10.1007/BF00444070; ROEDER GS, 1990, TRENDS GENET, V6, P385, DOI 10.1016/0168-9525(90)90297-J; Sacerdot C, 2008, FEMS YEAST RES, V8, P846, DOI 10.1111/j.1567-1364.2008.00409.x; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Solieri L, 2010, TRENDS MICROBIOL, V18, P521, DOI 10.1016/j.tim.2010.08.001; Suzuki C, 2003, YEAST, V20, P905, DOI 10.1002/yea.1017; Szekvolgyi L, 2010, FEBS J, V277, P571, DOI 10.1111/j.1742-4658.2009.07502.x; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsui CKM, 2008, FEMS YEAST RES, V8, P651, DOI 10.1111/j.1567-1364.2007.00342.x; VANDERWALT JP, 1977, A VAN LEEUW J MICROB, V43, P205, DOI 10.1007/BF00395675	60	19	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35842	10.1371/journal.pone.0035842	http://dx.doi.org/10.1371/journal.pone.0035842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574125	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800021
J	van de Sande, MGH; de Hair, MJH; Schuller, Y; van de Sande, GPM; Wijbrandts, CA; Dinant, HJ; Gerlag, DM; Tak, PP				van de Sande, Marleen G. H.; de Hair, Maria J. H.; Schuller, Yvonne; van de Sande, Gijs P. M.; Wijbrandts, Carla A.; Dinant, Huib J.; Gerlag, Danielle M.; Tak, Paul P.			The Features of the Synovium in Early Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria	PLOS ONE			English	Article							RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; PREDICTION RULE; CELL INFILTRATE; TISSUE; DIAGNOSIS; BIOPSIES	Objective: It has been shown in early arthritis cohorts that the 2010 ACR/EULAR criteria for rheumatoid arthritis (RA) enable an earlier diagnosis, perhaps at the cost of a somewhat more heterogeneous patient population. We describe the features of synovial inflammation in RA patients classified according to these new criteria. Methods: At baseline, synovial tissue biopsy samples were obtained from disease-modifying antirheumatic drug (DMARD)-naive early RA patients (clinical signs and symptoms <1 year). Synovial tissue was analyzed for cell infiltration, vascularity, and expression of adhesion molecules. Stained sections were evaluated by digital image analysis. Patients were classified according to the two different sets of classification criteria, autoantibody status, and outcome. Findings: Synovial tissue of 69 RA patients according to 2010 ACR/EULAR criteria was analyzed: 56 patients who fulfilled the criteria for RA at baseline and 13 who were initially diagnosed as undifferentiated arthritis but fulfilled criteria for RA upon follow up. The synovium at baseline was infiltrated by plasma cells, macrophages, and T cells as well as other cells, and findings were comparable to those when patients were selected based on the 1987 ACR criteria for RA. There was no clear cut difference in the characteristics of the synovium between RA patients initially diagnosed as undifferentiated arthritis and those who already fulfilled classification criteria at baseline. Conclusion: The features of synovial inflammation are similar when the 2010 ACR/EULAR classification criteria are used compared to the 1987 ACR criteria.	[van de Sande, Marleen G. H.; de Hair, Maria J. H.; Schuller, Yvonne; van de Sande, Gijs P. M.; Wijbrandts, Carla A.; Dinant, Huib J.; Gerlag, Danielle M.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van de Sande, MGH (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.p.tak@amc.uva.nl			Dutch Arthritis Association [06-1-303]; European Community's FP6 funding (Autocure)	Dutch Arthritis Association; European Community's FP6 funding (Autocure)	This research project was funded by the Dutch Arthritis Association (nr 06-1-303) and the European Community's FP6 funding (Autocure). This publication reflects only the authors' views; the European Community is not liable for any use that may be made of the information herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Cader MZ, 2011, ANN RHEUM DIS; Canete JD, 2009, ANN RHEUM DIS, V68, P751, DOI 10.1136/ard.2008.089284; Cantaert T, 2008, J IMMUNOL, V181, P785, DOI 10.4049/jimmunol.181.1.785; de Hair MJH, 2012, ARTHRITIS RHEUM-US, V64, P389, DOI 10.1002/art.33348; de Hair MJH, 2011, J RHEUMATOL, V38, P2068, DOI 10.3899/jrheum.110426; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Gerlag D, 2005, BEST PRACT RES CL RH, V19, P387, DOI 10.1016/j.berh.2005.01.005; Gerlag DM, 2007, NAT CLIN PRACT RHEUM, V3, P248, DOI 10.1038/ncprheum0485; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Kraan MC, 1999, RHEUMATOLOGY, V38, P1074, DOI 10.1093/rheumatology/38.11.1074; Kraan MC, 2000, RHEUMATOLOGY, V39, P43, DOI 10.1093/rheumatology/39.1.43; Nell VPK, 2004, RHEUMATOLOGY, V43, P906, DOI 10.1093/rheumatology/keh199; Smeets TJM, 2003, ANN RHEUM DIS, V62, P635, DOI 10.1136/ard.62.7.635; TAK PP, 1995, ARTHRITIS RHEUM, V38, P1457, DOI 10.1002/art.1780381012; Thurlings RM, 2008, ARTHRITIS RHEUM, V58, P1582, DOI 10.1002/art.23505; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P423, DOI 10.1136/ard.2010.139550; van der Hall Pascal O., 2007, V135, P121; van der Heijde D, 1999, J RHEUMATOL, V26, P743; van der Helm-van Mil AH, 2008, ARTHRITIS RHEUM-US, V58, P2241, DOI 10.1002/art.23681; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; van der Linden MPM, 2011, ARTHRITIS RHEUM-US, V63, P37, DOI 10.1002/art.30100; van Oosterhout M, 2008, ARTHRITIS RHEUM, V58, P53, DOI 10.1002/art.23148; Visser H, 2002, ARTHRITIS RHEUM, V46, P357, DOI 10.1002/art.10117	26	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36668	10.1371/journal.pone.0036668	http://dx.doi.org/10.1371/journal.pone.0036668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574210	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800107
J	Wang, LH; Liu, LP; Shi, Y; Cao, HW; Chaturvedi, R; Calcutt, MW; Hu, TH; Ren, XB; Wilson, KT; Polk, DB; Yan, F				Wang, Lihong; Liu, Liping; Shi, Yan; Cao, Hanwei; Chaturvedi, Rupesh; Calcutt, M. Wade; Hu, Tianhui; Ren, Xiubao; Wilson, Keith T.; Polk, D. Brent; Yan, Fang			Berberine Induces Caspase-Independent Cell Death in Colon Tumor Cells through Activation of Apoptosis-Inducing Factor	PLOS ONE			English	Article							SIGNALING PATHWAYS; CANCER; MITOCHONDRIAL; PROTEASES; MUTATION; NECROSIS; STRESS; TRIAL; STAGE; LINES	Berberine, an isoquinoline alkaloid derived from plants, is a traditional medicine for treating bacterial diarrhea and intestinal parasite infections. Although berberine has recently been shown to suppress growth of several tumor cell lines, information regarding the effect of berberine on colon tumor growth is limited. Here, we investigated the mechanisms underlying the effects of berberine on regulating the fate of colon tumor cells, specifically the mouse immorto-Min colonic epithelial (IMCE) cells carrying the Apc(min) mutation, and of normal colon epithelial cells, namely young adult mouse colonic epithelium (YAMC) cells. Berberine decreased colon tumor colony formation in agar, and induced cell death and LDH release in a time- and concentration-dependent manner in IMCE cells. In contrast, YAMC cells were not sensitive to berberine-induced cell death. Berberine did not stimulate caspase activation, and PARP cleavage and berberine-induced cell death were not affected by a caspase inhibitor in IMCE cells. Rather, berberine stimulated a caspase-independent cell death mediator, apoptosis-inducing factor (AIF) release from mitochondria and nuclear translocation in a ROS production-dependent manner. Amelioration of berberine-stimulated ROS production or suppression of AIF expression blocked berberine-induced cell death and LDH release in IMCE cells. Furthermore, two targets of ROS production in cells, cathepsin B release from lysosomes and PARP activation were induced by berberine. Blockage of either of these pathways decreased berberine-induced AIF activation and cell death in IMCE cells. Thus, berberine-stimulated ROS production leads to cathepsin B release and PARP activation-dependent AIF activation, resulting in caspase-independent cell death in colon tumor cells. Notably, normal colon epithelial cells are less susceptible to berberine-induced cell death, which suggests the specific inhibitory effects of berberine on colon tumor cell growth.	[Wang, Lihong; Liu, Liping; Shi, Yan; Cao, Hanwei; Yan, Fang] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Wang, Lihong; Liu, Liping; Shi, Yan; Cao, Hanwei; Yan, Fang] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Wang, Lihong; Hu, Tianhui] Xiamen Univ, Coll Med, Canc Res Ctr, Xiamen, Peoples R China; [Chaturvedi, Rupesh; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Calcutt, M. Wade] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Ren, Xiubao; Yan, Fang] Tianjin Med Univ, Canc Inst & Hosp, Dept Biotherapy, Tianjin, Peoples R China; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Polk, D. Brent] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	Vanderbilt University; Vanderbilt University; Xiamen University; Vanderbilt University; Vanderbilt University; Tianjin Medical University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Southern California; Children's Hospital Los Angeles	Wang, LH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	fang.yan@vanderbilt.edu	Shi, Y/G-3964-2010; Hu, T/G-3381-2010; liu, li/HGC-0900-2022	Wilson, Keith/0000-0003-4421-1830	NIH [R01DK081134, R01DK56008, R01AT004821, R01DK053620, P30DK058404]; Department of Veterans Affairs; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK081134, R01DK056008, R01DK053620] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grants R01DK081134 (F.Y.), R01DK56008 (D. B. P.), R01AT004821 and R01DK053620 (K. T. W.), P30DK058404 (Vanderbilt University Digestive Disease Research Center) and Department of Veterans Affairs (K. T. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain KS, 2006, CLIN LUNG CANCER, V7, P417, DOI 10.3816/CLC.2006.n.027; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Burgeiro A, 2011, ANTI-CANCER DRUG, V22, P507, DOI 10.1097/CAD.0b013e32834438f6; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hyun MS, 2010, J CELL BIOCHEM, V109, P329, DOI 10.1002/jcb.22384; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li X, 2007, NEUROSCIENCE, V144, P56, DOI 10.1016/j.neuroscience.2006.08.065; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021416; Ma XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013489; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Rugo H, 2007, BREAST CANCER RES TR, V105, P17, DOI 10.1007/s10549-006-9430-6; Sun YY, 2009, ANTI-CANCER DRUG, V20, P757, DOI 10.1097/CAD.0b013e328330d95b; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Turk V, 2004, CANCER CELL, V5, P409, DOI 10.1016/S1535-6108(04)00117-5; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; WHITEHEAD RH, 1994, EPITHELIAL CELL BIOL, V3, P119; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	33	81	86	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36418	10.1371/journal.pone.0036418	http://dx.doi.org/10.1371/journal.pone.0036418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574158	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800054
J	Miralem, T; Lerner-Marmarosh, N; Gibbs, PEM; Tudor, C; Hagen, FK; Maines, MD				Miralem, Tihomir; Lerner-Marmarosh, Nicole; Gibbs, Peter E. M.; Tudor, Cicerone; Hagen, Fred K.; Maines, Mahin D.			The Human Biliverdin Reductase-based Peptide Fragments and Biliverdin Regulate Protein Kinase C delta Activity THE PEPTIDES ARE INHIBITORS OR SUBSTRATE FOR THE PROTEIN KINASE C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PKC-DELTA; HEME OXYGENASE-1; OXIDATIVE STRESS; TYROSINE KINASE; ACTIVATION MECHANISMS; GOODPASTURE ANTIGEN; SIGNALING PATHWAYS; STRUCTURAL BASIS; BINDING PROTEIN	PKC delta, a Ser/Thr kinase, promotes cell growth, tumorigenesis, and apoptosis. Human biliverdin reductase (hBVR), a Ser/Thr/Tyr kinase, inhibits apoptosis by reducing biliverdin-IX to antioxidant bilirubin. The enzymes are activated by similar stimuli. Reportedly, hBVR is a kinase-independent activator of PKC delta and is transactivated by the PKC (Gibbs, P. E., Miralem, T., Lerner-Marmarosh, N., Tudor, C., and Maines, M. D. (2012) J. Biol. Chem. 287, 1066-1079). Presently, we examined interactions between the two proteins in the context of regulation of their activities and defining targets of hBVR phosphorylation by PKC delta. LC-MS/MS analysis of PKC delta-activated intact hBVR identified phosphorylated serine positions 21, 33, 230, and 237, corresponding to the hBVR Src homology-2 domain motif (Ser(230) and Ser(237)), flanking the ATP-binding motif (Ser(21)) and in PHPS sequence (Ser(33)) as targets of PKC delta. Ser(21) and Ser(230) were also phosphorylated in hBVR-based peptides. The Ser(230)-containing peptide was a high affinity substrate for PKC delta in vitro and in cells; the relative affinity was PKC delta > PKC beta II > PKC zeta. Two overlapping peptides spanning this substrate, KRNRYLSF and SFHFKSGSL, were effective inhibitors of PKC delta kinase activity and PKC delta-supported activation of transcription factors Elk1 and NF-kappa B. Only SFHFKSGSL, in PKC delta-transfected phorbol 12-myristate 13-acetate-stimulated cells, caused membrane blebbing and cell loss. Biliverdin noncovalently inhibited PKC delta, whereas PKC delta potentiated hBVR reductase activity and accelerated the rate of bilirubin formation. This study, together with previous findings, reveals an unexpected regulatory interplay between PKC delta and hBVR in modulating cell death/survival in response to various activating stimuli. In addition, this study has identified novel substrates for and inhibitors of PKC delta. We suggest that hBVR-based technology may have utility to modulate PKC delta-mediated functions in the cell.	[Maines, Mahin D.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Tudor, Cicerone] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Hagen, Fred K.] Univ Rochester, Sch Med & Dent, Rochester Prote Ctr, Rochester, NY 14642 USA	University of Rochester; Max Planck Society; University of Rochester	Maines, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	mahin_maines@urmc.rochester.edu	Miralem, Tihomir/F-7576-2013	Miralem, Tihomir/0000-0001-7705-0442	National Institutes of Health [ES04066, ES12187]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012187, R01ES004066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health cifically PKC beta II and PKC delta, the conventional and atypical Grants ES04066 and ES12187.	Ahmad Z, 2002, J BIOL CHEM, V277, P9226, DOI 10.1074/jbc.M108239200; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Brandt S, 2009, CELL MOTIL CYTOSKEL, V66, P874, DOI 10.1002/cm.20373; Clark AS, 2003, CANCER RES, V63, P780; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Ding B, 2011, FASEB J, V25, P301, DOI 10.1096/fj.10-166454; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; EWING JF, 1991, P NATL ACAD SCI USA, V88, P5364, DOI 10.1073/pnas.88.12.5364; Fukunaga M, 2001, BIOCHEM BIOPH RES CO, V289, P573, DOI 10.1006/bbrc.2001.6025; Gibbs PEM, 2007, INT J CANCER, V121, P2567, DOI 10.1002/ijc.22978; Gibbs PEM, 2012, J BIOL CHEM, V287, P1066, DOI 10.1074/jbc.M111.279612; Gorelik G, 2007, J IMMUNOL, V179, P5553, DOI 10.4049/jimmunol.179.8.5553; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gschwendt M, 1999, EUR J BIOCHEM, V259, P555, DOI 10.1046/j.1432-1327.1999.00120.x; Hampton MB, 1998, TOXICOL LETT, V103, P355, DOI 10.1016/S0378-4274(98)00333-6; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANNUN YA, 1990, J BIOL CHEM, V265, P2962; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Immenschuh S, 2005, CELL MOL BIOL, V51, P471, DOI 10.1170/T652; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kabu K, 2006, J IMMUNOL, V177, P1296, DOI 10.4049/jimmunol.177.2.1296; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Kim YK, 2006, BIOCHEM BIOPH RES CO, V347, P1088, DOI 10.1016/j.bbrc.2006.06.196; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; Kumar S, 2001, J BIOL CHEM, V276, P17281, DOI 10.1074/jbc.M101414200; Kwon MJ, 2007, MOL IMMUNOL, V44, P2841, DOI 10.1016/j.molimm.2007.01.035; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Lerner-Marmarosh N, 2007, FASEB J, V21, P3949, DOI 10.1096/fj.07-8544com; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Maghzal GJ, 2009, J BIOL CHEM, V284, P29251, DOI 10.1074/jbc.M109.037119; Maines MD, 2007, ANTIOXID REDOX SIGN, V9, P2187, DOI 10.1089/ars.2007.1805; Maines MD, 2007, J BIOL CHEM, V282, P8110, DOI 10.1074/jbc.M513427200; MAINES MD, 1993, ARCH BIOCHEM BIOPHYS, V300, P320, DOI 10.1006/abbi.1993.1044; Maines MD, 1996, EUR J BIOCHEM, V235, P372, DOI 10.1111/j.1432-1033.1996.00372.x; Majewski M, 2007, INT IMMUNOL, V19, P719, DOI 10.1093/intimm/dxm034; Mancuso C, 2006, REDOX REP, V11, P207, DOI 10.1179/135100006X154978; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; McCracken MA, 2003, MOL CANCER THER, V2, P273; McDonagh AF, 2001, NAT STRUCT BIOL, V8, P198, DOI 10.1038/84915; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; Miralem T, 2010, J BIOL CHEM, V285, P12551, DOI 10.1074/jbc.M109.032771; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; Ryer EJ, 2005, J BIOL CHEM, V280, P35310, DOI 10.1074/jbc.M507187200; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Salim M, 2001, J BIOL CHEM, V276, P10929, DOI 10.1074/jbc.M010753200; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; Shindo M, 2001, BIOORGAN MED CHEM, V9, P2073, DOI 10.1016/S0968-0896(01)00100-6; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; Stempka L, 1997, J BIOL CHEM, V272, P6805, DOI 10.1074/jbc.272.10.6805; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Wegiel B, 2009, J BIOL CHEM, V284, P21369, DOI 10.1074/jbc.M109.027433; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Zhao J, 1998, J BIOL CHEM, V273, P23072, DOI 10.1074/jbc.273.36.23072	81	17	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24698	24712		10.1074/jbc.M111.326504	http://dx.doi.org/10.1074/jbc.M111.326504			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22584576	Green Published, hybrid			2022-12-25	WOS:000306651100063
J	Bao, Y; Zheng, J; Han, CF; Jin, J; Han, HX; Liu, YP; Lau, YL; Tu, WW; Cao, XT				Bao, Yan; Zheng, Jian; Han, Chaofeng; Jin, Jing; Han, Huanxing; Liu, Yinping; Lau, Yu-Lung; Tu, Wenwei; Cao, Xuetao			Tyrosine Kinase Btk Is Required for NK Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; B-CELLS; ADAPTIVE IMMUNITY; X-CHROMOSOME; LIVER-INJURY; IFN-GAMMA; B-1 CELLS; T-CELLS; INNATE; MICE	Bruton tyrosine kinase (Btk) is not only critical for B cell development and differentiation but is also involved in the regulation of Toll-like receptor-triggered innate response of macrophages. However, whether Btk is involved in the regulation of natural killer (NK) cell innate function remains unknown. Here, we show that Btk expression is up-regulated during maturation and activation of mouse NK cells. Murine Btk(-/-) NKcells have decreased innate immune responses to the TLR3 ligand, with reduced expressions of IFN-gamma, perforin, and granzyme-B and decreased cytotoxic activity. Furthermore, Btk is found to promote TLR3-triggered NK cell activation mainly by activating the NF-kappa B pathway. Poly(I:C)-induced NK cell-mediated acute hepatitis was observed to be attenuated in Btk(-/-) mice or the mice with in vivo administration of the Btk inhibitor. Correspondingly, liver damage was aggravated in Btk(-/-) mice after the adoptive transfer of Btk(+/+) NK cells, further indicating that Btk-mediated NK cell activation contributes to TLR3-triggered acute liver injury. Importantly, reduced TLR3-triggered activation of human NK cells was observed in Btk-deficient patients with X-linked agammaglobulinemia, as evidenced by the reduced IFN-gamma, CD69, and CD107a expression and cytotoxic activity. These results indicate that Btk is required for activation of NK cells, thus providing insight into the physiological significance of Btk in the regulation of immune cell functions and innate inflammatory response.	[Bao, Yan; Han, Chaofeng; Jin, Jing; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Bao, Yan; Han, Chaofeng; Jin, Jing; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; Changzheng Hosp, Translat Med Ctr, Shanghai 200433, Peoples R China; [Zheng, Jian; Liu, Yinping; Lau, Yu-Lung; Tu, Wenwei] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; University of Hong Kong	Bao, Y (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, 7th Floor,Lib Bldg,800 Xiangyin Rd, Shanghai 200433, Peoples R China.	baoyan@yahoo.cn; wwtu@hku.hk	Lau, Yu Lung/C-4322-2009; Tu, Wenwei/C-4429-2009	Lau, Yu Lung/0000-0002-4780-0289; Tu, Wenwei/0000-0002-6801-8798				Bao Y, 2011, EUR J IMMUNOL, V41, P657, DOI 10.1002/eji.201040840; Becknell B, 2007, BLOOD, V109, P2481, DOI 10.1182/blood-2006-10-050096; Bouaziz A, 2007, THROMB HAEMOSTASIS, V98, P375, DOI 10.1160/TH07-01-0061; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Contreras CM, 2007, MOL IMMUNOL, V44, P2719, DOI 10.1016/j.molimm.2006.11.023; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Dong ZJ, 2004, J HEPATOL, V41, P966, DOI 10.1016/j.jhep.2004.08.021; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Khare A, 2011, APOPTOSIS, V16, P334, DOI 10.1007/s10495-010-0569-6; Kubo T, 2009, J EXP MED, V206, P1971, DOI 10.1084/jem.20082392; Lee SH, 2008, J BIOL CHEM, V283, P11526, DOI 10.1074/jbc.M708935200; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Liu Y., 2012, J CLIN IMMU IN PRESS; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Ng YY, 2010, LEUKEMIA, V24, P1617, DOI 10.1038/leu.2010.140; Nisitani S, 2000, P NATL ACAD SCI USA, V97, P2737, DOI 10.1073/pnas.050583597; Ormsby T, 2011, BLOOD, V118, P936, DOI 10.1182/blood-2010-11-317016; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Rosenberger CM, 2008, P NATL ACAD SCI USA, V105, P2544, DOI 10.1073/pnas.0712182105; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Smith MA, 2010, J IMMUNOL, V185, P6058, DOI 10.4049/jimmunol.1001682; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun R, 2004, GASTROENTEROLOGY, V127, P1525, DOI 10.1053/j.gastro.2004.08.055; Taneichi H, 2008, CLIN IMMUNOL, V126, P148, DOI 10.1016/j.clim.2007.10.005; Tato CM, 2006, INT IMMUNOL, V18, P505, DOI 10.1093/intimm/dxh391; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Vijayan V, 2011, J IMMUNOL, V187, P817, DOI 10.4049/jimmunol.1003631; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang NH, 2010, J IMMUNOL, V185, P5683, DOI 10.4049/jimmunol.1001974; Zhang MG, 2009, HEPATOLOGY, V50, P1606, DOI 10.1002/hep.23168; Zheng JA, 2011, EUR J IMMUNOL, V41, P128, DOI 10.1002/eji.201040724	37	49	50	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23769	23778		10.1074/jbc.M112.372425	http://dx.doi.org/10.1074/jbc.M112.372425			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589540	Green Published, hybrid			2022-12-25	WOS:000306511300047
J	Lee, MJ; Kim, DE; Zakrzewska, A; Yoo, YD; Kim, SH; Kim, ST; Seo, JW; Lee, YS; Dorn, GW; Oh, U; Kim, BY; Kwon, YT				Lee, Min Jae; Kim, Dong Eun; Zakrzewska, Adriana; Yoo, Young Dong; Kim, Su-Hyeon; Kim, Sung Tae; Seo, Jai Wha; Lee, Young Sook; Dorn, Gerald W., II; Oh, UhTaek; Kim, Bo Yeon; Kwon, Yong Tae			Characterization of Arginylation Branch of N-end Rule Pathway in G-protein-mediated Proliferation and Signaling of Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR PRINCIPLES; UBIQUITIN LIGASE; HEART-FAILURE; EXPRESSION; RECOGNITION; MOUSE; MICE; RGS4; ARGINYLTRANSFERASE; COMPONENT	The N-end rule pathway is a proteolytic system in which destabilizing N-terminal amino acids of short lived proteins are recognized by recognition components (N-recognins) as an essential element of degrons, called N-degrons. In eukaryotes, the major way to generate N-degrons is through arginylation by ATE1 arginyl-tRNA-protein transferases, which transfer Arg from aminoacyl-tRNA to N-terminal Asp and Glu (and Cys as well in mammals). We have shown previously that ATE1-deficient mice die during embryogenesis with defects in cardiac and vascular development. Here, we characterized the arginylation-dependent N-end rule pathway in cardiomyocytes. Our results suggest that the cardiac and vascular defects in ATE1-deficient embryos are independent from each other and cell-autonomous. ATE1-deficient myocardium and cardiomyocytes therein, but not non-cardiomyocytes, showed reduced DNA synthesis and mitotic activity similar to 24 h before the onset of cardiac and vascular defects at embryonic day 12.5 associated with the impairment in the phospholipase C/PKC-MEK1-ERK axis of G alpha(q)-mediated cardiac signaling pathways. Cardiac overexpression of G alpha(q) rescued ATE1-deficient embryos from thin myocardium and ventricular septal defect but not from vascular defects, genetically dissecting vascular defects from cardiac defects. The misregulation in cardiovascular signaling can be attributed in part to the failure in hypoxia-sensitive degradation of RGS4, a GTPase-activating protein for G alpha(q). This study is the first to characterize the N-end rule pathway in cardiomyocytes and reveals the role of its arginylation branch in G alpha(q)-mediated signaling of cardiomyocytes in part through N-degron-based, oxygen-sensitive proteolysis of G-protein regulators.	[Lee, Min Jae; Kim, Dong Eun; Zakrzewska, Adriana; Kim, Sung Tae; Seo, Jai Wha; Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Lee, Min Jae] Kyung Hee Univ, Dept Appl Chem, Coll Appl Sci, Yongin 446701, South Korea; [Lee, Min Jae; Kim, Dong Eun; Zakrzewska, Adriana; Kim, Sung Tae; Seo, Jai Wha; Kwon, Yong Tae] Univ Pittsburgh, Dept Pharmaceut Sci, Sch Pharm, Pittsburgh, PA 15261 USA; [Yoo, Young Dong; Oh, UhTaek; Kwon, Yong Tae] Seoul Natl Univ, World Class Univ WCU Program, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul 110799, South Korea; [Yoo, Young Dong; Oh, UhTaek; Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Seoul 110799, South Korea; [Kim, Su-Hyeon; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, WCI, Ochang 363883, South Korea; [Lee, Young Sook] Univ Wisconsin, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Dorn, Gerald W., II] Washington Univ, Dept Med, Ctr Pharmacogen, Sch Med, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kyung Hee University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Kwon, YT (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, 3501 Terrace St, Pittsburgh, PA 15261 USA.	yok5@pitt.edu	Lee, Min Jae/C-9814-2015	Lee, Min Jae/0000-0002-3252-6467	National Institutes of Health [HL083365, HL067050]; World Class University Grant [R31-2008-000-10103-0]; World Class Institute; Ministry of Education, Science, and Technology [2011-0007990, 2011-0030938]; Ministry of Health and Welfare Grant [A111227]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067050, R01HL083365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University Grant; World Class Institute; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL083365 (to Y.T.K.) and HL067050 (to Y.S.L.). This work was also supported by World Class University Grant R31-2008-000-10103-0 (to Y.T.K.), the World Class Institute (to B.Y.K.), Ministry of Education, Science, and Technology Grants 2011-0007990 and 2011-0030938 (to M.J.L.), and Ministry of Health and Welfare Grant A111227 (to M.J.L.).	Adams LD, 2000, CIRC RES, V87, P623, DOI 10.1161/01.RES.87.7.623; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BALZI E, 1990, J BIOL CHEM, V265, P7464; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Decca MB, 2006, NEUROCHEM RES, V31, P401, DOI 10.1007/s11064-005-9037-z; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Graciet E, 2009, P NATL ACAD SCI USA, V106, P13618, DOI 10.1073/pnas.0906404106; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; KAJI H, 1963, BIOCHIM BIOPHYS ACTA, V76, P477; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kurosaka S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000878; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee MJ, 2008, P NATL ACAD SCI USA, V105, P100, DOI 10.1073/pnas.0708465105; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Leu NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007734; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Owen VJ, 2001, EUR HEART J, V22, P1015, DOI 10.1053/euhj.2000.2578; Patten M, 2003, N-S ARCH PHARMACOL, V368, P360, DOI 10.1007/s00210-003-0798-0; Rogers JH, 2001, J MOL CELL CARDIOL, V33, P209, DOI 10.1006/jmcc.2000.1307; Spradling AC, 1999, GENETICS, V153, P135; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Sriram SM, 2010, NAT STRUCT MOL BIOL, V17, P1164, DOI 10.1038/nsmb1010-1164; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x	45	39	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					24043	24052		10.1074/jbc.M112.364117	http://dx.doi.org/10.1074/jbc.M112.364117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22577142	hybrid, Green Published			2022-12-25	WOS:000306511300072
J	Pietri, R; Zerbs, S; Corgliano, DM; Allaire, M; Collart, FR; Miller, LM				Pietri, Ruth; Zerbs, Sarah; Corgliano, Danielle M.; Allaire, Marc; Collart, Frank R.; Miller, Lisa M.			Biophysical and Structural Characterization of a Sequence-diverse Set of Solute-binding Proteins for Aromatic Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; BACTERIUM RHODOPSEUDOMONAS-PALUSTRIS; STRUCTURE PREDICTION; RESOLUTION STRUCTURE; BIOLOGICAL MACROMOLECULES; ABC TRANSPORTERS; ACTIVE-TRANSPORT; I-TASSER; SERVER	Rhodopseudomonas palustris metabolizes aromatic compounds derived from lignin degradation products and has the potential for bioremediation of xenobiotic compounds. We recently identified four possible solute-binding proteins in R. palustris that demonstrated binding to aromatic lignin monomers. Characterization of these proteins in the absence and presence of the aromatic ligands will provide unprecedented insights into the specificity and mode of aromatic ligand binding in solute-binding proteins. Here, we report the thermodynamic and structural properties of the proteins with aromatic ligands using isothermal titration calorimetry, small/wide angle x-ray scattering, and theoretical predictions. The proteins exhibit high affinity for the aromatic substrates with dissociation constants in the low micromolar to nanomolar range. The global shapes of the proteins are characterized by flexible ellipsoid-like structures with maximum dimensions in the 80-90-angstrom range. The data demonstrate that the global shapes remained unaltered in the presence of the aromatic ligands. However, local structural changes were detected in the presence of some ligands, as judged by the observed features in the wide angle x-ray scattering regime at q similar to 0.20- 0.40 angstrom(-1). The theoretical models confirmed the elongated nature of the proteins and showed that they consist of two domains linked by a hinge. Evaluation of the protein-binding sites showed that the ligands were found in the hinge region and that ligand stabilization was primarily driven by hydrophobic interactions. Taken together, this study shows the capability of identifying solute-binding proteins that interact with lignin degradation products using high throughput genomic and biophysical approaches, which can be extended to other organisms.	[Miller, Lisa M.] Brookhaven Natl Lab, Natl Synchrotron Light Source, Photon Sci Directorate, Upton, NY 11973 USA; [Zerbs, Sarah; Corgliano, Danielle M.; Collart, Frank R.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Miller, LM (corresponding author), Brookhaven Natl Lab, Natl Synchrotron Light Source, Photon Sci Directorate, Bldg 725D,75 Brookhaven Ave, Upton, NY 11973 USA.	lmiller@bnl.gov		Collart, Frank/0000-0001-6942-4483; Miller, Lisa/0000-0002-2912-7991	United States Department of Energy, Office of Biological and Environmental Research; United States Department of Energy [DE-AC02-98CH10886]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy, Office of Biological and Environmental Research, as part of the BER Genomic Science Program. This contribution originates from the "Environment Sensing and Response" Scientific Focus Area Program at Argonne National Laboratory.; We thank Dr. Lin Yang for scientific and technical support at beamline X9. The National Synchrotron Light Source is supported by United States Department of Energy Contract DE-AC02-98CH10886.	Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chan S, 2010, ACTA CRYSTALLOGR F, V66, P242, DOI 10.1107/S1744309109055158; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; ELDER DJE, 1992, ARCH MICROBIOL, V157, P148, DOI 10.1007/BF00245283; Fischetti RF, 2004, CHEM BIOL, V11, P1431, DOI 10.1016/j.chembiol.2004.08.013; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Giuliani SE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S8; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lee HS, 2009, J CHEM INF MODEL, V49, P2419, DOI 10.1021/ci9002365; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Makowski L, 2008, J MOL BIOL, V375, P529, DOI 10.1016/j.jmb.2007.07.075; Makowski L, 2011, BIOPOLYMERS, V95, P531, DOI 10.1002/bip.21631; Makowski Lee, 2010, Journal of Structural and Functional Genomics, V11, P9, DOI 10.1007/s10969-009-9075-x; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Pan C, 2008, MOL CELL PROTEOMICS, V7, P938, DOI 10.1074/mcp.M700147-MCP200; PFLUGRATH JW, 1988, J MOL BIOL, V200, P163, DOI 10.1016/0022-2836(88)90341-5; RAHALKAR SB, 1993, CURR MICROBIOL, V26, P1, DOI 10.1007/BF01577235; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shoreit Ahmed A. M., 1994, Biodegradation, V5, P71; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	38	13	13	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23748	23756		10.1074/jbc.M112.352385	http://dx.doi.org/10.1074/jbc.M112.352385			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22577139	Green Published, hybrid			2022-12-25	WOS:000306511300045
J	Winter, R; Kuhn, U; Hause, G; Schwarz, E				Winter, Reno; Kuehn, Uwe; Hause, Gerd; Schwarz, Elisabeth			Polyalanine-independent Conformational Conversion of Nuclear Poly(A)-binding Protein 1 (PABPN1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; MESSENGER-RNA POLYADENYLATION; N-TERMINAL DOMAIN; AMYLOID-LIKE FIBRILS; POLY(A) TAIL LENGTH; PHYSICAL-PROPERTIES; SPECIFICITY FACTOR; CRYSTAL-STRUCTURE; BINDING; AGGREGATION	Oculopharyngeal muscular dystrophy is a late-onset disease caused by an elongation of a natural 10-alanine segment within the N-terminal domain of the nuclear poly(A)-binding protein 1 (PABPN1) to maximally 17 alanines. The disease is characterized by intranuclear deposits consisting primarily of PABPN1. In previous studies, we could show that the N-terminal domain of PABPN1 forms amyloid-like fibrils. Here, we analyze fibril formation of full-length PABPN1. Unexpectedly, fibril formation was independent of the presence of the alanine segment. With regard to fibril formation kinetics and resistance against denaturants, fibrils formed by full-length PABPN1 had completely different properties from those formed by the N-terminal domain. Fourier transformed infrared spectroscopy and limited proteolysis showed that fibrillar PABPN1 has a structure that differs from native PABPN1. Circumstantial evidence is presented that the C-terminal domain is involved in fibril formation.	[Winter, Reno; Schwarz, Elisabeth] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Saale, Germany; [Hause, Gerd] Univ Halle Wittenberg, Bioctr, D-06120 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Schwarz, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Saale, Germany.	elisabeth.schwarz@biochemtech.uni-halle.de			"Protein Conformational States with Cell Biological and Medical Relevance" [SFB610]	"Protein Conformational States with Cell Biological and Medical Relevance"	This work was supported by the SFB610 "Protein Conformational States with Cell Biological and Medical Relevance" Subproject A9.	Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4; Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bosse-Doenecke E, 2008, PROTEIN EXPRES PURIF, V58, P114, DOI 10.1016/j.pep.2007.10.012; Bousset L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009760; Brais B, 1999, SEMIN NEUROL, V19, P59, DOI 10.1055/s-2008-1040826; BRAIS B, 1995, HUM MOL GENET, V4, P429, DOI 10.1093/hmg/4.3.429; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; BROWN P, 1990, J INFECT DIS, V161, P467, DOI 10.1093/infdis/161.3.467; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Calado A, 2000, RNA, V6, P245, DOI 10.1017/S1355838200991908; Chartier A, 2006, EMBO J, V25, P2253, DOI 10.1038/sj.emboj.7601117; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; DURANCEAU AC, 1983, SURG CLIN N AM, V63, P825; Fan XP, 2001, HUM MOL GENET, V10, P2341, DOI 10.1093/hmg/10.21.2341; FRIED K, 1975, J MED GENET, V12, P416, DOI 10.1136/jmg.12.4.416; Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200; Ge HH, 2008, PROTEINS, V71, P1539, DOI 10.1002/prot.21973; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lodderstedt G, 2008, BIOCHEMISTRY-US, V47, P2181, DOI 10.1021/bi701322g; Lodderstedt G, 2007, FEBS J, V274, P346, DOI 10.1111/j.1742-4658.2006.05595.x; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Sackewitz M, 2008, J AM CHEM SOC, V130, P7172, DOI 10.1021/ja800120s; Sackewitz M, 2008, PROTEIN SCI, V17, P1044, DOI 10.1110/ps.073276308; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scheuermann T, 2003, PROTEIN SCI, V12, P2685, DOI 10.1110/ps.03214703; Schroder-Tittmann K, 2010, BIOCHEMISTRY-US, V49, P7956, DOI 10.1021/bi101159s; Song JK, 2008, P NATL ACAD SCI USA, V105, P15317, DOI 10.1073/pnas.0801274105; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Tome FMS, 1997, NEUROMUSCULAR DISORD, V7, pS63, DOI 10.1016/S0960-8966(97)00085-0; Verheesen P, 2006, HUM MOL GENET, V15, P105, DOI 10.1093/hmg/ddi432; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800	43	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22662	22671		10.1074/jbc.M112.362327	http://dx.doi.org/10.1074/jbc.M112.362327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570486	Green Published, hybrid			2022-12-25	WOS:000306495000023
J	Zimmermann, M; Arachchige-Don, AS; Donaldson, MS; Dallapiazza, RF; Cowan, CE; Horne, MC				Zimmermann, Maike; Arachchige-Don, Aruni S.; Donaldson, Michaela S.; Dallapiazza, Robert F.; Cowan, Colleen E.; Horne, Mary C.			Elevated Cyclin G2 Expression Intersects with DNA Damage Checkpoint Signaling and Is Required for a Potent G(2)/M Checkpoint Arrest Response to Doxorubicin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BREAST-CANCER CELLS; GENE-EXPRESSION; IONIZING-RADIATION; PHOSPHOINOSITIDE 3-KINASE; INDEPENDENT MECHANISMS; TRANSCRIPTION FACTORS; CHK2; ATR; GROWTH	To maintain genomic integrity DNA damage response (DDR), signaling pathways have evolved that restrict cellular replication and allow time for DNA repair. CCNG2 encodes an unconventional cyclin homolog, cyclin G2 (CycG2), linked to growth inhibition. Its expression is repressed by mitogens but up-regulated during cell cycle arrest responses to anti-proliferative signals. Here we investigate the potential link between elevated CycG2 expression and DDR signaling pathways. Expanding our previous finding that CycG2 overexpression induces a p53-dependent G(1)/S phase cell cycle arrest in HCT116 cells, we now demonstrate that this arrest response also requires the DDR checkpoint protein kinase Chk2. In accord with this finding we establish that ectopic CycG2 expression increases phosphorylation of Chk2 on threonine 68. We show that DNA double strand break-inducing chemotherapeutics stimulate CycG2 expression and correlate its up-regulation with checkpoint-induced cell cycle arrest and phospho-modification of proteins in the ataxia telangiectasia mutated (ATM) and ATM and Rad3-related (ATR) signaling pathways. Using pharmacological inhibitors and ATM-deficient cell lines, we delineate the DDR kinase pathway promoting CycG2 up-regulation in response to doxorubicin. Importantly, RNAi-mediated blunting of CycG2 attenuates doxorubicin-induced cell cycle checkpoint responses in multiple cell lines. Employing stable clones, we test the effect that CycG2 depletion has on DDR proteins and signals that enforce cell cycle checkpoint arrest. Our results suggest that CycG2 con-tributes to DNA damage-induced G(2)/M checkpoint by enforcing checkpoint inhibition of CycB1-Cdc2 complexes.	[Zimmermann, Maike; Donaldson, Michaela S.; Horne, Mary C.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Zimmermann, Maike; Arachchige-Don, Aruni S.; Dallapiazza, Robert F.; Cowan, Colleen E.; Horne, Mary C.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	University of California System; University of California Davis; University of Iowa	Horne, MC (corresponding author), Univ Calif Davis, Dept Pharmacol, Tupper Hall,Rm 2219B,451 E Hlth Sci Dr, Davis, CA 95616 USA.	mhorne@ucdavis.edu		Horne, Mary/0000-0002-2799-3212; Zimmermann, Maike/0000-0001-9005-3795	National Institutes of Health [P20CA103672]; NATIONAL CANCER INSTITUTE [P20CA103672, P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P20CA103672 (University of Iowa Cancer and Aging Program's NIA/NCI program project (pilot grand sub-awarded to M. C. H.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Arlander SJH, 2008, CANCER RES, V68, P89, DOI 10.1158/0008-5472.CAN-07-0675; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Bansal P, 2007, CANCER RES, V67, P3356, DOI 10.1158/0008-5472.CAN-06-3685; Bates S, 1996, ONCOGENE, V13, P1103; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carlessi L, 2010, BBA-MOL CELL RES, V1803, P1213, DOI 10.1016/j.bbamcr.2010.06.002; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chabalier-Taste C, 2008, BBA-MOL CELL RES, V1783, P2223, DOI 10.1016/j.bbamcr.2008.08.006; Chehab NH, 2000, GENE DEV, V14, P278; Chen J, 2006, J IMMUNOL, V176, P2711, DOI 10.4049/jimmunol.176.5.2711; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Darbon JM, 2000, J BIOL CHEM, V275, P15363, DOI 10.1074/jbc.275.20.15363; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Faradji F, 2011, CELL CYCLE, V10, P805, DOI 10.4161/cc.10.5.14959; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Freeman AK, 2010, CELL CYCLE, V9, P736, DOI 10.4161/cc.9.4.10613; Gajate C, 2002, J BIOL CHEM, V277, P41580, DOI 10.1074/jbc.M204644200; Golan A, 2010, CELL CYCLE, V9, P2647, DOI 10.4161/cc.9.13.12121; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; HARPER JW, 1993, CELL, V75, P805; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hill R, 2010, CELL CYCLE, V9, P3460, DOI 10.4161/cc.9.17.13043; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Ito Y, 2003, ANTICANCER RES, V23, P2335; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jensen MR, 1999, GENE, V230, P171, DOI 10.1016/S0378-1119(99)00057-8; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; Landsverk KS, 2011, CELL CYCLE, V10, P819, DOI 10.4161/cc.10.5.14968; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Lee J, 2009, MOL BIOL CELL, V20, P1891, DOI 10.1091/mbc.E08-08-0818; Lee KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.212969; Lemaire M, 2010, FEBS LETT, V584, P1199, DOI 10.1016/j.febslet.2010.02.043; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; McSherry TD, 2004, MOL CELL BIOL, V24, P9968, DOI 10.1128/MCB.24.22.9968-9985.2004; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Miyata H, 2001, CANCER RES, V61, P3188; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Ohtsuka T, 2004, ONCOGENE, V23, P5405, DOI 10.1038/sj.onc.1207693; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Okamoto K, 1999, ONCOGENE, V18, P4606, DOI 10.1038/sj.onc.1202821; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sarkaria JN, 1999, CANCER RES, V59, P4375; Seo HR, 2006, CELL DEATH DIFFER, V13, P1475, DOI 10.1038/sj.cdd.4401822; Shimada M, 2003, MOL CELL BIOL, V23, P4107, DOI 10.1128/MCB.23.12.4107-4120.2003; Shimizu A, 1998, BIOCHEM BIOPH RES CO, V242, P529, DOI 10.1006/bbrc.1997.8004; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Shiotani B, 2009, J CELL SCI, V122, P301, DOI 10.1242/jcs.035105; Siu WY, 2004, MOL CANCER THER, V3, P621; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Suenaga Y, 2009, J BIOL CHEM, V284, P35433, DOI 10.1074/jbc.M109.050047; Theard D, 2001, BIOCHEM BIOPH RES CO, V289, P1199, DOI 10.1006/bbrc.2001.6095; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai MH, 2006, ONCOGENE, V25, P622, DOI 10.1038/sj.onc.1209082; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang XQ, 2007, RADIAT RES, V168, P706, DOI 10.1667/RR1075.1; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu GX, 2008, MOL BIOL CELL, V19, P4968, DOI 10.1091/mbc.E08-03-0259; ZAUBERMAN A, 1995, ONCOGENE, V10, P2361; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhao L, 2003, MOL CANCER RES, V1, P195; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	84	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22838	22853		10.1074/jbc.M112.376855	http://dx.doi.org/10.1074/jbc.M112.376855			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589537	hybrid, Green Published			2022-12-25	WOS:000306495000041
J	Polizzotti, BD; Arab, S; Kuhn, B				Polizzotti, Brian D.; Arab, Shima; Kuehn, Bernhard			Intrapericardial Delivery of Gelfoam Enables the Targeted Delivery of Periostin Peptide after Myocardial Infarction by Inducing Fibrin Clot Formation	PLOS ONE			English	Article							CONTROLLED-RELEASE POLYMER; SYSTEMIC DELIVERY; OCULAR DEVICE; CARDIAC-HYPERTROPHY; TGF-BETA; PROLIFERATION; EXPRESSION; INSULIN; REPAIR; HEART	Background: Administration of a recombinant peptide of Periostin (rPN) has recently been shown to stimulate cardiomyocyte proliferation and angiogensis after myocardial infarction (MI) [1]. However, strategies for targeting the delivery of rPN to the heart are lacking. Intrapericardial administration of drug-eluting hydrogels may provide a clinically viable strategy for increasing myocardial retention, therapeutic efficacy, and bioactivity of rPN and to decrease systemic re-circulation. Methods and Results: We investigated the ability of intrapericardial injections of drug-eluting hydrogels to deliver and prolong the release of rPN to the myocardium in a large animal model of myocardial infarction. Gelfoam is an FDA-approved hemostatic material commonly used in surgery, and is known to stimulate fibrin clot formation. We show that Gelfoam disks loaded with rPN, when implanted within the pericardium or peritoneum of mammals becomes encapsulated within a non-fibrotic fibrin-rich hydrogel, prolonging the in vitro and in vivo release of rPN. Administration into the pericardial cavity of pigs, following a complete occlusion of the left anterior descending artery, leads to greater induction of cardiomyocyte mitosis, increased cardiomyocyte cell cycle activity, and enhanced angiogenesis compared to direct injection of rPN alone. Conclusions: The results of this study suggest that intrapericardial drug delivery of Gelfoam, enhanced by triggered clot formation, can be used to effectively deliver rPN to the myocardium in a clinically relevant model of myocardial infarction. The work presented here should enhance the translational potential of pharmaceutical-based strategies that must be targeted to the myocardium.	[Polizzotti, Brian D.; Arab, Shima; Kuehn, Bernhard] Childrens Hosp Boston, Dept Cardiol, Boston, MA 02115 USA; [Polizzotti, Brian D.; Kuehn, Bernhard] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Polizzotti, BD (corresponding author), Childrens Hosp Boston, Dept Cardiol, Boston, MA 02115 USA.	brian.polizzotti@childrens.harvard.edu; bkuhn@enders.tch.harvard.edu	Polizzotti, Brian/K-1617-2019		NIH [K08HL085143, R01HL106302-01]; Department of Cardiology; Translational Investigator Service at Children's Hospital Boston;  [NIH T32HL007572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106302, K08HL085143, T32HL007572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Cardiology; Translational Investigator Service at Children's Hospital Boston; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	BDP was supported with an institutional training grant (NIH T32HL007572). This work was supported by the NIH (K08HL085143, R01HL106302-01), the Department of Cardiology, and the Translational Investigator Service at Children's Hospital Boston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2008, HURSTS HEART, P724; ARNAD AG, 1986, NEUROSURGERY, V18, P223, DOI 10.1227/00006123-198602000-00022; Barbolt TA, 2001, NEUROL RES, V23, P537, DOI 10.1179/016164101101198794; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Blanchard C, 2008, MUCOSAL IMMUNOL, V1, P289, DOI 10.1038/mi.2008.15; BREM H, 1989, SELECT CANCER THER, V5, P55, DOI 10.1089/sct.1989.5.55; Chan JM, 2010, P NATL ACAD SCI USA, V107, P2213, DOI 10.1073/pnas.0914585107; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Hamalainen KM, 1998, J CONTROL RELEASE, V56, P273, DOI 10.1016/S0168-3659(98)00094-7; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Howard MA, 2003, BRAIN RES PROTOC, V10, P125, DOI 10.1016/S1385-299X(02)00202-7; Johnatty SE, 2000, J MOL CELL CARDIOL, V32, P805, DOI 10.1006/jmcc.2000.1122; Kobayashi H, 2008, CARDIOVASC RES, V79, P611, DOI 10.1093/cvr/cvn154; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Ladage D, 2011, GENE THER; Laham RJ, 2003, CATHETER CARDIO INTE, V58, P375, DOI 10.1002/ccd.10378; Lee YC, 1997, J PHARM SCI, V86, P430, DOI 10.1021/js960423s; Lee YC, 1997, J PHARM SCI, V86, P1361, DOI 10.1021/js970191c; Lin CC, 2009, PHARM RES-DORDR, V26, P631, DOI 10.1007/s11095-008-9801-2; Maurer FW, 1940, AM J PHYSIOL, V129, P0635, DOI 10.1152/ajplegacy.1940.129.3.635; Morawiecki A, 1995, COLLAGEN CONTAINING; NADKARNI SR, 1993, PHARMACEUT RES, V10, P109, DOI 10.1023/A:1018985332376; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097; Scott RC, 2007, BIOTECHNOL BIOENG, V96, P795, DOI 10.1002/bit.21233; Segers VFM, 2010, J CARDIOVASC TRANSL, V3, P469, DOI 10.1007/s12265-010-9207-5; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Simamora P, 1996, J PHARM SCI, V85, P1128, DOI 10.1021/js960176s; Simamora P, 1998, INT J PHARM, V170, P209, DOI 10.1016/S0378-5173(98)00141-0; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Stanton LW, 2000, CIRC RES, V86, P939, DOI 10.1161/01.RES.86.9.939; TAMARGO RJ, 1989, J BIOMED MATER RES, V23, P253, DOI 10.1002/jbm.820230209; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Woo YJ, 2007, J THORAC CARDIOV SUR, V133, P927, DOI 10.1016/j.jtcvs.2006.07.057; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104	38	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36788	10.1371/journal.pone.0036788	http://dx.doi.org/10.1371/journal.pone.0036788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590609	Green Published, gold			2022-12-25	WOS:000305336400036
J	Huang, CY; Chen, JY; Wu, SC; Tan, CH; Tzeng, RY; Lu, PJ; Wu, YF; Chen, RH; Wu, YC				Huang, Chun-Yi; Chen, Jia-Yun; Wu, Shu-Chun; Tan, Chieh-Hsiang; Tzeng, Ruei-Ying; Lu, Pei-Ju; Wu, Yu-Feng; Chen, Ruey-Hwa; Wu, Yi-Chun			C. elegans EIF-3.K Promotes Programmed Cell Death through CED-3 Caspase	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; INTERMEDIATE-FILAMENTS; INDUCED APOPTOSIS; CRYSTAL-STRUCTURE; DNA-DEGRADATION; GENETIC-CONTROL; PROTEIN; NEMATODE; HOMOLOG; SUBUNIT	Programmed cell death (apoptosis) is essential for the development and homeostasis of metazoans. The central step in the execution of programmed cell death is the activation of caspases. In C. elegans, the core cell death regulators EGL-1(a BH3 domain-containing protein), CED-9 (Bcl-2), and CED-4 (Apaf-1) act in an inhibitory cascade to activate the CED-3 caspase. Here we have identified an additional component eif-3.K (eukaryotic translation initiation factor 3 subunit k) that acts upstream of ced-3 to promote programmed cell death. The loss of eif-3. K reduced cell deaths in both somatic and germ cells, whereas the overexpression of eif-3.K resulted in a slight but significant increase in cell death. Using a cell-specific promoter, we show that eif-3.K promotes cell death in a cell-autonomous manner. In addition, the loss of eif-3.K significantly suppressed cell death-induced through the overexpression of ced-4, but not ced-3, indicating a distinct requirement for eif-3.K in apoptosis. Reciprocally, a loss of ced-3 suppressed cell death induced by the overexpression of eif-3.K. These results indicate that eif-3.K requires ced-3 to promote programmed cell death and that eif-3. K acts upstream of ced-3 to promote this process. The EIF-3. K protein is ubiquitously expressed in embryos and larvae and localizes to the cytoplasm. A structure-function analysis revealed that the 61 amino acid long WH domain of EIF-3.K, potentially involved in protein-DNA/RNA interactions, is both necessary and sufficient for the cell death-promoting activity of EIF-3. K. Because human eIF3k was able to partially substitute for C. elegans eif-3. K in the promotion of cell death, this WH domain-dependent EIF-3.K-mediated cell death process has potentially been conserved throughout evolution.	[Huang, Chun-Yi; Chen, Jia-Yun; Wu, Shu-Chun; Tan, Chieh-Hsiang; Tzeng, Ruei-Ying; Wu, Yu-Feng; Wu, Yi-Chun] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Chen, Jia-Yun; Lu, Pei-Ju; Chen, Ruey-Hwa] Natl Taiwan Univ, Inst Mol Med, Taipei 10764, Taiwan; [Chen, Ruey-Hwa] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10764, Taiwan; [Wu, Yi-Chun] Natl Taiwan Univ, Ctr Syst Biol, Taipei 10764, Taiwan; [Wu, Yi-Chun] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Chen, Ruey-Hwa] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Wu, Yi-Chun] Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Huang, CY (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	rhchen@gate.sinica.edu.tw; yichun@ntu.edu.tw	Wu, Yi-Chun/F-7934-2012; Chen, Ruey-Hwa/G-6121-2019	Wu, Yi-Chun/0000-0002-8621-4098; Chen, Ruey-Hwa/0000-0001-8124-5832; Tzeng, Ruei-Ying/0000-0002-9009-9483; Tan, Chieh-Hsiang/0000-0002-5432-0160	National Taiwan University [10R70602A3]; National Science Council (Taiwan)	National Taiwan University(National Taiwan University); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported in part by a National Taiwan University grant (10R70602A3) and the National Science Council (Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; BRENNER S, 1974, GENETICS, V77, P71; Browning KS, 2001, TRENDS BIOCHEM SCI, V26, P284, DOI 10.1016/S0968-0004(01)01825-4; Carberry K, 2009, CELL MOTIL CYTOSKEL, V66, P852, DOI 10.1002/cm.20372; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Chen L, 2008, CURR BIOL, V18, P1025, DOI 10.1016/j.cub.2008.06.065; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; De Martelaere K, 2007, CELL SIGNAL, V19, P278, DOI 10.1016/j.cellsig.2006.06.012; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, GENETICS, V129, P79; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Geng X, 2009, CELL DEATH DIFFER, V16, P1385, DOI 10.1038/cdd.2009.88; Geng X, 2008, NAT STRUCT MOL BIOL, V15, P1094, DOI 10.1038/nsmb.1488; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Guenther C, 1996, DEVELOPMENT, V122, P3509; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Karki S, 2002, MOL BIOL CELL, V13, P1722, DOI 10.1091/mbc.02-02-0011; Kelly WG, 1997, GENETICS, V146, P227; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; Ledwich D, 2000, METHOD ENZYMOL, V322, P76; Lin YM, 2008, J CELL SCI, V121, P2382, DOI 10.1242/jcs.021394; Luke-Glaser S, 2007, MOL CELL BIOL, V27, P4526, DOI 10.1128/MCB.01724-06; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Mayeur GL, 2003, EUR J BIOCHEM, V270, P4133, DOI 10.1046/j.1432-1033.2003.03807.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Pourkarimi E, 2012, CELL DEATH DIFFER, V19, P406, DOI 10.1038/cdd.2011.104; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Schwartz HT, 2007, NAT PROTOC, V2, P705, DOI 10.1038/nprot.2007.93; Seshagiri S, 1997, CURR BIOL, V7, P455, DOI 10.1016/S0960-9822(06)00216-8; Shaham S, 1999, GENETICS, V153, P1655; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; Shen QF, 2009, MOL CELL BIOL, V29, P3881, DOI 10.1128/MCB.01509-08; Shen XY, 2004, FEBS LETT, V573, P139, DOI 10.1016/j.febslet.2004.07.071; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; Stergiou L, 2007, CELL DEATH DIFFER, V14, P1129, DOI 10.1038/sj.cdd.4402115; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Wu DY, 1999, DEVELOPMENT, V126, P2021; Wu DY, 1997, J BIOL CHEM, V272, P21449, DOI 10.1074/jbc.272.34.21449; Wu YC, 2000, GENE DEV, V14, P536; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	70	7	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36584	10.1371/journal.pone.0036584	http://dx.doi.org/10.1371/journal.pone.0036584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590572	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336100043
J	Van Hout, AJM; Pinxten, R; Geens, A; Eens, M				Van Hout, Alain J. -M.; Pinxten, Rianne; Geens, Ann; Eens, Marcel			Non-Breeding Song Rate Reflects Nutritional Condition Rather than Body Condition	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SINGING BEHAVIOR; SEASONAL-CHANGES; BIRD SONG; TESTOSTERONE; MASS; EVOLUTION; TRAITS; TITS	Numerous studies have focused on song in songbirds as a signal involved in mate choice and intrasexual competition. It is expected that song traits such as song rate reflect individual quality by being dependent on energetic state or condition. While seasonal variation in bird song (i.e., breeding versus non-breeding song) and its neural substrate have received a fair amount of attention, the function and information content of song outside the breeding season is generally much less understood. Furthermore, typically only measures of condition involving body mass are examined with respect to song rate. Studies investigating a potential relationship between song rate and other indicators of condition, such as physiological measures of nutritional condition, are scant. In this study, we examined whether non-breeding song rate in male European starlings (Sturnus vulgaris) reflects plasma metabolite levels (high-density lipoproteins (HDL), albumin, triglycerides and cholesterol) and/or body mass. Song rate was significantly positively related to a principal component representing primarily HDL, albumin and cholesterol (and to a lesser degree plasma triglyceride levels). There was only a trend toward a significant positive correlation between song rate and body mass, and no significant correlation between body mass and the abovementioned principal component. Therefore, our results indicate that nutritional condition and body mass represent different aspects of condition, and that song rate reflects nutritional rather than body condition. Additionally, we also found that intra-individual song rate consistency (though not song rate itself) was significantly positively related to lutein levels, but not to body mass or nutritional condition. Together our results suggest that the relation between physiological measures of nutritional condition and song rate, as well as other signals, may present an interesting line of future research, both inside and outside the breeding season.	[Van Hout, Alain J. -M.; Pinxten, Rianne; Geens, Ann; Eens, Marcel] Univ Antwerp, Res Grp Ethol, Antwerp, Belgium	University of Antwerp	Van Hout, AJM (corresponding author), Univ Antwerp, Res Grp Ethol, Antwerp, Belgium.	alain.vanhout@ua.ac.be	Eens, Marcel/AAC-8466-2020		FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen) [G.0130.07]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen); University of Antwerp	FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen)(FWO); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen)(FWO); University of Antwerp	This study was supported by a research project (G.0130.07) to ME from FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen). AVH was funded by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). AG was funded by FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen). ME and RP were funded by the University of Antwerp and supported by FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN PC, 1987, COMP BIOCHEM PHYS B, V87, P313, DOI 10.1016/0305-0491(87)90145-3; Alonso-Alvarez C, 2002, WATERBIRDS, V25, P253, DOI 10.1675/1524-4695(2002)025[0253:CIPBAB]2.0.CO;2; Andersson Malte, 1994; Ardia DR, 2006, COMP BIOCHEM PHYS A, V143, P62, DOI 10.1016/j.cbpa.2005.10.024; Atagan Y, 2012, ANIM BEHAV, V83, P69, DOI 10.1016/j.anbehav.2011.10.006; BALL GF, 1987, PHYSIOL ZOOL, V60, P191, DOI 10.1086/physzool.60.2.30158643; Ball GF, 2004, ANN NY ACAD SCI, V1016, P586, DOI 10.1196/annals.1298.043; Barnett CA, 2011, ETHOLOGY, V117, P28, DOI 10.1111/j.1439-0310.2010.01844.x; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Foerster K, 2002, J AVIAN BIOL, V33, P269, DOI 10.1034/j.1600-048X.2002.330309.x; Geens A, 2009, COMP BIOCHEM PHYS C, V150, P155, DOI 10.1016/j.cbpc.2009.04.007; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Goode EL, 2007, TWIN RES HUM GENET, V10, P703, DOI 10.1375/twin.10.5.703; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Hegyi G, 2010, NATURWISSENSCHAFTEN, V97, P567, DOI 10.1007/s00114-010-0672-0; Heimovics SA, 2011, NEUROSCIENCE, V182, P133, DOI 10.1016/j.neuroscience.2011.03.012; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Jenni-Eiermann Susanne, 1999, Biologia e Conservazione della Fauna, V102, P312; Kwiterovich PO, 2000, AM J CARDIOL, V86, p5L; Lailvaux SP, 2011, P ROY SOC B-BIOL SCI, V278, P321, DOI 10.1098/rspb.2010.1591; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; McGraw KJ, 2006, PHYSIOL BEHAV, V87, P103, DOI 10.1016/j.physbeh.2005.09.001; Pascalon-Pekelniczky A, 1998, VET RES, V29, P197; Pavlova DZ, 2007, BEHAVIOUR, V144, P663, DOI 10.1163/156853907781347835; Pinxten R, 2002, HORM BEHAV, V42, P307, DOI 10.1006/hbeh.2002.1824; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Riters LV, 2011, NEUROSCI BIOBEHAV R, V35, P1837, DOI 10.1016/j.neubiorev.2010.12.017; Riters LV, 2002, J COMP NEUROL, V444, P63, DOI 10.1002/cne.10131; Riters LV, 2000, HORM BEHAV, V38, P250, DOI 10.1006/hbeh.2000.1623; Riters LV, 2001, J NEUROENDOCRINOL, V13, P985, DOI 10.1046/j.1365-2826.2001.00723.x; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; Van Hout AJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016326; Van Hout AJM, 2009, HORM BEHAV, V56, P564, DOI 10.1016/j.yhbeh.2009.09.010; Wingfield JC, 2002, INTEGR COMP BIOL, V42, P11, DOI 10.1093/icb/42.1.11	36	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36547	10.1371/journal.pone.0036547	http://dx.doi.org/10.1371/journal.pone.0036547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590563	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336100037
J	Leke, R; de Oliveira, DL; Mussulini, BHM; Pereira, MS; Kazlauckas, V; Mazzini, G; Hartmann, CR; Silveira, TR; Simonsen, M; Bak, LK; Waagepetersen, HS; Keiding, S; Schousboe, A; Portela, LV				Leke, Renata; de Oliveira, Diogo L.; Mussulini, Ben Hur M.; Pereira, Mery S.; Kazlauckas, Vanessa; Mazzini, Guilherme; Hartmann, Carolina R.; Silveira, Themis R.; Simonsen, Mette; Bak, Lasse K.; Waagepetersen, Helle S.; Keiding, Susanne; Schousboe, Arne; Portela, Luis V.			Impairment of the Organization of Locomotor and Exploratory Behaviors in Bile Duct-Ligated Rats	PLOS ONE			English	Article							MINIMAL HEPATIC-ENCEPHALOPATHY; CHRONIC LIVER-FAILURE; PORTACAVAL ANASTOMOSIS; MOVEMENT INITIATION; EXPERIMENTAL-MODELS; CIRRHOTIC-PATIENTS; MOTOR-ACTIVITY; HYPERAMMONEMIA; BRADYKINESIA; OBSTRUCTION	Hepatic encephalopathy (HE) arises from acute or chronic liver diseases and leads to several problems, including motor impairment. Animal models of chronic liver disease have extensively investigated the mechanisms of this disease. Impairment of locomotor activity has been described in different rat models. However, these studies are controversial and the majority has primarily analyzed activity parameters. Therefore, the aim of the present study was to evaluate locomotor and exploratory behavior in bile duct-ligated (BDL) rats to explore the spatial and temporal structure of behavior. Adult female Wistar rats underwent common bile duct ligation (BDL rats) or the manipulation of common bile duct without ligation (control rats). Six weeks after surgery, control and BDL rats underwent open-field, plus-maze and foot-fault behavioral tasks. The BDL rats developed chronic liver failure and exhibited a decrease in total distance traveled, increased total immobility time, smaller number of rearings, longer periods in the home base area and decreased percentage of time in the center zone of the arena, when compared to the control rats. Moreover, the performance of the BDL rats was not different from the control rats for the elevated plus-maze and foot-fault tasks. Therefore, the BDL rats demonstrated disturbed spontaneous locomotor and exploratory activities as a consequence of altered spatio-temporal organization of behavior.	[Leke, Renata; de Oliveira, Diogo L.; Mussulini, Ben Hur M.; Pereira, Mery S.; Kazlauckas, Vanessa; Mazzini, Guilherme; Portela, Luis V.] Univ Fed Rio Grande do Sul, ICBS, Dept Biochem, Porto Alegre, RS, Brazil; [Hartmann, Carolina R.] Hosp Clin Porto Alegre, Dept Pathol, Porto Alegre, RS, Brazil; [Silveira, Themis R.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Res Ctr, Expt Hepatol & Gastroenterol Lab, Porto Alegre, RS, Brazil; [Simonsen, Mette; Keiding, Susanne] Aarhus Univ Hosp, Positron Emiss Tomog Ctr, DK-8000 Aarhus, Denmark; [Keiding, Susanne] Aarhus Univ Hosp, Dept Med Hepatol & Gastroenterol 5, DK-8000 Aarhus, Denmark; [Bak, Lasse K.; Waagepetersen, Helle S.; Schousboe, Arne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Aarhus University; Aarhus University; University of Copenhagen	Leke, R (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Dept Biochem, Porto Alegre, RS, Brazil.	renataleke@hotmail.com	Silveira, Themis/H-4286-2016; Portela, Luis V/I-3410-2014	Portela, Luis Valmor/0000-0001-6113-8466; Bak, Lasse K./0000-0003-0784-7864; Marins Mussulini, Ben Hur/0000-0003-4321-5709; Waagepetersen, Helle/0000-0003-4583-8379; Losch de Oliveira, Diogo/0000-0002-9028-6959; Schousboe, Arne/0000-0001-9600-402X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (INCT-EN)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (INCT-EN)	This work has been supported by Brazilian funding agencies Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (INCT-EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahboucha S, 2008, NEUROGASTROENT MOTIL, V20, P949, DOI 10.1111/j.1365-2982.2008.01132.x; Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Amodio P, 2005, METAB BRAIN DIS, V20, P115, DOI 10.1007/s11011-005-4149-3; Amodio P, 2004, METAB BRAIN DIS, V19, P253, DOI 10.1023/B:MEBR.0000043975.01841.de; Apelqvist C, 1999, BEHAV BRAIN RES, V106, P165, DOI 10.1016/S0166-4328(99)00104-7; Bruck J, 2011, J HEPATOL, V54, P251, DOI 10.1016/j.jhep.2010.06.035; Butterworth RF, 2009, LIVER INT, V29, P783, DOI 10.1111/j.1478-3231.2009.02034.x; CAMPBELL A, 1984, PHARMACOL BIOCHEM BE, V20, P875, DOI 10.1016/0091-3057(84)90010-8; Cauli O, 2007, EUR J NEUROSCI, V25, P2112, DOI 10.1111/j.1460-9568.2007.05435.x; Cauli O, 2006, J HEPATOL, V45, P654, DOI 10.1016/j.jhep.2006.06.019; Chan CY, 2004, EUR J CLIN INVEST, V34, P122, DOI 10.1111/j.1365-2362.2004.01295.x; Eilam D, 2003, BEHAV BRAIN RES, V142, P53, DOI 10.1016/S0166-4328(02)00382-0; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Garcia-Ayllon MS, 2008, BRAIN, V131, P2946, DOI 10.1093/brain/awn209; Giewekemeyer K, 2007, J HEPATOL, V46, P1034, DOI 10.1016/j.jhep.2007.01.038; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Hazell AS, 1999, P SOC EXP BIOL MED, V222, P99, DOI 10.1046/j.1525-1373.1999.d01-120.x; Joebges EM, 2003, J HEPATOL, V38, P273, DOI 10.1016/S0168-8278(02)00423-3; Jover R, 2005, J HEPATOL, V42, P659, DOI 10.1016/j.jhep.2004.12.030; Jover R, 2006, HEPATOLOGY, V43, P1257, DOI 10.1002/hep.21180; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; Leke R, 2011, J NEUROCHEM, V117, P824, DOI 10.1111/j.1471-4159.2011.07244.x; MARTIN JR, 1983, PHARMACOL BIOCHEM BE, V18, P269, DOI 10.1016/0091-3057(83)90374-X; Mendez M, 2008, BEHAV BRAIN RES, V188, P32, DOI 10.1016/j.bbr.2007.10.019; Mendez M, 2009, BEHAV BRAIN RES, V198, P346, DOI 10.1016/j.bbr.2008.11.015; Oria M, 2010, HEPATOLOGY, V52, P2077, DOI 10.1002/hep.23938; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; SCOTTCONNER CEH, 1994, J SURG RES, V57, P316, DOI 10.1006/jsre.1994.1151; Sergeeva OA, 2005, NEUROSCIENCE, V134, P1091, DOI 10.1016/j.neuroscience.2005.05.031; TARTER RE, 1984, GASTROENTEROLOGY, V86, P1421; Violle N, 2009, BEHAV BRAIN RES, V203, P35, DOI 10.1016/j.bbr.2009.04.015; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weissenborn K, 2005, AIDS, V19, pS93, DOI 10.1097/01.aids.0000192076.03443.6d; Weissenborn K, 2003, J HEPATOL, V39, P320, DOI 10.1016/S0168-8278(03)00295-2	34	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36322	10.1371/journal.pone.0036322	http://dx.doi.org/10.1371/journal.pone.0036322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586467	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000029
J	Luo, JX; Turner, MS				Luo, Jamie X.; Turner, Matthew S.			Evolving Sensitivity Balances Boolean Networks	PLOS ONE			English	Article							GENETIC NETWORKS; CELL; MODEL; ROBUSTNESS; FIBROBLASTS; EVOLUTION; PREDICTS; CLOCK; NOISY	We investigate the sensitivity of Boolean Networks (BNs) to mutations. We are interested in Boolean Networks as a model of Gene Regulatory Networks (GRNs). We adopt Ribeiro and Kauffman's Ergodic Set and use it to study the long term dynamics of a BN. We define the sensitivity of a BN to be the mean change in its Ergodic Set structure under all possible loss of interaction mutations. Insilico experiments were used to selectively evolve BNs for sensitivity to losing interactions. We find that maximum sensitivity was often achievable and resulted in the BNs becoming topologically balanced, i.e. they evolve towards network structures in which they have a similar number of inhibitory and excitatory interactions. In terms of the dynamics, the dominant sensitivity strategy that evolved was to build BNs with Ergodic Sets dominated by a single long limit cycle which is easily destabilised by mutations. We discuss the relevance of our findings in the context of Stem Cell Differentiation and propose a relationship between pluripotent stem cells and our evolved sensitive networks.	[Luo, Jamie X.; Turner, Matthew S.] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Luo, Jamie X.; Turner, Matthew S.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Luo, JX (corresponding author), Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England.	m.s.turner@warwick.ac.uk	Turner, Matthew/D-1121-2011	Turner, Matthew/0000-0002-3441-678X	UK EPSRC (Engineering and Physical Sciences Research Council) [EP/E501311/1, EP/I005439/1]; Engineering and Physical Sciences Research Council [EP/I005439/1] Funding Source: researchfish; EPSRC [EP/I005439/1] Funding Source: UKRI	UK EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the UK EPSRC (Engineering and Physical Sciences Research Council) under grant numbers EP/E501311/1 and EP/I005439/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alvarez-Buylla ER, 2010, SEMIN CELL DEV BIOL, V21, P108, DOI 10.1016/j.semcdb.2009.11.010; Ayed A, 2011, MOL BIOL INTELLIGENC, V1, p[65, 53], DOI DOI 10.1007/978-1-4419-8231-5-5; Azpeitia E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-134; Baron MH, 1993, CURR OPIN CELL BIOL, V5, P1050, DOI 10.1016/0955-0674(93)90091-4; Benitez M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-98; Bornholdt S, 2000, P ROY SOC B-BIOL SCI, V267, P2281, DOI 10.1098/rspb.2000.1280; Bornholdt S, 1998, PHYS REV LETT, V81, P236, DOI 10.1103/PhysRevLett.81.236; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Braunewell S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.060902; Burda Z, 2011, P NATL ACAD SCI USA, V108, P17263, DOI 10.1073/pnas.1109435108; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; DERRIDA B, 1986, EUROPHYS LETT, V1, P45, DOI 10.1209/0295-5075/1/2/001; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Ge H, 2009, J COMPUT BIOL, V16, P119, DOI 10.1089/cmb.2007.0181; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kauffman S.A., 1993, ORIGINS ORDER; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; KNABE JF, 2006, ARTIF LIFE, V10, P15; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Qian XN, 2009, J THEOR BIOL, V257, P560, DOI 10.1016/j.jtbi.2008.12.023; Ribeiro AS, 2007, J THEOR BIOL, V247, P743, DOI 10.1016/j.jtbi.2007.04.020; Serra R, 2010, J THEOR BIOL, V265, P185, DOI 10.1016/j.jtbi.2010.04.012; Shmulevich I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.048701; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Szejka A, 2007, EUR PHYS J B, V56, P373, DOI 10.1140/epjb/e2007-00135-2; Szejka A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021908; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Villani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017703; WOLPERT L, 1994, SCIENCE, V266, P571, DOI 10.1126/science.7939707	44	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36010	10.1371/journal.pone.0036010	http://dx.doi.org/10.1371/journal.pone.0036010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586459	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000021
J	Ravasi, G; Pelucchi, S; Trombini, P; Mariani, R; Tomosugi, N; Modignani, GL; Pozzi, M; Nemeth, E; Ganz, T; Hayashi, H; Barisani, D; Piperno, A				Ravasi, Giulia; Pelucchi, Sara; Trombini, Paola; Mariani, Raffaella; Tomosugi, Naohisa; Modignani, Giulia Litta; Pozzi, Matteo; Nemeth, Elizabeth; Ganz, Tomas; Hayashi, Hisao; Barisani, Donatella; Piperno, Alberto			Hepcidin Expression in Iron Overload Diseases Is Variably Modulated by Circulating Factors	PLOS ONE			English	Article							HEMOCHROMATOSIS; THALASSEMIA; DIAGNOSIS; SYSTEM; HFE	Hepcidin is a regulatory hormone that plays a major role in controlling body iron homeostasis. Circulating factors (holotransferrin, cytokines, erythroid regulators) might variably contribute to hepcidin modulation in different pathological conditions. There are few studies analysing the relationship between hepcidin transcript and related protein expression profiles in humans. Our aims were: a. to measure hepcidin expression at either hepatic, serum and urinary level in three paradigmatic iron overload conditions (hemochromatosis, thalassemia and dysmetabolic iron overload syndrome) and in controls; b. to measure mRNA hepcidin expression in two different hepatic cell lines (HepG2 and Huh-7) exposed to patients and controls sera to assess whether circulating factors could influence hepcidin transcription in different pathological conditions. Our findings suggest that hepcidin assays reflect hepatic hepcidin production, but also indicate that correlation is not ideal, likely due to methodological limits and to several post trascriptional events. In vitro study showed that THAL sera down-regulated, HFE-HH and C-NAFLD sera up-regulated hepcidin synthesis. HAMP mRNA expression in Huh-7 cells exposed to sera form C-Donors, HFE-HH and THAL reproduced, at lower level, the results observed in HepG2, suggesting the important but not critical role of HFE in hepcidin regulation.	[Ravasi, Giulia; Pelucchi, Sara; Modignani, Giulia Litta; Pozzi, Matteo; Piperno, Alberto] Univ Milano Bicocca, Dept Clin Med & Prevent, Monza, Italy; [Trombini, Paola; Mariani, Raffaella; Piperno, Alberto] S Gerardo Hosp, Ctr Diag & Treatment Hemochromatosis, Monza, Italy; [Tomosugi, Naohisa; Hayashi, Hisao] Kanazawa Med Univ, Dept Internal Med, Div Nephrol, Uchinada, Ishikawa, Japan; [Nemeth, Elizabeth; Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Med, Los Angeles, CA 90095 USA; [Barisani, Donatella] Univ Milano Bicocca, Dept Expt Med, Monza, Italy; [Piperno, Alberto] Consortium Human Mol Genet, Monza, Italy	University of Milano-Bicocca; Kanazawa Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Milano-Bicocca	Ravasi, G (corresponding author), Univ Milano Bicocca, Dept Clin Med & Prevent, Monza, Italy.	alberto.piperno@unimib.it	Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Nemeth, Elizabeta/0000-0002-3477-2397; Pozzi, Matteo/0000-0001-8235-9313; Ganz, Tomas/0000-0002-2830-5469; Piperno, Alberto/0000-0002-0343-0204	PRIN [CUP H41J10000000001]; CARIPLO [CUP H51J09000950003]; Associazione per lo Studio dell'Emocromatosi +Fe - ONLUS, Monza, Italy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082717] Funding Source: NIH RePORTER	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CARIPLO(Fondazione Cariplo); Associazione per lo Studio dell'Emocromatosi +Fe - ONLUS, Monza, Italy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by PRIN 2008 (CUP H41J10000000001) and CARIPLO 2009 (CUP H51J09000950003) to AP. SP was partially supported by Associazione per lo Studio dell'Emocromatosi +Fe - ONLUS, Monza, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barisani D, 2008, J HEPATOL, V49, P123, DOI 10.1016/j.jhep.2008.03.011; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Camaschella C, 2011, THESCIENTIFICWORLDJO, V11, P1357, DOI 10.1100/tsw.2011.130; Detivaud L, 2005, BLOOD, V106, P746, DOI 10.1182/blood-2004-12-4855; DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R; Fujita N, 2008, J HEPATOL, V49, P702, DOI 10.1016/j.jhep.2008.05.014; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kaneko Y, 2010, J GASTROENTEROL, V45, P1163, DOI 10.1007/s00535-010-0259-8; Kattamis A, 2006, HAEMATOLOGICA, V91, P809; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendler MH, 2005, LIVER INT, V25, P294, DOI 10.1111/j.1478-3231.2005.01052.x; Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5; Murao N, 2007, RAPID COMMUN MASS SP, V21, P4033, DOI 10.1002/rcm.3319; Murphy AT, 2007, BLOOD, V110, P1048, DOI 10.1182/blood-2006-11-057471; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Pantopoulos K, 2008, WORLD J GASTROENTERO, V14, P6893, DOI 10.3748/wjg.14.6893; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Piperno A, 2004, LIVER INT, V24, P471, DOI 10.1111/j.1478-3231.2004.0988.x; Piperno A, 2011, BLOOD, V117, P2953, DOI 10.1182/blood-2010-08-299859; Piperno A, 2009, WORLD J GASTROENTERO, V15, P538, DOI 10.3748/wjg.15.538; Riva A, 2008, WORLD J GASTROENTERO, V14, P4745, DOI 10.3748/wjg.14.4745; Ruivard M, 2009, J HEPATOL, V50, P1219, DOI 10.1016/j.jhep.2009.01.029; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Theurl I, 2010, BRIT J HAEMATOL, V148, P449, DOI 10.1111/j.1365-2141.2009.07961.x; Traglia M, 2011, J MED GENET, V48, P629, DOI 10.1136/jmedgenet-2011-100061; Trombini P, 2007, J HEPATOL, V46, P549, DOI 10.1016/j.jhep.2007.01.004; Trombini P, 2011, LIVER INT, V31, P994, DOI 10.1111/j.1478-3231.2011.02520.x; Tsochatzis E, 2010, J VIRAL HEPATITIS, V17, P800, DOI 10.1111/j.1365-2893.2009.01244.x; Vecchi C, 2010, HEPATOLOGY, V51, P654, DOI 10.1002/hep.23410; Weizer-Stern O, 2006, BRIT J HAEMATOL, V135, P129, DOI 10.1111/j.1365-2141.2006.06258.x	37	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36425	10.1371/journal.pone.0036425	http://dx.doi.org/10.1371/journal.pone.0036425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586470	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335000032
J	Kim, SU; Lee, JH; Kim, DY; Ahn, SH; Jung, KS; Choi, EH; Park, YN; Han, KH; Chon, CY; Park, JY				Kim, Seung Up; Lee, Ji Hoon; Kim, Do Young; Ahn, Sang Hoon; Jung, Kyu Sik; Choi, Eun Hee; Park, Young Nyun; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong			Prediction of Liver-Related Events Using Fibroscan in Chronic Hepatitis B Patients Showing Advanced Liver Fibrosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; STIFFNESS MEASUREMENT; TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; ESOPHAGEAL-VARICES; CIRRHOSIS; RISK; MANAGEMENT; LAMIVUDINE; INFECTION	Background: Liver stiffness measurement (LSM) using transient elastography (FibroScan (R)) can assess liver fibrosis noninvasively. This study investigated whether LSM can predict the development of liver-related events (LREs) in chronic hepatitis B (CHB) patients showing histologically advanced liver fibrosis. Methods: Between March 2006 and April 2010, 128 CHB patients with who underwent LSM and liver biopsy (LB) before starting nucleot(s)ide analogues and showed histologically advanced fibrosis (>= F3) with a high viral loads [HBV DNA >= 2,000 IU/mL] were enrolled. All patients were followed regularly to detect LRE development, including hepatic decompensation (variceal bleeding, ascites, hepatic encephalopathy, spontaneous bacterial peritonitis, hepatorenal syndrome) and hepatocellular carcinoma (HCC). Results: The mean age of the patient (72 men, 56 women) was 52.2 years. During the median follow-up period [median 27.8 (12.6-61.6) months], LREs developed in 19 (14.8%) patients (five with hepatic decompensation, 13 with HCC, one with both). Together with age, multivariate analysis identified LSM as an independent predictor of LRE development [P<0.044; hazard ratio (HR), 1.038; 95% confidence interval (CI), 1.002-1.081]. When the study population was stratified into two groups using the optimal cutoff value (19 kPa), which maximized the sum of sensitivity (61.1%) and specificity (86.2%) from a time-dependent receiver operating characteristic curve, patients with LSM>19 kPa were at significantly greater risk than those with LSM <= 19 kPa for LRE development (HR, 7.176; 95% CI, 2.257-22.812; P = 0.001). Conclusion: LSM can be a useful predictor of LRE development in CHB patients showing histologically advanced liver fibrosis.	[Kim, Seung Up; Lee, Ji Hoon; Kim, Do Young; Ahn, Sang Hoon; Jung, Kyu Sik; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Choi, Eun Hee] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Ahn, Sang Hoon; Park, Young Nyun; Han, Kwang-Hyub] Brain Korea 21 Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	DRPJY@yuhs.ac	Park, Jun Yong/H-7127-2019	Kim, Seung Up/0000-0002-9658-8050; Choi, Eunhee/0000-0002-3449-0672; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Jun Yong/0000-0001-6324-2224; Ahn, Sang Hoon/0000-0002-3629-4624; Park, Young Nyun/0000-0003-0357-7967	grant of the Korea Healthcare Technology R & D project, Ministry of Health and Welfare, Republic of Korea [A102065]	grant of the Korea Healthcare Technology R & D project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R & D project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; COLOMBO M, 1991, NEW ENGL J MED, V325, P675, DOI 10.1056/NEJM199109053251002; Di Marco V, 1999, HEPATOLOGY, V30, P257, DOI 10.1002/hep.510300109; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886, DOI 10.1111/j.1572-0241.2002.07057.x; FATTOVICH G, 1995, HEPATOLOGY, V21, P77; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fung SK, 2005, J HEPATOL, V42, pS54, DOI 10.1016/j.jhep.2004.11.014; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Gines P, 1999, J AM SOC NEPHROL, V10, P1833; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; KATO Y, 1994, CANCER, V74, P2234, DOI 10.1002/1097-0142(19941015)74:8<2234::AID-CNCR2820740805>3.0.CO;2-6; Kazemi F, 2006, J HEPATOL, V45, P230, DOI 10.1016/j.jhep.2006.04.006; Kim BK, 2010, AM J GASTROENTEROL, V105, P1382, DOI 10.1038/ajg.2009.750; Kim DY, 2009, DIGEST DIS SCI, V54, P1758, DOI 10.1007/s10620-008-0541-2; Kim SU, 2010, HEPATOL INT, V4, P673, DOI 10.1007/s12072-010-9201-7; Kim SU, 2012, PLOS ONE, V7; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; LIAW YF, 1989, LIVER, V9, P235; LIAW YF, 1986, GASTROENTEROLOGY, V90, P263, DOI 10.1016/0016-5085(86)90919-4; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lin SM, 1999, HEPATOLOGY, V29, P971, DOI 10.1002/hep.510290312; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; MARGOLIS HS, 1991, SEMIN LIVER DIS, V11, P84, DOI 10.1055/s-2008-1040427; Masuzaki R, 2008, J CLIN GASTROENTEROL, V42, P839, DOI 10.1097/MCG.0b013e318050074f; Mazzella G, 1996, J HEPATOL, V24, P141, DOI 10.1016/S0168-8278(96)80022-5; Min Albert D, 2007, Clin Liver Dis, V11, P851, DOI 10.1016/j.cld.2007.08.003; Moore KP, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.099580; OON CJ, 1992, CANCER CHEMOTH PHARM, V31, pS137, DOI 10.1007/BF00687123; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; 김화숙, 2007, [The Korean Journal of Medicine, 대한내과학회지], V72, P459; Patch D, 2001, WORLD J GASTROENTERO, V7, P466; Prakash R, 2010, NAT REV GASTRO HEPAT, V7, P515, DOI 10.1038/nrgastro.2010.116; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sobesky R, 1999, GASTROENTEROLOGY, V116, P378, DOI 10.1016/S0016-5085(99)70135-6; Such J, 1998, CLIN INFECT DIS, V27, P669, DOI 10.1086/514940; Suzuki Y, 1999, J HEPATOL, V30, P743, DOI 10.1016/S0168-8278(99)80123-8; Talaat Zakareya, 2010, NILE LIVER J, V1, P49; TANAKA R, 1987, LIVER, V7, P316; Wong GLH, 2011, ANTIVIR THER, V16, P165, DOI 10.3851/IMP1726	46	76	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36676	10.1371/journal.pone.0036676	http://dx.doi.org/10.1371/journal.pone.0036676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574212	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800109
J	Liu, N; Zhang, YJ; Chang, SJ; Kan, HM; Lin, LJ				Liu, Nan; Zhang, Yingjun; Chang, Shujuan; Kan, Haiming; Lin, Lijun			Impact of Grazing on Soil Carbon and Microbial Biomass in Typical Steppe and Desert Steppe of Inner Mongolia	PLOS ONE			English	Article							DEGRADED SANDY GRASSLAND; ORGANIC-CARBON; MIXED-GRASS; TERM MANAGEMENT; ALPINE MEADOW; STOCKING RATE; NITROGEN; PLANT; SEQUESTRATION; INTENSITY	The potential of grazing lands to sequester carbon must be understood to develop effective soil conservation measures and sustain livestock production. Our objective was to evaluate the effects of grazing on soil organic carbon (SOC), total nitrogen (TN), microbial biomass carbon (MBC) in Typical steppe and Desert steppe ecosystems, which are both important grassland resources for animal grazing and ecological conservation in China, and to derive region-specific soil C changes associated with different stocking rates (ungrazed, UG; lightly grazed, LG; moderately grazed, MG; heavily grazed, HG). This study substantiated that significant higher SOC, TN and MBC appeared with the treatment of LG in typical steppe. From 2004 to 2010, grazing treatments increased soil carbon storage in desert steppe, which was partly due to the grazing history. The higher MBC concentration and MBC/SOC suggest a great potential for carbon sequestration in the desert steppe ecosystem. The greater MBC in desert steppe than typical steppe was mainly the result of higher precipitation and temperature, instead of soil substrate. The change of MBC and the strong positive relationships between MBC and SOC indicated that MBC in the soil was a sensitive index to indicate the dynamics of soil organic carbon in both steppes in Inner Mongolia of China.	[Liu, Nan; Zhang, Yingjun; Chang, Shujuan; Kan, Haiming; Lin, Lijun] China Agr Univ, Coll Anim Sci & Technol, Inst Grassland Sci, Beijing 100094, Peoples R China	China Agricultural University	Liu, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Inst Grassland Sci, Beijing 100094, Peoples R China.	zhangyj@cau.edu.cn	Zhang, Yingjun/A-2400-2015	Zhang, Yingjun/0000-0001-5776-4392	earmarked fund for Modern Agro-industry Technology Research System [CARS-35]; 973 project [2007CB106805];  [200903060]	earmarked fund for Modern Agro-industry Technology Research System; 973 project(National Basic Research Program of China); 	Research was funded by the earmarked fund for Modern Agro-industry Technology Research System (CARS-35) and the 973 project (Grant 2007CB106805) and the project (200903060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril A, 2001, APPL SOIL ECOL, V16, P243, DOI 10.1016/S0929-1393(00)00122-0; Ananyeva ND, 1999, BIOL FERT SOILS, V29, P291, DOI 10.1007/s003740050555; Anderson JD, 2008, APPL SOIL ECOL, V40, P387, DOI 10.1016/j.apsoil.2008.06.008; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bird SB, 2002, ENVIRON POLLUT, V116, P445, DOI 10.1016/S0269-7491(01)00222-6; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Derner JD, 2007, J SOIL WATER CONSERV, V62, P77; Derner JD, 2006, PLANT SOIL, V280, P77, DOI 10.1007/s11104-005-2554-3; DORMAAR JF, 1990, J RANGE MANAGE, V43, P456, DOI 10.2307/3899012; Du Preez C. C., 1993, African Journal of Range and Forage Science, V10, P108, DOI 10.1080/10220119.1993.9638333; FRANK AB, 1995, J RANGE MANAGE, V48, P470, DOI 10.2307/4002255; Frazao LA, 2010, AGR ECOSYST ENVIRON, V135, P161, DOI 10.1016/j.agee.2009.09.003; GALLAHER RN, 1976, SOIL SCI SOC AM J, V40, P887, DOI 10.2136/sssaj1976.03615995004000060026x; Gao YH, 2007, POL J ECOL, V55, P469; Gao YH, 2009, J FOOD AGRIC ENVIRON, V7, P749; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Guodong HD, 2008, AGR ECOSYST ENVIRON, V125, P21, DOI 10.1016/j.agee.2007.11.009; Harris WN, 2007, ACTA OECOL, V32, P207, DOI 10.1016/j.actao.2007.05.001; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Heady HF., 2019, RANGELAND ECOLOGY MA, V1st; Holt JA, 1997, APPL SOIL ECOL, V5, P143, DOI 10.1016/S0929-1393(96)00145-X; HU J.Y, 2009, STUDY EEOLOGICAL CHA; Ingram LJ, 2008, SOIL SCI SOC AM J, V72, P939, DOI 10.2136/sssaj2007.0038; INSAM H, 1988, MICROBIAL ECOL, V15, P177, DOI 10.1007/BF02011711; Kelly RH, 1996, ECOLOGY, V77, P2516, DOI 10.2307/2265750; KIEFT TL, 1994, BIOL FERT SOILS, V18, P155, DOI 10.1007/BF00336463; Li CL, 2008, AGR ECOSYST ENVIRON, V128, P109, DOI 10.1016/j.agee.2008.05.008; Lin Y, 2010, AGR ECOSYST ENVIRON, V138, P282, DOI 10.1016/j.agee.2010.05.013; Liu WX, 2010, GEODERMA, V158, P259, DOI 10.1016/j.geoderma.2010.05.004; Lu FM, 2011, BIOL FERT SOILS, V47, P187, DOI 10.1007/s00374-010-0522-4; Murray S., 2000, PILOT ANAL GLOBAL EC; NAETH MA, 1991, J RANGE MANAGE, V44, P7, DOI 10.2307/4002629; Nardoto GB, 2003, PESQUI AGROPECU BRAS, V38, P955, DOI 10.1590/S0100-204X2003000800008; Nielsen MN, 2002, MICROORGANISMS INDIC; Northup BK, 1999, APPL SOIL ECOL, V13, P259, DOI 10.1016/S0929-1393(99)00039-6; Pineiro G, 2010, RANGELAND ECOL MANAG, V63, P109, DOI 10.2111/08-255.1; Reeder JD, 2004, ENVIRON MANAGE, V33, P485, DOI 10.1007/s00267-003-9106-5; Reeder JD, 2002, ENVIRON POLLUT, V116, P457, DOI 10.1016/S0269-7491(01)00223-8; Schonbach P, 2009, CROP PASTURE SCI, V60, P963, DOI 10.1071/CP09048; Schonbach P, 2011, PLANT SOIL, V340, P103, DOI 10.1007/s11104-010-0366-6; Schuman GE, 1999, ECOL APPL, V9, P65, DOI 10.1890/1051-0761(1999)009[0065:IOGMOT]2.0.CO;2; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; SHARIFF AR, 1994, J RANGE MANAGE, V47, P444, DOI 10.2307/4002994; Shrestha G, 2008, AGR ECOSYST ENVIRON, V125, P173, DOI 10.1016/j.agee.2007.12.007; Smith JL, 1990, SOIL BIOCH, V6, P357; SPARLING GP, 1992, AUST J SOIL RES, V30, P195, DOI 10.1071/SR9920195; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Su YZ, 2005, CATENA, V59, P267, DOI 10.1016/j.catena.2004.09.001; Su YZ, 2003, NEW ZEAL J AGR RES, V46, P321, DOI 10.1080/00288233.2003.9513560; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang Changting, 2008, Chinese Journal of Applied and Environmental Biology, V14, P225; Wang QiLan, 2008, Acta Prataculturae Sinica, V17, P39; Wang ZW, 2011, RANGELAND ECOL MANAG, V64, P249, DOI 10.2111/REM-D-09-00033.1; XIAO XM, 1995, J ARID ENVIRON, V31, P283, DOI 10.1016/S0140-1963(05)80033-3; Yang Hao, 2009, Chinese Journal of Plant Ecology, V33, P499, DOI 10.3773/j.issn.1005-264x.2009.03.009; Yang Y, 2010, THESIS INNER MONGOLI; Yu M, 2004, J ENVIRON QUAL, V33, P1675, DOI 10.2134/jeq2004.1675	60	75	81	18	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36434	10.1371/journal.pone.0036434	http://dx.doi.org/10.1371/journal.pone.0036434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574161	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349800057
J	Salem, M; Vallejo, RL; Leeds, TD; Palti, Y; Liu, SX; Sabbagh, A; Rexroad, CE; Yao, JB				Salem, Mohamed; Vallejo, Roger L.; Leeds, Timothy D.; Palti, Yniv; Liu, Sixin; Sabbagh, Annas; Rexroad, Caird E., III; Yao, Jianbo			RNA-Seq Identifies SNP Markers for Growth Traits in Rainbow Trout	PLOS ONE			English	Article							SINGLE GENETIC LINE; SALMON SALMO-SALAR; FEED-EFFICIENCY; MITOCHONDRIAL-FUNCTION; ONCORHYNCHUS-MYKISS; ABNORMAL GROWTH; ASSOCIATION; GENOME; MUSCLE; EXPRESSION	Fast growth is an important and highly desired trait, which affects the profitability of food animal production, with feed costs accounting for the largest proportion of production costs. Traditional phenotype-based selection is typically used to select for growth traits; however, genetic improvement is slow over generations. Single nucleotide polymorphisms (SNPs) explain 90% of the genetic differences between individuals; therefore, they are most suitable for genetic evaluation and strategies that employ molecular genetics for selective breeding. SNPs found within or near a coding sequence are of particular interest because they are more likely to alter the biological function of a protein. We aimed to use SNPs to identify markers and genes associated with genetic variation in growth. RNA-Seq whole-transcriptome analysis of pooled cDNA samples from a population of rainbow trout selected for improved growth versus unselected genetic cohorts (10 fish from 1 full-sib family each) identified SNP markers associated with growth-rate. The allelic imbalances (the ratio between the allele frequencies of the fast growing sample and that of the slow growing sample) were considered at scores >5.0 as an amplification and <0.2 as loss of heterozygosity. A subset of SNPs (n = 54) were validated and evaluated for association with growth traits in 778 individuals of a three-generation parent/offspring panel representing 40 families. Twenty-two SNP markers and one mitochondrial haplotype were significantly associated with growth traits. Polymorphism of 48 of the markers was confirmed in other commercially important aquaculture stocks. Many markers were clustered into genes of metabolic energy production pathways and are suitable candidates for genetic selection. The study demonstrates that RNA-Seq at low sequence coverage of divergent populations is a fast and effective means of identifying SNPs, with allelic imbalances between phenotypes. This technique is suitable for marker development in non-model species lacking complete and well-annotated genome reference sequences.	[Salem, Mohamed; Sabbagh, Annas; Yao, Jianbo] W Virginia Univ, Lab Anim Biotechnol & Genom, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [Vallejo, Roger L.; Leeds, Timothy D.; Palti, Yniv; Liu, Sixin; Rexroad, Caird E., III] Natl Ctr Cool & Cold Water Aquaculture, Kearneysville, WV USA	West Virginia University	Salem, M (corresponding author), W Virginia Univ, Lab Anim Biotechnol & Genom, Div Anim & Nutr Sci, Morgantown, WV 26506 USA.	mosalem@mail.wvu.edu	Salem, Mohamed/AGB-2739-2022; Vallejo, Roger/AAE-7591-2020	Salem, Mohamed/0000-0003-2142-6716; Vallejo, Roger/0000-0002-5399-3531; Leeds, Timothy/0000-0002-9872-1134	United States Department of Agriculture Cooperative State Research, Education, and Extension Service; States Department of Agriculture Cooperative Agreement [58-1930-5-537]; National Research Initiative Competitive Grant [2007-35205-17914]; Agriculture and Food Research Initiative Competitive Grant	United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); States Department of Agriculture Cooperative Agreement; National Research Initiative Competitive Grant; Agriculture and Food Research Initiative Competitive Grant	This project was supported by the United States Department of Agriculture Cooperative State Research, Education, and Extension Service; United States Department of Agriculture Cooperative Agreement No. 58-1930-5-537; National Research Initiative Competitive Grant No. 2007-35205-17914 and Agriculture and Food Research Initiative Competitive Grant no. It is published with the approval of the Director of the West Virginia Agriculture and Forestry Experiment Station as scientific paper No. 3130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg P, 2006, P 8 WORLD C GEN APPL, P27; Bernard C, 2009, MEAT SCI, V82, P205, DOI 10.1016/j.meatsci.2009.01.012; Blangero J, 2009, HUM BIOL, V81, P849, DOI 10.3378/027.081.0626; BOLDMAN KG, 1995, MANUAL USE IN PRESS; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; Bottje WG, 2009, J ANIM SCI, V87, pE48, DOI 10.2527/jas.2008-1379; Brookes A.J, 2007, SINGLE NUCLEOTIDE PO; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Castro-Gago M, 2010, ACTA PAEDIATR, V99, P796, DOI 10.1111/j.1651-2227.2010.01738.x; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dekkers J. C. M., 2004, J ANIM SCI, V82, pE313; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Eya JC, 2011, AQUACULTURE, V321, P71, DOI 10.1016/j.aquaculture.2011.08.037; Eya JC, 2010, N AM J AQUACULT, V72, P225, DOI 10.1577/A09-058.1; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Haller JF, 2011, BBA-MOL BASIS DIS, V1812, P1393, DOI 10.1016/j.bbadis.2011.07.007; Havill LM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S91; Iqbal M, 2004, POULTRY SCI, V83, P474, DOI 10.1093/ps/83.3.474; Johnson NA, 2007, AQUACULTURE, V266, P53, DOI 10.1016/j.aquaculture.2007.02.054; MacMillan JR, 2003, AQUACULTURE, V226, P91, DOI 10.1016/S0044-8486(03)00470-8; Miller Neil A, 2008, J Comput Sci Syst Biol, V1, P132; Moen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-223; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Nathanailides C, 1996, J FISH BIOL, V48, P549, DOI 10.1006/jfbi.1996.0054; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palti Y, 2012, MAR BIOTECHNOL, V14, P343, DOI 10.1007/s10126-011-9418-z; Palti Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-180; Paulson TG, 1999, GENOME RES, V9, P482; PELLETIER D, 1993, J EXP ZOOL, V265, P477, DOI 10.1002/jez.1402650503; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Ryynanen HJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-192; Salem M, 2006, PHYSIOL GENOMICS, V28, P33, DOI 10.1152/physiolgenomics.00114.2006; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Salem M, 2010, J PROTEOMICS, V73, P778, DOI 10.1016/j.jprot.2009.10.014; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Sarropoulou E, 2008, MAR BIOTECHNOL, V10, P227, DOI 10.1007/s10126-007-9066-5; SAS, 2007, HELP DOC; SAS Institute Inc, 2007, SAS 9 1 3 HELP DOC; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Sillanpaa MJ, 2011, HEREDITY, V106, P511, DOI 10.1038/hdy.2010.91; Silverstein JT, 2006, N AM J AQUACULT, V68, P168, DOI 10.1577/A05-010.1; Silverstein JT, 2004, AQUAC RES, V35, P40, DOI 10.1111/j.1365-2109.2004.00979.x; Thorgaard GH, 2002, COMP BIOCHEM PHYS B, V133, P609, DOI 10.1016/S1096-4959(02)00167-7; Vallejo RL, 2010, J ANIM SCI, V88, P3814, DOI 10.2527/jas.2010-2951; VANDERWALT LD, 1993, COMP BIOCHEM PHYS B, V104, P765, DOI 10.1016/0305-0491(93)90210-V; Villanueva B, 2004, J ANIM SCI, V82, P1305; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Wolf K., 1985, Journal of Applied Ichthyology, V1, P131, DOI 10.1111/j.1439-0426.1985.tb00422.x; Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x; Zador E, 2007, CELL CALCIUM, V41, P379, DOI 10.1016/j.ceca.2006.08.001; Zardoya R, 1995, J MOL EVOL, V41, P942, DOI 10.1007/BF00173174	63	114	123	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36264	10.1371/journal.pone.0036264	http://dx.doi.org/10.1371/journal.pone.0036264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574143	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800039
J	Sperling, LE; Klaczinski, J; Schutz, C; Rudolph, L; Layer, PG				Sperling, Laura E.; Klaczinski, Janine; Schuetz, Corina; Rudolph, Lydia; Layer, Paul G.			Mouse Acetylcholinesterase Enhances Neurite Outgrowth of Rat R28 Cells Through Interaction With Laminin-1	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; PERIPHERAL ANIONIC SITE; C-TERMINAL PEPTIDE; NEURONS IN-VITRO; READTHROUGH ACETYLCHOLINESTERASE; TRANSMEMBRANE PROTEIN; HIPPOCAMPAL-NEURONS; ALZHEIMERS FIBRILS; PROMOTING SITE; BINDING SITES	The enzyme acetylcholinesterase (AChE) terminates synaptic transmission at cholinergic synapses by hydrolyzing the neurotransmitter acetylcholine, but can also exert 'non-classical', morpho-regulatory effects on developing neurons such as stimulation of neurite outgrowth. Here, we investigated the role of AChE binding to laminin-1 on the regulation of neurite outgrowth by using cell culture, immunocytochemistry, and molecular biological approaches. To explore the role of AChE, we examined fiber growth of cells overexpressing different forms of AChE, and/or during their growth on laminin-1. A significant increase of neuritic growth as compared with controls was observed for neurons over-expressing AChE. Accordingly, addition of globular AChE to the medium increased total length of neurites. Co-transfection with PRIMA, a membrane anchor of AChE, led to an increase in fiber length similar to AChE overexpressing cells. Transfection with an AChE mutant that leads to the retention of AChE within cells had no stimulatory effect on neurite length. Noticeably, the longest neurites were produced by neurons overexpressing AChE and growing on laminin-1, suggesting that the AChE/laminin interaction is involved in regulating neurite outgrowth. Our findings demonstrate that binding of AChE to laminin-1 alters AChE activity and leads to increased neurite growth in culture. A possible mechanism of the AChE effect on neurite outgrowth is proposed due to the interaction of AChE with laminin-1.	[Sperling, Laura E.; Klaczinski, Janine; Schuetz, Corina; Rudolph, Lydia; Layer, Paul G.] Tech Univ Darmstadt, Fachbereich Biol, Darmstadt, Germany	Technical University of Darmstadt	Sperling, LE (corresponding author), Tech Univ Darmstadt, Fachbereich Biol, Darmstadt, Germany.	sperling@bio.tu-darmstadt.de	Sperling, Laura Elena/H-1649-2011	Sperling, Laura Elena/0000-0001-9171-7696	EU [QLK4-CT-2002-02264]	EU(European Commission)	This work was supported by the EU contract SENS-PESTI, QLK4-CT-2002-02264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez A, 1998, J NEUROSCI, V18, P3213; Anderson AA, 2008, J CELL PHYSIOL, V215, P82, DOI 10.1002/jcp.21288; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Bataille S, 1998, EUR J NEUROSCI, V10, P560, DOI 10.1046/j.1460-9568.1998.00065.x; Beeri R, 1997, J NEUROCHEM, V69, P2441; Bigbee JW, 2000, BRAIN RES, V861, P354, DOI 10.1016/S0006-8993(00)02046-1; Birikh KR, 2003, P NATL ACAD SCI USA, V100, P283, DOI 10.1073/pnas.0135647100; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN SS, 1983, P NATL ACAD SCI-BIOL, V80, P5927, DOI 10.1073/pnas.80.19.5927; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; Bytyqi AH, 2004, EUR J NEUROSCI, V20, P2953, DOI 10.1111/j.1460-9568.2004.03753.x; CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369; Chen VP, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00036; Day T, 2002, NEUROSCIENCE, V111, P649, DOI 10.1016/S0306-4522(02)00031-3; De Ferrari GV, 2001, BIOCHEMISTRY-US, V40, P10447, DOI 10.1021/bi0101392; De Jaco A, 2006, J BIOL CHEM, V281, P9667, DOI 10.1074/jbc.M510262200; De Jaco A, 2002, J NEUROSCI RES, V70, P756, DOI 10.1002/jnr.10436; DECURTIS I, 1991, J CELL BIOL, V113, P405, DOI 10.1083/jcb.113.2.405; DELAESCALERA S, 1990, EMBO J, V9, P3593, DOI 10.1002/j.1460-2075.1990.tb07570.x; Deutsch VR, 2002, EXP HEMATOL, V30, P1153, DOI 10.1016/S0301-472X(02)00900-1; Dori A, 2006, J MOL NEUROSCI, V28, P247, DOI 10.1385/JMN:28:3:247; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Giordano C, 2007, BIOCHEM BIOPH RES CO, V356, P398, DOI 10.1016/j.bbrc.2007.02.146; Greenberg DS, 2010, NEURODEGENER DIS, V7, P60, DOI 10.1159/000285507; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Grisaru D, 2001, MOL MED, V7, P93, DOI 10.1007/BF03401943; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hanin G, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00028; HUCHO F, 1991, TRENDS PHARMACOL SCI, V12, P422; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Ido H, 2008, J BIOL CHEM, V283, P28149, DOI 10.1074/jbc.M803553200; Inestrosa NC, 1996, MOL PSYCHIATR, V1, P359; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Johnson G, 1999, BIOCHEM BIOPH RES CO, V258, P758, DOI 10.1006/bbrc.1999.0705; Johnson G, 2004, BIOCHEM BIOPH RES CO, V319, P448, DOI 10.1016/j.bbrc.2004.05.018; Johnson G, 2004, J CELL BIOCHEM, V91, P999, DOI 10.1002/jcb.10785; Johnson G, 2003, NEUROSCI LETT, V337, P37, DOI 10.1016/S0304-3940(02)01298-3; Johnson G, 2000, APPL BIOCHEM BIOTECH, V83, P131, DOI 10.1385/ABAB:83:1-3:131; Johnson G, 2008, FEBS J, V275, P5129, DOI 10.1111/j.1742-4658.2008.06644.x; Johnson G, 2008, BIOCHEM J, V411, P507, DOI 10.1042/BJ20071404; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Karpel R, 1996, J NEUROCHEM, V66, P114; KLEINMAN HK, 1990, ANN NY ACAD SCI, V580, P302, DOI 10.1111/j.1749-6632.1990.tb17939.x; Koenigsberger C, 1997, J NEUROCHEM, V69, P1389; LAYER PG, 1987, P NATL ACAD SCI USA, V84, P284, DOI 10.1073/pnas.84.1.284; LAYER PG, 1993, CELL TISSUE RES, V273, P219, DOI 10.1007/BF00312823; LAYER PG, 1995, PROG HISTOCHEM CYTOC, V29, P1; LevLehman E, 1997, BLOOD, V89, P3644, DOI 10.1182/blood.V89.10.3644.3644_3644_3653; Liang D, 2009, J BIOL CHEM, V284, P5195, DOI 10.1074/jbc.M806260200; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Olivera S, 2003, MOL CELL NEUROSCI, V23, P96, DOI 10.1016/S1044-7431(03)00021-6; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Paraoanu LE, 2004, FEBS LETT, V576, P161, DOI 10.1016/j.febslet.2004.08.078; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; Seigel GM, 1996, IN VITRO CELL DEV-AN, V32, P66; Seigel GM, 2004, CURR EYE RES, V28, P257, DOI 10.1076/ceyr.28.4.257.27831; Sharma KV, 1998, J NEUROSCI RES, V53, P454, DOI 10.1002/(SICI)1097-4547(19980815)53:4<454::AID-JNR7>3.3.CO;2-E; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Sternfeld M, 1998, J NEUROSCI, V18, P1240; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Vogel-Hopker A, 2011, PROTEIN PEPT LETT; Woolf NJ, 1997, CONSCIOUS COGN, V6, P574, DOI 10.1006/ccog.1997.0319	67	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36683	10.1371/journal.pone.0036683	http://dx.doi.org/10.1371/journal.pone.0036683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570738	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400054
J	Morris, DS; Tynan, MA				Morris, Daniel S.; Tynan, Michael A.			Fiscal and Policy Implications of Selling Pipe Tobacco for Roll-Your-Own Cigarettes in the United States	PLOS ONE			English	Article								Background: The Federal excise tax was increased for tobacco products on April 1, 2009. While excise tax rates prior to the increase were the same for roll-your-own (RYO) and pipe tobacco, the tax on pipe tobacco was $21.95 per pound less than the tax on RYO tobacco after the increase. Subsequently, tobacco manufacturers began labeling loose tobacco as pipe tobacco and marketing these products to RYO consumers at a lower price. Retailers refer to these products as "dual purpose'' or "dual use'' pipe tobacco. Methods: Data on tobacco tax collections comes from the Alcohol and Tobacco Tax and Trade Bureau. Joinpoint software was used to identify changes in sales trends. Estimates were generated for the amount of pipe tobacco sold for RYO use and for Federal and state tax revenue lost through August 2011. Results: Approximately 45 million pounds of pipe tobacco has been sold for RYO use from April 2009 to August 2011, lowering state and Federal revenue by over $1.3 billion. Conclusions: Marketing pipe tobacco as "dual purpose'' and selling it for RYO use provides an opportunity to avoid paying higher cigarette prices. This blunts the public health impact excise tax increases would otherwise have on reducing tobacco use through higher prices. Selling pipe tobacco for RYO use decreases state and Federal revenue and also avoids regulations on flavored tobacco, banned descriptors, prohibitions on shipping, and reporting requirements.	[Morris, Daniel S.] Oregon Hlth Author, Tobacco Prevent & Educ Program, Portland, OR USA; [Tynan, Michael A.] Ctr Dis Control & Prevent, Off Smoking & Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Morris, DS (corresponding author), Oregon Hlth Author, Tobacco Prevent & Educ Program, Portland, OR USA.	daniel.s.morris@state.or.us						Alcohol and Tobacco Tax and Trade Bureau, 2011, TTBGOV TOB STAT; Alcohol and Tobacco Tax and Trade Bureau, 2010, FREQ ASK QUEST REG T; Alcohol and Tobacco Tax and Trade Bureau, 2011, TTBGOV TAX FEE RAT; Alcohol and Tobacco Tax and Trade Bureau, PIP TOB; Alcohol and Tobacco Tax and Trade Bureau, 2010, TTB RUL 2010 4 CIG M; [Anonymous], JOINP REGR PROGR VER; Apuzzo Matt, ASS PRESS; Chaloupka FJ, 2011, TOB CONTROL, V20, P235, DOI 10.1136/tc.2010.039982; DeCicca P, 2010, EXCISE TAX AVOIDANCE; Dougher C, 2011, S FLORIDA SUN SENTIN; Farrelly MC, 2003, STATE CIGARETTE EXCI; Hunstinger D, 2011, INDIANAPOLIS STAR; *I MED, 2007, END TOB PROBL BLUEPR; Kesmodel D, 2010, WALL STREET J; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Morris DS, 2010, TOB CONTROL, V19, P421, DOI 10.1136/tc.2009.034280; Orzechowski W, 2011, TAX BURDEN TOBACCO, V45; Powell M., 2011, SEATTLE TIMES; Shelley D, 2007, AM J PUBLIC HEALTH, V97, P1483, DOI 10.2105/AJPH.2005.079921; Stehr M, 2005, J HEALTH ECON, V24, P277, DOI 10.1016/j.jhealeco.2004.08.005; US Department of Health and Human Services, 2000, RED TOB US REP SURG; Wisconsin Department of Revenue, 2011, REV ISS NOT ROLL YOU; World Health Organization, 2008, MPOWER POL PACK REV; Young D, 2006, TOB CONTROL, V15, P76, DOI 10.1136/tc.2005.013268	24	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36487	10.1371/journal.pone.0036487	http://dx.doi.org/10.1371/journal.pone.0036487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567159	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500078
J	Yang, K; Mooney, C; Spahlinger, G; Schuetze, S; Arias-Pulido, H; Verschraegen, C; Gimotty, P; Buckanovich, RJ				Yang, Kun; Mooney, Colin; Spahlinger, Greg; Schuetze, Scott; Arias-Pulido, Hugo; Verschraegen, Claire; Gimotty, Phyllis; Buckanovich, Ronald J.			DR6 as a Diagnostic and Predictive Biomarker in Adult Sarcoma	PLOS ONE			English	Article							RECEPTOR SUPERFAMILY; DEATH; EXPRESSION; IDENTIFICATION; CLASSIFICATION; MEMBER; ALPHA	Background: The Death Receptor 6 (DR6) protein is elevated in the serum of ovarian cancer patients. We tested DR6 serum protein levels as a diagnostic/predictive biomarker in several epithelial tumors and sarcomas. Methods: DR6 gene expression profiles were screened in publically available arrays of solid tumors. A quantitative immunofluorescent western blot analysis was developed to test the serum of healthy controls and patients with sarcoma, uterine carcinosarcoma, bladder, liver, and pancreatic carcinomas. Change in DR6 serum levels was used to assay the ability of DR6 to predict the response to therapy of sarcoma patients. Results: DR6 mRNA is highly expressed in all tumor types assayed. Western blot analysis of serum DR6 protein demonstrated high reproducibility (r = 0.97). Compared to healthy donor controls, DR6 serum levels were not elevated in patients with uterine carcinosarcoma, bladder, liver, or pancreatic cancers. Serum DR6 protein levels from adult sarcoma patients were significantly elevated (p < 0.001). This was most evident for patients with synovial sarcoma. Change in serum DR6 levels during therapy correlated with clinical benefit from therapy (sensitivity 75%, and positive predictive value 87%). Conclusion: DR6 may be a clinically useful diagnostic and predictive serum biomarker for some adult sarcoma subtypes. Impact: Diagnosis of sarcoma can be difficult and can lead to improper management of these cancers. DR6 serum protein may be a tool to aid in the diagnosis of some sarcomatous tumors to improve treatment planning. For patients with advanced disease, rising DR6 levels predict non-response to therapy and may expedite therapeutic decision making and reduce reliance on radiologic imaging.	[Yang, Kun; Mooney, Colin; Spahlinger, Greg; Schuetze, Scott; Buckanovich, Ronald J.] Univ Michigan, Dept Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Arias-Pulido, Hugo; Verschraegen, Claire] Univ New Mexico, Div Hematol Oncol, Dept Internal Med, Albuquerque, NM 87131 USA; [Gimotty, Phyllis] Univ Penn, Dept Biostat, Philadelphia, PA 19104 USA; [Buckanovich, Ronald J.] Univ Michigan, Dept Obstet & Gynecol, Div Gynecol Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of New Mexico; University of Pennsylvania; University of Michigan System; University of Michigan	Yang, K (corresponding author), Univ Michigan, Dept Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA.	ronaldbu@med.umich.edu	Gimotty, Phyllis/GWZ-4136-2022; Verschraegen, Claire/AAE-7620-2020; Arias-Pulido, Hugo/AEN-1741-2022	Gimotty, Phyllis/0000-0002-3850-9799; Verschraegen, Claire/0000-0001-6544-3089; Arias-Pulido, Hugo/0000-0003-4941-1110	Damon Runyon Cancer Research Foundation; National Institutes of Health DP2 Award [00440377]	Damon Runyon Cancer Research Foundation; National Institutes of Health DP2 Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was generously supported by the Damon Runyon Cancer Research Foundation and the National Institutes of Health DP2 Award grant #00440377. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benschop R, 2009, ADV EXP MED BIOL, V647, P186, DOI 10.1007/978-0-387-89520-8_13; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; Fletcher CDM, 2002, PATHOLOGY GENETICS T; Gronchi A, 2010, ANN SURG, V251, P506, DOI 10.1097/SLA.0b013e3181cf87fa; Herbst RS, 2010, CLIN CANCER RES, V16, P5883, DOI 10.1158/1078-0432.CCR-10-0631; Hsu HC, 2006, CURR DIRECT AUTOIMMU, V9, P37; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kasof GM, 2001, ONCOGENE, V20, P7965, DOI 10.1038/sj.onc.1204985; LOPRINZI CL, 1986, J CLIN ONCOL, V4, P46, DOI 10.1200/JCO.1986.4.1.46; Nash PT, 2005, MED J AUSTRALIA, V183, P205, DOI 10.5694/j.1326-5377.2005.tb06998.x; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Segal NH, 2003, J CLIN ONCOL, V21, P1775, DOI 10.1200/JCO.2003.10.108; Su AI, 2001, CANCER RES, V61, P7388; Ta HM, 2010, P NATL ACAD SCI USA, V107, P20281, DOI 10.1073/pnas.1011686107; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; TANABE KK, 1994, CANCER-AM CANCER SOC, V73, P1652, DOI 10.1002/1097-0142(19940315)73:6<1652::AID-CNCR2820730617>3.0.CO;2-X; Tetu B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1503; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484	22	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36525	10.1371/journal.pone.0036525	http://dx.doi.org/10.1371/journal.pone.0036525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567163	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500083
J	Skrypek, N; Duchene, B; Hebbar, M; Leteurtre, E; van Seuningen, I; Jonckheere, N				Skrypek, N.; Duchene, B.; Hebbar, M.; Leteurtre, E.; van Seuningen, I.; Jonckheere, N.			The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family	ONCOGENE			English	Article						MUC4; mucin; pancreatic cancer; gemcitabine; hCNT1; NF-kappa B	KAPPA-B; ADJUVANT GEMCITABINE; TRANSCRIPTION FACTOR; ANTITUMOR-ACTIVITY; ORTHOTOPIC MODEL; BILE-ACIDS; GENE; EXPRESSION; SURVIVAL; PROTEIN	The fluorinated analog of deoxycytidine, Gemcitabine (Gemzar), is the main chemotherapeutic drug in pancreatic cancer, but survival remains weak mainly because of the high resistance of tumors to the drug. Recent works have shown that the mucin MUC4 may confer an advantage to pancreatic tumor cells by modifying their susceptibility to drugs. However, the cellular mechanism(s) responsible for this MUC4-mediated resistance is unknown. The aim of this work was to identify the cellular mechanisms responsible for gemcitabine resistance linked to MUC4 expression. CAPAN-2 and CAPAN-1 adenocarcinomatous pancreatic cancer (PC) cell lines were used to establish stable MUC4-deficient clones (MUC4-KD) by shRNA interference. Measurement of the IC50 index using tetrazolium salt test indicated that MUC4-deficient cells were more sensitive to gemcitabine. This was correlated with increased Bax/Bcl(XL) ratio and apoptotic cell number. Expression of Equilibrative/Concentrative Nucleoside Transporter (hENT1, hCNT1/3), deoxycytidine kinase (dCK), ribonucleotide reductase (RRM1/2) and Multidrug-Resistance Protein (MRP3/4/5) was evaluated by quantitative RT-PCR (qRT-PCR) and western blotting. Alteration of MRP3, MRP4, hCNT1 and hCNT3 expression was observed in MUC4-KD cells, but only hCNT1 alteration was correlated to MUC4 expression and sensitivity to gemcitabine. Decreased activation of MAPK, JNK and NF-kappa B pathways was observed in MUC4-deficient cells, in which the NF-kappa B pathway was found to have an important role in both sensitivity to gemcitabine and hCNT1 regulation. Finally, and in accordance with our in vitro data, we found that MUC4 expression was conversely correlated to that of hCNT1 in tissues from patients with pancreatic adenocarcinoma. This work describes a new mechanism of PC cell resistance to gemcitabine, in which the MUC4 mucin negatively regulates the hCNT1 transporter expression via the NF-kappa B pathway. Altogether, these data point out to MUC4 and hCNT1 as potential targets to ameliorate the response of pancreatic tumors to gemcitabine treatment. Oncogene (2013) 32, 1714-1723; doi:10.1038/onc.2012.179; published online 14 May 2012	[Skrypek, N.; Duchene, B.; Hebbar, M.; Leteurtre, E.; van Seuningen, I.; Jonckheere, N.] INSERM, JPARC, UMR837, F-59045 Lille, France; [Skrypek, N.; Duchene, B.; Hebbar, M.; Leteurtre, E.; van Seuningen, I.; Jonckheere, N.] Univ Lille Nord France, Lille, France; [Skrypek, N.; Duchene, B.; van Seuningen, I.; Jonckheere, N.] Ctr Hosp Reg & Univ Lille, Lille, France; [Hebbar, M.] Ctr Hosp Reg & Univ Lille, Dept Med Oncol, Lille, France; [Leteurtre, E.] Ctr Hosp Reg & Univ Lille, Ctr Biol Pathol, Dept Pathol, Lille, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Jonckheere, N (corresponding author), INSERM, JPARC, UMR837, Rue Polonovski, F-59045 Lille, France.	nicolas.jonckheere@inserm.fr	Jonckheere, Nicolas/J-6028-2013; VAN SEUNINGEN, Isabelle/N-6176-2016	Jonckheere, Nicolas/0000-0002-0496-0661; Duchene, Belinda/0000-0002-4810-4680; VAN SEUNINGEN, Isabelle/0000-0002-3131-2694	PhD fellowship of Centre Hospitalier Regional et Universitaire (CHRU) de Lille; Region Nord-Pas de Calais; Institut National du Cancer (INCa); Ligue Nationale contre le Cancer (LNCC); la Ligue Nationale contre le Cancer (Equipe Labellisee Ligue, IVS); 'Contrat Hospitalier de Recherche Translationnelle'/CHRT, AVIESAN	PhD fellowship of Centre Hospitalier Regional et Universitaire (CHRU) de Lille; Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer (LNCC)(Ligue nationale contre le cancer); la Ligue Nationale contre le Cancer (Equipe Labellisee Ligue, IVS); 'Contrat Hospitalier de Recherche Translationnelle'/CHRT, AVIESAN	We thank MH Gevaert and R Siminsky (Department of Histology, Faculty of Medicine, University of Lille 2) and the technical platform IFR114/IMPRT for flow cytometry (Dr N Jouy) and luciferase (AS Drucbert) analyses. Gemcitabine and oxaliplatin are a kind gift from Dr A Lansiaux (Centre Oscar Lambret, Universite Lille Nord de France, Inserm UMR837, team 4, Lille, France). Cytarabine/aracytin ARA-C is a kind gift from Pr B Quesnel (Oncohaematology department, Centre Hospitalier Regional et Universitaire de Lille, Inserm UMR837, team 3, Lille, France). We thank Dr JL Desseyn (Inserm U995) for his help in designing MUC4 shRNA. Nicolas Skrypek is a recipient of a PhD fellowship of Centre Hospitalier Regional et Universitaire (CHRU) de Lille and Region Nord-Pas de Calais. Dr Nicolas Jonckheere is a recipient of postdoctoral fellowship from the Institut National du Cancer (INCa) and Ligue Nationale contre le Cancer (LNCC). This work is supported by a grant from la Ligue Nationale contre le Cancer (Equipe Labellisee Ligue 2010, IVS). Isabelle Van Seuningen is the recipient of a 'Contrat Hospitalier de Recherche Translationnelle'/CHRT 2010, AVIESAN. The funders had no role in study design, data collection and analysis, decision to publish or in preparation of the paper.	Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Bafna S, 2009, BRIT J CANCER, V101, P1155, DOI 10.1038/sj.bjc.6605285; Banerjee S, 2005, CANCER RES, V65, P9064, DOI 10.1158/0008-5472.CAN-05-1330; Bhutia YD, 2011, CANCER RES, V71, P1825, DOI 10.1158/0008-5472.CAN-10-2736; Blackstock AW, 2001, CLIN CANCER RES, V7, P3263; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Damaraju VL, 2003, ONCOGENE, V22, P7524, DOI 10.1038/sj.onc.1206952; Farrell JJ, 2009, GASTROENTEROLOGY, V136, P187, DOI 10.1053/j.gastro.2008.09.067; Garcia-Manteiga J, 2003, CLIN CANCER RES, V9, P5000; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Hagmann W, 2010, NEOPLASIA, V12, P740, DOI 10.1593/neo.10576; Hu YP, 2003, BIOCHEM PHARMACOL, V65, P1419, DOI 10.1016/S0006-2952(03)00086-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jonckheere N, 2004, ONCOGENE, V23, P5729, DOI 10.1038/sj.onc.1207769; Jonckheere N, 2009, BRIT J CANCER, V101, P637, DOI 10.1038/sj.bjc.6605190; Jonckheere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032232; Jonckheere Nicolas, 2010, Cancers (Basel), V2, P1794, DOI 10.3390/cancers2041794; Jordheim LP, 2011, LANCET ONCOL, V12, P693, DOI 10.1016/S1470-2045(10)70244-8; Kalra AV, 2007, BRIT J CANCER, V97, P910, DOI 10.1038/sj.bjc.6603972; Kalra AV, 2009, EUR J CANCER, V45, P164, DOI 10.1016/j.ejca.2008.10.008; Komatsu M, 2000, INT J CANCER, V87, P480, DOI 10.1002/1097-0215(20000815)87:4<480::AID-IJC4>3.0.CO;2-6; Kong R, 2010, CANCER LETT, V291, P90, DOI 10.1016/j.canlet.2009.10.001; Konig J, 2005, INT J CANCER, V115, P359, DOI 10.1002/ijc.20831; Krajewski S, 1999, ENDOCR-RELAT CANCER, V6, P29, DOI 10.1677/erc.0.0060029; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Lee K, 2000, JNCI-J NATL CANCER I, V92, P1934, DOI 10.1093/jnci/92.23.1934; Mackey TJ, 1998, UROLOGY, V52, P1085, DOI 10.1016/S0090-4295(98)00360-4; Marechal R, 2010, CANCER-AM CANCER SOC, V116, P5200, DOI 10.1002/cncr.25303; Marechal R, 2009, CLIN CANCER RES, V15, P2913, DOI 10.1158/1078-0432.CCR-08-2080; Mariette C, 2004, BIOCHEM J, V377, P701, DOI 10.1042/BJ20031132; O'Reilly Eileen M, 2009, Gastrointest Cancer Res, V3, pS11; Oguri T, 2001, INT J CANCER, V93, P584, DOI 10.1002/ijc.1369; Ohishi Y, 2002, CLIN CANCER RES, V8, P3767; Piessen G, 2007, BIOCHEM J, V402, P81, DOI 10.1042/BJ20061461; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Theile D, 2009, BIOCHEM PHARMACOL, V78, P1366, DOI 10.1016/j.bcp.2009.07.006; Tian Q, 2005, PHARM RES-DORDR, V22, P1837, DOI 10.1007/s11095-005-7595-z; van der Sluis M, 2004, BIOCHEM BIOPH RES CO, V325, P952, DOI 10.1016/j.bbrc.2004.10.108; Van Seuningen I, 2000, BIOCHEM J, V348, P675; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Wang WX, 1999, CLIN CANCER RES, V5, P119; Workman HC, 2009, CANCER RES, V69, P2845, DOI 10.1158/0008-5472.CAN-08-2089	49	111	112	2	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2013	32	13					1714	1723		10.1038/onc.2012.179	http://dx.doi.org/10.1038/onc.2012.179			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22580602	Green Accepted, Green Submitted			2022-12-25	WOS:000316855800011
J	Amato, AA; Rajagopalan, S; Lin, JZ; Carvalho, BM; Figueira, ACM; Lu, J; Ayers, SD; Mottin, M; Silveira, RL; Souza, PCT; Mourao, RHV; Saad, MJA; Togashi, M; Simeoni, LA; Abdalla, DSP; Skaf, MS; Polikparpov, I; Lima, MCA; Galdino, SL; Brennan, RG; Baxter, JD; Pitta, IR; Webb, P; Phillips, KJ; Neves, FAR				Amato, Angelica A.; Rajagopalan, Senapathy; Lin, Jean Z.; Carvalho, Bruno M.; Figueira, Ana C. M.; Lu, Jenny; Ayers, Stephen D.; Mottin, Melina; Silveira, Rodrigo L.; Souza, Paulo C. T.; Mourao, Rosa H. V.; Saad, Mario J. A.; Togashi, Marie; Simeoni, Luiz A.; Abdalla, Dulcineia S. P.; Skaf, Munir S.; Polikparpov, Igor; Lima, Maria C. A.; Galdino, Suely L.; Brennan, Richard G.; Baxter, John D.; Pitta, Ivan R.; Webb, Paul; Phillips, Kevin J.; Neves, Francisco A. R.			GQ-16, a Novel Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Ligand, Promotes Insulin Sensitization without Weight Gain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MINERAL DENSITY; MOLECULAR-DYNAMICS; THIAZOLIDINEDIONE; ROSIGLITAZONE; OBESITY; SYSTEM; AGONIST	The recent discovery that peroxisome proliferator-activated receptor gamma (PPAR gamma) targeted anti-diabetic drugs function by inhibiting Cdk5-mediated phosphorylation of the receptor has provided a new viewpoint to evaluate and perhaps develop improved insulin-sensitizing agents. Herein we report the development of a novel thiazolidinedione that retains similar anti-diabetic efficacy as rosiglitazone in mice yet does not elicit weight gain or edema, common side effects associated with full PPAR gamma activation. Further characterization of this compound shows GQ-16 to be an effective inhibitor of Cdk5-mediated phosphorylation of PPAR gamma. The structure of GQ-16 bound to PPAR gamma demonstrates that the compound utilizes a binding mode distinct from other reported PPAR gamma ligands, although it does share some structural features with other partial agonists, such as MRL-24 and PA-082, that have similarly been reported to dissociate insulin sensitization from weight gain. Hydrogen/deuterium exchange studies reveal that GQ-16 strongly stabilizes the beta-sheet region of the receptor, presumably explaining the compound's efficacy in inhibiting Cdk5-mediated phosphorylation of Ser-273. Molecular dynamics simulations suggest that the partial agonist activity of GQ-16 results from the compound's weak ability to stabilize helix 12 in its active conformation. Our results suggest that the emerging model, whereby "ideal" PPAR gamma-based therapeutics stabilize the beta-sheet/Ser-273 region and inhibit Cdk5-mediated phosphorylation while minimally invoking adipogenesis and classical agonism, is indeed a valid framework to develop improved PPAR gamma modulators that retain antidiabetic actions while minimizing untoward effects.	[Rajagopalan, Senapathy; Lu, Jenny; Ayers, Stephen D.; Baxter, John D.; Webb, Paul; Phillips, Kevin J.] Methodist Hosp, Res Inst, Diabet Res Ctr, Houston, TX 77030 USA; [Amato, Angelica A.; Togashi, Marie; Simeoni, Luiz A.; Neves, Francisco A. R.] Univ Brasilia, Lab Farmacol Mol, Dept Ciencias Farmaceut, Fac Ciencias Saude, BR-70919970 Brasilia, DF, Brazil; [Lin, Jean Z.] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA; [Carvalho, Bruno M.; Saad, Mario J. A.] Univ Estadual Campinas, Dept Med Interna, BR-13083887 Sao Paulo, Brazil; [Figueira, Ana C. M.] Brazilian Assoc Synchrotron Light Technol, Natl Inst Biosci, BR-13083970 Sao Paulo, Brazil; [Mottin, Melina; Silveira, Rodrigo L.; Souza, Paulo C. T.; Skaf, Munir S.] Univ Estadual Campinas, Inst Chem, BR-13084862 Sao Paulo, Brazil; [Abdalla, Dulcineia S. P.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508900 Sao Paulo, Brazil; [Mourao, Rosa H. V.] Univ Fed Oeste Para, Lab Bioprospeccao & Biol Expt, BR-68040070 Santarem, Para, Brazil; [Lima, Maria C. A.; Galdino, Suely L.; Pitta, Ivan R.] Univ Fed Pernambuco, Dept Antibiot, BR-50670901 Recife, PE, Brazil; [Polikparpov, Igor] Univ Sao Paulo, BR-13560970 Sao Carlos, SP, Brazil; [Polikparpov, Igor] Inst Fis Sao Carlos, Dept Fis, BR-13560970 Sao Carlos, SP, Brazil; [Brennan, Richard G.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Universidade de Brasilia; University of Houston System; University of Houston; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal do Oeste do Para; Universidade Federal de Pernambuco; Universidade de Sao Paulo; Duke University	Phillips, KJ (corresponding author), Methodist Hosp, Res Inst, Diabet Res Ctr, 6535 Fannin, Houston, TX 77030 USA.	kphillips@tmhs.org; nevesfar@gmail.com	Togashi, Marie/L-3092-2018; Saad, Mario/ABD-8262-2020; Carvalho, Bruno/G-1255-2012; Simeoni, Luiz Alberto/A-9088-2008; Telles de Souza, Paulo Cesar/E-5072-2013; Skaf, Munir S/B-1614-2013; Ayers, Stephen D/O-4535-2014; Pitta, Ivan/C-9265-2014; Silveira, Rodrigo L/I-3961-2014; Amato, Angélica/B-9247-2015; Mottin, Melina/D-8700-2016; Figueira, Ana Carolina/X-1649-2019	Carvalho, Bruno/0000-0002-6792-0288; Simeoni, Luiz Alberto/0000-0003-3401-290X; Telles de Souza, Paulo Cesar/0000-0003-0660-1301; Skaf, Munir S/0000-0001-7485-1228; Ayers, Stephen D/0000-0003-1390-8969; Pitta, Ivan/0000-0002-2899-4049; Silveira, Rodrigo L/0000-0001-9515-3082; Amato, Angélica/0000-0002-8454-5504; Mottin, Melina/0000-0003-0878-9029; Figueira, Ana Carolina/0000-0002-7023-8490; Brennan, Richard/0000-0001-7647-485X	MCT/CNPq/CT-Infra/CT-Grant [620195/2008-8, 485811/2011-1]; Fundacao de Amparo a Pesquisa do Estado de Sao 598 Paulo (FAPESP) [2010/17048-8]; FAPESP [2010/08680-2, 2009/14108-2]; National Institutes of Health, NIGMS; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]	MCT/CNPq/CT-Infra/CT-Grant; Fundacao de Amparo a Pesquisa do Estado de Sao 598 Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE))	The Molecular Pharmacology Laboratory Group was supported by MCT/CNPq/CT-Infra/CT-Grant 620195/2008-8 and 485811/2011-1.; Supported by Fundacao de Amparo a Pesquisa do Estado de Sao 598 Paulo (FAPESP) Grant 2010/17048-8.; Supported by FAPESP Grant 2010/08680-2.; Supported by FAPESP Grant 2009/14108-2.; We thank Dr. Carlos Pantoja for invaluable assistance with the adipogenesis studies, Rilva Soares Pinho Grigorio for excellent technical assistance, and Eduardo J. Pilau and Fabio C. Gozzo of the Dalton Mass Spectrometry Group at UNICAMP for assistance with the HDX studies. The Berkeley Center for Structural Biology is supported in part by National Institutes of Health, NIGMS, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Acton JJ, 2005, BIOORG MED CHEM LETT, V15, P357, DOI 10.1016/j.bmcl.2004.10.068; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Leite LFCD, 2007, EUR J MED CHEM, V42, P1263, DOI 10.1016/j.ejmech.2007.02.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Figueira ACM, 2011, MOL ENDOCRINOL, V25, P15, DOI 10.1210/me.2010-0202; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Hansson A, 2011, INT J QUANTUM CHEM, V111, P1346, DOI 10.1002/qua.22638; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Leach A., 2001, MOL MODELLING PRINCI; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; Martinez L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-306; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Mourao RH, 2005, EUR J MED CHEM, V40, P1129, DOI 10.1016/j.ejmech.2005.06.002; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwartz AV, 2006, J CLIN ENDOCR METAB, V91, P3349, DOI 10.1210/jc.2005-2226; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Yaturu S, 2007, DIABETES CARE, V30, P1574, DOI 10.2337/dc06-2606; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102	45	85	90	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28169	28179		10.1074/jbc.M111.332106	http://dx.doi.org/10.1074/jbc.M111.332106			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22584573	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000307840700090
J	Sato, Y; Hatta, M; Karim, MF; Sawa, T; Wei, FY; Sato, S; Magnuson, MA; Gonzalez, FJ; Tomizawa, K; Akaike, T; Yoshizawa, T; Yamagata, K				Sato, Yoshifumi; Hatta, Mitsutoki; Karim, Md Fazlul; Sawa, Tomohiro; Wei, Fan-Yan; Sato, Shoki; Magnuson, Mark A.; Gonzalez, Frank J.; Tomizawa, Kazuhito; Akaike, Takaaki; Yoshizawa, Tatsuya; Yamagata, Kazuya			Anks4b, a Novel Target of HNF4 alpha Protein, Interacts with GRP78 Protein and Regulates Endoplasmic Reticulum Stress-induced Apoptosis in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR 4-ALPHA; HYPERINSULINEMIC HYPOGLYCEMIA; INSULIN-SECRETION; ALPHA-GENE; HEPATOCYTE; EXPRESSION; TRANSCRIPTION; MUTATIONS; YOUNG; SIGNALS	Mutations of the HNF4A gene cause a form of maturity-onset diabetes of the young (MODY1) that is characterized by impairment of pancreatic beta-cell function. HNF4 alpha is a transcription factor belonging to the nuclear receptor superfamily (NR2A1), but its target genes in pancreatic beta-cells are largely unknown. Here, we report that ankyrin repeat and sterile alpha motif domain containing 4b (Anks4b) is a target of HNF4 alpha in pancreatic beta-cells. Expression of Anks4b was decreased in both beta HNF4 alpha KO islets and HNF4 alpha knockdown MIN6 beta-cells, and HNF4 alpha activated Anks4b promoter activity. Anks4b bound to glucose-regulated protein 78 (GRP78), a major endoplasmic reticulum (ER) chaperone protein, and overexpression of Anks4b enhanced the ER stress response and ER stress-associated apoptosis of MIN6 cells. Conversely, suppression of Anks4b reduced beta-cell susceptibility to ER stress-induced apoptosis. These results indicate that Anks4b is a HNF4 alpha target gene that regulates ER stress in beta-cells by interacting with GRP78, thus suggesting that HNF4 alpha is involved in maintenance of the ER.	[Sato, Yoshifumi; Hatta, Mitsutoki; Karim, Md Fazlul; Sato, Shoki; Yoshizawa, Tatsuya; Yamagata, Kazuya] Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto 8608556, Japan; [Sawa, Tomohiro; Akaike, Takaaki] Kumamoto Univ, Fac Life Sci, Dept Microbiol, Kumamoto 8608556, Japan; [Sawa, Tomohiro] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 332001, Japan; [Wei, Fan-Yan; Tomizawa, Kazuhito] Kumamoto Univ, Fac Life Sci, Dept Mol Physiol, Kumamoto 8608556, Japan; [Magnuson, Mark A.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20814 USA	Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST); Kumamoto University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yamagata, K (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto 8608556, Japan.	k-yamaga@kumamoto-u.ac.jp	Magnuson, Mark/AAY-7172-2021; Sato, Yoshifumi/GYQ-7230-2022; Wei, Fan-Yan/AAD-8461-2021; Tomizawa, Kazuhito/F-2405-2015; Magnuson, Mark A/B-1335-2009	Magnuson, Mark/0000-0002-8824-6499; Tomizawa, Kazuhito/0000-0002-5663-2627; Magnuson, Mark A/0000-0002-8824-6499; Wei, Fan-Yan/0000-0002-4843-724X; Yoshizawa, Tatsuya/0000-0002-5728-1996; Sato, Yoshifumi/0000-0003-0697-1476	Ministry of Health Labour and Welfare; Takeda Science Foundation; Novo Nordisk Insulin Research Foundation; Banyu Life Science Foundation International; Japan Diabetes Foundation; International Priority Graduate Programs Advanced Graduate Courses for International Students, Ministry of Education, Culture, Sports, Science, and Technology in Japan; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23126521] Funding Source: KAKEN	Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novo Nordisk Insulin Research Foundation; Banyu Life Science Foundation International(Banyu Life Science Foundation International); Japan Diabetes Foundation; International Priority Graduate Programs Advanced Graduate Courses for International Students, Ministry of Education, Culture, Sports, Science, and Technology in Japan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research (B), a grant-in-aid for scientific research (S), a grant-in-aid for scientific research in innovative areas, a grant from the Ministry of Health Labour and Welfare, a grant from Takeda Science Foundation, a grant from Novo Nordisk Insulin Research Foundation, a grant from Banyu Life Science Foundation International, and a grant from Japan Diabetes Foundation.; Supported by a scholarship from the International Priority Graduate Programs Advanced Graduate Courses for International Students, Ministry of Education, Culture, Sports, Science, and Technology in Japan.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; [Anonymous], 2001, NUCL RECEPTORS GENET; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Boj SF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000970; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eeckhoute J, 2004, NUCLEIC ACIDS RES, V32, P2586, DOI 10.1093/nar/gkh581; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Ihara A, 2005, BIOCHEM BIOPH RES CO, V329, P984, DOI 10.1016/j.bbrc.2005.02.072; Johnston AM, 2004, GENES CELLS, V9, P967, DOI 10.1111/j.1365-2443.2004.00776.x; Kapoor RR, 2008, DIABETES, V57, P1659, DOI 10.2337/db07-1657; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Nammo T, 2008, GENE EXPR PATTERNS, V8, P96, DOI 10.1016/j.modgep.2007.09.006; Ozeki T, 2001, BIOCHEM J, V355, P537, DOI 10.1042/0264-6021:3550537; Pagny S, 1999, J EXP BOT, V50, P157, DOI 10.1093/jexbot/50.331.157; Pearson ER, 2007, PLOS MED, V4, P760, DOI 10.1371/journal.pmed.0040118; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yang Q, 2000, DIABETOLOGIA, V43, P520, DOI 10.1007/s001250051338; Zhang LH, 2010, J CELL BIOCHEM, V110, P1299, DOI 10.1002/jcb.22679	41	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23236	23245		10.1074/jbc.M112.368779	http://dx.doi.org/10.1074/jbc.M112.368779			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589549	Green Published, hybrid			2022-12-25	WOS:000306495000078
J	Christie, JM; Hitomi, K; Arvai, AS; Hartfield, KA; Mettlen, M; Pratt, AJ; Tainer, JA; Getzoff, ED				Christie, John M.; Hitomi, Kenichi; Arvai, Andrew S.; Hartfield, Kimberly A.; Mettlen, Marcel; Pratt, Ashley J.; Tainer, John A.; Getzoff, Elizabeth D.			Structural Tuning of the Fluorescent Protein iLOV for Improved Photostability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOACTIVE YELLOW PROTEIN; BLUE-LIGHT RECEPTOR; LOV2 DOMAIN; PHOTORECEPTOR PHOTOTROPIN; MUTATIONAL ANALYSIS; REPORTER PROTEINS; PHOTOCYCLE; OXYGEN; DIMERIZATION; CHROMOPHORE	Fluorescent proteins derived from light, oxygen, or voltage (LOV) domains offer advantages over green fluorescent protein (GFP) from their small size and efficacy under anaerobic conditions. The flavoprotein improved LOV (iLOV) was engineered from the blue light receptor phototropin as a reporter of viral infection. To inform the molecular basis for the improved, photoreversible, fluorescent properties of iLOV, we employed directed evolution and determined five LOV crystallographic structures. Comparative structural analyses between iLOV and its progenitors reveal mutation-induced constraints in the environment of the flavin mononucleotide (FMN) chromophore; in iLOV, the methyl group of Thr-394 "crowds" the FMN isoalloxazine ring, Leu-470 triggers side chain "flipping" of Leu-472, and the terminal FMN phosphate shows increased anchoring. We further engineered iLOV variants that are readily detectable in bacterial and mammalian cells due to order-of-magnitude photostability increases. Structure determination of a resulting representative photostable iLOV (phiLOV) variant reveals additional constraints on the chromophore. Aromatic residues Tyr-401 and Phe-485 in phiLOV sandwich the FMN isoalloxazine ring from both sides, whereas Ser-390 anchors the side chain of FMN-interacting Gln-489 Our combined structural and mutational results reveal that constraining the FMN fluorophore yields improved photochemical properties for iLOV and its new photostable derivative. These findings provide a framework for structural fine-tuning of LOV scaffold proteins to maximize their potential as oxygen-independent fluorescent reporters.	[Christie, John M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Christie, John M.; Hitomi, Kenichi; Arvai, Andrew S.; Hartfield, Kimberly A.; Pratt, Ashley J.; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Christie, John M.; Hitomi, Kenichi; Arvai, Andrew S.; Hartfield, Kimberly A.; Pratt, Ashley J.; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Mettlen, Marcel] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Hitomi, Kenichi; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hitomi, Kenichi] Natl Inst Biomed Innovat, Sect Lab Equipment, Osaka 5670085, Japan	University of Glasgow; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institute of Health Sciences - Japan	Christie, JM (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	john.christie@glasgow.ac.uk; edg@scripps.edu	Pratt, Ashley/A-1754-2012; Tainer, John/GWQ-4878-2022; Mettlen, Marcel B/A-2357-2011	Pratt, Ashley/0000-0002-9702-8805; Tainer, John/0000-0003-1659-2429; Mettlen, Marcel B/0000-0001-7047-2749; Christie, John/0000-0002-9976-0055; , ENIGMA/0000-0002-0894-2831	Royal Society University Research Fellowship; National Institutes of Health [GM37684]; Skaggs Institute for Chemical Biology; United States Department of Energy (DOE) [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684] Funding Source: NIH RePORTER	Royal Society University Research Fellowship(Royal Society of London); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; United States Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the award of a Royal Society University Research Fellowship (to J. M. C.), National Institutes of Health Grant GM37684 (to E. D. G.), and a grant from the Skaggs Institute for Chemical Biology (to K. H.).; We are very grateful to Sandra Schmid for providing cell culture and imaging facilities. The SIBYLS beamline facilities at the Advanced Light Source of Lawrence Berkeley National Laboratory are supported in part by the United States Department of Energy (DOE) program Integrated Diffraction Analysis Technologies under Contract DE-AC02-05CH11231, with John Tainer's effort on anaerobic tags by DOE program ENIGMA. We also thank Hideki Kandori and Tatsuya Iwata for helpful discussions and Chiharu Hitomi for technical assistance.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BACA M, 1994, BIOCHEMISTRY-US, V33, P14369, DOI 10.1021/bi00252a001; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Eisenreich W, 2009, BIOCHEM SOC T, V37, P382, DOI 10.1042/BST0370382; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Genick UK, 1998, NATURE, V392, P206, DOI 10.1038/32462; Iwata T, 2005, BIOCHEMISTRY-US, V44, P7427, DOI 10.1021/bi047281y; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kay CWM, 2003, J BIOL CHEM, V278, P10973, DOI 10.1074/jbc.M205509200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pathak GP, 2009, ENVIRON MICROBIOL, V11, P2388, DOI 10.1111/j.1462-2920.2009.01967.x; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2004, FEBS LETT, V572, P8, DOI 10.1016/j.febslet.2004.06.081; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tielker D, 2009, EUKARYOT CELL, V8, P913, DOI 10.1128/EC.00394-08; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto A, 2008, BIOCHEMISTRY-US, V47, P922, DOI 10.1021/bi701851v	39	110	113	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22295	22304		10.1074/jbc.M111.318881	http://dx.doi.org/10.1074/jbc.M111.318881			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573334	Green Published, hybrid			2022-12-25	WOS:000306418600067
J	Sugitani, H; Hirano, E; Knutsen, RH; Shifren, A; Wagenseil, JE; Ciliberto, C; Kozel, BA; Urban, Z; Davis, EC; Broekelmann, TJ; Mecham, RP				Sugitani, Hideki; Hirano, Eiichi; Knutsen, Russell H.; Shifren, Adrian; Wagenseil, Jessica E.; Ciliberto, Christopher; Kozel, Beth A.; Urban, Zsolt; Davis, Elaine C.; Broekelmann, Thomas J.; Mecham, Robert P.			Alternative Splicing and Tissue-specific Elastin Misassembly Act as Biological Modifiers of Human Elastin Gene Frameshift Mutations Associated with Dominant Cutis Laxa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL ARTIFICIAL CHROMOSOMES; MESSENGER-RNA; POINT MUTATIONS; FIBER FORMATION; TROPOELASTIN; DISEASE; FIBULIN-4; IDENTIFICATION; MECHANISMS; DEPOSITION	Elastin is the extracellular matrix protein in vertebrates that provides elastic recoil to blood vessels, the lung, and skin. Because the elastin gene has undergone significant changes in the primate lineage, modeling elastin diseases in non-human animals can be problematic. To investigate the pathophysiology underlying a class of elastin gene mutations leading to autosomal dominant cutis laxa, we engineered a cutis laxa mutation (single base deletion) into the human elastin gene contained in a bacterial artificial chromosome. When expressed as a transgene in mice, mutant elastin was incorporated into elastic fibers in the skin and lung with adverse effects on tissue function. In contrast, only low levels of mutant protein incorporated into aortic elastin, which explains why the vasculature is relatively unaffected in this disease. RNA stability studies found that alternative exon splicing acts as a modifier of disease severity by influencing the spectrum of mutant transcripts that survive nonsense-mediated decay. Our results confirm the critical role of the C-terminal region of tropoelastin in elastic fiber assembly and suggest tissue-specific differences in the elastin assembly pathway.	[Sugitani, Hideki; Hirano, Eiichi; Knutsen, Russell H.; Shifren, Adrian; Ciliberto, Christopher; Broekelmann, Thomas J.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Wagenseil, Jessica E.] St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA; [Kozel, Beth A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Urban, Zsolt] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Davis, Elaine C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3Z 1J4, Canada	Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McGill University	Mecham, RP (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	bmecham@wustl.edu	Kozel, Beth/AAP-9177-2020; Urban, Zsolt/A-2018-2013; Wagenseil, Jessica/C-2801-2014	Kozel, Beth/0000-0002-9757-7118; Urban, Zsolt/0000-0003-3890-1843; Wagenseil, Jessica/0000-0001-7972-448X	National Institutes of Health [HL53325, HL74138, HL105314, HL084922, K12 HL089968, HL087563]; Canadian Institutes of Heath Research Grant [MOP86713]; National Marfan Foundation; Grant National Institutes of Health [HL29594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090648, K12HL089968, R01HL053325, R01HL074138, P01HL029594, P50HL084922, R37HL053325, R00HL087563, R01HL105314, K99HL087563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Heath Research Grant(Canadian Institutes of Health Research (CIHR)); National Marfan Foundation; Grant National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL53325, HL74138, HL105314, and HL084922 (to R. P. M.), K12 HL089968 (to A. S.), and HL087563 (to J. E. W.). This work was also by Canadian Institutes of Heath Research Grant MOP86713 (to E. C. D.) and by a grant from the National Marfan Foundation (to R. P. M.).; We thank Ron McCarthy of the Washington University Pulmonary Mouse Core (supported by Grant National Institutes of Health Grant HL29594) for oocyte injection and production of the hBAC<SUP>CL</SUP> mice. We also thank Terese Hall for administrative support.	BARRINEAU LL, 1981, DEV BIOL, V87, P46, DOI 10.1016/0012-1606(81)90059-2; BAULE VJ, 1988, BIOCHEM BIOPH RES CO, V154, P1054, DOI 10.1016/0006-291X(88)90247-1; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Callewaert B, 2011, HUM MUTAT, V32, P445, DOI 10.1002/humu.21462; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Claus S, 2008, J INVEST DERMATOL, V128, P1442, DOI 10.1038/sj.jid.5701211; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; COWEN T, 1985, HISTOCHEMISTRY, V82, P205, DOI 10.1007/BF00501396; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; DAMKIER A, 1991, CLIN GENET, V39, P321; Dasouki M, 2007, AM J MED GENET A, V143A, P2635, DOI 10.1002/ajmg.a.31980; DAVIS EC, 1993, LAB INVEST, V68, P89; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; FOSTER JA, 1990, AM J PHYSIOL, V259, pL13, DOI 10.1152/ajplung.1990.259.2.L13; Graul-Neumann LM, 2008, AM J MED GENET A, V146A, P977, DOI 10.1002/ajmg.a.32242; HEIM RA, 1991, MATRIX, V11, P359, DOI 10.1016/S0934-8832(11)80207-6; Hirano E, 2007, CIRC RES, V101, P523, DOI 10.1161/CIRCRESAHA.107.153510; Hsiao H, 1999, CONNECT TISSUE RES, V40, P83, DOI 10.3109/03008209909029104; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Hu QR, 2010, MATRIX BIOL, V29, P621, DOI 10.1016/j.matbio.2010.06.005; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; INDIK Z, 1987, CONNECT TISSUE RES, V16, P197, DOI 10.3109/03008208709006976; Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Kozel BA, 2011, BIOL EXTRACELL MATR, P267, DOI 10.1007/978-3-642-16555-9_8; Lalioti MD, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e14; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; LIEM KF, 1988, AM ZOOL, V28, P739; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Muyrers JPP, 2000, EMBO REP, V1, P239, DOI 10.1093/embo-reports/kvd049; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; OLSON TM, 1995, HUM MOL GENET, V4, P1677, DOI 10.1093/hmg/4.9.1677; Pedersen L, 2003, SKIN RES TECHNOL, V9, P111, DOI 10.1034/j.1600-0846.2003.00021.x; Pober BR, 2008, J CLIN INVEST, V118, P1606, DOI 10.1172/JCI35309; Rodriguez-Revenga L, 2004, ARCH DERMATOL, V140, P1135, DOI 10.1001/archderm.140.9.1135; Shifren A, 2007, AM J PHYSIOL-LUNG C, V292, pL778, DOI 10.1152/ajplung.00352.2006; Szabo Z, 2006, J MED GENET, V43, P255, DOI 10.1136/jmg.2005.034157; Szabo Z, 1999, J MOL EVOL, V49, P664, DOI 10.1007/PL00006587; Tassabehji M, 1998, HUM MOL GENET, V7, P1021, DOI 10.1093/hmg/7.6.1021; Urban Z, 2000, HUM GENET, V106, P577, DOI 10.1007/s004390050028; Urban Z, 2005, J INVEST DERMATOL, V124, P1193, DOI 10.1111/j.0022-202X.2005.23758.x; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Wagenseil JE, 2005, AM J PHYSIOL-HEART C, V289, pH1209, DOI 10.1152/ajpheart.00046.2005; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WRENN DS, 1987, J BIOL CHEM, V262, P2244; YEH H, 1989, BIOCHEMISTRY-US, V28, P2365, DOI 10.1021/bi00432a003; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	51	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22055	22067		10.1074/jbc.M111.327940	http://dx.doi.org/10.1074/jbc.M111.327940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573328	hybrid, Green Published			2022-12-25	WOS:000306418600043
J	Hammouda, A; Selmi, S; Pearce-Duvet, J; Chokri, MA; Arnal, A; Gauthier-Clerc, M; Boulinier, T				Hammouda, Abdessalem; Selmi, Slaheddine; Pearce-Duvet, Jessica; Chokri, Mohamed Ali; Arnal, Audrey; Gauthier-Clerc, Michel; Boulinier, Thierry			Maternal Antibody Transmission in Relation to Mother Fluctuating Asymmetry in a Long-Lived Colonial Seabird: The Yellow-Legged Gull Larus michahellis	PLOS ONE			English	Article							BURGDORFERI-SENSU-LATO; IMMUNE-RESPONSE; TESTOSTERONE; YOLK; QUALITY; GROWTH; COSTS; BIRD; MECHANISM; ECOLOGY	Female birds transfer antibodies to their offspring via the egg yolk, thus possibly providing passive immunity against infectious diseases to which hatchlings may be exposed, thereby affecting their fitness. It is nonetheless unclear whether the amount of maternal antibodies transmitted into egg yolks varies with female quality and egg laying order. In this paper, we investigated the transfer of maternal antibodies against type A influenza viruses (anti-AIV antibodies) by a long-lived colonial seabird, the yellow-legged gull (Larus michahellis), in relation to fluctuating asymmetry in females, i.e. the random deviation from perfect symmetry in bilaterally symmetric morphological and anatomical traits. In particular, we tested whether females with greater asymmetry transmitted fewer antibodies to their eggs, and whether within-clutch variation in yolk antibodies varied according to the maternal level of fluctuating asymmetry. We found that asymmetric females were in worse physical condition, produced fewer antibodies, and transmitted lower amounts of antibodies to their eggs. We also found that, within a given clutch, yolk antibody level decreased with egg laying order, but this laying order effect was more pronounced in clutches laid by the more asymmetric females. Overall, our results support the hypothesis that maternal quality interacts with egg laying order in determining the amount of maternal antibodies transmitted to the yolks. They also highlight the usefulness of fluctuating asymmetry as a sensitive indicator of female quality and immunocompetence in birds.	[Hammouda, Abdessalem; Selmi, Slaheddine; Chokri, Mohamed Ali] UR, Fac Sci Gabes, Dept Sci Vie, UR11ES86, Gabes, Tunisia; [Pearce-Duvet, Jessica; Arnal, Audrey; Boulinier, Thierry] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Gauthier-Clerc, Michel] Ctr Rech Tour Valat, Arles, France	Universite de Gabes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Hammouda, A (corresponding author), UR, Fac Sci Gabes, Dept Sci Vie, UR11ES86, Gabes, Tunisia.	h_abdesslem@yahoo.fr	arnal, audrey/ABR-6358-2022; Slaheddine, Selmi/AAD-1495-2021	Slaheddine, Selmi/0000-0002-7204-9159; HAMMOUDA, Abdessalem/0000-0003-4078-7592; BOULINIER, Thierry/0000-0002-5898-7667	Agence Inter-etablissements de Recherche pour le Developpement, France; Chateaubriand Postdoctoral Fellowship (France); National Science Foundation; CNRS (French National Centre for Scientific Research); ANR (French National Research Agency)	Agence Inter-etablissements de Recherche pour le Developpement, France; Chateaubriand Postdoctoral Fellowship (France); National Science Foundation(National Science Foundation (NSF)); CNRS (French National Centre for Scientific Research)(Centre National de la Recherche Scientifique (CNRS)); ANR (French National Research Agency)(French National Research Agency (ANR))	This work was supported by ARDIGRIP project (Agence Inter-etablissements de Recherche pour le Developpement, France), Chateaubriand Postdoctoral Fellowship (France), National Science Foundation (International Research Fellowship Program), CNRS (French National Centre for Scientific Research), and ANR (French National Research Agency; Evolutionary Ecology of the Maternal Transfer Antibodies grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat JA, 2007, ECOL RES, V22, P282, DOI 10.1007/s11284-006-0022-z; BALMFORD A, 1993, P ROY SOC B-BIOL SCI, V252, P245, DOI 10.1098/rspb.1993.0072; Blount JD, 2002, P ROY SOC B-BIOL SCI, V269, P29, DOI 10.1098/rspb.2001.1840; BOLTON M, 1993, CAN J ZOOL, V71, P273, DOI 10.1139/z93-039; Bosch M, 2000, J APPL ECOL, V37, P369, DOI 10.1046/j.1365-2664.2000.00501.x; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Brown CR, 2002, J EVOLUTION BIOL, V15, P1067, DOI 10.1046/j.1420-9101.2002.00474.x; Buechler K, 2002, J ANIM ECOL, V71, P247, DOI 10.1046/j.1365-2656.2002.00591.x; CRAMP S, 1998, BIRDS W PALEARCTIC C; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Fair JM, 1999, P ROY SOC B-BIOL SCI, V266, P1735, DOI 10.1098/rspb.1999.0840; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gasparini J, 2002, ECOL LETT, V5, P519, DOI 10.1046/j.1461-0248.2002.00345.x; Gasparini J, 2001, P ROY SOC B-BIOL SCI, V268, P647, DOI 10.1098/rspb.2000.1411; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Grindstaff JL, 2008, J EXP BIOL, V211, P654, DOI 10.1242/jeb.012344; Grindstaff JL, 2005, J ANIM ECOL, V74, P1051, DOI 10.1111/j.1365-2656.2005.01002.x; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Hargitai R, 2006, FUNCT ECOL, V20, P829, DOI 10.1111/j.1365-2435.2006.01171.x; HARRIS M. P., 1964, IBIS, V106, P432, DOI 10.1111/j.1474-919X.1964.tb03725.x; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; Heeb P, 1998, P ROY SOC B-BIOL SCI, V265, P51, DOI 10.1098/rspb.1998.0263; Hoi-Leitner M, 2001, BEHAV ECOL SOCIOBIOL, V49, P333, DOI 10.1007/s002650000310; Isenmann P, 2005, OISEAUX TUNISIE; Klasing K.C., 1999, OSTRICH, V69, P32; Klasing KC, 1998, POULTRY SCI, V77, P1119, DOI 10.1093/ps/77.8.1119; Lipar JL, 1999, AUK, V116, P231, DOI 10.2307/4089471; Mateos C, 2008, ANIM BEHAV, V75, P1629, DOI 10.1016/j.anbehav.2007.10.016; MOHAMMED HO, 1986, AVIAN DIS, V30, P398, DOI 10.2307/1590547; Moller A.P., 1997, DEV STABILITY EVOLUT; Moller AP, 2006, INFECT GENET EVOL, V6, P133, DOI 10.1016/j.meegid.2005.03.005; Moller AP, 1999, J EVOLUTION BIOL, V12, P450; Muller W, 2004, FUNCT ECOL, V18, P719, DOI 10.1111/j.0269-8463.2004.00902.x; Oro D, 2007, ANIM CONSERV, V10, P117, DOI 10.1111/j.1469-1795.2006.00082.x; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; Polak M., 2003, CAUSES CONSEQUENCES; Potti J, 1999, OECOLOGIA, V120, P1, DOI 10.1007/s004420050826; Read AF, 2000, SCIENCE, V290, P1104, DOI 10.1126/science.290.5494.1104; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Sahin O, 2003, APPL ENVIRON MICROB, V69, P5372, DOI 10.1128/AEM.69.9.5372-5379.2003; Saino N, 2001, J EVOLUTION BIOL, V14, P95, DOI 10.1046/j.1420-9101.2001.00252.x; Saino N, 2008, PHYSIOL BIOCHEM ZOOL, V81, P211, DOI 10.1086/527454; SAS Statistical Institute, 1998, SAS STAT US GUID VER; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; SLAGSVOLD T, 1984, AUK, V101, P685, DOI 10.2307/4086895; SYDEMAN WJ, 1991, J ANIM ECOL, V60, P135, DOI 10.2307/5450; THOMAS ALR, 1993, P ROY SOC B-BIOL SCI, V254, P181, DOI 10.1098/rspb.1993.0144; Vidal E, 1998, BIODIVERS CONSERV, V7, P1013, DOI 10.1023/A:1008805030578; WATSON PJ, 1994, TRENDS ECOL EVOL, V9, P21, DOI 10.1016/0169-5347(94)90227-5	54	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e34966	10.1371/journal.pone.0034966	http://dx.doi.org/10.1371/journal.pone.0034966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590497	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336100003
J	Lin, C; Zhao, XY; Li, L; Liu, HY; Cao, K; Wan, Y; Liu, XY; Nie, CL; Liu, L; Tong, AP; Deng, HX; Li, J; Yuan, Z; Wei, YQ				Lin, Chao; Zhao, Xin-Yu; Li, Lei; Liu, Huan-Yi; Cao, Kang; Wan, Yang; Liu, Xin-Yu; Nie, Chun-Lai; Liu, Lei; Tong, Ai-Ping; Deng, Hong-Xin; Li, Jiong; Yuan, Zhu; Wei, Yu-Quan			NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin	PLOS ONE			English	Article							BCL-X-L; INDUCED APOPTOSIS; CARCINOMA CELLS; DOWN-REGULATION; BH3-ONLY MEMBER; TUMOR-GROWTH; P53 STATUS; IN-VIVO; DEATH; GENE	Ovarian cancer is the most common cause of death from gynecologic malignancy. Deregulation of p53 and/or p73-associated apoptotic pathways contribute to the platinum-based resistance in ovarian cancer. NOXA, a pro-apoptotic BH3-only protein, is identified as a transcription target of p53 and/or p73. In this study, we found that genetic variants of Bcl-2 proteins exist among cisplatin-sensitive and -resistant ovarian cancer cells, and the responses of NOXA and Bax to cisplatin are regulated mainly by p53. We further evaluated the effect of NOXA on cisplatin. NOXA induced apoptosis and sensitized A2780s and SKOV3 cells to cisplatin in vitro and in vivo. The effects were mediated by elevated Bax expression, enhanced caspase activation, release of Cyt C and Smac into the cytosol. Furthermore, gene silencing of Bax or Smac significantly attenuated NOXA and/or cisplatin-induced apoptosis in chemosensitive A2780s cells, whereas overexpression of Bax or addition of Smac-N7 peptide significantly increased NOXA and/or cisplatin-induced apoptosis in chemoresistant SKOV3 cells. To our knowledge, these data suggest a new mechanism by which NOXA chemosensitized ovarian cancer cells to cisplatin by inducing alterations in the Bax/Smac axis. Taken together, our findings show that NOXA is potentially useful as a chemosensitizer in ovarian cancer therapy.	[Lin, Chao; Zhao, Xin-Yu; Li, Lei; Wan, Yang; Liu, Xin-Yu; Nie, Chun-Lai; Liu, Lei; Tong, Ai-Ping; Deng, Hong-Xin; Li, Jiong; Yuan, Zhu; Wei, Yu-Quan] Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610064, Peoples R China; [Liu, Huan-Yi] Chengdu Mil Gen Hosp, Ctr Canc, Chengdu, Peoples R China; [Cao, Kang] Chengdu Med Coll, Dept Pathogen Biol, Chengdu, Peoples R China	Sichuan University; Chengdu Medical College	Lin, C (corresponding author), Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610064, Peoples R China.	niecl1022@scu.edu.cn; yuanzhujyx@gmail.com; niecl1022@scu.edu.cn	Li, Li/AEM-3636-2022; li, li/HII-4157-2022; Cao, Kang/AAV-1997-2020; LI, LI/GVS-5344-2022		National Key Basic Research Program of China [2010CB529900]; Natural Science Foundation of China [30900744, 81071817/H1609, 81001010]	National Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (2010CB529900) and Natural Science Foundation of China (30900744; 81071817/H1609; 81001010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Asselin E, 2001, CANCER RES, V61, P1862; Blezinger P, 1999, NAT BIOTECHNOL, V17, P343, DOI 10.1038/7895; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Debernardis D, 1997, CANCER RES, V57, P870; DeFeudis P, 1997, BRIT J CANCER, V76, P474, DOI 10.1038/bjc.1997.412; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Dodier P, 2006, GYNECOL ONCOL, V100, P254, DOI 10.1016/j.ygyno.2005.08.028; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Gallardo D, 1996, CANCER RES, V56, P4891; Hassan M, 2008, ONCOGENE, V27, P4557, DOI 10.1038/onc.2008.90; Henkels KM, 1999, CANCER RES, V59, P3077; Hu WB, 2012, J BIOL CHEM, V287, P68, DOI 10.1074/jbc.M111.271205; Ibrahim N, 2010, CANCER RES, V70, P7155, DOI 10.1158/0008-5472.CAN-10-0668; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kassim SK, 1999, CLIN BIOCHEM, V32, P333, DOI 10.1016/S0009-9120(99)00026-0; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu JR, 1998, GYNECOL ONCOL, V70, P398, DOI 10.1006/gyno.1998.5125; Muscolini M, 2008, MOL CANCER THER, V7, P1410, DOI 10.1158/1535-7163.MCT-08-0299; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Perego P, 1996, CANCER RES, V56, P556; Reles A, 2001, CLIN CANCER RES, V7, P2984; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; Salzberg M, 2005, ONCOLOGY-BASEL, V68, P293, DOI 10.1159/000086967; Sasaki H, 2000, CANCER RES, V60, P5659; Sauter BV, 2000, P NATL ACAD SCI USA, V97, P4802, DOI 10.1073/pnas.090065597; Seo YW, 2003, J BIOL CHEM, V278, P48292, DOI 10.1074/jbc.M308785200; Simonin K, 2009, MOL CANCER THER, V8, P3162, DOI 10.1158/1535-7163.MCT-09-0493; Suzuki S, 2009, CANCER SCI, V100, P759, DOI 10.1111/j.1349-7006.2009.01096.x; Villedieu M, 2007, GYNECOL ONCOL, V105, P31, DOI 10.1016/j.ygyno.2006.12.011; WEI YQ, 1994, CANCER RES, V54, P4952; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yu J, 2004, CURR OPIN ONCOL, V16, P19, DOI 10.1097/00001622-200401000-00005; Yuan Z, 2009, CANCER SCI, V100, P1757, DOI 10.1111/j.1349-7006.2009.01242.x; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	44	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36722	10.1371/journal.pone.0036722	http://dx.doi.org/10.1371/journal.pone.0036722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590594	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336100055
J	Fontela, PS; Quach, C; Buckeridge, D; Pai, M; Platt, RW				Fontela, Patricia S.; Quach, Caroline; Buckeridge, David; Pai, Madukhar; Platt, Robert W.			Surveillance Length and Validity of Benchmarks for Central Line-Associated Bloodstream Infection Incidence Rates in Intensive Care Units	PLOS ONE			English	Article							NETWORK NHSN REPORT; SYSTEM; NETHERLANDS; HOSPITALS	Introduction: Several national and regional central line-associated bloodstream infections (CLABSI) surveillance programs do not require continuous hospital participation. We evaluated the effect of different hospital participation requirements on the validity of annual CLABSI incidence rate benchmarks for intensive care units (ICUs). Methods: We estimated the annual pooled CLABSI incidence rates for both a real regional (< 100 ICUs) and a simulated national (600 ICUs) surveillance program, which were used as a reference for the simulations. We simulated scenarios where the annual surveillance participation was randomly or non-randomly reduced. Each scenario's annual pooled CLABSI incidence rate was estimated and compared to the reference rates in terms of validity, bias, and proportion of simulation iterations that presented valid estimates (ideal if >= 90%). Results: All random scenarios generated valid CLABSI incidence rates estimates (bias -0.37 to 0.07 CLABSI/1000 CVC-days), while non-random scenarios presented a wide range of valid estimates (0 to 100%) and higher bias (-22.18 to 1.27 CLABSI/1000 CVC-days). In random scenarios, the higher the number of participating ICUs, the shorter the participation required to generate >= 90% valid replicates. While participation requirements in a countrywide program ranged from 3 to 13 surveillance blocks (1 block = 28 days), requirements for a regional program ranged from 9 to 13 blocks. Conclusions: Based on the results of our model of national CLABSI reporting, the shortening of participation requirements may be suitable for nationwide ICU CLABSI surveillance programs if participation months are randomly chosen. However, our regional models showed that regional programs should opt for continuous participation to avoid biased benchmarks.	[Fontela, Patricia S.; Quach, Caroline; Buckeridge, David; Pai, Madukhar; Platt, Robert W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Fontela, Patricia S.; Quach, Caroline; Platt, Robert W.] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University	Fontela, PS (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	robert.platt@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021; Fontela, Patricia/S-6455-2019; Quach, Caroline/AAT-6987-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Quach, Caroline/0000-0002-1170-9475; Platt, Robert/0000-0002-5981-8443				Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Coello R, 2001, INFECT CONT HOSP EP, V22, P393, DOI 10.1086/501923; Cooke EM, 2000, J HOSP INFECT, V46, P1, DOI 10.1053/jhin.2000.0801; Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Fontela PS, 2011, AM J INFECT CONTROL, V39, P329, DOI 10.1016/j.ajic.2010.07.007; Geubbels ELPE, 2000, INFECT CONT HOSP EP, V21, P311, DOI 10.1086/501762; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; McKibben L, 2005, INFECT CONT HOSP EP, V26, P580, DOI 10.1086/502585; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Perla RJ, 2009, AM J INFECT CONTROL, V37, P615, DOI 10.1016/j.ajic.2009.03.003; Quach C, 2006, RAPPORT SURVEILLANCE; Quach C, 2005, RAPPORT SURVEILLANCE; Quach C, 2007, RAPPORT SURVEILLANCE; Richards C, 2001, AM J INFECT CONTROL, V29, P400, DOI 10.1067/mic.2001.118408; Robert J, 2000, INFECT CONT HOSP EP, V21, P12, DOI 10.1086/501690; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; WENZEL RP, 1983, INFECT CONT HOSP EP, V4, P371, DOI 10.1017/S0195941700059774	22	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36582	10.1371/journal.pone.0036582	http://dx.doi.org/10.1371/journal.pone.0036582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586480	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335000041
J	Ferguson, BW; Gao, XS; Kil, H; Lee, JH; Benavides, F; Abba, MC; Aldaz, CM				Ferguson, Brent W.; Gao, Xinsheng; Kil, Hyunsuk; Lee, Jaeho; Benavides, Fernando; Abba, Martin C.; Aldaz, C. Marcelo			Conditional Wwox Deletion in Mouse Mammary Gland by Means of Two Cre Recombinase Approaches	PLOS ONE			English	Article							CHROMOSOMAL FRAGILE SITE; TUMOR-SUPPRESSOR PROTEIN; GENE-EXPRESSION; BREAST-CANCER; TGF-BETA; WNT5A; FRA16D; TUMORIGENICITY; BIOINFORMATICS; IDENTIFICATION	Loss of WWOX expression has been reported in many different cancers including breast cancer. Elucidating the function of this gene in adult tissues has not been possible with full Wwox knockout models. Here we characterize the first conditional models of Wwox ablation in mouse mammary epithelium utilizing two transgenic lines expressing Cre recombinase, keratin 5-Cre (BK5-Cre) and MMTV-Cre. In the BK5-Cre model we observed very efficient Wwox ablation in KO mammary glands. However, BK5-Cre Wwox KO animals die prematurely for unknown reasons. In the MMTV-Cre model we observed significant ablation of Wwox in mammary epithelium with no effect on survival. In both of these models we found that Wwox deletion resulted in impaired mammary branching morphogenesis. We demonstrate that loss of Wwox is not carcinogenic in our KO models. Furthermore, no evidence of increase proliferation or development of premalignant lesions was observed. In none of the models did loss of a single Wwox allele (i.e. haploinsufficiency) have any observable phenotypic effect in mammary gland. To better understand the function of Wwox in the mammary gland, transcriptome profiling was performed. We observed that Wwox ablation results in the deregulation of genes involved in various cellular processes. We found that expression of the non-canonical Wnt ligand, Wnt5a, was significantly upregulated in Wwox KO mammary epithelium. Interestingly, we also determined that components of the Jak/Stat3 signaling pathway were upregulated in KO mice and this correlated with a very robust increase in phospho-Stat3 signaling, which warrants further testing. Even though the loss of Wwox expression in breast and other cancers is very well documented, our findings suggest that Wwox does not act as a classical tumor suppressor as previously thought.	[Ferguson, Brent W.; Gao, Xinsheng; Kil, Hyunsuk; Lee, Jaeho; Benavides, Fernando; Aldaz, C. Marcelo] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Abba, Martin C.] Univ Nacl La Plata, Fac Med, CINIBA, La Plata, Buenos Aires, Argentina	University of Texas System; UTMD Anderson Cancer Center; National University of La Plata	Ferguson, BW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA.	maaldaz@mdanderson.org	Aldaz, C. Marcelo/E-7868-2011	Aldaz, C. Marcelo/0000-0002-2453-2939; Abba, Martin/0000-0002-9206-2369; Benavides, Fernando/0000-0003-1275-4320	National Institutes of Health/National Cancer Institute [R01 CA102444-6]; National Institute of Environmental Health Sciences (NIEHS) Center for Research on Environmental Disease [ES007784]; Cancer Center Support Grant [CA016672]; Research Training in Carcinogenesis and Mutagenesis [T32CA009480]; NATIONAL CANCER INSTITUTE [T32CA009480, R01CA102444, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences (NIEHS) Center for Research on Environmental Disease; Cancer Center Support Grant; Research Training in Carcinogenesis and Mutagenesis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Health/National Cancer Institute (grant number R01 CA102444-6; http://cancer.gov/) to CMA; the National Institute of Environmental Health Sciences (NIEHS) Center for Research on Environmental Disease (grant number ES007784; http://cred.mdanderson.org/); a Cancer Center Support Grant (grant number CA016672; http://cancer.gov/); and Research Training in Carcinogenesis and Mutagenesis (grant number T32CA009480; http://cancer.gov/) to BWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen SK, 2011, ONCOGENE, V30, P3900, DOI 10.1038/onc.2011.115; Aldaz CM, 2002, ONCOGENE, V21, P6366, DOI 10.1038/sj.onc.1205816; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, CANCER RES, V67, P5606, DOI 10.1158/0008-5472.CAN-07-1081; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Aqeilian RI, 2007, CANCER RES, V67, P9330, DOI 10.1158/0008-5472.CAN-07-2147; Bednarek AK, 2000, CANCER RES, V60, P2140; Bednarek AK, 2001, CANCER RES, V61, P8068; Bouteille N, 2009, ONCOGENE, V28, P2569, DOI 10.1038/onc.2009.120; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; DEOME KB, 1959, CANCER RES, V19, P515; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gourley C, 2009, CANCER RES, V69, P4835, DOI 10.1158/0008-5472.CAN-08-2974; Guler G, 2005, PATHOL INT, V55, P471, DOI 10.1111/j.1440-1827.2005.01855.x; Guler G, 2009, CANCER-AM CANCER SOC, V115, P899, DOI 10.1002/cncr.24103; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Katoh M, 2007, INT J MOL MED, V19, P273; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Krummel KA, 2000, GENOMICS, V69, P37, DOI 10.1006/geno.2000.6321; Krummel KA, 2002, GENE CHROMOSOME CANC, V34, P154, DOI 10.1002/gcc.10047; Kurek KC, 2010, CANCER RES, V70, P5577, DOI 10.1158/0008-5472.CAN-09-4602; Lewandowska U, 2009, J PHYSIOL PHARMACOL, V60, P47; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Ludes-Meyers JH, 2003, CYTOGENET GENOME RES, V100, P101, DOI 10.1159/000072844; Ludes-Meyers JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007775; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; McCall KD, 2007, ENDOCRINOLOGY, V148, P4226, DOI 10.1210/en.2007-0459; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nunez M, 2005, BREAST CANCER RES TR, V89, P99, DOI 10.1007/s10549-004-1474-x; Pensa S, 2009, J MAMMARY GLAND BIOL, V14, P121, DOI 10.1007/s10911-009-9124-x; Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Ramos D, 2006, ADV EXP MED BIOL, V587, P149; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496	48	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36618	10.1371/journal.pone.0036618	http://dx.doi.org/10.1371/journal.pone.0036618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574198	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800095
J	Gao, C; Jiang, TY; Dou, PP; Ma, CQ; Li, LX; Kong, J; Xu, P				Gao, Chao; Jiang, Tianyi; Dou, Peipei; Ma, Cuiqing; Li, Lixiang; Kong, Jian; Xu, Ping			NAD-Independent L-Lactate Dehydrogenase Is Required for L-Lactate Utilization in Pseudomonas stutzeri SDM	PLOS ONE			English	Article							BOUND L-LACTATE; CORYNEBACTERIUM-GLUTAMICUM; ESCHERICHIA-COLI; (S)-MANDELATE DEHYDROGENASE; NEISSERIA-GONORRHOEAE; SOLUBLE MUTANT; MEMBRANE; PURIFICATION; EXPRESSION; SEQUENCE	Background: Various Pseudomonas strains can use L-lactate as their sole carbon source for growth. However, the L-lactate-utilizing enzymes in Pseudomonas have never been identified and further studied. Methodology/Principal Findings: An NAD-independent L-lactate dehydrogenase (L-iLDH) was purified from the membrane fraction of Pseudomonas stutzeri SDM. The enzyme catalyzes the oxidation of L-lactate to pyruvate by using FMN as cofactor. After cloning its encoding gene (lldD), L-iLDH was successfully expressed, purified from a recombinant Escherichia coli strain, and characterized. An lldD mutant of P. stutzeri SDM was constructed by gene knockout technology. This mutant was unable to grow on L-lactate, but retained the ability to grow on pyruvate. Conclusions/Significance: It is proposed that L-iLDH plays an indispensable function in Pseudomonas L-lactate utilization by catalyzing the conversion of L-lactate into pyruvate.	[Gao, Chao; Jiang, Tianyi; Dou, Peipei; Ma, Cuiqing; Li, Lixiang; Kong, Jian; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Gao, Chao; Dou, Peipei; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Gao, Chao; Dou, Peipei; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, C (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	macq@sdu.edu.cn; pingxu@sjtu.edu.cn		Ma, Cuiqing/0000-0002-7468-1027; Gao, Chao/0000-0002-5205-0670	National Natural Science Foundation of China [31000014, 31070062]; Ministry of Science and Technology of China; National Basic Research Program of China [2007CB707803]; Research Fund for the Doctoral Program of Higher Education of China [20090131110036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The work was supported by the National Natural Science Foundation of China (31000014 and 31070062), and by the grants from the Ministry of Science and Technology of China, National Basic Research Program of China (2007CB707803), and the Research Fund for the Doctoral Program of Higher Education of China (Grant no. 20090131110036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATNAGAR RK, 1989, J GEN MICROBIOL, V135, P353; BLACK MT, 1989, BIOCHEM J, V258, P255, DOI 10.1042/bj2580255; BROWN PR, 1987, J GEN MICROBIOL, V133, P1521; Chapman SK, 1996, BIOCHEM SOC T, V24, P73, DOI 10.1042/bst0240073; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; Eppink MHM, 1997, J BACTERIOL, V179, P6680, DOI 10.1128/jb.179.21.6680-6687.1997; FU KS, 1989, INFECT IMMUN, V57, P2173, DOI 10.1128/IAI.57.7.2173-2178.1989; FUTAI M, 1977, J BIOL CHEM, V252, P5820; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Goffin P, 2004, J BACTERIOL, V186, P6661, DOI 10.1128/JB.186.19.6661-6666.2004; Hao JR, 2007, BIOTECHNOL LETT, V29, P105, DOI 10.1007/s10529-006-9204-6; Jasso-Chavez R, 2001, ARCH BIOCHEM BIOPHYS, V390, P295, DOI 10.1006/abbi.2001.2353; Jiang TY, 2012, J BACTERIOL, V194, P894, DOI 10.1128/JB.06478-11; Jimenez JI, 2008, P NATL ACAD SCI USA, V105, P11329, DOI 10.1073/pnas.0802273105; Kato O, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-321; KEMP MB, 1972, BIOCHEM J, V130, P307, DOI 10.1042/bj1300307; Kose M, 2004, TURKISH J PEDIATR, V46, P177; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; LE KHD, 1991, J BIOL CHEM, V266, P20877; Ma CQ, 2007, APPL MICROBIOL BIOT, V77, P91, DOI 10.1007/s00253-007-1132-4; MAEDAYORITA K, 1995, BIOCHIMIE, V77, P631, DOI 10.1016/0300-9084(96)88178-8; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MITRA B, 1993, BIOCHEMISTRY-US, V32, P12959, DOI 10.1021/bi00211a003; NAGEL M, 1990, ARCH MICROBIOL, V154, P605; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Neuner A, 2011, BIOTECHNOL J, V6, P318, DOI 10.1002/biot.201000307; OBRIEN RW, 1977, AUST J BIOL SCI, V30, P553, DOI 10.1071/BI9770553; Parsons NJ, 1996, MICROB PATHOGENESIS, V21, P193, DOI 10.1006/mpat.1996.0054; Rejman J, 2007, HUM GENE THER, V18, P642, DOI 10.1089/hum.2006.192; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schweizer HP, 2001, CURR OPIN BIOTECH, V12, P439, DOI 10.1016/S0958-1669(00)00242-1; Seki M, 2004, J BACTERIOL, V186, P2046, DOI 10.1128/JB.186.7.2046-2051.2004; Sharkey MA, 2011, ARCH MICROBIOL, V193, P731, DOI 10.1007/s00203-011-0711-z; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Smith H, 2001, INFECT IMMUN, V69, P6565, DOI 10.1128/IAI.69.11.6565-6572.2001; Stansen C, 2005, APPL ENVIRON MICROB, V71, P5920, DOI 10.1128/AEM.71.10.5920-5928.2005; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sukumar N, 2001, BIOCHEMISTRY-US, V40, P9870, DOI 10.1021/bi010938k; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSOU AY, 1990, BIOCHEMISTRY-US, V29, P9856, DOI 10.1021/bi00494a015; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; VOLOKITA M, 1987, J BIOL CHEM, V262, P15825; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M; Yates E, 2000, INT J MED MICROBIOL, V290, P627	46	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36519	10.1371/journal.pone.0036519	http://dx.doi.org/10.1371/journal.pone.0036519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574176	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349800073
J	Niemiec, MS; Weise, CF; Wittung-Stafshede, P				Niemiec, Moritz S.; Weise, Christoph F.; Wittung-Stafshede, Pernilla			In Vitro Thermodynamic Dissection of Human Copper Transfer from Chaperone to Target Protein	PLOS ONE			English	Article							WILSON-DISEASE PROTEIN; TRANSPORTING ATPASES; MENKES PROTEIN; CU(I) BINDING; ATOX1; COPZ; METALLOCHAPERONES; TRAFFICKING; DOMAIN-4; DYNAMICS	Transient protein-protein and protein-ligand interactions are fundamental components of biological activity. To understand biological activity, not only the structures of the involved proteins are important but also the energetics of the individual steps of a reaction. Here we use in vitro biophysical methods to deduce thermodynamic parameters of copper (Cu) transfer from the human copper chaperone Atox1 to the fourth metal-binding domain of the Wilson disease protein (WD4). Atox1 and WD4 have the same fold (ferredoxin-like fold) and Cu-binding site (two surface exposed cysteine residues) and thus it is not clear what drives metal transfer from one protein to the other. Cu transfer is a two-step reaction involving a metal-dependent ternary complex in which the metal is coordinated by cysteines from both proteins (i.e., Atox1-Cu-WD4). We employ size exclusion chromatography to estimate individual equilibrium constants for the two steps. This information together with calorimetric titration data are used to reveal enthalpic and entropic contributions of each step in the transfer process. Upon combining the equilibrium constants for both steps, a metal exchange factor (from Atox1 to WD4) of 10 is calculated, governed by a negative net enthalpy change of similar to 10 kJ/mol. Thus, small variations in interaction energies, not always obvious upon comparing protein structures alone, may fuel vectorial metal transfer.	[Niemiec, Moritz S.; Weise, Christoph F.; Wittung-Stafshede, Pernilla] Umea Univ, Dept Chem, Chem Biol Ctr, Umea, Sweden	Umea University	Niemiec, MS (corresponding author), Umea Univ, Dept Chem, Chem Biol Ctr, Umea, Sweden.	pernilla.wittung@chem.umu.se	wittung-stafshede, pernilla/AAV-4392-2021	wittung-stafshede, pernilla/0000-0003-1058-1964	Swedish Natural Research Council; Knut and Alice Wallenberg Foundation; Goran Gustafsson Foundation; Umea University	Swedish Natural Research Council(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Goran Gustafsson Foundation; Umea University	The Swedish Natural Research Council, the Knut and Alice Wallenberg Foundation, Goran Gustafsson Foundation, and Umea University provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Badarau A, J AM CHEM SOC, V133, P2983; Banci L, 2005, FEBS J, V272, P865, DOI 10.1111/j.1742-4658.2004.04526.x; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Banci L, 2009, BIOCHEM J, V422, P37, DOI 10.1042/BJ20090422; Banci L, 2009, J BIOL CHEM, V284, P9354, DOI 10.1074/jbc.M805981200; Festa R. A., CURR BIOL, V21, pR877; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Hansson H, 2001, FEBS LETT, V489, P67, DOI 10.1016/S0014-5793(00)02438-8; Harris ED, 2003, CRIT REV CL LAB SCI, V40, P547, DOI 10.1080/10408360390250649; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Hussain F, 2008, P NATL ACAD SCI USA, V105, P11158, DOI 10.1073/pnas.0802928105; Hussain F, 2009, J AM CHEM SOC, V131, P16371, DOI 10.1021/ja9058266; Kihlken MA, 2002, BIOCHEM J, V368, P729, DOI 10.1042/BJ20021036; Luke K, 2005, BIOPHYS J, V89, P3332, DOI 10.1529/biophysj.105.067223; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Multhaup G, 2001, BIOCHEM BIOPH RES CO, V288, P172, DOI 10.1006/bbrc.2001.5757; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; POUNTNEY DL, 1994, BIOCHEMISTRY-US, V33, P9699, DOI 10.1021/bi00198a040; PRESTA A, 1995, EUR J BIOCHEM, V227, P226, DOI 10.1111/j.1432-1033.1995.tb20380.x; Privalov PL, 1999, J MOL BIOL, V294, P997, DOI 10.1006/jmbi.1999.3285; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Robinson NJ, ANN REV BIOCH, V79, P537; Rodriguez-Granillo A, J PHYS CHEM B, V114, P3698; Rodriguez-Granillo A, 2008, J PHYS CHEM B, V112, P4583, DOI 10.1021/jp711787x; Rodriguez-Granillo A, 2009, BIOCHEMISTRY-US, V48, P5849, DOI 10.1021/bi900235g; Stillman M J, 1994, Met Based Drugs, V1, P375, DOI 10.1155/MBD.1994.375; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; Wernimont AK, 2004, J BIOL CHEM, V279, P12269, DOI 10.1074/jbc.M311213200; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Wittung-Stafshede P, 2004, INORG CHEM, V43, P7926, DOI 10.1021/ic049398g; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200	36	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36102	10.1371/journal.pone.0036102	http://dx.doi.org/10.1371/journal.pone.0036102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574136	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800032
J	Pau, E; Cheung, YH; Loh, C; Lajoie, G; Wither, JE				Pau, Evelyn; Cheung, Yui-Ho; Loh, Christina; Lajoie, Ginette; Wither, Joan E.			TLR Tolerance Reduces IFN-Alpha Production Despite Plasmacytoid Dendritic Cell Expansion and Anti-Nuclear Antibodies in NZB Bicongenic Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; I INTERFERON; B-CELL; IMMUNE-COMPLEXES; AUTOANTIBODY PRODUCTION; T-CELL; DISEASE; ACTIVATION; RESPONSES; STIMULATION	Genetic loci on New Zealand Black (NZB) chromosomes 1 and 13 play a significant role in the development of lupus-like autoimmune disease. We have previously shown that C57BL/6 (B6) congenic mice with homozygous NZB chromosome 1 (B6.NZBc1) or 13 (B6.NZBc13) intervals develop anti-nuclear antibodies and mild glomerulonephritis (GN), together with increased T and B cell activation. Here, we produced B6. NZBc1c13 bicongenic mice with both intervals, and demonstrate several novel phenotypes including: marked plasmacytoid and myeloid dendritic cell expansion, and elevated IgA production. Despite these changes, only minor increases in anti-nuclear antibody production were seen, and the severity of GN was reduced as compared to B6.NZBc1 mice. Although bicongenic mice had increased levels of baff and tnf-alpha mRNA in their spleens, the levels of IFN-alpha-induced gene expression were reduced. Splenocytes from bicongenic mice also demonstrated reduced secretion of IFN-alpha following TLR stimulation in vitro. This reduction was not due to inhibition by TNF-alpha and IL-10, or regulation by other cellular populations. Because pDC in bicongenic mice are chronically exposed to nuclear antigen-containing immune complexes in vivo, we examined whether repeated stimulation of mouse pDC with TLR ligands leads to impaired IFN-alpha production, a phenomenon termed TLR tolerance. Bone marrow pDC from both B6 and bicongenic mice demonstrated markedly inhibited secretion of IFN-alpha following repeated stimulation with a TLR9 ligand. Our findings suggest that the expansion of pDC and production of anti-nuclear antibodies need not be associated with increased IFN-alpha production and severe kidney disease, revealing additional complexity in the regulation of autoimmunity in systemic lupus erythematosus.	[Pau, Evelyn; Cheung, Yui-Ho; Loh, Christina; Wither, Joan E.] Toronto Western Res Inst, Arthrit Ctr Excellence, Toronto, ON, Canada; [Pau, Evelyn; Cheung, Yui-Ho; Loh, Christina; Wither, Joan E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Lajoie, Ginette] Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada; [Lajoie, Ginette] William Osler Hlth Ctr, Toronto, ON, Canada; [Wither, Joan E.] Univ Hlth Network, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Pau, E (corresponding author), Toronto Western Res Inst, Arthrit Ctr Excellence, Toronto, ON, Canada.	jwither@uhnres.utoronto.ca		Wither, Joan/0000-0001-5961-9228	Arthritis Society of Canada; Canadian Institutes of Health Research (CIHR); Arthritis Centre of Excellence; CIHR studentship; Edward Dunlop award	Arthritis Society of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Arthritis Centre of Excellence; CIHR studentship(Canadian Institutes of Health Research (CIHR)); Edward Dunlop award	This work was supported by grants from The Arthritis Society of Canada and Canadian Institutes of Health Research (CIHR). JW and YHC are supported by the Arthritis Centre of Excellence. CL is the recipient of a CIHR studentship and EP is the recipient of an Edward Dunlop award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bjoerck P, 2011, J IMMUNOL, V186, P1477, DOI 10.4049/jimmunol.1000454; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; BURLINGAME RW, 1994, J CLIN INVEST, V94, P184, DOI 10.1172/JCI117305; Cheung YH, 2005, J IMMUNOL, V175, P8154, DOI 10.4049/jimmunol.175.12.8154; Cheung YH, 2009, SEMIN IMMUNOL, V21, P372, DOI 10.1016/j.smim.2009.10.005; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Eloranta ML, 2009, ARTHRITIS RHEUM-US, V60, P2418, DOI 10.1002/art.24686; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gohlke PR, 2009, AUTOIMMUNITY, V42, P183, DOI 10.1080/08916930802668586; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jorgensen TN, 2010, J IMMUNOL, V184, P775, DOI 10.4049/jimmunol.0901322; Kikuchi S, 2005, BLOOD, V106, P1323, DOI 10.1182/blood-2005-02-0558; Kwok SK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2382; Lech M, 2008, J EXP MED, V205, P1879, DOI 10.1084/jem.20072646; Lian ZX, 2004, J IMMUNOL, V173, P5283, DOI 10.4049/jimmunol.173.8.5283; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lovgren T, 2006, ARTHRITIS RHEUM-US, V54, P1917, DOI 10.1002/art.21893; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Pau E, 2011, CLIN IMMUNOL, V139, P215, DOI 10.1016/j.clim.2011.02.005; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Stohl W, 2003, ARTHRITIS RHEUM-US, V48, P3475, DOI 10.1002/art.11354; Waibler Z, 2008, EUR J IMMUNOL, V38, P3127, DOI 10.1002/eji.200838184; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wither JE, 2005, J IMMUNOL, V175, P4309, DOI 10.4049/jimmunol.175.7.4309; Wither JE, 2003, J IMMUNOL, V171, P1697, DOI 10.4049/jimmunol.171.4.1697; YAGER TD, 1989, BIOCHEMISTRY-US, V28, P2271, DOI 10.1021/bi00431a045	40	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36761	10.1371/journal.pone.0036761	http://dx.doi.org/10.1371/journal.pone.0036761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574220	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800117
J	Peng, L; Oberst, MD; Huang, JQ; Brohawn, P; Morehouse, C; Lekstrom, K; Baeuerle, PA; Wu, H; Yao, YH; Coats, SR; Dall'Acqua, W; Damschroder, M; Hammond, SA				Peng, Li; Oberst, Michael D.; Huang, Jiaqi; Brohawn, Philip; Morehouse, Chris; Lekstrom, Kristen; Baeuerle, Patrick A.; Wu, Herren; Yao, Yihong; Coats, Steven R.; Dall'Acqua, William; Damschroder, Melissa; Hammond, Scott A.			The CEA/CD3-Bispecific Antibody MEDI-565 (MT111) Binds a Nonlinear Epitope in the Full-Length but Not a Short Splice Variant of CEA	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; CARCINOEMBRYONIC ANTIGEN CEA; MONOCLONAL-ANTIBODIES; COLORECTAL-CANCER; TUMOR-GROWTH; THERAPEUTIC WINDOW; POTENT CONTROL; BITE ANTIBODY; CELL LYSIS; CONSTRUCTS	MEDI-565 (also known as MT111) is a bispecific T-cell engager (BiTE (R)) antibody in development for the treatment of patients with cancers expressing carcinoembryonic antigen (CEA). MEDI-565 binds CEA on cancer cells and CD3 on T cells to induce T-cell mediated killing of cancer cells. To understand the molecular basis of human CEA recognition by MEDI-565 and how polymorphisms and spliced forms of CEA may affect MEDI-565 activity, we mapped the epitope of MEDI-565 on CEA using mutagenesis and homology modeling approaches. We found that MEDI-565 recognized a conformational epitope in the A2 domain comprised of amino acids 326-349 and 388-410, with critical residues F-326, T-328, N-333, V-388, G(389), P-390, E-392, I-408, and N-410. Two non-synonymous single-nucleotide polymorphisms (SNPs) (rs10407503, rs7249230) were identified in the epitope region, but they are found at low homozygosity rates. Searching the National Center for Biotechnology Information GenBank (R) database, we further identified a single, previously uncharacterized mRNA splice variant of CEA that lacks a portion of the N-terminal domain, the A1 and B1 domains, and a large portion of the A2 domain. Real-time quantitative polymerase chain reaction analysis of multiple cancers showed widespread expression of full-length CEA in these tumors, with less frequent but concordant expression of the CEA splice variant. Because the epitope was largely absent from the CEA splice variant, MEDI-565 did not bind or mediate T-cell killing of cells solely expressing this form of CEA. In addition, the splice variant did not interfere with MEDI-565 binding or activity when co-expressed with full-length CEA. Thus MEDI-565 may broadly target CEA-positive tumors without regard for expression of the short splice variant of CEA. Together our data suggest that MEDI-565 activity will neither be impacted by SNPs nor by a splice variant of CEA.	[Peng, Li; Lekstrom, Kristen; Wu, Herren; Coats, Steven R.; Dall'Acqua, William; Damschroder, Melissa] MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA; [Oberst, Michael D.; Hammond, Scott A.] MedImmune LLC, Preclin Oncol, Gaithersburg, MD USA; [Huang, Jiaqi; Brohawn, Philip; Morehouse, Chris; Yao, Yihong] MedImmune LLC, Translat Sci, Gaithersburg, MD USA; [Baeuerle, Patrick A.] Amgen Res Munich GmbH, Munich, Germany	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; Amgen; Amgen Research Munich GmbH	Peng, L (corresponding author), MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA.	damschroderm@medimmune.com; hammonds@medimmune.com		Damschroder, Melissa/0000-0001-9453-6532				Amann M, 2009, CANCER IMMUNOL IMMUN, V58, P95, DOI 10.1007/s00262-008-0529-y; Amann M, 2008, CANCER RES, V68, P143, DOI 10.1158/0008-5472.CAN-07-2182; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; BEAUCHEMIN N, 1987, MOL CELL BIOL, V7, P3221, DOI 10.1128/MCB.7.9.3221; Behr TM, 2002, CANCER-AM CANCER SOC, V94, P1373, DOI 10.1002/cncr.10308; Bjerner J, 2002, TUMOR BIOL, V23, P249, DOI 10.1159/000067255; BOXER GM, 1994, BRIT J CANCER, V69, P307, DOI 10.1038/bjc.1994.56; Brandl C, 2007, CANCER IMMUNOL IMMUN, V56, P1551, DOI 10.1007/s00262-007-0298-z; Brischwein K, 2007, J IMMUNOTHER, V30, P798, DOI 10.1097/CJI.0b013e318156750c; CHESTER KA, 1994, INT J CANCER, V57, P67, DOI 10.1002/ijc.2910570113; Dreier T, 2003, J IMMUNOL, V170, P4397, DOI 10.4049/jimmunol.170.8.4397; Duffy MJ, 2001, CLIN CHEM, V47, P624; Francis RJ, 2002, BRIT J CANCER, V87, P600, DOI 10.1038/sj.bjc.6600517; Fuhrmann S, 2010, AACR M; GOLDENBERG DM, 1993, J NUCL MED, V34, P61; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Haas C, 2009, IMMUNOBIOLOGY, V214, P441, DOI 10.1016/j.imbio.2008.11.014; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; HAMMARSTROM S, 1989, CANCER RES, V49, P4852; Hammond SA, 2007, CANCER RES, V67, P3927, DOI 10.1158/0008-5472.CAN-06-2760; Hampton R, 2002, ONCOGENE, V21, P7817, DOI 10.1038/sj.onc.1205906; HARWOOD PJ, 1986, BRIT J CANCER, V54, P75, DOI 10.1038/bjc.1986.154; HASS GM, 1991, CANCER RES, V51, P1876; HEFTA SA, 1988, P NATL ACAD SCI USA, V85, P4648, DOI 10.1073/pnas.85.13.4648; Herrmann I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013474; Hong H, 2008, BIOMARK INSIGHTS, V3, P435; Huang Emina H, 2002, Expert Rev Vaccines, V1, P49, DOI 10.1586/14760584.1.1.49; Kaplan BE, 1998, J PEPT RES, V52, P249; Kim HJ, 2009, ACTA ONCOL, V48, P385, DOI 10.1080/02841860802446761; Kischel R, 2009, AACR M; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Loffler A, 2000, BLOOD, V95, P2098, DOI 10.1182/blood.V95.6.2098; Lutterbuese R, 2009, J IMMUNOTHER, V32, P341, DOI 10.1097/CJI.0b013e31819b7c70; Mack M, 1997, J IMMUNOL, V158, P3965; MACK M, 1995, P NATL ACAD SCI USA, V92, P7021, DOI 10.1073/pnas.92.15.7021; Moffat FL, 1996, J CLIN ONCOL, V14, P2295, DOI 10.1200/JCO.1996.14.8.2295; MURAKAMI M, 1995, HYBRIDOMA, V14, P19, DOI 10.1089/hyb.1995.14.19; Nagorsen D, 2011, EXP CELL RES, V317, P1255, DOI 10.1016/j.yexcr.2011.03.010; NAP M, 1992, CANCER RES, V52, P2329; Offner S, 2006, MOL IMMUNOL, V43, P763, DOI 10.1016/j.molimm.2005.03.007; OIKAWA S, 1987, BIOCHEM BIOPH RES CO, V144, P634, DOI 10.1016/S0006-291X(87)80013-X; OIKAWA S, 1987, BIOCHEM BIOPH RES CO, V142, P511, DOI 10.1016/0006-291X(87)90304-4; Osada T, 2010, BRIT J CANCER, V102, P124, DOI 10.1038/sj.bjc.6605364; Rother M, 2007, J CLIN ONCOL, V25, P1293, DOI 10.1200/JCO.2006.10.0974; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; SCHWARZ K, 1988, MOL IMMUNOL, V25, P889, DOI 10.1016/0161-5890(88)90126-5; Solassol I, 2001, TUMOR BIOL, V22, P184, DOI 10.1159/000050614; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Wimberger P, 2003, INT J CANCER, V105, P241, DOI 10.1002/ijc.11056; Witthauer J, 2009, BREAST CANCER RES TR, V117, P471, DOI 10.1007/s10549-008-0185-0; Wolf E, 2005, DRUG DISCOV TODAY, V10, P1237, DOI 10.1016/S1359-6446(05)03554-3; Yamamoto M, 2004, HEPATO-GASTROENTEROL, V51, P147; ZHOU H, 1993, J CELL BIOL, V122, P951, DOI 10.1083/jcb.122.4.951	56	24	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36412	10.1371/journal.pone.0036412	http://dx.doi.org/10.1371/journal.pone.0036412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574157	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349800053
J	Han, RJ; Kitlinska, JB; Munday, WR; Gallicano, GI; Zukowska, Z				Han, Ruijun; Kitlinska, Joanna B.; Munday, William R.; Gallicano, G. Ian; Zukowska, Zofia			Stress Hormone Epinephrine Enhances Adipogenesis in Murine Embryonic Stem Cells by Up-Regulating the Neuropeptide Y System	PLOS ONE			English	Article							MECHANISMS LINKING OBESITY; WHITE ADIPOSE-TISSUE; IN-VIVO; INSULIN-RESISTANCE; SELF-RENEWAL; FAT; DIFFERENTIATION; ADIPOCYTES; COTRANSMISSION; THERMOGENESIS	Prenatal stress, psychologically and metabolically, increases the risk of obesity and diabetes in the progeny. However, the mechanisms of the pathogenesis remain unknown. In adult mice, stress activates NPY and its Y2R in a glucocorticoid-dependent manner in the abdominal fat. This increased adipogenesis and angiogenesis, leading to abdominal obesity and metabolic syndrome which were inhibited by intra-fat Y2R inactivation. To determine whether stress elevates NPY system and accelerates adipogenic potential of embryo, here we "stressed" murine embryonic stem cells (mESCs) in vitro with epinephrine (EPI) during their adipogenic differentiation. EPI was added during the commitment stage together with insulin, and followed by dexamethasone in the standard adipogenic differentiation medium. Undifferentiated embryonic bodies (EBs) showed no detectable expression of NPY. EPI markedly up-regulated the expression NPY and the Y1R at the commitment stage, followed by increased Y2R mRNA at the late of the commitment stage and the differentiation stage. EPI significantly increased EB cells proliferation and expression of the preadipocyte marker Pref-1 at the commitment stage. EPI also accelerated and amplified adipogenic differentiation detected by increasing the adipocyte markers FABP4 and PPAR gamma mRNAs and Oil-red O-staining at the end of the differentiation stage. EPI-induced adipogenesis was completely prevented by antagonists of the NPY receptors (Y1R+Y2R+Y5R), indicating that it was mediated by the NPY system in mESC's. Taken together, these data suggest that stress may play an important role in programing ESCs for accelerated adipogenesis by altering the stress induced hormonal regulation of the NPY system.	[Han, Ruijun; Zukowska, Zofia] Univ Minnesota, Dept Integrat Biol & Physiol, Stress Physiol Ctr, Minneapolis, MN 55455 USA; [Han, Ruijun; Kitlinska, Joanna B.; Munday, William R.; Zukowska, Zofia] Georgetown Univ, Med Ctr, Dept Physiol, Washington, DC 20007 USA; [Han, Ruijun; Kitlinska, Joanna B.; Munday, William R.; Zukowska, Zofia] Georgetown Univ, Med Ctr, Dept Biophys, Washington, DC 20007 USA; [Gallicano, G. Ian] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20007 USA; [Gallicano, G. Ian] Georgetown Univ, Med Ctr, Dept Cellular & Mol Biol, Washington, DC 20007 USA	University of Minnesota System; University of Minnesota Twin Cities; Georgetown University; Georgetown University; Georgetown University; Georgetown University	Han, RJ (corresponding author), Univ Minnesota, Dept Integrat Biol & Physiol, Stress Physiol Ctr, Minneapolis, MN 55455 USA.	rhan@umn.edu	Han, Ruijun/K-6614-2012		United States National Institutes of Health [R01HL067357, R37HL055310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116476, R37HL055310, R01HL067357] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by United States National Institutes of Health grants R01HL067357 and R37HL055310 to Z.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005341; Abe K, 2010, EXP BIOL MED, V235, P1179, DOI 10.1258/ebm.2010.009136; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BALBI D, 1994, MOL BRAIN RES, V23, P310, DOI 10.1016/0169-328X(94)90240-2; Bartness TJ, 2005, P NUTR SOC, V64, P53, DOI 10.1079/PNS2004409; Bedoui S, 2002, J NEUROIMMUNOL, V132, P25, DOI 10.1016/S0165-5728(02)00278-3; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Bowers RR, 2004, AM J PHYSIOL-REG I, V286, pR1167, DOI 10.1152/ajpregu.00558.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; Couture JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004743; Dani C, 1997, J CELL SCI, V110, P1279; Dodt C, 2003, ACTA PHYSIOL SCAND, V177, P351, DOI 10.1046/j.1365-201X.2003.01077.x; Feng GS, 2007, CELL RES, V17, P37, DOI 10.1038/sj.cr.7310140; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hales CN, 2003, DIABETOLOGIA, V46, P1013, DOI 10.1007/s00125-003-1131-7; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kos K, 2007, AM J PHYSIOL-ENDOC M, V293, pE1335, DOI 10.1152/ajpendo.00333.2007; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Kuo LE, 2008, ANN NY ACAD SCI, V1148, P232, DOI 10.1196/annals.1410.035; Li LJ, 2003, ARTERIOSCL THROM VAS, V23, P1204, DOI 10.1161/01.ATV.0000071349.30914.25; Lu M, 2008, J ENDOCRINOL, V196, P159, DOI 10.1677/JOE-07-0452; Lundberg JM, 1996, PHARMACOL REV, V48, P113; LUNDBERG JM, 1989, NEUROSCIENCE, V28, P475, DOI 10.1016/0306-4522(89)90193-0; MCMAHON TJ, 1992, PHYS REV B, V45, P4512, DOI 10.1103/PhysRevB.45.4512; Mobley S, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/701212; Monteiro MC, 2011, STEM CELLS, V29, P1837, DOI 10.1002/stem.737; Morganstein DL, 2010, CELL RES, V20, P434, DOI 10.1038/cr.2010.11; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pons J, 2008, CAN J PHYSIOL PHARM, V86, P438, DOI [10.1139/Y08-054, 10.1139/y08-054]; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; Son MY, 2011, J CELL MOL MED, V15, P152, DOI 10.1111/j.1582-4934.2009.00956.x; Sousa DM, 2009, CURR DRUG TARGETS, V10, P9, DOI 10.2174/138945009787122888; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spencer SJ, 2011, STRESS, V14, P233, DOI 10.3109/10253890.2010.534831; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Szabo E, 2009, STEM CELLS, V27, P2092, DOI 10.1002/stem.137; Tai TC, 2007, J NEUROCHEM, V101, P1108, DOI 10.1111/j.1471-4159.2007.04484.x; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Turtzo LC, 2002, HORM METAB RES, V34, P607, DOI 10.1055/s-2002-38245; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vazao H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017771; WAHLESTEDT C, 1990, AM J PHYSIOL, V258, pR736, DOI 10.1152/ajpregu.1990.258.3.R736; Yang KP, 2008, FASEB J, V22, P2452, DOI 10.1096/fj.07-100735; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504; Zou CH, 2008, J NUTR BIOCHEM, V19, P277, DOI 10.1016/j.jnutbio.2007.06.006	56	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36609	10.1371/journal.pone.0036609	http://dx.doi.org/10.1371/journal.pone.0036609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570731	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343400047
J	Bannach, O; Birkmann, E; Reinartz, E; Jaeger, KE; Langeveld, JPM; Rohwer, RG; Gregori, L; Terry, LA; Willbold, D; Riesner, D				Bannach, Oliver; Birkmann, Eva; Reinartz, Elke; Jaeger, Karl-Erich; Langeveld, Jan P. M.; Rohwer, Robert G.; Gregori, Luisa; Terry, Linda A.; Willbold, Dieter; Riesner, Detlev			Detection of Prion Protein Particles in Blood Plasma of Scrapie Infected Sheep	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; CREUTZFELDT-JAKOB-DISEASE; INFECTIVITY; REMOVAL; AMPLIFICATION; COMPONENTS; LEVEL; PRPSC	Prion diseases are transmissible neurodegenerative diseases affecting humans and animals. The agent of the disease is the prion consisting mainly, if not solely, of a misfolded and aggregated isoform of the host-encoded prion protein (PrP). Transmission of prions can occur naturally but also accidentally, e.g. by blood transfusion, which has raised serious concerns about blood product safety and emphasized the need for a reliable diagnostic test. In this report we present a method based on surface-FIDA (fluorescence intensity distribution analysis), that exploits the high state of molecular aggregation of PrP as an unequivocal diagnostic marker of the disease, and show that it can detect infection in blood. To prepare PrP aggregates from blood plasma we introduced a detergent and lipase treatment to separate PrP from blood lipophilic components. Prion protein aggregates were subsequently precipitated by phosphotungstic acid, immobilized on a glass surface by covalently bound capture antibodies, and finally labeled with fluorescent antibody probes. Individual PrP aggregates were visualized by laser scanning microscopy where signal intensity was proportional to aggregate size. After signal processing to remove the background from low fluorescence particles, fluorescence intensities of all remaining PrP particles were summed. We detected PrP aggregates in plasma samples from six out of ten scrapie-positive sheep with no false positives from uninfected sheep. Applying simultaneous intensity and size discrimination, ten out of ten samples from scrapie sheep could be differentiated from uninfected sheep. The implications for ante mortem diagnosis of prion diseases are discussed.	[Bannach, Oliver; Birkmann, Eva; Reinartz, Elke; Willbold, Dieter; Riesner, Detlev] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Birkmann, Eva; Willbold, Dieter] Res Ctr Julich, Inst Complex Syst ICS 6, Julich, Germany; [Jaeger, Karl-Erich] Univ Dusseldorf, Res Ctr Julich, Inst Mol Enzyme Technol, Julich, Germany; [Langeveld, Jan P. M.] Cent Vet Inst Wageningen UR CVI, Lelystad, Netherlands; [Rohwer, Robert G.; Gregori, Luisa] VA Med Ctr, Med Res Serv 151, Mol Neurovirol Lab, VA Maryland Hlth Care Syst, Baltimore, MD USA; [Terry, Linda A.] Anim Hlth & Vet Labs Agcy, Addlestone, Surrey, England; [Gregori, Luisa] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Wageningen University & Research; Veterinary Laboratories Agency; University System of Maryland; University of Maryland Baltimore	Bannach, O (corresponding author), Ctr Biol Evaluat & Res, Food & Drug Adm, Rockville, MD USA.	bannacho@hhu.de	Bannach, Oliver/A-4794-2015; Birkmann, Eva/H-6019-2013; Willbold, Dieter/A-6280-2013; jaeger, karl/ABB-1955-2020	Bannach, Oliver/0000-0002-7438-3791; Birkmann, Eva/0000-0002-2069-0630; Willbold, Dieter/0000-0002-0065-7366; 	UK Food Standards Agency [M03063]; VA Merit Review funding; NIH [N01-NS-0-2327]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [N01NS002327] Funding Source: NIH RePORTER	UK Food Standards Agency; VA Merit Review funding(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the UK Food Standards Agency (project M03063). RGR and LG were supported by VA Merit Review funding and NIH Contract: N01-NS-0-2327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Beekes M, 1996, TRANSMISSIBLE SUBACUTE SPONGIFORM ENCEPHALOPATHIES: PRION DISEASES, P143; Birkmann E, 2006, BIOL CHEM, V387, P95, DOI 10.1515/BC.2006.013; Birkmann E, 2007, VET MICROBIOL, V123, P294, DOI 10.1016/j.vetmic.2007.04.001; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Flan B, 2007, TRANSFUS CLIN BIOL, V14, P51, DOI 10.1016/j.tracli.2007.04.008; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Gregori L, 2006, LANCET, V368, P2226, DOI 10.1016/S0140-6736(06)69897-8; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Ironside JW, 2010, HAEMOPHILIA, V16, P175, DOI 10.1111/j.1365-2516.2010.02317.x; Janissen R, 2009, COLLOID SURFACE B, V71, P200, DOI 10.1016/j.colsurfb.2009.02.011; Knight R, 2010, TRANSFUS APHER SCI, V43, P387, DOI 10.1016/j.transci.2010.09.003; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Lacroux C, 2012, J VIROL, V86, P2056, DOI 10.1128/JVI.06532-11; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Orru CD, 2012, PRION, V6; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Post K, 1998, BIOL CHEM, V379, P1307, DOI 10.1515/bchm.1998.379.11.1307; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rohwer RG, 2004, CHIS TSE M; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Safar JG, 2006, P NATL ACAD SCI USA, V103, P11312, DOI 10.1073/pnas.0604021103; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2004, NAT REV MICROBIOL, V2, P809, DOI 10.1038/nrmicro1003; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Stucki M, 2008, BIOLOGICALS, V36, P239, DOI 10.1016/j.biologicals.2008.01.004; Tateishi J, 2001, BIOLOGICALS, V29, P17, DOI 10.1006/biol.2001.0269; Tateishi Jun, 1993, Membrane, V18, P357; Terry LA, 2009, J VIROL, V83, P12552, DOI 10.1128/JVI.00311-09; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Trieschmann L, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-26; Van Holten RW, 2003, VOX SANG, V85, P20, DOI 10.1046/j.1423-0410.2003.00312.x; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; World Health Organisation, 2006, WHO TABL TISS INF DI; Yunoki M, 2008, BIOLOGICALS, V36, P27, DOI 10.1016/j.biologicals.2007.04.005; Yunoki M, 2010, BIOLOGICALS, V38, P311, DOI 10.1016/j.biologicals.2009.10.018	49	30	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36620	10.1371/journal.pone.0036620	http://dx.doi.org/10.1371/journal.pone.0036620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567169	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500089
J	Wang, JJ; Li, YQ; Han, ZJ; Zhu, YL; Xie, ZJ; Wang, J; Liu, YP; Li, XC				Wang, Jianjun; Li, Yanqing; Han, Zhaojun; Zhu, Youli; Xie, Zhijuan; Wang, Jian; Liu, Yaping; Li, Xianchun			Molecular Characterization of a Ryanodine Receptor Gene in the Rice Leaffolder, Cnaphalocrocis medinalis (Guenee)	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; NEGATIVE SPLICE VARIANT; ANTHRANILIC DIAMIDES; CDNA CLONING; IDENTIFICATION; REVEALS; BINDING; DOMAIN; LOOP; FLUBENDIAMIDE	Ryanodine receptors (RyRs) are the targets of two novel classes of synthetic insecticidal chemicals, phthalic acid diamides and anthranilic diamides. Isolation of full-length RyR cDNAs is a critical step towards the structural and functional characterization of insect RyRs and an understanding of the molecular mechanisms underlying the species selective toxicity of diamide insecticides. However, there has been little research on the insect RyR genes due to the high molecular weight of the RyR proteins. In this study, we isolated a full-length RyR cDNA (named as CmRyR) from Cnaphalocrocis medinalis, an important rice pest throughout Southeast Asia. The composite CmRyR gene contains an ORF of 15264 bp encoding a protein of 5087 amino acid residues, which shares 79% overall identity with its Drosophila melanogaster homologue. All hallmarks of the RyR proteins are conserved in the CmRyR protein, suggesting that CmRyR is a structural and functional analogue of known RyRs. A multiple sequence alignment illustrates that the insect RyRs share high levels of amino acid sequence identity at the the COOH-terminal region. However, the amino acid residues analogous to the CmRyR residues N-4922, N-4924, N-4935, L-4950, L-4981, N-5013 and T-5064 are unique to lepidopteran RyRs compared with non-lepidopteran insect RyRs. This finding suggests that these residues may be involved in the differences in channel properties between lepidopteran and non-lepidopteran insect RyRs and in the species selective toxicity of diamide insecticides. Furthermore, two alternative splicing sites were identified in the CmRyR gene, one of which was located in the central part of the predicted second SPRY domain. Diagnostic PCR showed that the inclusion frequencies of two mutually exclusive exons (a/b) and one optional exon (c) differed between developmental stages or adult anatomical regions. Our results imply that alternative splicing may be a major means of generating functional diversity in C. medinalis RyR channel.	[Wang, Jianjun; Li, Yanqing; Zhu, Youli; Xie, Zhijuan; Wang, Jian; Liu, Yaping] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Peoples R China; [Li, Xianchun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Li, Xianchun] Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA; [Han, Zhaojun] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Peoples R China	Yangzhou University; University of Arizona; University of Arizona; Nanjing Agricultural University	Wang, JJ (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Peoples R China.	wangjj@yzu.edu.cn			National Natural Science Foundation of China [31171841]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 31171841 to JJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; Bloomquist JR, 1996, ANNU REV ENTOMOL, V41, P163, DOI 10.1146/annurev.en.41.010196.001115; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cui YF, 2009, INT J BIOCHEM CELL B, V41, P677, DOI 10.1016/j.biocel.2008.08.004; Dabertrand F, 2006, CELL CALCIUM, V40, P11, DOI 10.1016/j.ceca.2006.03.008; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Ebbinghaus-Kintscher U, 2006, CELL CALCIUM, V39, P21, DOI 10.1016/j.ceca.2005.09.002; FUTATSUGI A, 1995, BIOCHEM J, V305, P373, DOI 10.1042/bj3050373; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; George CH, 2007, CIRC RES, V100, P874, DOI 10.1161/01.RES.0000260804.77807.cf; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Gutteridge S., 2003, U.S. Patent, Patent No. [7,205,147, 7205147]; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; HALL LM, 1995, ACS SYM SER, V591, P162; INUI M, 1987, J BIOL CHEM, V262, P15637; Jiang DW, 2003, J BIOL CHEM, V278, P4763, DOI 10.1074/jbc.M210410200; Kato K, 2009, BIOCHEMISTRY-US, V48, P10342, DOI 10.1021/bi900866s; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kimura T, 2009, CELL CALCIUM, V45, P264, DOI 10.1016/j.ceca.2008.11.005; Lahm G.P., 2007, PESTICIDE CHEM CROP, P111, DOI [10.1002/9783527611249.ch11, DOI 10.1002/9783527611249.CH11]; Lahm GP, 2005, BIOORG MED CHEM LETT, V15, P4898, DOI 10.1016/j.bmcl.2005.08.034; Leeb T, 1998, FEBS LETT, V423, P367, DOI 10.1016/S0014-5793(98)00124-0; Marziah G, 1996, FEBS LETT, V394, P76, DOI 10.1016/0014-5793(96)00944-1; Masaki T, 2006, MOL PHARMACOL, V69, P1733, DOI 10.1124/mol.105.020339; MIGNERY GA, 1993, METH NEUROSCI, V18, P247; Miyatake R, 1996, FEBS LETT, V395, P123, DOI 10.1016/0014-5793(96)01022-8; Nauen R, 2006, PEST MANAG SCI, V62, P690, DOI 10.1002/ps.1254; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Puente E, 2000, INSECT BIOCHEM MOLEC, V30, P335, DOI 10.1016/S0965-1748(00)00009-6; Ross D, 2002, CELL CALCIUM, V32, P307, DOI 10.1016/S0143-4160(02)00198-7; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; SORRENTINO V, 1993, TRENDS PHARMACOL SCI, V14, P98, DOI 10.1016/0165-6147(93)90072-R; Takasawa S, 2010, BIOCHEM BIOPH RES CO, V397, P140, DOI 10.1016/j.bbrc.2010.05.051; TAKESHIMA H, 1994, FEBS LETT, V337, P81, DOI 10.1016/0014-5793(94)80634-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tohnishi M, 2005, J PESTIC SCI, V30, P354, DOI 10.1584/jpestics.30.354; Wang XL, 2012, PESTIC BIOCHEM PHYS, V102, P204, DOI 10.1016/j.pestbp.2012.01.009; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Xiong H, 1998, BIOCHEMISTRY-US, V37, P4804, DOI 10.1021/bi971198b; Xu XH, 2000, BIOPHYS J, V78, P1270, DOI 10.1016/S0006-3495(00)76683-5; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; ZORZATO F, 1994, BIOCHEM BIOPH RES CO, V203, P1725, DOI 10.1006/bbrc.1994.2385; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	48	33	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36623	10.1371/journal.pone.0036623	http://dx.doi.org/10.1371/journal.pone.0036623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567170	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341500090
J	Li, C; Meng, QL; Yu, XF; Jing, X; Xu, PX; Luo, DL				Li, Chen; Meng, Qingli; Yu, Xinfeng; Jing, Xian; Xu, Pingxiang; Luo, Dali			Regulatory Effect of Connexin 43 on Basal Ca2+ Signaling in Rat Ventricular Myocytes	PLOS ONE			English	Article							C6 GLIOMA-CELLS; GAP JUNCTIONAL COMMUNICATION; ATP RELEASE; HEMICHANNELS; EXPRESSION; HYPERCONTRACTURE; PROPAGATION; CONTRIBUTE; MECHANISM; SPARKS	Background: It has been found that gap junction-associated intracellular Ca2+ [Ca2+](i) disturbance contributes to the arrhythmogenesis and hyperconstriction in diseased heart. However, whether functional gaps are also involved in the regulation of normal Ca2+ signaling, in particular the basal [Ca2+](i) activities, is unclear. Methods and Results: Global and local Ca2+ signaling and gap permeability were monitored in cultured neonatal rat ventricular myocytes (NRVMs) and freshly isolated mouse ventricular myocytes by Fluo4/AM and Lucifer yellow (LY), respectively. The results showed that inhibition of gap communication by heptanol, Gap 27 and flufenamic acid or interference of connexin 43 (Cx43) with siRNA led to a significant suppression of LY uptake and, importantly, attenuations of global Ca2+ transients and local Ca2+ sparks in monolayer NRVMs and Ca2+ sparks in adult ventricular myocytes. In contrast, overexpression of rat-Cx43 in NRVMs induced enhancements in the above measurements, and so did in HEK293 cells expressing rat Cx43. Additionally, membrane-permeable inositol 1,4,5-trisphosphate (IP3 butyryloxymethyl ester) and phenylephrine, an agonist of adrenergic receptor, could relieve the inhibited Ca2+ signal and LY uptake by gap uncouplers, whereas blockade of IP3 receptor with xestospongin C or 2-aminoethoxydiphenylborate mimicked the effects of gap inhibitors. More importantly, all these gap-associated effects on Ca2+ signaling were also found in single NRVMs that only have hemichannels instead of gap junctions. Further immunostaining/immunoblotting single myocytes with antibody against Cx43 demonstrated apparent increases in membrane labeling of Cx43 and non-junctional Cx43 in overexpressed cells, suggesting functional hemichannels exist and also contribute to the Ca2+ signaling regulation in cardiomyocytes. Conclusions: These data demonstrate that Cx43-associated gap coupling plays a role in the regulation of resting Ca2+ signaling in normal ventricular myocytes, in which IP3/IP3 receptor coupling is involved. This finding may provide a novel regulatory pathway for mediation of spontaneous global and local Ca2+ activities in cardiomyocytes.	[Li, Chen; Meng, Qingli; Yu, Xinfeng; Jing, Xian; Xu, Pingxiang; Luo, Dali] Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Beijing, Peoples R China	Capital Medical University	Li, C (corresponding author), Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Beijing, Peoples R China.	luodl@ccmu.edu.cn			National Natural Science Foundation [30973537]; Beijing Natural Science Foundation [7082018, 5122006]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by grants from the National Natural Science Foundation (30973537), and the Beijing Natural Science Foundation (7082018 and 5122006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2010, CARDIOVASC RES, V85, P751, DOI 10.1093/cvr/cvp353; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; Bruzzone S, 2001, FASEB J, V15, P10; Chen LH, 2011, CELL SIGNAL, V23, P497, DOI 10.1016/j.cellsig.2010.11.005; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Fry T, 2001, MICROSC RES TECHNIQ, V52, P289, DOI 10.1002/1097-0029(20010201)52:3<289::AID-JEMT1014>3.0.CO;2-0; GarciaDorado D, 1997, CIRCULATION, V96, P3579; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Gossman DG, 2008, CELL COMMUN ADHES, V15, P305, DOI 10.1080/15419060802357217; Hayashi H, 2010, CIRC J, V74, P2558, DOI 10.1253/circj.CJ-10-0983; Hoeker GS, 2009, AM J PHYSIOL-HEART C, V297, pH1235, DOI 10.1152/ajpheart.01320.2008; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Kostin S, 2003, MOL CELL BIOCHEM, V242, P135, DOI 10.1023/A:1021154115673; Leite MF, 2002, J BIOL CHEM, V277, P16313, DOI 10.1074/jbc.M109207200; Li FG, 2001, J MOL CELL CARDIOL, V33, P2145, DOI 10.1006/jmcc.2001.1477; Li WH, 1997, TETRAHEDRON, V53, P12017, DOI 10.1016/S0040-4020(97)00714-X; Luo DL, 2008, CELL CALCIUM, V43, P165, DOI 10.1016/j.ceca.2007.04.017; NAUS CCG, 1992, CELL MOL NEUROBIOL, V12, P163, DOI 10.1007/BF00713370; Opsahl H, 2000, CELL ADHES COMMUN, V7, P367, DOI 10.3109/15419060009109019; Oyamada Y, 2002, EXP CELL RES, V273, P85, DOI 10.1006/excr.2001.5411; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Ruiz-Meana M, 1999, CIRC RES, V85, P280, DOI 10.1161/01.RES.85.3.280; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Spach MS, 1997, PACE, V20, P397, DOI 10.1111/j.1540-8159.1997.tb06199.x; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Tong D, 2006, AM J PHYSIOL-CELL PH, V290, pC290, DOI 10.1152/ajpcell.00297.2005; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; WATTS SW, 1994, J VASC RES, V31, P307, DOI 10.1159/000159057; Wier WG, 1999, CIRC RES, V85, P770, DOI 10.1161/01.RES.85.9.770; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	40	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36165	10.1371/journal.pone.0036165	http://dx.doi.org/10.1371/journal.pone.0036165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22577485	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000144
J	Ahlqvist, K; Saamarthy, K; Khaja, ASS; Bjartell, A; Massoumi, R				Ahlqvist, K.; Saamarthy, K.; Khaja, A. S. Syed; Bjartell, A.; Massoumi, R.			Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer	ONCOGENE			English	Article						Bcl-3; prostate cancer; interleukin-6; inhibitor of DNA binding (Id)	NF-KAPPA-B; PROLIFERATIVE INFLAMMATORY ATROPHY; PROMOTES CELL-SURVIVAL; BREAST-CANCER; ACTIVATION; APOPTOSIS; PATHWAY; NF-KAPPA-B2/P52; INTERLEUKIN-6; INHIBITOR	B-cell leukemia 3 (Bcl-3) is a member of the inhibitor of kappa B family, which regulates a wide range of biological processes by functioning as a transcriptional activator or as a repressor of target genes. As high levels of Bcl-3 expression and activation have been detected in different types of human cancer, Bcl-3 has been labeled a proto-oncogene. Our study uncovered a markedly upregulated Bcl-3 expression in human prostate cancer (PCa), where inflammatory cell infiltration was observed. Elevated Bcl-3 expression in PCa was dependent on the proinflammatory cytokine interleukin-6-mediated STAT3 activation. Microarray analyses, using Bcl-3 knockdown in PCa cells, identified the inhibitor of DNA-binding (Id) family of helix-loop-helix proteins as potential Bcl-3-regulated genes. Bcl-3 knockdown reduced the abundance of Id-1 and Id-2 proteins and boosted PCa cells to be more receptive to undergoing apoptosis following treatment with anticancer drug. Our data imply that inactivation of Bcl-3 may lead to sensitization of cancer cells to chemotherapeutic drug-induced apoptosis, thus suggesting a potential therapeutic strategy in PCa treatment. Oncogene (2013) 32, 1601-1608; doi:10.1038/onc.2012.175; published online 14 May 2012	[Ahlqvist, K.; Saamarthy, K.; Massoumi, R.] Lund Univ, Skane Univ Hosp, Dept Lab Med, Ctr Mol Tumor Pathol, SE-20502 Malmo, Sweden; [Khaja, A. S. Syed; Bjartell, A.] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Div Urol Canc, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	Massoumi, R (corresponding author), Lund Univ, Skane Univ Hosp, Dept Lab Med, SUS, Entrance 78,2nd Floor, SE-20502 Malmo, Sweden.	Ramin.Massoumi@med.lu.se	Massoumi, Ramin/AAG-4786-2019; Syed Khaja, Azharuddin Sajid/AAF-2693-2021	Syed Khaja, Azharuddin Sajid/0000-0003-1594-1826	Swedish Society for Medical Research; Swedish Cancer Foundation; Swedish Medical Research Council; Royal Physiographic Society in Lund; U-MAS Research Foundations; European Research Council under the European Union [260460]	Swedish Society for Medical Research; Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Royal Physiographic Society in Lund; U-MAS Research Foundations; European Research Council under the European Union(European Research Council (ERC))	We thank Elise Nilsson for excellent technical assistance, Dr Zoran Culig (Innsbruck Medical University, Austria) for providing us the LNCaP-IL-6<SUP>+</SUP> cells, Dr Takashi Tokino (Cancer Research Institute, Sapporo, Japan) for human Id-2 promoter luciferase reporter construct, Dr Roland M Schmid (Technical University Munich, Munich, Germany) for FLAG-Bcl-3 expression construct, Dr David Ulmert (Lund University, Lund, Sweden) for characterization of the human PCa tissue microarray and Dr Srinivas Veerla (SCIBLU, Lund University, Lund, Sweden) for microarray analysis and gene expression profiling. This work was supported by the Swedish Society for Medical Research, Swedish Cancer Foundation, Swedish Medical Research Council, Royal Physiographic Society in Lund, U-MAS Research Foundations, and funding from the European Research Council under the European Union's seventh framework program ERC grant agreement (260460 to RM).	Brocke-Heidrich K, 2006, ONCOGENE, V25, P7297, DOI 10.1038/sj.onc.1209711; Brocke-Heidrich K, 2004, BLOOD, V103, P242, DOI 10.1182/blood-2003-04-1048; Cai C, 2011, PATHOL ONCOL RES, V17, P873, DOI 10.1007/s12253-011-9396-5; Cheung HW, 2004, CARCINOGENESIS, V25, P881, DOI 10.1093/carcin/bgh087; Choi HJ, 2010, BIOCHEM BIOPH RES CO, V400, P396, DOI 10.1016/j.bbrc.2010.08.084; Chung TDK, 2000, PROSTATE, V42, P1; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; CORREA P, 1992, CANCER RES, V52, P6735; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Forootan SS, 2007, HUM PATHOL, V38, P1321, DOI 10.1016/j.humpath.2007.02.011; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hobisch A, 2000, J PATHOL, V191, P239, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X; Hobisch A, 2001, CLIN CANCER RES, V7, P2941; Hua H, 2007, ENDOCRINE, V32, P329, DOI 10.1007/s12020-008-9039-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Keutgens A, 2010, MOL CELL BIOL, V30, P4006, DOI 10.1128/MCB.01600-09; Kim H, 2008, BREAST CANCER RES TR, V112, P287, DOI 10.1007/s10549-007-9871-6; Kuphal S, 2011, ONCOGENE, V30, P4523, DOI 10.1038/onc.2011.163; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Ling MT, 2003, ONCOGENE, V22, P4498, DOI 10.1038/sj.onc.1206693; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; MCKEITHAN TW, 1987, P NATL ACAD SCI USA, V84, P9257, DOI 10.1073/pnas.84.24.9257; Monticelli LA, 2009, P NATL ACAD SCI USA, V106, P19461, DOI 10.1073/pnas.0908249106; Nadiminty N, 2010, CANCER RES, V70, P3309, DOI 10.1158/0008-5472.CAN-09-3703; Nadiminty N, 2008, PROSTATE, V68, P1725, DOI 10.1002/pros.20839; Paule B, 2007, WORLD J UROL, V25, P477, DOI 10.1007/s00345-007-0175-6; Rebollo A, 2000, MOL CELL BIOL, V20, P3407, DOI 10.1128/MCB.20.10.3407-3416.2000; Smith PC, 2001, PROSTATE, V48, P47; Sottnik JL, 2011, CANCER MICROENVIRON, V4, P283, DOI 10.1007/s12307-011-0073-8; Thornburg NJ, 2003, CANCER RES, V63, P8293; TWILLIE DA, 1995, UROLOGY, V45, P542, DOI 10.1016/S0090-4295(99)80034-X; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Wong YC, 2008, ADV EXP MED BIOL, V617, P565, DOI 10.1007/978-0-387-69080-3_58; Zha S, 2001, CANCER RES, V61, P8617; Zhang HM, 2007, AM J PATHOL, V171, P1113, DOI 10.2353/ajpath.2007.070226; Zhang XM, 2007, J BIOL CHEM, V282, P33284, DOI 10.1074/jbc.M705089200; Zhang XM, 2007, CANCER SCI, V98, P308, DOI 10.1111/j.1349-7006.2007.00400.x; Zhang XM, 2006, INT J CANCER, V118, P2072, DOI 10.1002/ijc.21592; Zielinski AJ, 2010, INT J CANCER, V126, P2490, DOI 10.1002/ijc.24811	45	30	35	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2013	32	12					1601	1608		10.1038/onc.2012.175	http://dx.doi.org/10.1038/onc.2012.175			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22580608				2022-12-25	WOS:000316456000013
J	Foley, CJ; Luo, C; O'Callaghan, K; Hinds, PW; Covic, L; Kuliopulos, A				Foley, Caitlin J.; Luo, Chi; O'Callaghan, Katie; Hinds, Philip W.; Covic, Lidija; Kuliopulos, Athan			Matrix Metalloprotease-1a Promotes Tumorigenesis and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; CELL-PENETRATING PEPDUCINS; BREAST-CANCER METASTASIS; INTERSTITIAL COLLAGENASE; COUPLED RECEPTORS; PROGNOSTIC VALUE; POOR-PROGNOSIS; SIGNALING AXIS; METALLOPROTEINASE-1; EXPRESSION	Matrix metalloprotease-1 (MMP1), a collagenase and activator of the G protein-coupled protease activated receptor-1 (PAR1), is an emerging new target implicated in oncogenesis and metastasis in diverse cancers. However, the functional mouse homologue of MMP1 in cancer models has not yet been clearly defined. We report here that Mmp1a is a functional MMP1 homologue that promotes invasion and metastatic progression of mouse lung cancer and melanoma. LLC1 (Lewis lung carcinoma) and primary mouse melanoma cells harboring active BRAF express high levels of endogenous Mmp1a, which is required for invasion through collagen. Silencing of either Mmp1a or PAR1 suppressed invasive stellate growth of lung cancer cells in three-dimensional matrices. Conversely, ectopic expression of Mmp1a conferred an invasive phenotype in epithelial cells that do not express endogenous Mmp1a. Consistent with Mmp1a acting as a PAR1 agonist in an autocrine loop, inhibition or silencing of PAR1 resulted in a loss of the Mmp1a-driven invasive phenotype. Knockdown of Mmp1a on tumor cells resulted in significantly decreased tumorigenesis, invasion, and metastasis in xenograft models. Together, these data demonstrate that cancer cell-derived Mmp1a acts as a robust functional homologue of MMP1 by conferring protumorigenic and metastatic behavior to cells.	[Foley, Caitlin J.; Luo, Chi; O'Callaghan, Katie; Hinds, Philip W.; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Tufts Med Ctr, Mol Oncol Res Inst, Sch Med, Boston, MA 02111 USA; [Foley, Caitlin J.; Luo, Chi; Hinds, Philip W.; Kuliopulos, Athan] Tufts Univ, Genet Program, Sackler Sch Grad Biomed Sci, Sch Med, Boston, MA 02111 USA; [Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University; Tufts University	Kuliopulos, A (corresponding author), Tufts Univ, Tufts Med Ctr, Mol Oncol Res Inst, Sch Med, MORI Box 7510,800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu		LUO, CHI/0000-0001-7669-9506	National Institutes of Health [F30-HL104835, CA122992, HL64701, CA104406, CA095798, CA104322]; Sackler Family Cancer Award; NATIONAL CANCER INSTITUTE [R01CA095798, R01CA122992, R01CA104406, R01CA104322] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064701, F30HL104835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sackler Family Cancer Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health grants F30-HL104835 (to C. J. F.), CA122992 and HL64701 (to A. K.), CA104406 (to L. C.), CA095798, and CA104322 and a Sackler Family Cancer Award (to P. W. H. and C. L.).	Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417; Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bostrom P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-348; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Depasquale I, 2008, HISTOPATHOLOGY, V52, P500, DOI 10.1111/j.1365-2559.2008.02978.x; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Du XL, 2011, JPN J CLIN ONCOL, V41, P1086, DOI 10.1093/jjco/hyr108; Eck SM, 2009, MOL CANCER RES, V7, P1033, DOI 10.1158/1541-7786.MCR-09-0015; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Ghio P, 2006, CLIN LUNG CANCER, V7, P395, DOI 10.3816/CLC.2006.n.023; Giricz Orsi, 2010, J Biomol Tech, V21, P194; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grisaru-Granovsky S, 2005, INT J CANCER, V113, P372, DOI 10.1002/ijc.20607; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; Kamath L, 2001, CANCER RES, V61, P5933; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kuliopulos A, 2003, LIFE SCI, V74, P255, DOI 10.1016/j.lfs.2003.09.012; Liao MM, 2012, PATHOL ONCOL RES, V18, P397, DOI 10.1007/s12253-011-9458-8; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Murray GI, 1998, J PATHOL, V185, P256; Nakopoulou L, 1999, HUM PATHOL, V30, P436, DOI 10.1016/S0046-8177(99)90120-X; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Nikkola J, 2002, INT J CANCER, V97, P432, DOI 10.1002/ijc.1636; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Pfaffen S, 2010, EXP CELL RES, V316, P836, DOI 10.1016/j.yexcr.2009.11.004; Poola I, 2005, NAT MED, V11, P481, DOI 10.1038/nm1243; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rutter JL, 1998, CANCER RES, V58, P5321; Ryu B, 2011, J INVEST DERMATOL, V131, P1579, DOI 10.1038/jid.2011.65; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Shah SA, 2010, J THORAC CARDIOV SUR, V139, P984, DOI 10.1016/j.jtcvs.2009.12.016; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Swift S, 2000, J BIOL CHEM, V275, P2627, DOI 10.1074/jbc.275.4.2627; Tomita M, 2007, TOXICOLOGY, V231, P200, DOI 10.1016/j.tox.2006.12.005; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Ugalde AP, 2010, METHODS MOL BIOL, V622, P3, DOI 10.1007/978-1-60327-299-5_1; VAIDYA AB, 1978, VIROLOGY, V90, P12, DOI 10.1016/0042-6822(78)90328-8; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Villares GJ, 2008, CANCER RES, V68, P9078, DOI 10.1158/0008-5472.CAN-08-2397; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Whitehead IP, 2001, ONCOGENE, V20, P1547, DOI 10.1038/sj.onc.1204188; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Ye S, 2001, CANCER RES, V61, P1296	71	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24330	24338		10.1074/jbc.M112.356303	http://dx.doi.org/10.1074/jbc.M112.356303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22573325	Green Published, hybrid			2022-12-25	WOS:000306651100027
J	Hou, S; Wieczorek, SA; Kaminski, TS; Ziebacz, N; Tabaka, M; Sorto, NA; Foss, MH; Shaw, JT; Thanbichler, M; Weibel, DB; Nieznanski, K; Holyst, R; Garstecki, P				Hou, Sen; Wieczorek, Stefan A.; Kaminski, Tomasz S.; Ziebacz, Natalia; Tabaka, Marcin; Sorto, Nohemy A.; Foss, Marie H.; Shaw, Jared T.; Thanbichler, Martin; Weibel, Douglas B.; Nieznanski, Krzysztof; Holyst, Robert; Garstecki, Piotr			Characterization of Caulobacter crescentus FtsZ Protein Using Dynamic Light Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL DIVISION; MYCOBACTERIUM-TUBERCULOSIS FTSZ; SYMMETRIC TOP MACROMOLECULES; ESCHERICHIA-COLI; CIRCULAR-CYLINDERS; ASSEMBLY DYNAMICS; RING FORMATION; POLYMERIZATION; VISUALIZATION; CYTOSKELETON	The self-assembly of the tubulin homologue FtsZ at the mid-cell is a critical step in bacterial cell division. We introduce dynamic light scattering (DLS) spectroscopy as a new method to study the polymerization kinetics of FtsZ in solution. Analysis of the DLS data indicates that the FtsZ polymers are remarkably monodisperse in length, independent of the concentrations of GTP, GDP, and FtsZ monomers. Measurements of the diffusion coefficient of the polymers demonstrate that their length is remarkably stable until the free GTP is consumed. We estimated the mean size of the FtsZ polymers within this interval of stable length to be between 9 and 18 monomers. The rates of FtsZ polymerization and depolymerization are likely influenced by the concentration of GDP, as the repeated addition of GTP to FtsZ increased the rate of polymerization and slowed down depolymerization. Increasing the FtsZ concentration did not change the size of FtsZ polymers; however, it increased the rate of the depolymerization reaction by depleting free GTP. Using transmission electron microscopy we observed that FtsZ forms linear polymers in solutions which rapidly convert to large bundles upon contact with surfaces at time scales as short as several seconds. Finally, the best studied small molecule that binds to FtsZ, PC190723, had no stabilizing effect on Caulobacter crescentus FtsZ filaments in vitro, which complements previous studies with Escherichia coli FtsZ and confirms that this class of small molecules binds Gram-negative FtsZ weakly.	[Hou, Sen; Wieczorek, Stefan A.; Kaminski, Tomasz S.; Ziebacz, Natalia; Tabaka, Marcin; Holyst, Robert; Garstecki, Piotr] Polish Acad Sci, Inst Phys Chem, PL-01224 Warsaw, Poland; [Sorto, Nohemy A.; Shaw, Jared T.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Foss, Marie H.; Weibel, Douglas B.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Thanbichler, Martin] Philipps Univ, Max Planck Inst Terr Microbiol, LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany; [Thanbichler, Martin] Philipps Univ, Fac Biol, D-35043 Marburg, Germany; [Nieznanski, Krzysztof] Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; Philipps University Marburg; Philipps University Marburg; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Holyst, R (corresponding author), Polish Acad Sci, Inst Phys Chem, Kasprzaka 44-52, PL-01224 Warsaw, Poland.	holyst@ptys.ichf.edu.pl; garst@ichf.edu.pl	Kaminski, Tomasz/AAD-6449-2020; hou, sen/B-6733-2011; Thanbichler, Martin/E-6035-2010; Garstecki, Piotr/ABA-9188-2020; Nieznanski, Krzysztof/R-4220-2016	Kaminski, Tomasz/0000-0001-5124-4548; hou, sen/0000-0002-6871-4419; Garstecki, Piotr/0000-0001-9101-7163; Nieznanski, Krzysztof/0000-0003-0440-2632; Wieczorek, Stefan/0000-0003-4174-3591; Holyst, Robert/0000-0002-3211-4286; Tabaka, Marcin/0000-0002-6166-2820; Shaw, Jared/0000-0001-5190-493X	National Institutes of Health Grant [R01AI08093]; Human Frontier Science Program [RGY0069/2008-C103]; European Union "European Regional Development Fund": NanoFun [POIG.02.02.00-00-025/09]; Foundation for Polish Science [TEAM/2008-2/2]; European Union; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080931] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); European Union "European Regional Development Fund": NanoFun; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported, in whole or in part, by National Institutes of Health Grant R01AI08093 (to J.T.S.). This work was also supported by Collaborative Research Grant RGY0069/2008-C103 from the Human Frontier Science Program (to P.G., M.T., and D.B.W.) and by programs co-financed by the European Union "European Regional Development Fund": NanoFun POIG.02.02.00-00-025/09 and TEAM/2008-2/2 operated by the Foundation for Polish Science. Microscopic studies were performed in the Laboratory of Electron Microscopy (Nencki Institute of Experimental Biology, Warsaw, Poland) using equipment installed within the project sponsored by the European Union Structural Funds: Centre of Advanced Technology BIM, equipment purchase for the Laboratory of Biological and Medical Imaging.	Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Andreu JM, 2010, J BIOL CHEM, V285, P14239, DOI 10.1074/jbc.M109.094722; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BLOOMFIE.V, 1967, BIOPOLYMERS, V5, P135, DOI 10.1002/bip.1967.360050202; Casini GL, 2004, VIROLOGY, V325, P320, DOI 10.1016/j.virol.2004.04.034; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Hamon L, 2009, LANGMUIR, V25, P3331, DOI 10.1021/la8035743; Harry EJ, 2001, MOL MICROBIOL, V40, P795, DOI 10.1046/j.1365-2958.2001.02370.x; Hou S, 2011, SOFT MATTER, V7, P6967, DOI 10.1039/c1sm05449j; Kiessling J, 2000, J CELL BIOL, V151, P945, DOI 10.1083/jcb.151.4.945; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Paez A, 2009, SOFT MATTER, V5, P2625, DOI 10.1039/b902935d; Popp D, 2010, J BIOL CHEM, V285, P11281, DOI 10.1074/jbc.M109.084079; Quardokus EM, 2002, MOL MICROBIOL, V45, P605, DOI 10.1046/j.1365-2958.2002.03040.x; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; SEILS J, 1995, MACROMOLECULES, V28, P661, DOI 10.1021/ma00107a001; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Sorto NA, 2010, J ORG CHEM, V75, P7946, DOI 10.1021/jo101720y; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; TIRADO MM, 1979, J CHEM PHYS, V71, P2581, DOI 10.1063/1.438613; TIRADO MM, 1980, J CHEM PHYS, V73, P1986, DOI 10.1063/1.440288; VANDESANDE W, 1985, J PHYS CHEM-US, V89, P404, DOI 10.1021/j100249a007; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; Wyatt PJ, 1998, J COLLOID INTERF SCI, V197, P9, DOI 10.1006/jcis.1997.5215	38	18	19	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23878	23886		10.1074/jbc.M111.309492	http://dx.doi.org/10.1074/jbc.M111.309492			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22573335	hybrid, Green Published			2022-12-25	WOS:000306511300058
J	Moriyama, K; Yoshizawa-Sugata, N; Obuse, C; Tsurimoto, T; Masai, H				Moriyama, Kenji; Yoshizawa-Sugata, Naoko; Obuse, Chikashi; Tsurimoto, Toshiki; Masai, Hisao			Epstein-Barr Nuclear Antigen 1 (EBNA1)-dependent Recruitment of Origin Recognition Complex (Orc) on oriP of Epstein-Barr Virus with Purified Proteins STIMULATION BY Cdc6 THROUGH ITS DIRECT INTERACTION WITH EBNA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATENT REPLICATION ORIGIN; DNA-REPLICATION; PLASMID REPLICATION; HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; BINDING PROTEIN; T-ANTIGEN; IN-VITRO; TRANSCRIPTION	Origin recognition complex (Orc) plays an essential role in directing assembly of prereplicative complex at selective sites on chromosomes. However, Orc from vertebrates is reported to bind to DNA in a sequence-nonspecific manner, and it is still unclear how it selects specific genomic loci and how Cdc6, another conserved AAA(+) factor known to interact with Orc, participates in this process. Replication from oriP, the latent origin of Epstein-Barr virus, provides an excellent model system for the study of initiation on the host chromosomes because it is known to depend on prereplicative complex factors, including Orc and Mcm. Here, we show that Orc is recruited selectively at the essential dyad symmetry element in nuclear extracts in a manner dependent on EBNA1, which specifically binds to dyad symmetry. With purified proteins, EBNA1 can recruit both Cdc6 and Orc independently on a DNA containing EBNA1 binding sites, and Cdc6 facilitates the Orc recruitment by EBNA1. Purified Cdc6 directly binds to EBNA1, whereas association of Orc with EBNA1 requires the presence of the oriP DNA. Nuclease protection assays suggest that Orc associates with DNA segments on both sides adjacent to the EBNA1 binding sites and that this process is stimulated by the presence of Cdc6. Thus, EBNA1 can direct localized assembly of Orc in a process that is facilitated by Cdc6. The possibility of similar modes of recruitment of Orc/Cdc6 at the human chromosomal origins will be discussed.	[Moriyama, Kenji; Yoshizawa-Sugata, Naoko; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Dept Genome Med, Setagaya Ku, Tokyo 1568506, Japan; [Obuse, Chikashi] Hokkaido Univ, Div Mol Life Sci, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Tsurimoto, Toshiki] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan	Tokyo Metropolitan Institute of Medical Science; Hokkaido University; Kyushu University	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Dept Genome Med, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	masai-hs@igakuken.or.jp	Obuse, Chikashi/F-5273-2011	Tsurimoto, Toshiki/0000-0001-7597-2216; Yoshizawa-Sugata, Naoko/0000-0001-8792-8669	Ministry of Education, Culture, Sports, Science, and Technology of Japan [14208079, 17570125, 17080014]; Grants-in-Aid for Scientific Research [23657081, 23570243] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (A) 14208079 (to H.M.), Grant-in-Aid for Scientific Research (C) 17570125 (to K.M.), and Grant-in-Aid for Scientific Research on Priority Area "Chromosome Cycle" 17080014 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H.M.).	Aiyar A, 1998, EMBO J, V17, P6394, DOI 10.1093/emboj/17.21.6394; Almqvist J, 2005, J GEN VIROL, V86, P1261, DOI 10.1099/vir.0.80620-0; AMBINDER RF, 1990, J VIROL, V64, P2369, DOI 10.1128/JVI.64.5.2369-2379.1990; Atanasiu C, 2006, EMBO REP, V7, P716, DOI 10.1038/sj.embor.7400730; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; Bochkarev A, 1998, J MOL BIOL, V284, P1273, DOI 10.1006/jmbi.1998.2247; Borestrom C, 2012, J GEN VIROL, V93, P1065, DOI 10.1099/vir.0.038752-0; BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Chaudhuri B, 2001, P NATL ACAD SCI USA, V98, P10085, DOI 10.1073/pnas.181347998; Chen ZQ, 2008, P NATL ACAD SCI USA, V105, P10326, DOI 10.1073/pnas.0803829105; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; Deng Z, 2002, MOL CELL, V9, P493, DOI 10.1016/S1097-2765(02)00476-8; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRAPPIER L, 1992, J VIROL, V66, P1786, DOI 10.1128/JVI.66.3.1786-1790.1992; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; HEARING J, 1992, J VIROL, V66, P694, DOI 10.1128/JVI.66.2.694-705.1992; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Hirai K, 2001, CURR TOP MICROBIOL, V258, P13; Kanda T, 2001, MOL CELL BIOL, V21, P3576, DOI 10.1128/MCB.21.10.3576-3588.2001; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; Koons MD, 2001, J VIROL, V75, P10582, DOI 10.1128/JVI.75.22.10582-10592.2001; KOWALSKI D, 1984, NUCLEIC ACIDS RES, V12, P7071, DOI 10.1093/nar/12.18.7071; KRYSAN PJ, 1989, MOL CELL BIOL, V9, P1026, DOI 10.1128/MCB.9.3.1026; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; Lim C, 2002, J VIROL, V76, P10320, DOI 10.1128/JVI.76.20.10320-10331.2002; Liu SX, 2011, P NATL ACAD SCI USA, V108, P7373, DOI 10.1073/pnas.1013676108; Mackey D, 1999, MOL CELL BIOL, V19, P3349, DOI 10.1128/mcb.19.5.3349; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Matsunaga F, 2010, EXTREMOPHILES, V14, P21, DOI 10.1007/s00792-009-0284-9; Minami H, 2006, MOL CELL BIOL, V26, P8770, DOI 10.1128/MCB.00949-06; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Natale DA, 2000, EMBO J, V19, P2728, DOI 10.1093/emboj/19.11.2728; Norseen J, 2008, EMBO J, V27, P3024, DOI 10.1038/emboj.2008.221; Ohta S, 2003, J BIOL CHEM, V278, P41535, DOI 10.1074/jbc.M307535200; PARSONS R, 1990, J VIROL, V64, P509, DOI 10.1128/JVI.64.2.509-518.1990; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; Saitoh Y, 2002, NUCLEIC ACIDS RES, V30, P5205, DOI 10.1093/nar/gkf642; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; SEXTON CJ, 1989, J VIROL, V63, P5505, DOI 10.1128/JVI.63.12.5505-5508.1989; SHALLOWAY D, 1980, CELL, V20, P411, DOI 10.1016/0092-8674(80)90627-3; Shirakata M, 1998, J BIOCHEM-TOKYO, V123, P175; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Sideridou M, 2011, J CELL BIOL, V195, P1123, DOI 10.1083/jcb.201108121; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Tanaka T, 2006, J BIOL CHEM, V281, P3484, DOI 10.1074/jbc.M510979200; Tatsumi Y, 2003, J BIOL CHEM, V278, P41528, DOI 10.1074/jbc.M307534200; Tempera I, 2010, BBA-GENE REGUL MECH, V1799, P236, DOI 10.1016/j.bbagrm.2009.10.004; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang LD, 2005, J CELL BIOCHEM, V94, P247, DOI 10.1002/jcb.20324; Wu H, 2002, J VIROL, V76, P2480, DOI 10.1128/JVI.76.5.2480-2490.2002; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Zhou J, 2010, J VIROL, V84, P4979, DOI 10.1128/JVI.01300-09; Zhou J, 2009, J VIROL, V83, P2154, DOI 10.1128/JVI.02115-08	68	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23977	23994		10.1074/jbc.M112.368456	http://dx.doi.org/10.1074/jbc.M112.368456			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589552	Green Published, hybrid			2022-12-25	WOS:000306511300067
J	Pollak, AJ; Reich, NO				Pollak, Adam J.; Reich, Norbert O.			Proximal Recognition Sites Facilitate Intrasite Hopping by DNA Adenine Methyltransferase MECHANISTIC EXPLORATION OF EPIGENETIC GENE REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE VARIATION; DAM; METHYLATION; PROTEIN; TARGET; STRANDS; TRANSLOCATION; GLYCOSYLASE; PATHWAYS; SEQUENCE	The methylation of adenine in palindromic 5'-GATC-3' sites by Escherichia coli Dam supports diverse roles, including the essential regulation of virulence genes in several human pathogens. As a result of a unique hopping mechanism, Dam methylates both strands of the same site prior to fully dissociating from the DNA, a process referred to as intrasite processivity. The application of a DpnI restriction endonuclease-based assay allowed the direct interrogation of this mechanism with a variety of DNA substrates. Intrasite processivity is disrupted when the DNA flanking a single GATC site is longer than 400 bp on either side. Interestingly, the introduction of a second GATC site within this flanking DNA reinstates intrasite methylation of both sites. Our results show that intrasite methylation occurs only when GATC sites are clustered, as is found in gene segments both known and postulated to undergo in vivo epigenetic regulation by Dam methylation. We propose a model for intrasite methylation in which Dam bound to flanking DNA is an obligate intermediate. Our results provide insights into how intrasite processivity, which appears to be context-dependent, may contribute to the diverse biological roles that are carried out by Dam.	[Pollak, Adam J.; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu						BOYE E, 1992, J BACTERIOL, V174, P1682, DOI 10.1128/jb.174.5.1682-1685.1992; Broadbent SE, 2010, MOL MICROBIOL, V77, P337, DOI 10.1111/j.1365-2958.2010.07203.x; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Coffin SR, 2008, J BIOL CHEM, V283, P20106, DOI 10.1074/jbc.M802502200; Coffin SR, 2009, J BIOL CHEM, V284, P18390, DOI 10.1074/jbc.M109.005876; Coffin SR, 2009, BIOCHEMISTRY-US, V48, P7399, DOI 10.1021/bi9008006; Fersht A., 1998, STRUCTURE MECH PROTE, P143; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Handa V, 2005, J MOL BIOL, V348, P1103, DOI 10.1016/j.jmb.2005.02.044; Hedglin M, 2010, ACS CHEM BIOL, V5, P427, DOI 10.1021/cb1000185; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Kaminska R, 2010, J BACTERIOL, V192, P1937, DOI 10.1128/JB.01629-09; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Mashhoon N, 2004, J BIOL CHEM, V279, P52075, DOI 10.1074/jbc.M408182200; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Rau DC, 2010, J MOL BIOL, V395, P408, DOI 10.1016/j.jmb.2009.10.049; RINGQUIST S, 1992, P NATL ACAD SCI USA, V89, P4539, DOI 10.1073/pnas.89.10.4539; Sasnauskas G, 2011, NUCLEIC ACIDS RES, V39, P8844, DOI 10.1093/nar/gkr588; Sasnauskas G, 2010, NUCLEIC ACIDS RES, V38, P2399, DOI 10.1093/nar/gkp1194; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Tafvizi A, 2011, CHEMPHYSCHEM, V12, P1481, DOI 10.1002/cphc.201100112; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; Touzain F, 2011, NAT REV MICROBIOL, V9, P15, DOI 10.1038/nrmicro2477; van der Woude MW, 2011, CURR OPIN MICROBIOL, V14, P205, DOI 10.1016/j.mib.2011.01.002; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Zhou HX, 2011, P NATL ACAD SCI USA, V108, P8651, DOI 10.1073/pnas.1101555108; Zinoviev VV, 2007, BIOL CHEM, V388, P1199, DOI 10.1515/BC.2007.142	34	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22873	22881		10.1074/jbc.M111.332502	http://dx.doi.org/10.1074/jbc.M111.332502			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570478	Green Published, hybrid			2022-12-25	WOS:000306495000044
J	Wang, CJ; Tang, SM; Wilkes, A; Jiang, YY; Han, GD; Huang, D				Wang, Cheng-Jie; Tang, Shi-Ming; Wilkes, Andreas; Jiang, Yuan-Yuan; Han, Guo-Dong; Huang, Ding			Effect of Stocking Rate on Soil-Atmosphere CH4 Flux during Spring Freeze-Thaw Cycles in a Northern Desert Steppe, China	PLOS ONE			English	Article							CARBON-DIOXIDE; METHANE UPTAKE; INNER; GRASSLANDS; CATTLE; IMPACT; SHEEP	Background: Methane (CH4) uptake by steppe soils is affected by a range of specific factors and is a complex process. Increased stocking rate promotes steppe degradation, with unclear consequences for gas exchanges. To assess the effects of grazing management on CH4 uptake in desert steppes, we investigated soil-atmosphere CH4 exchange during the winter-spring transition period. Methodology/Main Finding: The experiment was conducted at twelve grazing plots denoting four treatments defined along a grazing gradient with three replications: non-grazing (0 sheep/ha, NG), light grazing (0.75 sheep/ha, LG), moderate grazing (1.50 sheep/ha, MG) and heavy grazing (2.25 sheep/ha, HG). Using an automatic cavity ring-down spectrophotometer, we measured CH4 fluxes from March 1 to April 29 in 2010 and March 2 to April 27 in 2011. According to the status of soil freeze-thaw cycles (positive and negative soil temperatures occurred in alternation), the experiment was divided into periods I and II. Results indicate that mean CH4 uptake in period I (7.51 mu g CH4-C m(-2) h(-1)) was significantly lower than uptake in period II (83.07 mu g CH4-C m(-2) h(-1)). Averaged over 2 years, CH4 fluxes during the freeze-thaw period were -84.76 mu g CH4-C m(-2) h(-1) (NG), -88.76 mu g CH4-C m(-2) h(-1) (LG), -64.77 mu g CH4-C m(-2) h(-1) (MG) and -28.80 mu g CH4-C m(-2) h(-1) (HG). Conclusions/Significance: CH4 uptake activity is affected by freeze-thaw cycles and stocking rates. CH4 uptake is correlated with the moisture content and temperature of soil. MG and HG decreases CH4 uptake while LG exerts a considerable positive impact on CH4 uptake during spring freeze-thaw cycles in the northern desert steppe in China.	[Wang, Cheng-Jie; Tang, Shi-Ming; Jiang, Yuan-Yuan; Han, Guo-Dong] Inner Mongolia Agr Univ, Coll Ecol & Environm Sci, Hohhot, Peoples R China; [Wilkes, Andreas] World Agroforestry Ctr, Beijing, Peoples R China; [Huang, Ding] China Agr Univ, Inst Grassland Sci, Beijing 100094, Peoples R China	Inner Mongolia Agricultural University; China Agricultural University	Wang, CJ (corresponding author), Inner Mongolia Agr Univ, Coll Ecol & Environm Sci, Hohhot, Peoples R China.	cjwang3@sohu.com	jiang, anyi/GPT-0379-2022; han, guodong/A-2303-2013; Wang, Chengjie/A-3984-2013		Chinese National Natural Science Foundation [31160109, 30960072, 31070413]; Inner Mongolia Palmary Youth Project [2010JQ04]; National Commonweal Project [200903060, 201003019]; Inner Mongolia Agricultural University Innovation Group [NDTD2010-5]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Inner Mongolia Palmary Youth Project; National Commonweal Project; Inner Mongolia Agricultural University Innovation Group	This research was funded by the Chinese National Natural Science Foundation (31160109, 30960072, 31070413), Inner Mongolia Palmary Youth Project (2010JQ04), and National Commonweal Project (200903060, 201003019), Inner Mongolia Agricultural University Innovation Group (NDTD2010-5) and Management and Policy Support to Combat Land Degradation Project: PRC-GEF Partnership on Land Degradation in Dryland Ecosystems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, SPSS STAT PACK SOC S; Aronson EL, 2010, ECOLOGY, V91, P3242, DOI 10.1890/09-2185.1; Chen WW, 2011, GLOBAL CHANGE BIOL, V17, P2803, DOI 10.1111/j.1365-2486.2011.02444.x; Clegg CD, 2006, APPL SOIL ECOL, V31, P73, DOI 10.1016/j.apsoil.2005.04.003; Dorsch P, 2004, NUTR CYCL AGROECOSYS, V70, P117, DOI 10.1023/B:FRES.0000048473.11362.63; Holst J, 2008, PLANT SOIL, V308, P105, DOI 10.1007/s11104-008-9610-8; IPCC [Intergovernmental Panel on Climate Change], 2007, CONTR WORK GROUP 3 4; Jiang YY, 2012, ASIAN AUSTRAL J ANIM, V25, P207, DOI 10.5713/ajas.2011.11261; Kotelnikova S, 2002, EARTH-SCI REV, V58, P367, DOI 10.1016/S0012-8252(01)00082-4; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Li CL, 2008, AGR ECOSYST ENVIRON, V128, P109, DOI 10.1016/j.agee.2008.05.008; LIAO G, 1996, GRASSLAND RESOURCE C; Liu CY, 2007, ATMOS ENVIRON, V41, P5948, DOI 10.1016/j.atmosenv.2007.03.017; Mosier AR, 1996, GLOBAL BIOGEOCHEM CY, V10, P387, DOI 10.1029/96GB01454; NSBC (National Statistics Bureau of China), 2002, CHIN STAT YB 2002; Pietola L, 2005, SOIL TILL RES, V82, P99, DOI 10.1016/j.still.2004.08.004; [齐玉春 Qi Yuchun], 2005, [资源科学, Resources science], V27, P103; Rivkina EM, 2000, APPL ENVIRON MICROB, V66, P3230, DOI 10.1128/AEM.66.8.3230-3233.2000; Sharma S, 2006, APPL ENVIRON MICROB, V72, P2148, DOI 10.1128/AEM.72.3.2148-2154.2006; Smith KA, 2003, EUR J SOIL SCI, V54, P779, DOI 10.1046/j.1351-0754.2003.0567.x; Soussana JF, 2004, SOIL USE MANAGE, V20, P219, DOI 10.1079/SUM2003234; van den Pol-van Dasselaar A, 1998, PLANT SOIL, V204, P213, DOI 10.1023/A:1004371309361; Wager C, 1996, APPL ENVIRON MICROB, V62, P494; Wang YS, 2005, CHEMOSPHERE, V58, P205, DOI 10.1016/j.chemosphere.2004.04.043; Wolf B, 2010, NATURE, V464, P881, DOI 10.1038/nature08931; Zhou XQ, 2008, NUTR CYCL AGROECOSYS, V80, P145, DOI 10.1007/s10705-007-9127-1	26	15	17	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36794	10.1371/journal.pone.0036794	http://dx.doi.org/10.1371/journal.pone.0036794			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590610	gold, Green Submitted, Green Published			2022-12-25	WOS:000305335500029
J	Guo, Y; Wang, YX; Xu, L; Jonas, JB				Guo, Yin; Wang, Ya Xing; Xu, Liang; Jonas, Jost B.			Five-Year Follow-Up of Parapapillary Atrophy: The Beijing Eye Study	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OPTIC-NERVE DAMAGE; VISUAL-FIELD DAMAGE; OPEN-ANGLE GLAUCOMA; PERIPAPILLARY ATROPHY; CHORIORETINAL ATROPHY; OCULAR HYPERTENSION; DISC MORPHOLOGY; PROGRESSION; POPULATION	Purpose: To assess longitudinal changes in parapapillary atrophy in the adult population of Greater Beijing. Methods: The population-based Beijing Eye Study 2006 included 3251 subjects who had participated in the Beijing Eye Study 2001 and returned for re-examination. The mean age was 60.4 +/- 10.1 years. Using optic disc photographs, we measured parapapillary atrophy which was divided into alpha zone and beta zone. Results: Overall progression rate of alpha zone was seen in 0.6 +/- 0.1% (95% confidence interval (CI): 0.3,0.9) of the subjects and of beta zone in 8.2 +/- 0.5% (95% CI: 7.2,9.1) of the subjects. In binary regression analysis, rate of progression of alpha zone was significantly associated higher age (P = 0.04) and the co-progression of zone Beta (P<0.001). Rate of progression of beta zone was significantly associated with higher age (P< 0.001; odds ratio (OR): 1.11; 95% CI: 1.10,1.14), higher intraocular pressure (P<0.001; OR: 1.10; 95% CI: 1.05,1.14), higher myopic refractive error (P<0.001; OR: 0.71; 95% CI: 0.67,0.75), rural region of habitation (P = 0.002; OR: 0.58; 95% CI: 0.41,0.82), presence of glaucomatous optic nerve damage (P<0.001; OR: 2.89; 95% CI: 1.62,5.14), co-progression of alpha zone (P<0.001; OR: 7.13; 95% CI: 2.43,20.9), absence of arterial hypertension (P = 0.03; OR: 0.70; 95% CI: 0.51,0.96), and thicker central corneal thickness (P = 0.02; OR: 1.01; 95% CI: 1.00,1.01). Subjects with a non-glaucomatous optic nerve damage (n = 22) as compared to the remaining subjects did not vary in the progression rate of alpha zone (0.0% versus 0.6 +/- 0.1%; P = 1.0) and beta zone (8.2 +/- 0.5% versus 6.3 +/- 0.6%; P = 1.0). Conclusions: In adult Chinese in Greater Beijing, the 5-year progression rate of beta zone of parapapillary atrophy (seen in 8.2 +/- 0.5% of subjects) was significantly correlated with higher age, rural region of habitation, absence of arterial hypertension, higher intraocular pressure, higher myopic refractive error, thicker central corneal thickness, and presence of glaucoma. It was not associated with non-glaucomatous optic nerve damage.	[Guo, Yin; Wang, Ya Xing; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Guo, Y (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@gmail.com	wang, YA XING/K-9671-2016; Guo, Yin/ABC-2134-2020	wang, YA XING/0000-0003-2749-7793; Guo, Yin/0000-0003-3806-3771	National Key Laboratory Fund, Beijing, China; Beijing Natural Science Foundation, Beijing, China	National Key Laboratory Fund, Beijing, China; Beijing Natural Science Foundation, Beijing, China(Beijing Natural Science Foundation)	This work is supported by the National Key Laboratory Fund, Beijing, China, and the Beijing Natural Science Foundation, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAIE M, 1994, OPHTHALMOLOGY, V101, P1440; Bucklers M., 1929, ARCH OPHTHALMOL-CHIC, V121, P243; De Moraes CGV, 2011, ARCH OPHTHALMOL-CHIC, V129, P562, DOI 10.1001/archophthalmol.2011.72; Elschnig A., 1901, DENKSCHR AKAD WISS, V70, P219; Emdadi A, 1999, AM J OPHTHALMOL, V128, P595, DOI 10.1016/S0002-9394(99)00189-0; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Hayreh SS, 2001, OPHTHALMOLOGY, V108, P1586, DOI 10.1016/S0161-6420(01)00649-2; Jonas JB, 1999, AM J OPHTHALMOL, V127, P523, DOI 10.1016/S0002-9394(99)00030-6; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; Jonas JB, 1997, GRAEF ARCH CLIN EXP, V235, P627, DOI 10.1007/BF00946938; Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Kawano J, 2006, AM J OPHTHALMOL, V142, P40, DOI 10.1016/j.ajo.2006.01.087; Kono Y, 1999, AM J OPHTHALMOL, V127, P674, DOI 10.1016/S0002-9394(99)00045-8; Lee EJ, 2011, INVEST OPHTH VIS SCI, V52, P4422, DOI 10.1167/iovs.10-6818; PANDAJONAS S, 1994, OPHTHALMOLOGY, V101, P519; Park KH, 1996, OPHTHALMOLOGY, V103, P1899, DOI 10.1016/S0161-6420(96)30409-0; Park SC, 2010, INVEST OPHTH VIS SCI, V51, P6408, DOI 10.1167/iovs.09-5100; Primrose J, 1971, T OPHTHAL SOC UK, V89, P585; Radcliffe NM, 2008, AM J OPHTHALMOL, V146, P735, DOI 10.1016/j.ajo.2008.06.018; Ramrattan RS, 1999, OPHTHALMOLOGY, V106, P1588, DOI 10.1016/S0161-6420(99)90457-8; Sugiyama K, 1997, OPHTHALMOLOGY, V104, P1926, DOI 10.1016/S0161-6420(97)30005-0; Teng CC, 2010, OPHTHALMOLOGY, V117, P909, DOI 10.1016/j.ophtha.2009.10.016; Tezel G, 1997, ARCH OPHTHALMOL-CHIC, V115, P1503, DOI 10.1001/archopht.1997.01100160673001; Tezel G, 1997, ARCH OPHTHALMOL-CHIC, V115, P1509, DOI 10.1001/archopht.1997.01100160679003; Tezel G, 2001, ARCH OPHTHALMOL-CHIC, V119, P813; Uchida H, 1998, OPHTHALMOLOGY, V105, P1541, DOI 10.1016/S0161-6420(98)98044-7; Wang Y, 2008, EYE, V22, P261, DOI 10.1038/sj.eye.6702601; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; WILENSKY JT, 1976, AM J OPHTHALMOL, V81, P341, DOI 10.1016/0002-9394(76)90251-8; Xu L, 2007, AM J OPHTHALMOL, V144, P541, DOI 10.1016/j.ajo.2007.05.038; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071; You QS, 2011, OPHTHALMOLOGY, V118, P1069, DOI 10.1016/j.ophtha.2010.09.032	34	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e32005	10.1371/journal.pone.0032005	http://dx.doi.org/10.1371/journal.pone.0032005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586440	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000002
J	Mao, C; Zhou, JH; Yang, ZY; Huang, YF; Wu, XY; Shen, H; Tang, JL; Chen, Q				Mao, Chen; Zhou, Junhua; Yang, Zuyao; Huang, Yafang; Wu, Xinyin; Shen, Hong; Tang, Jinling; Chen, Qing			KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer	PLOS ONE			English	Article							TARGETED MONOCLONAL-ANTIBODIES; CETUXIMAB PLUS IRINOTECAN; K-RAS; EGFR; CHEMOTHERAPY; BENEFIT; DETERMINANTS; ASSOCIATION; PANITUMUMAB; RESISTANCE	Background: To investigate the frequency and relationship of the KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer (CRC). Methodology/Principal Findings: Genomic DNA was extracted from the formalin-fixed paraffin-embedded (FFPE) tissues of 69 patients with histologically confirmed CRC. Automated sequencing analysis was conducted to detect mutations in the KRAS (codons 12, 13, and 14), BRAF (codon 600) and PIK3CA (codons 542, 545 and 1047). PTEN protein expression was evaluated by immunohistochemistry on 3 mm FFPE tissue sections. Statistical analysis was carried out using SPSS 16.0 software. The frequency of KRAS, BRAF and PIK3CA mutations and loss of PTEN expression was 43.9% (25/57), 25.4% (15/59), 8.2% (5/61) and 47.8% (33/69), respectively. The most frequent mutation in KRAS, BRAF and PIK3CA was V14G (26.7% of all mutations), V600E (40.0% of all mutations) and V600L (40.0% of all mutations), and H1047L (80.0% of all mutations), respectivly. Six KRAS mutatant patients (24.0%) harbored BRAF mutations. BRAF and PIK3CA mutations were mutually exclusive. No significant correlation was observed between the four biomarkers and patients' characteristics. Conclusions/Significance: BRAF mutation rate is much higher in this study than in other studies, and overlap a lot with KRAS mutations. Besides, the specific types of KRAS and PIK3CA mutations in Chinese patients could be quite different from that of patients in other countries. Further studies are warranted to examine their impact on prognosis and response to targeted treatment.	[Mao, Chen; Zhou, Junhua; Chen, Qing] So Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Mao, Chen; Yang, Zuyao; Huang, Yafang; Wu, Xinyin; Tang, Jinling] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Shen, Hong] So Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Chinese University of Hong Kong; Southern Medical University - China	Mao, C (corresponding author), So Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.	jltang@cuhk.edu.hk; qingchen@fimmu.com	Mao, Chen/AAW-2742-2020; Tang, JL/G-1759-2013; Mao, Chen/G-9805-2013	Mao, Chen/0000-0002-6537-6215; Mao, Chen/0000-0001-7471-1516				Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Fiore F, 2010, BRIT J CANCER, V103, P1765, DOI 10.1038/sj.bjc.6606008; Food and Drug Administration, 2011, CLASS LAB CHANG ANT; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Freeman DJ, 2008, CLIN COLORECTAL CANC, V7, P184, DOI 10.3816/CCC.2008.n.024; He X, 2009, MODERN PRACTICAL MED, V21, P698; Huang WF, 2010, MED J CHIN PAPF, V21, P925; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Li HT, 2011, ONCOL REP, V25, P1691, DOI 10.3892/or.2011.1217; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; Liou JM, 2011, INT J COLORECTAL DIS, V26, P1387, DOI 10.1007/s00384-011-1229-1; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Lu X, 2009, CANC RES CLIN, V21, P596; Lu X, 2009, CANC RES CLIN, V21, P588; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Molinari F, 2009, BRIT J CANCER, V100, P1087, DOI 10.1038/sj.bjc.6604848; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Negri FV, 2010, BRIT J CANCER, V102, P162, DOI 10.1038/sj.bjc.6605471; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Sartore-Bianchi A, 2010, TARGET ONCOL, V5, P19, DOI 10.1007/s11523-010-0138-5; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Schrag D, 2004, NEW ENGL J MED, V351, P317, DOI 10.1056/NEJMp048143; Shen H, 2011, WORLD J GASTROENTERO, V17, P809, DOI 10.3748/wjg.v17.i6.809; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Tol J, 2010, CLIN THER, V32, P437, DOI 10.1016/j.clinthera.2010.03.012; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Vaughn CP, 2011, GENE CHROMOSOME CANC, V50, P307, DOI 10.1002/gcc.20854	38	54	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36653	10.1371/journal.pone.0036653	http://dx.doi.org/10.1371/journal.pone.0036653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586484	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335000045
J	Saikolappan, S; Estrella, J; Sasindran, SJ; Khan, A; Armitige, LY; Jagannath, C; Dhandayuthapani, S				Saikolappan, Sankaralingam; Estrella, Jaymie; Sasindran, Smitha J.; Khan, Arshad; Armitige, Lisa Y.; Jagannath, Chinnaswamy; Dhandayuthapani, Subramanian			The fbpA/sapM Double Knock Out Strain of Mycobacterium tuberculosis Is Highly Attenuated and Immunogenic in Macrophages	PLOS ONE			English	Article							PROGRESSIVE PULMONARY TUBERCULOSIS; BALB/C MOUSE MODEL; PHAGOSOME MATURATION; PROTECTIVE IMMUNITY; VACCINE EFFICACY; DENDRITIC CELLS; ANTIGEN 85B; PANTOTHENATE AUXOTROPH; MURINE MACROPHAGES; TUBERCLE-BACILLI	Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is the leading cause of death due to bacterial infections in mankind, and BCG, an attenuated strain of Mycobacterium bovis, is an approved vaccine. BCG sequesters in immature phagosomes of antigen presenting cells (APCs), which do not fuse with lysosomes, leading to decreased antigen processing and reduced Th1 responses. However, an Mtb derived Delta fbpA attenuated mutant underwent limited phagosome maturation, enhanced immunogenicity and was as effective as BCG in protecting mice against TB. To facilitate phagosome maturation of Delta fbpA, we disrupted an additional gene sapM, which encodes for an acid phosphatase. Compared to the wild type Mtb, the Delta fbpA Delta sapM (double knock out; DKO) strain was attenuated for growth in mouse macrophages and PMA activated human THP1 macrophages. Attenuation correlated with increased oxidants in macrophages in response to DKO infection and enhanced labeling of lysosomal markers (CD63 and rab7) on DKO phagosomes. An in vitro Antigen 85B peptide presentation assay was used to determine antigen presentation to T cells by APCs infected with DKO or other mycobacterial strains. This revealed that DKO infected APCs showed the strongest ability to present Ag85B to T cells (>2500 pgs/mL in 4 hrs) as compared to APCs infected with wild type Mtb or Delta fbpA or Delta sapM strain (<1000 pgs/mL in 4 hrs), indicating that DKO strain has enhanced immunogenicity than other strains. The ability of DKO to undergo lysosomal fusion and vacuolar acidification correlated with antigen presentation since bafilomycin, that inhibits acidification in APCs, reduced antigen presentation. Finally, the DKO vaccine elicited a better Th1 response in mice after subcutaneous vaccination than either Delta fbpA or Delta sapM. Since Delta fbpA has been used in mice as a candidate vaccine and the DKO (Delta fbpA Delta sapM) mutant is more immunogenic than Delta fbpA, we propose the DKO is a potential anti-tuberculosis vaccine.	[Saikolappan, Sankaralingam; Sasindran, Smitha J.; Dhandayuthapani, Subramanian] Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Edinburg, TX USA; [Saikolappan, Sankaralingam; Sasindran, Smitha J.; Dhandayuthapani, Subramanian] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, Edinburg, TX USA; [Estrella, Jaymie; Khan, Arshad; Armitige, Lisa Y.; Jagannath, Chinnaswamy] Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, Houston, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health Science Center Houston	Saikolappan, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Edinburg, TX USA.	Jagannath@uth.tmc.edu; dhandayutha@uthscsa.edu	Khan, Arshad/E-6855-2015	Khan, Arshad/0000-0003-3655-2854	National Institutes of Health/National Institute of Allergy and Infectious Diseases grants [AI78420, AI49534]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049534, R01AI078420] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grants AI78420 (CJ & SD) and AI49534 (CJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2007, CLIN EXP IMMUNOL, V147, P330, DOI 10.1111/j.1365-2249.2006.03284.x; Aguilar LD, 2006, VACCINE, V24, P2333, DOI 10.1016/j.vaccine.2005.11.051; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2001, TRENDS IMMUNOL, V22, P160, DOI 10.1016/S1471-4906(01)01865-8; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Asensio JAG, 2008, EXPERT OPIN BIOL TH, V8, P201, DOI 10.1517/14712598.8.2.201 ; AUSUBEL F, 1989, CURRENT PRTOCOLS MOL; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brosch R, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P19; Clemens DL, 1996, TRENDS MICROBIOL, V4, P113, DOI 10.1016/0966-842X(96)81528-9; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Copenhaver RH, 2004, INFECT IMMUN, V72, P7084, DOI 10.1128/IAI.72.12.7084-7095.2004; Daniel DS, 2006, J IMMUNOL, V177, P4688, DOI 10.4049/jimmunol.177.7.4688; Dhandayuthapani S, 2007, FRONT BIOSCI-LANDMRK, V12, P4676, DOI 10.2741/2417; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Festjens N, 2011, EMBO MOL MED, V3, P222, DOI 10.1002/emmm.201000125; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Henao-Tamayo M, 2007, VACCINE, V25, P7153, DOI 10.1016/j.vaccine.2007.07.042; Hess J, 1998, P NATL ACAD SCI USA, V95, P5299, DOI 10.1073/pnas.95.9.5299; Hinchey J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015857; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Infante E, 2005, CLIN EXP IMMUNOL, V141, P21, DOI 10.1111/j.1365-2249.2005.02832.x; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Jackson M, 1999, INFECT IMMUN, V67, P2867, DOI 10.1128/IAI.67.6.2867-2873.1999; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Katti MK, 2008, CELL MICROBIOL, V10, P1286, DOI 10.1111/j.1462-5822.2008.01126.x; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Larsen MH, 2009, VACCINE, V27, P4709, DOI 10.1016/j.vaccine.2009.05.050; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; Orme IA, 2005, MICROBES INFECT, V7, P905, DOI 10.1016/j.micinf.2005.03.008; PANCHOLI P, 1993, SCIENCE, V260, P984, DOI 10.1126/science.8098550; Pando RH, 2010, INFECT IMMUN, V78, P3168, DOI 10.1128/IAI.00023-10; Parida SK, 2010, CURR OPIN IMMUNOL, V22, P374, DOI 10.1016/j.coi.2010.04.006; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pavelka MS, 2003, INFECT IMMUN, V71, P4190, DOI 10.1128/IAI.71.7.4190-4192.2003; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Ramachandra L, 2005, INFECT IMMUN, V73, P1097, DOI 10.1128/IAI.73.2.1097-1105.2005; Ramachandra L, 2001, J EXP MED, V194, P1421, DOI 10.1084/jem.194.10.1421; Roche CM, 2011, J VACCINE VACC UNPUB; Roy E, 2006, IMMUNOL LETT, V103, P196, DOI 10.1016/j.imlet.2005.10.011; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Russell DG, 1998, TRENDS MICROBIOL, V6, P212, DOI 10.1016/S0966-842X(98)01286-4; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sambandamurthy VK, 2005, MICROBES INFECT, V7, P955, DOI 10.1016/j.micinf.2005.04.001; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Singh CR, 2006, J IMMUNOL, V177, P3250, DOI 10.4049/jimmunol.177.5.3250; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Soualhine H, 2007, J IMMUNOL, V179, P5137, DOI 10.4049/jimmunol.179.8.5137; VANSOOLINGEN D, 1995, EUR RESPIR J, V8, pS649; Venketaraman V, 2003, TUBERCULOSIS, V83, P311, DOI 10.1016/S1472-9792(03)00050-7; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001	67	34	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36198	10.1371/journal.pone.0036198	http://dx.doi.org/10.1371/journal.pone.0036198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574140	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800036
J	Zhang, ZL; Wu, XM; Duan, J; Hinrichs, D; Wegmann, K; Zhang, GL; Hall, M; Rosenbaum, JT				Zhang, Zili; Wu, Xiumei; Duan, Jie; Hinrichs, David; Wegmann, Keith; Zhang, Gary L.; Hall, Mark; Rosenbaum, James T.			Low Dose Rapamycin Exacerbates Autoimmune Experimental Uveitis	PLOS ONE			English	Article							INDUCED CELL-DEATH; MAMMALIAN TARGET; METABOLIC-REGULATION; T-CELLS; MTOR; SIROLIMUS; ACTIVATION; AUTOPHAGY; EXPRESSION; RESPONSES	Background: Rapamycin, a potent immune modulator, is used to treat transplant rejection and some autoimmune diseases. Uveitis is a potentially severe inflammatory eye disease, and 2 clinical trials of treating uveitis with rapamycin are under way. Unexpectedly, recent research has demonstrated that low dose rapamycin enhances the memory T cell population and function. However, it is unclear how low dose rapamycin influences the immune response in the setting of uveitis. Design and Methods: B10.RIII mice were immunized to induce experimental autoimmune uveitis (EAU). Ocular inflammation of control and rapamycin-treated mice was compared based on histological change. ELISPOT and T cell proliferation assays were performed to assess splenocyte response to ocular antigen. In addition, we examined the effect of rapamycin on activation-induced cell death (AICD) using the MitoCapture assay and Annexin V staining. Results: Administration of low dose rapamycin exacerbated EAU, whereas treating mice with high dose rapamycin attenuated ocular inflammation. The progression of EAU by low dose rapamycin coincided with the increased frequency of antigen-reactive lymphocytes. Lastly, fewer rapamycin-treated T cells underwent AICD, which might contribute to exaggerated ocular inflammation and the uveitogenic immune response. Conclusion: These data reveal a paradoxical role for rapamycin in uveitis in a dose-dependent manner. This study has a potentially important clinical implication as rapamycin might cause unwanted consequences dependent on dosing and pharmacokinetics. Thus, more research is needed to further define the mechanism by which low dose rapamycin augments the immune response.	[Zhang, Zili; Wu, Xiumei; Duan, Jie; Zhang, Gary L.; Hall, Mark] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Hinrichs, David; Wegmann, Keith] Portland VA Med Ctr, Portland, OR USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University	Zhang, ZL (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	zhangzi@ohsu.edu; rosenbaj@ohsu.edu			National Institutes of Health [EY016788, EY013093, EY006484]; Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; Research to Prevent Blindness; William C. Kuzell Foundation; NATIONAL EYE INSTITUTE [R01EY006484, F32EY006484, R01EY013093, K08EY016788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); William C. Kuzell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY016788 (ZZ), EY013093 (JTR), and EY006484 (JTR). Funds from the Stan and Madelle Rosenfeld Family Trust, the William and Mary Bauman Foundation, Research to Prevent Blindness and William C. Kuzell Foundation also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Anglicheau D, 2007, TRANSPL P, V39, P2142, DOI 10.1016/j.transproceed.2007.06.018; Anglicheau D, 2007, PHARMACOGENOMICS, V8, P835, DOI 10.2217/14622416.8.7.835; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Budd RC, 2001, CURR OPIN IMMUNOL, V13, P356, DOI 10.1016/S0952-7915(00)00227-2; Cao JT, 2010, INVEST OPHTH VIS SCI, V51, P6009, DOI 10.1167/iovs.09-4956; CASPI RR, 1988, J IMMUNOL, V140, P1490; Cortes LM, 2008, INVEST OPHTH VIS SCI, V49, P1946, DOI 10.1167/iovs.07-0868; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Fattori R, 2003, LANCET, V361, P247, DOI 10.1016/S0140-6736(03)12275-1; Ferrer IR, 2010, J IMMUNOL, V185, P2004, DOI 10.4049/jimmunol.1001176; FEUERSTEIN N, 1995, J BIOL CHEM, V270, P9454, DOI 10.1074/jbc.270.16.9454; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haydar AA, 2004, AM J TRANSPLANT, V4, P137, DOI 10.1046/j.1600-6135.2003.00292.x; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jham BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019103; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Luger D, 2008, SEMIN IMMUNOPATHOL, V30, P135, DOI 10.1007/s00281-008-0108-5; Mayer DF, 2003, CURR OPIN RHEUMATOL, V15, P219, DOI 10.1097/00002281-200305000-00008; Mayerhofer M, 2002, BLOOD, V100, P3767, DOI 10.1182/blood-2002-01-0109; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Nussenblatt RB, 1996, J AUTOIMMUN, V9, P575, DOI 10.1006/jaut.1996.0077; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peter C, 2010, CURR OPIN IMMUNOL, V22, P655, DOI 10.1016/j.coi.2010.08.010; Pham PTT, 2004, TRANSPLANTATION, V77, P1215, DOI 10.1097/01.TP.0000118413.92211.B6; Pierdominici M, 2011, CURR PHARM DESIGN, V17, P3888, DOI 10.2174/138161211798357809; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Prlic M, 2009, NATURE, V460, P41, DOI 10.1038/460041a; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Strasser A, 1996, Behring Inst Mitt, P101; Strauss L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005994; Thaunat O, 2005, TRANSPLANTATION, V80, P1212, DOI 10.1097/01.tp.0000179106.07382.6a; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Turner AP, 2011, AM J TRANSPLANT, V11, P613, DOI 10.1111/j.1600-6143.2010.03407.x; Uthaisangsook S, 2003, EXP BIOL MED, V228, P1023, DOI 10.1177/153537020322800906; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Walmsley SR, 2005, TRENDS IMMUNOL, V26, P434, DOI 10.1016/j.it.2005.06.007; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wang Y, 2011, J IMMUNOL, V186, P2809, DOI 10.4049/jimmunol.0903805; Weiner SM, 2007, NEPHROL DIAL TRANSPL, V22, P3631, DOI 10.1093/ndt/gfm420; Wu XM, 2011, INVEST OPHTH VIS SCI, V52, P8520, DOI 10.1167/iovs.11-7664; Wulff BC, 2008, J INVEST DERMATOL, V128, P2467, DOI 10.1038/jid.2008.121; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang CS, 2006, CELL MICROBIOL, V8, P1158, DOI 10.1111/j.1462-5822.2006.00699.x; Young DA, 2005, CURR OPIN PHARMACOL, V5, P418, DOI 10.1016/j.coph.2005.03.004; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	56	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36589	10.1371/journal.pone.0036589	http://dx.doi.org/10.1371/journal.pone.0036589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574188	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800085
J	Domingo, C; Escadafal, C; Rumer, L; Mendez, JA; Garcia, P; Sall, AA; Teichmann, A; Donoso-Mantke, O; Niedrig, M				Domingo, Cristina; Escadafal, Camille; Rumer, Leonid; Mendez, Jairo A.; Garcia, Paquita; Sall, Amadou A.; Teichmann, Anette; Donoso-Mantke, Oliver; Niedrig, Matthias			First International External Quality Assessment Study on Molecular and Serological Methods for Yellow Fever Diagnosis	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; VIRUS-INFECTION; DENGUE VIRUS; FLAVIVIRUSES; ASSAY; IDENTIFICATION; ACCURACY	Objective: We describe an external quality assurance (EQA) study designed to assess the efficiency and accurateness of molecular and serological methods used by expert laboratories performing YF diagnosis. Study Design: For molecular diagnosis evaluation, a panel was prepared of 14 human plasma samples containing specific RNA of different YFV strains (YFV-17D, YFV South American strain [Brazil], YFV IvoryC1999 strain), and specificity samples containing other flaviviruses and negative controls. For the serological panel, 13 human plasma samples with anti-YFV-specific antibodies against different strains of YFV (YFV-17D strain, YFV IvoryC1999 strain, and YFV Brazilian strain), as well as specificity and negative controls, were included. Results: Thirty-six laboratories from Europe, the Americas, Middle East, and Africa participated in these EQA activities. Only 16% of the analyses reported met all evaluation criteria with optimal performance. Serial dilutions of YFV-17D showed that in general the methodologies reported provided a suitable sensitivity. Failures were mainly due to the inability to detect wild-type strains or the presence of false positives. Performance in the serological diagnosis varied, mainly depending on the methodology used. Anti-YFV IgM detection was not performed in 16% of the reports using IIF or ELISA techniques, although it is preferable for the diagnosis of YFV acute infections. A good sensitivity profile was achieved in general; however, in the detection of IgM antibodies a lack of sensitivity of anti-YFV antibodies against the vaccine strain 17D was observed, and of the anti-YFV IgG antibodies against a West African strain. Neutralization assays showed a very good performance; however, the unexpected presence of false positives underlined the need of improving the running protocols. Conclusion: This EQA provides information on each laboratory's efficacy of RT-PCR and serological YFV diagnosis techniques. The results indicate the need for improving serological and molecular diagnosis techniques and provide a follow-up of the diagnostic profiles.	[Domingo, Cristina; Escadafal, Camille; Rumer, Leonid; Teichmann, Anette; Donoso-Mantke, Oliver; Niedrig, Matthias] Robert Koch Inst, Ctr Biol Secur, Berlin, Germany; [Mendez, Jairo A.] Inst Nacl Salud, Lab Virol, Bogota, Colombia; [Garcia, Paquita] Inst Nacl Salud, Lab Enfermedades Metaxen, Lima, Peru; [Sall, Amadou A.] Inst Pasteur, Dakar, Senegal	Robert Koch Institute; Instituto Nacional de Salud (Colombia); Instituto Nacional de Salud - Peru; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Domingo, C (corresponding author), Robert Koch Inst, Ctr Biol Secur, Berlin, Germany.	Domingo-CarrascoC@rki.de	Domingo, Cristina/AAW-2819-2021	Domingo, Cristina/0000-0003-0957-3377	European Centre for Disease Prevention and Control (ECDC) [ECDC/2008/011]	European Centre for Disease Prevention and Control (ECDC)	This study was performed by the European Network for the Diagnostics of 'Imported' Viral Diseases-Collaborative Laboratory Response Network (ENIVD-CLRN) funded by the European Centre for Disease Prevention and Control (ECDC), contract no. ECDC/2008/011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, WKLY EPIDEMIOL REC, V83, P105; ANSARI MZ, 1993, J CLIN LAB ANAL, V7, P230, DOI 10.1002/jcla.1860070408; Bae HG, 2005, J CLIN VIROL, V33, P274, DOI 10.1016/j.jcv.2004.12.001; Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0; Brown T M, 1994, Clin Diagn Virol, V2, P41, DOI 10.1016/0928-0197(94)90034-5; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Charlier N, 2004, J VIROL, V78, P7418, DOI 10.1128/JVI.78.14.7418-7426.2004; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Doblas A, 2006, J CLIN VIROL, V36, P156, DOI 10.1016/j.jcv.2006.02.005; Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10; Domingo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000833; Domingo C, 2009, DIAGN MICR INFEC DIS, V65, P42, DOI 10.1016/j.diagmicrobio.2009.05.004; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; Heraud JM, 1999, EMERG INFECT DIS, V5, P429, DOI 10.3201/eid0503.990314; Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2; Lemmer A, 2004, J CLIN VIROL, V30, P291, DOI 10.1016/j.jcv.2003.11.002; Mantel N, 2008, J VIROL METHODS, V151, P40, DOI 10.1016/j.jviromet.2008.03.026; Mantke OD, 2004, J CLIN VIROL, V29, P105, DOI 10.1016/S1386-6532(03)00110-0; Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0; Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206; Niedrig M, 2009, CLIN MICROBIOL INFEC, V15, P880, DOI 10.1111/j.1469-0691.2009.02851.x; Niedrig M, 2007, EUROSURVEILLANCE, V12; Niedrig M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-72; Panning M, 2009, EMERG INFECT DIS, V15, P469, DOI 10.3201/eid1503.081104; Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Takacs Maria, 1994, Acta Microbiologica et Immunologica Hungarica, V41, P83; Talarmin A, 1998, J CLIN MICROBIOL, V36, P1189, DOI 10.1128/JCM.36.5.1189-1192.1998; Van der Stuyft P, 1999, LANCET, V353, P1558, DOI 10.1016/S0140-6736(99)03291-2; WHO, 2003, WHO REC STAND SURV S, P40; WHO, 1998, WHO REP GLOB SURV EP; WHO Media Centre, 2009, YELL FEV FACT SHEET; 2006, WKLY EPIDEMIOL REC, V81, P317	34	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36291	10.1371/journal.pone.0036291	http://dx.doi.org/10.1371/journal.pone.0036291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570700	Green Published, gold			2022-12-25	WOS:000305343400016
J	Kohn, KW; Zeeberg, BR; Reinhold, WC; Sunshine, M; Luna, A; Pommier, Y				Kohn, Kurt W.; Zeeberg, Barry R.; Reinhold, William C.; Sunshine, Margot; Luna, Augustin; Pommier, Yves			Gene Expression Profiles of the NCI-60 Human Tumor Cell Lines Define Molecular Interaction Networks Governing Cell Migration Processes	PLOS ONE			English	Article							R-RAS; MESENCHYMAL TRANSITION; INTERACTION MAPS; E-CADHERIN; KAPPA-B; CANCER; AXL; ACTIVATION; RECEPTOR; INTEGRIN	Although there is extensive information on gene expression and molecular interactions in various cell types, integrating those data in a functionally coherent manner remains challenging. This study explores the premise that genes whose expression at the mRNA level is correlated over diverse cell lines are likely to function together in a network of molecular interactions. We previously derived expression-correlated gene clusters from the database of the NCI-60 human tumor cell lines and associated each cluster with function categories of the Gene Ontology (GO) database. From a cluster rich in genes associated with GO categories related to cell migration, we extracted 15 genes that were highly cross-correlated; prominent among them were RRAS, AXL, ADAM9, FN14, and integrin-beta1. We then used those 15 genes as bait to identify other correlated genes in the NCI-60 database. A survey of current literature disclosed, not only that many of the expression-correlated genes engaged in molecular interactions related to migration, invasion, and metastasis, but that highly cross-correlated subsets of those genes engaged in specific cell migration processes. We assembled this information in molecular interaction maps (MIMs) that depict networks governing 3 cell migration processes: degradation of extracellular matrix, production of transient focal complexes at the leading edge of the cell, and retraction of the rear part of the cell. Also depicted are interactions controlling the release and effects of calcium ions, which may regulate migration in a spaciotemporal manner in the cell. The MIMs and associated text comprise a detailed and integrated summary of what is currently known or surmised about the role of the expression cross-correlated genes in molecular networks governing those processes.	[Kohn, Kurt W.; Zeeberg, Barry R.; Reinhold, William C.; Sunshine, Margot; Luna, Augustin; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kohn, KW (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	kohnk@mail.nih.gov	zeeberg, barry/AAO-1246-2020; Reinhold, William/J-6704-2017	Reinhold, William/0000-0001-5513-9323	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC006150, ZIABC006192] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bagorda A, 2006, THROMB HAEMOSTASIS, V95, P12, DOI 10.1160/TH05-07-0483; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Cavet ME, 2010, HYPERTENSION, V56, P105, DOI 10.1161/HYPERTENSIONAHA.109.144642; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Chorianopoulos E, 2010, BASIC RES CARDIOL, V105, P301, DOI 10.1007/s00395-009-0046-y; Conklin MW, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-14; Coon BG, 2010, J BIOL CHEM, V285, P33073, DOI 10.1074/jbc.M110.124123; Dang M, 2011, J BIOL CHEM, V286, P17704, DOI 10.1074/jbc.M110.187823; Devbhandari RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024901; Dolznig H, 2011, AM J PATHOL, V179, P487, DOI 10.1016/j.ajpath.2011.03.015; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Faye C, 2009, J BIOL CHEM, V284, P22041, DOI 10.1074/jbc.M109.002964; Fritzsche FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-179; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Gawecka JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011269; Giannone G, 2004, J BIOL CHEM, V279, P28715, DOI 10.1074/jbc.M404054200; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; GO-project, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI DOI 10.1093/NAR/GKJ021; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Haile WB, 2010, NEUROSCIENCE; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; John AS, 2010, J ONCOL, V2010, DOI 10.1155/2010/645376; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Kim J, 2006, BIOCHEM BIOPH RES CO, V344, P1284, DOI 10.1016/j.bbrc.2006.04.016; Kohn KW, 2006, MOL BIOL CELL, V17, P1, DOI 10.1091/mbc.E05-09-0824; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Kunishima S, 2010, CURR OPIN HEMATOL, V17, P405, DOI 10.1097/MOH.0b013e32833c069c; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Luna A, 2011, BIOINFORMATICS, V27, P2165, DOI 10.1093/bioinformatics/btr336; Mahimkar RM, 2005, BIOCHEM J, V385, P461, DOI 10.1042/BJ20041133; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Page RE, 2007, CELL ONCOL, V29, P289; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Polavarapu R, 2005, J NEUROSCI, V25, P10094, DOI 10.1523/JNEUROSCI.3382-05.2005; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Reinhold WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025991; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Shang X, 2011, J BIOL CHEM, V286, P24068, DOI 10.1074/jbc.M111.226951; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Vicente-Manzanares M, 2011, METHODS MOL BIOL, V769, P1, DOI 10.1007/978-1-61779-207-6_1; Vuoriluoto K, 2010, ONCOGENE; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wei C, 2011, CURR OPIN CELL BIOL, V24, P1; Weinstein JN, 2006, MOL CANCER THER, V5, P2601, DOI 10.1158/1535-7163.MCT-06-0640; Weinstein John N, 2004, Breast Dis, V19, P11; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Xu MZ, 2010, ONCOGENE; Yan Q, 2011, BIOCHEMISTRY-US, V50, P566, DOI 10.1021/bi101639y; Yan Q, 2010, BIOCHEMISTRY-US, V49, P3685, DOI 10.1021/bi902067f; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zeeberg BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030317; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zigrino P, 2007, J BIOL CHEM, V282, P30785, DOI 10.1074/jbc.M701658200	91	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35716	10.1371/journal.pone.0035716	http://dx.doi.org/10.1371/journal.pone.0035716			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570691	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343400007
J	Mileykovskaya, E; Penczek, PA; Fang, J; Mallampalli, VKPS; Sparagna, GC; Dowhan, W				Mileykovskaya, Eugenia; Penczek, Pawel A.; Fang, Jia; Mallampalli, Venkata K. P. S.; Sparagna, Genevieve C.; Dowhan, William			Arrangement of the Respiratory Chain Complexes in Saccharomyces cerevisiae Supercomplex III2IV2 Revealed by Single Particle Cryo-Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; C-OXIDASE; MEMBRANE-PROTEIN; YEAST; CARDIOLIPIN; ORGANIZATION; ROLES; PURIFICATION; RESPIRASOME; COMPONENTS	Here we present for the first time a three-dimensional cryo-EM map of the Saccharomyces cerevisiae respiratory supercomplex composed of dimeric complex III flanked on each side by one monomeric complex IV. A precise fit of the existing atomic x-ray structures of complex III from yeast and complex IV from bovine heart into the cryo-EM map resulted in a pseudo-atomic model of the three-dimensional structure for the supercomplex. The distance between cytochrome c binding sites of complexes III and IV is about 6 nm, which supports proposed channeling of cytochrome c between the individual complexes. The opposing surfaces of complexes III and IV differ considerably from those reported for the bovine heart supercomplex as determined by cryo-EM. A closer association between the individual complex domains at the aqueous membrane interface and larger spaces between the membrane-embedded domains where lipid molecules may reside are also demonstrated. The supercomplex contains about 50 molecules of cardiolipin ( CL) with a fatty acid composition identical to that of the inner membrane CL pool, consistent with CL-dependent stabilization of the supercomplex.	[Mileykovskaya, Eugenia; Penczek, Pawel A.; Fang, Jia; Mallampalli, Venkata K. P. S.; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sparagna, Genevieve C.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Texas System; University of Texas Health Science Center Houston; University of Colorado System; University of Colorado Boulder	Dowhan, W (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St,Suite 6-200, Houston, TX 77030 USA.	William.Dowhan@uth.tmc.edu	Mallampalli, Venkata KPS/I-3208-2019	Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health [GM R01 56389, GM R01 60635, GM-069338]; John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635, R01GM056389, U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R01 56389 and the John Dunn Research Foundation (to W. D.), National Institutes of Health Grant GM R01 60635 (to P. A. P.).; We thank Dr. Richard Kulmacz for use of his Clark electrode and Drs. Srinivas Mullapudi and Jun Liu for assistance with operation of the Polara electron microscope, which is supported in part, through the Structural Biology Imaging Center at UTHSC-Houston. We thank Dr. Robert Murphy for the use of the LIPID MAPS mass spectrometry facility at the University of Colorado at Denver, which is supported by the National Institutes of Health Large Scale Collaborative Grant GM-069338. The Texas Advanced Computing Center at The University of Texas at Austin provided high performance computing resources for this project.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Boumans H, 1998, J BIOL CHEM, V273, P4872, DOI 10.1074/jbc.273.9.4872; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Braun HP, 2009, METHOD ENZYMOL, V456, P183, DOI 10.1016/S0076-6879(08)04410-8; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mueller DM, 2004, PROTEIN EXPRES PURIF, V37, P479, DOI 10.1016/j.pep.2004.06.035; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	44	96	99	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23095	23103		10.1074/jbc.M112.367888	http://dx.doi.org/10.1074/jbc.M112.367888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573332	Green Published, hybrid			2022-12-25	WOS:000306495000065
J	Scheidt, HA; Morgado, I; Huster, D				Scheidt, Holger A.; Morgado, Isabel; Huster, Daniel			Solid-state NMR Reveals a Close Structural Relationship between Amyloid-beta Protofibrils and Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ATOMIC-FORCE MICROSCOPY; FIBRIL FORMATION; PEPTIDE; DYNAMICS; STABILIZATION; RESOLUTION; DOMAIN; SHEET; MODEL	We have studied tertiary contacts in protofibrils and mature fibrils of amyloid-beta (A beta) peptides using solid-state NMR spectroscopy. Although intraresidue contacts between Glu-22 and Ile-31 were found in A beta protofibrils, these contacts were completely absent in mature A beta fibrils. This is consistent with the current models of mature A beta fibrils. As these intramolecular contacts have also been reported in A beta oligomers, our measurements suggest that A beta protofibrils are structurally more closely related to oligomers than to mature fibrils. This suggests that some structural alterations have to take place on the pathway from A beta oligomers/protofibrils to mature fibrils, in agreement with a model that suggests a conversion of intramolecular hydrogen-bonded structures of A beta oligomers to the intermolecular stabilized mature fibrils (Hoyer, W., Gronwall, C., Jonsson, A., Stahl, S., and Hard, T. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 5099-5104).	[Scheidt, Holger A.; Huster, Daniel] Univ Leipzig, Inst Med Phys & Biophys, D-04107 Leipzig, Germany; [Morgado, Isabel] Univ Halle Wittenberg, Inst Biochem Biotechnol, D-06120 Halle, Germany	Leipzig University; Martin Luther University Halle Wittenberg	Huster, D (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.	daniel.huster@medizin.uni-leipzig.de	Scheidt, Holger A./C-1416-2014; Morgado, Isabel/J-4798-2013	Morgado, Isabel/0000-0002-7826-997X	Deutsche Forschungsgemeinschaft [Transregio-SFB 102, A6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grants Transregio-SFB 102 and A6 and a personal grant to I. M.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Antzutkin ON, 2004, MAGN RESON CHEM, V42, P231, DOI 10.1002/mrc.1341; Barre P, 2003, BIOCHEMISTRY-US, V42, P8377, DOI 10.1021/bi034239e; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; DaSilva KA, 2010, EXP NEUROL, V223, P311, DOI 10.1016/j.expneurol.2009.08.032; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hard T, 2011, FEBS J, V278, P3884, DOI 10.1111/j.1742-4658.2011.08295.x; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Haupt C, 2012, ANGEW CHEM INT EDIT, V51, P1576, DOI 10.1002/anie.201105638; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Huster D, 2005, PROG NUCL MAG RES SP, V46, P79, DOI 10.1016/j.pnmrs.2005.01.001; Huster D, 2001, BIOCHEMISTRY-US, V40, P7662, DOI 10.1021/bi0027231; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Masuda Y, 2011, BIOORGAN MED CHEM, V19, P5967, DOI 10.1016/j.bmc.2011.08.052; Morgado I, 2011, CURR OPIN COLLOID IN, V16, P508, DOI 10.1016/j.cocis.2011.06.016; MUNOWITZ MG, 1981, J AM CHEM SOC, V103, P2529, DOI 10.1021/ja00400a007; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; RHIM WK, 1973, J CHEM PHYS, V58, P1772, DOI 10.1063/1.1679423; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Scheidt HA, 2012, J BIOL CHEM, V287, P2017, DOI 10.1074/jbc.M111.308619; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Schmidt-Rohr K., 1994, MULTIDIMENSIONAL SOL, P95; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Zhang FL, 2004, J AM CHEM SOC, V126, P13180, DOI 10.1021/ja047241h	34	61	63	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22822	22826		10.1074/jbc.M112.367474	http://dx.doi.org/10.1074/jbc.M112.367474			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589542	Green Published, hybrid			2022-12-25	WOS:000306495000039
J	Fisher, JT; Liu, XM; Yan, ZY; Luo, MH; Zhang, YL; Zhou, WH; Lee, BJ; Song, Y; Guo, CH; Wang, YJ; Lukacs, GL; Engelhardt, JF				Fisher, John T.; Liu, Xiaoming; Yan, Ziying; Luo, Meihui; Zhang, Yulong; Zhou, Weihong; Lee, Ben J.; Song, Yi; Guo, Chenhong; Wang, Yujiong; Lukacs, Gergely L.; Engelhardt, John F.			Comparative Processing and Function of Human and Ferret Cystic Fibrosis Transmembrane Conductance Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CHLORIDE CHANNELS; CFTR; GENE; IDENTIFICATION; DEGRADATION; STABILITY; MEMBRANE; DISEASE; MUTATION	The most common cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation is Delta F508, and this causes cystic fibrosis (CF). New CF models in the pig and ferret have been generated that develop lung, pancreatic, liver, and intestinal pathologies that reflect disease in CF patients. Species-specific biology in the processing of CFTR has demonstrated that pig and mouse Delta F508-CFTR proteins are more effectively processed to the apical membrane of airway epithelia than human Delta F508-CFTR. The processing behavior of ferret WT- and Delta F508-CFTR proteins remains unknown, and such information is important to predicting the utility of a Delta F508-CFTR ferret. To this end, we sought to compare processing, membrane stability, and function of human and ferret WT- and Delta F508-CFTR proteins in a heterologous expression system using HT1080, HEK293T, BHK21, and Cos7 cells as well as human and ferret CF polarized airway epithelia. Analysis of the protein processing and stability by metabolic pulse-chase and surface On-Cell Western blots revealed that WT-fCFTR half-life and membrane stability were increased relative to WT-hCFTR. Furthermore, in BHK21, Cos7, and CuFi cells, human and ferret Delta F508-CFTR processing was negligible, whereas low levels of processing of Delta F508-fCFTR could be seen in HT1080 and HEK293T cells. Only the WT-fCFTR, but not Delta F508-fCFTR, produced functional cAMP-inducible chloride currents in both CF human and ferret airway epithelia. Further elucidation of the mechanism responsible for elevated fCFTR protein stability may lead to new therapeutic approaches to augment CFTR function. These findings also suggest that generation of a ferret CFTR Delta F508/Delta F508 animal model may be useful.	[Engelhardt, John F.] Univ Iowa, Sch Med, Dept Anat & Cell Biol, Coll Med, Iowa City, IA 52242 USA; [Engelhardt, John F.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Engelhardt, John F.] Univ Iowa, Coll Med, Ctr Gene Therapy Cyst Fibrosis & Other Genet Dis, Iowa City, IA 52242 USA; [Guo, Chenhong; Wang, Yujiong] Ningxia Univ, Coll Life Sci, Ningxia 750021, Peoples R China; [Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	University of Iowa; University of Iowa; University of Iowa; Ningxia University; McGill University	Engelhardt, JF (corresponding author), Univ Iowa, Sch Med, Dept Anat & Cell Biol, Coll Med, 51 Newton Rd,Rm 1-111 BSB, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu		Yan, Ziying/0000-0001-8210-5567; Engelhardt, John/0000-0003-2389-9277; Lukacs, Gergely/0000-0003-0900-0675; LIU, XIAOMING/0000-0002-3902-9105	National Institutes of Health [DK047967, HL108902, HL091842, DK075302, DK54759]; Cystic Fibrosis Foundation; Canadian Institute of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108902, P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075302, R37DK047967, P30DK054759, R01DK047967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK047967, HL108902, HL091842, DK075302, and DK54759. This work was also supported by the Cystic Fibrosis Foundation and the Canadian Institute of Health Research.	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; BRADBURY NA, 1994, J BIOL CHEM, V269, P8296; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; Egan M, 2009, DRUG DISCO TODAY DIS, V6, P35, DOI DOI 10.1016/J.DDM0D.2009.03.009; Farinha CM, 2004, MOL CELL PROBE, V18, P235, DOI 10.1016/j.mcp.2004.03.005; Fisher JT, 2011, METHODS MOL BIOL, V742, P311, DOI 10.1007/978-1-61779-120-8_19; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Liu XM, 2007, AM J RESP CELL MOL, V36, P313, DOI 10.1165/rcmb.2006-0286OC; Liu YL, 2008, BIOCHEM BIOPH RES CO, V373, P113, DOI 10.1016/j.bbrc.2008.06.009; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIORDAN JR, 1993, ANNU REV PHYSIOL, V55, P609, DOI 10.1146/annurev.ph.55.030193.003141; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rosenstein BJ, 1998, LANCET, V351, P277, DOI 10.1016/S0140-6736(97)09174-5; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Skach WR, 2000, KIDNEY INT, V57, P825, DOI 10.1046/j.1523-1755.2000.00921.x; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; WARD CL, 1994, J BIOL CHEM, V269, P25710; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	34	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21673	21685		10.1074/jbc.M111.336537	http://dx.doi.org/10.1074/jbc.M111.336537			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570484	Green Published, hybrid			2022-12-25	WOS:000306418600010
J	Staunstrup, NH; Madsen, J; Primo, MN; Li, J; Liu, Y; Kragh, PM; Li, R; Schmidt, M; Purup, S; Dagnaes-Hansen, F; Svensson, L; Petersen, TK; Callesen, H; Bolund, L; Mikkelsen, JG				Staunstrup, Nicklas Heine; Madsen, Johannes; Primo, Maria Nascimento; Li, Juan; Liu, Ying; Kragh, Peter M.; Li, Rong; Schmidt, Mette; Purup, Stig; Dagnaes-Hansen, Frederik; Svensson, Lars; Petersen, Thomas K.; Callesen, Henrik; Bolund, Lars; Mikkelsen, Jacob Giehm			Development of Transgenic Cloned Pig Models of Skin Inflammation by DNA Transposon-Directed Ectopic Expression of Human beta 1 and alpha 2 Integrin	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; SLEEPING-BEAUTY; NUCLEAR TRANSFER; GENE-EXPRESSION; MOUSE MODEL; KERATINOCYTE ADHESION; PROTEIN PSORIASIN; HANDMADE CLONING; EGF RECEPTOR	Integrins constitute a superfamily of transmembrane signaling receptors that play pivotal roles in cutaneous homeostasis by modulating cell growth and differentiation as well as inflammatory responses in the skin. Subrabasal expression of integrins alpha 2 and/or beta 1 entails hyperproliferation and aberrant differentiation of keratinocytes and leads to dermal and epidermal influx of activated T-cells. The anatomical and physiological similarities between porcine and human skin make the pig a suitable model for human skin diseases. In efforts to generate a porcine model of cutaneous inflammation, we employed the Sleeping Beauty DNA transposon system for production of transgenic cloned Gottingen minipigs expressing human beta 1 or alpha 2 integrin under the control of a promoter specific for subrabasal keratinocytes. Using pools of transgenic donor fibroblasts, cloning by somatic cell nuclear transfer was utilized to produce reconstructed embryos that were subsequently transferred to surrogate sows. The resulting pigs were all transgenic and harbored from one to six transgene integrants. Molecular analyses on skin biopsies and cultured keratinocytes showed ectopic expression of the human integrins and localization within the keratinocyte plasma membrane. Markers of perturbed skin homeostasis, including activation of the MAPK pathway, increased expression of the pro-inflammatory cytokine IL-1 alpha, and enhanced expression of the transcription factor c-Fos, were identified in keratinocytes from beta 1 and alpha 2 integrin-transgenic minipigs, suggesting the induction of a chronic inflammatory phenotype in the skin. Notably, cellular dysregulation obtained by overexpression of either beta 1 or alpha 2 integrin occurred through different cellular signaling pathways. Our findings mark the creation of the first cloned pig models with molecular markers of skin inflammation. Despite the absence of an overt psoriatic phenotype, these animals may possess increased susceptibility to severe skin damage-induced inflammation and should be of great potential in studies aiming at the development and refinement of topical therapies for cutaneous inflammation including psoriasis.	[Staunstrup, Nicklas Heine; Primo, Maria Nascimento; Dagnaes-Hansen, Frederik; Bolund, Lars; Mikkelsen, Jacob Giehm] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Madsen, Johannes; Svensson, Lars; Petersen, Thomas K.] LEO Pharma, Dept Dis Pharmacol, Ballerup, Denmark; [Li, Juan; Liu, Ying; Kragh, Peter M.; Li, Rong; Purup, Stig; Callesen, Henrik] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Liu, Ying] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Schmidt, Mette] Univ Copenhagen, Dept Vet Reprod & Obstet, Frederiksberg, Denmark; [Svensson, Lars] HuaDa JiYin BGI, Shenzhen, Peoples R China	Aarhus University; LEO Pharma; Aarhus University; Nanjing Agricultural University; University of Copenhagen	Staunstrup, NH (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	giehm@hum-gen.au.dk	Liu, Ying/T-5064-2019; Primo, Maria/P-1780-2017; Staunstrup, Nicklas Heine/D-4870-2017	Primo, Maria/0000-0003-2808-0607; Staunstrup, Nicklas Heine/0000-0002-5989-9298; Callesen, Henrik/0000-0002-0185-7300; Dagnaes-Hansen, Frederik/0000-0002-6622-0853; Mikkelsen, Jacob Giehm/0000-0002-1322-3209	Danish National Advanced Technology Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Kgl. Hofbuntmager Aage Bangs Foundation; Helga and Peter Kornings Foundation	Danish National Advanced Technology Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Kgl. Hofbuntmager Aage Bangs Foundation; Helga and Peter Kornings Foundation	This work was made possible by support from the Danish National Advanced Technology Foundation (http://hoejteknologifonden.dk/en/),the Lundbeck Foundation (http://www.lundbeckfoundation.com/Frontpage.20.aspx), the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en/), Kgl. Hofbuntmager Aage Bangs Foundation (http://www.danderm-pdv.is.kkh.dk/h11u-5.htm), and Helga and Peter Kornings Foundation (http://www.korningfonden.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; BARTEK MJ, 1972, J INVEST DERMATOL, V58, P114, DOI 10.1111/1523-1747.ep12538909; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; CARROLL JM, 1992, J CELL SCI, V103, P925; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Defilippi P, 2005, J CELL BIOL, V168, P1099, DOI 10.1083/jcb.200405116; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Du Y, 2007, THERIOGENOLOGY, V68, P1104, DOI 10.1016/j.theriogenology.2007.07.021; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; GROVES RW, 1992, J INVEST DERMATOL, V98, P384, DOI 10.1111/1523-1747.ep12499816; Haase I, 2001, J CLIN INVEST, V108, P527, DOI 10.1172/JCI200112153; HERTLE MD, 1995, J INVEST DERMATOL, V104, P260, DOI 10.1111/1523-1747.ep12612801; Hobbs RM, 2003, J BIOL CHEM, V278, P19798, DOI 10.1074/jbc.M300513200; HOTCHIN NA, 1995, J CELL BIOL, V128, P1209, DOI 10.1083/jcb.128.6.1209; HOTCHIN NA, 1993, J CELL SCI, V106, P1131; Hyun S, 2003, BIOL REPROD, V69, P1060, DOI 10.1095/biolreprod.102.014886; Ivaska J, 2003, NAT CELL BIOL, V5, P363, DOI 10.1038/ncb957; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2000, J MOL BIOL, V302, P93, DOI 10.1006/jmbi.2000.4047; Jakobsen JE, 2011, TRANSGENIC RES, V20, P533, DOI 10.1007/s11248-010-9438-x; Jakobsen JE, 2010, TRANSGENIC RES; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Klekotka PA, 2001, J BIOL CHEM, V276, P9503, DOI 10.1074/jbc.M006286200; Klekotka PA, 2001, J BIOL CHEM, V276, P32353, DOI 10.1074/jbc.M101921200; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kragh PM, 2004, REPROD FERT DEVELOP, V16, P315, DOI 10.1071/RD04007; LARJAVA H, 1990, J CELL BIOL, V110, P803, DOI 10.1083/jcb.110.3.803; Lee RT, 1997, J IMMUNOL, V159, P5084; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; Li SP, 2003, CANCER RES, V63, P3473; Liu L, 2006, MOL THER, V13, P1006, DOI 10.1016/j.ymthe.2005.11.021; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mee JB, 2005, J INVEST DERMATOL, V124, P1267, DOI 10.1111/j.0022-202X.2005.23684.x; Meyer W, 1978, Curr Probl Dermatol, V7, P39; Mikkelsen JG, 2003, MOL THER, V8, P654, DOI 10.1016/S1525-0016(03)00216-8; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Ottaviani C, 2006, EUR J IMMUNOL, V36, P118, DOI 10.1002/eji.200535243; Owens DM, 2001, CANCER RES, V61, P5248; Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344; Park KW, 2002, BIOL REPROD, V66, P1001, DOI 10.1095/biolreprod66.4.1001; Petersson S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-205; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Ramirez-Amador V, 1996, Oral Dis, V2, P188; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Romero MR, 1999, EXP DERMATOL, V8, P53, DOI 10.1111/j.1600-0625.1999.tb00348.x; Schiller M, 2006, ONCOGENE, V25, P4449, DOI 10.1038/sj.onc.1209479; SCHLAAK JF, 1994, J INVEST DERMATOL, V102, P145, DOI 10.1111/1523-1747.ep12371752; Schmidt M, 2010, THERIOGENOLOGY, V74, P1233, DOI 10.1016/j.theriogenology.2010.05.026; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Sinzelle L, 2006, TRANSGENIC RES, V15, P751, DOI 10.1007/s11248-006-9014-6; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Teige I, 2010, INT IMMUNOPHARMACOL, V10, P107, DOI 10.1016/j.intimp.2009.10.004; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Watanabe S, 2005, BIOL REPROD, V72, P309, DOI 10.1095/biolreprod.104.031591; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xue W, 1997, CANCER RES, V57, P1682; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Yu X, 2000, J CELL SCI, V113, P2139	84	37	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36658	10.1371/journal.pone.0036658	http://dx.doi.org/10.1371/journal.pone.0036658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590584	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336400025
J	Xie, GQ; Ye, JH				Xie, Guiqin; Ye, Jiang-Hong			Salsolinol Facilitates Glutamatergic Transmission to Dopamine Neurons in the Posterior Ventral Tegmental Area of Rats	PLOS ONE			English	Article							MU-OPIOID RECEPTORS; NUCLEUS-ACCUMBENS; IN-VITRO; CENTRAL AMYGDALA; MESSENGER-RNA; BRAIN-SLICES; ETHANOL; ALCOHOL; INVOLVEMENT; BEHAVIOR	Although in vivo evidence indicates that salsolinol, the condensation product of acetaldehyde and dopamine, has properties that may contribute to alcohol abuse, the underlying mechanisms have not been fully elucidated. We have reported previously that salsolinol stimulates dopamine neurons in the posterior ventral tegmental area (p-VTA) partly by reducing inhibitory GABAergic transmission, and that ethanol increases glutamatergic transmission to VTA-dopamine neurons via the activation of dopamine D-1 receptors (D(1)Rs). In this study, we tested the hypothesis that salsolinol stimulates dopamine neurons involving activation of D(1)Rs. By using whole-cell recordings on p-VTA-dopamine neurons in acute brain slices of rats, we found that salsolinol-induced increase in spike frequency of dopamine neurons was substantially attenuated by DL-2-amino-5phosphono-valeric acid and 6, 7-dinitroquinoxaline-2, 3-dione, the antagonists of glutamatergic N-Methyl-D-aspartic acid and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Moreover, salsolinol increased the amplitude of evoked excitatory postsynaptic currents (EPSCs) and the frequency but not the amplitude of spontaneous EPSCs. Additionally, SKF83566, a D1R antagonist attenuated the salsolinol-induced facilitation of EPSCs and of spontaneous firing of dopamine neurons. Our data reveal that salsolinol enhances glutamatergic transmission onto dopamine neurons via activation of D(1)Rs at the glutamatergic afferents in dopamine neurons, which contributes to salsolinol's stimulating effect on p-VTA dopamine neurons. This appears to be a novel mechanism which contributes toward rewarding properties of salsolinol.	[Xie, Guiqin; Ye, Jiang-Hong] Univ Med & Dent New Jersey, Dept Anesthesiol Pharmacol & Physiol, New Jersey Med Sch, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Xie, GQ (corresponding author), Univ Med & Dent New Jersey, Dept Anesthesiol Pharmacol & Physiol, New Jersey Med Sch, Newark, NJ 07103 USA.	ye@umdnj.edu			National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism [AA016964, AA016618]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA016618, R01AA016964] Funding Source: NIH RePORTER	National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is made possible by the support from National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism [grants AA016964 and AA016618] to JHY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; Bonci A, 1997, J NEUROSCI, V17, P796; Brodie MS, 1998, ALCOHOL CLIN EXP RES, V22, P236, DOI 10.1111/j.1530-0277.1998.tb03644.x; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Chieng B, 2011, J PHYSIOL-LONDON, V589, P3775, DOI 10.1113/jphysiol.2011.210807; Dahchour A, 2000, ALCOHOL ALCOHOLISM, V35, P548, DOI 10.1093/alcalc/35.6.548; DAVIS VE, 1970, SCIENCE, V167, P1005; Deng CY, 2009, NEUROPSYCHOPHARMACOL, V34, P1233, DOI 10.1038/npp.2008.143; Deng Xin-sheng, 2008, Curr Drug Abuse Rev, V1, P3; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; DUNCAN C, 1980, PHARMACOL BIOCHEM BE, V13, P265, DOI 10.1016/0091-3057(80)90083-0; Eckardt MJ, 1998, ALCOHOL CLIN EXP RES, V22, P998, DOI 10.1111/j.1530-0277.1998.tb03695.x; El-Ghundi M, 1998, EUR J PHARMACOL, V353, P149, DOI 10.1016/S0014-2999(98)00414-2; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Guan YZ, 2010, NEUROPSYCHOPHARMACOL, V35, P1841, DOI 10.1038/npp.2010.51; Haber H, 1996, ALCOHOL CLIN EXP RES, V20, P87, DOI 10.1111/j.1530-0277.1996.tb01049.x; Hernandez A, 2007, NEUROSCI LETT, V425, P188, DOI 10.1016/j.neulet.2007.08.026; Hipolito L, 2011, NEUROCHEM INT, V59, P559, DOI 10.1016/j.neuint.2011.04.014; Johnson SW, 2004, BRAIN RES, V1019, P293, DOI 10.1016/j.brainres.2004.06.022; KALIVAS PW, 1995, J NEUROSCI, V15, P5379, DOI 10.1523/jneurosci.15-07-05379.1995; Kitai ST, 1999, CURR OPIN NEUROBIOL, V9, P690, DOI 10.1016/S0959-4388(99)00040-9; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; Liu X, 2002, J NEUROSCI, V22, P7856; Lu XY, 1997, SYNAPSE, V25, P205, DOI 10.1002/(SICI)1098-2396(199702)25:2<205::AID-SYN11>3.0.CO;2-X; MANSOUR A, 1992, NEUROSCIENCE, V46, P959, DOI 10.1016/0306-4522(92)90197-A; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Mereu G, 1997, NEUROSCIENCE, V77, P1029, DOI 10.1016/S0306-4522(96)00474-5; Morikawa H, 2010, INT REV NEUROBIOL, V91, P235, DOI 10.1016/S0074-7742(10)91008-8; MYERS RD, 1982, PHARMACOL BIOCHEM BE, V16, P995, DOI 10.1016/0091-3057(82)90059-4; Omelchenko N, 2007, NEUROSCIENCE, V146, P1259, DOI 10.1016/j.neuroscience.2007.02.016; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Paladini CA, 1999, BRAIN RES, V832, P145, DOI 10.1016/S0006-8993(99)01484-5; Roberto M, 2004, J NEUROSCI, V24, P1594, DOI 10.1523/JNEUROSCI.5077-03.2004; Rodd ZA, 2003, ALCOHOL CLIN EXP RES, V27, P440, DOI 10.1097/01.ALC.0000056612.89957.B4; Rodd ZA, 2008, ALCOHOL CLIN EXP RES, V32, P230, DOI 10.1111/j.1530-0277.2007.00572.x; ROMMELSPACHER H, 1995, ALCOHOL, V12, P309, DOI 10.1016/0741-8329(95)00004-B; Selim M, 1996, BRAIN RES, V716, P157, DOI 10.1016/0006-8993(95)01385-7; Siggins GR, 2005, PHARMACOL THERAPEUT, V107, P80, DOI 10.1016/j.pharmthera.2005.01.006; SUAUDCHAGNY MF, 1992, NEUROSCIENCE, V49, P63, DOI 10.1016/0306-4522(92)90076-E; Threlfell S., 2007, USING FAST SCAN CYCL; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Xiao C, 2009, NEUROPSYCHOPHARMACOL, V34, P307, DOI 10.1038/npp.2008.99; Xie G, 2011, J PHARM EXP THER; Ye JH, 2004, J NEUROSCI, V24, P8961, DOI 10.1523/JNEUROSCI.2016-04.2004; Ye JH, 2006, J NEUROSCI METH, V158, P251, DOI 10.1016/j.jneumeth.2006.06.006; Zhu W, 2007, J NEUROSCI, V27, P289, DOI 10.1523/JNEUROSCI.3912-06.2007	47	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36716	10.1371/journal.pone.0036716	http://dx.doi.org/10.1371/journal.pone.0036716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590592	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336400028
J	Das, M; Quint, DA; Schwarz, JM				Das, Moumita; Quint, D. A.; Schwarz, J. M.			Redundancy and Cooperativity in the Mechanics of Compositely Crosslinked Filamentous Networks	PLOS ONE			English	Article							BOND-BENDING FORCES; F-ACTIN NETWORKS; ELASTIC NETWORKS; ALPHA-ACTININ; ARP2/3 COMPLEX; PERCOLATION; PROTEINS; DYNAMICS; LAMELLIPODIA; FILAMINS	The cytoskeleton of living cells contains many types of crosslinkers. Some crosslinkers allow energy-free rotations between filaments and others do not. The mechanical interplay between these different crosslinkers is an open issue in cytoskeletal mechanics. Therefore, we develop a theoretical framework based on rigidity percolation to study a generic filamentous system containing both stretching and bond-bending forces to address this issue. The framework involves both analytical calculations via effective medium theory and numerical simulations on a percolating triangular lattice with very good agreement between both. We find that the introduction of angle-constraining crosslinkers to a semiflexible filamentous network with freely rotating crosslinks can cooperatively lower the onset of rigidity to the connectivity percolation threshold-a result argued for years but never before obtained via effective medium theory. This allows the system to ultimately attain rigidity at the lowest concentration of material possible. We further demonstrate that introducing angle-constraining crosslinks results in mechanical behaviour similar to just freely rotating crosslinked semflexible filaments, indicating redundancy and universality. Our results also impact upon collagen and fibrin networks in biological and bio-engineered tissues.	[Das, Moumita] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands; [Quint, D. A.; Schwarz, J. M.] Syracuse Univ, Dept Phys, Syracuse, NY USA	Vrije Universiteit Amsterdam; Syracuse University	Das, M (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands.	jschwarz@physics.syr.edu		Quint, David/0000-0003-0323-0402	NWO, The Netherlands;  [NSF-DMR-0645373]	NWO, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); 	JMS is supported by NSF-DMR-0645373. MD is supported by a VENI fellowship from NWO, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 1998, PHYS REP, V296, P65, DOI 10.1016/S0370-1573(97)00069-0; Bai M, 2011, ACTA BIOMATER, V7, P2109, DOI 10.1016/j.actbio.2010.12.025; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Broedersz CP, 2011, NAT PHYS, V7, P983, DOI [10.1038/nphys2127, 10.1038/NPHYS2127]; Carlisle CR, 2010, J THROMB HAEMOST, V8, P1135, DOI 10.1111/j.1538-7836.2010.03824.x; Courson DS, 2010, J BIOL CHEM, V285, P26350, DOI 10.1074/jbc.M110.123117; Das M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038101; Das M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.138102; DEGENNES PG, 1976, J PHYS LETT-PARIS, V37, pL1, DOI 10.1051/jphyslet:019760037010100; DiDonna BA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068104; Esue O, 2010, PHYS REV LETT, V105; FENG S, 1984, PHYS REV LETT, V52, P216, DOI 10.1103/PhysRevLett.52.216; FENG S, 1985, PHYS REV B, V31, P276, DOI 10.1103/PhysRevB.31.276; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; Head DA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061907; Heussinger C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017802; Heussinger C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.105501; HUGHES GD, 1990, J PHYS-CONDENS MAT, V2, P3399, DOI 10.1088/0953-8984/2/14/024; Huisman EM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.118101; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; KANTOR Y, 1984, PHYS REV LETT, V52, P1891, DOI 10.1103/PhysRevLett.52.1891; Kreis T., 1999, GUIDEBOOK CYTOSKELET, V2nd; Lammers G, 2009, BIOMATERIALS, V30, P6213, DOI 10.1016/j.biomaterials.2009.07.050; Maxwell JC., 1864, LOND EDINBURGH DUBLI, V27, P294, DOI [10.1080/14786446408643668, DOI 10.1080/14786446408643668]; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Pelletier V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188303; Piechocka IK, 2010, BIOPHYS J, V98, P2281, DOI 10.1016/j.bpj.2010.01.040; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Press W. H., 1992, ART SCI COMPUTING; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Rivero F, 1999, J CELL SCI, V112, P2737; SAHIMI M, 1993, PHYS REV B, V47, P703, DOI 10.1103/PhysRevB.47.703; Schmoller KM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118102; Schmoller KM, 2009, BIOPHYS J, V97, P83, DOI 10.1016/j.bpj.2009.04.040; SCHWARTZ LM, 1985, PHYS REV B, V32, P4607, DOI 10.1103/PhysRevB.32.4607; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tempel M, 1996, PHYS REV E, V54, P1802, DOI 10.1103/PhysRevE.54.1802; THORPE MF, 1989, J NON-CRYST SOLIDS, V114, P19, DOI 10.1016/0022-3093(89)90056-2; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Wilhelm J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108103; Wyart M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.215501; YURCHENCO PD, 1987, J CELL BIOL, V105, P2559, DOI 10.1083/jcb.105.6.2559	49	36	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35939	10.1371/journal.pone.0035939	http://dx.doi.org/10.1371/journal.pone.0035939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590515	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336100013
J	Sugimura, S; Akai, T; Hashiyada, Y; Somfai, T; Inaba, Y; Hirayama, M; Yamanouchi, T; Matsuda, H; Kobayashi, S; Aikawa, Y; Ohtake, M; Kobayashi, E; Konishi, K; Imai, K				Sugimura, Satoshi; Akai, Tomonori; Hashiyada, Yutaka; Somfai, Tamas; Inaba, Yasushi; Hirayama, Muneyuki; Yamanouchi, Tadayuki; Matsuda, Hideo; Kobayashi, Shuji; Aikawa, Yoshio; Ohtake, Masaki; Kobayashi, Eiji; Konishi, Kazuyuki; Imai, Kei			Promising System for Selecting Healthy In Vitro-Fertilized Embryos in Cattle	PLOS ONE			English	Article							INDIVIDUAL BOVINE EMBRYOS; NUCLEAR TRANSFER EMBRYOS; DEVELOPMENTAL COMPETENCE; INTERFERON-TAU; OXYGEN-CONSUMPTION; PREGNANCY RATE; 1ST CLEAVAGE; VIVO; CULTURE; TIME	Conventionally, in vitro-fertilized (IVF) bovine embryos are morphologically evaluated at the time of embryo transfer to select those that are likely to establish a pregnancy. This method is, however, subjective and results in unreliable selection. Here we describe a novel selection system for IVF bovine blastocysts for transfer that traces the development of individual embryos with time-lapse cinematography in our developed microwell culture dish and analyzes embryonic metabolism. The system can noninvasively identify prognostic factors that reflect not only blastocyst qualities detected with histological, cytogenetic, and molecular analysis but also viability after transfer. By assessing a combination of identified prognostic factors-(i) timing of the first cleavage; (ii) number of blastomeres at the end of the first cleavage; (iii) presence or absence of multiple fragments at the end of the first cleavage; (iv) number of blastomeres at the onset of lag-phase, which results in temporary developmental arrest during the fourth or fifth cell cycle; and (v) oxygen consumption at the blastocyst stage-pregnancy success could be accurately predicted (78.9%). The conventional method or individual prognostic factors could not accurately predict pregnancy. No newborn calves showed neonatal overgrowth or death. Our results demonstrate that these five predictors and our system could provide objective and reliable selection of healthy IVF bovine embryos.	[Sugimura, Satoshi; Hashiyada, Yutaka; Somfai, Tamas; Inaba, Yasushi; Hirayama, Muneyuki; Yamanouchi, Tadayuki; Matsuda, Hideo; Kobayashi, Shuji; Aikawa, Yoshio; Ohtake, Masaki; Kobayashi, Eiji; Konishi, Kazuyuki; Imai, Kei] Natl Livestock Breeding Ctr, Fukushima, Japan; [Akai, Tomonori] Dai Nippon Printing Co Ltd, Kashiwa, Chiba, Japan; [Somfai, Tamas; Inaba, Yasushi] Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan	Dai Nippon Printing Co. Ltd.; National Agriculture & Food Research Organization - Japan	Sugimura, S (corresponding author), Natl Livestock Breeding Ctr, Fukushima, Japan.	k0imai@nlbc.go.jp	Sugimura, Satoshi/B-9877-2015	Sugimura, Satoshi/0000-0002-6473-5941	Research and Development Program for New Bio-Industry Initiatives	Research and Development Program for New Bio-Industry Initiatives	This work was supported by the Research and Development Program for New Bio-Industry Initiatives. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; De Sousa PA, 2001, BIOL REPROD, V65, P23, DOI 10.1095/biolreprod65.1.23; Dihazi H, 2005, MOL CELL PROTEOMICS, V4, P1445, DOI 10.1074/mcp.M400184-MCP200; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; Ezashi T, 1998, P NATL ACAD SCI USA, V95, P7882, DOI 10.1073/pnas.95.14.7882; FARIN PW, 1995, THERIOGENOLOGY, V44, P339, DOI 10.1016/0093-691X(95)00189-F; Farin PW, 1999, THERIOGENOLOGY, V52, P659, DOI 10.1016/S0093-691X(99)00160-0; Fenwick J, 2002, HUM REPROD, V17, P407, DOI 10.1093/humrep/17.2.407; Gjorret JO, 2003, BIOL REPROD, V69, P1193, DOI 10.1095/biolreprod.102.013243; HARE WCD, 1980, CAN J GENET CYTOL, V22, P615, DOI 10.1139/g80-067; Hashiyada Y, 2005, J REPROD DEVELOP, V51, P749, DOI 10.1262/jrd.17032; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Holm P, 2002, REPRODUCTION, V123, P553, DOI 10.1530/rep.0.1230553; Imai K., 2006, J REPROD DEVELOP, V52, pS19; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Keltz MD, 2006, FERTIL STERIL, V86, P321, DOI 10.1016/j.fertnstert.2006.01.048; Koo DB, 2002, BIOL REPROD, V67, P487, DOI 10.1095/biolreprod67.2.487; KOYAMA H, 1994, BIOL REPROD, V50, P163, DOI 10.1095/biolreprod50.1.163; Lequarre AS, 2003, BIOL REPROD, V69, P1707, DOI 10.1095/biolreprod.103.017178; Lonergan P, 1999, J REPROD FERTIL, V117, P159, DOI 10.1530/jrf.0.1170159; Lopes AS, 2007, HUM REPROD, V22, P558, DOI 10.1093/humrep/del404; Magli MC, 2007, FERTIL STERIL, V87, P534, DOI 10.1016/j.fertnstert.2006.07.1512; MASSIP A, 1982, J ANAT, V134, P399; Matoba S, 2010, REPROD FERT DEVELOP, V22, P839, DOI 10.1071/RD09277; Menard S., 2000, APPL LOGISTIC REGRES; Roberts RM, 1996, J INTERF CYTOK RES, V16, P271, DOI 10.1089/jir.1996.16.271; Robertson I., 1998, MANUAL INT EMBRYO TR, P103; ROSENKRANS CF, 1993, BIOL REPROD, V49, P459, DOI 10.1095/biolreprod49.3.459; Sakurai T, 2009, BIOL REPROD, V80, P1223, DOI 10.1095/biolreprod.108.073916; Schroder B., 2004, ROC PLOTTING AUC CAL; Shiku H, 2001, ANAL CHEM, V73, P3751, DOI 10.1021/ac010339j; Shoukir Y, 1997, HUM REPROD, V12, P1531, DOI 10.1093/humrep/12.7.1531; Somfai T, 2010, J REPROD DEVELOP, V56, P200, DOI 10.1262/jrd.09-097A; Sugimura S, 2012, CELL REPROGRAM, V14, P29, DOI 10.1089/cell.2011.0060; Sugimura S, 2010, BIOL REPROD, V83, P970, DOI 10.1095/biolreprod.110.085522; Sugimura S, 2010, CELL REPROGRAM, V12, P463, DOI 10.1089/cell.2009.0111; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; Thrasher AJ, 2004, REPROD BIOMED ONLINE, V8, P99, DOI 10.1016/S1472-6483(10)60503-2; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Viuff D, 1999, BIOL REPROD, V60, P1273, DOI 10.1095/biolreprod60.6.1273; Wakefield SL, 2011, BIOL REPROD, V84, P572, DOI 10.1095/biolreprod.110.087262; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Yabe-Nishimura C, 2003, CHEM-BIOL INTERACT, V143, P317, DOI 10.1016/S0009-2797(02)00189-8; Yamanaka K, 2009, J REPROD DEVELOP, V55, P299, DOI 10.1262/jrd.20174; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Ziebe S, 1997, HUM REPROD, V12, P1545, DOI 10.1093/humrep/12.7.1545	46	74	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36627	10.1371/journal.pone.0036627	http://dx.doi.org/10.1371/journal.pone.0036627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590579	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100049
J	Meynard, CN; Mouillot, D; Mouquet, N; Douzery, EJP				Meynard, Christine N.; Mouillot, David; Mouquet, Nicolas; Douzery, Emmanuel J. P.			A Phylogenetic Perspective on the Evolution of Mediterranean Teleost Fishes	PLOS ONE			English	Article							MITOCHONDRIAL CYTOCHROME-B; MOLECULAR PHYLOGENY; TETRAODONTIFORM FISHES; DIVERGENCE TIME; NUCLEAR; PERCIFORMES; SEQUENCES; PISCES; GENOME; MODEL	The Mediterranean Sea is a highly diverse, highly studied, and highly impacted biogeographic region, yet no phylogenetic reconstruction of fish diversity in this area has been published to date. Here, we infer the timing and geographic origins of Mediterranean teleost species diversity using nucleotide sequences collected from GenBank. We assembled a DNA supermatrix composed of four mitochondrial genes (12S ribosomal DNA, 16S ribosomal DNA, cytochrome c oxidase subunit I and cytochrome b) and two nuclear genes (rhodopsin and recombination activating gene I), including 62% of Mediterranean teleost species plus 9 outgroups. Maximum likelihood and Bayesian phylogenetic and dating analyses were calibrated using 20 fossil constraints. An additional 124 species were grafted onto the chronogram according to their taxonomic affinity, checking for the effects of taxonomic coverage in subsequent diversification analyses. We then interpreted the time-line of teleost diversification in light of Mediterranean historical biogeography, distinguishing non-endemic natives, endemics and exotic species. Results show that the major Mediterranean orders are of Cretaceous origin, specifically similar to 100-80 Mya, and most Perciformes families originated 80-50 Mya. Two important clade origin events were detected. The first at 100-80 Mya, affected native and exotic species, and reflects a global diversification period at a time when the Mediterranean Sea did not yet exist. The second occurred during the last 50 Mya, and is noticeable among endemic and native species, but not among exotic species. This period corresponds to isolation of the Mediterranean from Indo-Pacific waters before the Messinian salinity crisis. The Mediterranean fish fauna illustrates well the assembly of regional faunas through origination and immigration, where dispersal and isolation have shaped the emergence of a biodiversity hotspot.	[Meynard, Christine N.] INRA, UMR CBGP INRA IRD Cirad Montpellier SupAgro, Montferrier Sur Lez, France; [Meynard, Christine N.; Mouquet, Nicolas; Douzery, Emmanuel J. P.] Univ Montpellier 2, CNRS IRD, UMR 5554, Inst Sci Evolut, Montpellier, France; [Mouillot, David] UMR 5119 CNRS UM2 IFREMER IRD, Montpellier, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS)	Meynard, CN (corresponding author), INRA, UMR CBGP INRA IRD Cirad Montpellier SupAgro, Campus Int Baillarguet,CS 30016, Montferrier Sur Lez, France.	Christine.Meynard@supagro.inra.fr	MOUQUET, Nicolas/AAL-1440-2021; DOUZERY, Emmanuel J. P./ABC-4050-2020; Meynard, Christine N/B-2082-2010	DOUZERY, Emmanuel J. P./0000-0001-5286-647X; Meynard, Christine N/0000-0002-5983-6289; Mouquet, Nicolas/0000-0003-1840-6984	bioinformatics cluster of the Institut des Sciences de l'Evolution de Montpellier (ISE-M); computer grid of University Montpellier 2; Agence Nationale de la Recherche [ANR-08-EMER-011, BIOSYS06_136906, ANR-09-PEXT-01102]; Fondation pour la Recherche sur la Biodiversite; Fondation TOTAL; Institut Universitaire de France; FABIO; BIODIVMED	bioinformatics cluster of the Institut des Sciences de l'Evolution de Montpellier (ISE-M); computer grid of University Montpellier 2; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche sur la Biodiversite; Fondation TOTAL; Institut Universitaire de France; FABIO; BIODIVMED	This work has been supported by the bioinformatics cluster of the Institut des Sciences de l'Evolution de Montpellier (ISE-M), the computer grid of University Montpellier 2, by the Agence Nationale de la Recherche "Domaines Emergents'' (ANR-08-EMER-011 "PhylAriane''), "Biologie Systemique'' (BIOSYS06_136906 "MITOSYS''), and "6eme extinction'' (ANR-09-PEXT-01102 "EVORANGE''), by two projects from the "Fondation pour la Recherche sur la Biodiversite" (FABIO and BIODIVMED), and by the "Fondation TOTAL.'' DM received funding from the "Institut Universitaire de France.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arratia Gloria, 2000, Estudios Oceanologicos, V19, P19; Azevedo MFC, 2008, GENET MOL BIOL, V31, P284, DOI 10.1590/S1415-47572008000200023; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton Michael J., 2009, P35; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Carnevale G, 2006, J GEOL SOC LONDON, V163, P75, DOI 10.1144/0016-764904-158; Carnevale G, 2008, PALAEOGEOGR PALAEOCL, V257, P81, DOI 10.1016/j.palaeo.2007.09.005; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavin L, 2007, PALAEOGEOGR PALAEOCL, V245, P353, DOI 10.1016/j.palaeo.2006.08.010; Cavin L, 2007, BIOL LETTERS, V3, P201, DOI 10.1098/rsbl.2006.0602; Cavin L, 2008, GEOL SOC SPEC PUBL, V295, P165, DOI 10.1144/SP295.11; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Chiba SN, 2009, GENES GENET SYST, V84, P153, DOI 10.1266/ggs.84.153; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Criscuolo A, 2006, SYST BIOL, V55, P740, DOI 10.1080/10635150600969872; De la Herran R, 2001, HEREDITY, V87, P691, DOI 10.1046/j.1365-2540.2001.00967.x; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dutheil J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-188; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Giovannotti M, 2007, J EXP ZOOL PART B, V308B, P722, DOI 10.1002/jez.b.21192; Girone A, 2010, FACIES, V56, P399, DOI 10.1007/s10347-010-0212-6; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Inoue JG, 2009, MOL PHYLOGENET EVOL, V51, P486, DOI 10.1016/j.ympev.2009.01.020; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Landini W, 2005, QUATERN INT, V131, P101, DOI 10.1016/j.quaint.2004.07.006; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Lasram FB, 2009, BIOL INVASIONS, V11, P697, DOI 10.1007/s10530-008-9284-4; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Li B, 2009, MOL PHYLOGENET EVOL, V50, P345, DOI 10.1016/j.ympev.2008.11.013; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li JT, 2009, MOL PHYLOGENET EVOL, V53, P509, DOI 10.1016/j.ympev.2009.06.023; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Miya M, 2001, MOL BIOL EVOL, V18, P1993, DOI 10.1093/oxfordjournals.molbev.a003741; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Nelson JS, 1984, FISHES WORLD; Orrell TM, 2004, MOL PHYLOGENET EVOL, V32, P425, DOI 10.1016/j.ympev.2004.01.012; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson C., 1993, P621; Peng ZG, 2006, GENE, V370, P113, DOI 10.1016/j.gene.2005.11.024; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2016, R FDN STAT COMP; Reed DL, 2002, MOL PHYLOGENET EVOL, V23, P513, DOI 10.1016/S1055-7903(02)00036-2; Roa-Varon A, 2009, MOL PHYLOGENET EVOL, V52, P688, DOI 10.1016/j.ympev.2009.03.020; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stiassny MLJ, 2004, ASSEMBLING THE TREE OF LIFE, P410; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Venkatesh B, 2001, P NATL ACAD SCI USA, V98, P11382, DOI 10.1073/pnas.201415598; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Yamanoue Y, 2007, MOL PHYLOGENET EVOL, V45, P89, DOI 10.1016/j.ympev.2007.03.008; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yamanoue Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-212; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Zheng LP, 2010, ZOOL SCR, V39, P559, DOI 10.1111/j.1463-6409.2010.00441.x	70	38	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36443	10.1371/journal.pone.0036443	http://dx.doi.org/10.1371/journal.pone.0036443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590545	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335500013
J	Zhu, JL; Wang, JF; Sheng, Y; Zou, Y; Bo, LL; Wang, F; Lou, JS; Fan, XH; Bao, R; Wu, YP; Chen, F; Deng, XM; Li, JB				Zhu, Jiali; Wang, Jiafeng; Sheng, Ying; Zou, Yun; Bo, Lulong; Wang, Fei; Lou, Jingsheng; Fan, Xiaohua; Bao, Rui; Wu, Youping; Chen, Feng; Deng, Xiaoming; Li, Jinbao			Baicalin Improves Survival in a Murine Model of Polymicrobial Sepsis via Suppressing Inflammatory Response and Lymphocyte Apoptosis	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; SEPTIC SHOCK; RATS; EPIDEMIOLOGY; SCUTELLARIA; MULTICENTER; ACTIVATION; ENDOTOXIN; MICE	Background: An imbalance between overwhelming inflammation and lymphocyte apoptosis is the main cause of high mortality in patients with sepsis. Baicalin, the main active ingredient of the Scutellaria root, exerts anti-inflammatory, anti-apoptotic, and even antibacterial properties in inflammatory and infectious diseases. However, the therapeutic effect of baicalin on polymicrobial sepsis remains unknown. Methodology/Principal Findings: Polymicrobial sepsis was induced by cecal ligation and puncture (CLP) in C57BL/6 mice. Mice were infused with baicalin intraperitoneally at 1 h, 6 h and 12 h after CLP. Survival rates were assessed over the subsequent 8 days. Bacterial burdens in blood and peritoneal cavity were calculated to assess the bacterial clearance. Neutrophil count in peritoneal lavage fluid was also calculated. Injuries to the lung and liver were detected by hematoxylin and eosin staining. Levels of cytokines, including tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-10 and IL-17, in blood and peritoneum were measured by enzyme-linked immunosorbent assay. Adaptive immune function was assessed by apoptosis of lymphocytes in the thymus and counts of different cell types in the spleen. Baicalin significantly enhanced bacterial clearance and improved survival of septic mice. The number of neutrophils in peritoneal lavage fluid was reduced by baicalin. Less neutrophil infiltration of the lung and liver in baicalin-treated mice was associated with attenuated injuries to these organs. Baicalin significantly reduced the levels of proinflammatory cytokines but increased the level of anti-inflammatory cytokine in blood and peritoneum. Apoptosis of CD3(+) T cell was inhibited in the thymus. The numbers of CD4(+), CD8(+) T lymphocytes and dendritic cells (DCs) were higher, while the number of CD4(+)CD25(+) regulatory T cells was lower in the baicalin group compared with the CLP group. Conclusions/Significance: Baicalin improves survival of mice with polymicrobial sepsis, and this may be attributed to its antibacterial property as well as its anti-inflammatory and anti-apoptotic effects.	[Zhu, Jiali; Wang, Jiafeng; Sheng, Ying; Zou, Yun; Bo, Lulong; Wang, Fei; Lou, Jingsheng; Fan, Xiaohua; Bao, Rui; Wu, Youping; Chen, Feng; Deng, Xiaoming; Li, Jinbao] Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol & Crit Care, Shanghai, Peoples R China	Naval Medical University	Zhu, JL (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol & Crit Care, Shanghai, Peoples R China.	deng_x@yahoo.com; lijinbaoshanghai@163.com	Deng, Xiaoming/E-2876-2010; Lou, Jingsheng/ABF-7902-2021	Lou, Jingsheng/0000-0002-0295-5105; Wang, Jia-feng/0000-0002-1753-6499; Chen, Feng/0000-0003-0013-479X	National Natural Science Foundation of China [81171788]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 81171788 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2006, LANCET, DOI DOI 10.1016/S0140-6736(06)69005-3; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Ayala A, 2008, CURR PHARM DESIGN, V14, P1853, DOI 10.2174/138161208784980617; BONE RC, 1995, CRIT CARE MED, V23, P994, DOI 10.1097/00003246-199506000-00003; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Cushnie TPT, 2003, MICROBIOL RES, V158, P281, DOI 10.1078/0944-5013-00206; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Ji Y, 2011, PLOS ONE, V6; Joshi VD, 2003, FEBS LETT, V555, P180, DOI 10.1016/S0014-5793(03)01271-7; KIBE S, 2011, J ANTIMICROB CHEMOTH, V2, P33; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lee YM, 2011, J ETHNOPHARMACOL, V135, P179, DOI 10.1016/j.jep.2011.03.009; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Liu LL, 2008, BIOCHEM PHARMACOL, V75, P914, DOI 10.1016/j.bcp.2007.10.009; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Novy P, 2011, J ANTIMICROB CHEMOTH, V66, P1298, DOI 10.1093/jac/dkr108; Peck-Palmer OM, 2009, SHOCK, V31, P359, DOI 10.1097/SHK.0b013e31818ba2a2; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Schwulst SJ, 2008, SHOCK, V30, P127, DOI [10.1097/SHK.0b013e318162cf17, 10.1097/shk.0b013e318162cf17]; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Shi C., 2011, J IMMUNOL; Tang YJ, 2010, INFLAMMATION, V33, P180, DOI 10.1007/s10753-009-9172-9; Tanino Y, 2002, AM J PHYSIOL-LUNG C, V283, pL156, DOI 10.1152/ajplung.00155.2001; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Zhang XP, 2009, HEPATOB PANCREAT DIS, V8, P85; Zhang XP, 2009, PANCREAS, V38, P732, DOI 10.1097/MPA.0b013e3181ad9735; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354; Zhao ZQ, 2002, CARDIOVASC RES, V55, P438, DOI 10.1016/S0008-6363(02)00442-X	38	73	81	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e35523	10.1371/journal.pone.0035523	http://dx.doi.org/10.1371/journal.pone.0035523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590504	Green Submitted, gold, Green Published			2022-12-25	WOS:000305335500003
J	Leenders, JJ; Wijnen, WJ; van der Made, I; Hiller, M; Swinnen, M; Vandendriessche, T; Chuah, M; Pinto, YM; Creemers, EE				Leenders, Joost J.; Wijnen, Wino J.; van der Made, Ingeborg; Hiller, Monika; Swinnen, Melissa; Vandendriessche, Thierry; Chuah, Marinee; Pinto, Yigal M.; Creemers, Esther E.			Repression of Cardiac Hypertrophy by KLF15: Underlying Mechanisms and Therapeutic Implications	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; KRUPPEL-LIKE FACTOR; GENE-EXPRESSION; TRANSCRIPTION FACTORS; CARDIOMYOCYTE HYPERTROPHY; BINDING-PROTEIN; MUSCLE-CELLS; IN-VIVO; MYOCARDIN; ACTIVATION	The Kruppel-like factor (KLF) family of transcription factors regulates diverse cell biological processes including proliferation, differentiation, survival and growth. Previous studies have shown that KLF15 inhibits cardiac hypertrophy by repressing the activity of pivotal cardiac transcription factors such as GATA4, MEF2 and myocardin. We set out this study to characterize the interaction of KLF15 with putative other transcription factors. We first show that KLF15 interacts with myocardin-related transcription factors (MRTFs) and strongly represses the transcriptional activity of MRTF-A and MRTF-B. Second, we identified a region within the C-terminal zinc fingers of KLF15 that contains the nuclear localization signal. Third, we investigated whether overexpression of KLF15 in the heart would have therapeutic potential. Using recombinant adeno-associated viruses (rAAV) we have overexpressed KLF15 specifically in the mouse heart and provide the first evidence that elevation of cardiac KLF15 levels prevents the development of cardiac hypertrophy in a model of Angiotensin II induced hypertrophy.	[Leenders, Joost J.; Wijnen, Wino J.; van der Made, Ingeborg; Hiller, Monika; Pinto, Yigal M.; Creemers, Esther E.] Univ Amsterdam, AMC, Heart Failure Res Ctr, Amsterdam, Netherlands; [Swinnen, Melissa; Vandendriessche, Thierry; Chuah, Marinee] Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Vandendriessche, Thierry; Chuah, Marinee] Free Univ Brussels, Dept Gene Therapy & Regenerat Med, Brussels, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Leenders, JJ (corresponding author), Univ Amsterdam, AMC, Heart Failure Res Ctr, Amsterdam, Netherlands.	e.e.creemers@amc.uva.nl	Wijnen, Wino/P-4774-2015	Wijnen, Wino/0000-0002-3513-3618; Vandendriessche, Thierry/0000-0003-4230-745X; Chuah, Marinee/0000-0001-8569-0175; Creemers, Esther/0000-0002-9001-3854	Dutch Heart Foundation [NHS2007-B077]; Research Foundation Flanders (FWO); Association Francaise contre les Myopathies (AFM)	Dutch Heart Foundation(Netherlands Heart Foundation); Research Foundation Flanders (FWO)(FWO); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by the Dutch Heart Foundation (NHS2007-B077), Research Foundation Flanders (FWO), and Association Francaise contre les Myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KE, 2010, REV MED VIROL, V20, P231, DOI 10.1002/rmv.648; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Creemers EE, 2011, NAT REV GENET, V12, P357, DOI 10.1038/nrg2983; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Himeda CL, 2010, MOL CELL BIOL, V30, P3430, DOI 10.1128/MCB.00302-10; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jaski BE, 2009, J CARD FAIL, V15, P171, DOI 10.1016/j.cardfail.2009.01.013; Kuwahara K, 2010, MOL CELL BIOL, V30, P4134, DOI 10.1128/MCB.00154-10; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Leenders JJ, 2011, J MOL CELL CARDIOL, V51, P156, DOI 10.1016/j.yjmcc.2011.04.017; Leenders JJ, 2010, J BIOL CHEM, V285, P27449, DOI 10.1074/jbc.M110.107292; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Ma HL, 2004, AM J PHYSIOL-CELL PH, V286, pC556, DOI 10.1152/ajpcell.00328.2003; MAR JH, 1988, J CELL BIOL, V107, P573, DOI 10.1083/jcb.107.2.573; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Otteson DC, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-15; Otteson DC, 2004, INVEST OPHTH VIS SCI, V45, P2522, DOI 10.1167/iovs.04-0072; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Prasad KMR, 2011, GENE THER, V18, P43, DOI 10.1038/gt.2010.105; Rodriguez E, 2009, CELL RES, V19, P1041, DOI 10.1038/cr.2009.103; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Swinnen M, 2009, CIRCULATION, V120, P1585, DOI 10.1161/CIRCULATIONAHA.109.863266; Uchida S, 2000, MOL CELL BIOL, V20, P7319, DOI 10.1128/MCB.20.19.7319-7331.2000; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Vandenberghe LH, 2009, GENE THER, V16, P311, DOI 10.1038/gt.2008.170; Vandendriessche T, 2007, J THROMB HAEMOST, V5, P16, DOI 10.1111/j.1538-7836.2006.02220.x; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wu JH, 2005, BIOCHEMISTRY-US, V44, P11098, DOI 10.1021/bi050166i; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e	44	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36754	10.1371/journal.pone.0036754	http://dx.doi.org/10.1371/journal.pone.0036754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586493	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000054
J	Dowd, EC; Barch, DM				Dowd, Erin C.; Barch, Deanna M.			Pavlovian Reward Prediction and Receipt in Schizophrenia: Relationship to Anhedonia	PLOS ONE			English	Article							BASAL GANGLIA; SIGNIFICANT ACTIVATION; NEURAL RESPONSE; WORKING-MEMORY; EXPECTED VALUE; REPRESENTATIONS; DOPAMINE; SYMPTOMS; SALIENCE; CORTEX	Reward processing abnormalities have been implicated in the pathophysiology of negative symptoms such as anhedonia and avolition in schizophrenia. However, studies examining neural responses to reward anticipation and receipt have largely relied on instrumental tasks, which may confound reward processing abnormalities with deficits in response selection and execution. 25 chronic, medicated outpatients with schizophrenia and 20 healthy controls underwent functional magnetic resonance imaging using a Pavlovian reward prediction paradigm with no response requirements. Subjects passively viewed cues that predicted subsequent receipt of monetary reward or non-reward, and blood-oxygen-level-dependent signal was measured at the time of cue presentation and receipt. At the group level, neural responses to both reward anticipation and receipt were largely similar between groups. At the time of cue presentation, striatal anticipatory responses did not differ between patients and controls. Right anterior insula demonstrated greater activation for nonreward than reward cues in controls, and for reward than nonreward cues in patients. At the time of receipt, robust responses to receipt of reward vs. nonreward were seen in striatum, midbrain, and frontal cortex in both groups. Furthermore, both groups demonstrated responses to unexpected versus expected outcomes in cortical areas including bilateral dorsolateral prefrontal cortex. Individual difference analyses in patients revealed an association between physical anhedonia and activity in ventral striatum and ventromedial prefrontal cortex during anticipation of reward, in which greater anhedonia severity was associated with reduced activation to money versus no-money cues. In ventromedial prefrontal cortex, this relationship held among both controls and patients, suggesting a relationship between anticipatory activity and anhedonia irrespective of diagnosis. These findings suggest that in the absence of response requirements, brain responses to reward receipt are largely intact in medicated individuals with chronic schizophrenia, while reward anticipation responses in left ventral striatum are reduced in those patients with greater anhedonia severity.	[Dowd, Erin C.] Washington Univ, Neurosci Program, Div Biol & Biomed Sci, St Louis, MO 63130 USA; [Barch, Deanna M.] Washington Univ, Dept Psychol Psychiat & Radiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Dowd, EC (corresponding author), Washington Univ, Neurosci Program, Div Biol & Biomed Sci, St Louis, MO 63130 USA.	dowde@wusm.wustl.edu	Barch, Deanna M/G-8638-2013		National Institute of Mental Health [MH071616]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071616, R01MH066031] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by National Institute of Mental Health grant MH071616. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004; Andreasen N.C., 1983, SCALE ASSESSMENT POS; ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341; Andreasen NC, 1983, SCALE ASSESSMENT NEG; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Barch DM, 2010, SCHIZOPHRENIA BULL, V36, P919, DOI 10.1093/schbul/sbq068; Barch DM, 2002, J ABNORM PSYCHOL, V111, P478, DOI 10.1037//0021-843X.111.3.478; Beck SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009251; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Chapman L. J., 1978, REVISED PHYS A UNPUB; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Dowd EC, 2010, BIOL PSYCHIAT, V67, P902, DOI 10.1016/j.biopsych.2009.10.020; Eckblad M.L., 1982, REVISED SOCIAL UNPUB; ERLENMEYERKIMLING L, 1993, SCHIZOPHRENIA BULL, V19, P141, DOI 10.1093/schbul/19.1.141; First MB, 2001, STRUCTURED CLIN INTE; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1994, HUM BRAIN MAPP, V2, P1; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Gold JM, 2008, SCHIZOPHRENIA BULL, V34, P835, DOI 10.1093/schbul/sbn068; Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; Harvey PO, 2010, J PSYCHIATR RES, V44, P707, DOI 10.1016/j.jpsychires.2009.12.008; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; Horan WP, 2011, SCHIZOPHR RES, V132, P140, DOI 10.1016/j.schres.2011.06.030; Horan WP, 2006, SCHIZOPHRENIA BULL, V32, P259, DOI 10.1093/schbul/sbj009; Jensen J, 2008, NEUROPSYCHOPHARMACOL, V33, P473, DOI 10.1038/sj.npp.1301437; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; Juckel G, 2006, PSYCHOPHARMACOLOGY, V187, P222, DOI 10.1007/s00213-006-0405-4; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koch K, 2010, NEUROIMAGE, V50, P223, DOI 10.1016/j.neuroimage.2009.12.031; Kring AM, 2008, SCHIZOPHRENIA BULL, V34, P819, DOI 10.1093/schbul/sbn071; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; McAvoy MP, 2001, NEUROIMAGE, V13, pS198; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Morris RW, 2012, MOL PSYCHIATR, V17, P235, DOI [10.1038/mp.2012.1, 10.1038/mp.2011.75]; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Romaniuk L, 2010, ARCH GEN PSYCHIAT, V67, P1246, DOI 10.1001/archgenpsychiatry.2010.169; Schlagenhauf F, 2009, BIOL PSYCHIAT, V65, P1032, DOI 10.1016/j.biopsych.2008.12.016; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Simon JJ, 2010, SCHIZOPHR RES, V118, P154, DOI 10.1016/j.schres.2009.11.007; Snyder A.Z., 1996, QUANTIFICATION BRAIN; Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Walter H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.062.2009; Walter H, 2009, PSYCHOPHARMACOLOGY, V206, P121, DOI 10.1007/s00213-009-1586-4; Waltz JA, 2010, NEUROPSYCHOPHARMACOL, V35, P2427, DOI 10.1038/npp.2010.126; Waltz JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1567, DOI 10.1038/npp.2008.214; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; WORSLEY KJ, 1994, ADV APPL PROBAB, V26, P13, DOI 10.2307/1427576; Ziauddeen H, 2010, CURR OPIN PSYCHIATR, V23, P91, DOI 10.1097/YCO.0b013e328336661b	67	105	106	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35622	10.1371/journal.pone.0035622	http://dx.doi.org/10.1371/journal.pone.0035622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WV	22574121	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800017
J	Feng, L; Gao, L; Lu, HW; Muller, R				Feng, Lin; Gao, Li; Lu, Hongwang; Mueller, Rolf			Noseleaf Dynamics during Pulse Emission in Horseshoe Bats	PLOS ONE			English	Article								Horseshoe bats emit their biosonar pulses nasally and diffract the outgoing ultrasonic waves by conspicuous structures that surrounded the nostrils. Here, we report quantitative experimental data on the motion of a prominent component of these structures, the anterior leaf, using synchronized laser Doppler vibrometry and acoustic recordings in the greater horseshoe bat (Rhinolophus ferrumequinum). The vibrometry data has demonstrated non-random motion patterns in the anterior leaf. In these patterns, the outer rim of the walls of the anterior leaf twitches forward and inwards to decrease the aperture of the noseleaf and increase the curvature of its surfaces. Noseleaf displacements were correlated with the emitted ultrasonic pulses. After their onset, the inward displacements increased monotonically towards their maximum value which was always reached within the duration of the biosonar pulse, typically towards its end. In other words, the anterior leaf's surfaces were moving inwards during most of the pulse. Non-random motions were not present in all recorded pulse trains, but could apparently be switched on or off. Such switches happened between sequences of consecutive pulses but were never observed between individual pulses within a sequence. The amplitudes of the emitted biosonar pulse and accompanying noseleaf movement were not correlated in the analyzed data set. The measured velocities of the noseleaf surface were too small to induce Doppler shifts of a magnitude with a likely significance. However, the displacement amplitudes were significant in comparison with the overall size of the anterior leaf and the sound wavelengths. These results indicate the possibility that horseshoe bats use dynamic sensing principles on the emission side of their biosonar system. Given the already available evidence that such mechanisms exist for biosonar reception, it may be hypothesized that time-variant mechanisms play a pervasive role in the biosonar sensing of horseshoe bats.	[Feng, Lin; Gao, Li; Lu, Hongwang; Mueller, Rolf] Shandong Univ, Sch Phys, SDU VT Int Lab, Jinan, Shandong, Peoples R China; [Mueller, Rolf] Virginia Tech, Dept Mech Engn, Danville, VA USA	Shandong University; Virginia Polytechnic Institute & State University	Feng, L (corresponding author), Shandong Univ, Sch Phys, SDU VT Int Lab, Jinan, Shandong, Peoples R China.	rolf.mueller@vt.edu			National Natural Science Foundation of China [11074149]; China Postdoctoral Science Foundation; Shandong Taishan Fund; Foundation for Young Scientists in Shandong Province [BS2011DX021]; Independent Innovation Foundation of Shandong University [2010HW005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Taishan Fund; Foundation for Young Scientists in Shandong Province; Independent Innovation Foundation of Shandong University	This work was supported by the National Natural Science Foundation of China (grant no: 11074149, http://www.nsfc.gov.cn), the China Postdoctoral Science Foundation, the Shandong Taishan Fund, the Foundation for Young Scientists in Shandong Province (grant no. BS2011DX021) and the Independent Innovation Foundation of Shandong University (grant no. 2010HW005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Csorba C, 2003, HORSESHOE BATS WORLD; Gao L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.214301; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Koopman K. F., 1994, CHIROPTERA SYSTEMATI; Kuc R, 2010, J ACOUST SOC AM, V128, P3190, DOI 10.1121/1.3488304; Metzner W, 2010, HBK BEHAV NEUROSCI, V19, P403, DOI 10.1016/B978-0-12-374593-4.00037-1; Muller R, 2010, J ACOUST SOC AM, V128, P1414, DOI 10.1121/1.3365246; Muller R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108701; OBRIST MK, 1993, J EXP BIOL, V180, P119; Reijniers J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.148701; SCHULLER G, 1979, J COMP PHYSIOL, V132, P47, DOI 10.1007/BF00617731; Zhang ZW, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038701; Zhuang Q, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218701; Zhuang Q, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051902	14	34	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e34685	10.1371/journal.pone.0034685	http://dx.doi.org/10.1371/journal.pone.0034685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574110	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800006
J	Gaiffe, E; Pretet, JL; Launay, S; Jacquin, E; Saunier, M; Hetzel, G; Oudet, P; Mougin, C				Gaiffe, Emilie; Pretet, Jean-Luc; Launay, Sophie; Jacquin, Elise; Saunier, Maelle; Hetzel, Genevieve; Oudet, Pierre; Mougin, Christiane			Apoptotic HPV Positive Cancer Cells Exhibit Transforming Properties	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; STAUROSPORINE-INDUCED APOPTOSIS; HUMAN-PAPILLOMAVIRUS; CERVICAL-CARCINOMA; ENDOTHELIAL-CELLS; TRANSFERRED DNA; UTERINE CERVIX; BODIES; TUMOR; P53	Previous studies have shown that DNA can be transferred from dying engineered cells to neighboring cells through the phagocytosis of apoptotic bodies, which leads to cellular transformation. Here, we provide evidence of an uptake of apoptotic-derived cervical cancer cells by human mesenchymal cells. Interestingly, HeLa (HPV 18+) or Ca Ski (HPV16+) cells, harboring integrated high-risk HPV DNA but not C-33 A cells (HPV-), were able to transform the recipient cells. Human primary fibroblasts engulfed the apoptotic bodies effectively within 30 minutes after co-cultivation. This mechanism is active and involves the actin cytoskeleton. In situ hybridization of transformed fibroblasts revealed the presence of HPV DNA in the nucleus of a subset of phagocytosing cells. These cells expressed the HPV16/18 E6 gene, which contributes to the disruption of the p53/p21 pathway, and the cells exhibited a tumorigenic phenotype, including an increased proliferation rate, polyploidy and anchorage independence growth. Such horizontal transfer of viral oncogenes to surrounding cells that lack receptors for HPV could facilitate the persistence of the virus, the main risk factor for cervical cancer development. This process might contribute to HPV-associated disease progression in vivo.	[Gaiffe, Emilie; Pretet, Jean-Luc; Launay, Sophie; Jacquin, Elise; Saunier, Maelle; Mougin, Christiane] Univ Franche Comte, Equipe Accueil 3181, F-25030 Besancon, France; [Gaiffe, Emilie; Pretet, Jean-Luc; Launay, Sophie; Jacquin, Elise; Saunier, Maelle; Mougin, Christiane] Univ Franche Comte, Inst Federatif Rech 133, F-25030 Besancon, France; [Pretet, Jean-Luc; Mougin, Christiane] Ctr Hosp Univ Besancon, Lab Biol Cellulaire & Mol, F-25030 Besancon, France; [Hetzel, Genevieve; Oudet, Pierre] Univ Strasbourg, Hop Univ Strasbourg, Strasbourg, France	Universite de Franche-Comte; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gaiffe, E (corresponding author), Univ Franche Comte, Equipe Accueil 3181, F-25030 Besancon, France.	christiane.mougin@univ-fcomte.fr	Jacquin, Elise/J-5293-2015; Prétet, Jean-Luc/B-2911-2012; Jacquin, Elise/GPX-1868-2022	Jacquin, Elise/0000-0003-0368-4113; Prétet, Jean-Luc/0000-0002-8430-214X; MOUGIN, CHRISTIANE/0000-0002-1573-8695	Region de Franche-Comte; Institut National du Cancer; Ligue Contre le Cancer, Comite du Doubs	Region de Franche-Comte(Region Bourgogne-Franche-Comte); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Contre le Cancer, Comite du Doubs	Fellowships and works were supported by public funds from the "Region de Franche-Comte," "Institut National du Cancer" and "Ligue Contre le Cancer, Comite du Doubs." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsmedh A, 2006, MOL CANCER RES, V4, P187, DOI 10.1158/1541-7786.MCR-05-0262; Bergsmedh A, 2002, CANCER RES, V62, P575; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Bernard B, 2001, CELL DEATH DIFFER, V8, P234, DOI 10.1038/sj.cdd.4400796; Charlot JF, 2006, APOPTOSIS, V11, P813, DOI 10.1007/s10495-006-5876-6; COLBURN NH, 1978, CANCER RES, V38, P624; de la Taille A, 1999, CANCER RES, V59, P5461; DINI L, 1995, J CELL SCI, V108, P967; DIPAOLO JA, 1989, ONCOGENE, V4, P395; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Ehnfors J, 2009, CELL DEATH DIFFER, V16, P749, DOI 10.1038/cdd.2009.7; Elit L, 2009, GYNECOL ONCOL, V114, P528, DOI 10.1016/j.ygyno.2009.06.001; Grayson W, 1997, INT J GYNECOL PATHOL, V16, P307, DOI 10.1097/00004347-199710000-00003; HALL SE, 1994, J IMMUNOL, V153, P3218; Hampson L, 2001, FASEB J, V15, P1445, DOI 10.1096/fj.00-0728fje; HAUSEN HZ, 1986, LANCET, V2, P489; HAYFLICK L, 1964, NATURE, V204, P146, DOI 10.1038/204146a0; Holmgren L, 1999, BLOOD, V93, P3956, DOI 10.1182/blood.V93.11.3956.411k05_3956_3963; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Isacson C, 1996, CANCER RES, V56, P669; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Laurendeau I, 1999, CLIN CHEM, V45, P982; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; LEVINE EL, 1995, RADIOTHER ONCOL, V37, P1, DOI 10.1016/0167-8140(95)01622-N; Loreto ELS, 2008, HEREDITY, V100, P545, DOI 10.1038/sj.hdy.6801094; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; LOWY DR, 1994, P NATL ACAD SCI USA, V91, P2436, DOI 10.1073/pnas.91.7.2436; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Plumb JA, 2004, METH MOLEC MED, V88, P159; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saunier M, 2008, J CLIN MICROBIOL, V46, P3678, DOI 10.1128/JCM.01212-08; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Simbulan-Rosenthal CM, 2002, J BIOL CHEM, V277, P24709, DOI 10.1074/jbc.M200281200; Slagle BL, 1998, CANCER-AM CANCER SOC, V83, P1401, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1401::AID-CNCR18>3.0.CO;2-8; SOMMERS GM, 1989, GYNECOL ONCOL, V35, P150, DOI 10.1016/0090-8258(89)90033-4; Spetz AL, 1999, J IMMUNOL, V163, P736; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tsang RW, 1999, RADIOTHER ONCOL, V50, P85, DOI 10.1016/S0167-8140(98)00120-0; Unger ER, 1999, HUM PATHOL, V30, P483, DOI 10.1016/S0046-8177(99)90127-2; van Elsas JD, 2002, FEMS MICROBIOL ECOL, V42, P187, DOI 10.1111/j.1574-6941.2002.tb01008.x; Weber JC, 2007, INT J CANCER, V120, P524, DOI 10.1002/ijc.22343; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; WINKLER B, 1984, CANCER, V53, P1081, DOI 10.1002/1097-0142(19840301)53:5<1081::AID-CNCR2820530511>3.0.CO;2-L; Yan B, 2006, BRIT J CANCER, V95, P1696, DOI 10.1038/sj.bjc.6603484; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36766	10.1371/journal.pone.0036766	http://dx.doi.org/10.1371/journal.pone.0036766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574222	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800119
J	Iqbal, MA; Bamezai, RNK				Iqbal, Mohd Askandar; Bamezai, Rameshwar N. K.			Resveratrol Inhibits Cancer Cell Metabolism by Down Regulating Pyruvate Kinase M2 via Inhibition of Mammalian Target of Rapamycin	PLOS ONE			English	Article							GLUCOSE-METABOLISM; COLORECTAL-CANCER; SCREENING TOOL; TUMOR-GROWTH; EXPRESSION; APOPTOSIS; ARREST; PTEN; AKT	Metabolism of cancer cells with pyruvate kinase M2 (PKM2) at its centre stage has assumed a prime significance in cancer research in recent times. Cancer cell metabolism, characterized by enhanced glucose uptake, production of lactate and anabolism is considered an ideal target for therapeutic interventions. Expression of PKM2 switches metabolism in favor of cancer cells, therefore, the present study was designed to investigate the hitherto unknown effect of resveratrol, a phytoalexin, on PKM2 expression and resultant implications on cancer metabolism. We observed that resveratrol down-regulated PKM2 expression by inhibiting mTOR signaling and suppressed cancer metabolism, adjudged by decreased glucose uptake, lactate production (aerobic glycolysis) and reduced anabolism (macromolecule synthesis) in various cancer cell lines. A contingent decrease in intracellular levels of ribose-5-phosphate (R5P), a critical intermediate of pentose phosphate pathway, accounted for a reduced anabolism. Consequently, the state of suppressed cancer metabolism resulted in decreased cellular proliferation. Interestingly, shRNA-mediated silencing of PKM2 inhibited glucose uptake and lactate production, providing evidence for the critical role of PKM2 and its mediation in the observed effects of resveratrol on cancer metabolism. Further, an over-expression of PKM2 abolished the observed effects of resveratrol, signifying the role of PKM2 downregulation as a critical function of resveratrol. The study reports a novel PKM2-mediated effect of resveratrol on cancer metabolism and provides a new dimension to its therapeutic potential.	[Iqbal, Mohd Askandar; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Iqbal, MA (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.	bamezai@hotmail.com		Iqbal, Mohammad Askandar/0000-0003-3485-3530; Bamezai, R.N.K/0000-0002-5128-2859	University Grants Commission, Government of India; University Grants Commission (UGC); UGC, Government of India	University Grants Commission, Government of India(University Grants Commission, India); University Grants Commission (UGC)(University Grants Commission, India); UGC, Government of India(University Grants Commission, India)	Research was funded by University Grants Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RNKB acknowledges the support provided by the University Grants Commission (UGC) to the Centre (NCAHG) and MA Iqbal acknowledges the support of UGC, Government of India, for research fellowship.	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Ewald N, 2005, Z GASTROENTEROL, V43, P1313, DOI 10.1055/s-2005-858657; Faber AC, 2006, BIOCHEM PHARMACOL, V72, P1246, DOI 10.1016/j.bcp.2006.08.009; Fustier P, 2003, BRIT J CANCER, V89, P168, DOI 10.1038/sj.bjc.6600983; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gupta V, 2010, J BIOL CHEM, V285, P16864, DOI 10.1074/jbc.M109.065029; Hardt PD, 2004, BRIT J CANCER, V91, P980, DOI 10.1038/sj.bjc.6602033; Hardt PD, 2008, EXPERT REV MOL DIAGN, V8, P579, DOI 10.1586/14737159.8.5.579; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill R, CANC RES, V70, P7114; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; KAYNE FJ, 1973, ARCH BIOCHEM BIOPHYS, V159, P292, DOI 10.1016/0003-9861(73)90455-4; Kim YA, 2003, INT J ONCOL, V23, P1143; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Kueck A, 2007, GYNECOL ONCOL, V107, P450, DOI 10.1016/j.ygyno.2007.07.065; Li Y, 2006, APPL BIOCHEM BIOTECH, V135, P181, DOI 10.1385/ABAB:135:3:181; Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255; Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782; Liu M., J BIOL CHEM, V285, P36387; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; NETZKER R, 1992, J BIOL CHEM, V267, P6421; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samuels Y, CURR TOP MICROBIOL I, V347, P21; Sgambato A, 2001, MUTAT RES-GEN TOX EN, V496, P171, DOI 10.1016/S1383-5718(01)00232-7; Sun Q, P NATL ACAD SCI US, V108, P4129; TENNANT DA, NAT REV CANC, V10, P267; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Whyte L, 2007, CANCER RES, V67, P12007, DOI 10.1158/0008-5472.CAN-07-2464; Yamada E, 1999, BIOCHEM BIOPH RES CO, V256, P257, DOI 10.1006/bbrc.1999.0228; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001	36	72	77	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36764	10.1371/journal.pone.0036764	http://dx.doi.org/10.1371/journal.pone.0036764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574221	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800118
J	Jiang, HW; Wu, PZ; Zhang, S; Song, C; Chen, YP; Li, MR; Jia, YX; Fang, XH; Chen, F; Wu, GJ				Jiang, Huawu; Wu, Pingzhi; Zhang, Sheng; Song, Chi; Chen, Yaping; Li, Meiru; Jia, Yongxia; Fang, Xiaohua; Chen, Fan; Wu, Guojiang			Global Analysis of Gene Expression Profiles in Developing Physic Nut (Jatropha curcas L.) Seeds	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; PENTOSE-PHOSPHATE PATHWAYS; BRASSICA-NAPUS; SEQUENCE TAGS; TRANSCRIPTOME ANALYSIS; REVEALS DIFFERENCES; DEVELOPING EMBRYOS; PLASTID ENVELOPE; METABOLIC FLUXES; OIL ACCUMULATION	Background: Physic nut (Jatropha curcas L.) is an oilseed plant species with high potential utility as a biofuel. Furthermore, following recent sequencing of its genome and the availability of expressed sequence tag (EST) libraries, it is a valuable model plant for studying carbon assimilation in endosperms of oilseed plants. There have been several transcriptomic analyses of developing physic nut seeds using ESTs, but they have provided limited information on the accumulation of stored resources in the seeds. Methodology/Principal Findings: We applied next-generation Illumina sequencing technology to analyze global gene expression profiles of developing physic nut seeds 14, 19, 25, 29, 35, 41, and 45 days after pollination (DAP). The acquired profiles reveal the key genes, and their expression timeframes, involved in major metabolic processes including: carbon flow, starch metabolism, and synthesis of storage lipids and proteins in the developing seeds. The main period of storage reserves synthesis in the seeds appears to be 29-41 DAP, and the fatty acid composition of the developing seeds is consistent with relative expression levels of different isoforms of acyl-ACP thioesterase and fatty acid desaturase genes. Several transcription factor genes whose expression coincides with storage reserve deposition correspond to those known to regulate the process in Arabidopsis. Conclusions/Significance: The results will facilitate searches for genes that influence de novo lipid synthesis, accumulation and their regulatory networks in developing physic nut seeds, and other oil seeds. Thus, they will be helpful in attempts to modify these plants for efficient biofuel production.	[Jiang, Huawu; Wu, Pingzhi; Zhang, Sheng; Chen, Yaping; Li, Meiru; Jia, Yongxia; Wu, Guojiang] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Zhang, Sheng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Song, Chi] BGI Shenzhen, Shenzhen, Peoples R China; [Fang, Xiaohua; Chen, Fan] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Jiang, HW (corresponding author), Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	fchen@genetics.ac.cn; wugj@scbg.ac.cn		Chen, Fan/0000-0003-4482-3116; ZHANG, SHENG/0000-0003-0843-0622	National Basic Research Program of China (973 Program) [2010CB126603]; NSFC-Guangdong Joint Fund of Natural Sciences [U0733005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); NSFC-Guangdong Joint Fund of Natural Sciences(National Natural Science Foundation of China (NSFC))	The research work was supported by grants from the National Basic Research Program of China (973 Program) (2010CB126603) (http://www.973.gov.cn/) and the NSFC-Guangdong Joint Fund of Natural Sciences (U0733005) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten WMJ, 2007, BIOFUEL BIOPROD BIOR, V1, P283, DOI 10.1002/bbb.39; Alonso AP, 2007, PLANT J, V52, P296, DOI 10.1111/j.1365-313X.2007.03235.x; Andriotis VME, 2010, PLANT J, V64, P128, DOI 10.1111/j.1365-313X.2010.04313.x; ARONDEL V, 1992, SCIENCE, V258, P1353, DOI 10.1126/science.1455229; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Bensmihen S, 2005, J EXP BOT, V56, P597, DOI 10.1093/jxb/eri050; Bocock PN, 2008, PLANTA, V227, P565, DOI 10.1007/s00425-007-0639-3; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Carles C, 2002, PLANT J, V30, P373, DOI 10.1046/j.1365-313X.2002.01295.x; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chen GQ, 2007, LIPIDS, V42, P263, DOI 10.1007/s11745-007-3022-z; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; daSilva PMFR, 1997, PLANTA, V203, P480, DOI 10.1007/s004250050217; Debnath M, 2008, CURR PHARM BIOTECHNO, V9, P288, DOI 10.2174/138920108785161541; DENNIS DT, 1982, ANNU REV PLANT PHYS, V33, P27, DOI 10.1146/annurev.pp.33.060182.000331; Eicks M, 2002, PLANT PHYSIOL, V128, P512, DOI 10.1104/pp.010576; Emes MJ, 2003, J EXP BOT, V54, P569, DOI 10.1093/jxb/erg089; FALES FW, 1951, J BIOL CHEM, V193, P113; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Fischer K, 2002, TRENDS PLANT SCI, V7, P345, DOI 10.1016/S1360-1385(02)02291-4; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Gubitz GM, 1999, BIORESOURCE TECHNOL, V67, P73, DOI 10.1016/S0960-8524(99)00069-3; Hajduch M, 2006, PLANT PHYSIOL, V141, P32, DOI 10.1104/pp.105.075390; Hajduch M, 2011, PROTEOMICS, V11, P1619, DOI 10.1002/pmic.201000644; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Houston NL, 2009, PLANT PHYSIOL, V151, P857, DOI 10.1104/pp.109.141622; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; KANG F, 1994, PLANT J, V6, P795, DOI 10.1046/j.1365-313X.1994.6060795.x; Kim HU, 2011, PLANT CELL PHYSIOL, V52, P983, DOI 10.1093/pcp/pcr051; King AJ, 2009, J EXP BOT, V60, P2897, DOI 10.1093/jxb/erp025; Knothe G, 2008, ENERG FUEL, V22, P1358, DOI 10.1021/ef700639e; KNUTZON DS, 1992, PLANT PHYSIOL, V100, P1751, DOI 10.1104/pp.100.4.1751; Krishnakumar J, 2008, THERM SCI, V12, P159, DOI 10.2298/TSCI0802159K; KUNST L, 1992, PLANT PHYSIOL BIOCH, V30, P425; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Li FP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-168; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Li-Beisson Y., 2010, ACYL LIPID METABOLIS; Lu CF, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-42; Luerssen K, 1998, PLANT J, V15, P755, DOI 10.1046/j.1365-313X.1998.00259.x; Makkar HPS, 1998, PLANT FOOD HUM NUTR, V52, P31, DOI 10.1023/A:1008054010079; Makkar HPS, 1998, FOOD CHEM, V62, P207, DOI 10.1016/S0308-8146(97)00183-0; Mendoza MS, 2005, FEBS LETT, V579, P4666, DOI 10.1016/j.febslet.2005.07.037; Monke G, 2004, PLANTA, V219, P158, DOI 10.1007/s00425-004-1206-9; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Niu Y, 2009, MOL PLANT, V2, P1107, DOI 10.1093/mp/ssp042; NORTON G, 1975, PLANTA, V123, P163, DOI 10.1007/BF00383865; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; PARCY F, 1994, PLANT CELL, V6, P1567, DOI 10.1105/tpc.6.11.1567; Parcy F, 1997, PLANT CELL, V9, P1265, DOI 10.1105/tpc.9.8.1265; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Periappuram C, 2000, PLANT PHYSIOL, V122, P1193, DOI 10.1104/pp.122.4.1193; Prabhakar V, 2010, PLANT CELL, V22, P2594, DOI 10.1105/tpc.109.073171; Rawsthorne S, 2002, PROG LIPID RES, V41, P182, DOI 10.1016/S0163-7827(01)00023-6; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; Reiser J, 2004, PLANT PHYSIOL, V136, P3524, DOI 10.1104/pp.104.049502; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Sarin R, 2007, FUEL, V86, P1365, DOI 10.1016/j.fuel.2006.11.040; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; SCHUNEMANN D, 1993, PLANT PHYSIOL, V103, P131, DOI 10.1104/pp.103.1.131; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; SIMCOX PD, 1977, PLANT PHYSIOL, V59, P1128, DOI 10.1104/pp.59.6.1128; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMITH RG, 1992, PLANT PHYSIOL, V98, P1233, DOI 10.1104/pp.98.4.1233; Sriram G, 2004, PLANT PHYSIOL, V136, P3043, DOI 10.1104/pp.104.050625; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Vigeolas H, 2004, PLANT PHYSIOL, V136, P2676, DOI 10.1104/pp.104.046854; Voelker TA, 1997, PLANT PHYSIOL, V114, P669, DOI 10.1104/pp.114.2.669; Wakao S, 2008, PLANT PHYSIOL, V146, P277, DOI 10.1104/pp.107.108423; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weber APM, 2011, ANNU REV PLANT BIOL, V62, P53, DOI 10.1146/annurev-arplant-042110-103903; Weber APM, 2005, ANNU REV PLANT BIOL, V56, P133, DOI 10.1146/annurev.arplant.56.032604.144228; White JA, 2000, PLANT PHYSIOL, V124, P1582, DOI 10.1104/pp.124.4.1582; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Wu PZ, 2009, TREE PHYSIOL, V29, P1299, DOI 10.1093/treephys/tpp054; Xu RH, 2011, BIOMASS BIOENERG, V35, P1683, DOI 10.1016/j.biombioe.2011.01.001; Yang Y, 2011, PLANT PHYSIOL, V156, P873, DOI 10.1104/pp.111.175950	84	62	71	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36522	10.1371/journal.pone.0036522	http://dx.doi.org/10.1371/journal.pone.0036522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574177	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349800074
J	Beucher, A; Gjernes, E; Collin, C; Courtney, M; Meunier, A; Collombat, P; Gradwohl, G				Beucher, Anthony; Gjernes, Elisabet; Collin, Caitlin; Courtney, Monica; Meunier, Aline; Collombat, Patrick; Gradwohl, Gerard			The Homeodomain-Containing Transcription Factors Arx and Pax4 Control Enteroendocrine Subtype Specification in Mice	PLOS ONE			English	Article							CELL FATE SPECIFICATION; PANCREATIC-ISLET CELLS; BETA-CELLS; ENDOCRINE PANCREAS; GASTROINTESTINAL-TRACT; GLUCOSE-HOMEOSTASIS; ABNORMAL GENITALIA; GENE-EXPRESSION; GUT HORMONES; ALPHA-CELL	Intestinal hormones are key regulators of digestion and energy homeostasis secreted by rare enteroendocrine cells. These cells produce over ten different hormones including GLP-1 and GIP peptides known to promote insulin secretion. To date, the molecular mechanisms controlling the specification of the various enteroendocrine subtypes from multipotent Neurog3(+) endocrine progenitor cells, as well as their number, remain largely unknown. In contrast, in the embryonic pancreas, the opposite activities of Arx and Pax4 homeodomain transcription factors promote islet progenitor cells towards the different endocrine cell fates. In this study, we thus investigated the role of Arx and Pax4 in enteroendocrine subtype specification. The small intestine and colon of Arx-and Pax4-deficient mice were analyzed using histological, molecular, and lineage tracing approaches. We show that Arx is expressed in endocrine progenitors (Neurog3(+)) and in early differentiating (ChromograninA(-)) GLP-1-, GIP-, CCK-, Sct-Gastrin- and Ghrelin-producing cells. We noted a dramatic reduction or a complete loss of all these enteroendocrine cell types in Arx mutants. Serotonin- and Somatostatin-secreting cells do not express Arx and, accordingly, the differentiation of Serotonin cells was not affected in Arx mutants. However, the number of Somatostatin-expressing D-cells is increased as Arx-deficient progenitor cells are redirected to the D-cell lineage. In Pax4-deficient mice, the differentiation of Serotonin and Somatostatin cells is impaired, as well as of GIP and Gastrin cells. In contrast, the number of GLP-1 producing L-cells is increased concomitantly with an upregulation of Arx. Thus, while Arx and Pax4 are necessary for the development of Land D-cells respectively, they conversely restrict D- and L-cells fates suggesting antagonistic functions in D/L cell allocation. In conclusion, these finding demonstrate that, downstream of Neurog3, the specification of a subset of enteroendocrine subtypes relies on both Arx and Pax4, while others depend only on Arx or Pax4.	[Beucher, Anthony; Collin, Caitlin; Meunier, Aline; Gradwohl, Gerard] Univ Strasbourg, IGBMC, INSERM U964, CNRS UMR 7104, Illkirch Graffenstaden, France; [Gjernes, Elisabet; Courtney, Monica; Collombat, Patrick] INSERM UMR 636, Diabet Genet Team, Nice, France; [Gjernes, Elisabet; Courtney, Monica; Collombat, Patrick] Univ Nice Sophia Antipolis, Lab Genet Dev Normal & Pathol, Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Beucher, A (corresponding author), Univ Strasbourg, IGBMC, INSERM U964, CNRS UMR 7104, Illkirch Graffenstaden, France.	gradwohl@igbmc.fr	Collin, Caitlin/H-9315-2012; collombat, patrick/P-3741-2019; Gradwohl, Gérard/AFM-9024-2022; collombat, patrick/F-4495-2015; Gradwohl, Gérard/H-8543-2014	collombat, patrick/0000-0001-8232-1438; Gradwohl, Gérard/0000-0002-6730-2615; collombat, patrick/0000-0001-8232-1438; Gradwohl, Gérard/0000-0002-6730-2615; Beucher, Anthony/0000-0003-4489-1848; Meunier, Aline/0000-0003-3594-168X	Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de la Recherche (ANR); Juvenile Diabetes Research foundation (JDRF); European Research Council (ERC); Fondation pour la Recherche Medicale (FRM); Association Francaise des Diabetiques (AFD); Fondation Schlumberger pour l'Education et la Recherche; Mr. and Mrs. Olivier Dorato	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Juvenile Diabetes Research foundation (JDRF)(Juvenile Diabetes Research Foundation); European Research Council (ERC)(European Research Council (ERC)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association Francaise des Diabetiques (AFD); Fondation Schlumberger pour l'Education et la Recherche; Mr. and Mrs. Olivier Dorato	The authors are supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Agence Nationale de la Recherche (ANR), the Juvenile Diabetes Research foundation (JDRF), the European Research Council (ERC), the Fondation pour la Recherche Medicale (FRM), the Association Francaise des Diabetiques (AFD), Mr. and Mrs. Olivier Dorato and the Fondation Schlumberger pour l'Education et la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen C, 2009, AM J PHYSIOL-GASTR L, V297, pG1126, DOI 10.1152/ajpgi.90586.2008; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Desai S, 2008, DEV BIOL, V313, P58, DOI 10.1016/j.ydbio.2007.09.047; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Gauthier BR, 2002, MOL ENDOCRINOL, V16, P170, DOI 10.1210/me.16.1.170; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; Hill JT, 2010, MOL ENDOCRINOL, V24, P381, DOI 10.1210/me.2009-0360; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Larsson LI, 1998, MECH DEVELOP, V79, P153, DOI 10.1016/S0925-4773(98)00182-8; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; Mellitzer G, 2010, J CLIN INVEST, V120, P1708, DOI 10.1172/JCI40794; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nanba Yukiko, 2007, No To Hattatsu, V39, P379; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; RINDI G, 1990, AM J PATHOL, V136, P1349; Sakata I, 2002, PEPTIDES, V23, P531, DOI 10.1016/S0196-9781(01)00633-7; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wang Q, 2008, DEV DYNAM, V237, P51, DOI 10.1002/dvdy.21379; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Ye DZ, 2009, GASTROENTEROLOGY, V137, P2052, DOI 10.1053/j.gastro.2009.08.059	34	60	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36449	10.1371/journal.pone.0036449	http://dx.doi.org/10.1371/journal.pone.0036449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570716	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400032
J	Ayub, MJ; Nyambega, B; Simonetti, L; Duffy, T; Longhi, SA; Gomez, KA; Hoebeke, J; Levin, MJ; Smulski, CR				Juri Ayub, Maximiliano; Nyambega, Benson; Simonetti, Leandro; Duffy, Tomas; Longhi, Silvia A.; Gomez, Karina A.; Hoebeke, Johan; Levin, Mariano J.; Smulski, Cristian R.			Selective Blockade of Trypanosomatid Protein Synthesis by a Recombinant Antibody Anti-Trypanosoma cruzi P2 beta Protein	PLOS ONE			English	Article							RIBOSOMAL-P PROTEINS; MONOCLONAL-ANTIBODY; BLOOD-STREAM; AUTOANTIBODIES; INTRABODIES; INHIBITION; EXPRESSION; ALIGNMENT; COMPLEX; BINDING	The ribosomal P proteins are located on the stalk of the ribosomal large subunit and play a critical role during the elongation step of protein synthesis. The single chain recombinant antibody C5 (scFv C5) directed against the C-terminal region of the Trypanosoma cruzi P2 beta protein (TcP2 beta) recognizes the conserved C-terminal end of all T. cruzi ribosomal P proteins. Although this region is highly conserved among different species, surface plasmon resonance analysis showed that the scFv C5 possesses very low affinity for the corresponding mammalian epitope, despite having only one single amino-acid change. Crystallographic analysis, in silico modelization and NMR assays support the analysis, increasing our understanding on the structural basis of epitope specificity. In vitro protein synthesis experiments showed that scFv C5 was able to specifically block translation by T. cruzi and Crithidia fasciculata ribosomes, but virtually had no effect on Rattus norvegicus ribosomes. Therefore, we used the scFv C5 coding sequence to make inducible intrabodies in Trypanosoma brucei. Transgenic parasites showed a strong decrease in their growth rate after induction. These results strengthen the importance of the P protein C terminal regions for ribosomal translation activity and suggest that trypanosomatid ribosomal P proteins could be a possible target for selective therapeutic agents that could be derived from structural analysis of the scFv C5 antibody paratope.	[Juri Ayub, Maximiliano; Nyambega, Benson; Simonetti, Leandro; Duffy, Tomas; Longhi, Silvia A.; Gomez, Karina A.; Levin, Mariano J.; Smulski, Cristian R.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, Lab Biol Mol Enfermedad Chagas, Buenos Aires, DF, Argentina; [Juri Ayub, Maximiliano] Univ Nacl San Luis, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Invest Biol San Luis, San Luis, Argentina; [Nyambega, Benson] Maseno Univ, Dept Med Biochem, Kisumu, Kenya; [Nyambega, Benson] Heidelberg Univ, Zentrum Mol Biol, D-6900 Heidelberg, Germany; [Hoebeke, Johan; Smulski, Cristian R.] IBMC, Immunol & Chim Therapeut UPR 9021, Strasbourg, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis; Maseno University; Ruprecht Karls University Heidelberg	Ayub, MJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, Lab Biol Mol Enfermedad Chagas, Buenos Aires, DF, Argentina.	CristianRoberto.Smulski@unil.ch	Duffy, Tomas/S-6045-2017; Nyambega, Benson/GOH-3417-2022	Nyambega, Benson/0000-0002-0947-0354; Gomez, Karina Andrea/0000-0001-8115-667X; Simonetti, Leandro/0000-0003-1283-9770; Smulski, Cristian/0000-0003-4186-8116; Juri Ayub, Maximiliano/0000-0002-5787-0993	World Health Organization/Special Program for Research and Training in Tropical Diseases; Universidad de Buenos Aires; Ministerio de Salud y Accion Social-Beca Ramon Carrillo-Arturo Onativia; National Agency of Scientific and Technological Promotion [FONCYT BID 1201/OC-AR 01-14389]; ECOS-SECyT project "Anticorps anti-proteines ribosomales P de T. cruzi comme inhibiteur specifique de la traduction" (France-Argentine); CONICET	World Health Organization/Special Program for Research and Training in Tropical Diseases(World Health Organization); Universidad de Buenos Aires(University of Buenos Aires); Ministerio de Salud y Accion Social-Beca Ramon Carrillo-Arturo Onativia; National Agency of Scientific and Technological Promotion(ANPCyT); ECOS-SECyT project "Anticorps anti-proteines ribosomales P de T. cruzi comme inhibiteur specifique de la traduction" (France-Argentine); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research has been initially supported by grants from the World Health Organization/Special Program for Research and Training in Tropical Diseases, Universidad de Buenos Aires, Ministerio de Salud y Accion Social-Beca Ramon Carrillo-Arturo Onativia, and the National Agency of Scientific and Technological Promotion (FONCYT BID 1201/OC-AR 01-14389). Support of ECOS-SECyT project "Anticorps anti-proteines ribosomales P de T. cruzi comme inhibiteur specifique de la traduction" (France-Argentine, 2005-2008) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Sylviane Muller and Prof. Sylvie Fournel (UPR 9021 Strasbourg, France) for helpful collaboration in the publication of this article as well as Dr. I. D. Algranati for his advice about in vitro translation experiments and helpful discussions about the manuscript. We sincerely thank Prof. Dr. Christine Clayton (ZMBH, Heidelberg, Germany) for facilitating the expressions in T. brucei. M.J.A., S. A. L. and K. A. G. are members of scientific career of CONICET. L. S. and T. D. have fellowships from CONICET.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayub MJ, 2008, EXP PARASITOL, V118, P442, DOI 10.1016/j.exppara.2007.09.002; Ayub MJ, 2005, GENE, V357, P129, DOI 10.1016/j.gene.2005.06.006; BaileySerres J, 1997, PLANT PHYSIOL, V114, P1293, DOI 10.1104/pp.114.4.1293; Ballesta JPG, 1999, FEMS MICROBIOL REV, V23, P537, DOI 10.1111/j.1574-6976.1999.tb00412.x; Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x; Berezov A, 2003, IMMUNOL RES, V27, P303, DOI 10.1385/IR:27:2-3:303; Bergami PL, 2003, BIOCHEM BIOPH RES CO, V301, P819, DOI 10.1016/S0006-291X(02)03074-4; Bergami PL, 2001, FASEB J, V15, P2602, DOI 10.1096/fj.01-0132com; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Boldicke T, 2005, J IMMUNOL METHODS, V300, P146, DOI 10.1016/j.jim.2005.03.007; Casset F, 2003, BIOCHEM BIOPH RES CO, V307, P198, DOI 10.1016/S0006-291X(03)01131-8; CLAYTON CE, 1987, J CELL BIOL, V105, P2649, DOI 10.1083/jcb.105.6.2649; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Kaplan D, 1997, P NATL ACAD SCI USA, V94, P10301, DOI 10.1073/pnas.94.19.10301; Kontermann RE, 2004, METHODS, V34, P163, DOI 10.1016/j.ymeth.2004.04.002; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LAVERGNE JP, 1987, FEBS LETT, V216, P83, DOI 10.1016/0014-5793(87)80761-5; LEVIN MJ, 1993, PARASITOL TODAY, V9, P381, DOI 10.1016/0169-4758(93)90088-W; LEVIN MJ, 1989, AM J TROP MED HYG, V41, P530, DOI 10.4269/ajtmh.1989.41.530; Mahler E, 2001, EUR J IMMUNOL, V31, P2210, DOI 10.1002/1521-4141(200107)31:7&lt;2210::AID-IMMU2210&gt;3.0.CO;2-J; Manful T, 2009, MOL BIOCHEM PARASIT, V166, P186, DOI 10.1016/j.molbiopara.2009.03.003; MESRI EA, 1990, J CLIN MICROBIOL, V28, P1219, DOI 10.1128/JCM.28.6.1219-1224.1990; MULLER S, 1985, BIOCHIM BIOPHYS ACTA, V827, P235, DOI 10.1016/0167-4838(85)90208-0; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Pizarro JC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001375; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; SARAGOVI HU, 1991, SCIENCE, V253, P792, DOI 10.1126/science.1876837; Smulski C, 2006, FASEB J, V20, P1396, DOI 10.1096/fj.05-5699com; Smulski CR, 2011, J MOL RECOGNIT, V24, P359, DOI 10.1002/jmr.1089; Soares MR, 2004, FEBS LETT, V560, P134, DOI 10.1016/S0014-5793(04)00088-2; STACEY DW, 1988, ARCH BIOCHEM BIOPHYS, V267, P398; Stocks MR, 2004, DRUG DISCOV TODAY, V9, P960, DOI 10.1016/S1359-6446(04)03269-6; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Zampieri S, 2003, CELL MOL LIFE SCI, V60, P588, DOI 10.1007/s000180300050	40	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36233	10.1371/journal.pone.0036233	http://dx.doi.org/10.1371/journal.pone.0036233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570698	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400014
J	Lakhani, B; Vette, AH; Mansfield, A; Miyasike-daSilva, V; McIlroy, WE				Lakhani, Bimal; Vette, Albert H.; Mansfield, Avril; Miyasike-daSilva, Veronica; McIlroy, William E.			Electrophysiological Correlates of Changes in Reaction Time Based on Stimulus Intensity	PLOS ONE			English	Article							SOMATOSENSORY EVOKED-POTENTIALS; CHOICE-REACTION TIME; SACCADIC REACTION-TIME; MEDIAN NERVE; PARKINSONS-DISEASE; LATENCY; MOVEMENTS; STIMULATION; TASK; AGE	Background: Although reaction time is commonly used as an indicator of central nervous system integrity, little is currently understood about the mechanisms that determine processing time. In the current study, we are interested in determining the differences in electrophysiological events associated with significant changes in reaction time that could be elicited by changes in stimulus intensity. The primary objective is to assess the effect of increasing stimulus intensity on the latency and amplitude of afferent inputs to the somatosensory cortex, and their relation to reaction time. Methods: Median nerve stimulation was applied to the non-dominant hand of 12 healthy young adults at two different stimulus intensities (HIGH & LOW). Participants were asked to either press a button as fast as possible with their dominant hand or remain quiet following the stimulus. Electroencephalography was used to measure somatosensory evoked potentials (SEPs) and event related potentials (ERPs). Electromyography from the flexor digitorum superficialis of the button-pressing hand was used to assess reaction time. Response time was the time of button press. Results: Reaction time and response time were significantly shorter following the HIGH intensity stimulus compared to the LOW intensity stimulus. There were no differences in SEP (N20 & P24) peak latencies and peak-to-peak amplitude for the two stimulus intensities. ERPs, locked to response time, demonstrated a significantly larger pre-movement negativity to positivity following the HIGH intensity stimulus over the Cz electrode. Discussion: This work demonstrates that rapid reaction times are not attributable to the latency of afferent processing from the stimulated site to the somatosensory cortex, and those latency reductions occur further along the sensorimotor transformation pathway. Evidence from ERPs indicates that frontal planning areas such as the supplementary motor area may play a role in transforming the elevated sensory volley from the somatosensory cortex into a more rapid motor response.	[Lakhani, Bimal; McIlroy, William E.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Lakhani, Bimal; Vette, Albert H.; Mansfield, Avril; McIlroy, William E.] Toronto Rehab, Mobil Res Team, Toronto, ON, Canada; [Vette, Albert H.; Miyasike-daSilva, Veronica; McIlroy, William E.] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Toronto; University of Waterloo	Lakhani, B (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada.	wmcilroy@uwaterloo.ca	Mansfield, Avril/B-8589-2013	Mansfield, Avril/0000-0002-0396-5815; Lakhani, Bimal/0000-0002-6833-6454; McIlroy, William/0000-0003-2319-1746	Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research; Toronto Rehabilitation Institute; Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Toronto Rehabilitation Institute(University of Toronto); Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario	The authors acknowledge the support of the Natural Sciences and Engineering Research Council of Canada, the Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research. The authors also acknowledge the support of Toronto Rehabilitation Institute who receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario. The views expressed do not necessarily reflect those of the Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JJ, 1999, ERGONOMICS, V42, P327, DOI 10.1080/001401399185685; Bell AH, 2006, EXP BRAIN RES, V174, P53, DOI 10.1007/s00221-006-0420-z; Brebner JT, 1980, REACTION TIMES; COHEN LG, 1987, BRAIN, V110, P451, DOI 10.1093/brain/110.2.451; DEECKE L, 1969, EXP BRAIN RES, V7, P158; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Gage WH, 2007, EXP BRAIN RES, V181, P627, DOI 10.1007/s00221-007-0959-3; Galton F., 1899, J ANTHR I, V19, P27, DOI 10.2307/2842529; GRICE GR, 1968, PSYCHOL REV, V75, P359, DOI 10.1037/h0026287; GRISOLIA JS, 1980, ELECTROEN CLIN NEURO, V50, P375, DOI 10.1016/0013-4694(80)90005-X; Hada Y, 2006, CLIN EEG NEUROSCI, V37, P25, DOI 10.1177/155005940603700106; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jaskowski P, 2004, PERCEPT PSYCHOPHYS, V66, P535, DOI 10.3758/BF03194899; KAKIGI R, 1994, NEUROSCI RES, V20, P165, DOI 10.1016/0168-0102(94)90034-5; Kida T, 2003, INT J PSYCHOPHYSIOL, V48, P275, DOI 10.1016/S0167-8760(03)00021-7; KOHFELD DL, 1971, J EXP PSYCHOL, V88, P251, DOI 10.1037/h0030891; KRAMER AF, 1988, BIOL PSYCHOL, V26, P231, DOI 10.1016/0301-0511(88)90022-1; KRITCHEVSKY M, 1978, ARCH NEUROL-CHICAGO, V35, P706, DOI 10.1001/archneur.1978.00500350010003; Kutukcu Y, 1999, BRAIN RES, V815, P367, DOI 10.1016/S0006-8993(98)01060-9; Lakhani B, 2011, BRAIN RES, V1416, P35, DOI 10.1016/j.brainres.2011.08.013; LeDoux J, 1996, PROG BRAIN RES, V107, P437; Legon W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-112; Luchies CW, 2002, J GERONTOL A-BIOL, V57, pM246, DOI 10.1093/gerona/57.4.M246; Maki BE, 1997, PHYS THER, V77, P488, DOI 10.1093/ptj/77.5.488; NOBLE CE, 1964, PERCEPT MOTOR SKILL, V19, P935, DOI 10.2466/pms.1964.19.3.935; Pins D, 1996, PERCEPT PSYCHOPHYS, V58, P390, DOI 10.3758/BF03206815; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Carreiro LRR, 2011, NEUROSCI LETT, V487, P345, DOI 10.1016/j.neulet.2010.10.053; Schubert M, 1998, NEUROSCI RES, V30, P125, DOI 10.1016/S0168-0102(97)00115-6; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Sibley KM, 2010, NEUROSCI LETT, V485, P217, DOI 10.1016/j.neulet.2010.09.015; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Thobois S, 2007, NEUROIMAGE, V37, P243, DOI 10.1016/j.neuroimage.2007.04.049; VaezMousavi SM, 2009, PHYSIOL BEHAV, V98, P326, DOI 10.1016/j.physbeh.2009.06.007; WELFORD AT, 1976, INT J AGING HUM DEV, V7, P189, DOI 10.2190/9477-XQE6-Q52U-758J; WIEDERHOLT WC, 1970, J NEUROL NEUROSUR PS, V33, P438, DOI 10.1136/jnnp.33.4.438	38	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36407	10.1371/journal.pone.0036407	http://dx.doi.org/10.1371/journal.pone.0036407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570711	Green Published, gold			2022-12-25	WOS:000305343400027
J	Olszewski, J; Haehnel, M; Taguchi, M; Liao, JC				Olszewski, Julia; Haehnel, Melanie; Taguchi, Masashige; Liao, James C.			Zebrafish Larvae Exhibit Rheotaxis and Can Escape a Continuous Suction Source Using Their Lateral Line	PLOS ONE			English	Article							FISHES; RHEOTROPISM; SOMATOTOPY; FLOW	Zebrafish larvae show a robust behavior called rheotaxis, whereby they use their lateral line system to orient upstream in the presence of a steady current. At 5 days post fertilization, rheotactic larvae can detect and initiate a swimming burst away from a continuous point-source of suction. Burst distance and velocity increase when fish initiate bursts closer to the suction source where flow velocity is higher. We suggest that either the magnitude of the burst reflects the initial flow stimulus, or fish may continually sense flow during the burst to determine where to stop. By removing specific neuromasts of the posterior lateral line along the body, we show how the location and number of flow sensors play a role in detecting a continuous suction source. We show that the burst response critically depends on the presence of neuromasts on the tail. Flow information relayed by neuromasts appears to be involved in the selection of appropriate behavioral responses. We hypothesize that caudally located neuromasts may be preferentially connected to fast swimming spinal motor networks while rostrally located neuromasts are connected to slow swimming motor networks at an early age.	[Olszewski, Julia] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Haehnel, Melanie; Taguchi, Masashige; Liao, James C.] Univ Florida, Dept Biol, Whitney Lab Marine Biosci, St Augustine, FL USA	Brown University; State University System of Florida; University of Florida	Olszewski, J (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	jliao@whitney.ufl.edu	Haehnel-Taguchi, Melanie/AAR-5589-2021	Haehnel-Taguchi, Melanie/0000-0003-0508-8171	National Institutes of Health NIH [RO1 DC010809]; National Science Foundation NSF REU [DBI 648969]; Deutsche Forschungsgemeinschaft [HA 6481/1-1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010809] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation NSF REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health NIH RO1 DC010809 to JCL, National Science Foundation NSF REU DBI 648969 to the Whitney Lab for Marine Bioscience and a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (HA 6481/1-1) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; ARNOLD GP, 1978, J EXP BIOL, V75, P147; ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; Baker CF, 1999, J COMP PHYSIOL A, V184, P519, DOI 10.1007/s003590050351; Chagnaud BP, 2008, J NEUROSCI, V28, P4479, DOI 10.1523/JNEUROSCI.4959-07.2008; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; EATON RC, 1986, T AM FISH SOC, V115, P128, DOI 10.1577/1548-8659(1986)115<128:ROTTER>2.0.CO;2; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; FERO K, 2010, ZEBRAFISH MODELS NEU; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Lyon EP, 1904, AM J PHYSIOL, V12, P149, DOI 10.1152/ajplegacy.1904.12.2.149; MATHEWSON RF, 1972, COMP BIOCHEM PHYSIOL, V42, P79, DOI 10.1016/0300-9629(72)90369-6; McClure MM, 2006, J FISH BIOL, V69, P553, DOI 10.1111/j.1095-8649.2006.01125.x; McHenry MJ, 2009, BIOL LETTERS, V5, P477, DOI 10.1098/rsbl.2009.0048; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; MONTGOMERY J, 1995, REV FISH BIOL FISHER, V5, P399, DOI 10.1007/BF01103813; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Pujol-Marti J, 2010, DEV DYNAM, V239, P1919, DOI 10.1002/dvdy.22320; Reichardt W, 1987, J COMP PHYSIOL A, V161, P533; Simmons A, 2004, J COMP PHYSIOL A, V190, P747, DOI 10.1007/s00359-004-0534-3	22	67	67	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36661	10.1371/journal.pone.0036661	http://dx.doi.org/10.1371/journal.pone.0036661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570735	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400051
J	Ruiz-Estevez, M; Lopez-Leon, MD; Cabrero, J; Camacho, JPM				Ruiz-Estevez, Mercedes; Dolores Lopez-Leon, Ma; Cabrero, Josefa; Camacho, Juan Pedro M.			B-Chromosome Ribosomal DNA Is Functional in the Grasshopper Eyprepocnemis plorans	PLOS ONE			English	Article							NUCLEOLAR ORGANIZER REGIONS; NOR ACTIVITY; RNA GENES; TRANSCRIPTION; EVOLUTION; PROTEINS; HETEROCHROMATIN; DISTORTION; SEQUENCES; MEIOSIS	B-chromosomes are frequently argued to be genetically inert elements, but activity for some particular genes has been reported, especially for ribosomal RNA (rRNA) genes whose expression can easily be detected at the cytological level by the visualization of their phenotypic expression, i.e., the nucleolus. The B-24 chromosome in the grasshopper Eyprepocnemis plorans frequently shows a nucleolus attached to it during meiotic prophase I. Here we show the presence of rRNA transcripts that unequivocally came from the B-24 chromosome. To detect these transcripts, we designed primers specifically anchoring at the ITS-2 region, so that the reverse primer was complementary to the B chromosome DNA sequence including a differential adenine insertion being absent in the ITS2 of A chromosomes. PCR analysis carried out on genomic DNA showed amplification in B-carrying males but not in B-lacking ones. PCR analyses performed on complementary DNA showed amplification in about half of B-carrying males. Joint cytological and molecular analysis performed on 34 B-carrying males showed a close correspondence between the presence of B-specific transcripts and of nucleoli attached to the B chromosome. In addition, the molecular analysis revealed activity of the B chromosome rDNA in 10 out of the 13 B-carrying females analysed. Our results suggest that the nucleoli attached to B chromosomes are actively formed by expression of the rDNA carried by them, and not by recruitment of nucleolar materials formed in A chromosome nucleolar organizing regions. Therefore, B-chromosome rDNA in E. plorans is functional since it is actively transcribed to form the nucleolus attached to the B chromosome. This demonstrates that some heterochromatic B chromosomes can harbour functional genes.	[Ruiz-Estevez, Mercedes; Dolores Lopez-Leon, Ma; Cabrero, Josefa; Camacho, Juan Pedro M.] Univ Granada, Dept Genet, Granada, Spain	University of Granada	Ruiz-Estevez, M (corresponding author), Univ Granada, Dept Genet, Granada, Spain.	jpmcamac@ugr.es	Cabrero, Josefa/L-8899-2014; López-León, María Dolores/L-9026-2014; Camacho, Juan Pedro M/L-6869-2014	Cabrero, Josefa/0000-0002-5848-6985; López-León, María Dolores/0000-0003-2337-7313; Camacho, Juan Pedro M/0000-0002-2507-9814	Spanish Ministerio de Ciencia e Innovacion [CGL2009-11917]; FEDER funds; fellowship (FPU) from the Spanish Ministerio de Ciencia e Innovacion	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER funds(European Commission); fellowship (FPU) from the Spanish Ministerio de Ciencia e Innovacion	This study was supported by a grant from the Spanish Ministerio de Ciencia e Innovacion (CGL2009-11917), and was partially performed by FEDER funds. M. Ruiz-Estevez was supported by a fellowship (FPU) from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidau CJ, 2004, CYTOGENET GENOME RES, V106, P295, DOI 10.1159/000079302; BIDAU CJ, 1986, CAN J GENET CYTOL, V28, P138, DOI 10.1139/g86-018; BROCKHOUSE C, 1989, GENOME, V32, P516, DOI 10.1139/g89-477; BUSCH H, 1979, CANCER RES, V39, P857; Busch H, 1997, J TUMOR MARKER ONCOL, V12, P5; Cabrero J, 2007, CYTOGENET GENOME RES, V119, P135, DOI 10.1159/000109630; Cabrero J, 1999, HEREDITY, V83, P435, DOI 10.1038/sj.hdy.6885960; CABRERO J, 1987, GENOME, V29, P116, DOI 10.1139/g87-020; Camacho JPM, 2004, CYTOGENET GENOME RES, V106, P325, DOI 10.1159/000079307; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Carchilan M, 2007, PLANT CELL, V19, P1738, DOI 10.1105/tpc.106.046946; Carchilan M, 2009, CHROMOSOMA, V118, P607, DOI 10.1007/s00412-009-0222-8; CARLSON WR, 1986, CRIT REV PLANT SCI, V3, P201, DOI 10.1080/07352688609382210; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Caspersson T., 1950, CELL GROWTH CELL FUN; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; DONALD TM, 1995, HEREDITY, V74, P556, DOI 10.1038/hdy.1995.77; Donald TM, 1997, GENOME, V40, P674, DOI 10.1139/g97-089; FOX DP, 1974, CHROMOSOMA, V45, P43; GREEN DM, 1988, CHROMOSOMA, V97, P55, DOI 10.1007/BF00331795; GREEN DM, 1990, GENOME, V33, P818, DOI 10.1139/g90-123; Han FP, 2007, PLANT CELL, V19, P524, DOI 10.1105/tpc.106.049577; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; ISHAK B, 1991, CHROMOSOMA, V100, P278, DOI 10.1007/BF00344162; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Leach CR, 2005, GENETICS, V171, P269, DOI 10.1534/genetics.105.043273; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Lopez-Leon MD, 1994, CHROMOSOME RES, V2, P87, DOI 10.1007/BF01553487; Lopez-Leon MD, 1999, CHROMOSOME RES, V7, P83, DOI 10.1023/A:1009270310092; LOPEZLEON MD, 1995, GENOME, V38, P68, DOI 10.1139/g95-008; LOPEZLEON MD, 1991, CHROMOSOMA, V100, P134, DOI 10.1007/BF00418247; LOPEZLEON MD, 1995, HEREDITY, V74, P296, DOI 10.1038/hdy.1995.43; Manrique-Poyato MI, 2006, CHROMOSOME RES, V14, P693, DOI 10.1007/s10577-006-1081-2; Manrique-Poyato MI, 2010, THESIS U GRANADA; Marschner S, 2007, GENOME, V50, P638, DOI 10.1139/G07-048; Mosgoeller W, 2004, MOL BIOL INTELL UNIT, P10; Nakamoto K, 2001, AM J PATHOL, V159, P1363, DOI 10.1016/S0002-9440(10)62523-0; OKABE Y, 1991, ANTICANCER RES, V11, P2031; Perfectti F, 2004, CYTOGENET GENOME RES, V106, P338, DOI 10.1159/000079309; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; Poletto AB, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-1, 10.1186/1471-2156-11-50]; ROUSSEL P, 1992, EXP CELL RES, V203, P259, DOI 10.1016/0014-4827(92)90063-E; ROUSSEL P, 1994, EXP CELL RES, V214, P465, DOI 10.1006/excr.1994.1283; Roussel P, 1996, J CELL BIOL, V133, P235, DOI 10.1083/jcb.133.2.235; RUFAS JS, 1982, ARCH BIOL, V93, P267; Sabrina B, 2009, CARYOLOGIA, V62, P95, DOI 10.1080/00087114.2004.10589674; Stitou S, 2004, CYTOGENET GENOME RES, V106, P344, DOI 10.1159/000079310; Teruel M, 2009, THESIS U GRANADA; Teruel M, 2007, CHROMOSOME RES, V15, P755, DOI 10.1007/s10577-007-1159-5; Teruel M, 2010, CHROMOSOMA, V119, P217, DOI 10.1007/s00412-009-0251-3; Teruel M, 2009, CHROMOSOMA, V118, P291, DOI 10.1007/s00412-008-0197-x; THIELE J, 1993, VIRCHOWS ARCH A, V423, P409, DOI 10.1007/BF01606529; van Vugt JJFA, 2005, CHROMOSOMA, V114, P410, DOI 10.1007/s00412-005-0026-4; Yoshida K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002203; Zurita S, 1998, EVOLUTION, V52, P274, DOI 10.1111/j.1558-5646.1998.tb05163.x	55	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36600	10.1371/journal.pone.0036600	http://dx.doi.org/10.1371/journal.pone.0036600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570730	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343400046
J	Yigit, MV; Ghosh, SK; Kumar, M; Petkova, V; Kavishwar, A; Moore, A; Medarova, Z				Yigit, M. V.; Ghosh, S. K.; Kumar, M.; Petkova, V.; Kavishwar, A.; Moore, A.; Medarova, Z.			Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis	ONCOGENE			English	Article						imaging; miRNA; metastasis; miR-10b; nanoparticle; therapy	SUPERPARAMAGNETIC IRON-OXIDE; CANCER; MICRORNA; THERAPEUTICS; LNA	Metastases, and not the primary tumor from which they originate, are the main reason for mortality from carcinoma. Although the molecular mechanisms behind metastasis are poorly understood, it is clear that epigenetic dysregulation at the level of microRNA expression is a key characteristic of the metastatic process that can be exploited for therapy. Here, we describe an miRNA-targeted therapeutic approach for the prevention and arrest of lymph node metastasis. Therapy relies on the inhibition of the pro-metastatic microRNA-10b. It is delivered to primary and lymph node metastatic tumor cells using an imaging-capable nanodrug that is designed to specifically home to these tissues. Treatment of invasive human breast tumor cells (MDA-MB-231) with the nanodrug in vitro downregulates miR-10b and abolishes the invasion and migration of the tumor cells. After intravenous delivery to mice bearing orthotopic MDA-MB-231-luc-D3H2LN tumors, the nanodrug accumulates in the primary tumor and lymph nodes. When treatment is initiated before metastasis to lymph nodes, metastasis is prevented. Treatment after the formation of lymph node metastases arrests the metastatic process without a concomitant effect on primary tumor growth raising the possibility of a context-dependent variation in miR-10b breast oncogenesis. Oncogene (2013) 32, 1530-1538; doi:10.1038/onc.2012.173; published online 14 May 2012	[Yigit, M. V.; Ghosh, S. K.; Kumar, M.; Kavishwar, A.; Moore, A.; Medarova, Z.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Mol Imaging Lab, Dept Radiol, Charlestown, MA USA; [Yigit, M. V.; Ghosh, S. K.; Kumar, M.; Kavishwar, A.; Moore, A.; Medarova, Z.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Petkova, V.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Moore, A (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol,Mol Imaging Lab,MGH MIT HMS Athinoula, Bldg 75,13th St, Charlestown, MA 02129 USA.	amoore@helix.mgh.harvard.edu; zmedarova@partners.org		Kavishwar, Amol/0000-0001-8214-6625	National Cancer Institute [R00CA129070]; Breast Cancer Alliance; NATIONAL CANCER INSTITUTE [R00CA129070, R01CA163461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025504] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Pamela Pantazopoulos and Alana Ross for help with the in-vitro, in-vivo and ex-vivo studies and Marytheresa Ifediba for proofreading the manuscript. Confocal microscopy was performed at the Confocal Microscopy Core at MGH with technical assistance from Igor A Bagayev, MS Work at the Martinos Center for Biomedical Imaging was supported in part under Grant R00CA129070 from the National Cancer Institute and a Research Grant from the Breast Cancer Alliance.	Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Beer AJ, 2008, J NUCL MED, V49, P255, DOI 10.2967/jnumed.107.045526; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Gabriely G, 2011, AUTOPHAGY, V7, P1384, DOI 10.4161/auto.7.11.17371; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Jepsen JS, 2004, OLIGONUCLEOTIDES, V14, P130, DOI 10.1089/1545457041526317; Kenny LM, 2008, J NUCL MED, V49, P879, DOI 10.2967/jnumed.107.049452; Kumar M, 2010, CANCER RES, V70, P7553, DOI 10.1158/0008-5472.CAN-10-2070; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Medarova Z, 2006, NAT PROTOC, V1, P429, DOI 10.1038/nprot.2006.63; Medarova Z, 2007, NAT MED, V13, P372, DOI 10.1038/nm1486; Medarova Z, 2009, CANCER RES, V69, P1182, DOI 10.1158/0008-5472.CAN-08-2001; Michel SCA, 2002, RADIOLOGY, V225, P527, DOI 10.1148/radiol.2252011605; Nathanson SD, 2009, ANN SURG ONCOL, V16, P3396, DOI 10.1245/s10434-009-0659-2; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; WEISSLEDER R, 1990, RADIOLOGY, V175, P494, DOI 10.1148/radiology.175.2.2326475; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499	26	70	71	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2013	32	12					1530	1538		10.1038/onc.2012.173	http://dx.doi.org/10.1038/onc.2012.173			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22580603	Green Accepted			2022-12-25	WOS:000316456000006
J	Feng, CZ; Zuo, ZY				Feng, Chenzhuo; Zuo, Zhiyi			Regulatory Factor X1-induced Down-regulation of Transforming Growth Factor beta 2 Transcription in Human Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR ANTIGEN; PROTEIN-KINASE; FACTOR X1; TGF-BETA; EXPRESSION; RFX1; GENE; IDENTIFICATION; PROMOTER; MATURE	Regulatory factor X (RFX) proteins are transcription factors. Seven mammalian RFX proteins have been identified. RFX1 is the prototype RFX. However, its biological functions are not known. Here, RFX1 overexpression reduced fetal bovine serum-stimulated proliferation of SH-SY5Y cells, a human neuroblastoma cell line. This inhibition is associated with decreased transforming growth factor beta 2 (TGF beta 2) and phospho-extracellular signal-regulated kinase (ERK). Exogenous TGF beta 2 increased cell proliferation and phospho-ERK in cells overexpressing RFX1. An anti-TGF beta 2 antibody and PD98059, an ERK activation inhibitor, inhibited SH-SY5Y cell proliferation. TGF beta 2 promoter activity was decreased in cells overexpressing RFX1. Chromosome immunoprecipitation assay showed that RFX1 bound the TGF beta 2 promoter. RFX1 down-regulation increased TGF beta 2 in SH-SY5Y and HCN-1A cells, a normal human neuronal cell line. More importantly, TGF beta 2 concentrations were negatively correlated with RFX1 levels in human medulloblastoma tissues with a R-2 of 0.464. These results suggest that RFX1 reduces cell proliferation through inhibiting the TGF beta 2-ERK signaling pathway. RFX1 blocks TGF beta 2 expression through its direct action on TGF beta 2 transcription. This effect also appears in human brain tumor tissues. Because TGF beta is known to be involved in cancer development, our results provide initial evidence to suggest that RFX1 may play an important role in human tumor biology.	[Feng, Chenzhuo; Zuo, Zhiyi] Univ Virginia, Sch Med, Dept Anesthesiol, Charlottesville, VA 22908 USA	University of Virginia	Zuo, ZY (corresponding author), 1 Hosp Dr,POB 800710, Charlottesville, VA 22908 USA.	zz3c@virginia.edu	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047	National Institutes of Health [R01 GM065211]; International Anesthesia Research Society (Frontiers in Anesthesia Research Award, Cleveland, OH); American Heart Association Mid-Atlantic Affiliate, Baltimore, MD [10GRNT3900019]; Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Anesthesia Research Society (Frontiers in Anesthesia Research Award, Cleveland, OH); American Heart Association Mid-Atlantic Affiliate, Baltimore, MD(American Heart Association); Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065211 (to Z. Z.), a International Anesthesia Research Society (2007 Frontiers in Anesthesia Research Award, Cleveland, OH (to Z. Z.), Grant-in-Aid 10GRNT3900019 from the American Heart Association Mid-Atlantic Affiliate, Baltimore, MD(to Z. Z.), and the Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA.	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Bickler PE, 2006, ANESTH ANALG, V103, P419, DOI 10.1213/01.ane.0000223671.49376.b2; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Chen L, 2000, J BIOL CHEM, V275, P32227, DOI 10.1074/jbc.M002645200; Clausen BE, 1998, IMMUNITY, V8, P143, DOI 10.1016/S1074-7613(00)80467-7; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; ECKENSTEIN FP, 1994, PROG BRAIN RES, V103, P55; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Feng CZ, 2011, FEBS LETT, V585, P2488, DOI 10.1016/j.febslet.2011.06.032; Feng CZ, 2011, FOLIA HISTOCHEM CYTO, V49, P344, DOI 10.5603/FHC.2011.0047; Hsu YC, 2010, J BIOL CHEM, V285, P13885, DOI 10.1074/jbc.M109.081463; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Liu MS, 1999, J BIOL CHEM, V274, P15433, DOI 10.1074/jbc.274.22.15433; Ma KW, 2006, J BIOL CHEM, V281, P21250, DOI 10.1074/jbc.M600521200; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; Ohashi Y, 2004, ONCOGENE, V23, P7772, DOI 10.1038/sj.onc.1208058; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; Watts JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002277; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zhai YS, 2008, EUR J PHARMACOL, V587, P196, DOI 10.1016/j.ejphar.2008.03.006	23	23	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22730	22739		10.1074/jbc.M111.338590	http://dx.doi.org/10.1074/jbc.M111.338590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22582395	Green Published, hybrid			2022-12-25	WOS:000306495000030
J	Duxin, JP; Moore, HR; Sidorova, J; Karanja, K; Honaker, Y; Dao, B; Piwnica-Worms, H; Campbell, JL; Monnat, RJ; Stewart, SA				Duxin, Julien P.; Moore, Hayley R.; Sidorova, Julia; Karanja, Kenneth; Honaker, Yuchi; Dao, Benjamin; Piwnica-Worms, Helen; Campbell, Judith L.; Monnat, Raymond J., Jr.; Stewart, Sheila A.			Okazaki Fragment Processing-independent Role for Human Dna2 Enzyme during DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE DNA2; YEAST DNA2; END-RESECTION; TELOMERE STABILITY; ENDONUCLEASE ACTIVITIES; FLAP ENDONUCLEASE-1; POLYMERASE-ALPHA; GENOME STABILITY; XENOPUS DNA2; LIGASE I	Dna2 is an essential helicase/nuclease that is postulated to cleave long DNA flaps that escape FEN1 activity during Okazaki fragment (OF) maturation in yeast. We previously demonstrated that the human Dna2 orthologue (hDna2) localizes to the nucleus and contributes to genomic stability. Here we investigated the role hDna2 plays in DNA replication. We show that Dna2 associates with the replisome protein And-1 in a cell cycle-dependent manner. Depletion of hDna2 resulted in S/G(2) phase-specific DNA damage as evidenced by increased gamma-H2AX, replication protein A foci, and Chk1 kinase phosphorylation, a readout for activation of the ATR-mediated S phase checkpoint. In addition, we observed reduced origin firing in hDna2-depleted cells consistent with Chk1 activation. We next examined the impact of hDna2 on OF maturation and replication fork progression in human cells. As expected, FEN1 depletion led to a significant reduction in OF maturation. Strikingly, the reduction in OF maturation had no impact on replication fork progression, indicating that fork movement is not tightly coupled to lagging strand maturation. Analysis of hDna2-depleted cells failed to reveal a defect in OF maturation or replication fork progression. Prior work in yeast demonstrated that ectopic expression of FEN1 rescues Dna2 defects. In contrast, we found that FEN1 expression in hDna2-depleted cells failed to rescue genomic instability. These findings suggest that the genomic instability observed in hDna2-depleted cells does not arise from defective OF maturation and that hDna2 plays a role in DNA replication that is distinct from FEN1 and OF maturation.	[Duxin, Julien P.; Moore, Hayley R.; Honaker, Yuchi; Dao, Benjamin; Piwnica-Worms, Helen; Stewart, Sheila A.] Dept Cell Biol & Physiol, St Louis, MO USA; [Duxin, Julien P.; Moore, Hayley R.; Honaker, Yuchi; Dao, Benjamin; Piwnica-Worms, Helen; Stewart, Sheila A.] BRIGHT Inst, St Louis, MO USA; [Sidorova, Julia; Monnat, Raymond J., Jr.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Karanja, Kenneth; Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA; [Piwnica-Worms, Helen; Stewart, Sheila A.] Washington Univ, Sch Med, Dept Med, St Louis, MO USA	University of Washington; University of Washington Seattle; California Institute of Technology; Washington University (WUSTL)	Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	sheila.stewart@wustl.edu	Piwnica-Worms, Helen/C-5214-2012; Stewart, Sheila A/C-5213-2012	Stewart, Sheila/0000-0002-2260-9576; Sidorova, Julia/0000-0001-5502-4323	National Institutes of Health [GM95924, GM04701, GM04707, P01 CA77852, GM078666]; Department of Defense Grant [CDMRP 09-0-0041]; Cancer Biology Pathway, Siteman Cancer Center at Barnes-Jewish Hospital; Washington University School of Medicine in St Louis; NATIONAL CANCER INSTITUTE [P01CA077852, T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078666, R01GM095924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Grant(United States Department of Defense); Cancer Biology Pathway, Siteman Cancer Center at Barnes-Jewish Hospital; Washington University School of Medicine in St Louis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM95924 (to S. A. S.), GM04701 and GM04707 (to H. P.-W.), P01 CA77852 (to R. J. M.), and GM078666 (to J. L. C.). This work was also supported by the Department of Defense Grant CDMRP 09-0-0041, Cancer Biology Pathway, Siteman Cancer Center at Barnes-Jewish Hospital, and Washington University School of Medicine in St Louis (to J. P. D. and H. R. M.).	Araki Y, 2003, GENES CELLS, V8, P465, DOI 10.1046/j.1365-2443.2003.00648.x; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bonetti D, 2009, MOL CELL, V35, P70, DOI 10.1016/j.molcel.2009.05.015; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Das-Bradoo S, 2010, CELL CYCLE, V9, P3674, DOI 10.4161/cc.9.18.13121; Das-Bradoo S, 2010, NAT CELL BIOL, V12, P74, DOI 10.1038/ncb2007; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Formosa T, 1999, GENETICS, V151, P1459; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Jackman J, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0803s00; Kang HY, 2000, GENETICS, V155, P1055; Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kohn EA, 2003, CANCER RES, V63, P31; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Liu QQ, 2000, J BIOL CHEM, V275, P1615, DOI 10.1074/jbc.275.3.1615; Mackenney VJ, 1997, J BIOL CHEM, V272, P11550; Mandahl N, 1998, CANCER GENET CYTOGEN, V103, P25, DOI 10.1016/S0165-4608(97)00268-9; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Murante RS, 1998, P NATL ACAD SCI USA, V95, P2244, DOI 10.1073/pnas.95.5.2244; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Peng G., 2012, CANC RES IN PRESS; Pike JE, 2010, J BIOL CHEM, V285, P41712, DOI 10.1074/jbc.M110.146894; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Saharia A, 2009, ONCOGENE, V28, P1162, DOI 10.1038/onc.2008.458; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Saharia A, 2010, J BIOL CHEM, V285, P27057, DOI 10.1074/jbc.M110.112276; Shi W, 2010, CARCINOGENESIS, V31, P994, DOI 10.1093/carcin/bgq035; Sidorova JM, 2009, NAT PROTOC, V4, P849, DOI 10.1038/nprot.2009.54; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Wawrousek KE, 2010, CELL CYCLE, V9, P1156, DOI 10.4161/cc.9.6.11049; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	61	43	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21980	21991		10.1074/jbc.M112.359018	http://dx.doi.org/10.1074/jbc.M112.359018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570476	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000306418600037
J	Zuo, DY; Bzdega, T; Olszewski, RT; Moffett, JR; Neale, JH				Zuo, Daiying; Bzdega, Tomasz; Olszewski, Rafal T.; Moffett, John R.; Neale, Joseph H.			Effects of N-Acetylaspartylglutamate (NAAG) Peptidase Inhibition on Release of Glutamate and Dopamine in Prefrontal Cortex and Nucleus Accumbens in Phencyclidine Model of Schizophrenia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MGLU2/3 RECEPTOR AGONIST; D-ASPARTATE RECEPTORS; CARBOXYPEPTIDASE-II; ACETYLASPARTATE IMMUNOREACTIVITIES; ANIMAL-MODELS; IN-VIVO; MGLUR3; LY379268; POTENT; GRM3	The "glutamate" theory of schizophrenia emerged from the observation that phencyclidine (PCP), an open channel antagonist of the NMDA subtype of glutamate receptor, induces schizophrenia-like behaviors in humans. PCP also induces a complex set of behaviors in animal models of this disorder. PCP also increases glutamate and dopamine release in the medial prefrontal cortex and nucleus accumbens, brain regions associated with expression of psychosis. Increased motor activation is among the PCP-induced behaviors that have been widely validated as models for the characterization of new antipsychotic drugs. The peptide transmitter N-acetylaspartylglutamate (NAAG) activates a group II metabotropic receptor, mGluR3. Polymorphisms in this receptor have been associated with schizophrenia. Inhibitors of glutamate carboxypeptidase II, an enzyme that inactivates NAAG following synaptic release, reduce several behaviors induced by PCP in animal models. This research tested the hypothesis that two structurally distinct NAAG peptidase inhibitors, ZJ43 and 2-(phosphonomethyl)-pentane- 1,5-dioic acid, would elevate levels of synaptically released NAAG and reduce PCP-induced increases in glutamate and dopamine levels in the medial prefrontal cortex and nucleus accumbens. NAAG-like immunoreactivity was found in neurons and presumptive synaptic endings in both regions. These peptidase inhibitors reduced the motor activation effects of PCP while elevating extracellular NAAG levels. They also blocked PCP-induced increases in glutamate but not dopamine or its metabolites. The mGluR2/3 antagonist LY341495 blocked these behavioral and neurochemical effects of the peptidase inhibitors. The data reported here provide a foundation for assessment of the neurochemical mechanism through which NAAG achieves its antipsychotic-like behavioral effects and support the conclusion NAAG peptidase inhibitors warrant further study as a novel antipsychotic therapy aimed at mGluR3.	[Zuo, Daiying; Bzdega, Tomasz; Olszewski, Rafal T.; Neale, Joseph H.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Zuo, Daiying] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang 110016, Peoples R China; [Moffett, John R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Neurosci Program, Bethesda, MD 20014 USA	Georgetown University; Shenyang Pharmaceutical University; Uniformed Services University of the Health Sciences - USA	Neale, JH (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	nealej@georgetown.edu			National Institutes of Health [R01 MH 79983]; Nancy and Daniel Paduano; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy and Daniel Paduano; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 MH 79983. This work was also supported by an endowment and generous gifts from Nancy and Daniel Paduano. The patent for ZJ43 is held by Georgetown University, but the authors have no proprietary interest in this compound.	Adams BW, 2001, BIOL PSYCHIAT, V50, P750, DOI 10.1016/S0006-3223(01)01195-7; Adedoyin MO, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-60; Arnsten AFT, 2011, INT J DEV NEUROSCI, V29, P215, DOI 10.1016/j.ijdevneu.2011.02.006; Arun P, 2008, J NEUROCHEM, V106, P1669, DOI 10.1111/j.1471-4159.2008.05524.x; Baune BT, 2010, GENES BRAIN BEHAV, V9, P459, DOI 10.1111/j.1601-183X.2010.00573.x; Berger UV, 1999, J COMP NEUROL, V415, P52, DOI 10.1002/(SICI)1096-9861(19991206)415:1<52::AID-CNE4>3.0.CO;2-K; Bondi C, 2012, CURR PHARM DESIGN, V18, P1593, DOI 10.2174/138161212799958576; Carlsson Arvid, 2006, Dialogues Clin Neurosci, V8, P137; Cartmell J, 1999, J PHARMACOL EXP THER, V291, P161; Cartmell J, 2000, PSYCHOPHARMACOLOGY, V148, P423, DOI 10.1007/s002130050072; Cartmell J, 2000, EUR J PHARMACOL, V400, P221, DOI 10.1016/S0014-2999(00)00423-4; CASSIDY M, 1993, NEUROPEPTIDES, V24, P271, DOI 10.1016/0143-4179(93)90015-3; Deutsch SI, 2002, EUR J PHARMACOL, V449, P121, DOI 10.1016/S0014-2999(02)02041-1; DiIorio P, 1996, J NEUROCHEM, V67, P302; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Fell MJ, 2008, J PHARMACOL EXP THER, V326, P209, DOI 10.1124/jpet.108.136861; FUHRMAN S, 1994, J NEUROCHEM, V62, P275; Gregory KJ, 2011, NEUROPHARMACOLOGY, V60, P66, DOI 10.1016/j.neuropharm.2010.07.007; Harrison PJ, 2008, J PSYCHOPHARMACOL, V22, P308, DOI 10.1177/0269881108089818; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Karch S., 2012, CURR PHARM IN PRESS; Katayama T, 2007, NEUROSCIENCE, V150, P442, DOI 10.1016/j.neuroscience.2007.09.007; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Kinon BJ, 2011, J CLIN PSYCHOPHARM, V31, P349, DOI 10.1097/JCP.0b013e318218dcd5; Kozikowski AP, 2004, J MED CHEM, V47, P1729, DOI 10.1021/jm0306226; Makoff A, 1996, MOL BRAIN RES, V40, P55, DOI 10.1016/0169-328X(96)00037-X; Mikell CB, 2009, STEREOT FUNCT NEUROS, V87, P256, DOI 10.1159/000225979; MOFFETT JR, 1993, J HISTOCHEM CYTOCHEM, V41, P559, DOI 10.1177/41.4.8450195; MOFFETT JR, 1995, J NEUROCYTOL, V24, P409, DOI 10.1007/BF01181604; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Monn JA, 1999, J MED CHEM, V42, P1027, DOI 10.1021/jm980616n; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Neale JH, 2011, J NEUROCHEM, V119, P891, DOI 10.1111/j.1471-4159.2011.07380.x; Ninan I, 2003, NEUROPHARMACOLOGY, V44, P462, DOI 10.1016/S0028-3908(03)00033-9; Olszewski RT, 2008, BIOL PSYCHIAT, V63, P86, DOI 10.1016/j.biopsych.2007.04.016; Olszewski RT, 2012, SCHIZOPHR RES, V136, P160, DOI 10.1016/j.schres.2012.01.007; Olszewski RT, 2004, J NEUROCHEM, V89, P876, DOI 10.1111/j.1471-4159.2004.02358.x; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Pehrson AL, 2010, PSYCHOPHARMACOLOGY, V211, P443, DOI 10.1007/s00213-010-1914-8; Profaci CP, 2011, PSYCHOPHARMACOLOGY, V216, P235, DOI 10.1007/s00213-011-2200-0; Rorick-Kehn LM, 2007, J PHARMACOL EXP THER, V321, P308, DOI 10.1124/jpet.106.110809; ROWLEY HL, 1995, J NEUROSCI METH, V57, P93, DOI 10.1016/0165-0270(94)00132-Z; Sanabria ERG, 2004, J NEUROPHYSIOL, V91, P182, DOI 10.1152/jn.00465.2003; Sartorius LJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2626, DOI 10.1038/sj.npp.1301669; Schlumberger C, 2009, BEHAV PHARMACOL, V20, P56, DOI 10.1097/FBP.0b013e3283242f57; Sebban C, 2002, BRIT J PHARMACOL, V135, P65, DOI 10.1038/sj.bjp.0704451; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Takatsu Y, 2011, BRAIN RES, V1371, P82, DOI 10.1016/j.brainres.2010.11.048; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; WILLIAMSON LC, 1988, BRAIN RES, V456, P375, DOI 10.1016/0006-8993(88)90243-0; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Wroblewska B, 1998, GLIA, V24, P172, DOI 10.1002/(SICI)1098-1136(199810)24:2<172::AID-GLIA2>3.0.CO;2-6; Wroblewska B, 2006, J NEUROCHEM, V96, P1071, DOI 10.1111/j.1471-4159.2005.03569.x; Wroblewska B, 2011, NEUROCHEM INT, V58, P176, DOI 10.1016/j.neuint.2010.11.012; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Yamamoto T, 2007, EUR J NEUROSCI, V25, P147, DOI 10.1111/j.1460-9568.2006.05272.x; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903	62	38	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21773	21782		10.1074/jbc.M112.363226	http://dx.doi.org/10.1074/jbc.M112.363226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570482	Green Published, hybrid			2022-12-25	WOS:000306418600019
J	Chatterjee, C; Sparks, DL				Chatterjee, Cynthia; Sparks, Daniel L.			Extracellular Nucleotides Inhibit Insulin Receptor Signaling, Stimulate Autophagy and Control Lipoprotein Secretion	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HDL ENDOCYTOSIS; ATP SYNTHASE; HEPG2 CELLS; BETA-CHAIN; P2Y(13); ADP; BINDING; DYSLIPIDEMIA; DEGRADATION	Hyperglycemia is associated with abnormal plasma lipoprotein metabolism and with an elevation in circulating nucleotide levels. We evaluated how extracellular nucleotides may act to perturb hepatic lipoprotein secretion. Adenosine diphosphate (ADP) (>10 mu M) acts like a proteasomal inhibitor to stimulate apoB100 secretion and inhibit apoA-I secretion from human liver cells at 4 h and 24 h. ADP blocks apoA-I secretion by stimulating autophagy. The nucleotide increases cellular levels of the autophagosome marker, LC3-II, and increases co-localization of LC3 with apoA-I in punctate autophagosomes. ADP affects autophagy and apoA-I secretion through P2Y(13). Overexpression of P2Y(13) increases cellular LC3-II levels by -50% and blocks induction of apoA-I secretion. Conversely, a siRNA-induced reduction in P2Y(13) protein expression of 50% causes a similar reduction in cellular LC3-II levels and a 3-fold stimulation in apoA-I secretion. P2Y(13) gene silencing blocks the effects of ADP on autophagy and apoA-I secretion. A reduction in P2Y(13) expression suppresses ERK1/2 phosphorylation, increases the phosphorylation of IR-beta and protein kinase B (Akt) >3-fold, and blocks the inhibition of Akt phosphorylation by TNF alpha and ADP. Conversely, increasing P2Y(13) expression significantly inhibits insulin-induced phosphorylation of insulin receptor (IR-beta) and Akt, similar to that observed after treatment with ADP. Nucleotides therefore act through P2Y(13), ERK1/2 and insulin receptor signaling to stimulate autophagy and affect hepatic lipoprotein secretion.	[Chatterjee, Cynthia; Sparks, Daniel L.] Univ Ottawa, Inst Heart, Atherosclerosis Genet & Cell Biol Grp, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute	Chatterjee, C (corresponding author), Univ Ottawa, Inst Heart, Atherosclerosis Genet & Cell Biol Grp, Ottawa, ON, Canada.	dsparks@ottawaheart.ca			Heart and Stroke Foundation of Ontario; Government of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Government of Ontario	This work was supported by a grant from the Heart and Stroke Foundation of Ontario (DLS). CC is the recipient of a Government of Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeli K, 1997, J BIOL CHEM, V272, P22489, DOI 10.1074/jbc.272.36.22489; Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Amisten S, 2010, DIABETOLOGIA, V53, P1927, DOI 10.1007/s00125-010-1807-8; Behan MW, 2010, CURR OPIN CARDIOL, V25, P321, DOI 10.1097/HCO.0b013e328338f7b5; Berthou L, 1996, J CLIN INVEST, V97, P2408, DOI 10.1172/JCI118687; Blom D, 2010, BBA-MOL CELL BIOL L, V1801, P1349, DOI 10.1016/j.bbalip.2010.08.013; BROWN PR, 1973, CLIN CHEM, V19, P919; Cattaneo M, 2010, CIRCULATION, V121, P171, DOI 10.1161/CIRCULATIONAHA.109.853069; Chatterjee C, 2009, BIOCHEMISTRY-US, V48, P5994, DOI 10.1021/bi802009e; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; De Meyer GRY, 2009, BBA-MOL CELL RES, V1793, P1485, DOI 10.1016/j.bbamcr.2008.12.011; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; Di Virgilio F, 2002, BRIT J PHARMACOL, V135, P831, DOI 10.1038/sj.bjp.0704524; Di Virgilio F, 2009, CURR OPIN PHARMACOL, V9, P507, DOI 10.1016/j.coph.2009.06.021; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dixon CJ, 2003, BRIT J PHARMACOL, V138, P272, DOI 10.1038/sj.bjp.0705016; Dwyer KM, 2007, PURINERG SIGNAL, V3, P171, DOI 10.1007/s11302-006-9050-y; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Fabre ACS, 2006, CELL MOL LIFE SCI, V63, P2829, DOI 10.1007/s00018-006-6325-y; Fabre AC, 2010, HEPATOLOGY, V52, P1477, DOI 10.1002/hep.23897; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; HARKNESS RA, 1984, CLIN CHIM ACTA, V143, P91, DOI 10.1016/0009-8981(84)90216-X; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Hopewell S, 2008, METABOLISM, V57, P1677, DOI 10.1016/j.metabol.2008.07.023; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Li XY, 2010, BIOCHEM PHARMACOL, V80, P1450, DOI 10.1016/j.bcp.2010.07.023; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Malaval C, 2009, CELL SIGNAL, V21, P120, DOI 10.1016/j.cellsig.2008.09.016; Marteau F, 2003, MOL PHARMACOL, V64, P104, DOI 10.1124/mol.64.1.104; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Nemchenko A, 2011, J MOL CELL CARDIOL, V51, P584, DOI 10.1016/j.yjmcc.2011.06.010; Nilsson J, 2006, ARTERIOSCL THROM VAS, V26, P794, DOI 10.1161/01.ATV.0000209513.00765.13; Pandey NR, 2009, NEUROSCIENCE, V164, P1744, DOI 10.1016/j.neuroscience.2009.09.062; Pandey NR, 2008, BIOCHEMISTRY-US, V47, P1579, DOI 10.1021/bi702148f; Pandey NR, 2009, AM J PATHOL, V175, P1777, DOI 10.2353/ajpath.2009.090082; RANGANATHAN S, 1990, BIOCHIM BIOPHYS ACTA, V1046, P223, DOI 10.1016/0005-2760(90)90193-2; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Rutledge AC, 2009, ARTERIOSCL THROM VAS, V29, P579, DOI 10.1161/ATVBAHA.108.181859; Schofl C, 1999, AM J PHYSIOL-GASTR L, V276, pG164, DOI 10.1152/ajpgi.1999.276.1.G164; Sellers MB, 2009, CURR OPIN CARDIOL, V24, P307, DOI 10.1097/HCO.0b013e32832e2b44; Solini A, 2005, KIDNEY INT, V67, P875, DOI 10.1111/j.1523-1755.2005.00152.x; Tan CY, 2010, CELL MOL LIFE SCI, V67, P445, DOI 10.1007/s00018-009-0191-3; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zhang LH, 2008, J LIPID RES, V49, P1195, DOI 10.1194/jlr.M700426-JLR200; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	53	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36916	10.1371/journal.pone.0036916	http://dx.doi.org/10.1371/journal.pone.0036916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590634	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336400044
J	Sertel, S; Tome, M; Briehl, MM; Bauer, J; Hock, K; Plinkert, PK; Efferth, T				Sertel, Serkan; Tome, Margaret; Briehl, Margaret M.; Bauer, Judith; Hock, Kai; Plinkert, Peter K.; Efferth, Thomas			Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MYELOID-LEUKEMIA CELLS; MULTIDRUG-RESISTANCE; OXIDATIVE STRESS; INDUCED APOPTOSIS; P-GLYCOPROTEIN; MULTIPLE-MYELOMA; MELANOMA-CELLS; IN-VITRO; CANCER	Previously, arsenic trioxide showed impressive regression rates of acute promyelocytic leukemia. Here, we investigated molecular determinants of sensitivity and resistance of cell lines of different tumor types towards arsenic trioxide. Arsenic trioxide was the most cytotoxic compound among 8 arsenicals investigated in the NCI cell line panel. We correlated transcriptome-wide microarray-based mRNA expression to the IC50 values for arsenic trioxide by bioinformatic approaches (COMPARE and hierarchical cluster analyses, Ingenuity signaling pathway analysis). Among the identified pathways were signaling routes for p53, integrin-linked kinase, and actin cytoskeleton. Genes from these pathways significantly predicted cellular response to arsenic trioxide. Then, we analyzed whether classical drug resistance factors may also play a role for arsenic trioxide. Cell lines transfected with cDNAs for catalase, thioredoxin, or the anti-apoptotic bcl-2 gene were more resistant to arsenic trioxide than mock vector transfected cells. Multidrug-resistant cells overexpressing the MDR1, MRP1 or BCRP genes were not cross-resistant to arsenic trioxide. Our approach revealed that response of tumor cells towards arsenic trioxide is multi-factorial.	[Sertel, Serkan; Plinkert, Peter K.] Heidelberg Univ, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany; [Tome, Margaret; Briehl, Margaret M.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Sertel, Serkan; Bauer, Judith; Hock, Kai; Efferth, Thomas] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Sertel, Serkan; Efferth, Thomas] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Biol, Inst Pharmaceut Biol, Mainz, Germany	Ruprecht Karls University Heidelberg; University of Arizona; Helmholtz Association; German Cancer Research Center (DKFZ); Johannes Gutenberg University of Mainz	Sertel, S (corresponding author), Heidelberg Univ, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany.	efferth@uni-mainz.de		Efferth, Thomas/0000-0002-3096-3292				Ahn WS, 2004, ONCOL REP, V12, P573; Allen T, 2004, BIOL TRACE ELEM RES, V100, P39, DOI 10.1385/BTER:100:1:039; ALLEY MC, 1988, CANCER RES, V48, P589; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Anderson KC, 2002, CANCER J, V8, P12, DOI 10.1097/00130404-200201000-00003; Au WY, 2002, HAEMATOLOGICA, V87, P1109; Baker A, 1997, CANCER RES, V57, P5162; Biswas S, 2010, LEUKEMIA RES, V34, P925, DOI 10.1016/j.leukres.2010.01.020; Bourdonnay E, 2009, MOL IMMUNOL, V46, P649, DOI 10.1016/j.molimm.2008.08.268; Bowling BD, 2008, CANCER CHEMOTH PHARM, V63, P37, DOI 10.1007/s00280-008-0705-y; Brown E, 2008, METAL IONS BIOL MED, V10, P583; Brugger D, 1999, LEUKEMIA RES, V23, P467, DOI 10.1016/S0145-2126(98)00192-1; Burnichon V, 2003, TOXICOL LETT, V143, P155, DOI 10.1016/S0378-4274(03)00171-1; Chan JYW, 2006, CANCER LETT, V236, P250, DOI 10.1016/j.canlet.2005.05.017; Chan PC, 1997, J ENVIRON SCI HEAL C, V15, P83; Chen GQ, 1996, BLOOD, V88, P1052; Chen X, 2009, ONCOL REP, V22, P73, DOI 10.3892/or_00000408; Coe E, 2008, LEUKEMIA LYMPHOMA, V49, P1976, DOI 10.1080/10428190802353617; Diaz Z, 2008, LEUKEMIA, V22, P1853, DOI 10.1038/leu.2008.194; Diaz Z, 2009, LEUKEMIA, V23, P431, DOI 10.1038/leu.2008.328; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Efferth T, 1997, LEUKEMIA, V11, P1180, DOI 10.1038/sj.leu.2400669; Efferth T, 2003, INT J ONCOL, V23, P1231; Efferth T, 2003, BIOCHEM PHARMACOL, V66, P613, DOI 10.1016/S0006-2952(03)00341-1; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2002, BIOCHEM PHARMACOL, V64, P617, DOI 10.1016/S0006-2952(02)01221-2; Efferth T, 2002, BLOOD CELL MOL DIS, V28, P160, DOI 10.1006/bcmd.2002.0492; Efferth Thomas, 2004, Cancer Genomics & Proteomics, V1, P363; Efferth Thomas, 2001, Current Molecular Medicine (Hilversum), V1, P45, DOI 10.2174/1566524013364194; Gartenhaus RB, 2002, CLIN CANCER RES, V8, P566; Gillet JP, 2007, BBA-REV CANCER, V1775, P237, DOI 10.1016/j.bbcan.2007.05.002; Gillet JP, 2004, CANCER RES, V64, P8987, DOI 10.1158/0008-5472.CAN-04-1978; Giommarelli C, 2009, FREE RADICAL BIO MED, V46, P1516, DOI 10.1016/j.freeradbiomed.2009.03.006; Haller J S, 1975, Pharm Hist, V17, P87; Han Bo, 2004, J Exp Ther Oncol, V4, P335; Han YH, 2008, MOL CELLS, V26, P18; Han YH, 2008, J CELL BIOCHEM, V104, P862, DOI 10.1002/jcb.21673; Hayashi T, 2002, MOL CANCER THER, V1, P851; Huang XJ, 1999, MED ONCOL, V16, P58, DOI 10.1007/BF02787360; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; KIMMIG A, 1990, CANCER RES, V50, P6793; Klassen CD, 1996, GOODMAN GILMANS PHAR, P1649; KNOWLES FC, 1983, TRENDS BIOCHEM SCI, V8, P178, DOI 10.1016/0968-0004(83)90168-8; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Laparra JM, 2008, TOXICOL IN VITRO, V22, P444, DOI 10.1016/j.tiv.2007.11.004; Lee CC, 2006, LEUKEMIA LYMPHOMA, V47, P521, DOI 10.1080/10428190500305851; Lehmann S, 2001, EUR J HAEMATOL, V66, P357, DOI 10.1034/j.1600-0609.2001.066006357.x; LETEURTRE F, 1994, J NATL CANCER I, V86, P1239, DOI 10.1093/jnci/86.16.1239; Li JJ, 2006, ACTA PHARMACOL SIN, V27, P1078, DOI 10.1111/j.1745-7254.2006.00345.x; Liang Hong, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P647; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Liu QA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-37; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Miller WH, 2002, CANCER RES, V62, P3893; Nakagawa Y, 2002, LIFE SCI, V70, P2253, DOI 10.1016/S0024-3205(01)01545-4; Perkins C, 2000, BLOOD, V95, P1014, DOI 10.1182/blood.V95.3.1014.003k04_1014_1022; Roboz GJ, 2000, BLOOD, V96, P1525, DOI 10.1182/blood.V96.4.1525.h8001525_1525_1530; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Salerno M, 2002, J BIOENERG BIOMEMBR, V34, P135, DOI 10.1023/A:1015180026665; Sawyers CL, 2001, SCIENCE, V294, P1834; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Seo T, 2005, ANTICANCER RES, V25, P991; Seo T, 2007, INT J HEMATOL, V85, P26, DOI 10.1532/IJH97.05142; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Takeshita A, 2003, LEUKEMIA, V17, P648, DOI 10.1038/sj.leu.2402851; Tome ME, 2001, CELL DEATH DIFFER, V8, P953, DOI 10.1038/sj.cdd.4400904; Tome ME, 2001, CANCER RES, V61, P2766; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Vernhet L, 2001, BIOCHEM PHARMACOL, V61, P1387, DOI 10.1016/S0006-2952(01)00606-2; Wang DH, 2005, PHARMACOL RES, V52, P376, DOI 10.1016/j.phrs.2005.05.010; Wang HY, 2003, ACTA PHARMACOL SIN, V24, P646; Wang Tao, 2007, Zhonghua Xue Ye Xue Za Zhi, V28, P438; Wang Xiuli, 2002, Zhonghua Zhongliu Zazhi, V24, P339; Wei HL, 2003, CHINESE MED J-PEKING, V116, P1644; Woo SH, 2002, INT J ONCOL, V21, P57; Wosikowski K, 1997, JNCI-J NATL CANCER I, V89, P1505, DOI 10.1093/jnci/89.20.1505; Xue DB, 2007, CHINESE MED J-PEKING, V120, P690, DOI 10.1097/00029330-200704020-00015; Xue Ying-wei, 2007, Yaoxue Xuebao, V42, P949; Yang CH, 1999, BRIT J CANCER, V81, P796, DOI 10.1038/sj.bjc.6690766; Yeh JY, 2002, CELL MOL LIFE SCI, V59, P1972, DOI 10.1007/PL00012519; Zhao SG, 2008, MOL BIOL REP, V35, P421, DOI 10.1007/s11033-007-9102-6; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	83	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e35584	10.1371/journal.pone.0035584	http://dx.doi.org/10.1371/journal.pone.0035584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590507	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336400003
J	Luzon-Toro, B; Torroglosa, A; Nunez-Torres, R; Enguix-Riego, MV; Fernandez, RM; de Agustin, JC; Antinolo, G; Borrego, S				Luzon-Toro, Berta; Torroglosa, Ana; Nunez-Torres, Rocio; Valle Enguix-Riego, Maria; Maria Fernandez, Raquel; Carlos de Agustin, Juan; Antinolo, Guillermo; Borrego, Salud			Comprehensive Analysis of NRG1 Common and Rare Variants in Hirschsprung Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENTERIC NERVOUS-SYSTEM; NEU DIFFERENTIATION FACTORS; TRANSCRIPTION FACTOR SOX10; SUSCEPTIBILITY LOCUS; CYTOPLASMIC TAIL; MOUSE MODEL; DISEASE; RET; GENE	Hirschsprung disease (HSCR, OMIM 142623) is a developmental disorder characterized by the absence of ganglion cells along variable lengths of the distal gastrointestinal tract, which results in tonic contraction of the aganglionic gut segment and functional intestinal obstruction. The RET proto-oncogene is the major gene for HSCR with differential contributions of its rare and common, coding and noncoding mutations to the multifactorial nature of this pathology. Many other genes have been described to be associated with the pathology, as NRG1 gene (8p12), encoding neuregulin 1, which is implicated in the development of the enteric nervous system (ENS), and seems to contribute by both common and rare variants. Here we present the results of a comprehensive analysis of the NRG1 gene in the context of the disease in a series of 207 Spanish HSCR patients, by both mutational screening of its coding sequence and evaluation of 3 common tag SNPs as low penetrance susceptibility factors, finding some potentially damaging variants which we have functionally characterized. All of them were found to be associated with a significant reduction of the normal NRG1 protein levels. The fact that those mutations analyzed alter NRG1 protein would suggest that they would be related with HSCR disease not only in Chinese but also in a Caucasian population, which reinforces the implication of NRG1 gene in this pathology.	[Luzon-Toro, Berta; Torroglosa, Ana; Nunez-Torres, Rocio; Valle Enguix-Riego, Maria; Maria Fernandez, Raquel; Antinolo, Guillermo; Borrego, Salud] Univ Seville, CSIC, Univ Hosp Virgen Rocio, Dept Genet Reprod & Fetal Med,Inst Biomed Seville, Seville, Spain; [Luzon-Toro, Berta; Torroglosa, Ana; Nunez-Torres, Rocio; Valle Enguix-Riego, Maria; Maria Fernandez, Raquel; Antinolo, Guillermo; Borrego, Salud] Ctr Biomed Network Res Rare Dis CIBERER, Seville, Spain; [Carlos de Agustin, Juan] Univ Hosp Virgen Rocio, Dept Pediat Surg, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Virgen del Rocio University Hospital	Luzon-Toro, B (corresponding author), Univ Seville, CSIC, Univ Hosp Virgen Rocio, Dept Genet Reprod & Fetal Med,Inst Biomed Seville, Seville, Spain.	salud.borrego.sspa@juntadeandalucia.es	IBIS, REPRODUCCION/P-3399-2015; Borrego, Salud/M-6314-2015; LUZON, BERTA/D-4884-2014; De Agustin, Juan/AAT-1824-2021; IBIS, MALFORMACIONES/H-7372-2016; Torroglosa, Ana/AAU-9812-2020; IBIS, GENETICA/P-3384-2015	De Agustin, Juan/0000-0002-2413-2871; Antinolo Gil, Guillermo/0000-0002-2113-074X; Torroglosa, Ana/0000-0003-1911-7906	Instituto de Salud Carlos III, Spain [PI1001290]; Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia [CTS-2590, CTS-7447]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia(Junta de Andalucia)	This study was funded by the Instituto de Salud Carlos III, Spain (PI1001290) and Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia (CTS-2590 and CTS-7447). The CIBER de Enfermedades Raras is an initiative of the ISCIII, Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Brooks AS, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038125; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chakravarti A, 2002, HIRSCHSPRUNG DIS MET; Crone SA, 2003, NEURON, V37, P29, DOI 10.1016/S0896-6273(02)01128-5; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fernandez RM, 2009, ANN HUM GENET, V73, P19, DOI 10.1111/j.1469-1809.2008.00479.x; Fernandez RM, 2005, J MED GENET, V42, P322, DOI 10.1136/jmg.2004.023960; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo MM, 2008, EUR J HUM GENET, V16, P833, DOI 10.1038/ejhg.2008.18; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; LU HS, 1995, J BIOL CHEM, V270, P4784, DOI 10.1074/jbc.270.9.4784; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; Nunez-Torres R, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-138; ORRURTREGER A, 1993, P NATL ACAD SCI USA, V90, P1867, DOI 10.1073/pnas.90.5.1867; Ota K, 1998, MOL CELL, V2, P495, DOI 10.1016/S1097-2765(00)80149-5; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Paratore C, 2001, DEVELOPMENT, V128, P3949; Phusantisampan T, 2012, J HUM GENET, V57, P286, DOI 10.1038/jhg.2012.18; PRIGENT SA, 1992, ONCOGENE, V7, P1273; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Ruiz-Ferrer M, 2008, J PEDIATR SURG, V43, P1308, DOI 10.1016/j.jpedsurg.2008.02.076; Ruiz-Ferrer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023475; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Schroering A, 1998, J BIOL CHEM, V273, P30643, DOI 10.1074/jbc.273.46.30643; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tang CSM, 2012, HUM GENET, V131, P67, DOI 10.1007/s00439-011-1035-4; Tang CSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016181; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909	41	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36524	10.1371/journal.pone.0036524	http://dx.doi.org/10.1371/journal.pone.0036524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574178	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800075
J	Macedo, E; Zanetta, DMT; Abdulkader, RCRM				Macedo, Etienne; Zanetta, Dirce M. T.; Abdulkader, Regina C. R. M.			Long-Term Follow-Up of Patients after Acute Kidney Injury: Patterns of Renal Functional Recovery	PLOS ONE			English	Article							ACUTE TUBULAR-NECROSIS; BASE-LINE CREATININE; REPLACEMENT THERAPY; FAILURE; EPIDEMIOLOGY; SURVIVORS; DIALYSIS; OUTCOMES; DECLINE; RISK	Background and Objectives: Patients who survive acute kidney injury (AKI), especially those with partial renal recovery, present a higher long-term mortality risk. However, there is no consensus on the best time to assess renal function after an episode of acute kidney injury or agreement on the definition of renal recovery. In addition, only limited data regarding predictors of recovery are available. Design, Setting, Participants, & Measurements: From 1984 to 2009, 84 adult survivors of acute kidney injury were followed by the same nephrologist (RCRMA) for a median time of 4.1 years. Patients were seen at least once each year after discharge until end stage renal disease (ESRD) or death. In each consultation serum creatinine was measured and glomerular filtration rate estimated. Renal recovery was defined as a glomerular filtration rate value >= 60 mL/min/1.73 m2. A multiple logistic regression was performed to evaluate factors independently associated with renal recovery. Results: The median length of follow-up was 50 months (30-90 months). All patients had stabilized their glomerular filtration rates by 18 months and 83% of them stabilized earlier: up to 12 months. Renal recovery occurred in 16 patients (19%) at discharge and in 54 (64%) by 18 months. Six patients died and four patients progressed to ESRD during the follow up period. Age (OR 1.09, p < 0.0001) and serum creatinine at hospital discharge (OR 2.48, p = 0.007) were independent factors associated with non renal recovery. The acute kidney injury severity, evaluated by peak serum creatinine and need for dialysis, was not associated with non renal recovery. Conclusions: Renal recovery must be evaluated no earlier than one year after an acute kidney injury episode. Nephrology referral should be considered mainly for older patients and those with elevated serum creatinine at hospital discharge.	[Macedo, Etienne; Abdulkader, Regina C. R. M.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Zanetta, Dirce M. T.] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Macedo, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.	kader@usp.br	Macedo, Etienne/D-4659-2012; Zanetta, Dirce M T/G-4950-2013	Macedo, Etienne/0000-0002-3669-6519; Zanetta, Dirce Maria/0000-0002-7273-5087				Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Andrikos Emilios, 2009, Blood Purif, V28, P239, DOI 10.1159/000231986; Augustine JJ, 2004, AM J KIDNEY DIS, V44, P1000, DOI 10.1053/j.ajkd.2004.08.022; Bagshaw SM, 2006, CURR OPIN CRIT CARE, V12, P544; Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159; Bellomo R, 2005, CRIT CARE CLIN, V21, P223, DOI 10.1016/j.ccc.2004.12.001; Bhandari S, 1996, QJM-MON J ASSOC PHYS, V89, P415; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; COSENTINO F, 1994, NEPHROL DIAL TRANSPL, V9, P179; Goldberg R, 2008, ADV CHRONIC KIDNEY D, V15, P297, DOI 10.1053/j.ackd.2008.04.009; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; James MT, 2010, KIDNEY INT, V78, P803, DOI 10.1038/ki.2010.258; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Liano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; McCullough PA, 2011, AM J KIDNEY DIS, V57, pS1, DOI 10.1053/j.ajkd.2010.11.011; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pickering JW, 2010, CLIN J AM SOC NEPHRO, V5, P1165, DOI 10.2215/CJN.08531109; Ponte B, 2008, NEPHROL DIAL TRANSPL, V23, P3859, DOI 10.1093/ndt/gfn398; Schiffl H, 2006, NEPHROL DIAL TRANSPL, V21, P1248, DOI 10.1093/ndt/gfk069; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Sesso R, 2008, NEPHROLOGY, V13, P99, DOI 10.1111/j.1440-1797.2008.00919.x; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Tolwani A, 2008, INT J ARTIF ORGANS, V31, P190, DOI 10.1177/039139880803100212; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Uchino S, 2007, INTENS CARE MED, V33, P1563, DOI 10.1007/s00134-007-0754-4; van Kuijk JP, 2010, CLIN J AM SOC NEPHRO, V5, P1198, DOI 10.2215/CJN.00020110; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322	32	43	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36388	10.1371/journal.pone.0036388	http://dx.doi.org/10.1371/journal.pone.0036388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574153	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800049
J	Maudoux, A; Lefebvre, P; Cabay, JE; Demertzi, A; Vanhaudenhuyse, A; Laureys, S; Soddu, A				Maudoux, Audrey; Lefebvre, Philippe; Cabay, Jean-Evrard; Demertzi, Athena; Vanhaudenhuyse, Audrey; Laureys, Steven; Soddu, Andrea			Auditory Resting-State Network Connectivity in Tinnitus: A Functional MRI Study	PLOS ONE			English	Article							RESONANCE-IMAGING FMRI; DEFAULT NETWORK; CORTEX; ACTIVATION; MECHANISMS; MODE; PAIN	The underlying functional neuroanatomy of tinnitus remains poorly understood. Few studies have focused on functional cerebral connectivity changes in tinnitus patients. The aim of this study was to test if functional MRI "resting-state'' connectivity patterns in auditory network differ between tinnitus patients and normal controls. Thirteen chronic tinnitus subjects and fifteen age-matched healthy controls were studied on a 3 tesla MRI. Connectivity was investigated using independent component analysis and an automated component selection approach taking into account the spatial and temporal properties of each component. Connectivity in extra-auditory regions such as brainstem, basal ganglia/NAc, cerebellum, parahippocampal, right prefrontal, parietal, and sensorimotor areas was found to be increased in tinnitus subjects. The right primary auditory cortex, left prefrontal, left fusiform gyrus, and bilateral occipital regions showed a decreased connectivity in tinnitus. These results show that there is a modification of cortical and subcortical functional connectivity in tinnitus encompassing attentional, mnemonic, and emotional networks. Our data corroborate the hypothesized implication of non-auditory regions in tinnitus physiopathology and suggest that various regions of the brain seem involved in the persistent awareness of the phenomenon as well as in the development of the associated distress leading to disabling chronic tinnitus.	[Maudoux, Audrey; Demertzi, Athena; Vanhaudenhuyse, Audrey; Laureys, Steven; Soddu, Andrea] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium; [Maudoux, Audrey; Lefebvre, Philippe] Univ Liege, OtoRhinoLaryngol Head & Neck Surg Dept, Liege, Belgium; [Cabay, Jean-Evrard] Univ Liege, CHU Sart Tilman Hosp, Dept Radiol, Liege, Belgium; [Laureys, Steven] Univ Liege, CHU Sart Tilman Hosp, Dept Neurol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Maudoux, A (corresponding author), Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium.	amaudoux@doct.ulg.ac.be; Andrea.Soddu@ulg.ac.be	Demertzi, Athena/I-1251-2019; Laureys, Steven/A-3349-2011; Soddu, Andrea/K-7087-2014; Vanhaudenhuyse, Audrey/AAP-2455-2020; Laureys, Steven/AAN-2097-2021	Demertzi, Athena/0000-0001-8021-3759; Soddu, Andrea/0000-0001-6833-745X; Laureys, Steven/0000-0002-3096-3807	Belgian National Funds for Scientific Research (FNRS) [FNRS 9.4501.12]; European Commission; James McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action [ARC-06/11-340]; Public Utility Foundation "Universite Europeenne du Travail''; Fondazione Europea di Ricerca Biomedica; University and University Hospital of Liege	Belgian National Funds for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); James McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action; Public Utility Foundation "Universite Europeenne du Travail''; Fondazione Europea di Ricerca Biomedica; University and University Hospital of Liege	This research was funded by the Belgian National Funds for Scientific Research (FNRS), the Tinnitus Prize 2011 (FNRS 9.4501.12), the European Commission, the James McDonnell Foundation, the Mind Science Foundation, the French Speaking Community Concerted Research Action (ARC-06/11-340), the Public Utility Foundation "Universite Europeenne du Travail,'' "Fondazione Europea di Ricerca Biomedica,'' and the University and University Hospital of Liege. AM is a Research Fellow; AV and AS are Post-Doctoral Fellows, and SL is a Senior Research Associate at the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Barrs DM, 1984, J LARYNGOL OTOL S, V98, P287; BEARD AW, 1965, J PSYCHOSOM RES, V9, P29, DOI 10.1016/0022-3999(65)90008-5; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Cacace AT, 2003, HEARING RES, V175, P112, DOI 10.1016/S0378-5955(02)00717-7; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; De Ridder D, 2006, ACTA OTO-LARYNGOL, V126, P50, DOI 10.1080/03655230600895580; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Demertzi A, 2011, PROG BRAIN RES, V193, P309, DOI 10.1016/B978-0-444-53839-0.00020-X; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Engelien A, 2000, ANN NY ACAD SCI, V911, P477; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hallam RS., 1996, MANUAL TINNITUS QUES; House J W, 1981, Ciba Found Symp, V85, P204; Hunter MD, 2006, P NATL ACAD SCI USA, V103, P189, DOI 10.1073/pnas.0506268103; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; Knight R.T., 1995, ADV NEUROL, V66, P34; KNIGHT RT, 1995, ADV NEUROL, V66, P21; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Larson PS, 2012, NEUROSURGERY, V70, P398, DOI 10.1227/NEU.0b013e3182320ab5; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lockwood AH, 2001, NEUROLOGY, V56, P472, DOI 10.1212/WNL.56.4.472; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Moller, 2011, TXB TINNITUS; MURPHY JP, 1951, YALE J BIOL MED, V23, P493; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Osaki Y, 2005, NEUROREPORT, V16, P1625, DOI 10.1097/01.wnr.0000183899.85277.08; Petacchi A, 2005, HUM BRAIN MAPP, V25, P118, DOI 10.1002/hbm.20137; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Reyes SA, 2002, HEARING RES, V171, P43, DOI 10.1016/S0378-5955(02)00346-5; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Soddu A, 2012, HUM BRAIN MAPP, V33, P778, DOI 10.1002/hbm.21249; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vanneste S, 2011, EUR J NEUROSCI, V34, P718, DOI 10.1111/j.1460-9568.2011.07793.x; Vanneste S, 2011, EXP BRAIN RES, V210, P217, DOI 10.1007/s00221-011-2617-z; WATTS J W, 1946, J Int Coll Surg, V9, P679; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; WHO, 1991, HEARING NETWORK NEWS, V1; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	57	144	153	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36222	10.1371/journal.pone.0036222	http://dx.doi.org/10.1371/journal.pone.0036222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574141	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800037
J	Penwell, WF; Arivett, BA; Actis, LA				Penwell, William F.; Arivett, Brock A.; Actis, Luis A.			The Acinetobacter baumannii entA Gene Located Outside the Acinetobactin Cluster Is Critical for Siderophore Production, Iron Acquisition and Virulence	PLOS ONE			English	Article							2,3-DIHYDROXYBENZOIC ACID; VIBRIO-ANGUILLARUM; BRUCELLA-ABORTUS; GENOME SEQUENCE; PLASMID PJM1; PATHOGEN; BIOSYNTHESIS; SYSTEM; VIBRIO-ANGUILLARUM-775; IDENTIFICATION	Acinetobacter baumannii causes severe infections in compromised patients, who present an iron-limited environment that controls bacterial growth. This pathogen has responded to this restriction by expressing high-affinity iron acquisition systems including that mediated by the siderophore acinetobactin. Gene cloning, functional assays and biochemical tests showed that the A. baumannii genome contains a single functional copy of an entA ortholog. This gene, which is essential for the biosynthesis of the acinetobactin precursor 2,3-dihydroxybenzoic acid (DHBA), locates outside of the acinetobactin gene cluster, which otherwise harbors all genes needed for acinetobactin biosynthesis, export and transport. In silico analyses and genetic complementation tests showed that entA locates next to an entB ortholog, which codes for a putative protein that contains the isochorismatase lyase domain, which is needed for DHBA biosynthesis from isochorismic acid, but lacks the aryl carrier protein domain, which is needed for tethering activated DHBA and completion of siderophore biosynthesis. Thus, basF, which locates within the acinetobactin gene cluster, is the only fully functional entB ortholog present in ATCC 19606(T). The differences in amino acid length and sequences between these two EntB orthologs and the differences in the genetic context within which the entA and entB genes are found in different A. baumannii isolates indicate that they were acquired from different sources by horizontal transfer. Interestingly, the AYE strain proved to be a natural entA mutant capable of acquiring iron via an uncharacterized siderophore-mediated system, an observation that underlines the ability of different A. baumannii isolates to acquire iron using different systems. Finally, experimental infections using in vivo and ex vivo models demonstrate the role of DHBA and acinetobactin intermediates in the virulence of the ATCC 19606(T) cells, although to a lesser extent when compared to the responses obtained with bacteria producing and using fully matured acinetobactin to acquire iron.	[Penwell, William F.; Arivett, Brock A.; Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Penwell, WF (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	actisla@muohio.edu	Arivett, Brock/T-2569-2018	Arivett, Brock/0000-0002-1291-3814	US Public Health [AI070174]; NSF [0420479]; Miami University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070174] Funding Source: NIH RePORTER	US Public Health(United States Department of Health & Human ServicesUnited States Public Health Service); NSF(National Science Foundation (NSF)); Miami University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	US Public Health AI070174 and NSF 0420479 grants and Miami University funds supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Alice AF, 2005, J BACTERIOL, V187, P2209, DOI 10.1128/JB.187.6.2209-2214.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANSTEY NM, 1992, CLIN INFECT DIS, V14, P83, DOI 10.1093/clinids/14.1.83; Antunes LCS, 2011, RES MICROBIOL, V162, P279, DOI 10.1016/j.resmic.2010.10.010; Arnow LE, 1937, J BIOL CHEM, V118, P531; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Bellaire BH, 2003, INFECT IMMUN, V71, P2927, DOI 10.1128/IAI.71.5.2927-2932.2003; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Centers for Disease Control and Prevention, 2004, MMWR MORB MORTAL WKL, V53, P1063; Charnot-Katsikas A, 2009, J CLIN MICROBIOL, V47, P258, DOI 10.1128/JCM.01250-08; Crichton RR., 2009, IRON METABOLISM MOL; Crosa JH., 2004, IRON TRANSPORT BACTE; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; Di Lorenzo M, 2003, J BACTERIOL, V185, P5822, DOI 10.1128/JB.185.19.5822-5830.2003; Di Lorenzo M, 2011, BIOMETALS, V24, P629, DOI 10.1007/s10534-011-9416-7; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dorsey CW, 2004, MICROBIOL-SGM, V150, P3657, DOI 10.1099/mic.0.27371-0; Dorsey CW, 2003, J CLIN MICROBIOL, V41, P4188, DOI 10.1128/JCM.41.9.4188-4193.2003; Dorsey CW, 2003, MICROBIOL-SGM, V149, P1227, DOI 10.1099/mic.0.26204-0; Dorsey CW, 2002, APPL ENVIRON MICROB, V68, P6353, DOI 10.1128/AEM.68.12.6353-6360.2002; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Earhart C.F., 1996, ESCHERICHIA COLI SAL, V2nd ed., P1075; ECHENIQUE JR, 1992, J BACTERIOL, V174, P7670, DOI 10.1128/JB.174.23.7670-7679.1992; Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; Mihara K, 2004, MICROBIOL-SGM, V150, P2587, DOI 10.1099/mic.0.27141-0; Naka H, 2008, ENVIRON MICROBIOL, V10, P265, DOI 10.1111/j.1462-2920.2007.01450.x; Naka H, 2012, BIOMETALS, V25, P125, DOI 10.1007/s10534-011-9488-4; Parent MA, 2002, MICROB PATHOGENESIS, V32, P239, DOI 10.1006/mpat.2002.0500; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Sambrook J, 2001, MOL CLONING LAB MANU; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; STAAB JF, 1990, J BACTERIOL, V172, P6403, DOI 10.1128/jb.172.11.6403-6410.1990; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/BF00301846; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhou Z, 2007, P NATL ACAD SCI USA, V104, P11621, DOI 10.1073/pnas.0705122104; Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3	52	51	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36493	10.1371/journal.pone.0036493	http://dx.doi.org/10.1371/journal.pone.0036493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570720	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400036
J	Draber, P; Stepanek, O; Hrdinka, M; Drobek, A; Chmatal, L; Mala, L; Ormsby, T; Angelisova, P; Horejsi, V; Brdicka, T				Draber, Peter; Stepanek, Ondrej; Hrdinka, Matous; Drobek, Ales; Chmatal, Lukas; Mala, Linda; Ormsby, Tereza; Angelisova, Pavla; Horejsi, Vaclav; Brdicka, Tomas			LST1/A Is a Myeloid Leukocyte-specific Transmembrane Adaptor Protein Recruiting Protein Tyrosine Phosphatases SHP-1 and SHP-2 to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TNF REGION; MOTH-EATEN; T-CELLS; GENE; INFLAMMATION; RECEPTOR; SIGLECS; IDENTIFICATION; INTERFERON	Transmembrane adaptor proteins are membrane-anchored proteins consisting of a short extracellular part, a transmembrane domain, and a cytoplasmic part with various protein-protein interaction motifs but lacking any enzymatic activity. They participate in the regulation of various signaling pathways by recruiting other proteins to the proximity of cellular membranes where the signaling is often initiated and propagated. In this work, we show that LST1/A, an incompletely characterized protein encoded by MHCIII locus, is a palmitoylated transmembrane adaptor protein. It is expressed specifically in leukocytes of the myeloid lineage, where it localizes to the tetraspanin-enriched microdomains. In addition, it binds SHP-1 and SHP-2 phosphatases in a phosphotyrosine-dependent manner, facilitating their recruitment to the plasma membrane. These data suggest a role for LST1/A in negative regulation of signal propagation.	[Draber, Peter; Stepanek, Ondrej; Hrdinka, Matous; Drobek, Ales; Chmatal, Lukas; Mala, Linda; Ormsby, Tereza; Angelisova, Pavla; Horejsi, Vaclav; Brdicka, Tomas] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Brdicka, T (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CR-14220 Prague, Czech Republic.	tomas.brdicka@img.cas.cz	Stepanek, Ondrej/F-8882-2013; Brdicka, Tomas/G-6205-2014; Stepanek, Ondrej/AAG-3180-2020; Angelisova, Pavla/G-3131-2014; Hrdinka, Matous/B-9187-2011; Draber, Peter/G-3141-2014; Drobek, Aleš/T-3994-2017; Horejsi, Vaclav/G-3113-2014; Ormsby, Tereza/O-3854-2018; Ormsby, Tereza/AAA-4527-2022	Stepanek, Ondrej/0000-0002-2735-3311; Brdicka, Tomas/0000-0002-1560-4398; Stepanek, Ondrej/0000-0002-2735-3311; Hrdinka, Matous/0000-0002-2981-2825; Draber, Peter/0000-0001-8658-4614; Horejsi, Vaclav/0000-0003-4925-0142; Ormsby, Tereza/0000-0002-2953-9208; Ormsby, Tereza/0000-0002-2953-9208; Drobek, Ales/0000-0003-1066-9413	Academy of Sciences of the Czech Republic [AVOZ50520514, RVO68378050]; GACR [MEM/09/E011, P302/12/G101]; Center of Molecular and Cellular Immunology project, Ministry of Education, Youth and Sports of the Czech Republic [1M0506]; Faculty of Science, Charles University, Prague, Czech Republic	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); GACR(Grant Agency of the Czech Republic); Center of Molecular and Cellular Immunology project, Ministry of Education, Youth and Sports of the Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic(Czech Republic Government)	This work was supported by Academy of Sciences of the Czech Republic (AVOZ50520514 and RVO68378050), GACR Projects MEM/09/E011 and P302/12/G101, and by Center of Molecular and Cellular Immunology Project 1M0506, Ministry of Education, Youth and Sports of the Czech Republic.; Supported in part by the Faculty of Science, Charles University, Prague, Czech Republic.	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; ANGELISOVA P, 1994, IMMUNOGENETICS, V39, P249; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Bauler TJ, 2011, DIS MODEL MECH, V4, P228, DOI 10.1242/dmm.006130; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251, DOI 10.14670/HH-22.1251; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; deBaey A, 1997, GENOMICS, V45, P591, DOI 10.1006/geno.1997.4963; Draber P, 2011, MOL CELL BIOL, V31, P4550, DOI 10.1128/MCB.05817-11; Gruen JR, 2001, FRONT BIOSCI-LANDMRK, V6, pD960, DOI 10.2741/Gruen; HOLZINGER I, 1995, IMMUNOGENETICS, V42, P315, DOI 10.1007/BF00179392; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Hrdinka M, 2011, J BIOL CHEM, V286, P19617, DOI 10.1074/jbc.M110.175117; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mulcahy H, 2006, IMMUNOGENETICS, V57, P893, DOI 10.1007/s00251-005-0057-2; Paul SP, 2000, BLOOD, V96, P483; Raghunathan A, 2001, EXP CELL RES, V268, P230, DOI 10.1006/excr.2001.5290; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Rollinger-Holzinger I, 2000, J IMMUNOL, V164, P3169, DOI 10.4049/jimmunol.164.6.3169; Schiller C, 2009, HYBRIDOMA, V28, P281, DOI 10.1089/hyb.2009.0021; SPIES T, 1989, SCIENCE, V243, P214, DOI 10.1126/science.2911734; Staub E, 2004, CELL SIGNAL, V16, P435, DOI 10.1016/j.cellsig.2003.08.013; TSUGE I, 1987, IMMUNOGENETICS, V26, P378, DOI 10.1007/BF00343709; Tsui FWL, 2006, IMMUNOL RES, V35, P127, DOI 10.1385/IR:35:1:127; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Ulyanova T, 2001, J BIOL CHEM, V276, P14451, DOI 10.1074/jbc.M011650200; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Walter RB, 2008, TRAFFIC, V9, P267, DOI 10.1111/j.1600-0854.2007.00682.x; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Yu CCK, 1996, J EXP MED, V183, P371, DOI 10.1084/jem.183.2.371; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X	41	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22812	22821		10.1074/jbc.M112.339143	http://dx.doi.org/10.1074/jbc.M112.339143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589543	Green Published, hybrid			2022-12-25	WOS:000306495000038
J	Thomas, RM; Gamper, CJ; Ladle, BH; Powell, JD; Wells, AD				Thomas, Rajan M.; Gamper, Christopher J.; Ladle, Brian H.; Powell, Jonathan D.; Wells, Andrew D.			De Novo DNA Methylation Is Required to Restrict T Helper Lineage Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; IFN-GAMMA PROMOTER; METHYLTRANSFERASE 3A; H3K4 METHYLATION; TH17 CELLS; DIFFERENTIATION; GENE; CYTOKINE; TRANSCRIPTION; BET	Naive CD4+ T cells are highly plastic and can differentiate into discrete lineages with unique functions during an immune response. Once differentiated, helper T cells maintain a stable transcriptional memory of their initial lineage choice and resist redifferentiation. During embryogenesis, de novo DNA methylation operates on the hypomethylated genome of the blastocyst to achieve tissue-specific patterns of gene expression. Similarly, the ifn gamma promoter is hypomethylated in naive T cells, but Th2, Th17, and iTreg differentiation is accompanied by substantial de novo DNA methylation at this locus. To determine whether de novo DNA methylation is required to restrict T helper lineage plasticity, we used mice with T cell-specific deletion of the methyltransferase DNMT3a. Induction of lineage-specific cytokines occurred normally in the absence of DNMT3a, however, DNMT3a-deficient Th2, Th17, and iTreg completely failed to methylate the ifn gamma promoter. This was accompanied by an increase in the transcriptionally permissive trimethyl H3K4 mark, and a reduction in inhibitory H3K27 methylation at the ifn gamma locus. Failed de novo methylation resulted in failed silencing of the ifn gamma gene, as DNMT3a-deficient Th2, Th17, and iTreg cells produced significant levels of IFN gamma following restimulation in the presence of IL-12. Therefore, DNMT3a-mediated DNA methylation restricts T helper plasticity by establishing an epigenetically silent chromatin structure at regulatory regions of the ifn gamma gene.	[Thomas, Rajan M.; Wells, Andrew D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Thomas, Rajan M.; Wells, Andrew D.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Gamper, Christopher J.; Ladle, Brian H.; Powell, Jonathan D.] Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD 21287 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Johns Hopkins University	Gamper, CJ (corresponding author), 1650 Orleans St, Baltimore, MD 21287 USA.	cgamper1@jhmi.edu; adwells@mail.med.upenn.edu	Thomas, Rajan M/AAW-7207-2021	Gamper, Christopher/0000-0003-0253-2177	National Institutes of Health [AI070807, HL108346]; American Cancer Society [RSG109185]; Hyundai Scholar Award; Joan and Jonas Cash Foundation; Optimist International Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL108346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Hyundai Scholar Award; Joan and Jonas Cash Foundation; Optimist International Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI070807 (to A. D. W.) and HL108346 (to C. J. G.). This work was also supported by American Cancer Society Grant RSG109185 (to J. D. P.).; A St. Baldrick's Scholar (180359) and supported by a Hyundai Scholar Award and the Joan and Jonas Cash Foundation. To whom correspondence may be addressed: 1650 Orleans St., Baltimore, MD 21287. Tel.: 410-502-2342; E-mail: cgamper1@jhmi.edu.; Supported by an Optimist International Research Fellowship.	Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chang SJ, 2008, J IMMUNOL, V181, P8372, DOI 10.4049/jimmunol.181.12.8372; Cohen CJ, 2011, J IMMUNOL, V187, P5615, DOI 10.4049/jimmunol.1101058; Gamper CJ, 2009, J IMMUNOL, V183, P2267, DOI 10.4049/jimmunol.0802960; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Lande-Diner L, 2007, J BIOL CHEM, V282, P12194, DOI 10.1074/jbc.M607838200; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Makar KW, 2004, J IMMUNOL, V173, P4402, DOI 10.4049/jimmunol.173.7.4402; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Rowel E, 2008, CURR OPIN IMMUNOL, V20, P272, DOI 10.1016/j.coi.2008.03.012; Thomas RM, 2007, GENES IMMUN, V8, P613, DOI 10.1038/sj.gene.6364415; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Tong YK, 2005, P NATL ACAD SCI USA, V102, P2034, DOI 10.1073/pnas.0409510102; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Winders BR, 2004, J IMMUNOL, V173, P7377, DOI 10.4049/jimmunol.173.12.7377; YOUNG HA, 1994, J IMMUNOL, V153, P3603	34	54	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22900	22909		10.1074/jbc.M111.312785	http://dx.doi.org/10.1074/jbc.M111.312785			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584578	hybrid, Green Published			2022-12-25	WOS:000306495000047
J	Pinto, AR; Paolicelli, R; Salimova, E; Gospocic, J; Slonimsky, E; Bilbao-Cortes, D; Godwin, JW; Rosenthal, NA				Pinto, Alexander R.; Paolicelli, Rosa; Salimova, Ekaterina; Gospocic, Janko; Slonimsky, Esfir; Bilbao-Cortes, Daniel; Godwin, James W.; Rosenthal, Nadia A.			An Abundant Tissue Macrophage Population in the Adult Murine Heart with a Distinct Alternatively-Activated Macrophage Profile	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GROWTH FACTOR-I; ADIPOSE-TISSUE; DENDRITIC CELLS; STEM-CELLS; FRACTALKINE RECEPTOR; MUSCLE REGENERATION; GENE SIGNATURE; MONOCYTE; VIVO	Cardiac tissue macrophages (cTMs) are a previously uncharacterised cell type that we have identified and characterise here as an abundant GFP(+) population within the adult Cx(3)cr1(GFP/+) knock-in mouse heart. They comprise the predominant myeloid cell population in the myocardium, and are found throughout myocardial interstitial spaces interacting directly with capillary endothelial cells and cardiomyocytes. Flow cytometry-based immunophenotyping shows that cTMs exhibit canonical macrophage markers. Gene expression analysis shows that cTMs (CD45(+)CD11b(+)GFP(+)) are distinct from mononuclear CD45(+)CD11b(+)GFP(+) cells sorted from the spleen and brain of adult Cx(3)cr1(GFP/+) mice. Gene expression profiling reveals that cTMs closely resemble alternatively-activated anti-inflammatory M2 macrophages, expressing a number of M2 markers, including Mrc1, CD163, and Lyve-1. While cTMs perform normal tissue macrophage homeostatic functions, they also exhibit a distinct phenotype, involving secretion of salutary factors (including IGF-1) and immune modulation. In summary, the characterisation of cTMs at the cellular and molecular level defines a potentially important role for these cells in cardiac homeostasis.	[Pinto, Alexander R.; Paolicelli, Rosa; Salimova, Ekaterina; Gospocic, Janko; Slonimsky, Esfir; Bilbao-Cortes, Daniel; Rosenthal, Nadia A.] European Mol Biol Lab, Mouse Biol Unit, Rome, Italy; [Pinto, Alexander R.; Godwin, James W.; Rosenthal, Nadia A.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Rosenthal, Nadia A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, London, England	European Molecular Biology Laboratory (EMBL); Australian Regenerative Medicine Institute; Monash University; Imperial College London	Pinto, AR (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Rome, Italy.	alex.pinto@monash.edu; nadia.rosenthal@monash.edu	Pinto, Alexander/AAF-5556-2021	Pinto, Alexander/0000-0001-6421-4970; Paolicelli, Rosa Chiara/0000-0001-6851-0849; Godwin, James/0000-0002-9234-7807; Rosenthal, Nadia/0000-0002-7599-7365; Bilbao Cortes, Daniel/0000-0003-1630-8811; , Ekaterina/0000-0002-4362-7108	European Union [EUCOMM:LSHM-CT-2005-018931, EUMODIC:LSHG-CT-2006-037188, EUCOMMTOOLS:HEALTH-F4-2010-261492]; HeartRepair: Heart Failure and Repair [LSHM-CT-2005-018630]; Australian Government; State Government of Victoria	European Union(European Commission); HeartRepair: Heart Failure and Repair; Australian Government(Australian GovernmentCGIAR); State Government of Victoria	This work was funded by grants to NR from the European Union (EUCOMM:LSHM-CT-2005-018931; EUMODIC:LSHG-CT-2006-037188; EUCOMMTOOLS:HEALTH-F4-2010-261492; and HeartRepair: Heart Failure and Repair LSHM-CT-2005-018630). The Australian Regenerative Medicine Institute is supported by grants from the Australian Government and State Government of Victoria. NR is an NHMRC Australia Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bosschaerts T, 2008, J IMMUNOL, V180, P6168, DOI 10.4049/jimmunol.180.9.6168; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Cihakova D, 2008, AM J PATHOL, V172, P1195, DOI 10.2353/ajpath.2008.070207; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fairweather D, 2006, J IMMUNOL, V176, P3516, DOI 10.4049/jimmunol.176.6.3516; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GRANT MB, 1993, DIABETOLOGIA, V36, P282, DOI 10.1007/BF00400229; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Klimchenko O, 2011, BLOOD, V117, P3065, DOI 10.1182/blood-2010-07-295246; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lim JP, IMMUNOL CELL BIOL; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Musaro A, 2007, EUR J HISTOCHEM, V51, P35; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; NAKAOHAYASHI J, 1992, ATHEROSCLEROSIS, V92, P141, DOI 10.1016/0021-9150(92)90273-J; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Santini MP, 2007, CIRC RES, V100, P1732, DOI 10.1161/CIRCRESAHA.107.148791; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Semenova E, 2008, AM J PATHOL, V173, P1295, DOI 10.2353/ajpath.2008.071177; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Teng XW, 2003, CIRC RES, V92, P1065, DOI 10.1161/01.RES.0000073999.07698.33; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	57	143	150	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36814	10.1371/journal.pone.0036814	http://dx.doi.org/10.1371/journal.pone.0036814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590615	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336400037
J	Alter, SE; Newsome, SD; Palumbi, SR				Alter, S. Elizabeth; Newsome, Seth D.; Palumbi, Stephen R.			Pre-Whaling Genetic Diversity and Population Ecology in Eastern Pacific Gray Whales: Insights from Ancient DNA and Stable Isotopes	PLOS ONE			English	Article							TIME DEPENDENCY; CYTOCHROME-B; SIZE; COALESCENT; PATTERNS; BIOGEOCHEMISTRY; RADIOCARBON; MANAGEMENT; MIGRATION; WILDLIFE	Commercial whaling decimated many whale populations, including the eastern Pacific gray whale, but little is known about how population dynamics or ecology differed prior to these removals. Of particular interest is the possibility of a large population decline prior to whaling, as such a decline could explain the similar to 5-fold difference between genetic estimates of prior abundance and estimates based on historical records. We analyzed genetic (mitochondrial control region) and isotopic information from modern and prehistoric gray whales using serial coalescent simulations and Bayesian skyline analyses to test for a pre-whaling decline and to examine prehistoric genetic diversity, population dynamics and ecology. Simulations demonstrate that significant genetic differences observed between ancient and modern samples could be caused by a large, recent population bottleneck, roughly concurrent with commercial whaling. Stable isotopes show minimal differences between modern and ancient gray whale foraging ecology. Using rejection-based Approximate Bayesian Computation, we estimate the size of the population bottleneck at its minimum abundance and the pre-bottleneck abundance. Our results agree with previous genetic studies suggesting the historical size of the eastern gray whale population was roughly three to five times its current size.	[Alter, S. Elizabeth; Palumbi, Stephen R.] Stanford Univ, Dept Biol Sci, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Newsome, Seth D.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	Stanford University; University of Wyoming	Alter, SE (corresponding author), CUNY York Coll, Dept Biol, Jamaica, NY 11451 USA.	ealter@york.cuny.edu			Teresa Heinz Scholars for Environmental Research award	Teresa Heinz Scholars for Environmental Research award	Funding was provided by a Teresa Heinz Scholars for Environmental Research award to SEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Alter SE, 2009, J MOL EVOL, V68, P97, DOI 10.1007/s00239-008-9193-2; Alter SE, 2009, J HERED, V100, P34, DOI 10.1093/jhered/esn090; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; Axelsson E, 2008, MOL BIOL EVOL, V25, P2181, DOI 10.1093/molbev/msn163; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Barnes I, 2007, CURR BIOL, V17, P1072, DOI 10.1016/j.cub.2007.05.035; Beaumont MA, 2002, GENETICS, V162, P2025; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Chan YL, 2006, PLOS GENET, V2, P451, DOI 10.1371/journal.pgen.0020059; CLAPHAM P, 2005, J CETACEAN RES MAN S, V7, P386; Clapham PJ, 2008, MAR MAMMAL SCI, V24, P183, DOI 10.1111/j.1748-7692.2007.00175.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Darling JD, 1998, MAR MAMMAL SCI, V14, P692, DOI 10.1111/j.1748-7692.1998.tb00757.x; de Bruyn M, 2011, TRENDS ECOL EVOL, V26, P405, DOI 10.1016/j.tree.2011.03.021; Druffel ERM, 2001, RADIOCARBON, V43, P15; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frasier Timothy R., 2011, Endangered Species Research, V14, P39, DOI 10.3354/esr00340; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hedrick P, 2005, EVOLUTION, V59, P1596; HENDERSON DA, 1972, MEN WHALES SCAMMONS; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Hideshima S, 2001, RADIOCARBON, V43, P473; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2007, MOL BIOL EVOL, V24, P1416, DOI 10.1093/molbev/msm062; Ho SYW, 2011, SYST BIOL, V60, P366, DOI 10.1093/sysbio/syq099; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HUDSON RR, 1992, GENETICS, V132, P583; Huelsbeck D. R., 1994, OZETTE ARCHAEOLOGICA, VII, P265; Jackson JA, 2009, MOL BIOL EVOL, V26, P2427, DOI 10.1093/molbev/msp169; Kalinowski ST, 2002, CONSERV BIOL, V16, P129, DOI 10.1046/j.1523-1739.2002.00134.x; Kienast SS, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000650; Krupnik II, 1984, GRAY WHALE; LeDuc R. G., 2002, Journal of Cetacean Research and Management, V4, P1; Moore SE, 2003, CAN J ZOOL, V81, P734, DOI 10.1139/Z03-043; Navascues M, 2009, MOL ECOL, V18, P4390, DOI 10.1111/j.1365-294X.2009.04333.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Newsome SD, 2007, P NATL ACAD SCI USA, V104, P9709, DOI 10.1073/pnas.0610986104; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; NUNNEY L, 1994, CONSERV BIOL, V8, P175, DOI 10.1046/j.1523-1739.1994.08010175.x; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Perryman WL, 2002, MAR MAMMAL SCI, V18, P121, DOI 10.1111/j.1748-7692.2002.tb01023.x; Phillips CD, 2009, MOL ECOL, V18, P3379, DOI 10.1111/j.1365-294X.2009.04283.x; Pinksky ML, 2010, MOL ECOL, V19, P2418; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pyenson ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021295; Ramakrishnan U, 2005, MOL ECOL, V14, P2915, DOI 10.1111/j.1365-294X.2005.02586.x; Rambaut A, 2009, MOL BIOL EVOL, V26, P245, DOI 10.1093/molbev/msn256; Reeves RR, 2002, MAMMAL REV, V32, P71, DOI 10.1046/j.1365-2907.2002.00100.x; Rice DW., 1971, LIFE HIST ECOLOGY GR, DOI DOI 10.5962/BHL.TITLE.39537; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Rooney AP, 2001, EVOLUTION, V55, P1678; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rugh David J., 2005, Journal of Cetacean Research and Management, V7, P1; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Steeves TE, 2001, CONSERV GENET, V2, P379, DOI 10.1023/A:1012590315579; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Townsend CH, 1885, B US FISHERIES COMMI, V6, P340; Voss M, 2001, DEEP-SEA RES PT I, V48, P1905, DOI 10.1016/S0967-0637(00)00110-2; Wade PR, 2002, IWC SCI COMM S UNPUB; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yang DY, 2006, MOL ECOL NOTES, V6, P605, DOI 10.1111/j.1471-8286.2006.01370.x; Yoneda M, 2007, NUCL INSTRUM METH B, V259, P432, DOI 10.1016/j.nimb.2007.01.184	77	50	53	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35039	10.1371/journal.pone.0035039	http://dx.doi.org/10.1371/journal.pone.0035039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590499	Green Published, gold			2022-12-25	WOS:000305336100005
J	Hartwig, T; Corvalan, C; Best, NB; Budka, JS; Zhu, JY; Choe, S; Schulz, B				Hartwig, Thomas; Corvalan, Claudia; Best, Norman B.; Budka, Joshua S.; Zhu, Jia-Ying; Choe, Sunghwa; Schulz, Burkhard			Propiconazole Is a Specific and Accessible Brassinosteroid (BR) Biosynthesis Inhibitor for Arabidopsis and Maize	PLOS ONE			English	Article							TRACHEARY-ELEMENT DIFFERENTIATION; GIBBERELLIN BIOSYNTHESIS; SIGNAL-TRANSDUCTION; LAMINA INCLINATION; DWARF4 EXPRESSION; GENE-EXPRESSION; MUTANT; GROWTH; CYTOCHROME-P450; DEGRADATION	Brassinosteroids (BRs) are steroidal hormones that play pivotal roles during plant development. In addition to the characterization of BR deficient mutants, specific BR biosynthesis inhibitors played an essential role in the elucidation of BR function in plants. However, high costs and limited availability of common BR biosynthetic inhibitors constrain their key advantage as a species-independent tool to investigate BR function. We studied propiconazole (Pcz) as an alternative to the BR inhibitor brassinazole (Brz). Arabidopsis seedlings treated with Pcz phenocopied BR biosynthetic mutants. The steady state mRNA levels of BR, but not gibberellic acid (GA), regulated genes increased proportional to the concentrations of Pcz. Moreover, root inhibition and Pcz-induced expression of BR biosynthetic genes were rescued by 24epi-brassinolide, but not by GA3 co-applications. Maize seedlings treated with Pcz showed impaired mesocotyl, coleoptile, and true leaf elongation. Interestingly, the genetic background strongly impacted the tissue specific sensitivity towards Pcz. Based on these findings we conclude that Pcz is a potent and specific inhibitor of BR biosynthesis and an alternative to Brz. The reduced cost and increased availability of Pcz, compared to Brz, opens new possibilities to study BR function in larger crop species.	[Hartwig, Thomas; Best, Norman B.; Budka, Joshua S.; Schulz, Burkhard] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Corvalan, Claudia; Choe, Sunghwa] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Zhu, Jia-Ying] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA; [Choe, Sunghwa] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Seoul National University (SNU); Carnegie Institution for Science; Seoul National University (SNU)	Hartwig, T (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	shchoe@snu.ac.kr; bschulz@purdue.edu	Best, Norman B/G-1969-2015; Choe, Sunghwa/K-5650-2013	Best, Norman B/0000-0002-6572-5999; Choe, Sunghwa/0000-0001-5541-484X	Plant Molecular Breeding Center [PJ008051]; Cooperative Research Program for Agriculture Science & Technology Development [PJ906910]; Rural Development Administration, Republic of Korea; Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [110033-5]; Ministry of Education, Science, and Technology of the Korean Government; Department of Horticulture and Landscape Architecture, Purdue University; Direct For Biological Sciences [1054918] Funding Source: National Science Foundation	Plant Molecular Breeding Center; Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Ministry of Education, Science, and Technology of the Korean Government(Ministry of Education, Science & Technology (MEST), Republic of Korea); Department of Horticulture and Landscape Architecture, Purdue University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by grants from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center no. PJ008051) and the Cooperative Research Program for Agriculture Science & Technology Development (project no. PJ906910), Rural Development Administration, Republic of Korea, by Technology Development Program (110033-5) for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (to SC), and the BK21 Research Fellowships funded by the Ministry of Education, Science, and Technology of the Korean Government (to CC). This work was also supported by startup funds from the Department of Horticulture and Landscape Architecture, Purdue University (to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Asami T, 1999, TRENDS PLANT SCI, V4, P348, DOI 10.1016/S1360-1385(99)01456-9; Asami T, 2001, J BIOL CHEM, V276, P25687, DOI 10.1074/jbc.M103524200; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Belkhadir Y, 2010, GENETICS, V185, P1283, DOI 10.1534/genetics.109.111898; Blackwell HE, 2003, PLANT PHYSIOL, V133, P448, DOI 10.1104/pp.103.031138; Cheon J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-270; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; Choe SW, 1999, PLANT CELL, V11, P207, DOI 10.1105/tpc.11.2.207; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Chung Y, 2011, PLANT J, V66, P564, DOI 10.1111/j.1365-313X.2011.04513.x; Clouse SD, 1999, BRASSINOSTEROIDS, P163; Clouse Steven D, 2011, Arabidopsis Book, V9, pe0151, DOI 10.1199/tab.0151; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; DELEENS E, 1984, PLANT SCI LETT, V37, P35, DOI 10.1016/0304-4211(84)90199-8; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Eggermont K, 1996, PLANT MOL BIOL REP, V14, P273, DOI 10.1007/BF02671663; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; GACHOTTE D, 1995, PLANT J, V8, P407, DOI 10.1046/j.1365-313X.1995.08030407.x; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gomes MMA, 2011, BRASSINOSTEROIDS: A CLASS OF PLANT HORMONE, P193, DOI 10.1007/978-94-007-0189-2_7; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; IWAHORI S, 1990, PLANT GROWTH REGUL, V9, P119, DOI 10.1007/BF00027439; IWASAKI T, 1991, PLANT CELL PHYSIOL, V32, P1007, DOI 10.1093/oxfordjournals.pcp.a078163; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Kim HB, 2006, PLANT PHYSIOL, V140, P548, DOI 10.1104/pp.105.067918; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kim TW, 2012, NATURE; Kim YS, 2005, PHYTOCHEMISTRY, V66, P1000, DOI 10.1016/j.phytochem.2005.03.007; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Li L, 2009, PLANT J, V58, P275, DOI 10.1111/j.1365-313X.2008.03778.x; Li ZH, 2013, ENVIRON TOXICOL, V28, P119, DOI 10.1002/tox.20701; Liu KJ, 2003, GENETICS, V165, P2117; Maharjan PM, 2011, J PLANT BIOL, V54, P425, DOI 10.1007/s12374-011-9183-6; Maharjan PM, 2011, J PLANT BIOL, V54, P126, DOI 10.1007/s12374-010-9138-3; Makarevitch I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030798; Min YK, 1999, BIOORG MED CHEM LETT, V9, P425, DOI 10.1016/S0960-894X(99)00008-6; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Noguchi T, 1999, PLANT PHYSIOL, V120, P833, DOI 10.1104/pp.120.3.833; Orlova I, 2009, PLANT CELL, V21, P4002, DOI 10.1105/tpc.109.071282; OWEN WJ, 1986, PESTIC BIOCHEM PHYS, V26, P75, DOI 10.1016/0048-3575(86)90064-7; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Rademacher W., 2020, PLANT BIOCH REGULATO, P169; Raikhel N, 2005, PLANT PHYSIOL, V138, P563, DOI 10.1104/pp.104.900155; SASSE JM, 1995, P PLANT GROWTH REGUL, V22, P136; Schnabel G, 2003, PEST MANAG SCI, V59, P1143, DOI 10.1002/ps.744; Schulz B, 2006, FEBS LETT, V580, P1010, DOI 10.1016/j.febslet.2006.01.002; Sekimata K, 2002, J AGR FOOD CHEM, V50, P3486, DOI 10.1021/jf011716w; Sekimata K, 2001, PLANTA, V213, P716, DOI 10.1007/s004250100546; Song L, 2009, MOL PLANT, V2, P755, DOI 10.1093/mp/ssp039; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Thorstensen CW, 2001, J ENVIRON QUAL, V30, P947, DOI 10.2134/jeq2001.303947x; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; WADA K, 1981, PLANT CELL PHYSIOL, V22, P323; WADA K, 1984, AGR BIOL CHEM TOKYO, V48, P719, DOI 10.1080/00021369.1984.10866208; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; WIGGINS TE, 1984, PESTIC SCI, V15, P206, DOI 10.1002/ps.2780150212; Xu YL, 1997, PLANT PHYSIOL, V114, P1471, DOI 10.1104/pp.114.4.1471; Xu YL, 1999, PLANT CELL, V11, P927, DOI 10.1105/tpc.11.5.927; Yamamoto R, 1997, PLANT CELL PHYSIOL, V38, P980, DOI 10.1093/oxfordjournals.pcp.a029262; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; YOKOTA T, 1991, GIBBERELLINS, P339; YOSHIDA Y, 1991, BIOCHEM SOC T, V19, P778, DOI 10.1042/bst0190778; Zar JH., 2010, BIOSTAT ANAL; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	74	91	95	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36625	10.1371/journal.pone.0036625	http://dx.doi.org/10.1371/journal.pone.0036625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590578	gold, Green Published			2022-12-25	WOS:000305336100048
J	Liu, WZ; Wu, JB; Xiao, L; Bai, YJ; Qu, AQ; Zheng, Z; Yuan, ZQ				Liu, Weizhe; Wu, Junbing; Xiao, Lei; Bai, Yujie; Qu, Aiqin; Zheng, Zheng; Yuan, Zengqiang			Regulation of Neuronal Cell Death by c-Abl-Hippo/MST2 Signaling Pathway	PLOS ONE			English	Article							KINASE MST2; TYROSINE KINASE; C-ABL; APOPTOSIS; PHOSPHORYLATION; ACTIVATION; CASPASE	Background: Mammalian Ste20-like kinases (MSTs) are the mammalian homologue of Drosophila hippo and play critical roles in regulation of cell death, organ size control, proliferation and tumorigenesis. MSTs exert pro-apoptotic function through cleavage, autophosphorylation and in turn phosphorylation of downstream targets, such as Histone H2B and FOXO ( Forkhead box O). Previously we reported that protein kinase c-Abl mediates oxidative stress-induced neuronal cell death through phosphorylating MST1 at Y433, which is not conserved among mammalian MST2, Drosophila Hippo and C. elegans cst-1/2. Methodology/Principal Findings: Using immunoblotting, in vitro kinase and cell death assay, we demonstrate that c-Abl kinase phosphorylates MST2 at an evolutionarily conserved site, Y81, within the kinase domain. We further show that the phosphorylation of MST2 by c-Abl leads to the disruption of the interaction with Raf-1 proteins and the enhancement of homodimerization of MST2 proteins. It thereby enhances the MST2 activation and induces neuronal cell death. Conclusions/Significance: The identification of the c-Abl tyrosine kinase as a novel upstream activator of MST2 suggests that the conserved c-Abl-MST signaling cascade plays an important role in oxidative stress-induced neuronal cell death.	[Wu, Junbing; Xiao, Lei; Bai, Yujie; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Liu, Weizhe] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Liaoning, Peoples R China; [Liu, Weizhe; Qu, Aiqin] Shandong Univ, Coll Life Sci, Jinan, Shandong, Peoples R China; [Zheng, Zheng] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Beijing, Peoples R China; [Wu, Junbing; Xiao, Lei; Bai, Yujie] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Dalian Medical University; Shandong University; Capital Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, WZ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	zqyuan@ibp.ac.cn	Xiao, Lei/I-3655-2017; xiao, Lei/J-4217-2017	Yuan, Zengqiang/0000-0001-5739-2867	National Science Foundation of China [30870792, 81030025]; National Basic Research Program of China (973 Program) [2009CB918704, 2012CB910701]; CAS	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); CAS(Chinese Academy of Sciences)	This work was supported by the National Science Foundation of China (Grant No. 30870792 and 81030025), the National Basic Research Program of China (973 Program, Grant No. 2009CB918704 and 2012CB910701) and CAS Knowledge Innovation Program to Z.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT RL, 1992, DEVELOPMENT, V116, P953; Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; Cancino GI, 2011, NEUROBIOL AGING, V32, P1249, DOI 10.1016/j.neurobiolaging.2009.07.007; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Kim D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009616; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Pan D, DEV CELL, V19, P491; Romano D, 2010, CANCER RES, V70, P1195, DOI 10.1158/0008-5472.CAN-09-3147; Xiao L, 2011, J NEUROSCI, V31, P9611, DOI 10.1523/JNEUROSCI.0035-11.2011; Xiao L, 2010, PROTEIN CELL, V1, P706, DOI 10.1007/s13238-010-0097-8; Yoshida K, 2007, ADV EXP MED BIOL, V604, P155, DOI 10.1007/978-0-387-69116-9_15; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	18	43	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36562	10.1371/journal.pone.0036562	http://dx.doi.org/10.1371/journal.pone.0036562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590567	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336100040
J	Smal, C; Alonso, LG; Wetzler, DE; Heer, A; Gay, GD				Smal, Clara; Alonso, Leonardo G.; Wetzler, Diana E.; Heer, Angeles; de Prat Gay, Gonzalo			Ordered Self-Assembly Mechanism of a Spherical Oncoprotein Oligomer Triggered by Zinc Removal and Stabilized by an Intrinsically Disordered Domain	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; E7 ONCOPROTEIN; VIRAL ONCOPROTEIN; IN-VITRO; PROTEIN; DEGRADATION; AGGREGATION; PEPTIDE; MODEL; PHOSPHORYLATION	Background: Self-assembly is a common theme in proteins of unrelated sequences or functions. The human papillomavirus E7 oncoprotein is an extended dimer with an intrinsically disordered domain, that can form large spherical oligomers. These are the major species in the cytosol of HPV transformed and cancerous cells. E7 binds to a large number of targets, some of which lead to cell transformation. Thus, the assembly process not only is of biological relevance, but represents a model system to investigate a widely distributed mechanism. Methodology/Principal Findings: Using various techniques, we monitored changes in secondary, tertiary and quaternary structure in a time course manner. By applying a robust kinetic model developed by Zlotnik, we determined the slow formation of a monomeric "Z-nucleus'' after zinc removal, followed by an elongation phase consisting of sequential second-order events whereby one monomer is added at a time. This elongation process takes place at a strikingly slow overall average rate of one monomer added every 28 seconds at 20 mu M protein concentration, strongly suggesting either a rearrangement of the growing complex after binding of each monomer or the existence of a "conformation editing'' mechanism through which the monomer binds and releases until the appropriate conformation is adopted. The oligomerization determinant lies within its small 5 kDa C-terminal globular domain and, remarkably, the E7 N-terminal intrinsically disordered domain stabilizes the oligomer, preventing an insoluble amyloid route. Conclusion: We described a controlled ordered mechanism with features in common with soluble amyloid precursors, chaperones, and other spherical oligomers, thus sharing determining factors for symmetry, size and shape. In addition, such a controlled and discrete polymerization reaction provides a valuable tool for nanotechnological applications. Finally, its increased immunogenicity related to its supramolecular structure is the basis for the development of a promising therapeutic vaccine candidate for treating HPV cancerous lesions.	[Smal, Clara; Heer, Angeles; de Prat Gay, Gonzalo] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Smal, Clara; Heer, Angeles; de Prat Gay, Gonzalo] Inst Invest Bioquim Conicet, Buenos Aires, DF, Argentina; [Alonso, Leonardo G.] XBio Inc, Buenos Aires, DF, Argentina; [Wetzler, Diana E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Leloir Institute; University of Buenos Aires	Smal, C (corresponding author), Fdn Inst Leloir, Buenos Aires, DF, Argentina.	gpg@leloir.org.ar		Alonso, Leonardo Gabriel/0000-0002-0596-703X; Wetzler, Diana Elena/0000-0003-2231-6690; Prat Gay, Gonzalo/0000-0001-5748-6863	Universidad de Buenos Aires (UBA)	Universidad de Buenos Aires (UBA)(University of Buenos Aires)	LGA, DEW and GdPG are Career Investigator from Concejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). CS held a doctoral fellowship from Universidad de Buenos Aires (UBA). AH holds a doctoral fellowship from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LG, 2006, BIOCHEMISTRY-US, V45, P657, DOI 10.1021/bi0522549; Alonso LG, 2004, BIOCHEMISTRY-US, V43, P3310, DOI 10.1021/bi036037o; Alonso LG, 2002, BIOCHEMISTRY-US, V41, P10510, DOI 10.1021/bi025579n; Angeline M, 2003, VIROLOGY, V317, P13, DOI 10.1016/j.virol.2003.08.024; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; BARBOSA MS, 1989, J VIROL, V63, P1404, DOI 10.1128/JVI.63.3.1404-1407.1989; Bartolini M, 2007, CHEMBIOCHEM, V8, P2152, DOI 10.1002/cbic.200700427; Boyer SN, 1996, CANCER RES, V56, P4620; Cerutti ML, 2011, INT J CANC; Chemes LB, 2012, WILEY SER PROTEIN P, P313; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Clements A, 2000, BIOCHEMISTRY-US, V39, P16033, DOI 10.1021/bi002111g; Crouch PJ, 2011, J NEUROCHEM, V119, P220, DOI 10.1111/j.1471-4159.2011.07402.x; CSERMELY P, 1988, BIOCHEM BIOPH RES CO, V154, P578, DOI 10.1016/0006-291X(88)90179-9; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; DOBSON CM, 2005, PROTEIN FOLDING HDB, P1093; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Endres D, 2002, BIOPHYS J, V83, P1217, DOI 10.1016/S0006-3495(02)75245-4; Freire E, 2008, PROTEINS, V70, P450, DOI 10.1002/prot.21580; Gammoh N, 2006, J VIROL, V80, P1787, DOI 10.1128/JVI.80.4.1787-1797.2006; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; Gelain F, 2011, ACS NANO, V5, P1845, DOI 10.1021/nn102663a; Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026; Grana-Montes R, 2012, ANTIOXID REDOX SIGN, V16, P1, DOI 10.1089/ars.2011.3936; GREENFIELD I, 1991, P NATL ACAD SCI USA, V88, P11217, DOI 10.1073/pnas.88.24.11217; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hou SY, 2002, J BIOL CHEM, V277, P45619, DOI 10.1074/jbc.M206829200; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Liu DX, 2006, BIOCHEMISTRY-US, V45, P10963, DOI 10.1021/bi060955f; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Mishra PP, 2008, LANGMUIR, V24, P9308, DOI 10.1021/la801366r; Ohlenschlager O, 2006, ONCOGENE, V25, P5953, DOI 10.1038/sj.onc.1209584; Pigga JM, 2010, LANGMUIR, V26, P9449, DOI 10.1021/la100467p; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Rey O, 2000, VIROLOGY, V268, P372, DOI 10.1006/viro.1999.0175; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Smal C, 2009, BIOCHEMISTRY-US, V48, P11939, DOI 10.1021/bi901415k; SMOTKIN D, 1987, J VIROL, V61, P1686, DOI 10.1128/JVI.61.5.1686-1689.1987; Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Wetzler DE, 2007, PROTEIN SCI, V16, P744, DOI 10.1110/ps.062594007; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Zhang J, 2009, J AM CHEM SOC, V131, P15152, DOI 10.1021/ja903548m; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a; Zlotnick A, 2003, TRENDS BIOTECHNOL, V21, P536, DOI 10.1016/j.tibtech.2003.09.012; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473; Zlotnick A, 2011, TRENDS MICROBIOL, V19, P14, DOI 10.1016/j.tim.2010.11.003	53	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36457	10.1371/journal.pone.0036457	http://dx.doi.org/10.1371/journal.pone.0036457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590549	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100031
J	Haynes, GD; Latch, EK				Haynes, Gwilym D.; Latch, Emily K.			Identification of Novel Single Nucleotide Polymorphisms (SNPs) in Deer (Odocoileus spp.) Using the BovineSNP50 BeadChip	PLOS ONE			English	Article							WHITE-TAILED DEER; MULE DEER; POPULATION-STRUCTURE; INTROGRESSIVE HYBRIDIZATION; GENETIC-RELATIONSHIPS; MITOCHONDRIAL; LOCI; CONSERVATION; VIRGINIANUS; SELECTION	Single nucleotide polymorphisms (SNPs) are growing in popularity as a genetic marker for investigating evolutionary processes. A panel of SNPs is often developed by comparing large quantities of DNA sequence data across multiple individuals to identify polymorphic sites. For non-model species, this is particularly difficult, as performing the necessary large-scale genomic sequencing often exceeds the resources available for the project. In this study, we trial the Bovine SNP50 BeadChip developed in cattle (Bos taurus) for identifying polymorphic SNPs in cervids Odocoileus hemionus (mule deer and black-tailed deer) and O. virginianus (white-tailed deer) in the Pacific Northwest. We found that 38.7% of loci could be genotyped, of which 5% (n = 1068) were polymorphic. Of these 1068 polymorphic SNPs, a mixture of putatively neutral loci (n = 878) and loci under selection (n = 190) were identified with the F-ST-outlier method. A range of population genetic analyses were implemented using these SNPs and a panel of 10 microsatellite loci. The three types of deer could readily be distinguished with both the SNP and microsatellite datasets. This study demonstrates that commercially developed SNP chips are a viable means of SNP discovery for non-model organisms, even when used between very distantly related species (the Bovidae and Cervidae families diverged some 25.1-30.1 million years before present).	[Haynes, Gwilym D.; Latch, Emily K.] Univ Wisconsin, Dept Biol Sci, Behav & Mol Ecol Res Grp, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Haynes, GD (corresponding author), Univ Wisconsin, Dept Biol Sci, Behav & Mol Ecol Res Grp, POB 413, Milwaukee, WI 53201 USA.	latch@uwm.edu			University of Wisconsin - Milwaukee Research Growth Initiative	University of Wisconsin - Milwaukee Research Growth Initiative	This research was funded by the University of Wisconsin - Milwaukee Research Growth Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Anderson EC, 2006, GENETICS, V172, P2567, DOI 10.1534/genetics.105.048074; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Baker RH, 1984, WHITE TAILED DEER EC; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Belkhir K., 2004, GENETIX LOGICIEL SOU; Benjamini Y, 2001, ANN STAT, V29, P1165; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Bradley RD, 2003, SOUTHWEST NAT, V48, P654, DOI 10.1894/0038-4909(2003)048&lt;0654:IOHBWD&gt;2.0.CO;2; Brooks SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000909; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Bunch TD, 2006, J HERED, V97, P21, DOI 10.1093/jhered/esi127; CARR SM, 1993, J MAMMAL, V74, P331, DOI 10.2307/1382388; CARR SM, 1986, P NATL ACAD SCI USA, V83, P9576, DOI 10.1073/pnas.83.24.9576; Cathey JC, 1998, EVOLUTION, V52, P1224, DOI [10.1111/j.1558-5646.1998.tb01850.x, 10.2307/2411253]; Chakraborty R, 1999, ELECTROPHORESIS, V20, P1682; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; CRONIN MA, 1991, CAN J ZOOL, V69, P1270, DOI 10.1139/z91-179; CRONIN MA, 1991, J MAMMAL, V72, P553, DOI 10.2307/1382139; CRONIN MA, 1988, J WILDLIFE MANAGE, V52, P320, DOI 10.2307/3801243; Davoli R, 2003, ANIM GENET, V34, P221, DOI 10.1046/j.1365-2052.2003.00992.x; DERR JN, 1991, J WILDLIFE MANAGE, V55, P228, DOI 10.2307/3809144; DeYoung RW, 2003, MOL ECOL, V12, P3237, DOI 10.1046/j.1365-294X.2003.01996.x; DeYoung RW, 2003, WILDLIFE SOC B, V31, P220; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; GALLAGHER DS, 1994, J HERED, V85, P204, DOI 10.1093/oxfordjournals.jhered.a111436; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; GAVIN TA, 1988, J WILDLIFE MANAGE, V52, P1, DOI 10.2307/3801048; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Groves C, 2006, EUR J WILDLIFE RES, V52, P14, DOI 10.1007/s10344-005-0011-5; Hassanin A, 2003, SYST BIOL, V52, P206, DOI 10.1080/10635150390192726; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hornbeck GE, 2000, WILDLIFE SOC B, V28, P1012; Hubisz MJ, 2009, MOL ECOLOGY RESOURCE, P9; HUGHES GA, 1993, CAN J ZOOL, V71, P524, DOI 10.1139/z93-073; IUCN, 2019, IUCN RED LIST THREAT; Jackson H. H. T., 1921, Journal of Mammalogy, V2, P140, DOI 10.2307/1373602; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KAY CE, 1992, GREAT BASIN NAT, V52, P290; Kolbehdari D, 2008, J DAIRY SCI, V91, P2844, DOI 10.3168/jds.2007-0585; Krawczak M, 1999, ELECTROPHORESIS, V20, P1676, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1676::AID-ELPS1676>3.3.CO;2-4; Langella O., 1999, POPULATIONS 1 2 30 P; Latch EK, 2008, ANIM CONSERV, V11, P234, DOI 10.1111/j.1469-1795.2008.00174.x; Latch EK, 2011, MOL ECOL, V20, P5265, DOI 10.1111/j.1365-294X.2011.05349.x; Latch EK, 2009, MOL ECOL, V18, P1730, DOI 10.1111/j.1365-294X.2009.04153.x; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-177; Mackie R.J., 1981, MULE BLACK TAILED DE, P487; MCCLYMONT RA, 1982, J WILDLIFE MANAGE, V46, P540, DOI 10.2307/3808677; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miller JM, 2011, MOL ECOL RESOUR, V11, P314, DOI 10.1111/j.1755-0998.2010.02918.x; Morin PA, 2007, MOL ECOL NOTES, V7, P937, DOI 10.1111/j.1471-8286.2007.01804.x; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Moscarella RA, 2003, J MAMMAL, V84, P1300, DOI 10.1644/BRB-028; Nagylaki T, 1998, GENETICS, V148, P1325; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nosil P, 2011, TRENDS ECOL EVOL, V26, P160, DOI 10.1016/j.tree.2011.01.001; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; Pertoldi C, 2010, CONSERV GENET, V11, P627, DOI 10.1007/s10592-009-9977-y; Pollard KS, 2008, DIVISION BIOSTATISTI; Polziehn RO, 1998, MOL PHYLOGENET EVOL, V10, P249, DOI 10.1006/mpev.1998.0527; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Seabury CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015811; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Slate J, 2010, TRENDS GENET, V26, P275, DOI 10.1016/j.tig.2010.03.005; Smith CT, 2007, T AM FISH SOC, V136, P1674, DOI 10.1577/T06-227.1; TAYLOR WP, 1956, DEER N AM; U.S. Fish and Wildlife Service, 2011, END SPEC DAT; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WALLMO OC, 1981, MULE BLACK TAILED DE; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wright S, 1931, GENETICS, V16, P0097; Wright S., 1978, EVOLUTION GENETICS P, V4; Xu TJ, 2011, GENET MOL RES, V10, P53, DOI 10.4238/vol10-1gmr960	86	45	51	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36536	10.1371/journal.pone.0036536	http://dx.doi.org/10.1371/journal.pone.0036536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590559	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335500015
J	Chung, RH; Chen, YE				Chung, Ren-Hua; Chen, Ying-Erh			A Two-Stage Random Forest-Based Pathway Analysis Method	PLOS ONE			English	Article							GENE-GENE; ASSOCIATION; SUSCEPTIBILITY; POLYMORPHISMS; GENOTYPES; RISK; MDM2; SNPS	Pathway analysis provides a powerful approach for identifying the joint effect of genes grouped into biologically-based pathways on disease. Pathway analysis is also an attractive approach for a secondary analysis of genome-wide association study (GWAS) data that may still yield new results from these valuable datasets. Most of the current pathway analysis methods focused on testing the cumulative main effects of genes in a pathway. However, for complex diseases, gene-gene interactions are expected to play a critical role in disease etiology. We extended a random forest-based method for pathway analysis by incorporating a two-stage design. We used simulations to verify that the proposed method has the correct type I error rates. We also used simulations to show that the method is more powerful than the original random forest-based pathway approach and the set-based test implemented in PLINK in the presence of gene-gene interactions. Finally, we applied the method to a breast cancer GWAS dataset and a lung cancer GWAS dataset and interesting pathways were identified that have implications for breast and lung cancers.	[Chung, Ren-Hua] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli, Taiwan; [Chung, Ren-Hua] Univ Miami, Miller Sch Med, John P Hussman Inst Human Gen, Ctr Genet Epidemiol & Stat Genet, Miami, FL 33136 USA; [Chen, Ying-Erh] N Carolina State Univ, Dept Econ, Raleigh, NC 27695 USA	National Health Research Institutes - Taiwan; University of Miami; University of North Carolina; North Carolina State University	Chung, RH (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli, Taiwan.	rchung@nhri.org.tw	Chung, Ren-Hua/AAB-8364-2019; Chung, Ren-Hua/A-8833-2012		National Health Research Institutes [PH-101-PP-47]	National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by a grant from the National Health Research Institutes (PH-101-PP-47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; De Lobel L, 2010, EUR J HUM GENET, V18, P1127, DOI 10.1038/ejhg.2010.48; Edwards TL, 2008, LECT NOTES COMPUT SC, V4973, P24, DOI 10.1007/978-3-540-78757-0_3; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Lind H, 2006, INT J CANCER, V119, P718, DOI 10.1002/ijc.21872; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Meng YA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-78; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pang H, 2006, BIOINFORMATICS, V22, P2028, DOI 10.1093/bioinformatics/btl344; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schwarz DF, 2010, BIOINFORMATICS, V26, P1752, DOI 10.1093/bioinformatics/btq257; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Zhang XM, 2006, HUM MUTAT, V27, P110, DOI 10.1002/humu.20277	27	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36662	10.1371/journal.pone.0036662	http://dx.doi.org/10.1371/journal.pone.0036662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586488	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335000049
J	Castro, DP; Moraes, CS; Gonzalez, MS; Ratcliffe, NA; Azambuja, P; Garcia, ES				Castro, Daniele P.; Moraes, Caroline S.; Gonzalez, Marcelo S.; Ratcliffe, Norman A.; Azambuja, Patricia; Garcia, Eloi S.			Trypanosoma cruzi Immune Response Modulation Decreases Microbiota in Rhodnius prolixus Gut and Is Crucial for Parasite Survival and Development	PLOS ONE			English	Article							NITRIC-OXIDE; SERRATIA-MARCESCENS; RANGELI; VECTOR; TRANSMISSION; AZADIRACHTIN; TRIATOMINAE; DYNAMICS; INSECTS; MIDGUT	Trypanosoma cruzi in order to complete its development in the digestive tract of Rhodnius prolixus needs to overcome the immune reactions and microbiota trypanolytic activity of the gut. We demonstrate that in R. prolixus following infection with epimastigotes of Trypanosoma cruzi clone Dm28c and, in comparison with uninfected control insects, the midgut contained (i) fewer bacteria, (ii) higher parasite numbers, and (iii) reduced nitrite and nitrate production and increased phenoloxidase and antibacterial activities. In addition, in insects pre-treated with antibiotic and then infected with Dm28c, there were also reduced bacteria numbers and a higher parasite load compared with insects solely infected with parasites. Furthermore, and in contrast to insects infected with Dm28c, infection with T. cruzi Y strain resulted in a slight decreased numbers of gut bacteria but not sufficient to mediate a successful parasite infection. We conclude that infection of R. prolixus with the T. cruzi Dm28c clone modifies the host gut immune responses to decrease the microbiota population and these changes are crucial for the parasite development in the insect gut.	[Castro, Daniele P.; Moraes, Caroline S.; Ratcliffe, Norman A.; Azambuja, Patricia; Garcia, Eloi S.] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Bioquim & Fisiol Insetos, Rio De Janeiro, Brazil; [Gonzalez, Marcelo S.] UFF Niteroi, Inst Biol, Dept Biol Geral, Lab Biol Insetos, Rio De Janeiro, Brazil; [Azambuja, Patricia; Garcia, Eloi S.] Inst Nacl Entomol Mol INCT EM, Dept Entomol Mol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Castro, DP (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Bioquim & Fisiol Insetos, Rio De Janeiro, Brazil.	danicastro@ioc.fiocruz.br	de Castro, Daniele Pereira/R-4194-2019; de Azambuja Penna, Patricia/AAA-3763-2019; Castro, Daniele/A-9337-2013; Gonzalez, Marcelo/G-6128-2012	de Castro, Daniele Pereira/0000-0002-2827-6258; , Caroline/0000-0003-2197-6937; Azambuja, Patricia/0000-0002-1405-8743	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fiocruz	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fiocruz	The work is supported by funds by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Fiocruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman-Anderson L, 2007, INFECT IMMUN, V75, P4012, DOI 10.1128/IAI.00645-07; Araujo CAC, 2006, INSECT BIOCHEM MOLEC, V36, P547, DOI 10.1016/j.ibmb.2006.04.003; Ascenzi P, 2002, IUBMB LIFE, V53, P121, DOI [10.1080/10399710290039016, 10.1080/15216540211472]; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007; Azambuja P, 1983, J INSECT PHYSL, V29, P833; Azambuja P. de, 1997, The molecular biology of insect disease vectors: a methods manual., P56; Bexfield A, 2004, MICROBES INFECT, V6, P1297, DOI 10.1016/j.micinf.2004.08.011; Boulanger N, 2006, TRENDS PARASITOL, V22, P262, DOI 10.1016/j.pt.2006.04.003; Carton Y, 2009, J PARASITOL, V95, P1134, DOI 10.1645/GE-2091.1; Castro DP, 2007, EXP PARASITOL, V117, P201, DOI 10.1016/j.exppara.2007.04.014; Castro DP, 2007, EXP PARASITOL, V115, P200, DOI 10.1016/j.exppara.2006.08.001; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; Dias João Carlos Pinto, 2002, Rev. Soc. Bras. Med. Trop., V35, P669, DOI 10.1590/S0037-86822002000600021; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Eichler S, 2002, EXP PARASITOL, V100, P17, DOI 10.1006/expr.2001.4653; Garcia E. de S., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P43; Garcia ES, 2007, J INSECT PHYSIOL, V53, P11, DOI 10.1016/j.jinsphys.2006.10.006; Garcia ES, 2010, MEM I OSWALDO CRUZ, V105, P605, DOI 10.1590/S0074-02762010000500001; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; Garcia ES, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-33; GARCIA ES, 1991, PARASITOL TODAY, V7, P240, DOI 10.1016/0169-4758(91)90237-I; Garcia ES, 2004, TOXICON, V44, P431, DOI 10.1016/j.toxicon.2004.05.007; Genta FA, 2010, J INSECT PHYSIOL, V56, P1253, DOI 10.1016/j.jinsphys.2010.03.027; Gomes SAO, 2003, J INSECT PHYSIOL, V49, P829, DOI 10.1016/S0022-1910(03)00133-1; Gonzalez MS, 1999, EXP PARASITOL, V92, P100, DOI 10.1006/expr.1998.4387; Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; McGwire BS, 2010, EXP PARASITOL, V126, P397, DOI 10.1016/j.exppara.2010.02.006; Mello CB, 1996, EXP PARASITOL, V82, P112, DOI 10.1006/expr.1996.0015; MONCADA S, 1992, ACTA PHYSIOL SCAND, V145, P201, DOI 10.1111/j.1748-1716.1992.tb09359.x; Nogueira NFS, 1997, J INVERTEBR PATHOL, V69, P58, DOI 10.1006/jipa.1996.4635; POMERANTZ SH, 1963, J BIOL CHEM, V238, P2351; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; Thomas S, 1999, J Tissue Viability, V9, P127; Ursic-Bedoya R, 2011, INSECT MOL BIOL, V20, P775, DOI 10.1111/j.1365-2583.2011.01107.x; Ursic-Bedoya RJ, 2007, DEV COMP IMMUNOL, V31, P109, DOI 10.1016/j.dci.2006.05.008; Vallejo GA, 2009, ACTA TROP, V110, P137, DOI 10.1016/j.actatropica.2008.10.001; Vijay S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018400; Waniek PJ, 2011, VECTOR-BORNE ZOONOT, V11, P845, DOI 10.1089/vbz.2010.0020; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Whitten MMA, 2007, INSECT BIOCHEM MOLEC, V37, P440, DOI 10.1016/j.ibmb.2007.02.001; Whitten MMA, 2001, EXP PARASITOL, V98, P44, DOI 10.1006/expr.2001.4615	45	86	88	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36591	10.1371/journal.pone.0036591	http://dx.doi.org/10.1371/journal.pone.0036591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574189	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800086
J	Cat, AND; Escoubet, B; Agrapart, V; Griol-Charhbili, V; Schoeb, T; Feng, WG; Jaimes, E; Warnock, DG; Jaisser, F				Cat, Aurelie Nguyen Dinh; Escoubet, Brigitte; Agrapart, Vincent; Griol-Charhbili, Violaine; Schoeb, Trenton; Feng, Wenguang; Jaimes, Edgar; Warnock, David G.; Jaisser, Frederic			Cardiomyopathy and Response to Enzyme Replacement Therapy in a Male Mouse Model for Fabry Disease	PLOS ONE			English	Article							ALPHA-GALACTOSIDASE; MINERALOCORTICOID RECEPTOR; CARDIAC MANIFESTATIONS; NATURAL-HISTORY; DEFICIENT MICE; OUTCOME SURVEY; HEART; EXPRESSION; PREVALENCE; REGISTRY	Fabry disease is an X-linked disorder of glycosphingolipid metabolism that results in progressive accumulation of neutral glycosphingolipids, (predominately globotriaosylceramide; GL-3) in lysosomes, as well as other cellular compartments and the extracellular space. Our aim was to characterize the cardiac phenotype of male knock-out mice that are deficient in alpha-galactosidase A activity, as a model for Fabry disease and test the efficacy of Enzyme Replacement Therapy with agalsidase-beta. Male mice (3-4 months of age) were characterized with awake blood pressure and heart rate measurements, cardiac echocardiography and electrocardiography measurements under light anesthesia, histological studies and molecular studies with real-time polymerase chain reaction. The Fabry knock-out mouse has bradycardia and lower blood pressure than control wild type (CB7BL/6J) mice. In Fabry knock-out mice, the cardiomyopathy associated mild hypertrophy at echography with normal systolic LV function and mild diastolic dysfunction. Premature atrial contractions were more frequent in without conduction defect. Heart weight normalized to tibial length was increased in Fabry knockout mice. Ascending aorta dilatation was observed. Molecular studies were consistent with early stages of cardiac remodeling. A single dose of agalsidase-beta (3 mg/kg) did not affect the LV hypertrophy, function or heart rate, but did improve the mRNA signals of early cardiac remodeling. In conclusion, the alpha-galactosidase A deficient mice at 3 to 4 months of age have cardiac and vascular alterations similar to that described in early clinical stage of Fabry disease in children and adolescents. Enzyme replacement therapy affects cardiac molecular remodeling after a single dose.	[Cat, Aurelie Nguyen Dinh; Escoubet, Brigitte; Agrapart, Vincent; Griol-Charhbili, Violaine; Jaisser, Frederic] Inserm, U872, Team 1, Paris, France; [Cat, Aurelie Nguyen Dinh; Agrapart, Vincent; Griol-Charhbili, Violaine; Jaisser, Frederic] Univ Paris 06, Paris, France; [Escoubet, Brigitte] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Escoubet, Brigitte] Univ Paris 07, Bichat Federat Res Inst 02, Ctr Explorat Fonct Imagerie, Paris, France; [Schoeb, Trenton; Feng, Wenguang; Jaimes, Edgar; Warnock, David G.] Univ Alabama Birmingham, Birmingham, AL USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Alabama System; University of Alabama Birmingham	Cat, AND (corresponding author), Inserm, U872, Team 1, Paris, France.	frederic.jaisser@crc.jussieu.fr	CAT, Aurelie NGUYEN DINH/H-8182-2013; Jaisser, Frederic/P-4287-2017	Jaisser, Frederic/0000-0001-9051-1901	Institut National de la Sante et de la Recherche Medicale; GENZYME Investigator Sponsored Research Program; Centre de Recherche Industrielle et Technique; INSERM/Conseil Regional Ile de France; Lefoulon-Delalande postdoctoral fellowship; Division of Nephrology and Department of Medicine at the University of Alabama at Birmingham, Birmingham Alabama, United States of America; Genzyme Corporation, Cambridge, Massachusetts, United States of America; GENZYME Corporation through the GENZYME Investigator Sponsored Research Program	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); GENZYME Investigator Sponsored Research Program; Centre de Recherche Industrielle et Technique; INSERM/Conseil Regional Ile de France; Lefoulon-Delalande postdoctoral fellowship; Division of Nephrology and Department of Medicine at the University of Alabama at Birmingham, Birmingham Alabama, United States of America; Genzyme Corporation, Cambridge, Massachusetts, United States of America; GENZYME Corporation through the GENZYME Investigator Sponsored Research Program	This work was supported by grants to FJ from Institut National de la Sante et de la Recherche Medicale, the GENZYME Investigator Sponsored Research Program and the Centre de Recherche Industrielle et Technique. ANDC held a PhD grant from INSERM/Conseil Regional Ile de France; VG-C held a Lefoulon-Delalande postdoctoral fellowship. DGW received support from the Division of Nephrology and Department of Medicine at the University of Alabama at Birmingham, Birmingham Alabama, United States of America, and Genzyme Corporation, Cambridge, Massachusetts, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Part of the work was financed by GENZYME Corporation through the GENZYME Investigator Sponsored Research Program. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2014, METABOLIC MOL BASES; Barbey F, 2010, EUR HEART J, V31, P347, DOI 10.1093/eurheartj/ehp426; Bichara M, 2006, GLYCOBIOLOGY, V16, P36, DOI 10.1093/glycob/cwj035; Bierer G, 2005, RESPIRATION, V72, P504, DOI 10.1159/000087675; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; Chimenti C, 2008, AM J PATHOL, V172, P1482, DOI 10.2353/ajpath.2008.070576; Eitzman DT, 2003, J AM SOC NEPHROL, V14, P298, DOI 10.1097/01.ASN.0000043901.45141.D4; Fervenza FC, 2008, KIDNEY INT, V73, P1193, DOI 10.1038/sj.ki.5002677; FERVENZA FC, 2008, BIOLOGICS, V2, P1; Guo X, 2002, AM J PHYSIOL-HEART C, V283, pH1829, DOI 10.1152/ajpheart.00224.2002; Hopkin RJ, 2008, PEDIATR RES, V64, P550, DOI 10.1203/PDR.0b013e318183f132; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Kampmann C, 2008, ACTA PAEDIATR, V97, P463, DOI 10.1111/j.1651-2227.2008.00700.x; Kaneski CR, 2006, NEUROLOGY, V67, P2045, DOI 10.1212/01.wnl.0000247278.88077.09; Kouris NT, 2005, INT J CARDIOL, V99, P327, DOI 10.1016/j.ijcard.2003.10.065; Linhart A, 2007, EUR HEART J, V28, P1228, DOI 10.1093/eurheartj/ehm153; Lobo T, 2008, INTERN MED J, V38, P407, DOI 10.1111/j.1445-5994.2008.01669.x; Mallon AM, 2008, NUCLEIC ACIDS RES, V36, pD715, DOI 10.1093/nar/gkm728; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; Mehta A, 2009, J MED GENET, V46, P548, DOI 10.1136/jmg.2008.065904; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Olivotto I, 2003, J AM COLL CARDIOL, V41, P315, DOI 10.1016/S0735-1097(02)02713-4; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Park JL, 2008, CLIN EXP PHARMACOL P, V35, P1156, DOI 10.1111/j.1440-1681.2008.04984.x; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Ries M, 2005, PEDIATRICS, V115, pE344, DOI 10.1542/peds.2004-1678; Rozenfeld PA, 2011, CAN J CARDIOL, V27, P339, DOI 10.1016/j.cjca.2010.12.035; Sadick Norman, 2007, Heart Lung Circ, V16, P200, DOI 10.1016/j.hlc.2007.03.007; Sainte-Marie Y, 2007, FASEB J, V21, P3133, DOI 10.1096/fj.07-8357com; Schellings MWM, 2004, CARDIOVASC RES, V64, P24, DOI 10.1016/j.cardiores.2004.06.006; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Shah JS, 2005, AM J CARDIOL, V96, P842, DOI 10.1016/j.amjcard.2005.05.033; Shah JS, 2005, ACTA PAEDIATR, V94, P11, DOI 10.1080/08035320510028058; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Shu L, 2009, J AM SOC NEPHROL; Shu LM, 2005, J AM SOC NEPHROL, V16, P2636, DOI 10.1681/ASN.2005040383; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Tahir H, 2007, J AM SOC NEPHROL, V18, P2609, DOI 10.1681/ASN.2006121400; Takenaka T, 2008, J CARDIOL, V51, P50, DOI 10.1016/j.jjcc.2007.12.001; Toro R, 2009, INT J CARDIOL, V132, P38, DOI 10.1016/j.ijcard.2008.04.075; Tsai CT, 2010, J AM COLL CARDIOL, V55, P758, DOI 10.1016/j.jacc.2009.09.045; Waldek S, 2009, GENET MED, V11, P790, DOI 10.1097/GIM.0b013e3181bb05bb; Wanner C, 2010, CLIN J AM SOC NEPHRO, V5, P2220, DOI 10.2215/CJN.04340510; Warnock DG, 2011, RENAL OUTCOMES AGALS; Weidemann F, 2011, ANNU REV MED, V62, P59, DOI 10.1146/annurev-med-090910-085119; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278	48	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e33743	10.1371/journal.pone.0033743	http://dx.doi.org/10.1371/journal.pone.0033743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574107	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349800003
J	Ito, S; Ishii, A; Kakusho, N; Taniyama, C; Yamazaki, S; Fukatsu, R; Sakaue-Sawano, A; Miyawaki, A; Masai, H				Ito, Sayuri; Ishii, Ai; Kakusho, Naoko; Taniyama, Chika; Yamazaki, Satoshi; Fukatsu, Rino; Sakaue-Sawano, Asako; Miyawaki, Atsushi; Masai, Hisao			Mechanism of Cancer Cell Death Induced by Depletion of an Essential Replication Regulator	PLOS ONE			English	Article							IN-VITRO PHOSPHORYLATION; DNA-REPLICATION; CDC7 KINASE; S-PHASE; NUCLEAR-LOCALIZATION; DEPENDENT ACTIVATION; MITOTIC CATASTROPHE; INDUCED APOPTOSIS; MAMMALIAN-CELLS; FISSION YEAST	Background: Depletion of replication factors often causes cell death in cancer cells. Depletion of Cdc7, a kinase essential for initiation of DNA replication, induces cancer cell death regardless of its p53 status, but the precise pathways of cell death induction have not been characterized. Methodology/Principal Findings: We have used the recently-developed cell cycle indicator, Fucci, to precisely characterize the cell death process induced by Cdc7 depletion. We have also generated and utilized similar fluorescent cell cycle indicators using fusion with other cell cycle regulators to analyze modes of cell death in live cells in both p53-positive and -negative backgrounds. We show that distinct cell-cycle responses are induced in p53-positive and -negative cells by Cdc7 depletion. p53-negative cells predominantly arrest temporally in G2-phase, accumulating CyclinB1 and other mitotic regulators. Prolonged arrest at G2-phase and abrupt entry into aberrant M-phase in the presence of accumulated CyclinB1 are followed by cell death at the post-mitotic state. Abrogation of cytoplasmic CyclinB1 accumulation partially decreases cell death. The ATR-MK2 pathway is responsible for sequestration of CyclinB1 with 14-3-3s protein. In contrast, p53-positive cancer cells do not accumulate CyclinB1, but appear to die mostly through entry into aberrant S-phase after Cdc7 depletion. The combination of Cdc7 inhibition with known anti-cancer agents significantly stimulates cell death effects in cancer cells in a genotype-dependent manner, providing a strategic basis for future combination therapies. Conclusions: Our results show that the use of Fucci, and similar fluorescent cell cycle indicators, offers a convenient assay system with which to identify cell cycle events associated with cancer cell death. They also indicate genotype-specific cell death modes induced by deficient initiation of DNA replication in cancer cells and its potential exploitation for development of efficient cancer therapies.	[Ito, Sayuri; Ishii, Ai; Kakusho, Naoko; Taniyama, Chika; Yamazaki, Satoshi; Fukatsu, Rino; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct & Dynam, Wako, Saitama, Japan	Tokyo Metropolitan Institute of Medical Science; RIKEN	Ito, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo, Japan.	masai-hs@igakuken.or.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Basic Scientific Research (A) and a Grant-in-Aid for Scientific Research on Priority Area "Chromosome Cycle'' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alvarez-Fernandez M, 2010, EMBO REP, V11, P452, DOI 10.1038/embor.2010.46; Arai R, 2002, J CELL SCI, V115, P887; BARINAGA M, 1994, SCIENCE, V265, P1175, DOI 10.1126/science.8066458; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Im JS, 2008, J BIOL CHEM, V283, P25171, DOI 10.1074/jbc.M802851200; Ito S, 2008, DRUG NEWS PERSPECT, V21, P481, DOI 10.1358/dnp.2008.21.9.1290818; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kan QM, 2008, J BIOL CHEM, V283, P17864, DOI 10.1074/jbc.M802055200; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lau E, 2009, MOL BIOL CELL, V20, P3953, DOI 10.1091/mbc.E09-01-0022; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Matsumoto S, 2010, CELL CYCLE, V9, P4627, DOI 10.4161/cc.9.23.13937; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2004, CANCER RES, V64, P7110, DOI 10.1158/0008-5472.CAN-04-1547; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; Pandit B, 2009, CELL CYCLE, V8, P3425, DOI 10.4161/cc.8.20.9628; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Porter LA, 2003, BLOOD, V101, P1928, DOI 10.1182/blood-2002-04-1103; Porter LA, 2000, BLOOD, V95, P2645; Rodriguez-Acebes S, 2010, AM J PATHOL, V177, P2034, DOI 10.2353/ajpath.2010.100421; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Sawa Masaaki, 2009, Drug Des Devel Ther, V2, P255; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Tudzarova S, 2010, EMBO J, V29, P3381, DOI 10.1038/emboj.2010.201; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yamashita N, 2005, GENES CELLS, V10, P551, DOI 10.1111/j.1365-2443.2005.00857.x; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200	47	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36372	10.1371/journal.pone.0036372	http://dx.doi.org/10.1371/journal.pone.0036372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574151	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800047
J	Lin, YF; Jamison, S; Lin, WS				Lin, Yifeng; Jamison, Stephanie; Lin, Wensheng			Interferon-gamma Activates Nuclear Factor-kappa B in Oligodendrocytes through a Process Mediated by the Unfolded Protein Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS LESIONS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL-CYCLE EXIT; IFN-GAMMA; STAT1-INDEPENDENT PATHWAYS; INDUCED MEDULLOBLASTOMA; TRANSCRIPTION FACTORS; MEDICAL PROGRESS	Our previous studies have demonstrated that the effects of the immune cytokine interferon-gamma (IFN-gamma) in immune-mediated demyelinating diseases are mediated, at least in part, by the unfolded protein response (UPR) in oligodendrocytes. Data indicate that some biological effects of IFN-gamma are elicited through activation of the transcription factor nuclear factor-kappa B (NF-kappa B). Interestingly, it has been shown that activation of the pancreatic endoplasmic reticulum kinase (PERK) branch of the UPR triggers NF-kappa B activation. In this study, we showed that IFN-gamma-induced NF-kappa B activation was associated with activation of PERK signaling in the oligodendroglial cell line Oli-neu. We further demonstrated that blockage of PERK signaling diminished IFN-gamma-induced NF-kappa B activation in Oli-neu cells. Importantly, we showed that NF-kappa B activation in oligodendrocytes correlated with activation of PERK signaling in transgenic mice that ectopically express IFN-gamma in the central nervous system (CNS), and that enhancing IFN-gamma-induced activation of PERK signaling further increased NF-kappa B activation in oligodendrocytes. Additionally, we showed that suppression of the NF-kappa B pathway rendered Oli-neu cells susceptible to the cytotoxicity of IFN-gamma, reactive oxygen species, and reactive nitrogen species. Our results indicate that the UPR is involved in IFN-gamma-induced NF-kappa B activation in oligodendrocytes and suggest that NF-kappa B activation by IFN-gamma represents one mechanism by which IFN-gamma exerts its effects on oligodendrocytes in immune-mediated demyelinating diseases.	[Lin, Yifeng; Jamison, Stephanie; Lin, Wensheng] Univ S Alabama, Coll Med, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Lin, Wensheng] Univ S Alabama, Coll Med, Dept Comparat Med, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama	Lin, YF (corresponding author), Univ S Alabama, Coll Med, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA.	wlin@usouthal.edu	Lin, Wensheng/J-2661-2019	Lin, Wensheng/0000-0003-4931-7642	National Multiple Sclerosis Society [TA 3026-A-1]; National Institutes of Health [S10RR027535]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027535] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the National Multiple Sclerosis Society to WL (TA 3026-A-1). This work utilized the Nikon A1 confocal microscope funded by S10RR027535 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanov R, 2007, J NEUROSCI, V27, P2013, DOI 10.1523/JNEUROSCI.4689-06.2007; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Baud O, 2004, EUR J NEUROSCI, V20, P1713, DOI 10.1111/j.1460-9568.2004.03616.x; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bonetti B, 1999, AM J PATHOL, V155, P1433, DOI 10.1016/S0002-9440(10)65456-9; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Buntinx M, 2002, CRIT REV IMMUNOL, V22, P391; Chew LJ, 2005, GLIA, V52, P127, DOI 10.1002/glia.20232; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Gveric D, 1998, J NEUROPATH EXP NEUR, V57, P168, DOI 10.1097/00005072-199802000-00008; Hamanoue M, 2004, NEUROCHEM RES, V29, P1571, DOI 10.1023/B:NERE.0000029571.39497.56; Hilliard B, 1999, J IMMUNOL, V163, P2937; Horwitz MS, 1997, NAT MED, V3, P1037, DOI 10.1038/nm0997-1037; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kondo A, 2010, BLOOD, V116, P1124, DOI 10.1182/blood-2009-12-255125; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Lees JR, 2007, J CLIN INVEST, V117, P297, DOI 10.1172/JCI31254; Lin WS, 2008, AM J PATHOL, V173, P1508, DOI 10.2353/ajpath.2008.080449; Lin WS, 2007, J CLIN INVEST, V117, P448, DOI 10.1172/JCI29571; Lin WS, 2011, J NEUROSCI RES, V89, P1586, DOI 10.1002/jnr.22693; Lin WS, 2010, J NEUROSCI RES, V88, P2569, DOI 10.1002/jnr.22425; Lin WS, 2006, BRAIN, V129, P1306, DOI 10.1093/brain/awl044; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mc Guire C, 2010, J IMMUNOL, V185, P7646, DOI 10.4049/jimmunol.1000930; Mhaille AN, 2008, J NEUROPATH EXP NEUR, V67, P200, DOI 10.1097/NEN.0b013e318165b239; Nicholas RS, 2001, EUR J NEUROSCI, V13, P959, DOI 10.1046/j.0953-816x.2001.01470.x; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Tanner DC, 2011, J NEUROSCI, V31, P6235, DOI 10.1523/JNEUROSCI.5905-10.2011; Thapa RJ, 2011, MOL CELL BIOL, V31, P2934, DOI 10.1128/MCB.05445-11; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Vollgraf U, 1999, J NEUROCHEM, V73, P2501, DOI 10.1046/j.1471-4159.1999.0732501.x; Yan J, 2008, CNS NEUROL DISORD-DR, V7, P536, DOI 10.2174/187152708787122941; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	46	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36408	10.1371/journal.pone.0036408	http://dx.doi.org/10.1371/journal.pone.0036408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574154	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349800050
J	Liu, SH; Lin, JL; Weng, CH; Yang, HY; Hsu, CW; Chen, KH; Huang, WH; Yen, TH				Liu, Shou-Hsuan; Lin, Ja-Liang; Weng, Cheng-Hao; Yang, Huang-Yu; Hsu, Ching-Wei; Chen, Kuan-Hsing; Huang, Wen-Hung; Yen, Tzung-Hai			Heart Rate-Corrected QT Interval Helps Predict Mortality after Intentional Organophosphate Poisoning	PLOS ONE			English	Article							RESPIRATORY-FAILURE; PROLONGED QTC; DISEASE; POINTES; ARRHYTHMIAS; DISPERSION; TRAUMA; AGE	Introduction: In this study, we investigated the outcomes for patients with intentional organophosphate poisoning. Previous reports indicate that in contrast to normal heart rate-corrected QT intervals (QTc), QTc prolongation might be indicative of a poor prognosis for patients exposed to organophosphates. . Methods: We analyzed the records of 118 patients who were referred to Chang Gung Memorial Hospital for management of organophosphate poisoning between 2000 and 2011. Patients were grouped according to their initial QTc interval, i.e., normal (<0.44 s) or prolonged (<0.44 s). Demographic, clinical, laboratory, and mortality data were obtained for analysis. Results: The incidence of hypotension in patients with prolonged QTc intervals was higher than that in the patients with normal QTc intervals (P = 0.019). By the end of the study, 18 of 118 (15.2%) patients had died, including 3 of 75 (4.0%) patients with normal QTc intervals and 15 of 43 (34.9%) patients with prolonged QTc intervals. Using multivariate-Cox-regression analysis, we found that hypotension (OR = 10.930, 95% CI = 2.961-40.345, P = 0.000), respiratory failure (OR = 4.867, 95% CI = 1.062-22.301, P = 0.042), coma (OR = 3.482, 95% CI = 1.184-10.238, P = 0.023), and QTc prolongation (OR = 7.459, 95% CI = 2.053-27.099, P = 0.002) were significant risk factors for mortality. Furthermore, it was revealed that non-survivors not only had longer QTc interval (503.00 +/- 41.56 versus 432.71 +/- 51.21 ms, P = 0.002), but also suffered higher incidences of hypotension (83.3 versus 12.0%, P = 0.000), shortness of breath (64 versus 94.4%, P = 0.010), bronchorrhea (55 versus 94.4%, P = 0.002), bronchospasm (50.0 versus 94.4%, P = 0.000), respiratory failure (94.4 versus 43.0%, P = 0.000) and coma (66.7 versus 11.0%, P = 0.000) than survivors. Finally, Kaplan-Meier analysis demonstrated that cumulative mortality was higher among patients with prolonged QTc intervals than among those with normal QTc intervals (Log-rank test, Chi-square test = 20.36, P<0.001). Conclusions: QTc interval helps predict mortality after intentional organophosphate poisoning.	[Liu, Shou-Hsuan] Chang Gung Univ, Chang Gung Mem Hosp, Dept Nephrol, Div Clin Toxicol, Taipei, Taiwan; Chang Gung Univ, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Liu, SH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Nephrol, Div Clin Toxicol, Taipei, Taiwan.	m19570@adm.cgmh.org.tw	huang, wen/GXW-0661-2022; Yen, Tzung-Hai/AAQ-4525-2020	Yen, Tzung-Hai/0000-0002-0907-1505; YANG, HUANG-YU/0000-0001-6826-9717				Akdur O, 2010, HUM EXP TOXICOL, V29, P419, DOI 10.1177/0960327110364640; Anand S, 2009, CLIN TOXICOL, V47, P230, DOI 10.1080/15563650902724813; Antonijevic B, 2007, CLIN MED RES, V5, P71, DOI 10.3121/cmr.2007.701; Bar-Meir E, 2007, CRIT REV TOXICOL, V37, P279, DOI 10.1080/10408440601177855; Baydin A, 2007, INT J CLIN PRACT, V61, P927, DOI 10.1111/j.1742-1241.2006.00931.x; BURNS TR, 1990, MODERN PATHOL, V3, P336; CAPASSO JM, 1983, AM J PHYSIOL, V245, pH72, DOI 10.1152/ajpheart.1983.245.1.H72; Chuang FR, 1996, AM J EMERG MED, V14, P451, DOI 10.1016/S0735-6757(96)90148-5; Foroughi Mahnoosh, 2009, Asian Cardiovasc Thorac Ann, V17, P604, DOI 10.1177/0218492309349068; Gaspari RJ, 2009, NEUROTOXICOLOGY, V30, P298, DOI 10.1016/j.neuro.2009.01.006; Hage FG, 2010, CLIN CARDIOL, V33, P361, DOI 10.1002/clc.20768; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Kamanyire R, 2004, OCCUP MED-OXFORD, V54, P69, DOI 10.1093/occmed/kqh018; Kosar F, 2007, ANGIOLOGY, V58, P218, DOI 10.1177/0003319707300368; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; Lin TJ, 2008, CLIN TOXICOL, V46, P794, DOI 10.1080/15563650801986695; LUDOMIRSKY A, 1982, AM J CARDIOL, V49, P1654, DOI 10.1016/0002-9149(82)90242-9; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; PFEIFER MA, 1983, AM J MED, V75, P249, DOI 10.1016/0002-9343(83)91201-9; Rossing P, 2001, DIABETIC MED, V18, P199, DOI 10.1046/j.1464-5491.2001.00446.x; Shadnia S, 2009, J MED TOXICOL, V5, P196, DOI 10.1007/BF03178266; Shantsila E, 2007, EUROPACE, V9, P37, DOI 10.1093/europace/eum169; Sicouri S, 2008, EXPERT OPIN DRUG SAF, V7, P181, DOI [10.1517/14740338.7.2.181, 10.1517/14740338.7.2.181 ]; Stead LG, 2009, J STROKE CEREBROVASC, V18, P469, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.006; Steinberg DH, 2010, EUR HEART J SUPPL, V12, pE2, DOI 10.1093/eurheartj/suq012; Su HM, 2006, AGE AGEING, V35, P636, DOI 10.1093/ageing/afl114; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5; Vijayakumar S, 2011, CARDIOVASC TOXICOL, V11, P113, DOI 10.1007/s12012-011-9104-4; WHO, 2009, WHO REC CLASS PEST H; Yurumez Y, 2009, J EMERG MED, V36, P39, DOI 10.1016/j.jemermed.2007.08.063; Zhang YY, 2011, ARCH INTERN MED, V171, P1727, DOI 10.1001/archinternmed.2011.433; Zulli R, 2006, INTERN EMERG MED, V1, P279, DOI 10.1007/BF02934761	33	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36576	10.1371/journal.pone.0036576	http://dx.doi.org/10.1371/journal.pone.0036576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574184	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800081
J	Reznichenko, A; Snieder, H; van den Born, J; de Borst, MH; Damman, J; van Dijk, MCRF; van Goor, H; Hepkema, BG; Hillebrands, JL; Leuvenink, HGD; Niesing, J; Bakker, SJL; Seelen, M; Navis, G				Reznichenko, Anna; Snieder, Harold; van den Born, Jacob; de Borst, Martin H.; Damman, Jeffrey; van Dijk, Marcory C. R. F.; van Goor, Harry; Hepkema, Bouke G.; Hillebrands, Jan-Luuk; Leuvenink, Henri G. D.; Niesing, Jan; Bakker, Stephan J. L.; Seelen, Marc; Navis, Gerjan		REGaTTA REnal GeneTics TrAnsplanta	CUBN as a Novel Locus for End-Stage Renal Disease: Insights from Renal Transplantation	PLOS ONE			English	Article							ASSOCIATION; TOOL; SET	Chronic kidney disease (CKD) is a complex disorder. As genome-wide association studies identified cubilin gene CUBN as a locus for albuminuria, and urinary protein loss is a risk factor for progressive CKD, we tested the hypothesis that common genetic variants in CUBN are associated with end-stage renal disease (ESRD) and proteinuria. First, a total of 1142 patients with ESRD, admitted for renal transplantation, and 1186 donors were genotyped for SNPs rs7918972 and rs1801239 (case-control study). The rs7918972 minor allele frequency (MAF) was higher in ESRD patients comparing to kidney donors, implicating an increased risk for ESRD (OR 1.39, p = 0.0004) in native kidneys. Second, after transplantation recipients were followed for 5.8 [3.8-9.2] years (longitudinal study) documenting ESRD in transplanted kidneys - graft failure (GF). During post-transplant follow-up 92 (9.6%) cases of death-censored GF occurred. Donor rs7918972 MAF, representing genotype of the transplanted kidney, was 16.3% in GF vs 10.7% in cases with functioning graft. Consistently, a multivariate Cox regression analysis showed that donor rs7918972 is a predictor of GF, although statistical significance was not reached (HR 1.53, p = 0.055). There was no association of recipient rs7918972 with GF. Rs1801239 was not associated with ESRD or GF. In line with an association with the outcome, donor rs7918972 was associated with elevated proteinuria levels cross-sectionally at 1 year after transplantation. Thus, we identified CUBN rs7918972 as a novel risk variant for renal function loss in two independent settings: ESRD in native kidneys and GF in transplanted kidneys.	[Reznichenko, Anna; van den Born, Jacob; de Borst, Martin H.; Bakker, Stephan J. L.; Seelen, Marc; Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Damman, Jeffrey; Leuvenink, Henri G. D.; Niesing, Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [van Dijk, Marcory C. R. F.; van Goor, Harry; Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Hepkema, Bouke G.] Univ Groningen, Univ Med Ctr Groningen, Dept Transplant Immunol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Reznichenko, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands.	a.reznichenko@umcg.nl	Bakker, Stephan J. L./J-4023-2015; van+Goor, Harry/AAS-7712-2020	Bakker, Stephan J. L./0000-0003-3356-6791; Leuvenink, Henri/0000-0001-5036-2999; Hillebrands, Jan-Luuk/0000-0003-3135-3274; De Borst, Martin/0000-0002-4127-8733; van Goor, Harry/0000-0002-6670-1577	GENECURE grant [EU_FP-6037697]	GENECURE grant	Funding was provided by GENECURE grant EU_FP-6037697. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Boger CA, 2011, KIDNEY BLOOD PRESS R, V34, P225, DOI 10.1159/000326901; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Broekroelofs J, 1998, J AM SOC NEPHROL, V9, P2075; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Grasbeck R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-17; Hollenberg Norman K, 2003, Curr Hypertens Rep, V5, P356; Hunter DJ, 2002, CLIN SCI, V103, P259, DOI 10.1042/cs1030259; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kottgen A, 2010, AM J KIDNEY DIS, V56, P743, DOI 10.1053/j.ajkd.2010.05.018; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Ovunc B, 2011, J AM SOC NEPHROL, V22, P1815, DOI 10.1681/ASN.2011040337; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382	15	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36512	10.1371/journal.pone.0036512	http://dx.doi.org/10.1371/journal.pone.0036512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574174	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800071
J	Sabbagh, SC; Lepage, C; McClelland, M; Daigle, F				Sabbagh, Sebastien C.; Lepage, Christine; McClelland, Michael; Daigle, France			Selection of Salmonella enterica Serovar Typhi Genes Involved during Interaction with Human Macrophages by Screening of a Transposon Mutant Library	PLOS ONE			English	Article							III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; HELICOBACTER-PYLORI UREASE; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; INTRACELLULAR SURVIVAL; ANTIBIOTIC-RESISTANCE; BACTERIAL VIRULENCE; PROTEIN ANTIGENS; CANNOT SURVIVE	The human-adapted Salmonella enterica serovar Typhi (S. Typhi) causes a systemic infection known as typhoid fever. This disease relies on the ability of the bacterium to survive within macrophages. In order to identify genes involved during interaction with macrophages, a pool of approximately 10(5) transposon mutants of S. Typhi was subjected to three serial passages of 24 hours through human macrophages. Mutants recovered from infected macrophages ( output) were compared to the initial pool (input) and those significantly underrepresented resulted in the identification of 130 genes encoding for cell membrane components, fimbriae, flagella, regulatory processes, pathogenesis, and many genes of unknown function. Defined deletions in 28 genes or gene clusters were created and mutants were evaluated in competitive and individual infection assays for uptake and intracellular survival during interaction with human macrophages. Overall, 26 mutants had defects in the competitive assay and 14 mutants had defects in the individual assay. Twelve mutants had defects in both assays, including acrA, exbDB, flhCD, fliC, gppA, mlc, pgtE, typA, waaQGP, SPI-4, STY1867-68, and STY2346. The complementation of several mutants by expression of plasmid-borne wild-type genes or gene clusters reversed defects, confirming that the phenotypic impairments within macrophages were gene-specific. In this study, 35 novel phenotypes of either uptake or intracellular survival in macrophages were associated with Salmonella genes. Moreover, these results reveal several genes encoding molecular mechanisms not previously known to be involved in systemic infection by human-adapted typhoidal Salmonella that will need to be elucidated.	[Sabbagh, Sebastien C.; Lepage, Christine; Daigle, France] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [McClelland, Michael] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92717 USA	Universite de Montreal; University of California System; University of California Irvine	Sabbagh, SC (corresponding author), Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada.	france.daigle@umontreal.ca		McClelland, Michael/0000-0003-1788-9347; Daigle, France/0000-0001-6847-4729	Canadian Natural Sciences and Engineering Research Council (NSERC) [251114-06]; NSERC; Fonds de la Recherche en Sante du Quebec (FRSQ); Centre de Recherche en Infectiologie Porcine(CRIP)	Canadian Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Centre de Recherche en Infectiologie Porcine(CRIP)	The work described in this manuscript was supported by the Canadian Natural Sciences and Engineering Research Council (NSERC) grant number 251114-06. SCS was supported by scholarships from NSERC and the Fonds de la Recherche en Sante du Quebec (FRSQ). CL was supported by a scholarship from the Centre de Recherche en Infectiologie Porcine(CRIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abromaitis S, 2005, FEMS MICROBIOL LETT, V242, P305, DOI 10.1016/j.femsle.2004.11.024; Angelakopoulos H, 2000, INFECT IMMUN, V68, P2135, DOI 10.1128/IAI.68.4.2135-2141.2000; Barker HC, 2000, MOL MICROBIOL, V35, P1518, DOI 10.1046/j.1365-2958.2000.01820.x; Basso H, 2002, INFECT IMMUN, V70, P5404, DOI 10.1128/IAI.70.10.5404-5411.2002; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; BEAMAN L, 1984, ANNU REV MICROBIOL, V38, P27; Beckering CL, 2002, J BACTERIOL, V184, P6395, DOI 10.1128/JB.184.22.6395-6402.2002; Blair JMA, 2009, J ANTIMICROB CHEMOTH, V64, P965, DOI 10.1093/jac/dkp311; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Chan K, 2005, INFECT IMMUN, V73, P5438, DOI 10.1128/IAI.73.9.5438-5449.2005; Charles RC, 2010, CLIN VACCINE IMMUNOL, V17, P1188, DOI 10.1128/CVI.00104-10; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; CREEGER ES, 1979, J BIOL CHEM, V254, P804; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; DiPetrillo MD, 1999, VACCINE, V18, P449, DOI 10.1016/S0264-410X(99)00246-7; DRAGUNSKY EM, 1990, VACCINE, V8, P263, DOI 10.1016/0264-410X(90)90056-R; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P1145, DOI 10.1128/AAC.48.4.1145-1150.2004; Farris M, 1998, MOL MICROBIOL, V28, P265, DOI 10.1046/j.1365-2958.1998.00793.x; Faucher SP, 2009, MICROBIOL-SGM, V155, P477, DOI 10.1099/mic.0.022988-0; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Forest CG, 2010, MICROBIOL-SGM, V156, P3689, DOI 10.1099/mic.0.041624-0; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Garvis SG, 2001, CELL MICROBIOL, V3, P731, DOI 10.1046/j.1462-5822.2001.00153.x; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; Grant AJ, 2001, GENE, V280, P145, DOI 10.1016/S0378-1119(01)00769-7; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Guzman CA, 2006, VACCINE, V24, P3804, DOI 10.1016/j.vaccine.2005.07.111; Haneda T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-324; HARA A, 1983, J BIOL CHEM, V258, P1678; Harris JB, 2006, INFECT IMMUN, V74, P5161, DOI 10.1128/IAI.00488-06; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002; Hoare A, 2006, INFECT IMMUN, V74, P1555, DOI 10.1128/IAI.74.3.1555-1564.2006; HONE DM, 1988, INFECT IMMUN, V56, P1326, DOI 10.1128/IAI.56.5.1326-1333.1988; HONE DM, 1991, VACCINE, V9, P810, DOI 10.1016/0264-410X(91)90218-U; Hu Y, 2009, SCI CHINA SER C, V52, P942, DOI 10.1007/s11427-009-0127-z; Jeong JH, 2008, J BACTERIOL, V190, P6340, DOI 10.1128/JB.00385-08; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; KEASLING JD, 1993, P NATL ACAD SCI USA, V90, P7029, DOI 10.1073/pnas.90.15.7029; Kim JS, 2011, INFECT IMMUN, V79, P1440, DOI 10.1128/IAI.01231-10; Kimata K, 1998, MOL MICROBIOL, V29, P1509, DOI 10.1046/j.1365-2958.1998.01035.x; Kitagawa R, 2010, J BACTERIOL, V192, P5645, DOI 10.1128/JB.00590-10; Kong QK, 2011, INFECT IMMUN, V79, P4227, DOI 10.1128/IAI.05398-11; Lahteenmaki K, 2005, CELL MICROBIOL, V7, P529, DOI 10.1111/j.1462-5822.2004.00483.x; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Libby SJ, 2010, P NATL ACAD SCI USA, V107, P15589, DOI 10.1073/pnas.1005566107; LIU SL, 1988, INFECT IMMUN, V56, P1967, DOI 10.1128/IAI.56.8.1967-1973.1988; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Merighi M, 2006, J BACTERIOL, V188, P141, DOI 10.1128/JB.188.1.141-149.2006; Merighi M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-42; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Morgan E, 2007, INFECT IMMUN, V75, P1524, DOI 10.1128/IAI.01438-06; Nagy G, 2006, INFECT IMMUN, V74, P5914, DOI 10.1128/IAI.00619-06; OCALLAGHAN D, 1990, MOL GEN GENET, V223, P156, DOI 10.1007/BF00315809; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Parker CT, 2001, FEMS MICROBIOL LETT, V204, P287, DOI 10.1111/j.1574-6968.2001.tb10899.x; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2008, CURR OPIN INFECT DIS, V21, P531, DOI 10.1097/QCO.0b013e32830f453a; Pfennig PL, 2001, MOL GENET GENOMICS, V266, P313, DOI 10.1007/s004380100559; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; Porwollik S, 2003, NUCLEIC ACIDS RES, V31, P1869, DOI 10.1093/nar/gkg298; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Reva ON, 2006, J BACTERIOL, V188, P4079, DOI 10.1128/JB.00101-06; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; SAMBROOK J, 1989, MOLE CLONING LAB MAN; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; Stepanova H, 2011, FEMS MICROBIOL LETT, V321, P37, DOI 10.1111/j.1574-6968.2011.02305.x; TACKET CO, 1992, INFECT IMMUN, V60, P536, DOI 10.1128/IAI.60.2.536-541.1992; TACKET CO, 1992, VACCINE, V10, P443, DOI 10.1016/0264-410X(92)90392-W; Tamayo R, 2005, FEMS IMMUNOL MED MIC, V43, P249, DOI 10.1016/j.femsim.2004.08.007; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09; Xia XQ, 2009, BIOINFORMATICS, V25, P2425, DOI 10.1093/bioinformatics/btp430; Yu EW, 2003, J BACTERIOL, V185, P5657, DOI 10.1128/JB.185.19.5657-5664.2003; Zenk SF, 2009, J IMMUNOL, V183, P2697, DOI 10.4049/jimmunol.0900937; Zhao YX, 2002, INFECT IMMUN, V70, P5319, DOI 10.1128/IAI.70.9.5319-5321.2002	99	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36643	10.1371/journal.pone.0036643	http://dx.doi.org/10.1371/journal.pone.0036643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574205	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800102
J	Yiu, KH; Atsma, DE; Delgado, V; Ng, ACT; Witkowski, TG; Ewe, SH; Auger, D; Holman, ER; van Mil, AM; Breuning, MH; Tse, HF; Bax, JJ; Schalij, MJ; Marsan, NA				Yiu, Kai Hang; Atsma, Douwe E.; Delgado, Victoria; Ng, Arnold C. T.; Witkowski, Tomasz G.; Ewe, See Hooi; Auger, Dominique; Holman, Eduard R.; van Mil, Anneke M.; Breuning, Martijn H.; Tse, Hung Fat; Bax, Jeroen J.; Schalij, Martin J.; Marsan, Nina Ajmone			Myocardial Structural Alteration and Systolic Dysfunction in Preclinical Hypertrophic Cardiomyopathy Mutation Carriers	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; STANDARDS COMMITTEE; RISK STRATIFICATION; MAGNETIC-RESONANCE; DIASTOLIC FUNCTION; TASK-FORCE; ABNORMALITIES; TISSUE; ECHOCARDIOGRAPHY; DIAGNOSIS	Background: To evaluate the presence of myocardial structural alterations and subtle myocardial dysfunction during familial screening in asymptomatic mutation carriers without hypertrophic cardiomyopathy (HCM) phenotype. Methods and Findings: Sixteen HCM families with pathogenic mutation were studied and 46 patients with phenotype expression (Mut+/Phen+) and 47 patients without phenotype expression (Mut+/Phen-) were observed. Twenty-five control subjects, matched with the Mut+/Phen- group, were recruited for comparison. Echocardiography was performed to evaluate conventional parameters, myocardial structural alteration by calibrated integrated backscatter (cIBS) and global and segmental longitudinal strain by speckle tracking analysis. All 3 groups had similar left ventricular dimensions and ejection fraction. Basal anteroseptal cIBS was the highest in Mut+/Phen+ patients (-14.0+/-4.6 dB, p<0.01) and was higher in Mut+/Phen- patients as compared to controls (-17.0+/-2.3 vs. -22.6+/-2.9 dB, p<0.01) suggesting significant myocardial structural alterations. Global and basal anteroseptal longitudinal strains (-8.4+/-4.0%, p<0.01) were the most impaired in Mut+/Phen+ patients as compared to the other 2 groups. Although global longitudinal strain was similar between Mut+/Phen- group and controls, basal anteroseptal strain was lower in Mut+/Phen- patients (-14.1+/-3.8%, p<0.01) as compared to controls (-19.9+/-2.9%, p<0.01), suggesting a subclinical segmental systolic dysfunction. A combination of >-19.0 dB basal anteroseptal cIBS or >-18.0% basal anteroseptal longitudinal strain had a sensitivity of 98% and a specificity of 72% in differentiating Mut+/Phen- group from controls. Conclusion: The use of cIBS and segmental longitudinal strain can differentiate HCM Mut+/Phen- patients from controls with important clinical implications for the family screening and follow-up of these patients.	[Yiu, Kai Hang; Atsma, Douwe E.; Delgado, Victoria; Ng, Arnold C. T.; Witkowski, Tomasz G.; Ewe, See Hooi; Auger, Dominique; Holman, Eduard R.; Bax, Jeroen J.; Schalij, Martin J.; Marsan, Nina Ajmone] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Yiu, Kai Hang; Tse, Hung Fat] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Yiu, Kai Hang; Marsan, Nina Ajmone] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [van Mil, Anneke M.; Breuning, Martijn H.] Leiden Univ, Med Ctr, Dept Human & Clin Genet, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Hong Kong; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Yiu, KH (corresponding author), Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands.	n.ajmone@lumc.nl	ajmone marsan, nina/AAJ-8108-2021; Tse, Hung-Fat/C-4426-2009; Delgado, Victoria/AAL-4731-2021; Yiu, Kai Hang/AAI-2879-2021; Auger, Dominique/AAG-3819-2020; /D-1427-2011	ajmone marsan, nina/0000-0001-7208-5769; Tse, Hung-Fat/0000-0002-9578-7808; Delgado, Victoria/0000-0002-9841-2737; /0000-0003-2145-3108; Ng, Arnold/0000-0002-1925-9958; Witkowski, Tomasz/0000-0002-9383-4578	Hong Kong Heart Foundation; Biotronik; Medtronic; Boston Scientific Corporation; Lantheus Medical Imaging; St Jude Medical; GE Healthcare; Edwards Lifesciences	Hong Kong Heart Foundation; Biotronik; Medtronic(Medtronic); Boston Scientific Corporation(Boston Scientific); Lantheus Medical Imaging; St Jude Medical(St. Jude Medical); GE Healthcare(General ElectricGE Healthcare); Edwards Lifesciences	Kai Hang Yiu is financially supported by a research grant from the Hong Kong Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to disclose the following conflicts of interest: The Department of Cardiology of Leiden University Medical Centre received research grants from Biotronik, Medtronic, Boston Scientific Corporation, Lantheus Medical Imaging, St Jude Medical, GE Healthcare, and Edwards Lifesciences. Dr Victoria Delgado received consultant fees from St Jude Medical. The remaining authors have no financial or other conflicts of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alders M, 2003, EUR HEART J, V24, P1848, DOI 10.1016/S0195-668X(03)00466-4; Bertini M, 2010, CIRC-CARDIOVASC IMAG, V3, P86, DOI 10.1161/CIRCIMAGING.109.882324; Christiaans I, 2011, EUR HEART J, V32, P1161, DOI 10.1093/eurheartj/ehr092; Christiaans I, 2010, EUR HEART J, V31, P842, DOI 10.1093/eurheartj/ehp539; Delgado V, 2008, J AM COLL CARDIOL, V51, P1944, DOI 10.1016/j.jacc.2008.02.040; Germans T, 2006, J AM COLL CARDIOL, V48, P2518, DOI 10.1016/j.jacc.2006.08.036; Gersh BJ, 2011, CIRCULATION, V124, pE783, DOI 10.1161/CIR.0b013e318223e2bd; Ghio S, 2009, EUR J HEART FAIL, V11, P952, DOI 10.1093/eurjhf/hfp122; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Ho CY, 2009, CIRC-CARDIOVASC GENE, V2, P314, DOI 10.1161/CIRCGENETICS.109.862128; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; KLUES HG, 1995, J AM COLL CARDIOL, V26, P1699, DOI 10.1016/0735-1097(95)00390-8; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; MADARAS EI, 1988, J ACOUST SOC AM, V83, P762, DOI 10.1121/1.396119; Marian AJ, 2000, LANCET, V355, P58, DOI 10.1016/S0140-6736(99)06187-5; Maron BJ, 2004, J AM COLL CARDIOL, V44, P2125, DOI 10.1016/j.jacc.2004.08.052; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron MS, 2009, J AM COLL CARDIOL, V54, P220, DOI 10.1016/j.jacc.2009.05.006; McKenna WJ, 1997, HEART, V77, P130, DOI 10.1136/hrt.77.2.130; Michels M, 2009, EUR HEART J, V30, P2593, DOI 10.1093/eurheartj/ehp306; Michels M, 2009, JACC-CARDIOVASC IMAG, V2, P58, DOI 10.1016/j.jcmg.2008.08.003; Mizuno R, 2001, CARDIOLOGY, V96, P16, DOI 10.1159/000047381; MOTTLEY JG, 1988, J ACOUST SOC AM, V83, P755, DOI 10.1121/1.396118; Nagueh SF, 2003, CIRCULATION, V108, P395, DOI 10.1161/01.CIR.0000084500.72232.8D; Nagueh SF, 2001, CIRCULATION, V104, P128, DOI 10.1161/01.CIR.104.2.128; Nagueh SF, 1999, CIRCULATION, V99, P254, DOI 10.1161/01.CIR.99.2.254; Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Russel IK, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-3; Smedema JP, 2005, J AM COLL CARDIOL, V45, P1683, DOI 10.1016/j.jacc.2005.01.047	31	30	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36115	10.1371/journal.pone.0036115	http://dx.doi.org/10.1371/journal.pone.0036115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574137	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800033
J	de Silva, S; Planelles, V; Wu, L				de Silva, Suresh; Planelles, Vicente; Wu, Li			Differential Effects of Vpr on Single-cycle and Spreading HIV-1 Infections in CD4(+) T-cells and Dendritic Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL PROTEIN-R; MACROPHAGE INFECTION; NONDIVIDING CELLS; MUTATIONAL ANALYSIS; MYELOID CELLS; IN-VIVO; TRANSMISSION; REPLICATION; ACTIVATION	The Vpr protein of human immunodeficiency virus type 1 (HIV-1) contributes to viral replication in non-dividing cells, specifically those of the myeloid lineage. However, the effects of Vpr in enhancing HIV-1 infection in dendritic cells have not been extensively investigated. Here, we evaluated the role of Vpr during infection of highly permissive peripheral blood mononuclear cells (PBMCs) and CD4(+) T-cells and compared it to that of monocyte-derived dendritic cells (MDDCs), which are less susceptible to HIV-1 infection. Infections of dividing PBMCs and non-dividing MDDCs were carried out with single-cycle and replication-competent HIV-1 encoding intact Vpr or Vpr-defective mutants. In contrast to previous findings, we observed that single-cycle HIV-1 infection of both PBMCs and MDDCs was significantly enhanced in the presence of Vpr when the viral stocks were carefully characterized and titrated. HIV-1 DNA quantification revealed that Vpr only enhanced the reverse transcription and nuclear import processes in single-cycle HIV-1 infected MDDCs, but not in CD4(+) T-cells. However, a significant enhancement in HIV-1 gag mRNA expression was observed in both CD4(+) T-cells and MDDCs in the presence of Vpr. Furthermore, Vpr complementation into HIV-1 virions did not affect single-cycle viral infection of MDDCs, suggesting that newly synthesized Vpr plays a significant role to facilitate single-cycle HIV-1 infection. Over the course of a spreading infection, Vpr significantly enhanced replication-competent HIV-1 infection in MDDCs, while it modestly promoted viral infection in activated PBMCs. Quantification of viral DNA in replication-competent HIV-1 infected PBMCs and MDDCs revealed similar levels of reverse transcription products, but increased nuclear import in the presence of Vpr independent of the cell types. Taken together, our results suggest that Vpr has differential effects on single-cycle and spreading HIV-1 infections, which are dependent on the permissiveness of the target cell.	[de Silva, Suresh; Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA; [Planelles, Vicente] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT USA	University System of Ohio; Ohio State University; Utah System of Higher Education; University of Utah	de Silva, S (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487	NIH [AI068493, AI078762, AI098524]; Public Health Preparedness for Infectious Diseases of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098524, R21AI078762, R21AI102822, R01AI068493] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Preparedness for Infectious Diseases of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (AI068493) to L. W. from the NIH and by the program of Public Health Preparedness for Infectious Diseases of The Ohio State University. L. W. and S. D. were supported in part by grants AI078762 and AI098524 to L. W. from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini I, 1996, J MOL BIOL, V261, P599, DOI 10.1006/jmbi.1996.0485; Andersen JL, 2005, CURR HIV RES, V3, P43, DOI 10.2174/1570162052772988; Ao Z, 2004, J VIROL, V78, P3170, DOI 10.1128/JVI.78.6.3170-3177.2004; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Cecilia D, 1998, J VIROL, V72, P6988, DOI 10.1128/JVI.72.9.6988-6996.1998; Coleman CM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-26; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DEDERA D, 1989, J VIROL, V63, P3205, DOI 10.1128/JVI.63.7.3205-3208.1989; DeHart JL, 2008, J VIROL, V82, P1066, DOI 10.1128/JVI.01628-07; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Gummuluru S, 1999, J VIROL, V73, P5422, DOI 10.1128/JVI.73.7.5422-5430.1999; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Janas Alicia M, 2009, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2605s43; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Majumder B, 2005, J VIROL, V79, P7990, DOI 10.1128/JVI.79.13.7990-8003.2005; Majumder B, 2009, CURR HIV RES, V7, P169, DOI 10.2174/157016209787581445; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; PLANELLES V, 1995, J VIROL, V69, P5883, DOI 10.1128/JVI.69.9.5883-5889.1995; Planelles V, 2011, VIRUSES-BASEL, V3, P1624, DOI 10.3390/v3091624; Planelles V, 2009, CURR TOP MICROBIOL, V339, P177, DOI 10.1007/978-3-642-02175-6_9; Rey F, 1998, J GEN VIROL, V79, P1083, DOI 10.1099/0022-1317-79-5-1083; Riviere L, 2010, J VIROL, V84, P729, DOI 10.1128/JVI.01952-09; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; SCHWARTZ S, 1991, VIROLOGY, V183, P677, DOI 10.1016/0042-6822(91)90996-O; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; St Gelais C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-55; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Wang JH, 2007, J VIROL, V81, P2497, DOI 10.1128/JVI.01970-06; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2005, PLOS PATHOG, V1, P170, DOI 10.1371/journal.ppat.0010018; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09; Zhu YH, 2001, J VIROL, V75, P3791, DOI 10.1128/JVI.75.8.3791-3801.2001	53	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35385	10.1371/journal.pone.0035385	http://dx.doi.org/10.1371/journal.pone.0035385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570689	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343400005
J	Yu, ZP; Fan, DS; Gui, B; Shi, L; Xuan, CH; Shan, L; Wang, Q; Shang, YF; Wang, Y				Yu, Zhipeng; Fan, Dongsheng; Gui, Bin; Shi, Lei; Xuan, Chenghao; Shan, Lin; Wang, Qian; Shang, Yongfeng; Wang, Yan			Neurodegeneration-associated TDP-43 Interacts with Fragile X Mental Retardation Protein (FMRP)/Staufen (STAU1) and Regulates SIRT1 Expression in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; DNA-BINDING PROTEIN; FRONTOTEMPORAL LOBAR DEGENERATION; MESSENGER-RNA TRANSPORT; FUNCTIONAL IMPLICATIONS; TRANSCRIPTION FACTORS; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; TARDBP MUTATIONS	Despite the identification of the 43 kDa transactive response DNA- binding protein (TDP-43) as a major pathological signatory protein in a wide range of neurodegenerative diseases, the mechanistic role of TDP-43 in neurodegenerative disorders is still poorly understood. Here, we report that TDP-43 is physically associated with fragile X mental retardation protein (FMRP) and Staufen (STAU1) to form a functional complex. Differential microarray analysis revealed that the expression of a collection of functionally important genes including Sirtuin (SIRT1) is regulated by this complex. RNA-immunoprecipitation (RIP) and RNA pull-down assays demonstrated that TDP43/FMRP/STAU1 specifically binds to the 3'-UTR of SIRT1 mRNA, and that knockdown the expression of any one of these three proteins resulted in the reduction of SIRT1 mRNA and protein. SIRT1 is implicated in double-stranded DNA break repair and is required for cell survival. Indeed, depletion of TDP-43/FMRP/STAU1 sensitizes cells to apoptosis and DNA damages. Collectively, our results revealed a molecular mechanism for the cellular function of TDP-43 and might shed new light on the understanding of the mechanistic role of TDP-43 in neurodegenerative diseases.	[Yu, Zhipeng; Fan, Dongsheng; Gui, Bin] Peking Univ, Hosp 3, Beijing 100191, Peoples R China; [Shi, Lei; Xuan, Chenghao; Shan, Lin; Wang, Qian; Shang, Yongfeng; Wang, Yan] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Fan, DS (corresponding author), 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	fandongshengls@126.com; yanwang@tmu.edu.cn			National Natural Science Foundation of China [90919053, 31171240, 81030019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 90919053 and 31171240 (to Y. W.) and 81030019 (to D. F.) from the National Natural Science Foundation of China.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Barmada SJ, 2010, REV NEUROSCIENCE, V21, P251; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Cook C, 2008, EXPERT OPIN BIOL TH, V8, P969, DOI 10.1517/14712598.8.7.969 ; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; DUBERLEY RM, 1995, J NEUROL SCI, V129, P109, DOI 10.1016/0022-510X(95)00079-H; Fiesel FC, 2011, FEBS J, V278, P3550, DOI 10.1111/j.1742-4658.2011.08258.x; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HSIANG YH, 1989, CANCER RES, V49, P5077; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Kiebler MA, 2000, NEURON, V25, P19, DOI 10.1016/S0896-6273(00)80868-5; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Montie HL, 2011, J NEUROSCI, V31, P17425, DOI 10.1523/JNEUROSCI.3958-11.2011; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tosar Leandro Julian Martinez, 2012, Front Biosci (Schol Ed), V4, P432; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893	65	41	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22560	22572		10.1074/jbc.M112.357582	http://dx.doi.org/10.1074/jbc.M112.357582			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584570	Green Published, hybrid			2022-12-25	WOS:000306495000013
J	Bai, XY; Meng, G; Luo, M; Zheng, XF				Bai, Xiaoyun; Meng, Geng; Luo, Ming; Zheng, Xiaofeng			Rigidity of Wedge Loop in PACSIN 3 Protein Is a Key Factor in Dictating Diameters of Tubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE INVAGINATION; BAR DOMAINS; SYNDAPIN-II; CURVATURE; DYNAMIN; AMPHIPHYSIN; RECRUITMENT; MECHANISM; BIND; PITS	BAR (Bin/amphiphysin/Rvs) domain-containing proteins participate in cellular membrane remodeling. The F-BAR proteins normally generate low curvature tubules. However, in the PACSIN subfamily, the F-BAR domain from PACSIN 1 and 2 can induce both high and low curvature tubules. We found that unlike PACSIN 1 and 2, PACSIN 3 could only induce low curvature tubules. To elucidate the key factors that dictate the tubule curvature, crystal structures of all three PACSIN F-BAR domains were determined. A novel type of lateral interaction mediated by a wedge loop is observed between the F-BAR neighboring dimers. Comparisons of the structures of PACSIN 3 with PACSIN 1 and 2 indicate that the wedge loop of PACSIN 3 is more rigid, which influences the lateral interactions between assembled dimers. We further identified the residues that affect the rigidity of the loop by mutagenesis and determined the structures of two PACSIN 3 wedge loop mutants. Our results suggest that the rigidity-mediated conformations of the wedge loop correlate well with the various crystal packing modes and membrane tubulations. Thus, the rigidity of the wedge loop is a key factor in dictating tubule diameters.	[Bai, Xiaoyun; Meng, Geng; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Bai, Xiaoyun; Meng, Geng; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Luo, Ming] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Peking University; Peking University; University of Alabama System; University of Alabama Birmingham	Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	Meng, Geng/ACY-1510-2022		National High Technology and Development Program of China [2010CB911804]; National Science Foundation of China [30930020]; International Centre for Genetic Engineering and Biotechnology [CRP/CHN09-01]	National High Technology and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Centre for Genetic Engineering and Biotechnology	This work was supported by National High Technology and Development Program of China Grant 2010CB911804, National Science Foundation of China Grant 30930020, and International Centre for Genetic Engineering and Biotechnology Project CRP/CHN09-01.	Bai XY, 2010, ACTA CRYSTALLOGR F, V66, P73, DOI 10.1107/S1744309109049549; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dvorak AM, 2001, J HISTOCHEM CYTOCHEM, V49, P419, DOI 10.1177/002215540104900401; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Futterer K, 2007, CELL, V129, P655, DOI 10.1016/j.cell.2007.05.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Grimm-Gunter EMS, 2008, EXP CELL RES, V314, P1991, DOI 10.1016/j.yexcr.2008.03.015; Halbach A, 2007, FEBS J, V274, P773, DOI 10.1111/j.1742-4658.2006.05622.x; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kessels MM, 2006, J CELL SCI, V119, P1504, DOI 10.1242/jcs.02877; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Modregger J, 2000, J CELL SCI, V113, P4511; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Plomann M, 2010, J MOL BIOL, V400, P129, DOI 10.1016/j.jmb.2010.05.008; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rippe B, 2002, J VASC RES, V39, P375, DOI 10.1159/000064521; Ritter B, 1999, FEBS LETT, V454, P356, DOI 10.1016/S0014-5793(99)00830-3; Scott IC, 2003, NATURE, V425, P461, DOI 10.1038/425461a; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shimada A, 2010, FEBS LETT, V584, P1111, DOI 10.1016/j.febslet.2010.02.058; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106	38	12	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22387	22396		10.1074/jbc.M112.358960	http://dx.doi.org/10.1074/jbc.M112.358960			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573331	hybrid, Green Published			2022-12-25	WOS:000306418600075
J	Hughes, RM; Vrana, JD; Song, JQ; Tucker, CL				Hughes, Robert M.; Vrana, Justin D.; Song, Junqi; Tucker, Chandra L.			Light-dependent, Dark-promoted Interaction between Arabidopsis Cryptochrome 1 and Phytochrome B Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT; FUNCTIONAL INTERACTION; FLORAL INITIATION; COP1 ACTIVITY; NUCLEAR; SPA1; PHOTOMORPHOGENESIS; PHOTORECEPTOR; TRANSCRIPTION; SYNERGISM	Plant photoreceptors transduce environmental light cues to downstream signaling pathways, regulating a wide array of processes during growth and development. Two major plant photoreceptors with critical roles in photomorphogenesis are phytochrome B (phyB), a red/far-red absorbing photoreceptor, and cryptochrome 1 (CRY1), a UV-A/blue photoreceptor. Despite substantial genetic evidence for cross-talk between phyB and CRY1 pathways, a direct interaction between these proteins has not been observed. Here, we report that Arabidopsis phyB interacts directly with CRY1 in a light-dependent interaction. Surprisingly, the interaction is light-dissociated; CRY1 interacts specifically with the dark/far-red (Pr) state of phyB, but not with the red light-activated (Pfr) or the chromophore unconjugated form of the enzyme. The interaction is also regulated by light activation of CRY1; phyB Pr interacts only with the unstimulated form of CRY1 but not with the photostimulated protein. Further studies reveal that a small domain extending from the photolyase homology region (PHR) of CRY1 regulates the specificity of the interaction with different conformational states of phyB. We hypothesize that in plants, the phyB/CRY1 interaction may mediate cross-talk between the red/far-red- and blue/UV-sensing pathways, enabling fine-tuning of light responses to different spectral inputs.	[Vrana, Justin D.; Tucker, Chandra L.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Hughes, Robert M.; Song, Junqi; Tucker, Chandra L.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University	Tucker, CL (corresponding author), Univ Colorado Denver, Dept Pharmacol, Mail Stop 8303, Aurora, CO 80045 USA.	chandra.tucker@ucdenver.edu	Tucker, Chandra/F-6842-2011; Song, Junqi/N-9219-2019	Song, Junqi/0000-0002-2555-3408; Tucker, Chandra/0000-0003-3033-1786; Hughes, Robert/0000-0002-4465-4212	National Institutes of Health [R01 GM100225]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM100225 (to C. L. T).	Ahmad M, 1997, PLANT J, V11, P421, DOI 10.1046/j.1365-313X.1997.11030421.x; Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; CASAL JJ, 1995, PLANTA, V197, P213; Casal JJ, 1998, PLANT PHYSIOL, V118, P19, DOI 10.1104/pp.118.1.19; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Castillon A, 2009, GENETICS, V182, P161, DOI 10.1534/genetics.108.099887; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Exner V, 2010, PLANT PHYSIOL, V154, P1633, DOI 10.1104/pp.110.160895; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Hennig L, 1999, PLANT J, V20, P289, DOI 10.1046/j.1365-313X.1999.t01-1-00599.x; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li Jigang, 2011, Arabidopsis Book, V9, pe0148, DOI 10.1199/tab.0148; LI LM, 1994, P NATL ACAD SCI USA, V91, P12535, DOI 10.1073/pnas.91.26.12535; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Lian HL, 2011, GENE DEV, V25, P1023, DOI 10.1101/gad.2025111; Liu B, 2011, GENE DEV, V25, P1029, DOI 10.1101/gad.2025011; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Meijer G, 1965, PHOTOCHEM PHOTOBIOL, V4, P251; Miller JH., 1972, EXPT MOL GENETICS; Mohr Hans, 1994, P353; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Sakamoto K, 1996, PLANT J, V10, P859, DOI 10.1046/j.1365-313X.1996.10050859.x; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Shin DH, 2010, J BIOL CHEM, V285, P32151, DOI 10.1074/jbc.M110.133710; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Toettcher JE, 2011, METHOD ENZYMOL, V497, P409, DOI 10.1016/B978-0-12-385075-1.00017-2; Tucker CL, 2009, GENETICS, V182, P1377, DOI 10.1534/genetics.109.103069; Usami T, 2004, PLANT CELL PHYSIOL, V45, P1798, DOI 10.1093/pcp/pch205; Usami T, 2007, PLANT CELL PHYSIOL, V48, P424, DOI 10.1093/pcp/pcm012; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu G, 2007, P NATL ACAD SCI USA, V104, P18813, DOI 10.1073/pnas.0705082104; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yu Xuhong, 2010, Arabidopsis Book, V8, pe0135, DOI 10.1199/tab.0135; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797; Zuo ZC, 2011, CURR BIOL, V21, P841, DOI 10.1016/j.cub.2011.03.048	51	28	36	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22165	22172		10.1074/jbc.M112.360545	http://dx.doi.org/10.1074/jbc.M112.360545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577138	Green Published, hybrid			2022-12-25	WOS:000306418600055
J	Kim, B; Nguyen, LA; Daddacha, W; Hollenbaugh, JA				Kim, Baek; Nguyen, Laura A.; Daddacha, Waaqo; Hollenbaugh, Joseph A.			Tight Interplay among SAMHD1 Protein Level, Cellular dNTP Levels, and HIV-1 Proviral DNA Synthesis Kinetics in Human Primary Monocyte-derived Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE MUTANT; RESTRICTION FACTOR SAMHD1; RIBONUCLEOTIDE REDUCTASE; DENDRITIC CELLS; VPX; REPLICATION; SUBSTRATE; TRIPHOSPHATES; MECHANISM	Recently, SAMHD1 has come under intense focus as a host anti-HIV factor. SAMHD1 is a dNTP triphosphohydrolase, which leads to the regulation of DNA metabolism in host cells. HIV-2/SIV (simian immunodeficiency virus) viral protein x (Vpx) has been shown to promote the degradation of SAMHD1. In this study, we examine the kinetics of SAMHD1 degradation, the increase in the dNTP pool level, and the efficiency of proviral DNA synthesis in Vpx+ virus-like particle (VLP)-treated monocyte-derived macrophages (MDMs). Our results indicate a very close temporal link with a reduction in SAMHD1 detected within the first few hours of Vpx+ VLP treatment. This loss of SAMHD1 is followed by a significant increase in cellular dNTP levels by 8 h after Vpx+ VLP addition, ultimately leading to the enhancement of the HIV proviral DNA synthesis rate and HIV infection in MDMs. Finally, the pretreatment of MDMs with the Vpx+ VLPs, which is a widely used protocol, displayed identical proviral DNA synthesis as compared with MDMs co-treated with Vpx+ VLP and HIV vector. These findings further indicate that Vpx degradation of SAMHD1 is sufficiently rapid to enable appropriate progression of reverse transcription in MDMs, even when present at the time of infection. Overall, this study demonstrates a tight interplay between SAMHD1 level, dNTP levels, and HIV proviral DNA synthesis kinetics in MDMs.	[Kim, Baek; Daddacha, Waaqo; Hollenbaugh, Joseph A.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Nguyen, Laura A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu			National Institutes of Health [AI049781, F31 GM095190, F32 AI089079-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI089079, R01AI049781, R56AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM095190, R01GM104198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI049781 (to K. B.), F31 GM095190 to (W. D.) and F32 AI089079-01A1 (to J. A. H.).	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Casey L, 2010, CYTOKINE, V51, P1, DOI 10.1016/j.cyto.2010.02.018; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; ELLEDGE SJ, 1993, BIOESSAYS, V15, P333, DOI 10.1002/bies.950150507; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kennedy EM, 2011, J BIOL CHEM, V286, P25047, DOI 10.1074/jbc.M111.234047; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Muthumani K, 2000, DNA CELL BIOL, V19, P179, DOI 10.1089/104454900314564; Nguyen LA, 2012, J MOL BIOL, V415, P248, DOI 10.1016/j.jmb.2011.11.014; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Schultz J, 1997, PROTEIN SCI, V6, P249; Stubbe J, 2000, CURR OPIN STRUC BIOL, V10, P731, DOI 10.1016/S0959-440X(00)00153-6; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; TRISTEM M, 1990, NATURE, V347, P341, DOI 10.1038/347341b0; Ueno F, 2003, MICROBES INFECT, V5, P387, DOI 10.1016/S1286-4579(03)00042-X; Van Cor-Hosmer SK, 2012, VIROLOGY, V422, P393, DOI 10.1016/j.virol.2011.11.004; Van Cor-Hosmer SK, 2010, VIROLOGY, V406, P253, DOI 10.1016/j.virol.2010.07.028; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r	36	155	156	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21570	21574		10.1074/jbc.C112.374843	http://dx.doi.org/10.1074/jbc.C112.374843			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22589553	hybrid, Green Published			2022-12-25	WOS:000306418600001
J	Dudaniec, RY; Spear, SF; Richardson, JS; Storfer, A				Dudaniec, Rachael Y.; Spear, Stephen F.; Richardson, John S.; Storfer, Andrew			Current and Historical Drivers of Landscape Genetic Structure Differ in Core and Peripheral Salamander Populations	PLOS ONE			English	Article							DICAMPTODON-TENEBROSUS; AMPHIBIAN DECLINES; DIVERSITY; RANGE; EXPANSION; REFUGIA; FROG; SOFTWARE; TESTS; FLOW	With predicted decreases in genetic diversity and greater genetic differentiation at range peripheries relative to their cores, it can be difficult to distinguish between the roles of current disturbance versus historic processes in shaping contemporary genetic patterns. To address this problem, we test for differences in historic demography and landscape genetic structure of coastal giant salamanders (Dicamptodon tenebrosus) in two core regions (Washington State, United States) versus the species' northern peripheral region (British Columbia, Canada) where the species is listed as threatened. Coalescent-based demographic simulations were consistent with a pattern of post-glacial range expansion, with both ancestral and current estimates of effective population size being much larger within the core region relative to the periphery. However, contrary to predictions of recent human-induced population decline in the less genetically diverse peripheral region, there was no genetic signature of population size change. Effects of current demographic processes on genetic structure were evident using a resistance-based landscape genetics approach. Among core populations, genetic structure was best explained by length of the growing season and isolation by resistance (i.e. a 'flat' landscape), but at the periphery, topography (slope and elevation) had the greatest influence on genetic structure. Although reduced genetic variation at the range periphery of D. tenebrosus appears to be largely the result of biogeographical history rather than recent impacts, our analyses suggest that inherent landscape features act to alter dispersal pathways uniquely in different parts of the species' geographic range, with implications for habitat management.	[Dudaniec, Rachael Y.; Richardson, John S.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Spear, Stephen F.; Storfer, Andrew] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	University of British Columbia; Washington State University	Dudaniec, RY (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	rachael.dudaniec@gmail.com	Dudaniec, Rachael Y/F-4001-2011; Richardson, John S/G-1513-2012; Dudaniec, Rachael/AAR-7034-2020	Richardson, John S/0000-0001-8135-7447; Dudaniec, Rachael/0000-0002-1854-6808	Forest Investment Account/Forest Science Program, British Columbia [Y102082]; Canadian Wildlife Federation; Cooperative Monitoring, Evaluation and Research Committee [IAA-06-047]	Forest Investment Account/Forest Science Program, British Columbia; Canadian Wildlife Federation; Cooperative Monitoring, Evaluation and Research Committee	This work was supported by the Forest Investment Account/Forest Science Program, British Columbia (grant number Y102082), the Canadian Wildlife Federation (www.cwf-fcf.org), and the Cooperative Monitoring, Evaluation and Research Committee under the Washington Department of Natural Resources Forest Practices Management Program (grant number IAA-06-047 to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, INFORM THEORY EXTENS; Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Bahn V, 2006, OIKOS, V115, P89, DOI 10.1111/j.2006.0030-1299.14825.x; Beaumont MA, 1999, GENETICS, V153, P2013; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Bull RAS, 2011, MOL ECOL, V20, P1092, DOI 10.1111/j.1365-294X.2010.04944.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Chiucci JE, 2010, MOL ECOL, V19, P5435; Cornuet JM, 1996, GENETICS, V144, P2001; Curtis JMR, 2004, BIOL CONSERV, V115, P45, DOI 10.1016/S0006-3207(03)00092-2; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dudaniec RY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014333; Dudaniec Rachael Y., 2008, BMC Ecology, V8, P13, DOI 10.1186/1472-6785-8-13; Dudaniec RY, HERPETOLOGI IN PRESS; Duellman W. E., 1986, BIOL AMPHIBIANS; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Faurby S, 2010, MOL ECOL, V19, P3088, DOI 10.1111/j.1365-294X.2010.04732.x; Ferguson H, 1998, THESIS U BRIT COLUMB; Ferguson HM, 2000, CAN J ZOOL, V78, P1238, DOI 10.1139/cjz-78-7-1238; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gapare WJ, 2008, CONSERV GENET, V9, P411, DOI 10.1007/s10592-007-9353-8; Garner TWJ, 2004, MOL ECOL, V13, P1047, DOI 10.1111/j.1365-294X.2004.02119.x; Gibson SY, 2009, CONSERV BIOL, V23, P1369, DOI 10.1111/j.1523-1739.2009.01375.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hoban SM, 2010, MOL ECOL, V19, P4876, DOI 10.1111/j.1365-294X.2010.04834.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; Johansson M, 2006, MOL ECOL, V15, P975, DOI 10.1111/j.1365-294X.2006.02866.x; Johnston B, 2002, CAN J ZOOL, V80, P2170, DOI 10.1139/Z02-213; Jordan MA, 2009, CONSERV GENET, V10, P1647, DOI 10.1007/s10592-008-9741-8; Kark S, 2004, BIOL J LINN SOC, V81, P313, DOI 10.1111/j.1095-8312.2004.00296.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Kroll AJ, 2008, FOREST ECOL MANAG, V255, P3726, DOI 10.1016/j.foreco.2008.03.005; Lee-Yaw JA, 2008, MOL ECOL, V17, P867, DOI 10.1111/j.1365-294X.2007.03611.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lowe WH, 2008, MOL ECOL, V17, P4459, DOI 10.1111/j.1365-294X.2008.03928.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Munwes I, 2010, MOL ECOL, V19, P2675, DOI 10.1111/j.1365-294X.2010.04712.x; Murphy MA, 2010, MOL ECOL, V19, P3634, DOI 10.1111/j.1365-294X.2010.04723.x; Nussbaum RA, 1976, GEOGRAPIC VARIATION; Okello JBA, 2008, MOL ECOLOGY, P17; Pannell JR, 2000, PHILOS T R SOC B, V355, P1851, DOI 10.1098/rstb.2000.0740; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rehfeldt G.E, 2006, SPLINE MODEL CLIMATE; Sambrook J, 2001, MOL CLONING LAB MANU; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; SMITH BJ, 2005, BOA BAYESIAN OUTPUT; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Spear SF, 2008, MOL ECOL, V17, P4642, DOI 10.1111/j.1365-294X.2008.03952.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Steele CA, 2009, MOL ECOL, V18, P1629, DOI 10.1111/j.1365-294X.2009.04135.x; Steele CA, 2008, MOL ECOLOGY RESOURCE; Steele CA, 2006, MOL ECOL, V15, P2477, DOI 10.1111/j.1365-294X.2006.02950.x; Storfer A, 2003, DIVERS DISTRIB, V9, P151, DOI 10.1046/j.1472-4642.2003.00014.x; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Storz JF, 2002, EVOLUTION, V56, P154; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Zellmer AJ, 2009, MOL ECOL, V18, P3593, DOI 10.1111/j.1365-294X.2009.04305.x	79	34	34	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36769	10.1371/journal.pone.0036769	http://dx.doi.org/10.1371/journal.pone.0036769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590604	Green Published, gold			2022-12-25	WOS:000305336400033
J	Pasche, M; Matti, U; Hof, D; Rettig, J; Becherer, U				Pasche, Mathias; Matti, Ulf; Hof, Detlef; Rettig, Jens; Becherer, Ute			Docking of LDCVs Is Modulated by Lower Intracellular [Ca2+] than Priming	PLOS ONE			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; SECRETORY GRANULE MOTION; CHROMAFFIN CELLS; VESICLE DOCKING; PLASMA-MEMBRANE; EXOCYTOSIS; RELEASE; PROTEIN; ACTS; TRANSPORT	Many regulatory steps precede final membrane fusion in neuroendocrine cells. Some parts of this preparatory cascade, including fusion and priming, are dependent on the intracellular Ca2+ concentration ([Ca2+](i)). However, the functional implications of [Ca2+](i) in the regulation of docking remain elusive and controversial due to an inability to determine the modulatory effect of [Ca2+](i). Using a combination of TIRF-microscopy and electrophysiology we followed the movement of large dense core vesicles (LDCVs) close to the plasma membrane, simultaneously measuring membrane capacitance and [Ca2+](i). We found that a free [Ca2+](i) of 700 nM maximized the immediately releasable pool and minimized the lateral mobility of vesicles, which is consistent with a maximal increase of the pool size of primed LDCVs. The parameters that reflect docking, i.e. axial mobility and the fraction of LDCVs residing at the plasma membrane for less than 5 seconds, were strongly decreased at a free [Ca2+](i) of 500 nM. These results provide the first evidence that docking and priming occur at different free intracellular Ca2+ concentrations, with docking efficiency being the most robust at 500 nM.	[Pasche, Mathias; Matti, Ulf; Hof, Detlef; Rettig, Jens; Becherer, Ute] Univ Saarland, Inst Physiol, Homburg, Germany	Saarland University	Pasche, M (corresponding author), MRC Lab Mol Biol, Cambridge, England.	Ute.Becherer@uks.eu	Becherer, Ute/AGW-2576-2022; Rettig, Jens/K-5103-2013; Becherer, Ute/F-6711-2010	Rettig, Jens/0000-0001-6160-3954; Becherer, Ute/0000-0001-6005-7517; Matti, Ulf/0000-0001-5548-1081	HOMFOR, Universitat des Saarlandes; Deutsche Forschungsgemeinschaft Sonderforschungsbereich [530]	HOMFOR, Universitat des Saarlandes; Deutsche Forschungsgemeinschaft Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by local funding (HOMFOR, Universitat des Saarlandes; http://www.uniklinikum-saarland.de/de/forschung/HOMFOR) and by grants from the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 530 (to J.R. and U.B.; http://www. dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allersma MW, 2006, MOL BIOL CELL, V17, P2424, DOI 10.1091/mbc.E05-10-0938; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Becherer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000505; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; BRANDT BL, 1976, J PHYSIOL-LONDON, V263, P417, DOI 10.1113/jphysiol.1976.sp011638; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; DELCASTILLO AR, 1990, EMBO J, V9, P43, DOI 10.1002/j.1460-2075.1990.tb08078.x; Duncan RR, 1999, J BIOL CHEM, V274, P27347, DOI 10.1074/jbc.274.39.27347; Fish KN, 2009, CURR PROTOCOL CYTOM, V50; Friedrich R, 2008, J NEUROSCI, V28, P6794, DOI 10.1523/JNEUROSCI.0538-08.2008; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Karatekin E, 2008, BIOPHYS J, V94, P2891, DOI 10.1529/biophysj.107.116756; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; Pene TD, 2005, J NEUROCHEM, V92, P780, DOI 10.1111/j.1471-4159.2004.02907.x; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Stevens D, 2009, MOL NEUROBIOL, V39, P62, DOI 10.1007/s12035-009-8052-5; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Yizhar O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002694; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028	40	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36416	10.1371/journal.pone.0036416	http://dx.doi.org/10.1371/journal.pone.0036416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590540	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336400013
J	Yang, MZ; Chen, YY; Zhou, Y; Wang, LW; Zhang, HT; Bi, LJ; Zhang, XE				Yang, Mingzhang; Chen, Yuanyuan; Zhou, Ying; Wang, Liwei; Zhang, Hongtai; Bi, Li-Jun; Zhang, Xian-En			MSMEG_2731, an Uncharacterized Nucleic Acid Binding Protein from Mycobacterium smegmatis, Physically Interacts with RPS1	PLOS ONE			English	Article							RIBOSOMAL PROTEIN-S1; ESCHERICHIA-COLI; TUBERCULOSIS H37RV; GENOME SEQUENCE; RNA-POLYMERASE; S1; TRANSLATION; DOMAINS	While the M. smegmatis genome has been sequenced, only a small portion of the genes have been characterized experimentally. Here, we purify and characterize MSMEG_2731, a conserved hypothetical alanine and arginine rich M. smegmatis protein. Using ultracentrifugation, we show that MSMEG_2731 is a monomer in vitro. MSMEG_2731 exists at a steady level throughout the M. smegmatis life-cycle. Combining results from pull-down techniques and LS-MS/MS, we show that MSMEG_2731 interacts with ribosomal protein S1. The existence of this interaction was confirmed by co-immunoprecipitation. We also show that MSMEG_2731 can bind ssDNA, dsDNA and RNA in vitro. Based on the interactions of MSMEG_2731 with RPS1 and RNA, we propose that MSMEG_2731 is involved in the transcription-translation process in vivo.	[Yang, Mingzhang; Chen, Yuanyuan; Zhou, Ying; Wang, Liwei; Zhang, Hongtai; Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Key Lab Noncoding RNA, Beijing 100080, Peoples R China; [Zhang, Xian-En] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Yang, Mingzhang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, MZ (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Noncoding RNA, Beijing 100080, Peoples R China.	blj@sun5.ibp.ac.cn; x.zhang@wh.iov.cn	Yang, Mingzhang/AAF-3510-2020; Chen, Yuanyuan/GXG-2130-2022; ZHANG, Xian-En/AAJ-5579-2021; Yang, Mingzhang/AAN-1046-2021	Yang, Mingzhang/0000-0002-7038-5677; 	Chinese Academy of Sciences [KSCX2-YW-R-164]; National Natural Science Foundation of China [30970590]; National Protein Research Fund [2009CB825402, 2011CB910302]; Chinese Ministry of Health [2008ZX10003-005]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Protein Research Fund; Chinese Ministry of Health	The support of the Chinese Academy of Sciences (Grant No. KSCX2-YW-R-164) and the National Natural Science Foundation of China (Grant No. 30970590) is acknowledged. Li-Jun Bi was supported by the National Protein Research Fund (Grant Nos. 2009CB825402 and 2011CB910302), and the Chinese Ministry of Health's Key Projects for Infectious Diseases (2008ZX10003-005) are also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprandi P, 2008, J BIOL CHEM, V283, P13289, DOI 10.1074/jbc.M707111200; Auerbach D, 2002, PROTEOMICS, V2, P611, DOI 10.1002/1615-9861(200206)2:6<611::AID-PROT611>3.0.CO;2-Y; Biswas T, 2009, BIOCHEMISTRY-US, V48, P2839, DOI 10.1021/bi8022416; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dick T, 1998, FEMS MICROBIOL LETT, V163, P159, DOI 10.1111/j.1574-6968.1998.tb13040.x; Domenech P, 2001, CURR OPIN MICROBIOL, V4, P28, DOI 10.1016/S1369-5274(00)00160-0; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FARWELL MA, 1992, MOL MICROBIOL, V6, P3375, DOI 10.1111/j.1365-2958.1992.tb02205.x; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; Mukherjee A, 2009, FEMS MICROBIOL LETT, V291, P232, DOI 10.1111/j.1574-6968.2008.01458.x; POTAPOV AP, 1992, BIOCHEM INT, V27, P745; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P3740, DOI 10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.3.CO;2-V; Salah P, 2009, NUCLEIC ACIDS RES, V37, P5578, DOI 10.1093/nar/gkp547; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; SUBRAMANIAN AR, 1977, MOL GEN GENET, V158, P1, DOI 10.1007/BF00455113; SUBRAMANIAN AR, 1983, PROG NUCLEIC ACID RE, V28, P101, DOI 10.1016/S0079-6603(08)60085-9; Sukhodolets MV, 2006, RNA, V12, P1505, DOI 10.1261/rna.2321606; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; Tyagi JS, 2002, TRENDS MICROBIOL, V10, P68, DOI 10.1016/S0966-842X(01)02296-X; TZAREVA NV, 1994, FEBS LETT, V337, P189, DOI 10.1016/0014-5793(94)80271-8; Wang Z, 1994, TRANSCRIPTION FACTOR; YAMADA T, 1982, FEBS LETT, V142, P267, DOI 10.1016/0014-5793(82)80149-X; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3	28	2	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36666	10.1371/journal.pone.0036666	http://dx.doi.org/10.1371/journal.pone.0036666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590585	Green Published, gold			2022-12-25	WOS:000305336100051
J	Burns, ALJ; Herbert-Read, JE; Morrell, LJ; Ward, AJW				Burns, Alicia L. J.; Herbert-Read, James E.; Morrell, Lesley J.; Ward, Ashley J. W.			Consistency of Leadership in Shoals of Mosquitofish (Gambusia holbrooki) in Novel and in Familiar Environments	PLOS ONE			English	Article							STICKLEBACKS GASTEROSTEUS-ACULEATUS; ROACH RUTILUS-RUTILUS; 3-SPINED STICKLEBACKS; ANIMAL GROUPS; NOTEMIGONUS-CRYSOLEUCAS; NUTRITIONAL STATE; INDIVIDUALS LEAD; SCHOOLING FISH; GOLDEN SHINERS; GPS TRACKING	In social animal groups, an individual's spatial position is a major determinant of both predation risk and foraging rewards. Additionally, the occupation of positions in the front of moving groups is generally assumed to correlate with the initiation of group movements. However, whether some individuals are predisposed to consistently occupy certain positions and, in some instances, to consistently lead groups over time is as yet unresolved in many species. Using the mosquitofish (Gambusia holbrooki), we examined the consistency of individuals' spatial positions within a moving group over successive trials. We found that certain individuals consistently occupied front positions in moving groups and also that it was typically these individuals that initiated group decisions. The number of individuals involved in leading the group varied according to the amount of information held by group members, with a greater number of changes in leadership in a novel compared to a relatively familiar environment. Finally, our results show that the occupation of lead positions in moving groups was not explained by characteristics such as dominance, size or sex, suggesting that certain individuals are predisposed to leadership roles. This suggests that being a leader or a follower may to some extent be an intrinsic property of the individual.	[Burns, Alicia L. J.; Herbert-Read, James E.; Ward, Ashley J. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Morrell, Lesley J.] Univ Hull, Dept Biol Sci, Kingston Upon Hull, East Yorkshire, England	University of Sydney; University of Hull	Burns, ALJ (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	ashleyjwward@gmail.com	Ward, Ashley/B-6227-2011; Morrell, Lesley J/A-4311-2008	Morrell, Lesley J/0000-0003-0256-7871; Ward, Ashley/0000-0003-0842-533X; Herbert-Read, James/0000-0003-0243-4518	University of Sydney	University of Sydney(University of Sydney)	This work was funded by a Vice Chancellor's Grant provided by the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.R., 2002, FIELD GUIDE FRESHWAT; Biro D, 2002, J EXP BIOL, V205, P3833; Bouissou MF, 2001, FARM ANIMALS, P113; Bourjade M, 2010, BEHAV PROCESS, V84, P648, DOI 10.1016/j.beproc.2010.02.027; BREDER CM, 1951, COPEIA, P162; Bumann D, 1997, BEHAVIOUR, V134, P1063, DOI 10.1163/156853997X00403; BUMANN D, 1993, BEHAVIOUR, V125, P189, DOI 10.1163/156853993X00236; CALDWELL MELBA C., 1962, BULL SOUTHERN CALIFORNIA ACAD SCI, V61, P37; Chen T, 2011, BIOL LETTERS, V7, P343, DOI 10.1098/rsbl.2010.1020; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Dell'Ariccia G, 2009, J EXP BIOL, V212, P178, DOI 10.1242/jeb.024554; Freeman R, 2011, BIOL LETTERS, V7, P63, DOI 10.1098/rsbl.2010.0627; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Ihl C, 2011, J MAMMAL, V92, P819, DOI 10.1644/10-MAMM-A-109.1; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; King AJ, 2010, BEHAV PROCESS, V84, P671, DOI 10.1016/j.beproc.2010.03.006; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; KRAUSE J, 1994, BIOL REV, V69, P187, DOI 10.1111/j.1469-185X.1994.tb01505.x; Krause J, 1998, BEHAVIOUR, V135, P1031, DOI 10.1163/156853998792913519; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; LAMPRECHT J, 1992, BEHAVIOUR, V122, P105, DOI 10.1163/156853992X00336; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; Levin LE, 1996, BEHAV PROCESS, V37, P1, DOI 10.1016/0376-6357(95)00067-4; Leyhausen P, 1975, APPL ANIM ETHOL, V1, P206; Lusseau D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1067, DOI 10.1007/s00265-009-0740-7; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Morrell LJ, 2008, BEHAV ECOL, V19, P909, DOI 10.1093/beheco/arn050; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Pavlov D.S., 2000, J ICHTHYOL+, V40, pS163; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; PITCHER TJ, 1982, ANIM BEHAV, V30, P932, DOI 10.1016/S0003-3472(82)80170-X; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Reebs SG, 2001, BEHAVIOUR, V138, P797, DOI 10.1163/156853901753172656; RHINE RJ, 1981, FOLIA PRIMATOL, V35, P77, DOI 10.1159/000155968; ROWELL TE, 1969, ANIM BEHAV, V17, P159, DOI 10.1016/0003-3472(69)90125-0; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; SHAW E, 1962, SCI AM, V206, P128, DOI 10.1038/scientificamerican0662-128; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Squires V. R., 1975, Applied Animal Ethology, V1, P263, DOI 10.1016/0304-3762(75)90019-X; Stroeymeyt N, 2011, J EXP BIOL, V214, P3046, DOI 10.1242/jeb.059188; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013059; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Utne-Palm AC, 2000, OIKOS, V91, P225, DOI 10.1034/j.1600-0706.2000.910203.x; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Ward AJW, 2003, FISH FISH, V4, P348, DOI 10.1046/j.1467-2979.2003.00135.x; Ward AJW, 2002, J ANIM ECOL, V71, P10, DOI 10.1046/j.0021-8790.2001.00571.x; Ward AJW, 2012, BEHAV ECOL SOCIOBIOL, V66, P223, DOI 10.1007/s00265-011-1270-7; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Webster MM, 2007, ANIM BEHAV, V74, P253, DOI 10.1016/j.anbehav.2006.07.021; Wilson ADM, 2010, BEHAV ECOL, V21, P57, DOI 10.1093/beheco/arp157	59	38	39	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36567	10.1371/journal.pone.0036567	http://dx.doi.org/10.1371/journal.pone.0036567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590568	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335500017
J	Avitabile, C; Moggio, L; Malgieri, G; Capasso, D; Di Gaetano, S; Saviano, M; Pedone, C; Romanelli, A				Avitabile, Concetta; Moggio, Loredana; Malgieri, Gaetano; Capasso, Domenica; Di Gaetano, Sonia; Saviano, Michele; Pedone, Carlo; Romanelli, Alessandra			gamma sulphate PNA (PNA S): Highly Selective DNA Binding Molecule Showing Promising Antigene Activity	PLOS ONE			English	Article							PEPTIDE NUCLEIC-ACID; SEQUENCE B-DNA; STRAND INVASION; MIXED-SEQUENCE; CELLULAR DELIVERY; GENE-EXPRESSION; DUPLEX DNA; RECOGNITION; INHIBITION; CLEAVAGE	Peptide Nucleic Acids (PNAs), nucleic acid analogues showing high stability to enzyme degradation and strong affinity and specificity of binding toward DNA and RNA are widely investigated as tools to interfere in gene expression. Several studies have been focused on PNA analogues with modifications on the backbone and bases in the attempt to overcome solubility, uptake and aggregation issues. gamma PNAs, PNA derivatives having a substituent in the gamma position of the backbone show interesting properties in terms of secondary structure and affinity of binding toward complementary nucleic acids. In this paper we illustrate our results obtained on new analogues, bearing a sulphate in the gamma position of the backbone, developed to be more DNA-like in terms of polarity and charge. The synthesis of monomers and oligomers is described. NMR studies on the conformational properties of monomers and studies on the secondary structure of single strands and triplexes are reported. Furthermore the hybrid stability and the effect of mismatches on the stability have also been investigated. Finally, the ability of the new analogue to work as antigene, interfering with the transcription of the ErbB2 gene on a human cell line overexpressing ErbB2 (SKBR3), assessed by FACS and qPCR, is described.	[Avitabile, Concetta; Moggio, Loredana; Capasso, Domenica; Pedone, Carlo; Romanelli, Alessandra] Univ Naples Federico II, Fac Sci Biotecnol, Dipartimento Sci Biol, Naples, Italy; [Malgieri, Gaetano] Seconda Univ Napoli, Dipartimento Sci Ambientali, Caserta, Italy; [Di Gaetano, Sonia; Pedone, Carlo; Romanelli, Alessandra] CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy; [Saviano, Michele] CNR, Ist Cristallog, I-70126 Bari, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR)	Avitabile, C (corresponding author), Univ Naples Federico II, Fac Sci Biotecnol, Dipartimento Sci Biol, Naples, Italy.	alessandra.romanelli@unina.it	Saviano, Michele/R-1693-2016; Malgieri, Gaetano/N-1678-2016	Saviano, Michele/0000-0001-5086-2459; Capasso, Domenica/0000-0001-7201-3431; Di Gaetano, Sonia/0000-0001-5523-3619; MALGIERI, Gaetano/0000-0002-4070-9458; Avitabile, Concetta/0000-0001-5542-6920; ROMANELLI, Alessandra/0000-0002-7609-4061	Ministero dell'Universita, dell'lstruzione e della Ricerca- Progetti di ricerca di Rilevante Interesse Nazionale [MIUR PRIN2009, 20093N774P]	Ministero dell'Universita, dell'lstruzione e della Ricerca- Progetti di ricerca di Rilevante Interesse Nazionale	Ministero dell'Universita, dell'lstruzione e della Ricerca- Progetti di ricerca di Rilevante Interesse Nazionale (MIUR PRIN2009, Prot 20093N774P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrian-Herrada G, 1998, J PEPT SCI, V4, P266, DOI 10.1002/(SICI)1099-1387(199806)4:4<266::AID-PSC143>3.0.CO;2-C; Armitage B, 1997, NUCLEIC ACIDS RES, V25, P4674, DOI 10.1093/nar/25.22.4674; Avitabile C, 2010, TETRAHEDRON LETT, V51, P3716, DOI 10.1016/j.tetlet.2010.05.026; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bentin T, 2003, J AM CHEM SOC, V125, P6378, DOI 10.1021/ja029936t; BETTS L, 1995, SCIENCE, V270, P1838, DOI 10.1126/science.270.5243.1838; Bigey P, 1997, BIOCONJUGATE CHEM, V8, P267, DOI 10.1021/bc9700190; Borgatti M, 2002, BIOCHEM PHARMACOL, V64, P609, DOI 10.1016/S0006-2952(02)01188-7; Campos SV, 2002, J CHEM SOC PERK T 1, P682, DOI 10.1039/b107320f; Chen J, 2010, P NATL ACAD SCI USA, V107, P16846, DOI 10.1073/pnas.0912896107; Cortesi R, 2004, AAPS PHARMSCI, V6; de Koning MC, 2006, TETRAHEDRON, V62, P3248, DOI 10.1016/j.tet.2006.01.065; DEMIDOV V, 1993, NUCLEIC ACIDS RES, V21, P2103, DOI 10.1093/nar/21.9.2103; Doyle DF, 2001, BIOCHEMISTRY-US, V40, P53, DOI 10.1021/bi0020630; Dragulescu-Andrasi A, 2006, J AM CHEM SOC, V128, P16104, DOI 10.1021/ja063383v; Dragulescu-Andrasi A, 2006, J AM CHEM SOC, V128, P10258, DOI 10.1021/ja0625576; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Englund EA, 2007, ANGEW CHEM INT EDIT, V46, P1414, DOI 10.1002/anie.200603483; Finn PJ, 1996, NUCLEIC ACIDS RES, V24, P3357, DOI 10.1093/nar/24.17.3357; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Hamilton SE, 1999, CHEM BIOL, V6, P343, DOI 10.1016/S1074-5521(99)80046-5; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; He GF, 2009, J AM CHEM SOC, V131, P12088, DOI 10.1021/ja900228j; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Ishizuka T, 2008, NUCLEIC ACIDS RES, V36, P1464, DOI 10.1093/nar/gkm1154; Jensen KK, 1997, BIOCHEMISTRY-US, V36, P5072, DOI 10.1021/bi9627525; Kaihatsu K, 2003, BIOCHEMISTRY-US, V42, P13996, DOI 10.1021/bi035194k; Koppelhus U, 2003, ADV DRUG DELIVER REV, V55, P267, DOI 10.1016/S0169-409X(02)00182-5; KOSYNKINA L, 1994, TETRAHEDRON LETT, V35, P5173, DOI 10.1016/S0040-4039(00)77056-0; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Kumar VA, 2005, ACCOUNTS CHEM RES, V38, P404, DOI 10.1021/ar030277e; Mitra R, 2011, CHEM COMMUN, V47, P1198, DOI 10.1039/c0cc03988h; Mokhir AA, 2003, BIOCONJUGATE CHEM, V14, P877, DOI 10.1021/bc0256345; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Okamoto A, 2001, ORG LETT, V3, P925, DOI 10.1021/ol015549x; Pensato S, 2007, EXPERT OPIN BIOL TH, V7, P1219, DOI 10.1517/14712598.7.8.1219; Pensato S, 2010, BIOORG CHEM, V38, P196, DOI 10.1016/j.bioorg.2010.06.002; Petraccone L, 2005, J AM CHEM SOC, V127, P16215, DOI 10.1021/ja0545923; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Rapireddy S, 2007, J AM CHEM SOC, V129, P15596, DOI 10.1021/ja074886j; Rapireddy S, 2011, BIOCHEMISTRY-US, V50, P3913, DOI 10.1021/bi2002554; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Ross GF, 2003, BIOCONJUGATE CHEM, V14, P962, DOI 10.1021/bc034050f; Roviello GN, 2010, MOL BIOSYST, V6, P199, DOI 10.1039/b910278g; Sahu B, 2011, J ORG CHEM, V76, P5614, DOI 10.1021/jo200482d; Sahu B, 2009, J ORG CHEM, V74, P1509, DOI 10.1021/jo802211n; Seo YJ, 2011, NUCLEIC ACIDS RES, V39, P7329, DOI 10.1093/nar/gkr360; Sforza S, 2007, EUR J ORG CHEM, V2007, P5879, DOI 10.1002/ejoc.200700644; Shiraishi T, 2008, NUCLEIC ACIDS RES, V36, P4424, DOI 10.1093/nar/gkn401; Tedeschi T, 2005, TETRAHEDRON LETT, V46, P8395, DOI 10.1016/j.tetlet.2005.09.157; Timar Z, 2000, J CHEM SOC PERK T 1, P19, DOI 10.1039/a907832k; Tomac S, 1996, J AM CHEM SOC, V118, P5544, DOI 10.1021/ja960495l; Wu Y, 2001, TETRAHEDRON, V57, P8107, DOI 10.1016/S0040-4020(01)00789-X; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yeh JI, 2010, J AM CHEM SOC, V132, P10717, DOI 10.1021/ja907225d; Zhilina ZV, 2006, BIOCONJUGATE CHEM, V17, P214, DOI 10.1021/bc0502964	57	37	41	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35774	10.1371/journal.pone.0035774	http://dx.doi.org/10.1371/journal.pone.0035774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586450	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000012
J	He, JD; Peng, MS; Quang, HH; Dang, KP; Trieu, AV; Wu, SF; Jin, JQ; Murphy, RW; Yao, YG; Zhang, YP				He, Jun-Dong; Peng, Min-Sheng; Huy Ho Quang; Khoa Pham Dang; An Vu Trieu; Wu, Shi-Fang; Jin, Jie-Qiong; Murphy, Robert W.; Yao, Yong-Gang; Zhang, Ya-Ping			Patrilineal Perspective on the Austronesian Diffusion in Mainland Southeast Asia	PLOS ONE			English	Article							INFERRING ADMIXTURE PROPORTIONS; Y-CHROMOSOME; MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; MOLECULAR-DATA; POPULATIONS; DIVERSITY; POLYMORPHISMS; RESOLUTION; INDIA	The Cham people are the major Austronesian speakers of Mainland Southeast Asia (MSEA) and the reconstruction of the Cham population history can provide insights into their diffusion. In this study, we analyzed non-recombining region of the Y chromosome markers of 177 unrelated males from four populations in MSEA, including 59 Cham, 76 Kinh, 25 Lao, and 17 Thai individuals. Incorporating published data from mitochondrial DNA (mtDNA), our results indicated that, in general, the Chams are an indigenous Southeast Asian population. The origin of the Cham people involves the genetic admixture of the Austronesian immigrants from Island Southeast Asia (ISEA) with the local populations in MSEA. Discordance between the overall patterns of Y chromosome and mtDNA in the Chams is evidenced by the presence of some Y chromosome lineages that prevail in South Asians. Our results suggest that male-mediated dispersals via the spread of religions and business trade might play an important role in shaping the patrilineal gene pool of the Cham people.	[He, Jun-Dong; Peng, Min-Sheng; Wu, Shi-Fang; Jin, Jie-Qiong; Murphy, Robert W.; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [He, Jun-Dong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [He, Jun-Dong; Peng, Min-Sheng; Zhang, Ya-Ping] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Peoples R China; [Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Huy Ho Quang; Khoa Pham Dang; An Vu Trieu] Hanoi Med Univ, Dept Immunol, Hanoi, Vietnam; [Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada; [Peng, Min-Sheng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Yunnan University; Hanoi Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, JD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn	Yao, Yong-Gang/AAH-2303-2021	Yao, Yong-Gang/0000-0002-2955-0693; Murphy, Robert/0000-0001-8555-2338	National Natural Science Foundation of China; Bureau of Science and Technology of Yunnan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province	This research was supported by grants from National Natural Science Foundation of China, and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bellwood P, 2006, AUSTRONESIANS: HISTORICAL AND COMPARATIVE PERSPECTIVES, P103; Bellwood P, 2006, AUSTRONESIANS: HISTORICAL AND COMPARATIVE PERSPECTIVES, P1; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Debnath M, 2011, J HUM GENET, V56, P765, DOI 10.1038/jhg.2011.98; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; HE P, 2006, ORIGIN EVOLUTION NAT; Higham C., 2002, EARLY CULTURES MAINL; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kim Soon-Hee, 2011, Investig Genet, V2, P10, DOI 10.1186/2041-2223-2-10; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kutanan W, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-56; Lewis M. P., ETHNOLOGUE LANGUAGES; Mohammad T, 2009, HEREDITY, V103, P425, DOI 10.1038/hdy.2009.72; Nakamura R, 2009, CHAMPA ARCHAEOLOGY M, P78; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Prinz M, 1997, FORENSIC SCI INT, V85, P209, DOI 10.1016/S0379-0738(96)02096-8; Reid, 1988, SE ASIA AGE COMMERCE, V2; REID ANTHONY, 1988, SE ASIA AGE COMMERCE, VI; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; SOLHEIM WG, 2006, ARCHAEOLOGY CULTURE; Southworth W. A., 2004, SE ASIA PREHISTORY H, P209; Thangaraj K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015283; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thurgood G, 2005, AUSTRONESIAN LANGUAG, P489; Thurgood G, 1999, ANCIENT CHAM MODERN, Vxvii, P407; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wilkins JF, 2006, BIOESSAYS, V28, P290, DOI 10.1002/bies.20378; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052	40	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36437	10.1371/journal.pone.0036437	http://dx.doi.org/10.1371/journal.pone.0036437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586471	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000033
J	Rubach, MP; Mukemba, J; Florence, S; John, B; Crookston, B; Lopansri, BK; Yeo, TW; Piera, KA; Alder, SC; Weinberg, JB; Anstey, NM; Granger, DL; Mwaikambo, ED				Rubach, Matthew P.; Mukemba, Jackson; Florence, Salvatore; John, Bernard; Crookston, Benjamin; Lopansri, Bert K.; Yeo, Tsin W.; Piera, Kim A.; Alder, Stephen C.; Weinberg, J. Brice; Anstey, Nicholas M.; Granger, Donald L.; Mwaikambo, Esther D.			Plasma Plasmodium falciparum Histidine-Rich Protein-2 Concentrations Are Associated with Malaria Severity and Mortality in Tanzanian Children	PLOS ONE			English	Article								Plasma Plasmodium falciparum histidine-rich protein-2 (PfHRP-2) concentrations, a measure of parasite biomass, have been correlated with malaria severity in adults, but not yet in children. We measured plasma PfHRP-2 in Tanzanian children with uncomplicated (n = 61) and cerebral malaria (n = 45; 7 deaths). Median plasma PfHRP-2 concentrations were higher in cerebral malaria (1008 [IQR 342-2572] ng/mL) than in uncomplicated malaria (465 [IQR 36-1426] ng/mL; p = 0.017). In cerebral malaria, natural log plasma PfHRP-2 was associated with coma depth (r = -0.42; p = 0.006) and mortality (OR: 3.0 [95% CI 1.03-8.76]; p = 0.04). In this relatively small cohort study in a mesoendemic transmission area of Africa, plasma PfHRP-2 was associated with pediatric malaria severity and mortality. Further studies among children in areas of Africa with higher malaria transmission and among children with different clinical manifestations of severe malaria will help determine the wider utility of quantitative PfHRP-2 as a measure of parasite biomass and prognosis in sub-Saharan Africa.	[Rubach, Matthew P.; Crookston, Benjamin; Alder, Stephen C.; Granger, Donald L.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Rubach, Matthew P.; Crookston, Benjamin; Alder, Stephen C.; Granger, Donald L.] Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Mukemba, Jackson; Florence, Salvatore; John, Bernard; Mwaikambo, Esther D.] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania; [Lopansri, Bert K.] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Yeo, Tsin W.; Piera, Kim A.; Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Yeo, Tsin W.; Piera, Kim A.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Yeo, Tsin W.; Anstey, Nicholas M.] Royal Darwin Hosp, Darwin, NT, Australia; [Weinberg, J. Brice] VA Med Ctr, Durham, NC USA; [Rubach, Matthew P.] Duke Univ, Div Infect Dis, Durham, NC 27705 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Loyola University Chicago; Charles Darwin University; Charles Darwin University; Menzies School of Health Research; Duke University	Rubach, MP (corresponding author), Duke Univ, Div Infect Dis, Durham, NC 27705 USA.	Donald.Granger@va.gov	Yeo, Tsin Wen/F-9505-2015	Rubach, Matthew/0000-0001-5262-1421	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [U01 AI0575655, 2R01AI041764-11]; VA Research Service; American Academy of Pediatrics; National Health and Medical Research Council; FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI041764, R01AI041764] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); VA Research Service(US Department of Veterans Affairs); American Academy of Pediatrics; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (U01 AI0575655 to DLG and 2R01AI041764-11 to JBW), by the VA Research Service (DLG and JBW), and by the American Academy of Pediatrics (Residency Research Grant to MPR). TWY and NMA are supported by National Health and Medical Research Council Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Desakorn V, 2005, T ROY SOC TROP MED H, V99, P517, DOI 10.1016/j.trstmh.2004.11.014; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Manning L, 2011, CLIN INFECT DIS, V52, P440, DOI 10.1093/cid/ciq105; Ochola LB, 2005, PARASITOLOGY, V131, P449, DOI 10.1017/S0031182005008085; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tjitra E, 2001, J CLIN MICROBIOL, V39, P1025, DOI 10.1128/JCM.39.3.1025-1031.2001; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105	14	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35985	10.1371/journal.pone.0035985	http://dx.doi.org/10.1371/journal.pone.0035985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586457	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000019
J	Solemdal, K; Sandvik, L; Willumsen, T; Mowe, M; Hummel, T				Solemdal, Kirsten; Sandvik, Leiv; Willumsen, Tiril; Mowe, Morten; Hummel, Thomas			The Impact of Oral Health on Taste Ability in Acutely Hospitalized Elderly	PLOS ONE			English	Article							NUTRITIONAL-STATUS; SJOGRENS-SYNDROME; SMELL; SALIVA; SENSITIVITY; DISEASE; CARIES; SEX; AGE; MALNUTRITION	Objective: To investigate to what extent various oral health variables are associated with taste ability in acutely hospitalized elderly. Background: Impaired taste may contribute to weight loss in elderly. Many frail elderly have poor oral health characterized by caries, poor oral hygiene, and dry mouth. However, the possible influence of such factors on taste ability in acutely hospitalized elderly has not been investigated. Materials and Methods: The study was cross-sectional. A total of 174 (55 men) acutely hospitalized elderly, coming from their own homes and with adequate cognitive function, were included. Dental status, decayed teeth, oral bacteria, oral hygiene, dry mouth and tongue changes were recorded. Growth of oral bacteria was assessed with CRT (R) Bacteria Kit. Taste ability was evaluated with 16 taste strips impregnated with sweet, sour, salty and bitter taste solutions in 4 concentrations each. Correct identification was given score 1, and maximum total taste score was 16. Results: Mean age was 84 yrs. (range 70-103 yrs.). Total taste score was significantly and markedly reduced in patients with decayed teeth, poor oral hygiene, high growth of oral bacteria and dry mouth. Sweet and salty taste were particularly impaired in patients with dry mouth. Sour taste was impaired in patients with high growth of oral bacteria. Conclusion: This study shows that taste ability was reduced in acutely hospitalized elderly with caries activity, high growth of oral bacteria, poor oral hygiene, and dry mouth. Our findings indicate that good oral health is important for adequate gustatory function. Maintaining proper oral hygiene in hospitalized elderly should therefore get high priority among hospital staff.	[Solemdal, Kirsten; Sandvik, Leiv; Willumsen, Tiril] Univ Oslo, Fac Dent, Oslo, Norway; [Mowe, Morten] Univ Oslo, Dept Med, Oslo Univ Hosp, Oslo, Norway; [Mowe, Morten] Univ Oslo, Fac Med, Oslo, Norway; [Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany	University of Oslo; University of Oslo; University of Oslo; Technische Universitat Dresden	Solemdal, K (corresponding author), Univ Oslo, Fac Dent, Oslo, Norway.	kirsso@odont.uio.no	Willumsen, Tiril/N-4133-2018		The Norwegian Society for Elderly	The Norwegian Society for Elderly	The authors thank The Norwegian Society for Elderly for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohmer T, 2000, AGE AGEING, V29, P47, DOI 10.1093/ageing/29.1.47; Chapman-Novakofski K, 1999, J AM DIET ASSOC, V99, P1536, DOI 10.1016/S0002-8223(99)00377-6; Doty RL, 2008, DRUG SAFETY, V31, P199, DOI 10.2165/00002018-200831030-00002; Duffy VB, 1999, CHEM SENSES, V24, P671, DOI 10.1093/chemse/24.6.671; FIKENTSCHER R, 1977, CLIN OTOLARYNGOL, V2, P183, DOI 10.1111/j.1365-2273.1977.tb01356.x; Finkelstein JA, 1999, PHYSIOL BEHAV, V66, P173, DOI 10.1016/S0031-9384(98)00261-3; Genton L, 2011, INT J VITAM NUTR RES, V81, P143, DOI 10.1024/0300-9831/a000058; Gimmestad AL, 2006, NOR TANNLAEGEFOREN T, V5, P268; HENRICSSON V, 1990, SCAND J DENT RES, V98, P520; Henriksen B M, 1999, Spec Care Dentist, V19, P154, DOI 10.1111/j.1754-4505.1999.tb01378.x; Henriksen Birgitte M, 2005, Oral Health Prev Dent, V3, P203; Henriksen Birgitte Moesgaard, 2004, Spec Care Dentist, V24, P254; Henriksen BM, KRITERIEBESKRIVELSE; HYDE RJ, 1981, NEUROBIOL AGING, V2, P315, DOI 10.1016/0197-4580(81)90041-5; Kamel UF, 2009, RHEUMATOLOGY, V48, P1512, DOI 10.1093/rheumatology/kep249; Konsberg R, 1985, SV SJUKHUSTANDL TIDN, V10, P3; Kostka E, 2008, LARYNGO RHINO OTOL, V87, P546, DOI 10.1055/s-2007-995614; Landis BN, 2009, J NEUROL, V256, P242, DOI 10.1007/s00415-009-0088-y; LANGAN MJ, 1976, J GERONTOL, V31, P413, DOI 10.1093/geronj/31.4.413; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Lundgren T, 2007, ORAL DIS, V13, P177, DOI 10.1111/j.1601-0825.2006.01261.x; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; MATTES RD, 1994, J AM DIET ASSOC, V94, P50, DOI 10.1016/0002-8223(94)92041-9; MCWHIRTER JP, 1994, BRIT MED J, V308, P945, DOI 10.1136/bmj.308.6934.945; Mese H, 2007, J ORAL REHABIL, V34, P711, DOI 10.1111/j.1365-2842.2007.01794.x; Mowe M, 2002, J Nutr Health Aging, V6, P81; MOWE M, 1994, AM J CLIN NUTR, V59, P317, DOI 10.1093/ajcn/59.2.317; Mueller C, 2003, RHINOLOGY, V41, P2; Mulder I, 1999, J GERONTOL A-BIOL, V54, pB324; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Nederfors T, 1997, COMMUNITY DENT ORAL, V25, P211, DOI 10.1111/j.1600-0528.1997.tb00928.x; Norderyd O, 2012, GERODONTOLOGY, V29, P4, DOI 10.1111/j.1741-2358.2010.00380.x; Ohno Tomohisa, 2003, Journal of Medical and Dental Sciences, V50, P101; Pajukoski H, 1999, ORAL SURG ORAL MED O, V88, P437, DOI 10.1016/S1079-2104(99)70058-2; Planas M, 2004, CLIN NUTR, V23, P1016, DOI 10.1016/j.clnu.2004.01.003; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; Quirynen M, 2004, J CLIN PERIODONTOL, V31, P506, DOI 10.1111/j.0303-6979.2004.00507.x; Samson H, 2009, EUR J ORAL SCI, V117, P575, DOI 10.1111/j.1600-0722.2009.00673.x; Sanchez-Garcia S, 2008, GERODONTOLOGY, V25, P26, DOI 10.1111/j.1741-2358.2007.00184.x; Saotome Yasuhiko, 2006, Gerodontology, V23, P219, DOI 10.1111/j.1741-2358.2006.00127.x; Sasano T, 2010, BIOL PHARM BULL, V33, P1791, DOI 10.1248/bpb.33.1791; Schiffman SS, 2000, EUR J CLIN NUTR, V54, pS54, DOI 10.1038/sj.ejcn.1601026; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; Ship J A, 1992, Clin Geriatr Med, V8, P483; Solemdal K, 2011, GERODONTOLOGY; SPIELMAN AI, 1990, J DENT RES, V69, P838, DOI 10.1177/00220345900690030101; THUMFART W, 1980, Z GERONTOL, V13, P158; Vilstrup L, 2007, GERODONTOLOGY, V24, P3, DOI 10.1111/j.1741-2358.2007.00141.x; Wayler A H, 1990, Spec Care Dentist, V10, P107, DOI 10.1111/j.1754-4505.1990.tb00771.x; WEIFFENBACH JM, 1982, J GERONTOL, V37, P372, DOI 10.1093/geronj/37.3.372; WEIFFENBACH JM, 1995, PHYSIOL BEHAV, V57, P89, DOI 10.1016/0031-9384(94)00211-M; WHO, 1997, BAS METH; Winkler S, 1999, J AM DENT ASSOC, V130, P1759, DOI 10.14219/jada.archive.1999.0133; Woschnagg H, 2002, LANCET, V359, P891, DOI 10.1016/S0140-6736(02)07933-3	54	52	53	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36557	10.1371/journal.pone.0036557	http://dx.doi.org/10.1371/journal.pone.0036557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570725	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400041
J	Kashyap, A; Zimmerman, T; Ergul, N; Bosserhoff, A; Hartman, U; Alla, V; Bataille, F; Galle, PR; Strand, S; Strand, D				Kashyap, A.; Zimmerman, T.; Erguel, N.; Bosserhoff, A.; Hartman, U.; Alla, V.; Bataille, F.; Galle, P. R.; Strand, S.; Strand, D.			The human Lgl polarity gene, Hugl-2, induces MET and suppresses Snail tumorigenesis	ONCOGENE			English	Article						Lgl; Hugl-2; Snail; EMT; MET; tumour suppression	EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; SQUAMOUS-CELL CARCINOMAS; E-CADHERIN EXPRESSION; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; DROSOPHILA-MELANOGASTER; PANCREATIC-CANCER; BREAST-CANCER; PRIMARY HEAD	Lethal giant larvae proteins have key roles in regulating polarity in a variety of cell types and function as tumour suppressors. A transcriptional programme initiated by aberrant Snail expression transforms epithelial cells to potentially aggressive cancer cells. Although progress in defining the molecular determinants of this programme has been made, we have little knowledge as to how the Snail-induced phenotype can be suppressed. In our studies we identified the human lethal giant larvae homologue 2, Hugl-2, (Llgl2/Lgl2) polarity gene as downregulated by Snail. Snail binds E-boxes in the Hugl-2 promoter and represses Hugl-2 expression, whereas removal of the E-boxes releases Hugl-2 from Snail repression. We demonstrate that inducing Hugl-2 in cells with constitutive Snail expression reverses the phenotype including changes in morphology, motility, tumour growth and dissemination in vivo, and expression of epithelial markers. Hugl-2 expression reduced the nuclear localization of Snail and thus binding of Snail to its target promoters. Our results placing Hugl-2 within the Snail network as well as its ability to suppress Snail carcinogenesis identifies Hugl-2 as a target molecule driving cascades, which may have preventative and therapeutic promise to minimize cancer progression. Oncogene (2013) 32, 1396-1407; doi:10.1038/onc.2012.162; published online 14 May 2012	[Kashyap, A.; Zimmerman, T.; Erguel, N.; Hartman, U.; Alla, V.; Galle, P. R.; Strand, S.; Strand, D.] Johannes Gutenberg Univ Mainz, Dept Internal Med 1, D-55101 Mainz, Germany; [Bosserhoff, A.; Bataille, F.] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany	Johannes Gutenberg University of Mainz; University of Regensburg	Strand, D (corresponding author), Johannes Gutenberg Univ Mainz, Dept Internal Med 1, Obere Zahlbacherstr 63, D-55101 Mainz, Germany.	dstrand@uni-mainz.de	Galle, Peter/ABE-2872-2021; Bosserhoff, Anja/GNH-4801-2022; Galle, Peter R/T-5292-2018	Galle, Peter/0000-0001-8294-0992; Galle, Peter R/0000-0001-8294-0992; Bosserhoff, Anja/0000-0001-8147-394X	MAIFOR program	MAIFOR program	We thank A Garcia de Herreros for allowing us to use the Snail-HA expression plasmid and PH Krammer for providing anti-Apo-1 antibody. MDA-MB-231 cells were a gift of Thomas Efferth. We kindly thank Anil K Rustgi and Eric R Fearon for providing CyclinD1- and E-cadherin-luciferase constructs, respectively. The expert technical assistance of Mirjam Weisser, Daniela Gottfried, Henry Alizor, Shenchu Jin and Henning Janssen is gratefully acknowledged. Special thanks to the laser-scanning microscopy Core Facility of the Forschungszentrum Immunolgie Mainz. This work was supported by grants from the MAIFOR program to DS and SS. DS and SS should be considered as equal senior authors.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Aichberger KJ, 2009, BLOOD, V114, P5342, DOI 10.1182/blood-2008-08-175190; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Froldi F, 2008, CURR GENOMICS, V9, P147, DOI 10.2174/138920208784340786; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; GATEFF E, 1967, AM ZOOL, V7, P760; Gavert N, 2008, TRENDS MOL MED, V14, P199, DOI 10.1016/j.molmed.2008.03.004; Grifoni D, 2007, ONCOGENE, V26, P5960, DOI 10.1038/sj.onc.1210389; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Harada T, 2009, PANCREATOLOGY, V9, P13, DOI 10.1159/000178871; Hensen EF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-168; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Lisovsky M, 2010, HUM PATHOL, V41, P902, DOI 10.1016/j.humpath.2009.12.004; Lisovsky M, 2009, MODERN PATHOL, V22, P977, DOI 10.1038/modpathol.2009.68; Lu XF, 2009, CLIN CANCER RES, V15, P3287, DOI 10.1158/1078-0432.CCR-08-2078; Maas K, 2002, J IMMUNOL, V169, P5, DOI 10.4049/jimmunol.169.1.5; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; Miyoshi A, 2005, BRIT J CANCER, V92, P252, DOI 10.1038/sj.bjc.6602266; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Ohali A, 2004, ONCOGENE, V23, P8997, DOI 10.1038/sj.onc.1208060; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pena C, 2009, ONCOGENE, V28, P4375, DOI 10.1038/onc.2009.285; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Skotheim RI, 2002, CANCER RES, V62, P2359; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Taxman DJ, 2003, CANCER RES, V63, P5095; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomioka H, 2006, J ORAL PATHOL MED, V35, P206, DOI 10.1111/j.1600-0714.2006.00410.x; Tsuruga T, 2007, ONCOL RES, V16, P431, DOI 10.3727/000000007783980855; Veekony H, 2007, CLIN CANCER RES, V13, P3133, DOI 10.1158/1078-0432.CCR-06-2555; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398	51	23	24	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2013	32	11					1396	1407		10.1038/onc.2012.162	http://dx.doi.org/10.1038/onc.2012.162			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22580609				2022-12-25	WOS:000316455600006
J	Brandmayr, J; Poomvanicha, M; Domes, K; Ding, J; Blaich, A; Wegener, JW; Moosmang, S; Hofmann, F				Brandmayr, Julia; Poomvanicha, Montatip; Domes, Katrin; Ding, Jie; Blaich, Anne; Wegener, Joerg W.; Moosmang, Sven; Hofmann, Franz			Deletion of the C-terminal Phosphorylation Sites in the Cardiac beta-Subunit Does Not Affect the Basic beta-Adrenergic Response of the Heart and the Cav1.2 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CA(V)1.2 CALCIUM-CHANNEL; CA2+ CHANNELS; FACILITATION; STIMULATION; EXPRESSION; ALPHA(1C); REQUIRES; CARDIOMYOCYTES; IDENTIFICATION	Phosphorylation of the cardiac beta subunit (Ca-v beta(2)) of the Cav1.2 L-type Ca2+ channel complex has been proposed as a mechanism for regulation of L-type Ca2+ channels by various protein kinases including PKA, CaMKII, Akt/PKB, and PKG. To test this hypothesis directly in vivo, we generated a knock-in mouse line with targeted mutation of the Ca-v beta(2) gene by insertion of a stop codon after proline 501 in exon 14 (mouse sequence Cacnb2; beta Stop mouse). This mutation prevented translation of the Ca-v beta(2) C terminus that contains the relevant phosphorylation sites for the above protein kinases. Homozygous cardiac beta Stop mice were born at Mendelian ratio, had a normal life expectancy, and normal basal L-type I-Ca. The regulation of the L-type current by stimulation of the beta-adrenergic receptor was unaffected in vivo and in cardiomyocytes (CMs). beta Stop mice were cross-bred with mice expressing the Cav1.2 gene containing the mutation S1928A (SA beta Stop) or S1512A and S1570A (SF beta Stop) in theCterminus of the alpha(1C) subunit. The beta-adrenergic regulation of the cardiac ICa was unaltered in these mouse lines. In contrast, truncation of the Cav1.2 at Asp1904 abolished beta-adrenergic up-regulation of ICa in murine embryonic CMs. We conclude that phosphorylation of the C-terminal sites in Ca-v beta(2), Ser1928, Ser1512, and Ser1570 of the Cav1.2 protein is functionally not involved in the adrenergic regulation of the murine cardiac Cav1.2 channel.	[Brandmayr, Julia; Poomvanicha, Montatip; Domes, Katrin; Ding, Jie; Blaich, Anne; Wegener, Joerg W.; Moosmang, Sven; Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, Forschergrp 923, D-80802 Munich, Germany	Technical University of Munich	Hofmann, F (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, FOR923, Biedersteiner Str 29, D-80802 Munich, Germany.	franz.hofmann@mytum.de		Wegener, Jorg/0000-0002-8129-1537	Deutsche Forschungsgemeinschaft; Fond der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie)	This work was supported by grants from Deutsche Forschungsgemeinschaft and Fond der Chemischen Industrie.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blaich A, 2010, P NATL ACAD SCI USA, V107, P10285, DOI 10.1073/pnas.0914287107; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Catterall WA, 2006, J RECEPT SIG TRANSD, V26, P577, DOI 10.1080/10799890600915100; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Domes K, 2011, J BIOL CHEM, V286, P33863, DOI 10.1074/jbc.M111.252312; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Fu Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175307; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Jiang LH, 2000, J BIOL CHEM, V275, P6135, DOI 10.1074/jbc.275.9.6135; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Ludwig A, 1997, J NEUROSCI, V17, P1339; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; McHugh D, 2000, P NATL ACAD SCI USA, V97, P12334, DOI 10.1073/pnas.210384297; Meissner M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227819; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; OSTERRIEDER W, 1982, NATURE, V298, P576, DOI 10.1038/298576a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Poomvanicha M, 2011, J BIOL CHEM, V286, P26702, DOI 10.1074/jbc.M111.247841; REUTER H, 1974, J PHYSIOL-LONDON, V242, P429, DOI 10.1113/jphysiol.1974.sp010716; SCULPTOREANU A, 1993, P NATL ACAD SCI USA, V90, P10135, DOI 10.1073/pnas.90.21.10135; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; SINGERLAHAT D, 1992, FEBS LETT, V306, P113, DOI 10.1016/0014-5793(92)80980-U; Sun H, 2006, CIRC RES, V98, P1390, DOI 10.1161/01.RES.0000223321.34482.8c; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Yang L, 2007, CIRC RES, V101, P465, DOI 10.1161/CIRCRESAHA.107.156976; Yang L, 2009, BIOCHEMISTRY-US, V48, P6674, DOI 10.1021/bi900322a	42	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22584	22592		10.1074/jbc.M112.366484	http://dx.doi.org/10.1074/jbc.M112.366484			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589548	hybrid, Green Published			2022-12-25	WOS:000306495000015
J	Sundvall, M; Korhonen, A; Vaparanta, K; Anckar, J; Halkilahti, K; Salah, Z; Aqeilan, RI; Palvimo, JJ; Sistonen, L; Elenius, K				Sundvall, Maria; Korhonen, Anna; Vaparanta, Katri; Anckar, Julius; Halkilahti, Kalle; Salah, Zaidoun; Aqeilan, Rami I.; Palvimo, Jorma J.; Sistonen, Lea; Elenius, Klaus			Protein Inhibitor of Activated STAT3 (PIAS3) Protein Promotes SUMOylation and Nuclear Sequestration of the Intracellular Domain of ErbB4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; BH3-ONLY PROTEIN; MAMMARY-GLAND; EXPRESSION; ISOFORM; GROWTH; CANCER; DIFFERENTIATION; LOCALIZATION; CLEAVAGE	ErbB4 is a receptor tyrosine kinase implicated in the development and homeostasis of the heart, central nervous system, and mammary gland. Cleavable isoforms of ErbB4 release a soluble intracellular domain (ICD) that can translocate to the nucleus and function as a transcriptional coregulator. In search of regulatory mechanisms of ErbB4 ICD function, we identified PIAS3 as a novel interaction partner of ErbB4 ICD. In keeping with the small ubiquitin-like modifier (SUMO) E3 ligase function of protein inhibitor of activated STAT (PIAS) proteins, we showed that the ErbB4 ICD is modified by SUMO, and that PIAS3 stimulates the SUMOylation. Upon overexpression of PIAS3, the ErbB4 ICD generated from the full-length receptor accumulated into the nucleus in a manner that was dependent on the functional nuclear localization signal of ErbB4. In the nucleus, ErbB4 colocalized with PIAS3 and SUMO-1 in promyelocytic leukemia nuclear bodies, nuclear domains involved in regulation of transcription. Accordingly, PIAS3 overexpression had an effect on the transcriptional coregulatory activity of ErbB4, repressing its ability to coactivate transcription with Yes-associated protein. Finally, knockdown of PIAS3 with siRNA partially rescued the inhibitory effect of the ErbB4 ICD on differentiation of MDA-MB-468 breast cancer and HC11 mammary epithelial cells. Our findings illustrate that PIAS3 is a novel regulator of ErbB4 receptor tyrosine kinase, controlling its nuclear sequestration and function.	[Sundvall, Maria; Korhonen, Anna; Vaparanta, Katri; Halkilahti, Kalle; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Sundvall, Maria; Korhonen, Anna; Vaparanta, Katri; Halkilahti, Kalle; Elenius, Klaus] Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; [Korhonen, Anna] Univ Turku, Turku Doctoral Program Biomed Sci, FIN-20520 Turku, Finland; [Sundvall, Maria; Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland; [Anckar, Julius; Sistonen, Lea] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Anckar, Julius; Sistonen, Lea] Abo Akad Univ, Turku, Finland; [Salah, Zaidoun; Aqeilan, Rami I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, IL-91120 Jerusalem, Israel; [Palvimo, Jorma J.] Univ Eastern Finland, Inst Biomed Med Biochem, Kuopio 70211, Finland; [Palvimo, Jorma J.] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; Abo Akademi University; Hebrew University of Jerusalem; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	klaus.elenius@utu.fi	Elenius, Klaus/AAI-7594-2021; Aqeilan, Rami/R-4443-2016; Aqeilan, Rami/AAT-7785-2020	Elenius, Klaus/0000-0001-5700-0827; Aqeilan, Rami/0000-0002-6034-023X; Palvimo, Jorma/0000-0003-2373-0578; Sistonen, Lea/0000-0003-1341-2867; Sundvall, Maria H/0000-0002-0494-2965	Academy of Finland; EU; Finnish Cancer Organizations; Finnish Cultural Foundation; Juselius Foundation; Turku Doctoral Program of Biomedical Sciences; Turku University Central Hospital; Turku University Foundation	Academy of Finland(Academy of Finland); EU(European Commission); Finnish Cancer Organizations; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Juselius Foundation; Turku Doctoral Program of Biomedical Sciences; Turku University Central Hospital; Turku University Foundation	This study was supported by the Academy of Finland, the EU-FP7 Marie Curie Grant, Finnish Cancer Organizations, the Finnish Cultural Foundation, the Juselius Foundation, the Turku Doctoral Program of Biomedical Sciences, Turku University Central Hospital, and the Turku University Foundation.	Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kew TY, 2000, BRIT J CANCER, V82, P1163, DOI 10.1054/bjoc.1999.1057; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Linggi B, 2006, J BIOL CHEM, V281, P25373, DOI 10.1074/jbc.M603998200; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; McHale K, 2008, MODERN PATHOL, V21, P565, DOI 10.1038/modpathol.2008.7; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Muraoka-Cook RS, 2009, MOL CELL BIOL, V29, P4935, DOI 10.1128/MCB.01705-08; Naresh A, 2008, CANCER RES, V68, P6387, DOI 10.1158/0008-5472.CAN-08-0538; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Paatero I, 2012, J BIOL CHEM, V287, P9659, DOI 10.1074/jbc.M111.299537; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pircher TJ, 1997, MOL CELL ENDOCRINOL, V133, P169, DOI 10.1016/S0303-7207(97)00164-0; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Srinivasan R, 2000, CANCER RES, V60, P1483; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; Thor AD, 2009, AM J PATHOL, V175, P1802, DOI 10.2353/ajpath.2009.090204; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Wang LM, 2004, ONCOL REP, V11, P1319; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	45	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23216	23226		10.1074/jbc.M111.335927	http://dx.doi.org/10.1074/jbc.M111.335927			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584572	hybrid, Green Published			2022-12-25	WOS:000306495000076
J	Boyer, NP; Higbee, D; Currin, MB; Blakeley, LR; Chen, CH; Ablonczy, Z; Crouch, RK; Koutalos, Y				Boyer, Nicholas P.; Higbee, Daniel; Currin, Mark B.; Blakeley, Lorie R.; Chen, Chunhe; Ablonczy, Zsolt; Crouch, Rosalie K.; Koutalos, Yiannis			Lipofuscin and N-Retinylidene-N-Retinylethanolamine (A2E) Accumulate in Retinal Pigment Epithelium in Absence of Light Exposure THEIR ORIGIN IS 11-cis-RETINAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER ABCA4; STARGARDT-DISEASE; RPE LIPOFUSCIN; FLUOROPHORE; BIOSYNTHESIS; FLUORESCENCE; CELLS; DEGENERATION; GENERATION; SUBSTRATE	The age-dependent accumulation of lipofuscin in the retinal pigment epithelium (RPE) has been associated with the development of retinal diseases, particularly age-related macular degeneration and Stargardt disease. A major component of lipofuscin is the bis-retinoid N-retinylidene-N-retinylethanolamine (A2E). The current model for the formation of A2E requires photoactivation of rhodopsin and subsequent release of all-trans-retinal. To understand the role of light exposure in the accumulation of lipofuscin and A2E, we analyzed RPEs and isolated rod photoreceptors from mice of different ages and strains, reared either in darkness or cyclic light. Lipofuscin levels were determined by fluorescence imaging, whereas A2E levels were quantified by HPLC and UV-visible absorption spectroscopy. The identity of A2E was confirmed by tandem mass spectrometry. Lipofuscin and A2E levels in the RPE increased with age and more so in the Stargardt model Abca4(-/-) than in the wild type strains 129/sv and C57Bl/6. For each strain, the levels of lipofuscin precursor fluorophores in dark-adapted rods and the levels and rates of increase of RPE lipofuscin and A2E were not different between dark-reared and cyclic light-reared animals. Both 11-cis-and all-trans-retinal generated lipofuscin-like fluorophores when added to metabolically compromised rod outer segments; however, it was only 11-cis-retinal that generated such fluorophores when added to metabolically intact rods. The results suggest that lipofuscin originates from the free 11-cis-retinal that is continuously supplied to the rod for rhodopsin regeneration and outer segment renewal. The physiological role of Abca4 may include the translocation of 11-cis-retinal complexes across the disk membrane.	[Koutalos, Yiannis] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Koutalos, Y (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA.	koutalo@musc.edu			National Institutes of Health [EY020661, EY004939, EY014850, EY014793]; Extramural Research Facilities Program of NCRR [C06 RR015455]; Foundation Fighting Blindness, Inc.; Departments of Ophthalmology at Medical University of South Carolina from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019065, R21EY020661, R01EY004939, R01EY014850, R24EY014793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Extramural Research Facilities Program of NCRR; Foundation Fighting Blindness, Inc.; Departments of Ophthalmology at Medical University of South Carolina from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the Extramural Research Facilities Program of NCRR.; This work was supported, in whole or in part, by National Institutes of Health Grants EY020661 (to Z. A. and R. K. C.), EY004939 (to R. K. C.), EY014850 (to Y. K.), and EY014793 (to Medical University of South Carolina Vision Core). This work was also supported by the Foundation Fighting Blindness, Inc. (to R. K. C.) and unrestricted awards to the Departments of Ophthalmology at Medical University of South Carolina from Research to Prevent Blindness.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; Boyer N. P., 2012, PHOTOCHEM P IN PRESS; Bui TV, 2006, J BIOL CHEM, V281, P18112, DOI 10.1074/jbc.M601380200; Chen CH, 2010, PHOTOCH PHOTOBIO SCI, V9, P1475, DOI 10.1039/c0pp00124d; Chen CH, 2009, INVEST OPHTH VIS SCI, V50, P3589, DOI 10.1167/iovs.08-3336; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; Grey AC, 2011, INVEST OPHTH VIS SCI, V52, P3926, DOI 10.1167/iovs.10-7020; Gutierrez DB, 2010, PHOTOCH PHOTOBIO SCI, V9, P1513, DOI 10.1039/c0pp00230e; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; KATZ ML, 1989, INVEST OPHTH VIS SCI, V30, P37; KATZ ML, 1986, EXP EYE RES, V43, P561, DOI 10.1016/S0014-4835(86)80023-9; Katz ML, 2002, ARCH GERONTOL GERIAT, V34, P169, DOI 10.1016/S0167-4943(02)00005-5; Katz ML, 1996, MECH AGEING DEV, V92, P159, DOI 10.1016/S0047-6374(96)01817-9; Katz ML, 2001, INVEST OPHTH VIS SCI, V42, P3023; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; Ng KP, 2008, MOL CELL PROTEOMICS, V7, P1397, DOI 10.1074/mcp.M700525-MCP200; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Rozanowska M, 1998, FREE RADICAL BIO MED, V24, P1107, DOI 10.1016/S0891-5849(97)00395-X; Salvador GA, 1998, LIPIDS, V33, P853, DOI 10.1007/s11745-998-0281-z; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; WING GL, 1978, INVEST OPHTH VIS SCI, V17, P601; Winkler BS, 1999, MOL VIS, V5; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	54	90	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22276	22286		10.1074/jbc.M111.329235	http://dx.doi.org/10.1074/jbc.M111.329235			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570475	Green Published, hybrid			2022-12-25	WOS:000306418600065
J	Zhu, JX; Zheng, HJ; Ai, GM; Zhang, GS; Liu, D; Liu, XL; Dong, XZ				Zhu, Jinxing; Zheng, Huajun; Ai, Guomin; Zhang, Guishan; Liu, Di; Liu, Xiaoli; Dong, Xiuzhu			The Genome Characteristics and Predicted Function of Methyl-Group Oxidation Pathway in the Obligate Aceticlastic Methanogens, Methanosaeta spp.	PLOS ONE			English	Article							ENERGY-CONSERVATION; ELECTRON-TRANSPORT; ISOTOPE RATIO; ACETIVORANS; REVEALS; THERMOPHILA; DATABASE; GENES; MAZEI	In this work, we report the complete genome sequence of an obligate aceticlastic methanogen, Methanosaeta harundinacea 6Ac. Genome comparison indicated that the three cultured Methanosaeta spp., M. thermophila, M. concilii and M. harundinacea 6Ac, each carry an entire suite of genes encoding the proteins involved in the methyl-group oxidation pathway, a pathway whose function is not well documented in the obligately aceticlastic methanogens. Phylogenetic analysis showed that the methyl-group oxidation-involving proteins, Fwd, Mtd, Mch, and Mer from Methanosaeta strains cluster with the methylotrophic methanogens, and were not closely related to those from the hydrogenotrophic methanogens. Quantitative PCR detected the expression of all genes for this pathway, albeit ten times lower than the genes for aceticlastic methanogenesis in strain 6Ac. Western blots also revealed the expression of fwd and mch, genes involved in methyl-group oxidation. Moreover, C-13-labeling experiments suggested that the Methanosaeta strains might use the pathway as a methyl oxidation shunt during the aceticlastic metabolism. Because the mch mutants of Methanosarcina barkeri or M. acetivorans failed to grow on acetate, we suggest that Methanosaeta may use methyl-group oxidation pathway to generate reducing equivalents, possibly for biomass synthesis. An fpo operon, which encodes an electron transport complex for the reduction of CoM-CoB heterodisulfide, was found in the three genomes of the Methanosaeta strains. However, an incomplete protein complex lacking the FpoF subunit was predicted, as the gene for this protein was absent. Thus, F420H2 was predicted not to serve as the electron donor. In addition, two gene clusters encoding the two types of heterodisulfide reductase (Hdr), hdrABC, and hdrED, respectively, were found in the three Methanosaeta genomes. Quantitative PCR determined that the expression of hdrED was about ten times higher than hdrABC, suggesting that hdrED plays a major role in aceticlastic methanogenesis.	[Zhu, Jinxing; Ai, Guomin; Zhang, Guishan; Liu, Xiaoli; Dong, Xiuzhu] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Zhu, Jinxing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Liu, Di] Chinese Acad Sci, Inst Microbiol, Informat Ctr, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Zhu, JX (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	dongxz@im.ac.cn	Liu, Di/ABD-2729-2021; Dong, Xiuzhu/EBF-2196-2022; Liu, Xiaoli/HGE-7614-2022; Liu, Di/G-6135-2014	Liu, Di/0000-0003-3693-2726; Dong, Xiuzhu/0000-0002-6926-5459; Liu, Di/0000-0003-3693-2726	National Natural Science Foundation of China [30621005, 30830007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China under grant no. 30621005 and 30830007 (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACETI DJ, 1988, J BIOL CHEM, V263, P15444; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Buan NR, 2010, MOL MICROBIOL, V75, P843, DOI 10.1111/j.1365-2958.2009.06990.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Deppenmeier U, 1996, ARCH MICROBIOL, V165, P149, DOI 10.1007/BF01692856; Deppenmeier U, 1999, FEBS LETT, V457, P291, DOI 10.1016/S0014-5793(99)01026-1; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Egwuagu CE, 1997, J IMMUNOL, V159, P3109; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; FERRY JG, 1992, J BACTERIOL, V174, P5489, DOI 10.1128/JB.174.17.5489-5495.1992; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Guss AM, 2005, MOL MICROBIOL, V55, P1671, DOI 10.1111/j.1365-2958.2005.04514.x; HAROLD FM, 1972, BACTERIOL REV, V36, P172, DOI 10.1128/MMBR.36.2.172-230.1972; Hattori R, 2010, J AGR FOOD CHEM, V58, P7115, DOI 10.1021/jf100406y; Hochheimer A, 1998, ARCH MICROBIOL, V170, P389, DOI 10.1007/s002030050658; HUSER BA, 1982, ARCH MICROBIOL, V132, P1, DOI 10.1007/BF00690808; Li JB, 2011, APPL ENVIRON MICROB, V77, P6141, DOI 10.1128/AEM.00657-11; Li QB, 2006, J BACTERIOL, V188, P702, DOI 10.1128/JB.188.2.702-710.2006; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Ma K, 2006, INT J SYST EVOL MICR, V56, P127, DOI 10.1099/ijs.0.63887-0; Maeder DL, 2006, J BACTERIOL, V188, P7922, DOI 10.1128/JB.00810-06; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moran James J., 2005, Archaea, V1, P303, DOI 10.1155/2005/650670; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Paiva S, 2004, YEAST, V21, P201, DOI 10.1002/yea.1056; Serra F, 2007, J MASS SPECTROM, V42, P361, DOI 10.1002/jms.1168; Spring S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/690737; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; TERLESKY KC, 1987, J BIOL CHEM, V262, P15392; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Welander PV, 2005, P NATL ACAD SCI USA, V102, P10664, DOI 10.1073/pnas.0502623102; Welte C, 2011, J BACTERIOL IN PRESS; Welte C, 2010, J BACTERIOL, V192, P674, DOI 10.1128/JB.01307-09; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Zhu J, 2011, INT J SYST IN PRESS	45	24	28	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36756	10.1371/journal.pone.0036756	http://dx.doi.org/10.1371/journal.pone.0036756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590603	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336400032
J	Guryanov, SG; Selivanova, OM; Nikulin, AD; Enin, GA; Melnik, BS; Kretov, DA; Serdyuk, IN; Ovchinnikov, LP				Guryanov, Sergey G.; Selivanova, Olga M.; Nikulin, Alexey D.; Enin, Gennady A.; Melnik, Bogdan S.; Kretov, Dmitry A.; Serdyuk, Igor N.; Ovchinnikov, Lev P.			Formation of Amyloid-Like Fibrils by Y-Box Binding Protein 1 (YB-1) Is Mediated by Its Cold Shock Domain and Modulated by Disordered Terminal Domains	PLOS ONE			English	Article							MESSENGER-RIBONUCLEOPROTEIN PARTICLES; MIGRATION INHIBITORY FACTOR; TRANSCRIPTION FACTOR; DNA-BINDING; IN-VITRO; NONCLASSICAL PATHWAY; GENE-EXPRESSION; BREAST-CANCER; RNA; PROMOTES	YB-1, a multifunctional DNA- and RNA-binding nucleocytoplasmic protein, is involved in the majority of DNA- and mRNA-dependent events in the cell. It consists of three structurally different domains: its central cold shock domain has the structure of a beta-barrel, while the flanking domains are predicted to be intrinsically disordered. Recently, we showed that YB1 is capable of forming elongated fibrils under high ionic strength conditions. Here we report that it is the cold shock domain that is responsible for formation of YB-1 fibrils, while the terminal domains differentially modulate this process depending on salt conditions. We demonstrate that YB-1 fibrils have amyloid-like features, including affinity for specific dyes and a typical X-ray diffraction pattern, and that in contrast to most of amyloids, they disassemble under nearly physiological conditions.	[Guryanov, Sergey G.; Kretov, Dmitry A.; Ovchinnikov, Lev P.] Russian Acad Sci, Inst Prot Res, Grp Prot Biosynth Regulat, Pushchino 142292, Russia; [Selivanova, Olga M.; Enin, Gennady A.; Serdyuk, Igor N.] Russian Acad Sci, Inst Prot Res, Grp Nucleoprot Phys, Pushchino 142292, Russia; [Nikulin, Alexey D.] Russian Acad Sci, Inst Prot Res, Grp Struct Studies Ribosomal Prot, Pushchino 142292, Russia; [Melnik, Bogdan S.] Russian Acad Sci, Inst Prot Res, Lab Prot Phys, Pushchino 142292, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences	Guryanov, SG (corresponding author), Russian Acad Sci, Inst Prot Res, Grp Prot Biosynth Regulat, Pushchino 142292, Russia.	ovchinn@vega.protres.ru	Melnik, Bogdan/U-1988-2017; Nikulin, Alexey/B-8226-2011; Selivanova, Olga/HDL-9515-2022; Selivanova, Olga/M-3184-2015; Kretov, Dmitry/AAU-6058-2020; Ovchinnikov, Lev/L-2397-2015	Melnik, Bogdan/0000-0002-9176-6452; Nikulin, Alexey/0000-0001-5391-6184; Gurianov, Sergei/0000-0003-3058-5460; Kretov, Dmitry/0000-0003-1829-8610	Russian Foundation for Basic Research [11-04-00267]; Presidium of the Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	This work has been performed with financial support of the Russian Foundation for Basic Research grant 11-04-00267 and grants of the "Molecular and Cellular Biology'' and "Fundamental Sciences to Medicine'' Programs, Presidium of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrescu AT, 1999, J MOL BIOL, V291, P1191, DOI 10.1006/jmbi.1999.3039; Bader AG, 2003, P NATL ACAD SCI USA, V100, P12384, DOI 10.1073/pnas.2135336100; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; Chansky HA, 2001, CANCER RES, V61, P3586; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; Chernov Konstantin G., 2008, BMC Biochemistry, V9, P23, DOI 10.1186/1471-2091-9-23; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Davies AH, 2011, ONCOGENE, V30, P3649, DOI 10.1038/onc.2011.82; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Evdokimova VM, 1998, J BIOL CHEM, V273, P3574, DOI 10.1074/jbc.273.6.3574; Evdokimova VM, 1999, INT J BIOCHEM CELL B, V31, P139, DOI 10.1016/S1357-2725(98)00137-X; EVDOKIMOVA VM, 1995, J BIOL CHEM, V270, P3186, DOI 10.1074/jbc.270.7.3186; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Gonda K, 2006, J BIOL CHEM, V281, P8153, DOI 10.1074/jbc.M512890200; Holm PS, 2002, J BIOL CHEM, V277, P10427, DOI 10.1074/jbc.M106955200; Janz M, 2002, INT J CANCER, V97, P278, DOI 10.1002/ijc.1610; JANZ M, 2000, GENE FUNCT DIS, V1, P57; Jaskolski M, 2001, ACTA BIOCHIM POL, V48, P807; Klement K, 2007, J MOL BIOL, V373, P1321, DOI 10.1016/j.jmb.2007.08.068; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Lashuel HA, 2005, BIOCHEM BIOPH RES CO, V338, P973, DOI 10.1016/j.bbrc.2005.10.040; Lobanov MY, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035004; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Maury CPJ, 2009, J INTERN MED, V265, P329, DOI 10.1111/j.1365-2796.2008.02068.x; Max KEA, 2007, FEBS J, V274, P1265, DOI 10.1111/j.1742-4658.2007.05672.x; McGlinchey RP, 2011, BIOCHEMISTRY-US, V50, P10567, DOI 10.1021/bi201578h; Mertens PR, 1998, J BIOL CHEM, V273, P32957, DOI 10.1074/jbc.273.49.32957; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Norman JT, 2001, J BIOL CHEM, V276, P29880, DOI 10.1074/jbc.M103145200; OZER J, 1990, J BIOL CHEM, V265, P22143; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Ruzanov PV, 1999, J CELL SCI, V112, P3487; Selivanova OM, 2010, BIOCHEMISTRY-MOSCOW+, V75, P115, DOI 10.1134/S0006297910010153; Serpell LC, 1999, METHOD ENZYMOL, V309, P526; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Tacke F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-185; TAFURI SR, 1992, NEW BIOL, V4, P349; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196; Yang WH, 2007, RNA, V13, P704, DOI 10.1261/rna.411907	56	22	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36969	10.1371/journal.pone.0036969	http://dx.doi.org/10.1371/journal.pone.0036969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590640	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335500034
J	Pedeboscq, S; Rey, C; Petit, M; Harpey, C; De Giorgi, F; Ichas, F; Lartigue, L				Pedeboscq, Stephane; Rey, Christophe; Petit, Muriel; Harpey, Catherine; De Giorgi, Francesca; Ichas, Francois; Lartigue, Lydia			Non-Antioxidant Properties of alpha-Tocopherol Reduce the Anticancer Activity of Several Protein Kinase Inhibitors In Vitro	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; VITAMIN-E; LUNG-CANCER; HUMAN MONOCYTES; BCR-ABL; PHASE-I; APOPTOSIS; STAUROSPORINE; MUTATIONS; GEFITINIB	The antioxidant properties of alpha-tocopherol have been proposed to play a beneficial chemopreventive role against cancer. However, emerging data also indicate that it may exert contrasting effects on the efficacy of chemotherapeutic treatments when given as dietary supplement, being in that case harmful for patients. This dual role of alpha-tocopherol and, in particular, its effects on the efficacy of anticancer drugs remains poorly documented. For this purpose, we studied here, using high throughput flow cytometry, the direct impact of alpha-tocopherol on apoptosis and cell cycle arrest induced by different cytotoxic agents on various models of cancer cell lines in vitro. Our results indicate that physiologically relevant concentrations of alpha-tocopherol strongly compromise the cytotoxic and cytostatic action of various protein kinase inhibitors (KI), while other classes of chemotherapeutic agents or apoptosis inducers are unaffected by this vitamin. Interestingly, these anti-chemotherapeutic effects of alpha-tocopherol appear to be unrelated to its antioxidant properties since a variety of other antioxidants were completely neutral toward KI-induced cell cycle arrest and cell death. In conclusion, our data suggest that dietary alpha-tocopherol could limit KI effects on tumour cells, and, by extent, that this could result in a reduction of the clinical efficacy of anti-cancer treatments based on KI molecules.	[Pedeboscq, Stephane; Rey, Christophe; De Giorgi, Francesca; Ichas, Francois; Lartigue, Lydia] Univ Bordeaux 2, Inst Bergonie, INSERM, VINCO U916, F-33076 Bordeaux, France; [Pedeboscq, Stephane] CHU Bordeaux, Hop St Andre, Serv Pharm, Bordeaux, France; [Petit, Muriel; De Giorgi, Francesca; Ichas, Francois] Fluofarma, Pessac, France; [Harpey, Catherine] Inst Rech Servier, F-92150 Suresnes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; CHU Bordeaux; Servier; Institut de Recherches Internationales Servier	Pedeboscq, S (corresponding author), Univ Bordeaux 2, Inst Bergonie, INSERM, VINCO U916, F-33076 Bordeaux, France.	lartigue-faustin@bergonie.org	lartigue, lydia/I-9548-2014; Ichas, François/ABD-8277-2020	Ichas, François/0000-0001-8184-5248; De Giorgi, Francesca/0000-0003-4850-3582	National Agency of Research (ANR); French National Institute for Medical Research (INSERM); Region of Aquitaine; French Ministry of Research; Institute Bergonie; Association for Cancer Research; Ligue Contre le Cancer; Canceropole Grand Sud-Ouest	National Agency of Research (ANR)(French National Research Agency (ANR)); French National Institute for Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region of Aquitaine(Region Nouvelle-Aquitaine); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institute Bergonie; Association for Cancer Research; Ligue Contre le Cancer(Ligue nationale contre le cancer); Canceropole Grand Sud-Ouest	The authors were supported by grants from the National Agency of Research (ANR), the French National Institute for Medical Research (INSERM), the Region of Aquitaine, the French Ministry of Research, the Institute Bergonie, the Association for Cancer Research, the Ligue Contre le Cancer and the Canceropole Grand Sud-Ouest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlemeyer B, 2000, NEUROCHEM INT, V36, P1, DOI 10.1016/S0197-0186(99)00101-1; Aratri E, 1999, FEBS LETT, V447, P91, DOI 10.1016/S0014-5793(99)00277-X; AZZI A, 1993, MOL ASPECTS MED, V14, P265, DOI 10.1016/0098-2997(93)90014-5; Azzi A, 2000, PROG LIPID RES, V39, P231, DOI 10.1016/S0163-7827(00)00006-0; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Berger MM, 2005, CLIN NUTR, V24, P172, DOI 10.1016/j.clnu.2004.10.003; Bjelakovic G, 2004, LANCET, V364, P1219, DOI 10.1016/S0140-6736(04)17138-9; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; BOSCOBOINIK D, 1991, J BIOL CHEM, V266, P6188; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; Cachia O, 1998, J BIOL CHEM, V273, P32801, DOI 10.1074/jbc.273.49.32801; CHATELAIN E, 1993, BIOCHIM BIOPHYS ACTA, V1176, P83, DOI 10.1016/0167-4889(93)90181-N; Coyoy A, 2008, FREE RADICAL BIO MED, V45, P1056, DOI 10.1016/j.freeradbiomed.2008.06.027; Devaraj S, 1996, J CLIN INVEST, V98, P756, DOI 10.1172/JCI118848; Devaraj S, 1997, ARTERIOSCL THROM VAS, V17, P2273, DOI 10.1161/01.ATV.17.10.2273; Devaraj S, 1999, ARTERIOSCL THROM VAS, V19, P1125, DOI 10.1161/01.ATV.19.4.1125; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Freedman JE, 1996, CIRCULATION, V94, P2434, DOI 10.1161/01.CIR.94.10.2434; Gescher A, 1998, GEN PHARMACOL, V31, P721, DOI 10.1016/S0306-3623(98)00069-X; Gulcin I, 2005, CHEM PHARM BULL, V53, P281, DOI 10.1248/cpb.53.281; ISHIZAKI Y, 1993, J CELL BIOL, V121, P899, DOI 10.1083/jcb.121.4.899; JARVIS WD, 1994, CANCER RES, V54, P1707; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Keaney JF, 1999, FASEB J, V13, P965, DOI 10.1096/fasebj.13.9.965; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Martin-Nizard F, 1998, J Cardiovasc Risk, V5, P339, DOI 10.1097/00043798-199810000-00010; Mizutani H, 2005, LIFE SCI, V76, P1439, DOI 10.1016/j.lfs.2004.05.040; Monnerat C, 2004, ANN ONCOL, V15, P316, DOI 10.1093/annonc/mdh052; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; Propper DJ, 2001, J CLIN ONCOL, V19, P1485, DOI 10.1200/JCO.2001.19.5.1485; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Ricciarelli R, 2001, FASEB J, V15, P2314, DOI 10.1096/fj.01-0258rev; Schembri L, 2009, ANAL CHEM, V81, P9590, DOI 10.1021/ac9015227; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sigounas G, 1997, NUTR CANCER, V28, P30, DOI 10.1080/01635589709514549; Sordet O, 2004, J BIOL CHEM, V279, P50499, DOI 10.1074/jbc.M410277200; Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543; Sylvester PW, 2007, VITAM HORM, V76, P329, DOI 10.1016/S0083-6729(07)76012-0; Tada H, 1997, METABOLISM, V46, P779, DOI 10.1016/S0026-0495(97)90122-0; Tasinato A, 1995, P NATL ACAD SCI USA, V92, P12190, DOI 10.1073/pnas.92.26.12190; Temkin V, 2007, IMMUNOL REV, V220, P8, DOI 10.1111/j.1600-065X.2007.00560.x; Upston JM, 1999, FASEB J, V13, P977, DOI 10.1096/fasebj.13.9.977; Vignot S, 2008, B CANCER, V95, P683, DOI 10.1684/bdc.2008.0665; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Yano M, 2000, J NUTR, V130, P1095, DOI 10.1093/jn/130.5.1095	52	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36811	10.1371/journal.pone.0036811	http://dx.doi.org/10.1371/journal.pone.0036811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590613	gold, Green Submitted, Green Published			2022-12-25	WOS:000305335500030
J	Dudley, DM; Chin, EN; Bimber, BN; Sanabani, SS; Tarosso, LF; Costa, PR; Sauer, MM; Kallas, EG; O'Connor, DH				Dudley, Dawn M.; Chin, Emily N.; Bimber, Benjamin N.; Sanabani, Sabri S.; Tarosso, Leandro F.; Costa, Priscilla R.; Sauer, Mariana M.; Kallas, Esper G.; O'Connor, David H.			Low-Cost Ultra-Wide Genotyping Using Roche/454 Pyrosequencing for Surveillance of HIV Drug Resistance	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; HIV-1-INFECTED PATIENTS; TREATMENT-NAIVE; SCALING-UP; MUTATIONS; PREVALENCE; VARIANTS; CHILDREN; FAILURE	Background: Great efforts have been made to increase accessibility of HIV antiretroviral therapy (ART) in low and middle-income countries. The threat of wide-scale emergence of drug resistance could severely hamper ART scale-up efforts. Population-based surveillance of transmitted HIV drug resistance ensures the use of appropriate first-line regimens to maximize efficacy of ART programs where drug options are limited. However, traditional HIV genotyping is extremely expensive, providing a cost barrier to wide-scale and frequent HIV drug resistance surveillance. Methods/Results: We have developed a low-cost laboratory-scale next-generation sequencing-based genotyping method to monitor drug resistance. We designed primers specifically to amplify protease and reverse transcriptase from Brazilian HIV subtypes and developed a multiplexing scheme using multiplex identifier tags to minimize cost while providing more robust data than traditional genotyping techniques. Using this approach, we characterized drug resistance from plasma in 81 HIV infected individuals collected in Sao Paulo, Brazil. We describe the complexities of analyzing next-generation sequencing data and present a simplified open-source workflow to analyze drug resistance data. From this data, we identified drug resistance mutations in 20% of treatment naive individuals in our cohort, which is similar to frequencies identified using traditional genotyping in Brazilian patient samples. Conclusion: The developed ultra-wide sequencing approach described here allows multiplexing of at least 48 patient samples per sequencing run, 4 times more than the current genotyping method. This method is also 4-fold more sensitive (5% minimal detection frequency vs. 20%) at a cost 3-5 x less than the traditional Sanger-based genotyping method. Lastly, by using a benchtop next-generation sequencer (Roche/454 GS Junior), this approach can be more easily implemented in low-resource settings. This data provides proof-of-concept that next-generation HIV drug resistance genotyping is a feasible and low-cost alternative to current genotyping methods and may be particularly beneficial for in-country surveillance of transmitted drug resistance.	[Dudley, Dawn M.; Bimber, Benjamin N.; O'Connor, David H.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA; [Chin, Emily N.] Univ Wisconsin Madison, Dept Cellular & Mol Biol, Madison, WI USA; [O'Connor, David H.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Sanabani, Sabri S.] Univ Sao Paulo, Sao Paulo Inst Trop Med, Sao Paulo, Brazil; [Tarosso, Leandro F.; Costa, Priscilla R.; Sauer, Mariana M.; Kallas, Esper G.] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universidade de Sao Paulo; Universidade de Sao Paulo	Dudley, DM (corresponding author), Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA.	doconnor@primate.wisc.edu	Tarosso, Leandro F./H-6267-2012; Sanabani, Sabri Saeed/F-5600-2012	Sanabani, Sabri Saeed/0000-0002-8876-8262; Bimber, Benjamin/0000-0001-8092-3080; o'connor, david/0000-0003-2139-470X; Kallas, Esper/0000-0003-2026-6925	National Institutes of Health R01 grant [Al077376]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2004/15856-9, 2006/50096-0]; CAPES scholarships; FAPESP scholarships	National Institutes of Health R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES scholarships(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP scholarships(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Work at UW-Madison was supported by a National Institutes of Health R01 grant Al077376. The study was also supported by grants 2004/15856-9 and 2006/50096-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). SS and MMS have been supported by CAPES scholarships; LFT and PRC have been supported by FAPESP scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEBENEK K, 1989, J BIOL CHEM, V264, P16948; Bennett DE, 2008, ANTIVIR THER, V13, P25; De Wolf H, 2011, J VIROL METHODS, V175, P129, DOI 10.1016/j.jviromet.2011.04.023; Delobel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021655; Eshleman SH, 2004, J CLIN MICROBIOL, V42, P2711, DOI 10.1128/JCM.42.6.2711-2717.2004; Ferreira FGF, 2010, AIDS RES HUM RETROV, V26, P229, DOI 10.1089/aid.2009.0146; Gonsalez CR, 2007, VIRUS RES, V129, P87, DOI 10.1016/j.virusres.2007.06.021; Ji HZ, 2011, ANTIVIR THER, V16, P871, DOI 10.3851/IMP1839; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Pedroso C, 2007, JAIDS-J ACQ IMM DEF, V45, P251, DOI 10.1097/QAI.0b013e318050d8b0; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; Sungkanuparph S, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-12; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS UNICEF, 2009, UN ACC SCAL HIV INT; World Health Organization, 2010, WHO HIVRESNET HIV DR; World Health Organization, 2010, UN ACC SCAL PRIOR HI	31	69	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36494	10.1371/journal.pone.0036494	http://dx.doi.org/10.1371/journal.pone.0036494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574170	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800066
J	Zheng, WW; Peng, T; He, W; Zhang, HY				Zheng, Weiwei; Peng, Tao; He, Wei; Zhang, Hongyu			High-Throughput Sequencing to Reveal Genes Involved in Reproduction and Development in Bactrocera dorsalis (Diptera: Tephritidae)	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; PROGRAMMED CELL-DEATH; ORIENTAL FRUIT-FLY; DROSOPHILA-MELANOGASTER; JUVENILE-HORMONE; PHOSPHOINOSITIDE 3-KINASE; SEXUAL ORIENTATION; SIGNALING PATHWAY; BTB DOMAIN; BEHAVIOR	Background: Tephritid fruit flies in the genus Bactrocera are of major economic significance in agriculture causing considerable loss to the fruit and vegetable industry. Currently, there is no ideal control program. Molecular means is an effective method for pest control at present, but genomic or transcriptomic data for members of this genus remains limited. To facilitate molecular research into reproduction and development mechanisms, and finally effective control on these pests, an extensive transcriptome for the oriental fruit fly Bactrocera dorsalis was produced using the Roche 454-FLX platform. Results: We obtained over 350 million bases of cDNA derived from the whole body of B. dorsalis at different developmental stages. In a single run, 747,206 sequencing reads with a mean read length of 382 bp were obtained. These reads were assembled into 28,782 contigs and 169,966 singletons. The mean contig size was 750 bp and many nearly full-length transcripts were assembled. Additionally, we identified a great number of genes that are involved in reproduction and development as well as genes that represent nearly all major conserved metazoan signal transduction pathways, such as insulin signal transduction. Furthermore, transcriptome changes during development were analyzed. A total of 2,977 differentially expressed genes (DEGs) were detected between larvae and pupae libraries, while there were 1,621 DEGs between adults and larvae, and 2,002 between adults and pupae. These DEGs were functionally annotated with KEGG pathway annotation and 9 genes were validated by qRT-PCR. Conclusion: Our data represent the extensive sequence resources available for B. dorsalis and provide for the first time access to the genetic architecture of reproduction and development as well as major signal transduction pathways in the Tephritid fruit fly pests, allowing us to elucidate the molecular mechanisms underlying courtship, ovipositing, development and detailed analyses of the signal transduction pathways.	[Zheng, Weiwei; Peng, Tao; Zhang, Hongyu] Huazhong Agr Univ, State Key Lab Agr Microbiol, Hubei Key Lab Insect Resource Applicat & Sustaina, Coll Plant Sci & Technol, Wuhan, Hunan, Peoples R China; [Zheng, Weiwei; Peng, Tao; Zhang, Hongyu] Huazhong Agr Univ, Inst Urban & Hort Pests, Coll Plant Sci & Technol, Wuhan, Hunan, Peoples R China; [He, Wei] Shanghai Hanyu Biolab, Shanghai, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Zheng, WW (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Hubei Key Lab Insect Resource Applicat & Sustaina, Coll Plant Sci & Technol, Wuhan, Hunan, Peoples R China.	hongyu.zhang@mail.hzau.edu.cn			Special Fund for Agro-Scientific Research in the Public Interest [200903047]; China Postdoctoral Science Foundation [5220112958]; Fundamental Research Funds for the Central Universities [529020900202225]; Ph.D. Programs Foundation of Ministry of Education of China [4010121026]; earmarked fund for Modern Agro-Industry Technology Research System [CARS-27]	Special Fund for Agro-Scientific Research in the Public Interest; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); earmarked fund for Modern Agro-Industry Technology Research System	This research was supported by the Special Fund for Agro-Scientific Research in the Public Interest (No. 200903047), the China Postdoctoral Science Foundation (No. 5220112958), the Fundamental Research Funds for the Central Universities (No. 529020900202225), the Ph.D. Programs Foundation of Ministry of Education of China (No. 4010121026), and the earmarked fund for Modern Agro-Industry Technology Research System (No. CARS-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2001, GENETICS, V158, P1569; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Beaver LM, 2004, CURR BIOL, V14, P1492, DOI 10.1016/j.cub.2004.08.022; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carney GE, 2003, GENETICS, V164, P173; Chen SL, 2008, INSECT BIOCHEM MOLEC, V38, P155, DOI 10.1016/j.ibmb.2007.10.003; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Gaines P, 2000, GENETICS, V154, P1627; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Hansen IA, 2007, INSECT BIOCHEM MOLEC, V37, P985, DOI 10.1016/j.ibmb.2007.05.008; Herr DR, 2004, J BIOL CHEM, V279, P12685, DOI 10.1074/jbc.M310647200; Huang H, 1999, DEVELOPMENT, V126, P5365; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kuniyoshi H, 2002, GENETICS, V162, P1775; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Lukacsovich T, 2003, ARCH INSECT BIOCHEM, V54, P77, DOI 10.1002/arch.10105; Mesce KA, 2002, FRONT NEUROENDOCRIN, V23, P179, DOI 10.1006/frne.2002.0228; Metcalf RL, 1992, PLANT KAIROMONES INS; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ren Q, 2009, FISH SHELLFISH IMMUN, V26, P787, DOI 10.1016/j.fsi.2009.03.004; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Suganya R, 2010, ARCH INSECT BIOCHEM, V75, P45, DOI 10.1002/arch.20383; Toivonen JM, 2001, GENETICS, V159, P241; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Villella A, 1997, GENETICS, V147, P1107; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zheng WW, 2010, MOL CELL ENDOCRINOL, V315, P282, DOI 10.1016/j.mce.2009.10.018; Zhou XF, 2002, DEVELOPMENT, V129, P2259	55	52	56	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36463	10.1371/journal.pone.0036463	http://dx.doi.org/10.1371/journal.pone.0036463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570719	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400035
J	Chen, H; Li, JY; Li, HY; Hu, YH; Tevebaugh, W; Yamamoto, M; Que, JW; Chen, XX				Chen, Hao; Li, Jianying; Li, Haiyan; Hu, Yuhui; Tevebaugh, Whitney; Yamamoto, Masayuki; Que, Jianwen; Chen, Xiaoxin			Transcript Profiling Identifies Dynamic Gene Expression Patterns and an Important Role for Nrf2/Keap1 Pathway in the Developing Mouse Esophagus	PLOS ONE			English	Article							BARRETTS-ESOPHAGUS; PPAR-BETA/DELTA; EPITHELIAL-CELLS; FACTOR NRF2; DIFFERENTIATION; ACTIVATION; FOREGUT; LUNG; MORPHOGENESIS; MODULATION	Background and Aims: Morphological changes during human and mouse esophageal development have been well characterized. However, changes at the molecular level in the course of esophageal morphogenesis remain unclear. This study aims to globally profile critical genes and signaling pathways during the development of mouse esophagus. By using microarray analysis this study also aims to determine how the Nrf2/Keap1 pathway regulates the morphogenesis of the esophageal epithelium. Methods: Gene expression microarrays were used to survey gene expression in the esophagus at three critical phases: specification, metaplasia and maturation. The esophagi were isolated from wild-type, Nrf2(-/-), Keap1(-/-), or Nrf2(-/-) Keap1(-/-) embryos or young adult mice. Array data were statistically analyzed for differentially expressed genes and pathways. Histochemical and immunohistochemical staining were used to verify potential involvement of the Wnt pathway, Ppar beta/delta and the PI3K/Akt pathway in the development of esophageal epithelium. Results: Dynamic gene expression patterns accompanied the morphological changes of the developing esophagus at critical phases. Particularly, the Nrf2/Keap1 pathway had a baseline activity in the metaplasia phase and was further activated in the maturation phase. The Wnt pathway was active early and became inactive later in the metaplasia phase. In addition, Keap1(-/-) mice showed increased expression of Nrf2 downstream targets and genes involved in keratinization. Microarray and immunostaining data also suggested that esophageal hyperkeratosis in the Keap1(-/-) mice was due to activation of Ppar beta/delta and the PI3K/Akt pathway. Conclusions: Morphological changes of the esophageal epithelium are associated with dynamic changes in gene expression. Nrf2/Keap1 pathway activity is required for maturation of mouse esophageal epithelium.	[Chen, Hao; Hu, Yuhui; Tevebaugh, Whitney; Chen, Xiaoxin] N Carolina Cent Univ, Canc Res Program, JLC BBRI, Durham, NC USA; [Li, Jianying] Frontier Bioinformat Solut LLC, Cary, NC USA; [Li, Haiyan] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY USA; [Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi 980, Japan; [Que, Jianwen] Univ Rochester, Dept Biomed Genet, Rochester, NY USA; [Chen, Xiaoxin] Univ N Carolina, Div Gastroenterol & Hepatol, Ctr Esophageal Dis & Swallowing, Chapel Hill, NC USA	University of North Carolina; North Carolina Central University; University of Rochester; Tohoku University; University of Rochester; University of North Carolina; University of North Carolina Chapel Hill	Chen, H (corresponding author), N Carolina Cent Univ, Canc Res Program, JLC BBRI, Durham, NC USA.	jianwen_que@urmc.rochester.edu; lchen@nccu.edu	Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436	NCI NIH HHS [U54 CA156735] Funding Source: Medline; NIDDK NIH HHS [K99 DK082650, R00 DK082650] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA156735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK082650, R00DK082650] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chou JW, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-427; Clement G, 2007, EXPERT OPIN THER TAR, V11, P375, DOI 10.1517/14728222.11.3.375; Coleman JD, 2007, FREE RADICAL BIO MED, V42, P1155, DOI 10.1016/j.freeradbiomed.2007.01.003; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DUAN HJ, 1993, CELL MOL BIOL, V39, P309; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Goldman A, 2011, AM J PHYSIOL-GASTR L, V300, pG292, DOI 10.1152/ajpgi.00461.2010; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Herring W, 2010, GASTROENTEROLOGY, V139, pE6, DOI 10.1053/j.gastro.2009.09.074; Higashiyama H, 2007, HISTOCHEM CELL BIOL, V127, P485, DOI 10.1007/s00418-007-0279-5; Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010; Jiang YJ, 2010, J INVEST DERMATOL, V130, P511, DOI 10.1038/jid.2009.245; JOHNS BAE, 1952, J ANAT, V86, P431; Jonker L, 2004, MECH DEVELOP, V121, P1313, DOI 10.1016/j.mod.2004.07.002; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kerns M, 2010, MOL BIOL CELL, V21, P4068, DOI 10.1091/mbc.E10-02-0153; Kerns ML, 2007, P NATL ACAD SCI USA, V104, P14460, DOI 10.1073/pnas.0706486104; Kim DJ, 2006, CELL DEATH DIFFER, V13, P53, DOI 10.1038/sj.cdd.4401713; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; MENARD D, 1995, MICROSC RES TECHNIQ, V31, P215, DOI 10.1002/jemt.1070310305; Milano F, 2007, GASTROENTEROLOGY, V132, P2412, DOI 10.1053/j.gastro.2007.03.026; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Oshima T, 2011, AM J PHYSIOL-CELL PH, V300, pC1422, DOI 10.1152/ajpcell.00376.2010; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; RAYMOND C, 1991, ANAT REC, V230, P225, DOI 10.1002/ar.1092300210; Rodriguez P, 2010, DEVELOPMENT, V137, P4171, DOI 10.1242/dev.056077; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Sherwood RI, 2009, DEV DYNAM, V238, P29, DOI 10.1002/dvdy.21810; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; SPEED T, STAT ANAL GENE EXPRE; Suzuki A, 2003, CANCER RES, V63, P674; Suzuki T, 2011, CANCER RES, V71, P1700, DOI 10.1158/0008-5472.CAN-10-2939; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Taccioli C, 2009, GASTROENTEROLOGY, V136, P953, DOI 10.1053/j.gastro.2008.11.039; Taylor JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007651; Vermeij WP, 2011, J INVEST DERMATOL, V131, P1435, DOI 10.1038/jid.2010.433; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wang DH, 2010, GASTROENTEROLOGY, V138, P1810, DOI 10.1053/j.gastro.2010.01.048; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Westergaard M, 2001, J INVEST DERMATOL, V116, P702, DOI 10.1046/j.1523-1747.2001.01329.x; Yu WY, 2005, DEV BIOL, V284, P157, DOI 10.1016/j.ydbio.2005.04.042; Zhu F, 2009, HISTOL HISTOPATHOL, V24, P265, DOI 10.14670/HH-24.265	53	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36504	10.1371/journal.pone.0036504	http://dx.doi.org/10.1371/journal.pone.0036504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567161	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500081
J	Martinez-Alborcia, MJ; Valverde, A; Parrilla, I; Vazquez, JM; Martinez, EA; Roca, J				Martinez-Alborcia, Maria J.; Valverde, Anthony; Parrilla, Inmaculada; Vazquez, Juan M.; Martinez, Emilio A.; Roca, Jordi			Detrimental Effects of Non-Functional Spermatozoa on the Freezability of Functional Spermatozoa from Boar Ejaculate	PLOS ONE			English	Article							SPERM CRYOPRESERVATION; ANIMAL VARIABILITY; LIPID-COMPOSITION; COOLING RATES; SEMEN; PLASMA; MALONDIALDEHYDE; INSEMINATION; INCUBATION; INSIGHTS	In the present study, the impact of non-functional spermatozoa on the cryopreservation success of functional boar spermatozoa was evaluated. Fifteen sperm-rich ejaculate fractions collected from five fertile boars were frozen with different proportions of induced non-functional sperm (0 -native semen sample-, 25, 50 and 75% non-functional spermatozoa). After thawing, the recovery of motile and viable spermatozoa was assessed, and the functional of the spermatozoa was evaluated from plasma membrane fluidity and intracellular reactive oxygen species (ROS) generation upon exposure to capacitation conditions. In addition, the lipid peroxidation of the plasma membrane was assessed by the indirect measurement of malondialdehyde (MDA) generation. The normalized (with respect to a native semen sample) sperm motility (assessed by CASA) and viability (cytometrically assessed after staining with Hoechst 33342, propidium iodide and fluorescein-conjugated peanut agglutinin) decreased (p < 0.01) as the proportion of functional spermatozoa in the semen samples before freezing decreased, irrespective of the semen donor. However, the magnitude of the effect differed (p < 0.01) among boars. Moreover, semen samples with the largest non-functional sperm subpopulation before freezing showed the highest (p < 0.01) levels of MDA after thawing. The thawed viable spermatozoa of semen samples with a high proportion of nonfunctional spermatozoa before freezing were also functionally different from those of samples with a low proportion of nonfunctional spermatozoa. These differences consisted of higher (p < 0.01) levels of intracellular ROS generation (assessed with 5-(and-6) chloromethyl-20,70-dichlorodihydrofluorescein diacetate acetyl ester; CM-H(2)DCFDA) and increased (p < 0.01) membrane fluidity (assessed with Merocyanine 540). These findings indicate that non-functional spermatozoa in the semen samples before freezing negatively influence the freezability of functional spermatozoa.	[Martinez-Alborcia, Maria J.; Parrilla, Inmaculada; Vazquez, Juan M.; Martinez, Emilio A.; Roca, Jordi] Univ Murcia, Dept Med & Anim Surg, Fac Vet Sci, Murcia, Spain; [Valverde, Anthony] Costa Rica Inst Technol, Agron Sch, Cartago, Costa Rica	University of Murcia; Instituto Tecnologico de Costa Rica	Martinez-Alborcia, MJ (corresponding author), Univ Murcia, Dept Med & Anim Surg, Fac Vet Sci, Murcia, Spain.	roca@um.es	Parrilla, Inmaculada/I-1045-2015; Martinez, Emilio A/I-1901-2015; Vazquez, Juan M/C-2053-2008; Valverde, Anthony/GQO-7737-2022; Abarca, Anthony Valverde/AAF-6652-2019; Roca, Jordi/H-9365-2015	Martinez, Emilio A/0000-0003-1260-9721; Abarca, Anthony Valverde/0000-0002-3191-6965; Roca, Jordi/0000-0002-4213-3093; Parrilla, Inmaculada/0000-0002-5121-758X; Martinez-Alborcia, Maria Jose/0000-0001-5533-5463; Vazquez, Juan Maria/0000-0002-8674-6350	Comision Interministerial de Ciencia y Tecnologia (CICYT-Ganaderia), Madrid, Spain [AGL2008-04127]; Grupos de Excelencia de la Region de Murcia (GERM), Murcia, Spain [04543/07]; The IAMZ of Zaragoza (Spain)	Comision Interministerial de Ciencia y Tecnologia (CICYT-Ganaderia), Madrid, Spain; Grupos de Excelencia de la Region de Murcia (GERM), Murcia, Spain; The IAMZ of Zaragoza (Spain)	This experimental study was supported by the Comision Interministerial de Ciencia y Tecnologia (CICYT-Ganaderia, AGL2008-04127), Madrid, Spain and Grupos de Excelencia de la Region de Murcia (GERM,04543/07), Murcia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to AIM Iberica for supplying the boar ejaculates used in this study. The IAMZ of Zaragoza (Spain) is acknowledged for funding scholarships for A. Valverde.	Agarwal Ashok, 2005, Indian Journal of Experimental Biology, V43, P963; Aitken R John, 2003, Adv Exp Med Biol, V518, P85; Aitken RJ, 1998, J CELL SCI, V111, P645; Awda BJ, 2009, BIOL REPROD, V81, P553, DOI 10.1095/biolreprod.109.076471; Bailey JL, 2008, THERIOGENOLOGY, V70, P1251, DOI 10.1016/j.theriogenology.2008.06.014; Bansal Amrit Kaur, 2010, Vet Med Int, V2010, DOI 10.4061/2011/686137; Caballero I, 2009, INT J ANDROL, V32, P505, DOI 10.1111/j.1365-2605.2008.00887.x; Cerolini S, 2001, REPRODUCTION, V121, P395, DOI 10.1530/rep.0.1210395; Chiba L., 2009, ANIMAL NUTR HDB, P285; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Cremades T, 2005, J ANDROL, V26, P610, DOI 10.2164/jandrol.05028; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Grossfeld R, 2008, THERIOGENOLOGY, V70, P1225, DOI 10.1016/j.theriogenology.2008.07.017; Guthrie HD, 2008, THERIOGENOLOGY, V70, P1209, DOI 10.1016/j.theriogenology.2008.06.017; Guthrie HD, 2006, J ANIM SCI, V84, P2089, DOI 10.2527/jas.2005-766; Guthrie HD, 2005, THERIOGENOLOGY, V63, P396, DOI 10.1016/j.theriogenology.2004.09.020; Harrison RAP, 1996, MOL REPROD DEV, V45, P378, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V; Hernandez M, 2007, J ANDROL, V28, P689, DOI 10.2164/jandrol.107.002725; Hernandez M, 2007, THERIOGENOLOGY, V67, P1436, DOI 10.1016/j.theriogenology.2007.02.012; Holt WV, 2005, THERIOGENOLOGY, V63, P370, DOI 10.1016/j.theriogenology.2004.09.018; JANERO DR, 1989, LIPIDS, V24, P125, DOI 10.1007/BF02535249; JOHNSON LA, 1988, ZUCHTHYGIENE, V23, P49; Juarez JD, 2011, REPROD FERT DEVELOP, V23, P681, DOI 10.1071/RD10216; Makker K, 2009, INDIAN J MED RES, V129, P357; Maldjian A, 2005, THERIOGENOLOGY, V63, P411, DOI 10.1016/j.theriogenology.2004.09.021; Maxwell WMC, 1997, MOL REPROD DEV, V46, P408, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;408::AID-MRD21&gt;3.0.CO;2-T; Medrano A, 2002, REPRODUCTION, V123, P315, DOI 10.1530/rep.0.1230315; Medrano A, 2009, ANDROLOGIA, V41, P246, DOI 10.1111/j.1439-0272.2009.00927.x; Morrell JM, 2011, REPROD DOMEST ANIM, V46, P18, DOI 10.1111/j.1439-0531.2011.01866.x; Morrell J M, 2010, Vet Med Int, V2011, DOI 10.4061/2011/894767; Rath D., 2009, SOC REPROD FERTIL S, V66, P51, DOI DOI 10.1530/BIOSCIPROCS.18.0004; Roca J, 2006, J ANIM SCI, V84, P2692, DOI 10.2527/jas.2006-094; Roca J, 2011, REPROD DOMEST ANIM, V46, P79, DOI 10.1111/j.1439-0531.2011.01828.x; Saravia F, 2005, THERIOGENOLOGY, V63, P1320, DOI 10.1016/j.theriogenology.2004.06.012; Sikka Suresh C., 1996, Frontiers in Bioscience (online), V1, pE78; TAMULI MK, 1994, VET REC, V135, P160, DOI 10.1136/vr.135.7.160; Thurston LM, 2002, BIOL REPROD, V66, P545, DOI 10.1095/biolreprod66.3.545; Upreti GC, 1998, ANIM REPROD SCI, V51, P275, DOI 10.1016/S0378-4320(98)00082-7	38	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36550	10.1371/journal.pone.0036550	http://dx.doi.org/10.1371/journal.pone.0036550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567165	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500085
J	Muller, PAJ; Trinidad, AG; Timpson, P; Morton, JP; Zanivan, S; van den Berghe, PVE; Nixon, C; Karim, SA; Caswell, PT; Noll, JE; Coffill, CR; Lane, DP; Sansom, OJ; Neilsen, PM; Norman, JC; Vousden, KH				Muller, P. A. J.; Trinidad, A. G.; Timpson, P.; Morton, J. P.; Zanivan, S.; van den Berghe, P. V. E.; Nixon, C.; Karim, S. A.; Caswell, P. T.; Noll, J. E.; Coffill, C. R.; Lane, D. P.; Sansom, O. J.; Neilsen, P. M.; Norman, J. C.; Vousden, K. H.			Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion	ONCOGENE			English	Article						mutant p53; MET; recycling	HEPATOCYTE GROWTH-FACTOR; WILD-TYPE P53; RECEPTOR TYROSINE KINASES; LI-FRAUMENI-SYNDROME; C-MET; BREAST-CANCER; MALIGNANT MESOTHELIOMA; TUMOR-SUPPRESSOR; GENE CONTRIBUTES; CARCINOMA CELLS	Tumour-derived mutant p53 proteins promote invasion, in part, by enhancing Rab coupling protein (RCP)-dependent receptor recycling. Here we identified MET as an RCP-binding protein and showed that mutant p53 promoted MET recycling. Mutant p53-expressing cells were more sensitive to hepatocyte growth factor, the ligand for MET, leading to enhanced MET signalling, invasion and cell scattering that was dependent on both MET and RCP. In cells expressing the p53 family member TAp63, inhibition of TAp63 also lead to cell scattering and MET-dependent invasion. However, in cells that express very low levels of TAp63, the ability of mutant p53 to promote MET-dependent cell scattering was independent of TAp63. Taken together, our data show that mutant p53 can enhance MET signalling to promote cell scattering and invasion through both TAp63-dependent and -independent mechanisms. MET has a predominant role in metastatic progression and the identification of mechanisms through which mutations in p53 can drive MET signalling may help to identify and direct therapy. Oncogene (2013) 32, 1252-1265; doi:10.1038/onc.2012.148; published online 14 May 2012	[Muller, P. A. J.; Trinidad, A. G.; Timpson, P.; Morton, J. P.; Zanivan, S.; van den Berghe, P. V. E.; Nixon, C.; Karim, S. A.; Sansom, O. J.; Norman, J. C.; Vousden, K. H.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Caswell, P. T.] Univ Manchester, Welcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Noll, J. E.; Neilsen, P. M.] Univ Adelaide, Canc Therapeut Labs, Adelaide, SA, Australia; [Coffill, C. R.] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Lane, D. P.] ASTAR, Lab P53, Singapore, Singapore	Beatson Institute; University of Manchester; University of Adelaide; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Agency for Science Technology & Research (A*STAR)	Vousden, KH (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	j.norman@beatson.gla.ac.uk; k.vousden@beatson.gla.ac.uk	Timpson, Paul/A-9429-2016; Muller, Patricia AJ/AAH-1888-2019; Morton, Jennifer P/E-1633-2011; Morton, Jennifer/AAJ-5113-2021; Zanivan, Sara/GOV-5505-2022; Caswell, Patrick/N-3063-2015	Muller, Patricia AJ/0000-0002-0926-1499; Morton, Jennifer P/0000-0001-5766-9141; Morton, Jennifer/0000-0001-5766-9141; Caswell, Patrick/0000-0002-2633-2324; NORMAN, Jim/0000-0002-0098-3014; Zanivan, Sara/0000-0002-9880-9099; Neilsen, Paul/0000-0001-7937-3675; Sansom, Owen J./0000-0001-9540-3010; Coffill, Cynthia/0000-0003-2914-4481; Noll, Jacqueline/0000-0001-7375-635X; Timpson, Paul/0000-0002-5514-7080; Lane, David/0000-0003-0551-3545	Cancer Research UK; AICR; Rubicon Fellowship from the Netherlands Organisation for Scientific Research; Cancer Research UK [12935, 12481] Funding Source: researchfish; Worldwide Cancer Research [11-0626] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); AICR; Rubicon Fellowship from the Netherlands Organisation for Scientific Research; Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	We thank Cancer Research UK and the AICR for funding of work in KHV and JCN's laboratories. PAJM is a recipient of a Rubicon Fellowship from the Netherlands Organisation for Scientific Research. We thank Julin Wong from DPL's lab for the MET construct, Bert Vogelstein for the HCT116 p53 null and HCT116 248W cells, Karen Oien for help with quantifying the staining in the pancreatic tumours and Christine Gundry for help with optimizing the recycling assays.	Accornero P, 2010, J MOL ENDOCRINOL, V44, P115, DOI 10.1677/JME-09-0035; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Brevet M, 2011, J THORAC ONCOL, V6, P864, DOI 10.1097/JTO.0b013e318215a07d; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Corso S, 2008, ONCOGENE, V27, P684, DOI 10.1038/sj.onc.1210697; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; DOGAN A, 1995, J CLIN PATHOL, V48, P143, DOI 10.1136/jcp.48.2.143; Edward M, 2005, CARCINOGENESIS, V26, P1215, DOI 10.1093/carcin/bgi064; FUKUYAMA R, 1991, JPN J CANCER RES, V82, P8, DOI 10.1111/j.1349-7006.1991.tb01737.x; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Herrera R, 1998, J CELL SCI, V111, P1039; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Kawaguchi K, 2009, CARCINOGENESIS, V30, P1097, DOI 10.1093/carcin/bgp097; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Leonard MK, 2011, CELL DEATH DIFFER, V18, P1924, DOI 10.1038/cdd.2011.73; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Liu J, 2012, DNA REPAIR, V11, P167, DOI 10.1016/j.dnarep.2011.10.016; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; NALDINI L, 1991, ONCOGENE, V6, P501; Noll JE, 2011, ONCOGENE; O'Farrell TJ, 2004, CANCER RES, V64, P8199, DOI 10.1158/0008-5472.CAN-03-3639; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Parachoniak CA, 2011, DEV CELL, V20, P751, DOI 10.1016/j.devcel.2011.05.007; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Sayan BS, 2007, P NATL ACAD SCI USA, V104, P10871, DOI 10.1073/pnas.0700761104; Seol DW, 1999, J BIOL CHEM, V274, P3565, DOI 10.1074/jbc.274.6.3565; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sigal A, 2000, CANCER RES, V60, P6788; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; STOKER M, 1985, J CELL SCI, V77, P209; Stolarov J, 2001, P NATL ACAD SCI USA, V98, P13043, DOI 10.1073/pnas.221450598; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; TAJIMA H, 1992, EXP CELL RES, V202, P423, DOI 10.1016/0014-4827(92)90095-P; Tepper CG, 2005, PROSTATE, V65, P375, DOI 10.1002/pros.20308; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Wong MYW, 2011, INT J ONCOL, V38, P1189, DOI 10.3892/ijo.2011.970; Xu H, 2011, CLIN CANCER RES, V17, P4425, DOI 10.1158/1078-0432.CCR-10-3339; Zalcenstein A, 2006, ONCOGENE, V25, P359, DOI 10.1038/sj.onc.1209061; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622; Zhang YH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214585	65	145	147	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 7	2013	32	10					1252	1265		10.1038/onc.2012.148	http://dx.doi.org/10.1038/onc.2012.148			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22580601	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000316454500006
J	Galdieri, L; Vancura, A				Galdieri, Luciano; Vancura, Ales			Acetyl-CoA Carboxylase Regulates Global Histone Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; COENZYME-A SYNTHETASE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; GENOME-WIDE; GENE-EXPRESSION; PROTEIN ACETYLATION; CELLULAR-METABOLISM; LYSINE ACETYLATION; PROMOTER SYSTEM	Histone acetylation depends on intermediary metabolism for supplying acetyl-CoA in the nucleocytosolic compartment. However, because nucleocytosolic acetyl-CoA is also used for de novo synthesis of fatty acids, histone acetylation and synthesis of fatty acids compete for the same acetyl-CoA pool. The first and rate-limiting reaction in de novo synthesis of fatty acids is carboxylation of acetyl-CoA to form malonyl-CoA, catalyzed by acetyl-CoA carboxylase. In yeast Saccharomyces cerevisiae, acetyl-CoA carboxylase is encoded by the ACC1 gene. In this study, we show that attenuated expression of ACC1 results in increased acetylation of bulk histones, globally increased acetylation of chromatin histones, and altered transcriptional regulation. Together, our data indicate that Acc1p activity regulates the availability of acetyl-CoA for histone acetyltransferases, thus representing a link between intermediary metabolism and epigenetic mechanisms of transcriptional regulation.	[Galdieri, Luciano; Vancura, Ales] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA	Saint John's University	Vancura, A (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA.	vancuraa@stjohns.edu	Galdieri, Luciano/GYD-4538-2022	Vancura, Ales/0000-0002-5895-1218	National Institutes of Health Grant [GM087674]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM087674] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087674 (to A.V.).	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; ALLIS CD, 1979, P NATL ACAD SCI USA, V76, P4857, DOI 10.1073/pnas.76.10.4857; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Chang CS, 2009, GENETICS, V183, P149, DOI 10.1534/genetics.109.103846; CHIRALA SS, 1994, NUCLEIC ACIDS RES, V22, P412, DOI 10.1093/nar/22.3.412; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Colbert CL, 2010, P NATL ACAD SCI USA, V107, P18820, DOI 10.1073/pnas.1012736107; Demczuk A, 2008, EUKARYOT CELL, V7, P967, DOI 10.1128/EC.00438-07; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Erkina TY, 2006, MOL CELL BIOL, V26, P7587, DOI 10.1128/MCB.00666-06; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; GANSHEROFF LJ, 1995, GENETICS, V139, P523; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Geng FQ, 2001, MOL CELL BIOL, V21, P4311, DOI 10.1128/MCB.21.13.4311-4320.2001; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; GREGOLIN C, 1966, P NATL ACAD SCI USA, V56, P148, DOI 10.1073/pnas.56.1.148; Guarente L, 2011, CELL METAB, V14, P151, DOI 10.1016/j.cmet.2011.07.007; Guha N, 2007, MOL BIOL CELL, V18, P2419, DOI 10.1091/mbc.E06-10-0946; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Heyland J, 2009, MICROBIOL-SGM, V155, P3827, DOI 10.1099/mic.0.030213-0; HUDAK KA, 1994, GENETICS, V136, P475; Ivessa AS, 1997, EUR J CELL BIOL, V74, P399; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lafon A, 2007, ONCOGENE, V26, P5373, DOI 10.1038/sj.onc.1210606; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lindstrom KC, 2006, MOL CELL BIOL, V26, P6117, DOI 10.1128/MCB.00642-06; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Matsuhashi M., 1969, METHOD ENZYMOL, V14, P3; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Mitchell L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025336; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pilch DR, 2004, METHOD ENZYMOL, V375, P76; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Rathmell JC, 2009, SCIENCE, V324, P1021, DOI 10.1126/science.1174665; Richon VM, 2004, METHOD ENZYMOL, V376, P199; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Schneiter R, 1996, MOL CELL BIOL, V16, P7161; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Shukla V, 2008, MUTAT RES-FUND MOL M, V637, P1, DOI 10.1016/j.mrfmmm.2007.07.012; Smedsgaard J, 2005, J EXP BOT, V56, P273, DOI 10.1093/jxb/eri068; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wishart JA, 2005, YEAST, V22, P565, DOI 10.1002/yea.1225; WOODS A, 1994, J BIOL CHEM, V269, P19509; Zadra G, 2010, CLIN CANCER RES, V16, P3322, DOI 10.1158/1078-0432.CCR-09-1955; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	75	126	128	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23865	23876		10.1074/jbc.M112.380519	http://dx.doi.org/10.1074/jbc.M112.380519			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22580297	Green Published, hybrid			2022-12-25	WOS:000306511300057
J	Liu, GD; Razanau, A; Hai, Y; Yu, JK; Sohail, M; Lobo, VG; Chu, JY; Kung, SKP; Xie, JY				Liu, Guodong; Razanau, Aleh; Hai, Yan; Yu, Jiankun; Sohail, Muhammad; Lobo, Vincent G.; Chu, Jiayou; Kung, Sam K. P.; Xie, Jiuyong			A Conserved Serine of Heterogeneous Nuclear Ribonucleoprotein L (hnRNP L) Mediates Depolarization-regulated Alternative Splicing of Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACT-BINDING-PROTEIN; MESSENGER-RNA; BK CHANNELS; IV; RECOGNITION; STRESS; CELLS; TRANSLATION; ELEMENTS; COMPLEX	Molecular mechanisms of gene regulation underlying the activity-dependent long term changes of cellular electrical properties, such as those during memory, are largely unknown. We have shown that alternative splicing can be dynamically regulated in response to membrane depolarization and Ca2+/calmodulin-dependent protein kinase IV (CaMKIV) activation, through special CaM kinase responsive RNA elements. However, proteins that mediate this regulation and how they are affected by CaMKIV are not known. Here we show that the regulation of the stress axis-regulated exon of the Slo1 potassium channel transcripts by membrane depolarization requires a highly conserved CaMKIV target serine (Ser-513) of the heterogeneous ribonucleoprotein L. Ser-513 phosphorylation within the RNA recognition motif 4 enhanced heterogeneous ribonucleoprotein L interaction with the CaMKIV-responsive RNA element 1 of stress axis-regulated exon and inhibited binding of the large subunit of the U2 auxiliary factor U2AF65. Both of these activities were abolished by a S513A mutation. Thus, through Ser-513, membrane depolarization/calcium signaling controls a critical spliceosomal assembly step to regulate the variant subunit composition of potassium channels.	[Liu, Guodong; Razanau, Aleh; Hai, Yan; Yu, Jiankun; Sohail, Muhammad; Lobo, Vincent G.; Xie, Jiuyong] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB R3E 0J9, Canada; [Kung, Sam K. P.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0J9, Canada; [Xie, Jiuyong] Univ Manitoba, Fac Med, Dept Biochem & Mol Genet, Winnipeg, MB R3E 0J9, Canada; [Yu, Jiankun; Chu, Jiayou] Chinese Acad Med Sci, Inst Med Biol, Kunming 650018, Peoples R China; [Yu, Jiankun; Chu, Jiayou] Peking Union Med Coll, Kunming 650018, Peoples R China	University of Manitoba; University of Manitoba; University of Manitoba; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xie, JY (corresponding author), 439 BMSB,745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	xiej@cc.umanitoba.ca	Xie, Jiuyong/D-2899-2013	Xie, Jiuyong/0000-0003-2909-1033; Yu, Jiankun/0000-0001-9916-1012	Canadian Institutes of Health Research (CIHR) [FRN106608]; Manitoba Health Research Council	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council	This work was supported by Canadian Institutes of Health Research (CIHR) Grant FRN106608 (to J. X.), by a Manitoba Health Research Council post-doctoral fellowship (to Y. H.), and by a Manitoba Health Research Council graduate studentship (to G. L.).	Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Brunton PJ, 2007, ENDOCRINOLOGY, V148, P5496, DOI 10.1210/en.2007-0319; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cao WG, 2011, RNA BIOL, V8, P1061, DOI 10.4161/rna.8.6.16691; Corcoran EE, 2003, J BIOL CHEM, V278, P10516, DOI 10.1074/jbc.M210642200; Gray AC, 2007, CELL CALCIUM, V42, P409, DOI 10.1016/j.ceca.2007.04.003; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Heiner M, 2010, RNA BIOL, V7, P56, DOI 10.4161/rna.7.1.10402; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, RNA, V9, P931, DOI 10.1261/rna.5660803; Hwang B, 2009, BIOCHEM BIOPH RES CO, V378, P584, DOI 10.1016/j.bbrc.2008.11.091; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; Kung SKP, 2010, METHODS MOL BIOL, V612, P233, DOI 10.1007/978-1-60761-362-6_16; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Moore MJ, 2000, NAT STRUCT BIOL, V7, P14, DOI 10.1038/71207; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Rohmann KN, 2009, MOL BIOL EVOL, V26, P1509, DOI 10.1093/molbev/msp060; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Skrisovska L, 2008, J MOL BIOL, V375, P151, DOI 10.1016/j.jmb.2007.09.030; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yu JK, 2009, J BIOL CHEM, V284, P1505, DOI 10.1074/jbc.M805113200; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	36	54	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22709	22716		10.1074/jbc.M112.357343	http://dx.doi.org/10.1074/jbc.M112.357343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570490	Green Published, hybrid			2022-12-25	WOS:000306495000028
J	Saunders, RJ; Paul, NA; Hu, Y; de Nys, R				Saunders, Richard J.; Paul, Nicholas A.; Hu, Yi; de Nys, Rocky			Sustainable Sources of Biomass for Bioremediation of Heavy Metals in Waste Water Derived from Coal-Fired Power Generation	PLOS ONE			English	Article							HYDRODICTYON-RETICULATUM; TROPHIC TRANSFER; BROWN-ALGAE; NEW-ZEALAND; BIOSORPTION; REMOVAL; BIOACCUMULATION; GROWTH; IONS; BIOAVAILABILITY	Biosorption of heavy metals using dried algal biomass has been extensively described but rarely implemented. We contend this is because available algal biomass is a valuable product with a ready market. Therefore, we considered an alternative and practical approach to algal bioremediation in which algae were cultured directly in the waste water stream. We cultured three species of algae with and without nutrient addition in water that was contaminated with heavy metals from an Ash Dam associated with coal-fired power generation and tested metal uptake and bioremediation potential. All species achieved high concentrations of heavy metals (to 8% dry mass). Two key elements, V and As, reached concentrations in the biomass of 1543 mg.kg(-1) DW and 137 mg.kg(-1) DW. Growth rates were reduced by more than half in neat Ash Dam water than when nutrients were supplied in excess. Growth rate and bioconcentration were positively correlated for most elements, but some elements (e.g. Cd, Zn) were concentrated more when growth rates were lower, indicating the potential to tailor bioremediation depending on the pollutant. The cosmopolitan nature of the macroalgae studied, and their ability to grow and concentrate a suite of heavy metals from industrial wastes, highlights a clear benefit in the practical application of waste water bioremediation.	[Saunders, Richard J.; Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Saunders, Richard J.; Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Hu, Yi] James Cook Univ, Adv Analyt Ctr, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University	Saunders, RJ (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	richard.saunders@jcu.edu.au	Paul, Nicholas/B-6496-2009; Saunders, Richard/F-4319-2012; Saunders, Richard/AAN-2427-2021; de Nys, Rocky/D-6741-2012	Saunders, Richard/0000-0001-9890-1998; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Advanced Manufacturing Cooperative Research Centre; Australian Government's Cooperative Research Centre Scheme [2.3.2]	Advanced Manufacturing Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The project is supported by the Advanced Manufacturing Cooperative Research Centre, funded through the Australian Government's Cooperative Research Centre Scheme, grant number 2.3.2. The funders had no role in study design, data collection and analysis or preparation of the manuscript and have provided permission to publish.	Abu Al-Rub FA, 2004, PROCESS BIOCHEM, V39, P1767, DOI 10.1016/j.procbio.2003.08.002; Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006; ALBERTS JJ, 1985, WATER AIR SOIL POLL, V26, P111, DOI 10.1007/BF00292062; Batley GE, 2004, AUST J CHEM, V57, P903, DOI 10.1071/CH04095; Bird MI, 2011, BIORESOURCE IN PRESS; Boullemant A, 2009, ENVIRON SCI TECHNOL, V43, P3308, DOI 10.1021/es802832u; Chopin T., 2004, Bulletin of the Aquaculture Association of Canada, V104, P4; Chopin T., 2009, ENCY OCEAN SCI, P317, DOI DOI 10.1016/B978-012374473-9.00757-8; Cornelis G, 2008, APPL GEOCHEM, V23, P955, DOI 10.1016/j.apgeochem.2008.02.001; DAVIS LS, 1990, J PHYCOL, V26, P611, DOI 10.1111/j.0022-3646.1990.00611.x; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; de Silva PH, 2008, AQUACULTURE, V284, P74; DeForest DK, 2007, AQUAT TOXICOL, V84, P236, DOI 10.1016/j.aquatox.2007.02.022; Fei XG, 2004, HYDROBIOLOGIA, V512, P145, DOI 10.1023/B:HYDR.0000020320.68331.ce; FRANCKE JA, 1983, AQUAT BOT, V15, P375, DOI 10.1016/0304-3770(83)90005-0; Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011; Geng WH, 2009, TALANTA, V79, P369, DOI 10.1016/j.talanta.2009.03.067; Ghimire KN, 2008, BIORESOURCE TECHNOL, V99, P32, DOI 10.1016/j.biortech.2006.11.057; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HAWES I, 1993, J APPL PHYCOL, V5, P437, DOI 10.1007/BF02182736; Hedouin L, 2008, MAR ENVIRON RES, V66, P438, DOI 10.1016/j.marenvres.2008.07.005; Hubbe MA, 2011, BIORESOURCES, V6, P2161; Israel A, 2005, AQUACULTURE, V249, P311, DOI 10.1016/j.aquaculture.2005.04.058; Jasonsmith JF, 2008, MAR FRESHWATER RES, V59, P1048, DOI 10.1071/MF08197; Kebede-Westhead E, 2006, J APPL PHYCOL, V18, P41, DOI 10.1007/s10811-005-9012-8; KUYUCAK N, 1988, BIOTECHNOL LETT, V10, P137, DOI 10.1007/BF01024641; MASON RP, 1995, WATER AIR SOIL POLL, V80, P915, DOI 10.1007/BF01189744; Mehta SK, 2005, CRIT REV BIOTECHNOL, V25, P113, DOI 10.1080/07388550500248571; Mulbry WW, 2001, J APPL PHYCOL, V13, P301, DOI 10.1023/A:1017545116317; Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015; Romero-Gonzalez ME, 2001, ENVIRON SCI TECHNOL, V35, P3025, DOI 10.1021/es991133r; Ruhl L, 2009, ENVIRON SCI TECHNOL, V43, P6326, DOI 10.1021/es900714p; RYTHER JH, 1972, BIOSCIENCE, V22, P144, DOI 10.2307/1296076; Senn DB, 2010, ENVIRON SCI TECHNOL, V44, P1630, DOI 10.1021/es902361j; Slaveykova VI, 2005, ENVIRON CHEM, V2, P9, DOI 10.1071/EN04076; Stengel DB, 2005, ESTUAR COAST SHELF S, V65, P687, DOI 10.1016/j.ecss.2005.07.003; Stephens E, 2010, NAT BIOTECHNOL, V28, P126, DOI 10.1038/nbt0210-126; Sternberg SPK, 2002, BIORESOURCE TECHNOL, V81, P249, DOI 10.1016/S0960-8524(01)00131-6; Tang Q, 2011, MARINE ECOLOGY PROGR, P424; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; Volland S, 2011, J PHYCOL, V47, P565, DOI 10.1111/j.1529-8817.2011.00988.x; Wells RDS, 1999, J AQUAT PLANT MANAGE, V37, P49; Yee N, 2011, ALGAKEY INTERACTIVE	43	49	50	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36470	10.1371/journal.pone.0036470	http://dx.doi.org/10.1371/journal.pone.0036470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590550	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000305336100032
J	Chinapaw, MJM; Yildirim, M; Altenburg, TM; Singh, AS; Kovacs, E; Molnar, D; Brug, J				Chinapaw, Mai J. M.; Yildirim, Mine; Altenburg, Teatske M.; Singh, Amika S.; Kovacs, Eva; Molnar, Denes; Brug, Johannes			Objective and Self-Rated Sedentary Time and Indicators of Metabolic Health in Dutch and Hungarian 10-12 Year Olds: The ENERGY-Project	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; OBESITY; CHILDHOOD; INACTIVITY; SCHOOLCHILDREN; RELIABILITY; OVERWEIGHT; ADULTHOOD	Background: The association between objectively assessed sedentary time and metabolic risk factors in childhood have rarely been studied. Therefore, we examined the independent relationship between objectively assessed and self-rated sedentary time and indicators of metabolic health in Dutch and Hungarian 10-12 year olds. Methodology/Principal Findings: We performed a cross-sectional survey in primary schools. Participants were Dutch and Hungarian girls (n = 73, aged 12.2 +/- 0.6 years, 18% overweight/obese) and boys (n = 69, aged 12.2 +/- 0.7 years, 38% overweight/obese). Sedentary time and physical activity were assessed by the Actigraph accelerometer. TV and PC time were assessed by self-report. Adiposity indicators included body weight, height, and waist circumference (WC). Fasting plasma glucose, C-peptide, total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, and triglycerides were determined in capillary blood and summed into a metabolic risk score. Linear regression analyses were adjusted for physical activity, number of sedentary bouts and WC. Children spent on average 7.6 hours of their daily waking time in sedentary behavior and self-reported 116 +/- 64 min/day watching TV and 85 +/- 57 min/day using the computer. Comparing the 1st and 4th quartile of objectively assessed sedentary time, C-Peptide levels, WC and BMI were significantly higher in the most sedentary quartile, while the difference in metabolic risk score was borderline significant (p = 0.09). Comparing the 1st and 4th quartile of TV time, BMI was significantly higher in the most sedentary quartile, while the difference in WC score was borderline significant (p = 0.06). In the adjusted linear regression analysis we found no significant association of sedentary time with metabolic risk. Conclusions/Significance: Although BMI and WC were higher in the most sedentary versus the least sedentary children; we found no further evidence that more sedentary children were at increased metabolic risk.	[Chinapaw, Mai J. M.; Yildirim, Mine; Altenburg, Teatske M.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Kovacs, Eva; Molnar, Denes] Univ Pecs, Dept Paediat, Pecs, Hungary; [Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Pecs; Vrije Universiteit Amsterdam	Chinapaw, MJM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	m.chinapaw@vumc.nl	Molnár, Dénes/AAB-6820-2022; Paw, Mai Chin A/N-1665-2019; Brug, Johannes/A-8242-2018; Singh, Amika/F-5033-2012; Altenburg, Teatske/S-2059-2016	Paw, Mai Chin A/0000-0001-6259-2441; Brug, Johannes/0000-0002-1904-7349; Altenburg, Teatske/0000-0002-8764-5631	European Commission [FP7-HEALTH-2007-B]; World Cancer Research Fund (WCRF) [2008/65]	European Commission(European CommissionEuropean Commission Joint Research Centre); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF))	The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7, http://cordis.europa.eu/fp7/home_en.html) of the European Commission, HEALTH (FP7-HEALTH-2007-B). The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein. The contribution of MY was funded by the World Cancer Research Fund (WCRF grant 2008/65 http://www.wcrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Bokor S, 2008, INT J PEDIATR OBES, V3, P3, DOI 10.1080/17477160802404509; Brug J, 2012, PLOS ONE IN PRESS; Brug J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-276; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; Chinapaw MJM, 2011, OBES REV, V12, pE621, DOI 10.1111/j.1467-789X.2011.00865.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Ekelund U, 2009, AM J CLIN NUTR, V89, P90, DOI 10.3945/ajcn.2008.26649; Fischer CC, 2012, PED EXERC S IN PRESS; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gootjes J, 2009, CLIN CHIM ACTA, V401, P152, DOI 10.1016/j.cca.2008.12.016; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; Levine JA, 2006, ARTERIOSCL THROM VAS, V26, P729, DOI 10.1161/01.ATV.0000205848.83210.73; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rowlands AV, 2008, PREV MED, V46, P317, DOI 10.1016/j.ypmed.2007.11.004; Rudolf MCJ, 2004, ARCH DIS CHILD, V89, P235, DOI 10.1136/adc.2002.020552; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Treuth MS, 2004, MED SCI SPORT EXER, V36, P1259, DOI 10.1249/01.MSS.0000074670.03001.98; Treuth MS, 2003, MED SCI SPORT EXER, V35, P532, DOI 10.1249/01.MSS.0000053702.03884.3F; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Yildirim M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-182; Zderic TW, 2006, J APPL PHYSIOL, V100, P249, DOI 10.1152/japplphysiol.00925.2005	32	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36657	10.1371/journal.pone.0036657	http://dx.doi.org/10.1371/journal.pone.0036657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586487	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000048
J	Sonkaria, S; Fuentes, G; Verma, C; Narang, R; Khare, V; Fischer, A; Faivre, D				Sonkaria, Sanjiv; Fuentes, Gloria; Verma, Chandra; Narang, Ram; Khare, Varsha; Fischer, Anna; Faivre, Damien			Insight into the Assembly Properties and Functional Organisation of the Magnetotactic Bacterial Actin-like Homolog, MamK	PLOS ONE			English	Article							F-ACTIN; POLYMERIZATION PROPERTIES; MECHANICAL-PROPERTIES; PROTEIN MAMK; FILAMENTS; MAGNETOSOMES; NUCLEOTIDES; SEQUENCE; FTSZ; MREB	Magnetotactic bacteria (MTB) synthesize magnetosomes, which are intracellular vesicles comprising a magnetic particle. A series of magnetosomes arrange themselves in chains to form a magnetic dipole that enables the cell to orient itself along the Earth's magnetic field. MamK, an actin-like homolog of MreB has been identified as a central component in this organisation. Gene deletion, fluorescence microscopy and in vitro studies have yielded mechanistic differences in the filament assembly of MamK with other bacterial cytoskeletal proteins within the cell. With little or no information on the structural and behavioural characteristics of MamK outside the cell, the mamK gene from Magnetospirillium gryphiswaldense was cloned and expressed to better understand the differences in the cytoskeletal properties with its bacterial homologues MreB and acitin. Despite the low sequence identity shared between MamK and MreB (22%) and actin (18%), the behaviour of MamK monitored by light scattering broadly mirrored that of its bacterial cousin MreB primarily in terms of its pH, salt, divalent metal-ion and temperature dependency. The broad size variability of MamK filaments revealed by light scattering studies was supported by transmission electron microscopy (TEM) imaging. Filament morphology however, indicated that MamK conformed to linearly orientated filaments that appeared to be distinctly dissimilar compared to MreB suggesting functional differences between these homologues. The presence of a nucleotide binding domain common to actin-like proteins was demonstrated by its ability to function both as an ATPase and GTPase. Circular dichroism and structural homology modelling showed that MamK adopts a protein fold that is consistent with the 'classical' actin family architecture but with notable structural differences within the smaller domains, the active site region and the overall surface electrostatic potential.	[Sonkaria, Sanjiv; Faivre, Damien] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Fuentes, Gloria; Verma, Chandra] ASTAR, Bioinformat Inst, Singapore, Singapore; [Verma, Chandra] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Narang, Ram] Max Planck Inst Mol Plant Physiol, Bioinformat Grp, Potsdam, Germany; [Khare, Varsha] Max Planck Inst Colloids & Interfaces, Dept Colloid Chem, Potsdam, Germany; [Fischer, Anna] Tech Univ Berlin, Inst Chem, Berlin, Germany	Max Planck Society; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Max Planck Society; Max Planck Society; Technical University of Berlin	Sonkaria, S (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany.	sanjiv.sonkaria@mpikg.mpg.de	Fischer, Anna/F-1810-2013; faivre, damien/D-3713-2009; fuentes, gloria/A-5018-2010; Khare, Varsha/A-1676-2010; Fischer, Anna/ABG-8100-2021; Fischer, Anna T. L./L-8830-2015	faivre, damien/0000-0001-6191-3389; fuentes, gloria/0000-0003-3676-9666; Fischer, Anna/0000-0003-4567-3009; Fischer, Anna T. L./0000-0003-4567-3009	Max Planck Society; German Science Foundation [FA 835/2, 1420]; European Research Council [256915-MB2]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This research was supported by the Max Planck Society, the German Science Foundation (Grant FA 835/2 within the priority programme 1420), and the European Research Council (Grant 256915-MB2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; BETTACHE N, 1990, BIOCHEMISTRY-US, V29, P9085, DOI 10.1021/bi00490a028; Bombardier H, 1997, BIOCHEM BIOPH RES CO, V236, P798, DOI 10.1006/bbrc.1997.7052; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V17, P266; Claessens MMAE, 2008, P NATL ACAD SCI USA, V105, P8819, DOI 10.1073/pnas.0711149105; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Ding Y, 2010, J BACTERIOL, V192, P1097, DOI 10.1128/JB.01292-09; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Faivre D, 2010, BIOPHYS J, V99, P1268, DOI 10.1016/j.bpj.2010.05.034; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; GERSHMAN LC, 1989, BIOCHIM BIOPHYS ACTA, V995, P109, DOI 10.1016/0167-4838(89)90068-X; Golaszewska HS, 1968, BIOCHIM BIOPHYS ACTA, V162, P581; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; KASAI M, 1962, BIOCHIM BIOPHYS ACTA, V57, P22, DOI 10.1016/0006-3002(62)91073-9; Katzmann E, 2010, MOL MICROBIOL, V77, P208, DOI 10.1111/j.1365-2958.2010.07202.x; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Lieleg O, 2009, SOFT MATTER, V5, P1796, DOI 10.1039/b814555p; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Mayer JA, 2009, CELL MOTIL CYTOSKEL, V66, P109, DOI 10.1002/cm.20332; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; OOSAWA F, 1975, THERMODYNAMICS POLYM, P41; Peer B, 1992, P NATL ACAD SCI USA, V89, P7290; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; Popp D, 2010, J BIOL CHEM, V285, P15858, DOI 10.1074/jbc.M109.095901; Pradel N, 2006, P NATL ACAD SCI USA, V103, P17485, DOI 10.1073/pnas.0603760103; Rioux JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009151; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Sael L, 2008, PROTEINS, V73, P1, DOI 10.1002/prot.22141; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Schirner K, 2009, MICROBIOL-SGM, V155, P3611, DOI 10.1099/mic.0.030692-0; Schubbe S, 2009, APPL ENVIRON MICROB, V75, P4835, DOI 10.1128/AEM.02874-08; Smith MJ, 2006, BIOPHYS J, V91, P1098, DOI 10.1529/biophysj.106.085167; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUCK D, 1981, P NATL ACAD SCI-BIOL, V78, P4319, DOI 10.1073/pnas.78.7.4319; TAKACS FP, 1964, J BACTERIOL, V87, P510, DOI 10.1128/JB.87.3.510-518.1964; Taoka A, 2007, J BACTERIOL, V189, P8737, DOI 10.1128/JB.00899-07; Tilney LG, 2000, J CELL BIOL, V148, P87, DOI 10.1083/jcb.148.1.87; TOBACMAN LS, 1983, J BIOL CHEM, V258, P3207; Ullrich S, 2005, J BACTERIOL, V187, P7176, DOI 10.1128/JB.187.21.7176-7184.2005; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672	50	24	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e34189	10.1371/journal.pone.0034189	http://dx.doi.org/10.1371/journal.pone.0034189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586444	Green Published, gold			2022-12-25	WOS:000305335000006
J	Cardoso, MA; Scopel, KKG; Muniz, PT; Villamor, E; Ferreira, MU				Cardoso, Marly A.; Scopel, Kezia K. G.; Muniz, Pascoal T.; Villamor, Eduardo; Ferreira, Marcelo U.			Underlying Factors Associated with Anemia in Amazonian Children: A Population-Based, Cross-Sectional Study	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; IRON-DEFICIENCY; PREGNANT-WOMEN; YOUNG-CHILDREN; MALARIA; PREVALENCE; HEALTH; SCHOOLCHILDREN; CONSEQUENCES; NUTRITION	Background: Although iron deficiency is considered to be the main cause of anemia in children worldwide, other contributors to childhood anemia remain little studied in developing countries. We estimated the relative contributions of different factors to anemia in a population-based, cross-sectional survey. Methodology: We obtained venous blood samples from 1111 children aged 6 months to 10 years living in the frontier town of Acrelandia, northwest Brazil, to estimate the prevalence of anemia and iron deficiency by measuring hemoglobin, erythrocyte indices, ferritin, soluble transferrin receptor, and C-reactive protein concentrations. Children were simultaneously screened for vitamin A, vitamin B-12, and folate deficiencies; intestinal parasite infections; glucose-6-phosphate dehydrogenase deficiency; and sickle cell trait carriage. Multiple Poisson regression and adjusted prevalence ratios (aPR) were used to describe associations between anemia and the independent variables. Principal Findings: The prevalence of anemia, iron deficiency, and iron-deficiency anemia were 13.6%, 45.4%, and 10.3%, respectively. Children whose families were in the highest income quartile, compared with the lowest, had a lower risk of anemia (aPR, 0.60; 95% CI, 0.37-0.98). Child age (<24 months, 2.90; 2.01-4.20) and maternal parity (>2 pregnancies, 2.01; 1.40-2.87) were positively associated with anemia. Other associated correlates were iron deficiency (2.1; 1.4-3.0), vitamin B-12 (1.4; 1.0-2.2), and folate (2.0; 1.3-3.1) deficiencies, and C-reactive protein concentrations (>5 mg/L, 1.5; 1.1-2.2). Conclusions: Addressing morbidities and multiple nutritional deficiencies in children and mothers and improving the purchasing power of poorer families are potentially important interventions to reduce the burden of anemia.	[Cardoso, Marly A.] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil; [Scopel, Kezia K. G.] Univ Fed Juiz de Fora, Dept Parasitol Immunol & Microbiol, Juiz De Fora, Minas Gerais, Brazil; [Muniz, Pascoal T.] Univ Fed Acre, Dept Hlth Sci, Rio Branco, Acre, Brazil; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci & Epidemiol, Ann Arbor, MI 48109 USA; [Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Juiz de Fora; Universidade Federal do Acre (UFAC); University of Michigan System; University of Michigan; Universidade de Sao Paulo	Cardoso, MA (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.	marlyac@usp.br	Ferreira, Marcelo U/G-8289-2011; Cardoso, Marly Augusto/B-8010-2013	Ferreira, Marcelo U/0000-0002-5293-9090; Cardoso, Marly Augusto/0000-0003-0973-3908	Sao Paulo State Research Agency [FAPESP 07/53042-1]; National Research Agency of Brazil [CNPq 470573/2007-4]	Sao Paulo State Research Agency; National Research Agency of Brazil	This work was supported by the Sao Paulo State Research Agency (FAPESP 07/53042-1) and the National Research Agency of Brazil (CNPq 470573/2007-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agho KE, 2008, J HEALTH POPUL NUTR, V26, P200; [Anonymous], 2009, WHO GLOBAL DATABASE; [Anonymous], 2008, WORLDW PREV AN 1993; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; BOWDEN DK, 1985, LANCET, V2, P1025; Brasil, 2008, PESQ NAC DEM SAUD CR; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; CARDOSO MA, 1994, EUR J CLIN NUTR, V48, P326; Castro TG, 2009, PUBLIC HEALTH NUTR, V12, P2335, DOI 10.1017/S1368980009004923; Chaparro CM, 2008, J NUTR, V138, P2529, DOI 10.1093/jn/138.12.2529; Cogswell ME, 2009, AM J CLIN NUTR, V89, P1334, DOI 10.3945/ajcn.2008.27151; Cook JD, 2005, BEST PRACT RES CL HA, V18, P319, DOI 10.1016/j.beha.2004.08.022; Cusick SE, 2008, AM J CLIN NUTR, V88, P1611, DOI 10.3945/ajcn.2008.25926; Darrow LA, 2011, EPIDEMIOLOGY, V22, P53, DOI 10.1097/EDE.0b013e3181fce49b; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; Ferreira MU, 2007, AM J PUBLIC HEALTH, V97, P237, DOI 10.2105/AJPH.2005.078121; Ferreira RGM, 2002, HUM BIOL, V74, P607, DOI 10.1353/hub.2002.0041; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Gomes LF, 2004, ANTIOXID REDOX SIGN, V6, P237, DOI 10.1089/152308604322899305; GYORKOS TW, 1989, AM J EPIDEMIOL, V130, P976, DOI 10.1093/oxfordjournals.aje.a115430; Hamel AR, 2002, BLOOD CELL MOL DIS, V28, P399, DOI 10.1006/bcmd.2002.0524; Instituto Brasileiro de Geografia e Estatistica, 2000, RES AM CENS DEM 2000; Kalaivani K, 2009, INDIAN J MED RES, V130, P627; Katsuragawa Tony H., 2004, Rev. Bras. Hematol. Hemoter., V26, P268, DOI 10.1590/S1516-84842004000400007; Levy A, 2005, EUR J EPIDEMIOL, V20, P277, DOI 10.1007/s10654-004-6515-6; Lewis DK, 2005, T ROY SOC TROP MED H, V99, P561, DOI 10.1016/j.trstmh.2005.01.002; Lopez-Antunano FJ, 1999, SALUD PUBLICA MEXICO, V41, P410, DOI 10.1590/S0036-36341999000500010; Lutter CK, 2008, J NUTR, V138, P2523, DOI 10.3945/jn.108.095406; Maslova E, 2009, FOOD NUTR BULL, V30, P103, DOI 10.1177/156482650903000201; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Menendez C, 2001, AM J TROP MED HYG, V65, P138, DOI 10.4269/ajtmh.2001.65.138; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195; Muniz PT, 2007, CAD SAUDE PUBLICA, V23, P1283, DOI 10.1590/S0102-311X2007000600004; Oliveira JM, 2008, NUTR REV, V66, P141, DOI 10.1111/j.1753-4887.2008.00018.x; Pasricha SR, 2011, AM J CLIN NUTR, V94, P1358, DOI 10.3945/ajcn.111.018580; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI 10.1038/sj.ejcn.1601320; Stoltzfus RJ, 2008, J NUTR, V138, P2542, DOI 10.3945/jn.108.094888; Stoltzfus RJ, 2000, J NUTR, V130, P1724, DOI 10.1093/jn/130.7.1724; Thurlow RA, 2005, AM J CLIN NUTR, V82, P380, DOI 10.1093/ajcn/82.2.380; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Travassos Claudia, 2004, Cad. Saúde Pública, V20, P660, DOI 10.1590/S0102-311X2004000300003; van den Broek NR, 1998, BRIT J HAEMATOL, V103, P817, DOI 10.1046/j.1365-2141.1998.01035.x; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Villamor E, 2008, J NUTR, V138, P1391, DOI 10.1093/jn/138.7.1391; WHO, 2006, ACTA PAEDIATR, P76, DOI DOI 10.1111/J.1651-2227.2006.TB02378.X; WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry (1993: Geneva S Organization WH, 1995, PHYS STAT US INT ANT; World Health Organization, 2001, IR DEF AN ASS ED PRE; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP	50	66	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36341	10.1371/journal.pone.0036341	http://dx.doi.org/10.1371/journal.pone.0036341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574149	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800045
J	Li, SF; Zou, QH; Li, J; Li, J; Wang, DY; Yan, CG; Dong, Q; Zang, YF				Li, Sufang; Zou, Qihong; Li, Jun; Li, Jin; Wang, Deyi; Yan, Chaogan; Dong, Qi; Zang, Yu-Feng			5-HTTLPR Polymorphism Impacts Task-Evoked and Resting-State Activities of the Amygdala in Han Chinese	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; MAJOR DEPRESSIVE DISORDER; LATE-LIFE DEPRESSION; REGIONAL HOMOGENEITY; FUNCTIONAL POLYMORPHISM; ANTIDEPRESSANT RESPONSE; ALLELIC VARIATION; BIASED ATTENTION; PARKINSONS-DISEASE; NO ASSOCIATION	Background: Prior research has shown that the amygdala of carriers of the short allele (s) of the serotonin transporter (5-HTT) gene (5-HTTLPR) have a larger response to negative emotional stimuli and higher spontaneous activity during the resting state than non-carriers. However, recent studies have suggested that the effects of 5-HTTLPR may be specific to different ethnic groups. Few studies have been conducted to address this issue. Methodology/Principal Findings: Blood oxygenation level dependent (BOLD) functional magnetic resonance imaging (fMRI) was conducted on thirty-eight healthy Han Chinese subjects (l/l group, n = 19; s/s group, n = 19) during the resting state and during an emotional processing task. Compared with the s/s group, the l/l group showed significantly increased regional homogeneity or local synchronization in the right amygdala during the resting state (vertical bar t vertical bar. 2.028, p<0.05, corrected), but no significant difference was found in the bilateral amygdala in response to negative stimuli in the emotional processing task. Conclusions/Significance: 5-HTTLPR can alter the spontaneous activity of the amygdala in Han Chinese. However, the effect of 5-HTTLPR on the amygdala both in task state and resting state in Asian population was no similar with Caucasians. They suggest that the effect of 5-HTTLPR on the amygdala may be modulated by ethnic differences.	[Li, Sufang; Li, Jun; Li, Jin; Wang, Deyi; Yan, Chaogan; Dong, Qi; Zang, Yu-Feng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zou, Qihong] Peking Univ, MRI Res Ctr, Beijing 100871, Peoples R China; [Zou, Qihong] Peking Univ, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China	Beijing Normal University; Peking University; Peking University; Hangzhou Normal University	Li, SF (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zangyf@hznu.edu.cn	Li, Sufang/N-5697-2016; ZANG, Yu-Feng/J-1558-2012; Yan, Chao-Gan/D-1713-2015	Li, Sufang/0000-0002-4716-4761; ZANG, Yu-Feng/0000-0003-1833-8010; Yan, Chao-Gan/0000-0003-3413-5977	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT); 111 Project from Ministry of Education of China [B07008]; NSFC [81020108022, 30770594]	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project from Ministry of Education of China(Ministry of Education, China - 111 Project); NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT), the 111 Project from the Ministry of Education of China (B07008), and NSFC (81020108022, 30770594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beck AT, MANUAL BECK ANXIETY; Beevers CG, 2007, J ABNORM PSYCHOL, V116, P208, DOI 10.1037/0021-843X.116.1.208; Beitchman JH, 2006, AM J PSYCHIAT, V163, P1103, DOI 10.1176/appi.ajp.163.6.1103; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Cullen KR, 2011, BRAIN CONNECT, V1, P61, DOI 10.1089/brain.2010.0001; Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x; Dorado P, 2007, FUND CLIN PHARMACOL, V21, P451, DOI 10.1111/j.1472-8206.2007.00501.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Goldman N, 2010, DEPRESS ANXIETY, V27, P260, DOI 10.1002/da.20660; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hauser J, 2003, EUR PSYCHIAT, V18, P129, DOI 10.1016/S0924-9338(03)00026-9; Heils A, 1996, J NEUROCHEM, V66, P2621; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Heinz A, 2007, BIOL PSYCHIAT, V61, P1011, DOI 10.1016/j.biopsych.2006.08.019; Hoefgen B, 2005, BIOL PSYCHIAT, V57, P247, DOI 10.1016/j.biopsych.2004.11.027; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; [黄宇霞 Huang Yuxia], 2004, [中国心理卫生杂志, Chinese Mental Health Journal], V18, P631; Joo YH, 2007, J KOREAN MED SCI, V22, P138, DOI 10.3346/jkms.2007.22.1.138; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042; Kim H, 2006, JAMA-J AM MED ASSOC, V296, P1609, DOI 10.1001/jama.296.13.1609; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Kiyohara C, 2010, PSYCHIAT GENET, V20, P49, DOI 10.1097/YPG.0b013e328335112b; Kunugi H, 1997, MOL PSYCHIATR, V2, P457, DOI 10.1038/sj.mp.4000334; Kwang T, 2010, DEPRESS ANXIETY, V27, P746, DOI 10.1002/da.20708; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lee BT, 2008, GENES BRAIN BEHAV, V7, P899, DOI 10.1111/j.1601-183X.2008.00429.x; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lesch KP, 2005, PROG NEURO-PSYCHOPH, V29, P1062, DOI 10.1016/j.pnpbp.2005.03.012; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; Mrazek DA, 2009, AM J MED GENET B, V150B, P341, DOI 10.1002/ajmg.b.30816; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Ohara K, 1998, BIOL PSYCHIAT, V44, P550, DOI 10.1016/S0006-3223(98)00112-7; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pollock BG, 2000, NEUROPSYCHOPHARMACOL, V23, P587, DOI 10.1016/S0893-133X(00)00132-9; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Salvador R, 2010, HUM BRAIN MAPP, V31, P2003, DOI 10.1002/hbm.20993; Shi M, 2008, ACTA NEUROPSYCHIATR, V20, P139, DOI 10.1111/j.1601-5215.2008.00282.x; Shukla DK, 2010, NEUROSCI LETT, V476, P46, DOI 10.1016/j.neulet.2010.03.080; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; Smolka MN, 2007, MOL PSYCHIATR, V12, P307, DOI 10.1038/sj.mp.4001946; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Viviani R, 2010, BIOL PSYCHIAT, V67, P317, DOI 10.1016/j.biopsych.2009.08.035; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang T, 2010, NEUROREPORT, V21, P786, DOI 10.1097/WNR.0b013e32833cadf0; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yoshida K, 2002, PROG NEURO-PSYCHOPH, V26, P383, DOI 10.1016/S0278-5846(01)00287-1; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang JL, 2009, NEUROSCI LETT, V455, P155, DOI 10.1016/j.neulet.2009.03.037; Zhang KR, 2009, J AFFECT DISORDERS, V114, P224, DOI 10.1016/j.jad.2008.07.012; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	75	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36513	10.1371/journal.pone.0036513	http://dx.doi.org/10.1371/journal.pone.0036513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574175	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800072
J	Tebbets, B; Stewart, D; Lawry, S; Nett, J; Nantel, A; Andes, D; Klein, BS				Tebbets, Brad; Stewart, Douglas; Lawry, Stephanie; Nett, Jeniel; Nantel, Andre; Andes, David; Klein, Bruce S.			Identification and Characterization of Antifungal Compounds Using a Saccharomyces cerevisiae Reporter Bioassay	PLOS ONE			English	Article							2-COMPONENT HISTIDINE KINASE; ACTIVATED PROTEIN-KINASE; OSMOTIC-STRESS RESPONSE; CANDIDA-ALBICANS; HYPHAL DEVELOPMENT; DNA-DAMAGE; RESISTANCE; GENE; FLUCONAZOLE; FLUDIOXONIL	New antifungal drugs are urgently needed due to the currently limited selection, the emergence of drug resistance, and the toxicity of several commonly used drugs. To identify drug leads, we screened small molecules using a Saccharomyces cerevisiae reporter bioassay in which S. cerevisiae heterologously expresses Hik1, a group III hybrid histidine kinase (HHK) from Magnaporthe grisea. Group III HHKs are integral in fungal cell physiology, and highly conserved throughout this kingdom; they are absent in mammals, making them an attractive drug target. Our screen identified compounds 13 and 33, which showed robust activity against numerous fungal genera including Candida spp., Cryptococcus spp. and molds such as Aspergillus fumigatus and Rhizopus oryzae. Drug-resistant Candida albicans from patients were also highly susceptible to compounds 13 and 33. While the compounds do not act directly on HHKs, microarray analysis showed that compound 13 induced transcripts associated with oxidative stress, and compound 33, transcripts linked with heavy metal stress. Both compounds were highly active against C. albicans biofilm, in vitro and in vivo, and exerted synergy with fluconazole, which was inactive alone. Thus, we identified potent, broad-spectrum antifungal drug leads from a small molecule screen using a high-throughput, S. cerevisiae reporter bioassay.	[Tebbets, Brad; Stewart, Douglas; Lawry, Stephanie; Klein, Bruce S.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Nett, Jeniel; Andes, David] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA; [Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Internal Med, Madison, WI USA; [Tebbets, Brad; Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI USA; [Lawry, Stephanie] Univ Wisconsin Madison, Sch Med & Publ Hlth, Cellular & Mol Pathol Program, Madison, WI USA; [Tebbets, Brad] Univ Wisconsin Madison, Sch Med & Publ Hlth, Microbiol Doctoral Training Program, Madison, WI USA; [Nantel, Andre] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Research Council Canada	Tebbets, B (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	bsklein@wisc.edu	Andes, David/ABE-8033-2020	Lawry, Stephanie/0000-0002-1172-7577; Andes, David/0000-0002-7927-9950	National Institutes of Health [AI086025, AI35681]; Canadian Institutes of Health Research [MOP-84341]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086025, R37AI035681, R01AI035681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI086025 and AI35681 (BK) and Canadian Institutes of Health Research grant MOP-84341 (AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana DM, 2010, J ANTIMICROB CHEMOTH, V65, P54, DOI 10.1093/jac/dkp407; Avenot H, 2005, CURR GENET, V47, P234, DOI 10.1007/s00294-005-0568-2; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Clemons KV, 2002, MED MYCOL, V40, P259, DOI 10.1080/mmy.40.3.259.262; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Florio AR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-97; Green S. R., 2001, CURRENT PROTOCOLS CE; Gupte M, 2002, APPL MICROBIOL BIOT, V58, P46, DOI 10.1007/s002530100822; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P1003, DOI 10.1271/bbb.60665; Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450, DOI 10.1128/JCM.36.5.1450-1452.1998; Hussein B, 2011, EUKARYOT CELL, V10, P384, DOI 10.1128/EC.00278-10; Kanetis L, 2008, PHYTOPATHOLOGY, V98, P205, DOI 10.1094/PHYTO-98-2-0205; Kobayashi D, 2002, ANTIMICROB AGENTS CH, V46, P3113, DOI 10.1128/AAC.46.10.3113-3117.2002; Lamb D, 1999, DRUG RESIST UPDATE, V2, P390, DOI 10.1054/drup.1999.0112; Li DM, 2010, CURR OPIN MICROBIOL, V13, P424, DOI 10.1016/j.mib.2010.04.007; Masson JY, 1996, MOL CELL BIOL, V16, P2091; MCCALLA DR, 1971, CANCER RES, V31, P2184; Motoyama T, 2005, CURR GENET, V47, P298, DOI 10.1007/s00294-005-0572-6; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; MUKHERJEE U, 1990, CANCER BIOCHEM BIOPH, V11, P275; Nantel A., 2007, MED MYCOLOGY CELLULA, P181; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nett JE, 2010, INFECT IMMUN, V78, P3650, DOI 10.1128/IAI.00480-10; Ochiai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2209, DOI 10.1271/bbb.66.2209; Ochiai N, 2001, PEST MANAG SCI, V57, P437, DOI 10.1002/ps.302; Pott GB, 2000, FUNGAL GENET BIOL, V31, P55, DOI 10.1006/fgbi.2000.1225; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Schmitt MA, 2007, J AM CHEM SOC, V129, P417, DOI 10.1021/ja0666553; Sharma M, 2010, FEMS YEAST RES, V10, P570, DOI 10.1111/j.1567-1364.2010.00637.x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Uppuluri P, 2008, ANTIMICROB AGENTS CH, V52, P1127, DOI 10.1128/AAC.01397-07; Vylkova S, 2007, EUKARYOT CELL, V6, P1876, DOI 10.1128/EC.00039-07; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Yamada-Okabe T, 1999, J BACTERIOL, V181, P7243, DOI 10.1128/JB.181.23.7243-7247.1999; Yoshimi A, 2004, MOL GENET GENOMICS, V271, P228, DOI 10.1007/s00438-003-0974-4	38	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36021	10.1371/journal.pone.0036021	http://dx.doi.org/10.1371/journal.pone.0036021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574132	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800028
J	Frank, JG; Mendelowitz, D				Frank, Julie G.; Mendelowitz, David			Synaptic and Intrinsic Activation of GABAergic Neurons in the Cardiorespiratory Brainstem Network	PLOS ONE			English	Article							RESPIRATORY RHYTHM GENERATION; CARDIAC VAGAL NEURONS; PRE-BOTZINGER COMPLEX; PREBOTZINGER COMPLEX; PACEMAKER NEURONS; NUCLEUS AMBIGUUS; PARASYMPATHETIC NEURONS; NICOTINIC RECEPTORS; NEURAL-NETWORK; SPINAL-CORD	GABAergic pathways in the brainstem play an essential role in respiratory rhythmogenesis and interactions between the respiratory and cardiovascular neuronal control networks. However, little is known about the identity and function of these GABAergic inhibitory neurons and what determines their activity. In this study we have identified a population of GABAergic neurons in the ventrolateral medulla that receive increased excitatory post-synaptic potentials during inspiration, but also have spontaneous firing in the absence of synaptic input. Using transgenic mice that express GFP under the control of the Gad1 (GAD67) gene promoter, we determined that this population of GABAergic neurons is in close apposition to cardioinhibitory parasympathetic cardiac neurons in the nucleus ambiguus (NA). These neurons fire in synchronization with inspiratory activity. Although they receive excitatory glutamatergic synaptic inputs during inspiration, this excitatory neurotransmission was not altered by blocking nicotinic receptors, and many of these GABAergic neurons continue to fire after synaptic blockade. The spontaneous firing in these GABAergic neurons was not altered by the voltage-gated calcium channel blocker cadmium chloride that blocks both neurotransmission to these neurons and voltage-gated Ca2+ currents, but spontaneous firing was diminished by riluzole, demonstrating a role of persistent sodium channels in the spontaneous firing in these cardiorespiratory GABAergic neurons that possess a pacemaker phenotype. The spontaneously firing GABAergic neurons identified in this study that increase their activity during inspiration would support respiratory rhythm generation if they acted primarily to inhibit post-inspiratory neurons and thereby release inspiration neurons to increase their activity. This population of inspiratory-modulated GABAergic neurons could also play a role in inhibiting neurons that are most active during expiration and provide a framework for respiratory sinus arrhythmia as there is an increase in heart rate during inspiration that occurs via inhibition of premotor parasympathetic cardioinhibitory neurons in the NA during inspiration.	[Frank, Julie G.; Mendelowitz, David] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA	George Washington University	Frank, JG (corresponding author), George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA.	dmendel@gwu.edu			National Institutes of Health National Heart, Lung, and Blood Institute [HL-49965, HL-72006, HL-59895]; American Heart Association; The National Center for Research Resources [1S10RR025565-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025565] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059895, R29HL049965, R01HL049965, R01HL072006] Funding Source: NIH RePORTER	National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); The National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health National Heart, Lung, and Blood Institute Grants HL-49965, HL-72006, and HL-59895 to Dr. Mendelowitz and American Heart Association predoctoral fellowship to Dr. Frank. Confocal images were generated with a grant from The National Center for Research Resources 1S10RR025565-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALIS UJ, 1994, BIOL CYBERN, V70, P311, DOI 10.1007/BF00200329; Dehkordi O, 2004, RESP PHYSIOL NEUROBI, V141, P21, DOI 10.1016/j.resp.2004.03.006; Dehkordi O, 2007, BRAIN RES, V1185, P95, DOI 10.1016/j.brainres.2007.09.027; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; DUFFIN J, 1991, NEUROREPORT, V2, P623, DOI 10.1097/00001756-199110000-00018; Ellenberger HH, 1999, J COMP NEUROL, V411, P130, DOI 10.1002/(SICI)1096-9861(19990816)411:1<130::AID-CNE10>3.0.CO;2-C; Favero MT, 2011, RESP PHYSL NEUROBIOL; FELDMAN JL, 1989, ANN NY ACAD SCI, V563, P114, DOI 10.1111/j.1749-6632.1989.tb42194.x; Frank JG, 2009, J NEUROPHYSIOL, V101, P1755, DOI 10.1152/jn.91134.2008; Johnson SM, 2001, J NEUROPHYSIOL, V85, P1772, DOI 10.1152/jn.2001.85.4.1772; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Kuwana SI, 2006, EUR J NEUROSCI, V23, P667, DOI 10.1111/j.1460-9568.2006.04591.x; Loewy AD, CENTRAL REGULATION A; Mendelowitz D, 1996, AM J PHYSIOL-HEART C, V271, pH2609, DOI 10.1152/ajpheart.1996.271.6.H2609; MENDELOWITZ D, 1991, NEUROSCI LETT, V132, P217, DOI 10.1016/0304-3940(91)90305-D; Muller KJ, 2009, PHILOS T R SOC B, V364, P2485, DOI 10.1098/rstb.2009.0070; Neff RA, 2003, CIRC RES, V93, P565, DOI 10.1161/01.RES.0000090361.45027.5B; Neff RA, 1998, BRAIN RES, V792, P277, DOI 10.1016/S0006-8993(98)00149-8; Neff RA, 1998, CIRC RES, V83, P1241, DOI 10.1161/01.RES.83.12.1241; OGILVIE MD, 1992, AM J PHYSIOL, V263, pR962, DOI 10.1152/ajpregu.1992.263.4.R962; Pace RW, 2007, J PHYSIOL-LONDON, V580, P485, DOI 10.1113/jphysiol.2006.124602; PATRICK J, 1987, ANN NY ACAD SCI, V505, P194; Richter D W, 1992, Curr Opin Neurobiol, V2, P788, DOI 10.1016/0959-4388(92)90135-8; Rybak IA, 1997, J NEUROPHYSIOL, V77, P1994, DOI 10.1152/jn.1997.77.4.1994; Shao XM, 2001, J NEUROPHYSIOL, V85, P2461, DOI 10.1152/jn.2001.85.6.2461; Shao XSM, 2002, J NEUROPHYSIOL, V88, P1851, DOI 10.1152/jn.2002.88.4.1851; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Stornetta RL, 2004, J COMP NEUROL, V479, P257, DOI 10.1002/cne.20332; Stornetta RL, 1999, J COMP NEUROL, V407, P367; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thoby-Brisson M, 2001, J NEUROPHYSIOL, V86, P104, DOI 10.1152/jn.2001.86.1.104; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; URBANSKI RW, 1988, J AUTONOM NERV SYST, V25, P181, DOI 10.1016/0165-1838(88)90023-9; Wang JJ, 2002, NEUROSCI LETT, V332, P195, DOI 10.1016/S0304-3940(02)00957-6; Wang JJ, 2001, BRAIN RES, V889, P78, DOI 10.1016/S0006-8993(00)03112-7; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Weber CS, 2010, EUR J APPL PHYSIOL, V109, P201, DOI 10.1007/s00421-009-1341-x; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yakel JL, 2010, J PHYSIOL-LONDON, V588, P597, DOI 10.1113/jphysiol.2009.182691	39	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36459	10.1371/journal.pone.0036459	http://dx.doi.org/10.1371/journal.pone.0036459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570717	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400033
J	Wallin, JJ; Guan, J; Edgar, KA; Zhou, W; Francis, R; Torres, AC; Haverty, PM; Eastham-Anderson, J; Arena, S; Bardelli, A; Griffin, S; Goodall, JE; Grimshaw, KM; Hoeflich, KP; Torrance, C; Belvin, M; Friedman, LS				Wallin, Jeffrey J.; Guan, Jane; Edgar, Kyle A.; Zhou, Wei; Francis, Ross; Torres, Anthony C.; Haverty, Peter M.; Eastham-Anderson, Jeffrey; Arena, Sabrina; Bardelli, Alberto; Griffin, Sue; Goodall, John E.; Grimshaw, Kyla M.; Hoeflich, Klaus P.; Torrance, Christopher; Belvin, Marcia; Friedman, Lori S.			Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; I PHOSPHATIDYLINOSITIDE 3-KINASES; BREAST-CANCER CELLS; PIK3CA MUTATIONS; GENE-EXPRESSION; ONCOGENIC PATHWAYS; INHIBITOR; KINASE; POTENT; LINES	The PTEN/PI3K pathway is commonly mutated in cancer and therefore represents an attractive target for therapeutic intervention. To investigate the primary phenotypes mediated by increased pathway signaling in a clean, patient-relevant context, an activating PIK3CA mutation (H1047R) was knocked-in to an endogenous allele of the MCF10A non-tumorigenic human breast epithelial cell line. Introduction of an endogenously mutated PIK3CA allele resulted in a marked epithelial-mesenchymal transition (EMT) and invasive phenotype, compared to isogenic wild-type cells. The invasive phenotype was linked to enhanced PIP3 production via a S6K-IRS positive feedback mechanism. Moreover, potent and selective inhibitors of PI3K were highly effective in reversing this phenotype, which is optimally revealed in 3-dimensional cell culture. In contrast, inhibition of Akt or mTOR exacerbated the invasive phenotype. Our results suggest that invasion is a core phenotype mediated by increased PTEN/PI3K pathway activity and that therapeutic agents targeting different nodes of the PI3K pathway may have dramatic differences in their ability to reverse or promote cancer metastasis.	[Wallin, Jeffrey J.; Guan, Jane; Edgar, Kyle A.; Zhou, Wei; Francis, Ross; Torres, Anthony C.; Hoeflich, Klaus P.; Belvin, Marcia; Friedman, Lori S.] Genentech Inc, Dept Canc Signaling, San Francisco, CA 94080 USA; [Wallin, Jeffrey J.; Guan, Jane; Edgar, Kyle A.; Zhou, Wei; Francis, Ross; Torres, Anthony C.; Hoeflich, Klaus P.; Belvin, Marcia; Friedman, Lori S.] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Haverty, Peter M.] Genentech Inc, Bioinformat, San Francisco, CA 94080 USA; [Eastham-Anderson, Jeffrey] Genentech Inc, Pathol, San Francisco, CA 94080 USA; [Arena, Sabrina; Bardelli, Alberto] Univ Turin, Sch Med, Mol Genet Lab, Inst Canc Res & Treatment, Candiolo, Italy; [Bardelli, Alberto] FIRC Inst Mol Oncol, Milan, Italy; [Griffin, Sue; Goodall, John E.; Grimshaw, Kyla M.; Torrance, Christopher] Horizon Discovery Ltd, Cambridge, England	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; IFOM - FIRC Institute of Molecular Oncology	Wallin, JJ (corresponding author), Genentech Inc, Dept Canc Signaling, San Francisco, CA 94080 USA.	jwallin@gene.com	Arena, Sabrina/H-4985-2012; BARDELLI, Alberto/J-9721-2018	Arena, Sabrina/0000-0002-1318-2494; Wallin, Jeffrey/0000-0002-5952-3813; BARDELLI, Alberto/0000-0003-1647-5070	Italian Association for Cancer Research (AIRC); Italian Ministry of Health, Regione Piemonte; Italian Ministry of University and Research; CRT Progetto Alfieri; Fondazione Monte dei Paschi di Siena, Siena, Italy; Association for International Cancer Research (AICR-UK); EU [037297]; EU FP7 Marie Curie CAN-GENE	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health, Regione Piemonte; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); CRT Progetto Alfieri; Fondazione Monte dei Paschi di Siena, Siena, Italy; Association for International Cancer Research (AICR-UK); EU(European Commission); EU FP7 Marie Curie CAN-GENE	Alberto Bardelli is supported by grants from Italian Association for Cancer Research (AIRC) (AB), Italian Ministry of Health, Regione Piemonte (AB), Italian Ministry of University and Research, CRT Progetto Alfieri (AB), Fondazione Monte dei Paschi di Siena, Siena, Italy (AS) and Association for International Cancer Research (AICR-UK) (AB), EU FP6 contract 037297 (AB), and EU FP7 Marie Curie CAN-GENE (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus SE, CLIN CANC RES, V16, P790; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Da Silva L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2603; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Edgar KA, CANC RES, V70, P1164; Finlay M, 2008, MORPHOLINO PYRIMIDIN, VS-151, P85; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li SY, 2006, BREAST CANCER RES TR, V96, P91, DOI 10.1007/s10549-005-9048-0; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Wallin JJ, 2011, MOL CANC THER; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Yao E, 2009, CLIN CANCER RES, V15, P4147, DOI 10.1158/1078-0432.CCR-08-2814; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhao ZJ, 2005, BIOORG MED CHEM LETT, V15, P905, DOI 10.1016/j.bmcl.2004.12.062	48	41	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36402	10.1371/journal.pone.0036402	http://dx.doi.org/10.1371/journal.pone.0036402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570710	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400026
J	Jez, J; Antes, B; Castilho, A; Kainer, M; Wiederkum, S; Grass, J; Ruker, F; Woisetschlager, M; Steinkellner, H				Jez, Jakub; Antes, Bernhard; Castilho, Alexandra; Kainer, Manuela; Wiederkum, Susanne; Grass, Josephine; Rueker, Florian; Woisetschlaeger, Max; Steinkellner, Herta			Significant Impact of Single N-Glycan Residues on the Biological Activity of Fc-based Antibody-like Fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; MONOCLONAL-ANTIBODIES; GAMMA-RIII; GLYCOSYLATION PATTERN; DEVELOPMENT TRENDS; CARBOHYDRATE; TRANSFECTION; EXPRESSION; VACCINES; RECEPTOR	Recent studies have demonstrated that IgG-Fc fragments (Fcabs) can be engineered to form antigen-binding sites with antibody properties. Thus they may serve as an attractive alternative to conventional antibodies in therapeutic applications. The critical influence of Fc glycosylation on effector functions of IgGs is well documented; however, whether this applies to Fcabs is not known. Here we used human cells, wild type, and glycoengineered plants to generate four different glycoforms of H10-03-6, an Fcab with engineered HER2/neu-binding sites. Plant-derived H10-03-6 differed in the presence/absence of single oligosaccharide residues, i.e., core fucose and xylose, and terminal galactose. All of the glycoforms had similar binding to HER2/neu expressed on human tumor cells. By contrast, glycoforms that lacked core oligosaccharide modifications (i.e., core alpha 1,3-fucose and beta 1,2-xylose) showed significantly enhanced binding to the Fc gamma receptor IIIa, irrespective of whether plant or human expression systems were used. Consistent with this finding, plant-derived H10-03-6 glycoforms lacking core N-glycan residues mediated higher antibody-dependent cellular cytotoxicity against human tumor cells. No alteration in gamma-receptor binding and antibody-dependent cellular cytotoxicity activity was observed upon decoration of N-glycans by terminal galactose. The results point to a significant impact of distinct N-glycan residues on effector functions of Fcabs. Moreover, the outcomes imply that the effector functions mediated by H10-03-6 can be optimized by altering the N-glycosylation profile. Biasing vaccine-induced immune responses toward optimal Fc glycosylation patterns could result in improved vaccine efficacy.	[Jez, Jakub; Castilho, Alexandra; Steinkellner, Herta] Univ Nat Resources & Life Sci BOKU Wien, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Grass, Josephine] Univ Nat Resources & Life Sci BOKU Wien, Dept Chem, A-1190 Vienna, Austria; [Rueker, Florian] Univ Nat Resources & Life Sci BOKU Wien, Dept Biotechnol, A-1190 Vienna, Austria; [Antes, Bernhard; Kainer, Manuela; Wiederkum, Susanne; Woisetschlaeger, Max] F Star Biotechnol Forsch, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Steinkellner, H (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria.	herta.steinkellner@boku.ac.at	Castilho, Alexandra/AAC-8927-2020; Steinkellner, Herta/N-4267-2016	Castilho, Alexandra/0000-0003-4114-7861; Steinkellner, Herta/0000-0003-4823-1505; Rueker, Florian/0000-0001-7639-2686; Jez, Jakub/0000-0002-6481-4383	Der Wissenschaftsfonds [FWF-TR]; Die Osterreichische Forschungsforderungs-Gesellschaft [L575-B13]; Laura Bassi Centres of Expertise [822757]; Austrian Science Fund (FWF) [L 575] Funding Source: researchfish	Der Wissenschaftsfonds(Austrian Science Fund (FWF)); Die Osterreichische Forschungsforderungs-Gesellschaft; Laura Bassi Centres of Expertise; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Der Wissenschaftsfonds Grant FWF-TR, Die Osterreichische Forschungsforderungs-Gesellschaft Grant L575-B13, and Laura Bassi Centres of Expertise Grant 822757.	Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Castilho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026040; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Junttila TT, 2010, CANCER RES, V70, P4481, DOI 10.1158/0008-5472.CAN-09-3704; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Loos A, 2011, PLANT PHYSIOL, V155, P2036, DOI 10.1104/pp.110.171330; Loos A, 2011, PLANT BIOTECHNOL J, V9, P179, DOI 10.1111/j.1467-7652.2010.00540.x; Lux A, 2011, ADV EXP MED BIOL, V780, P113, DOI 10.1007/978-1-4419-5632-3_10; Ma JKC, 2005, EMBO REP, V6, P593, DOI 10.1038/sj.embor.7400470; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; Whaley KJ, 2011, HUM VACCINES, V7, P349, DOI 10.4161/hv.7.3.14266; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005; Wozniak-Knopp G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030083; Wurch T, 2008, CURR PHARM BIOTECHNO, V9, P502, DOI 10.2174/138920108786786385; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575	30	20	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24313	24319		10.1074/jbc.M112.360701	http://dx.doi.org/10.1074/jbc.M112.360701			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22589538	hybrid, Green Published			2022-12-25	WOS:000306651100025
J	Szeto, SSW; Reinke, SN; Oyedotun, KS; Sykes, BD; Lemire, BD				Szeto, Samuel S. W.; Reinke, Stacey N.; Oyedotun, Kayode S.; Sykes, Brian D.; Lemire, Bernard D.			Expression of Saccharomyces cerevisiae Sdh3p and Sdh4p Paralogs Results in Catalytically Active Succinate Dehydrogenase Isoenzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL COMPLEX-II; QUINONE-BINDING-SITES; UBIQUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI; RESPIRATORY-CHAIN; INNER MEMBRANE; FUMARATE REDUCTASE; CYTOCHROME B(562); IMPORTED PROTEINS; ELECTRON-TRANSFER	Succinate dehydrogenase (SDH), also known as complex II, is required for respiratory growth; it couples the oxidation of succinate to the reduction of ubiquinone. The enzyme is composed of two domains. A membrane-extrinsic catalytic domain composed of the Sdh1p and Sdh2p subunits harbors the flavin and iron-sulfur cluster cofactors. A membrane-intrinsic domain composed of the Sdh3p and Sdh4p subunits interacts with ubiquinone and may coordinate a b-type heme. In many organisms, including Saccharomyces cerevisiae, possible alternative SDH subunits have been identified in the genome. S. cerevisiae contains one paralog of the Sdh3p subunit, Shh3p (YMR118c), and two paralogs of the Sdh4p subunit, Shh4p (YLR164w) and Tim18p (YOR297c). We cloned and expressed these alternative subunits. Shh3p and Shh4p were able to complement Delta sdh3 and Delta sdh4 deletion mutants, respectively, and support respiratory growth. Tim18p was unable to do so. Microarray and proteomics data indicate that the paralogs are expressed under respiratory and other more restrictive growth conditions. Strains expressing hybridSDH enzymes have distinct metabolic profiles that we distinguished by H-1 NMR analysis of metabolites. Surprisingly, the Sdh3p subunit can form SDH isoenzymes with Sdh4p or with Shh4p as well as be a subunit of the TIM22 mitochondrial protein import complex.	[Lemire, Bernard D.] Univ Alberta, Dept Biochem, Sch Translat Med, Edmonton, AB T6G 2H7, Canada	University of Alberta	Lemire, BD (corresponding author), Univ Alberta, Dept Biochem, Sch Translat Med, Edmonton, AB T6G 2H7, Canada.	bernard.lemire@ualberta.ca		Reinke, Stacey/0000-0002-0758-0330	Canadian Institutes of Health Research [MT-15290, MOP-84455, MOP-37769]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grants MT-15290 and MOP-84455 (to B. D. L.) and MOP-37769 (to B. D. S.).	Albayrak T, 2003, MOL BIOL CELL, V14, P3082, DOI 10.1091/mbc.e02-10-0631; Arikawa Y, 1999, J BIOSCI BIOENG, V87, P333, DOI 10.1016/S1389-1723(99)80041-3; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Brasseur G, 1997, EUR J BIOCHEM, V246, P103, DOI 10.1111/j.1432-1033.1997.t01-1-00103.x; Briere JJ, 2005, CELL MOL LIFE SCI, V62, P2317, DOI 10.1007/s00018-005-5237-6; BRUEL C, 1995, J BIOL CHEM, V270, P22321, DOI 10.1074/jbc.270.38.22321; BULLIS BL, 1994, J BIOL CHEM, V269, P6543; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Colby G, 1998, YEAST, V14, P1001, DOI 10.1002/(SICI)1097-0061(199808)14:11<1001::AID-YEA304>3.0.CO;2-K; COLE ST, 1985, BIOCHIM BIOPHYS ACTA, V811, P381, DOI 10.1016/0304-4173(85)90008-4; DAIGNANFORNIER B, 1994, J BIOL CHEM, V269, P15469; Ebeler SE, 2001, FOOD REV INT, V17, P45, DOI 10.1081/FRI-100000517; Elorza A, 2006, PLANT CELL PHYSIOL, V47, P14, DOI 10.1093/pcp/pci218; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Eriksson L, 2006, MOL DIVERS, V10, P169, DOI 10.1007/s11030-006-9024-6; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gebert N, 2011, MOL CELL, V44, P811, DOI 10.1016/j.molcel.2011.09.025; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Hederstedt L, 1999, SCIENCE, V284, P1941, DOI 10.1126/science.284.5422.1941; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Ishii T, 2005, CANCER RES, V65, P203; Iwata F, 2008, PARASITOL INT, V57, P54, DOI 10.1016/j.parint.2007.08.002; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kerscher O, 2000, MOL BIOL CELL, V11, P103, DOI 10.1091/mbc.11.1.103; Koehler CM, 2000, MOL CELL BIOL, V20, P1187, DOI 10.1128/MCB.20.4.1187-1193.2000; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lemire BD, 2002, BBA-BIOENERGETICS, V1553, P102, DOI 10.1016/S0005-2728(01)00229-8; Maklashina E, 2010, BBA-BIOENERGETICS, V1797, P747, DOI 10.1016/j.bbabio.2010.01.019; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Morales J, 2009, J BIOL CHEM, V284, P7255, DOI 10.1074/jbc.M806623200; Oyedotun KS, 2007, BBA-BIOENERGETICS, V1767, P1436, DOI 10.1016/j.bbabio.2007.09.008; Oyedotun KS, 2004, J BIOL CHEM, V279, P9424, DOI 10.1074/jbc.M311876200; Oyedotun KS, 2004, J BIOL CHEM, V279, P9432, DOI 10.1074/jbc.M311877200; Oyedotun KS, 1999, FEBS LETT, V442, P203, DOI 10.1016/S0014-5793(98)01657-3; Oyedotun KS, 2001, J BIOL CHEM, V276, P16936, DOI 10.1074/jbc.M100184200; Oyedotun KS, 1999, J BIOL CHEM, V274, P23956, DOI 10.1074/jbc.274.34.23956; Oyedotun KS, 1997, J BIOL CHEM, V272, P31382, DOI 10.1074/jbc.272.50.31382; Pasini B, 2008, EUR J HUM GENET, V16, P79, DOI 10.1038/sj.ejhg.5201904; Polychroniadou E, 2003, BIORESOURCE TECHNOL, V87, P337, DOI 10.1016/S0960-8524(02)00237-7; Reinke SN, 2010, MOL GENET METAB, V100, P274, DOI 10.1016/j.ymgme.2010.03.013; Rich P, 1999, BIOCHEM SOC T, V27, P561, DOI 10.1042/bst0270561; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Robinson KM, 1995, METHOD ENZYMOL, V260, P34, DOI 10.1016/0076-6879(95)60128-7; ROBINSON KM, 1991, J BIOL CHEM, V266, P21347; Romano P, 2003, INT J FOOD MICROBIOL, V86, P169, DOI 10.1016/S0168-1605(03)00290-3; ROOS MH, 1994, MOL BIOCHEM PARASIT, V66, P273, DOI 10.1016/0166-6851(94)90154-6; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Scheffler IE, 2001, MITOCHONDRION, V1, P3, DOI 10.1016/S1567-7249(00)00002-7; Schimke RN, 2010, AM J MED GENET A, V152A, P1531, DOI 10.1002/ajmg.a.33384; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sitkin Y, 2007, BBA-BIOENERGETICS, V1767, P143, DOI 10.1016/j.bbabio.2006.11.017; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tran QM, 2007, P NATL ACAD SCI USA, V104, P18007, DOI 10.1073/pnas.0707732104; Tran QM, 2006, J BIOL CHEM, V281, P32310, DOI 10.1074/jbc.M607476200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	72	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22509	22520		10.1074/jbc.M112.344275	http://dx.doi.org/10.1074/jbc.M112.344275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573324	hybrid, Green Published			2022-12-25	WOS:000306495000009
J	Bao, JQ; Li, D; Wang, L; Wu, JW; Hu, YQ; Wang, ZG; Chen, Y; Cao, XK; Jiang, CZ; Yan, W; Xu, C				Bao, Jianqiang; Li, Ding; Wang, Li; Wu, Jingwen; Hu, Yanqin; Wang, Zhugang; Chen, Yan; Cao, Xinkai; Jiang, Cizhong; Yan, Wei; Xu, Chen			MicroRNA-449 and MicroRNA-34b/c Function Redundantly in Murine Testes by Targeting E2F Transcription Factor-Retinoblastoma Protein (E2F-pRb) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALE GERM-CELLS; MIR-17-92 CLUSTER; PROSTATE-CANCER; MALE-FERTILITY; MESSENGER-RNA; DNA-BINDING; SPERMATOGENESIS; EXPRESSION; MICE; GENE	MicroRNAs (miRNAs) mainly function as post-transcriptional regulators and are involved in a wide range of physiological and pathophysiological processes such as cell proliferation, differentiation, apoptosis, and tumorigenesis. Mouse testes express a large number of miRNAs. However, the physiological roles of these testicular miRNAs remain largely unknown. Using microarray and quantitative real time PCR assays, we identified that miRNAs of the microRNA-449 (miR-449) cluster were preferentially expressed in the mouse testis, and their levels were drastically up-regulated upon meiotic initiation during testicular development and in adult spermatogenesis. The expression pattern of the miR-449 cluster resembled that of microRNA-34b/c (miR-34b/c) during spermatogenesis. Further analyses identified that cAMP-responsive element modulator tau and SOX5, two transcription factors essential for regulating male germ cell gene expression, acted as the upstream transactivators to stimulate the expression of the miR-449 cluster in mouse testes. Despite its abundant expression in testicular germ cells, miR-449-null male mice developed normally and exhibited normal spermatogenesis and fertility. Our data further demonstrated that miR-449 shared a cohort of target genes that belong to the E2F transcription factor-retinoblastoma protein pathway with the miR-34 family, and levels of miR-34b/c were significantly up-regulated in miR-449-null testes. Taken together, our data suggest that the miR-449 cluster and miR-34b/c function redundantly in the regulation of male germ cell development in murine testes.	[Bao, Jianqiang; Yan, Wei] Univ Nevada, Dept Physiol & Cell Biol, Sch Med, Reno, NV 89557 USA; [Bao, Jianqiang; Li, Ding; Wang, Li; Wu, Jingwen; Hu, Yanqin; Xu, Chen] Shanghai Jiao Tong Univ, Sch Med, Dept Histol & Embryol, Shanghai 200025, Peoples R China; [Bao, Jianqiang; Li, Ding; Wang, Li; Wu, Jingwen; Hu, Yanqin; Xu, Chen] Shanghai Key Lab Reprod Med, Shanghai 200025, Peoples R China; [Wang, Zhugang; Chen, Yan] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, Shanghai 200025, Peoples R China; [Wang, Zhugang; Chen, Yan] Shanghai Res Ctr Model Organisms, Shanghai 200025, Peoples R China; [Cao, Xinkai; Jiang, Cizhong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Nevada System of Higher Education (NSHE); University of Nevada Reno; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Yan, W (corresponding author), Univ Nevada, Dept Physiol & Cell Biol, Sch Med, 1664 N Virginia St,MS575, Reno, NV 89557 USA.	wyan@unr.edu; chenx@shsmu.edu.cn	Bao, Jianqiang/G-9184-2016; Bao, Jianqiang/T-7299-2019; Yan, Wei/AAH-7943-2019	Bao, Jianqiang/0000-0003-1248-2687; Chen, Yan/0000-0001-5325-1151	National Institutes of Health [HD050281, HD060858]; National Natural Science Foundation of China [30771139, 30900776]; Shanghai Natural Science Foundation [09ZR1416200]; Science and Technology Commission of Shanghai Municipality [10DZ2270600]; Shanghai Leading Academic Discipline Project [S30201]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060858] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants HD050281 and HD060858 (to W. Y.). This work was also supported by National Natural Science Foundation of China Grants 30771139 and 30900776, Shanghai Natural Science Foundation Grant 09ZR1416200, Science and Technology Commission of Shanghai Municipality Grant 10DZ2270600, and Shanghai Leading Academic Discipline Project Grant S30201 (to C. X.).	Bao JQ, 2011, MOL CELL ENDOCRINOL, V333, P134, DOI 10.1016/j.mce.2010.12.021; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; CONNER F, 1994, NUCLEIC ACIDS RES, V22, P3339, DOI 10.1093/nar/22.16.3339; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; De Cesare D, 2003, MOL ENDOCRINOL, V17, P2554, DOI 10.1210/me.2003-0280; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; Feng M, 2010, CELL CYCLE, V9, P213, DOI 10.4161/cc.9.2.10502; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hoja MR, 2004, CELL DEATH DIFFER, V11, P354, DOI 10.1038/sj.cdd.4401362; Holmberg C, 1998, ONCOGENE, V17, P143, DOI 10.1038/sj.onc.1201915; Idler R. K., 2012, J ANDROL IN PRESS; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29; Kimble J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002683; Kiselak EA, 2010, J BIOL CHEM, V285, P30496, DOI 10.1074/jbc.M110.121590; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Lu WJ, 2010, SCIENCE, V328, P1278, DOI 10.1126/science.1185640; Luan L, 2001, CELL DEATH DIFFER, V8, P316, DOI 10.1038/sj.cdd.4400828; Macho B, 2002, SCIENCE, V298, P2388, DOI 10.1126/science.1077265; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Monaco L, 2004, INT J ANDROL, V27, P322, DOI 10.1111/j.1365-2605.2004.00494.x; Nalam RL, 2009, MOL ENDOCRINOL, V23, P1900, DOI 10.1210/me.2009-0184; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Novotny GW, 2007, CELL DEATH DIFFER, V14, P879, DOI 10.1038/sj.cdd.4402090; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Redshaw N, 2009, BRAIN RES, V1250, P20, DOI 10.1016/j.brainres.2008.11.020; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schwartz D, 1999, CELL GROWTH DIFFER, V10, P665; Singh S, 2010, BBA-GENE REGUL MECH, V1799, P788, DOI 10.1016/j.bbagrm.2010.07.004; Spiller CM, 2010, BIOL REPROD, V82, P433, DOI 10.1095/biolreprod.109.078691; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wu JW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-64; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106	61	155	170	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21686	21698		10.1074/jbc.M111.328054	http://dx.doi.org/10.1074/jbc.M111.328054			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570483	Green Published, hybrid			2022-12-25	WOS:000306418600011
J	Eek, P; Jarving, R; Jarving, I; Gilbert, NC; Newcomer, ME; Samel, N				Eek, Priit; Jaerving, Reet; Jaerving, Ivar; Gilbert, Nathaniel C.; Newcomer, Marcia E.; Samel, Nigulas			Structure of a Calcium-dependent 11R-Lipoxygenase Suggests a Mechanism for Ca2+ Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLATELET 12-LIPOXYGENASE; X-RAY; MAMMALIAN LIPOXYGENASES; POSITIONAL SPECIFICITY; MOUSE 8S-LIPOXYGENASE; PRIMARY DETERMINANT; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ARACHIDONIC-ACID; MEMBRANE-BINDING	Lipoxygenases (LOXs) are a key part of several signaling pathways that lead to inflammation and cancer. Yet, the mechanisms of substrate binding and allosteric regulation by the various LOX isoforms remain speculative. Here we report the 2.47-angstrom resolution crystal structure of the arachidonate 11R-LOX from Gersemia fruticosa, which sheds new light on the mechanism of LOX catalysis. Our crystallographic and mutational studies suggest that the aliphatic tail of the fatty acid is bound in a hydrophobic pocket with two potential entrances. We speculate that LOXs share a common T-shaped substrate channel architecture that gives rise to the varying positional specificities. A general allosteric mechanism is proposed for transmitting the activity-inducing effect of calcium binding from the membrane-targeting PLAT (polycystin-1/lipoxygenase/alpha-toxin) domain to the active site via a conserved pi-cation bridge.	[Eek, Priit; Jaerving, Reet; Jaerving, Ivar; Samel, Nigulas] Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia; [Gilbert, Nathaniel C.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Tallinn University of Technology; Louisiana State University System; Louisiana State University	Samel, N (corresponding author), Tallinn Univ Technol, Dept Chem, Akad Tee 15, EE-12618 Tallinn, Estonia.	nigulas.samel@ttu.ee	Eek, Priit/A-1842-2019; Gilbert, Nathaniel/I-8223-2018; Samel, Nigulas/A-1420-2019	Eek, Priit/0000-0003-0702-9466; Gilbert, Nathaniel/0000-0002-6706-811X	Louisiana Governors' Biotechnology Initiative; National Center for Research Resources at the National Institutes of Health [RR-15301]; United States DOE [DE-AC02-06CH11357]; National Science Foundation [MCB 0818387]; Estonian Science Foundation [8276, 9410]; Estonian Ministry of Education and Research [SF140010s08]; European Union [VFP414]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER	Louisiana Governors' Biotechnology Initiative; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States DOE(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Cory LaCrouts for expert assistance in protein expression and purification, and Dr. David Neau in data collection. Preliminary work was performed at the Center for Advanced Microstructures and Devices (Baton Rouge), funded in part by the Louisiana Governors' Biotechnology Initiative. X-ray data were collected at Beam Line 24-ID-E of NE-CAT at the Advanced Photon Source, supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357.; This work was supported by National Science Foundation Grant MCB 0818387 (to M. E. N.), Estonian Science Foundation Grants 8276 (to I. J.) and 9410 (to N. S.), the Estonian Ministry of Education and Research Grant SF140010s08 (to N. S.), and the European Union Seventh Framework Programme Project VFP414 (to Prof. Mihkel Kaljurand and Dr. Mihkel Koel).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Allard JB, 2005, CURR PROTEIN PEPT SC, V6, P125, DOI 10.2174/1389203053545417; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boeglin WE, 2008, LIPIDS, V43, P979, DOI 10.1007/s11745-008-3230-1; Borngraber S, 1996, J MOL BIOL, V264, P1145, DOI 10.1006/jmbi.1996.0702; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHEN XS, 1993, FASEB J, V7, P694, DOI 10.1096/fasebj.7.8.8500694; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Chruszcz M, 2008, BIOPHYS J, V95, P1, DOI 10.1529/biophysj.108.131789; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esser J, 2010, BIOCHEM J, V425, P265, DOI 10.1042/BJ20090856; Gan QF, 1996, J BIOL CHEM, V271, P25412, DOI 10.1074/jbc.271.41.25412; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Ivanov I, 2011, BBA-MOL CELL BIOL L, V1811, P1001, DOI 10.1016/j.bbalip.2011.08.008; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jankun J, 2008, CURR MOL MED, V8, P768, DOI 10.2174/156652408786733757; Jisaka M, 2005, BIOCHEM BIOPH RES CO, V338, P136, DOI 10.1016/j.bbrc.2005.08.029; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Mortimer M, 2006, ARCH BIOCHEM BIOPHYS, V445, P147, DOI 10.1016/j.abb.2005.10.023; Naylor CE, 1999, J MOL BIOL, V294, P757, DOI 10.1006/jmbi.1999.3279; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Palmieri-Thiers C, 2011, ARCH BIOCHEM BIOPHYS, V509, P82, DOI 10.1016/j.abb.2011.02.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Shang WF, 2011, J MOL BIOL, V409, P654, DOI 10.1016/j.jmb.2011.04.035; Skrzypczak-Jankun E, 2006, ACTA CRYSTALLOGR D, V62, P766, DOI 10.1107/S0907444906016982; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Toledo L, 2011, J COMPUT AID MOL DES, V25, P825, DOI 10.1007/s10822-011-9466-5; Toledo L, 2010, J PHYS CHEM B, V114, P7037, DOI 10.1021/jp912120n; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Walther M, 2004, J BIOL CHEM, V279, P3717, DOI 10.1074/jbc.M309564200; Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yoshida H, 2010, CLIN CHIM ACTA, V411, P1875, DOI 10.1016/j.cca.2010.08.038; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182	59	42	44	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22377	22386		10.1074/jbc.M112.343285	http://dx.doi.org/10.1074/jbc.M112.343285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573333	Green Published, hybrid			2022-12-25	WOS:000306418600074
J	Jaldety, Y; Glick, Y; Orr-Urtreger, A; Ickowicz, D; Gerber, D; Breitbart, H				Jaldety, Yael; Glick, Yair; Orr-Urtreger, Avi; Ickowicz, Debby; Gerber, Doron; Breitbart, Haim			Sperm Epidermal Growth Factor Receptor (EGFR) Mediates alpha 7 Acetylcholine Receptor (AChR) Activation to Promote Fertilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACROSOME REACTION; ZONA-PELLUCIDA; MOUSE SPERM; MICE DEFICIENT; CHOLINE-ACETYLTRANSFERASE; TYROSINE PHOSPHORYLATION; EGG ZP3; CHANNELS; TRANSACTIVATION; IDENTIFICATION	To attain fertilization the spermatozoon binds to the egg zona pellucida (ZP) via sperm receptor(s) and undergoes an acrosome reaction (AR). Several sperm receptors have been described in the literature; however, the identity of this receptor is not yet certain. In this study, we suggest that the alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR) might be a sperm receptor activated by ZP to induce epidermal growth factor receptor (EGFR)-mediated AR. We found that isolated ZP or alpha 7 agonists induced the AR in sperm from WT but not alpha 7-null spermatozoa, and the induced AR was inhibited by alpha 7 or EGFR antagonists. Moreover, alpha 7-null sperm showed very little binding to the egg, and microfluidic affinity in vitro assay clearly showed that alpha 7nAChR, as well as EGFR, interacted with ZP3. Induction of EGFR activation and the AR by an alpha 7 agonist was inhibited by a Src family kinase (SFK) inhibitor. In conclusion we suggest that activation of alpha 7 by ZP leads to SFK-dependent EGFR activation, Ca2+ influx, and the acrosome reaction.	[Jaldety, Yael; Glick, Yair; Ickowicz, Debby; Gerber, Doron; Breitbart, Haim] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Orr-Urtreger, Avi] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Genet Inst, IL-69978 Tel Aviv, Israel; [Orr-Urtreger, Avi] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Breitbart, H (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	haim.breitbart@biu.ac.il		Orr-Urtreger, Avi/0000-0001-9305-6203				Almog T, 2008, J BIOL CHEM, V283, P14479, DOI 10.1074/jbc.M710492200; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Arnoult C, 1996, J CELL BIOL, V134, P637, DOI 10.1083/jcb.134.3.637; Berg DK, 2002, J NEUROBIOL, V53, P512, DOI 10.1002/neu.10116; Blanchet MR, 2006, AM J PHYSIOL-LUNG C, V291, pL757, DOI 10.1152/ajplung.00409.2005; BLEIL JD, 1986, J CELL BIOL, V102, P1363, DOI 10.1083/jcb.102.4.1363; Bodis J, 2002, GYNECOL ENDOCRINOL, V16, P259, DOI 10.1080/713603093; Bray C, 2005, MOL HUM REPROD, V11, P881, DOI 10.1093/molehr/gah245; Bray C, 2005, BIOL REPROD, V73, P807, DOI 10.1095/biolreprod.105.042184; Bray C, 2002, BIOL REPROD, V67, P782, DOI 10.1095/biolreprod.102.004580; Breitbart H, 2010, MOL CELL ENDOCRINOL, V314, P234, DOI 10.1016/j.mce.2009.06.009; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cohen G, 2004, DEV BIOL, V267, P230, DOI 10.1016/j.ydbio.2003.10.034; Daniel L, 2010, DEV BIOL, V344, P650, DOI 10.1016/j.ydbio.2010.05.490; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Einav S, 2008, NAT BIOTECHNOL, V26, P1019, DOI 10.1038/nbt.1490; Escoffier J, 2007, J CELL PHYSIOL, V212, P753, DOI 10.1002/jcp.21075; Etkovitz N, 2007, BIOL REPROD, V77, P263, DOI 10.1095/biolreprod.106.056705; Etkovitz N, 2009, DEV BIOL, V334, P447, DOI 10.1016/j.ydbio.2009.08.002; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; Florman HM, 2008, INT J DEV BIOL, V52, P503, DOI 10.1387/ijdb.082696hf; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; FLORMAN HM, 1989, DEV BIOL, V135, P133, DOI 10.1016/0012-1606(89)90164-4; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; Fuhrer C, 1997, EMBO J, V16, P4951, DOI 10.1093/emboj/16.16.4951; Fukami K, 2003, J CELL BIOL, V161, P79, DOI 10.1083/jcb.200210057; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; IBANEZ CF, 1991, P NATL ACAD SCI USA, V88, P3676, DOI 10.1073/pnas.88.9.3676; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kassner PD, 1998, MOL CELL NEUROSCI, V10, P258, DOI 10.1006/mcne.1998.0664; Kornya L, 2001, GYNECOL OBSTET INVES, V52, P104, DOI 10.1159/000052952; Kumar P, 2005, J BIOL CHEM, V280, P25928, DOI 10.1074/jbc.M502435200; LAX Y, 1994, FEBS LETT, V339, P234, DOI 10.1016/0014-5793(94)80422-2; Lyng Robert, 2007, Soc Reprod Fertil Suppl, V65, P335; Mayerhofer A, 1999, MEDICINA-BUENOS AIRE, V59, P542; Meizel S, 2005, MOL REPROD DEV, V72, P250, DOI 10.1002/mrd.20336; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Mitchell LA, 2008, MOL HUM REPROD, V14, P235, DOI 10.1093/molehr/gan007; Mitsui T, 2000, J CELL BIOCHEM, V77, P584, DOI 10.1002/(SICI)1097-4644(20000615)77:4<584::AID-JCB6>3.0.CO;2-U; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; NELSON L, 1976, EXP CELL RES, V101, P221, DOI 10.1016/0014-4827(76)90371-2; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; PLACZEK R, 1988, ARCH ANDROLOGY, V21, P1; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Sanchez-Gonzalez P, 2010, FEBS J, V277, P327, DOI 10.1111/j.1742-4658.2009.07469.x; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Shah BH, 2003, TRENDS PHARMACOL SCI, V24, P239, DOI 10.1016/S0165-6147(03)00079-8; Shirakawa H, 1999, DEV BIOL, V208, P70, DOI 10.1006/dbio.1998.9194; Shoop RD, 2000, J NEUROSCI, V20, P4021; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Son JH, 2003, BIOL REPROD, V68, P1348, DOI 10.1095/biolreprod.102.011163; STEWART TA, 1978, BIOL REPROD, V19, P271, DOI 10.1095/biolreprod19.2.271; STEWART TA, 1978, BIOL REPROD, V19, P965, DOI 10.1095/biolreprod19.5.965; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; SWOPE SL, 1995, ANN NY ACAD SCI, V757, P197, DOI 10.1111/j.1749-6632.1995.tb17476.x; Trevino CL, 2004, FEBS LETT, V563, P87, DOI 10.1016/S0014-5793(04)00257-1; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; WARD CR, 1993, DEV BIOL, V158, P9, DOI 10.1006/dbio.1993.1165; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; YOSHIMATSU N, 1988, GAMETE RES, V21, P115, DOI 10.1002/mrd.1120210202; YOUNG RJ, 1991, MOL REPROD DEV, V28, P55, DOI 10.1002/mrd.1080280109	74	19	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22328	22340		10.1074/jbc.M111.292292	http://dx.doi.org/10.1074/jbc.M111.292292			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577141	Green Published, hybrid			2022-12-25	WOS:000306418600070
J	Stanger, K; Gorelik, M; Davidson, AR				Stanger, Karen; Gorelik, Maryna; Davidson, Alan R.			Yeast Adaptor Protein, Nbp2p, Is Conserved Regulator of Fungal Ptc1p Phosphatases and Is Involved in Multiple Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH3 DOMAIN; VACUOLE INHERITANCE; KINASE; SPECIFICITY; DELETION; PROVIDES; NETWORK; TARGETS	Nbp2p is an Src homology 3 (SH3) domain-containing yeast protein that is involved in a variety of cellular processes. This small adaptor protein binds to a number of different proteins through its SH3 domain, and a region N-terminal to the SH3 domain binds to the protein phosphatase, Ptc1p. Despite its involvement in a large number of physical and genetic interactions, the only well characterized function of Nbp2p is to recruit Ptc1p to the high osmolarity glycerol pathway, which results in down-regulation of this pathway. In this study, we have discovered that Nbp2p orthologues exist in all Ascomycete and Basidiomycete fungal genomes and that all possess an SH3 domain and a conserved novel Ptc1p binding motif. The ubiquitous occurrence of these two features, which we have shown are both critical for Nbp2p function in Saccharomyces cerevisiae, implies that a conserved role of Nbp2p in all of these fungal species is the targeting of Ptc1p to proteins recognized by the SH3 domain. We also show that in a manner analogous to its role in the high osmolarity glycerol pathway, Nbp2p functions in the down-regulation of the cell wall integrity pathway through SH3 domain-mediated interaction with Bck1p, a component kinase of this pathway. Based on functional studies on the Schizosaccharomyces pombe and Neurospora crassa Nbp2p orthologues and the high conservation of the Nbp2p binding site in Bck1p orthologues, this function of Nbp2p appears to be conserved across Ascomycetes. Our results also clearly imply a function for the Nbp2p-Ptc1p complex other cellular processes.	[Gorelik, Maryna; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Stanger, Karen; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	alan.davidson@utoronto.ca			Canadian Institutes of Health Research Operating Grant [MOP-13609]; Natural Sciences and Engineering Research Council Scholarship PGS-D; Natural Sciences and Engineering Research Council Scholarship PGS-M	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council Scholarship PGS-D; Natural Sciences and Engineering Research Council Scholarship PGS-M	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-13609 and Natural Sciences and Engineering Research Council Scholarships PGS-D (to M. G.) and PGS-M (to K. S.).	Bartholomew CR, 2009, EUKARYOT CELL, V8, P560, DOI 10.1128/EC.00111-08; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Carbo N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001009; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Gorelik M, 2012, J BIOL CHEM, V287, P9168, DOI 10.1074/jbc.M111.330753; Gorelik M, 2011, J BIOL CHEM, V286, P19470, DOI 10.1074/jbc.M111.229294; Haynes J, 2007, GENETICS, V176, P193, DOI 10.1534/genetics.106.070300; Hoang A, 2001, AM J HEALTH-SYST PH, V58, P1206, DOI 10.1093/ajhp/58.13.1206; Hruby A, 2011, J CELL SCI, V124, P35, DOI 10.1242/jcs.077065; Jin Y, 2009, MOL BIOL CELL, V20, P1312, DOI 10.1091/mbc.E08-09-0954; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Ohkuni K, 2003, GENETICS, V165, P517; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Winters MJ, 2005, MOL CELL BIOL, V25, P2177, DOI 10.1128/MCB.25.6.2177-2190.2005; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425	30	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22133	22141		10.1074/jbc.M112.348052	http://dx.doi.org/10.1074/jbc.M112.348052			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570491	Green Published, hybrid			2022-12-25	WOS:000306418600050
J	Matrkova, J; Remes, V				Matrkova, Jana; Remes, Vladimir			Environmental and Genetic Effects on Pigment-Based vs. Structural Component of Yellow Feather Colouration	PLOS ONE			English	Article							TIT PARUS-MAJOR; NESTLING BLUE TITS; CAROTENOID-BASED COLORATION; SIGNAL DIFFERENT ASPECTS; GREAT TIT; PLUMAGE COLORATION; CONDITION-DEPENDENCE; CYANISTES-CAERULEUS; SEXUAL SELECTION; DIET QUALITY	Background: Carotenoid plumage is of widespread use in bird communication. Carotenoid-based feather colouration has recently been shown to be dependent on both pigment concentration and feather structure. If these two components are determined differently, one plumage patch may potentially convey different aspects of individual quality. Methodology/Principal Findings: We evaluated the effects of genetic and environmental factors on carotenoid-based yellow breast colouration of Great Tit (Parus major) nestlings. By partial cross-fostering, we separated the genetic and prenatal vs. post-natal parental effects on both the structural and the pigment-based component of carotenoid-based plumage colouration. We also simultaneously manipulated the post-hatching environment by brood size manipulation. The structural component of nestling colouration reflected features of female colouration. On the other hand, the pigment-based component was more affected by rearing conditions presumably representing food quality. While the structural component was related to both origin- and environment-related factors, the pigment-based component seemed to be environment-dependent only. These results support the notion that pigment-based and structural components of feather colouration are determined differently. Conclusions/Significance: Chromatic and achromatic components of carotenoid-based feather colouration reflected different aspects of individual quality and history, and thus may potentially form a multicomponent signal.	[Matrkova, Jana] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; Palacky Univ, Ornithol Lab, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc	Matrkova, J (corresponding author), Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic.	jana.matrkova@seznam.cz	Remeš, Vladimír/B-6842-2016		Czech Ministry of Education [MSM6198959212]; Palacky University [IGA Prf_2012_021]	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Palacky University	This work was supported by Czech Ministry of Education (grant no. MSM6198959212; http://www.msmt.cz) and Palacky University (grant no. IGA Prf_2012_021; http://www.upol.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S., 2006, BIRD COLORATION, P76; Arnold KE, 2010, BIOL J LINN SOC, V99, P708, DOI 10.1111/j.1095-8312.2010.01377.x; Arriero E, 2006, NATURWISSENSCHAFTEN, V93, P173, DOI 10.1007/s00114-006-0090-5; Biard C, 2005, OECOLOGIA, V144, P32, DOI 10.1007/s00442-005-0048-x; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; Biard C, 2007, J EVOLUTION BIOL, V20, P326, DOI 10.1111/j.1420-9101.2006.01194.x; Bitton PP, 2008, J AVIAN BIOL, V39, P446, DOI 10.1111/j.2008.0908-8857.04283.x; Blount Jonathan D., 2008, V4, P213, DOI 10.1007/978-3-7643-7499-0_11; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Senar JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010716; del Cerro S, 2010, OECOLOGIA, V162, P825, DOI 10.1007/s00442-009-1510-y; Delhey K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011582; Delhey Kaspar, 2010, BMC Ecology, V10, P13, DOI 10.1186/1472-6785-10-13; Eeva T, 1998, FUNCT ECOL, V12, P607, DOI 10.1046/j.1365-2435.1998.00221.x; Eeva T, 2009, J AVIAN BIOL, V40, P491, DOI 10.1111/j.1600-048X.2008.04535.x; Eeva T, 2008, ECOHEALTH, V5, P328, DOI 10.1007/s10393-008-0184-y; Espmark Y., 2000, ANIMAL SIGNALS SIGNA; Evans SR, 2012, AM NAT, V179, P79, DOI 10.1086/663198; Evans SR, 2010, BIOL J LINN SOC, V101, P777, DOI 10.1111/j.1095-8312.2010.01548.x; Ferns PN, 2008, IBIS, V150, P152; Fitze PS, 2006, J EVOLUTION BIOL, V19, P618, DOI 10.1111/j.1420-9101.2005.01008.x; Fitze PS, 2003, OECOLOGIA, V137, P148, DOI 10.1007/s00442-003-1323-3; Fitze PS, 2003, EVOLUTION, V57, P144; Fitzpatrick S, 1998, ANN ZOOL FENN, V35, P67; Galvan I, 2008, J AVIAN BIOL, V39, P277, DOI 10.1111/j.0908-8857.2008.04273.x; Galvan I, 2009, ACTA ORNITHOL, V44, P139, DOI 10.3161/000164509X482722; Geens A, 2009, COMP BIOCHEM PHYS C, V150, P155, DOI 10.1016/j.cbpc.2009.04.007; Grafen A., 2002, MODERN STAT LIFE SCI; Grether GF, 2004, BIOL REV, V79, P583, DOI 10.1017/S1464793103006390; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Hadfield JD, 2007, J EVOLUTION BIOL, V20, P549, DOI 10.1111/j.1420-9101.2006.01262.x; Hadfield JD, 2006, J EVOLUTION BIOL, V19, P1104, DOI 10.1111/j.1420-9101.2006.01095.x; Hadfield JD, 2006, P ROY SOC B-BIOL SCI, V273, P1347, DOI 10.1098/rspb.2005.3459; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hill G. E., 2002, RED BIRD BROWN BAG F; Hill GE, 2005, ANIM BEHAV, V69, P387, DOI 10.1016/j.anbehav.2004.03.013; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; Hill GE., 2006, BIRD COLOURATION, P507, DOI [10.4159/9780674273788, DOI 10.4159/9780674273788]; Horak P, 2000, NATURWISSENSCHAFTEN, V87, P460, DOI 10.1007/s001140050759; Isaksson C, 2008, P ROY SOC B-BIOL SCI, V275, P309, DOI 10.1098/rspb.2007.1474; Isaksson C, 2006, BEHAV ECOL SOCIOBIOL, V60, P556, DOI 10.1007/s00265-006-0200-6; Isaksson C, 2008, BIOL J LINN SOC, V95, P758, DOI 10.1111/j.1095-8312.2008.01033.x; Jacot A, 2007, BEHAV ECOL, V18, P34, DOI 10.1093/beheco/arl054; Jacot A, 2010, AM NAT, V176, P55, DOI 10.1086/653000; Jenni L., 1994, BIOL MOULT BIRDS; Johnsen A, 2003, P ROY SOC B-BIOL SCI, V270, P1263, DOI 10.1098/rspb.2003.2375; Lambrechts MM, 2010, ACTA ORNITHOL, V45, P1, DOI 10.3161/000164510X516047; Larcombe SD, 2010, NATURWISSENSCHAFTEN, V97, P903, DOI 10.1007/s00114-010-0708-5; Matysiokova B, 2011, J ORNITHOL, V152, P337, DOI 10.1007/s10336-010-0594-9; Matysiokova B, 2010, ETHOLOGY, V116, P596, DOI 10.1111/j.1439-0310.2010.01776.x; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; McGlothlin JW, 2007, BEHAV ECOL SOCIOBIOL, V61, P1391, DOI 10.1007/s00265-007-0370-x; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Olson VA, 2005, J EVOLUTION BIOL, V18, P1534, DOI 10.1111/j.1420-9101.2005.00940.x; Peters A, 2011, J EVOLUTION BIOL, V24, P976, DOI 10.1111/j.1420-9101.2011.02229.x; Peters A, 2007, AM NAT, V169, pS122, DOI 10.1086/510139; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Prum RO, 2006, BIRD COLORATION, V1, P295; Quesada J, 2009, BEHAVIOUR, V146, P1235, DOI 10.1163/156853909X420017; Quesada J, 2006, J AVIAN BIOL, V37, P609, DOI 10.1111/j.0908-8857.2006.03636.x; Remes V, 2011, J AVIAN BIOL, V42, P387, DOI 10.1111/j.1600-048X.2011.05402.x; Remes V, 2011, BEHAV ECOL SOCIOBIOL, V65, P1257, DOI 10.1007/s00265-011-1139-9; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Senar JC, 2002, P ROY SOC B-BIOL SCI, V269, P257, DOI 10.1098/rspb.2001.1882; Shawkey MD, 2006, P R SOC B, V273, P2985, DOI 10.1098/rspb.2006.3675; Shawkey MD, 2009, J R SOC INTERFACE, V6, pS221, DOI 10.1098/rsif.2008.0459.focus; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Siefferman L, 2005, EVOLUTION, V59, P1819, DOI 10.1111/j.0014-3820.2005.tb01828.x; Siitari H, 2007, AM NAT, V169, pS81, DOI 10.1086/510140; Sillanpaa S, 2009, ACTA OECOL, V35, P805, DOI 10.1016/j.actao.2009.08.006; SLAGSVOLD T, 1985, J ZOOL, V206, P321; Svensson PA, 2011, BEHAVIOUR, V148, P131, DOI 10.1163/000579510X548673; Tanner M, 2008, BEHAV ECOL, V19, P369, DOI 10.1093/beheco/arm142; Tschirren B, 2003, J EVOLUTION BIOL, V16, P91, DOI 10.1046/j.1420-9101.2003.00483.x; Tschirren B, 2005, OECOLOGIA, V143, P477, DOI 10.1007/s00442-004-1812-z	77	12	12	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36640	10.1371/journal.pone.0036640	http://dx.doi.org/10.1371/journal.pone.0036640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590581	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336400024
J	Bazile, V; Moran, JA; Le Moguedec, G; Marshall, DJ; Gaume, L				Bazile, Vincent; Moran, Jonathan A.; Le Moguedec, Gilles; Marshall, David J.; Gaume, Laurence			A Carnivorous Plant Fed by Its Ant Symbiont: A Unique Multi-Faceted Nutritional Mutualism	PLOS ONE			English	Article							PITCHER PLANT; NEPENTHES-BICALCARATA; ASSIMILATORY ORGANS; FOLIAR REFLECTANCE; HOST-PLANT; NITROGEN; PREY; ABSORPTION; EVOLUTION; MODEL	Scarcity of essential nutrients has led plants to evolve alternative nutritional strategies, such as myrmecotrophy (ant-waste-derived nutrition) and carnivory (invertebrate predation). The carnivorous plant Nepenthes bicalcarata grows in the Bornean peatswamp forests and is believed to have a mutualistic relationship with its symbiotic ant Camponotus schmitzi. However, the benefits provided by the ant have not been quantified. We tested the hypothesis of a nutritional mutualism, using foliar isotopic and reflectance analyses and by comparing fitness-related traits between ant-inhabited and uninhabited plants. Plants inhabited by C. schmitzi produced more leaves of greater area and nitrogen content than unoccupied plants. The ants were estimated to provide a 200% increase in foliar nitrogen to adult plants. Inhabited plants also produced more and larger pitchers containing higher prey biomass. C. schmitzi-occupied pitchers differed qualitatively in containing C. schmitzi wastes and captured large ants and flying insects. Pitcher abortion rates were lower in inhabited plants partly because of herbivore deterrence as herbivory-aborted buds decreased with ant occupation rate. Lower abortion was also attributed to ant nutritional service. The ants had higher delta N-15 values than any tested prey, and foliar delta N-15 increased with ant occupation rate, confirming their predatory behaviour and demonstrating their direct contribution to the plant-recycled N. We estimated that N. bicalcarata derives on average 42% of its foliar N from C. schmitzi wastes, (76% in highly-occupied plants). According to the Structure Independent Pigment Index, plants without C. schmitzi were nutrient stressed compared to both occupied plants, and pitcher-lacking plants. This attests to the physiological cost of pitcher production and poor nutrient assimilation in the absence of the symbiont. Hence C. schmitzi contributes crucially to the nutrition of N. bicalcarata, via protection of assimilatory organs, enhancement of prey capture, and myrmecotrophy. This combination of carnivory and myrmecotrophy represents an outstanding strategy of nutrient sequestration.	[Bazile, Vincent; Le Moguedec, Gilles; Gaume, Laurence] Univ Montpellier 2, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France; [Le Moguedec, Gilles] INRA, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France; [Gaume, Laurence] CNRS, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France; [Moran, Jonathan A.] Royal Rd Univ, Sch Environm & Sustainabil, Victoria, BC, Canada; [Marshall, David J.] Univ Brunei Darussalam, Dept Biol, Gadong, Brunei	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University Brunei Darussalam	Bazile, V (corresponding author), Univ Montpellier 2, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France.	Vincent.Bazile@cirad.fr		Marshall, David/0000-0003-3771-5950	Centre National de la Recherche Scientifique (CNRS) through the PEPS/INEE	Centre National de la Recherche Scientifique (CNRS) through the PEPS/INEE	The work was supported by Centre National de la Recherche Scientifique (CNRS) through the PEPS/INEE-2010 grant devoted to the "CarniBiop" project supervised by LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2003, OIKOS, V1, P1989; [Anonymous], 2001, FLORA MALESIANA 1; Athauda SBP, 2004, BIOCHEM J, V381, P295, DOI 10.1042/BJ20031575; BEATTIE A, 1989, TRENDS ECOL EVOL, V4, P172, DOI 10.1016/0169-5347(89)90122-5; Beaver R.A., 1983, P129; Beccari O, 1885, PLANTES FOURMIS ARCH; BENZING DH, 1991, ANT - PLANT INTERACTIONS, P353; BENZING DH, 1987, TRENDS ECOL EVOL, V2, P364, DOI 10.1016/0169-5347(87)90137-6; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Bonhomme V, 2011, NEW PHYTOL, V191, P545, DOI 10.1111/j.1469-8137.2011.03696.x; Bonhomme V, 2011, J TROP ECOL, V27, P15, DOI 10.1017/S0266467410000532; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; CARTER GA, 1994, INT J REMOTE SENS, V15, P697, DOI 10.1080/01431169408954109; Clarke C., 1998, Sandakania, P27; Clarke C., 1997, NEPENTHES OF BORNEO; CLARKE CM, 1993, ECOL ENTOMOL, V18, P7, DOI 10.1111/j.1365-2311.1993.tb01074.x; CLARKE CM, 1995, J TROP ECOL, V11, P589, DOI 10.1017/S0266467400009160; COMBES C, 1995, PARASITISM ECOLOGY E; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Defossez E, 2011, P ROY SOC B-BIOL SCI, V278, P1419, DOI 10.1098/rspb.2010.1884; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Ellis AG, 1996, OECOLOGIA, V106, P478, DOI 10.1007/BF00329705; Ellison AM, 2006, PLANT BIOLOGY, V8, P740, DOI 10.1055/s-2006-923956; Ellison AM, 2003, ADV ECOL RES, V33, P1, DOI 10.1016/S0065-2504(03)33009-0; Ellison AM, 2002, P NATL ACAD SCI USA, V99, P4409, DOI 10.1073/pnas.022057199; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Gamon JA, 1997, OECOLOGIA, V112, P492, DOI 10.1007/s004420050337; Gaume L, 2004, ARTHROPOD STRUCT DEV, V33, P103, DOI 10.1016/j.asd.2003.11.005; Gaume L, 1998, P ROY SOC B-BIOL SCI, V265, P569, DOI 10.1098/rspb.1998.0332; Gaume L, 2009, ANN BOT-LONDON, V104, P1281, DOI 10.1093/aob/mcp238; Gaume L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001185; GAY H, 1993, BIOL J LINN SOC, V50, P221, DOI 10.1111/j.1095-8312.1993.tb00928.x; Grafe TU, 2011, BIOL LETTERS, V7, P436, DOI 10.1098/rsbl.2010.1141; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; JACQUEMOUD S, 1990, REMOTE SENS ENVIRON, V34, P75, DOI 10.1016/0034-4257(90)90100-Z; Juniper B.E., 1989, CARNIVOROUS PLANTS; Leroy C, 2011, J ECOL, V99, P583, DOI 10.1111/j.1365-2745.2010.01763.x; McKey Doyle, 2005, P386, DOI 10.1017/CBO9780511541971.017; McPherson S.R., 2009, PITCHER PLANTS OLD W, V1-2; Merbach Marlis A., 2007, Ecotropica-Bonn, V13, P45; Merbach Marlis A., 1999, Ecotropica, V5, P45; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moon DC, 2010, OECOLOGIA, V164, P185, DOI 10.1007/s00442-010-1670-9; Moran JA, 2003, INT J PLANT SCI, V164, P635, DOI 10.1086/375422; Moran JA, 2001, ANN BOT-LONDON, V88, P307, DOI 10.1006/anbo.2001.1460; Moran JA, 1998, INT J PLANT SCI, V159, P996; Moran JA, 2000, TREE PHYSIOL, V20, P1113; Moran JA, 2010, J EXP BOT, V61, P1365, DOI 10.1093/jxb/erq004; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; Osunkoya OO, 2008, ANN BOT-LONDON, V102, P845, DOI 10.1093/aob/mcn162; Osunkoya OO, 2007, ANN BOT-LONDON, V99, P895, DOI 10.1093/aob/mcm023; Pavlovic A, 2009, ANN BOT-LONDON, V104, P307, DOI 10.1093/aob/mcp121; PENUELAS J, 1995, PHOTOSYNTHETICA, V31, P221; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; RICKSON FR, 1979, AM J BOT, V66, P87, DOI 10.2307/2442629; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; RICOGRAY V, 1989, AM J BOT, V76, P603, DOI 10.2307/2444355; Schulze W, 1997, OECOLOGIA, V112, P464, DOI 10.1007/s004420050333; Shaerer G., 1988, STABLE ISOTOPES ECOL, V68, P342; Solano PJ, 2004, BIOL J LINN SOC, V83, P433, DOI 10.1111/j.1095-8312.2004.00381.x; THOMPSON JN, 1981, BIOL J LINN SOC, V16, P147, DOI 10.1111/j.1095-8312.1981.tb01647.x; Thornham DG, 2011, FUNCTIONAL ECOLOGY; TRESEDER KK, 1995, NATURE, V375, P137, DOI 10.1038/375137a0	63	38	38	4	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36179	10.1371/journal.pone.0036179	http://dx.doi.org/10.1371/journal.pone.0036179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590524	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100020
J	Mundia, MM; Demers, RW; Chow, ML; Perieteanu, AA; Dawson, JF				Mundia, Maureen M.; Demers, Ryan W.; Chow, Melissa L.; Perieteanu, Alexandru A.; Dawson, John F.			Subdomain Location of Mutations in Cardiac Actin Correlate with Type of Functional Change	PLOS ONE			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; TETRAMETHYLRHODAMINE-LABELED ACTIN; DNASE-I; DILATED CARDIOMYOPATHY; THERMAL-DENATURATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ATP HYDROLYSIS; GENE-MUTATIONS; STATE	Determining the molecular mechanisms that lead to the development of heart failure will help us gain better insight into the most costly health problem in the Western world. To understand the roles that the actin protein plays in the development of heart failure, we have taken a systematic approach toward characterizing human cardiac actin mutants that have been associated with either hypertrophic or dilated cardiomyopathy. Seven known cardiac actin mutants were expressed in a baculovirus system, and their intrinsic properties were studied. In general, the changes to the properties of the actin proteins themselves were subtle. The R312H variant exhibited reduced stability, with a T-m of 53.6 degrees C compared to 56.8 degrees C for WT actin, accompanied with increased polymerization critical concentration and Pi release rate, and a marked increase in nucleotide release rates. Substitution of methionine for leucine at amino acid 305 showed no impact on the increase in Pi release was observed. Increases to both the Tm and DNase-I inhibition activity suggested interactions between E99K actin molecules under monomer-promoting conditions. Y166C actin had a higher critical concentration protein correlated with the molecular effects; in general, mutations in subdomain 3 affected the stability of the ACTC protein or affect the polymerization of actin filaments, while mutations in subdomains 1 and 4 more likely affect protein-protein interactions.	[Mundia, Maureen M.; Demers, Ryan W.; Chow, Melissa L.; Perieteanu, Alexandru A.; Dawson, John F.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Mundia, MM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jdawso01@uoguelph.ca	Dawson, John/HDM-6702-2022		Heart and Stroke Foundation of Canada [NA 6469]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	JFD was supported by a Grant-in-aid from the Heart and Stroke Foundation of Canada (#NA 6469, www.heartandstroke.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler GM, 2005, J MOL BIOL, V353, P385, DOI 10.1016/j.jmb.2005.07.062; BERTAZZON A, 1990, BIOCHEMISTRY-US, V29, P291, DOI 10.1021/bi00453a040; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Conchaudron AP, 2006, J BIOL CHEM, V281, P24036, DOI 10.1074/jbc.M602747200; CONTAXIS CC, 1977, CAN J BIOCHEM CELL B, V55, P325, DOI 10.1139/o77-045; Debold EP, 2010, J MOL CELL CARDIOL, V48, P286, DOI 10.1016/j.yjmcc.2009.09.014; DRUMMOND DR, 1992, EUR J BIOCHEM, V209, P171, DOI 10.1111/j.1432-1033.1992.tb17274.x; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kaski JP, 2009, CIRC-CARDIOVASC GENE, V2, P436, DOI 10.1161/CIRCGENETICS.108.821314; Kudryashov DS, 2010, J BIOL CHEM, V285, P25591, DOI 10.1074/jbc.M110.123869; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; LE BIHAN T, 1993, BIOCHEM BIOPH RES CO, V194, P1065, DOI 10.1006/bbrc.1993.1930; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Morrison SS, 2007, ANAL BIOCHEM, V364, P159, DOI 10.1016/j.ab.2007.02.027; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Olson TM, 2000, J MOL CELL CARDIOL, V32, P1687, DOI 10.1006/jmcc.2000.1204; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Perieteanu AA, 2008, BIOCHEMISTRY-US, V47, P9688, DOI 10.1021/bi800421u; Perrot A, 2007, EUR J HEART FAIL, V9, P4, DOI 10.1016/j.ejheart.2006.04.010; Rutkevich LA, 2006, CAN J PHYSIOL PHARM, V84, P111, DOI 10.1139/Y05-140; Sablin EP, 2002, P NATL ACAD SCI USA, V99, P10945, DOI 10.1073/pnas.152329899; Saeki K, 2000, BIOCHEMISTRY-US, V39, P1324, DOI 10.1021/bi991297k; Schrodinger L., 2020, PYMOL; Schuler H, 2000, EUR J BIOCHEM, V267, P476, DOI 10.1046/j.1432-1327.2000.01023.x; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Song WH, 2011, J BIOL CHEM, V286, P27582, DOI 10.1074/jbc.M111.252320; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; STRZELECKAGOLASZEWSKA H, 1995, BIOCHEM J, V307, P527, DOI 10.1042/bj3070527; Vang S, 2005, FEBS J, V272, P2037, DOI 10.1111/j.1742-4658.2005.04630.x; WERTMAN KF, 1992, GENETICS, V132, P337; Wong WNW, 2001, J MUSCLE RES CELL M, V22, P665, DOI 10.1023/A:1016354308436; Yates SP, 2007, ARCH BIOCHEM BIOPHYS, V466, P58, DOI 10.1016/j.abb.2007.07.018; Yates SP, 2009, BIOCHEM CELL BIOL, V87, P853, DOI [10.1139/O09-039, 10.1139/o09-039]	40	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36821	10.1371/journal.pone.0036821	http://dx.doi.org/10.1371/journal.pone.0036821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590617	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335500031
J	Wiede, F; Chew, SH; van Vliet, C; Poulton, IJ; Kyparissoudis, K; Sasmono, T; Loh, K; Tremblay, ML; Godfrey, DI; Sims, NA; Tiganis, T				Wiede, Florian; Chew, Sock Hui; van Vliet, Catherine; Poulton, Ingrid J.; Kyparissoudis, Konstantinos; Sasmono, Tedjo; Loh, Kim; Tremblay, Michel L.; Godfrey, Dale I.; Sims, Natalie A.; Tiganis, Tony			Strain-Dependent Differences in Bone Development, Myeloid Hyperplasia, Morbidity and Mortality in Ptpn2-Deficient Mice	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR; TC-PTP; NEGATIVE REGULATOR; MARROW MICROENVIRONMENT; EMBRYONIC LETHALITY; SIGNALING PATHWAY; DEFICIENT MICE; EGF RECEPTOR; STEM-CELLS	Single nucleotide polymorphisms in the gene encoding the protein tyrosine phosphatase TCPTP (encoded by PTPN2) have been linked with the development of autoimmunity. Here we have used Cre/LoxP recombination to generate Ptpn2(ex2-/ex2-) mice with a global deficiency in TCPTP on a C57BL/6 background and compared the phenotype of these mice to Ptpn2(-/-) mice (BALB/c-129SJ) generated previously by homologous recombination and backcrossed onto the BALB/c background. Ptpn2(ex2-/ex2-) mice exhibited growth retardation and a median survival of 32 days, as compared to 21 days for Ptpn2(-/-) (BALB/c) mice, but the overt signs of morbidity (hunched posture, piloerection, decreased mobility and diarrhoea) evident in Ptpn2(-/-) (BALB/c) mice were not detected in Ptpn2(ex2-/ex2-) mice. At 14 days of age, bone development was delayed in Ptpn2(-/-) (BALB/c) mice. This was associated with increased trabecular bone mass and decreased bone remodeling, a phenotype that was not evident in Ptpn2(ex2-/ex2-) mice. Ptpn2(ex2-/ex2-) mice had defects in erythropoiesis and B cell development as evident in Ptpn2(-/-) (BALB/c) mice, but not splenomegaly and did not exhibit an accumulation of myeloid cells in the spleen as seen in Ptpn2(-/-) (BALB/c) mice. Moreover, thymic atrophy, another feature of Ptpn2(-/-) (BALB/c) mice, was delayed in PPtpn2(ex2-/ex2-) mice and preceded by an increase in thymocyte positive selection and a concomitant increase in lymph node T cells. Backcrossing Ptpn2(-/-) (BALB/c) mice onto the C57BL/6 background largely recapitulated the phenotype of PPtpn2(ex2-/ex2-) mice. Taken together these results reaffirm TCPTP's important role in lymphocyte development and indicate that the effects on morbidity, mortality, bone development and the myeloid compartment are straindependent.	[Wiede, Florian; Chew, Sock Hui; van Vliet, Catherine; Sasmono, Tedjo; Loh, Kim; Tiganis, Tony] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Poulton, Ingrid J.; Sims, Natalie A.] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Kyparissoudis, Konstantinos; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Tremblay, Michel L.] McGill Univ, McGill Canc Ctr, Montreal, PQ, Canada; [Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ, Canada	Monash University; St. Vincent's Institute of Medical Research; University of Melbourne; McGill University; McGill University	Wiede, F (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	Tony.Tiganis@monash.edu	Sims, Natalie Ann/A-7192-2012; Sasmono, Tedjo/H-5680-2016; Tiganis, Tony/AAV-3495-2020	Sims, Natalie Ann/0000-0003-1421-8468; Sasmono, Tedjo/0000-0003-0986-2590; Tiganis, Tony/0000-0002-8065-9942; Loh, Kim/0000-0003-3781-1926; Wiede, Florian/0000-0001-5145-7180; Godfrey, Dale/0000-0002-3009-5472	National Health and Medical Research Council (NHMRC) of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (www.nhmrc.gov.au) to T.T., NA.S. & D.I.G.; N.A.S., T.T. and D.I.G. are NHMRC Research Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aoki N, 2002, MOL ENDOCRINOL, V16, P58, DOI 10.1210/me.16.1.58; Bonyadi M, 1997, NAT GENET, V15, P207, DOI 10.1038/ng0297-207; Bourdeau A, 2007, BLOOD, V109, P4220, DOI 10.1182/blood-2006-08-044370; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Doody KM, 2012, ARTHRITIS RHEUM-US, V64, P752, DOI 10.1002/art.33399; Fayad R, 2005, EUR J IMMUNOL, V35, P2304, DOI 10.1002/eji.200526062; Fukushima A, 2010, DIABETES, V59, P1906, DOI 10.2337/db09-1365; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hassan SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008868; Heinonen KM, 2004, BLOOD; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Kaul A, 2000, CELL, V102, P17, DOI 10.1016/S0092-8674(00)00006-4; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Klingler-Hoffmann M, 2001, J BIOL CHEM, V276, P46313, DOI 10.1074/jbc.M106571200; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; Lee CF, 2009, WORLD J GASTROENTERO, V15, P356, DOI 10.3748/wjg.15.356; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Long SA, 2011, GENES IMMUN, V12, P116, DOI 10.1038/gene.2010.54; Lu XQ, 2007, MOL CELL BIOL, V27, P2166, DOI 10.1128/MCB.01234-06; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; Samitas K, 2010, ARCH IMMUNOL THER EX, V58, P209, DOI 10.1007/s00005-010-0073-2; Scacheri PC, 2001, GENESIS, V30, P259, DOI 10.1002/gene.1072; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Shimizu T, 2004, EXP HEMATOL, V32, P1057, DOI 10.1016/j.exphem.2004.07.024; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Simoncic PD, 2006, MOL CELL BIOL, V26, P4149, DOI 10.1128/MCB.01932-05; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zee T, 2012, MOL CELL BIOL, V32, P1080, DOI 10.1128/MCB.06279-11	49	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36703	10.1371/journal.pone.0036703	http://dx.doi.org/10.1371/journal.pone.0036703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590589	gold, Green Published			2022-12-25	WOS:000305335500024
J	Albert, MV; Kording, K; Herrmann, M; Jayaraman, A				Albert, Mark V.; Kording, Konrad; Herrmann, Megan; Jayaraman, Arun			Fall Classification by Machine Learning Using Mobile Phones	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; FEAR; PREVENTION; INJURY; WOMEN	Fall prevention is a critical component of health care; falls are a common source of injury in the elderly and are associated with significant levels of mortality and morbidity. Automatically detecting falls can allow rapid response to potential emergencies; in addition, knowing the cause or manner of a fall can be beneficial for prevention studies or a more tailored emergency response. The purpose of this study is to demonstrate techniques to not only reliably detect a fall but also to automatically classify the type. We asked 15 subjects to simulate four different types of falls-left and right lateral, forward trips, and backward slips-while wearing mobile phones and previously validated, dedicated accelerometers. Nine subjects also wore the devices for ten days, to provide data for comparison with the simulated falls. We applied five machine learning classifiers to a large time-series feature set to detect falls. Support vector machines and regularized logistic regression were able to identify a fall with 98% accuracy and classify the type of fall with 99% accuracy. This work demonstrates how current machine learning approaches can simplify data collection for prevention in fall-related research as well as improve rapid response to potential injuries due to falls.	[Albert, Mark V.; Kording, Konrad] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Albert, Mark V.; Kording, Konrad; Jayaraman, Arun] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Herrmann, Megan; Jayaraman, Arun] Northwestern Univ, Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Herrmann, Megan; Jayaraman, Arun] Northwestern Univ, Rehabil Inst Chicago, Max Nader Ctr Rehabil Technol & Outcomes Res, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; Shirley Ryan AbilityLab; Northwestern University; Shirley Ryan AbilityLab	Albert, MV (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	mark@mva.me	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499	National Institutes of Health [P01NS044393, R01NS063399]; Max Nader Center at the Rehabilitation Institute of Chicago; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399, P01NS044393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Nader Center at the Rehabilitation Institute of Chicago; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the National Institutes of Health (P01NS044393, R01NS063399) and the Max Nader Center at the Rehabilitation Institute of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieber G, 2009, LECT NOTES COMPUT SC, V5615, P289, DOI 10.1007/978-3-642-02710-9_32; Bourke AK, 2007, GAIT POSTURE, V26, P194, DOI 10.1016/j.gaitpost.2006.09.012; Bourke AK, 2011, IEEE ENG MED BIO, P4449, DOI 10.1109/IEMBS.2011.6091103; Brezmes T, 2009, LECT NOTES COMPUT SC, V5518, P796, DOI 10.1007/978-3-642-02481-8_120; Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Delbaere K, 2004, AGE AGEING, V33, P368, DOI 10.1093/ageing/afh106; Fernandes HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020290; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Gyorbiro N, 2009, MOBILE NETW APPL, V14, P82, DOI 10.1007/s11036-008-0112-y; Jiangpeng Dai, 2010, 2010 8th IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops), P292, DOI 10.1109/PERCOMW.2010.5470652; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Kwapisz JR., 2011, ACM SIGKDD EXPLORATI, V12, P74, DOI [10.1145/1964897.1964918, DOI 10.1145/1964897.1964918]; Lee RYW, 2011, AGE AGEING, V40, P690, DOI [10.1093/ageing/afr050, 10.1155/2011/653570]; Liu Y, 2011, IEEE ENG MED BIO, P1499, DOI 10.1109/IEMBS.2011.6090342; Hidalgo JLT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-910; Lutrek M., 2009, INFORMATICA, V33, P205; Mann R, 2006, AGE AGEING, V35, P143, DOI 10.1093/ageing/afj013; Peek-Asa C, 2003, EPIDEMIOL REV, V25, P77, DOI 10.1093/epirev/mxg006; RYYNANEN OP, 1992, Z GERONTOL, V25, P278; Sadigh S, 2004, J COMMUN HEALTH, V29, P129, DOI 10.1023/B:JOHE.0000016717.22032.03; Scuffham P, 2003, J EPIDEMIOL COMMUN H, V57, P740, DOI 10.1136/jech.57.9.740; Seguin R, 2003, AM J PREV MED, V25, P141, DOI 10.1016/S0749-3797(03)00177-6; Sixsmith A, 2004, IEEE PERVAS COMPUT, V3, P42, DOI 10.1109/MPRV.2004.1316817; Spice CL, 2009, AGE AGEING, V38, P33, DOI 10.1093/ageing/afn192; Sposaro F, 2009, IEEE ENG MED BIO, P6119, DOI 10.1109/IEMBS.2009.5334912; Tideiksaar R, 1998, FALLING OLD AGE PREV; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; Tolkiehn M, 2011, IEEE ENG MED BIO, P369, DOI 10.1109/IEMBS.2011.6090120; U.S. Census Bureau, 2010, POP DAT PUBL WEB SIT; Vellas BJ, 1997, AGE AGEING, V26, P189, DOI 10.1093/ageing/26.3.189; Wang Y, 2009, MOBISYS'09: PROCEEDINGS OF THE 7TH ACM INTERNATIONAL CONFERENCE ON MOBILE SYSTEMS, APPLICATIONS, AND SERVICES, P179, DOI 10.1016/B978-044306732-7.50020-9; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357	33	146	148	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36556	10.1371/journal.pone.0036556	http://dx.doi.org/10.1371/journal.pone.0036556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TC	22586477	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335000038
J	Bettinger, JC; Leung, K; Bolling, MH; Goldsmith, AD; Davies, AG				Bettinger, Jill C.; Leung, Kapo; Bolling, Mia H.; Goldsmith, Andrew D.; Davies, Andrew G.			Lipid Environment Modulates the Development of Acute Tolerance to Ethanol in Caenorhabditis elegans	PLOS ONE			English	Article							ACUTE FUNCTIONAL TOLERANCE; C-ELEGANS; GENETIC-DIFFERENCES; NEUROPEPTIDE-Y; BK CHANNELS; H-RAS; ALCOHOL; RECEPTOR; PROTEIN; CHOLESTEROL	The development of tolerance to a drug at the level of the neuron reflects a homeostatic mechanism by which neurons respond to perturbations of their function by external stimuli. Acute functional tolerance (AFT) to ethanol is a fast compensatory response that develops within a single drug session and normalizes neuronal function despite the continued presence of the drug. We performed a genetic screen to identify genes required for the development of acute functional tolerance to ethanol in the nematode C. elegans. We identified mutations affecting multiple genes in a genetic pathway known to regulate levels of triacylglycerols (TAGs) via the lipase LIPS-7, indicating that there is an important role for TAGs in the development of tolerance. Genetic manipulation of lips-7 expression, up or down, produced opposing effects on ethanol sensitivity and on the rate of development of AFT. Further, decreasing cholesterol levels through environmental manipulation mirrored the effects of decreased TAG levels. Finally, we found that genetic alterations in the levels of the TAG lipase LIPS-7 can modify the phenotype of gain-of-function mutations in the ethanol-inducible ion channel SLO-1, the voltage-and calcium-sensitive BK channel. This study demonstrates that the lipid milieu modulates neuronal responses to ethanol that include initial sensitivity and the development of acute tolerance. These results lend new insight into studies of alcohol dependence, and suggest a model in which TAG levels are important for the development of AFT through alterations of the action of ethanol on membrane proteins.	[Bettinger, Jill C.; Leung, Kapo; Bolling, Mia H.; Davies, Andrew G.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Bettinger, Jill C.; Davies, Andrew G.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Bettinger, Jill C.; Davies, Andrew G.] Virginia Commonwealth Univ, Alcohol Res Ctr, Richmond, VA USA; [Bettinger, Jill C.; Goldsmith, Andrew D.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Bettinger, JC (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	jcbettinger@vcu.edu	Davies, Andrew G/AAY-3567-2020		National Institutes of Health (NIH) [R01AA016837]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by the National Institutes of Health (NIH) (R01AA016837 to JCB). The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Alcohol Abuse and Alcoholism or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; AVDULOV NA, 1994, ALCOHOL CLIN EXP RES, V18, P53, DOI 10.1111/j.1530-0277.1994.tb00880.x; BRENNER S, 1974, GENETICS, V77, P71; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Cai T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000447; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Ghare S, 2011, ALCOHOL CLIN EXP RES, V35, P1435, DOI 10.1111/j.1530-0277.2011.01479.x; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; GOLDSTEIN DB, 1984, ANNU REV PHARMACOL, V24, P43, DOI 10.1146/annurev.pa.24.040184.000355; Harris R A, 1981, Curr Alcohol, V8, P379; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Heath AC, 1999, PSYCHOL MED, V29, P1069, DOI 10.1017/S0033291799008909; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Lin MW, 2006, CHINESE J PHYSIOL, V49, P1; Lind PA, 2010, TWIN RES HUM GENET, V13, P10, DOI 10.1375/twin.13.1.10; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Nicholas HR, 2008, J MOL BIOL, V375, P1, DOI 10.1016/j.jmb.2007.10.041; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Ponomarev I, 2002, J PHARMACOL EXP THER, V302, P257, DOI 10.1124/jpet.302.1.257; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Suvarna N, 2005, J BIOL CHEM, V280, P31450, DOI 10.1074/jbc.M504120200; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Thiele TE, 2000, PHARMACOL BIOCHEM BE, V67, P683, DOI 10.1016/S0091-3057(00)00413-5; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wallace MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P127, DOI 10.1038/sj.npp.1301059; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yuan C, 2008, J BIOL CHEM, V283, P5090, DOI 10.1074/jbc.M708214200; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200; Yuan CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027572	44	28	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35192	10.1371/journal.pone.0035192	http://dx.doi.org/10.1371/journal.pone.0035192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574115	Green Published, gold			2022-12-25	WOS:000305349800011
J	Sun, M; Gao, L; Liu, Y; Zhao, YQ; Wang, XQ; Pan, YQ; Ning, T; Cai, H; Yang, HJ; Zhai, WW; Ke, Y				Sun, Min; Gao, Lei; Liu, Ying; Zhao, Yiqiang; Wang, Xueqian; Pan, Yaqi; Ning, Tao; Cai, Hong; Yang, Haijun; Zhai, Weiwei; Ke, Yang			Whole Genome Sequencing and Evolutionary Analysis of Human Papillomavirus Type 16 in Central China	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; CERVICAL-CANCER PATIENTS; LONG CONTROL REGION; AMINO-ACID SITES; VARIANT ANALYSIS; E6 VARIANTS; L1 GENES; NUCLEOTIDE SUBSTITUTION; NATURAL VARIANTS; PHYSICAL STATE	Human papillomavirus type 16 plays a critical role in the neoplastic transformation of cervical cancers. Molecular variants of HPV16 existing in different ethnic groups have shown substantial phenotypic differences in pathogenicity, immunogenicity and tumorigenicity. In this study, we sequenced the entire HPV16 genome of 76 isolates originated from Anyang, central China. Phylogenetic analysis of these sequences identified two major variants of HPV16 in the Anyang area, namely the European prototype (E(p)) and the European Asian type (E(As)). These two variants show a high degree of divergence between groups, and the E(p) comprised higher genetic diversity than the E(As). Analysis with two measurements of genetic diversity indicated that viral population size was relatively stable in this area in the past. Codon based likelihood models revealed strong statistical support for adaptive evolution acting on the E6 gene. Bayesian analysis identified several important amino acid positions that may be driving adaptive selection in the HPV 16 population, including R10G, D25E, L83V, and E113D in the E6 gene. We hypothesize that the positive selection at these codons might be a contributing factor responsible for the phenotypic differences in carcinogenesis and immunogenicity among cervical cancers in China based on the potential roles of these molecular variants reported in other studies.	[Sun, Min; Gao, Lei; Liu, Ying; Zhao, Yiqiang; Wang, Xueqian; Pan, Yaqi; Ning, Tao; Cai, Hong; Ke, Yang] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100871, Peoples R China; [Zhai, Weiwei] Chinese Acad Sci, Ctr Computat Biol, Beijing, Peoples R China; [Zhai, Weiwei] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing, Peoples R China; [Yang, Haijun] Anyang Canc Hosp, Anyang, Henan, Peoples R China	Peking University; Chinese Academy of Sciences; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Sun, M (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100871, Peoples R China.	weiweizhai@big.ac.cn; keyang@bjmu.edu.cn		Zhai, Weiwei/0000-0001-7938-0226	Natural Science Foundation of China [30872937, 30930102, 31000957, 91131011]; National Ministry of Science and Technology [2011CB504301, 2012CB316505, 2006AA2Z467]; Charity Project of National Ministry of Health [200902002]; Natural Science Foundation of Beijing [7100001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Science and Technology; Charity Project of National Ministry of Health; Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work is supported in part by Natural Science Foundation of China 30872937, 30930102, 31000957 and 91131011, "973" Project of National Ministry of Science and Technology Grant 2011CB504301, 2012CB316505, "863" Key Projects of National Ministry of Science and Technology Grant 2006AA2Z467, Charity Project of National Ministry of Health 200902002, and Natural Science Foundation of Beijing 7100001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2000, BRIT J CANCER, V83, P307, DOI 10.1054/bjoc.2000.1247; [Anonymous], 2007, IARC MON EV CARC RIS; Asadurian Y, 2007, J MED VIROL, V79, P1751, DOI 10.1002/jmv.20978; Bernard HU, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P417, DOI 10.1016/B978-0-12-374153-0.00018-7; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Blakaj DM, 2009, FRONT BIOSCI-LANDMRK, V14, P900, DOI 10.2741/3285; Bravo IG, 2004, J VIROL, V78, P13613, DOI 10.1128/JVI.78.24.13613-13626.2004; Cai HB, 2010, EJSO-EUR J SURG ONC, V36, P160, DOI 10.1016/j.ejso.2009.07.186; Chakrabarti O, 2004, J VIROL, V78, P5934, DOI 10.1128/JVI.78.11.5934-5945.2004; Chan PKS, 2002, J INFECT DIS, V186, P696, DOI 10.1086/342048; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Choo KB, 2000, J MED VIROL, V61, P298, DOI 10.1002/1096-9071(200007)61:3&lt;298::AID-JMV3&gt;3.0.CO;2-Y; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Souza PSD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-246; de Boer MA, 2004, GYNECOL ONCOL, V94, P488, DOI 10.1016/j.ygyno.2004.05.037; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Ding TA, 2010, INT J GYNECOL CANCER, V20, P1391, DOI 10.1111/IGC.0b013e3181eced04; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garcia-Vallve S, 2005, TRENDS MICROBIOL, V13, P514, DOI 10.1016/j.tim.2005.09.003; Giannoudis A, 2001, BRIT J CANCER, V84, P1058, DOI 10.1054/bjoc.2001.1695; Giannoudis A, 2001, J PATHOL, V193, P295, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH809&gt;3.0.CO;2-C; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; Hu Y, 2011, REPROD SCI, V18, P406, DOI 10.1177/1933719110387830; Hudelist G, 2004, GYNECOL ONCOL, V92, P873, DOI 10.1016/j.ygyno.2003.11.035; JONES RE, 1990, J BIOL CHEM, V265, P12782; Kang S, 2005, INT J GYNECOL CANCER, V15, P107, DOI 10.1111/j.1048-891x.2005.15010.x; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lichtig H, 2006, VIROLOGY, V350, P216, DOI 10.1016/j.virol.2006.01.038; MacCallum C, 2006, PLOS BIOL, V4, P293, DOI 10.1371/journal.pbio.0040087; Masterson PJ, 1998, J VIROL, V72, P7407, DOI 10.1128/JVI.72.9.7407-7419.1998; Matsumoto K, 2003, INT J CANCER, V106, P919, DOI 10.1002/ijc.11332; Matsumoto K, 2000, CANCER LETT, V156, P159, DOI 10.1016/S0304-3835(00)00457-2; Meyers G, 1997, HUMAN PAPILLOMAVIRUS; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 1998, GENETICS, V148, P929; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Picconi MA, 2003, J MED VIROL, V69, P546, DOI 10.1002/jmv.10343; Qiu AD, 2007, GYNECOL ONCOL, V104, P77, DOI 10.1016/j.ygyno.2006.07.016; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; Shang QL, 2011, J CLIN MICROBIOL, V49, P2656, DOI 10.1128/JCM.02203-10; Sharp PM, 2002, CELL, V108, P305, DOI 10.1016/S0092-8674(02)00639-6; SLATKIN M, 1991, GENETICS, V129, P555; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stephen AL, 2000, INT J CANCER, V86, P695, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;695::AID-IJC15&gt;3.0.CO;2-C; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Sun ZR, 2011, INT J GYNECOL CANCER, V21, P551, DOI 10.1097/IGC.0b013e3182112023; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; TAJIMA F, 1989, GENETICS, V123, P585; Vaeteewoottacharn K, 2003, ANTICANCER RES, V23, P1927; van Duin M, 2000, J GEN VIROL, V81, P317, DOI 10.1099/0022-1317-81-2-317; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Wang XQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-19; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wu YP, 2006, J GEN VIROL, V87, P1181, DOI 10.1099/vir.0.81649-0; Xi LF, 2002, CANCER EPIDEM BIOMAR, V11, P343; Xiong Guang-Wu, 2010, Yichuan, V32, P339, DOI 10.3724/SP.J.1005.2010.00339; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zehbe I, 2003, HUM IMMUNOL, V64, P538, DOI 10.1016/S0198-8859(03)00033-8; Zehbe I, 2001, INT J CANCER, V94, P711, DOI 10.1002/ijc.1520; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971	78	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36577	10.1371/journal.pone.0036577	http://dx.doi.org/10.1371/journal.pone.0036577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574185	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800082
J	Vinnemeier, CD; Schwarz, NG; Sarpong, N; Loag, W; Acquah, S; Nkrumah, B; Huenger, F; Adu-Sarkodie, Y; May, J				Vinnemeier, Christof David; Schwarz, Norbert Georg; Sarpong, Nimako; Loag, Wibke; Acquah, Samuel; Nkrumah, Bernard; Huenger, Frank; Adu-Sarkodie, Yaw; May, Juergen			Predictive Value of Fever and Palmar Pallor for P. falciparum Parasitaemia in Children from an Endemic Area	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; CLINICAL ALGORITHM; INTEGRATED MANAGEMENT; CHILDHOOD ILLNESS; AFRICAN CHILDREN; SEVERE ANEMIA; MALARIA; TRANSMISSION; ACCURACY; FEATURES	Introduction: Although the incidence of Plasmodium falciparum malaria in some parts of sub-Saharan Africa is reported to decline and other conditions, causing similar symptoms as clinical malaria are gaining in relevance, presumptive antimalarial treatment is still common. This study traced for age-dependent signs and symptoms predictive for P. falciparum parasitaemia. Methods: In total, 5447 visits of 3641 patients between 2-60 months of age who attended an outpatient department (OPD) of a rural hospital in the Ashanti Region, Ghana, were analysed. All Children were examined by a paediatrician and a full blood count and thick smear were done. A Classification and Regression Tree (CART) model was used to generate a clinical decision tree to predict malarial parasitaemia a7nd predictive values of all symptoms were calculated. Results: Malarial parasitaemia was detected in children between 2-12 months and between 12-60 months of age with a prevalence of 13.8% and 30.6%, respectively. The CART-model revealed age-dependent differences in the ability of the variables to predict parasitaemia. While palmar pallor was the most important symptom in children between 2-12 months, a report of fever and an elevated body temperature of >= 37.5 degrees C gained in relevance in children between 12-60 months. The variable palmar pallor was significantly (p<0.001) associated with lower haemoglobin levels in children of all ages. Compared to the Integrated Management of Childhood Illness (IMCI) algorithm the CART-model had much lower sensitivities, but higher specificities and positive predictive values for a malarial parasitaemia. Conclusions: Use of age-derived algorithms increases the specificity of the prediction for P. falciparum parasitaemia. The predictive value of palmar pallor should be underlined in health worker training. Due to a lack of sensitivity neither the best algorithm nor palmar pallor as a single sign are eligible for decision-making and cannot replace presumptive treatment or laboratory diagnosis.	[Vinnemeier, Christof David; Schwarz, Norbert Georg; Loag, Wibke; May, Juergen] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Sarpong, Nimako; Acquah, Samuel; Nkrumah, Bernard; Huenger, Frank] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Huenger, Frank] Inst Transfus Med, Lab Med & Med Microbiol, Dortmund, Germany	Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology	Vinnemeier, CD (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.	vinnemeier@bni-hamburg.de	Schwarz, Norbert G/C-8797-2012	Schwarz, Norbert G/0000-0002-8387-2837; Acquah, Samuel/0000-0002-3896-2665; May, Jurgen/0000-0001-7831-8420	Swiss foundation	Swiss foundation(Swiss National Science Foundation (SNSF))	The study was supported by Swiss foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-202; Bojang KA, 2000, TROP MED INT HEALTH, V5, P231, DOI 10.1046/j.1365-3156.2000.00538.x; Bonner K, MALAR J, V10, P73; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-166; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-300; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; Ceesay SJ, PLOS ONE, V5; Chalco Juan P, 2005, BMC Pediatr, V5, P46, DOI 10.1186/1471-2431-5-46; Chandramohan D, 2001, TROP MED INT HEALTH, V6, P505, DOI 10.1046/j.1365-3156.2001.00739.x; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Gay-Andrieu F, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-10; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; Kalantri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008545; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Marshall RJ, 2001, J CLIN EPIDEMIOL, V54, P603, DOI 10.1016/S0895-4356(00)00344-9; Muhe L, 1999, ARCH DIS CHILD, V81, P216, DOI 10.1136/adc.81.3.216; Mwangi TW, 2005, TROP MED INT HEALTH, V10, P530, DOI 10.1111/j.1365-3156.2005.01439.x; Olaleye BO, 1998, T ROY SOC TROP MED H, V92, P300, DOI 10.1016/S0035-9203(98)91021-5; Redd SC, 1996, LANCET, V347, P223, DOI 10.1016/S0140-6736(96)90404-3; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Ronald LA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-105; Sarpong N, 2010, TROP MED INT HEALTH, V15, P191, DOI 10.1111/j.1365-3156.2009.02439.x; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Speybroeck N, 2011, INT J PUBLIC HLTH; STROBACH RS, 1988, ARCH INTERN MED, V148, P831, DOI 10.1001/archinte.148.4.831; UNICEF, UNICEF PROGR CHILDR; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P113; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, WHO GLOB MAL PARTN R; WHO, 1999, WHO MAT NEWB CHILD A; WHO, 2004, WHO IMCI DOC EXP PRO; WHO, 2005, WHO CHILD AD HLTH DE; Ye Y, 2007, ANN TROP MED PARASIT, V101, P297, DOI 10.1179/136485907X176391	42	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36678	10.1371/journal.pone.0036678	http://dx.doi.org/10.1371/journal.pone.0036678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574213	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800110
J	Wei, JH; Xue, Y; Wu, L; Ma, J; Yi, XL; Zhang, JR; Lu, B; Li, CY; Shi, DS; Shi, ST; Feng, XH; Cai, T				Wei, Jianhua; Xue, Yang; Wu, Lian; Ma, Jie; Yi, Xiuli; Zhang, Junrui; Lu, Bin; Li, Chunying; Shi, Dashuang; Shi, Songtao; Feng, Xinghua; Cai, Tao			Analysis of Large Phenotypic Variability of EEC and SHFM4 Syndromes Caused by K193E Mutation of the TP63 Gene	PLOS ONE			English	Article							SPLIT-HAND/SPLIT-FOOT; DNA-BINDING DOMAIN; P63 GENE; CLEFT-LIP; HAND/FOOT MALFORMATION; ECTODERMAL DYSPLASIA; CHINESE FAMILY; HAND; INHERITANCE; PALATE	EEC (ectrodactyly, ectodermal dysplasia, clefting; OMIM 604292) is an autosomal dominant developmental disorder resulting mainly from pathogenic mutations of the DNA-binding domain (DBD) of the TP63 gene. In this study, we showed that K193E mutation in nine affected individuals of a four-generation kindred with a large degree of phenotypic variability causes four different syndromes or TP63-related disorders: EEC, Ectrodactyly-ectodermal dysplasia (EE), isolated ectodermal dysplasia, and isolated Split Hand/Foot Malformation type 4 (SHFM4). Genotype-phenotype and DBD structural modeling analysis showed that the K193-located loop L2-A is associated with R280 through hydrogen bonding interactions, while R280 mutations also often cause large phenotypic variability of EEC and SHFM4. Thus, we speculate that K193 and several other DBD mutation-associated syndromes may share similar pathogenic mechanisms, particularly in the case of the same mutation with different phenotypes. Our study and others also suggest that the phenotypic variability of EEC is attributed, at least partially, to genetic and/or epigenetic modifiers.	[Wei, Jianhua; Ma, Jie; Zhang, Junrui; Lu, Bin; Feng, Xinghua; Cai, Tao] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Xue, Yang; Li, Chunying] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Biol, Xian 710032, Shaanxi Provinc, Peoples R China; [Wu, Lian] Fourth Mil Med Univ, Sch Stomatol, Dept Paediat Dent, Xian 710032, Shaanxi Provinc, Peoples R China; [Yi, Xiuli] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Shaanxi Provinc, Peoples R China; [Shi, Dashuang] George Washington Univ, Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC USA; [Shi, Dashuang] George Washington Univ, Childrens Natl Med Ctr, Dept Integrat Syst Biol, Washington, DC USA; [Shi, Songtao] Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA; [Cai, Tao] Natl Inst Dent & Craniofacial Res, Oral Infect & Immun Branch, Natl Inst Hlth, Bethesda, MD USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Children's National Health System; George Washington University; Children's National Health System; George Washington University; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Wei, JH (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi Provinc, Peoples R China.	fengxh@fmmu.edu.cn; tcai@dir.nidcr.nih.gov	cai, tao/C-5060-2011	Cai, Tao/0000-0002-2877-8637; Shi, Dashuang/0000-0002-5491-1104	Fourth Military Medical University (FMMU), China	Fourth Military Medical University (FMMU), China	This research was partially supported by the Genetic Disease Research Fund (2011) at the Fourth Military Medical University (FMMU), China. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomaria A, 2010, CELL CYCLE, V9, P3730, DOI 10.4161/cc.9.18.12933; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chen C, 2011, P NATL ACAD SCI USA, V108, P6456, DOI 10.1073/pnas.1013657108; Clements SE, 2010, BRIT J DERMATOL, V162, P201, DOI 10.1111/j.1365-2133.2009.09496.x; Dai Li, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P379, DOI 10.3760/cma.j.issn.1003-9406.2011.04.004; Duijf PHG, 2003, HUM MOL GENET, V12, pR51, DOI 10.1093/hmg/ddg090; Elliott AM, 2006, AM J MED GENET A, V140A, P1419, DOI 10.1002/ajmg.a.31244; Ergin H, 2010, TURKISH J PEDIATR, V52, P529; Huang YP, 2004, CELL CYCLE, V3, P1587, DOI 10.4161/cc.3.12.1290; Ianakiev P, 2000, AM J HUM GENET, V67, P59, DOI 10.1086/302972; Jindal Geetanjali, 2009, Indian J Hum Genet, V15, P140, DOI 10.4103/0971-6866.60191; Kantaputra PN, 2011, AM J MED GENET A, V155A, P1432, DOI 10.1002/ajmg.a.34011; Kantaputra PN, 2011, AM J MED GENET A; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Leoyklang P, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036442; Lopardo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002715; Luo TX, 2008, MUTAT RES-FUND MOL M, V637, P182, DOI 10.1016/j.mrfmmm.2007.08.010; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Ray AK, 2004, CLIN GENET, V66, P217, DOI 10.1111/j.1399-0004.2004.00287.x; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Rinne T, 2006, AM J MED GENET A, V140A, P1396, DOI 10.1002/ajmg.a.31271; Roelfsema NM, 1996, CLIN DYSMORPHOL, V5, P115, DOI 10.1097/00019605-199604000-00003; Romano RA, 2012, J DENT RES, V91, P125, DOI 10.1177/0022034511411302; Rossi M, 2006, CELL CYCLE, V5, P1816, DOI 10.4161/cc.5.16.2861; Sorasio L, 2009, CLIN EXP DERMATOL, V34, pE726, DOI 10.1111/j.1365-2230.2009.03451.x; SPRANGER M, 1988, EUR J PEDIATR, V147, P202, DOI 10.1007/BF00442225; Ugur SA, 2008, HUM MOL GENET, V17, P2644, DOI 10.1093/hmg/ddn164; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Witters I, 2001, PRENATAL DIAG, V21, P1119, DOI 10.1002/pd.181; Yin W, 2010, J DENT RES, V89, P813, DOI 10.1177/0022034510366804	33	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35337	10.1371/journal.pone.0035337	http://dx.doi.org/10.1371/journal.pone.0035337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574117	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800013
J	Bier, C; Hecht, R; Kunst, L; Scheiding, S; Wunsch, D; Goesswein, D; Schneider, G; Kramer, OH; Knauer, SK; Stauber, RH				Bier, Carolin; Hecht, Rouven; Kunst, Lena; Scheiding, Sabine; Wuensch, Desiree; Goesswein, Dorothee; Schneider, Guenter; Kraemer, Oliver H.; Knauer, Shirley K.; Stauber, Roland H.			Overexpression of the Catalytically Impaired Taspase1(T234V) or Taspase1(D233A) Variants Does Not Have a Dominant Negative Effect in T(4;11) Leukemia Cells	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; FUSION PROTEIN; LIVING CELLS; MLL; COMPLEX; LOCALIZATION; ACTIVATION; EXPRESSION; INHIBITORS; STABILITY	Background: The chromosomal translocation t(4;11)(q21;q23) is associated with high-risk acute lymphoblastic leukemia of infants. The resulting AF4.MLL oncoprotein becomes activated by Taspase1 hydrolysis and is considered to promote oncogenic transcriptional activation. Hence, Taspase1's proteolytic activity is a critical step in AF4.MLL pathophysiology. The Taspase1 proenzyme is autoproteolytically processed in its subunits and is assumed to assemble into an alpha beta beta alpha-heterodimer, the active protease. Therefore, we investigated here whether overexpression of catalytically inactive Taspase1 variants are able to interfere with the proteolytic activity of the wild type enzyme in AF4.MLL model systems. Methodology/Findings: The consequences of overexpressing the catalytically dead Taspase1 mutant, Taspase1(T234V), or the highly attenuated variant, Taspase1(D233A), on Taspase1's processing of AF4.MLL and of other Taspase1 targets was analyzed in living cancer cells employing an optimized cell-based assay. Notably, even a nine-fold overexpression of the respective Taspase1 mutants neither inhibited Taspase1's cis- nor trans-cleavage activity in vivo. Likewise, enforced expression of the alpha- or beta-subunits showed no trans-dominant effect against the ectopically or endogenously expressed enzyme. Notably, co-expression of the individual alpha- and beta-subunits did not result in their assembly into an enzymatically active protease complex. Probing Taspase1 multimerization in living cells by a translocation-based protein interaction assay as well as by biochemical methods indicated that the inactive Taspase1 failed to assemble into stable heterocomplexes with the wild type enzyme. Conclusions: Collectively, our results demonstrate that inefficient heterodimerization appears to be the mechanism by which inactive Taspase1 variants fail to inhibit wild type Taspase1's activity in trans. Our work favours strategies targeting Taspase1's catalytic activity rather than attempts to block the formation of active Taspase1 dimers to interfere with the pathobiological function of AF4.MLL.	[Bier, Carolin; Wuensch, Desiree; Goesswein, Dorothee; Stauber, Roland H.] Univ Hosp Mainz, MSC, Mainz, Germany; [Hecht, Rouven; Kunst, Lena; Knauer, Shirley K.] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Inst Mol Biol, Essen, Germany; [Scheiding, Sabine; Kraemer, Oliver H.] Univ Jena, Inst Biochem & Biophys, Ctr Mol Biomed, Jena, Germany; [Schneider, Guenter] Tech Univ Munich, Dept Internal Med 2, D-8000 Munich, Germany	University Hospital Mainz; University of Duisburg Essen; Friedrich Schiller University of Jena; Technical University of Munich	Bier, C (corresponding author), Univ Hosp Mainz, MSC, Mainz, Germany.	bier@uni-mainz.de; shirley.knauer@uni-due.de; rstauber@uni-mainz.de	Knauer, Shirley K/E-7931-2012; Krämer, Oliver H/L-9266-2015; Gül, Désirée/AAB-5965-2022	Knauer, Shirley K/0000-0003-4321-0924; Krämer, Oliver H/0000-0003-3973-045X; Guel, Desiree/0000-0002-2446-5756; Stauber, Roland/0000-0002-1341-4523	German Cancer Aid [FKZ102362]; Head and Neck Cancer Foundation; Rheinland-Pfalz fur Innovationen; Mainz Screening Center; DFG [KN973/1-1, INST371/5-1FUGG]; Inneruniversity Funds; MAIFOR Mainz Support Program	German Cancer Aid(Deutsche Krebshilfe); Head and Neck Cancer Foundation; Rheinland-Pfalz fur Innovationen; Mainz Screening Center; DFG(German Research Foundation (DFG)); Inneruniversity Funds; MAIFOR Mainz Support Program	Grant support: German Cancer Aid (FKZ102362), Head and Neck Cancer Foundation (CB), donation by R. Patzke, Rheinland-Pfalz fur Innovationen, Mainz Screening Center, DFG KN973/1-1 and DFG INST371/5-1FUGG, and the Inneruniversity Funds and MAIFOR Mainz Support Program (RS and SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Benedikt A, 2011, LEUKEMIA, V25, P135, DOI 10.1038/leu.2010.249; Bier C, 2011, TRAFFIC, V12, P703, DOI 10.1111/j.1600-0854.2011.01191.x; Bier C, 2011, J BIOL CHEM, V286, P3007, DOI 10.1074/jbc.M110.161646; Bursen A, 2004, ONCOGENE, V23, P6237, DOI 10.1038/sj.onc.1207837; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Heger P, 1999, ONCOGENE, V18, P4080, DOI 10.1038/sj.onc.1202762; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Huang YPJ, 2008, MOL CELL PROTEOMICS, V7, P2048, DOI 10.1074/mcp.M700550-MCP200; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Knauer SK, 2007, CELL CYCLE, V6, P1502; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Knauer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018253; Knauer SK, 2005, ANAL CHEM, V77, P4815, DOI 10.1021/ac050413o; Knauer SK, 2005, TRAFFIC, V6, P594, DOI 10.1111/j.1600-0854.2005.00298.x; Knauer SK, 2005, MOL CELL BIOL, V25, P2573, DOI 10.1128/MCB.25.7.2573-2582.2005; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Marschalek R, 2010, FEBS J, V277, P1822, DOI 10.1111/j.1742-4658.2010.07608.x; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Pless B, 2011, LEUKEMIA, V25, P663, DOI 10.1038/leu.2010.308; Schlingemann J, 2005, LAB INVEST, V85, P1024, DOI 10.1038/labinvest.3700293; Srinivasan RS, 2004, LEUKEMIA, V18, P1364, DOI 10.1038/sj.leu.2403415; Stauber RH, 1998, VIROLOGY, V251, P38, DOI 10.1006/viro.1998.9295; Tanaka T, 2008, CELL CYCLE, V7, P1569, DOI 10.4161/cc.7.11.6061; Tenzer S, 2011, ACS NANO; Weber L, 2010, EXPERT OPIN THER PAT, V20, P179, DOI 10.1517/13543770903514129; Wichmann C, 2007, CANCER RES, V67, P2280, DOI 10.1158/0008-5472.CAN-06-3360; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e34142	10.1371/journal.pone.0034142	http://dx.doi.org/10.1371/journal.pone.0034142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570686	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343400002
J	Rauschhuber, C; Ehrhardt, A				Rauschhuber, Christina; Ehrhardt, Anja			RNA Interference Is Responsible for Reduction of Transgene Expression after Sleeping Beauty Transposase Mediated Somatic Integration	PLOS ONE			English	Article							TOMBUSVIRUS-ENCODED P19; NUCLEAR EXPORT; FACTOR-IX; VECTOR; DNA; MICRORNA; IDENTIFICATION; TRANSCRIPTION; SUPPRESSION; VIRUSES	Background: Integrating non-viral vectors based on transposable elements are widely used for genetically engineering mammalian cells in functional genomics and therapeutic gene transfer. For the Sleeping Beauty (SB) transposase system it was demonstrated that convergent transcription driven by the SB transposase inverted repeats (IRs) in eukaryotic cells occurs after somatic integration. This could lead to formation of double-stranded RNAs potentially presenting targets for the RNA interference (RNAi) machinery and subsequently resulting into silencing of the transgene. Therefore, we aimed at investigating transgene expression upon transposition under RNA interference knockdown conditions. Principal Findings: To establish RNAi knockdown cell lines we took advantage of the P19 protein, which is derived from the tomato bushy stunt virus. P19 binds and inhibits 21 nucleotides long, small-interfering RNAs and was shown to sufficiently suppress RNAi. We found that transgene expression upon SB mediated transposition was enhanced, resulting into a 3.2-fold increased amount of colony forming units (CFU) after transposition. In contrast, if the transgene cassette is insulated from the influence of chromosomal position effects by the chicken-derived cHS4 insulating sequences or when applying the Forg Prince transposon system, that displays only negligible transcriptional activity, similar numbers of CFUs were obtained. Conclusion: In summary, we provide evidence for the first time that after somatic integration transposon derived transgene expression is regulated by the endogenous RNAi machinery. In the future this finding will help to further improve the molecular design of the SB transposase vector system.	[Rauschhuber, Christina; Ehrhardt, Anja] Univ Munich, Dept Virol, Max Von Pettenkofer Inst, Munich, Germany; [Ehrhardt, Anja] Univ Witten Herdecke, Dept Human Med, Inst Microbiol & Virol, Ctr Biomed Educ & Res,Fac Hlth, Witten, Germany	University of Munich; Witten Herdecke University	Rauschhuber, C (corresponding author), Univ Munich, Dept Virol, Max Von Pettenkofer Inst, Munich, Germany.	anja.ehrhardt@uni-wh.de			German Research Foundation (DFG) [SFB 455, EH 192/5-1, EH 192/4-1]; EU	German Research Foundation (DFG)(German Research Foundation (DFG)); EU(European Commission)	This work was supported in part by the German Research Foundation (DFG) grants SFB 455, EH 192/5-1, EH 192/4-1 (Heisenberg-Programme) and EU Framework Programme 7 (Persistent Transgenesis) to A. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Calero-Nieto FJ, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-3; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Doherty JE, 2011, HUM GENE THER; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Dunoyer P, 2004, J VIROL, V78, P2301, DOI 10.1128/JVI.78.5.2301-2309.2004; Ehrhardt A, 2005, MOL THER, V11, P695, DOI 10.1016/j.ymthe.2005.01.010; Ehrhardt A, 2002, BLOOD, V99, P3923, DOI 10.1182/blood.V99.11.3923; Ehrhardt A, 2007, MOL THER, V15, P146, DOI 10.1038/sj.mt.6300011; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garrison BS, 2007, MOL CELL BIOL, V27, P8824, DOI 10.1128/MCB.00498-07; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; KUHSTOSS S, 1991, J MOL BIOL, V222, P897, DOI 10.1016/0022-2836(91)90584-S; Li CL, 2008, GENE THER, V15, P49, DOI 10.1038/sj.gt.3303009; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miskey C, 2003, NUCLEIC ACIDS RES, V31, P6873, DOI 10.1093/nar/gkg910; Moldt B, 2007, HUM GENE THER, V18, P1193, DOI 10.1089/hum.2007.099; Morris K, 2005, CELL MOL LIFE SCI, V62, P3057, DOI 10.1007/s00018-005-5182-4; Morris KV, 2009, EPIGENETICS-US, V4, P296, DOI 10.4161/epi.4.5.9282; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Nakazawa Y, 2011, MOL THER; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Omarov R, 2006, J VIROL, V80, P3000, DOI 10.1128/JVI.80.6.3000-3008.2006; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pinto MGV, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-165; Robert VJP, 2004, COLD SPRING HARB SYM, V69, P397, DOI 10.1101/sqb.2004.69.397; Scholthof HB, 2006, NAT REV MICROBIOL, V4, P405, DOI 10.1038/nrmicro1395; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Walisko O, 2008, MOL THER, V16, P359, DOI 10.1038/sj.mt.6300366; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yant SR, 2002, NAT BIOTECHNOL, V20, P999, DOI 10.1038/nbt738; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824	56	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35389	10.1371/journal.pone.0035389	http://dx.doi.org/10.1371/journal.pone.0035389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570690	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400006
J	Tsang, YHN; Wu, XW; Lim, JS; Ong, CW; Salto-Tellez, M; Ito, K; Ito, Y; Chen, LF				Tsang, Y-H Nicole; Wu, X-W; Lim, J-S; Ong, C. Wee; Salto-Tellez, M.; Ito, K.; Ito, Y.; Chen, L-F			Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer	ONCOGENE			English	Article						breast cancer; degradation; Pin1; RUNX3; tumor suppressor; ubiquitination	PROMOTER HYPERMETHYLATION; PHOSPHORYLATION; GENE; ISOMERIZATION; ACETYLATION; BETA; UBIQUITINATION; DEGRADATION; RECEPTOR; ALPHA	Emerging evidence demonstrates that RUNX3 is a tumor suppressor in breast cancer. Inactivation of RUNX3 in mice results in spontaneous mammary gland tumors, and decreased or silenced expression of RUNX3 is frequently found in breast cancer cell lines and human breast cancer samples. However, the underlying mechanism for initiating RUNX3 inactivation in breast cancer remains elusive. Here, we identify prolyl isomerase Pin1, which is often overexpressed in breast cancer, as a key regulator of RUNX3 inactivation. In human breast cancer cell lines and breast cancer samples, expression of Pin1 inversely correlates with the expression of RUNX3. In addition, Pin1 recognizes four phosphorylated Ser/Thr-Pro motifs in RUNX3 via its WW domain. Binding of Pin1 to RUNX3 suppresses the transcriptional activity of RUNX3. Furthermore, Pin1 reduces the cellular levels of RUNX3 in an isomerase activity-dependent manner by inducing the ubiquitination and proteasomal degradation of RUNX3. Knocking down Pin1 enhances the cellular levels and transcriptional activity of RUNX3 by inhibiting the ubiquitination and degradation of RUNX3. Our results identify Pin1 as a new regulator of RUNX3 inactivation in breast cancer. Oncogene (2013) 32, 1488-1496; doi:10.1038/onc.2012.178; published online 14 May 2012	[Tsang, Y-H Nicole; Wu, X-W; Lim, J-S; Chen, L-F] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Tsang, Y-H Nicole; Ito, Y.] Natl Univ Singapore, Inst Mol & Cell Biol, Dept Canc Genet, Singapore 117548, Singapore; [Ong, C. Wee; Salto-Tellez, M.] Natl Univ Singapore, Dept Pathol, Singapore 117548, Singapore; [Ong, C. Wee; Salto-Tellez, M.; Ito, Y.] Natl Univ Singapore, Canc Sci Inst Singapore, Dept Canc Biol, Singapore 117548, Singapore; [Ito, K.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan; [Chen, L-F] Univ Illinois, Coll Med, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; National University of Singapore; Nagasaki University; University of Illinois System; University of Illinois Urbana-Champaign	Chen, LF (corresponding author), Univ Illinois, Coll Med, Dept Biochem, 600 S Matthews Ave,MC-714, Urbana, IL 61801 USA.	lfchen@life.illinois.edu		Salto-Tellez, Manuel/0000-0001-8586-282X	UIUC; NIH [DK-085158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085158] Funding Source: NIH RePORTER	UIUC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs Lu KP and Kao HY for the gift of reagents and members in the Chen lab for discussion. This work is supported in part by fund provided by UIUC (to LFC) and NIH grants DK-085158 (to LFC). YHT is an A*STAR-Illinois Partnership fellow.	Bae JS, 2003, BIOCHEM BIOPH RES CO, V305, P1094, DOI 10.1016/S0006-291X(03)00869-6; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Butt AJ, 2008, ADV EXP MED BIOL, V630, P189; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2012, J CELL BIOCHEM, V113, P1470, DOI 10.1002/jcb.24074; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; Chuang LSH, 2010, ONCOGENE, V29, P2605, DOI 10.1038/onc.2010.88; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Huang B, 2012, ONCOGENE, V31, P527, DOI 10.1038/onc.2011.252; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Hwang KT, 2007, J KOREAN MED SCI, V22, pS24, DOI 10.3346/jkms.2007.22.S.S24; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Jiang Y, 2008, PATHOBIOLOGY, V75, P244, DOI 10.1159/000132385; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee EYHP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003236; Lim JH, 2011, J BIOL CHEM, V286, P44403, DOI 10.1074/jbc.M111.289512; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Subramaniam MM, 2009, BREAST CANCER RES TR, V113, P113, DOI 10.1007/s10549-008-9917-4; Tsang YH, 2010, ONCOGENE, V29, P5643, DOI 10.1038/onc.2010.304; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Zhang DH, 2003, LIFE SCI, V73, P3189, DOI 10.1016/j.lfs.2003.05.006; Zhang M, 2009, J CELL SCI, V122, P1382, DOI 10.1242/jcs.040709; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	40	24	24	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2013	32	12					1488	1496		10.1038/onc.2012.178	http://dx.doi.org/10.1038/onc.2012.178			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22580604	Green Accepted			2022-12-25	WOS:000316456000002
J	Joubert, MK; Hokom, M; Eakin, C; Zhou, L; Deshpande, M; Baker, MP; Goletz, TJ; Kerwin, BA; Chirmule, N; Narhi, LO; Jawa, V				Joubert, Marisa K.; Hokom, Martha; Eakin, Catherine; Zhou, Lei; Deshpande, Meghana; Baker, Matthew P.; Goletz, Theresa J.; Kerwin, Bruce A.; Chirmule, Naren; Narhi, Linda O.; Jawa, Vibha			Highly Aggregated Antibody Therapeutics Can Enhance the in Vitro Innate and Late-stage T-cell Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLERANT MICE; HEMOPHILIA-A; FC-RECEPTOR; FACTOR-VIII; WILD-TYPE; IMMUNOGENICITY; ACTIVATION; COMPLEXES; PARTICLES; MECHANISMS	Aggregation of biotherapeutics has the potential to induce an immunogenic response. Here, we show that aggregated therapeutic antibodies, previously generated and determined to contain a variety of attributes (Joubert, M. K., Luo, Q., Nashed-Samuel, Y., Wypych, J., and Narhi, L.O. (2011) J. Biol. Chem. 286, 25118-25133), can enhance the in vitro innate immune response of a population of naive human peripheral blood mononuclear cells. This response depended on the aggregate type, inherent immunogenicity of the monomer, and donor responsiveness, and required a high number of particles, well above that detected in marketed drug products, at least in this in vitro system. We propose a cytokine signature as a potential biomarker of the in vitro peripheral blood mononuclear cell response to aggregates. The cytokines include IL-1 beta, IL-6, IL-10, MCP-1, MIP-1 alpha, MIP-1 beta, MMP-2, and TNF-alpha. IL-6 and IL-10 might have an immunosuppressive effect on the long term immune response. Aggregates made by stirring induced the highest response compared with aggregates made by other methods. Particle size in the 2-10 mu m range and the retention of some folded structure were associated with an increased response. The mechanism of aggregate activation at the innate phase was found to occur through specific cell surface receptors ( the toll-like receptors TLR-2 and TLR-4, Fc gamma Rs, and the complement system). The innate signal was shown to progress to an adaptive T-cell response characterized by T-cell proliferation and secretion of T-cell cytokines. Investigating the ability of aggregates to induce cytokine signatures as biomarkers of immune responses is essential for determining their risk of immunogenicity.	[Joubert, Marisa K.; Narhi, Linda O.] Amgen Inc, Dept Prod Attribute Sci, Thousand Oaks, CA 91320 USA; [Hokom, Martha; Deshpande, Meghana; Chirmule, Naren; Jawa, Vibha] Amgen Inc, Dept Clin Immunol, Thousand Oaks, CA 91320 USA; [Zhou, Lei] Amgen Inc, Dept Med Sci, Thousand Oaks, CA 91320 USA; [Eakin, Catherine] Amgen Inc, Dept Drug Substance Dev, Seattle, WA 98119 USA; [Kerwin, Bruce A.] Amgen Inc, Dept Drug Prod Dev, Seattle, WA 98119 USA; [Goletz, Theresa J.] Amgen Inc, Dept Clin Immunol, Seattle, WA 98119 USA; [Baker, Matthew P.] Antitope Ltd, Babraham Inst, Cambridge CB22 3AT, England	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Joubert, MK (corresponding author), 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	mjoubert@amgen.com; vjawa01@amgen.com						ANDERSON CL, 1980, J IMMUNOL, V125, P2735; Babiuk S, 2004, J MED VIROL, V72, P138, DOI 10.1002/jmv.10540; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Braun A, 1997, PHARMACEUT RES, V14, P1472, DOI 10.1023/A:1012193326789; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brinks V, 2011, PHARM RES-DORDR, V28, P2379, DOI 10.1007/s11095-011-0523-5; Bussiere J L, 2003, Dev Biol (Basel), V112, P135; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Catelas I, 1998, J BIOMED MATER RES, V41, P600, DOI 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.0.CO;2-I; Corry DB, 2004, FASEB J, V18, P995, DOI 10.1096/fj.03-1412fje; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Demeule B, 2006, EUR J PHARM BIOPHARM, V62, P121, DOI 10.1016/j.ejpb.2005.08.008; den Engelsman J, 2011, PHARM RES-DORDR, V28, P920, DOI 10.1007/s11095-010-0297-1; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; Descotes J, 2007, CYTOKINES HUMAN HLTH, P193; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Fradkin AH, 2011, J PHARM SCI-US, V100, P4953, DOI 10.1002/jps.22683; Fradkin AH, 2009, J PHARM SCI-US, V98, P3247, DOI 10.1002/jps.21834; Hazenbos WLW, 1998, J IMMUNOL, V161, P3026; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Hermeling S, 2005, PHARM RES-DORDR, V22, P1997, DOI 10.1007/s11095-005-8177-9; Hertz CJ, 2001, J IMMUNOL, V166, P2444, DOI 10.4049/jimmunol.166.4.2444; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Jaber Amer, 2007, Drugs R D, V8, P335; Jaber A, 2007, J PHARMACEUT BIOMED, V43, P1256, DOI 10.1016/j.jpba.2006.10.023; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Laborde EA, 2007, J IMMUNOL, V179, P673, DOI 10.4049/jimmunol.179.1.673; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Luo QZ, 2011, J BIOL CHEM, V286, P25134, DOI 10.1074/jbc.M110.160440; Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200; Magi M, 2004, J ALLERGY CLIN IMMUN, V114, P545, DOI 10.1016/j.jaci.2004.04.014; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Patten P A, 2003, Dev Biol (Basel), V112, P81; Perry LCA, 2008, DRUGS R&D, V9, P385, DOI 10.2165/0126839-200809060-00004; Popi AF, 2004, IMMUNOLOGY, V113, P348, DOI 10.1111/j.1365-2567.2004.01969.x; Prior S, 2002, EUR J PHARM SCI, V15, P197, DOI 10.1016/S0928-0987(01)00218-4; Purohit VS, 2006, J PHARM SCI-US, V95, P358, DOI 10.1002/jps.20529; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Reichert JM, 2010, MABS-AUSTIN, V2, P84, DOI 10.4161/mabs.2.1.10677; Reipert BM, 2007, BRIT J HAEMATOL, V136, P12, DOI 10.1111/j.1365-2141.2006.06359.x; Roberts J. P., 2011, GENET ENG BIOTECHNOL, V31, P7; ROBINSON JJ, 1994, ANN RHEUM DIS, V53, P515, DOI 10.1136/ard.53.8.515; Ronnelid J, 2003, ANN RHEUM DIS, V62, P37, DOI 10.1136/ard.62.1.37; Rosenberg A, 2011, IMMUNOGENICITY 2011, P6; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Ryff JC, 2002, TRENDS PHARMACOL SCI, V23, P254, DOI 10.1016/S0165-6147(02)02024-2; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Schellekens H, 2002, NAT REV DRUG DISCOV, V1, P457, DOI 10.1038/nrd818; Seaver S, 2008, BIOQUALITY, V13, P3; Singh SK, 2010, J PHARM SCI-US, V99, P3302, DOI 10.1002/jps.22097; Singh SK, 2011, J PHARM SCI-US, V100, P354, DOI 10.1002/jps.22276; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; Vultaggio A, 2011, CURR OPIN ALLERGY CL, V11, P262, DOI 10.1097/ACI.0b013e3283464bcd; Wang W, 2003, PHARM RES-DORDR, V20, P693, DOI 10.1023/A:1023271405005; WILLS RJ, 1992, CLIN PHARMACOKINET, V23, P406, DOI 10.2165/00003088-199223060-00002; Wullner D, 2010, CLIN IMMUNOL, V137, P5, DOI 10.1016/j.clim.2010.06.018; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016	65	184	195	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25266	25279		10.1074/jbc.M111.330902	http://dx.doi.org/10.1074/jbc.M111.330902			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22584577	Green Published, hybrid			2022-12-25	WOS:000306651700035
J	Li, L; Yan, B; Shi, YQ; Zhang, WQ; Wen, ZL				Li, Li; Yan, Bo; Shi, Yu-Qian; Zhang, Wen-Qing; Wen, Zi-Long			Live Imaging Reveals Differing Roles of Macrophages and Neutrophils during Zebrafish Tail Fin Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; GRANULOCYTE APOPTOSIS; GENE-EXPRESSION; INFLAMMATION; RESOLUTION; CELLS; IDENTIFICATION; BEHAVIOR; INJURY; REPAIR	Macrophages and neutrophils are the pivotal immune phagocytes that enter the wound after tissue injury to remove the cell debris and invaded microorganisms, which presumably facilitate the regrowth of injured tissues. Taking advantage of the regeneration abilities of zebrafish and the newly generated leukocyte-specific zebrafish lines with labeling of both leukocyte lineages, we assessed the behaviors and functions of neutrophils and macrophages during tail fin regeneration. Live imaging showed that within 6 hours post amputation, the inflammatory stage, neutrophils were the primary cells scavenging apoptotic bodies and small cell debris, although they had limited phagocytic capacity and quickly underwent apoptosis. From 6 hours post amputation on, the resolution and regeneration stage, macrophages became the dominant scavengers, efficiently resolving inflammation and facilitating tissue remodeling and regrowth. Ablation of macrophages but not neutrophils severely impaired the inflammatory resolution and tissue regeneration, resulting in the formation of large vacuoles in the regenerated fins. In contrast, removal of neutrophils slightly accelerates the regrowth of injured fin. Our study documents the differing behaviors and functions of macrophages and neutrophils during tissue regeneration.	[Zhang, Wen-Qing] So Med Univ, Key Lab Zebrafish Modeling & Drug Screening Human, Guangdong Higher Educ Inst, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China; [Li, Li] Southwest Univ, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Three Gorges Area,Sch Life Sci, State Key Lab Breeding Base Ecoenvironm & Bioreso, Chongqing 400715, Peoples R China; [Li, Li; Yan, Bo; Shi, Yu-Qian; Wen, Zi-Long] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Kowloon 999077, Hong Kong, Peoples R China	Southern Medical University - China; Southwest University - China; Hong Kong University of Science & Technology	Zhang, WQ (corresponding author), So Med Univ, Key Lab Zebrafish Modeling & Drug Screening Human, Guangdong Higher Educ Inst, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China.	zzwwqq@smu.edu.cn; zilong@ust.hk	zhang, wenqing/GYA-0786-2022; Shi, Yuqian/D-7230-2017	Shi, Yuqian/0000-0002-7218-5337; Wen, Zilong/0000-0002-4260-7682	Research Grants Council of the Hong Kong Special Administrative Region General Research Fund [663109, HKUST6/CRF/09]; National Basic Research Program of China Grant [2012CB945102]; National Natural Science Foundation of China Grants [31171403, 30828020]	Research Grants Council of the Hong Kong Special Administrative Region General Research Fund; National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC))	This work was supported by Research Grants Council of the Hong Kong Special Administrative Region General Research Fund Grants 663109 and HKUST6/CRF/09, National Basic Research Program of China Grant 2012CB945102, and National Natural Science Foundation of China Grants 31171403 and 30828020.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; Dobson JT, 2009, BRIT J HAEMATOL, V144, P732, DOI 10.1111/j.1365-2141.2008.07527.x; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Gray C, 2011, THROMB HAEMOSTASIS, V105, P811, DOI 10.1160/TH10-08-0525; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hallett JM, 2008, TRENDS PHARMACOL SCI, V29, P250, DOI 10.1016/j.tips.2008.03.002; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hogan BM, 2006, CURR BIOL, V16, P506, DOI 10.1016/j.cub.2006.01.047; Jin H, 2006, DEV DYNAM, V235, P60, DOI 10.1002/dvdy.20613; Jin H., 2012, BLOOD IN PRESS; Jin H, 2009, DEVELOPMENT, V136, P647, DOI 10.1242/dev.029637; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; LEIBOVICH SJ, 1976, AM J PATHOL, V84, P501; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Leitch AE, 2008, MUCOSAL IMMUNOL, V1, P350, DOI 10.1038/mi.2008.31; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Lugo-Villarino G, 2010, P NATL ACAD SCI USA, V107, P15850, DOI 10.1073/pnas.1000494107; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qian F, 2007, PLOS BIOL, V5, P1110, DOI 10.1371/journal.pbio.0050132; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Westerfield M, 1999, METHOD CELL BIOL, V60, P339; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989; Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Zhang Y, 2008, J IMMUNOL, V181, P2155, DOI 10.4049/jimmunol.181.3.2155	46	215	220	8	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25353	25360		10.1074/jbc.M112.349126	http://dx.doi.org/10.1074/jbc.M112.349126			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22573321	Green Published, hybrid			2022-12-25	WOS:000306651700043
J	Koo, BH; Kim, YH; Han, JH; Kim, DS				Koo, Bon-Hun; Kim, Yeon Hyang; Han, Jung Ho; Kim, Doo-Sik			Dimerization of Matrix Metalloproteinase-2 (MMP-2) FUNCTIONAL IMPLICATION IN MMP-2 ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN NEUTROPHIL GELATINASE; PROTEIN-KINASE-C; IV COLLAGENASE; REGULATORY MECHANISM; ENDOTHELIAL-CELLS; ALPHA-LACTALBUMIN; COMPLEX-FORMATION; STRUCTURAL BASIS; SNAKE-VENOM	Matrix metalloproteinase-2 (MMP-2) functions in diverse bio-logical processes through the degradation of extracellular and non-extracellular matrix molecules. Because of its potential for tissue damage, there are several ways to regulateMMP-2activity, including gene expression, compartmentalization, zymogen activation, and enzyme inactivation by extracellular inhibitors. Enzyme regulation through zymogen activation is important for the regulation ofMMP-2activity. In our previous studies, we showed that thrombin directly cleaved the propeptide of MMP-2 at specific sites for enzyme activation. We also demonstrated that heparan sulfate was required for thrombin-mediated activation of pro-MMP-2 by binding to thrombin, presumably through conformational changes at the active site of the enzyme. This suggests a regulatory mechanism for thrombin-mediated activation of pro-MMP-2. In this study, we found that MMP-2 formed a reduction-sensitive homodimerin a controlled manner and that Ca2+ ion was essential for homodimerization of MMP-2. Homodimerization was not associated with protein kinase C-mediated phosphorylation of MMP-2. MMP-2 formed a homodimer through an intermolecular disulfide bond between Cys(102) and the neighboring Cys(102). Homodimerization of MMP-2 enhanced thrombin-mediated activation of pro-MMP-2. Moreover, the MMP-2 homodimer could cleave a small peptide substrate without removal of the propeptide. Taken together, our experimental data suggest a novel regulatory mechanism for pro-MMP-2 activation that is modulated through Downloaded from www. jbc. org at ISI, Thomson Scientific, on July 17, 2012	[Koo, Bon-Hun; Kim, Yeon Hyang; Kim, Doo-Sik] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Han, Jung Ho] Seoul Natl Univ, Coll Med, Med Res Ctr, Seoul 110799, South Korea	Yonsei University; Seoul National University (SNU)	Koo, BH (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, 134 Sinchon Dong, Seoul 120749, South Korea.	k4119@yonsei.ac.kr; dskim@yonsei.ac.kr			Future-based Technology Development Program through National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2009-0081760]	Future-based Technology Development Program through National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Future-based Technology Development Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science, and Technology Grant 2009-0081760.	Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Bescond A, 1999, BIOCHEM BIOPH RES CO, V263, P498, DOI 10.1006/bbrc.1999.1391; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Chang JY, 2002, BIOCHEMISTRY-US, V41, P8405, DOI 10.1021/bi020169k; Chen DX, 2008, J EXP MED, V205, P1739, DOI 10.1084/jem.20071427; Chen JM, 1998, BIOCHEM J, V335, P111, DOI 10.1042/bj3350111; Cominetti MR, 2003, ARCH BIOCHEM BIOPHYS, V416, P171, DOI 10.1016/S0003-9861(03)00298-4; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; Fernandez-Patron C, 2000, CIRC RES, V87, P670, DOI 10.1161/01.RES.87.8.670; Fujisaki S, 2003, BIOCHEM BIOPH RES CO, V300, P135, DOI 10.1016/S0006-291X(02)02791-2; Galis ZS, 1997, ARTERIOSCL THROM VAS, V17, P483, DOI 10.1161/01.ATV.17.3.483; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Henderson N, 2007, AM J PHYSIOL-LUNG C, V292, pL1030, DOI 10.1152/ajplung.00317.2006; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jackson MT, 2009, ARTHRITIS RHEUM-US, V60, P780, DOI 10.1002/art.24303; KAHAN C, 1992, J BIOL CHEM, V267, P13369; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Koo BH, 2010, J BIOL CHEM, V285, P41270, DOI 10.1074/jbc.M110.171595; Koo BH, 2009, J BIOL CHEM, V284, P23375, DOI 10.1074/jbc.M109.036848; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Mikhailova EO, 2009, BIOCHEMISTRY-MOSCOW+, V74, P308, DOI 10.1134/S0006297909030109; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakada M, 2001, CANCER RES, V61, P8896; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Nguyen M, 1999, LAB INVEST, V79, P467; Nie J, 2003, CANCER RES, V63, P6758; Nikai T, 2000, ARCH BIOCHEM BIOPHYS, V378, P6, DOI 10.1006/abbi.2000.1795; OISHI K, 1994, J CELL BIOCHEM, V55, P168, DOI 10.1002/jcb.240550203; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; RAO KR, 1989, BIOCHEM BIOPH RES CO, V163, P1390, DOI 10.1016/0006-291X(89)91133-9; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Wang ZB, 2009, NEUROSCI LETT, V451, P199, DOI 10.1016/j.neulet.2009.01.003; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11; Yazdanparast R, 2005, BIOTECHNOL APPL BIOC, V41, P157; Zhu DM, 1998, CLIN CANCER RES, V4, P2967	52	29	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22643	22653		10.1074/jbc.M111.337949	http://dx.doi.org/10.1074/jbc.M111.337949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577146	hybrid, Green Published			2022-12-25	WOS:000306495000021
J	Tung, HH; Lee, SL				Tung, Hsiu-Hui; Lee, Sheau-Ling			Neural Transmembrane Protease and Endothelial G(s) Protein Activation in Cell Contact-dependent Signaling between Neural Stem/Progenitor Cells and Brain Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; VASCULAR NICHE; SERINE-PROTEASE; FUSION PROTEIN; BLOOD-VESSELS; ADULT BRAIN; IN-VITRO; INTERLEUKIN-6; MIGRATION; DIFFERENTIATION	Vasculature is an important component of the neural stem cell niche in brain. It regulates neural stem/progenitor (NS/P) cell self-renewal, differentiation, and migration. In the neurogenic niches of adult brain, NS/P cells lie close to blood vessels, and proliferating NS/P cells frequently contact the vasculature. In the present study we showed that NS/P cells in co-culture with brain endothelial (bEND) cells activated endothelial G proteins and p38 mitogen-activated protein kinase ( p38 MAPK) and stimulated cytokine/ chemokine expression. These NS/P cell-induced endothelial responses took place during NS/P cell and bEND cell direct contact and were critically dependent on the expression of the type II transmembrane serine protease matriptase (MTP) by NS/P cells, because knocking down of MTP in NS/P cells impaired and re-expression of MTP restored their ability to induce endothelial cytokine/chemokine expression, p38 MAPK, or G protein activation. Cholera toxin blocked NS/P cell-induced endothelial responses, suggesting that the endothelial G protein activated by NS/P MTP is in the G(s) subfamily. The addition of p38 MAPK inhibitor impaired NS/P cell-induced endothelial cytokine/ chemokine expression. The known G protein-coupled receptor substrate of MTP, protease-activated receptor 2, was not involved in this system. These results revealed a novel signaling pathway in neural stem cell vascular niches that is mediated by neural MTP and endothelial Gs protein signaling at the cell-cell interface. This is the first report of direct cell-cell signaling between NS/P and bEND cells.	[Tung, Hsiu-Hui; Lee, Sheau-Ling] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan Town 35053, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Lee, SL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	sllee@nhri.org.tw			National Health Research Institutes, Taiwan, Republic of China [00A1-CSPP13-014]	National Health Research Institutes, Taiwan, Republic of China(National Health Research Institutes - Taiwan)	This work was supported by National Health Research Institutes Grant 00A1-CSPP13-014 (to S.-L. L.) Taiwan, Republic of China.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Dong CY, 2008, EXP HEMATOL, V36, P938, DOI 10.1016/j.exphem.2008.03.009; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Fee D, 2000, CYTOKINE, V12, P655, DOI 10.1006/cyto.1999.0599; Gonzalez R, 2007, REGEN MED, V2, P771, DOI 10.2217/17460751.2.5.771; Gupta P, 2008, J CELL PHYSIOL, V215, P827, DOI 10.1002/jcp.21369; Hakkoum D, 2007, J NEUROCHEM, V100, P747, DOI 10.1111/j.1471-4159.2006.04257.x; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Honeth G, 2006, EXP CELL RES, V312, P1265, DOI 10.1016/j.yexcr.2005.12.018; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Jinquan T, 2001, J IMMUNOL, V167, P4405, DOI 10.4049/jimmunol.167.8.4405; Kaliberova LN, 2009, CANCER GENE THER, V16, P794, DOI 10.1038/cgt.2009.23; Kalwitz G, 2010, CONNECT TISSUE RES, V51, P113, DOI 10.3109/03008200903111906; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Poindexter NJ, 2010, EXP DERMATOL, V19, P714, DOI 10.1111/j.1600-0625.2010.01077.x; Rahmani M, 2010, MOL PHARMACOL, V78, P1096, DOI 10.1124/mol.110.068007; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Schafer KH, 1999, J INTERF CYTOK RES, V19, P527, DOI 10.1089/107999099313974; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zerlin M, 1997, J COMP NEUROL, V387, P537, DOI 10.1002/(SICI)1096-9861(19971103)387:4<537::AID-CNE5>3.0.CO;2-3	36	8	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22497	22508		10.1074/jbc.M111.330589	http://dx.doi.org/10.1074/jbc.M111.330589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577149	hybrid, Green Published			2022-12-25	WOS:000306495000008
J	Soule, J; Alme, M; Myrum, C; Schubert, M; Kanhema, T; Bramham, CR				Soule, Jonathan; Alme, Maria; Myrum, Craig; Schubert, Manja; Kanhema, Tambudzai; Bramham, Clive R.			Balancing Arc Synthesis, mRNA Decay, and Proteasomal Degradation MAXIMAL PROTEIN EXPRESSION TRIGGERED BY RAPID EYE MOVEMENT SLEEP-LIKE BURSTS OF MUSCARINIC CHOLINERGIC RECEPTOR STIMULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; MUSCARINIC ACETYLCHOLINE-RECEPTORS; EARLY GENE ARC/ARG3.1; SH-SY5Y NEUROBLASTOMA-CELLS; PONTINE-WAVE GENERATOR; GYRUS IN-VIVO; SYNAPTIC PLASTICITY; ENDOPLASMIC-RETICULUM; RAT HIPPOCAMPUS; DORSAL HIPPOCAMPUS	Cholinergic signaling induces Arc/Arg3.1, an immediate early gene crucial for synaptic plasticity. However, the molecular mechanisms that dictate Arc mRNA and protein dynamics during and after cholinergic epochs are little understood. Using human SH-SY5Y neuroblastoma cells, we show that muscarinic cholinergic receptor (mAchR) stimulation triggers Arc synthesis, whereas translation-dependent RNA decay and proteasomal degradation strictly limit the amount and duration of Arc expression. Chronic application of the mAchR agonist, carbachol (Cch), induces Arc transcription via ERK signaling and release of calcium from IP3-sensitive stores. Arc translation requires ERK activation, but not changes in intracellular calcium. Proteasomal degradation of Arc (half-life similar to 37 min) was enhanced by thapsigargin, an inhibitor of the endoplasmic calcium-ATPase pump. Similar mechanisms of Arc protein regulation were observed in cultured rat hippocampal slices. Functionally, we studied the impact of cholinergic epoch duration and temporal pattern on Arc protein expression. Acute Cch treatment (as short as 2 min) induces transient, moderate Arc expression, whereas continuous treatment of more than 30 min induces maximal expression, followed by rapid decline. Cholinergic activity associated with rapid eye movement sleep may function to facilitate long term synaptic plasticity and memory. Employing a paradigm designed to mimic intermittent rapid eye movement sleep epochs, we show that application of Cch in a series of short bursts generates persistent and maximal Arc protein expression. The results demonstrate dynamic, multifaceted control of Arc synthesis during mAchR signaling, and implicate cholinergic epoch duration and repetition as critical determinants of Arc expression and function in synaptic plasticity and behavior.	[Soule, Jonathan; Alme, Maria; Myrum, Craig; Schubert, Manja; Kanhema, Tambudzai; Bramham, Clive R.] Univ Bergen, Dept Biomed, KG Jebsen Ctr Res Neuropsychiat Disorders, N-5009 Bergen, Norway	University of Bergen	Bramham, CR (corresponding author), Univ Bergen, Dept Biomed, KG Jebsen Ctr Res Neuropsychiat Disorders, Jonas Lies Vei 91, N-5009 Bergen, Norway.	clive.bramham@biomed.uib.no	Schubert, Manja/AAJ-9575-2021; Bramham, Clive/Q-1854-2018	Schubert, Manja/0000-0003-3592-2470; Bramham, Clive/0000-0001-5958-7115	Research Council of Norway [191912, 186115, 204861]; Western Norway Regional Health Authority; University of Bergen	Research Council of Norway(Research Council of Norway); Western Norway Regional Health Authority; University of Bergen	This work was supported by Research Council of Norway Grants 191912, 186115, and 204861, the Western Norway Regional Health Authority, and the University of Bergen.	Adams SV, 2004, HIPPOCAMPUS, V14, P413, DOI 10.1002/hipo.10197; AUERBACH JM, 1994, J NEUROPHYSIOL, V72, P2034, DOI 10.1152/jn.1994.72.4.2034; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Best J, 2007, J BIOL RHYTHM, V22, P220, DOI 10.1177/0748730407301239; BLOKLAND A, 1992, PSYCHOPHARMACOLOGY, V109, P373, DOI 10.1007/BF02245886; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; BRAMHAM CR, 1989, BRAIN RES, V493, P74, DOI 10.1016/0006-8993(89)91001-9; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Chotiner JK, 2010, LEARN MEMORY, V17, P117, DOI 10.1101/lm.1585910; Comte JC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056127; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Datta S, 2008, EUR J NEUROSCI, V27, P1876, DOI 10.1111/j.1460-9568.2008.06166.x; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ebihara T, 2006, J BIOCHEM, V139, P449, DOI 10.1093/jb/mvj064; FEIG S, 1993, J NEUROSCI, V13, P1010; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Fletcher BR, 2007, HIPPOCAMPUS, V17, P227, DOI 10.1002/hipo.20261; Garavito-Aguilar ZV, 2004, BRAIN RES, V1011, P177, DOI 10.1016/j.brainres.2004.03.020; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Gil-Bea FJ, 2011, HIPPOCAMPUS, V21, P999, DOI 10.1002/hipo.20812; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guo X, 2011, J BIOL CHEM, V286, P18037, DOI 10.1074/jbc.M111.225615; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Hong M, 2004, J CELL BIOCHEM, V92, P723, DOI 10.1002/jcb.20118; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Ichikawa H, 2003, J PHARMACOL SCI, V91, P247; Ishikawa A, 2006, EUR J NEUROSCI, V24, P243, DOI 10.1111/j.1460-9568.2006.04874.x; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1, DOI 10.1016/B978-0-444-53702-7.00001-4; Kim JY, 1999, BIOCHEM J, V337, P275, DOI 10.1042/0264-6021:3370275; Leung LS, 2003, J NEUROSCI, V23, P9297; Lopez J, 2008, NEUROSCIENCE, V153, P44, DOI 10.1016/j.neuroscience.2008.01.072; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; MARROSU F, 1995, BRAIN RES, V671, P329, DOI 10.1016/0006-8993(94)01399-3; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MATESIC DF, 1991, FEBS LETT, V284, P184, DOI 10.1016/0014-5793(91)80680-2; MATHES C, 1994, J GEN PHYSIOL, V104, P107, DOI 10.1085/jgp.104.1.107; MATHES C, 1995, J GEN PHYSIOL, V106, P975, DOI 10.1085/jgp.106.5.975; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Natsume K, 1997, NEUROSCI RES, V27, P335, DOI 10.1016/S0168-0102(97)01167-X; Navakkode S, 2012, HIPPOCAMPUS, V22, P335, DOI 10.1002/hipo.20902; OFFERMANNS S, 1993, BIOCHEM J, V294, P545, DOI 10.1042/bj2940545; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Peng FW, 2010, J BIOL CHEM, V285, P21615, DOI 10.1074/jbc.M110.107003; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Ravassard P, 2009, SLEEP, V32, P227, DOI 10.1093/sleep/32.2.227; Ribeiro S, 2012, PFLUG ARCH EUR J PHY, V463, P111, DOI 10.1007/s00424-011-1031-5; Rogers JL, 2003, NEUROBIOL LEARN MEM, V80, P332, DOI 10.1016/S1074-7427(03)00063-7; Romcy-Pereira R, 2004, EUR J NEUROSCI, V20, P3453, DOI 10.1111/j.1460-9568.2004.03808.x; Rosenblum K, 2000, J NEUROSCI, V20, P977, DOI 10.1523/JNEUROSCI.20-03-00977.2000; SADEE W, 1987, CANCER RES, V47, P5207; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Teber I, 2004, MOL BRAIN RES, V121, P131, DOI 10.1016/j.molbrainres.2003.11.017; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Toresson H, 2005, EUR J NEUROSCI, V22, P1793, DOI 10.1111/j.1460-9568.2005.04342.x; Ulloor J, 2005, J NEUROCHEM, V95, P418, DOI 10.1111/j.1471-4159.2005.03378.x; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; VIVALDI EA, 1994, J NEUROPHYSIOL, V72, P1745; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wylie PG, 1999, BIOCHEM J, V338, P619, DOI 10.1042/0264-6021:3380619; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	85	48	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22354	22366		10.1074/jbc.M112.376491	http://dx.doi.org/10.1074/jbc.M112.376491			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22584581	Green Published, hybrid			2022-12-25	WOS:000306418600072
J	Chapman, EJ; Greenham, K; Castillejo, C; Sartor, R; Bialy, A; Sun, TP; Estelle, M				Chapman, Elisabeth J.; Greenham, Kathleen; Castillejo, Cristina; Sartor, Ryan; Bialy, Agniezska; Sun, Taiping; Estelle, Mark			Hypocotyl Transcriptome Reveals Auxin Regulation of Growth-Promoting Genes through GA-Dependent and -Independent Pathways	PLOS ONE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; LATERAL ROOT-FORMATION; OF-FUNCTION MUTATION; INTERACTING FACTOR 4; BOX PROTEIN TIR1; ARABIDOPSIS-THALIANA; SHADE AVOIDANCE; COINCIDENCE MECHANISM; DIFFERENTIAL GROWTH; PLANT DEVELOPMENT	Many processes critical to plant growth and development are regulated by the hormone auxin. Auxin responses are initiated through activation of a transcriptional response mediated by the TIR1/AFB family of F-box protein auxin receptors as well as the AUX/IAA and ARF families of transcriptional regulators. However, there is little information on how auxin regulates a specific cellular response. To begin to address this question, we have focused on auxin regulation of cell expansion in the Arabidopsis hypocotyl. We show that auxin-mediated hypocotyl elongation is dependent upon the TIR1/AFB family of auxin receptors and degradation of AUX/IAA repressors. We also use microarray studies of elongating hypocotyls to show that a number of growth-associated processes are activated by auxin including gibberellin biosynthesis, cell wall reorganization and biogenesis, and others. Our studies indicate that GA biosynthesis is required for normal response to auxin in the hypocotyl but that the overall transcriptional auxin output consists of PIF-dependent and - independent genes. We propose that auxin acts independently from and interdependently with PIF and GA pathways to regulate expression of growth-associated genes in cell expansion.	[Chapman, Elisabeth J.; Greenham, Kathleen; Castillejo, Cristina; Sartor, Ryan; Bialy, Agniezska] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Sun, Taiping] Duke Univ, Dept Biol, Durham, NC USA; [Estelle, Mark] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Duke University; Howard Hughes Medical Institute; University of California System; University of California San Diego	Chapman, EJ (corresponding author), Forage Genet Int, W Salem, WI USA.	mestelle@ucsd.edu	Estelle, Mark/ABD-6742-2021; CASTILLEJO, CRISTINA/R-6802-2018	CASTILLEJO, CRISTINA/0000-0003-2596-8790; Greenham, Kathleen/0000-0001-7681-5263	National Institute of Health Institute of General Medicine [GM 43644]; Department of Energy [De-FG02-02ER15312]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043644, R01GM100051] Funding Source: NIH RePORTER	National Institute of Health Institute of General Medicine; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health Institute of General Medicine (GM 43644) and the Department of Energy (De-FG02-02ER15312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Al-Sady B, 2008, P NATL ACAD SCI USA, V105, P2232, DOI 10.1073/pnas.0711675105; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Benjamins R, 2003, PLANT PHYSIOL, V132, P1623, DOI 10.1104/pp.103.019943; Berleth T, 2004, CURR OPIN PLANT BIOL, V7, P553, DOI 10.1016/j.pbi.2004.07.016; Beuchat J, 2010, NEW PHYTOL, V188, P23, DOI 10.1111/j.1469-8137.2010.03387.x; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; Desgagne-Penix I, 2008, J EXP BOT, V59, P2057, DOI 10.1093/jxb/ern063; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Franklin KA, 2011, P NATL ACAD SCI USA, V108, P20231, DOI 10.1073/pnas.1110682108; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Gallego-Bartolome J, 2011, PLANT PHYSIOL, V156, P1819, DOI 10.1104/pp.111.173971; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Greenham K, 2011, CURR BIOL, V21, P520, DOI 10.1016/j.cub.2011.02.029; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hu Y, 2006, PLANT J, V47, P1, DOI 10.1111/j.1365-313X.2006.02750.x; Hu YX, 2003, PLANT CELL, V15, P1951, DOI 10.1105/tpc.013557; Hyun Y, 2006, PLANT MOL BIOL, V61, P283, DOI 10.1007/s11103-006-0010-2; Jamet E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-505; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Kunihiro A, 2011, PLANT CELL PHYSIOL, V52, P1315, DOI 10.1093/pcp/pcr076; Lee DK, 2003, PLANT PHYSIOL, V131, P985, DOI 10.1104/pp.009902; Lee YK, 2006, DEVELOPMENT, V133, P4305, DOI 10.1242/dev.02604; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Leyser O, 2010, PLANT PHYSIOL, V154, P501, DOI 10.1104/pp.110.161323; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Lucyshyn D, 2009, CURR BIOL, V19, pR265, DOI 10.1016/j.cub.2009.01.051; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Niwa Y, 2009, PLANT CELL PHYSIOL, V50, P838, DOI 10.1093/pcp/pcp028; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Nozue K, 2011, PLANT PHYSIOL, V156, P357, DOI 10.1104/pp.111.172684; O'Neill DP, 2010, PLANTA, V232, P1141, DOI 10.1007/s00425-010-1248-0; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Paponov IA, 2008, MOL PLANT, V1, P321, DOI 10.1093/mp/ssm021; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Roig-Villanova I, 2007, EMBO J, V26, P4756, DOI 10.1038/sj.emboj.7601890; Ross JJ, 2000, PLANT J, V21, P547, DOI 10.1046/j.1365-313x.2000.00702.x; Ross JJ, 2001, J PLANT GROWTH REGUL, V20, P346, DOI 10.1007/s003440010034; Ross JJ, 2011, PHYSIOL PLANTARUM, V141, P299, DOI 10.1111/j.1399-3054.2011.01444.x; Sato A, 2008, PHYSIOL PLANTARUM, V133, P397, DOI 10.1111/j.1399-3054.2008.01055.x; Savaldi-Goldstein S, 2008, P NATL ACAD SCI USA, V105, P15190, DOI 10.1073/pnas.0806324105; SCOTT TK, 1972, ANN REV PLANT PHYSIO, V23, P235, DOI 10.1146/annurev.pp.23.060172.001315; Shin J, 2009, P NATL ACAD SCI USA, V106, P7660, DOI 10.1073/pnas.0812219106; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Sibout R, 2006, PLOS GENET, V2, P1898, DOI 10.1371/journal.pgen.0020202; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stavang JA, 2009, PLANT J, V60, P589, DOI 10.1111/j.1365-313X.2009.03983.x; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Sun JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002594; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; TIMPTE C, 1994, GENETICS, V138, P1239; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Tromas A, 2010, CR BIOL, V333, P297, DOI 10.1016/j.crvi.2010.01.005; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; ULMASOV T, 1995, PLANT CELL, V7, P1611, DOI 10.1105/tpc.7.10.1611; Arana MV, 2011, P NATL ACAD SCI USA, V108, P9292, DOI 10.1073/pnas.1101050108; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Voesenek LACJ, 2003, ANN BOT-LONDON, V91, P205, DOI 10.1093/aob/mcf116; Walsh TA, 2006, PLANT PHYSIOL, V142, P542, DOI 10.1104/pp.106.085969; Watahiki MK, 1997, PLANT PHYSIOL, V115, P419, DOI 10.1104/pp.115.2.419; WILSON AK, 1990, MOL GEN GENET, V222, P377, DOI 10.1007/BF00633843; Yamada M, 2009, PLANT PHYSIOL, V151, P168, DOI 10.1104/pp.109.138859; Yang XQ, 2004, PLANT J, V40, P772, DOI 10.1111/j.1365-313X.2004.02254.x; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	106	102	108	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36210	10.1371/journal.pone.0036210	http://dx.doi.org/10.1371/journal.pone.0036210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590525	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100021
J	Hu, ZH; Zhou, J; Xu, XF; Li, ZW; Zhou, L; Wu, J; Zhang, M; Zheng, SS				Hu, Zhenhua; Zhou, Jie; Xu, Xiaofeng; Li, Zhiwei; Zhou, Lin; Wu, Jian; Zhang, Min; Zheng, Shusen			Salvage Liver Transplantation Is a Reasonable Option for Selected Patients Who Have Recurrent Hepatocellular Carcinoma after Liver Resection	PLOS ONE			English	Article							LIVING DONOR; CIRRHOTIC-PATIENTS; STRATEGY; HEPATECTOMY; SURVIVAL; OUTCOMES; PATTERN; SINGLE	Background: Salvage liver transplantation (SLT) has been reported as being feasible for patients who develop recurrent hepatocellular carcinoma (HCC) after primary liver resection, but this finding remains controversial. We retrospectively studied the clinical characteristics of SLT recipients and conducted a comparison between SLT recipients and primary liver transplantation (PLT) recipients. Methodology and Principal Findings: A retrospective study examined data from the China Liver Transplant Registry (CLTR) for 6,975 transplants performed from January 1999 to December 2009. A total of 6,087 patients underwent PLT and 888 patients underwent SLT for recurrence. Living donor liver transplantation (LDLT) was performed in 389 patients, while 6,586 patients underwent deceased donor liver transplantation (DDLT). Kaplan-Meier curves were used to compare survival rates. The 1-year, 3-year, and 5-year overall survival of SLT recipients was similar to that of PLT recipients: 73.00%, 51.77%, and 45.84% vs. 74.49%, 55.10%, and 48.81%, respectively (P = 0.260). The 1-year, 3-year and 5-year disease-free survival of SLT recipients was inferior to that of PLT recipients: 64.79%, 45.57%, and 37.78% vs. 66.39%, 50.39%, and 43.50%, respectively (P = 0.048). Similar survival results were observed for SLT and PLT within both the LDLT and DDLT recipients. Within the SLT group, the 1-year, 3-year, and 5-year overall survival for LDLT and DDLT recipients was similar: 93.33%, 74.67%, and 74.67% vs. 80.13%, 62.10%, and 54.18% (P = 0.281), as was the disease-free survival: 84.85%, 62.85%, and 62.85% vs. 70.54%, 53.94%, and 43.57% (P = 0.462). Conclusions: Our study demonstrates that for selected patients, SLT has similar survival to that of PLT, indicating that SLT is acceptable for patients with recurrent HCC after liver resection. Given the limited organ donor pool, salvage LDLT might be considered as a possible treatment.	[Hu, Zhenhua; Zhou, Jie; Xu, Xiaofeng; Li, Zhiwei; Zhou, Lin; Wu, Jian; Zhang, Min; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Zhenhua; Zhou, Jie; Xu, Xiaofeng; Li, Zhiwei; Zhou, Lin; Wu, Jian; Zhang, Min; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Minist Publ Hlth,Key Lab Combined Multiorgan Tran, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Zhenhua; Zhou, Jie; Xu, Xiaofeng; Li, Zhiwei; Zhou, Lin; Wu, Jian; Zhang, Min; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Organ Transplantat, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Hu, ZH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			National Basic Research Program of China (973 Program) [2009CB522403]; National Natural Science Foundation of China [30730085]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program) (No. 2009CB522403) and National Natural Science Foundation of China (No. 30730085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2003, ANN SURG, V238, P508, DOI 10.1097/01.sla.0000090449.87109.44; Belghiti J, 2007, LIVER TRANSPLANT, V13, P636, DOI 10.1002/lt.21023; BISMUTH H, 1993, ANN SURG, V218, P145, DOI 10.1097/00000658-199308000-00005; Bismuth H, 1999, SEMIN LIVER DIS, V19, P311, DOI 10.1055/s-2007-1007120; Del Gaudio M, 2008, AM J TRANSPLANT, V8, P1177, DOI 10.1111/j.1600-6143.2008.02229.x; Dmitrewski J, 1998, J Hepatobiliary Pancreat Surg, V5, P18, DOI 10.1007/PL00009945; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Eguchi S, 2009, J GASTROENTEROL, V44, P624, DOI 10.1007/s00535-009-0043-9; Facciuto ME, 2008, ANN SURG ONCOL, V15, P1383, DOI 10.1245/s10434-008-9851-z; Fan ST, 2000, J GASTROEN HEPATOL, V15, pE181, DOI 10.1046/j.1440-1746.2000.02119.x; Figueras J, 2000, J AM COLL SURGEONS, V190, P580, DOI 10.1016/S1072-7515(00)00251-9; Hwang S, 2005, LIVER TRANSPLANT, V11, P1265, DOI 10.1002/lt.20549; Hwang S, 2007, LIVER TRANSPLANT, V13, P741, DOI 10.1002/lt.21157; Laurent A, 2009, J HEPATO-BILIARY-PAN, V16, P310, DOI 10.1007/s00534-009-0063-0; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Lo CM, 2007, BRIT J SURG, V94, P78, DOI 10.1002/bjs.5528; Majno PE, 2000, HEPATOLOGY, V31, P899, DOI 10.1053/he.2000.5763; Man K, 2008, ANN SURG, V247, P1049, DOI 10.1097/SLA.0b013e31816ffab6XXX; Margarit C, 2005, LIVER TRANSPLANT, V11, P1242, DOI 10.1002/lt.20398; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Michel J, 1997, J HEPATOL, V26, P1274, DOI 10.1016/S0168-8278(97)80462-X; Mor E, 1998, ANN INTERN MED, V129, P643, DOI 10.7326/0003-4819-129-8-199810150-00013; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; Sarasin FP, 2001, HEPATOLOGY, V33, P1073, DOI 10.1053/jhep.2001.23311; Strong RW, 2000, SEMIN SURG ONCOL, V19, P189, DOI 10.1002/1098-2388(200009)19:2<189::AID-SSU10>3.0.CO;2-U; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Vennarecci G, 2007, TRANSPL P, V39, P1857, DOI 10.1016/j.transproceed.2007.05.073; Yao FY, 2003, LIVER TRANSPLANT, V9, P684, DOI 10.1053/jlts.2003.50147; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4	29	21	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36587	10.1371/journal.pone.0036587	http://dx.doi.org/10.1371/journal.pone.0036587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574187	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349800084
J	Khatau, SB; Kusuma, S; Hanjaya-Putra, D; Mali, P; Cheng, LZ; Lee, JSH; Gerecht, S; Wirtz, D				Khatau, Shyam B.; Kusuma, Sravanti; Hanjaya-Putra, Donny; Mali, Prashant; Cheng, Linzhao; Lee, Jerry S. H.; Gerecht, Sharon; Wirtz, Denis			The Differential Formation of the LINC-Mediated Perinuclear Actin Cap in Pluripotent and Somatic Cells	PLOS ONE			English	Article							OUTER NUCLEAR-MEMBRANE; EMBRYONIC STEM-CELLS; ENVELOPE; PROTEIN; SUN; LOCALIZATION; KASH; REQUIREMENTS; EXPRESSION; NESPRIN-3	The actin filament cytoskeleton mediates cell motility and adhesion in somatic cells. However, whether the function and organization of the actin network are fundamentally different in pluripotent stem cells is unknown. Here we show that while conventional actin stress fibers at the basal surface of cells are present before and after onset of differentiation of mouse (mESCs) and human embryonic stem cells (hESCs), actin stress fibers of the actin cap, which wrap around the nucleus, are completely absent from undifferentiated mESCs and hESCs and their formation strongly correlates with differentiation. Similarly, the perinuclear actin cap is absent from human induced pluripotent stem cells (hiPSCs), while it is organized in the parental lung fibroblasts from which these hiPSCs are derived and in a wide range of human somatic cells, including lung, embryonic, and foreskin fibroblasts and endothelial cells. During differentiation, the formation of the actin cap follows the expression and proper localization of nuclear lamin A/C and associated linkers of nucleus and cytoskeleton (LINC) complexes at the nuclear envelope, which physically couple the actin cap to the apical surface of the nucleus. The differentiation of hESCs is accompanied by the progressive formation of a perinuclear actin cap while induced pluripotency is accompanied by the specific elimination of the actin cap, and that, through lamin A/C and LINC complexes, this actin cap is involved in progressively shaping the nucleus of hESCs undergoing differentiation. While, the localization of lamin A/C at the nuclear envelope is required for perinuclear actin cap formation, it is not sufficient to control nuclear shape.	[Khatau, Shyam B.; Kusuma, Sravanti; Hanjaya-Putra, Donny; Lee, Jerry S. H.; Gerecht, Sharon; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Khatau, Shyam B.; Kusuma, Sravanti; Hanjaya-Putra, Donny; Gerecht, Sharon; Wirtz, Denis] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Khatau, Shyam B.; Kusuma, Sravanti; Hanjaya-Putra, Donny; Gerecht, Sharon; Wirtz, Denis] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA; [Kusuma, Sravanti; Mali, Prashant] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Cheng, Linzhao] Johns Hopkins Sch Med, Inst Cell Engn, Baltimore, MD USA; [Cheng, Linzhao] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Lee, Jerry S. H.] NCI, Ctr Strateg Sci Initiat, Off Director, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Khatau, SB (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Lee, Jerry/K-4553-2014; Lee, Jerry S.H./AAL-1072-2021; Gerecht, Sharon/A-3388-2010; Lee, Jerry/A-3189-2008; Hanjaya-Putra, Donny/P-1611-2017	Lee, Jerry S.H./0000-0003-1515-0952; Lee, Jerry/0000-0003-1515-0952; Hanjaya-Putra, Donny/0000-0002-3039-9206	National Institutes of Health [R01GM075305, U54CA143868, RC2HL101582]; March of Dimes Basil O'Conner Scholar Award; National Science Foundation graduate training program in the Johns Hopkins Institute for NanoBioTechnology; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Conner Scholar Award; National Science Foundation graduate training program in the Johns Hopkins Institute for NanoBioTechnology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM075305 and U54CA143868 (to DW), RC2HL101582 (to LC), and March of Dimes Basil O'Conner Scholar Award (to SG). SBK was partially supported by a National Science Foundation graduate training program in the Johns Hopkins Institute for NanoBioTechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Burke B, 2009, DEV CELL, V17, P587, DOI 10.1016/j.devcel.2009.10.018; Celedon A, 2011, BIOPHYS J, V101, P1880, DOI 10.1016/j.bpj.2011.09.008; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Daniels BR, 2010, BIOPHYS J, V99, P3563, DOI 10.1016/j.bpj.2010.10.007; Gay O, 2011, P NATL ACAD SCI USA, V108, P11464, DOI 10.1073/pnas.1104211108; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Khatau SB, 2010, NUCLEUS-PHILA, V1, P337, DOI 10.4161/nucl.1.4.12331; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Malone C, 2003, CELL MOTIL CYTOSKEL, V54, P168; McGee MD, 2006, MOL BIOL CELL, V17, P1790, DOI 10.1091/mbc.E05-09-0894; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Panorchan P, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041906; Panorchan P, 2004, J BIOL CHEM, V279, P43462, DOI 10.1074/jbc.M402474200; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2001, DEVELOPMENT, V128, P5039; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Technau M, 2008, FLY, V2, P82, DOI 10.4161/fly.6288; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhen YY, 2002, J CELL SCI, V115, P3207	37	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36689	10.1371/journal.pone.0036689	http://dx.doi.org/10.1371/journal.pone.0036689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574215	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800112
J	Sanchez, LM; Wong, WR; Riener, RM; Schulze, CJ; Linington, RG				Sanchez, Laura M.; Wong, Weng Ruh; Riener, Romina M.; Schulze, Christopher J.; Linington, Roger G.			Examining the Fish Microbiome: Vertebrate-Derived Bacteria as an Environmental Niche for the Discovery of Unique Marine Natural Products	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOTA; DIVERSITY; COMMUNITY	Historically, marine invertebrates have been a prolific source of unique natural products, with a diverse array of biological activities. Recent studies of invertebrate-associated microbial communities are revealing microorganisms as the true producers of many of these compounds. Inspired by the human microbiome project, which has highlighted the human intestine as a unique microenvironment in terms of microbial diversity, we elected to examine the bacterial communities of fish intestines (which we have termed the fish microbiome) as a new source of microbial and biosynthetic diversity for natural products discovery. To test the hypothesis that the fish microbiome contains microorganisms with unique capacity for biosynthesizing natural products, we examined six species of fish through a combination of dissection and culture-dependent evaluation of intestinal microbial communities. Using isolation media designed to enrich for marine Actinobacteria, we have found three main clades that show taxonomic divergence from known strains, several of which are previously uncultured. Extracts from these strains exhibit a wide range of activities against both Gram-positive and Gram-negative human pathogens, as well as several fish pathogens. Exploration of one of these extracts has identified the novel bioactive lipid sebastenoic acid as an anti-microbial agent, with activity against Staphylococcus aureus, Bacillus subtilis, Enterococcus faecium, and Vibrio mimicus.	[Sanchez, Laura M.; Wong, Weng Ruh; Riener, Romina M.; Schulze, Christopher J.; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Sanchez, LM (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	rliningt@ucsc.edu	Sanchez, Laura/AAT-8338-2020; Linington, Roger/ABD-5582-2021	Sanchez, Laura/0000-0001-9223-7977; Linington, Roger/0000-0003-1818-4971	NIH [ICBG FIC TW006634, 2R25GM05803-12]; UCSC Committee on Research Special Research Grant; Malaysia Biotechnology Corporation under the QB3-Malaysia Postdoctoral Fellowship program; NSF; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSC Committee on Research Special Research Grant; Malaysia Biotechnology Corporation under the QB3-Malaysia Postdoctoral Fellowship program; NSF(National Science Foundation (NSF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by NIH grant ICBG FIC TW006634, UCSC Committee on Research Special Research Grant, NIH grant for Undergraduate Research 2R25GM05803-12, the Malaysia Biotechnology Corporation under the QB3-Malaysia Postdoctoral Fellowship program (WW) and an NSF graduate research fellowship (LMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crawford JM, 2011, CHEM COMMUN, V47, P7559, DOI 10.1039/c1cc11574j; Davies J, 2011, CURR OPIN CHEM BIOL, V15, P5, DOI 10.1016/j.cbpa.2010.11.001; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gomez GD, 2008, FEMS IMMUNOL MED MIC, V52, P145, DOI 10.1111/j.1574-695X.2007.00343.x; Gulder TAM, 2009, CURR OPIN MICROBIOL, V12, P252, DOI 10.1016/j.mib.2009.05.002; Hauff S, 2010, LIPIDS, V45, P357, DOI 10.1007/s11745-010-3400-9; Hong K, 2009, MAR DRUGS, V7, P495, DOI 10.3390/md7040495; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hughes CC, 2010, CHEM-EUR J, V16, P12512, DOI 10.1002/chem.201001279; Jensen PR, 2005, ENVIRON MICROBIOL, V7, P1039, DOI 10.1111/j.1462-2920.2005.00785.x; Khan ST, 2009, INT J SYST EVOL MICR, V59, P2094, DOI 10.1099/ijs.0.007666-0; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Kim TK, 2005, ENVIRON MICROBIOL, V7, P509, DOI 10.1111/j.1462-2920.2005.00716.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KITAHARA T, 1995, BIOSCI BIOTECH BIOCH, V59, P78, DOI 10.1271/bbb.59.78; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lin Z, 2011, J MED CHEM, V54, P3746, DOI 10.1021/jm101621u; Lin ZJ, 2010, J NAT PROD, V73, P1922, DOI 10.1021/np100588c; Murray PR, 2007, MAUNAL CLIN MICROBIO; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Noga EJ, 2010, FISH DIS DIAGNOSIS T, V2nd, P193; Oh DC, 2011, ORG LETT, V13, P752, DOI 10.1021/ol102991d; Peraud O, 2009, APPL ENVIRON MICROB, V75, P6820, DOI 10.1128/AEM.01238-09; Poulsen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016763; Quang DN, 2004, J NAT PROD, V67, P1152, DOI 10.1021/np040063l; Radjasa OK, 2011, BIOORGAN MED CHEM, V19, P6658, DOI 10.1016/j.bmc.2011.07.017; Reid HI, 2009, AQUACULTURE, V288, P36, DOI 10.1016/j.aquaculture.2008.11.022; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sheeja M.S., 2011, Middle-East Journal of Scientific Research, V7, P327; Smriga S, 2010, FEMS MICROBIOL ECOL, V73, P31, DOI 10.1111/j.1574-6941.2010.00879.x; Sonnenburg JL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001626; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thornburg CC, 2010, J NAT PROD, V73, P489, DOI 10.1021/np900662k; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Ward NL, 2009, EXTREMOPHILES, V13, P679, DOI 10.1007/s00792-009-0252-4; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2	51	57	59	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35398	10.1371/journal.pone.0035398	http://dx.doi.org/10.1371/journal.pone.0035398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574119	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800015
J	Zhang, YR; Zhao, YQ; Huang, JF				Zhang, Yu-Ru; Zhao, Yu-Qi; Huang, Jing-Fei			Retinoid-Binding Proteins: Similar Protein Architectures Bind Similar Ligands via Completely Different Ways	PLOS ONE			English	Article							ACID; COMPLEX; IDENTIFICATION; SUMMARIES; ALIGNMENT; RECEPTOR; DATABASE; FAMILY; PDBSUM; SITE	Background: Retinoids are a class of compounds that are chemically related to vitamin A, which is an essential nutrient that plays a key role in vision, cell growth and differentiation. In vivo, retinoids must bind with specific proteins to perform their necessary functions. Plasma retinol-binding protein (RBP) and epididymal retinoic acid binding protein (ERABP) carry retinoids in bodily fluids, while cellular retinol-binding proteins (CRBPs) and cellular retinoic acid-binding proteins (CRABPs) carry retinoids within cells. Interestingly, although all of these transport proteins possess similar structures, the modes of binding for the different retinoid ligands with their carrier proteins are different. Methodology/Principal Findings: In this work, we analyzed the various retinoid transport mechanisms using structure and sequence comparisons, binding site analyses and molecular dynamics simulations. Our results show that in the same family of proteins and subcellular location, the orientation of a retinoid molecule within a binding protein is same, whereas when different families of proteins are considered, the orientation of the bound retinoid is completely different. In addition, none of the amino acid residues involved in ligand binding is conserved between the transport proteins. However, for each specific binding protein, the amino acids involved in the ligand binding are conserved. The results of this study allow us to propose a possible transport model for retinoids. Conclusions/Significance: Our results reveal the differences in the binding modes between the different retinoid-binding proteins.	[Zhang, Yu-Ru; Zhao, Yu-Qi; Huang, Jing-Fei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Zhang, Yu-Ru; Zhao, Yu-Qi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Huang, Jing-Fei] Chinese Univ Hongkong, Joint Res Ctr Bioresources & Human Dis Mech, Kunming Inst Zool, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese University of Hong Kong	Zhang, YR (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	huangjf@mail.kiz.ac.cn	Zhao, Yuqi/L-5639-2016	Zhao, Yuqi/0000-0003-0730-5854; Zhao, Yuqi/0000-0002-4256-4512	National Program on Key Basic Research Project (973 Program) [2009CB941302]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China)	This work have supported by the National Program on Key Basic Research Project (973 Program)(Grant No. 2009CB941302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BASS NM, 1993, MOL CELL BIOCHEM, V123, P191, DOI 10.1007/BF01076492; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bostrom J, 2006, J MED CHEM, V49, P6716, DOI 10.1021/jm060167o; Calderone V, 2003, J MOL BIOL, V329, P841, DOI 10.1016/S0022-2836(03)00468-6; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; DONOVAN M, 1995, J STEROID BIOCHEM, V53, P459, DOI 10.1016/0960-0760(95)00092-E; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Folli C, 2002, J BIOL CHEM, V277, P41970, DOI 10.1074/jbc.M207124200; Folli C, 2001, P NATL ACAD SCI USA, V98, P3710, DOI 10.1073/pnas.061455898; Franzoni L, 2002, J BIOL CHEM, V277, P21983, DOI 10.1074/jbc.M201994200; Grune T, 2010, J NUTR, V140, p2268S, DOI 10.3945/jn.109.119024; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; Holland LZ, 2007, NATURE, V447, P153, DOI 10.1038/447153a; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2010, METHODS MOL BIOL, V652, P341, DOI 10.1007/978-1-60327-325-1_20; KLEYWEGT GJ, 1994, STRUCTURE, V2, P1241, DOI 10.1016/S0969-2126(94)00125-1; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lu JY, 2003, J MOL BIOL, V330, P799, DOI 10.1016/S0022-2836(03)00629-6; Marcelino AMC, 2006, PROTEINS, V63, P373, DOI 10.1002/prot.20860; NEWCOMER ME, 1995, FASEB J, V9, P229, DOI 10.1096/fasebj.9.2.7781925; NEWCOMER ME, 1993, STRUCTURE, V1, P7, DOI 10.1016/0969-2126(93)90004-Z; Redondo C, 2008, FASEB J, V22, P1043, DOI 10.1096/fj.07-8939com; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P561; STUMP DG, 1991, J BIOL CHEM, V266, P4622; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; ZANOTTI G, 1993, J MOL BIOL, V230, P613, DOI 10.1006/jmbi.1993.1173; Zanotti G, 2004, VITAM HORM, V69, P271, DOI 10.1016/S0083-6729(04)69010-8	33	24	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36772	10.1371/journal.pone.0036772	http://dx.doi.org/10.1371/journal.pone.0036772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574224	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800121
J	Park, JE; Son, AI; Hua, R; Wang, LQ; Zhang, X; Zhou, RP				Park, Jeong Eun; Son, Alexander I.; Hua, Rui; Wang, Lianqing; Zhang, Xue; Zhou, Renping			Human Cataract Mutations in EPHA2 SAM Domain Alter Receptor Stability and Function	PLOS ONE			English	Article							DOMINANT CONGENITAL CATARACT; TYROSINE KINASE; CELL-MIGRATION; ECTODERMAL DYSPLASIA; MISSENSE MUTATION; CORTICAL CATARACT; ALPHA-CRYSTALLIN; CHROMOSOME 1P; RAPP-HODGKIN; GENE	The cellular and molecular mechanisms underlying the pathogenesis of cataracts leading to visual impairment remain poorly understood. In recent studies, several mutations in the cytoplasmic sterile-alpha-motif (SAM) domain of human EPHA2 on chromosome 1p36 have been associated with hereditary cataracts in several families. Here, we have investigated how these SAM domain mutations affect EPHA2 activity. We showed that the SAM domain mutations dramatically destabilized the EPHA2 protein in a proteasome-dependent pathway, as evidenced by the increase of EPHA2 receptor levels in the presence of the proteasome inhibitor MG132. In addition, the expression of wild-type EPHA2 promoted the migration of the mouse lens epithelial alpha TN4-1 cells in the absence of ligand stimulation, whereas the mutants exhibited significantly reduced activity. In contrast, stimulation of EPHA2 with its ligand ephrin-A5 eradicates the enhancement of cell migration accompanied by Akt activation. Taken together, our studies suggest that the SAM domain of the EPHA2 protein plays critical roles in enhancing the stability of EPHA2 by modulating the proteasome-dependent process. Furthermore, activation of Akt switches EPHA2 from promoting to inhibiting cell migration upon ephrin-A5 binding. Our results provide the first report of multiple EPHA2 cataract mutations contributing to the destabilization of the receptor and causing the loss of cell migration activity.	[Park, Jeong Eun; Son, Alexander I.; Zhou, Renping] Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Hua, Rui; Wang, Lianqing; Zhang, Xue] Chinese Acad Med Sci, Inst Basic Med Sci, McKusick Zhang Ctr Genet Med, State Key Lab Med Mol Biol,Peking Union Med Coll, Beijing 100730, Peoples R China	Rutgers State University New Brunswick; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Park, JE (corresponding author), Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA.	rzhou@rci.rutgers.edu	Wang, Lianqing/AAX-5278-2020	Wang, Lianqing/0000-0002-7161-4718	National Institutes of Health (NIH) [1RO1EY019012]; National Natural Science Foundation of China (NSFC) [30973276]; NATIONAL EYE INSTITUTE [R01EY019012] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by the National Institutes of Health (NIH) grant (1RO1EY019012) to Dr. Zhou, and the National Natural Science Foundation of China (NSFC) grant (30973276) to Dr. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Brannan JM, 2009, CANCER PREV RES, V2, P1039, DOI 10.1158/1940-6207.CAPR-09-0212; Brantley-Sieders DM, 2005, FASEB J, V19, P1884, DOI 10.1096/fj.05-4038fje; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chai A, 2008, HUM MOL GENET, V17, P266, DOI 10.1093/hmg/ddm303; Chang Q, 2008, BRIT J CANCER, V99, P1074, DOI 10.1038/sj.bjc.6604676; Cicero DO, 2006, CELL BIOCHEM BIOPHYS, V44, P475, DOI 10.1385/CBB:44:3:475; Cooper MA, 2008, P NATL ACAD SCI USA, V105, P16620, DOI 10.1073/pnas.0808987105; Dufour A, 2006, DEVELOPMENT, V133, P4415, DOI 10.1242/dev.02623; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V320, P1096, DOI 10.1016/j.bbrc.2004.06.054; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Goichberg P, 2011, CIRC RES, V108, P1071, DOI 10.1161/CIRCRESAHA.110.239459; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Huang WC, 2004, EUR J BIOCHEM, V271, P4114, DOI 10.1111/j.1432-1033.2004.04349.x; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kannabiran C, 1998, Mol Vis, V4, P21; Kantaputra PN, 2011, AM J MED GENET A, V155A, P1432, DOI 10.1002/ajmg.a.34011; Kantaputra PN, 2003, J DENT RES, V82, P433, DOI 10.1177/154405910308200606; Kaplan N, 2012, INVEST OPHTH VIS SCI, V53, P936, DOI 10.1167/iovs.11-8685; Kaul H, 2010, MOL VIS, V16, P511; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; Mackay DS, 2002, AM J HUM GENET, V71, P1216, DOI 10.1086/344212; McCarty CA, 2001, INVEST OPHTH VIS SCI, V42, P1677; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; McKay JD, 2005, BRIT J OPHTHALMOL, V89, P831, DOI 10.1136/bjo.2004.058495; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mueller M, 2009, HUM MOL GENET, V18, P1052, DOI 10.1093/hmg/ddn440; Pande A, 2010, BIOCHEMISTRY-US, V49, P6122, DOI 10.1021/bi100664s; Park EK, 2004, MOL BIOL CELL, V15, P1647, DOI 10.1091/mbc.E03-09-0674; Parri M, 2005, J BIOL CHEM, V280, P34008, DOI 10.1074/jbc.M502879200; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qiao F, 2005, SCI STKE, P286; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Sahin MT, 2004, CLIN EXP DERMATOL, V29, P486, DOI 10.1111/j.1365-2230.2004.01584.x; SanGiovanni JP, 2002, ARCH OPHTHALMOL-CHIC, V120, P1559, DOI 10.1001/archopht.120.11.1559; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Shiels A, 2008, MOL VIS, V14, P2042; Smalla M, 1999, PROTEIN SCI, V8, P1954, DOI 10.1110/ps.8.10.1954; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Tan W, 2011, MOL VIS, V17, P1553; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Tognon CE, 2004, MOL CELL BIOL, V24, P4636, DOI 10.1128/MCB.24.11.4636-4650.2004; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Winer IS, 2006, J BIOL CHEM, V281, P26181, DOI 10.1074/jbc.M604217200; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Xu J., 2005, CURR PROT MOL BIOL, V28, P28; YAMADA T, 1990, CURR EYE RES, V9, P31, DOI 10.3109/02713689009000052; Yamazaki T, 2009, J CELL SCI, V122, P243, DOI 10.1242/jcs.036467; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yue X, 2008, DEV NEUROBIOL, V68, P1269, DOI 10.1002/dneu.20657; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	72	24	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36564	10.1371/journal.pone.0036564	http://dx.doi.org/10.1371/journal.pone.0036564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570727	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343400043
J	Singh, RK; Gonzalez, M; Kabbaj, MHM; Gunjan, A				Singh, Rakesh Kumar; Gonzalez, Melanie; Kabbaj, Marie-Helene Miquel; Gunjan, Akash			Novel E3 Ubiquitin Ligases That Regulate Histone Protein Levels in the Budding Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							CELL-CYCLE; S-PHASE; GLOBAL ANALYSIS; RBR FAMILY; DEGRADATION; PHOSPHORYLATION; REVEALS; DISEASE; COMPLEX; DNA	Core histone proteins are essential for packaging the genomic DNA into chromatin in all eukaryotes. Since multiple genes encode these histone proteins, there is potential for generating more histones than what is required for chromatin assembly. The positively charged histones have a very high affinity for negatively charged molecules such as DNA, and any excess of histone proteins results in deleterious effects on genomic stability and cell viability. Hence, histone levels are known to be tightly regulated via transcriptional, posttranscriptional and posttranslational mechanisms. We have previously elucidated the posttranslational regulation of histone protein levels by the ubiquitin-proteasome pathway involving the E2 ubiquitin conjugating enzymes Ubc4/5 and the HECT (Homologous to E6-AP C-Terminus) domain containing E3 ligase Tom1 in the budding yeast. Here we report the identification of four additional E3 ligases containing the RING (Really Interesting New Gene) finger domains that are involved in the ubiquitylation and subsequent degradation of excess histones in yeast. These E3 ligases are Pep5, Snt2 as well as two previously uncharacterized Open Reading Frames (ORFs) YKR017C and YDR266C that we have named Hel1 and Hel2 (for Histone E3 Ligases) respectively. Mutants lacking these E3 ligases are sensitive to histone overexpression as they fail to degrade excess histones and accumulate high levels of endogenous histones on histone chaperones. Co-immunoprecipitation assays showed that these E3 ligases interact with the major E2 enzyme Ubc4 that is involved in the degradation related ubiquitylation of histones. Using mutagenesis we further demonstrate that the RING domains of Hel1, Hel2 and Snt2 are required for histone regulation. Lastly, mutants corresponding to Hel1, Hel2 and Pep5 are sensitive to replication inhibitors. Overall, our results highlight the importance of posttranslational histone regulatory mechanisms that employ multiple E3 ubiquitin ligases to ensure excess histone degradation and thus contribute to the maintenance of genomic stability.	[Singh, Rakesh Kumar; Gonzalez, Melanie; Kabbaj, Marie-Helene Miquel; Gunjan, Akash] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Singh, RK (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	rakesh.singh@med.fsu.edu; akash.gunjan@med.fsu.edu		Gunjan, Akash/0000-0001-8478-3978				Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Alibhoy Abbas A, 2011, World J Biol Chem, V2, P239, DOI 10.4331/wjbc.v2.i11.239; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Ardley HC, 2004, NEURODEGENER DIS, V1, P71, DOI 10.1159/000080048; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Ciechanover A, 2003, BIOCHEM SOC T, V31, P474, DOI 10.1042/BST0310474; Ciechanover A, 2002, HEPATOLOGY, V35, P3, DOI 10.1053/jhep.2002.30316; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Cook AJL, 2011, MOL CELL, V44, P918, DOI 10.1016/j.molcel.2011.11.021; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Dingwall C, 1990, Semin Cell Biol, V1, P11; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Geng FQ, 2008, MOL BIOL CELL, V19, P3616, DOI 10.1091/mbc.E08-01-0050; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; HAAS AL, 1982, J BIOL CHEM, V257, P2543; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Huizing M, 2001, GENE, V264, P241, DOI 10.1016/S0378-1119(01)00333-X; JONES EW, 1977, GENETICS, V85, P23; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liang D, 2012, NUCL ACIDS IN PRESS; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Morillo-Huesca M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000964; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; Singh RK, 2010, CELL CYCLE, V9, P4236, DOI 10.4161/cc.9.20.13636; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Singh RK, 2009, FRONT BIOSCI-LANDMRK, V14, P3145, DOI 10.2741/3441; Srivastava A, 2000, GENETICS, V156, P105; Sutton A, 2001, GENETICS, V158, P587; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; van Holde K.E., 1988, CHROMATIN; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Ward LD, 2008, BIOINFORMATICS, V24, pI165, DOI 10.1093/bioinformatics/btn154; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wolffe A., 1995, CHROMATIN STRUCTURE; WOODLAND HR, 1977, DEV BIOL, V57, P118, DOI 10.1016/0012-1606(77)90359-1; Yang Y, 2010, CELL RES, V20, P1276, DOI 10.1038/cr.2010.146; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	69	39	45	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36295	10.1371/journal.pone.0036295	http://dx.doi.org/10.1371/journal.pone.0036295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570702	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400018
J	Van Vaerenbergh, J; Baeyen, S; De Vos, P; Maes, M				Van Vaerenbergh, Johan; Baeyen, Steve; De Vos, Paul; Maes, Martine			Sequence Diversity in the Dickeya fliC Gene: Phylogeny of the Dickeya Genus and TaqMan (R) PCR for 'D. solani', New Biovar 3 Variant on Potato in Europe	PLOS ONE			English	Article							ERWINIA-CHRYSANTHEMI; BACTERIAL FLAGELLIN; SENSITIVE DETECTION; PLANT; STRAINS; RECA; PECTOBACTERIUM; CLADE; RFLP	Worldwide, Dickeya (formerly Erwinia chrysanthemi) is causing soft rot diseases on a large diversity of crops and ornamental plants. Strains affecting potato are mainly found in D. dadantii, D. dianthicola and D. zeae, which appear to have a marked geographical distribution. Furthermore, a few Dickeya isolates from potato are attributed to D. chrysanthemi and D. dieffenbachiae. In Europe, isolates of Erwinia chrysanthemi biovar 1 and biovar 7 from potato are now classified in D. dianthicola. However, in the past few years, a new Dickeya biovar 3 variant, tentatively named 'Dickeya solani', has emerged as a common major threat, in particular in seed potatoes. Sequences of a fliC gene fragment were used to generate a phylogeny of Dickeya reference strains from culture collections and with this reference backbone, to classify pectinolytic isolates, i.e. Dickeya spp. from potato and ornamental plants. The reference strains of the currently recognized Dickeya species and 'D. solani' were unambiguously delineated in the fliC phylogram. D. dadantii, D. dianthicola and 'D. solani' displayed unbranched clades, while D. chrysanthemi, D. zeae and D. dieffenbachiae branched into subclades and lineages. Moreover, Dickeya isolates from diagnostic samples, in particular biovar 3 isolates from greenhouse ornamentals, formed several new lineages. Most of these isolates were positioned between the clade of 'D. solani' and D. dadantii as transition variants. New lineages also appeared in D. dieffenbachiae and in D. zeae. The strains and isolates of D. dianthicola and 'D. solani' were differentiated by a fliC sequence useful for barcode identification. A fliC TaqMan (R) real-time PCR was developed for 'D. solani' and the assay was provisionally evaluated in direct analysis of diagnostic potato samples. This molecular tool can support the efforts to control this particular phytopathogen in seed potato certification.	[Van Vaerenbergh, Johan; Baeyen, Steve; Maes, Martine] Inst Agr & Fisheries Res ILVO, Unit Plant Sci Crop Protect, Merelbeke, Belgium; [De Vos, Paul] Univ Ghent, Microbiol Lab, BCCM LMG Bacteria Collect, B-9000 Ghent, Belgium	Institute For Agricultural & Fisheries Research; Ghent University	Van Vaerenbergh, J (corresponding author), Inst Agr & Fisheries Res ILVO, Unit Plant Sci Crop Protect, Merelbeke, Belgium.	johan.vanvaerenbergh@ilvo.vlaanderen.be	Baeyen, Steve/R-1869-2019; De Vos, Paul/J-5392-2013	Baeyen, Steve/0000-0002-7192-2403; 	Government of Flanders	Government of Flanders	The research was performed with funds of the Government of Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amhaz JMK, 2004, FEMS MICROBIOL LETT, V235, P259, DOI 10.1016/j.femsle.2004.04.044; Antunez-Lamas M, 2009, MICROBIOL-SGM, V155, P434, DOI 10.1099/mic.0.022244-0; Bellingham NF, 2001, SYST APPL MICROBIOL, V24, P157, DOI 10.1078/0723-2020-00031; Brady C.L., 2011, INT J SYST EVOL MICR, V62, P1592, DOI DOI 10.1099/IJS.0.035055-0; DARRASSE A, 1994, APPL ENVIRON MICROB, V60, P1437, DOI 10.1128/AEM.60.5.1437-1443.1994; DICKEY RS, 1984, PHYTOPATHOLOGY, V74, P1388, DOI 10.1094/Phyto-74-1388; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Haque M, 2006, BANGLADESH J MICROBI, V25, P36; Hossein MM, 2005, PHYSIOL MOL PLANT P, V17, P943; Jahn CE, 2008, MOL PLANT MICROBE IN, V21, P1431, DOI 10.1094/MPMI-21-11-1431; JANSE JD, 1988, PHYTOPATHOLOGY, V78, P800, DOI 10.1094/Phyto-78-800; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Lee YA, 2006, J MICROBIOL METH, V64, P200, DOI 10.1016/j.mimet.2005.04.031; Ma B, 2007, PHYTOPATHOLOGY, V97, P1150, DOI 10.1094/PHYTO-97-9-1150; MULHOLLAND V, 1993, MOL MICROBIOL, V9, P343, DOI 10.1111/j.1365-2958.1993.tb01695.x; Nassar A, 1996, APPL ENVIRON MICROB, V62, P2228, DOI 10.1128/AEM.62.7.2228-2235.1996; Nei M., 2000, MOL EVOLUTION PHYLOG; Paiva JB, 2009, BRAZ J POULTRY SCI, V11, P271, DOI 10.1590/S1516-635X2009000400009; PARISH CR, 1969, BIOCHEM J, V113, P501, DOI 10.1042/bj1130501; Parkinson N, 2007, INT J SYST EVOL MICR, V57, P2881, DOI 10.1099/ijs.0.65220-0; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P2388, DOI 10.1099/ijs.0.009258-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Samson R., 1978, Proceedings of the IVth International Conference on Plant Pathogenic Bacteria. Vol. II., P547; Samson R., 1987, EPPO B, V17, P11, DOI [10.1111/j.1365-2338.1987.tb00002.x, DOI 10.1111/J.1365-2338.1987.TB00002.X]; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Schonfeld J, 2003, APPL ENVIRON MICROB, V69, P7248, DOI 10.1128/AEM.69.12.7248-7256.2003; Slawiak M, 2009, EUR J PLANT PATHOL, V125, P245, DOI 10.1007/s10658-009-9479-2; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Waleron M, 2002, MICROBIOL-SGM, V148, P583, DOI 10.1099/00221287-148-2-583; Wang L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Winstanley C, 1999, J MED MICROBIOL, V48, P657, DOI 10.1099/00222615-48-7-657; Winstanley C, 1997, MICROBIOL-SGM, V143, P3071, DOI 10.1099/00221287-143-10-3071; YAKRUS M, 1979, PHYTOPATHOLOGY, V69, P517, DOI 10.1094/Phyto-69-517; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456; Young JM, 2007, SYST APPL MICROBIOL, V30, P343, DOI 10.1016/j.syapm.2007.03.002; Zhang S, 1997, J PHYTOPATHOL, V145, P267, DOI 10.1111/j.1439-0434.1997.tb00398.x	43	23	25	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35738	10.1371/journal.pone.0035738	http://dx.doi.org/10.1371/journal.pone.0035738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570692	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343400008
J	Pasco, MY; Leopold, P				Pasco, Matthieu Y.; Leopold, Pierre			High Sugar-Induced Insulin Resistance in Drosophila Relies on the Lipocalin Neural Lazarillo	PLOS ONE			English	Article							HEPATIC STEATOSIS; RETINOL-BINDING-PROTEIN-4; GROWTH; GENE; MICE; PEPTIDES; RECEPTOR; OBESITY; CELLS; CARBOXYLASE-2	In multicellular organisms, insulin/IGF signaling (IIS) plays a central role in matching energy needs with uptake and storage, participating in functions as diverse as metabolic homeostasis, growth, reproduction and ageing. In mammals, this pleiotropy of action relies in part on a dichotomy of action of insulin, IGF-I and their respective membrane-bound receptors. In organisms with simpler IIS, this functional separation is questionable. In Drosophila IIS consists of several insulin-like peptides called Dilps, activating a unique membrane receptor and its downstream signaling cascade. During larval development, IIS is involved in metabolic homeostasis and growth. We have used feeding conditions (high sugar diet, HSD) that induce an important change in metabolic homeostasis to monitor possible effects on growth. Unexpectedly we observed that HSD-fed animals exhibited severe growth inhibition as a consequence of peripheral Dilp resistance. Dilp-resistant animals present several metabolic disorders similar to those observed in type II diabetes (T2D) patients. By exploring the molecular mechanisms involved in Drosophila Dilp resistance, we found a major role for the lipocalin Neural Lazarillo (NLaz), a target of JNK signaling. NLaz expression is strongly increased upon HSD and animals heterozygous for an NLaz null mutation are fully protected from HSD-induced Dilp resistance. NLaz is a secreted protein homologous to the Retinol-Binding Protein 4 involved in the onset of T2D in human and mice. These results indicate that insulin resistance shares common molecular mechanisms in flies and human and that Drosophila could emerge as a powerful genetic system to study some aspects of this complex syndrome.	[Pasco, Matthieu Y.; Leopold, Pierre] Univ Nice, CNRS, UMR 7707, INSERM UMR 1091,iBV, F-06034 Nice, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Pasco, MY (corresponding author), Univ Nice, CNRS, UMR 7707, INSERM UMR 1091,iBV, F-06034 Nice, France.	leopold@unice.fr	Pasco, Matthieu/K-1243-2014	Pasco, Matthieu/0000-0002-8073-5896	ANR [Blan07-2 192851]; FRM; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale	ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	The work was supported by the following funding agencies: ANR Blan07-2 192851 "CoGroDro'', http://www.agence-nationale-recherche.fr/; and FRM Equipe 2009 "Etude du controle de la Croissance'', http://www.frm.org/. P. L. was supported by the Centre National de la Recherche Scientifique and the Institut National de la Sante et de la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Brankatschk M, 2010, J NEUROSCI, V30, P10441, DOI 10.1523/JNEUROSCI.5943-09.2010; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Erikstrup C, 2006, NEW ENGL J MED, V355, P1393; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hull-Thompson J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000460; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kim JJ, 2002, GROWTH HORM IGF RES, V12, P84, DOI 10.1054/ghir.2002.0265; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Mohan V, 2009, BRIT J NUTR, V102, P1498, DOI 10.1017/S0007114509990468; Munkhtulga L, 2007, HUM GENET, V120, P879, DOI 10.1007/s00439-006-0264-4; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Musselman LP, 2011, DIS MODEL MECH; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Odegaard AO, 2010, AM J EPIDEMIOL, V171, P701, DOI 10.1093/aje/kwp452; Oh J, 2006, NEW ENGL J MED, V355, P1394; Polonsky KS, 2006, NEW ENGL J MED, V354, P2596, DOI 10.1056/NEJMe068091; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Sheard NF, 2004, DIABETES CARE, V27, P2266, DOI 10.2337/diacare.27.9.2266; Takashima N, 2006, NEW ENGL J MED, V355, P1392; van Dam RM, 2007, CLIN CHEM, V53, P5, DOI 10.1373/clinchem.2006.080432; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600; Zinke I, 1999, DEVELOPMENT, V126, P5275	39	138	141	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36583	10.1371/journal.pone.0036583	http://dx.doi.org/10.1371/journal.pone.0036583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567167	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500087
J	Cabrera, PV; Pang, M; Marshall, JL; Kung, R; Nelson, SF; Stalnaker, SH; Wells, L; Crosbie-Watson, RH; Baum, LG				Cabrera, Paula V.; Pang, Mabel; Marshall, Jamie L.; Kung, Raymond; Nelson, Stanley F.; Stalnaker, Stephanie H.; Wells, Lance; Crosbie-Watson, Rachelle H.; Baum, Linda G.			High Throughput Screening for Compounds That Alter Muscle Cell Glycosylation Identifies New Role for N-Glycans in Regulating Sarcolemmal Protein Abundance and Laminin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS MUSCULAR-DYSTROPHY; CT GALNAC TRANSFERASE; ALPHA-DYSTROGLYCAN; SKELETAL-MUSCLE; GLYCOPROTEIN COMPLEX; O-GLYCAN; MDX MICE; OVEREXPRESSION; EXPRESSION; LOBELINE	Duchenne muscular dystrophy is an X-linked disorder characterized by loss of dystrophin, a cytoskeletal protein that connects the actin cytoskeleton in skeletal muscle cells to extracellular matrix. Dystrophin binds to the cytoplasmic domain of the transmembrane glycoprotein beta-dystroglycan (beta-DG), which associates with cell surface alpha-dystroglycan (alpha-DG) that binds laminin in the extracellular matrix. beta-DG can also associate with utrophin, and this differential association correlates with specific glycosylation changes on alpha-DG. Genetic modification of alpha-DG glycosylation can promote utrophin binding and rescue dystrophic phenotypes in mouse dystrophy models. We used high throughput screening with the plant lectin Wisteria floribunda agglutinin (WFA) to identify compounds that altered muscle cell surface glycosylation, with the goal of finding compounds that increase abundance of alpha-DG and associated sarcolemmal glycoproteins, increase utrophin usage, and increase laminin binding. We identified one compound, lobeline, from the Prestwick library of Food and Drug Administration-approved compounds that fulfilled these criteria, increasing WFA binding to C2C12 cells and to primary muscle cells from wild type and mdx mice. WFA binding and enhancement by lobeline required complex N-glycans but not O-mannose glycans that bind laminin. However, inhibiting complex N-glycan processing reduced laminin binding to muscle cell glycoproteins, although O-mannosylation was intact. Glycan analysis demonstrated a general increase in N-glycans on lobeline-treated cells rather than specific alterations in cell surface glycosylation, consistent with increased abundance of multiple sarcolemmal glycoproteins. This demonstrates the feasibility of high throughput screening with plant lectins to identify compounds that alter muscle cell glycosylation and identifies a novel role for N-glycans in regulating muscle cell function.	[Cabrera, Paula V.; Pang, Mabel; Kung, Raymond; Baum, Linda G.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Sch Med, Los Angeles, CA 90095 USA; [Nelson, Stanley F.] Univ Calif Los Angeles, Dept Human Genet, Sch Med, Los Angeles, CA 90095 USA; [Marshall, Jamie L.; Crosbie-Watson, Rachelle H.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Crosbie-Watson, Rachelle H.; Baum, Linda G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Stalnaker, Stephanie H.; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Stalnaker, Stephanie H.; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Baum, LG (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Sch Med, 10833 LeConte Ave, Los Angeles, CA 90095 USA.	lbaum@mednet.ucla.edu	Nelson, Stanley F/D-4771-2009; Wells, Lance/H-3118-2013	Nelson, Stanley F/0000-0002-2082-3114; Kung, Raymond/0000-0003-3476-9013; Wells, Lance/0000-0003-4956-5363	National Institutes of Health [P30 AR057230, R01 AR048179, T32 GM07104]; Foundation to Eradicate Duchenne, Department of Defense [8528-01-03]; Muscular Dystrophy Association [RG 135449]; Edith Hyde Fellowship; Eureka Fellowship; UCLA Muscular Dystrophy Core Center (National Institutes of Health) [P30 AR057230]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230, R01AR048179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007104, P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation to Eradicate Duchenne, Department of Defense(United States Department of Defense); Muscular Dystrophy Association(Muscular Dystrophy Association); Edith Hyde Fellowship; Eureka Fellowship; UCLA Muscular Dystrophy Core Center (National Institutes of Health); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 AR057230 (to L. G. B and R. C.-W.), R01 AR048179 (to R. C.-W.), and T32 GM07104 (to J. L. M.). This work was also supported by the Foundation to Eradicate Duchenne, Department of Defense Award 8528-01-03, and Muscular Dystrophy Association Grant RG 135449 (to L. G. B and R. C.-W.) and the Edith Hyde Fellowship and Eureka Fellowship (to J. L. M.). Support was also provided by the UCLA Muscular Dystrophy Core Center (National Institutes of Health Grant P30 AR057230), including the Bioinformatics and Genomics Core and the High Throughput Screening Core, using the UCLA Molecular Screening Shared Resource, in the Center for Duchenne Muscular Dystrophy at UCLA.	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Blake Derek J., 1994, Trends in Cell Biology, V4, P19, DOI 10.1016/0962-8924(94)90034-5; Bozzi M, 2009, MATRIX BIOL, V28, P179, DOI 10.1016/j.matbio.2009.03.003; CAPALDI MJ, 1985, HISTOCHEM J, V17, P81, DOI 10.1007/BF01003405; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Dwoskin LP, 2002, BIOCHEM PHARMACOL, V63, P89, DOI 10.1016/S0006-2952(01)00899-1; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Esapa CT, 2003, FEBS LETT, V555, P209, DOI 10.1016/S0014-5793(03)01230-4; Gundry RL, 2009, MOL CELL PROTEOMICS, V8, P2555, DOI 10.1074/mcp.M900195-MCP200; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Hu YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016866; Jayasinha V, 2003, BIOCHEM BIOPH RES CO, V302, P831, DOI 10.1016/S0006-291X(03)00271-7; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; Kimura E, 2008, HUM MOL GENET, V17, P2507, DOI 10.1093/hmg/ddn151; Lee WC, 2010, J NEUROSCI, V30, P5489, DOI 10.1523/JNEUROSCI.6383-09.2010; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Nguyen HH, 2002, P NATL ACAD SCI USA, V99, P5616, DOI 10.1073/pnas.082613599; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Orlando R, 2009, J PROTEOME RES, V8, P3816, DOI 10.1021/pr8010028; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peter AK, 2009, HUM MOL GENET, V18, P318, DOI 10.1093/hmg/ddn358; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; Santha E, 2000, J PHARMACOL EXP THER, V294, P302; Sgambato A, 2005, J CELL PHYSIOL, V205, P163, DOI 10.1002/jcp.20411; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Wilhelm CJ, 2008, BIOCHEM PHARMACOL, V75, P1411, DOI 10.1016/j.bcp.2007.11.019; Xia B, 2002, DEV BIOL, V242, P58, DOI 10.1006/dbio.2001.0530; Xu R, 2007, AM J PATHOL, V171, P181, DOI 10.2353/ajpath.2007.060927; Xu R, 2009, AM J PATHOL, V175, P235, DOI 10.2353/ajpath.2009.080967; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yoon JH, 2009, MOL CELL NEUROSCI, V41, P448, DOI 10.1016/j.mcn.2009.04.013; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhang P, 2012, GLYCOBIOLOGY, V22, P235, DOI 10.1093/glycob/cwr131; Zhang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019080	39	12	12	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22759	22770		10.1074/jbc.M111.334581	http://dx.doi.org/10.1074/jbc.M111.334581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570487	hybrid, Green Published			2022-12-25	WOS:000306495000033
J	Li, XF; Kuang, JQ; Shen, Y; Majer, MM; Nelson, CC; Parsawar, K; Heichman, KA; Kuwada, SK				Li, Xiufen; Kuang, Jinqiu; Shen, Yi; Majer, Martin M.; Nelson, Chad C.; Parsawar, Krishna; Heichman, Karen A.; Kuwada, Scott K.			The Atypical Histone MacroH2A1.2 Interacts with HER-2 Protein in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL OVARIAN-CANCER; EPIDERMAL-GROWTH-FACTOR; HUMAN BREAST-CANCER; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; IONIZING-RADIATION; COLORECTAL-CANCER; TYROSINE KINASE; ERBB RECEPTORS; POOR SURVIVAL	Because HER-2 has been demonstrated in the nuclei of cancer cells, we hypothesized that it might interact with transcription factors that activate ERBB2 transcription. Macrohistone 2A1 ( H2AFY; mH2A1) was found to interact with HER-2 in cancer cells that overexpress HER-2. Of the two human mH2A1 isoforms, mH2A1.2, but not mH2A1.1, interacted with HER-2 in human cancer cell lines. Overexpression of mH2A1.2, but not mH2A1.1, in cancer cells significantly increased HER-2 expression and tumorigenicity. Inhibition of HER-2 kinase activity diminished mH2A1 expression and mH2A1.2-induced ERBB2 transcription in cancer cells. Chromatin immunoprecipitation of mH2A1.2 in cancer cells stably transfected with mH2A1.2 showed enrichment of mH2A1.2 at the HER-2 promoter, suggesting a role for mH2A1.2 in driving HER-2 overexpression. The evolutionarily conserved macro domain of mH2A1.2 was sufficient for the interaction between HER-2 and mH2A1.2 and for mH2A1.2-induced ERBB2 transcription. Within the macro domain of mH2A1.2, a trinucleotide insertion (-EIS-) sequence not found in mH2A1.1 was essential for the interaction between HER-2 and mH2A1.2 as well as mH2A1.2-induced HER-2 expression and cell proliferation.	[Li, Xiufen; Shen, Yi; Kuwada, Scott K.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96813 USA; [Kuang, Jinqiu; Majer, Martin M.] Corvallis Clin, Corvallis, OR 97330 USA; [Nelson, Chad C.; Parsawar, Krishna] Univ Utah, Dept Med Chem, Salt Lake City, UT 84132 USA; [Heichman, Karen A.] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA	University of Hawaii System; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kuwada, SK (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Med, 651 Ilalo St,BSB 211D, Honolulu, HI 96813 USA.	skkuwada@hawaii.edu			National Institutes of Health [5 G12 RR003061]; National Center for Research Resources; National Institute on Minority Health and Health Disparities [8 G12 MD007601]; NCI Cancer Center support grant; Veterans Affairs research grant; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCI Cancer Center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs research grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 G12 RR003061, a Research Centers in Minority Institutions grant from the National Center for Research Resources, and 8 G12 MD007601 from the National Institute on Minority Health and Health Disparities and an NCI Cancer Center support grant (to the Huntsman Cancer Institute). This work was also supported by a Veterans Affairs research grant (to S. K. K.).	Beguelin W, 2010, MOL CELL BIOL, V30, P5456, DOI 10.1128/MCB.00012-10; BERCHUCK A, 1990, CANCER RES, V50, P4087; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Dittmann K, 2010, FEBS LETT, V584, P3878, DOI 10.1016/j.febslet.2010.08.005; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Farin K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006128; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Half E, 2004, INT J CANCER, V108, P540, DOI 10.1002/ijc.11599; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Kapitanovic S, 1997, GASTROENTEROLOGY, V112, P1103, DOI 10.1016/S0016-5085(97)70120-3; KAPITANOVIC S, 1994, CANCER DETECT PREV, V18, P97; Kapitanovic S, 2000, J CANCER RES CLIN, V126, P205, DOI 10.1007/s004320050034; Koka V, 2002, ANTICANCER RES, V22, P1593; Kono K, 2002, INT J CANCER, V98, P216, DOI 10.1002/ijc.10179; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Kuwada SK, 2004, INT J CANCER, V109, P291, DOI 10.1002/ijc.11686; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Marti U, 2001, THYROID, V11, P137, DOI 10.1089/105072501300042785; Nathanson DR, 2003, INT J CANCER, V105, P796, DOI 10.1002/ijc.11137; Novotny J, 2001, NEOPLASMA, V48, P188; Ogawa Y, 2005, BIOCHEM BIOPH RES CO, V336, P204, DOI 10.1016/j.bbrc.2005.08.046; Pegram MD, 1998, BREAST CANCER RES TR, V52, P65, DOI 10.1023/A:1006111117877; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Ross JS, 2001, CANCER INVEST, V19, P554, DOI 10.1081/CNV-100103852; SADASIVAN R, 1993, J UROLOGY, V150, P126, DOI 10.1016/S0022-5347(17)35413-7; Saxby AJ, 2005, AM J SURG PATHOL, V29, P1125, DOI 10.1097/01.pas.0000160979.85457.73; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; TIWARI RK, 1992, ANTICANCER RES, V12, P419; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294	43	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23171	23183		10.1074/jbc.M112.379412	http://dx.doi.org/10.1074/jbc.M112.379412			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589551	Green Published, hybrid			2022-12-25	WOS:000306495000072
J	Rybin, VO; Guo, JF; Harleton, E; Zhang, F; Steinberg, SF				Rybin, Vitalyi O.; Guo, Jianfen; Harleton, Erin; Zhang, Fan; Steinberg, Susan F.			Regulatory Domain Determinants That Control PKD1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-D; C-MU; PROTEOLYTIC CLEAVAGE; D ACTIVATION; D1; IDENTIFICATION; CELLS	The canonical pathway for protein kinase D1 (PKD1) activation by growth factor receptors involves diacylglycerol binding to the C1 domain and protein kinase C-dependent phosphorylation at the activation loop. PKD1 then autophosphorylates at Ser(916), a modification frequently used as a surrogate marker of PKD1 activity. PKD1 also is cleaved by caspase-3 at a site in the C1-PH interdomain during apoptosis; the functional consequences of this cleavage event remain uncertain. This study shows that PKD1-Delta 1-321 (an N-terminal deletion mutant lacking the C1 domain and flanking sequence that models the catalytic fragment that accumulates during apoptosis) and PKD1-CD ( the isolated catalytic domain) display high basal Ser916 autocatalytic activity and robust activity toward CREBtide ( a peptide substrate) but little to no activation loop autophosphorylation and no associated activity toward protein substrates, such as cAMP-response element binding protein and cardiac troponin I. In contrast, PKD1-Delta PH (a PH domain deletion mutant) is recovered as a constitutively active enzyme, with high basal autocatalytic activity and high basal activity toward peptide and protein substrates. These results indicate that individual regions in the regulatory domain act in a distinct manner to control PKD1 activity. Finally, cell-based studies show that PKD1-Delta 1-321 does not substitute for WT-PKD1 as an in vivo activator of cAMP-response element binding protein and ERK phosphorylation. Proteolytic events that remove the C1 domain ( but not the autoinhibitory PH domain) limit maximal PKD1 activity toward physiologically relevant protein substrates and lead to a defect in PKD1-dependent cellular responses.	[Rybin, Vitalyi O.; Guo, Jianfen; Harleton, Erin; Zhang, Fan; Steinberg, Susan F.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University	Steinberg, SF (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pharmacol, 630 W 168 St, New York, NY 10032 USA.	sfs1@columbia.edu			National Institutes of Health (NIH), NHLBI [HL 77860]; National Center for Research Resources (NCRR) [TL1 RR024158]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077860, R01HL112388] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NHLBI, Grant HL 77860 and National Center for Research Resources (NCRR) (a component of the NIH and NIH Roadmap for Medical Research) Grant TL1 RR024158.	Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Gschwendt M, 1997, J BIOL CHEM, V272, P20742, DOI 10.1074/jbc.272.33.20742; Guo JF, 2011, J BIOL CHEM, V286, P6500, DOI 10.1074/jbc.M110.208058; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Haussermann S, 1999, FEBS LETT, V462, P442, DOI 10.1016/S0014-5793(99)01577-X; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Kim MS, 2009, DIABETES, V58, P2464, DOI 10.2337/db09-0681; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Vantus T, 2004, CELL SIGNAL, V16, P703, DOI 10.1016/j.cellsig.2003.11.009	15	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22609	22615		10.1074/jbc.M112.379719	http://dx.doi.org/10.1074/jbc.M112.379719			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22582392	hybrid, Green Published			2022-12-25	WOS:000306495000017
J	Stockwell, MP; Clulow, J; Mahony, MJ				Stockwell, Michelle Pirrie; Clulow, John; Mahony, Michael Joseph			Sodium Chloride Inhibits the Growth and Infective Capacity of the Amphibian Chytrid Fungus and Increases Host Survival Rates	PLOS ONE			English	Article							PATHOGEN BATRACHOCHYTRIUM-DENDROBATIDIS; HYDROGEN-PEROXIDE; EMERGING DISEASE; CHYTRIDIOMYCOSIS; MORTALITY; DECLINES; BACTERIA; SAPROLEGNIOSIS; BIODIVERSITY; AUSTRALIA	The amphibian chytrid fungus Batrachochytrium dendrobatidis is a recently emerged pathogen that causes the infectious disease chytridiomycosis and has been implicated as a contributing factor in the global amphibian decline. Since its discovery, research has been focused on developing various methods of mitigating the impact of chytridiomycosis on amphibian hosts but little attention has been given to the role of antifungal agents that could be added to the host's environment. Sodium chloride is a known antifungal agent used routinely in the aquaculture industry and this study investigates its potential for use as a disease management tool in amphibian conservation. The effect of 0-5 ppt NaCl on the growth, motility and survival of the chytrid fungus when grown in culture media and its effect on the growth, infection load and survivorship of infected Peron's tree frogs (Litoria peronii) in captivity, was investigated. The results reveal that these concentrations do not negatively affect the survival of the host or the pathogen. However, concentrations greater than 3 ppt significantly reduced the growth and motility of the chytrid fungus compared to 0 ppt. Concentrations of 1-4 ppt NaCl were also associated with significantly lower host infection loads while infected hosts exposed to 3 and 4 ppt NaCl were found to have significantly higher survival rates. These results support the potential for NaCl to be used as an environmentally distributed antifungal agent for the prevention of chytridiomycosis in susceptible amphibian hosts. However, further research is required to identify any negative effects of salt exposure on both target and non-target organisms prior to implementation.	[Stockwell, Michelle Pirrie; Clulow, John; Mahony, Michael Joseph] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Newcastle	Stockwell, MP (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	michelle.stockwell@newcastle.edu.au		Clulow, John/0000-0001-8991-1449	Kooragang Wetland Rehabilitation Project	Kooragang Wetland Rehabilitation Project	Work was funded by the Kooragang Wetland Rehabilitation Project: http://www.hcr.cma.nsw.gov.au/kooragang/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bd-Maps (n.d.), GLOB BD MAPP PROJ; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; BERGER L, 1999, DECLINES DISAPPEARAN; Berger L, 2009, RES VET SCI, V87, P106, DOI 10.1016/j.rvsc.2008.11.005; Blomberg A., 1993, STRESS TOLERANCE FUN, P209; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Garner TWJ, 2009, DIS AQUAT ORGAN, V83, P257, DOI 10.3354/dao02008; Gleason FH, 2006, MYCOL RES, V110, P869, DOI 10.1016/j.mycres.2006.04.002; Halse SA, 2003, AUST J BOT, V51, P673, DOI 10.1071/BT02113; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7; Li MH, 1996, J WORLD AQUACULT SOC, V27, P1, DOI 10.1111/j.1749-7345.1996.tb00587.x; Martel A, 2010, MED MYCOLOGY; McConnell TH, 2007, NATURE DIS; McDonald K. R., 2005, PAC CONSERV BIOL, V11, P114, DOI DOI 10.1071/PC050114; McKenzie NL, 2003, AUST J BOT, V51, P725, DOI 10.1071/BT02116; Mifsud C, 2008, AQUAC RES, V39, P1175, DOI 10.1111/j.1365-2109.2008.01981.x; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Schreier TM, 1996, AQUACULTURE, V140, P323, DOI 10.1016/0044-8486(95)01182-X; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sparling Donald W., 2010, P105; SPEARE R, 2005, CHYTRIDIOMYCOSIS STA; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Stockwell M, 2011, THESIS U NEWCASTLE; Stockwell MP, 2010, ANIM CONSERV, V13, P62, DOI 10.1111/j.1469-1795.2010.00407.x; Stockwell MP, 2010, DIS AQUAT ORGAN, V88, P177, DOI 10.3354/dao02165; Stockwell M. P., 2008, Australian Zoologist, V34, P379; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tamukai K, 2010, J VET MED SCI; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; WATERSTRAT PR, 1995, PROG FISH CULT, V57, P287, DOI 10.1577/1548-8640(1995)057&lt;0287:CCEOFH&gt;2.3.CO;2; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Wright Kevin M., 2001, P309	53	39	39	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36942	10.1371/journal.pone.0036942	http://dx.doi.org/10.1371/journal.pone.0036942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590639	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336400049
J	Ye, W; Chen, Y; Wang, W; Yu, QF; Li, YX; Zhang, J; Chen, HF				Ye, Wei; Chen, Yue; Wang, Wei; Yu, Qingfen; Li, Yixue; Zhang, Jian; Chen, Hai-Feng			Insight into the Stability of Cross-beta Amyloid Fibril from VEALYL Short Peptide with Molecular Dynamics Simulation	PLOS ONE			English	Article							STRUCTURAL STABILITY; FOLDING SIMULATIONS; FORMING PEPTIDE; PRION PROTEIN; EARLY STEPS; AGGREGATION; OLIGOMERS; MECHANISM; BINDING; POLYMORPHISM	Amyloid fibrils are found in many fatal neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, type II diabetes, and prion disease. The VEALYL short peptide from insulin has been confirmed to aggregate amyloid-like fibrils. However, the aggregation mechanism of amyloid fibril is poorly understood. Here, we utilized molecular dynamics simulation to analyse the stability of VEALYL hexamer. The statistical results indicate that hydrophobic residues play key roles in stabilizing VEALYL hexamer. Single point and two linkage mutants confirmed that Val1, Leu4, and Tyr5 of VEALYL are key residues. The consistency of the results for the VEALYL oligomer suggests that the intermediate states might be trimer (3-0) and pentamer(3-2). These results can help us to obtain an insight into the aggregation mechanism of amyloid fibril. These methods can be used to study the stability of amyloid fibril from other short peptides.	[Ye, Wei; Chen, Yue; Wang, Wei; Yu, Qingfen; Chen, Hai-Feng] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Li, Yixue; Chen, Hai-Feng] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Ye, W (corresponding author), Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	yxli@scbit.org; jian.zhang@sjtu.edu.cn; haifengchen@sjtu.edu.cn	Chen, Haifeng/AAT-7444-2020; Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; Ye, Wei/0000-0001-6268-2703	 [2012CB721003];  [2012AA020403];  [YG2010MS67];  [10ZR1414500];  [10PJD010];  [10PJ1406800];  [12ZZ023]	; ; ; ; ; ; 	2012CB721003 http://www.most.gov.cn/; 2012AA020403 http://www.most.gov.cn/; YG2010MS67 http://www.sjtu.edu.cn/10ZR1414500; http://www.stcsm.gov.cn/; 10PJD010 http://www.stcsm.gov.cn/; 10PJ1406800 http://www.stcsm.gov.cn/; 12ZZ023 http://www.shdrc.gov.cn The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berryman JT, 2011, BIOPHYS J, V100, P2234, DOI 10.1016/j.bpj.2011.02.060; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Boucher G, 2006, PROTEINS, V65, P877, DOI 10.1002/prot.21134; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CASE DA, 2004, AMBER 8; Chebaro Y, 2009, PROTEINS, V75, P442, DOI 10.1002/prot.22254; Chen HF, 2008, J CHEM THEORY COMPUT, V4, P1360, DOI 10.1021/ct800030s; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Chen HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006516; Chen HF, 2009, COMPUT BIOL CHEM, V33, P41, DOI 10.1016/j.compbiolchem.2008.07.023; Chen J, 2010, J AM CHEM SOC, V132, P17015, DOI 10.1021/ja107552s; Chen Y, 2010, BIOPOLYMERS, V93, P578, DOI 10.1002/bip.21405; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Connelly L, 2012, J PHYS CHEM B, V116, P1728, DOI 10.1021/jp2108126; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2005, P NATL ACAD SCI USA, V102, P13445, DOI 10.1073/pnas.0501773102; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Derreumaux P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408414; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Esposito L, 2006, P NATL ACAD SCI USA, V103, P11533, DOI 10.1073/pnas.0602345103; Gnanakaran S, 2006, J AM CHEM SOC, V128, P2158, DOI 10.1021/ja0548337; Gsponer J, 2003, P NATL ACAD SCI USA, V100, P5154, DOI 10.1073/pnas.0835307100; Kent A, 2008, J PHYS CHEM B, V112, P6175, DOI 10.1021/jp077099h; Lin YF, 2010, BIOPOLYMERS, V94, P269, DOI 10.1002/bip.21322; Lipfert J, 2005, J MOL BIOL, V349, P648, DOI 10.1016/j.jmb.2005.03.083; Liu G, 2010, J AM CHEM SOC, V132, P18223, DOI 10.1021/ja1069882; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Lwin TZ, 2006, PROTEIN SCI, V15, P2642, DOI 10.1110/ps.062438006; Masman MF, 2009, J PHYS CHEM B, V113, P11710, DOI 10.1021/jp901057w; Miller Y, 2011, J AM CHEM SOC, V133, P2742, DOI 10.1021/ja1100273; Miller Y, 2010, P NATL ACAD SCI USA, V107, P14128, DOI 10.1073/pnas.1004704107; Miller Y, 2009, BIOPHYS J, V97, P1168, DOI 10.1016/j.bpj.2009.05.042; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Ono K, 2011, J NEUROCHEM, V117, P19, DOI 10.1111/j.1471-4159.2011.07187.x; Qin F, 2012, PHYS CHEM CHEM PHYS, V14, P538, DOI 10.1039/c1cp22610j; Qin F, 2011, PHYS CHEM CHEM PHYS, V13, P1407, DOI 10.1039/c0cp00701c; Qin F, 2010, RNA, V16, P1053, DOI 10.1261/rna.2008110; Qin F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3224126; Reddy G, 2010, P NATL ACAD SCI USA, V107, P21459, DOI 10.1073/pnas.1008616107; Rychaert J.P., 1977, COMPUT PHYS, V23, P327; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; Toschi F, 2009, J PHYS CHEM B, V113, P369, DOI 10.1021/jp807896g; Wang J, 2008, BIOPHYS J, V95, P5037, DOI 10.1529/biophysj.108.131672; Wu C, 2011, BIOPHYS J, V100, P1316, DOI 10.1016/j.bpj.2011.01.058; Zheng J, 2008, FRONT BIOSCI-LANDMRK, V13, P3919, DOI 10.2741/2980; Zheng J, 2008, BIOCHEMISTRY-US, V47, P2497, DOI 10.1021/bi7019194; Zheng J, 2006, BIOPHYS J, V91, P824, DOI 10.1529/biophysj.106.083246	49	10	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36382	10.1371/journal.pone.0036382	http://dx.doi.org/10.1371/journal.pone.0036382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590535	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400011
J	Zhou, WS; Dowell, DR; Huckabee, MM; Newcomb, DC; Boswell, MG; Goleniewska, K; Lotz, MT; Toki, S; Yin, HY; Yao, SY; Natarajan, C; Wu, PS; Sriram, S; Breyer, RM; FitzGerald, GA; Peebles, RS				Zhou, Weisong; Dowell, Dustin R.; Huckabee, Matthew M.; Newcomb, Dawn C.; Boswell, Madison G.; Goleniewska, Kasia; Lotz, Matthew T.; Toki, Shinji; Yin, Huiyong; Yao, Songyi; Natarajan, Chandramohan; Wu, Pingsheng; Sriram, Subramaniam; Breyer, Richard M.; FitzGerald, Garret A.; Peebles, R. Stokes, Jr.			Prostaglandin I-2 Signaling Drives Th17 Differentiation and Exacerbates Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; CD4 T-CELLS; CYTOKINE PRODUCTION; DENDRITIC CELLS; HOST-DEFENSE; INFLAMMATION; IL-17; RECEPTOR; LINEAGE; T(H)17	Background: Prostaglandin I-2 (PGI(2)), a lipid mediator currently used in treatment of human disease, is a critical regulator of adaptive immune responses. Although PGI(2) signaling suppressed Th1 and Th2 immune responses, the role of PGI(2) in Th17 differentiation is not known. Methodology/Principal Findings: In mouse CD4(+)CD62L(+) naive T cell culture, the PGI(2) analogs iloprost and cicaprost increased IL-17A and IL-22 protein production and Th17 differentiation in vitro. This effect was augmented by IL-23 and was dependent on PGI(2) receptor IP signaling. In mouse bone marrow-derived CD11c(+) dendritic cells (BMDCs), PGI(2) analogs increased the ratio of IL-23/IL-12, which is correlated with increased ability of BMDCs to stimulate naive T cells for IL-17A production. Moreover, IP knockout mice had delayed onset of a Th17-associated neurological disease, experimental autoimmune encephalomyelitis (EAE), and reduced infiltration of IL-17A-expressing mononuclear cells in the spinal cords compared to wild type mice. These results suggest that PGI(2) promotes in vivo Th17 responses. Conclusion: The preferential stimulation of Th17 differentiation by IP signaling may have important clinical implications as PGI(2) and its analogs are commonly used to treat human pulmonary hypertension.	[Zhou, Weisong; Dowell, Dustin R.; Huckabee, Matthew M.; Newcomb, Dawn C.; Boswell, Madison G.; Goleniewska, Kasia; Lotz, Matthew T.; Toki, Shinji; Wu, Pingsheng; Peebles, R. Stokes, Jr.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Yao, Songyi; Natarajan, Chandramohan; Sriram, Subramaniam] Vanderbilt Univ, Sch Med, Dept Med, Div Neurol, Nashville, TN 37212 USA; [Yin, Huiyong] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Breyer, Richard M.] Vanderbilt Univ, Sch Med, Dept Med, Div Nephrol, Nashville, TN 37212 USA; [FitzGerald, Garret A.] Univ Penn, Dept Med & Pharmacol, Philadelphia, PA 19104 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Pennsylvania	Zhou, WS (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA.	weisong.zhou@vanderbilt.edu			National Institute of Health [R56 AI076411, R01 AI 070672, R01 AI 059108, GM 015431, F32 HL091653]; Veteran Affairs [1I01BX000624]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL091653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070672, R56AI076411, R01AI059108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000624] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by National Institute of Health grants R56 AI076411, R01 AI 070672, R01 AI 059108, GM 015431, F32 HL091653 and Veteran Affairs grant 1I01BX000624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SP, 2009, AM J PHYSIOL-HEART C, V296, pH1617, DOI 10.1152/ajpheart.01226.2008; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; DANIEL VC, 1994, J CHROMATOGR B, V653, P117, DOI 10.1016/0378-4347(93)E0432-P; Galie N, 2001, CLIN CHEST MED, V22, P529, DOI 10.1016/S0272-5231(05)70289-6; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hashimoto K, 2004, J VIROL, V78, P10303, DOI 10.1128/JVI.78.19.10303-10309.2004; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Idzko M, 2007, J CLIN INVEST, V117, P464, DOI 10.1172/JCI28949; Iniguez Miguel A., 2008, Archives of Physiology and Biochemistry, V114, P201, DOI [10.1080/13813450802180882, 10.1080/13813450802180882 ]; Jaffar Z, 2002, J IMMUNOL, V169, P5997, DOI 10.4049/jimmunol.169.10.5997; Jaffar Z, 2007, J IMMUNOL, V179, P6193, DOI 10.4049/jimmunol.179.9.6193; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106; Li H, 2011, AM J RESP CRIT CARE, V184, P37, DOI 10.1164/rccm.201010-1637OC; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Momcilovic M, 2008, NEUROSCI LETT, V447, P148, DOI 10.1016/j.neulet.2008.09.082; Nagao K, 2003, AM J RESP CELL MOL, V29, P314, DOI 10.1165/rcmb.2003-0035OC; Napolitani G, 2009, EUR J IMMUNOL, V39, P1301, DOI 10.1002/eji.200838969; Newcomb DC, 2009, J IMMUNOL, V182, P5317, DOI 10.4049/jimmunol.0803868; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Sheibanie AF, 2004, FASEB J, V18, P1318, DOI 10.1096/fj.03-1367fje; Sheibanie AF, 2007, ARTHRITIS RHEUM-US, V56, P2608, DOI 10.1002/art.22794; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhou WS, 2007, J LEUKOCYTE BIOL, V81, P809, DOI 10.1189/jlb.0606375; Zhou WS, 2007, J IMMUNOL, V178, P702, DOI 10.4049/jimmunol.178.2.702	41	20	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e33518	10.1371/journal.pone.0033518	http://dx.doi.org/10.1371/journal.pone.0033518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590492	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400002
J	Miller-Coleman, RL; Dodsworth, JA; Ross, CA; Shock, EL; Williams, AJ; Hartnett, HE; McDonald, AI; Havig, JR; Hedlund, BP				Miller-Coleman, Robin L.; Dodsworth, Jeremy A.; Ross, Christian A.; Shock, Everett L.; Williams, Amanda J.; Hartnett, Hilairy E.; McDonald, Austin I.; Havig, Jeff R.; Hedlund, Brian P.			Korarchaeota Diversity, Biogeography, and Abundance in Yellowstone and Great Basin Hot Springs and Ecological Niche Modeling Based on Machine Learning	PLOS ONE			English	Article							EAST PACIFIC RISE; NATIONAL-PARK; ARCHAEAL DIVERSITY; PHYLOGENETIC DIVERSITY; BACTERIAL COMMUNITIES; HYDROTHERMAL SYSTEM; MICROBIAL DIVERSITY; AQUEOUS-SOLUTION; THERMAL SPRINGS; METAL-IONS	Over 100 hot spring sediment samples were collected from 28 sites in 12 areas/regions, while recording as many coincident geochemical properties as feasible (>60 analytes). PCR was used to screen samples for Korarchaeota 16S rRNA genes. Over 500 Korarchaeota 16S rRNA genes were screened by RFLP analysis and 90 were sequenced, resulting in identification of novel Korarchaeota phylotypes and exclusive geographical variants. Korarchaeota diversity was low, as in other terrestrial geothermal systems, suggesting a marine origin for Korarchaeota with subsequent niche-invasion into terrestrial systems. Korarchaeota endemism is consistent with endemism of other terrestrial thermophiles and supports the existence of dispersal barriers. Korarchaeota were found predominantly in >55 degrees C springs at pH 4.7-8.5 at concentrations up to 6.6x10(6) 16S rRNA gene copies g(-1) wet sediment. In Yellowstone National Park (YNP), Korarchaeota were most abundant in springs with a pH range of 5.7 to 7.0. High sulfate concentrations suggest these fluids are influenced by contributions from hydrothermal vapors that may be neutralized to some extent by mixing with water from deep geothermal sources or meteoric water. In the Great Basin (GB), Korarchaeota were most abundant at spring sources of pH, 7.2 with high particulate C content and high alkalinity, which are likely to be buffered by the carbonic acid system. It is therefore likely that at least two different geological mechanisms in YNP and GB springs create the neutral to mildly acidic pH that is optimal for Korarchaeota. A classification support vector machine (C-SVM) trained on single analytes, two analyte combinations, or vectors from non-metric multidimensional scaling models was able to predict springs as Korarchaeota-optimal or sub-optimal habitats with accuracies up to 95%. To our knowledge, this is the most extensive analysis of the geochemical habitat of any high-level microbial taxon and the first application of a C-SVM to microbial ecology.	[Miller-Coleman, Robin L.; Dodsworth, Jeremy A.; Ross, Christian A.; Williams, Amanda J.; McDonald, Austin I.; Hedlund, Brian P.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Shock, Everett L.; Hartnett, Hilairy E.; Havig, Jeff R.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Shock, Everett L.; Hartnett, Hilairy E.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Miller-Coleman, RL (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	brian.hedlund@unlv.edu		Hedlund, Brian/0000-0001-8530-0448; Dodsworth, Jeremy/0000-0003-2014-5488; McDonald, Austin/0000-0002-3161-5388; Havig, Jeff/0000-0002-1326-3382; Hartnett, Hilairy/0000-0003-0736-7844; Shock, Everett/0000-0002-4283-0163; Ross, Paige/0000-0002-4157-3951	National Science Foundation [EPS-9977809, MCB-0546865]; start-up funds from the University of Nevada Las Vegas; National Institutes of Health from the National Center for Research Resources, a component of the National Institutes of Health [_P20 RR016464_]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; Office Of Internatl Science &Engineering [0968421] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); start-up funds from the University of Nevada Las Vegas; National Institutes of Health from the National Center for Research Resources, a component of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Science Foundation Grant Numbers EPS-9977809, MCB-0546865, and start-up funds from the University of Nevada Las Vegas to BPH. CAR, AIM and the Nevada Genomics Center were supported by National Institutes of Health Grant Number_P20 RR016464_ from the National Center for Research Resources, a component of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, BROCK BIOL MICROORGA; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Auchtung TA, 2006, APPL ENVIRON MICROB, V72, P5077, DOI 10.1128/AEM.00052-06; Auchtung TA, 2011, EXTREMOPHILES, V15, P105, DOI 10.1007/s00792-010-0340-5; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Boyd ES, 2010, ISME J, V4, P1485, DOI 10.1038/ismej.2010.76; Brock T.D., 1966, PRINCIPLES MICROBIAL; BROCK TD, 1971, GEOL SOC AM BULL, V82, P1393, DOI 10.1130/0016-7606(1971)82[1393:BDOPVO]2.0.CO;2; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Burggraf S, 1997, NATURE, V385, P780, DOI 10.1038/385780a0; Byvatov E, 2003, J CHEM INF COMP SCI, V43, P1882, DOI 10.1021/ci0341161; Chang C.-C., LIBSVM LIB SUPPORT V; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Dyer JA, 1998, ENVIRON PROG, V17, P1, DOI 10.1002/ep.670170112; Ehrhardt CJ, 2007, ENVIRON MICROBIOL, V9, P900, DOI 10.1111/j.1462-2920.2006.01211.x; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; FARRAR CD, 1995, NATURE, V376, P675, DOI 10.1038/376675a0; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRY B, 1992, ANAL CHEM, V64, P288, DOI 10.1021/ac00027a009; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Goni MA, 2006, ESTUAR COAST SHELF S, V69, P225, DOI 10.1016/j.ecss.2006.04.012; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; HEDLUND BP, 2003, MICROBIAL DIVERSITY, P225; Hirayama H, 2007, APPL ENVIRON MICROB, V73, P7642, DOI 10.1128/AEM.01258-07; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Johnson DB, 2001, ENVIRON MICROBIOL, V3, P630, DOI 10.1046/j.1462-2920.2001.00234.x; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marteinsson VT, 2001, APPL ENVIRON MICROB, V67, P827, DOI 10.1128/AEM.67.2.827-833.2001; Mathur J, 2007, APPL ENVIRON MICROB, V73, P2612, DOI 10.1128/AEM.02567-06; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Nakagawa S, 2005, FEMS MICROBIOL ECOL, V54, P141, DOI 10.1016/j.femsec.2005.03.007; Nakagawa T, 2004, FEMS MICROBIOL LETT, V232, P145, DOI 10.1016/S0378-1097(04)00044-8; Navarro J, 2009, MICROB ECOL, V57, P307, DOI 10.1007/s00248-008-9426-3; Nercessian O, 2003, ENVIRON MICROBIOL, V5, P492, DOI 10.1046/j.1462-2920.2003.00437.x; Nordstrom DK, 2009, APPL GEOCHEM, V24, P191, DOI 10.1016/j.apgeochem.2008.11.019; Palumbo AV, 2004, APPL ENVIRON MICROB, V70, P6525, DOI 10.1128/AEM.70.11.6525-6534.2004; Reigstad LJ, 2010, ISME J, V4, P346, DOI 10.1038/ismej.2009.126; Reysenbach AL, 2000, EXTREMOPHILES, V4, P61, DOI 10.1007/s007920050008; Rha SY, 2009, INT J ONCOL, V34, P837, DOI 10.3892/ijo_00000210; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rogers KL, 2005, GEOBIOLOGY, V3, P319, DOI 10.1111/j.1472-4669.2006.00064.x; Ross C, 2006, PLANT MOL BIOL, V62, P233, DOI 10.1007/s11103-006-9017-y; Schramm A, 2009, CANCER LETT, V282, P55, DOI 10.1016/j.canlet.2009.02.052; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shock EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4005, DOI 10.1016/j.gca.2009.08.036; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Skirnisdottir S, 2000, APPL ENVIRON MICROB, V66, P2835, DOI 10.1128/AEM.66.7.2835-2841.2000; SMITH AE, 1973, ANALYST, V98, P65, DOI 10.1039/an9739800065; SMITH AE, 1973, ANALYST, V98, P209, DOI 10.1039/an9739800209; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Takacs-Vesbach C, 2008, ENVIRON MICROBIOL, V10, P1681, DOI 10.1111/j.1462-2920.2008.01584.x; Takai K, 1999, FEMS MICROBIOL ECOL, V28, P177, DOI 10.1111/j.1574-6941.1999.tb00573.x; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Vick TJ, 2010, GEOBIOLOGY, V8, P140, DOI 10.1111/j.1472-4669.2009.00228.x; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Zehner R.E., 2006, GEOTHERMAL RESOURCES, V30, P117	65	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35964	10.1371/journal.pone.0035964	http://dx.doi.org/10.1371/journal.pone.0035964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574130	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800026
J	Ohara, K; Enomoto, A; Kato, T; Hashimoto, T; Isotani-Sakakibara, M; Asai, N; Ishida-Takagishi, M; Weng, L; Nakayama, M; Watanabe, T; Kato, K; Kaibuchi, K; Murakumo, Y; Hirooka, Y; Goto, H; Takahashi, M				Ohara, Kei; Enomoto, Atsushi; Kato, Takuya; Hashimoto, Takahiko; Isotani-Sakakibara, Mayu; Asai, Naoya; Ishida-Takagishi, Maki; Weng, Liang; Nakayama, Masanori; Watanabe, Takashi; Kato, Katsuhiro; Kaibuchi, Kozo; Murakumo, Yoshiki; Hirooka, Yoshiki; Goto, Hidemi; Takahashi, Masahide			Involvement of Girdin in the Determination of Cell Polarity during Cell Migration	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; G-ALPHA-I; TIGHT JUNCTION; PAR PROTEINS; COMPLEX; AKT; ACTIVATION; CANCER; ROLES; GIV	Cell migration is a critical cellular process that determines embryonic development and the progression of human diseases. Therefore, cell- or context-specific mechanisms by which multiple promigratory proteins differentially regulate cell migration must be analyzed in detail. Girdin (girders of actin filaments) (also termed GIV,G alpha-interacting vesicle associated protein) is an actin-binding protein that regulates migration of various cells such as endothelial cells, smooth muscle cells, neuroblasts, and cancer cells. Here we show that Girdin regulates the establishment of cell polarity, the deregulation of which may result in the disruption of directional cell migration. We found that Girdin interacts with Par-3, a scaffolding protein that is a component of the Par protein complex that has an established role in determining cell polarity. RNA interference-mediated depletion of Girdin leads to impaired polarization of fibroblasts and mammary epithelial cells in a way similar to that observed in Par-3-depleted cells. Accordingly, the expression of Par- 3 mutants unable to interact with Girdin abrogates cell polarization in fibroblasts. Further biochemical analysis suggests that Girdin is present in the Par protein complex that includes Par-3, Par-6, and atypical protein kinase C. Considering previous reports showing the role of Girdin in the directional migration of neuroblasts, network formation of endothelial cells, and cancer invasion, these data may provide a specific mechanism by which Girdin regulates cell movement in biological contexts that require directional cell movement.	[Ohara, Kei; Enomoto, Atsushi; Kato, Takuya; Hashimoto, Takahiko; Isotani-Sakakibara, Mayu; Asai, Naoya; Ishida-Takagishi, Maki; Weng, Liang; Murakumo, Yoshiki; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan; [Ohara, Kei; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol, Nagoya, Aichi 4648601, Japan; [Enomoto, Atsushi; Asai, Naoya; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Pathol, Nagoya, Aichi 4648601, Japan; [Nakayama, Masanori; Watanabe, Takashi; Kato, Katsuhiro; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4648601, Japan; [Kaibuchi, Kozo] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Hirooka, Yoshiki; Goto, Hidemi] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Ohara, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan.	enomoto@iar.nagoya-u.ac.jp; mtakaha@med.nagoya-u.ac.jp	TAKAHASHI, Masahide/I-7244-2014; Weng, Liang/B-8451-2016; Kaibuchi, Kozo/M-4887-2014; ASAI, Naoya/I-7377-2014; Hirooka, Yoshiki/I-7351-2014; Takahashi, Masahide/AAN-4770-2020; Kato, Katsuhiro/AAV-8356-2020; Enomoto, Atsushi/I-7272-2014	Kaibuchi, Kozo/0000-0003-0714-1992; Hirooka, Yoshiki/0000-0001-9639-7425; Takahashi, Masahide/0000-0002-2803-2683; Enomoto, Atsushi/0000-0002-9206-6116; Weng, Liang/0000-0001-7058-8274; Watanabe, Takashi/0000-0002-9015-5246; Takagishi, Maki/0000-0002-6745-3982	Program for Improvement of Research Environment for Young Researchers; Special Coordination Funds for Promoting Science and Technology (SCF); Naito Foundation;  [23249020];  [22117005]; Grants-in-Aid for Scientific Research [23249020, 22117005] Funding Source: KAKEN	Program for Improvement of Research Environment for Young Researchers; Special Coordination Funds for Promoting Science and Technology (SCF)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Global Center of Excellence (GCOE) Research, Scientific Research (A) (23249020), a Grant-in-Aid for Scientific Research on Innovative Areas (22117005) (to MT), the Program for Improvement of Research Environment for Young Researchers, Special Coordination Funds for Promoting Science and Technology (SCF) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to AE), and the Naito Foundation (to AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2006, ANN NY ACAD SCI, V1086, P169, DOI 10.1196/annals.1377.016; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Insolera R, 2011, DEV NEUROBIOL, V71, P483, DOI 10.1002/dneu.20867; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kunnev D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-318; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lin CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002049; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Natsume A, 2012, ONCOGENE IN PRESS; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Wang Y, 2011, J NEUROSCI, V31, P8109, DOI 10.1523/JNEUROSCI.1130-11.2011; Weng L, 2010, CANCER SCI, V101, P836, DOI 10.1111/j.1349-7006.2010.01487.x; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Zen K, 2009, ONCOGENE, V28, P2910, DOI 10.1038/onc.2009.148	63	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36681	10.1371/journal.pone.0036681	http://dx.doi.org/10.1371/journal.pone.0036681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574214	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349800111
J	Paraskevopoulos, E; Kuchenbuch, A; Herholz, SC; Pantev, C				Paraskevopoulos, Evangelos; Kuchenbuch, Anja; Herholz, Sibylle C.; Pantev, Christo			Evidence for Training-Induced Plasticity in Multisensory Brain Structures: An MEG Study	PLOS ONE			English	Article							MISMATCH-NEGATIVITY MMN; AUDITORY-CORTEX; MUSIC; NEUROSCIENCE; INFORMATION; PERCEPTION; SPEECH	Multisensory learning and resulting neural brain plasticity have recently become a topic of renewed interest in human cognitive neuroscience. Music notation reading is an ideal stimulus to study multisensory learning, as it allows studying the integration of visual, auditory and sensorimotor information processing. The present study aimed at answering whether multisensory learning alters uni-sensory structures, interconnections of uni-sensory structures or specific multisensory areas. In a short-term piano training procedure musically naive subjects were trained to play tone sequences from visually presented patterns in a music notation-like system [Auditory-Visual-Somatosensory group (AVS)], while another group received audio-visual training only that involved viewing the patterns and attentively listening to the recordings of the AVS training sessions [Auditory-Visual group (AV)]. Training-related changes in cortical networks were assessed by pre- and post-training magnetoencephalographic (MEG) recordings of an auditory, a visual and an integrated audio-visual mismatch negativity (MMN). The two groups (AVS and AV) were differently affected by the training. The results suggest that multisensory training alters the function of multisensory structures, and not the uni-sensory ones along with their interconnections, and thus provide an answer to an important question presented by cognitive models of multisensory training.	[Paraskevopoulos, Evangelos; Kuchenbuch, Anja; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Herholz, Sibylle C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	University of Munster; McGill University	Paraskevopoulos, E (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	pantev@uni-muenster.de		Paraskevopoulos, Evangelos/0000-0003-4063-4182	Deutsche Forschungsgemeinschaft [PA392/12-2, HE6067-1/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [PA392/12-2 and HE6067-1/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 1999, PSYCHOPHYSIOLOGY, V36, P737, DOI 10.1111/1469-8986.3660737; Bocquillon P, 2011, CLIN NEUROPHYSIOLOGY; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Davis KD, 2000, J NEUROPHYSIOL, V83, P3575, DOI 10.1152/jn.2000.83.6.3575; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lappe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021493; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; Marco-Pallares J, 2005, NEUROIMAGE, V25, P471, DOI 10.1016/j.neuroimage.2004.11.028; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1995, EAR HEARING, V16, P6; Naatanen R, 2008, INT J AUDIOL, V47, pS16, DOI 10.1080/14992020802340116; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park HJ, 2002, HUM BRAIN MAPP, V17, P168, DOI 10.1002/hbm.10059; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Sadato N, 2005, NEUROSCIENTIST, V11, P577, DOI 10.1177/1073858405277314; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; Urakawa T, 2010, PSYCHOPHYSIOLOGY, V47, P905, DOI 10.1111/j.1469-8986.2010.00987.x; von Kriegstein K, 2006, PLOS BIOL, V4, P1809, DOI 10.1371/journal.pbio.0040326; Waberski TD, 2001, NEUROSCI LETT, V308, P107, DOI 10.1016/S0304-3940(01)01988-7; Widmann A, 2004, PSYCHOPHYSIOLOGY, V41, P709, DOI 10.1111/j.1469-8986.2004.00208.x; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I; Yumoto M, 2005, NEUROREPORT, V16, P1175, DOI 10.1097/00001756-200508010-00008; Yumoto M, 2005, NEUROREPORT, V16, P803, DOI 10.1097/00001756-200505310-00005; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	39	30	31	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36534	10.1371/journal.pone.0036534	http://dx.doi.org/10.1371/journal.pone.0036534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VF	22570723	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343400039
J	Mohammad, I; Arora, PD; Naghibzadeh, Y; Wang, YQ; Li, J; Mascarenhas, W; Janmey, PA; Dawson, JF; McCulloch, CA				Mohammad, Ibrahim; Arora, Pamma D.; Naghibzadeh, Yeganeh; Wang, Yongqiang; Li, Jeff; Mascarenhas, Wendall; Janmey, Paul A.; Dawson, John F.; McCulloch, Christopher A.			Flightless I is a focal adhesion-associated actin-capping protein that regulates cell migration	FASEB JOURNAL			English	Article						connective tissue; actin-binding proteins; wound healing; collagen; integrins; vinculin	LEUCINE-RICH REPEAT; COLLAGEN PHAGOCYTOSIS; INTERFERENCE-REFLECTION; BINDING PROTEIN; GELSOLIN-LIKE; FIBROBLASTS; FILAMIN; ACTIVATION; INTEGRINS; TALIN	The role of adhesion-associated actin-binding proteins in cell migration is not well defined. In mouse fibroblasts we screened for focal adhesion-associated proteins that were isolated with collagen-coated beads and detected by tandem mass spectrometry. We identified flightless I (FliI) as an actin-binding protein in focal adhesion fractions, which was verified by immuno-blotting. By confocal microscopy most FliI was distributed throughout the cytosol and in focal adhesions. By sedimentation assays and in vitro binding assays, we found that FliI associates with actin filaments and actin monomers. Assays using purified proteins showed that FliI inhibits actin polymerization and caps but does not sever actin filaments. Cells with FliI knockdown or cells overexpressing FliI migrated more or less rapidly, respectively, than wild-type controls. Compared with controls, cells with FliI knockdown were less adherent than wild-type cells, exhibited reduced numbers of focal adhesions containing activated beta 1 integrins and vinculin, and exhibited increased incorporation of actin monomers into nascent filaments at focal adhesions. These data indicate that FliI regulates cell migration through its localization to focal adhesions and its ability to cap actin filaments, which collectively affect focal adhesion maturation.-Mohammad, I., Arora, P. D., Naghibzadeh, Y., Wang, Y., Li, J., Mascarenhas, W., Janmey, P. A., Dawson, J. F., McCulloch, C. A. Flightless I is a focal adhesion-associated actin-capping protein that regulates cell migration. FASEB J. 26, 3260-3272 (2012). www.fasebj.org	[Mohammad, Ibrahim; Arora, Pamma D.; Naghibzadeh, Yeganeh; Wang, Yongqiang; Li, Jeff; Mascarenhas, Wendall; McCulloch, Christopher A.] Univ Toronto, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada; [Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Dawson, John F.] Univ Guelph, Guelph, ON N1G 2W1, Canada	University of Toronto; University of Pennsylvania; Pennsylvania Medicine; University of Guelph	McCulloch, CA (corresponding author), Univ Toronto, Matrix Dynam Grp, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca	Dawson, John/HDM-6702-2022		Canadian Institutes of Health Research operating grant [MOP-36322]; Ontario Heart and Stroke Foundation grant [T-6022]; Canada Research Chair	Canadian Institutes of Health Research operating grant(Canadian Institutes of Health Research (CIHR)); Ontario Heart and Stroke Foundation grant; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by Canadian Institutes of Health Research operating grant MOP-36322 and Ontario Heart and Stroke Foundation grant T-6022 to C.A.M., who is also supported by a Canada Research Chair (tier 1). Mouse FliI cDNA was provided by Dr. J. Yuan (Department of Cell Biology, Harvard Medical School, Boston, MA, USA).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Abreu MTH, 2008, AM J PHYSIOL-CELL PH, V294, pC931, DOI 10.1152/ajpcell.00359.2007; Adams DH, 2008, INT J BIOCHEM CELL B, V40, P1555, DOI 10.1016/j.biocel.2007.11.024; Alberts B, 2002, MOL BIOL CELL; ALLEN PG, 1994, J BIOL CHEM, V269, P32916; Arora PD, 2008, MOL BIOL CELL, V19, P5032, DOI 10.1091/mbc.E08-04-0430; Arora PD, 2004, MOL BIOL CELL, V15, P588, DOI 10.1091/mbc.E03-07-0468; Arora PD, 1996, J BIOL CHEM, V271, P20516, DOI 10.1074/jbc.271.34.20516; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Chong SAC, 2007, J BIOL CHEM, V282, P8510, DOI 10.1074/jbc.M609859200; Cowin AJ, 2007, J PATHOL, V211, P572, DOI 10.1002/path.2143; CUNNINGHAM CC, 1991, SCIENCE, V251, P1233, DOI 10.1126/science.1848726; Darzynkiewicz Zbigniew, 2004, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0507s60; Davy DA, 2001, J CELL SCI, V114, P549; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dzamba B. J., 2001, CELL ADHESION INTEGR; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Glogauer M, 1997, J CELL SCI, V110, P11; Goshima M, 1999, BIOCHEM BIOPH RES CO, V257, P111, DOI 10.1006/bbrc.1999.0420; HEATH JP, 1978, J CELL SCI, V29, P197; Higashi T, 2010, J BIOL CHEM, V285, P16231, DOI 10.1074/jbc.M109.079236; IZZARD CS, 1976, J CELL SCI, V21, P129; JACOBSON K, 1984, P NATL ACAD SCI-BIOL, V81, P6747, DOI 10.1073/pnas.81.21.6747; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2008, EXP CELL RES, V314, P834, DOI 10.1016/j.yexcr.2007.11.022; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Kligys K, 2009, J INVEST DERMATOL, V129, P1856, DOI 10.1038/jid.2009.171; Kopecki Z, 2011, J INVEST DERMATOL, V131, P1450, DOI 10.1038/jid.2011.69; Kopecki Z, 2009, J INVEST DERMATOL, V129, P2031, DOI 10.1038/jid.2008.461; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Liu YT, 1998, J BIOL CHEM, V273, P7920, DOI 10.1074/jbc.273.14.7920; Meyer SC, 1998, J BIOL CHEM, V273, P3013, DOI 10.1074/jbc.273.5.3013; Morrison SS, 2007, ANAL BIOCHEM, V364, P159, DOI 10.1016/j.ab.2007.02.027; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pedersen SF, 1999, EXP CELL RES, V252, P63, DOI 10.1006/excr.1999.4615; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; SUN HQ, 1995, CURR OPIN CELL BIOL, V7, P102, DOI 10.1016/0955-0674(95)80051-4; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409; Yuen A, 2010, MATRIX BIOL, V29, P537, DOI 10.1016/j.matbio.2010.04.004; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Ziegler WH, 2008, BIOCHEM SOC T, V36, P235, DOI 10.1042/BST0360235	61	23	24	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3260	3272		10.1096/fj.11-202051	http://dx.doi.org/10.1096/fj.11-202051			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22581781				2022-12-25	WOS:000307162800017
J	Trattnig, SM; Harpsoe, K; Thygesen, SB; Rahr, LM; Ahring, PK; Balle, T; Jensen, AA				Trattnig, Sarah M.; Harpsoe, Kasper; Thygesen, Sarah B.; Rahr, Louise M.; Ahring, Philip K.; Balle, Thomas; Jensen, Anders A.			Discovery of a Novel Allosteric Modulator of 5-HT3 Receptors INHIBITION AND POTENTIATION OF CYS-LOOP RECEPTOR SIGNALING THROUGH A CONSERVED TRANSMEMBRANE INTERSUBUNIT SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; X-RAY-STRUCTURE; GLYCINE RECEPTOR; FUNCTIONAL-CHARACTERIZATION; GENERAL-ANESTHETICS; GABA(A) RECEPTORS; LIGAND-BINDING; ACTIVATION; IVERMECTIN; PHARMACOLOGY	The ligand-gated ion channels in the Cys-loop receptor superfamily mediate the effects of neurotransmitters acetylcholine, serotonin, GABA, and glycine. Cys-loop receptor signaling is susceptible to modulation by ligands acting through numerous allosteric sites. Here we report the discovery of a novel class of negative allosteric modulators of the 5-HT3 receptors (5-HT(3)Rs). PU02 (6-[(1-naphthylmethyl)thio]-9H-purine) is a potent and selective antagonist displaying IC50 values of similar to 1 mu M at 5-HT(3)Rs and substantially lower activities at other Cys-loop receptors. In an elaborate mutagenesis study of the 5-HT(3)A receptor guided by a homology model, PU02 is demonstrated to act through a transmembrane intersubunit site situated in the upper three helical turns of TM2 and TM3 in the (+)-subunit and TM1 and TM2 in the (+)-subunit. The Ser(248), Leu(288), Ile(290), Thr(294), and Gly(306) residues are identified as important molecular determinants of PU02 activity with minor contributions from Ser(292) and Val(310), and we propose that the naphthalene group of PU02 docks into the hydrophobic cavity formed by these. Interestingly, specific mutations of Ser(248), Thr(294), and Gly(306) convert PU02 into a complex modulator, potentiating and inhibiting 5-HT-evoked signaling through these mutants at low and high concentrations, respectively. The PU02 binding site in the 5-HT3R corresponds to allosteric sites in anionic Cysloop receptors, which emphasizes the uniform nature of the molecular events underlying signaling through the receptors. Moreover, the dramatic changes in the functional properties of PU02 induced by subtle changes in its binding site bear witness to the delicate structural discrimination between allosteric inhibition and potentiation of Cys-loop receptors.	[Trattnig, Sarah M.; Harpsoe, Kasper; Thygesen, Sarah B.; Rahr, Louise M.; Balle, Thomas; Jensen, Anders A.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Ahring, Philip K.] NeuroSearch AS, DK-2750 Ballerup, Denmark	University of Copenhagen	Jensen, AA (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Univ Pk 2, DK-2100 Copenhagen, Denmark.	aaj@farma.ku.dk	Harpsøe, Kasper/V-6870-2018; Jensen, Anders/AAJ-3335-2020	Harpsøe, Kasper/0000-0002-9326-9644; Jensen, Anders/0000-0002-7927-5052; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350	Lundbeck Foundation; Carlsberg Foundation; Drug Research Academy; FARMA; University of Copenhagen; Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation [R31-2008-2516] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); Drug Research Academy; FARMA; University of Copenhagen; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Lundbeck Foundation (to S. M. T., T. B., and A. A. J.), the Carlsberg Foundation (to K. H. and A. A. J.), the Drug Research Academy, FARMA, University of Copenhagen (to K. H. and T. B.), the Danish Medical Research Council (to A. A. J.), and the Novo Nordisk Foundation (to A. A. J.). Part of this work was presented in the form of a poster by S. M. T. at the Society of Neuroscience conference in San Diego, November 13-17, 2010.	ADODRA S, 1995, BRIT J PHARMACOL, V115, P953, DOI 10.1111/j.1476-5381.1995.tb15903.x; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Barann M, 2000, N-S ARCH PHARMACOL, V362, P255, DOI 10.1007/s002100000288; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2010, BBA-BIOMEMBRANES, V1798, P1608, DOI 10.1016/j.bbamem.2010.04.014; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Christensen JK, 2004, J PHARMACOL EXP THER, V309, P1003, DOI 10.1124/jpet.103.062794; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Davies PA, 2011, CURR OPIN PHARMACOL, V11, P75, DOI 10.1016/j.coph.2011.01.010; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Feuerbach D, 2005, NEUROPHARMACOLOGY, V48, P215, DOI 10.1016/j.neuropharm.2004.10.003; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Hsiao B, 2006, MOL PHARMACOL, V69, P27, DOI 10.1124/mol.105.015164; Hsiao B, 2001, J NEUROSCI, V21, P1848, DOI 10.1523/JNEUROSCI.21-06-01848.2001; Jensen AA, 2004, BIOCHEM PHARMACOL, V67, P1789, DOI 10.1016/j.bcp.2003.12.037; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Jensen AA, 2008, TRENDS PHARMACOL SCI, V29, P437, DOI 10.1016/j.tips.2008.06.001; Jensen AA, 2007, J MED CHEM, V50, P4616, DOI 10.1021/jm070574f; Jorgensen CG, 2011, CHEMMEDCHEM, V6, P725, DOI 10.1002/cmdc.201000444; Karadsheh MS, 2004, J NEUROCHEM, V91, P1138, DOI 10.1111/j.1471-4159.2004.02801.x; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Krzywkowski K, 2008, P NATL ACAD SCI USA, V105, P722, DOI 10.1073/pnas.0708454105; Krzywkowski K, 2007, PHARMACOGENET GENOM, V17, P255, DOI 10.1097/FPC.0b013e3280117269; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lochner M, 2010, BIOPHYS J, V98, P1494, DOI 10.1016/j.bpj.2009.12.4313; Madsen C, 2007, J MED CHEM, V50, P4147, DOI 10.1021/jm070447j; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2008, NAT STRUCT MOL BIOL, V15, P1084, DOI 10.1038/nsmb.1492; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pistis M, 1997, BRIT J PHARMACOL, V122, P1707, DOI 10.1038/sj.bjp.0701563; Rojas C, 2008, ANESTH ANALG, V107, P469, DOI 10.1213/ane.0b013e318172fa74; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Thompson AJ, 2011, J PHYSIOL-LONDON, V589, P4243, DOI 10.1113/jphysiol.2011.208439; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	58	26	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25241	25254		10.1074/jbc.M112.360370	http://dx.doi.org/10.1074/jbc.M112.360370			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22589534	Green Published, hybrid			2022-12-25	WOS:000306651700033
J	Milbradt, J; Auerochs, S; Sevvana, M; Muller, YA; Sticht, H; Marschall, M				Milbradt, Jens; Auerochs, Sabrina; Sevvana, Madhumati; Muller, Yves A.; Sticht, Heinrich; Marschall, Manfred			Specific Residues of a Conserved Domain in the N Terminus of the Human Cytomegalovirus pUL50 Protein Determine Its Intranuclear Interaction with pUL53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; SIMPLEX-VIRUS 1; NUCLEAR EGRESS COMPLEX; MEMBRANE CURVATURE; U(L)34 PROTEIN; VIRAL-PROTEINS; LAMINA; REPLICATION; ENVELOPMENT; UL34	Herpesviral capsids are assembled in the host cell nucleus and are subsequently translocated to the cytoplasm. During this process it has been demonstrated that the human cytomegalovirus proteins pUL50 and pUL53 interact and form, together with other viral and cellular proteins, the nuclear egress complex at the nuclear envelope. In this study we provide evidence that specific residues of a conserved N-terminal region of pUL50 determine its intranuclear interaction with pUL53. In silico evaluation and biophysical analyses suggested that the conserved region forms a regular secondary structure adopting a globular fold. Importantly, site-directed replacement of individual amino acids by alanine indicated a strong functional influence of specific residues inside this globular domain. In particular, mutation of the widely conserved residues Glu-56 or Tyr-57 led to a loss of interaction with pUL53. Consistent with the loss of binding properties, mutants E56A and Y57A showed a defective function in the recruitment of pUL53 to the nuclear envelope in expression plasmid-transfected and human cyto-megalovirus-infected cells. In addition, in silico analysis suggested that residues 3-20 form an amphipathic alpha-helix that appears to be conserved among Herpesviridae. Point mutants revealed a structural role of this N-terminal alpha-helix for pUL50 stability rather than a direct role in the binding of pUL53. In contrast, the central part of the globular domain including Glu-56 and Tyr-57 is directly responsible for the functional interaction with pUL53 and thus determines formation of the basic nuclear egress complex.	[Milbradt, Jens; Auerochs, Sabrina; Marschall, Manfred] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Div Biotechnol, D-91054 Erlangen, Germany; [Sevvana, Madhumati; Muller, Yves A.] Univ Erlangen Nurnberg, Dept Biol, Div Bioinformat, D-91054 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Milbradt, J (corresponding author), Schlossgarten 4, D-91054 Erlangen, Germany.	jens.milbradt@viro.med.uni-erlangen.de	Muller, Yves A/R-5397-2016; Sevvana, Madhumati/S-3297-2019	Muller, Yves A/0000-0003-0519-8928; Sevvana, Madhumati/0000-0003-4992-6296; Milbradt, Jens/0000-0003-2172-7471; Sticht, Heinrich/0000-0001-5644-045X	Deutsche Forschungsgemeinschaft [MA 1289/6-1, 7-1];  [SFB796]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by SFB796 Subprojects A2, A3, B3, C3, and Z as well as Deutsche Forschungsgemeinschaft MA 1289/6-1 and 7-1.	Bjerke SL, 2003, J VIROL, V77, P7601, DOI 10.1128/JVI.77.13.7601-7610.2003; Bubeck A, 2004, J VIROL, V78, P8026, DOI 10.1128/JVI.78.15.8026-8035.2004; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Buser C, 2007, J VIROL, V81, P3042, DOI 10.1128/JVI.01564-06; Camozzi D, 2008, J GEN VIROL, V89, P731, DOI 10.1099/vir.0.83377-0; Chen DH, 1999, VIROLOGY, V260, P10, DOI 10.1006/viro.1999.9791; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Fuchs W, 2002, J VIROL, V76, P364, DOI 10.1128/JVI.76.1.364-378.2002; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Haugo AC, 2011, J VIROL, V85, P7203, DOI 10.1128/JVI.00262-11; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Klupp BG, 2007, P NATL ACAD SCI USA, V104, P7241, DOI 10.1073/pnas.0701757104; Lake CM, 2004, VIROLOGY, V320, P99, DOI 10.1016/j.virol.2003.11.018; Lee CP, 2010, REV MED VIROL, V20, P214, DOI 10.1002/rmv.643; Liang L, 2005, J VIROL, V79, P3797, DOI 10.1128/JVI.79.6.3797-3806.2005; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lotzerich M, 2006, J VIROL, V80, P73, DOI 10.1128/JVI.80.1.73-84.2006; Marschall M, 2011, ADV VIRUS RES, V80, P69, DOI 10.1016/B978-0-12-385987-7.00004-X; Mettenleiter TC, 2006, VET MICROBIOL, V113, P163, DOI 10.1016/j.vetmic.2005.11.040; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Milbradt J, 2007, J GEN VIROL, V88, P2642, DOI 10.1099/vir.0.82924-0; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Mou F, 2009, J VIROL, V83, P5181, DOI 10.1128/JVI.00090-09; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; Roller RJ, 2011, J VIROL, V85, P11615, DOI 10.1128/JVI.05730-11; Roller RJ, 2010, J VIROL, V84, P3921, DOI 10.1128/JVI.01638-09; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sam MD, 2009, J VIROL, V83, P2996, DOI 10.1128/JVI.02441-08; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sanchez V, 2002, SCIENCE, V297, P778, DOI 10.1126/science.1075102; Schregel V, 2007, J GEN VIROL, V88, P395, DOI 10.1099/vir.0.82393-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	44	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					24004	24016		10.1074/jbc.M111.331207	http://dx.doi.org/10.1074/jbc.M111.331207			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589554	hybrid, Green Published			2022-12-25	WOS:000306511300069
J	Iyoda, T; Zhang, FQ; Sun, LS; Hao, F; Schmitz-Peiffer, C; Xu, XM; Cui, MZ				Iyoda, Takuya; Zhang, Fuqiang; Sun, Longsheng; Hao, Feng; Schmitz-Peiffer, Carsten; Xu, Xuemin; Cui, Mei-Zhen			Lysophosphatidic Acid Induces Early Growth Response-1 (Egr-1) Protein Expression via Protein Kinase C delta-regulated Extracellular Signal-regulated Kinase (ERK) and c-Jun N-terminal Kinase (JNK) Activation in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR EXPRESSION; BRONCHIAL EPITHELIAL-CELLS; LOW-DENSITY-LIPOPROTEIN; INTERLEUKIN-8 SECRETION; ENDOTHELIAL-CELLS; FACTOR GENE; PATHWAY; PHOSPHORYLATION; INDUCTION; CREB	Lysophosphatidic acid (LPA) modulates vascular cell function in vitro and in vivo via regulating the expression of specific genes. Previously, we reported that a transcriptional mechanism controls LPA-induced expression of Egr-1 in vascular smooth muscle cells. Egr-1 is a master transcription factor mediating the expression of various genes that have been implied to modulate a broad spectrum of vascular pathologies. In this study, we determined the essential intracellular signaling pathway leading to LPA-induced Egr-1 expression. Our data demonstrate that activation of ERK1/2 and JNK, but not p38 MAPK, is required for LPA-induced Egr-1 expression in smooth muscle cells. We provide the first evidence that MEK-mediated JNK activation leads to LPA-induced gene expression. JNK2 is required for Egr-1 induction. Examining the upstream kinases that mediate ERK and JNK activation, leading to Egr-1 expression, we found that LPA-induced activation of MAPKs and expression of Egr-1 are dependent on PKC activation. We observed that LPA rapidly activates PKC delta and PKC0. Overexpression of dominant-negative PKC delta, but not dominant-negative PKC delta, diminished activation of ERK and JNK and blocked LPA-induced expression of Egr-1 mRNA and protein. We also evaluated LPA receptor involvement. Our data reveal an intracellular regulatory mechanism: LPA induction of Egr-1 expression is via LPA cognate receptor (LPA receptor 1)-dependent and PKC delta-mediated ERK and JNK activation. This study provides the first evidence that PKC delta mediates ERK and JNK activation in the LPA signaling pathway and that this pathway is required for LPA-induced gene regulation as evidenced by Egr-1 expression.	[Iyoda, Takuya; Zhang, Fuqiang; Sun, Longsheng; Hao, Feng; Xu, Xuemin; Cui, Mei-Zhen] Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA; [Schmitz-Peiffer, Carsten] Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW 2010, Australia; [Zhang, Fuqiang] Jilin Univ, Coll Pharm, Dept Med Bioengn, Changchun 130021, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Garvan Institute of Medical Research; Jilin University	Cui, MZ (corresponding author), Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, 2407 River Dr, Knoxville, TN 37996 USA.	cuim@utk.edu	Schmitz-Peiffer, Carsten/J-6918-2012	Schmitz-Peiffer, Carsten/0000-0001-7330-7255; Cui, Mei-Zhen/0000-0003-4745-6999	National Institutes of Health [HL074341, HL107466, AG026640]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074341, R01HL107466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026640, R21AG039596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL074341 and HL107466 (to M.-Z. C.) and AG026640 (to X. X.).	Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bea F, 2003, CIRC RES, V92, P394, DOI 10.1161/01.RES.0000059982.43865.75; Blaschke F, 2004, REV ENDOCR METAB DIS, V5, P249, DOI 10.1023/B:REMD.0000032413.88756.ee; BROCK TA, 1985, HYPERTENSION, V7, pI105, DOI 10.1161/01.HYP.7.3_Pt_2.I105; Budnik LT, 2002, BIOL REPROD, V67, P935, DOI 10.1095/biolreprod.101.003087; Cazzolli R, 2002, AM J PHYSIOL-ENDOC M, V282, pE1204, DOI 10.1152/ajpendo.00487.2001; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Chung WC, 2009, J IMMUNOL, V182, P2349, DOI 10.4049/jimmunol.0713637; Cui MZ, 2011, CLIN LIPIDOL, V6, P413, DOI 10.2217/CLP.11.38; Cui MZ, 2006, ARTERIOSCL THROM VAS, V26, P1029, DOI 10.1161/01.ATV.0000214980.90567.b5; Cui MZ, 1999, J BIOL CHEM, V274, P32795, DOI 10.1074/jbc.274.46.32795; Cui MZ, 2003, ARTERIOSCL THROM VAS, V23, P224, DOI 10.1161/01.ATV.0000054660.61191.7D; Cui MZ, 1996, J BIOL CHEM, V271, P2731, DOI 10.1074/jbc.271.5.2731; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Gelain DP, 2006, CELL SIGNAL, V18, P1685, DOI 10.1016/j.cellsig.2006.01.008; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hao F, 2010, AM J PHYSIOL-HEART C, V298, pH974, DOI 10.1152/ajpheart.00895.2009; HORDIJK PL, 1994, J BIOL CHEM, V269, P645; HOWE LR, 1993, J BIOL CHEM, V268, P20717; Kaneyuki U, 2007, VASC PHARMACOL, V46, P286, DOI 10.1016/j.vph.2006.11.002; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Ohtani K, 2004, GENE THER, V11, P126, DOI 10.1038/sj.gt.3302153; Prince JM, 2007, SHOCK, V27, P157, DOI 10.1097/01.shk.0000245025.01365.8e; Reiser COA, 1998, BIOCHEM J, V330, P1107; Rupp J, 2005, P NATL ACAD SCI USA, V102, P3447, DOI 10.1073/pnas.0407759102; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Springael C, 2007, BIOCHEM PHARMACOL, V73, P515, DOI 10.1016/j.bcp.2006.10.034; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	33	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22635	22642		10.1074/jbc.M111.335695	http://dx.doi.org/10.1074/jbc.M111.335695			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577133	hybrid, Green Published			2022-12-25	WOS:000306495000020
J	Bouzigon, E; Monier, F; Boussaha, M; Le Moual, N; Huyvaert, H; Matran, R; Letort, S; Bousquet, J; Pin, I; Lathrop, M; Kauffmann, F; Demenais, F; Nadif, R				Bouzigon, Emmanuelle; Monier, Florent; Boussaha, Mekki; Le Moual, Nicole; Huyvaert, Helene; Matran, Regis; Letort, Sebastien; Bousquet, Jean; Pin, Isabelle; Lathrop, Mark; Kauffmann, Francine; Demenais, Florence; Nadif, Rachel		EGEA Cooperative Grp	Associations between Nitric Oxide Synthase Genes and Exhaled NO-Related Phenotypes according to Asthma Status	PLOS ONE			English	Article							BRONCHIAL HYPERRESPONSIVENESS; ATOPY; EOSINOPHILS; ENVIRONMENT; GENOTYPE; GENETICS; CHILDREN; PATHWAY; BREATH; COPD	Background: The nitric oxide (NO) pathway is involved in asthma, and eosinophils participate in the regulation of the NO pool in pulmonary tissues. We investigated associations between single nucleotide polymorphisms (SNPs) of NO synthase genes (NOS) and biological NO-related phenotypes measured in two compartments (exhaled breath condensate and plasma) and blood eosinophil counts. Methodology: SNPs (N=121) belonging to NOS1, NOS2 and NOS3 genes were genotyped in 1277 adults from the French Epidemiological study on the Genetics and Environment of Asthma (EGEA). Association analyses were conducted on four quantitative phenotypes: the exhaled fraction of NO (FENO), plasma and exhaled breath condensate (EBC) nitrite-nitrate levels (NO2-NO3) and blood eosinophils in asthmatics and non-asthmatics separately. Genetic heterogeneity of these phenotypes between asthmatics and non-asthmatics was also investigated. Principal Findings: In non-asthmatics, after correction for multiple comparisons, we found significant associations of Fe-NO levels with three SNPs in NOS3 and NOS2 (P <= 0.002), and of EBC NO2-NO3 level with NOS2 (P=0.002). In asthmatics, a single significant association was detected between FENO levels and one SNP in NOS3 (P=0.004). Moreover, there was significant heterogeneity of NOS3 SNP effect on Fe-NO between asthmatics and non-asthmatics (P=0.0002 to 0.005). No significant association was found between any SNP and NO2-NO3 plasma levels or blood eosinophil counts. Conclusions: Variants in NO synthase genes influence Fe-NO and EBC NO2-NO3 levels in adults. These genetic determinants differ according to asthma status. Significant associations were only detected for exhaled phenotypes, highlighting the critical relevance to have access to specific phenotypes measured in relevant biological fluid.	[Bouzigon, Emmanuelle; Boussaha, Mekki; Letort, Sebastien; Lathrop, Mark; Demenais, Florence] INSERM, U946, Paris, France; [Bouzigon, Emmanuelle; Boussaha, Mekki; Letort, Sebastien; Demenais, Florence] Univ Paris Diderot, Sorbonne Paris Cite, Inst Univ Hematol, Paris, France; [Bouzigon, Emmanuelle; Boussaha, Mekki; Letort, Sebastien; Demenais, Florence] CEPH, Fdn Jean Dausset, Paris, France; [Monier, Florent; Le Moual, Nicole; Bousquet, Jean; Kauffmann, Francine; Nadif, Rachel] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Monier, Florent; Le Moual, Nicole; Bousquet, Jean; Kauffmann, Francine; Nadif, Rachel] INSERM, U1018, Environm Epidemiol Team, Villejuif, France; [Monier, Florent; Le Moual, Nicole; Kauffmann, Francine; Nadif, Rachel] Univ Paris 11, UMRS 1018, Villejuif, France; [Huyvaert, Helene; Matran, Regis] Univ Lille Nord, Lille, France; [Huyvaert, Helene; Matran, Regis] CHU Lille, F-59037 Lille, France; [Bousquet, Jean] CHU Arnaud Villeneuve, Montpellier, France; [Pin, Isabelle] INSERM, U823, Inst Albert Bonniot, Grenoble, France; [Pin, Isabelle] Univ Grenoble 1, Grenoble, France; [Pin, Isabelle] CHU Grenoble, F-38043 Grenoble, France; [Lathrop, Mark] Ctr Natl Genotypage, Commissariat Energie Atom, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Bouzigon, E (corresponding author), INSERM, U946, Paris, France.	rachel.nadif@inserm.fr	Le Moual, Nicole/GNP-5114-2022; Dizier, Marie-Hélène/K-8463-2018; Demenais, Florence/G-3298-2013; Nadif, Rachel/R-2876-2016; Bousquet, Jean/O-4221-2019; PIN, Isabelle/N-3020-2013; Bouzigon, Emmanuelle/L-2766-2017; Le Moual, Nicole/R-8976-2016	Le Moual, Nicole/0000-0002-2723-5569; Dizier, Marie-Hélène/0000-0001-8460-7667; Demenais, Florence/0000-0001-8361-0936; Nadif, Rachel/0000-0003-4938-9339; Bouzigon, Emmanuelle/0000-0001-5756-4286; Le Moual, Nicole/0000-0002-2723-5569; boussaha, mekki/0000-0002-5432-4604	PHRC-Paris; PHRC-Grenoble [ANR 05-SEST-020-02/05-9-97, ANR-06-CEBS, ANR-CES-2009]; Region Nord Pas-de-Calais; Merck Sharp Dohme (MSD); GA2LEN project; Global Allergy and Asthma European Network; GABRIEL; European Community from the European Commission [018996]; EGEA; CIC-Inserm of Necker, Grenoble; CIC-Inserm of Necker, Marseille	PHRC-Paris; PHRC-Grenoble; Region Nord Pas-de-Calais(Region Hauts-de-France); Merck Sharp Dohme (MSD)(Merck & Company); GA2LEN project; Global Allergy and Asthma European Network; GABRIEL; European Community from the European Commission; EGEA; CIC-Inserm of Necker, Grenoble; CIC-Inserm of Necker, Marseille	This research is funded in part by PHRC-Paris, PHRC-Grenoble, ANR 05-SEST-020-02/05-9-97, ANR-06-CEBS, ANR-CES-2009, Region Nord Pas-de-Calais, Merck Sharp & Dohme (MSD), the GA2LEN project, Global Allergy and Asthma European Network and GABRIEL, a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community (contract 018996 from the European Commission). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FD received a grant of (sic)720 000 in November 2002 for the follow-up and genetic studies of the EGEA cohort. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; The authors thank all those who participated to the setting of the study and on the various aspects of the examinations involved: interviewers, technicians for lung function testing and skin prick tests, blood sampling, IgE determinations, coders, those involved in quality control, data and sample management and all those who supervised the study in all centers. The authors are grateful to the three CIC-Inserm of Necker, Grenoble and Marseille who supported the study and in which subjects were examined. They are also grateful to the three biobanks in Lille (CIC-Inserm), Evry (Centre National du Genotypage) and at Annemasse (Etablissement francais du sang) where biological samples are stored. They are indebted to all the individuals who participated without whom that study would not have been possible. The authors thank Anna-Carin Olin and Fredrick Nyberg for having supplied the results of the ADONIX study cohort that were in press in the meantime of the review of this manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; [Anonymous], 2006, AM J RESP CRIT CARE, V173, P811; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Batra J, 2007, THORAX, V62, P16, DOI 10.1136/thx.2006.057935; Dahgam S, 2012, J MED GENET, V49, P200, DOI 10.1136/jmedgenet-2011-100584; delPozo V, 1997, J IMMUNOL, V158, P859; Dweik RA, 2005, THORAX, V60, P265, DOI 10.1136/thx.2004.038471; Dweik RA, 2011, OFFICIAL ATS CLIN PR; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V124, P990, DOI 10.1016/j.jaci.2009.08.039; Ghosh S, 2011, BBA-GEN SUBJECTS, V1810, P1008, DOI 10.1016/j.bbagen.2011.06.009; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Hunt J, 2007, IMMUNOL ALLERGY CLIN, V27, P587, DOI 10.1016/j.iac.2007.09.001; Iijima H, 2001, AM J RESP CRIT CARE, V163, P1233, DOI 10.1164/ajrccm.163.5.2003145; Kauffmann F, 1999, CLIN EXP ALLERGY, V29, P17; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2010, NITRIC OXIDE-BIOL CH, V22, P61, DOI 10.1016/j.niox.2009.11.004; Malerba M, 2008, CHEST, V134, P733, DOI 10.1378/chest.08-0763; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; MOSHAGE H, 1995, CLIN CHEM, V41, P892; Nadif R, 2010, ANN ALLERG ASTHMA IM, V104, P385, DOI 10.1016/j.anai.2010.03.013; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Queto T, 2010, AM J RESP CRIT CARE, V181, P429, DOI 10.1164/rccm.200905-0800OC; Ricciardolo FLM, 2006, EUR J PHARMACOL, V533, P240, DOI 10.1016/j.ejphar.2005.12.057; Salam MT, 2011, ALLERGY, V66, P412, DOI 10.1111/j.1398-9995.2010.02492.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Taylor DR, 2009, THORAX, V64, P261, DOI 10.1136/thx.2008.098640; van's Gravesande Karin Storm, 2003, American Journal of Respiratory and Critical Care Medicine, V168, P228, DOI 10.1164/rccm.200212-1491BC; Villanueva C, 2010, FREE RADICAL BIO MED, V49, P307, DOI 10.1016/j.freeradbiomed.2010.04.004; Wechsler ME, 2000, AM J RESP CRIT CARE, V162, P2043, DOI 10.1164/ajrccm.162.6.2003089; Weitzberg E, 2010, ANESTHESIOLOGY, V113, P1460, DOI 10.1097/ALN.0b013e3181fcf3cc	36	23	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36672	10.1371/journal.pone.0036672	http://dx.doi.org/10.1371/journal.pone.0036672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590587	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100052
J	Genead, R; Fischer, H; Hussain, A; Jaksch, M; Andersson, AB; Ljung, K; Bulatovic, I; Franco-Cereceda, A; Elsheikh, E; Corbascio, M; Smith, CIE; Sylven, C; Grinnemo, KH				Genead, Rami; Fischer, Helene; Hussain, Alamdar; Jaksch, Marie; Andersson, Agneta B.; Ljung, Karin; Bulatovic, Ivana; Franco-Cereceda, Anders; Elsheikh, Elzafir; Corbascio, Matthias; Smith, C. I. Edvard; Sylven, Christer; Grinnemo, Karl-Henrik			Ischemia-Reperfusion Injury and Pregnancy Initiate Time-Dependent and Robust Signs of Up-Regulation of Cardiac Progenitor Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; STEM-CELLS; MAST-CELLS; MYOCARDIAL REGENERATION; MAMMALIAN HEART; SMOOTH-MUSCLE; FACTOR-I; DIFFERENTIATION; MULTIPOTENT; INFARCTION	To explore how cardiac regeneration and cell turnover adapts to disease, different forms of stress were studied for their effects on the cardiac progenitor cell markers c-Kit and Isl1, the early cardiomyocyte marker Nkx2.5, and mast cells. Adult female rats were examined during pregnancy, after myocardial infarction and ischemia-reperfusion injury with/out insulin like growth factor-1(IGF-1) and hepatocyte growth factor (HGF). Different cardiac sub-domains were analyzed at one and two weeks post-intervention, both at the mRNA and protein levels. While pregnancy and myocardial infarction up-regulated Nkx2.5 and c-Kit (adjusted for mast cell activation), ischemia-reperfusion injury induced the strongest up-regulation which occurred globally throughout the entire heart and not just around the site of injury. This response seems to be partly mediated by increased endogenous production of IGF-1 and HGF. Contrary to c-Kit, Isl1 was not up-regulated by pregnancy or myocardial infarction while ischemia-reperfusion injury induced not a global but a focal up-regulation in the outflow tract and also in the peri-ischemic region, correlating with the up-regulation of endogenous IGF-1. The addition of IGF-1 and HGF did boost the endogenous expression of IGF and HGF correlating to focal up-regulation of Isl1. c-Kit expression was not further influenced by the exogenous growth factors. This indicates that there is a spatial mismatch between on one hand c-Kit and Nkx2.5 expression and on the other hand Isl1 expression. In conclusion, ischemia-reperfusion injury was the strongest stimulus with both global and focal cardiomyocyte progenitor cell marker up-regulations, correlating to the endogenous up-regulation of the growth factors IGF-1 and HGF. Also pregnancy induced a general up-regulation of c-Kit and early Nkx2.5+ cardiomyocytes throughout the heart. Utilization of these pathways could provide new strategies for the treatment of cardiac disease.	[Genead, Rami; Andersson, Agneta B.; Elsheikh, Elzafir; Sylven, Christer] Karolinska Inst, Div Cardiol, Dept Med, Stockholm, Sweden; [Fischer, Helene] Karolinska Inst, Dept Physiol, S-10401 Stockholm, Sweden; [Hussain, Alamdar; Smith, C. I. Edvard] Karolinska Inst, Dept Lab Med, Clin Res Ctr, Stockholm, Sweden; [Hussain, Alamdar] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Jaksch, Marie; Ljung, Karin; Bulatovic, Ivana; Franco-Cereceda, Anders; Corbascio, Matthias; Grinnemo, Karl-Henrik] Karolinska Univ Hosp, Div Cardiothorac Surg & Anaesthesiol, Dept Mol Med & Surg, Karolinska Inst, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; COMSATS University Islamabad (CUI); Karolinska Institutet; Karolinska University Hospital	Genead, R (corresponding author), Karolinska Inst, Div Cardiol, Dept Med, Stockholm, Sweden.	rami.genead@ki.se		Grinnemo, Karl-Henrik/0000-0001-6717-3393; SMITH, C. I. Edvard/0000-0003-1907-3392; Grinnemo, Karl-Henrik/0000-0002-6100-6209	Swedish Research Council; Heart and Lung Foundation; Karolinska Institutets Fonder; Signhild Engqvist Foundation; Mats Kleberg Stiftelse; Egyptian ministry of higher education	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutets Fonder(Karolinska Institutet); Signhild Engqvist Foundation; Mats Kleberg Stiftelse; Egyptian ministry of higher education(Science and Technology Development Fund (STDF))	This study was supported by grants from the Swedish Research Council, the Heart and Lung Foundation, the "Karolinska Institutets Fonder'', the Signhild Engqvist Foundation, the Mats Kleberg Stiftelse and the Egyptian ministry of higher education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghestanian M, 1997, BLOOD, V90, P4438; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BRODSKY VY, 1994, VIRCHOWS ARCH, V424, P429; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Ellison GM, 2011, J AM COLL CARDIOL; Frangogiannis NG, 1998, CIRCULATION, V98, P699, DOI 10.1161/01.CIR.98.7.699; Frangogiannis Nikolaos G, 2006, Methods Mol Biol, V315, P91; Genead R, 2010, STEM CELLS DEV, V19, P1601, DOI 10.1089/scd.2009.0483; Genead R, 2010, STEM CELL RES, V4, P69, DOI 10.1016/j.scr.2009.10.001; Goumans MJ, 2008, STEM CELL RES, V1, P138, DOI 10.1016/j.scr.2008.02.003; Guo JL, 2009, INT J EXP PATHOL, V90, P355, DOI 10.1111/j.1365-2613.2009.00659.x; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; ITO BR, 1993, AM J PHYSIOL, V264, pH1346, DOI 10.1152/ajpheart.1993.264.5.H1346; Kara RJ, 2012, CIRC RES, V110, P82, DOI 10.1161/CIRCRESAHA.111.249037; Kasahara H, 1999, MOL CELL BIOL, V19, P526; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miyamoto S, 2010, STEM CELLS DEV, V19, P105, DOI 10.1089/scd.2009.0041; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; PFITZER P, 1971, VIRCHOWS ARCH B, V9, P180; Pouly J, 2008, J THORAC CARDIOV SUR, V135, P673, DOI 10.1016/j.jtcvs.2007.10.024; Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097; Sandstedt J, 2010, BASIC RES CARDIOL, V105, P545, DOI 10.1007/s00395-010-0088-1; Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Suleiman MS, 2007, PHARMACOL THERAPEUT, V114, P278, DOI 10.1016/j.pharmthera.2007.03.001; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Tomita N, 2003, CIRCULATION, V107, P1411, DOI 10.1161/01.CIR.0000055331.41937.AA; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Torella Daniele, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P53, DOI 10.2174/187152508783329984; Torella Daniele, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS8, DOI 10.1038/ncpcardio0409; Virgen-Ortiz A, 2009, J PHYSIOL SCI, V59, P391, DOI 10.1007/s12576-009-0047-5; Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhou Y, 2010, J HISTOCHEM CYTOCHEM, V58, P309, DOI 10.1369/jhc.2009.955146	45	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36804	10.1371/journal.pone.0036804	http://dx.doi.org/10.1371/journal.pone.0036804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590612	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336100062
J	Hou, JM; Wang, LW				Hou, Junmei; Wang, Liewei			FKBP5 as a Selection Biomarker for Gemcitabine and Akt Inhibitors in Treatment of Pancreatic Cancer	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE PATHWAY; GENOME-WIDE ASSOCIATION; PROTEIN-KINASE; RESPONSE BIOMARKERS; PI3K/AKT PATHWAY; DRUG RESPONSE; PHOSPHORYLATION; CHEMOTHERAPY; GROWTH; TRIAL	We have recently shown that the immunophilin FKBP5 (also known as FKBP51) is a scaffolding protein that can enhance PHLPP-AKT interaction and facilitate PHLPP-mediated dephosphorylation of Akt Ser473, negatively regulating Akt activation in vitro. Therefore, FKBP5 might function as a tumor suppressor, and levels of FKBP5 would affect cell response to chemotherapy. In the current study, we have taken a step forward by using a pancreatic cancer xenograft mice model to show that down regulation of FKBP5 in shFKBP5 xenograft mice promotes tumor growth and resistance to gemcitabine, a phenomenon consistent with our previous findings in pancreatic cell lines. In addition, we also found that inhibitors targeting the Akt pathway, including PI3K inhibitor, Akt inhibitor and mTOR inhibitor had a different effect on sensitization to gemcitabine and other chemotherapeutic agents in cell lines, with a specific Akt inhibitor, triciribine, having the greatest sensitization effect. We then tested the hypothesis that addition of triciribine can sensitize gemcitabine treatment, especially in shFKBP5 pancreatic cancer xenograft mice. We found that combination treatment with gemcitabine and triciribine has a better effect on tumor inhibition than either drug alone (p<0.005) and that the inhibition effect is more significant in shFKBP5 xenograft mice than wt mice (p<0.05). These effects were correlated with level of Akt 473 phosphorylation as well as proliferation rate, as indicated by Ki67 staining in xenograft tumor tissues. These results provide evidence in support of future clinical trials designed to tailor therapy based on our observations.	[Hou, Junmei; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA	Mayo Clinic	Hou, JM (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA.	wang.liewei@mayo.edu			U.S. National Institutes of Health [K22 CA130828, R01 CA138461, P50 CA102701, U19 GM61388]; NATIONAL CANCER INSTITUTE [P50CA102701, K22CA130828, R01CA138461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by U.S. National Institutes of Health grants K22 CA130828, R01 CA138461, P50 CA102701, and U19 GM61388 (The Pharmacogenomics Research Network). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; El-Rayes Basil F, 2003, Clin Adv Hematol Oncol, V1, P430; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Farnell MB, 2005, SURGERY, V138, P618, DOI 10.1016/j.surg.2005.06.044; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Li L, 2008, CANCER RES, V68, P7050, DOI 10.1158/0008-5472.CAN-08-0405; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Pino Simona M, 2004, Curr Oncol Rep, V6, P199, DOI 10.1007/s11912-004-0050-1; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shi Y, 2005, INT J INF TECH DECIS, V4, P1; Wang H, 1999, P NATL ACAD SCI USA, V96, P13989, DOI 10.1073/pnas.96.24.13989; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yachida S, 2009, ARCH PATHOL LAB MED, V133, P413, DOI 10.1043/1543-2165-133.3.413; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yeo CJ, 2002, ANN SURG, V236, P355, DOI 10.1097/00000658-200209000-00012; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100	35	33	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36252	10.1371/journal.pone.0036252	http://dx.doi.org/10.1371/journal.pone.0036252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590527	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336100023
J	Cuthill, JH; Charleston, M				Cuthill, Jennifer Hoyal; Charleston, Michael			Phylogenetic Codivergence Supports Coevolution of Mimetic Heliconius Butterflies	PLOS ONE			English	Article							MULLERIAN MIMICRY; POPULATION-SIZE; MUELLERIAN MIMICRY; RACE FORMATION; EVOLUTION; TREES; DIVERSITY; INFERENCE; DYNAMICS; PATTERNS	The unpalatable and warning-patterned butterflies Heliconius erato and Heliconius melpomene provide the best studied example of mutualistic Mullerian mimicry, thought-but rarely demonstrated-to promote coevolution. Some of the strongest available evidence for coevolution comes from phylogenetic codivergence, the parallel divergence of ecologically associated lineages. Early evolutionary reconstructions suggested codivergence between mimetic populations of H. erato and H. melpomene, and this was initially hailed as one of the most striking known cases of coevolution. However, subsequent molecular phylogenetic analyses found discrepancies in phylogenetic branching patterns and timing (topological and temporal incongruence) that argued against codivergence. We present the first explicit cophylogenetic test of codivergence between mimetic populations of H. erato and H. melpomene, and re-examine the timing of these radiations. We find statistically significant topological congruence between multilocus coalescent population phylogenies of H. erato and H. melpomene. Cophylogenetic historical reconstructions support repeated codivergence of mimetic populations, from the base of the sampled radiations. Pairwise distance correlation tests, based on our coalescent analyses plus recently published AFLP and wing colour pattern gene data, also suggest that the phylogenies of H. erato and H. melpomene show significant topological congruence. Divergence time estimates, based on a Bayesian coalescent model, suggest that the evolutionary radiations of H. erato and H. melpomene occurred over the same time period, and are compatible with a series of temporally congruent codivergence events. Our results suggest that differences in within-species genetic divergence are the result of a greater overall effective population size for H. erato relative to H. melpomene and do not imply incongruence in the timing of their phylogenetic radiations. Repeated codivergence between Mullerian co-mimics, predicted to exert mutual selection pressures, strongly suggests coevolution. Our results therefore support a history of reciprocal coevolution between Mullerian co-mimics characterised by phylogenetic codivergence and parallel phenotypic change.	[Cuthill, Jennifer Hoyal; Charleston, Michael] Univ Sydney, Sch Informat Technol, Sydney, NSW 2006, Australia	University of Sydney	Cuthill, JH (corresponding author), Univ Sydney, Sch Informat Technol, Sydney, NSW 2006, Australia.	jenhc@it.usyd.edu.au	Charleston, Michael A/O-4903-2017	Charleston, Michael A/0000-0001-8385-341X; Hoyal Cuthill, Jennifer/0000-0002-3139-9750	Australian Research Council [DP1094891]	Australian Research Council(Australian Research Council)	This research was supported by a Discovery Project grant (number DP1094891) from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arias CF, 2008, MOL ECOL, V17, P4699, DOI 10.1111/j.1365-294X.2008.03934.x; Bates HW., 1862, T LINN SOC LOND, V23, P495, DOI [DOI 10.1111/J.1096-3642.1860.TB00146.X, 10.1111/j.1096-3642.1860.tb00146.x]; Baxter SW, 2010, PLOS GENET, V6, P1; Beltran M, 2002, MOL BIOL EVOL, V19, P2176, DOI 10.1093/oxfordjournals.molbev.a004042; Beltran M, 2007, BIOL J LINN SOC, V92, P221, DOI 10.1111/j.1095-8312.2007.00830.x; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; BROWN KS, 1974, PROC R SOC SER B-BIO, V187, P369, DOI 10.1098/rspb.1974.0082; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; Ceccarelli FS, 2007, J EVOLUTION BIOL, V20, P286, DOI 10.1111/j.1420-9101.2006.01199.x; CHAI P, 1986, BIOL J LINN SOC, V29, P161, DOI 10.1111/j.1095-8312.1986.tb01772.x; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; Charleston MA, 2002, SYST BIOL, V51, P528, DOI 10.1080/10635150290069940; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eckert AJ, 2008, MOL PHYLOGENET EVOL, V49, P832, DOI 10.1016/j.ympev.2008.09.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eltringham H, 1916, T ENTOMOLOGICAL SOC, V1916, P101; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; Flanagan NS, 2004, P NATL ACAD SCI USA, V101, P9704, DOI 10.1073/pnas.0306243101; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Futuyma DJ, 1986, EVOL BIOL; Futyma DJ, 1983, COEVOLUTION, P1; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gilbert L.E., 1983, P263; Gilbert L.E., 1984, Symposia of the Royal Entomological Society of London, P41; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 1997, GENETICS, V145, P833; Hines HM, 2011, P NATL ACAD SCI USA, V108, P19666, DOI 10.1073/pnas.1110096108; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Knapp S, 2003, SCIENCE, V300, P71, DOI 10.1126/science.1083007; Kronforst MR, 2008, P ROY SOC B-BIOL SCI, V275, P493, DOI 10.1098/rspb.2007.1378; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Lamas G, 2004, ATLAS NEOTROPICAL 4A, V5A; Maddison W, MESQUITE MODULAR SYS; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Mallet J, 1996, CURR BIOL, V6, P937, DOI 10.1016/S0960-9822(02)00631-0; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; Pinheiro CEG, 2003, BIOTROPICA, V35, P356, DOI 10.1646/02128; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quek SP, 2010, P NATL ACAD SCI USA, V107, P7365, DOI 10.1073/pnas.0911572107; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Simonsen TJ, 2011, CLADISTICS, V27, P113, DOI 10.1111/j.1096-0031.2010.00326.x; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; THOMPSON JN, 1989, TRENDS ECOL EVOL, V4, P179, DOI 10.1016/0169-5347(89)90125-0; Thompson JN, 1994, COEVOLUTIONARY PROCE; TURNER JRG, 1987, ECOL ENTOMOL, V12, P81, DOI 10.1111/j.1365-2311.1987.tb00987.x; Wakeley J, 1997, GENETICS, V145, P847; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wright S, 1931, GENETICS, V16, P0097; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	68	34	34	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36464	10.1371/journal.pone.0036464	http://dx.doi.org/10.1371/journal.pone.0036464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586474	gold, Green Submitted, Green Published			2022-12-25	WOS:000305335000036
J	Fritsche, M; Reinholdt, LG; Lessard, M; Handel, MA; Bewersdorf, J; Heermann, DW				Fritsche, Miriam; Reinholdt, Laura G.; Lessard, Mark; Handel, Mary Ann; Bewersdorf, Joerg; Heermann, Dieter W.			The Impact of Entropy on the Spatial Organization of Synaptonemal Complexes within the Cell Nucleus	PLOS ONE			English	Article							MEIOTIC CHROMOSOMES; POLYMER-CHAIN; LENGTH; MICROSCOPY; STIFFNESS; CROSSOVER; PROTEINS; PROPHASE; MEIOSIS	We employ 4Pi-microscopy to study SC organization in mouse spermatocyte nuclei allowing for the three-dimensional reconstruction of the SC's backbone arrangement. Additionally, we model the SCs in the cell nucleus by confined, self-avoiding polymers, whose chain ends are attached to the envelope of the confining cavity and diffuse along it. This work helps to elucidate the role of entropy in shaping pachytene SC organization. The framework provided by the complex interplay between SC polymer rigidity, tethering and confinement is able to qualitatively explain features of SC organization, such as mean squared end-to-end distances, mean squared center-of-mass distances, or SC density distributions. However, it fails in correctly assessing SC entanglement within the nucleus. In fact, our analysis of the 4Pi-microscopy images reveals a higher ordering of SCs within the nuclear volume than what is expected by our numerical model. This suggests that while effects of entropy impact SC organization, the dedicated action of proteins or actin cables is required to fine-tune the spatial ordering of SCs within the cell nucleus.	[Fritsche, Miriam; Heermann, Dieter W.] Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany; [Reinholdt, Laura G.; Lessard, Mark; Handel, Mary Ann; Bewersdorf, Joerg; Heermann, Dieter W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Heermann, Dieter W.] Interdisciplinary Ctr Sci Comp, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Jackson Laboratory; Ruprecht Karls University Heidelberg	Fritsche, M (corresponding author), Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany.	fritsche@tphys.uni-heidelberg.de; Joerg.Bewersdorf@yale.edu		Lessard, Mark/0000-0002-1927-2204; Bewersdorf, Joerg/0000-0002-4085-7020	Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (HGS MathComp); W. M. Keck Foundation; National Science Foundation [DBI-0421007]; National Institutes of Health [HD48998]; Ministry for Education and Research; Ministry for Science, Research and Arts Baden-Wuerttemberg; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033816] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048998] Funding Source: NIH RePORTER	Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (HGS MathComp); W. M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry for Education and Research; Ministry for Science, Research and Arts Baden-Wuerttemberg; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	MF gratefully acknowledges funding from the Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (HGS MathComp). Funding for the 4Pi confocal laser scanning microscope was provided by the W. M. Keck Foundation and National Science Foundation Grant DBI-0421007. Additional funding was provided by National Institutes of Health HD48998 (to MAH, LGR). For this work, bwGRiD parallel computing facilities (http://www.bw-grid.de), member of the German D-Grid initiative, funded by the Ministry for Education and Research and the Ministry for Science, Research and Arts Baden-Wuerttemberg, as well as the high performance PC cluster HELICS II at the Interdisciplinary Center for Scientific Computing (IWR) were used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheimer M, 1999, MOL BIOL CELL, V10, P1235, DOI 10.1091/mbc.10.4.1235; ARTECA GA, 1994, PHYS REV E, V49, P2417, DOI 10.1103/PhysRevE.49.2417; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Carlton PM, 2008, CHROMOSOME RES, V16, P351, DOI 10.1007/s10577-008-1231-9; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Codina-Pascual M, 2006, MOL HUM REPROD, V12, P123, DOI 10.1093/molehr/gal007; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; CREMER C, 1978, MICROSC ACTA, V81, P31; Diesinger PM, 2008, EUR PHYS J B, V62, P209, DOI 10.1140/epjb/e2008-00145-6; Dresser M, 2008, PLOS GENET, V4, P1; Fritsche M, 2011, NUCLEIC ACIDS RES, P1; Fritsche M, 2011, SOFT MATTER, V7, P6906, DOI 10.1039/c1sm05445g; Fritsche M, 2010, MACROMOL THEOR SIMUL, V19, P440, DOI 10.1002/mats.201000025; Gugel H, 2004, BIOPHYS J, V87, P4146, DOI 10.1529/biophysj.104.045815; HALPERIN A, 1992, ADV POLYM SCI, V100, P31; HELL SW, 1994, OPT LETT, V19, P222, DOI 10.1364/OL.19.000222; HOLM PB, 1982, MUTAT RES, V95, P45, DOI 10.1016/0027-5107(82)90065-3; Hsu HP, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/28003; Hsu HP, 2010, MACROMOLECULES, V43, P3094, DOI 10.1021/ma902715e; Jahn D, 2010, NUCLEUS-PHILA, V1, P273, DOI 10.4161/nucl.1.3.11800; Jun S, 2010, NAT REV MICROBIOL, V8, P600, DOI 10.1038/nrmicro2391; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Klenin K, 2000, BIOPOLYMERS, V54, P307, DOI 10.1002/1097-0282(20001015)54:5<307::AID-BIP20>3.0.CO;2-Y; Koszul R, 2008, CELL, V133, P1188, DOI 10.1016/j.cell.2008.04.050; Liu Y, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026004; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; MOENS PB, 1990, J CELL SCI, V97, P1; MOSES MJ, 1969, GENETICS, V61, P41; Nicodemi M, 2008, GENETICS, V179, P717, DOI 10.1534/genetics.107.083154; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; RASMUSSEN SW, 1986, CARLSBERG RES COMMUN, V51, P401, DOI 10.1007/BF02907315; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Rother D, 2008, IEEE ACM T COMPUT BI, V5, P42, DOI 10.1109/TCBB.2007.1061; Rubinstein M, 2003, POLYM PHYS; Scherthan H, 2011, CHROMOSOMA, V120, P151, DOI 10.1007/s00412-010-0295-4; Sokal AD, 1997, FUNCTIONAL INTEGRATI; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; VANRENSBURG EJJ, 1992, J PHYS A-MATH GEN, V25, P6557, DOI 10.1088/0305-4470/25/24/010; Vranis NM, 2010, GENES-BASEL, V1, P505, DOI 10.3390/genes1030505; Wang CJR, 2009, GENETICS, V183, P905, DOI 10.1534/genetics.109.108688; Watts FZ, 2011, BIOESSAYS, V33, P529, DOI 10.1002/bies.201100002; White EJ, 2004, GENETICS, V167, P51, DOI 10.1534/genetics.167.1.51; Wiggins PA, 2010, P NATL ACAD SCI USA, V107, P4991, DOI 10.1073/pnas.0912062107; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	47	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36282	10.1371/journal.pone.0036282	http://dx.doi.org/10.1371/journal.pone.0036282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574147	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800043
J	Guzman-Aranguez, A; Woodward, AM; Pintor, J; Argueso, P				Guzman-Aranguez, Ana; Woodward, Ashley M.; Pintor, Jesus; Argueeso, Pablo			Targeted Disruption of Core 1 beta 1,3-galactosyltransferase (C1galt1) Induces Apical Endocytic Trafficking in Human Corneal Keratinocytes	PLOS ONE			English	Article							EPITHELIAL-CELLS; ASIALOGLYCOPROTEIN RECEPTOR; MEDIATED ENDOCYTOSIS; RAT HEPATOCYTES; O-GLYCANS; IN-VITRO; SURFACE; MEMBRANE; MUCIN; INFECTION	Background: Exposed mucosal surfaces limit constitutive endocytosis under physiological conditions to prevent uptake of macromolecules and pathogens and, therefore, cellular damage. It is now accepted that cell surface mucins, a group of high molecular weight glycoproteins on the epithelial glycocalyx, defined by their extensive O-glycosylation, play a major role in maintaining barrier function in these surfaces, but the precise mechanisms are unclear. Methodology/Principal Findings: In this work, we utilized a stable tetracycline-inducible RNA interfering system targeting the core 1 beta 1,3-galactosyltransferase (C1galt1 or T-synthase), a critical galactosyltransferase required for the synthesis of core 1 O-glycans, to explore the role of mucin-type carbohydrates in apical endocytic trafficking in human corneal keratinocytes. Using cell surface biotinylation and subcellular fractionation, we found increased accumulation of plasma membrane protein in endosomes after C1galt1 depletion. Confocal laser scanning microscopy and fluorometry revealed increased translocation of negatively charged fluorescent nanospheres after C1galt1 knockdown sustained by an active transport process and largely independent of apical intercellular junctions. Internalization of nanospheres could be blocked by dynasore, nocodazole, chlorpromazine, and hyperosmotic sucrose, suggesting a mechanism for clathrin-coated pit budding and vesicular trafficking. This possibility was supported by experiments showing nanosphere colocalization with clathrin heavy chain in the cytoplasm. Conclusions/Significance: Together, the data suggest that core 1 O-glycans contribute to maintenance of apical barrier function on exposed mucosal surfaces by preventing clathrin-mediated endocytosis.	[Guzman-Aranguez, Ana; Pintor, Jesus] Univ Complutense Madrid, Escuela Univ Opt, Dept Bioquim & Biol Mol, Madrid, Spain; [Guzman-Aranguez, Ana; Woodward, Ashley M.; Argueeso, Pablo] Harvard Univ, Sch Med, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA USA	Complutense University of Madrid; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Guzman-Aranguez, A (corresponding author), Univ Complutense Madrid, Escuela Univ Opt, Dept Bioquim & Biol Mol, Madrid, Spain.	pablo.argueso@schepens.harvard.edu	guzman, ana/Y-8286-2019	Guzman-Aranguez, Ana/0000-0001-6722-2044; Argueso, Pablo/0000-0001-7321-9503	National Eye Institute of the United States National Institutes of Health [R01 EY014847]; NATIONAL EYE INSTITUTE [R01EY014847] Funding Source: NIH RePORTER	National Eye Institute of the United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by National Eye Institute of the United States National Institutes of Health, Grant #R01 EY014847 to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Baribaud F, 1999, J VIROL, V73, P7899, DOI 10.1128/JVI.73.9.7899-7902.1999; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Hao J, 2010, BRAIN RES BULL, V81, P256, DOI 10.1016/j.brainresbull.2009.06.011; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kardon R, 1999, INVEST OPHTH VIS SCI, V40, P1328; Kinlough CL, 2004, J BIOL CHEM, V279, P53071, DOI 10.1074/jbc.M409360200; Komatsu M, 1997, J BIOL CHEM, V272, P33245, DOI 10.1074/jbc.272.52.33245; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; MADARA JL, 1990, AM J PATHOL, V137, P1273; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Ryeom SW, 2000, MOL BIOL CELL, V11, P1687, DOI 10.1091/mbc.11.5.1687; SCARMATO P, 1986, BIOL CELL, V56, P255, DOI 10.1111/j.1768-322X.1986.tb00457.x; Shah A, 2010, MOL VIS, V16, P2476; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Stonebraker JR, 2004, J VIROL, V78, P13755, DOI 10.1128/JVI.78.24.13755-13768.2004; Sumiyoshi M, 2008, INVEST OPHTH VIS SCI, V49, P197, DOI 10.1167/iovs.07-1038; Sundaram S, 2009, FASEB J, V23, P3752, DOI 10.1096/fj.09-129825; THOFT RA, 1975, EXP EYE RES, V21, P409, DOI 10.1016/0014-4835(75)90123-2; Ulloa F, 2003, J BIOL CHEM, V278, P12374, DOI 10.1074/jbc.M211909200; van der Bijl Pieter, 2004, Current Drug Delivery, V1, P129; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; Yamamoto N, 2005, INVEST OPHTH VIS SCI, V46, P1348, DOI 10.1167/iovs.04-0542	39	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36628	10.1371/journal.pone.0036628	http://dx.doi.org/10.1371/journal.pone.0036628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574202	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800099
J	Li, YY; Bao, YL; Song, ZB; Sun, LG; Wu, P; Zhang, Y; Fan, C; Huang, YX; Wu, Y; Yu, CL; Sun, Y; Zheng, LH; Wang, GN; Li, YX				Li, Yu-Yin; Bao, Yong-Li; Song, Zhen-Bo; Sun, Lu-Guo; Wu, Ping; Zhang, Yu; Fan, Cong; Huang, Yan-Xin; Wu, Yin; Yu, Chun-Lei; Sun, Ying; Zheng, Li-Hua; Wang, Guan-Nan; Li, Yu-Xin			The Threonine Protease Activity of Testes-Specific Protease 50 (TSP50) Is Essential for Its Function in Cell Proliferation	PLOS ONE			English	Article							NF-KAPPA-B; SELF-RENEWAL; I-TASSER; CLONOGENIC CELLS; APOPTOSIS; INFLAMMATION; ACTIVATION; IMMUNITY; SYSTEM; GROWTH	Background: Testes-specific protease 50 (TSP50), a newly discovered threonine enzyme, has similar amino acid sequences and enzymatic structures to those of many serine proteases. It may be an oncogene. TSP50 is up-regulated in breast cancer epithelial cells, and ectopic expression of TSP50 in TSP50-deficient Chinese hamster ovary (CHO) cells has been found to promote cell proliferation. However, the mechanisms by which TSP50 exerts its growth-promoting effects are not yet fully understood. Methodology/Principal Findings: To delineate whether the threonine protease activity of TSP50 is essential to its function in cell proliferation, we constructed and characterized a mutant TSP50, called TSP50 T310A, which was identified as a protease-dead mutant of TSP50. By a series of proliferation analyses, colony formation assays and apoptosis analyses, we showed that T310A mutation significantly depresses TSP50-induced cell proliferation in vitro. Next, the CHO stable cell line expressing either wild-type or T310A mutant TSP50 was injected subcutaneously into nude mice. We found that the T310A mutation could abolish the tumorigenicity of TSP50 in vivo. A mechanism investigation revealed that the T310A mutation prevented interaction between TSP50 and the NF-kappa BI kappa B alpha complex, which is necessary for TSP50 to perform its function in cell proliferation. Conclusion: Our data highlight the importance of threonine 310, the most critical protease catalytic site in TSP50, to TSP50-induced cell proliferation and tumor formation.	[Li, Yu-Yin; Bao, Yong-Li; Song, Zhen-Bo; Sun, Lu-Guo; Wu, Ping; Huang, Yan-Xin; Yu, Chun-Lei] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Li, Yu-Yin; Zhang, Yu; Fan, Cong; Wu, Yin; Yu, Chun-Lei; Li, Yu-Xin] NE Normal Univ, Res Ctr Agr & Med Gene Engn, Minist Educ, Changchun, Peoples R China; [Sun, Lu-Guo; Sun, Ying; Zheng, Li-Hua; Wang, Guan-Nan; Li, Yu-Xin] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China	Li, YY (corresponding author), NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China.	baoyl800@nenu.edu.cn; liyx486@nenu.edu.cn	Li, yu/HHZ-5236-2022; Li, yuxin/GSD-1668-2022; zhang, yu/J-6095-2014; li, yu/HGL-9518-2022; li, Yu/HCI-9086-2022		National Natural Science Foundation of China [30672068]; China Postdoctoral Science Foundation [20090451122]; Fundamental Research Funds for the Central Universities; Ministry of Science and Technology [2011ZX09401-305-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Natural Science Foundation of China (grant number 30672068), the China Postdoctoral Science Foundation (grant number 20090451122), the Fundamental Research Funds for the Central Universities, and the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (grant number 2011ZX09401-305-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari KM, 2008, MOL CANCER RES, V6, P1003, DOI 10.1158/1541-7786.MCR-07-2144; BUICK RN, 1981, BRIT J CANCER, V44, P349, DOI 10.1038/bjc.1981.191; Cheng HC, 1998, J BIOL CHEM, V273, P24207, DOI 10.1074/jbc.273.37.24207; Cheng JD, 2002, CANCER RES, V62, P4767; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Fiore M, 1999, EXP CELL RES, V251, P102, DOI 10.1006/excr.1999.4542; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HEDSTROM L, 2002, CURR PROTOC PROTEIN, pCH21; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Majdalawieh A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823821; MCLEMORE TL, 1988, CANCER RES, V48, P2880; NELSEN B, 1988, MOL CELL BIOL, V8, P3526, DOI 10.1128/MCB.8.8.3526; Page MJ, 2008, J BIOL CHEM, V283, P30010, DOI 10.1074/jbc.M804650200; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SCHREINER C, 1991, CANCER RES, V51, P1738; Shan JD, 2002, CANCER RES, V62, P290; Song ZB, 2011, BIOCHEM J, V436, P457, DOI 10.1042/BJ20101780; THOMSON SP, 1982, CANCER RES, V42, P4606; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wlodawer A, 2003, ACTA BIOCHIM POL, V50, P81; Xu HP, 2007, CANCER RES, V67, P1239, DOI 10.1158/0008-5472.CAN-06-3688; Xu HP, 2004, UROLOGY, V64, P826, DOI 10.1016/j.urology.2004.05.012; Yousef GM, 2004, BBA-PROTEINS PROTEOM, V1698, P77, DOI 10.1016/j.bbapap.2003.10.008; Yuan LM, 1999, CANCER RES, V59, P3215; Zhang J, 2006, CHEM RES CHINESE U, V22, P308, DOI 10.1016/S1005-9040(06)60104-9; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zheng C, 2011, CELL RES, V21, P183, DOI 10.1038/cr.2010.171; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022203; Zhou LA, 2010, IUBMB LIFE, V62, P825, DOI 10.1002/iub.390	40	21	21	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35030	10.1371/journal.pone.0035030	http://dx.doi.org/10.1371/journal.pone.0035030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574111	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349800007
J	Chen, FK; Zhang, ZY; Lin, K; Qian, TL; Zhang, Y; You, DL; He, XY; Wang, ZJ; Liang, JD; Deng, ZX; Wu, G				Chen, Fukun; Zhang, Zhenyi; Lin, Kui; Qian, Tianle; Zhang, Yan; You, Delin; He, Xinyi; Wang, Zhijun; Liang, Jingdan; Deng, Zixin; Wu, Geng			Crystal Structure of the Cysteine Desulfurase DndA from Streptomyces lividans Which Is Involved in DNA Phosphorothioation	PLOS ONE			English	Article							ESCHERICHIA-COLI COUNTERPART; NIFS-LIKE PROTEIN; CLUSTER; SULFUR; GENE; CSDB; PURIFICATION; HOMOLOG	DNA phosphorothioation is widespread among prokaryotes, and might function to restrict gene transfer among different kinds of bacteria. There has been little investigation into the structural mechanism of the DNA phosphorothioation process. DndA is a cysteine desulfurase which is involved in the first step of DNA phosphorothioation. In this study, we determined the crystal structure of Streptomyces lividans DndA in complex with its covalently bound cofactor PLP, to a resolution of 2.4 angstrom. Our structure reveals the molecular mechanism that DndA employs to recognize its cofactor PLP, and suggests the potential binding site for the substrate L-cysteine on DndA. In contrast to previously determined structures of cysteine desulfurases, the catalytic cysteine of DndA was found to reside on a beta strand. This catalytic cysteine is very far away from the presumable location of the substrate, suggesting that a conformational change of DndA is required during the catalysis process to bring the catalytic cysteine close to the substrate cysteine. Moreover, our in vitro enzymatic assay results suggested that this conformational change is unlikely to be a simple result of random thermal motion, since moving the catalytic cysteine two residues forward or backward in the primary sequence completely disabled the cysteine desulfurase activity of DndA.	[Chen, Fukun; Zhang, Zhenyi; Lin, Kui; Qian, Tianle; Zhang, Yan; You, Delin; He, Xinyi; Wang, Zhijun; Liang, Jingdan; Deng, Zixin; Wu, Geng] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Chen, FK (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	klin@sjtu.edu.cn; geng.wu@sjtu.edu.cn			National Natural Science Foundation of China [30900225, 30821005, 90919021]; Innovation Program of Shanghai Municipal Education Commission [09ZZ23]; "Dawn" Program of Shanghai Education Commission [08SG11]; Shanghai Pujiang Program [09PJ1405500]; Key Project of Chinese Ministry of Education [109060]; Program for Professor of Special Appointment at Shanghai Institutions of Higher Learning; National Comprehensive Technology Platforms for Innovative Drug RD [2009ZX09301-007]; State Key Laboratory of Bioorganic; Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); "Dawn" Program of Shanghai Education Commission; Shanghai Pujiang Program(Shanghai Pujiang Program); Key Project of Chinese Ministry of Education(Ministry of Education, China); Program for Professor of Special Appointment at Shanghai Institutions of Higher Learning; National Comprehensive Technology Platforms for Innovative Drug RD; State Key Laboratory of Bioorganic; Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China)	This work was supported by grants from National Natural Science Foundation of China (grant numbers 30900225, 30821005, and 90919021), Innovation Program of Shanghai Municipal Education Commission (grant number 09ZZ23), the "Dawn" Program of Shanghai Education Commission (grant number 08SG11), Shanghai Pujiang Program (grant number 09PJ1405500), the Key Project of Chinese Ministry of Education (grant number 109060), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, the National Comprehensive Technology Platforms for Innovative Drug R&D (2009ZX09301-007), the State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen FK, 2011, ACTA CRYSTALLOGR F, V67, P1440, DOI 10.1107/S1744309111036694; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint DH, 1996, J BIOL CHEM, V271, P16068; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Liu GA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001253; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Ou HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005132; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Tirupati B, 2004, BIOCHEMISTRY-US, V43, P12210, DOI 10.1021/bi0491447; Wang LR, 2011, P NATL ACAD SCI USA, V108, P2963, DOI 10.1073/pnas.1017261108; Xu TG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-41; You DL, 2007, BIOCHEMISTRY-US, V46, P6126, DOI 10.1021/bi602615k; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; ZHOU XF, 1988, NUCLEIC ACIDS RES, V16, P4341, DOI 10.1093/nar/16.10.4341; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x	22	3	7	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36635	10.1371/journal.pone.0036635	http://dx.doi.org/10.1371/journal.pone.0036635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570733	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400049
J	Orlichenko, L; Stolz, DB; Noel, P; Behari, J; Liu, SG; Singh, VP				Orlichenko, Lidiya; Stolz, Donna B.; Noel, Pawan; Behari, Jaideep; Liu, Shiguang; Singh, Vijay P.			ADP-ribosylation Factor 1 Protein Regulates Trypsinogen Activation via Organellar Trafficking of Procathepsin B Protein and Autophagic Maturation in Acute Pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACINAR-CELLS; CATHEPSIN-B; CERULEIN-PANCREATITIS; DUCT OBSTRUCTION; PLASMA-MEMBRANE; EARLY EVENTS; IN-VITRO; GOLGI; MICE; INHIBITION	Several studies have suggested that autophagy might play a deleterious role in acute pancreatitis via intra-acinar activation of digestive enzymes. The prototype for this phenomenon is cathepsin B-mediated trypsin generation. To determine the organellar basis of this process, we investigated the subcellular distribution of the cathepsin B precursor, procathepsin B. We found that procathepsin B is enriched in Golgi-containing microsomes, suggesting a role for the ADP-ribosylation (ARF)-dependent trafficking of cathepsin B. Indeed, caerulein treatment increased processing of procathepsin B, whereas a known ARF inhibitor brefeldin A (BFA) prevented this. Similar treatment did not affect processing of procathepsin L. BFA-mediated ARF1 inhibition resulted in reduced cathepsin B activity and consequently reduced trypsinogen activation. However, formation of light chain 3 (LC3-II) was not affected, suggesting that BFA did not prevent autophagy induction. Instead, sucrose density gradient centrifugation and electron microscopy showed that BFA arrested caerulein-induced autophagosomal maturation. Therefore, ARF1-dependent trafficking of procathepsin B and the maturation of autophagosomes results in cathepsin B-mediated trypsinogen activation induced by caerulein.	[Orlichenko, Lidiya; Noel, Pawan; Behari, Jaideep; Liu, Shiguang; Singh, Vijay P.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA; [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, VP (corresponding author), Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, 566,Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	singhv2@upmc.edu		Singh, Vijay/0000-0001-6611-1908	University of Pittsburgh Department of Medicine	University of Pittsburgh Department of Medicine(University of Pittsburgh)	This work was supported by a startup package from the University of Pittsburgh Department of Medicine (to V. P. S.).	Bhagat L, 2002, GASTROENTEROLOGY, V122, P156, DOI 10.1053/gast.2002.30314; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Caglic D, 2007, J BIOL CHEM, V282, P33076, DOI 10.1074/jbc.M705761200; Chagas JR, 1996, FEBS LETT, V392, P233, DOI 10.1016/0014-5793(96)00822-8; Chiari H, 1906, ZEUTRALBL PATHOL, V17, P798; Crozier SJ, 2008, AM J PHYSIOL-GASTR L, V294, pG1148, DOI 10.1152/ajpgi.00426.2007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; FIGARELLA C, 1988, BIOL CHEM H-S, V369, P293; FOX T, 1992, BIOCHEMISTRY-US, V31, P12571, DOI 10.1021/bi00165a005; Gaiser S, 2011, GUT, V60, P1379, DOI 10.1136/gut.2010.226175; Geng JF, 2010, AUTOPHAGY, V6, P950, DOI 10.4161/auto.6.7.13009; Grady T, 1997, GASTROENTEROLOGY, V113, P1966, DOI 10.1016/S0016-5085(97)70017-9; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; HENDRICKS LC, 1992, EUR J CELL BIOL, V58, P202; HENDRICKS LC, 1992, P NATL ACAD SCI USA, V89, P7242, DOI 10.1073/pnas.89.15.7242; HIRANO T, 1991, J CLIN INVEST, V87, P865, DOI 10.1172/JCI115091; HIRAOKA T, 1984, WORLD J SURG, V8, P766, DOI 10.1007/BF01655776; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; KLOPPEL G, 1986, VIRCHOWS ARCH A, V409, P791, DOI 10.1007/BF00710764; Lippincott-Schwartz J, 1998, HISTOCHEM CELL BIOL, V109, P449, DOI 10.1007/s004180050247; MACH L, 1994, J BIOL CHEM, V269, P13030; MACH L, 1993, BIOCHEM J, V293, P437, DOI 10.1042/bj2930437; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; NEVALAINEN TJ, 1974, VIRCHOWS ARCH B, V15, P107; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Ohmuraya M, 2006, PANCREAS, V33, P104, DOI 10.1097/01.mpa.0000226889.86322.9b; Orlichenko LS, 2010, AM J PHYSIOL-GASTR L, V299, pG867, DOI 10.1152/ajpgi.00177.2010; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; SAITO I, 1987, AM J PHYSIOL, V253, pG517, DOI 10.1152/ajpgi.1987.253.4.G517; SALUJA A, 1989, J CLIN INVEST, V84, P1260, DOI 10.1172/JCI114293; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Sausville E A, 1996, Cancer J Sci Am, V2, P52; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Singh VP, 2008, MOL BIOL CELL, V19, P2339, DOI 10.1091/mbc.E07-11-1130; Singh VP, 2009, AM J PHYSIOL-GASTR L, V296, pG1040, DOI 10.1152/ajpgi.90642.2008; Singh VP, 2001, J CLIN INVEST, V108, P1387, DOI 10.1172/JCI200112874; STEER ML, 1984, DIGEST DIS SCI, V29, P934, DOI 10.1007/BF01312483; Stolz DB, 1999, AM J PATHOL, V155, P1487, DOI 10.1016/S0002-9440(10)65464-8; Sutton R, 2003, PANCREATOLOGY, V3, P497, DOI 10.1159/000075581; Suzuki T, 2006, MOL CELL BIOL, V26, P6149, DOI 10.1128/MCB.00298-06; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Torgerson RR, 1998, J CELL SCI, V111, P2911; Van Acker GJD, 2007, AM J PHYSIOL-GASTR L, V292, pG1738, DOI 10.1152/ajpgi.00543.2006; Van Acker GJD, 2002, AM J PHYSIOL-GASTR L, V283, pG794, DOI 10.1152/ajpgi.00363.2001; Waldthaler A, 2010, DIGEST DIS, V28, P364, DOI 10.1159/000319416; Wartmann T, 2010, GASTROENTEROLOGY, V138, P726, DOI 10.1053/j.gastro.2009.10.048; WATANABE O, 1984, AM J PHYSIOL, V246, pG457, DOI 10.1152/ajpgi.1984.246.4.G457; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; WILLEMER S, 1990, HISTOCHEMISTRY, V94, P161, DOI 10.1007/BF02440183; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	59	9	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24284	24293		10.1074/jbc.M111.328815	http://dx.doi.org/10.1074/jbc.M111.328815			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22570480	hybrid, Green Published			2022-12-25	WOS:000306651100022
J	Thein, M; Bonde, M; Bunikis, I; Denker, K; Sickmann, A; Bergstrom, S; Benz, R				Thein, Marcus; Bonde, Mari; Bunikis, Ignas; Denker, Katrin; Sickmann, Albert; Bergstroem, Sven; Benz, Roland			DipA, a Pore-Forming Protein in the Outer Membrane of Lyme Disease Spirochetes Exhibits Specificity for the Permeation of Dicarboxylates	PLOS ONE			English	Article							LIPID BILAYER-MEMBRANES; FRACTURE ELECTRON-MICROSCOPY; BORRELIA-BURGDORFERI; ESCHERICHIA-COLI; BINDING-SITE; INSERTIONAL INACTIVATION; MITOCHONDRIAL PORIN; POLYACRYLAMIDE GELS; TREPONEMA-PALLIDUM; MOLECULAR ANALYSIS	Lyme disease Borreliae are highly dependent on the uptake of nutrients provided by their hosts. Our study describes the identification of a 36 kDa protein that functions as putative dicarboxylate-specific porin in the outer membrane of Lyme disease Borrelia. The protein was purified by hydroxyapatite chromatography from Borrelia burgdorferi B31 and designated as DipA, for dicarboxylate-specific porin A. DipA was partially sequenced, and corresponding genes were identified in the genomes of B. burgdorferi B31, Borrelia garinii PBi and Borrelia afzelii PKo. DipA exhibits high homology to the Oms38 porins of relapsing fever Borreliae. B. burgdorferi DipA was characterized using the black lipid bilayer assay. The protein has a single-channel conductance of 50 pS in 1 M KCl, is slightly selective for anions with a permeability ratio for cations over anions of 0.57 in KCl and is not voltage-dependent. The channel could be partly blocked by different di- and tricarboxylic anions. Particular high stability constants up to about 28,000 l/mol (in 0.1 M KCl) were obtained among the 11 tested anions for oxaloacetate, 2-oxoglutarate and citrate. The results imply that DipA forms a porin specific for dicarboxylates which may play an important role for the uptake of specific nutrients in different Borrelia species.	[Thein, Marcus; Denker, Katrin; Sickmann, Albert; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Bonde, Mari; Bunikis, Ignas; Bergstroem, Sven] Umea Univ, Dept Mol Biol, Umea, Sweden; [Sickmann, Albert] Leibniz Inst Analyt Wissensch ISAS, Dept Bioanalyt, Dortmund, Germany; [Benz, Roland] Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany	German Research Foundation (DFG); University of Wurzburg; Umea University; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Bremen	Thein, M (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany.	r.benz@jacobs-university.de	Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265; Benz, Roland/0000-0002-9510-9265	Stint (Swedish Foundation for International Cooperation in Research and Higher Education); DAAD (German Academic Exchange Service); Deutsche Forschungsgemeinschaft [BE865/15]; Swedish Research Council; German Research Foundation (DFG); University of Wuerzburg	Stint (Swedish Foundation for International Cooperation in Research and Higher Education); DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by Stint (Swedish Foundation for International Cooperation in Research and Higher Education) and DAAD (German Academic Exchange Service), Deutsche Forschungsgemeinschaft (project BE865/15), and the Swedish Research Council. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Andersen C, 2003, J BIOL CHEM, V278, P24269, DOI 10.1074/jbc.M213087200; ASBRINK E, 1984, ACTA DERM-VENEREOL, V64, P291; Bagos PG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-29; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; Barcena-Uribarri I, 2010, BBA-BIOMEMBRANES, V1798, P1197, DOI 10.1016/j.bbamem.2010.02.011; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; BENZ R, 1988, EUR J BIOCHEM, V176, P699, DOI 10.1111/j.1432-1033.1988.tb14333.x; Benz R., 2001, MICROBIAL TRANSPORT, P227; Benz R., 1994, BACTERIAL CELL WALL, P397; BERGSTROM S, 1989, MOL MICROBIOL, V3, P479, DOI 10.1111/j.1365-2958.1989.tb00194.x; BERNARDINI ML, 1993, INFECT IMMUN, V61, P3625, DOI 10.1128/IAI.61.9.3625-3635.1993; BLEDSOE HA, 1994, J BACTERIOL, V176, P7447, DOI 10.1128/JB.176.24.7447-7455.1994; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; BUNIKIS J, 1995, FEMS MICROBIOL LETT, V131, P139, DOI 10.1111/j.1574-6968.1995.tb07768.x; BURGDORFER W, 1984, YALE J BIOL MED, V57, P515; CAPORALE DA, 1994, MOL BIOL EVOL, V11, P51; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Charbit A, 2003, FRONT BIOSCI, V8, pS265, DOI 10.2741/1046; Cox DL, 2001, MICROBIOL-SGM, V147, P1161, DOI 10.1099/00221287-147-5-1161; Cox DL, 1996, P NATL ACAD SCI USA, V93, P7973, DOI 10.1073/pnas.93.15.7973; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Delcour AH, 2002, J MOL MICROB BIOTECH, V4, P1; deSilva AM, 1997, J CLIN INVEST, V99, P377, DOI 10.1172/JCI119169; Ding W, 2000, J MOL BIOL, V302, P1153, DOI 10.1006/jmbi.2000.4119; EIFFERT H, 1991, MED MICROBIOL IMMUN, V180, P229, DOI 10.1007/BF00202557; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FREITAG H, 1982, FEBS LETT, V145, P72, DOI 10.1016/0014-5793(82)81209-X; Gromiha MM, 2004, J COMPUT CHEM, V25, P762, DOI 10.1002/jcc.10386; HANCOCK REW, 1986, BIOCHIM BIOPHYS ACTA, V860, P699, DOI 10.1016/0005-2736(86)90569-9; Hyde JA, 2007, J BACTERIOL, V189, P437, DOI 10.1128/JB.01109-06; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; JOHNSON RC, 1977, ANNU REV MICROBIOL, V31, P89, DOI 10.1146/annurev.mi.31.100177.000513; Kubo A, 2001, MICROBIOL-SGM, V147, P3135, DOI 10.1099/00221287-147-11-3135; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKEY JH, 1989, EUR J BIOCHEM, V186, P303, DOI 10.1111/j.1432-1033.1989.tb15209.x; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; LUDWIG O, 1986, BIOCHIM BIOPHYS ACTA, V860, P268, DOI 10.1016/0005-2736(86)90523-7; MAGNARELLI LA, 1989, J INFECT DIS, V159, P43, DOI 10.1093/infdis/159.1.43; MAIER C, 1988, J BIOL CHEM, V263, P2493; Mirzabekov Tajib A., 1996, Biophysical Journal, V70, pA205; Mulay V, 2007, J BACTERIOL, V189, P2063, DOI 10.1128/JB.01239-06; Nadelman RB, 1998, LANCET, V352, P557, DOI 10.1016/S0140-6736(98)01146-5; Nilsson CL, 2002, J AM SOC MASS SPECTR, V13, P295, DOI 10.1016/S1044-0305(01)00365-8; Noppa L, 2001, INFECT IMMUN, V69, P3323, DOI 10.1128/IAI.69.5.3323-3334.2001; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Ostberg Y, 2002, J BACTERIOL, V184, P6811, DOI 10.1128/JB.184.24.6811-6819.2002; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinne M, 2007, FEMS MICROBIOL LETT, V266, P241, DOI 10.1111/j.1574-6968.2006.00529.x; PROBERT WS, 1995, INFECT IMMUN, V63, P1933, DOI 10.1128/IAI.63.5.1933-1939.1995; RADOLF JD, 1995, INFECT IMMUN, V63, P2154, DOI 10.1128/IAI.63.6.2154-2163.1995; RADOLF JD, 1994, J BACTERIOL, V176, P21, DOI 10.1128/JB.176.1.21-31.1994; Ras NM, 1996, INT J SYST BACTERIOL, V46, P859; Reumann S, 1998, EUR J BIOCHEM, V251, P359, DOI 10.1046/j.1432-1327.1998.2510359.x; Sadziene A, 1996, INFECTION, V24, P195, DOI 10.1007/BF01713339; SADZIENE A, 1992, J EXP MED, V176, P799, DOI 10.1084/jem.176.3.799; Saier MH, 2000, J MEMBRANE BIOL, V175, P165, DOI 10.1007/s00232001065; Sallmann FR, 1999, J BIOL CHEM, V274, P16107, DOI 10.1074/jbc.274.23.16107; Schindler J, 2008, J PROTEOME RES, V7, P432, DOI 10.1021/pr0704736; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; Schwan TG, 1996, INFECT AGENT DIS, V5, P167; SEN K, 1988, J BIOL CHEM, V263, P1182; Shang ES, 1998, INFECT IMMUN, V66, P1082, DOI 10.1128/IAI.66.3.1082-1091.1998; Skare JT, 1996, J BACTERIOL, V178, P4909, DOI 10.1128/jb.178.16.4909-4918.1996; SKARE JT, 1995, J CLIN INVEST, V96, P2380, DOI 10.1172/JCI118295; Skare JT, 1997, INFECT IMMUN, V65, P3654, DOI 10.1128/IAI.65.9.3654-3661.1997; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Srivastava SY, 2008, J BACTERIOL, V190, P3429, DOI 10.1128/JB.00085-08; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Stewart PE, 2005, PLASMID, V53, P1, DOI 10.1016/j.plasmid.2004.10.006; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Thein M, 2008, J BACTERIOL, V190, P7035, DOI 10.1128/JB.00818-08; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIAS J, 1992, SCIENCE, V258, P1479, DOI 10.1126/science.1279810; WALKER EM, 1991, J BACTERIOL, V173, P5585, DOI 10.1128/jb.173.17.5585-5588.1991; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilske B, 2003, VECTOR-BORNE ZOONOT, V3, P215, DOI 10.1089/153036603322662200; Yu SL, 1998, J BIOMED SCI, V5, P370, DOI 10.1159/000025351	91	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36523	10.1371/journal.pone.0036523	http://dx.doi.org/10.1371/journal.pone.0036523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590556	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336400021
J	Kamphuis, T; Meijerhof, T; Stegmann, T; Lederhofer, J; Wilschut, J; de Haan, A				Kamphuis, Tobias; Meijerhof, Tjarko; Stegmann, Toon; Lederhofer, Julia; Wilschut, Jan; de Haan, Aalzen			Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice	PLOS ONE			English	Article							INFECTION; DISEASE; IMMUNIZATION; RESPONSES; GLYCOPROTEIN; ANTIBODIES; CHILDREN; INFANTS; ADULTS; TLR4	Respiratory Syncytial Virus (RSV) is a major cause of viral brochiolitis in infants and young children and is also a significant problem in elderly and immuno-compromised adults. To date there is no efficacious and safe RSV vaccine, partially because of the outcome of a clinical trial in the 1960s with a formalin-inactivated RSV vaccine (FI-RSV). This vaccine caused enhanced respiratory disease upon exposure to the live virus, leading to increased morbidity and the death of two children. Subsequent analyses of this incident showed that FI-RSV induces a Th2-skewed immune response together with poorly neutralizing antibodies. As a new approach, we used reconstituted RSV viral envelopes, i.e. virosomes, with incorporated monophosphoryl lipid A (MPLA) adjuvant to enhance immunogenicity and to skew the immune response towards a Th1 phenotype. Incorporation of MPLA stimulated the overall immunogenicity of the virosomes compared to non-adjuvanted virosomes in mice. Intramuscular administration of the vaccine led to the induction of RSV-specific IgG2a levels similar to those induced by inoculation of the animals with live RSV. These antibodies were able to neutralize RSV in vitro. Furthermore, MPLA-adjuvanted RSV virosomes induced high amounts of IFN gamma and low amounts of IL5 in both spleens and lungs of immunized and subsequently challenged animals, compared to levels of these cytokines in animals vaccinated with FI-RSV, indicating a Th1-skewed response. Mice vaccinated with RSV-MPLA virosomes were protected from live RSV challenge, clearing the inoculated virus without showing signs of lung pathology. Taken together, these data demonstrate that RSV-MPLA virosomes represent a safe and efficacious vaccine candidate which warrants further evaluation.	[Kamphuis, Tobias; Meijerhof, Tjarko; Stegmann, Toon; Lederhofer, Julia; Wilschut, Jan; de Haan, Aalzen] Univ Groningen, Dept Med Microbiol, Mol Virol Sect, Univ Med Ctr Groningen, Groningen, Netherlands; [Stegmann, Toon] Mymetics BV, Leiden, Netherlands	University of Groningen	Kamphuis, T (corresponding author), Univ Groningen, Dept Med Microbiol, Mol Virol Sect, Univ Med Ctr Groningen, Groningen, Netherlands.	t.kamphuis@umcg.nl		Lederhofer, Julia/0000-0001-9096-9701	Consortium of Top Institute Pharma, the Netherlands [T4-214]	Consortium of Top Institute Pharma, the Netherlands	This work was supported by Consortium T4-214 of Top Institute Pharma, the Netherlands. The funders had no role in study design, data collection and analysis or preparation of the manuscript. The manuscript was evaluated and subsequently approved for publication by TI Pharma.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Boukhvalova MS, 2006, VACCINE, V24, P5027, DOI 10.1016/j.vaccine.2006.03.064; Budimir N, 2010, VACCINE, V28, P8280, DOI 10.1016/j.vaccine.2010.10.007; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Crommelin D, 2010, NAT REV DRUG DISCOV, V9, P99, DOI 10.1038/nrd3087; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Falsey AR, 2007, SEMIN RESP CRIT CARE, V28, P171, DOI 10.1055/s-2007-976489; Falsey AR, 2006, CLIN INFECT DIS, V42, P518, DOI 10.1086/499955; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Garcon N, 2011, VACCINE, V29, P4453, DOI 10.1016/j.vaccine.2011.04.046; Garcon N, 2011, EXPERT OPIN BIOL TH, V11, P667, DOI 10.1517/14712598.2011.573624; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Groothuis JR, 2011, ADV THER, V28, P110, DOI 10.1007/s12325-010-0101-y; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hampp C, 2011, ARCH PEDIAT ADOL MED, V165, P498, DOI 10.1001/archpediatrics.2010.298; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; JOHNSON RS, 1990, J BIOL CHEM, V265, P8108; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KIM H, 1969, AM J; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Moghaddam A, 2006, NAT MED, V12, P905, DOI 10.1038/nm1456; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P197, DOI 10.1128/JCM.24.2.197-202.1986; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Polack FP, 2004, PEDIATR INFECT DIS J, V23, pS65, DOI 10.1097/01.inf.0000108194.71892.95; Prince GA, 2001, VACCINE, V19, P2048, DOI 10.1016/S0264-410X(00)00417-5; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Stegmann T, 2010, VACCINE, V28, P5543, DOI 10.1016/j.vaccine.2010.06.041; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; WELLIVER RC, 1984, J IMMUNOL, V133, P1925; WELLIVER RC, 1981, NEW ENGL J MED, V305, P841, DOI 10.1056/NEJM198110083051501	44	61	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36812	10.1371/journal.pone.0036812	http://dx.doi.org/10.1371/journal.pone.0036812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590614	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100063
J	Ospina, S; Rusch, GM; Pezo, D; Casanoves, F; Sinclair, FL				Ospina, Sonia; Rusch, Graciela M.; Pezo, Danilo; Casanoves, Fernando; Sinclair, Fergus L.			More Stable Productivity of Semi Natural Grasslands than Sown Pastures in a Seasonally Dry Climate	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; SILVOPASTORAL SYSTEMS; PLANT DIVERSITY; NORTH-AMERICAN; PRECIPITATION; BIODIVERSITY; VARIABILITY; SAVANNAS; RAINFALL; BIOMASS	In the Neotropics the predominant pathway to intensify productivity is generally thought to be to convert grasslands to sown pastures, mostly in monoculture. This article examines how above-ground net primary productivity (ANPP) in semi-natural grasslands and sown pastures in Central America respond to rainfall by: (i) assessing the relationships between ANPP and accumulated rainfall and indices of rainfall distribution, (ii) evaluating the variability of ANPP between and within seasons, and (iii) estimating the temporal stability of ANPP. We conducted sequential biomass harvests during 12 periods of 22 days and related those to rainfall. There were significant relationships between ANPP and cumulative rainfall in 22-day periods for both vegetation types and a model including a linear and quadratic term explained 74% of the variation in the data. There was also a significant correlation between ANPP and the number of rainfall events for both vegetation types. Sown pastures had higher ANPP increments per unit rainfall and higher ANPP at the peak of the rainy season than semi-natural grasslands. In contrast, semi-natural grasslands showed higher ANPP early in the dry season. The temporal stability of ANPP was higher in semi-natural grasslands than in the sown pastures in the dry season and over a whole annual cycle. Our results reveal that, contrary to conventional thinking amongst pasture scientists, there appears to be no increase in ANPP arising from replacing semi-natural grasslands with sown pastures under prevailing pasture management practices in seasonally dry climates, while the temporal distribution of ANPP is more even in semi-natural grasslands. Neither sown pastures nor semi-natural grasslands are productive towards the end of the dry season, indicating the potential importance of the widespread practice of retaining tree cover in pastures.	[Ospina, Sonia] Ctr Res Sustainable Agr Prod Syst, Area Sustainable Livestock, Cali, Colombia; [Rusch, Graciela M.] Norwegian Inst Nat Res, Dept Terr Ecol, N-7004 Trondheim, Norway; [Pezo, Danilo] Trop Agr Res & Higher Educ Ctr, Livestock & Environm Program, Turrialba, Costa Rica; [Casanoves, Fernando] Trop Agr Res & Higher Educ Ctr, Biometr Unit, Turrialba, Costa Rica; [Sinclair, Fergus L.] Bangor Univ, Coll Nat Sci, Bangor, Gwynedd, Wales; [Sinclair, Fergus L.] World Agroforestry Ctr, Nairobi, Kenya	Norwegian Institute Nature Research; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; Bangor University; CGIAR; World Agroforestry (ICRAF)	Ospina, S (corresponding author), Ctr Res Sustainable Agr Prod Syst, Area Sustainable Livestock, Cali, Colombia.	sospina@cipav.org.co	Casanoves, Fernando/I-3588-2016	Casanoves, Fernando/0000-0001-8765-9382; Rusch, Graciela/0000-0003-3769-8345	Norwegian Institute for Nature Research; Tropical Agricultural Research and Higher Education Center (CATIE); University of Oslo - SUM; Norwegian Agency for Development Cooperation; "Multi-stake holders participatory development of sustainable land use alternatives for degraded pasturelands in Central America" project; Norwegian Ministry of Foreign Affairs; Research Council of Norway; Norwegian Agency for Development Cooperation (Norad); Pastures in Central America project	Norwegian Institute for Nature Research(Bioforsk); Tropical Agricultural Research and Higher Education Center (CATIE); University of Oslo - SUM; Norwegian Agency for Development Cooperation; "Multi-stake holders participatory development of sustainable land use alternatives for degraded pasturelands in Central America" project; Norwegian Ministry of Foreign Affairs; Research Council of Norway(Research Council of Norway); Norwegian Agency for Development Cooperation (Norad)(CGIAR); Pastures in Central America project	This study was funded in part by the Pastures in Central America project, a collaboration by the Norwegian Institute for Nature Research, the Tropical Agricultural Research and Higher Education Center (CATIE) and the University of Oslo - SUM funded by the Norwegian Agency for Development Cooperation. Additional support was provided by the "Multi-stake holders participatory development of sustainable land use alternatives for degraded pasturelands in Central America" project, led by CATIE and funded by the Norwegian Ministry of Foreign Affairs, and by the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Andreas Nieuwenhuyse, for his assistance with the characterization of soils, as well as to Eddie and Norman Salazar for their support with the design of a database for this study. We also thank: Evaristo Lanuza, Otilio Castro, Eddie Gonzalez, Santiago Espino, Adolfo Roque, Adolfo Zeledon, Vicente Moreno, Rosalio Bermudez, Luis Rocha and their families for allowing us to work in their farms. The research was funded by the Norwegian Agency for Development Cooperation (Norad) and the Research Council of Norway.	Altesor A, 2005, PLANT ECOL, V179, P83, DOI 10.1007/s11258-004-5800-5; Andrade HJ, 2008, PLANT SOIL, V308, P11, DOI 10.1007/s11104-008-9600-x; Baeza S, 2010, APPL VEG SCI, V13, P72, DOI 10.1111/j.1654-109X.2009.01051.x; Baruch Z, 2005, FLORA, V200, P49, DOI 10.1016/j.flora.2004.06.001; Baruch Z, 1996, PLANT SOIL, V181, P175, DOI 10.1007/BF00012051; Bullock S.H., 1995, SEASONALLY DRY TROPI; Cajas-Giron YS, 2001, AGROFOREST SYST, V53, P215, DOI 10.1023/A:1013384706085; Caldeira MC, 2005, OIKOS, V110, P115, DOI 10.1111/j.0030-1299.2005.13873.x; Camberlin P, 2009, THEOR APPL CLIMATOL, V98, P237, DOI 10.1007/s00704-009-0113-1; Chidumayo EN, 2003, J TROP ECOL, V19, P407, DOI 10.1017/S0266467403003456; de Bello F, 2009, AGR ECOSYST ENVIRON, V131, P303, DOI 10.1016/j.agee.2009.02.002; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; Dias-Filho M.B., 2007, DEGRADACAO PASTAGENS, Vfourth.; Dias-Filho MB, 2005, DEGRADACAO PASTAGNES; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fahey T. J., 2007, Principles and standards for measuring primary production, P3; FISHER MJ, 1994, NATURE, V371, P236, DOI 10.1038/371236a0; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Guenni O, 2004, PLANT SOIL, V258, P249, DOI 10.1023/B:PLSO.0000016555.53797.58; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Holdridge LR, 2000, ECOLOGIA BASADA ZONA; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2006, OECOLOGIA, V149, P456, DOI 10.1007/s00442-006-0468-2; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loik ME, 2004, OECOLOGIA, V141, P269, DOI 10.1007/s00442-004-1570-y; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; Maass MJ, 1995, SEASONALLY DRY TROPI, P399; Marengo JA, 2001, J CLIMATE, V14, P833, DOI 10.1175/1520-0442(2001)014<0833:OAEOTR>2.0.CO;2; Moron V, 2007, J CLIMATE, V20, P5244, DOI 10.1175/2007JCLI1623.1; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Pieters A, 1997, J RANGE MANAGE, V50, P268, DOI 10.2307/4003728; Poorter H., 2007, FUNCTIONAL PLANT ECO, P67, DOI DOI 10.1201/9781420007626; Rivas L, POTENTIAL EC IMPACT; Sala OE, 2000, METHODS IN ECOSYSTEM SCIENCE, P31; Sarmiento G, 1984, ECOLOGY NEOTROPICAL; Sarmiento G, 1999, ECOLOGICAL SOCIOECON, P295; Savadogo P, 2007, AGR ECOSYST ENVIRON, V118, P80, DOI 10.1016/j.agee.2006.05.002; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Simpson P, 1996, NEW ZEAL J AGR RES, V39, P601, DOI 10.1080/00288233.1996.9513219; Snyman HA, 2009, AGR ECOSYST ENVIRON, V131, P247, DOI 10.1016/j.agee.2009.01.023; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Team R. D. C, 2011, R LANG ENV STAT COMP; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614	51	23	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35555	10.1371/journal.pone.0035555	http://dx.doi.org/10.1371/journal.pone.0035555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590506	gold, Green Published			2022-12-25	WOS:000305336100010
J	Osvath, M; Karvonen, E				Osvath, Mathias; Karvonen, Elin			Spontaneous Innovation for Future Deception in a Male Chimpanzee	PLOS ONE			English	Article							MENTAL TIME-TRAVEL; WESTERN SCRUB-JAYS; TACTICAL DECEPTION; ANIMALS; FORESIGHT; EVOLUTION; COGNITION; MEMORY; RAVENS; FOOD	Background: The ability to invent means to deceive others, where the deception lies in the perceptually or contextually detached future, appears to require the coordination of sophisticated cognitive skills toward a single goal. Meanwhile innovation for a current situation has been observed in a wide range of species. Planning, on the one hand, and the social cognition required for deception on the other, have been linked to one another, both from a co-evolutionary and a neuroanatomical perspective. Innovation and deception have also been suggested to be connected in their nature of relying on novelty. Methodology/Principal Findings: We report on systematic observations suggesting innovation for future deception by a captive male chimpanzee (Pan troglodytes). As an extension of previously described behaviour - caching projectiles for later throwing at zoo visitors - the chimpanzee, again in advance, manufactured concealments from hay, as well as used naturally occurring concealments. All were placed near the visitors' observation area, allowing the chimpanzee to make throws before the crowd could back off. We observed what was likely the first instance of this innovation. Further observations showed that the creation of future-oriented concealments became the significantly preferred strategy. What is more, the chimpanzee appeared consistently to combine two deceptive strategies: hiding projectiles and inhibiting dominance display behaviour. Conclusions/Significance: The findings suggest that chimpanzees can represent the future behaviours of others while those others are not present, as well as take actions in the current situation towards such potential future behaviours. Importantly, the behaviour of the chimpanzee produced a future event, rather than merely prepared for an event that had been reliably re-occurring in the past. These findings might indicate that the chimpanzee recombined episodic memories in perceptual simulations.	[Osvath, Mathias] Lund Univ, Dept Cognit Sci, Lund, Sweden; [Karvonen, Elin] Lund Univ, Primate Res Stn Furuvik, Furuvik, Sweden	Lund University; Lund University	Osvath, M (corresponding author), Lund Univ, Dept Cognit Sci, Lund, Sweden.	mathias.osvath@lucs.lu.se			Swedish Science Foundation [2009-2332]	Swedish Science Foundation	The work was supported by the Swedish Science Foundation, grant number 2009-2332. Link: http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett L, 2003, TRENDS COGN SCI, V7, P494, DOI 10.1016/j.tics.2003.09.005; Boyer P, 2008, TRENDS COGN SCI, V12, P219, DOI 10.1016/j.tics.2008.03.003; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Bugnyar T, 2004, ANIM COGN, V7, P69, DOI 10.1007/s10071-003-0189-4; Bugnyar T, 2006, ANIM COGN, V9, P369, DOI 10.1007/s10071-006-0035-6; Byrne R.W., 1990, Primate Report, P1; Byrne Richard W., 2003, P237; BYRNE RW, 1985, ANIM BEHAV, V33, P669, DOI 10.1016/S0003-3472(85)80093-2; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Clayton NS, 2008, ANIM BEHAV, V76, pE9, DOI 10.1016/j.anbehav.2008.06.020; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Clayton NS, 2003, TRENDS COGN SCI, V7, P436, DOI 10.1016/j.tics.2003.08.003; Correia SPC, 2007, CURR BIOL, V17, P856, DOI 10.1016/j.cub.2007.03.063; Dally JM, 2005, ANIM BEHAV, V70, P1251, DOI 10.1016/j.anbehav.2005.02.009; de Waal Frans B.M., 1992, Evolutionary Anthropology, V1, P86, DOI 10.1002/evan.1360010306; Dufour V, 2008, BEHAV PROCESS, V79, P19, DOI 10.1016/j.beproc.2008.04.003; Humphrey N., 1992, HIST MIND; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; Kwai M., 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; Lee P.C., 1991, P39; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Lurz RW, 2011, BRADFORD BOOKS, P1; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Naqshbandi M, 2006, J COMP PSYCHOL, V120, P345, DOI 10.1037/0735-7036.120.4.345; Osvath M, 2010, TRENDS COGN SCI, V14, P51, DOI 10.1016/j.tics.2009.11.007; Osvath M, 2008, ANIM COGN, V11, P661, DOI 10.1007/s10071-008-0157-0; Osvath M, 2010, ANIM COGN, V13, P777, DOI 10.1007/s10071-010-0336-7; Osvath M, 2009, CURR BIOL, V19, pR190, DOI 10.1016/j.cub.2009.01.010; Penn DC, 2007, PHILOS T R SOC B, V362, P731, DOI 10.1098/rstb.2006.2023; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Raby CR, 2009, BEHAV PROCESS, V80, P314, DOI 10.1016/j.beproc.2008.12.005; Reader S. M., 2003, ANIMAL INNOVATION, P3, DOI DOI 10.1093/ACPROF:OSO/9780198526223.001.0001; Rilling JK, 2007, P NATL ACAD SCI USA, V104, P17146, DOI 10.1073/pnas.0705132104; Roberts WA, 2010, TRENDS COGN SCI, V14, P52, DOI 10.1016/j.tics.2009.11.009; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Suddendorf T, 2003, TRENDS COGN SCI, V7, P437, DOI 10.1016/j.tics.2003.08.010; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Suddendorf T, 2008, ANIM BEHAV, V75, pE1, DOI 10.1016/j.anbehav.2008.01.006; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suddendorf T, 2010, BEHAV BRAIN RES, V215, P292, DOI 10.1016/j.bbr.2009.11.044; Suddendorf T, 2010, WIRES COGN SCI, V1, P99, DOI 10.1002/wcs.23; Suddendorf T, 2009, ANIM COGN, V12, P751, DOI 10.1007/s10071-009-0253-9; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Tulving E., 1972, ORG MEMORY, P423; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682	48	43	44	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36782	10.1371/journal.pone.0036782	http://dx.doi.org/10.1371/journal.pone.0036782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590606	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336100060
J	Brion, F; Le Page, Y; Piccini, B; Cardoso, O; Tong, SK; Chung, BC; Kah, O				Brion, Francois; Le Page, Yann; Piccini, Benjamin; Cardoso, Olivier; Tong, Sok-Keng; Chung, Bon-chu; Kah, Olivier			Screening Estrogenic Activities of Chemicals or Mixtures In Vivo Using Transgenic (cyp19a1b-GFP) Zebrafish Embryos	PLOS ONE			English	Article							BRAIN AROMATASE; ANDROGEN RECEPTOR; FATHEAD MINNOW; EXPRESSION; BINDING; GENE; WILDLIFE; 5-ALPHA-REDUCTASE; XENOESTROGENS; METABOLITES	The tg(cyp19a1b-GFP) transgenic zebrafish expresses GFP (green fluorescent protein) under the control of the cyp19a1b gene, encoding brain aromatase. This gene has two major characteristics: (i) it is only expressed in radial glial progenitors in the brain of fish and (ii) it is exquisitely sensitive to estrogens. Based on these properties, we demonstrate that natural or synthetic hormones (alone or in binary mixture), including androgens or progestagens, and industrial chemicals induce a concentration-dependent GFP expression in radial glial progenitors. As GFP expression can be quantified by in vivo imaging, this model presents a very powerful tool to screen and characterize compounds potentially acting as estrogen mimics either directly or after metabolization by the zebrafish embryo. This study also shows that radial glial cells that act as stem cells are direct targets for a large panel of endocrine disruptors, calling for more attention regarding the impact of environmental estrogens and/or certain pharmaceuticals on brain development. Altogether these data identify this in vivo bioassay as an interesting alternative to detect estrogen mimics in hazard and risk assessment perspective.	[Brion, Francois; Piccini, Benjamin; Cardoso, Olivier] Inst Natl Environm Ind & Risques INERIS, Unite Ecotoxicol Vitro & Vivo, Direct Risques Chron, Verneuil En Halatte, France; [Le Page, Yann; Kah, Olivier] Univ Rennes 1, Inst Rech Sante Environm & Travail IRSET, INSERM, BIOSIT,U1085, Rennes, France; [Tong, Sok-Keng; Chung, Bon-chu] Acad Sinica, Taiwan Inst Mol Biol, Taipei 115, Taiwan	Institut National de l'Environnement Industriel et des Risques (INERIS); Universite de Reims Champagne-Ardenne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Academia Sinica - Taiwan	Brion, F (corresponding author), Inst Natl Environm Ind & Risques INERIS, Unite Ecotoxicol Vitro & Vivo, Direct Risques Chron, Verneuil En Halatte, France.	olivier.kah@univ-rennes1.fr	BRION, Francois/Q-8713-2018; kah, olivier/K-7624-2012; Tong, Sok-Keng/Y-6513-2019; Le Page, yann/K-2868-2015	BRION, Francois/0000-0003-2341-4196; Le Page, yann/0000-0002-7194-8267; Tong, Sok Keng/0000-0002-8504-9473; Chung, Bon-chu/0000-0002-8612-0219	ANR NEED [CES-2008-11]; NEMO; NSC Taiwan-CNRS France exchange program	ANR NEED(French National Research Agency (ANR)); NEMO; NSC Taiwan-CNRS France exchange program	The ANR NEED (CES-2008-11) (to O.K. and F.B.), the Post-Grenelle grant NEMO (to F. B. and O.K.) and a NSC Taiwan-CNRS France exchange program (to B. C.C. and O.K.) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI [10.1897/1551-5028(2003)022&lt;1350:EOTAGP&gt;2.0.CO;2, 10.1002/etc.5620220623]; Bauer ERS, 2000, APMIS, V108, P838, DOI 10.1111/j.1600-0463.2000.tb00007.x; BERENBAUM MC, 1985, J THEOR BIOL, V114, P413, DOI 10.1016/S0022-5193(85)80176-4; Besse JP, 2008, TOXICOL LETT, V176, P104, DOI 10.1016/j.toxlet.2007.10.012; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; BOTELLA J, 1995, J STEROID BIOCHEM, V55, P77, DOI 10.1016/0960-0760(95)00156-T; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Chen H, 2010, AQUAT TOXICOL, V96, P53, DOI 10.1016/j.aquatox.2009.09.015; Cheshenko K, 2007, TOXICOL SCI, V96, P255, DOI 10.1093/toxsci/kfm003; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Cosnefroy A, 2009, TOXICOL IN VITRO, V23, P1450, DOI 10.1016/j.tiv.2009.07.003; Cosnefroy A, 2012, TOXICOL SCI, V125, P439, DOI 10.1093/toxsci/kfr297; Diotel N, 2011, EUR J NEUROSCI, V34, P45, DOI 10.1111/j.1460-9568.2011.07731.x; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Garcia-Becerra R, 2002, J STEROID BIOCHEM, V82, P333, DOI 10.1016/S0960-0760(02)00192-9; Gorelick DA, 2011, ENDOCRINOLOGY, V152, P2690, DOI 10.1210/en.2010-1257; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Larrea F, 2001, ENDOCRINOLOGY, V142, P3791, DOI 10.1210/en.142.9.3791; Le Page Y, 2006, ENVIRON HEALTH PERSP, V114, P752, DOI 10.1289/ehp.8141; Le Page Y, 2008, MOL REPROD DEV, V75, P1549, DOI 10.1002/mrd.20892; Legler J, 2002, ENVIRON SCI TECHNOL, V36, P4410, DOI 10.1021/es010323a; Lephart ED, 1996, BRAIN RES REV, V22, P1; Martinez-Cerdeno V, 2006, EUR J NEUROSCI, V24, P3475, DOI 10.1111/j.1460-9568.2006.05239.x; McCarthy MM, 2009, NEUROSCIENTIST, V15, P599, DOI 10.1177/1073858409340924; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; Miyashita M, 2004, CHEMOSPHERE, V54, P1273, DOI 10.1016/j.chemosphere.2003.10.035; Mouriec K, 2009, DEV DYNAM, V238, P2641, DOI 10.1002/dvdy.22069; Mouriec K, 2009, BIOL REPROD, V80, P889, DOI 10.1095/biolreprod.108.073643; Mueller SO, 2004, ANAL BIOANAL CHEM, V378, P582, DOI 10.1007/s00216-003-2238-x; OECD, 2006, DRAFT REP PREV INT V, P185; PASMANIK M, 1988, ENDOCRINOLOGY, V122, P1349, DOI 10.1210/endo-122-4-1349; PASMANIK M, 1985, GEN COMP ENDOCR, V60, P244, DOI 10.1016/0016-6480(85)90320-X; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Pillon A, 2005, ENVIRON HEALTH PERSP, V113, P278, DOI 10.1289/ehp.7522; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189; Sassi-Messai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004935; Schwartz P, 2010, SCI TOTAL ENVIRON, V409, P326, DOI 10.1016/j.scitotenv.2010.10.017; Sugiyama N, 2009, MOL PSYCHIATR, V14, P223, DOI 10.1038/mp.2008.118; Sugiyama N, 2010, TRENDS ENDOCRIN MET, V21, P545, DOI 10.1016/j.tem.2010.05.001; Thorpe KL, 2007, AQUAT TOXICOL, V85, P176, DOI 10.1016/j.aquatox.2007.08.012; Tong SK, 2009, GENESIS, V47, P67, DOI 10.1002/dvg.20459; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; Vosges M, 2010, AQUAT TOXICOL, V99, P479, DOI 10.1016/j.aquatox.2010.06.009; Wang L, 2003, P NATL ACAD SCI USA, V100, P703, DOI 10.1073/pnas.242735799; Wang L, 2001, P NATL ACAD SCI USA, V98, P2792, DOI 10.1073/pnas.041617498; Wilson VS, 2007, ENVIRON TOXICOL CHEM, V26, P1793, DOI 10.1897/06-593R.1; Zeman F, 2008, THESIS U MONTPELLIER, P164; Zsarnovszky A, 2005, ENDOCRINOLOGY, V146, P5388, DOI 10.1210/en.2005-0565	50	136	142	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36069	10.1371/journal.pone.0036069	http://dx.doi.org/10.1371/journal.pone.0036069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586461	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000023
J	Peyroche, G; Saveanu, C; Dauplais, M; Lazard, M; Beuneu, F; Decourty, L; Malabat, C; Jacquier, A; Blanquet, S; Plateau, P				Peyroche, Gerald; Saveanu, Cosmin; Dauplais, Marc; Lazard, Myriam; Beuneu, Francois; Decourty, Laurence; Malabat, Christophe; Jacquier, Alain; Blanquet, Sylvain; Plateau, Pierre			Sodium Selenide Toxicity Is Mediated by O-2-Dependent DNA Breaks	PLOS ONE			English	Article							5-(DIETHOXYPHOSPHORYL)-5-METHYL-1-PYRROLINE N-OXIDE; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; HOMOLOGOUS RECOMBINATION; GLUTATHIONE REDUCTASE; HYDROGEN-SULFIDE; GENES; YEAST; DAMAGE	Hydrogen selenide is a recurrent metabolite of selenium compounds. However, few experiments studied the direct link between this toxic agent and cell death. To address this question, we first screened a systematic collection of Saccharomyces cerevisiae haploid knockout strains for sensitivity to sodium selenide, a donor for hydrogen selenide (H2Se/HSe-/Se2-). Among the genes whose deletion caused hypresensitivity, homologous recombination and DNA damage checkpoint genes were over-represented, suggesting that DNA double-strand breaks are a dominant cause of hydrogen selenide toxicity. Consistent with this hypothesis, treatment of S. cerevisiae cells with sodium selenide triggered G2/M checkpoint activation and induced in vivo chromosome fragmentation. In vitro, sodium selenide directly induced DNA phosphodiester-bond breaks via an O-2-dependent reaction. The reaction was inhibited by mannitol, a hydroxyl radical quencher, but not by superoxide dismutase or catalase, strongly suggesting the involvement of hydroxyl radicals and ruling out participations of superoxide anions or hydrogen peroxide. The (OH)-O-center dot signature could indeed be detected by electron spin resonance upon exposure of a solution of sodium selenide to O-2. Finally we showed that, in vivo, toxicity strictly depended on the presence of O-2. Therefore, by combining genome-wide and biochemical approaches, we demonstrated that, in yeast cells, hydrogen selenide induces toxic DNA breaks through an O-2-dependent radical-based mechanism.	[Peyroche, Gerald; Dauplais, Marc; Lazard, Myriam; Blanquet, Sylvain; Plateau, Pierre] Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France; [Saveanu, Cosmin; Decourty, Laurence; Malabat, Christophe; Jacquier, Alain] Inst Pasteur, CNRS, Unite Genet Interact Macromol, URA2171, Paris, France; [Beuneu, Francois] Ecole Polytech, CNRS, Lab Solides Irradies, CEA,UMR7642, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; CNRS - Institute of Physics (INP)	Peyroche, G (corresponding author), Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France.	pierre.plateau@polytechnique.edu	Saveanu, Cosmin/Q-1251-2019; Saveanu, Cosmin/K-6494-2015	Saveanu, Cosmin/0000-0002-1677-7936; Saveanu, Cosmin/0000-0002-1677-7936; JACQUIER, ALAIN/0000-0001-5707-9184; Malabat, Christophe/0000-0003-2551-2355; Lazard, Myriam/0000-0002-7154-1352	CNRS; Ecole polytechnique; Ministere de l'Education Nationale; French Agence Nationale de la Recherche [ANR-08-JCJC-0019-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole polytechnique; Ministere de l'Education Nationale; French Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was funded by the CNRS, the Ecole polytechnique, the Ministere de l'Education Nationale (to GP) and the French Agence Nationale de la Recherche (ANR-08-JCJC-0019-01, GENO-GIM, to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; ANJARIA KB, 1988, MUTAT RES, V204, P605, DOI 10.1016/0165-1218(88)90063-8; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Game JC, 2003, RADIAT RES, V160, P14, DOI 10.1667/RR3019; GANTHER HE, 1971, BIOCHEMISTRY-US, V10, P4089, DOI 10.1021/bi00798a013; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; HSIEH HS, 1975, BIOCHEMISTRY-US, V14, P1632, DOI 10.1021/bi00679a014; Imura N., 1989, SE BIOL MED, P70, DOI [10.1007/978-3-642-74421-1_14, DOI 10.1007/978-3-642-74421-1_14]; Izquierdo A, 2010, MICROBIOL-SGM, V156, P2608, DOI 10.1099/mic.0.039719-0; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; KITAHARA J, 1995, GENETIC RESPONSE TO METALS, P121; KITAHARA J, 1993, JPN J TOX ENV HEALTH, V39, pP5; Ledesma MC, 2011, MOL MED, V17, P134, DOI 10.2119/molmed.2010.00136; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Letavayova L, 2008, MUTAT RES-GEN TOX EN, V652, P198, DOI 10.1016/j.mrgentox.2008.03.001; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; Lewinska A, 2008, FUNGAL GENET BIOL, V45, P1182, DOI 10.1016/j.fgb.2008.05.011; LIN Y, 1993, BIOCHEM PHARMACOL, V45, P429, DOI 10.1016/0006-2952(93)90080-G; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Manikova D, 2010, MUTAGENESIS, V25, P155, DOI 10.1093/mutage/gep056; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; Muecke R, 2010, INTEGR CANCER THER, V9, P136, DOI 10.1177/1534735410367648; NASHEF AS, 1977, ANAL BIOCHEM, V79, P394, DOI 10.1016/0003-2697(77)90413-4; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; NUTTALL KL, 1984, INORG CHIM A-BIOINOR, V91, P243, DOI 10.1016/S0020-1693(00)81844-7; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Pietri S, 1998, EUR J BIOCHEM, V254, P256, DOI 10.1046/j.1432-1327.1998.2540256.x; Pinson B, 2000, MOL MICROBIOL, V36, P679, DOI 10.1046/j.1365-2958.2000.01890.x; Salin H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-333; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Seitomer E, 2008, MOL NUTR FOOD RES, V52, P1305, DOI 10.1002/mnfr.200700347; Seko Y, 1997, BIOMED ENVIRON SCI, V10, P333; Selenius M, 2010, ANTIOXID REDOX SIGN, V12, P867, DOI 10.1089/ars.2009.2884; Shen HM, 2000, FREE RADICAL BIO MED, V28, P1115, DOI 10.1016/S0891-5849(00)00206-9; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tapley DW, 1999, BIOL BULL, V196, P52, DOI 10.2307/1543166; Tarze A, 2007, J BIOL CHEM, V282, P8759, DOI 10.1074/jbc.M610078200; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; WERES O, 1985, CORROSION, V41, P307, DOI 10.5006/1.3582010; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781	45	47	49	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36343	10.1371/journal.pone.0036343	http://dx.doi.org/10.1371/journal.pone.0036343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586468	gold, Green Published			2022-12-25	WOS:000305335000030
J	Zhang, YQ; Zhang, Y; Bone, RN; Cui, WX; Peng, JB; Siegal, GP; Wang, HJ; Wu, HJ				Zhang, Yanqing; Zhang, Yuan; Bone, Robert N.; Cui, Wanxing; Peng, Ji-Bin; Siegal, Gene P.; Wang, Hongjun; Wu, Hongju			Regeneration of Pancreatic Non-beta Endocrine Cells in Adult Mice following a Single Diabetes-Inducing Dose of Streptozotocin	PLOS ONE			English	Article							NEONATAL-RAT; PRECURSOR CELLS; ALPHA-CELLS; IN-VITRO; INSULIN; ISLETS; GLUCAGON; GROWTH; ONSET; PDX-1	The non-beta endocrine cells in pancreatic islets play an essential counterpart and regulatory role to the insulin-producing beta-cells in the regulation of blood-glucose homeostasis. While significant progress has been made towards the understanding of beta-cell regeneration in adults, very little is known about the regeneration of the non-b endocrine cells such as glucagon-producing alpha-cells and somatostatin producing delta-cells. Previous studies have noted the increase of alpha-cell composition in diabetes patients and in animal models. It is thus our hypothesis that non-beta-cells such as a-cells and delta-cells in adults can regenerate, and that the regeneration accelerates in diabetic conditions. To test this hypothesis, we examined islet cell composition in a streptozotocin ( STZ)-induced diabetes mouse model in detail. Our data showed the number of alpha-cells in each islet increased following STZ-mediated beta-cell destruction, peaked at Day 6, which was about 3 times that of normal islets. In addition, we found delta-cell numbers doubled by Day 6 following STZ treatment. These data suggest alpha-and delta-cell regeneration occurred rapidly following a single diabetes-inducing dose of STZ in mice. Using in vivo BrdU labeling techniques, we demonstrated alpha- and delta-cell regeneration involved cell proliferation. Co-staining of the islets with the proliferating cell marker Ki67 showed alpha- and delta-cells could replicate, suggesting self-duplication played a role in their regeneration. Furthermore, Pdx1(+)/Insulin(-) cells were detected following STZ treatment, indicating the involvement of endocrine progenitor cells in the regeneration of these non-beta cells. This is further confirmed by the detection of Pdx1(+)/glucagon(+) cells and Pdx1(+)/somatostatin(+) cells following STZ treatment. Taken together, our study demonstrated adult alpha-and delta-cells could regenerate, and both self-duplication and regeneration from endocrine precursor cells were involved in their regeneration.	[Zhang, Yanqing; Wu, Hongju] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Zhang, Yuan; Peng, Ji-Bin] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Bone, Robert N.; Siegal, Gene P.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Cui, Wanxing] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Siegal, Gene P.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Wang, Hongjun] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA; [Zhang, Yanqing] Guangzhou Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhang, Yanqing; Wu, Hongju] Tulane Univ, Dept Med, New Orleans, LA 70118 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Medical University of South Carolina; Guangzhou Medical University; Tulane University	Zhang, YQ (corresponding author), Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA.	hwu3@tulane.edu	Wang, Hongjun/AAA-1319-2021; Siegal, Gene/A-8653-2009	Siegal, Gene/0000-0003-3857-3368; Bone, Robert/0000-0003-3222-8918	Juvenile Diabetes Research Foundation [27-2009-378]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK081463]; American Heart Association Greater Southeast Affiliate [09GRNT2160024]; National Institutes of Health [R01DK072154]; CoBRE core facility; Histology Research Laboratory in Tulane University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072154, R01DK081463] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association Greater Southeast Affiliate(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CoBRE core facility; Histology Research Laboratory in Tulane University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Juvenile Diabetes Research Foundation grant 27-2009-378 and the National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK081463. J-B. Peng was supported by grants 09GRNT2160024 from the American Heart Association Greater Southeast Affiliate and R01DK072154 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Edward Phillips and Shawn Williams in the UAB High Resolution Imaging Facility for their excellent technical assistance with microscopic imaging. They are also thankful for the technical support from the Center for Metabolic Bone Disease Core Laboratory and the Animal Physiology Core in the Diabetes Research and Training Center at UAB. Finally, the authors want to thank the CoBRE core facility and Histology Research Laboratory in Tulane University for their kind support.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; BONNERWEIR S, 1981, DIABETES, V30, P64, DOI 10.2337/diabetes.30.1.64; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chen XJ, 2009, TRANSPLANTATION, V88, P496, DOI 10.1097/TP.0b013e3181b0d2ee; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; DALESSIO DA, 1989, J CLIN INVEST, V84, P857, DOI 10.1172/JCI114246; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Iki K, 2007, J HISTOCHEM CYTOCHEM, V55, P111, DOI 10.1369/jhc.6A7024.2006; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kaneto H, 2008, ENDOCR J, V55, P235, DOI 10.1507/endocrj.K07E-041; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Liu H, 2010, ENDOCRINOLOGY, V151, P520, DOI 10.1210/en.2009-0992; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016096; MANDARINO L, 1981, NATURE, V291, P76, DOI 10.1038/291076a0; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Offield MF, 1996, DEVELOPMENT, V122, P983; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; OReilly LA, 1997, DIABETES, V46, P599, DOI 10.2337/diabetes.46.4.599; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Pechhold K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004827; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; RAHIER J, 1983, DIABETOLOGIA, V24, P366; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; SAMOLS E, 1986, CLIN ENDOCRINOL META, V15, P33, DOI 10.1016/S0300-595X(86)80041-X; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Strowski MZ, 2000, ENDOCRINOLOGY, V141, P111, DOI 10.1210/en.141.1.111; TEITELMAN G, 1993, DEVELOPMENT, V118, P1031; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Unger RH, 2010, P NATL ACAD SCI USA, V107, P16009, DOI 10.1073/pnas.1006639107; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	44	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36675	10.1371/journal.pone.0036675	http://dx.doi.org/10.1371/journal.pone.0036675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586489	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335000050
J	Leppiniemi, J; Gronroos, T; Maatta, JAE; Johnson, MS; Kulomaa, MS; Hytonen, VP; Airenne, TT				Leppiniemi, Jenni; Gronroos, Toni; Maatta, Juha A. E.; Johnson, Mark S.; Kulomaa, Markku S.; Hytonen, Vesa P.; Airenne, Tomi T.			Structure of Bradavidin - C-Terminal Residues Act as Intrinsic Ligands	PLOS ONE			English	Article							AVIDIN PROTEIN FAMILY; STREPTAVIDIN-BINDING PEPTIDE; TAG II PEPTIDE; BIOTIN-BINDING; CHICKEN AVIDIN; STREP-TAG; RECOMBINANT PROTEINS; AFFINITY PEPTIDE; BRADYRHIZOBIUM-JAPONICUM; CORE STREPTAVIDIN	Bradavidin is a homotetrameric biotin-binding protein from Bradyrhizobium japonicum, a nitrogen fixing and root nodule-forming symbiotic bacterium of the soybean. Wild-type (wt) bradavidin has 138 amino acid residues, whereas the C-terminally truncated core-bradavidin has only 118 residues. We have solved the X-ray structure of wt bradavidin and found that the C-terminal amino acids of each subunit were uniquely bound to the biotin-binding pocket of an adjacent subunit. The biotin-binding pocket occupying peptide (SEKLSNTK) was named "Brad-tag" and it serves as an intrinsic stabilizing ligand in wt bradavidin. The binding of Brad-tag to core-bradavidin was analysed by isothermal titration calorimetry and a binding affinity of similar to 25 mu M was measured. In order to study the potential of Brad-tag, a green fluorescent protein tagged with Brad-tag was prepared and successfully concentrated from a bacterial cell lysate using core-bradavidin-functionalized Sepharose resin.	[Leppiniemi, Jenni; Gronroos, Toni; Maatta, Juha A. E.; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, Tampere Univ Hosp, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Leppiniemi, Jenni; Gronroos, Toni; Maatta, Juha A. E.; Kulomaa, Markku S.; Hytonen, Vesa P.] BioMediTech, Tampere, Finland; [Johnson, Mark S.; Airenne, Tomi T.] Abo Akad Univ, Dept Biosci, Turku, Finland	Tampere University; Tampere University Hospital; Abo Akademi University	Leppiniemi, J (corresponding author), Univ Tampere, Tampere Univ Hosp, Inst Biomed Technol, FIN-33101 Tampere, Finland.	tomi.airenne@abo.fi	Leppiniemi, Jenni/S-6262-2019; Määttä, Juha/A-6629-2016; Kulomaa, Markku S/C-9063-2014; Leppiniemi, Jenni/A-6641-2016; Hytonen, Vesa P./E-8855-2013	Leppiniemi, Jenni/0000-0002-7225-1648; Määttä, Juha/0000-0003-3885-6149; Leppiniemi, Jenni/0000-0002-7225-1648; Hytonen, Vesa P./0000-0002-9357-1480; Gronroos, Toni/0000-0002-2830-8192	Academy of Finland [115976, 121236]; ISB (National Graduate School in Informational and Structural Biology); TGPBB (Tampere Graduate Program in Biomedicine and Biotechnology); Institute of Biomedical Technology; Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation; Tampere University Hospital [9M019, 9M042]; Joe, Pentti and Tor Borg Memorial Fund; European Community; Academy of Finland	Academy of Finland(Academy of Finland); ISB (National Graduate School in Informational and Structural Biology); TGPBB (Tampere Graduate Program in Biomedicine and Biotechnology); Institute of Biomedical Technology; Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital; Joe, Pentti and Tor Borg Memorial Fund; European Community(European Commission); Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland [projects 115976 and 121236], ISB (National Graduate School in Informational and Structural Biology), TGPBB (Tampere Graduate Program in Biomedicine and Biotechnology), the Institute of Biomedical Technology, the Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging), the Sigrid Juselius Foundation, the Competitive Research Funding of the Tampere University Hospital [Grants 9M019 and 9M042], and the Joe, Pentti and Tor Borg Memorial Fund. The authors acknowledge support by the European Community - Research Infrastructure Action under the FP6 "Structuring the European Research Area" Programme and FIRI infrastructure support for structural biology from the Academy of Finland. Biocenter Finland is acknowledged for the infrastructure support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYER EA, 1989, BIOCHEM J, V259, P369, DOI 10.1042/bj2590369; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Byron A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001827; CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Denessiouk KA, 2003, J MOL BIOL, V333, P1025, DOI 10.1016/j.jmb.2003.09.017; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farres J, 2005, BIOCHEMISTRY-US, V44, P4125, DOI 10.1021/bi047389d; Gaj T, 2007, PROTEIN EXPRES PURIF, V56, P54, DOI 10.1016/j.pep.2007.06.010; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; Hytonen VP, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-28; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VP, 2003, BIOCHEM J, V372, P219, DOI 10.1042/BJ20021531; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; KORPELA JK, 1981, EXPERIENTIA, V37, P1065, DOI 10.1007/BF02085010; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Laitinen OH, 2002, BIOCHEM J, V363, P609, DOI 10.1042/0264-6021:3630609; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Le Trong L, 2006, J MOL BIOL, V356, P738, DOI 10.1016/j.jmb.2005.11.086; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lesch HP, 2010, EXPERT OPIN DRUG DEL, V7, P551, DOI 10.1517/17425241003677749; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Maatta JAE, 2008, CHEMBIOCHEM, V9, P1124, DOI 10.1002/cbic.200700671; Maatta JAE, 2011, BIOTECHNOL BIOENG, V108, P481, DOI 10.1002/bit.22962; Maatta JAE, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-63; Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meir A, 2009, J MOL BIOL, V386, P379, DOI 10.1016/j.jmb.2008.11.061; Meyer SC, 2006, CHEM BIOL DRUG DES, V68, P3, DOI 10.1111/j.1747-0285.2006.00401.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niederhauser B, 2012, J BIOTECHNOL, V157, P38, DOI 10.1016/j.jbiotec.2011.10.014; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; Nordlund HR, 2003, FEBS LETT, V555, P449, DOI 10.1016/S0014-5793(03)01302-4; Perbandt M, 2007, PROTEINS, V67, P1147, DOI 10.1002/prot.21236; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; Rosebrough SF, 1996, J NUCL MED, V37, P1380; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANO T, 1995, J BIOL CHEM, V270, P28204; Sardo A, 2011, PROTEIN EXPRES PURIF, V77, P131, DOI 10.1016/j.pep.2011.01.003; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6; SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109; Schrodinger L., 2020, PYMOL; Skerra A, 1999, BIOMOL ENG, V16, P79, DOI 10.1016/S1050-3862(99)00033-9; Takahashi S, 2012, ANAL BIOANAL CHEM, V402, P1749, DOI 10.1007/s00216-011-5317-4; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; Wilchek M, 2006, IMMUNOL LETT, V103, P27, DOI 10.1016/j.imlet.2005.10.022; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xie H, 2009, MOL BIOTECHNOL, V42, P135, DOI 10.1007/s12033-009-9148-x; Zhou M, 2007, BIOPOLYMERS, V88, P325, DOI 10.1002/bip.20655	72	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35962	10.1371/journal.pone.0035962	http://dx.doi.org/10.1371/journal.pone.0035962			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574129	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800025
J	Rubio-Diaz, S; Perez-Perez, JM; Gonzalez-Bayon, R; Munoz-Viana, R; Borrega, N; Mouille, G; Hernandez-Romero, D; Robles, P; Hofte, H; Ponce, MR; Micol, JL				Rubio-Diaz, Silvia; Perez-Perez, Jose Manuel; Gonzalez-Bayon, Rebeca; Munoz-Viana, Rafael; Borrega, Nero; Mouille, Gregory; Hernandez-Romero, Diana; Robles, Pedro; Hoefte, Herman; Ponce, Maria Rosa; Micol, Jose Luis			Cell Expansion-Mediated Organ Growth Is Affected by Mutations in Three EXIGUA Genes	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CELLULOSE SYNTHESIS; LEAF MORPHOGENESIS; SIZE CONTROL; MUTANTS; IDENTIFICATION; PLANT; PROLIFERATION; REVEALS; ENCODES	Organ growth depends on two distinct, yet integrated, processes: cell proliferation and post-mitotic cell expansion. Although the regulatory networks of plant cell proliferation during organ growth have begun to be unveiled, the mechanisms regulating post-mitotic cell growth remain mostly unknown. Here, we report the characterization of three EXIGUA (EXI) genes that encode different subunits of the cellulose synthase complex specifically required for secondary cell wall formation. Despite this highly specific role of EXI genes, all the cells within the leaf, even those that do not have secondary walls, display small sizes in the exi mutants. In addition, we found a positive correlation between cell size and the DNA ploidy levels in exi mutant leaves, suggesting that both processes share some regulatory components. Our results are consistent with the hypothesis that the collapsed xylem vessels of the exi mutants hamper water transport throughout the plant, which, in turn, limits the turgor pressure levels required for normal post-mitotic cell expansion during leaf growth.	[Rubio-Diaz, Silvia; Perez-Perez, Jose Manuel; Gonzalez-Bayon, Rebeca; Munoz-Viana, Rafael; Hernandez-Romero, Diana; Robles, Pedro; Ponce, Maria Rosa; Micol, Jose Luis] Univ Miguel Hernandez, Inst Bioingn, Alicante, Spain; [Borrega, Nero; Mouille, Gregory; Hoefte, Herman] INRA, Ctr Versailles Grignon, Inst Natl Rech Agron AgroParisTech, Inst Jean Pierre Bourgin,UMR1318, F-78026 Versailles, France	Universidad Miguel Hernandez de Elche; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Rubio-Diaz, S (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Campus de Elche, Alicante, Spain.	jlmicol@umh.es	Micol, José Luis/B-4832-2010; Perez-Perez, Jose Manuel/B-4247-2011; Gonzalez-Bayon, Rebeca/I-4605-2012; Ponce, María Rosa/C-8203-2014; Robles, Pedro/L-5104-2014	Micol, José Luis/0000-0002-0396-1750; Perez-Perez, Jose Manuel/0000-0003-2848-4919; Ponce, María Rosa/0000-0003-0770-4230; Robles, Pedro/0000-0002-4539-5435; Gonzalez-Bayon, Rebeca/0000-0002-9939-0795; Mouille, Gregory/0000-0002-5493-754X	Ministerio de Ciencia e Innovacion of Spain [BFU2011-22825, CSD2007-00057 (TRANSPLANTA)]; Generalitat Valenciana [PROMETEO/2009/112]; European Commission [LSHG-CT-2006-037704 (AGRON-OMICS)]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Ministerio de Ciencia e Innovacion of Spain [BFU2011-22825 and CSD2007-00057 (TRANSPLANTA) grants, awarded to JLM], the Generalitat Valenciana (PROMETEO/2009/112, to JLM) and the European Commission [LSHG-CT-2006-037704 (AGRON-OMICS), to JLM and HH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Barrero JM, 2005, J EXP BOT, V56, P2071, DOI 10.1093/jxb/eri206; Berna G, 1999, GENETICS, V152, P729; Bogre L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-226; Bosca S, 2006, PLANT PHYSIOL, V142, P1353, DOI 10.1104/pp.106.087700; Breuer C, 2010, CURR OPIN PLANT BIOL, V13, P654, DOI 10.1016/j.pbi.2010.10.006; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Brux A, 2008, PLANT CELL, V20, P1088, DOI 10.1105/tpc.108.058362; Candela H, 1999, DEV BIOL, V205, P205, DOI 10.1006/dbio.1998.9111; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Chu ZQ, 2007, PLANT PHYSIOL, V143, P213, DOI 10.1104/pp.106.088393; Cochard H, 2004, PLANT PHYSIOL, V134, P401, DOI 10.1104/pp.103.028357; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Desvoyes B, 2006, PLANT PHYSIOL, V140, P67, DOI 10.1104/pp.105.071027; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Faix O., 1992, METHODS LIGNIN CHEM, P83, DOI DOI 10.1007/978-3-642-74065-7_7; Ferjani A, 2007, PLANT PHYSIOL, V144, P988, DOI [10.1104/pp.107.099325, 10.1104/PP.107.099325]; Fujikura U, 2007, PLANT CELL PHYSIOL, V48, P278, DOI 10.1093/pcp/pcm002; GALBRAITH DW, 1991, PLANT PHYSIOL, V96, P985, DOI 10.1104/pp.96.3.985; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; Gille S, 2011, PLANT CELL, V23, P4041, DOI 10.1105/tpc.111.091728; Gonzalez N, 2007, PLANT J, V51, P642, DOI 10.1111/j.1365-313X.2007.03167.x; Gonzalez-Bayon R, 2006, J EXP BOT, V57, P3019, DOI 10.1093/jxb/erl063; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Hamann T, 2009, PLANT J, V57, P1015, DOI 10.1111/j.1365-313X.2008.03744.x; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Horiguchi G, 2006, J PLANT RES, V119, P37, DOI 10.1007/s10265-005-0232-4; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Horiguchi G, 2006, PLANT J, V48, P638, DOI 10.1111/j.1365-313X.2006.02896.x; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Kawade K, 2010, DEVELOPMENT, V137, P4221, DOI 10.1242/dev.057117; Kohorn BD, 2006, PLANT J, V46, P307, DOI 10.1111/j.1365-313X.2006.02695.x; Lefebvre V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016645; Liang YK, 2010, PLANT J, V64, P679, DOI 10.1111/j.1365-313X.2010.04362.x; Perez-Perez JM, 2009, INT J DEV BIOL, V53, P1623, DOI 10.1387/ijdb.072534jp; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Micol JL, 2009, CURR OPIN PLANT BIOL, V12, P9, DOI 10.1016/j.pbi.2008.11.001; Mouille G, 2003, PLANT J, V35, P393, DOI 10.1046/j.1365-313X.2003.01807.x; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Piazza P, 2005, NEW PHYTOL, V167, P693, DOI 10.1111/j.1469-8137.2005.01466.x; Ponce M. Rosa, 2006, V323, P105; Ponce MR, 1999, MOL GEN GENET, V261, P408, DOI 10.1007/s004380050982; Ponce MR, 1998, PLANT J, V14, P497, DOI 10.1046/j.1365-313X.1998.00146.x; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Sauter A, 2001, J EXP BOT, V52, P1991, DOI 10.1093/jexbot/52.363.1991; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Serrano-Cartagena J, 1999, MOL GEN GENET, V261, P725, DOI 10.1007/s004380050016; Serrano-Cartagena J, 2000, GENETICS, V156, P1363; Shimotohno A, 2006, PLANT J, V47, P701, DOI 10.1111/j.1365-313X.2006.02820.x; Skirycz A, 2011, J PROTEOME RES, V10, P1018, DOI 10.1021/pr100785n; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Tsukaya H, 2002, INT REV CYTOL, V217, P1; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Yi K, 2010, NAT GENET, V42, P264, DOI 10.1038/ng.529; Zhong RQ, 2003, PLANT PHYSIOL, V132, P786, DOI 10.1104/pp.102.019331; ZIMMERMANN U, 1978, ANNU REV PLANT PHYS, V29, P121, DOI 10.1146/annurev.pp.29.060178.001005	71	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36500	10.1371/journal.pone.0036500	http://dx.doi.org/10.1371/journal.pone.0036500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22586475	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349800069
J	Yang, JK; Chen, FY; Yan, XX; Miao, LH; Dai, JH				Yang, Jiang-Ke; Chen, Fang-Yuan; Yan, Xiang-Xiang; Miao, Li-Hong; Dai, Jiang-Hong			A Simple and Accurate Two-Step Long DNA Sequences Synthesis Strategy to Improve Heterologous Gene Expression in Pichia	PLOS ONE			English	Article							HIGH-FIDELITY; PCR; OLIGONUCLEOTIDES; OPTIMIZATION; DESIGN	In vitro gene chemical synthesis is a powerful tool to improve the expression of gene in heterologous system. In this study, a two-step gene synthesis strategy that combines an assembly PCR and an overlap extension PCR (AOE) was developed. In this strategy, the chemically synthesized oligonucleotides were assembled into several 200-500 bp fragments with 20-25 bp overlap at each end by assembly PCR, and then an overlap extension PCR was conducted to assemble all these fragments into a full length DNA sequence. Using this method, we de novo designed and optimized the codon of Rhizopus oryzae lipase gene ROL (810 bp) and Aspergillus niger phytase gene phyA (1404 bp). Compared with the original ROL gene and phyA gene, the codon-optimized genes expressed at a significantly higher level in yeasts after methanol induction. We believe this AOE method to be of special interest as it is simple, accurate and has no limitation with respect to the size of the gene to be synthesized. Combined with de novo design, this method allows the rapid synthesis of a gene optimized for expression in the system of choice and production of sufficient biological material for molecular characterization and biotechnological application.	[Yang, Jiang-Ke; Chen, Fang-Yuan; Miao, Li-Hong; Dai, Jiang-Hong] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Peoples R China; [Yan, Xiang-Xiang] Huazhong Univ Sci & Technol, Sch Life Sci, Wuhan 430074, Peoples R China	Wuhan Polytechnic University; Huazhong University of Science & Technology	Yang, JK (corresponding author), Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Peoples R China.	jiangke.yang@gmail.com			Human Resource Foundation of Wuhan Polytechnic University; Key Project of Chinese Ministry of Education [212118]; Chinese High Technology Research and Development Program [2007AA05Z417]	Human Resource Foundation of Wuhan Polytechnic University; Key Project of Chinese Ministry of Education(Ministry of Education, China); Chinese High Technology Research and Development Program	This work was granted by Human Resource Foundation of Wuhan Polytechnic University, the Key Project of Chinese Ministry of Education.(No. 212118) and Chinese High Technology Research and Development Program (No. 2007AA05Z417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL KL, 1970, NATURE, V227, P27, DOI 10.1038/227027a0; Bai JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022577; Gao XX, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng143; Gizzi G, 2008, J AOAC INT, V91, P259; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jayaraj S, 2005, NUCLEIC ACIDS RES, V33, P3011, DOI 10.1093/nar/gki614; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI [DOI 10.1016/S0003-2670(00)88444-5, 10.1016/S0003-2670(00)88444-5]; Oberg F, 2011, MOL MEMBR BIOL, V28, P398, DOI 10.3109/09687688.2011.602219; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; SANDHU GS, 1992, BIOTECHNIQUES, V12, P14; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Yang JK, 2010, J MOL CATAL B-ENZYM, V63, P164, DOI 10.1016/j.molcatb.2010.01.011; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	21	38	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36607	10.1371/journal.pone.0036607	http://dx.doi.org/10.1371/journal.pone.0036607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574193	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349800090
J	Barclay, RMR				Barclay, Robert M. R.			Variable Variation: Annual and Seasonal Changes in Offspring Sex Ratio in a Bat	PLOS ONE			English	Article							EPTESICUS-FUSCUS; BROWN BAT; REPRODUCTIVE-BIOLOGY; GROUND-SQUIRRELS; POPULATION; CHIROPTERA; ADJUSTMENT; SURVIVAL; HYPOTHESIS; ALLOCATION	Many organisms produce offspring with sex-ratios that deviate from equal numbers of males and females, and numerous adaptive explanations have been proposed. In some species, offspring sex-ratio varies across the reproductive season, again with several explanations as to why this might be adaptive. However, patterns for birds and mammals are inconsistent, and multiple factors are likely involved. Long-term studies on a variety of species may help untangle the complexity. I analyzed a long-term data set on the variation in offspring sex-ratio of the big brown bat, Eptesicus fuscus, a temperate-zone, insectivorous species. Sex ratio varied seasonally, but only in some years. Births early in the season were significantly female biased in years in which parturition occurred relatively early, but not in years with late parturition. Survival of female pups increased with earlier median birth date for the colony, and early-born females were more likely to survive and reproduce as one-year olds, compared to later-born pups. I argue that, due to the unusual timing of reproductive activities in male and female bats that hibernate, producing female offspring early in the year increases their probability of reproducing as one year olds, but this is not the case for male offspring. Thus, mothers that can give birth early in the year, benefit most by producing a female pup. The relative benefit of producing female or male offspring varies depending on the length of the growing season and thus the time available for female pups to reach sexual maturity. This suggests that not only does sex-ratio vary seasonally and among years, depending on the condition of the mother and the environment, but also likely varies geographically due to differences in season length.	Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Barclay, RMR (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	barclay@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada [DG 39695]; University of Calgary Research Grants Committee	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Calgary Research Grants Committee	Funding for this project was received from the Natural Sciences and Engineering Research Council of Canada through Discovery Grants to the author (DG 39695), and scholarships to graduate students. Further funding was provided by the University of Calgary Research Grants Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeta R, 2012, BIOL LETTERS, V8, P401, DOI 10.1098/rsbl.2011.1009; Bain J.R., 1986, Florida Scientist, V49, P22; Barbour R.W., 1969, BATS AM; Barclay RMR, 2003, BAT ECOLOGY, P209; Brunet-Rossinni Anja K., 2009, P315; BURNETT C D, 1983, Annals of Carnegie Museum, V52, P139; BURNETT CD, 1983, J MAMMAL, V64, P437, DOI 10.2307/1380356; CAGLE FR, 1950, J MAMMAL, V31, P400, DOI 10.2307/1375106; Cagnacci A, 2005, FERTIL STERIL, V84, P246, DOI 10.1016/j.fertnstert.2004.12.054; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; CHARNOV E L, 1982; Chaverri G, 2006, J ZOOL, V270, P650, DOI 10.1111/j.1469-7998.2006.00171.x; CHRISTIAN JOHN J., 1956, AMER MIDLAND NAT, V55, P66, DOI 10.2307/2422322; CLARK AB, 1978, SCIENCE, V201, P163, DOI 10.1126/science.201.4351.163; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; Cockburn A, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P266, DOI 10.1017/CBO9780511542053.014; Daan S, 1996, BEHAV ECOL, V7, P426, DOI 10.1093/beheco/7.4.426; DIJKSTRA C, 1990, FUNCT ECOL, V4, P143, DOI 10.2307/2389333; Entwistle AC, 2000, J ZOOL, V252, P11, DOI 10.1017/S095283690000902X; Fisher R.A., 1930, GENETICAL THEORY NAT; Freed LA, 2009, EVOL ECOL RES, V11, P731; French AR, 2000, LIFE IN THE COLD, P111; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Garroway CJ, 2007, J MAMMAL, V88, P1305, DOI 10.1644/06-MAMM-A-212R2.1; GRIFFIN DONALD R., 1940, JOUR MAMMAL, V21, P181, DOI 10.2307/1374974; GRINEVITCH L, 1995, J ZOOL, V235, P301, DOI 10.1111/j.1469-7998.1995.tb05146.x; HITCHCOCK HAROLD B., 1965, CAN FIELD NATUR, V79, P4; Holand O, 2006, P ROY SOC B-BIOL SCI, V273, P293, DOI 10.1098/rspb.2005.3330; Holroyd SL, 1993, THESIS U CALGARY; Hood WR, 2002, J ZOOL, V258, P355, DOI 10.1017/S0952836902001504; KRACKOW S, 1995, BIOL REV, V70, P225, DOI 10.1111/j.1469-185X.1995.tb01066.x; Kruger O, 2005, P ROY SOC B-BIOL SCI, V272, P375, DOI 10.1098/rspb.2004.2943; KUNZ TH, 1974, J MAMMAL, V55, P1, DOI 10.2307/1379252; KURTA A, 1990, Mammalian Species, P1, DOI 10.2307/3504258; Lerchl A, 1998, HUM REPROD, V13, P1401, DOI 10.1093/humrep/13.5.1401; Martin JGA, 2011, ECOLOGY, V92, P441, DOI 10.1890/09-2413.1; Mensing-Solick YR, 2003, ACTA CHIROPTEROL, V5, P91, DOI 10.3161/001.005.0108; MICHENER GR, 1985, J MAMMAL, V66, P280, DOI 10.2307/1381240; MILLER ROLAND E., 1939, JOUR MORPH, V64, P267, DOI 10.1002/jmor.1050640205; Millesi E, 1999, ETHOLOGY, V105, P163, DOI 10.1046/j.1439-0310.1999.00379.x; MILLIGAN BN, 1993, CAN J ZOOL, V71, P937, DOI 10.1139/z93-122; MILLS RS, 1975, J MAMMAL, V56, P591, DOI 10.2307/1379471; Monadjem A, 2005, BELG J ZOOL, V135, P103; MURIE JO, 1982, J MAMMAL, V63, P431, DOI 10.2307/1380440; Navara KJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P127, DOI 10.1086/648487; O'Donnell CFJ, 2002, J ZOOL, V257, P311, DOI 10.1017/S0952836902000912; O'Shea TJ, 2010, J MAMMAL, V91, P418, DOI 10.1644/08-MAMM-A-295.1; Racey P.A., 1973, Journal Reprod Fert, V19, P175; RACEY PA, 1981, J REPROD FERTIL, V61, P123; Racey Paul A., 2009, P249; RANSOME RD, 1994, ZOOL J LINN SOC-LOND, V112, P337, DOI 10.1006/zjls.1994.1046; RANSOME RD, 1973, PERIOD BIOL, V75, P169; RICE DALE W., 1957, JOUR MAMMAL, V38, P15, DOI 10.2307/1376471; Robert KA, 2011, MAMMAL REV, V41, P1, DOI 10.1111/j.1365-2907.2010.00168.x; Sakisaka Y, 2000, MOL ECOL, V9, P1711, DOI 10.1046/j.1365-294x.2000.01038.x; SCHOWALTER DB, 1979, CAN FIELD NAT, V93, P48; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; STIRLING I, 1971, J MAMMAL, V52, P842, DOI 10.2307/1378943; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Turmelle AS, 2011, MOL ECOL, V20, P357, DOI 10.1111/j.1365-294X.2010.04947.x; Tuttle M.D., 1982, P105; Veeroja R, 2010, J ANIM ECOL, V79, P169, DOI 10.1111/j.1365-2656.2009.01599.x; Vonhof MJ, 2006, MOL ECOL, V15, P241, DOI 10.1111/j.1365-294X.2005.02801.x; Wimsatt WA, 1944, ANAT REC, V88, P193, DOI 10.1002/ar.1090880206; WIMSATT WA, 1945, J MAMMAL, V26, P23, DOI 10.2307/1375029; WRIGHT DD, 1995, AM NAT, V145, P133, DOI 10.1086/285732; ZIJLSTRA M, 1992, FUNCT ECOL, V6, P553, DOI 10.2307/2390052	68	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36344	10.1371/journal.pone.0036344	http://dx.doi.org/10.1371/journal.pone.0036344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570704	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343400020
J	Schiffer, AM; Ahlheim, C; Wurm, MF; Schubotz, RI				Schiffer, Anne-Marike; Ahlheim, Christiane; Wurm, Moritz F.; Schubotz, Ricarda I.			Surprised at All the Entropy: Hippocampal, Caudate and Midbrain Contributions to Learning from Prediction Errors	PLOS ONE			English	Article							NEOCORTICAL CONTRIBUTIONS; STIMULUS REPRESENTATION; RECOGNITION MEMORY; INFORMATION-THEORY; DORSAL STRIATUM; BASAL GANGLIA; SYSTEMS; UNCERTAINTY; SUBSTRATE; DOPAMINE	Influential concepts in neuroscientific research cast the brain a predictive machine that revises its predictions when they are violated by sensory input. This relates to the predictive coding account of perception, but also to learning. Learning from prediction errors has been suggested for take place in the hippocampal memory system as well as in the basal ganglia. The present fMRI study used an action-observation paradigm to investigate the contributions of the hippocampus, caudate nucleus and midbrain dopaminergic system to different types of learning: learning in the absence of prediction errors, learning from prediction errors, and responding to the accumulation of prediction errors in unpredictable stimulus configurations. We conducted analyses of the regions of interests' BOLD response towards these different types of learning, implementing a bootstrapping procedure to correct for false positives. We found both, caudate nucleus and the hippocampus to be activated by perceptual prediction errors. The hippocampal responses seemed to relate to the associative mismatch between a stored representation and current sensory input. Moreover, its response was significantly influenced by the average information, or Shannon entropy of the stimulus material. In accordance with earlier results, the habenula was activated by perceptual prediction errors. Lastly, we found that the substantia nigra was activated by the novelty of sensory input. In sum, we established that the midbrain dopaminergic system, the hippocampus, and the caudate nucleus were to different degrees significantly involved in the three different types of learning: acquisition of new information, learning from prediction errors and responding to unpredictable stimulus developments. We relate learning from perceptual prediction errors to the concept of predictive coding and related information theoretic accounts.	[Schiffer, Anne-Marike] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Schiffer, Anne-Marike; Ahlheim, Christiane; Wurm, Moritz F.; Schubotz, Ricarda I.] Max Planck Inst Neurol Res, Motor Cognit Grp, D-50931 Cologne, Germany; [Ahlheim, Christiane; Schubotz, Ricarda I.] Univ Munster, Inst Psychol, Munster, Germany; [Wurm, Moritz F.] Univ Trento, Ctr Mind Brain Sci, Mattarello, Italy	University of Oxford; Max Planck Society; University of Munster; University of Trento	Schiffer, AM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	anne-marike.schiffer@psy.ox.ac.uk	Schubotz, Ricarda/B-2871-2013; Wurm, Moritz/AAB-2603-2019	Wurm, Moritz/0000-0003-4358-9815; Schubotz, Ricarda/0000-0001-5802-6869; Schiffer, Marike/0000-0002-7102-4064	Max Planck Institute	Max Planck Institute(Foundation CELLEX)	The Max Planck Institute financed the fMRI study (http://www.nf.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Atallah HE, 2004, NEUROBIOL LEARN MEM, V82, P253, DOI 10.1016/j.nlm.2004.06.004; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bubic A, 2010, FRONTIERS HUMAN NEUR; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Colder B, 2011, FRONTIERS HUMAN NEUR; Crapse TB, 2008, PROG BRAIN RES, V171, P383, DOI 10.1016/S0079-6123(08)00656-0; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Davis T, J EXP PSYCH IN PRESS; den Ouden HEJ, 2010, J NEUROSCI, V30, P11177; Devan BD, 1999, J NEUROSCI, V19, P2789; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Doya K., 2007, BAYESIAN BRAIN PROBA, P3, DOI [10.7551/mitpress/9780262042383.003.0001, DOI 10.7551/MITPRESS/9780262042383.003.0001]; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Duzel E, 2003, J NEUROSCI, V23, P9439; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Frank MJ, 2003, HIPPOCAMPUS, V13, P341, DOI 10.1002/hipo.10084; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006421; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; GLUCK MA, 1993, HIPPOCAMPUS, V3, P491, DOI 10.1002/hipo.450030410; Gluck MA, 2005, NEURAL NETWORKS, V18, P1265, DOI 10.1016/j.neunet.2005.08.003; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Harrison LM, 2006, NEURAL NETWORKS, V19, P535, DOI 10.1016/j.neunet.2005.11.002; Hikosaka O, 2008, CURR OPIN NEUROBIOL, V18, P203, DOI 10.1016/j.conb.2008.07.002; Huang YP, 2011, WIRES COGN SCI, V2, P580, DOI 10.1002/wcs.142; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Kersten D, 2011, OBJECT PERCEPTION BA; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kumaran D, 2008, NEURON, V60, P197, DOI 10.1016/j.neuron.2008.10.007; Kumaran D, 2006, PLOS BIOL, V4, P2372, DOI 10.1371/journal.pbio.0040424; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Luce RD, 2003, REV GEN PSYCHOL, V7, P183, DOI 10.1037/1089-2680.7.2.183; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty J, 2003, CURRENT OPINION NEUR, V14, P769; O'Reilly RC, 2002, TRENDS COGN SCI, V6, P505, DOI 10.1016/S1364-6613(02)02005-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Rugg MD, 2008, PROG BRAIN RES, V169, P339, DOI 10.1016/S0079-6123(07)00021-0; Schiffer AM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00038; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schutz-Bosbach Simone, 2007, Cogn Process, V8, P93, DOI 10.1007/s10339-007-0167-x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Spicer J, 2007, NEUROIMAGE, V34, P455, DOI 10.1016/j.neuroimage.2006.09.012; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Talairach J., 1988, COPLANAR STEREOTAXIC; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Turk-Browne NB, 2010, J NEUROSCI, V30, P11177, DOI 10.1523/JNEUROSCI.0858-10.2010; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	68	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36445	10.1371/journal.pone.0036445	http://dx.doi.org/10.1371/journal.pone.0036445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570715	gold, Green Published			2022-12-25	WOS:000305343400031
J	Whelly, S; Johnson, S; Powell, J; Borchardt, C; Hastert, MC; Cornwall, GA				Whelly, Sandra; Johnson, Seethal; Powell, Jonathan; Borchardt, Clinton; Hastert, Mary Catherine; Cornwall, Gail A.			Nonpathological Extracellular Amyloid Is Present during Normal Epididymal Sperm Maturation	PLOS ONE			English	Article							CYSTATIN-C; FIBRILS; OLIGOMERS; PROTEIN; CRES	Amyloids are aggregated proteins characterized by a specific cross-beta-sheet structure and are typically associated with neurodegenerative diseases including Alzheimer's disease. Recently, however, several nonpathological amyloids have been found in intracellular organelles of normal mammalian tissues suggesting that amyloid may also carry out biological functions. We previously have shown that the epididymal cystatin CRES (cystatin-related epididymal spermatogenic), cst8, a reproductive-specific member of the cystatin superfamily of cysteine protease inhibitors, forms amyloid in vitro suggesting that CRES amyloid may also form in vivo within the epididymal lumen. Here we show that amyloid structures containing CRES are a component of the normal mouse epididymal lumen without any apparent cytotoxic effects on spermatozoa and that these structures change along the length of the tubule. These studies suggest the presence of a functional amyloid structure that may carry out roles in sperm maturation or maintenance of the luminal milieu and which itself may undergo maturational changes along the epididymis. In contrast to previous examples of functional amyloid which were intracellular, our studies now show that nonpathological/functional amyloid can also be extracellular. The presence of an extracellular and nonpathological amyloid in the epididymis suggests that similar amyloid structures may be present in other organ systems and may carry out distinctive tissue-specific functions.	[Whelly, Sandra; Johnson, Seethal; Powell, Jonathan; Borchardt, Clinton; Cornwall, Gail A.] Texas Tech Univ Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79409 USA; [Hastert, Mary Catherine] Texas Tech Univ, Dept Biol, Imaging Ctr, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University	Whelly, S (corresponding author), Texas Tech Univ Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79409 USA.	gail.cornwall@ttuhsc.edu			National Institutes of Health (NIH) [HD56182]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056182] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NIH) HD56182 to G. A. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cloe AL, 2011, BIOCHEMISTRY-US, V50, P2026, DOI 10.1021/bi1016217; CORNWALL GA, 1995, MOL REPROD DEV, V41, P37, DOI 10.1002/mrd.1080410107; Cornwall GA, 2007, GENETICS OF MALE INFERTILITY, P211, DOI 10.1007/978-1-59745-176-5_13; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gatti JL, 2004, ANIM REPROD SCI, V82-3, P321, DOI 10.1016/j.anireprosci.2004.05.011; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Lane A, 2003, CLIN CHEM, V49, P1774, DOI 10.1373/49.10.1774; Leonhardt RM, 2011, J BIOL CHEM, V286, P9321, DOI 10.1074/jbc.M110.168088; Loksztejn A, 2009, BIOCHEMISTRY-US, V48, P4846, DOI 10.1021/bi900394b; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Parent AD, 2011, J ANDROL, V32, P444, DOI 10.2164/jandrol.110.010694; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Turner TT, 2007, ASIAN J ANDROL, V9, P565, DOI 10.1111/j.1745-7262.2007.00302.x; van Rooijen BD, 2010, CURR PROTEIN PEPT SC, V11, P334; von Horsten HH, 2007, J BIOL CHEM, V282, P32912, DOI 10.1074/jbc.M703956200; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Wang X, 2008, PRION, V2, P57, DOI 10.4161/pri.2.2.6746	24	43	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36394	10.1371/journal.pone.0036394	http://dx.doi.org/10.1371/journal.pone.0036394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570708	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400024
J	Yu, ZX; Visse, R; Inouye, M; Nagase, H; Brodsky, B				Yu, Zhuoxin; Visse, Robert; Inouye, Masayori; Nagase, Hideaki; Brodsky, Barbara			Defining Requirements for Collagenase Cleavage in Collagen Type III Using a Bacterial Collagen System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL COLLAGEN; HUMAN-FIBROBLAST-COLLAGENASE; C-TERMINAL DOMAIN; MOLECULAR-STRUCTURE; SUBSTRATE-SPECIFICITY; THERMAL-STABILITY; METALLOPROTEINASE; PEPTIDE; IDENTIFICATION; CATABOLISM	Degradation of fibrillar collagens is important in many physiological and pathological events. These collagens are resistant to most proteases due to the tightly packed triple-helical structure, but are readily cleaved at a specific site by collagenases, selected members of the matrix metalloproteinases (MMPs). To investigate the structural requirements for collagenolysis, varying numbers of GXY triplets from human type III collagen around the collagenase cleavage site were inserted between two triple helix domains of the Scl2 bacterial collagen protein. The original bacterial CL domain was not cleaved by MMP-1 (collagenase 1) or MMP-13 (collagenase 3). The minimum type III sequence necessary for cleavage by the two collagenases was 5 GXY triplets, including 4 residues before and 11 residues after the cleavage site (P4-P11'). Cleavage of these chimeric substrates was not achieved by the catalytic domain of MMP-1 or MMP-13, nor by full-length MMP-3. Kinetic analysis of the chimeras indicated that the rate of cleavage by MMP-1 of the chimera containing six triplets (P7-P11') of collagen III was similar to that of native collagen III. The collagenase-susceptible chimeras were cleaved very slowly by trypsin, a property also seen for native collagen III, supporting a local structural relaxation of the triple helix near the collagenase cleavage site. The recombinant bacterial-human collagen system characterized here is a good model to investigate the specificity and mechanism of action of collagenases.	[Visse, Robert; Nagase, Hideaki] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, London W6 8LH, England; [Yu, Zhuoxin; Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Yu, Zhuoxin; Inouye, Masayori] Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	University of Oxford; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tufts University	Nagase, H (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, 65 Aspenlea Rd, London W6 8LH, England.	h.nagase@imperial.ac.uk; barbara.brodsky@tufts.edu	Yu, Zhuoxin/L-1512-2013		National Institutes of Health [GM60048, EB011620]; Arthritis Research United Kingdom; Wellcome Trust [075473]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Research United Kingdom(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60048 and EB011620 (to B. B.). This work was also supported by Arthritis Research United Kingdom and Wellcome Trust Grant 075473 (to H. N.).	BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; BROWN FR, 1969, J MOL BIOL, V39, P307, DOI 10.1016/0022-2836(69)90319-2; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Cheng HM, 2011, J BIOL CHEM, V286, P2041, DOI 10.1074/jbc.M110.153965; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; DANIELSEN CC, 1987, BIOCHEM J, V247, P725, DOI 10.1042/bj2470725; DAVIS JM, 1993, J BIOL CHEM, V268, P25965; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fields GB, 2010, ORG BIOMOL CHEM, V8, P1237, DOI 10.1039/b920670a; Gross J., 1980, COLLAGENASE NORMAL P, P11; GUNJASMITH Z, 1989, BIOCHEM J, V258, P115, DOI 10.1042/bj2580115; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; HASTY KA, 1987, J BIOL CHEM, V262, P10048; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; MILLER EJ, 1976, BIOCHEMISTRY-US, V15, P787, DOI 10.1021/bi00649a009; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; MURPHY G, 1992, J BIOL CHEM, V267, P9612; NAGAI Y, 1966, BIOCHEMISTRY-US, V5, P3123, DOI 10.1021/bi00874a007; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Ottl J, 1996, FEBS LETT, V398, P31, DOI 10.1016/S0014-5793(96)01212-4; Patterson ML, 2001, FEBS LETT, V503, P158, DOI 10.1016/S0014-5793(01)02723-5; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Robichaud TK, 2011, J BIOL CHEM, V286, P37535, DOI 10.1074/jbc.M111.273391; Salsas-Escat R, 2010, BIOCHEMISTRY-US, V49, P4147, DOI 10.1021/bi9021473; Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; WELGUS HG, 1985, J BIOL CHEM, V260, P1052; WELGUS HG, 1982, J BIOL CHEM, V257, P1534; Williams KE, 2009, MATRIX BIOL, V28, P373, DOI 10.1016/j.matbio.2009.04.009; Woessner JF, 1998, BIOL EXTRAC, P1; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Xu YJ, 2009, METHOD ENZYMOL, V466, P211, DOI 10.1016/S0076-6879(09)66009-2; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134	56	56	57	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22988	22997		10.1074/jbc.M112.348979	http://dx.doi.org/10.1074/jbc.M112.348979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573319	hybrid, Green Published			2022-12-25	WOS:000306495000055
J	Baureder, M; Hederstedt, L				Baureder, Michael; Hederstedt, Lars			Genes Important for Catalase Activity in Enterococcus faecalis	PLOS ONE			English	Article							CYTOCHROME BD BIOSYNTHESIS; GRAM-POSITIVE BACTERIA; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; STREPTOCOCCUS-PYOGENES; BIOFILM FORMATION; NADH PEROXIDASE; IDENTIFICATION; TRANSPORTER; EXPRESSION	Little in general is known about how heme proteins are assembled from their constituents in cells. The Gram-positive bacterium Enterococcus faecalis cannot synthesize heme and does not depend on it for growth. However, when supplied with heme in the growth medium the cells can synthesize two heme proteins; catalase (KatA) and cytochrome bd (CydAB). To identify novel factors important for catalase biogenesis libraries of E. faecalis gene insertion mutants were generated using two different types of transposons. The libraries of mutants were screened for clones deficient in catalase activity using a colony zymogram staining procedure. Analysis of obtained clones identified, in addition to katA (encoding the catalase enzyme protein), nine genes distributed over five different chromosomal loci. No factors with a dedicated essential role in catalase biogenesis or heme trafficking were revealed, but the results indicate the RNA degradosome (srmB, rnjA), an ABC-type oligopeptide transporter (oppBC), a two-component signal transducer (etaR), and NADH peroxidase (npr) as being important for expression of catalase activity in E. faecalis. It is demonstrated that catalase biogenesis in E. faecalis is independent of the CydABCD proteins and that a conserved proline residue in the N-terminal region of KatA is important for catalase assembly.	[Baureder, Michael; Hederstedt, Lars] Lund Univ, Microbiol Grp, Dept Biol, Lund, Sweden	Lund University	Baureder, M (corresponding author), Lund Univ, Microbiol Grp, Dept Biol, Lund, Sweden.	Michael.Baureder@biol.lu.se		Hederstedt, Lars/0000-0002-6650-6296; Baureder, Michael/0000-0003-0810-4341	Swedish Research Council [621-2010-5672]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by grant 621-2010-5672 from the Swedish Research Council (http://www.vr.se/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugrysheva JV, 2010, MOL MICROBIOL, V75, P731, DOI 10.1111/j.1365-2958.2009.07012.x; Condon C, 2010, RNA BIOL, V7, P316, DOI 10.4161/rna.7.3.11913; Cotter PD, 1999, J BACTERIOL, V181, P6840, DOI 10.1128/JB.181.21.6840-6843.1999; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Fernandez A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000860; Flint A, 2012, J BACTERIOL, V194, P334, DOI 10.1128/JB.05740-11; Frankenberg L, 2002, J BACTERIOL, V184, P6351, DOI 10.1128/JB.184.22.6351-6356.2002; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; GEORGIOU CD, 1987, J BACTERIOL, V169, P2107, DOI 10.1128/jb.169.5.2107-2112.1987; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Hakansson KO, 2004, ACTA CRYSTALLOGR D, V60, P1374, DOI 10.1107/S0907444904012004; HANKER JS, 1975, J CLIN MICROBIOL, V2, P463; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kristich CJ, 2008, APPL ENVIRON MICROB, V74, P3377, DOI 10.1128/AEM.02665-07; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; Le Breton Y, 2003, ENVIRON MICROBIOL, V5, P329, DOI 10.1046/j.1462-2920.2003.00405.x; Lechardeur D, 2012, J BIOL CHEM, V287, P4752, DOI 10.1074/jbc.M111.297531; Lechardeur D, 2010, J BIOL CHEM, V285, P16032, DOI 10.1074/jbc.M109.024505; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; POOLE RK, 1993, MOL MICROBIOL, V10, P421, DOI 10.1111/j.1365-2958.1993.tb02673.x; ROSS RP, 1991, J MOL BIOL, V221, P857, DOI 10.1016/0022-2836(91)80180-3; Roux CM, 2011, J BACTERIOL, V193, P5520, DOI 10.1128/JB.05485-11; Teng F, 2002, INFECT IMMUN, V70, P1991, DOI 10.1128/IAI.70.4.1991-1996.2002; Winstedt L, 2000, J BACTERIOL, V182, P3863, DOI 10.1128/JB.182.13.3863-3866.2000; Winstedt L, 1998, J BACTERIOL, V180, P6571, DOI 10.1128/JB.180.24.6571-6580.1998; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046	31	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36725	10.1371/journal.pone.0036725	http://dx.doi.org/10.1371/journal.pone.0036725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590595	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336400030
J	Cardoso, FL; Kittel, A; Veszelka, S; Palmela, I; Toth, A; Brites, D; Deli, MA; Brito, MA				Cardoso, Filipa L.; Kittel, Agnes; Veszelka, Szilvia; Palmela, Ines; Toth, Andrea; Brites, Dora; Deli, Maria A.; Brito, Maria A.			Exposure to Lipopolysaccharide and/or Unconjugated Bilirubin Impair the Integrity and Function of Brain Microvascular Endothelial Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; P-GLYCOPROTEIN; IN-VITRO; GLUTAMATE RELEASE; OXIDATIVE STRESS; BARRIER FUNCTION; TIGHT JUNCTIONS; DOWN-REGULATION; REDOX STATUS	Background: Sepsis and jaundice are common conditions in newborns that can lead to brain damage. Though lipopolysaccharide (LPS) is known to alter the integrity of the blood-brain barrier (BBB), little is known on the effects of unconjugated bilirubin (UCB) and even less on the joint effects of UCB and LPS on brain microvascular endothelial cells (BMEC). Methodology/Principal Findings: Monolayers of primary rat BMEC were treated with 1 mu g/ml LPS and/or 50 mu M UCB, in the presence of 100 mM human serum albumin, for 4 or 24 h. Co-cultures of BMEC with astroglial cells, a more complex BBB model, were used in selected experiments. LPS led to apoptosis and UCB induced both apoptotic and necrotic-like cell death. LPS and UCB led to inhibition of P-glycoprotein and activation of matrix metalloproteinases-2 and -9 in mono-cultures. Transmission electron microscopy evidenced apoptotic bodies, as well as damaged mitochondria and rough endoplasmic reticulum in BMEC by either insult. Shorter cell contacts and increased caveolae-like invaginations were noticeable in LPS-treated cells and loss of intercellular junctions was observed upon treatment with UCB. Both compounds triggered impairment of endothelial permeability and transendothelial electrical resistance both in mono-and co-cultures. The functional changes were confirmed by alterations in immunostaining for junctional proteins beta-catenin, ZO-1 and claudin-5. Enlargement of intercellular spaces, and redistribution of junctional proteins were found in BMEC after exposure to LPS and UCB. Conclusions: LPS and/or UCB exert direct toxic effects on BMEC, with distinct temporal profiles and mechanisms of action. Therefore, the impairment of brain endothelial integrity upon exposure to these neurotoxins may favor their access to the brain, thus increasing the risk of injury and requiring adequate clinical management of sepsis and jaundice in the neonatal period.	[Cardoso, Filipa L.; Palmela, Ines; Brites, Dora; Brito, Maria A.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, P-1699 Lisbon, Portugal; [Kittel, Agnes] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Veszelka, Szilvia; Toth, Andrea; Deli, Maria A.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, Mol Neurobiol Lab, H-6701 Szeged, Hungary; [Brites, Dora; Brito, Maria A.] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Universidade de Lisboa	Cardoso, FL (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, P-1699 Lisbon, Portugal.	abrito@ff.ul.pt	Brites, Dora/AGY-4537-2022; Toth, Andrea E. E/T-1226-2018; Deli, Mária A./I-2885-2019; Brites, Dora/AAW-2001-2021; brito, maria/HDO-2541-2022; Brites, Dora/M-8293-2013; brito, maria/M-8278-2013; iMed.ULisboa, NeuronGliaBiol/B-5403-2014	Brites, Dora/0000-0002-3024-9777; Toth, Andrea E. E/0000-0001-6122-919X; Deli, Mária A./0000-0001-6084-6524; Brites, Dora/0000-0002-3024-9777; Brites, Dora/0000-0002-3024-9777; brito, maria/0000-0002-8493-4649; Cardoso, Filipa Lourenco/0000-0002-4391-1336; Veszelka, Szilvia/0000-0001-8864-1184	Fundacaopara a Ciencia e a Tecnologia (FCT), Lisbon, Portugal [PTDC/SAU-FCF/68819/2006]	Fundacaopara a Ciencia e a Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by grant PTDC/SAU-FCF/68819/2006 of the Fundacaopara a Ciencia e a Tecnologia (FCT), Lisbon, Portugal. No competing financial interests exist. The funder (FCT, http://alfa.fct.mctes.pt) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors CE, 2003, PEDIATRICS, V111, P1110, DOI 10.1542/peds.111.5.1110; Akin E, 2002, BRAIN RES, V931, P168, DOI 10.1016/S0006-8993(02)02276-X; Akrout N, 2009, CURR NEUROPHARMACOL, V7, P296, DOI 10.2174/157015909790031175; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Bachschmid M, 2003, FASEB J, V17, P914, DOI 10.1096/fj.02-0530fje; Barbieri SS, 2007, FASEB J, V21, P1831, DOI 10.1096/fj.06-7557com; Bauer H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/402593; Bohm F, 1995, PHOTOCHEM PHOTOBIOL, V62, P980; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brites D, 2012, NEONATAL JAUNDICE; Brito M. A., 2001, THESIS U LISBON; Brito MA, 2004, BRAIN RES, V1026, P33, DOI 10.1016/j.brainres.2004.07.063; Brito MA, 2001, ARCH BIOCHEM BIOPHYS, V387, P57, DOI 10.1006/abbi.2000.2210; Brito MA, 2011, J CHILD NEUROL; Brito MA, 2008, NEUROTOXICOLOGY, V29, P259, DOI 10.1016/j.neuro.2007.11.002; Brito MA, 2008, NEUROBIOL DIS, V29, P30, DOI 10.1016/j.nbd.2007.07.023; Brito MA, 2010, MOL MED, V16, P372, DOI 10.2119/molmed.2009.00152; Brito Maria Alexandra, 2006, P1; Calabria AR, 2008, J CEREBR BLOOD F MET, V28, P135, DOI 10.1038/sj.jcbfm.9600518; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Cepinskas G, 2008, AM J PHYSIOL-GASTR L, V294, pG184, DOI 10.1152/ajpgi.00348.2007; Choi YK, 2008, BMB REP, V41, P345, DOI 10.5483/BMBRep.2008.41.5.345; Colgan OC, 2008, BRAIN RES, V1193, P84, DOI 10.1016/j.brainres.2007.11.072; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Deli MA, 2009, BBA-BIOMEMBRANES, V1788, P892, DOI 10.1016/j.bbamem.2008.09.016; Descamps L, 2003, GLIA, V42, P46, DOI 10.1002/glia.10205; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Ding M, 2007, J PHARM PHARMACOL, V59, P1027, DOI 10.1211/jpp.59.7.0016; Dohgu S, 2008, EXP NEUROL, V210, P740, DOI 10.1016/j.expneurol.2007.12.028; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Falcao AS, 2005, NEUROBIOL DIS, V20, P199, DOI 10.1016/j.nbd.2005.03.001; Fernandes A, 2006, J NEUROCHEM, V96, P1667, DOI 10.1111/j.1471-4159.2006.03680.x; Fernandes A, 2004, J NEUROIMMUNOL, V153, P64, DOI 10.1016/j.jneuroim.2004.04.007; Fernandes A, 2007, EUR J NEUROSCI, V25, P1058, DOI 10.1111/j.1460-9568.2007.05340.x; Fernandes A, 2009, DEV NEUROBIOL, V69, P568, DOI 10.1002/dneu.20727; Fontaine M, 1996, LIFE SCI, V59, P1521, DOI 10.1016/0024-3205(96)00483-3; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Gesuete R, 2011, STROKE, V42, P1445, DOI 10.1161/STROKEAHA.110.603266; Gordo AC, 2006, J NEUROSCI RES, V84, P194, DOI 10.1002/jnr.20857; Gualazzi MG, 2007, THESIS U BOLOGNE; Hanko E, 2003, PEDIATR RES, V54, P441, DOI 10.1203/01.PDR.0000085169.87948.B6; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; He F, 2011, NEUROSCIENCE, V188, P35, DOI 10.1016/j.neuroscience.2011.04.025; Hoheisel D, 1998, BIOCHEM BIOPH RES CO, V244, P312, DOI 10.1006/bbrc.1997.8051; Karahashi H, 2009, J IMMUNOL, V182, P7280, DOI 10.4049/jimmunol.0801376; Kim HG, 2000, BIOCHEM BIOPH RES CO, V269, P401; Kis B, 1999, EUR J PHARMACOL, V368, P35, DOI 10.1016/S0014-2999(99)00024-2; Kis B, 2001, NEUROREPORT, V12, P4139, DOI 10.1097/00001756-200112210-00055; Kittel A, 1999, J HISTOCHEM CYTOCHEM, V47, P393, DOI 10.1177/002215549904700313; Kittel A, 2007, INT J DEV NEUROSCI, V25, P275, DOI 10.1016/j.ijdevneu.2007.05.007; Kondo T, 1996, NEUROSCI LETT, V208, P101, DOI 10.1016/0304-3940(96)12555-6; Lee SW, 2011, MOL MED REP, V4, P145, DOI 10.3892/mmr.2010.389; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu HC, 2004, J NEUROIMMUNOL, V146, P13, DOI 10.1016/j.jneuroim.2003.09.016; Maghzal GJ, 2009, J BIOL CHEM, V284, P29251, DOI 10.1074/jbc.M109.037119; Maisels J, 2009, PEDIATRICS, V124, P1193, DOI 10.1542/peds.2009-0329; Manning D, 2007, ARCH DIS CHILD-FETAL, V92, P342, DOI 10.1136/adc.2006.105361; Mariano C, 2011, EUR J CELL BIOL, V90, P787, DOI 10.1016/j.ejcb.2011.06.005; MCDONAGH AF, 1972, BIOCHEM J, V129, P797, DOI 10.1042/bj1290797; Nagyoszi P, 2010, NEUROCHEM INT, V57, P556, DOI 10.1016/j.neuint.2010.07.002; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Palmela I, 2011, CURR NEUROVASC RES, V8, P153, DOI 10.2174/156720211795495358; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Phillips PG, 2004, AM J PHYSIOL-LUNG C, V286, pL1055, DOI 10.1152/ajplung.00262.2003; Raimondi F, 2006, PEDIATR RES, V60, P30, DOI 10.1203/01.pdr.0000220344.09034.63; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Roca L, 2006, PEDIATR RES, V60, P724, DOI 10.1203/01.pdr.0000245992.89965.94; Rodrigues CMP, 2002, J HEPATOL, V36, P335, DOI 10.1016/S0168-8278(01)00279-3; Salkeni MA, 2009, J NEUROIMMUNE PHARM, V4, P276, DOI 10.1007/s11481-008-9138-y; Sequeira D, 2007, PEDIATR CRIT CARE ME, V8, P570, DOI 10.1097/01.PCC.0000288716.63685.1B; Shioiri T, 2009, BBA-MOL BASIS DIS, V1792, P1011, DOI 10.1016/j.bbadis.2009.06.006; Silva RFM, 2006, TOXICOL LETT, V163, P1, DOI 10.1016/j.toxlet.2005.09.033; Silva SL, 2011, J NEUROCHEM, V117, P412, DOI 10.1111/j.1471-4159.2011.07200.x; Silva SL, 2010, NEUROBIOL DIS, V40, P663, DOI 10.1016/j.nbd.2010.08.010; Singh AK, 2004, TOXICOLOGY, V201, P197, DOI 10.1016/j.tox.2004.04.015; Singh AK, 2007, TOXICOL MECH METHOD, V17, P331, DOI 10.1080/15376510601077029; Tien YC, 2010, J ETHNOPHARMACOL, V130, P505, DOI 10.1016/j.jep.2010.05.038; Tilling T, 1998, J NEUROCHEM, V71, P1151; Tomita M, 2010, INT J PHARMACEUT, V392, P35, DOI 10.1016/j.ijpharm.2010.03.019; Toth Andrea, 2011, Recent Pat CNS Drug Discov, V6, P107; Vaz AR, 2010, J NEUROCHEM, V112, P56, DOI 10.1111/j.1471-4159.2009.06429.x; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Veszelka S, 2007, NEUROCHEM INT, V50, P219, DOI 10.1016/j.neuint.2006.08.006; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Wang XY, 2004, J SURG RES, V122, P274, DOI 10.1016/j.jss.2004.07.008; Watchko JF, 1998, PEDIATR RES, V44, P763, DOI 10.1203/00006450-199811000-00020; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wu LL, 2011, CRIT CARE MED, V39, P2087, DOI 10.1097/CCM.0b013e31821cb40e; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yesilova Z, 2008, J GASTROEN HEPATOL, V23, P1556, DOI 10.1111/j.1440-1746.2008.05388.x; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632; Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012	93	78	84	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35919	10.1371/journal.pone.0035919	http://dx.doi.org/10.1371/journal.pone.0035919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586454	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335000016
J	Dubey, MK; Ubhayasekera, W; Sandgren, M; Jensen, DF; Karlsson, M				Dubey, Mukesh K.; Ubhayasekera, Wimal; Sandgren, Mats; Jensen, Dan Funck; Karlsson, Magnus			Disruption of the Eng18B ENGase Gene in the Fungal Biocontrol Agent Trichoderm atroviride Affetcs Growth Conidation and Antagonistic Ability	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; DEPENDENT PROTEIN-KINASE; MOLECULAR-CLONING; CHITINASES; OLIGOSACCHARIDES; BASIDIOMYCETE; PURIFICATION; SPECIFICITY; EVOLUTION; REVEALS	The recently identified phylogenetic subgroup B5 of fungal glycoside hydrolase family 18 genes encodes enzymes with mannosyl glycoprotein endo-N-acetyl-b-D-glucosaminidase (ENGase)-type activity. Intracellular ENGase activity is associated with the endoplasmic reticulum associated protein degradation pathway (ERAD) of misfolded glycoproteins, although the biological relevance in filamentous fungi is not known. Trichoderma atroviride is a mycoparasitic fungus that is used for biological control of plant pathogenic fungi. The present work is a functional study of the T. atroviride B5-group gene Eng18B, with emphasis on its role in fungal growth and antagonism. A homology model of T. atroviride Eng18B structure predicts a typical glycoside hydrolase family 18 (ab) 8 barrel architecture. Gene expression analysis shows that Eng18B is induced in dual cultures with the fungal plant pathogens Botrytis cinerea and Rhizoctonia solani, although a basal expression is observed in all growth conditions tested. Eng18B disruption strains had significantly reduced growth rates but higher conidiation rates compared to the wild-type strain. However, growth rates on abiotic stress media were significantly higher in Eng18B disruption strains compared to the wild-type strain. No difference in spore germination, germ-tube morphology or in hyphal branching was detected. Disruption strains produced less biomass in liquid cultures than the wild-type strain when grown with chitin as the sole carbon source. In addition, we determined that Eng18B is required for the antagonistic ability of T. atroviride against the grey mould fungus B. cinerea in dual cultures and that this reduction in antagonistic ability is partly connected to a secreted factor. The phenotypes were recovered by re-introduction of an intact Eng18B gene fragment in mutant strains. A putative role of Eng18B ENGase activity in the endoplasmic reticulum associated protein degradation pathway of endogenous glycoproteins in T. atroviride is discussed in relation to the observed phenotypes.	[Dubey, Mukesh K.; Jensen, Dan Funck; Karlsson, Magnus] Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, Uppsala BioCtr, S-75007 Uppsala, Sweden; [Ubhayasekera, Wimal] Lund Univ, MAX Lab, Lund, Sweden; [Ubhayasekera, Wimal] Univ Copenhagen, Inst Med Chem, Copenhagen, Denmark; [Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Biol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Lund University; University of Copenhagen; Swedish University of Agricultural Sciences	Dubey, MK (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, Uppsala BioCtr, Box 7026, S-75007 Uppsala, Sweden.	magnus.karlsson@slu.se	Karlsson, Magnus/P-6556-2014; Jensen, Dan/G-9041-2012	Karlsson, Magnus/0000-0001-6098-138X; Jensen, Dan/0000-0002-8855-5283; Sandgren, Mats/0000-0002-2358-4534	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [229-2009-1530]; Carl Trygger Foundation [CTS08:189]; Royal Swedish Academy of Sciences; Danish Agency for Science, Technology and Innovation; DANSCATT	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Carl Trygger Foundation; Royal Swedish Academy of Sciences; Danish Agency for Science, Technology and Innovation; DANSCATT	This work was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS, grant number 229-2009-1530), the Carl Trygger Foundation (grant number CTS08:189), the Royal Swedish Academy of Sciences, the Danish Agency for Science, Technology and Innovation and DANSCATT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Banno S, 2005, GENES GENET SYST, V80, P25, DOI 10.1266/ggs.80.25; Bartnicki-Garcia S, 1968, ANNU REV MICROBIOL, V22, P97; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; CUEVA R, 1990, FEMS MICROBIOL LETT, V69, P153, DOI 10.1016/0378-1097(90)90430-X; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Fujita K, 2004, ARCH BIOCHEM BIOPHYS, V432, P41, DOI 10.1016/j.abb.2004.09.013; Hamaguchi T, 2010, GLYCOBIOLOGY, V20, P420, DOI 10.1093/glycob/cwp188; HARMAN GE, 1993, PHYTOPATHOLOGY, V83, P313, DOI 10.1094/Phyto-83-313; Hjeljord L, 1998, TRICHODERMA GLIOCLAD, V2, P131; Ihrmark K, 2010, EVOL BIOINFORM, V6, P1; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Inglis GD, 2002, CAN J MICROBIOL, V48, P60, DOI 10.1139/W01-130; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karlsson M, 2008, EVOL BIOINFORM, V4, P47; Karlsson M, 2009, J MOL MICROB BIOTECH, V16, P208, DOI 10.1159/000151220; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuack U., 2006, FUNGAL GENET NEWSL, V53, P9, DOI DOI 10.4148/1941-4765.1106; Lee TS, 2008, EVOL BIOINFORM, V4, P7; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lopez-Mondejar R, 2009, FEBS J, V276, P5137, DOI 10.1111/j.1742-4658.2009.07211.x; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Nygren CMR, 2008, NEW PHYTOL, V180, P875, DOI 10.1111/j.1469-8137.2008.02618.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; Seidl V, 2005, FEBS J, V272, P5923, DOI 10.1111/j.1742-4658.2005.04994.x; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Shimizu K, 2001, GENETICS, V157, P591; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; TARENTINO AL, 1974, J BIOL CHEM, V249, P818; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Utermark J, 2008, NATURE PROTOCOLS ONL; Vogel H.J., 1956, MICROB GENET B, V13, P42; Xu RQ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-4; Yang Z, 2011, J STRUCT BIOL	50	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36152	10.1371/journal.pone.0036152	http://dx.doi.org/10.1371/journal.pone.0036152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586463	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000305335000025
J	Ridley, EV; Wong, ACN; Westmiller, S; Douglas, AE				Ridley, Emma V.; Wong, Adam C-N.; Westmiller, Stephanie; Douglas, Angela E.			Impact of the Resident Microbiota on the Nutritional Phenotype of Drosophila melanogaster	PLOS ONE			English	Article							GUT-MICROBIOTA; LIFE-SPAN; LACTOBACILLUS-PLANTARUM; HEALTHY-SUBJECTS; BLOOD-GLUCOSE; BACTERIA; INSULIN; HOMEOSTASIS; COLONIZATION; MECHANISMS	Background: Animals are chronically infected by benign and beneficial microorganisms that generally promote animal health through their effects on the nutrition, immune function and other physiological systems of the host. Insight into the host-microbial interactions can be obtained by comparing the traits of animals experimentally deprived of their microbiota and untreated animals. Drosophila melanogaster is an experimentally tractable system to study host-microbial interactions. Methodology/Principal Findings: The nutritional significance of the microbiota was investigated in D. melanogaster bearing unmanipulated microbiota, demonstrated by 454 sequencing of 16S rRNA amplicons to be dominated by the alpha-proteobacterium Acetobacter, and experimentally deprived of the microbiota by egg dechorionation (conventional and axenic flies, respectively). In axenic flies, larval development rate was depressed with no effect on adult size relative to conventional flies, indicating that the microbiota promotes larval growth rates. Female fecundity did not differ significantly between conventional and axenic flies, but axenic flies had significantly reduced metabolic rate and altered carbohydrate allocation, including elevated glucose levels. Conclusions/Significance: We have shown that elimination of the resident microbiota extends larval development and perturbs energy homeostasis and carbohydrate allocation patterns of of D. melanogaster. Our results indicate that the resident microbiota promotes host nutrition and interacts with the regulation of host metabolism.	[Ridley, Emma V.; Douglas, Angela E.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Ridley, Emma V.; Wong, Adam C-N.; Westmiller, Stephanie; Douglas, Angela E.] Cornell Univ, Dept Entomol, Ithaca, NY 10021 USA	University of York - UK; Cornell University	Ridley, EV (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	aes326@cornell.edu			NIH [1R01GM095372-01]; Biotechnology and Biological Sciences Research Council; Sarkaria Institute of Insect Physiology and Toxicology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095372] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sarkaria Institute of Insect Physiology and Toxicology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by NIH award 1R01GM095372-01 (http://www.nih.gov/), Studentship award of Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/), and The Sarkaria Institute of Insect Physiology and Toxicology (no website). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 2005, DROSOPHILA LAB HDB; BAKULA M, 1969, J INVERTEBR PATHOL, V14, P365, DOI 10.1016/0022-2011(69)90163-3; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; BRIGHENTI F, 1995, EUR J CLIN NUTR, V49, P242; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Chapman R. F., 1999, INSECTS STRUCTURE FU; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Faith JJ, 2010, ISME J, V4, P1094, DOI 10.1038/ismej.2010.110; Fukatsu T, 1998, APPL ENVIRON MICROB, V64, P3599; Johnston CS, 2010, ANN NUTR METAB, V56, P74, DOI 10.1159/000272133; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kunin V, 2010, OPEN J, V1, P1; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Matzkin LM, 2011, J NUTR, V141, P1127, DOI 10.3945/jn.111.138438; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; Morales-Jimenez J, 2009, MICROB ECOL, V58, P879, DOI 10.1007/s00248-009-9548-2; Musso G, 2010, CURR OPIN LIPIDOL, V21, P76, DOI 10.1097/MOL.0b013e3283347ebb; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; NUNNEY L, 1990, ECOLOGY, V71, P1904, DOI 10.2307/1937598; Ogawa N, 2000, J NUTR, V130, P507, DOI 10.1093/jn/130.3.507; Ostman EM, 2002, J CEREAL SCI, V36, P339, DOI 10.1006/jcrs.2002.0469; Reed LK, 2010, GENETICS, V185, P1009, DOI 10.1534/genetics.109.113571; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Roh SW, 2008, APPL ENVIRON MICROB, V74, P6171, DOI 10.1128/AEM.00301-08; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Stump CS, 2003, PNAS, V100, P7998; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Venema K, 2010, CURR OPIN CLIN NUTR, V13, P432, DOI 10.1097/MCO.0b013e32833a8b60; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	44	164	169	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36765	10.1371/journal.pone.0036765	http://dx.doi.org/10.1371/journal.pone.0036765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586494	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335000055
J	Storchi, R; Zippo, AG; Caramenti, GC; Valente, M; Biella, GEM				Storchi, Riccardo; Zippo, Antonio G.; Caramenti, Gian Carlo; Valente, Maurizio; Biella, Gabriele E. M.			Predicting Spike Occurrence and Neuronal Responsiveness from LFPs in Primary Somatosensory Cortex	PLOS ONE			English	Article							CONNECTIVITY; INTEGRATION; POTENTIALS; TRAINS; FMRI	Local Field Potentials (LFPs) integrate multiple neuronal events like synaptic inputs and intracellular potentials. LFP spatiotemporal features are particularly relevant in view of their applications both in research (e. g. for understanding brain rhythms, inter-areal neural communication and neronal coding) and in the clinics (e. g. for improving invasive Brain-Machine Interface devices). However the relation between LFPs and spikes is complex and not fully understood. As spikes represent the fundamental currency of neuronal communication this gap in knowledge strongly limits our comprehension of neuronal phenomena underlying LFPs. We investigated the LFP-spike relation during tactile stimulation in primary somatosensory (S-I) cortex in the rat. First we quantified how reliably LFPs and spikes code for a stimulus occurrence. Then we used the information obtained from our analyses to design a predictive model for spike occurrence based on LFP inputs. The model was endowed with a flexible meta-structure whose exact form, both in parameters and structure, was estimated by using a multi-objective optimization strategy. Our method provided a set of nonlinear simple equations that maximized the match between models and true neurons in terms of spike timings and Peri Stimulus Time Histograms. We found that both LFPs and spikes can code for stimulus occurrence with millisecond precision, showing, however, high variability. Spike patterns were predicted significantly above chance for 75% of the neurons analysed. Crucially, the level of prediction accuracy depended on the reliability in coding for the stimulus occurrence. The best predictions were obtained when both spikes and LFPs were highly responsive to the stimuli. Spike reliability is known to depend on neuron intrinsic properties (i.e. on channel noise) and on spontaneous local network fluctuations. Our results suggest that the latter, measured through the LFP response variability, play a dominant role.	[Storchi, Riccardo; Zippo, Antonio G.; Valente, Maurizio; Biella, Gabriele E. M.] Inst Mol Bioimaging & Physiol IBFM, Milan, Italy; [Caramenti, Gian Carlo] Inst Biomed Technol ITB, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Storchi, R (corresponding author), Inst Mol Bioimaging & Physiol IBFM, Milan, Italy.	gabriele.biella@ibfm.cnr.it	Zippo, Antonio Giuliano/AAF-8781-2020; Caramenti, Gian Carlo/AAH-9027-2021; Zippo, Antonio G./O-7313-2017	Zippo, Antonio Giuliano/0000-0001-8421-7554; Zippo, Antonio G./0000-0001-8421-7554; Storchi, Riccardo/0000-0002-3656-7514; Biella, Gabriele/0000-0001-8451-249X				Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; [Anonymous], DUEM; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Belitski A, 2010, J COMPUT NEUROSCI, V29, P533, DOI 10.1007/s10827-010-0230-y; Besserve M, 2010, J COMPUT NEUROSCI, V29, P547, DOI 10.1007/s10827-010-0236-5; Bonacina L, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023408; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Deb K, 2000, IEEE T EVOLUTIONARY, V6, P181, DOI DOI 10.1109/4235.996017; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Denker M, 2011, CEREB CORTEX, V21, P2681, DOI 10.1093/cercor/bhr040; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Foffani G, 2008, J NEUROPHYSIOL, V100, P268, DOI 10.1152/jn.01015.2007; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galindo-Leon EE, 2010, J COMPUT NEUROSCI, V29, P581, DOI 10.1007/s10827-010-0221-z; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; Gollub C, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013019; Hwang EJ, 2011, J NEUROPHYSIOL, V105, P1850, DOI 10.1152/jn.00802.2010; Jin Y., 2006, MULTIOBJECTIVE MACHI; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Knowles J, 2008, MULTIOBJECTIVE PROBL, P155; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; Kumar CA, 2010, INT J SOFT COMPUTING, V5, P83; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luccioli S, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041902; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Pedersen GK, 2006, P 8 ANN C GEN EV COM; Pesaran B, 2009, NEURON, V61, P1, DOI 10.1016/j.neuron.2008.12.019; Petersen RS, 2008, NEURON, V60, P890, DOI 10.1016/j.neuron.2008.09.041; Rasch MJ, 2008, J NEUROPHYSIOL, V99, P1461, DOI 10.1152/jn.00919.2007; Saravanan R, 2008, J INTELL ROBOT SYST, V52, P45, DOI 10.1007/s10846-008-9202-0; Saravanan R, 2008, INT J ADV MANUF TECH, V41, P1483; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Watson C, 2006, RAT BRAIN STEREOTAXI; Zanos TP, 2011, J NEUROPHYSIOL, V105, P474, DOI 10.1152/jn.00642.2010	46	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35850	10.1371/journal.pone.0035850	http://dx.doi.org/10.1371/journal.pone.0035850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586452	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335000014
J	Herold, C; Joshi, I; Chehadi, O; Hollmann, M; Gunturkun, O				Herold, Christina; Joshi, Illah; Chehadi, Omar; Hollmann, Michael; Guentuerkuen, Onur			Plasticity in D1-Like Receptor Expression Is Associated with Different Components of Cognitive Processes	PLOS ONE			English	Article							PREFRONTAL CORTEX; WORKING-MEMORY; DOPAMINE D1; EXTRACELLULAR DOPAMINE; NUCLEUS-ACCUMBENS; BASAL GANGLIA; NEURONS; D-1; BRAIN; LOCALIZATION	Dopamine D1-like receptors consist of D1 (D1A) and D5 (D1B) receptors and play a key role in working memory. However, their possibly differential contribution to working memory is unclear. We combined a working memory training protocol with a stepwise increase of cognitive subcomponents and real-time RT-PCR analysis of dopamine receptor expression in pigeons to identify molecular changes that accompany training of isolated cognitive subfunctions. In birds, the D1-like receptor family is extended and consists of the D1A, D1B, and D1D receptors. Our data show that D1B receptor plasticity follows a training that includes active mental maintenance of information, whereas D1A and D1D receptor plasticity in addition accompanies learning of stimulus-response associations. Plasticity of D1-like receptors plays no role for processes like response selection and stimulus discrimination. None of the tasks altered D2 receptor expression. Our study shows that different cognitive components of working memory training have distinguishable effects on D1-like receptor expression.	[Herold, Christina; Chehadi, Omar; Guentuerkuen, Onur] Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Biopsychol, Fac Psychol, Bochum, Germany; [Joshi, Illah; Hollmann, Michael] Ruhr Univ Bochum, Fac Chem & Biochem, Dept Biochem Receptor Biochem 1, Bochum, Germany; [Herold, Christina] Univ Dusseldorf, C&O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany	Ruhr University Bochum; Ruhr University Bochum; Heinrich Heine University Dusseldorf	Herold, C (corresponding author), Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Biopsychol, Fac Psychol, Univ Str 150, Bochum, Germany.	Christina.Herold@uni-duesseldorf.de	Chehadi, Omar/ABE-9469-2020	Chehadi, Omar/0000-0003-2458-0356; Hollmann, Michael/0000-0001-8000-7787; Gunturkun, Onur/0000-0003-4173-5233	fellowship of the Wilhelm; Gunter Esser Stiftung; DFG grant [SFB874]; fellowship of the Deutsche Forschungsgemeinschaft Graduate School [736]	fellowship of the Wilhelm; Gunter Esser Stiftung; DFG grant(German Research Foundation (DFG)); fellowship of the Deutsche Forschungsgemeinschaft Graduate School(German Research Foundation (DFG))	This work was supported by a fellowship of the Wilhelm and Gunter Esser Stiftung to C. H. and a DFG grant to O.G. via the SFB874. I.J. was supported by a fellowship of the Deutsche Forschungsgemeinschaft Graduate School 736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Ahn S, 2002, J NEUROSCI, V22, P10958; Alsio J, 2010, NEUROSCIENCE, V171, P779, DOI 10.1016/j.neuroscience.2010.09.046; Backman L, 2011, SCIENCE, V333, P718, DOI 10.1126/science.1204978; Bassareo V, 1997, J NEUROSCI, V17, P851; Bast T, 2002, J COMP NEUROL, V446, P58, DOI 10.1002/cne.10187; Bergson C, 1995, J NEUROSCI, V15, P7821; Bordelon-Glausier JR, 2008, J COMP NEUROL, V508, P893, DOI 10.1002/cne.21710; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Castner SA, 2007, BRAIN COGNITION, V63, P94, DOI 10.1016/j.bandc.2006.11.002; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Diekamp B, 2002, J NEUROSCI, V22, P9573; Diekamp B, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0002.2002; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; Durstewitz D, 1999, PROG NEUROBIOL, V59, P161, DOI 10.1016/S0301-0082(98)00100-2; Durstewitz D, 1998, NEUROSCIENCE, V83, P763, DOI 10.1016/S0306-4522(97)00450-8; Durstewitz D, 2006, NEUROSCIENCE, V139, P119, DOI 10.1016/j.neuroscience.2005.06.094; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; El-Ghundi M, 1999, EUR J PHARMACOL, V383, P95, DOI 10.1016/S0014-2999(99)00573-7; Fisher BE, 2004, J NEUROSCI RES, V77, P378, DOI 10.1002/jnr.20162; FUNAHASHI S, 1994, NEUROSCI RES, V21, P1, DOI 10.1016/0168-0102(94)90063-9; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Glausier JR, 2009, CEREB CORTEX, V19, P1820, DOI 10.1093/cercor/bhn212; GOLDMANRAKIC PS, 1989, P NATL ACAD SCI USA, V86, P9015, DOI 10.1073/pnas.86.22.9015; Gunturkun O, 2005, CURR OPIN NEUROBIOL, V15, P686, DOI 10.1016/j.conb.2005.10.003; GUNTURKUN O, 2001, BRAIN EVOLUTION COGN, P431; He Y, 2009, NEUROSCI BULL, V25, P43, DOI 10.1007/s12264-009-0107-0; Herold C, 2008, BEHAV BRAIN RES; Herold C, 2011, BRAIN STRUCT FUNCT, V216, P239, DOI 10.1007/s00429-011-0301-5; Herold C, 2010, BEHAV NEUROSCI, V124, P381, DOI 10.1037/a0019504; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Karakuyu D, 2007, EUR J NEUROSCI, V26, P2293, DOI 10.1111/j.1460-9568.2007.05840.x; Karten H.J., 1967, STEREOTAXIC ATLAS BR; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kroner S, 1999, J COMP NEUROL, V407, P228, DOI 10.1002/(SICI)1096-9861(19990503)407:2<228::AID-CNE6>3.0.CO;2-2; Kroner S, 2002, NEUROSCIENCE, V110, P459, DOI 10.1016/S0306-4522(01)00506-1; Kubikova L, 2010, J COMP NEUROL, V518, P741, DOI 10.1002/cne.22255; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nomoto K, 2010, J NEUROSCI, V30, P10692, DOI 10.1523/JNEUROSCI.4828-09.2010; Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007; Phillips AG, 2004, J NEUROSCI, V24, P547, DOI 10.1523/JNEUROSCI.4653-03.2004; QUINTANA J, 1988, BRAIN RES, V474, P211, DOI 10.1016/0006-8993(88)90436-2; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Reiner A, 2005, BRAIN RES BULL, V66, P317, DOI 10.1016/j.brainresbull.2005.05.007; Reiner A, 2002, BRAIN RES BULL, V57, P513, DOI 10.1016/S0361-9230(01)00667-0; Rose J, 2005, PLOS BIOL, V3, P1139, DOI 10.1371/journal.pbio.0030190; Rose J, 2010, NEUROSCIENCE, V167, P232, DOI 10.1016/j.neuroscience.2010.02.004; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Schnabel R, 1997, J COMP NEUROL, V388, P146, DOI 10.1002/(SICI)1096-9861(19971110)388:1<146::AID-CNE10>3.0.CO;2-T; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Soiza-Reilly M, 2004, BRAIN RES, V1004, P217, DOI 10.1016/j.brainres.2004.01.050; Sun ZQ, 2000, J CHEM NEUROANAT, V19, P211, DOI 10.1016/S0891-0618(00)00069-7; Takeda K, 2002, J NEUROPHYSIOL, V87, P567, DOI 10.1152/jn.00249.2001; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; WALDMANN C, 1993, BRAIN RES, V600, P225, DOI 10.1016/0006-8993(93)91377-5; Wang M, 2008, MOL CELLS, V25, P149; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795, DOI 10.1152/jn.1997.78.5.2795; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Yao WD, 2008, BIOCHEM PHARMACOL, V75, P2055, DOI 10.1016/j.bcp.2008.01.018	68	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36484	10.1371/journal.pone.0036484	http://dx.doi.org/10.1371/journal.pone.0036484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574169	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800065
J	Bock, M; Ogishima, S; Tanaka, H; Kramer, S; Kaderali, L				Boeck, Matthias; Ogishima, Soichi; Tanaka, Hiroshi; Kramer, Stefan; Kaderali, Lars			Hub-Centered Gene Network Reconstruction Using Automatic Relevance Determination	PLOS ONE			English	Article							REGULATORY NETWORKS; MODELS; ORGANIZATION; ANALYZE	Network inference deals with the reconstruction of biological networks from experimental data. A variety of different reverse engineering techniques are available; they differ in the underlying assumptions and mathematical models used. One common problem for all approaches stems from the complexity of the task, due to the combinatorial explosion of different network topologies for increasing network size. To handle this problem, constraints are frequently used, for example on the node degree, number of edges, or constraints on regulation functions between network components. We propose to exploit topological considerations in the inference of gene regulatory networks. Such systems are often controlled by a small number of hub genes, while most other genes have only limited influence on the network's dynamic. We model gene regulation using a Bayesian network with discrete, Boolean nodes. A hierarchical prior is employed to identify hub genes. The first layer of the prior is used to regularize weights on edges emanating from one specific node. A second prior on hyperparameters controls the magnitude of the former regularization for different nodes. The net effect is that central nodes tend to form in reconstructed networks. Network reconstruction is then performed by maximization of or sampling from the posterior distribution. We evaluate our approach on simulated and real experimental data, indicating that we can reconstruct main regulatory interactions from the data. We furthermore compare our approach to other state-of-the art methods, showing superior performance in identifying hubs. Using a large publicly available dataset of over 800 cell cycle regulated genes, we are able to identify several main hub genes. Our method may thus provide a valuable tool to identify interesting candidate genes for further study. Furthermore, the approach presented may stimulate further developments in regularization methods for network reconstruction from data.	[Boeck, Matthias; Kaderali, Lars] Heidelberg Univ, ViroQuant Res Grp Modeling, Heidelberg, Germany; [Boeck, Matthias; Kramer, Stefan] Tech Univ Munich, Inst Informat I12, D-8046 Garching, Germany; [Ogishima, Soichi; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Dept Bioinformat, Bunkyo Ku, Tokyo, Japan; [Kramer, Stefan] Johannes Gutenberg Univ Mainz, Inst Informat, Mainz, Germany; [Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometry, D-01062 Dresden, Germany	Ruprecht Karls University Heidelberg; Technical University of Munich; Tokyo Medical & Dental University (TMDU); Johannes Gutenberg University of Mainz; Technische Universitat Dresden	Bock, M (corresponding author), Heidelberg Univ, ViroQuant Res Grp Modeling, BioQuant BQ26, Heidelberg, Germany.	lars.kaderali@tu-dresden.de		Kaderali, Lars/0000-0002-2359-2294	German Federal Ministry for Education and Research (BMBF) [0313923, 0315523A]; European Commission [260429]; Deutsche Forschungsgemeinschaft (DFG) International Research Training Group "Regulation and Evolution of Cellular Systems" [GRK 1563]; Grants-in-Aid for Scientific Research [22700311] Funding Source: KAKEN	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft (DFG) International Research Training Group "Regulation and Evolution of Cellular Systems"(German Research Foundation (DFG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors acknowledge funding from the German Federal Ministry for Education and Research (BMBF), grant numbers 0313923 (Forsys/ViroQuant) and 0315523A (SysTec) and from the European Commission in the Seventh Framework Program, grant 260429 (SysPatho). SK and MB received funding from the Deutsche Forschungsgemeinschaft (DFG) International Research Training Group "Regulation and Evolution of Cellular Systems" (GRK 1563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnone MI, 1997, DEVELOPMENT, V124, P1851; Bernard A, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P459; Bishop C., 1998, NIPS, P382; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Chen T, 1999, Pac Symp Biocomput, P29; Chen T, 2001, PARALLEL COMPUT, V27, P141, DOI 10.1016/S0167-8191(00)00092-2; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DUANE S, 1987, PHYS LETT B, V195, P216, DOI 10.1016/0370-2693(87)91197-X; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Guthke R, 2005, BIOINFORMATICS, V21, P1626, DOI 10.1093/bioinformatics/bti226; Hartemink AJ, 2002, IEEE INTELL SYST, V17, P37, DOI 10.1109/MIS.2002.999218; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Harvey I, 1997, FROM ANIM ANIMAT, P67; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; KADERALI L, 2006, HIERARCHICAL BAYESIA; Kaderali L, 2009, BIOINFORMATICS, V25, P2229, DOI 10.1093/bioinformatics/btp375; Kaderali Lars, 2008, V94, P33; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liang S, 1998, Pac Symp Biocomput, P18; Lima-Mendez G, 2009, MOL BIOSYST, V5, P1482, DOI 10.1039/b908681a; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mazur J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-448; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Neal RM, 1996, LECT NOTES STAT, V118; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sales G, 2011, BIOINFORMATICS, V27, P1876, DOI 10.1093/bioinformatics/btr274; Shmulevich I, 2002, P IEEE, V90, P1778, DOI 10.1109/JPROC.2002.804686; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spiegelhalter DJ, 1996, BAYESIAN STAT, V5; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tan VYF, 2009, SPARS09 SIGNAL PROCE, P1; Van Someren E, 2001, P 2 INT C SYST BIOL, P222; Woolf PJ, 2000, PHYSIOL GENOMICS, V3, P9, DOI 10.1152/physiolgenomics.2000.3.1.9	45	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35077	10.1371/journal.pone.0035077	http://dx.doi.org/10.1371/journal.pone.0035077			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570688	Green Published, gold			2022-12-25	WOS:000305343400004
J	Sun, FF; Dai, CY; Xie, JS; Hu, X				Sun, Feifei; Dai, Chunyan; Xie, Jiansheng; Hu, Xun			Biochemical Issues in Estimation of Cytosolic Free NAD/NADH Ratio	PLOS ONE			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; AUGMENTS BLOOD-FLOW; REDOX STATE; ESCHERICHIA-COLI; SKELETAL-MUSCLE; FREE-RADICALS; LIVER; NADH; LACTATE; METABOLISM	Cytosolic free NAD/NADH ratio is fundamentally important in maintaining cellular redox homeostasis but current techniques cannot distinguish between protein-bound and free NAD/NADH. Williamson et al reported a method to estimate this ratio by cytosolic lactate/pyruvate (L/P) based on the principle of chemical equilibrium. Numerous studies used L/P ratio to estimate the cytosolic free NAD/NADH ratio by assuming that the conversion in cells was at near-equilibrium but not verifying how near it was. In addition, it seems accepted that cytosolic free NAD/NADH ratio was a dependent variable responding to the change of L/P ratio. In this study, we show (1) that the change of lactate/glucose (percentage of glucose that converts to lactate by cells) and L/P ratio could measure the status of conversion between pyruvate + NADH and lactate + NAD that tends to or gets away from equilibrium; (2) that cytosolic free NAD/NADH could be accurately estimated by L/P only when the conversion is at or very close to equilibrium otherwise a calculation error by one order of magnitude could be introduced; (3) that cytosolic free NAD/NADH is stable and L/P is highly labile, that the highly labile L/P is crucial to maintain the homeostasis of NAD/NADH; (4) that cytosolic free NAD/NADH is dependent on oxygen levels. Our study resolved the key issues regarding accurate estimation of cytosolic free NAD/NADH ratio and the relationship between NAD/NADH and L/P.	[Sun, Feifei; Dai, Chunyan; Xie, Jiansheng; Hu, Xun] Zhejiang Univ, Sch Med, Affiliated Hosp 2,Zhejiang Prov Key Lab Mol Biol, Inst Canc,China Natl Minist Educ,Key Lab Canc Int, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Sun, FF (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2,Zhejiang Prov Key Lab Mol Biol, Inst Canc,China Natl Minist Educ,Key Lab Canc Int, Hangzhou 310003, Zhejiang, Peoples R China.	huxun@zju.edu.cn			National 863 project [2007AA02Z143]; China Natural Sciences Foundation [30772544, 81071802]; National Ministry of Education, China	National 863 project(National High Technology Research and Development Program of China); China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); National Ministry of Education, China(Ministry of Education, China)	This work was supported in part by National 863 project (2007AA02Z143); China Natural Sciences Foundation projects (30772544, 81071802); and the Fundamental Research Funds for the Central Universities, National Ministry of Education, China, all to Dr. Hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; ARIEFF AI, 1976, METABOLISM, V25, P307, DOI 10.1016/0026-0495(76)90088-3; BACHELARD HS, 1974, J NEUROCHEM, V22, P395, DOI 10.1111/j.1471-4159.1974.tb07605.x; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Barron JT, 2000, AM J PHYSIOL-HEART C, V279, pH2872, DOI 10.1152/ajpheart.2000.279.6.H2872; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bisswanger H, 2002, ENZYME KINETICS PRIN; Burgess SC, 2008, J BIOL CHEM, V283, P1670, DOI 10.1074/jbc.M706540200; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; David L. N., 2008, LEHNINGER PRINCIPLES; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GIBSON GE, 1976, J NEUROCHEM, V27, P37, DOI 10.1111/j.1471-4159.1976.tb01540.x; GRANHOLM L, 1969, ACTA PHYSIOL SCAND, V77, P179, DOI 10.1111/j.1748-1716.1969.tb04562.x; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hausler N, 2006, BIOCHEM J, V394, P465, DOI 10.1042/BJ20051174; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu B., 1974, METHODS ENZYMATIC AN; Ido Y, 1997, DIABETOLOGIA, V40, pS115, DOI 10.1007/s001250051422; Ido Y, 2004, P NATL ACAD SCI USA, V101, P653, DOI 10.1073/pnas.0307458100; KATZ A, 1987, ACTA PHYSIOL SCAND, V131, P119, DOI 10.1111/j.1748-1716.1987.tb08213.x; Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Mazurek S, 1997, J BIOL CHEM, V272, P4941, DOI 10.1074/jbc.272.8.4941; Mintun MA, 2004, P NATL ACAD SCI USA, V101, P659, DOI 10.1073/pnas.0307457100; NITTA N, 1988, RES EXP MED, V188, P341, DOI 10.1007/BF01851202; Obrosova IG, 2001, FASEB J, V15, P123, DOI 10.1096/fj.01-0603fje; SAUER LA, 1985, J BIOL CHEM, V260, P7496; SCHWARTZ JP, 1974, J BIOL CHEM, V249, P4138; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; Swierczynski J, 2001, POL J PHARMACOL, V53, P125; TANAKA J, 1982, J SURG RES, V33, P49, DOI 10.1016/0022-4804(82)90008-7; Vary TC, 1998, MOL CELL BIOCHEM, V178, P81, DOI 10.1023/A:1006826331115; VEECH RL, 1970, BIOCHEM J, V117, P499, DOI 10.1042/bj1170499; WARBURG O, 1956, SCIENCE, V124, P269; WARD LD, 1983, BIOCHEM J, V215, P685, DOI 10.1042/bj2150685; Wasserman K, 1990, CIRCULATION S2, V81, P1114; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; WIMPENNY JW, 1972, J BACTERIOL, V11, P24, DOI 10.1128/JB.111.1.24-32.1972; YAGER JY, 1991, AM J PHYSIOL, V261, pH1102, DOI 10.1152/ajpheart.1991.261.4.H1102; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Ziegler M, 2005, FEBS J, V272, P4561, DOI 10.1111/j.1742-4658.2005.04893.x	49	89	90	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e34525	10.1371/journal.pone.0034525	http://dx.doi.org/10.1371/journal.pone.0034525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570687	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343400003
J	Liu, SY; Lin, JQ; Wu, HL; Wang, CC; Huang, SJ; Luo, YF; Sun, JH; Zhou, JX; Yan, SJ; He, JG; Wang, J; He, ZM				Liu, Si-Yang; Lin, Jian-Qing; Wu, Hong-Long; Wang, Cheng-Cheng; Huang, Shu-Jia; Luo, Yan-Feng; Sun, Ji-Hua; Zhou, Jian-Xiang; Yan, Shu-Jing; He, Jian-Guo; Wang, Jun; He, Zhu-Mei			Bisulfite Sequencing Reveals That Aspergillus flavus Holds a Hollow in DNA Methylation	PLOS ONE			English	Article							INDUCED POINT MUTATION; CYTOSINE METHYLTRANSFERASE HOMOLOG; SECONDARY METABOLISM; AFLATOXIN; CONTAINS; RIP; HETEROCHROMATIN; IDENTIFICATION; 5-AZACYTIDINE; ELEMENTS	Aspergillus flavus first gained scientific attention for its production of aflatoxin. The underlying regulation of aflatoxin biosynthesis has been serving as a theoretical model for biosynthesis of other microbial secondary metabolites. Nevertheless, for several decades, the DNA methylation status, one of the important epigenomic modifications involved in gene regulation, in A. flavus remains to be controversial. Here, we applied bisulfite sequencing in conjunction with a biological replicate strategy to investigate the DNA methylation profiling of A. flavus genome. Both the bisulfite sequencing data and the methylome comparisons with other fungi confirm that the DNA methylation level of this fungus is negligible. Further investigation into the DNA methyltransferase of Aspergillus uncovers its close relationship with RID-like enzymes as well as its divergence with the methyltransferase of species with validated DNA methylation. The lack of repeat contents of the A. flavus' genome and the high RIP-index of the small amount of remanent repeat potentially support our speculation that DNA methylation may be absent in A. flavus or that it may possess de novo DNA methylation which occurs very transiently during the obscure sexual stage of this fungal species. This work contributes to our understanding on the DNA methylation status of A. flavus, as well as reinforces our views on the DNA methylation in fungal species. In addition, our strategy of applying bisulfite sequencing to DNA methylation detection in species with low DNA methylation may serve as a reference for later scientific investigations in other hypomethylated species.	[Liu, Si-Yang; Lin, Jian-Qing; Wang, Cheng-Cheng; Luo, Yan-Feng; Zhou, Jian-Xiang; He, Jian-Guo; He, Zhu-Mei] Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Si-Yang; Wu, Hong-Long; Huang, Shu-Jia; Sun, Ji-Hua; Yan, Shu-Jing; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China	Sun Yat Sen University; Beijing Genomics Institute (BGI)	Liu, SY (corresponding author), Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn; wangj@genomics.org.cn; lsshezm@mail.sysu.edu.cn	贺, 竹梅/GVS-1592-2022; Huang, Shujia/GXG-8583-2022; Wang, Jun/A-7261-2013; Liu, Siyang/M-6127-2014; Lin, Jianqing/GYU-6251-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Huang, Shujia/0000-0003-2100-2534; Liu, Siyang/0000-0001-6780-9419; Nettleton, Dan/0000-0002-6045-1036; Wang, Jun/0000-0002-2113-5874; Yeh, Cheng-Ting/0000-0002-1392-2018; Wang, Jun/0000-0002-8540-8931; Schnable, Patrick/0000-0001-9169-5204	National Natural Science Foundation of China [30870024, 31170044]; Natural Science Foundation of Guangdong Province of China [9151027501000113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (grant no. 30870024 and grant no. 31170044), Natural Science Foundation of Guangdong Province of China (grant no. 9151027501000113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, no additional external funding received for this study.	ANTEQUERA F, 1984, J BIOL CHEM, V259, P8033; Aziz NH, 1997, NAHRUNG, V41, P150, DOI 10.1002/food.19970410307; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bestor TH, 1999, GENETICA, V107, P289, DOI 10.1023/A:1003990818251; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Cichewicz RH, 2010, NAT PROD REP, V27, P11, DOI 10.1039/b920860g; Cleveland TE, 2009, TRENDS BIOTECHNOL, V27, P151, DOI 10.1016/j.tibtech.2008.11.008; Clutterbuck AJ, 2011, FUNGAL GENET BIOL, V48, P306, DOI 10.1016/j.fgb.2010.09.002; Dahl C, 2003, BIOGERONTOLOGY, V4, P233, DOI 10.1023/A:1025103319328; Doiron KMJ, 1999, MUTAT RES-FUND MOL M, V429, P37, DOI 10.1016/S0027-5107(99)00099-8; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Gowher H, 2001, FEMS MICROBIOL LETT, V205, P151, DOI 10.1111/j.1574-6968.2001.tb10939.x; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hayatsu Hikoya, 2006, Nucleic Acids Symp Ser (Oxf), P69, DOI 10.1093/nass/nrl034; He ZM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-104; Horn BW, 2009, MYCOLOGIA, V101, P423, DOI 10.3852/09-011; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Lee DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002531; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; MAGILL JM, 1989, DEV GENET, V10, P63, DOI 10.1002/dvg.1020100202; Margolin BS, 1998, GENETICS, V149, P1787; Montiel MD, 2006, FUNGAL GENET BIOL, V43, P439, DOI 10.1016/j.fgb.2006.01.011; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rountree MR, 2010, HEREDITY, V105, P38, DOI 10.1038/hdy.2010.44; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; TAMAME M, 1983, MOL CELL BIOL, V3, P2287, DOI 10.1128/MCB.3.12.2287; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	49	121	129	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30349	10.1371/journal.pone.0030349	http://dx.doi.org/10.1371/journal.pone.0030349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22586469	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100036
J	Brown, JC; Huedo-Medina, TB; Pescatello, LS; Ryan, SM; Pescatello, SM; Moker, E; LaCroix, JM; Ferrer, RA; Johnson, BT				Brown, Justin C.; Huedo-Medina, Tania B.; Pescatello, Linda S.; Ryan, Stacey M.; Pescatello, Shannon M.; Moker, Emily; LaCroix, Jessica M.; Ferrer, Rebecca A.; Johnson, Blair T.			The Efficacy of Exercise in Reducing Depressive Symptoms among Cancer Survivors: A Meta-Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; BREAST-CANCER; PHYSICAL-ACTIVITY; REHABILITATION PROGRAM; CLINICAL DEPRESSION; AEROBIC EXERCISE; META-REGRESSION; WOMEN; FATIGUE	Introduction: The purpose of this meta-analysis was to examine the efficacy of exercise to reduce depressive symptoms among cancer survivors. In addition, we examined the extent to which exercise dose and clinical characteristics of cancer survivors influence the relationship between exercise and reductions in depressive symptoms. Methods: We conducted a systematic search identifying randomized controlled trials of exercise interventions among adult cancer survivors, examining depressive symptoms as an outcome. We calculated effect sizes for each study and performed weighted multiple regression moderator analysis. Results: We identified 40 exercise interventions including 2,929 cancer survivors. Diverse groups of cancer survivors were examined in seven exercise interventions; breast cancer survivors were examined in 26; prostate cancer, leukemia, and lymphoma were examined in two; and colorectal cancer in one. Cancer survivors who completed an exercise intervention reduced depression more than controls, d(+) = 20.13 (95% CI: -0.26, -0.01). Increases in weekly volume of aerobic exercise reduced depressive symptoms in dose-response fashion (beta = -0.24, p = 0.03), a pattern evident only in higher quality trials. Exercise reduced depressive symptoms most when exercise sessions were supervised (beta = -0.26, p = 0.01) and when cancer survivors were between 47-62 yr (beta = 0.27, p = 0.01). Conclusion: Exercise training provides a small overall reduction in depressive symptoms among cancer survivors but one that increased in dose-response fashion with weekly volume of aerobic exercise in high quality trials. Depressive symptoms were reduced to the greatest degree among breast cancer survivors, among cancer survivors aged between 47-62 yr, or when exercise sessions were supervised.	[Brown, Justin C.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Brown, Justin C.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Huedo-Medina, Tania B.; Pescatello, Linda S.; Moker, Emily; LaCroix, Jessica M.; Johnson, Blair T.] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA; [Ryan, Stacey M.] Univ Texas MD Anderson Canc Ctr, Dept Phys Therapy, Houston, TX 77030 USA; [Pescatello, Shannon M.] Western New England Coll, Dept Psychol, Springfield, MA USA; [Ferrer, Rebecca A.] NCI, Rockville, MD USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Connecticut; University of Texas System; UTMD Anderson Cancer Center; Western New England University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brown, JC (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	brownjus@mail.med.upenn.edu	Brown, Jennifer Valeska Elli/C-6947-2019	Brown, Jennifer Valeska Elli/0000-0003-0943-5177; Byrne, Thirimon Moe/0000-0002-2827-9715	University of Connecticut Research Advisory Council Foundation [433527]	University of Connecticut Research Advisory Council Foundation	Funding was provided by the University of Connecticut Research Advisory Council Foundation grant no. 433527 (PIs: Blair T. Johnson and Linda S. Pescatello). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Becker B. J., 2000, HDB APPL MULTIVARIAT, P499, DOI [DOI 10.1016/B978-012691360-6/50018-5, 10.1016/B978-012691360-6/50018-5]; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERGLUND G, 1994, EUR J CANCER, V30A, P1744, DOI 10.1016/0959-8049(94)00330-8; Brosse AL, 2002, SPORTS MED, V32, P741, DOI 10.2165/00007256-200232120-00001; Brown JC, 2011, CANCER EPIDEM BIOMAR, V20, P123, DOI 10.1158/1055-9965.EPI-10-0988; Burnham TR, 2002, MED SCI SPORT EXER, V34, P1863, DOI 10.1097/00005768-200212000-00001; Cadmus LA, 2009, PSYCHO-ONCOLOGY, V18, P343, DOI 10.1002/pon.1525; Chandwani Kavita D, 2010, J Soc Integr Oncol, V8, P43; Chang PH, 2008, J PAIN SYMPTOM MANAG, V35, P524, DOI 10.1016/j.jpainsymman.2007.06.013; Clark AM, 2010, EUR J CARDIOV PREV R, V17, P261, DOI 10.1097/HJR.0b013e32833090ef; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cohen L, 2004, CANCER-AM CANCER SOC, V100, P2253, DOI 10.1002/cncr.20236; Conn VS, 2010, ANN BEHAV MED, V39, P128, DOI 10.1007/s12160-010-9172-x; Courneya KS, 2007, J CLIN ONCOL, V25, P4396, DOI 10.1200/JCO.2006.08.2024; Courneya KS, 2009, J CLIN ONCOL, V27, P4605, DOI 10.1200/JCO.2008.20.0634; Courneya KS, 2003, EUR J CANCER CARE, V12, P347, DOI 10.1046/j.1365-2354.2003.00437.x; Courneya KS, 2003, PSYCHO-ONCOLOGY, V12, P357, DOI 10.1002/pon.658; Coventry PA, 2007, J PSYCHOSOM RES, V63, P551, DOI 10.1016/j.jpsychores.2007.08.002; Craft L, 2011, CANC EPIDEMIOL BIOMA; Culos-Reed SN, 2006, PSYCHO-ONCOLOGY, V15, P891, DOI 10.1002/pon.1021; Culos-Reed SN, 2010, SUPPORT CARE CANCER, V18, P591, DOI 10.1007/s00520-009-0694-3; Daley AJ, 2007, J CLIN ONCOL, V25, P1713, DOI 10.1200/JCO.2006.09.5083; Danhauer SC, 2009, PSYCHO-ONCOLOGY, V18, P360, DOI 10.1002/pon.1503; Demark-Wahnefried W, 2008, CLIN BREAST CANCER, V8, P70, DOI 10.3816/CBC.2008.n.005; Dimeo FC, 1999, CANCER, V85, P2273, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2273::AID-CNCR24>3.0.CO;2-B; Dodd MJ, 2010, CANCER NURS, V33, P245, DOI 10.1097/NCC.0b013e3181ddc58c; Drown JS, 2005, REHABIL ONCOL, V23, P11, DOI 10.1097/01893697-200523010-00004; Duijts SFA, 2011, PSYCHO-ONCOLOGY, V20, P115, DOI 10.1002/pon.1728; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eyigor S, 2010, EUR J PHYS REHAB MED, V46, P481; Ferrer RA, 2011, ANN BEHAV MED, V41, P32, DOI 10.1007/s12160-010-9225-1; GILBAR O, 1989, J PSYCHOSOM RES, V33, P1, DOI 10.1016/0022-3999(89)90100-1; Greenwood BN, 2011, EXERC SPORT SCI REV, V39, P140, DOI 10.1097/JES.0b013e31821f7e45; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Hedges L. V., 1985, STAT METHODS META AN, DOI [DOI 10.1016/B978-0-08-057065-5.50005-1, 10.2307/1164953, DOI 10.2307/1164953]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holland JC, 2010, J NATL COMPR CANC NE, V8, P448, DOI 10.6004/jnccn.2010.0034; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jarden M, 2009, J PAIN SYMPTOM MANAG, V38, P174, DOI 10.1016/j.jpainsymman.2008.09.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnson BT, 2011, RES SYN METHOD; Jones LW, 2010, LANCET ONCOL, V11, P914, DOI 10.1016/S1470-2045(10)70184-4; Kelly CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c693; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Latka RN, 2009, J CANCER SURVIV, V3, P148, DOI 10.1007/s11764-009-0088-z; LEBOVITS AH, 1990, CANCER, V65, P17, DOI 10.1002/1097-0142(19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I; Lee SA, 2010, CLIN REHABIL, V24, P600, DOI 10.1177/0269215510362324; Lipsey MW, 2001, PRACTICAL METAANALYS, P247; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Mao JJ, 2007, J AM BOARD FAM MED, V20, P434, DOI 10.3122/jabfm.2007.05.060225; McClure MK, 2010, AM J OCCUP THER, V64, P59, DOI 10.5014/ajot.64.1.59; Mock V, 1994, Oncol Nurs Forum, V21, P899; Mock V, 1997, Oncol Nurs Forum, V24, P991; Monga U, 2007, ARCH PHYS MED REHAB, V88, P1416, DOI 10.1016/j.apmr.2007.08.110; MOR V, 1994, CANCER-AM CANCER SOC, V74, P2118, DOI 10.1002/1097-0142(19941001)74:7+<2118::AID-CNCR2820741720>3.0.CO;2-N; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Mutrie N, 2007, BMJ-BRIT MED J, V334, P517, DOI 10.1136/bmj.39094.648553.AE; Newport DJ, 1998, J PSYCHOSOM RES, V45, P215, DOI 10.1016/S0022-3999(98)00011-7; North T C, 1990, Exerc Sport Sci Rev, V18, P379; O'Brien Kelly, 2010, Cochrane Database Syst Rev, pCD001796, DOI 10.1002/14651858.CD001796.pub3; Ohira T, 2006, CANCER-AM CANCER SOC, V106, P2076, DOI 10.1002/cncr.21829; Papakostas GI, 2008, J CLIN PSYCHIAT, V69, P1287, DOI 10.4088/JCP.v69n0812; Pasquini Massimo, 2007, Clin Pract Epidemiol Ment Health, V3, P2, DOI 10.1186/1745-0179-3-2; Patel SR, 2004, THESIS; Payne JK, 2008, ONCOL NURS FORUM, V35, P635, DOI 10.1188/08.ONF.635-642; Perna FM, 2010, INT J SPORT EXERC PS, V8, P36, DOI 10.1080/1612197X.2010.9671932; Pinto BM, 2003, PSYCHO-ONCOLOGY, V12, P118, DOI 10.1002/pon.618; Raghavendra RM, 2009, INTEGR CANCER THER, V8, P37, DOI 10.1177/1534735409331456; Rausch SM, 2007, THESIS; REDDON JR, 1985, J PSYCHOPATHOL BEHAV, V7, P243, DOI 10.1007/BF00960756; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Salkind M R, 1969, J R Coll Gen Pract, V18, P267; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Speck RM, 2010, J CANCER SURVIV, V4, P87, DOI 10.1007/s11764-009-0110-5; Spence RR, 2011, EUR J CANCER CARE, V20, P257, DOI 10.1111/j.1365-2354.2010.01214.x; SUTHERLAND HJ, 1988, CANCER NURS, V11, P303; Targ EF, 2002, GEN HOSP PSYCHIAT, V24, P238, DOI 10.1016/S0163-8343(02)00191-3; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thompson WR, ACSMS GUIDELINES EXE; Thorsen L, 2005, J CLIN ONCOL, V23, P2378, DOI 10.1200/JCO.2005.04.106; Velthuis MJ, 2010, CLIN ONCOL-UK, V22, P208, DOI 10.1016/j.clon.2009.12.005; Vito NL, 2007, THESIS; Watson M, 1999, LANCET, V354, P1331, DOI 10.1016/S0140-6736(98)11392-2; Whitehead S, 2009, QUAL HEALTH RES, V19, P894, DOI 10.1177/1049732309337523; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	90	216	222	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30955	10.1371/journal.pone.0030955	http://dx.doi.org/10.1371/journal.pone.0030955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	911GB	22586491	gold, Green Published			2022-12-25	WOS:000301704200049
J	Chen, YX; Zheng, SP; Qi, D; Zheng, SJ; Guo, JL; Zhang, SL; Weng, ZH				Chen, Yixiong; Zheng, Shaoping; Qi, Dan; Zheng, Shaojiang; Guo, Junli; Zhang, Shuling; Weng, Zhihong			Inhibition of Notch Signaling by a gamma-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; STELLATE CELLS; MAMMALIAN NOTCH; LIVER FIBROSIS; MYOFIBROBLAST DIFFERENTIATION; PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; DEFICIENT MICE; PATHWAY	Notch signaling is essential to the regulation of cell differentiation, and aberrant activation of this pathway is implicated in human fibrotic diseases, such as pulmonary, renal, and peritoneal fibrosis. However, the role of Notch signaling in hepatic fibrosis has not been fully investigated. In the present study, we show Notch signaling to be highly activated in a rat model of liver fibrosis induced by carbon tetrachloride (CCl4), as indicated by increased expression of Jagged1, Notch3, and Hes1. Blocking Notch signaling activation by a gamma-secretase inhibitor, DAPT, significantly attenuated liver fibrosis and decreased the expression of snail, vimentin, and TGF-beta 1 in association with the enhanced expression of E-cadherin. The study in vitro revealed that DAPT treatment could suppress the EMT process of rat hepatic stellate cell line (HSC-T6). Interestingly, DAPT treatment was found not to affect hepatocyte proliferation in vivo. In contrast, DAPT can inhibit hepatocyte apoptosis to some degree. Our study provides the first evidence that Notch signaling is implicated in hepatic fibrogenesis and DAPT treatment has a protective effect on hepatocytes and ameliorates liver fibrosis. These findings suggest that the inhibition of Notch signaling might present a novel therapeutic approach for hepatic fibrosis.	[Chen, Yixiong; Qi, Dan; Zhang, Shuling; Weng, Zhihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Zheng, Shaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ultrasonog, Wuhan 430074, Peoples R China; [Zheng, Shaojiang; Guo, Junli] Hainan Med Coll, Dept Pathol, Haikou, Peoples R China; [Zheng, Shaojiang; Guo, Junli] Hainan Med Coll, Hainan Prov Key Lab Trop Med, Haikou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hainan Medical University; Hainan Medical University	Weng, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China.	wzh941@126.com	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Kassis, Judith/0000-0001-9268-3213	National Natural Science Foundation of China [30900663]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Natural Science Foundation of China (30900663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi-Ikeda K, 2011, AM J RESP CELL MOL, V45, P136, DOI 10.1165/rcmb.2010-0140OC; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; BETTENHAUSEN B, 1995, GENOMICS, V28, P436, DOI 10.1006/geno.1995.1172; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Chen SW, 2008, GENE THER, V15, P1424, DOI 10.1038/gt.2008.93; Chen YX, 2012, WORLD J GASTROENTERO, V18, P1397, DOI 10.3748/wjg.v18.i12.1397; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kinoshita K, 2007, GUT, V56, P396, DOI 10.1136/gut.2005.085704; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lin Y, 2005, LIVER INT, V25, P796, DOI 10.1111/j.1478-3231.2005.01098.x; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nijjar SS, 2002, AM J PATHOL, V160, P1695, DOI 10.1016/S0002-9440(10)61116-9; Nijjar SS, 2001, HEPATOLOGY, V34, P1184, DOI 10.1053/jhep.2001.29399; Pan Q, 2007, DIGEST DIS SCI, V52, P2591, DOI 10.1007/s10620-006-9676-1; Rao PK, 2000, EXP CELL RES, V260, P379, DOI 10.1006/excr.2000.5034; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184; Shawber C, 1996, DEVELOPMENT, V122, P3765; Sheahan S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-191; Shimizu M, 2001, HEPATOLOGY, V33, P569, DOI 10.1053/jhep.2001.22650; Teng YQ, 2007, J CLIN INVEST, V117, P304, DOI 10.1172/JCI31200; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Wei P, 2010, MOL CANCER THER, V9, P1618, DOI 10.1158/1535-7163.MCT-10-0034; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu FX, 2010, AM J PATHOL, V176, P650, DOI 10.2353/ajpath.2010.090447	50	180	195	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46512	10.1371/journal.pone.0046512	http://dx.doi.org/10.1371/journal.pone.0046512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	22276200	Green Published, Green Submitted, gold			2022-12-25	WOS:000309454000052
J	Chen, YP; Xiao, XM; Li, J; Reichetzeder, C; Wang, ZN; Hocher, B				Chen, You-Peng; Xiao, Xiao-Min; Li, Jian; Reichetzeder, Christoph; Wang, Zi-Neng; Hocher, Berthold			Paternal Body Mass Index (BMI) Is Associated with Offspring Intrauterine Growth in a Gender Dependent Manner	PLOS ONE			English	Article							HIGH-FAT DIET; IMPAIRED GLUCOSE-TOLERANCE; BIRTH-WEIGHT; FOOD-INTAKE; METABOLIC SYNDROME; SEX-DIFFERENCES; DEVELOPMENTAL ORIGINS; BLOOD-PRESSURE; PROTEIN-DIET; PREGNANCY	Background: Environmental alternations leading to fetal programming of cardiovascular diseases in later life have been attributed to maternal factors. However, animal studies showed that paternal obesity may program cardio-metabolic diseases in the offspring. In the current study we tested the hypothesis that paternal BMI may be associated with fetal growth. Methods and Results: We analyzed the relationship between paternal body mass index (BMI) and birth weight, ultrasound parameters describing the newborn's body shape as well as parameters describing the newborns endocrine system such as cortisol, aldosterone, renin activity and fetal glycated serum protein in a birth cohort of 899 father/mother/child triplets. Since fetal programming is an offspring sex specific process, male and female offspring were analyzed separately. Multivariable regression analyses considering maternal BMI, paternal and maternal age, hypertension during pregnancy, maternal total glycated serum protein, parity and either gestational age (for birth weight) or time of ultrasound investigation (for ultrasound parameters) as confounding showed that paternal BMI is associated with growth of the male but not female offspring. Paternal BMI correlated with birth parameters of male offspring only: birth weight; biparietal diameter, head circumference; abdominal diameter, abdominal circumference; and pectoral diameter. Cortisol was likewise significantly correlated with paternal BMI in male newborns only. Conclusions: Paternal BMI affects growth of the male but not female offspring. Paternal BMI may thus represent a risk factor for cardiovascular diseases of male offspring in later life. It remains to be demonstrated whether this is linked to an offspring sex specific paternal programming of cortisol secretion.	[Chen, You-Peng; Hocher, Berthold] Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Xiao, Xiao-Min; Li, Jian; Wang, Zi-Neng] Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Reichetzeder, Christoph; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Nuthetal Potsdam, Germany; [Reichetzeder, Christoph; Hocher, Berthold] Inst Pharmacol, Cardiovasc Res Ctr, Berlin, Germany	Jinan University; Jinan University; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chen, YP (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China.	hocher@uni-potsdam.de	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Kassis, Judith/0000-0001-9268-3213	Hoffmann La Roche Ltd, Basel, Switzerland	Hoffmann La Roche Ltd, Basel, Switzerland(Hoffmann-La Roche)	This study was supported by a grant from Hoffmann La Roche Ltd, Basel, Switzerland to Dr. B. Hocher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Aufdenblatten M, 2009, PEDIATR RES, V65, P198, DOI 10.1203/PDR.0b013e31818d6c24; Augustyniak RA, 2010, AM J PHYSIOL-REG I, V298, pR1375, DOI 10.1152/ajpregu.00848.2009; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P1198, DOI 10.1111/j.1365-2826.2010.02067.x; Clausen JO, 1997, AM J EPIDEMIOL, V146, P23, DOI 10.1093/oxfordjournals.aje.a009188; Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hocher B, 2000, LANCET, V355, P1241, DOI 10.1016/S0140-6736(00)02094-8; Hocher B, 2007, J PHYSIOL-LONDON, V579, P287, DOI 10.1113/jphysiol.2007.127738; Hogberg U, 2000, GYNECOL OBSTET INVES, V49, P160, DOI 10.1159/000010239; Jahan-Mihan A, 2011, NUTR RES, V31, P644, DOI 10.1016/j.nutres.2011.08.003; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Leon DA, 2005, CIRCULATION, V112, P3478, DOI 10.1161/CIRCULATIONAHA.104.497610; Li J, 2012, NEUROSCI BIOBEHAV R, V36, P1085, DOI 10.1016/j.neubiorev.2011.12.006; Li J, 2011, J HYPERTENS, V29, P1712, DOI 10.1097/HJH.0b013e328349a2e6; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288; Manabe M, 2005, PEDIATR INT, V47, P60, DOI 10.1111/j.1442-200x.2004.02002.x; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Szeto IMY, 2008, AM J PHYSIOL-REG I, V295, pR575, DOI 10.1152/ajpregu.90354.2008; Tang C, 2010, CHIN J BIRTH HLTH HE, P4; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Thone-Reineke C, 2006, AM J PHYSIOL-REG I, V291, pR1025, DOI 10.1152/ajpregu.00898.2005; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; WIDDOWSON EM, 1975, PEDIATR RES, V9, P154, DOI 10.1203/00006450-197503000-00010; Xie Y, 2007, PROG OBSTET GYNECOL, V16, P440; Yazbek SN, 2010, HUM MOL GENET, V19, P4134, DOI 10.1093/hmg/ddq332; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462	45	180	195	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36329	10.1371/journal.pone.0036329	http://dx.doi.org/10.1371/journal.pone.0036329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22276200	Green Published, gold			2022-12-25	WOS:000305343400019
J	Li, CF; Zhou, DN; Kou, ZK; Zhang, ZS; Wang, JP; Cai, ML; Cao, CG				Li Cheng-Fang; Zhou Dan-Na; Kou Zhi-Kui; Zhang Zhi-Sheng; Wang Jin-Ping; Cai Ming-Li; Cao Cou-Gui			Effects of Tillage and Nitrogen Fertilizers on CH4 and CO2 Emissions and Soil Organic Carbon in Paddy Fields of Central China	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LONG-TERM APPLICATION; RICE FIELDS; NO-TILLAGE; METHANE EMISSIONS; CHEMICAL FERTILIZER; SYSTEMS; SEQUESTRATION; FLUXES; DIOXIDE	Quantifying carbon (C) sequestration in paddy soils is necessary to help better understand the effect of agricultural practices on the C cycle. The objective of the present study was to assess the effects of tillage practices [conventional tillage (CT) and no-tillage (NT)] and the application of nitrogen (N) fertilizer (0 and 210 kg N ha(-1)) on fluxes of CH4 and CO2, and soil organic C (SOC) sequestration during the 2009 and 2010 rice growing seasons in central China. Application of N fertilizer significantly increased CH4 emissions by 13%-66% and SOC by 21%-94% irrespective of soil sampling depths, but had no effect on CO2 emissions in either year. Tillage significantly affected CH4 and CO2 emissions, where NT significantly decreased CH4 emissions by 10%-36% but increased CO2 emissions by 22%-40% in both years. The effects of tillage on the SOC varied with the depth of soil sampling. NT significantly increased the SOC by 7%-48% in the 0-5 cm layer compared with CT. However, there was no significant difference in the SOC between NT and CT across the entire 0-20 cm layer. Hence, our results suggest that the potential of SOC sequestration in NT paddy fields may be overestimated in central China if only surface soil samples are considered.	[Li Cheng-Fang; Kou Zhi-Kui; Zhang Zhi-Sheng; Wang Jin-Ping; Cai Ming-Li; Cao Cou-Gui] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Zhou Dan-Na] Hubei Acad Agr Sci, Inst Anim Husb & Vet Sci, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Hubei Academy of Agricultural Sciences	Li, CF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	ccgui@mail.hzau.edu.cn		Li, Chaozheng/0000-0001-7639-7831; Yu, Xiao-Qiang/0000-0003-1419-9009; Puddick, Jonathan/0000-0001-7000-9180	National Technology Project for High Food Yield of China [2011BAD16B02]; National Natural Science Foundation of China [31100319]; Fundamental Research Funds for the Central Universities [2010QC032]; Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding [2011ZD152]	National Technology Project for High Food Yield of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding	The study was supported by the National Technology Project for High Food Yield of China (2011BAD16B02), National Natural Science Foundation of China (31100319), Fundamental Research Funds for the Central Universities (2010QC032) and the Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding (2011ZD152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz JJ, 2009, SOIL TILL RES, V104, P134, DOI 10.1016/j.still.2009.02.003; Alvarez R, 2005, SOIL USE MANAGE, V21, P38, DOI 10.1079/SUM2005291; Angers DA, 2008, SOIL SCI SOC AM J, V72, P1370, DOI 10.2136/sssaj2007.0342; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Ball BC, 1999, SOIL TILL RES, V53, P29, DOI 10.1016/S0167-1987(99)00074-4; BAO SD, 2000, ANAL SOIL AGR CHEM, P42; Burton AJ, 2004, GLOBAL CHANGE BIOL, V10, P1080, DOI 10.1111/j.1365-2486.2004.00737.x; ButterbachBahl K, 1997, PLANT CELL ENVIRON, V20, P1175, DOI 10.1046/j.1365-3040.1997.d01-142.x; Causarano HJ, 2006, J ENVIRON QUAL, V35, P1374, DOI 10.2134/jeq2005.0150; Christopher SF, 2009, SOIL SCI SOC AM J, V73, P207, DOI 10.2136/sssaj2007.0336; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P330, DOI 10.1016/j.soilbio.2006.08.003; Crill PM, 1988, GLOBAL BIOGEOCHEM CY, V2, P371, DOI 10.1029/GB002i004p00371; Deen W, 2003, SOIL TILL RES, V74, P143, DOI 10.1016/S0167-1987(03)00162-4; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; DeLuca TH, 2011, FRONT ECOL ENVIRON, V9, P407, DOI 10.1890/100063; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Drury CF, 2006, SOIL SCI SOC AM J, V70, P570, DOI 10.2136/sssaj2005.0042; Gao YJ, 2000, SOIL ENV SCI, V9, P27; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Guo JP, 2007, AGR FOREST METEOROL, V142, P270, DOI 10.1016/j.agrformet.2006.03.029; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Harada H, 2007, SOIL SCI PLANT NUTR, V53, P668, DOI 10.1111/j.1747-0765.2007.00174.x; He YingYing, 2010, Journal of Agro-Environment Science, V29, P200; Hutsch BW, 1998, BIOL FERT SOILS, V27, P284, DOI 10.1007/s003740050435; IPCC, 2007, CONTRIBUTION WORKING; Iqbal J, 2009, AGR ECOSYST ENVIRON, V131, P292, DOI 10.1016/j.agee.2009.02.001; [IRRI] International Rice Research Institute, 2004, RIC STAT DAT; Khan SA, 2007, J ENVIRON QUAL, V36, P1821, DOI 10.2134/jeq2007.0099; 郑循华, 1998, Advances in Atmospheric Sciences, V15, P569; Kroon PS, 2008, NUTR CYCL AGROECOSYS, V82, P175, DOI 10.1007/s10705-008-9179-x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lee DK, 2007, SOIL BIOL BIOCHEM, V39, P178, DOI 10.1016/j.soilbio.2006.07.004; Li CF, 2010, ATMOS ENVIRON, V44, P2696, DOI 10.1016/j.atmosenv.2010.04.045; Li CF, 2009, ARCH ENVIRON CON TOX, V56, P21, DOI 10.1007/s00244-008-9159-9; Li JT, 2007, PEDOSPHERE, V17, P568, DOI 10.1016/S1002-0160(07)60067-8; Liang W, 2007, PEDOSPHERE, V17, P630, DOI 10.1016/S1002-0160(07)60075-7; LINDAU CW, 1993, SOIL SCI, V156, P42, DOI 10.1097/00010694-199307000-00006; Liu XJ, 2006, PLANT SOIL, V280, P177, DOI 10.1007/s11104-005-2950-8; Lopez-Bellido RJ, 2010, AGRON J, V102, P310, DOI 10.2134/agronj2009.0165; Lou YL, 2011, SOIL TILL RES, V113, P70, DOI 10.1016/j.still.2011.01.007; Lou YS, 2003, WATER AIR SOIL POLL, V149, P281, DOI 10.1023/A:1025727504841; Lu F, 2009, GLOBAL CHANGE BIOL, V15, P281, DOI 10.1111/j.1365-2486.2008.01743.x; Lu WF, 2000, NUTR CYCL AGROECOSYS, V58, P65, DOI 10.1023/A:1009830232650; MINAMI K, 1995, FERT RES, V40, P71, DOI 10.1007/BF00749864; Mitra S, 2005, SOIL SCI SOC AM J, V69, P563, DOI 10.2136/sssaj2005.0563; Mosier AR, 2005, NUTR CYCL AGROECOSYS, V72, P67, DOI 10.1007/s10705-004-7356-0; Nayak P, 2009, NUTR CYCL AGROECOSYS, V83, P259, DOI 10.1007/s10705-008-9217-8; Neue HU, 2000, ATMOSPHERIC METHANE, P134; Nyamadzawo G, 2008, NUTR CYCL AGROECOSYS, V81, P85, DOI 10.1007/s10705-007-9154-y; OECD, 2000, ENV IND AGR METH AGR; Omonode RA, 2007, SOIL TILL RES, V95, P182, DOI 10.1016/j.still.2006.12.004; Oorts K, 2007, SOIL TILL RES, V95, P133, DOI 10.1016/j.still.2006.12.002; Pan GX, 2009, AGR ECOSYST ENVIRON, V131, P274, DOI 10.1016/j.agee.2009.01.020; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; PARKINSON KJ, 1981, J APPL ECOL, V18, P221, DOI 10.2307/2402491; Paustian K., 1997, SOIL ORGANIC MATTER; Reicosky DC, 1997, SOIL TILL RES, V41, P105, DOI 10.1016/S0167-1987(96)01080-X; Roberson T, 2008, J ENVIRON QUAL, V37, P535, DOI 10.2134/jeq2006.0386; SCHUTZ H, 1989, J GEOPHYS RES-ATMOS, V94, P16405, DOI 10.1029/JD094iD13p16405; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Su YZ, 2007, SOIL TILL RES, V92, P181, DOI 10.1016/j.still.2006.03.001; Tang Xiao-hong, 2007, Yingyong Shengtai Xuebao, V18, P1027; Tong CL, 2009, SOIL TILL RES, V106, P8, DOI 10.1016/j.still.2009.09.003; Ussiri DAN, 2009, SOIL TILL RES, V104, P247, DOI 10.1016/j.still.2009.03.001; Wang CJ, 2010, SCI CHINA LIFE SCI, V53, P858, DOI 10.1007/s11427-010-4028-y; Wang MX, 2002, NUTR CYCL AGROECOSYS, V64, P43, DOI 10.1023/A:1021183706235; Wang SX, 2012, J ZHEJIANG UNIV-SC B, V13, P274, DOI 10.1631/jzus.B1100145; WASSMANN R, 1993, BIOGEOCHEMISTRY, V20, P83, DOI 10.1007/BF00004136; Wassmann R, 2000, BIOL FERT SOILS, V31, P20, DOI 10.1007/s003740050619; Wilson HM, 2008, APPL SOIL ECOL, V39, P264, DOI 10.1016/j.apsoil.2007.12.013; Wright AL, 2005, BIOL FERT SOILS, V41, P95, DOI 10.1007/s00374-004-0819-2; Wright AL, 2008, APPL SOIL ECOL, V38, P168, DOI 10.1016/j.apsoil.2007.10.006; Xiao Y, 2005, AGR ECOSYST ENVIRON, V109, P273, DOI 10.1016/j.agee.2005.03.016; Xu H, 2000, NUTR CYCL AGROECOSYS, V58, P12, DOI DOI 10.1023/A:1009823425806; Zhan M, 2011, NUTR CYCL AGROECOSYS, V89, P1, DOI 10.1007/s10705-010-9371-7	78	180	206	28	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e34642	10.1371/journal.pone.0034642	http://dx.doi.org/10.1371/journal.pone.0034642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574109	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800005
J	Li, CY; Harper, A; Puddick, J; Wang, WY; McMahon, C				Li, Chunyi; Harper, Anne; Puddick, Jonathan; Wang, Wenying; McMahon, Chris			Proteomes and Signalling Pathways of Antler Stem Cells	PLOS ONE			English	Article							RETINOIC ACID; PROTEIN S100A4; EMBRYONAL CARCINOMA; DEER ANTLER; C-MYC; EXPRESSION; GENE; REGENERATION; GROWTH; PEDICLE	As the only known example of complete organ regeneration in mammals, deer antler in the growing or velvet phase is of major interest in developmental biology. This regeneration event initiates from self-renewing antler stem cells that exhibit pluripotency. At present, it remains unclear how the activation and quiescence of antler stem cells are regulated. Therefore, in the present study proteins that were differentially expressed between the antler stem cells and somatic cells (facial periosteum) were identified by a gel-based proteomic technique, and analysed using Ingenuity Pathway Analysis software. Several molecular pathways (PI3K/Akt, ERK/MAPK, p38 MAPK, etc.) were found to be activated during proliferation. Also expressed were the transcription factors POU5F1, SOX2, NANOG and MYC, which are key markers of embryonic stem cells. Expression of these proteins was confirmed in both cultured cells and fresh tissues by Western blot analysis. Therefore, the molecular pathways and transcription factors identified in the current study are common to embryonic and adult stem cells. However, expression of embryonic stem cell transcription factors would suggest that antler stem cells are, potentially, an intermediary stem cell type between embryonic and the more specialized tissue-specific stem cells like those residing in muscle, fat or from a hematopoietic origin. The retention of this embryonic, pluripotent lineage may be of fundamental importance for the subsequent regenerative capacity of antlers.	[Li, Chunyi; Harper, Anne; Wang, Wenying] AgResearch Ltd, Dev Biol Grp, Invermay Agr Ctr, Mosgiel, New Zealand; [Li, Chunyi] State Key Lab Mol Biol Special Econ Anim, Changchun, Peoples R China; [Puddick, Jonathan] Univ Waikato, Waikato Mass Spectrometry Facil, Hamilton, New Zealand; [McMahon, Chris] AgResearch Ltd, Dev Biol Grp, Ruakura Agr Ctr, Hamilton, New Zealand	AgResearch - New Zealand; University of Waikato; AgResearch - New Zealand	Li, CY (corresponding author), AgResearch Ltd, Dev Biol Grp, Invermay Agr Ctr, Mosgiel, New Zealand.	chris.mcmahon@agresearch.co.nz		Li, Chaozheng/0000-0001-7639-7831; Yu, Xiao-Qiang/0000-0003-1419-9009; Puddick, Jonathan/0000-0001-7000-9180	Foundation for Research, Science and Technology, New Zealand [C10X0207]	Foundation for Research, Science and Technology, New Zealand(New Zealand Foundation for Research, Science and Technology)	The work was funded by Foundation for Research, Science and Technology, New Zealand (C10X0207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Banks WJ, 1982, LIGHT MICROSCOPIC ST, P231; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Berg DK, 2007, BIOL REPROD, V77, P384, DOI 10.1095/biolreprod.106.058172; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brown R.D., 1982, ANTLER DEV CERVIDAE, P61; Bubenik GA, 1982, ENDOCRINE REGULATION, P73; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Clark DE, 2006, ANAT REC PART A, V288A, P1281, DOI 10.1002/ar.a.20393; Colitti M, 2005, J ANAT, V207, P339, DOI 10.1111/j.1469-7580.2005.00464.x; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Fennessy P.F., 1985, Royal Society of New Zealand Bulletin, P239; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Freemantle SJ, 2002, ONCOGENE, V21, P2880, DOI 10.1038/sj.onc.1205408; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Giguere V, 1990, MOL CLONING CDNA ENC, P6233; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; Gilbert SF, 2003, DEV BIOL, P143; Goss R.J., 1983, DEER ANTLERS REGENER; GOSS RJ, 1985, J EXP ZOOL, V235, P359, DOI 10.1002/jez.1402350307; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gyurjan I, 2007, MOL GENET GENOMICS, V277, P221, DOI 10.1007/s00438-006-0190-0; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Horie H, 1999, J NEUROSCI, V19, P9964; Kamal AM, 2005, MEM I OSWALDO CRUZ, V100, P39, DOI 10.1590/S0074-02762005000900008; Kami K, 2005, CURR DRUG TARGETS, V6, P395, DOI 10.2174/1389450054021918; Kierdorf U, 2003, ANAT REC PART A, V273A, P741, DOI 10.1002/ar.a.10082; Kierdorf U, 2007, J MORPHOL, V268, P726, DOI 10.1002/jmor.10546; Klingelhofer J, 1997, DEV DYNAM, V210, P87, DOI 10.1002/(SICI)1097-0177(199710)210:2<87::AID-AJA2>3.0.CO;2-5; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; Lai AKW, 2007, TISSUE CELL, V39, P35, DOI 10.1016/j.tice.2007.01.001; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; Li C., 2003, European Journal of Morphology, V41, P23, DOI 10.1076/ejom.41.1.23.28106; Li C, 2003, GEN COMP ENDOCR, V131, P21, DOI 10.1016/S0016-6480(02)00625-1; Li C, 2006, RECENT PROGR ANTLER; Li CY, 2007, CELL TISSUE RES, V328, P65, DOI 10.1007/s00441-006-0333-y; Li CY, 2009, CURR STEM CELL RES T, V4, P237, DOI 10.2174/157488809789057446; LI CY, 1994, ANAT REC, V239, P198, DOI 10.1002/ar.1092390211; Li CY, 2005, ANAT REC PART A, V282A, P163, DOI 10.1002/ar.a.20148; Li CY, 2002, ANAT REC, V268, P125, DOI 10.1002/ar.10120; Li CY, 2001, ANAT EMBRYOL, V204, P375, DOI 10.1007/s004290100204; Li CY, 1999, J EXP ZOOL, V284, P82, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;82::AID-JEZ11&gt;3.0.CO;2-K; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; LINCOLN GA, 1973, J EMBRYOL EXP MORPH, V29, P431; LINCOLN GA, 1976, J EXP ZOOL, V195, P247, DOI 10.1002/jez.1401950209; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Louro ID, 2002, CANCER RES, V62, P5867; Lu Y, 2000, BBA-GENE STRUCT EXPR, V1491, P13, DOI 10.1016/S0167-4781(00)00055-5; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Molnar A, 2007, MOL GENET GENOMICS, V277, P237, DOI 10.1007/s00438-006-0193-x; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Park HJ, 2004, PROTEOMICS, V4, P3642, DOI 10.1002/pmic.200401027; Phan E, 2007, MED SCI MONITOR, V13, pRA25; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; Rolf HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002064; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Solito E, 2006, FASEB J, V20, P1498, DOI 10.1096/fj.05-5319fje; Stocum DL, 2006, REGENERATIVE BIOL ME; SUTTIE JM, 1995, J EXP ZOOL, V271, P120, DOI 10.1002/jez.1402710207; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; WATANABE Y, 1993, FEBS LETT, V324, P51, DOI 10.1016/0014-5793(93)81530-D; Welstead GG, 2008, CURR OPIN GENET DEV, V18, P123, DOI 10.1016/j.gde.2008.01.013	71	180	206	28	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30026	10.1371/journal.pone.0030026	http://dx.doi.org/10.1371/journal.pone.0030026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22574109	gold, Green Submitted, Green Published			2022-12-25	WOS:000299771900039
J	Chen, SS; Luetje, CW				Chen, Sisi; Luetje, Charles W.			Identification of New Agonists and Antagonists of the Insect Odorant Receptor Co-Receptor Subunit	PLOS ONE			English	Article							MOLECULAR-BASIS; SYSTEM; TASTE	Background: Insects detect attractive and aversive chemicals using several families of chemosensory receptors, including the OR family of olfactory receptors, making these receptors appealing targets for the control of insects. Insect ORs are odorant-gated ion channels, comprised of at least one common subunit (the odorant receptor co-receptor subunit, Orco) and at least one variable odorant specificity subunit. Each of the many ORs of an insect species is activated or inhibited by an unique set of odorants that interact with the variable odorant specificity subunits, making the development of OR directed insect control agents complex and laborious. However, several N-,2-substituted triazolothioacetamide compounds (VUAA1, VU0450667 and VU0183254) were recently shown to act directly on the highly conserved Orco subunit, suggesting that broadly active compounds can be developed. We have explored the chemical space around the VUAA1 structure in order to identify new Orco ligands. Principal Findings: We screened ORs from several insect species, using heterologous expression in Xenopus oocytes and an electrophysiological assay, with a panel of 22 compounds structurally related to VUAA1. By varying the nitrogen position in the pyridine ring and altering the moieties decorating the phenyl ring, we identified two new agonists and a series of competitive antagonists. Screening smaller compounds, similar to portions of the VUAA1 structure, also yielded competitive antagonists. Importantly, we show that Orco antagonists inhibit odorant activation of ORs from several insect species. Detailed examination of one antagonist demonstrated inhibition to be through a non-competitive mechanism. Conclusions: A similar pattern of agonist and antagonist sensitivity displayed by Orco subunits from different species suggests a highly conserved binding site structure. The susceptibility to inhibition of odorant activation by Orco antagonism is conserved across disparate insect species, suggesing the ligand binding site on Orco as a promising target for the development of novel, broadly active insect repellants.	[Chen, Sisi; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Chen, SS (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	cluetje@med.miami.edu	CHEN, SI/GZL-4800-2022; WU, CHUN-HU/P-3958-2018	WU, CHUN-HU/0000-0001-6851-7936; Hung, Tai-Ho/0000-0003-2354-7060; Chen, Shaohua/0000-0001-8306-2626	National Institutes of Health [RO1 DC011091]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health [RO1 DC011091 to CWL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hughes DT, 2010, J CHEM ECOL, V36, P797, DOI 10.1007/s10886-010-9828-9; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	33	338	351	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36784	10.1371/journal.pone.0036784	http://dx.doi.org/10.1371/journal.pone.0036784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	23226289	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335500028
